{"docstore/metadata": {"86a336fa-a90d-4907-8629-775794e88f62": {"doc_hash": "b94216e695900f945da8585d9f211218c5989f2c92f9089ec5f79f49c5ef5dd4"}, "961a8292-db8c-4db5-963b-7d864a0838c0": {"doc_hash": "abec106fb2960b1f75df50c608d5a67566bc5c230c51ed184541399305e5e16b"}, "78be0d88-c369-4c8e-9d91-1800e4926fdd": {"doc_hash": "072fe1742f0da641535f096c36d3c0498e3cfdc0969b9be2d60c2024e9f80532"}, "62eb10f9-ce2b-43f2-9318-bc0a18912e28": {"doc_hash": "b0322a21b9a408e91fafa980a5c367c86a824bd56388ffe51ca45eeb92efc29a"}, "c3522668-be88-41f2-9480-faef9d189d32": {"doc_hash": "3a7d62fe3d3e821a1190266d139edd9c567349777c921b2d91f42eeef97b025e"}, "f8e9ae21-a651-4afa-8e36-4a233be2a449": {"doc_hash": "0d9b46923050a255b6af74523d95a6950717c0ae597eddd6d65fc843995f74d7"}, "2bb0d21c-ce1d-477d-940d-5a3f611d683b": {"doc_hash": "4343201e0a142e3b640aea5f0af50a798d33f16ffcb2d0dc93884a0b8262305d"}, "b93a38d9-3c56-4f55-834f-4a93ceec77a5": {"doc_hash": "e9ecbabcc19ac0e3b743db830c317b358b05f8ee3481e5e17f13876c3f60c7a8"}, "ff689c30-a77b-45df-a972-859622dd69c0": {"doc_hash": "b8c8c1783ef773e5e6da3c4a2341b708872990d9fd5d06c0ea17cb4391b4ae23"}, "21f404ae-13ec-48a6-925e-b8871340ef92": {"doc_hash": "7df49dc239e245605feeed789be5b0c9cd9b281292e8ab7dce9b85a40b00461b"}, "67af4b81-ecbb-46cc-9233-b353304ee704": {"doc_hash": "4ad758a6a46a0bbd6bb3909adbee0be91657a6836ccd5f8b814b228e71fff1b1"}, "9198468a-1196-4456-b38e-e81572af7560": {"doc_hash": "f2cb8c6c15d8a577e9b41685bdbc1f4cc7a510017df7ea459fcb518192848bd5"}, "6bc8af54-6469-4faa-add4-ee5b9ce80431": {"doc_hash": "db07b7a7c967e2e72c1846a198dbf3dccce49c24de0eaa456a90261612f86e95"}, "e6e61283-0840-4dd4-884c-0ebefae6bec2": {"doc_hash": "6f9e52cfadea7571101f0e59fa3b57ba09663342b1d1fa70fedb181a8ac8c25e"}, "0f1fda67-d6a8-4cdb-bf97-4ba7f6c3fdbd": {"doc_hash": "5d3e0ef3e8f7b524e0f1fd4a77c9a341a4a10b0f00c7bbbe2c3409712d3b7878"}, "2b1bb312-c026-42ee-8a17-1fad8143f1d0": {"doc_hash": "3e2897afc0b9e559debdd94acb0da850bb94c1dd1f5777d64205d098ef779c06"}, "bb81f289-a8c7-4488-9c4d-1021fb19d53c": {"doc_hash": "e0b83b552cd9f0be17b703811ade3b7685a1f7812ec856a08478b92592290ef6"}, "26eaa4bc-6103-41d7-a12c-30a698609ff3": {"doc_hash": "ffe7d87cb4ce68a8e2c45e232292e8edee62debe1dad4d3a199fc8077143b206"}, "b113ab81-802f-449b-9db6-3ee5f72033a2": {"doc_hash": "126892f2f7bca20dfa48a908c70c4c00f97b29bcd0739184f5d8fa577c9f695c"}, "00325f72-794d-4e9b-882d-c29ef0e4448f": {"doc_hash": "9e7ebac4a19e1d310df27c8ed70668096b63a34700081825459cfb385f26d9fc"}, "7e0567e9-06a3-4ca2-b2b9-c55cbf644f69": {"doc_hash": "3fa573628b0a64fa67861a9913c2204acec562b2aa1f3066d49a37bac2e0600e"}, "84687bc1-ed51-4ed6-9317-9b43e4a38b9c": {"doc_hash": "21afe4c105ecffd5ef21c512e7d5e5e0a3eeea938566ea453be8845c24245386"}, "7baa544f-5bc2-4628-9681-a43bf5e76965": {"doc_hash": "cc6049f4f8fe409391db4a6af88ff4f96560826d4a8793a944986ffbff38afdc"}, "823f7865-6a1f-42a0-8a62-38ef5969acb7": {"doc_hash": "79fb686b8ba47d55e3ea771b5ea1cc10378318e98f85af3c4c51952f59658c4f"}, "d553eb02-b777-43de-a92f-3fc3213102f4": {"doc_hash": "b2554075f719683a2cb48e5df75480e4d75c4f0081ec448059dba030cf604cf7"}, "39a662a1-e0ff-4e04-9fc1-c48c3a61c16a": {"doc_hash": "c782d969becd2ada9ddce4bce7e6adee9e0d0e58e9f44097f151710aead525e6"}, "39fe581c-3c10-4bb8-8919-1ed4a5fbe707": {"doc_hash": "4392145601a34f7335c0f9577011b4c0ebd172e065a77ee0d97f9a98783720bb"}, "3217b7f5-32db-48c6-a93b-f985b6b300a7": {"doc_hash": "154e1e11852a469c50c3aceb8e6c1fbbb588a68cccde5eb36338a4b2c15cf165"}, "ec27e265-2d91-48a2-8280-e1f8ee2d7da3": {"doc_hash": "cbd6c3a01acd439e9d3ef6207754fd0c213cb960d95f83215f54f5385f6da5d5"}, "ac918cfc-a1eb-40a4-bfa7-5958a6edeb13": {"doc_hash": "d6250f0ec1857b3f86385bebf44575b75d06f36f625d4c97474e33633cf7ed5d"}, "52c97290-6409-450f-b721-1d681b9f120e": {"doc_hash": "1f755166f95d53a8ce4679641f8681bebd2f3bae310cf631f570c2fe006caafe"}, "529f86b4-666a-4f51-b47d-a1976b2efe68": {"doc_hash": "f6e1e9b2a0c12d5d159bfabeabab61c85c45aa0b4c352ebd195f8aadc20f2d73"}, "445909e9-5f8d-419a-ab85-b6216db79d9e": {"doc_hash": "c58aa3e138da7c2e3190fcb5ad3c4616049fdbaacd201cb85e645c9fef30ae13"}, "08838fff-1123-4e92-ae96-c719f5412ae5": {"doc_hash": "0e11187b1712859c6e5365235301b51d0d1615207d06969cd743fca801792478"}, "7fb8eaab-4b53-40da-bf24-87d9d54aee3d": {"doc_hash": "330fb852319f466ca9802aadd795bdb3ef00d9ee5b2319a6777f18d111862abe"}, "b23807e2-193f-4f4e-a0e4-cd4dc812ea79": {"doc_hash": "6be7c3346c3ceb696a21dfc4cfa18e46445019fc907e8e8bf7cf20f0a235eaf7"}, "f66c3632-a5c9-4a2e-a889-c71dc1288dd6": {"doc_hash": "0123b8388404e9012c9ad10455ee755cdaf0ad8ad963e755ffa7fb834951f959"}, "3f46645f-a667-4ee6-8eba-de6e382515fe": {"doc_hash": "f232e8ae092a634f95e92bbbe9016e0d8a4b2decd13362bfeea0717a79e1e6d2"}, "00564d05-b1f7-454d-8a1f-0d692061ae2b": {"doc_hash": "21f7d8b5833a474122717785bc11e72729e79a51f473148d8313695bdb413577"}, "d8e07c12-cea3-495b-89ee-f3afcb526622": {"doc_hash": "2b3bb3595a0288378d10e5f24b3a8de4f773af474a24ec45ece8167966e66820"}, "6ec35928-2310-45b3-9da2-99cd68215bd5": {"doc_hash": "c7c4e4005c6203fbf4dc9338c684ddd2a7c3db0a6ff0f1c4a7ad32f412e8dd10"}, "0ed4567d-4935-44e9-a34b-df78b3c15084": {"doc_hash": "bcd57264645c34a2db27ab8d0a56289818cb140e1e72830339e660305e0b0c85"}, "2534cc9a-18f5-41f0-a729-92fac4ba474f": {"doc_hash": "d03152126eb69c91209bd3301e34c2b404838d649505ea6c188751f1811d0882"}, "1efaafc0-e785-4612-8d00-e7b5673de348": {"doc_hash": "3e4f4317c376981ce8392be69f7c61e2ab70585c0eac70b11d5127f25721baf0"}, "09480d51-21b1-44c5-a447-1ffd05fc03d5": {"doc_hash": "3a96bd1bfb2e964aa9a99ff71987646e81ff74561bc908468ce9beacb898580c"}, "f0ae9030-e6d8-4e4d-8202-31301c93e593": {"doc_hash": "29aa1455a2377a6d6db898c63b4cc02af15cd27d94c781ba33d6fc0426a7139f"}, "70711c2a-68ad-45d6-a017-5852ab1f8924": {"doc_hash": "15afb631e5d497bfd9feab6653f914ced08c0b1fdeb2ed3b55f7fd60f5214ba7"}, "6457b30f-c01e-4d9f-8a94-a8fe5ca848f6": {"doc_hash": "53215f19a0c8f870e3fbaf2ab112623908929d7321911f9258848105ac5e139c"}, "6357e222-3151-462c-a667-8015c9b9f16c": {"doc_hash": "0357f85efb208872135440bcf8a38253d2127c1127007048725886e564127a35"}, "d1807b48-048f-4fd6-8bfb-02f4e1f187d8": {"doc_hash": "b1731a1da5ed1ab49ad85e80ddb76793ca49393eaf71163ca8ae4a1a57d29315"}, "00715498-e154-41e0-ab3a-e806b74dfd54": {"doc_hash": "0b68b54a89a6b9571d23bda39daee572822b73e9113ef121383ca16670d7385e"}, "2a6746c3-b56d-446d-8ccd-b2fc4669bc40": {"doc_hash": "fdc3202bd0fa59f9f6212f99e4c7ef16c763805244fdb7f21eb9df753be0abc9"}, "3a60f030-3eb5-413e-9598-241e34b9bec9": {"doc_hash": "5e1a4893414c1a20fe454cf64ff9d5ad1349004d0928973e2701b63867b6ab33"}, "5c186084-fb71-45d3-b855-a98736e1a95a": {"doc_hash": "0d9c388ebbf55d64720d9b0bd6b4698abc40a1a59316c1acef3dd0ce8a1657e8"}, "1c9a8830-ff62-4803-8be1-4ac6234ce2cf": {"doc_hash": "3a1a5ba227364c42b32ec7b0618c20d2be24adea0d4b8b059e64a5884dccd551"}, "a1deb375-951e-4e71-bf42-6a4ab6a57b5c": {"doc_hash": "4830690741293dcc83c64c46bc971958eb37c964cee4c36b6414a436c0850f69"}, "0250c001-0c1e-42fa-88b0-5aca1a293795": {"doc_hash": "cd0ec97068584f525e0730f9c13e1aa5747c9572d391c34be7a4e45ef6a097b5"}, "a7645330-70b0-414f-8bb2-e6e11dcee001": {"doc_hash": "637d455197d0d0bf8463b934c59a010cbdda769b8aa9e94a7fec1df7b3cbd2f2"}, "b28a0ebc-7d27-4fbd-90df-81c2068607f3": {"doc_hash": "224acf82033db3f94943c5665e081411e7e8e553baed2348ecba3b42dd89d1e5"}, "d8d90c88-2534-4a46-bc16-4e73697c8299": {"doc_hash": "194c001b893c0122fd36e768ef9990e7b1e99b5da8e5e9199cac5afd33c4de5a"}, "071b3c18-eb34-4c8a-999c-71c77d9991f5": {"doc_hash": "2d76598ecc834427de3669b53d88e8978e70b4ee6e0af1f79e682edc55634257"}, "54dc9f07-3b07-4ed7-9871-d316f031969c": {"doc_hash": "c6b0f021e7c6142211ab98055dbe05ab3be1a569ae62bbd2231ae568d3f507db"}, "2a0685c0-8452-4277-b1ec-fdf56d91bd6a": {"doc_hash": "8f547fb063d3950edc6018a7dc9f6687a1f63079fd15f7004b54e1054f3c55d0"}, "42c595fe-0797-4aec-8287-5573da8ed21c": {"doc_hash": "436979242de42058cb2d12a94c63bff05157141fe70d7e82273bf40421b119ed"}, "1daf1db6-3e62-416a-b184-aa491a24914b": {"doc_hash": "78177b89465291e2c7e5ce54e825684e7e0e24fe6cb170a3db6cb443284ce934"}, "3620d4e0-f216-4393-be81-593694e12ce2": {"doc_hash": "0152e1ee7082bfb07ceef32a66d2ee02b160f097fd1aa327d69ef60851cd3ea9"}, "43a053a5-09a6-4740-b6e3-2cfcfda8ac27": {"doc_hash": "564820bab72d72ec5c0e199b941053f09754286f35b070a2e3f975ffc7a881cc"}, "961ba8b2-405c-4cf0-b5ac-4602557430b6": {"doc_hash": "24e34464afe50d4ff624e26624827234ebaf2c7c19c52a5a1b7903215b9e3bd4"}, "d6f48eae-aed5-454e-868e-6e4d9d442115": {"doc_hash": "a2af5b27d8a9182cf1a228acbe18bfffb38bc3ae100c2dbee4137fd9f12238ab"}, "6a37f4af-9884-4314-8d70-77d5027e0251": {"doc_hash": "57401ddb071074c881cd061bf62d7e531adaa72a010bf5078846e86e8a240b36"}, "38ae3605-b002-4eb6-89b3-86d45fab1ed6": {"doc_hash": "695c0a8f27d128fa2c1a21e6361215c3d7a4c197aed85f0d7111c3c40246cfe2"}, "567aae79-a880-408a-939e-99c8b5133ffb": {"doc_hash": "8d516bf40cdd5df5482890c3df5340ac093e9ea72b990312e9c939d4ee1d3e9f"}, "64ca66dc-833e-456e-8668-4b0007d264ab": {"doc_hash": "0ec797356bd2a73a56feca15a8853a64a90963a93194a54cea77c3c24c297bad"}, "ca8b6516-71b5-4584-bab5-6bb43bfa518c": {"doc_hash": "26dae6669aa9490bdec8e07ffb287858b4f63afac818339196bc1cdee74af5b2"}, "67b42b9a-3c8c-4249-9f2f-743d9b496ff4": {"doc_hash": "63bc8acc3eb6e377b0a04387069ac18433eedfd3e7a3d5e0179a42fe1f02ce4a"}, "ea11876b-0b66-4938-b379-08e830fd937b": {"doc_hash": "57132b17d11451070c8ccbd5ca9f385ea0b7ae9d31bb5e2c91e550540600ae47"}, "c4168171-6853-4beb-a468-13566f547133": {"doc_hash": "d513730b6e882ee92f957ea4cdeba04a0b6e3d3ac745a7dfcc1075aea63884f6"}, "a35e87cc-f90b-43ff-845c-0740974e82f9": {"doc_hash": "79d3de02edb8f76ef4f40afe37ba72d19ea13152bf2cad979e748f196e6b15fc"}, "ef8db99f-97c7-4e0a-9670-e9500e645146": {"doc_hash": "de1172661f28e09242c011a72dd61e638858191421d6571527035181a5fb1ba6"}, "eb6608a4-59f1-43ab-91db-3eb8fddf552c": {"doc_hash": "8ab694b01c2a214f8cae256f0814d8125f6ad10e509ac0cf6d67a165ea838758"}, "e47042cc-6ebc-4b6a-9d65-76c51768896b": {"doc_hash": "5748aa4541cd060fda2c4b9e582965927ca3e512ad6e1ae4c7527da87b221f40"}, "b9b7a13e-e917-4f2e-8bad-8ea72792d992": {"doc_hash": "ab69aa58155f02df2ba7bffc5e1a7589a64a0060185d1bba36e86e4955b8d9f2"}, "7213ac2f-3f81-4703-bc33-afcaeba8def5": {"doc_hash": "839fd4c3e08090459ab9717c887d5f3efcd8ea80a39913bff78a9d5bb62e6641"}, "4645bd29-25b7-4eb1-8486-47d9cd13cae8": {"doc_hash": "ab418b46e772c9a6a2c059f0321779df0ab888939d71cc9685dd529c42102659"}, "a6a35f7f-de88-4414-9c1d-0dad120b1252": {"doc_hash": "4faf1e525f5c0fae28cf739067b1b96260fd981626d6ce1d20ae2e17d0a480ea"}, "59aafca2-8010-4c9d-b176-84a2b5af7711": {"doc_hash": "a05d34330262bb3351debcd69efe829f7e7f00ff94d8a3db02ff5cbf671ef525"}, "82229160-01fb-44c6-87b1-8234a9b16f11": {"doc_hash": "a47cc32b0a5c3d5e1ab40cc69193d25ed71a63a3b19df7920ae94fc5d98c0336"}, "b2b7336b-f795-4a53-aade-de2970d7f8d6": {"doc_hash": "837bdfccacc4093a7cdb2f40e7033b9b3c73355d853e23d545c0a643ede40b90"}, "90dd798a-7795-4067-a885-9cbda366f052": {"doc_hash": "08b6dcf6ec7bcd9b04f07977bdb5e2a04a8f2d2dc33190c1606e1a14a58d2b3d"}, "f26f4991-ddd8-4aa9-8242-e8ea2539b0eb": {"doc_hash": "915b42f7d9a0e7efaee2f2f3f743d77d3ffaafeaae6712cebc4db54c400a0e64"}, "f3e364a2-7276-42ab-b342-f57a9662bf9e": {"doc_hash": "86df2dea8ef19b1221748c0b6e1db6104e832a9f031841e5b2d7261b27e3f66e"}, "2dbd0238-2671-4eb1-9eae-60c1ed39957c": {"doc_hash": "9cb59b92337e9ccd8f54928a93014066577a2a5cb6f26c8045dde3077cdf7529"}, "ef474a01-1f60-413a-b6ac-e40a87c78422": {"doc_hash": "a8b123f2498e0040b74adb40b0546edf5416b2b3820df0dab78f296579729128"}, "2021a54a-2bb1-4fce-82fa-d7d8c486c349": {"doc_hash": "108d28ebe17d91c9004f979b963faba3b0d69c13845a8cabbdd89675ed840f97"}, "c6a0330a-39c8-4a52-bd30-0ea44b2e721b": {"doc_hash": "4f2a3dfedc6e044b0a413b32d21a07368caee496693644f48e2543ef0791b8e3"}, "857c5ffa-e12d-4566-9528-ec2fb6ff725f": {"doc_hash": "e5350071dba4fa434357730b45f0d32b1b85c220ac69bdf82d4a71b4ca08e2e2"}, "bc49b419-b2d6-416a-a664-c6aa53cac0ec": {"doc_hash": "128ed15a60429b416d3d9967b16098f3f3aaab76c386b9fd3197db7b6206f268"}, "30007ce5-93e8-4522-aaa8-24663ed54454": {"doc_hash": "a07a147f655dbec5e3894ea7397f6e92b9479bc62402e5130d13721c45131078"}, "263e6387-9325-4935-913b-8a009ab2821b": {"doc_hash": "d470f304438280f6f6c42bd0d735c382037516ef279c80c3345a142233dd2d42"}, "09bb8409-4ec8-4fe4-a249-9669bafbc766": {"doc_hash": "73ca4d14c00d0ea1ed5064e6d3aad65346246474e6dd45794476b5b44ac5da68"}, "eb8680e4-92e4-44b4-8964-e1ba7e3a68c6": {"doc_hash": "bde2cc14fe4293de2bdc96eb023450b1056acfb6edf6f2767a08e91407ceb95f"}, "6bc349b6-01ff-4fb9-8add-ffba755e658e": {"doc_hash": "adb2ea79853e0eb01edb3a41fb19796c79b0f714491b35f5317373a5149b6909"}, "dbddadaf-9e36-44af-bde8-a20134fc72eb": {"doc_hash": "2c967a2a2f8a0040785712a1c9ea0aa11e5f578d63064d515026e518e0237338"}, "ea74c41a-6a95-489a-ae0f-232b07b85682": {"doc_hash": "5502b0e33a7ab5a48239bb966bd3cf05790d9769c21ee1fb4be324d17718980e"}, "6db64d16-215e-4c86-9d1f-d35886ba5b13": {"doc_hash": "2db560872ae6af8f2f0e648ef9aa5b9638f210321b134d47dd07049b511c7030"}, "483b3245-feb1-4e0b-8577-ee318f7c56e1": {"doc_hash": "a72eec2e7c1f347b1406a05cf3eed3d84ebe36299e0b0f2b25025c5a4a94130b"}, "dc0cb0dc-03ab-47d6-999e-ebf0f5f5222a": {"doc_hash": "c2d29b2f547aa6339aad3303d0ca14d931378242b65bfb5e5de49ad84936521e"}, "572b00b7-ccfc-488d-9f06-4a27f53371da": {"doc_hash": "72543859a45098cef57498e24c5aff43d40da885ab43f79706b99cbf633935a2"}, "19cd7d97-9d91-4aec-8963-80931e2ff5f4": {"doc_hash": "e30502d1f02faf1910a55ef019eb085d1223ee3a0df2b7d5e59a005ad0310c31"}, "b7eb73f8-0128-4489-ba25-62852c1fcd40": {"doc_hash": "0548bd46c95a3ab7da33757a04e462afe49d89f91f23e552f1d091ca0abece02"}, "6dd1751b-fdf3-4cd2-a9bc-ee2907f2e2f5": {"doc_hash": "e70f780f810aea100375542b13e5d056b8780d61072a8cab315d1192b221686c"}, "b6bd8a6b-4248-424a-993c-2b36da7c0c3b": {"doc_hash": "89fe3c1b0b2dfb718132ee15d2231a3fd8f30fc7b9a733a6e698cec76a33c4c4"}, "6554d30b-8467-4fd2-9a7c-96c89d0b82aa": {"doc_hash": "3abff4b0a575576d25044b9acfc56a257365c9ff26c53775eb82f74d217eb2e3"}, "52f25532-a246-4af2-9b90-83d86d828033": {"doc_hash": "36e7148f3f5d902dac9b3b773ec2623a95a022261eaa8bc007a2334092c198d9"}, "3554a06b-78d7-42ea-8ed5-b3ae6ad64807": {"doc_hash": "93517bd6a3cf5a1b3a3abd57d7f1d99bb02f4dcd57c9f7717561e5be3f49b7b1"}, "32273914-fe91-4464-8012-1f1d9e0e764c": {"doc_hash": "377c69b4c20eef84b005f3181716cb8f1dc7a6852d70cb00d98ff80d28bf40e6"}, "27d2d277-ba42-4135-85f3-d91d9f77978c": {"doc_hash": "ec4281fd30241df18651cda6bf127b77b8c4949420f5e27e6ba6259fe5d4db5f"}, "2fbdd8c6-7a1b-4435-8c09-7cc3f493e9b2": {"doc_hash": "a046c696dcde3b65b944b4c2c3d8e66887fd8f3d988be542ee773f192cc2f66b"}, "30fa772d-f408-4e2c-9898-dc79fed670e8": {"doc_hash": "ebef4fb4fb75dc2c684439f86d019a2b52ea59f0c7e94df1b81fe23ff3aadbc1"}, "c8334b17-fb1a-4ba1-822b-f92b2bd3c5d2": {"doc_hash": "1fd2ca20ef128507811e27286048d5b4358252ae1540a754b0fbb305b64b18c4"}, "80f3e14a-d82e-4007-bce5-067537fd8d75": {"doc_hash": "48312c8612251a0fafdd29f3845b72be8603e7822b1c20cab2291903a4cdd944"}, "4c8c58fb-249f-4fd6-8e2b-dc06481d3b5d": {"doc_hash": "450178f2da99d9fa484ee4b52a25984faa83477bae5ad9e8210441aa4e6b0d26"}, "d79d0dff-436d-4679-ab1c-cf1acd850ba7": {"doc_hash": "330b48e5c205c476893b463042d0a35450b1cdee755d324f4cedde1ecad5f46a"}, "b05bec41-f59d-401f-8e8d-3b4cb88e40c5": {"doc_hash": "c4d73d9d7f78dfbcbd71823b23c3c4850c800860fc521a36ada32577a13a000d"}, "68cc3412-3d3f-426b-bcf7-76c0e52f4033": {"doc_hash": "f642849e702b8ff8d5943498fd194874ec37704d5275c19c4067d93b79fc61c7"}, "0f56290c-df58-47b9-aa54-6d16d79c6be7": {"doc_hash": "c8f6a64158acf724fea9cd3b67746fa07e9f95a6f7da1d85f41417489f964632"}, "54d61ee5-a1e1-469e-8778-122a82f431ca": {"doc_hash": "5030d2cc8c681a7603790f887558c07937ac150cceaf15ba3526b71dac40d64a"}, "f4281936-1faa-44ff-b84f-3748f479f753": {"doc_hash": "3efb2ed00c4eb617e5fe7e6016b748ee399bf3a40ee7b217eaec4494cbfdb675"}, "738c000c-3b99-4a92-ade6-bc365a8004bd": {"doc_hash": "78cebb273bd4a677e77712dae8fadb797713d6c2f496f01e770f4294d137183d"}, "51afbf85-25b8-4372-b629-872f5163f1bf": {"doc_hash": "116ea44af1b562d4c49422921d1821e82dd6bdc348b9f931ed95c2b73bc48849"}, "deed3837-5ab1-4ecf-8dfb-7e8a2600747b": {"doc_hash": "0d453c1c5617587aee6eaf0177314ebc00cb42835b57bf19bd3026a256b21097"}, "8bdedb7b-5632-4426-87c7-87f6991f6858": {"doc_hash": "8bd7bed0cdf660cefbe2361ae00d39174522b538428f76f1422f95e9685cd84c"}, "f159d177-63f9-494c-8654-d2311e041997": {"doc_hash": "f2a35e0782daefc16b9105e00c7404f9d71ddf2b42a0d1fbfc2abd6ae0d08d9a"}, "415cabc4-4fd5-40d0-a1ec-43027e005c5a": {"doc_hash": "1b13d37dbce8d2986e80d8bf39882a5e7af5c0162d8851ddae6307663d1aebd5"}, "1715f803-3dc9-4eab-8cb5-c6e2f6717ffc": {"doc_hash": "7c96707b4b9a6cc3e32e026e28ac8de2e54a5b2bfa40f1e494da11b3bd9b3fbc"}, "a0341ccc-be28-40db-b729-b2978a76b542": {"doc_hash": "a07d1e09893eb21d4b03b0c5200c2ffe88c7f76bb0b0412be533727d47a4348e"}, "27faa2c5-9909-4f3b-b969-fa3e07644e06": {"doc_hash": "74ce487bb087e4dfd4ff1aa066384cbf4446b71862a0766db57057dba4c1ee2a"}, "719e9f14-ba21-4bd9-9a19-066dc540f630": {"doc_hash": "8f0669ff5074752dad9b34741a710d526a92a61c18f5b4625594eb80de12f949"}, "55b2c449-4125-43a3-9c00-fc45068338a0": {"doc_hash": "b0eb4b34d75406bde91cffd203ad01b9370ff9ee97b7867e7426a0dcd3676374"}, "36a0db1e-82b4-4c30-8398-8ed401fcb8ce": {"doc_hash": "5759b92532c7f310129dee4912b4a4386db59102429ac048a46a802f9e0c6063"}, "60c57d1c-8d19-4093-932d-a9815ba261fe": {"doc_hash": "e69d29c853158f59caf8445ba0142a47b13d6aecf0f4de8c90a94f3b9bd29bad"}, "d46b86a2-f2c0-475d-b314-cfc38a52041d": {"doc_hash": "0f986d855e5b28792c08c99b77d706106ddf9e87b7c68f46dbdcb9db35204f5d"}, "a6b66fa6-b561-4c69-b766-978830e9454c": {"doc_hash": "fa863cabb1ec4913f5a6557972e1abf50f66fd00f1f639e405546a064d1beaf7"}, "804457bb-87a6-4b4e-8cdc-d18d5fe87127": {"doc_hash": "8d15bc618aaf7a4635de0143f531efe9668c300daa394bb1230e7af60c4b18cc"}, "863bb77b-2dc7-449b-91fd-1520b23a7a82": {"doc_hash": "711068810b9347b338383c540de16e8081d4fe03e2e466f0bf192d5dd26b3bbb"}, "264604a1-8180-484d-91ac-4ebca56f333d": {"doc_hash": "950d82a7d4f84f5d8ee922d2097adc7fe0334c1e7e29704f33ff0bbf3a7eedb7"}, "745d1c63-e052-4f64-b3f6-be386b6d40fd": {"doc_hash": "0581b8fa019e327c722bd7ae788a09cac1f3e0efe572d6e32081f1602786ac59"}, "e85369e5-6c58-45a3-be8e-dce4eb419f49": {"doc_hash": "1a296e6b1a46fa8d2aa254935215691803d8f78a8e58a2a7cdc0415fae5f2a97"}, "af9e273f-eed2-4486-944a-2c1af1339bd1": {"doc_hash": "1a47935f2a8f93442685b78b0522f8a9bdcb16dabbb135d7b0f5498e68fa3811"}, "ccf102f9-e88f-4d29-be07-e92f42b7b1d6": {"doc_hash": "ff3877558a6c479e25c615e88e0b630447859dde946d52a22fc8692fe3f7449a"}, "07e4b533-c2b4-49a4-a034-15dabd7c7e3a": {"doc_hash": "0f7e82a8bd5436802a4a686b6531672332e0da3c15e34a92e0dcbc1376242d9a"}, "48d35682-eb3f-4915-8b06-9ee157a3fbbc": {"doc_hash": "dad501f00feaed36f5cfecb286484793ececf080dd6344c434da5e010d049af0"}, "19f35486-7398-482a-8e54-27fcdf03cbcb": {"doc_hash": "ed4946deee65d745d6971cb4684477d518d94fc8424395936864fc152bffa827"}, "983da09d-ba54-429d-a948-d560d34e0296": {"doc_hash": "1514c1a329a2cb6595d9194fa5bfb3cfcaae034d84e258308ad148d4e4948b26"}, "f9373df2-55be-4a05-949e-771fa578692b": {"doc_hash": "a4e61c898a2db3281be208aac462c5ccd3f2b11832ae907694d08ad0504dc5cf"}, "7d5024f8-d8a4-449e-b420-752f59e058a9": {"doc_hash": "6f64754554b93ef286063d3a4b441bdb19c97834947bb22917cfdef89632fe89"}, "148f5249-29aa-4f19-8e1c-f8eb619f17f0": {"doc_hash": "b8e1224ee1112017dae92f5fe730c728afb98a7e33b4d453cf1cf30c7894dc3b"}, "eeaae70e-8bf2-4d5e-aa65-18464b168555": {"doc_hash": "5e71a1b750d7b63d224bf57abf7b28940ff79c1ef8b2fc861db78a25b84ae842"}, "cf70586c-3ecf-460b-95af-531cbdf007af": {"doc_hash": "13c8895342a04536a652dd9f3f00bc30d8bbb1416f78b7608bb21fc6cad8798d"}, "b666503f-2dcc-4c92-a1bd-ba8d92062a38": {"doc_hash": "527adb8a064b900c090fc75fb8561bc0ace5822b544e699d80a3b85c0ce0b957"}, "66daea96-6cb5-442a-ab53-9b0c13410d5d": {"doc_hash": "a75939d31566c33277e73fe57804116537c820c8622a1a7a375e2666cd8a86e2"}, "5d337e49-a9c5-4c97-9f3f-ceb234dae7d7": {"doc_hash": "68993d79c547589b7e8ce824f650c3cd39c0ac6219fc721244bb8db585ad619b"}, "1f970326-be3a-4a32-ae04-0396010ba790": {"doc_hash": "8ef5cae7bc32027f617b9f0224a0e4b1ff1fba5c3c9b25500ebdf69279104d1d"}, "627af751-5bbd-4a44-9a21-db2733c16094": {"doc_hash": "aff739183311d0ee3355e7fe9a910842ee195e3c08214f0d4079907cca359c11"}, "0ec8f58b-20f4-4c09-937c-921c63ba514d": {"doc_hash": "457c3278f41cb96ac48bff1e3c37615557b156aa8806a1db8d0eff2751f12bd7"}, "550155b8-03cc-47b2-9f92-0ba4dc52593b": {"doc_hash": "84e1f5be51dd681bc63477f60d53277ffde25c50a03dd13163a9316c764cfa3e"}, "016ad7e7-e76c-421c-a6c1-120b648afe74": {"doc_hash": "f6f459d7b3e39d95e4af14fdca89afcb67fcf5f6d11a7b06227e04fb9232b009"}, "3c85ca06-1a84-4825-ac52-3c4027cf587c": {"doc_hash": "01d2ea64f21f93e9987d062fbcd0664e9c0ca6207641a06d4d4880e6198e83f4"}, "95381874-e431-4e61-ad84-35cd9828b11b": {"doc_hash": "9f4dcdd84a8bfdb387c70fbfc2146436a96e228cbdbe9845d53f47e3689b5abe"}, "48461c68-32d2-41f0-a052-a1108d006fc5": {"doc_hash": "e86867c6289f364777a65a96e88d4ee97750cb400c4b5f96eb7cfbe3b48c1f83"}, "26712588-e6d0-469a-93a7-26957b2a1c10": {"doc_hash": "0a9e705fe461a8a89de276bf52126823792a17471deb1e0e611e09d150e21a96"}, "134e2e1e-cae3-4af2-990b-7985a34472b4": {"doc_hash": "14355efa3dd2416162e206a8e48f77946fc48ad163ba029f6213dc5087d46856"}, "29111159-cbcd-4a15-a9f8-094ffffe6ffb": {"doc_hash": "238ef03f3589dedda0572b8e43702a11366be02a160f42a92dd81cd4b14d7d2c"}, "90592ea5-e9c9-47c7-9062-c2c19921c837": {"doc_hash": "82605ba8863fb57adecda4e931a36ba0fc92becc7e1eb055081b411c09a5f1ef"}, "d140e481-7a14-447d-a413-c1d4b8eadedd": {"doc_hash": "fe509fef1104092369f95cc42dd737299b8df45cec3d70b2fa2f1b267b80c60d"}, "26a76724-19a6-4202-bc5c-fb0c0134bf2d": {"doc_hash": "24134df23d0a5daecd418a170a3c2afff271c5321f2d9ffd770ba472f0c62e58"}, "65a949e0-67e0-4c09-96f4-2fe13e99c73f": {"doc_hash": "5827f193fafef4eceaaf5044fd10a7f3f47223a9dc841f30a5ae34fd7d750392"}, "0285bdcf-301c-47da-8431-7e14df23702f": {"doc_hash": "b6bd15589a88e3ceee3b7806f57f499b94bab122d2022086434de9f3ec7fa92e"}, "f3451a8f-2f63-4dce-aaa7-a0d00322d516": {"doc_hash": "86c24eea3c20a610670dec65217f752c5492f68455ffd441d75efcacdae64d9e"}, "e25b858f-c3cc-4010-928c-72d772296afb": {"doc_hash": "1411a3502af3e4b42de27c117368e5a72515bd6978d00464e1ee347c4a91fb52"}, "70f2c6f1-c01f-43ed-98a8-7c05b1286c70": {"doc_hash": "03dbbc243ea8e9b0f47afd52c402788ac60aa59274754c1cd6d25e4d9f38bc17"}, "42dac78a-62f5-4058-b218-0018e75ec054": {"doc_hash": "a58993a57e2faa930395c5989de6862d037773dba2d613e108bb62dcefd589a9"}, "dce9115a-8c6e-4887-bf76-cd49da79c16f": {"doc_hash": "ed936a2320c8266830b8e2e09a74ce9caf084f0de6ea577589fc93de11b0a584"}, "1f74f35a-6580-4a14-988b-b2f4c616e656": {"doc_hash": "1bbe3a4b67f2ba58440e07086d2ebab858763f24726ed501e87d851c35e0b564"}, "3dbf7c93-7227-4e6a-b7c0-c7096558be9b": {"doc_hash": "34f01abc7b1f571a32ac8b1a3de210a59c72bdab8875ca77bbe26d6c6bd8b5f9"}, "d31d96b4-731b-4e3a-9ec5-dc1877642053": {"doc_hash": "2dd8a9d7d455cecee78d5303bbcc9d22deae88ae8d665a1ebf4150decff997ea"}, "eabd1301-d510-4ef9-80db-ce018b3b5dbc": {"doc_hash": "557cfe93e0d0abcedd2cd2083282f403cc1ed0da7b97634411d9cfe698377d38"}, "e6e4e9fc-aa49-44e8-b5b0-55b80dc1f717": {"doc_hash": "38eb330d4ad09ebd6830c45a18901b92907fb9f0b2492ffe1a42f42bed24d296"}, "1cbb64c6-6a5e-4efe-931b-02abdc7d5f20": {"doc_hash": "10ff0d674fc1e2ce1c30e50c07d9e902788472d920e508c136fed762caa95386"}, "82de0c19-acc7-4f7c-8bd7-4353054f5668": {"doc_hash": "02777ea59b0687f8e6d74e31193c7543edc57e97d762efa0673c547e000518bb"}, "df64b0a0-fcd9-4faa-aae8-dd157031b0d7": {"doc_hash": "985f3cb7ded1a8889f739779416f381b216e3c2812b1eeb234076b33b7ba211d"}, "0bb35961-a35f-4a8a-a858-415fc3e963fe": {"doc_hash": "f54cc6817c504a3625d34f1af1f387eeac80ed20a21e14cf66f9c2db4ecfc2b9"}, "1be6e8f2-0252-4f6a-96ef-6c30d75ffeca": {"doc_hash": "a54f8b644d99764400b254b5fa45a27efc704b55bcf91e74b3cb4946e4aefa4b"}, "eb4c1063-ad6b-431d-8a20-8e9b2e468626": {"doc_hash": "7e683713cd8e6276f7a63e2cddbd6bb81b6d7e2e7a3b7cd7be3d71f1f0f9a7db"}, "e2757759-a170-4e87-8219-8169c2f9cc39": {"doc_hash": "dba0bd1d45be960c689f808eb379d696b78ae7f7a93a5e3d35380790325919fe"}, "b38c7021-cb3e-43de-901c-53ac3a0acd17": {"doc_hash": "36c4d33b262d424cab93de6c2e615b6deb39d6f3fbe67276605440b05e4175eb"}, "ec762da1-86de-4027-9501-9716c7ffaf90": {"doc_hash": "0193c66f0e3d71fd2ecef36e6eb0405a7291d24d2c5473af584e571579bc29de"}, "cacf2cf2-a20e-4779-8c26-d16c4eb5b5b4": {"doc_hash": "3629e5a1849504e668ed88fefba3d6b88cb95e1388d1ffd27bb1c1ef62938eb1"}, "12bf5697-b722-4a66-abfe-5a2c0cd7a210": {"doc_hash": "b374746e2f1fb1861eddfe1a56e5b5993417c5f05cd56b6c4dd6cc367944c298"}, "357c5ce4-1a1e-488c-806f-0fe3c21ead3d": {"doc_hash": "52bf5915bbc3a5281c36c3b63c149149fab33b336f6da0d7a47f2b59d3003db4"}, "54006636-f6ea-4e39-a7b4-a9dc57da7e11": {"doc_hash": "c29cf16036d29bf24607ff67d776894fb595a5d21ad561512c834e2184371a38"}, "ddc1d98d-bf62-468b-894e-b849e9a6b9ad": {"doc_hash": "0eb80b59da4f89f0beaf0e3cf59bc649921cfcf284e462e159a7d9372c1d3264"}, "15ccc356-f37e-4f74-a25c-ee88b5b46988": {"doc_hash": "c09696483001bc09041ec67a5700652f83a5517788bb32f5596cf0d1a5e56a79"}, "9108b43a-3b89-4065-acbd-3eddee4838f2": {"doc_hash": "80564cd900c273d54c3505b0cfc47485f52ea4c2f276aaeb72fb9f9cb5bebd27"}, "57c4c09d-5583-4a41-9140-bdaa07b6914b": {"doc_hash": "f82c72a718ba0b882b9e4e499bdfef35cddeb22893ddfc342f4bcbecea6ce12d"}, "de4c71d5-55b7-4c50-aca0-ad9edf8f235f": {"doc_hash": "b3f3e1b94e683eaf141cd5fc6d4ef88c5b422c9120f8c1437d5da783255a752f"}, "2887afae-bb2d-4c89-b8f5-f29c1f0429ac": {"doc_hash": "12772074bd8160b0d0ac3f2a8636f88b9734a0a8f29d2b578519a9952f8fca83"}, "385c6838-b164-4a93-8280-3d97b0baa7ee": {"doc_hash": "e971829dfbb915ea25886f63d5792fcec90272ca77c7a24c5a7dc1a6073bd974"}, "117fb19b-9133-4e78-91ae-3219ab301ff5": {"doc_hash": "fa92b8864994800b9733dd34caffb9066f7efa508afd4e51b803bda59c0e925a"}, "77150e98-9717-436e-ae5b-6a129f54ba46": {"doc_hash": "5f9234e185db89b060c7fa750134909a36613e202c8bb7249cff798bc3c7d3c6"}, "9884a721-51fb-4520-aef5-602714a6b320": {"doc_hash": "81acf0ca5cda721f188a0a498e3528a1bbbeb814c169fcf3a39f30628272d820"}, "0dfca31d-11fa-4be7-b596-c950092a1e09": {"doc_hash": "8fe996671e37c710a5027280a4a205b72b1313c538a8b4de347a5fb540a6afd4"}, "903e504e-69e1-45e9-b8ae-aadc78b49a1e": {"doc_hash": "ab60ad75c9f753e07792518592a5ff657adc3cfc10726e08b1fd65c5354d1a6d"}, "5c24a704-442c-4149-8eb8-871e561e53e9": {"doc_hash": "b64623baf96d622b1d335b056b2a454116e4a7036a61d5ad50b0ebb72e0db003"}, "1ed8ac25-fddd-442c-9f25-afb056379dd7": {"doc_hash": "5c7eb9b8fb0ae5a0b28e14167c0467d64915d2ad42048c91ffc65b5de012d943"}, "ede94ee4-5ba2-4357-985f-918ccacb55fc": {"doc_hash": "b90fb4ec97239a8f9280eb617795764e0a23a2ca1323ec96930c5124a4468960"}, "22c9cb55-fb0b-40d5-a2c3-dc0e7fb86bc5": {"doc_hash": "5a3a7a25014861c3c0e26d280a5adb779d03db731ab1bf2eb85fd8e38782d032"}, "4f21dbc5-e2f9-4d66-9b0f-1e30d61ae0f3": {"doc_hash": "819b5aeec44b488e3b99892f9f03d379c73a842775a2e19ba37031cc674eea75"}, "a3fa06fd-1be4-43bc-913f-fff5e8cc0bff": {"doc_hash": "10589c3bd5fa8edd05231016bf426f89dc638cbf05f2d072752e3dfdd045f6e5"}, "d29bf1b9-63ef-473b-b7a0-60751ce3ef65": {"doc_hash": "6f56872866dd3afdada05a94b068023e514976e4a8ac92aca1d85e959f57c88b"}, "65c1b426-4c93-4cd0-a8f2-9a0ba2a297f6": {"doc_hash": "82b36d24118391a4d85fe1a65cc2549d1eb4cea30ccdb423018f4b78ba2071af"}, "284a764a-ff44-4c5f-a25b-1ae6d960e950": {"doc_hash": "73e23f46fd3a0f619c9e77090e6722ed1f1f8cad09619e6cbb388e6e7d0d1919"}, "5cac06f1-0ae3-4569-874e-baf9050667fa": {"doc_hash": "085ebf85858e66daaba84e7bcd134d05ba9a0853937d86702992a9d4d6a15a28"}, "31293a19-82d0-407e-9178-224274d45777": {"doc_hash": "3a66349ffa34a5184a8c908032c298a246d4686f90d56054d25534e53f3703c0"}, "1c189957-56b9-4c3b-9555-71ac1653ea86": {"doc_hash": "687f6510c6f561be94fbc5091fb739763a2c515220a6b35f548e6e6271cb4348"}, "34204317-873a-40ce-8b59-7a28761ad12e": {"doc_hash": "89196cafc677dda13dd77655a91dd4214cc977d84695c83f4b0e6954f3b9c6af"}, "e8739237-8fac-421e-96ce-4803352e6dac": {"doc_hash": "4d70ebde13b87db53f4597143237d03ddd9ef5c30d80af53b7efe2d0d96aa877"}, "a0463727-fb3f-4c02-a387-c30181bb402b": {"doc_hash": "1747ace29dd0feaa77fad7f3a077f08ca817c3716634bd4c501edeafbdaeeea7"}, "dbb9e7c4-c1eb-4046-907e-ce6f1edf0055": {"doc_hash": "a8cbd6967f37f3c291a1d04ecc130d1022f53ef9cadb6babcd6f054edade747e"}, "9b4acfd2-7037-4b98-a3a4-16ba85722dc5": {"doc_hash": "2503a4f8618c99d0feaef253d1e39b3aaec65dafd387ecdd5d55691a457d2cc8"}, "85547109-727e-44e5-93d9-7e1caeab8f52": {"doc_hash": "d68adf44f4978c3dbdabcdfad09b9ec828ab1eca4d9f8916d421c69ead4090b5"}, "6326afcc-6ede-41f9-a5d8-182d84531875": {"doc_hash": "042cc02ebf4900a95a8f56261c3a0b3c4a963fd048e17e5d03c3fe03f552df54"}, "14c36e9f-1905-4b0a-a759-fcc756229fbd": {"doc_hash": "c6e458051568a2813adf77841dc561d1a4fd3296813f9b899e53faa9d5572f77"}, "bf990af5-6233-407a-8bd1-e22ec627665b": {"doc_hash": "776643b769ce35f6554c099a4c83f429358b177a3c566bfd3db8336e350242bf"}, "ead3175a-de46-47c5-9b0a-98b7426e92b4": {"doc_hash": "ca04d31e35c2c5de7288c65ac04520c54e4b0876bb22e8cc361852f51df56bf4"}, "3ea7d4a4-4e08-4437-83ff-984656b7ab96": {"doc_hash": "77f04ca5d34050777e99981993f91258816494c1bc0581ade350d86d6ab7c275"}, "f2b00d9d-9d43-4e7c-b5dc-2936e1593e83": {"doc_hash": "361f63cc61eaafd52745400944d0d898b1895237ec12e0e068797da7659624ea"}, "f8791b4e-8766-4301-b573-4a596d1579a8": {"doc_hash": "adcf6cecbf425fda294cb7f5feadb547ef946ca85a5d1e873e55bcbf65dc01af"}, "4c0aec2f-6acb-4932-a30a-4e742b6d8098": {"doc_hash": "382ac0d79ca68f93bbd424998c19be5dab09c688b603aefe7e0691dc8e32373f"}, "81736daa-03d5-4dcd-880b-6e598a65dc2c": {"doc_hash": "5074563c07ff03f77e2acfd799b12a89ed5bf6b2b0fb61f03c15204aebda7692"}, "fd56c657-6f9d-4353-a79a-3f27c16a1b3e": {"doc_hash": "0d91703cc8f7606ae1fc27a4a61a8039bdf2daf0d7b3b291e6538f76dd1085fa"}, "be1835b3-5068-4017-99b4-6e3087ef228c": {"doc_hash": "d05df0c88db6071e7b588ec405c28a59fe75b529615d1151f6dc6a4669805f6f"}, "ca37cb9f-d742-468d-83f7-b1d662174765": {"doc_hash": "7b081e47528a92c7ec9f8ba2895031bf98b5a1e8851ca42daf4636e4de19db0b"}, "58281e9d-3016-4bd6-8543-84b37d6738ef": {"doc_hash": "b0e94f6435bf4388cef0bc09982b0ec5c4f27e3ea6569c9041e6cb3d0afa4103"}, "837aa0bb-62a7-4ef8-a435-de2d6175c693": {"doc_hash": "a802a829185916ab21c38cd528b07ef9d1ac987a757cba2abaa032feba24160f"}, "0066c18d-7575-4518-9778-f463c3fbc6f2": {"doc_hash": "603461e5732eee8ca06e35e9851ec7086a82ffb1f354634c9e6f9acf3df7cf7e"}, "e6ae766b-6aa2-4374-8151-b9922797a28e": {"doc_hash": "3e1713e097c455c58976987453fd383d4f38ce0638865da04edd50cac87a41e2"}, "c90690b7-074b-4193-80fa-1137ecdf2a65": {"doc_hash": "4f39cb62129f830fb00e7fd0531c5044240232e2254cbe483078ca51d11c8a50"}, "47031e43-a8b6-491c-af45-7175b518a947": {"doc_hash": "5cec097351a37343b141b510a97c750509c6945c01762a06627e799927771a45"}, "f294f5e3-9039-4b1e-84d0-ff0e3bced4e1": {"doc_hash": "e97a7fdb6ace323a78ab02df019d7f03f1376608d98c6f63cf5fe23204616df4"}, "b3250294-a38e-475a-b6b8-38731a10396f": {"doc_hash": "f3c5cc1c6e1620f355dc92c60f604c761f0e2ea5abc4c4dfe40260399e49a6ea"}, "c09fb578-7439-4068-9a3a-cdf1db2853dd": {"doc_hash": "0d8e56333027dbf2a7e11b032bd1120a33943bccd572e49319da6ae6d16ff449"}, "2e0969a7-f48e-4621-b395-0a7e7d27f070": {"doc_hash": "d5a15c5d6037dfc0017ad3b7d46bc60ec4f5f3d0b0e6bbeb807297207a2f010d"}, "180835dc-f3d1-47df-b0c2-bbfa13e1dbe2": {"doc_hash": "2d4279d572cb85e9b14de099f40786068f4bb28e80f20e7f9da415bf00d9830c"}, "146fff57-fa20-4071-b0c8-2589e0628b4e": {"doc_hash": "215905369f5e9f524f5118819acf9bb1464916503b6b530b1c9d1497dcd8fbc2"}, "ae61ca21-7832-493d-ac68-b05c6bd7cb89": {"doc_hash": "56acc0ebc542d89f3fb5b43981cd14c1eed04907c8dd1e638e46d80c36b39787"}, "534e30a4-9ae8-4b82-b022-0b7913584e96": {"doc_hash": "cb228560bdcc0a6bb1bae9ff40b5943e7087ce1b1f48218485c70f11e7f5f9ee"}, "07c0cb8c-da65-4fb5-80af-03dff48ac169": {"doc_hash": "7dcb8c6d534c37a108f6485c27f3b4f68d9b3327b8f84e6c57713b4d7afd10f5"}, "af83969f-87d4-4922-be17-29d61bf5888a": {"doc_hash": "b2d598eede24004efdc26bd8c6bae7ce39aaa8ac6e68c41df9faeed4d9bf0f55"}, "77119e37-7cfe-4444-b343-010a3fd45017": {"doc_hash": "af350faef8502fff3f939ca3942f2e52d3d20e0ba99d38f5ff4da5baff789a8c"}, "6eb261d5-1394-4504-b06c-82fe149f968b": {"doc_hash": "df16370b01af50cda512dbe7579216d6096e890f198491f2bf3b8711be265764"}, "6d9b7cce-8710-4be7-a9ad-8d17040bf954": {"doc_hash": "a6e8c8651e827b1d87dd89b93646e2f2fffc25f3aa1a9c23c1ef7e52e2d098fe"}, "e748c262-8a76-4882-9ce8-75102957223e": {"doc_hash": "56b2b17dbcd147f73b9cbbfd60cb3b5be6bfbaff52a673d7f7b0e573b77ef7d7"}, "224112b9-91e4-4d1e-921c-cdfba587d1f0": {"doc_hash": "6c5b2da0bc31f2742716a9957c74eb68ee299c9a0ccfb15c62d7a87f992cea24"}, "2dfdbf72-4d71-479e-b4c7-95220a59601d": {"doc_hash": "8e8d2bb6ea48bd5eb132ddc588278a7cfa484aa0dccc98045a105e750c6f2f0e"}, "e049ab43-5135-4e93-ab71-033f2c046407": {"doc_hash": "a27bb86a9d7ff13b81dc266db4fafc0f195366d751a67fb566ae4700d262abcf"}, "02ce231c-4951-4dcb-96d7-64e5f549634b": {"doc_hash": "17ea14ee7f80bdf3e5fae37b8facd8857808856d0094db6e22f81f20b00f9aba"}, "a9072a7b-604f-482b-ae5b-afefdef942d7": {"doc_hash": "5433f88d9c72b76e4e60aa96b8ee8ea762e919a0ceef251b0429f8a96b9cb927"}, "9437165b-4bd4-4b18-a8e1-7150372fdd84": {"doc_hash": "b133e1eab5d84ad577b5d3bc5def06c08c1cbca91ddacd2bf75ef361906432a6"}, "d906264a-5ec3-4226-ad62-592b5571dae2": {"doc_hash": "b1978fb311b478dcc035effa0e749f3eca958a81b427089494886cd66941ae4e"}, "ffa271c5-8bc3-4b61-a40a-091ee8682ee7": {"doc_hash": "7828aa59a9a3d221383247939fa9c4a03d5a37a4abcc9f9c091524a886d0bc93"}, "bd8c8b96-25b7-4cb2-8542-ca5d73805814": {"doc_hash": "341d4d7b9b3979c92c2f963799fd69af23136a8ccb98a8b30e3f0dc5fa7e57b5"}, "5467a511-b4b2-425c-aa73-a7ce7d243d4e": {"doc_hash": "111e5a3999448e2b718e9cd72507aa5a869b79d94c5e151549c4b21bf98e4c3f"}, "4166a2df-0187-4828-9e27-9d1f69ec66f9": {"doc_hash": "f19f5718138f8891aeab882b77602864e057636663316c51b59a51659a49d7f5"}, "196447c9-6a7c-4687-bf71-c8f3a8667a2f": {"doc_hash": "ae16a283fbbd974f8bb8b6e477bf72a74e232beb67307995253b0f16db9df688"}, "62aef9fa-972f-4dc6-bd3b-58c57cd2c79b": {"doc_hash": "3f0735aa0b3d83c21b284e333322c5e6a953fd68c7d9cd3cdf7a0dc1ca511230"}, "5f782e5f-6270-4cff-b298-3f862f470c3d": {"doc_hash": "4bd2d704b85db169001093975cc04b1223799f6fe1f88730b346d45cc740b2e9"}, "850b1b48-179e-4c13-a894-a04ef2a6cd89": {"doc_hash": "fbdf94b2e522a9aacafafa76da979ebfc4aae87ee091a3ac81d0f0b0a844c47d"}, "05492b40-b08e-4709-8047-b5d30f6356fb": {"doc_hash": "2d263b57555dc004d99756aad7814a351d596092cbc36f9c7559ab84556c4a7e"}, "0c249186-652f-4df9-9788-742cf249f6f2": {"doc_hash": "becf233a2bb66f95c521e268e87821243e1c552a9c8234011abc441aa62fd824"}, "16889032-d35e-4f4e-920b-2cf6e2a2d318": {"doc_hash": "684b3bbb157e463bb2813a54e9221275242c756ee9a8e7c4c6e86335490dd1b1"}, "fc7c6253-26e6-4595-b74e-be84dcf3022d": {"doc_hash": "316614df0f46a4a4a68a82db37bb0b73c2d99c264721025a492202244efb8e6c"}, "e70249ae-2bef-4b5e-ada3-80914942a563": {"doc_hash": "52f814b4d66462292eb6431b7bb8e69dd4fa805c286e1f5b35bd43cfef53f5a9"}, "d624c26f-78d7-4a76-8d3d-772059739a2f": {"doc_hash": "381e6eccaad46c59a4e98cdf56a847fc858ec761d3ce1f0639f2f24faba49ad1"}, "022dff2e-75e0-42b0-b889-c42da654ea8c": {"doc_hash": "6cf3f07abdb31f6057b64667e950937bfecdf3d2dac626fa34f6cabcea170b19"}, "8509d6b2-a0ff-4c48-9ddf-bfbd29119087": {"doc_hash": "fde4d24cfa453ff98f01d1d36757cbafce043c193004efd6c5ed157a561f206e"}, "b4906c56-ea0b-41b1-a86e-d2fa9ad64737": {"doc_hash": "db04fea5a2def0de073d9bba13cab753be00e1e22425fe9c9dd630a64fc29a99"}, "5874d69f-e639-4389-bf95-a4fef0609af6": {"doc_hash": "0a07d049c2a0464c36a0f109043d4e48d16e174a24938717a29b57fcf6ca781b"}, "61a7f0d6-6450-4229-b840-dac0e48ebbc0": {"doc_hash": "2b923723203132097e6cf6ee5e109893531d343fc7ee3790c2a93bdc0c7b907a"}, "be0ed1b7-277b-4d61-83f0-3fc34c85cc2d": {"doc_hash": "fa371cf7f32503be0bb7943d9299a4bb4dfa136de1c664d1b617564c80a541e1"}, "66ac7d25-2069-48c3-a014-70d939bb643f": {"doc_hash": "627d589edeac7087f54ccea78fa234aa11058411e1b58b719fcd1d5de58744e3"}, "1f663f28-5b73-466e-b9ac-78da5972a78e": {"doc_hash": "c9dccfd584951e7874301aedf089511e3071aebcef5c828876fab05173c30669"}, "ca835ce7-c718-41ec-b221-7068087f69ed": {"doc_hash": "1ed89c4f8f554414dcd288f49a8c0ad56694fcdd180dde71449deee822fe686c"}, "3487f585-7221-4adc-a6f0-2ca981300209": {"doc_hash": "ea2a5d58af36294209c7e841e2596f23e556fc8ea870f085c3f93c2dfad99724"}, "b1816f85-d6ac-44b8-8397-25bc70fecb34": {"doc_hash": "d62c15f511eb44a227676b21cddaa15c68c509daae98b0ead86eedb739605690"}, "4abf18cd-6ca2-4431-99c4-1270dd3c14d3": {"doc_hash": "903f1319458b8245bd0f85d563fd840bef135a39d1e8d456307f68250411eb70"}, "cadeaa97-1ed5-4985-abfa-b50a7617b044": {"doc_hash": "206ad7045bc8812dd98d579bb075f86410dbc36cf45a6c4d4a60d6dd77f1e704"}, "ab659f33-9ad3-4346-99d9-db60a47fb277": {"doc_hash": "15fd6bc5c6d605658a6fe35817ad1b081b8262c4b9820556e8b1775246a03321"}, "1efd0ef9-1b4d-4f22-a896-9332bbb96506": {"doc_hash": "8c3b88c7f9fff716283e720ab43f9e885f12aff14fc8f83d72f2c65d47e983b1"}, "077a5dff-766e-47b1-bd89-2430a61d24bd": {"doc_hash": "37865348ae8790b3ceaba98590dcff94c14adb8df77268602598e2b293d959af"}, "1231a601-c0f1-426c-944b-bb0bbdf60aa7": {"doc_hash": "6cc433b85e13e826103b286230c6dc95f407e8d04481f939eaad4251158d688c"}, "bf43e2df-4b45-4fb2-b73b-8031ffbab3ab": {"doc_hash": "12e506aaeda6c3306facc92087c5b2ccc34bfbfb6fded385edf6d0261d5c6e18"}, "851d4b83-5891-417e-ba47-e567b286a375": {"doc_hash": "211cbabd70544215e814c4d3a61f1ecc23569421e5afb0150dcf224442898426"}, "ca98da3d-9123-4b95-9201-7d2a57a73ead": {"doc_hash": "fbeae9e15f9dbf71c13d0c821e2a29a0a8ef89ad18fe953bbbea77abe11f4a76"}, "d195a567-24fd-49cd-8066-59fd78454ca1": {"doc_hash": "45d901050ee82f0fb04794ab80d783ea7d7e361be790c42e6c8cc4fc5d78bd10"}, "d4243e59-b8ef-4df9-91a7-57642d7b152c": {"doc_hash": "916c23fb7ed2a52d07434a2ab0a12b7e536b6ad4c46314a89767dc5cc98b5819"}, "f67acc2f-221d-412b-a722-bfff43ee31bb": {"doc_hash": "5ecc745969f0648f74c01bfdaefc97a1948446e5e9f58d84c215d9cb92a0b895"}, "8216ea82-d3d6-4717-8668-230c8071509f": {"doc_hash": "e53cb80a41f86c2fe603fd81b37f732fa12969a004ed7f61a314a10cdfeaa5ed"}, "d3a898da-94ed-477a-9931-9f6ae930ae49": {"doc_hash": "da7674436f404f13dd670e0d62d976dd1f9c6b85fc3672c1eb329a82f7cd49dc"}, "d5d9cd94-11b8-48dc-b20f-1d4c6f697296": {"doc_hash": "38e613f3f3c46556959c9604579645d03cb3a05999d27e330a1e06994fd82ca2"}, "9831a442-860c-4d42-80be-452420dc3575": {"doc_hash": "4eea6a989c6870be20e73d7ef9379d54d04b9557a6fe2fe019ab0667a27a71cb"}, "58b7659b-9e72-4c6f-843c-25065d34c049": {"doc_hash": "fd5351de49b5a9a91f92edbc83e457dc42193142259e433cbee0232a441463bc"}, "790264fe-15dc-49c1-b185-a73e0edef92b": {"doc_hash": "381cda1c3be1c202f5f2da0941e327f85ce74691746f5ef319ebd6898ff5113d"}, "48803f8a-3b97-49e6-aa8b-1f1907feba63": {"doc_hash": "d20c01881279b556ddb630dbbbb16a84e403aad84d90367427f9698deba91e7f"}, "e781dc12-4ead-4dd3-b4e1-6dbcc6907fb4": {"doc_hash": "1c177e9600fb7651c8415a57b6fc40e51c66f52ec7c3991762cdd71f5073de78"}, "28f3484e-dcd8-4148-95ba-6fe7b0b89284": {"doc_hash": "6ac2abce05f66e0ab14964e8f5b4eb4de7b824c0adbbf653d28ba2df471ca6bf"}, "f91cd471-cce3-4f26-9e0f-7d656e596eba": {"doc_hash": "980169a07a3d839caca4731baf50251d8ab4a38b2382811fe2e35c3d9b489204"}, "12d91bc8-e76d-4b96-8f38-9ce5fc8d8bae": {"doc_hash": "821ccfd8be51e1338bcfe6533aa4715920539e588565ab9337dff3cb39ae0390"}, "adfdc12e-a7af-45c4-a37b-8271000964fd": {"doc_hash": "c952a6f7faa440a3e6b9847fae35e7472010acc4118d43bc2f6d531d11bdd2df"}, "39fe5a42-e5de-4532-8b89-3f6abcbdeee7": {"doc_hash": "5c024054f156192a6d6c838f779184197ec2c78ca396903d657fc0a9ab63e7d4"}, "e27c9ab3-6745-4bce-9b2c-9d247a6f7946": {"doc_hash": "00b5d8cab8288a3943249360ed6ea1849db42502746187e072ba5f4fc65e8220"}, "11d35be0-dbf0-44cb-acdb-2fac43d7f241": {"doc_hash": "5d323d1b605fc59cd8531a29c2bc1f55502f99c20ddf20667cbed7f001f73a4b"}, "0fc9370b-c299-4d51-b02b-a3a2b70cdc57": {"doc_hash": "424afcc1723d6117f7d521f6e72ee57e94794be2807db6f25e37ab43ff09f017"}, "dcbb194b-4b50-49f2-ae3b-35593ab90181": {"doc_hash": "db3c3d7e4d561de6e1f6246aa0422a048eeb4a1df55a2be92b0fc711c6f3009d"}, "ccc85c77-be47-4234-bdb5-df0f9354a378": {"doc_hash": "d1bddd7ebaabf506947bcf4ef115db05ca77bd5c60bfa64cfbe0fbcb0a712295"}, "ac0c2c7c-01f2-4eca-8bac-e54409c8cd37": {"doc_hash": "9e09aa929339a5542dc969b46d320b732e76aa61d45e8bd3598a337769a225f2"}, "50825653-8065-4fb1-8fba-8c86bb9b61ac": {"doc_hash": "648681c0d48e54b4b85827bfdabec155b06da5f8fd88b6f3f39280e9213cd99f"}, "e8313524-2bcb-4dfd-a7f3-6b64929ab14f": {"doc_hash": "71ba87dfe9a07ff15dadf1fdde4e85591f4cbfc2297a9f4a2f1faf5310cbce41"}, "636371f3-6b59-4f02-bc2c-d38f7c790d57": {"doc_hash": "1d500128b883546244a8ea0e2172ce5bafd820d73a877829fbb070308e4cd509"}, "6a261c19-7abd-4440-bb8f-b73c547b338d": {"doc_hash": "ff5a1f80add35d01e010c53d704e33a31eac2707568fe6a546200b8d50948ceb"}, "fdf1f935-4173-4cea-bb38-dd8972d6f371": {"doc_hash": "8f1402487caf1bf2d9dfc9f216be0f0a24b836c3fb9b7b14f37f4a5ef43e8dd9"}, "6cc15f68-cf3c-4a52-abf2-c1223ad10617": {"doc_hash": "5a2d5a7ca41c6e53c525f2848a226bb713d24904dc8643d31a59241443f68e61"}, "0049559a-77f4-4cb5-ade2-75fd5413b5dd": {"doc_hash": "69e423698987217fa2aa9cb17e4101d2c580fd81b092e79eac1b89cb3fb6c7c9"}, "6ad2f737-7d46-4997-81ca-bf3e9bad9ca5": {"doc_hash": "3e474dcf97638f26e33193ad12cef16583823aba680255c5d25ba33c6d93f2aa"}, "aca046ca-5a30-4c57-8305-7be3a2365069": {"doc_hash": "22cf10accd3c69505b123bd7baaaefb9b78e5a8455363ce11e67d1c6afa31cd5"}, "897b6679-3267-4bc9-8b80-a2cfe236d67d": {"doc_hash": "768e5596b2d8f9e86fe2d2d7943150a1cce8f8577b653c0729b4c847d957b121"}, "dd5d13cd-55a3-4381-938a-a6446337c7f9": {"doc_hash": "8b58d53b8a322f951b0490213bae101b9d2f6f9a53538a7e9549e3099e36ceda"}, "a18f6a85-0883-4e33-976f-179135859ada": {"doc_hash": "4978c50a31d6e9b24ac610111ac2eb85c407dfb94307b9d4c98556b486bcd160"}, "0573f79f-96c2-429e-81b2-18333869bb9f": {"doc_hash": "b52abc8f364a6affd530e887a35346e963396b901533f9c8a5cfec92422af0ac"}, "c679ec3a-77fa-43c5-809c-7139dbad247a": {"doc_hash": "78d038ef8a4ddcef4cc0873c83733768f9d9c075bfe43723e91d57119adfc8f6"}, "bd9ea46f-f4df-469e-930e-22dc8921e85e": {"doc_hash": "e951071769dbacf982860550b0a3593c6d59af0cd20f226d0336db5c644bcffd"}, "d9621b70-0205-4af1-ab94-9552f5581fd1": {"doc_hash": "da8c03f2ac2744f6d6b78b29c4f5ac02758b58936db12445d0d8d93ec2936d9e"}, "87d2a4c7-ed99-47de-ba57-407d010dc2a6": {"doc_hash": "ebf811e2e0ef214365ee54a28ef187af4aeaf21c9c74a84bc1152c55fe0ce95e"}, "dee0496d-78fe-41f8-b5c8-53cdeb488bcd": {"doc_hash": "940d9ac8106f9d72eb7bd619ec315c40fd41e256c93bbf5b1ff776b6558ba207"}, "46101aaa-5584-4139-8b93-58e3b270c390": {"doc_hash": "af401298b60bd7386a203aea7c8d3d0ac9fda84cb9e82954a75372f9742013eb"}, "e91d9423-0028-4f02-9b8f-1f666879d1e6": {"doc_hash": "0fbdd05d3b38bc70697af2bb24ed48ec64ad0bd7ac1572b1d9632b1bbf026da8"}, "02e02b10-65f8-41d5-a179-6ff25bdbd003": {"doc_hash": "0e1ec5b3aaf2893ed7b7e9c10f554ee2e1851f267bffadd6bc35b9c010febe53"}, "170ff836-ac26-4ab8-bef4-54faf54bb6b9": {"doc_hash": "532b958575626dddfe327ae916a0c988acbbfd4336e7c9d38283ab2cdb94dbe1"}, "a5c68f11-2106-4e30-9aed-c0f175a9d6cc": {"doc_hash": "c7adc45fb0a70442dcc9151bda2d6027f76e59ff3c66340a172594d381315654"}, "9789d345-c228-47fd-89f0-436c7d1d7b84": {"doc_hash": "54325ea85e0db10eba42afd90ed672b9cff45732210a63564602d6b21101fe9b"}, "ce7278ea-66eb-429f-bd20-12b04f6d67a2": {"doc_hash": "e275127591471f3eb501fed32e0d64d16e11bb25460a9b816a11ecea4b00f21f"}, "ca53e90c-8285-49b8-af6a-69794cc8bd68": {"doc_hash": "86cb7660df56bd28c64d664930dd2d13d2bd215364dbd41d1e8063ce8e64a015"}, "28e1917d-e8cf-4e89-b8ba-89dabead36d4": {"doc_hash": "09a8f877ef7352bf56e0a8c9d5fa74a89ce815018bc84c0903ce04ad7926b68c"}, "3be146d2-bbc0-4967-b795-d7e16b067861": {"doc_hash": "1c009b30e8ac9a89fe7ebcced245ede485cdfe5ad3c403ec7535327bf52dce56"}, "95595593-3501-4404-890f-4bc88a6e1e20": {"doc_hash": "e67b77cff231098b0e86aeb1f026257aa050275da2a077a07360d0ed38a4b62a"}, "1a79c130-3f9c-41a6-8220-c19b4bb4523f": {"doc_hash": "8d22e496afc83dac7a3903832607db8eba0574e6c995657164349240ac8ee9c6"}, "083a40d5-71b6-4cd8-bc44-ce0842bf5834": {"doc_hash": "b1250327540e199c014eefb3c0a16c5db467d8601294f32391aec7d488f013ce"}, "234c0449-cb1f-4345-a903-23d62d94ac12": {"doc_hash": "179b9fe1026a9070a9ff5b95d1c076bdde73a57530c2d9643f200956a2f90cd5"}, "d586f953-027c-4f70-b7db-04fa13a546e6": {"doc_hash": "70c70f9c437c9cecd6482867783ed03a2969e92f58ec4f5a094f2d83c15896b5"}, "2f6a0a0f-780a-4d3a-9730-17f9a41200dc": {"doc_hash": "9a5eb37082fe01a769cc89973d86372e13abf4897d5e07a755efba74a2dbed65"}, "4b4c7c41-d269-4c5f-9185-c669441d1062": {"doc_hash": "31f8413373cfb676d6817f5f615d4f2186244a0134eebdb01f3de3bfc28d163c"}, "d8a59c8d-d77a-43d6-8976-a856459fe07f": {"doc_hash": "fc3693923c6b314895633eecec6f876185f8f19dc4a8f4d5ad222e1702dd3214"}, "921c0272-ed93-4218-be54-f138a10a87a7": {"doc_hash": "122b790b93065a93085be726f21a3fbf1c8f2cd495e5be28d9680e5fe620e395"}, "0f428bfc-1b65-4406-b095-1c5e398960f8": {"doc_hash": "2ddcd517927cbc1f88dca740c43eb82d7414c476a80e08ada0b9bc977270cd72"}, "2c77557f-3e0d-4767-96c3-a468a290760a": {"doc_hash": "7e219fc74fdfdf569e091b1854abc317ec457558cafe47f90ef08b58e35ff18a"}, "dc734550-480b-4437-9e9e-e54439352817": {"doc_hash": "a1f1a6e6fbcfdfc0e94ff03c97e9414d66e0549a265fc8a795a9ed18dd757c45"}, "425fcd81-d7b1-4a13-8c46-55adbcff2ef4": {"doc_hash": "ccfe83a772733bcee76192ba916d3e502a26a8953cfb3864e731dc7c177a4c74"}, "06f20a7e-c8a6-45f6-8a96-203d3351d2dd": {"doc_hash": "9e89f4f664f0283418584045d166112e930b1911957b2f324a1c7ab496958d61"}, "ee554bda-b280-4f5b-9605-5a77ffd9974d": {"doc_hash": "4986dcd9aba3de0c18e4fdc50f40faf12b49039cded4ab96a379f1c6595da8b7"}, "cf4951a1-0e6b-4185-a9b3-fc404b11c0b9": {"doc_hash": "1bc7a46d933c756b47f39f03f2794a1ee9cfebd3a9dfcb2666610177ed819a97"}, "85d3aaa6-8ba8-4b91-a142-c0a109aab745": {"doc_hash": "36f9f34a1ca53a3f49f001d8d7ec745ebf9d5a90e21db3f49e5ae334383275d4"}, "5c0ca706-f1dc-42be-9d9c-2a187148fc6b": {"doc_hash": "6e500f5785756848c23052f4759b4c10d54ca01b798ee45db3cb90f33421f9cc"}, "be661258-2bd1-4019-924d-e6aa631ca982": {"doc_hash": "733bbe22667fe55377b818dcbecb868dc6e7ef4e31f3a8dc68050bd11d10b9c5"}, "a94a0c06-768e-4cc0-b542-049c964b11de": {"doc_hash": "e724d31126d98e30841cfa2a72038278b23e3fb8a3990289198f2c0ab92602af"}, "c646f8de-d8d0-4033-86a6-d6d74a7f23fc": {"doc_hash": "2896a81f0926949a2e16abd72373337aba5900e9d94b7c8e9e773c4739af5627"}, "775b54ea-5567-41ab-974f-aa3335796041": {"doc_hash": "73f68d7f12dd10c614ca4e23b26c6d30b105e5988c0ac8e5962dc8d0a0904c49"}, "b1a09b81-e97c-46b4-8219-f169d8249b38": {"doc_hash": "e48e60c0bd745e728ba06d299eec6ab80b955c4279090d948289dcc0e41a04e7"}, "f7d882b9-6173-4ff9-918f-ec406ccea0d8": {"doc_hash": "0573e1cc8bb4ef1d06b95e2088fed9bf27b38fbccabe3299111b97f983cd16f5"}, "f77565f6-0359-48ef-8bbe-d9f6f96fe6db": {"doc_hash": "b7a213cafd278adb73ea8e0626e0c1e9c75198dea5dbfc56d567a17cf0a2ec95"}, "bc72bd0b-9340-4c36-87bb-261b67d94989": {"doc_hash": "f9c6c4634c8689a157b5d5fdc9f5aaa6c6e21c7fafee45d09cfd352fc456377a"}, "f59e0007-e6ff-4c11-bb25-772c0b47af9d": {"doc_hash": "fa50bdf3bc53d156a5ba4f419008728f75fe14fadc6a5c6a5e3dcc60512863f1"}, "1922f186-6e73-444b-ae8b-b28f5184331d": {"doc_hash": "1e5fbc6783643ff66f04683b64d514f5f484a2852498dceafef3f44c5b7f2e1b"}, "3b275cf1-f139-4263-b401-b501bc83c8c9": {"doc_hash": "a50bfe2e3cacd869f7080285747314f8e7b6ae1af770f4d2b93e873a020d0bea"}, "d643ac5d-35fa-4dc3-8379-8057711c0d76": {"doc_hash": "7f1ff58fd0827c58e5c225afd7e7ccffa0c614780f05a818f4672ca314871b81"}, "7df68562-d35c-4110-bf60-f512b3b0788f": {"doc_hash": "0f6ad614a7ee8e16f595f256ee7440f80757c35ad65e9ff66e72525ff8d8ebe1"}, "a9244289-13e7-4001-9d8e-49f53f49aa67": {"doc_hash": "fafb5f463f0ca4e51837a3b65a5a30af067ee2a794e9438e531ba2bdc63560b7"}, "5cb54a7a-39c1-4b53-aa40-a74732532525": {"doc_hash": "0476c6f003cabdcb74b546e16d9bcdae553f737bda95927e4df89b46d95d9ea9"}, "ed8e5b08-2cc9-4e9c-a2f4-f017c3fe58a0": {"doc_hash": "0e13285e651eb9d869cf6f7582013c6aae602ef8ecd66c49617491037617d8d3"}, "421693c2-4526-4469-9ce0-1bd0d1176943": {"doc_hash": "90d6467e743e9d965c328d51141cfc667662464deea2d48155ebcb185cd73aee"}, "3405c67c-ee88-4fa7-849b-45f62ca0315a": {"doc_hash": "9338fa1c0b8fb0b1ec66c9af59421c09b89938ac64541160453730cbd90b32d5"}, "8401c088-705b-4463-a213-997ac3b63c28": {"doc_hash": "77af2bf009dd95052e1301c427642928cf7361cc2cabe508b1ae88f1d2a3c2b3"}, "ee3931b9-632a-4556-bd68-a29e3ae2e9e2": {"doc_hash": "139a885c32ae7ec70522cee43535090c7e35f068c2d4d916592b5bbc09d5d825"}, "216d3c89-5566-411e-8eb9-a8273ea2d283": {"doc_hash": "ac13f6eaaea19e58301021252a291242abf6d8a6d6bcde73c1507865c0a0b790"}, "602a71b8-6c70-474f-8805-eb620c229423": {"doc_hash": "d3524733aeea9ab4a2fd62f9830b5e1b97b6701bf614e6f5c39e43d9678f19e5"}, "aeeb624e-c3f3-46be-b9a3-10f9fafdaf83": {"doc_hash": "6b68462f95588f30046362ab7717143fb15bbb54a5d9bd3d311dd09ff38261e3"}, "91cf89d6-d60a-438f-a2b9-023262f98c9e": {"doc_hash": "21b4bef8e9b64122c4c81ba8725cc58c5c02d8a9a32b43e7ace634da54735628"}, "45aac0c9-d716-4bf6-af63-3fe2b4cf06a6": {"doc_hash": "8e76d53521fb2f35a21b048e5d2159e9c38cf9f4f962116bd624adf04504593c"}, "22eeda53-78cf-40e6-9842-f83dbb45844a": {"doc_hash": "1b8248bfd51845819c40063ca9cef18befdce7bbd6969549c9880630a0776c00"}, "63a1f3d8-06dd-47e0-8495-d78b5fdac9f6": {"doc_hash": "1588ee852b3a87d3b9e8abd41d0c6a2b8a717e2c977432d58fedc09536c18e72"}, "2cd1ebdf-75e7-4223-a4c1-b7491664d6d3": {"doc_hash": "4b492a3bb05ced7a956ca277cab1899e7d2d7cb1cdf3ea95bb81a0305f7bc117"}, "d11daa53-8c99-49eb-abe5-4483b02ac317": {"doc_hash": "50eb03197291e4b6e896fd5bd9f5c4c2b11080a5be8cc1e789685978270676c1"}, "57965d55-c1ad-4d7f-90a1-a3791a2a78c0": {"doc_hash": "fe7d5315f38179f277ed91cf40968196f65d8ab2947d1c35d1d41a00ba5e5c39"}, "31df4760-baa6-4df8-b6a3-ad6e87d4178d": {"doc_hash": "632b8e87ea071a86964e83d71af85100f18a428838eb8f49534c77c3c771b643"}, "6b582910-a64c-418a-a7c9-bc493f745ad5": {"doc_hash": "7965622e158f28b7c541f47fce3958c98c0ab375f2506a061bd1fbc4da98054c"}, "d93a2112-147a-4f5d-8fdf-5af9cd17b893": {"doc_hash": "38132f7299a919760094a7b2377aa696e7fae5fffca3c8bd8ae84c98625ed6f2"}, "f5ea06cc-02bd-4020-a102-5e446b0b6966": {"doc_hash": "5d198f746f3cec64f96cf042148b5d318f9b28cfadf60b7131cde7ccf0e23954"}, "6a1fe64d-f4a9-4062-863f-37cf1a17576a": {"doc_hash": "114435b3a075af96d9e97f4586293fae970688817de046ee999cf66f48043b3a"}, "d38ee834-7582-4bf7-84ec-a68555bd2bc2": {"doc_hash": "6fca9a4eacf98c3ecdb4be5e0afd5928bf995c7bed0d3a1a01db470807c899b5"}, "ceb135aa-8c1b-4cff-ba92-5561e4591ed8": {"doc_hash": "55e0b4a9c8712b375977547710ccfac5a5b70a12ca5e69688203e132184a4229"}, "733581aa-97e5-431c-9e31-485d6245edbd": {"doc_hash": "21fc9e44571ce55dfa183346a40acd075bcfd858e358ddaf2a002c8769bf9852"}, "0b1318a3-f7b1-4622-9b3d-2e42f66e5d8d": {"doc_hash": "3eef091ae385e4da0c106df5bbbd3ad405619aa17e561e8ac2d35f25fa0a054c"}, "4c2b9b37-0d6a-4241-99fd-d6c85afaa8c4": {"doc_hash": "9548d24253c512ee41bdc23ee4e80478ee9b1919563981f25ded322bfd66af54"}, "ae0db44a-ba09-4b74-b4e2-566d71094900": {"doc_hash": "cf2fa6465b1023f7b4f67a76f898db06af966bf0641c32eba597a38bb8861736"}, "16372890-a5f1-4c5e-8b81-8134278494a1": {"doc_hash": "2c0c0f4be472224ca919c121571419e9b8cb24fb8c1128a4223c9ff1121a8510"}, "0ae89faf-3ec0-40cd-a36e-2ff6a194988a": {"doc_hash": "68025cd3b3d86e9344a354414fe8035ef311e3088616876d474cf6dc79049269"}, "26a2de5a-37ca-4993-be72-f3451e471d09": {"doc_hash": "38796f4475d5a4f4c097f3c5d8f6b8395c3dce7d4e465df1071d0cb7d3d9c7da"}, "1bbbc91e-59c6-4d9a-86ee-93fb7ffac84b": {"doc_hash": "2204c8cdfa4e6287b5c1326b0a628a0311f50917e3efe927b246f578f598064c"}, "2bac64ee-5976-45ec-b2e0-7819b43e2d68": {"doc_hash": "a18050d8d04fb1d207ab4142a3a5f2cb3cdabb126b543738949222534954575f"}, "45f14817-c099-4e06-935e-244fb3622c55": {"doc_hash": "0b6c1ec951fa2ac60a233bc92dd0c3d188765fbde54f73543eb0b47b08fbcded"}, "81ef302a-8dc0-4838-910b-2908b0b0489c": {"doc_hash": "e5f2e08f198bef86afe199ce278872297c18fa5bb232e1570f921e7d06a2279f"}, "8277e6f2-c090-4bdf-ba6f-d4c3730d6597": {"doc_hash": "0748e7bd2601ca574c3b26bec5556e40eb54061802a38bcde1e6c51785f25e46"}, "76d20f18-e95d-4500-92c1-bea0f5a9eae7": {"doc_hash": "461b67ebfe1af9121abeb3a5557a3da9d56d746c0bdaefc321aa804434c3f0df"}, "a54d56db-33a2-4a37-8cb7-d478e2ef5510": {"doc_hash": "72274212c35939c971f99be135f5df83db31a351a5743ab93aded460facda345"}, "f8609595-4f2f-4262-affc-75255774868f": {"doc_hash": "ab7a3500a359ff38f0c0d075f68b4e6969a124db4863c9c03eb4f6c5af9a82e4"}, "9e2a9d2c-9026-4764-a237-af4877be3604": {"doc_hash": "019b5cbf8d000f802dac7405dcba55c23137ffa8e9842167204cd91982b91af1"}, "4fb76642-c6a1-4af3-bea3-5ce3ec162acf": {"doc_hash": "efad436d5318353ad16ef9e166adbaedcbe06156cd7d09649ba60eb4e7964386"}, "b5bb01f8-34ed-4001-a1de-5d393d12d3bc": {"doc_hash": "0b64ab46d8cdfe2d5a209c552db26e36466044734f1e4647a2b344a0ffb351bb"}, "dc40b0e1-c5f9-428a-86a2-10dd95b17f94": {"doc_hash": "fbedee60d370b7aa39e0c31a712189227a3cdde01ee7f4e7e07649715c138d62"}, "b0f95f32-a136-4524-a344-14ef4e6fd677": {"doc_hash": "21c7eb688f268e1a190856a7d6e3dd5405009e91bea18a2b1d8ecbac20988153"}, "da24a0bd-ea7d-4e60-951c-f458c0d2a6e1": {"doc_hash": "2504eec80b9534b1559b1da1094dc05a8036d3d4d72f9a1641df340294a421d0"}, "1982e495-a119-4fc3-80f2-9642414896f8": {"doc_hash": "b8c27deb4722c5e011fb3ee8768ccd86f941091900f06a0d895343ac92b3c8a3"}, "24d7e45c-607a-4d62-9587-bf023879a73c": {"doc_hash": "098986042ade8cfacaf27ad8c76a0dd1980889d0b650e638db780c9b6c4cefe1"}, "e395f3db-f03c-498e-8192-9970c56d21f1": {"doc_hash": "34627fb14d186b5c5c3f7f3983a2102fd7faa8bf5cf0f956680f86ade2cc2075"}, "46927469-ee86-4e08-9017-b52723046954": {"doc_hash": "928314c975391592d94dab565f9c1431eea102fbdd11bd935cb4a93ea5d54559"}, "9ed85387-4afd-4709-b45a-9141a7c0e4e6": {"doc_hash": "600af722174cfc495cc845ad352798b65f6dc820aac0241e07dc971a7e33fe1b"}, "0ea08a38-eccf-4460-8ad9-5fbe5bb43b41": {"doc_hash": "b004bb90c676d193863e0bd3fc2fc82bcc7345951ad8024b72584ee43d7c9dd6"}, "d8c0ec17-137a-42d1-bd12-adf8fb061db1": {"doc_hash": "bc43465b0544b72826c95332714e8a3619b73cd377430a6469f2a52bb6341a15"}, "26cdb1e4-9a7c-4f4d-86a2-b3ad0da865cf": {"doc_hash": "acba3e1c02968c90e6bdb759392ca5166a1fef68f0c98b49bb6927dfa763a121"}, "6f282b2e-ba44-46e9-adfd-35761c9b68d2": {"doc_hash": "120249164b7995252542572825c05d5d76113a45419db538780aab692946501e"}, "6eb113ae-4d87-4781-801b-6550e06b2f92": {"doc_hash": "cb72a0424cc2187b951edff1f307bae8555d448ead4de8000f38afb74af6fc87"}, "b615bd25-1ae2-4a7a-9d48-836752fae871": {"doc_hash": "c402c3d6ca17e9afd2d3a2c85e47d98ccb26791117b88824153782278baaac18"}, "3ac0ffdf-af59-4b99-94fe-8af07b0a4149": {"doc_hash": "e05b24ee94368e06508385eaa1def7bde3c1e40c46e667007791d703245fb467"}, "e70268a6-e9cf-41f4-884f-3f9ad1300828": {"doc_hash": "aa75047327ea4297dc8f562c73d6bbd015f0f1e1ba625755bbb0da9a3ef06d5d"}, "e0d0b33e-84c7-4e76-811f-98b1bfd619f4": {"doc_hash": "8174b1d71d09586c54b39daea049c33f9386f8dd293d65f046326900453cf809"}, "ea5abddb-c16a-4a92-a021-d6c7e380e39b": {"doc_hash": "19f8ebdf32c23ba646d5da55fb0c9227dd49e766644dd4c56dcab832d60e9af3"}, "c1343274-5a38-4f0b-820a-2b11e2ea0c53": {"doc_hash": "b9fa4a12067c8ef9e3abfd7658fafe56b22d7cddd5d62c1b4e287e2951a3789c"}, "7bc34106-b4ef-451e-999e-779866b856b2": {"doc_hash": "2406477c1a8a9bcbd78e62f5f4f01847557aef5f93118d52d9bcaa71ca6c47ec"}, "6e0bd672-07d5-46d1-b421-b037e5ab783b": {"doc_hash": "6f9fc9f729523da6217a6e196f46d2b1f97fde6fd8df177bc5f5eb803a9fcddc"}, "aadb65dc-3cb9-4f52-a6a8-3a3eaf220142": {"doc_hash": "069f41371aaaa8afcfe0f00f1124c5efefe1c10916f8ef02b6c03a49a4685141"}, "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f": {"doc_hash": "9b492fbad0b3b7af27e1ce4e300d1a64e3bc8291c056684ae2c8b08d6e18ab1f"}, "6f62a57b-a8b0-4ff4-b5c3-ccf8c967ff65": {"doc_hash": "79aa8e39227f44c37d6f529adf4f6f39b48d1f915c30f6958213f3f66ca18a52"}, "9b9cffea-5a56-4a6e-bbf2-47f6875d941c": {"doc_hash": "6377f20642643d205ac8dd39437cce5b1b8b365601c6230b977fa89dd3a87d7b"}, "3262b4aa-55a3-4633-b9e4-090add93b670": {"doc_hash": "6df22b60bd271a1423ba221bcdf3c47802ddfabc0999fcec3da3ee706962c2fe"}, "3fcae6e8-660a-41c5-abd3-6141943b9ee7": {"doc_hash": "ca66263b41be5e90ce9a54e726b49035fe5ac612416b11b040dc3c2a8c8a58bb"}, "72c1dd8d-45a7-4d98-9f36-a4df747f287f": {"doc_hash": "d5d15bd848026303ff590af83154700d735f2e4ed367055a7124e536b5bd641c"}, "596286fc-7286-42d6-a2be-460997c2e1bd": {"doc_hash": "fd4ad92cecde199e84c925ace4b18c1cae93ed1710455c92868ebd74b0fff4db"}, "cd5669f0-8768-45a2-8700-6e00aa39eb54": {"doc_hash": "b4c8581df48b2ee260e0f1f572b67063af841e89155ee9dc8b1677b1b7854bbd"}, "696df7ff-0499-40e1-856a-611c9a8c0f21": {"doc_hash": "430d76df997c128b5b0f30d14cb27374853a89aa06ebc3aa36408515b707e162"}, "cad38abf-5546-45a3-be24-40dce9faf12e": {"doc_hash": "41fe9d08bf2be806280ad6aa6d5dacc9c0137c55e9e9291c9320fe7cf451ea71"}, "d383be07-84e4-479a-b226-4de6a2076450": {"doc_hash": "5aa15b083f66c810aecad596bcc01087a1cc1e557f2e59e08b9c6531c5b0d44b"}, "4eafe6cb-6cd5-4d54-b898-55ad86b3c703": {"doc_hash": "40a9f296f5ad710f03841c10b7bb97f31f09d9248da50a07f19295a2ad72e84f"}, "70d0aa84-bacc-45ff-bac4-996c43a41502": {"doc_hash": "30e90f08e8a3986771ea0ebef6ab8150b49ed0c71a94ebbbf749de867967135d"}, "b458fdf1-2816-4b83-9ec7-042a7edf93b7": {"doc_hash": "422f933460d3276a1c7aa7d545327cdb554a3bf372ae3d264b130481ae639672"}, "e665bed8-e9dd-46e9-840d-beb5a980d49b": {"doc_hash": "5715dd3b8bd9b2956d6d37dd42263e8ac4b4e3c2ee2643008428cfbde7873482"}, "5ac04188-968b-4cc7-b7a4-541ee3c04d6b": {"doc_hash": "009e2873763f54d87c6a15ee0824dfe312346ca17e597f10b59cdf9f23ab64a9"}, "dd5d93fd-28dd-46cc-90c9-01dd1e1d3e04": {"doc_hash": "19042be5872bc4ee5061a975c7616979310218dd317439e20323feb78def3670"}, "8fadd21e-73f2-4359-933e-93e650849acf": {"doc_hash": "0d4acef5f5a16908daaecfb7dc3ccdb6703a98b0cf6d4edd3c159825145be692"}, "a8815e0d-98d5-454e-9e85-c15431126bb0": {"doc_hash": "7c9c9d53bf52da6702e939af7d50d447c44b9800a994403b948e36bc97e0bdf0"}, "7b6ca58d-df3d-4106-ad32-b03493eb6fec": {"doc_hash": "ac53eb532c2cdc3c489dde50b5ef7855cb4fbc872bd6db941935ed08cd032518"}, "3c121948-25a6-4b3a-b850-4202c2c55b4d": {"doc_hash": "51abfd256725899eb5144fad8ff3e32f8b672a95e8ce84e07a90efb81f46c8eb"}, "a22cebfd-4862-4be0-a6cf-22e0c45997af": {"doc_hash": "30b5c87fc1fc05d9cb1829088a91e3028c96828fc1cdd2a274cb6dd6cc67616c"}, "097b9294-3483-44bc-b101-44cfd738ab31": {"doc_hash": "5968ed4d40d514bb3937dea1f89ab3c882c8e3c599a480a680e65a45b5c06a65"}, "6f1c5cd5-4958-4f61-92ea-e165808eda85": {"doc_hash": "4bb9f16228dcb22de61be8bff7ef2a654461115aa81824296bd02f297787908a"}, "66f2466b-3464-4c59-9f94-5592c3cec3b9": {"doc_hash": "c0ff19539118bedbf470f999091c14b5f20c59609e7d85a7fdbb37be61de8934"}, "6c76a2ef-6994-4224-8b60-08f89a7b58ce": {"doc_hash": "126a29ac0f09da6711e538069e34522d3ea6ad52e982a4657f4a985db6deb3fc"}, "a1366068-f121-4afc-b703-7b6c9c5bbd82": {"doc_hash": "987a5ef2ae055fcf6722ac235ed9cbb87cd94f838dcab34e2c73ecf565e6c3f3"}, "fff33bcc-3118-4ccb-a956-b733a4aea3fa": {"doc_hash": "fdbd8ffa4dc9c00ca6be889b5a13fdd3cc81080a7f304f15e1aa6eae37e3b42d"}, "4294a3da-1df4-4124-8f1d-2ca8a9524bcf": {"doc_hash": "ecd0b7d6ada92b2c79da81122921518f2891b6464dd594bd5e365133c9b407db"}, "338921a6-dc4c-46aa-a742-86ed7e8ac4d4": {"doc_hash": "4bb1d97ec25fff8a7303faec6e00deead2d4e69418977567c763df87418b427f"}, "614859aa-9e47-4098-b7cb-c7c492c867a0": {"doc_hash": "2939a9871f07c636c7ccec73f822e94fe60f7af334f678d84d989a662a967776"}, "997361f6-035d-494b-b53c-589467c8286c": {"doc_hash": "8289a4227dfac569c48f9469c6f05f5468e4217d72005fe7e576748b1afa8f1c"}, "ccf944c1-e7f6-4113-8e94-e1ef5d8804a9": {"doc_hash": "898ac42bbf0bb56da32a14e867405837296e4d352fccb07f22e114d2db553ffa"}, "6368d491-2054-4793-91ba-0335accbb817": {"doc_hash": "089059325204c0be505d24588b19db8870694684f056aed3ca1b682ff89d7a2e"}, "fbfe30ea-c738-4a9c-b738-7202a960de77": {"doc_hash": "36caf2a5838500cf876d3a8f5c3e3687b8e7929417f69fb4f1e94e305b966f88"}, "13d96e67-c91f-47b4-a53f-4d39e6db72fa": {"doc_hash": "5a016ff71f93ab222062977551dd0cecdc557de6716dc3bc450cf8beee510ca3"}, "cb1bbc6a-73b6-4c93-aa25-fb451e1dc895": {"doc_hash": "b75016ec4a8e2be52050df23fb48cb55b3f89159e4631840d60b98d5373a5099"}, "a5b57957-05c1-4162-8bc2-2a45988523d1": {"doc_hash": "d7fe6f467c5888538a3b3f60e9a7bda9930030d2630db60ab69cc383425d07b1"}, "6b5a9268-49a8-4e11-8eb4-afd0ef9a7e57": {"doc_hash": "d891d3122f0d68a10ffc5a9e5d3cd782b92842df8ae56b19b37f5b75b9ee7a5e"}, "8f1e48d9-1b7c-4e7b-baf2-112029fe5bec": {"doc_hash": "f852f43239d275f42062bb80d4fa232153cb22c3d2059ae7f9af8924461a9fdc"}, "c7a08a80-3f9f-4fcb-9bd9-76f5d31703f3": {"doc_hash": "9cb0ba5edb04c1407805f1c21d5e740c0f6e73f5612e27ff908daed386ab7718"}, "a1a3e470-290c-42c6-a9ec-c0739f49daa7": {"doc_hash": "4981b6d0d559f1e2fc0b9e3950e412cb4fe64cea2ae03e012ca4384090c91e52"}, "aee496cd-8833-4126-9076-61ff13f1f550": {"doc_hash": "c7d6a14927cc9c4bac9f60856fd3c28fa820028a8a07b93b636e72a9bd2683f4"}, "3c9d15e8-677a-4f33-9955-9d5005325156": {"doc_hash": "208b198d0ad4461f7c85f3eae0dcc57bca6885a3e09dec96a87cc164ac484184"}, "642faa24-463a-4fc7-aeb4-538c958acf80": {"doc_hash": "4371bdb1b9f5afce0754adf24e160ded5d89b1a251491a0fbd10152a561028d8"}, "ea94f67f-0fcb-448c-a732-57b2d9f9d071": {"doc_hash": "861fc7ec3e5c4af41c1b74a8eca7d07c3c60ac7d5d84da82dac0573020cb073f"}, "f988e311-6937-47d3-bdbe-1fbd26cf9e6b": {"doc_hash": "52709f480439d24e18370dc6934ca9c1ebff04f6986bea9391b8d212f03c16da"}, "fdd49707-f4e0-4201-b243-aaad2e013138": {"doc_hash": "680285682667b7351c0dafb93e4bd7a2679b77d3c273f8eb7b6b054978b24e61"}, "a044a364-08a8-49b3-8489-990c6a3b1800": {"doc_hash": "83436c375aa89e608c26abfc2a406cac44f3e2b670c8479b30e1de3fa7a1005c"}, "e1e88af1-f877-4e13-bd8f-7f4a59693384": {"doc_hash": "34751aeaf17a1778bbb71a60e5a5d305387632d38eb5430483f60adbc97080d2"}, "2eb720d0-f96f-4905-ad66-a7e3af10f15e": {"doc_hash": "2c1ee499af4ed70b56641120b20b9c0513082c98106f9885e4ed216c5df59c76"}, "264ed794-faa5-40e2-96b8-4f2188d47be5": {"doc_hash": "64e85eb2272aa50e409453b66791364e69f9e5f33a2ad8a1a16372a1694227c0"}, "73d7d395-d05c-485f-a718-5c80d619654b": {"doc_hash": "c1acd24972135463111bc87f012b51514cfe5f1a06a3a2c0f3b1b9a16f396fac"}, "3b31322e-6d70-4a44-bb20-63b367c09a8c": {"doc_hash": "1e550b2aed2eeba82c7e03454c5b347da6abbe26215256299a743240c8ecd5b8"}, "b310ff1e-bd1b-4c31-83f7-98b40eebc7ec": {"doc_hash": "41f3be64bb2b3c2e504317725ca0565d568a93865dc7aa6c8fed3e4ec9e8975f"}, "a89a33d6-519d-43c2-a121-aa43525fa1e6": {"doc_hash": "86f6c29ac87835849383b4943c348ddeaccae16194d22ffcefefe7a7ba8142b6"}, "e3992249-d474-42a9-bb87-0b1d0562a364": {"doc_hash": "9b68e30982b61dcb1485c67057700263398a9b996e2c75ed1eb3c189c2d49bf0"}, "8ff9594a-be99-4026-8121-9b6d5df6eee7": {"doc_hash": "71502848dd0e56000da947e3e3106c4ebff247bf0947e2aa3e1b68cfb0c381e2"}, "ba81448f-0442-4c2f-b16c-bce67bc8038b": {"doc_hash": "b3eb3a669e764bb3da0fe278b6fe9fff7467798d6d8b7eae9f0a9d16667eb2ce"}, "8aa0ac21-e820-487b-9349-d7228e05c00c": {"doc_hash": "e568c6e2821dfa419bc34b89b3a976cf342bc9ddeb362b12c93b459c10f4a722"}, "5cf35a21-4456-4129-9c6d-8c3e26a936f8": {"doc_hash": "2483c61458ddca607f1a87f6b1e24bc52548fb253701127c8bf0c4769ab1780b"}, "a4831223-b50a-4dcf-862c-49bffc3222ed": {"doc_hash": "0c9c3c6fed81e0dac181ae3d9365e58a048c0f611701b27add3dcaa9f0965a0d"}, "9f18c7dd-0b93-45c7-84b2-f815311531d8": {"doc_hash": "a8669b2c4ab0d994a424902d613202359f66b65b55b3835e508aace029942d22"}, "a35cbd3c-cf26-4161-80d7-3901f6c2c469": {"doc_hash": "f7648dc8e698872bb5cd95138300270abe8375560fbefa6ff6f8c3389ff79285"}, "6a92d3ed-1101-4ca6-8ea5-92e9555cafb3": {"doc_hash": "64478a414ec84afedbe4511eae1dd54e0c6ca48f20f840c673e905e2b1942dd3"}, "0cc2738d-c326-411e-aa7b-6dbdae135a46": {"doc_hash": "8b584555889f9293ceb98bc1df9f86f03896345c70531d0740a543d290028b80"}, "59bce370-ead3-48a0-a98a-c4141d6550e1": {"doc_hash": "9eedabfc721f78d2dbc71d2011cf46ece5df925777a6753ac3b09dff0420c40b"}, "b9d06f77-becf-422f-a203-8ecd0c070ec7": {"doc_hash": "7bbab8212a4afa86a934204ccbed70f211d6eff532e2873088c494f01b14162f"}, "4da47ca7-499e-46d6-8e45-7f8b50eef566": {"doc_hash": "edb7cbd8153060b50bd7e30349c16f4d8f8f5c227932e0db2a33b8cb2b6495c3"}, "d781a0f7-a106-4e74-9761-12264b5d0ca0": {"doc_hash": "458a76c035928036c46e34d4b8ff09bf843f65eb1c8572512c8c161cc1bbafb0"}, "2fc404a3-0b9c-46c3-bd1c-80e5760176e8": {"doc_hash": "05a00bb9bcaa1f1c04d588743c985bda6c8d0ce1f92e58bd0869ae0dbbb0aecf"}, "28ae9adb-4011-451d-a9cd-b9dca6dcbadb": {"doc_hash": "e27397144841b1e4e1bc1400687f020db380eeb95e72a17cfb165cfc3865e3ef"}, "a88af453-b979-4a38-9136-3d4d40ffea01": {"doc_hash": "33179e19cc948315190fe73181048ac225bb211dd26d61175b19b1b2c2b9bd56"}, "6a3252ef-d6bb-4ab5-a290-65a2405fe179": {"doc_hash": "dd27768c738e9e717c49c4fc22e0dd349405218a276c56bc7f072dc62e16a7b0"}, "6d46bc92-2755-4d0b-90f3-7f006a9355f0": {"doc_hash": "b2cdc7c7f061e6ea917a8ddcb90eaec73bd6166f6fdd13117856a73d68b1de87"}, "334840fe-c0d9-44ac-ad83-e7814c616fbe": {"doc_hash": "5cf2f4333d4e99b996d27c24f3f2252ce03527027df4fcd6d8d9e9cec58465d3"}, "41107b66-0840-4c4e-9e5b-c86eee3aa48c": {"doc_hash": "b06e773abdfe5ae228be4461c1ad26499365e1aec8703d43941be3b76eef7b2f"}, "c5d758aa-9d5f-4e07-bca2-9e66dc661ed7": {"doc_hash": "90da7c36eda28eade3b0e35a68004381b011b6eaafbe622c3ed84d5e3127c986"}, "6bdd3480-78e3-4e1b-8a2f-56082cd10f98": {"doc_hash": "64abd632c1498e830e62fe0dbc4ef83c3f1392355a77c4fd3270c4b24deb7172"}, "7bb5fbf9-72e1-4185-a112-a35bc5d08029": {"doc_hash": "8f128a6da838d0707dc66a539af2b8b2e096ec3ca53c71a5228fca9e93f0d6e6"}, "fd6ecb25-da29-4603-8c7c-847d48028560": {"doc_hash": "2a61853d454544e73779d3bf38e182d34565fa9242c20e2406e2f8d970ebf399"}, "c4df8cc3-4a95-4ac8-9876-61aa3c88fe72": {"doc_hash": "5376fc14c01768f2c3b624030c5b7cdb127476a0408ef4fd9d34d5c5bec32d48"}, "c6c3138d-c4ea-41c5-82a0-9d6cbba3976b": {"doc_hash": "0a8adfcd97cf4772bb64676ff3c80142514481c5f1bc98842ccce079e750b056"}, "0a0b2be5-12d8-4c32-80b0-fbc723405f61": {"doc_hash": "69f7286d782cf143682f7d2961b209ea1fdd33fab6aed21a5e6d54088d21f55b"}, "32696bea-6ff2-4b60-a5da-5c5b7d62f06c": {"doc_hash": "15fc0900c990988acac07158fa1e687336ee19708c4816675126fb5a857d90d6"}, "3e773a27-c45f-4d6b-a1ec-12225542f4db": {"doc_hash": "f6f48c4524bfa79f3274eebd56bdae492c594335446bd3315fb2fbb17265b961"}, "e8e02b64-8d30-4aff-ab71-9b7bb0a3376c": {"doc_hash": "033a00e82d6bf0ef952d6ce45c55f44978e915dc15ead8d3bf3dee862641cc99"}, "09e342e1-1ebc-4272-8ad5-8c06e7d9778a": {"doc_hash": "14adecaa065027150d019dede9fc193df91f05f5985edea2163a77f40ad4dbd8"}, "97f2c2de-83a2-49f0-8d33-62717964451d": {"doc_hash": "2b8f4ac2788da9c52f52c07b67523a169cb4971c6999685d5632186c2318cfc3"}, "be350762-028d-4c47-a398-24816b706c87": {"doc_hash": "3f80c0b3a3bf1cc5a63f573d701633f46c0835db0c3157ca631c5f084136d7bc"}, "f6d2e636-1c20-4db5-b1ce-26059ec0e8f3": {"doc_hash": "621f1487f6f19940efe6bb7129ad879e3c44de74c392aefd3679384b7d385236"}, "b839f269-0355-4f87-9f73-81ead996a694": {"doc_hash": "082ad9a96598390cd18deb2e7f5e0ea836fc393faa8ee4aa57ed1150cacc71bb"}, "dbf97873-d5a8-4f59-85e8-a491f7808f0e": {"doc_hash": "73bdb115b9dcf5094a2102cc4348e1027300477bfc24e13a908597a345ebc609"}, "f81cb997-ad85-4462-a817-eb6293923ace": {"doc_hash": "69055fe25456edad9fbc5f9c4ea0ff32ce8c262b9a739cec589655ef0b5c4a42"}, "c0fed31f-5e8c-4f33-a2e3-ad634048ba78": {"doc_hash": "52751cf0483ca072e1fad90886c5c575438558e66f2e1d65aecf5d903f9eafe4"}, "6e18cf07-cbd2-4513-8156-635a63f903e9": {"doc_hash": "727685c365e86e1ec26a265298bf04d71e49b56c56f1fb9557a40658cfdc15b9"}, "bae113e6-52f4-42e2-a3ff-19ad468b9545": {"doc_hash": "12c71c77daf52c85463f51e710ed2df0d19c42196c4033ba6881e920de1a9216"}, "1242d105-7922-49c2-b69e-0b57fa3319ee": {"doc_hash": "7402d7b4bd1612329311eabd1686cc4cda872d6ee1462a276e58c06338d22516"}, "92c2d505-353a-40a3-8599-07f8b0c5b82a": {"doc_hash": "e667cbc877478021b761a76ca76ccfc4b791eaae83cc9e058dcddad03fb2bf62"}, "35b4a361-67a7-4fc9-8357-01978184fd31": {"doc_hash": "0214242b18b4fa3945c65c69733b3b2a8ad825fd172e8cfeb8bc291859e0a642"}, "279062c8-1cdd-40d6-945f-eb9542299ca4": {"doc_hash": "52cfe359f96c834b83f908475d257e3aff1ebefff6ac0e5c4b91a1014aec7dfb"}, "c41c8e6b-2663-49c0-a442-06d0d1b5c040": {"doc_hash": "55352aa660eeb7ae6343ee0693c37f620af89c183b26597f519a6525b785011b"}, "a9b12e86-8640-49fb-851b-93d641a9c67f": {"doc_hash": "822fc23f72be301f9b43014c875efaade243a65dba238d45742e9ae21887b034"}, "1867539c-3c6c-44ac-9580-729cb3b3960f": {"doc_hash": "6940d5559355a844a4060fb8dd194cacf9804d05ee060f1c203d4632e2145de3"}, "4eadccd5-73ee-4d1f-8dcc-11083f33e74a": {"doc_hash": "776d35b8e94c721698e5f54477b33844862ff02ff9329c5fa9e81eda100c35c9"}, "be246367-1e4b-4bc6-954b-9769289b3cd9": {"doc_hash": "b855b14ea2776d31bdd4773f7f145421b03b648fe9f3aa2f1b7145a9f10643f9"}, "94698283-d8a7-4477-b7b2-80eef423f4c6": {"doc_hash": "059e37059534281509a2f9e961ce77fab753468f7142ce50fd0c75a11b5610af"}, "a018680b-ab0e-40b9-a1dc-e47944555193": {"doc_hash": "ccb51a38057bfc1211b356562b39a7b73b44b48a92a5e102c9cdae64bd6c3c1d"}, "548505ec-72a0-4728-9ea6-34b61841854b": {"doc_hash": "cf710f3ebac51039997984a2bbeb7c2545f09cdcd2c92d7f78285db6d121b9f4"}, "0c5503f8-88e0-48ab-bafe-cf95ce3bf302": {"doc_hash": "8cf745cddfb1b5038c273291d2860a74af07f5a52e7df4ee28cf288ac56f2804"}, "94dc4d92-1732-4f79-8445-a5e9ea858543": {"doc_hash": "e80d34ba229dbf573f847a6f2b9de4a6b8cc5a3c588d4e071623623c6cfe98e4"}, "d4880f8c-df20-47a7-a667-60e16aafd687": {"doc_hash": "67852c5121b172f02a52dfeb44e3a1e2af9a450e47d66e5bdc4d923308b6b8e6"}, "e6a0d757-1805-4e21-8884-f50e8a2ad757": {"doc_hash": "0a6b0b1fde58a280570232ad3298b31d49704dc025ab4231770317d4daf96d59"}, "7468d813-627c-47d7-9a67-7b323b1585a7": {"doc_hash": "c96b71275585e230d4a417ed0f8c829a09f080542f2bf88a9ccb660f971db8e8"}, "d3b377d4-ea13-4932-99ed-46011b7560b9": {"doc_hash": "2a7b91456d88f236eb5a3aa788b8f32d167716e8b3d7e7855c0504b1c24694cc"}, "85e91e75-16a5-4840-9510-30fd5f8c08fc": {"doc_hash": "1b533e6f7d6657d9ccf245bcd183b4a6623ebe2c67e7df1f91e87d5e8ecf40b0"}, "7f42ea25-2d20-479d-a851-e11a7ebcef30": {"doc_hash": "a3c0cab5a5d0cfeaaf7f24247c017f25c8c9514bb9a8fcf41e594f367eb04e21"}, "1ae502f1-b57f-45ad-8c63-d88edec4926f": {"doc_hash": "c6423aacf1753b2e111f27e08f114dde474aaab3cd6921e7537ae34756cdf62d"}, "581d55a6-14c8-4fd2-b318-fd118d719471": {"doc_hash": "2019da42bd4af114bc70b76f57e962d4836f3849d486aa8ae88a08320b6c25d8"}, "76ef005e-8281-4cdd-b0c6-d0f7232a253c": {"doc_hash": "7934a34f19cf01f164147cdb2861f8039e54fc1aae37bac07556aa46499c82f4"}, "1a8548d5-5e01-4e8d-8c2b-f86719163755": {"doc_hash": "38e993fbf28ea55fab4a242ebd09219811b9126e33aa40fb044edcdd98fb9374"}, "74c4fa35-756a-4fce-9a6d-a95a3206c06f": {"doc_hash": "dbe173bb1a093a8bc41a3f086c9ffcf1515de90c61428d30f53b542d7a1990d1"}, "ce584bb2-c431-4af9-9e30-17f4589b697c": {"doc_hash": "0632add1fc21987ac4f507517749cf9d1ba143dd5458ec3f8374479d6bba591f"}, "38df8e15-792e-411c-8293-8fb13275554a": {"doc_hash": "65a7be1fa62eb679670918bed28e804a6659f5bc3397442c37372db90c7c4b98"}, "d49960a7-3881-47dd-894b-1fdaa340b827": {"doc_hash": "36eb5f444100079c63e7dd018ccd85c4b4c887bd7781c9fea965d807b916600b"}, "4b1b81ae-94d2-4aaa-8811-1cc911043e3a": {"doc_hash": "9036632dcdf05e231135ff89ba3e301a03977e4d4c4adf2f221eab33a6366e25"}, "6ea5f5c6-1dfb-4b57-b9f1-4eb7aa99eae9": {"doc_hash": "58521c238599f67d40375f605950fee59e544557626774a12265e8c924061d2e"}, "c60fd9ed-145a-4951-b9d2-bd917600cda8": {"doc_hash": "9e49dddbdb1b5880d677fdd92d4640ea8b34a75a66281d09f6d3a882f4352a50"}, "4216e4eb-e5eb-4db5-baf7-aa111da14c00": {"doc_hash": "bd17c69c9d30e8a25cb7198ad35748b0f79aa115c9aee6880c9f066ffce01898"}, "b11c04ae-d94b-43a3-bdd1-d10080e96ebf": {"doc_hash": "e15cfb097511b70a38bf5440b6f799b1ec0d055f19cdf0d1f07ffcdef167c32d"}, "ce867913-2ac3-4052-a73e-aa31979f7199": {"doc_hash": "4a1129af875a7b87c2f34195388a52dfd8982f9d26c8e1af0725963711c57dcb"}, "ba9dc1b5-5a61-4730-af41-ffd126776388": {"doc_hash": "7f90d9c5ae3b1992d4c581376404faf4175c54cf00e148f13cbfef8e8a4f63af"}, "3498c175-c3e5-4b1b-ad43-f1307428850e": {"doc_hash": "c12eb2e9961bc71d703f5c0fa1bd229b1c2c0beac6b06b1341c85d8f5d55c145"}, "3bbdeba5-f3a4-4835-8b71-7746d59293c8": {"doc_hash": "b03bcc2466ffd275a02f29f6ad4fba36ac9fbcff2bcc69098855b0e984cf87e8"}, "d54ea398-3832-4835-8095-c0d8dbf16de0": {"doc_hash": "daec8872ad9f1334db37651fc376725b8b43b85d4c2c5df1d1e6bdfbbdfb0cf7"}, "99e79fd2-7517-44b4-ac93-fa99dc4d26d9": {"doc_hash": "fe327240be7b918d45c4afa246ac47c3b6403e69689219efe60b883e4522568a"}, "a412e7eb-0d6a-4655-a2e1-fdac112f27bc": {"doc_hash": "add9955ae472f95b5795472d8c22fb9ea28f750ddc4980049cd7be65c22c3ee7"}, "ac318338-13ed-41d2-a783-42df447ea166": {"doc_hash": "a6199a088d50571749c599ffb4273ab7c7c76283b2f3a9beb0f9789fb04c9325"}, "32df3d74-c677-4e4e-9b11-e1a719b7a1bc": {"doc_hash": "cb0f57b71ab2a65d15f6013d4ccba4e9f07130894e212f3d4547907b7a3bcf9e"}, "1d479855-bc36-4d95-b5dc-04d096634c6d": {"doc_hash": "9571aee60938b99f5a47b5f4e4ed475311bd5a50b773ea3b74598fc35cc9abc5"}, "e4b1b799-2fb1-44a4-a48a-236ae2791027": {"doc_hash": "246bb0a37b693eeb4add5fe7f659c51252b22d771d6e138f4d1d353f629cc989", "ref_doc_id": "86a336fa-a90d-4907-8629-775794e88f62"}, "f57361d4-6a24-47c5-804b-481ee74724d5": {"doc_hash": "57f4da2d17ce7900764d80cafb245d285372bafd0f05eeaba185f30d8dfb1cf9", "ref_doc_id": "961a8292-db8c-4db5-963b-7d864a0838c0"}, "f4d6cebc-8919-41bf-98bc-fd359cd69adc": {"doc_hash": "fc7aef0223d8bd4722a889f35fe9373a6755ea9dd5d66c33f08ad174ee49b349", "ref_doc_id": "78be0d88-c369-4c8e-9d91-1800e4926fdd"}, "c0669caa-cc8f-4b2e-b0ce-0e85f08997dc": {"doc_hash": "84efec56739e81a69bfb58d34a9a27614d0c9471ce9789706ee7ae64d15e3269", "ref_doc_id": "62eb10f9-ce2b-43f2-9318-bc0a18912e28"}, "31e88b75-cf7f-4477-a7ad-b6f33acabd9e": {"doc_hash": "d5840dad73dd13d118671176007cde9b1d8c10d541bdd75d7d8b11016f937d66", "ref_doc_id": "c3522668-be88-41f2-9480-faef9d189d32"}, "f095d34f-8b4f-4e20-9b9f-e62e3ce80934": {"doc_hash": "03961c6bf933702415e900fdfe7badce405a49fe3e0a0df05f34250690364df2", "ref_doc_id": "f8e9ae21-a651-4afa-8e36-4a233be2a449"}, "18afac45-cecd-4237-97e0-764810c8aa67": {"doc_hash": "1477f57a6c1a4c44b0533958c01390937f8a493db588746d50741cdaa303a2a1", "ref_doc_id": "2bb0d21c-ce1d-477d-940d-5a3f611d683b"}, "33bc2f95-a781-4ce5-8289-b2ce542c2136": {"doc_hash": "58f4c64012eabb2aaec9ff33753baf62fd8e0d94e42c2d1a2d29c6de67e9336f", "ref_doc_id": "b93a38d9-3c56-4f55-834f-4a93ceec77a5"}, "bee71f84-e212-4f64-aec3-842db521d9cd": {"doc_hash": "def7d6b2bbe9df5a49816b106462d580f075a9e5e15b264d331f96765aa30e1b", "ref_doc_id": "ff689c30-a77b-45df-a972-859622dd69c0"}, "fb9be06b-95bd-46c2-b767-eff959e08014": {"doc_hash": "7843112e12139fd06615124ac57b07a04852dd661fb43354683e5bf5f64d978a", "ref_doc_id": "21f404ae-13ec-48a6-925e-b8871340ef92"}, "a4ba4867-190a-42df-9888-087277f72ec7": {"doc_hash": "916421ff15c16cfa3a1a9410be3bd91f819878be038ed3290442e9c1d08a75fe", "ref_doc_id": "67af4b81-ecbb-46cc-9233-b353304ee704"}, "b09d27ca-3433-434c-a11a-cd99ad8e8bbc": {"doc_hash": "2ab348ea188675dc85363ee183eac91d842c570a74eebe843bf0b389f1e25425", "ref_doc_id": "9198468a-1196-4456-b38e-e81572af7560"}, "171e6a50-9b28-46f3-a9f2-de76be1cf63b": {"doc_hash": "89dcff9c8c6dd74dae0a74b075827bde9547c936a61b0516e80ba60f7be08d54", "ref_doc_id": "6bc8af54-6469-4faa-add4-ee5b9ce80431"}, "678fb24e-5ec2-400f-8cba-7286f5786914": {"doc_hash": "6e0a959f091fa38470f0f909a172940232874935ca7f11ca9ec113c56000df19", "ref_doc_id": "6bc8af54-6469-4faa-add4-ee5b9ce80431"}, "a375298c-8d31-4a02-97e5-283b716d321e": {"doc_hash": "eab0fd966dd749fd33eb1b863503822cb9fa928829e54f50df4bd52ebcc14775", "ref_doc_id": "e6e61283-0840-4dd4-884c-0ebefae6bec2"}, "2927bf33-5aed-444c-9f12-e4b5a9d1f3d7": {"doc_hash": "29b64a9f3013ed6e295bc11dfd91f65ccfed67f072787d59827113621c7ac6bc", "ref_doc_id": "0f1fda67-d6a8-4cdb-bf97-4ba7f6c3fdbd"}, "0510bbb4-c156-4d83-aea9-bc8913313865": {"doc_hash": "6e97bd8a200bd8d4279b16cd5d95346b0dc64a43d02bcee8dcd0eaa59b3a4823", "ref_doc_id": "2b1bb312-c026-42ee-8a17-1fad8143f1d0"}, "59b0fd3e-a249-4ab1-bfd3-c387eb3fd75f": {"doc_hash": "33f77e6f76777d4064667f1af0b69fb8b555c87e4c5fd257989741d67321aeac", "ref_doc_id": "bb81f289-a8c7-4488-9c4d-1021fb19d53c"}, "8d792a9f-baea-4cc1-9b06-7682edcc8158": {"doc_hash": "62b5b08a388608b13e25739b94eeea97726b46861bcae0ff17e7a2934ac5d9e5", "ref_doc_id": "26eaa4bc-6103-41d7-a12c-30a698609ff3"}, "6c772066-41c6-4d4a-8013-4ade07dc3ec7": {"doc_hash": "45fbdc08ae513151dab062238dbf6413635b7e2e23756c6845ccdb5397dcbb4c", "ref_doc_id": "b113ab81-802f-449b-9db6-3ee5f72033a2"}, "e476c539-b38a-472e-9a8a-da62a8f8b36d": {"doc_hash": "b838b062648129d5406e6c83bf33ea309591bc7650f17fafa3165ede8d7f72b0", "ref_doc_id": "b113ab81-802f-449b-9db6-3ee5f72033a2"}, "900bd886-e07d-4431-9355-a03ecedd49f6": {"doc_hash": "bb50816a5f4f77260fb3ef6d90924dd628f16a5a656c039554f676b5cad4914b", "ref_doc_id": "b113ab81-802f-449b-9db6-3ee5f72033a2"}, "117eb082-65ae-4692-9ea1-da9985187517": {"doc_hash": "fe913146fc2d990b6dbaa9da101df561e95b9cfed06483d8fe12c47831839c32", "ref_doc_id": "00325f72-794d-4e9b-882d-c29ef0e4448f"}, "5debdcfe-33ce-41c7-9c13-a0b00a362e6f": {"doc_hash": "1f1f7daf050407b8ea506d80c2257c0d2c68321e925097ed66ba9a9f9608f2db", "ref_doc_id": "00325f72-794d-4e9b-882d-c29ef0e4448f"}, "df27b1af-962f-4fe4-82cd-c3a3c4f6f1d7": {"doc_hash": "51627ae9d8381f27bf214e29e0f66f372149325ddb5dffef846385d9c7795fd1", "ref_doc_id": "7e0567e9-06a3-4ca2-b2b9-c55cbf644f69"}, "37eea7be-b7d4-4bf3-8040-3f8a292e49f0": {"doc_hash": "19446f6aca67454dc50f7e8bc52410723d79b43cab61e1f1a18b8e5798674e14", "ref_doc_id": "84687bc1-ed51-4ed6-9317-9b43e4a38b9c"}, "4090f594-71a2-4615-9bae-2fa59b3d4354": {"doc_hash": "1a792eed375924b6e157486e2a8747274492bc70026c8743543fe5f11c454ab1", "ref_doc_id": "7baa544f-5bc2-4628-9681-a43bf5e76965"}, "931e04f8-1c4d-4f9a-a667-ec50d6bdad87": {"doc_hash": "3e97df2c796f48bfaef00dfcaefdbedeaa86597360713ef8755ff9dca2cc7331", "ref_doc_id": "823f7865-6a1f-42a0-8a62-38ef5969acb7"}, "9196c4de-297d-4896-bd7d-9894f9dd5bc8": {"doc_hash": "4344bb3f5a48ae7943ed7a6e7b999b938cf8f86b4c3ee92ad86ec8bf90e5c69d", "ref_doc_id": "d553eb02-b777-43de-a92f-3fc3213102f4"}, "35cf1243-be53-42bb-8da8-2925efa3d3bc": {"doc_hash": "44eafc4d11c432ca6c998d4f74982cf00cd2431098688ec010adeaab270124e3", "ref_doc_id": "39a662a1-e0ff-4e04-9fc1-c48c3a61c16a"}, "b4bb0665-64d6-424d-8070-1477e41aacb9": {"doc_hash": "8098324f85a1197272d2e3c861103111ef2bb3a3dfcd6fb8783ac91c8a50a0a4", "ref_doc_id": "39fe581c-3c10-4bb8-8919-1ed4a5fbe707"}, "57f2e0cf-dce7-4625-825c-a7b176cd2963": {"doc_hash": "2bb94a34d2f543a62abfd24e4835b97d52596846c2714377c63817205a747856", "ref_doc_id": "3217b7f5-32db-48c6-a93b-f985b6b300a7"}, "64363041-b4f3-47d4-ac95-6ea4c32e6032": {"doc_hash": "cf4168530428458938530fa2969fc2cdd535d5a63f18515455e8c641cb984d79", "ref_doc_id": "ec27e265-2d91-48a2-8280-e1f8ee2d7da3"}, "90f9ea2f-37cd-4130-bcb7-17b935456e51": {"doc_hash": "f9b81efae6fd451f75e412808fbbc1dd73326acedbb9d1bf218cfb17c89763b8", "ref_doc_id": "ac918cfc-a1eb-40a4-bfa7-5958a6edeb13"}, "396c1f40-d6cc-4df2-87a5-39578cd25395": {"doc_hash": "234fbf33dca9fe96dcbbeac0741a8e4a7ca182ba3d1404f27c364debb60349b0", "ref_doc_id": "ac918cfc-a1eb-40a4-bfa7-5958a6edeb13"}, "45ba85ce-819e-4370-b463-22b9226bd92a": {"doc_hash": "785997571bf0d30c53e848369491d2fbeb9f43aaf8709446db301baff33a43ff", "ref_doc_id": "ac918cfc-a1eb-40a4-bfa7-5958a6edeb13"}, "3684f11b-0477-419f-9fef-98a073e4dba7": {"doc_hash": "9426327e0e18be12a6d3650aac383075a85348ebc27def005ef465f78b651d71", "ref_doc_id": "52c97290-6409-450f-b721-1d681b9f120e"}, "9eafdd91-7c02-4adf-86a9-d1f74ce6a0bf": {"doc_hash": "cd5e0fcfb3de5d41cae20d1b91e9e0566269fb80e89dd2c8108173b2b8fcd031", "ref_doc_id": "529f86b4-666a-4f51-b47d-a1976b2efe68"}, "4ce49949-9fa9-44fc-8d92-e0d82ba20150": {"doc_hash": "64764bc03890a79b7ae7e07c6f125f7dfc13e2c7709e15902873f123131aa9c8", "ref_doc_id": "445909e9-5f8d-419a-ab85-b6216db79d9e"}, "40b1af4b-6630-4fd6-8eff-1b5f5f95f258": {"doc_hash": "41f945e4cfc469d056c1604998e5e7b4313f4b3ea28b57983d672a4b48d6e350", "ref_doc_id": "08838fff-1123-4e92-ae96-c719f5412ae5"}, "23a7c845-8511-4f98-9703-893052036c06": {"doc_hash": "ad0b0d6530e190967ce54a63ccdea5b0a20308c553412d588e4de6b71c35543b", "ref_doc_id": "08838fff-1123-4e92-ae96-c719f5412ae5"}, "6d670b1e-3b9a-4aec-9fb0-da3bdc2e8b54": {"doc_hash": "426eb51ffa16c6cc98a43feda010de21752cbd14109f97e9b3d1729314fd81e5", "ref_doc_id": "7fb8eaab-4b53-40da-bf24-87d9d54aee3d"}, "ee1e3af4-2d8b-4614-81f2-728cdc88bebb": {"doc_hash": "05a84df1228f5ce3762e57c163c9ae91ece3df3bf5b5e24f3148cc557cdb044b", "ref_doc_id": "b23807e2-193f-4f4e-a0e4-cd4dc812ea79"}, "945159ff-2093-42ca-939a-8e1054b1d701": {"doc_hash": "450a3980dc59f4c06af63a22b6d8f1277ee54b6575d695b231a071fb946e5bc4", "ref_doc_id": "f66c3632-a5c9-4a2e-a889-c71dc1288dd6"}, "f4cc50e0-6713-4aca-bfef-cd21204cbca7": {"doc_hash": "2b877ccda6b23315d464a88114b2171abac3852c98040e5b240e1de93c672e1c", "ref_doc_id": "3f46645f-a667-4ee6-8eba-de6e382515fe"}, "f9c1cbcc-82de-4ad8-819b-f19e0169a29d": {"doc_hash": "3b20f89d59fedf109458165bf3aa21e70103b176f5e96cf83bd003f72a91bae3", "ref_doc_id": "00564d05-b1f7-454d-8a1f-0d692061ae2b"}, "11d253aa-3ce4-41a5-8062-3d8fdbc772fc": {"doc_hash": "88f71a128ad7420d82783dff555a59780b7d1c661553da6694af9bcc622f7e22", "ref_doc_id": "d8e07c12-cea3-495b-89ee-f3afcb526622"}, "8f519c6e-8b28-4fe0-8ae6-64734a22f348": {"doc_hash": "9f4e7db72a6370df83cee39754e1d077d71d53909ada4084b3ffa99627990aba", "ref_doc_id": "6ec35928-2310-45b3-9da2-99cd68215bd5"}, "a6ec59a2-35ae-4dd0-9c14-0db1a94414e2": {"doc_hash": "3e99aadbea2992a47aee5662e7fe648a282ea82f05cce1d6add714826f3bf2e2", "ref_doc_id": "0ed4567d-4935-44e9-a34b-df78b3c15084"}, "16d74c8b-e437-4aef-99b0-a62a6d462481": {"doc_hash": "8789f1ddcb16d04c1686925157fc7eead2b7514fa880d021602642e0d1014757", "ref_doc_id": "2534cc9a-18f5-41f0-a729-92fac4ba474f"}, "c8e81117-0215-43c3-aa7c-a8a04b3e85e2": {"doc_hash": "02bee062fab5a884727beecd201ac53b4cda4b00b8651c225c251190922e39ec", "ref_doc_id": "1efaafc0-e785-4612-8d00-e7b5673de348"}, "b102b94f-d992-45fe-9e1a-270b474dff09": {"doc_hash": "5ab00e5df75ce5ddfb88c8e7841af22c2e2ad93c2023162e7da3e6f5ea0a78ea", "ref_doc_id": "09480d51-21b1-44c5-a447-1ffd05fc03d5"}, "0999b84f-94f1-40e1-ba7a-9213ea49a456": {"doc_hash": "78f0de3479701fecd8b50aea486ac09404e59deb912b5f71eaca20124c13f339", "ref_doc_id": "f0ae9030-e6d8-4e4d-8202-31301c93e593"}, "1faaf82b-64ab-45b0-aef3-6882bcc931ab": {"doc_hash": "50a96ae1bced91685e9df483bd2fef2170865d4c499a1c38abf22b6cd6033485", "ref_doc_id": "70711c2a-68ad-45d6-a017-5852ab1f8924"}, "ae905cd9-debd-4e60-bdec-daf328ec3e3c": {"doc_hash": "c8e7cfb52f53731e73f2bd47f4569b4857894d61a319e85c9f7872cf527558bc", "ref_doc_id": "6457b30f-c01e-4d9f-8a94-a8fe5ca848f6"}, "024d1b23-17ee-47b2-aa64-4d1ff684e43a": {"doc_hash": "328801da50c6743460a3a22fc61618bfca7998d172b4a632b376943db70e974a", "ref_doc_id": "6357e222-3151-462c-a667-8015c9b9f16c"}, "f681b665-5ee6-4702-97d0-cbbf254e6e9c": {"doc_hash": "e685a0409ab807b70fcb457ebe4fefed081567966d0f2e8602a9800b7ce3f369", "ref_doc_id": "d1807b48-048f-4fd6-8bfb-02f4e1f187d8"}, "9a0059ce-08de-4d28-a1a7-257ea5415776": {"doc_hash": "6043a38773d750168a728f3e5bc61c1c0f5f891a40e6d46c031822b9c06bc6b2", "ref_doc_id": "00715498-e154-41e0-ab3a-e806b74dfd54"}, "60c5f9b3-c7e1-4e28-95e1-fc1ccd76e11f": {"doc_hash": "28d06575fb540226a6d13c868deffd89787cb18c910dd20e7e2e38f1e47e4b2d", "ref_doc_id": "2a6746c3-b56d-446d-8ccd-b2fc4669bc40"}, "b9a80bbe-14d7-47bc-b013-a0de228e02d8": {"doc_hash": "08a22c01872d0fe376ca35f15026f6773c6c899d251d921b772ab8f47fb280d6", "ref_doc_id": "3a60f030-3eb5-413e-9598-241e34b9bec9"}, "37006fbc-f106-4a8d-ade7-f047cdd02493": {"doc_hash": "69c53c7f493fd0ec741067fc2363223ec77773564c0cc50bdbee04f8e7f1d6d8", "ref_doc_id": "5c186084-fb71-45d3-b855-a98736e1a95a"}, "cbc1b00b-8845-47c4-9596-bf6e167000d4": {"doc_hash": "2e12a62314a980bea0db91016d4407dd603af9dede6d43985ae411214b32ee76", "ref_doc_id": "1c9a8830-ff62-4803-8be1-4ac6234ce2cf"}, "77848daa-bb84-4593-b329-38b3f2c28a63": {"doc_hash": "9d63ba60b43544acf8265bda40b2b5f6e0f62ec25293957a626572487a0929c1", "ref_doc_id": "a1deb375-951e-4e71-bf42-6a4ab6a57b5c"}, "dbfadd46-7c34-496f-88c8-b8bc918efd75": {"doc_hash": "70a9a279f2efecdf6ec37a2f3b1eb3bd87db21fd9db446645168bf51b61ed4fc", "ref_doc_id": "0250c001-0c1e-42fa-88b0-5aca1a293795"}, "543487de-2d70-41b7-8aee-e1ed1f645887": {"doc_hash": "2027be8e9933f4ef4c2dd068450eb886d36e25efc0a21de27a9cb49384bf19f7", "ref_doc_id": "a7645330-70b0-414f-8bb2-e6e11dcee001"}, "e6c7af14-063e-420f-9e85-4c2693d757dc": {"doc_hash": "305bb8ffe3fd542f3ad1a09516b9362c9b38068a85e3b085543a7e2746d57953", "ref_doc_id": "b28a0ebc-7d27-4fbd-90df-81c2068607f3"}, "1c59e99d-7b15-4004-a449-92ee7376016f": {"doc_hash": "a738a98c4d0453bbcffaee11b39034bac81358bd5a770ebffc9354815831fb85", "ref_doc_id": "d8d90c88-2534-4a46-bc16-4e73697c8299"}, "703f6845-eef5-426e-bd7c-c01a3c3cf753": {"doc_hash": "2f73225c6a99d93354d29c22000c32b219d4b359c439a63ec5003ffa524cbac2", "ref_doc_id": "071b3c18-eb34-4c8a-999c-71c77d9991f5"}, "e526f18e-0157-4319-ad71-4a873a0bdd84": {"doc_hash": "5e2b18be9bc95f4cb423ed4468ec07fa58f92dcb2d22b1b2c2fa85657f876e85", "ref_doc_id": "54dc9f07-3b07-4ed7-9871-d316f031969c"}, "8b7eb893-1478-4859-80ca-b8e2024124d8": {"doc_hash": "5f6fb3a75e74ec18b05b6223b52c906b5d6af57d514affad32c9a8842816e1f4", "ref_doc_id": "2a0685c0-8452-4277-b1ec-fdf56d91bd6a"}, "b1286474-7973-48c6-95e9-42c67c42603e": {"doc_hash": "21c1fc6dd6adc3bef62ec698cb214dd452789744947a88d2d84f565a1fc61826", "ref_doc_id": "42c595fe-0797-4aec-8287-5573da8ed21c"}, "d38d0319-b90d-4f01-b6d8-a928f722fa5b": {"doc_hash": "0f44c5f72fb506d000edd5fa716fb8984a95a7f526b9fe93b29f93299eeac679", "ref_doc_id": "42c595fe-0797-4aec-8287-5573da8ed21c"}, "6341cc52-3023-4b49-a260-f4981f127bab": {"doc_hash": "e3f0b3af5c15de93f172181dc214e74638fb5b5e17e35e7d1d8fab1e3530a44a", "ref_doc_id": "1daf1db6-3e62-416a-b184-aa491a24914b"}, "4aff8cd1-3025-47fd-97c9-136422e4ab30": {"doc_hash": "72c14b43f829e6d70f7da7b5dc25c892b5f7ffba8cb2243d321d66ac4c60d9e5", "ref_doc_id": "3620d4e0-f216-4393-be81-593694e12ce2"}, "eaeb9a68-745f-40c1-ad19-fbbbda0354e5": {"doc_hash": "53513e8c0c57c187d9f793da646dca0bddb46fa4f74fe0e21ca2514a9345b843", "ref_doc_id": "43a053a5-09a6-4740-b6e3-2cfcfda8ac27"}, "7ea5efa6-f1dd-4a1c-8d17-0d45d6cb7666": {"doc_hash": "25e6b6e6e60ea239fe1839bc41b9b5123791bdd9d29369c45d6bd73b0e6cfb9f", "ref_doc_id": "961ba8b2-405c-4cf0-b5ac-4602557430b6"}, "d1286d1a-32db-4636-84d0-e828654815ca": {"doc_hash": "ed7b7bae9b2300147b7c281115eae6d1554736839ea2db1ddad6c2b60d7d46e5", "ref_doc_id": "d6f48eae-aed5-454e-868e-6e4d9d442115"}, "4af4abf8-4d3d-4bc6-8be2-a6f372711257": {"doc_hash": "2b5833350c660bfc4f77297c17c22cff51c75af37b938f509e33fb765bfa49f0", "ref_doc_id": "d6f48eae-aed5-454e-868e-6e4d9d442115"}, "8ce251f5-ee42-475d-b193-46141c72dca7": {"doc_hash": "089ed1f0d5f4a4b715895f2c3508c160aaecef89c6f127e31c141eeea480ccbf", "ref_doc_id": "6a37f4af-9884-4314-8d70-77d5027e0251"}, "8e412429-b2c4-4c7b-8d97-91c51abeb527": {"doc_hash": "681a8ad56331eba9cf1649920554db0f8842766622beccb43dd2c19382c632f9", "ref_doc_id": "38ae3605-b002-4eb6-89b3-86d45fab1ed6"}, "aafbd5f8-4ef1-44ff-8141-2b0ad2e401b9": {"doc_hash": "847bb8b113d193bb2af01830a4f643aeb5b57497e34dd87bb3c4704f4e04b86a", "ref_doc_id": "38ae3605-b002-4eb6-89b3-86d45fab1ed6"}, "05b8f910-d422-49c4-a386-7707d8c6cc83": {"doc_hash": "fb22e430a0d6a073b7e4e13c9336f77ad61666d1f2829440f0c589522a28a017", "ref_doc_id": "567aae79-a880-408a-939e-99c8b5133ffb"}, "efc16f7b-51c3-48bd-b52f-bb9b289b02c1": {"doc_hash": "a4ae84ccd1484f4efb8bd1e369b738c4ae07cf108be2be53d9ba3f789ec9d6d8", "ref_doc_id": "567aae79-a880-408a-939e-99c8b5133ffb"}, "3b2cfcf4-06ac-495b-9f1d-4c1bfe00b683": {"doc_hash": "bf561fa61e60b0c7dc8adf51ed02bbc27caf7f2e882bdd6c5260131775d06ef9", "ref_doc_id": "64ca66dc-833e-456e-8668-4b0007d264ab"}, "90c9f6c6-4cc0-4957-944a-ba3e4d987348": {"doc_hash": "19672029f1c9edb33bf7556622354e8970da9ddb30bd3be2b2205b2aa43a9376", "ref_doc_id": "ca8b6516-71b5-4584-bab5-6bb43bfa518c"}, "e63fb069-ddfb-4919-9cb4-0f1466175c1d": {"doc_hash": "e791233e1a0a2ffa09d5a1fde387d369cf004e6f84db6a3be03326ec5646fcd7", "ref_doc_id": "67b42b9a-3c8c-4249-9f2f-743d9b496ff4"}, "fa913110-6ee6-4b6e-8825-ba62c029224a": {"doc_hash": "e7d0ec5dac9554b67848e869aa143f787d7924da89be1acf209ed5474f9b9c0d", "ref_doc_id": "ea11876b-0b66-4938-b379-08e830fd937b"}, "4b42c3b1-657d-49e7-ae80-2f0159947b8a": {"doc_hash": "980ac6a0ad3322a661081a2fbc83189f0ec25942a72c5b9050946a9d15f368ec", "ref_doc_id": "c4168171-6853-4beb-a468-13566f547133"}, "dbc8844e-13a6-48e8-9d53-f6362402c8b8": {"doc_hash": "8c7b83046b504ff281a0fd3cf05a5ddba7fd4b69bfd72879819bef9010c724c1", "ref_doc_id": "a35e87cc-f90b-43ff-845c-0740974e82f9"}, "cf49409d-89c0-4587-96d0-5c92aa7701d9": {"doc_hash": "e645284ee64b0e328ed33747433f4344a2618b68390010276c3f2ee31a829bb9", "ref_doc_id": "ef8db99f-97c7-4e0a-9670-e9500e645146"}, "85d6ecb0-4c1c-4e25-aae8-d609b04d6506": {"doc_hash": "6e16802d2ba42832a5e3a49bdac91b47cfca8ca4b6f261e67a0d3f6c0882ca6e", "ref_doc_id": "eb6608a4-59f1-43ab-91db-3eb8fddf552c"}, "741d6354-3615-43ab-bbe6-9223c4183fc5": {"doc_hash": "61f4d5122c893ed2fe9bf4ff76a66d3d248083d5cc1c32e96a4e0868818bffa7", "ref_doc_id": "e47042cc-6ebc-4b6a-9d65-76c51768896b"}, "1c548914-935f-4c06-bb04-dde918cd414f": {"doc_hash": "0c67d613941a8e90abd7c390dd4112ef619757897c72dfc065a536efc450831c", "ref_doc_id": "b9b7a13e-e917-4f2e-8bad-8ea72792d992"}, "e4c0a39d-df69-4006-91cc-4a7a85d19c01": {"doc_hash": "7f54be4ad06bf7aa3ad1dcda6908dc115c34910cbe23d55a7910a76faddd42f4", "ref_doc_id": "7213ac2f-3f81-4703-bc33-afcaeba8def5"}, "c9d3311e-db07-4c25-98d0-ac53c1ba90d7": {"doc_hash": "298a286f0f232399fe6e5e17278cfdde6fd44a1c5cd08fdaf9a46ed52cab7937", "ref_doc_id": "4645bd29-25b7-4eb1-8486-47d9cd13cae8"}, "fcdcc07d-e08b-47df-ae2d-210ed3151033": {"doc_hash": "9e612c1031954b46e7a54d84bc47741acd8209dfabd4b6b27659eb528e7fd8f9", "ref_doc_id": "a6a35f7f-de88-4414-9c1d-0dad120b1252"}, "5d47da65-9233-4002-a5f7-be65e19bccb5": {"doc_hash": "b6f05212b28b899bb44b6df093669115e2d991380e1e5998470a7da3b7a8aeb3", "ref_doc_id": "59aafca2-8010-4c9d-b176-84a2b5af7711"}, "860aae7d-cab2-4867-ad30-7d2540b49808": {"doc_hash": "78600d4d63aa84ed138fa8e02552c801abdd500fb59d6593dabf256870c93949", "ref_doc_id": "59aafca2-8010-4c9d-b176-84a2b5af7711"}, "e02de7f5-89bc-44a9-baf4-e32504fa1560": {"doc_hash": "10d5712b13b582f9eb626e501fea095250ceb001576fb8dcffad272d2d26a666", "ref_doc_id": "82229160-01fb-44c6-87b1-8234a9b16f11"}, "7b9a2e42-d8b2-469d-8b80-df03c4c28ba3": {"doc_hash": "4d960adc08359354c810b30d66bff24b4314c0478cf500ca83255f4e317e07c7", "ref_doc_id": "b2b7336b-f795-4a53-aade-de2970d7f8d6"}, "eb51e895-a882-4ef5-b029-c141fc964f48": {"doc_hash": "736e54f8c78bf50bc19056c4c588da64bafe46a0198fdd6c67f1cf10dfdce154", "ref_doc_id": "b2b7336b-f795-4a53-aade-de2970d7f8d6"}, "e091b3d4-62e8-49d5-b3e2-491625306acb": {"doc_hash": "6387d569f59c042a9ffabe3a8143752d7b25c9bda721476073ac054f36e737bc", "ref_doc_id": "90dd798a-7795-4067-a885-9cbda366f052"}, "ed7504d5-3e4b-416b-8a0a-adbbf5f4ae5e": {"doc_hash": "b8428a1ad4935bdd5ae55162ab3b49b38046c8f5552d5d9f13eb8fcea77fcde8", "ref_doc_id": "90dd798a-7795-4067-a885-9cbda366f052"}, "1c3f8e7e-f540-4f01-8f59-be1f8e75b0b3": {"doc_hash": "367d5846b981acca75d90f76c5003f6283cdb6905ddb1b186610207e54bf2d11", "ref_doc_id": "f26f4991-ddd8-4aa9-8242-e8ea2539b0eb"}, "6fbc33f8-ef27-4fd9-b9cc-ce5b93902d2f": {"doc_hash": "d226ebe875722ad1a910b367aadf147601c4ce788dd0866525000054b8135e2f", "ref_doc_id": "f26f4991-ddd8-4aa9-8242-e8ea2539b0eb"}, "1ac74132-9760-4bb2-a942-1a65d51d8199": {"doc_hash": "39bce997310d100d0addc312a74788548fa1835bcfa3c8b1a4da0323041ff4f7", "ref_doc_id": "f3e364a2-7276-42ab-b342-f57a9662bf9e"}, "af0b47e9-7222-440a-b9ac-dbaf0dae0b51": {"doc_hash": "4847c9a3875302eb19e9a327b38c82020726b838b73d69f532e7e4a603ed158d", "ref_doc_id": "f3e364a2-7276-42ab-b342-f57a9662bf9e"}, "b7a9452c-44a1-4f7f-b83a-7f2be4543d4d": {"doc_hash": "21844687712f482f57ab97e07e28701538c09a32bd931252cf496f4a79f6c6de", "ref_doc_id": "2dbd0238-2671-4eb1-9eae-60c1ed39957c"}, "6b8d89df-eb45-4a45-ab50-f06f674b3855": {"doc_hash": "c4ea88b57977da3c0d2dc2c201aec916481a063e846b9fab71cbf743264a5354", "ref_doc_id": "ef474a01-1f60-413a-b6ac-e40a87c78422"}, "e58ca28a-d2b7-4f5a-81f6-63b8d78ff532": {"doc_hash": "b4d09860db3e4944ad356065fe2eb7fd42814c3cebcf55a5a093241baf705b8e", "ref_doc_id": "ef474a01-1f60-413a-b6ac-e40a87c78422"}, "44fe929c-c611-4ca7-92fd-d26d33919d11": {"doc_hash": "532c5e67d4d6c8584b30725a1d0b433fd1b0479d132e258d5aebc45f4e756fe9", "ref_doc_id": "ef474a01-1f60-413a-b6ac-e40a87c78422"}, "5d32116e-0195-48d4-9662-3ed3d344872d": {"doc_hash": "7a5811e690320490f2a12ad6c0b65c05e2e3398883e8065a132dfe6cf1645613", "ref_doc_id": "2021a54a-2bb1-4fce-82fa-d7d8c486c349"}, "1d6ca227-c350-471c-9edf-3b3f35244805": {"doc_hash": "0330c6dfdf422e5ce6e31651fff120cdb882edf420bced4bab405cbe735c0481", "ref_doc_id": "2021a54a-2bb1-4fce-82fa-d7d8c486c349"}, "7cf5c4f7-d1d0-4a7c-a940-e179b1c009c2": {"doc_hash": "a3b230486b2533464cd81ae8c8bed4b0fe1482d9ba2a2e143852a7086ea40e5c", "ref_doc_id": "c6a0330a-39c8-4a52-bd30-0ea44b2e721b"}, "354fb203-52c3-469a-bb29-1c610e62b8db": {"doc_hash": "102e0223b48d8c17ca793a52a4605ecbbd64c0f8007873474a425a755e64ac42", "ref_doc_id": "857c5ffa-e12d-4566-9528-ec2fb6ff725f"}, "33bd77b8-f474-4ba1-b249-6db422c20c78": {"doc_hash": "fdee6138222c6c1d158c58f18206f1abd5c78734cf4590d01a8e04aee902d1a8", "ref_doc_id": "bc49b419-b2d6-416a-a664-c6aa53cac0ec"}, "35e3b8f3-394c-4ade-8d52-93112aa726b2": {"doc_hash": "48ee7de543c8043adff0e96d9734f98d06bf751501556506d5f6ed2fcb21bb68", "ref_doc_id": "30007ce5-93e8-4522-aaa8-24663ed54454"}, "7ef19325-dc96-4a04-9297-725fe6201250": {"doc_hash": "5096fa044df35842912c428ba842b3b72f1ed729d60058e65e860b39d35ed50f", "ref_doc_id": "30007ce5-93e8-4522-aaa8-24663ed54454"}, "669a8ce0-fe2a-4020-9479-47cad68024ba": {"doc_hash": "0033af75fbca5926d95bcafcc22dc70a6915393dd7dc09ddacc73fdafbab9645", "ref_doc_id": "263e6387-9325-4935-913b-8a009ab2821b"}, "f70e1e86-477d-4f58-8e02-a2f6e24c2e72": {"doc_hash": "f8fd27c5b32d4995a2e14f47b75a33106c2cd4ec03ba43bdab2a0077949a1ba9", "ref_doc_id": "263e6387-9325-4935-913b-8a009ab2821b"}, "6354e179-af48-4d7f-acc9-aa3dc71f1112": {"doc_hash": "e820f090e740a77d85d1c52b3a1bbb9c51562e2ed7709928ca68e58bf752e3d2", "ref_doc_id": "09bb8409-4ec8-4fe4-a249-9669bafbc766"}, "c9809e7e-8b60-424e-b199-72a201c0f308": {"doc_hash": "10d87e8168d5cface655049a0eefd5f1489051bd36f4a65d74c2854e3be46f4c", "ref_doc_id": "eb8680e4-92e4-44b4-8964-e1ba7e3a68c6"}, "564d01d5-09b8-45bb-ac4a-9656e5590f1b": {"doc_hash": "6441823e629b019391a9baa5e79bdda7478a9bc17c1281c4ce065e70424cb419", "ref_doc_id": "6bc349b6-01ff-4fb9-8add-ffba755e658e"}, "295032d6-5a07-404b-9948-e61ae0dde624": {"doc_hash": "361b336950a112ae51a5c50a31358a754eaab175f652958a0645dceec8da709e", "ref_doc_id": "6bc349b6-01ff-4fb9-8add-ffba755e658e"}, "0e2ccbe5-d0c1-4520-9bdd-20a3d6b6742b": {"doc_hash": "69c38304cd3ee8493242c2f9c72a9b96bf3aad97fdb45146ba9f5cdc85fad8cf", "ref_doc_id": "dbddadaf-9e36-44af-bde8-a20134fc72eb"}, "8986bf2f-4afa-4cc3-9565-e7bcd98b85c6": {"doc_hash": "7fb3f2c3bcde8d99697c893a91762893d61d5adbb8058fb06fde85fdb5a498f4", "ref_doc_id": "ea74c41a-6a95-489a-ae0f-232b07b85682"}, "196ce6d5-0f3f-479e-8888-ee3b896a0552": {"doc_hash": "029d0e6f2cb19f6eade03872f821670156b15d5da3ecfdcfbd47b7cda875d315", "ref_doc_id": "6db64d16-215e-4c86-9d1f-d35886ba5b13"}, "cbd59b0a-c9d9-419e-a873-34911320b057": {"doc_hash": "91f829bbced44e7df8b664fa86de05b578e92678449fe6a5eb116a2846f1a7e6", "ref_doc_id": "6db64d16-215e-4c86-9d1f-d35886ba5b13"}, "7c28b978-5a7a-4cda-9985-ae33c6435d82": {"doc_hash": "11324c5603908df333ee97a0f93880a4248ebce4167554fe7fca75e7401c5a3e", "ref_doc_id": "483b3245-feb1-4e0b-8577-ee318f7c56e1"}, "ed6dfe1f-c3e8-4f0f-ac00-3ba9bd5d9f42": {"doc_hash": "5736be13794a7987ea6c54f5ebd643cb708759f1fad962e91c9b84af89fe9e0d", "ref_doc_id": "483b3245-feb1-4e0b-8577-ee318f7c56e1"}, "c5c27b8f-9fe7-45d1-8fcd-dbe24ea84940": {"doc_hash": "ca6dfdde30bc47528b7c3b4d976323cdc2739b3ce0c81fe3e44ca133e46c8f5a", "ref_doc_id": "dc0cb0dc-03ab-47d6-999e-ebf0f5f5222a"}, "f8f127ac-845d-4ef8-bbd5-2ab57106ed7a": {"doc_hash": "9939d0a31c87e2ba964d9661eb7215d1411979b77462817850689aac8366e17c", "ref_doc_id": "dc0cb0dc-03ab-47d6-999e-ebf0f5f5222a"}, "4fdce03c-9dd6-43d8-a1ef-da8f3b14a24b": {"doc_hash": "ccf484def56eb2afd62427f652032fdf2a46b0aa07d04e6c7cab08f1990152d4", "ref_doc_id": "dc0cb0dc-03ab-47d6-999e-ebf0f5f5222a"}, "caac29ff-734a-4157-a642-d8208024f7f6": {"doc_hash": "ed861c29cd0695df295f486210a853cc25db22bb57efe068049a9f9927b455c2", "ref_doc_id": "572b00b7-ccfc-488d-9f06-4a27f53371da"}, "9358f729-1da2-4093-b91c-134ac7ce7340": {"doc_hash": "16b6b54d718ac4b0fd349d3ecaa67972c0eaddb41abcd3b8a164875778de856b", "ref_doc_id": "572b00b7-ccfc-488d-9f06-4a27f53371da"}, "846f8ffd-22fb-4ced-bddf-714de99cda7c": {"doc_hash": "b6b54b8d23c7eb4d2577d3b36a58b65df14ec03463ea095ad783ce67c4713e05", "ref_doc_id": "19cd7d97-9d91-4aec-8963-80931e2ff5f4"}, "ef9fea72-145a-4950-93c7-fec4c1958461": {"doc_hash": "f6cfcebb430068d171cef4089db195ede3c36c8e5ce00c4cb1f5734240297a20", "ref_doc_id": "b7eb73f8-0128-4489-ba25-62852c1fcd40"}, "c8d60c44-acce-4332-bdb9-be64403ab179": {"doc_hash": "fdf8f70f745b4d78abe5a5b52c6582863d7dba555bf160d85cbc207d126b3e4a", "ref_doc_id": "b7eb73f8-0128-4489-ba25-62852c1fcd40"}, "6870f6c5-887d-41b8-bf2f-022b531f2fc5": {"doc_hash": "c18d202ce86febcd68a505b58bfa6994866fa5845e120e85bd71a029b4a16f72", "ref_doc_id": "6dd1751b-fdf3-4cd2-a9bc-ee2907f2e2f5"}, "a02a8944-9b73-4ebf-899c-ad95b47f39d3": {"doc_hash": "7777ee83c784bfb18f87ff5aa5585a42adb9990665b45a16dc42ed41ab7d7d80", "ref_doc_id": "b6bd8a6b-4248-424a-993c-2b36da7c0c3b"}, "548b213c-3948-479a-9b5f-4c3340730335": {"doc_hash": "930051ff90e94331daa6dc64ff80bac765ce782cb664a719fe916ffd32c6288d", "ref_doc_id": "b6bd8a6b-4248-424a-993c-2b36da7c0c3b"}, "d5ca1f8a-8aff-4660-a519-d40120779c93": {"doc_hash": "c41667c275393d8c82cda08858f5ce1c1864433b12242749fa519a675b2cec00", "ref_doc_id": "6554d30b-8467-4fd2-9a7c-96c89d0b82aa"}, "21e78b45-62dd-42a1-80d4-b49021b29fd5": {"doc_hash": "e1b996e5472feecf7273e01d1adc0a6fcf83fc79e72fa63782bf660bc3bae30b", "ref_doc_id": "6554d30b-8467-4fd2-9a7c-96c89d0b82aa"}, "b8be10e6-d7b8-414d-8255-0ea6e9263680": {"doc_hash": "91751ce2aef1b886d8da59bb85766bfb4c1b002124be2dcf0e426098c2a106fe", "ref_doc_id": "52f25532-a246-4af2-9b90-83d86d828033"}, "48f6f390-7e84-4e86-b763-be9d72cb6a5d": {"doc_hash": "a0532231f0eb38ddba1aaf9a556ed96ec6714a683f2fd0647779428daeff5e1d", "ref_doc_id": "52f25532-a246-4af2-9b90-83d86d828033"}, "71395785-1b4c-42c7-834c-0eed7c11a6b2": {"doc_hash": "4c425b19e0eda4466ca6264b77d1bd9ddc6adf00973d059dce32f4f39d64bbd6", "ref_doc_id": "3554a06b-78d7-42ea-8ed5-b3ae6ad64807"}, "bdd2ef22-8908-4c94-af9c-0dd72b417369": {"doc_hash": "9beae279436319c3ea7ec5a921c864909ade004c7152ef6a71c06924f182d1d3", "ref_doc_id": "3554a06b-78d7-42ea-8ed5-b3ae6ad64807"}, "943af8fc-7557-4ad0-a56e-b757f3a426ef": {"doc_hash": "eb92250c7b463ceb824a1dbb7be9dd5596a5a249fd0069f778969897ab4cb066", "ref_doc_id": "32273914-fe91-4464-8012-1f1d9e0e764c"}, "7f1e1ac2-3f3c-435e-abef-a1dbbd33e6ac": {"doc_hash": "a8df11e7a5ad8fd0226b954df43045a364b61aaa7e80318925151915772b5c82", "ref_doc_id": "27d2d277-ba42-4135-85f3-d91d9f77978c"}, "e8f2aa13-b179-43b2-adf1-00d2675c4422": {"doc_hash": "382c1c15c40915e056c5ee56dfeadf756e63c18d302ba1c2fa2a16a444dd7390", "ref_doc_id": "27d2d277-ba42-4135-85f3-d91d9f77978c"}, "85d02767-e85f-4f7d-b494-d0c0d979b74d": {"doc_hash": "226e2a1f34c230e611ac33a5038aabce2d1e4277703a28606a4e3bd9d2fe4b74", "ref_doc_id": "2fbdd8c6-7a1b-4435-8c09-7cc3f493e9b2"}, "388fbaea-6420-46a5-a675-d2a8521f0303": {"doc_hash": "983ea8c7f578d9269a1e3f37cfb346d7b0ff5e7c2ac7889ab195e485a403dbd7", "ref_doc_id": "2fbdd8c6-7a1b-4435-8c09-7cc3f493e9b2"}, "6dfaa4aa-7ea4-4f37-821c-50826e213213": {"doc_hash": "6c9c9d1358f36bd9ea85c3629ae1062c200a8d39f9e7d3b20022b4ae8d7d9f51", "ref_doc_id": "30fa772d-f408-4e2c-9898-dc79fed670e8"}, "053b006f-9de9-45f8-9f51-8a273a0fd8f8": {"doc_hash": "2e8936ec7a34700bc88599bb1098204c37283347be63058358a620ba8bbcc79f", "ref_doc_id": "30fa772d-f408-4e2c-9898-dc79fed670e8"}, "44fa9db8-7cfd-487f-8e12-f88329dfc1a8": {"doc_hash": "2441c2e2bc398750bb15feeb5b58689c175b5f085f8dc060e56f818b45d7e4e0", "ref_doc_id": "c8334b17-fb1a-4ba1-822b-f92b2bd3c5d2"}, "cb583312-cebd-45ae-989e-aafc91d4d829": {"doc_hash": "8394f6fbeae3ebbf6334edc2573793b403e883a2d162023c1969c6c7822976e5", "ref_doc_id": "c8334b17-fb1a-4ba1-822b-f92b2bd3c5d2"}, "79b2a2d2-1bba-41e0-8514-f56a83f47e90": {"doc_hash": "c28d7007ca4277687231a18c56a992f9e39b22119729febabcb4aa6784c02d51", "ref_doc_id": "80f3e14a-d82e-4007-bce5-067537fd8d75"}, "57280cd2-aa43-4f9f-a6dc-199e07687f85": {"doc_hash": "aaa140dc4ce8b749969ac55759d2907d56cc1b1dd45bae0436fc8bb934918f04", "ref_doc_id": "4c8c58fb-249f-4fd6-8e2b-dc06481d3b5d"}, "3c810dde-7f05-46e9-bb94-cf9029d55007": {"doc_hash": "59349a48789278231eb5035e9dd48ad71a7f47f0e7c3d7492aa6d8600e9762bb", "ref_doc_id": "4c8c58fb-249f-4fd6-8e2b-dc06481d3b5d"}, "b5a22ecd-71b4-431b-a671-dd60be6ff602": {"doc_hash": "561eaa6bc646ca88c96cf4f89117ada65fad4dd9a7d85ad89739c047a94552ab", "ref_doc_id": "d79d0dff-436d-4679-ab1c-cf1acd850ba7"}, "af802285-8e90-4bc9-8ecb-443b471cc9a5": {"doc_hash": "f9041a2474b8c489ed53ea7f99c779d767a62979c84cf9f3bfa0022eec611852", "ref_doc_id": "d79d0dff-436d-4679-ab1c-cf1acd850ba7"}, "82aacd6d-89d9-4099-8b30-51b4aee75422": {"doc_hash": "2a42096834e1f58d1fb70d71d6637030634b8a4952ae8f90798753bb793283b9", "ref_doc_id": "b05bec41-f59d-401f-8e8d-3b4cb88e40c5"}, "d87b03dd-f423-45ca-a00b-f80dbe2ed906": {"doc_hash": "1fb62406f32cc5da20e6ba32e27dfd573eaf4b2818f4cecc210d2b971add4712", "ref_doc_id": "b05bec41-f59d-401f-8e8d-3b4cb88e40c5"}, "1a6842c6-daaa-4cda-b17b-45b342f92889": {"doc_hash": "af9a3739e7d9e4b3b50f4c64fcf4126ad855f4d212a44949de04f953e6c1a0d3", "ref_doc_id": "68cc3412-3d3f-426b-bcf7-76c0e52f4033"}, "e3bd06c5-80fc-48cc-923e-663643301926": {"doc_hash": "fc4619051c2575f60671617687464e8a4a81ed99a6c3c5f4610d61397769582f", "ref_doc_id": "68cc3412-3d3f-426b-bcf7-76c0e52f4033"}, "0f2d82c6-d394-48b3-86da-ce691e6e52eb": {"doc_hash": "5f11a783e8cac26ef5a8f4fcdbcdc406deeb2be8c23538021fde0c5fa6216292", "ref_doc_id": "0f56290c-df58-47b9-aa54-6d16d79c6be7"}, "61cb07fc-2449-4421-b86c-5c98f89f6db6": {"doc_hash": "53e49fecb1b0c1f2c8214ebc72ea68bee521a32c298ccf2636dc3f1085b3ec37", "ref_doc_id": "0f56290c-df58-47b9-aa54-6d16d79c6be7"}, "9d60c064-a6ca-4438-8552-80b74a1ebcb5": {"doc_hash": "5c1a2f719840c1dd60fcf35013e90e4ed8a1ccaf87aa00a37930f9b6e54f8e68", "ref_doc_id": "54d61ee5-a1e1-469e-8778-122a82f431ca"}, "eef859e3-99e3-4c1a-98f0-26badf4a22e3": {"doc_hash": "1877bef6e499a4197510bc0f60a7db56eecc3ff8df06ee9de739f7e638609947", "ref_doc_id": "f4281936-1faa-44ff-b84f-3748f479f753"}, "db3506cd-f2a4-400f-a5ea-d6b9149b05ee": {"doc_hash": "b8fc3cfcdd9b725ca1942b6065e48790bcf42194add48afdbb74bd7d06635ba4", "ref_doc_id": "f4281936-1faa-44ff-b84f-3748f479f753"}, "16642a76-ea58-4d42-8ee0-0c3dec63fa79": {"doc_hash": "0420104b895520637f4665fea620d319135c889f6c304ae5bd6e7e40eb99c9eb", "ref_doc_id": "738c000c-3b99-4a92-ade6-bc365a8004bd"}, "8a6ae6ef-e362-4643-8e86-7dda45b3d82f": {"doc_hash": "52f3d383f2f160f4a2bccec1269dcca6b3ade4c5f252961dd29454d7d01bdaa4", "ref_doc_id": "738c000c-3b99-4a92-ade6-bc365a8004bd"}, "d61ce06c-efd3-4dd0-95b3-36add1340209": {"doc_hash": "31da7ec9d7f8023cf138d932712afd6a6274acb695241208ca2a71d8ec277a64", "ref_doc_id": "51afbf85-25b8-4372-b629-872f5163f1bf"}, "3a8e5bd2-4538-4e6a-b20e-df0617af0d96": {"doc_hash": "122e3759dff36282a5b8fdf99d290f9908d14a85b9e10f4b9f93a48e5eb79660", "ref_doc_id": "51afbf85-25b8-4372-b629-872f5163f1bf"}, "fb01c8aa-353a-49b1-949a-c48e49fc8e88": {"doc_hash": "c9c4ae00f63ba77cfafbd64b90c021b5d51ba4bdf5a11f47baa3dd58ed3a9324", "ref_doc_id": "deed3837-5ab1-4ecf-8dfb-7e8a2600747b"}, "60c03d05-a1b3-4e08-8553-4fd768d4eb57": {"doc_hash": "b68fc4413f6c72f2341cae7da76dd5a07b5c20fb025e62c26b8f589b153d2c88", "ref_doc_id": "8bdedb7b-5632-4426-87c7-87f6991f6858"}, "558e5df4-f91a-4dc8-91f3-3dda4ec44980": {"doc_hash": "33fdd41f233bec31c06fad50cb3a350ac327db88e7a09b0dbcf5af64006f0232", "ref_doc_id": "8bdedb7b-5632-4426-87c7-87f6991f6858"}, "943e7dc7-6b09-40d3-9867-d76c3038b2e4": {"doc_hash": "f83b586d731ef3520727017fa8ce5396cffe4faaf308cb45bae81d5c9ae70bc6", "ref_doc_id": "f159d177-63f9-494c-8654-d2311e041997"}, "0f44d399-0620-4cfc-8481-de5b0464f5cc": {"doc_hash": "b6bf44f254464cf47346381f924a632afb85310a01b7ab4aa71230e673834c44", "ref_doc_id": "f159d177-63f9-494c-8654-d2311e041997"}, "c3b94105-77e6-4f61-9bdd-07dd6054a63d": {"doc_hash": "333a2f7953574541aff0836f75c0d9e5d4f71743d59a71b9df966f0e77aa0e7c", "ref_doc_id": "415cabc4-4fd5-40d0-a1ec-43027e005c5a"}, "a2b13742-b59f-4d94-8efe-9fe299835dc4": {"doc_hash": "d27de1fc1a2c9f3a224d97c76df97357d9b55f9d6fa88c192a2f325ee51d069c", "ref_doc_id": "415cabc4-4fd5-40d0-a1ec-43027e005c5a"}, "b298f532-6687-4624-9a32-6dfdf9c05961": {"doc_hash": "837643dfbc149e2308bd58726100f10c52fc1a17c38c543684ce6b70d5f7ebab", "ref_doc_id": "1715f803-3dc9-4eab-8cb5-c6e2f6717ffc"}, "6fa67bfe-7bc0-46a3-9619-1afcaf29c7eb": {"doc_hash": "e324c9bc6087ab9a663bb4f6fe69b3ddc4805e03c72375737b32ccf02409b328", "ref_doc_id": "1715f803-3dc9-4eab-8cb5-c6e2f6717ffc"}, "a8e97bc5-b4a3-462f-b135-d6cd6a66e176": {"doc_hash": "c64ca4b3fb7917c7cbd69ac565b82401a6019e94160623dbd30aa35d5953cba9", "ref_doc_id": "a0341ccc-be28-40db-b729-b2978a76b542"}, "cdefad4b-4d92-4846-a3a4-f521644c2df0": {"doc_hash": "6043f061a7bc87011364a398d55ec22c4b976d179872c0e6e2eb28ccd23c7826", "ref_doc_id": "a0341ccc-be28-40db-b729-b2978a76b542"}, "67f95f4f-bac7-471e-bdd1-012b91119233": {"doc_hash": "9984f9e6166a3552639ce253059e9c2041c8e4172e325515ceadf02420f5f8cf", "ref_doc_id": "27faa2c5-9909-4f3b-b969-fa3e07644e06"}, "1456a941-acea-45a6-b048-1bee1a4944d7": {"doc_hash": "85a2fa79510308de56f105744b150cf8daec06f6c6624c1ae6e945328e110b1c", "ref_doc_id": "27faa2c5-9909-4f3b-b969-fa3e07644e06"}, "0425d687-d8b6-48f6-8f11-618c1dcc33e6": {"doc_hash": "632b2c26d15c4aad563cede8952180d96027f2640be03d56e144f2ecafc5cd59", "ref_doc_id": "719e9f14-ba21-4bd9-9a19-066dc540f630"}, "2c06198c-4739-4500-973d-0a423e3f85f1": {"doc_hash": "6ae347cdd58372d1e8e2b42ca24fdff514fe44b40f05a6d16259e655501b5afc", "ref_doc_id": "719e9f14-ba21-4bd9-9a19-066dc540f630"}, "881c5ba4-6399-4b73-ad3c-4a3d3ed67464": {"doc_hash": "7515ac4ec15ae63aa9f9ad03c7b386854c6a130eee7e72dc3c9d4422f7ff5877", "ref_doc_id": "55b2c449-4125-43a3-9c00-fc45068338a0"}, "b387b71b-c3f0-4f15-9e95-26d1f004b933": {"doc_hash": "be427315abcfbaecc5a68a7672228771bbab4b0c3f279f0a9d92d007a7b6dbe8", "ref_doc_id": "55b2c449-4125-43a3-9c00-fc45068338a0"}, "2b95c9d5-ac74-472a-a0e5-5e41176b9fdd": {"doc_hash": "c35a10b8a7228f62da76885fe974abb42eef5ab258b6861158cea41e51b98270", "ref_doc_id": "55b2c449-4125-43a3-9c00-fc45068338a0"}, "df7d66a5-b505-403b-af57-2568261e02d5": {"doc_hash": "fc80017227c1e1f7145b65a6d63b4aa4b1b106dca1dca7bac9733dfc6788ac24", "ref_doc_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce"}, "b84acfdd-e056-41a7-b442-c4d6249bffdb": {"doc_hash": "28b8c875de6713c9ab70a3c0a50433c17c8e21c9b3fa52e340c6fcee2b0842d5", "ref_doc_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce"}, "4e737e77-ade2-4e91-9458-c7d3a5cbf336": {"doc_hash": "4a1dd9f2df5f4fd185bc774ee4e5558a6436b499a7e09f8d9d373a32d4f841bd", "ref_doc_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce"}, "f42b0f24-c93c-4884-8c0b-d101df5a642f": {"doc_hash": "e245713853664889a77a73e15e4429bf02efdf94f31f14924ce1808a3856aea0", "ref_doc_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce"}, "0d1c6acb-fa59-4261-a80c-5f3b94f41d01": {"doc_hash": "3a79f8f7012c4dfc035c58dd0a3839fdc9b284da5de35e6498bb1d74b454451f", "ref_doc_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce"}, "f6060ff4-1839-4fd4-9148-2130500640a7": {"doc_hash": "7ddb2d0d48dbf0785cbed55c855e0a5b65857f597ed95b10547a90a76e3d58bd", "ref_doc_id": "60c57d1c-8d19-4093-932d-a9815ba261fe"}, "30b6c504-ba72-4a83-9bf6-a7c6c17ce387": {"doc_hash": "9d7533d0860fadd373d5e07547bbf0d6870bcb81da1d4f482e4724f0243d981a", "ref_doc_id": "60c57d1c-8d19-4093-932d-a9815ba261fe"}, "107e1e12-b1b9-40a5-908d-937e24fec5bb": {"doc_hash": "c1bf8c7245470e2f3fd8b1df399471d8fc441df26662a4878b1735e391ff2fd2", "ref_doc_id": "60c57d1c-8d19-4093-932d-a9815ba261fe"}, "f9787003-1c53-4fed-a586-dc7633b42999": {"doc_hash": "4f26d7ff3ef873babbcb9201f3ae81528bd2c74b9c2632256a1442786e64db84", "ref_doc_id": "60c57d1c-8d19-4093-932d-a9815ba261fe"}, "62a02373-3035-4f58-b814-c0ecfe1842db": {"doc_hash": "bdf5b0de51249e77b0075b13ec59a6dd93462b7d7b5ebb82e71df5f20972cc02", "ref_doc_id": "d46b86a2-f2c0-475d-b314-cfc38a52041d"}, "46e1dc06-5a72-4655-93ff-97c51fce9572": {"doc_hash": "850feef0fe55125c70c0dde753e7ed5b84eefd84d86f219c8de0c8042b907645", "ref_doc_id": "a6b66fa6-b561-4c69-b766-978830e9454c"}, "88b76e76-a62a-4ccd-9ea2-bd258310ff74": {"doc_hash": "7ccdb5c641eca633e9af9efcccfa5253e6cfaf90b3fe9e3a447cdf27cf2f164f", "ref_doc_id": "804457bb-87a6-4b4e-8cdc-d18d5fe87127"}, "a94f8c32-e9c4-499c-93c3-6c8e147cf82a": {"doc_hash": "71e38f08efaaaf19d702fe6bfe6b6f641b8e19d48724064004659d89369c8b5b", "ref_doc_id": "863bb77b-2dc7-449b-91fd-1520b23a7a82"}, "b4fdb5b6-53d2-4e79-996a-a1f5cda2afbe": {"doc_hash": "55242c4cd45f5de20b307d79d08cd98b78cef6875792a267bf68b2274d0de870", "ref_doc_id": "264604a1-8180-484d-91ac-4ebca56f333d"}, "4b6504ef-64e2-45e0-b824-324151127f34": {"doc_hash": "37499292ff3bb50894e3f0ace0f7f6adf95f6bb597d3bd86d8193ca66c42e54d", "ref_doc_id": "264604a1-8180-484d-91ac-4ebca56f333d"}, "15f1617c-fd19-4c81-987e-23000c57db58": {"doc_hash": "98bad48eebc366328e291018267d124eb548bd96c9cfcc9f2e9ca74105f3fe4f", "ref_doc_id": "745d1c63-e052-4f64-b3f6-be386b6d40fd"}, "ea48ae73-3034-424e-9150-091dfb6a999d": {"doc_hash": "02fd4022d6dc650c9cdf42e868c14d2932aede5025b03e2af2a0423cedabf4c1", "ref_doc_id": "745d1c63-e052-4f64-b3f6-be386b6d40fd"}, "a1c559a1-00d6-48c1-b98a-6001ed911aba": {"doc_hash": "b92f3be0a29d824fb724dd55b72ac1e66beeec61618fa5db82d923955baec7c8", "ref_doc_id": "e85369e5-6c58-45a3-be8e-dce4eb419f49"}, "a9ac55ce-6430-43f3-b93d-a15c0590f45c": {"doc_hash": "dc851bbb3ed6f92c99a2030f84411a89cef679541d13e6df866ff8394a683e78", "ref_doc_id": "af9e273f-eed2-4486-944a-2c1af1339bd1"}, "616837f4-1ac1-45ee-9156-574e3d796c47": {"doc_hash": "7d89d265c4da55460f7deffb09174c767da1cec93f0f0ff5db719a55fac0f7a9", "ref_doc_id": "af9e273f-eed2-4486-944a-2c1af1339bd1"}, "cca838dc-e537-4d6a-bca3-872c2eb7827b": {"doc_hash": "2f0a52fff1a165c49f099e2c2548f31e2f92899b5832f0d4b48152c9320595d0", "ref_doc_id": "ccf102f9-e88f-4d29-be07-e92f42b7b1d6"}, "70ea6496-5447-45c5-9958-7fd22e913d72": {"doc_hash": "0274f1457d060bf8b8bdf50b0f5b76801b98d9f7279ff76a63c020a5f93e0ef7", "ref_doc_id": "ccf102f9-e88f-4d29-be07-e92f42b7b1d6"}, "54f2ebd3-face-459d-bcc8-b41736d470f1": {"doc_hash": "d029fa1bbad300f887fb7a33e5833cf87fb381ee076f6cdc0a9333af68bc79a4", "ref_doc_id": "07e4b533-c2b4-49a4-a034-15dabd7c7e3a"}, "dbf30eb8-8cde-4235-a20f-286749cf1940": {"doc_hash": "5e1795968d6338681c1e38f4ac41b98fa909038e28a3a588e14004eda5f63a02", "ref_doc_id": "07e4b533-c2b4-49a4-a034-15dabd7c7e3a"}, "fa6d9118-32fb-4c7a-965e-551670d4aebc": {"doc_hash": "73155b5ca7303f0ba8f6f00f43157499a1aab875a4a5778dede7f4dd1209bb0e", "ref_doc_id": "48d35682-eb3f-4915-8b06-9ee157a3fbbc"}, "c36481dc-3fb8-4345-8d11-e961cf0d9e14": {"doc_hash": "29b5ee1a03b860c8b75734fa821586132fdc2a968db973076d8c3d996ebca795", "ref_doc_id": "48d35682-eb3f-4915-8b06-9ee157a3fbbc"}, "d3eb32fc-147d-437c-9b73-f5b1e8b8029b": {"doc_hash": "841275c61b5a38515ec9d0b5dfdffba3263c2d58f4984733e8b18bb16d307e04", "ref_doc_id": "19f35486-7398-482a-8e54-27fcdf03cbcb"}, "37aeff13-d27c-4e70-b089-b1ecf27bfbfd": {"doc_hash": "cdbc75328d1e729cd8f6e41c9d5db48788c8a5d73d02b2e099fb173dbe8f4d0c", "ref_doc_id": "19f35486-7398-482a-8e54-27fcdf03cbcb"}, "64e6460a-140b-4575-8f11-f7eb7963ca9b": {"doc_hash": "6283ba8b2a998fbadfa8fcd4072ac36c665dbe43c8602ee0de4248f4981dfc56", "ref_doc_id": "983da09d-ba54-429d-a948-d560d34e0296"}, "6d686cd7-5f30-4e33-8770-74f06f4c50c0": {"doc_hash": "4628cf073f1581b3774ae6db93f1ac6f331ab53c28ef16836000232dd20b2c96", "ref_doc_id": "983da09d-ba54-429d-a948-d560d34e0296"}, "3e096d5a-294a-4d4f-a035-2499adccf46a": {"doc_hash": "e75b31c807bc5d765f8a454c29247bdbd1305649bf0c54c3223fcc27ad3ba7e1", "ref_doc_id": "f9373df2-55be-4a05-949e-771fa578692b"}, "cd789ae6-075f-48b7-8ee6-ef29e4e134e1": {"doc_hash": "12d03f34450243e75fc918fbcbfd187938c2f2794bc038acc933a9555b0c1a59", "ref_doc_id": "f9373df2-55be-4a05-949e-771fa578692b"}, "07e24637-d937-4678-8a86-157ac391ec38": {"doc_hash": "0a5e8f84e0c87134e84de82a9a36d9178679d3771ea9b4a59a46b05753ac97e7", "ref_doc_id": "7d5024f8-d8a4-449e-b420-752f59e058a9"}, "96a108ac-c086-4222-b8ec-3b6f32e82ff1": {"doc_hash": "ec54ff3602039974c00070c3d0a34f929fc692fc7a9bb892905aa52031bdc1ea", "ref_doc_id": "148f5249-29aa-4f19-8e1c-f8eb619f17f0"}, "f1a9dcb1-a013-4b3c-8b41-3f563244f750": {"doc_hash": "8d20338afdc8fe9302d05b6e0bb151cdcdd31dd1fd93c22390f38e017d16a81d", "ref_doc_id": "eeaae70e-8bf2-4d5e-aa65-18464b168555"}, "c7773769-b664-4807-a96c-bb5bc4ef6764": {"doc_hash": "1da7b8a01909aa8b86c6b08f0cd256af8f25915963b47c81ca041aee36a4624d", "ref_doc_id": "cf70586c-3ecf-460b-95af-531cbdf007af"}, "a60db4d2-2354-49fa-a8e2-b4c4c07a58ff": {"doc_hash": "ce825821bc82c836cf0b1c8d29f49b085cfd438a7ac0cb65d1b641d80b96f570", "ref_doc_id": "cf70586c-3ecf-460b-95af-531cbdf007af"}, "8c782232-abee-49f9-b91c-14eff4cb929d": {"doc_hash": "2f14ee8744f1d7011f73dee07b8eeb63d6632b061c151186a9c3898983499bd5", "ref_doc_id": "b666503f-2dcc-4c92-a1bd-ba8d92062a38"}, "c6e0f797-f675-49a9-a913-326d96136e05": {"doc_hash": "5c8cc665ff136eb84f013ecf4292e0969061ccd9aad073604ca390abdf0ea63a", "ref_doc_id": "b666503f-2dcc-4c92-a1bd-ba8d92062a38"}, "78ba2d80-7631-4bfe-8e2f-ac91651265c8": {"doc_hash": "4c53d5dea2067baac244dc7ba19c2c8ea1d7a4b701e03561bfece61b17a47525", "ref_doc_id": "66daea96-6cb5-442a-ab53-9b0c13410d5d"}, "8316e18a-ca4d-4832-91c3-02a4ec0f8685": {"doc_hash": "419536f49f702021e10365cc0c1810b028ad8ab605df07349f1ba171800b1db0", "ref_doc_id": "66daea96-6cb5-442a-ab53-9b0c13410d5d"}, "3a2c24c2-123c-4bb9-b897-afe23c2d2c88": {"doc_hash": "154c0cf903af00a3e68cae0a628725bad73e8656aec5a081a841b6da3e536a60", "ref_doc_id": "5d337e49-a9c5-4c97-9f3f-ceb234dae7d7"}, "d6b7a500-7025-4871-89a5-149b48a681c3": {"doc_hash": "d936fe4ba27945d092830c905b63a2d46cf5a37c81d985147ffc342fa7d74ad0", "ref_doc_id": "5d337e49-a9c5-4c97-9f3f-ceb234dae7d7"}, "5fc7f427-2660-4f7c-9600-87264ad2c65c": {"doc_hash": "9a697c36581d4a710fd0042d6fae87496bdaa1b4571fae3a77354c901d4d0faf", "ref_doc_id": "1f970326-be3a-4a32-ae04-0396010ba790"}, "2ccbf18f-aca1-4935-90bc-56d8e440d6bb": {"doc_hash": "97f6931df8271afb0b6242158fdd39a2b6588557feb275d7d533f3c0a4027ac2", "ref_doc_id": "1f970326-be3a-4a32-ae04-0396010ba790"}, "3877fbdb-6554-4135-a190-6ae51c66667f": {"doc_hash": "2243da499586351499e8a3811548e9526d813a8d9a56af30da9130ae783da72b", "ref_doc_id": "627af751-5bbd-4a44-9a21-db2733c16094"}, "c36178db-5099-4218-acf7-a35c43c5a6e3": {"doc_hash": "45fb2889156b2506a760802e8e2a08eb4fed2c1ef5f4792e1ac7d59956b89082", "ref_doc_id": "627af751-5bbd-4a44-9a21-db2733c16094"}, "3b624330-d1d5-4714-89db-2a5d59a1b1c1": {"doc_hash": "69c2c5d68eb51a5666e7a885e74e27e881f802b7c1c01da44fbe160454f19533", "ref_doc_id": "0ec8f58b-20f4-4c09-937c-921c63ba514d"}, "ccbbfa8c-1754-4a0e-8df9-1499bbf1b80a": {"doc_hash": "058903b466bf916b5a83593c47020a739370c03622f0f7dc17dee3c170940b72", "ref_doc_id": "0ec8f58b-20f4-4c09-937c-921c63ba514d"}, "6864ea02-bcd8-4f7f-9e07-bab5a02dbb40": {"doc_hash": "bcf8fec1cbf96d9c5ca7c8842496c472f472bf6de86ceeff9683daeb36008f2a", "ref_doc_id": "550155b8-03cc-47b2-9f92-0ba4dc52593b"}, "ea6d9ee6-b61f-4bfa-a0e0-cc8489244dcc": {"doc_hash": "db00832ec69344b8398d4ea794beb1dfa97c839dfa6976f8aa9711aab8277acd", "ref_doc_id": "550155b8-03cc-47b2-9f92-0ba4dc52593b"}, "aadd2bad-c37c-499b-8a71-e03ca4ab1f0c": {"doc_hash": "9faf033c589046f94e52947b06e5975d42464eff39134110689db68eebc400bd", "ref_doc_id": "550155b8-03cc-47b2-9f92-0ba4dc52593b"}, "52a5f4e0-9162-45ac-a53f-f92124a03edd": {"doc_hash": "9c760355b9fa4767986eb0ad932a8b201bab87e66d741c6ad061cfe93602a452", "ref_doc_id": "016ad7e7-e76c-421c-a6c1-120b648afe74"}, "8e6b068d-1c7d-4729-84fd-1a06fdebe0b8": {"doc_hash": "d0cc0f1d81aef4132c4e78c98a91df266fac46dbbdc07bae0f7d7b6417cc19b1", "ref_doc_id": "016ad7e7-e76c-421c-a6c1-120b648afe74"}, "8c3d02c6-46e2-4d00-b10c-8682504ec8ff": {"doc_hash": "a963909e9d1040ad58b3efac54b5a655e8e6ac0ba8f0253b9019824040a44091", "ref_doc_id": "016ad7e7-e76c-421c-a6c1-120b648afe74"}, "91df385e-c944-4c07-8271-2700fc358ddb": {"doc_hash": "45c914eed022f916bc4b31f6ba95b461d7f3a1ef22432a02d08d8cdd2a030461", "ref_doc_id": "3c85ca06-1a84-4825-ac52-3c4027cf587c"}, "c43f0a11-303e-4364-98f0-8d6b5aa9a08f": {"doc_hash": "664caaee77633cfaaff40f07606e10eb8acfade6712909ee2c4a80dc533549a2", "ref_doc_id": "3c85ca06-1a84-4825-ac52-3c4027cf587c"}, "d3d58bab-a95e-42e8-a6bc-87adaa96157d": {"doc_hash": "3b647adbfe8928c35246f47e369b4f7b937e49eec9c74bfed4727402a534e433", "ref_doc_id": "95381874-e431-4e61-ad84-35cd9828b11b"}, "5b17253f-ebdb-4553-b5a1-6c7c35d5e093": {"doc_hash": "70d45f0857c0bdfaea34e9aeb97541a36bd19e4b1d3a95fb452a68cea209e4c9", "ref_doc_id": "95381874-e431-4e61-ad84-35cd9828b11b"}, "14ad805b-4ee8-48f0-aa19-40418d073ed8": {"doc_hash": "a8a616a2a00f120e422fa077e0ff7e736bd9ff820045fd920e2241b45c31db24", "ref_doc_id": "48461c68-32d2-41f0-a052-a1108d006fc5"}, "e80413f3-c327-4b9e-97b3-7995edbfc33f": {"doc_hash": "918d5d2b4d480fcff7f786d0b7edf57ee6a4d8b1049a1373c15d4f444389fe9a", "ref_doc_id": "26712588-e6d0-469a-93a7-26957b2a1c10"}, "66f6ed12-f106-4c33-8e07-a486e3d8e7d4": {"doc_hash": "aef149b960b05a5e0a4ae5bdfe723b45005bcdc01bc97fdd6f866de7e27007dd", "ref_doc_id": "26712588-e6d0-469a-93a7-26957b2a1c10"}, "ff48fa85-b768-4caf-baac-e984797965d3": {"doc_hash": "637b49450043118c3857be7ebd411fc648b996aa28e58972777caf1b2e1cf100", "ref_doc_id": "134e2e1e-cae3-4af2-990b-7985a34472b4"}, "3c5b649f-3a2a-41e8-a288-1b3fbd848e6e": {"doc_hash": "e9ecaba0747f05e2b33e65390d0d335307def05b58029dee03956f9a290ae50f", "ref_doc_id": "29111159-cbcd-4a15-a9f8-094ffffe6ffb"}, "3eb716e4-b1ef-48a0-9c43-924273b2b6a8": {"doc_hash": "50132f13b72062df714a870f6da12bbc61c5f567d2fe639ea114c3ca85cf914a", "ref_doc_id": "90592ea5-e9c9-47c7-9062-c2c19921c837"}, "28625096-67eb-440e-9c51-8af9262f907e": {"doc_hash": "60079fc81dafba6a4267e18f93771f660c48f14d7b03fccd38e22872a792ca54", "ref_doc_id": "90592ea5-e9c9-47c7-9062-c2c19921c837"}, "42fe300f-8bf2-4385-883a-bc6f801d0d98": {"doc_hash": "ce86d48aceedc228ad3cf137222ed2d556f6a05e1cd082081d572e6c1e214c91", "ref_doc_id": "d140e481-7a14-447d-a413-c1d4b8eadedd"}, "ee49c7f4-023a-4346-998b-4b249bc62dad": {"doc_hash": "658cd2dabb9cd88e98b891b277e9b0449a31ceaf70f86a6e0d0f67dc63fc981f", "ref_doc_id": "d140e481-7a14-447d-a413-c1d4b8eadedd"}, "73de97f8-492c-4657-a4f7-72301bd95c08": {"doc_hash": "192c318b93f47a2c771adb5bafd4cc788232d67d62f1145feb67ce314c4debc1", "ref_doc_id": "26a76724-19a6-4202-bc5c-fb0c0134bf2d"}, "a3f34d5a-d1d7-4ea3-bdf9-0f681eabc7d7": {"doc_hash": "faafd61217df1d71519b412c42aeaea468194c3b520c62baae0f0d016c98a9c1", "ref_doc_id": "65a949e0-67e0-4c09-96f4-2fe13e99c73f"}, "4f285986-e1a9-4a01-88ac-f64153137bb4": {"doc_hash": "333be9dd769b93b05e23b82323e516dae75bc9b62811269ff11d91465687a501", "ref_doc_id": "65a949e0-67e0-4c09-96f4-2fe13e99c73f"}, "7023d4fd-2a0f-46f6-abc8-b845aa4393cb": {"doc_hash": "78a2fd45f95f16018d2830730cabb3161b0ea49217f468c5fd8e71aa1b5bebae", "ref_doc_id": "0285bdcf-301c-47da-8431-7e14df23702f"}, "925ff65c-8101-4be5-9dc1-510d83aaead7": {"doc_hash": "f37550f0d49d14766067e3236e6fa21473f427095b9e81c24ccd1bbf3c7b451a", "ref_doc_id": "f3451a8f-2f63-4dce-aaa7-a0d00322d516"}, "377b8d0f-bc2b-4990-9269-20fa1deab0a5": {"doc_hash": "4e02c467d8be4922cad239c8ce81545b6cfb9eeb1532bfa5cba1e43a74ea6d28", "ref_doc_id": "f3451a8f-2f63-4dce-aaa7-a0d00322d516"}, "ff918a55-b9be-4f88-a925-138e567e9395": {"doc_hash": "a6a001045fe3e99223eec380ea30aa9c01de7b039dec053fffffeea1f6940cd8", "ref_doc_id": "e25b858f-c3cc-4010-928c-72d772296afb"}, "234350b2-67ea-4fe0-86fc-bdafb2c75cdc": {"doc_hash": "8ccdc49fff5b537fe04cbb2e04ab6c4d6d6c0a2b34648b020a5ea00d1ec858da", "ref_doc_id": "70f2c6f1-c01f-43ed-98a8-7c05b1286c70"}, "f31c1c28-ebf8-45bf-84d6-b327e6b95d9e": {"doc_hash": "fae0832fd0045b69f0db9039fb45f701daabe802adb184218c32b967ace33939", "ref_doc_id": "70f2c6f1-c01f-43ed-98a8-7c05b1286c70"}, "2cbc488f-1f31-4b83-a907-ad542a5abbe8": {"doc_hash": "fceb00aaf3d5af1e8db551093ff2f259be70a875343d376802fca0e29cd9cce8", "ref_doc_id": "42dac78a-62f5-4058-b218-0018e75ec054"}, "8e466b71-4cff-42ed-b703-87a5b7edb8b9": {"doc_hash": "3237f1e466177f32bd486f4dad23a5a71c020ce0c9af5681a19ecf35c9a23784", "ref_doc_id": "42dac78a-62f5-4058-b218-0018e75ec054"}, "f1bd0024-733a-4d78-98a2-7089d831494b": {"doc_hash": "8c30ac2fd62c40269c6ad2c837da63d6977bd330cafe33a8cd58276da3a14d8c", "ref_doc_id": "dce9115a-8c6e-4887-bf76-cd49da79c16f"}, "089420f5-fe9c-48fc-bb7b-365908e3ced0": {"doc_hash": "b13fa31e0e6529b57cbd2bf96ce865366e07eb15fc3b0bcf1d77feabbe2468b3", "ref_doc_id": "dce9115a-8c6e-4887-bf76-cd49da79c16f"}, "7429ad74-c24e-40a6-a19a-e321c8e49548": {"doc_hash": "39bb7e6ced68ec0820f681c1e366d5e747872563e21cc85f34c705a6106ba879", "ref_doc_id": "1f74f35a-6580-4a14-988b-b2f4c616e656"}, "bfd54050-5ba9-458b-a7fc-a863c1d91750": {"doc_hash": "6d5d306ca66e4a10556d711f5de3ad30b4852eb8d3d3ff940947bb0df151f7b0", "ref_doc_id": "1f74f35a-6580-4a14-988b-b2f4c616e656"}, "d905d2fe-346e-48b7-acc9-452772404f84": {"doc_hash": "a8b819e687bb0b7bda548b77c45982bfe7c639d152815765dd50f50b077621c4", "ref_doc_id": "3dbf7c93-7227-4e6a-b7c0-c7096558be9b"}, "aace67bc-59c5-47b7-b05e-c6647db75743": {"doc_hash": "5c27ef03013e64d4dbcae8c9620c0b91ff69f3d14433e45b6712a037c862cbbc", "ref_doc_id": "3dbf7c93-7227-4e6a-b7c0-c7096558be9b"}, "ddc951df-83c8-454b-a629-4f458eb58077": {"doc_hash": "1894ff907b328cf8230776018ab1963efd4334cf8393a9434e386ef567e8356e", "ref_doc_id": "d31d96b4-731b-4e3a-9ec5-dc1877642053"}, "959480ac-5bbd-459e-ae2c-54950e15bbd8": {"doc_hash": "06daec8c45208cbd7590221c8514b77dea9fdec4b40c74c3488cd2e1cc32378e", "ref_doc_id": "d31d96b4-731b-4e3a-9ec5-dc1877642053"}, "de491dbb-30f1-422e-8fad-3e29f57999bc": {"doc_hash": "e91b3591afce19a095f2b3035b6a16432ff50aaede4de1c137d4458a2dd1ed44", "ref_doc_id": "eabd1301-d510-4ef9-80db-ce018b3b5dbc"}, "9ac75c51-c2da-485b-8b3d-9a3c23f20bc8": {"doc_hash": "2b78a1d792e5fb746f62702f032cde8f00573a546c328a2b94d8b4599c55a857", "ref_doc_id": "eabd1301-d510-4ef9-80db-ce018b3b5dbc"}, "69feaeb6-e0e9-4f68-89d7-274dbb52a589": {"doc_hash": "f597d6cd63d5b12feeb25c8ab1d8009ed92f5ca4cdcc0f5664bd87d5d38f3143", "ref_doc_id": "e6e4e9fc-aa49-44e8-b5b0-55b80dc1f717"}, "af372453-493a-4562-8e42-8a0db46f2b41": {"doc_hash": "d44220d1687dc3e3699dae47b571ef61a1bc54607ec530383297c65a0303be5e", "ref_doc_id": "e6e4e9fc-aa49-44e8-b5b0-55b80dc1f717"}, "6c46be72-fb42-4c87-9fae-719eb60ed9f0": {"doc_hash": "0e3ce021ae4a05da9dce159539279e14e35bb2edccf41e640d8c1b2d881a0ce8", "ref_doc_id": "1cbb64c6-6a5e-4efe-931b-02abdc7d5f20"}, "a39134be-16f8-4fe4-8ea3-392dffcab1b5": {"doc_hash": "344ee26210edd6f62d0e12b9cc601e70a219d99978e991945fa291eab84d324f", "ref_doc_id": "1cbb64c6-6a5e-4efe-931b-02abdc7d5f20"}, "bf73776e-1e25-4e58-9bb0-8b11c44805a0": {"doc_hash": "4f9a217984b16e2c0c341bad84a36052b8f11edec95aa21136297ae1200c61a5", "ref_doc_id": "82de0c19-acc7-4f7c-8bd7-4353054f5668"}, "3414ac39-2162-465d-bcd3-71d36bb2d979": {"doc_hash": "3fff40df39692001d7a7e00e76a23f7c63e2bd30f3325f662ad7c5c8c59e7ba0", "ref_doc_id": "82de0c19-acc7-4f7c-8bd7-4353054f5668"}, "411fc571-22bb-44de-9cda-2c740695d7b7": {"doc_hash": "5a3a2a01425d47dc79cca9f9deea88b6a74d2ab5cb2e89929f03b5c1d8c4e01b", "ref_doc_id": "82de0c19-acc7-4f7c-8bd7-4353054f5668"}, "a0f62625-7125-4813-9341-8492d15e6d84": {"doc_hash": "aa12b6d5284ee4093ce58f64d13c17b5ee417809c8aeeb60cbda42f4a06e2ee4", "ref_doc_id": "df64b0a0-fcd9-4faa-aae8-dd157031b0d7"}, "82b901ec-bbcc-4f48-965c-aed9aa713ad3": {"doc_hash": "e928c75e37ca8c6db04f345c03a711a5b1d9fec4b95a4cfbde2fe3306e0fd9bb", "ref_doc_id": "df64b0a0-fcd9-4faa-aae8-dd157031b0d7"}, "f8bb1d97-d0a8-4f64-bbbc-d6b19dfcb32f": {"doc_hash": "a3b2d77dbb7cd86e6b04727db8e64994a2094741880cdf021b80c16402be5c29", "ref_doc_id": "0bb35961-a35f-4a8a-a858-415fc3e963fe"}, "0a3dba9f-1538-42b4-b622-b10cb9ff9879": {"doc_hash": "6bfacb97239c11ab97d7f8271bd20fe718f5f9385d0b2fbb15fc718956805048", "ref_doc_id": "1be6e8f2-0252-4f6a-96ef-6c30d75ffeca"}, "69726ad5-9ded-4bb8-8047-161666385162": {"doc_hash": "93eae1b63f4f1cb113fb02a39152f0b3e4a64b53e410d458f2d28659b94f7d58", "ref_doc_id": "1be6e8f2-0252-4f6a-96ef-6c30d75ffeca"}, "44997148-b73c-4986-880a-03bb4554d839": {"doc_hash": "1dbcd23651237063c6c305699928fc034fd50245cff62c6e5a0234d8280ed295", "ref_doc_id": "eb4c1063-ad6b-431d-8a20-8e9b2e468626"}, "4c61a8a9-0b87-446e-aebc-1ba93746df55": {"doc_hash": "717b78197b852ac67c8181e55177f2a5b9811cb0d40058888b11bab12b30c02f", "ref_doc_id": "eb4c1063-ad6b-431d-8a20-8e9b2e468626"}, "6ba046cf-5060-4a37-94ef-28891316eafb": {"doc_hash": "6ca3c9e90bbc06608b4dce6612f4f5b46ce110f0b2a26229970ef8f1fdbf54e1", "ref_doc_id": "e2757759-a170-4e87-8219-8169c2f9cc39"}, "c3e17cd6-d273-48f7-b3d3-7d4351b4c45f": {"doc_hash": "a32c72526a97afd2a2d88184574d13a272fd92ec57201ed2761e8ec36cc39242", "ref_doc_id": "e2757759-a170-4e87-8219-8169c2f9cc39"}, "2fdc476f-2084-4d55-bb07-de85204447f0": {"doc_hash": "fda7fdd1a6be7187fd0f15ec765dba606b7924a9b5de26c1b894ccc20d923e53", "ref_doc_id": "e2757759-a170-4e87-8219-8169c2f9cc39"}, "207e3ebc-4d1f-4866-82c3-b2a4194e6550": {"doc_hash": "fe9f9242db29516fb0d9a560c5a9f67555ea311abc7a6ff609450b7a182381a2", "ref_doc_id": "b38c7021-cb3e-43de-901c-53ac3a0acd17"}, "35fd706e-af26-421c-b8b3-97fcdbb5f04f": {"doc_hash": "76921fec1bba86e7827f2b481c142e1fccdf71c94494cc21ccb10fcd3f434f7b", "ref_doc_id": "ec762da1-86de-4027-9501-9716c7ffaf90"}, "59e8903e-f509-4160-ba0a-5a70cbf17e47": {"doc_hash": "835cade49defe8f3dc4a580007bc4edc67d1738c52343e363045a7674108abbc", "ref_doc_id": "ec762da1-86de-4027-9501-9716c7ffaf90"}, "1d5926e2-2da7-4e2f-be65-516fac2eed1a": {"doc_hash": "2077033ea0b2226182aa9b56f6bcc5316db64aee35e8e1c36d15222b1e95b4b4", "ref_doc_id": "cacf2cf2-a20e-4779-8c26-d16c4eb5b5b4"}, "5fe54bbf-9233-4808-b6ca-76433d402382": {"doc_hash": "fdac6b44b3870f02dbf4c39e3005541c3845921c3c02d4668442667724bf4fcd", "ref_doc_id": "cacf2cf2-a20e-4779-8c26-d16c4eb5b5b4"}, "45ac3c09-16bc-47ef-81b9-9f7daa2944a9": {"doc_hash": "79ac194e04d159c805de76d5057999f69b0c9e1eda55eaccf5546686d5219d59", "ref_doc_id": "12bf5697-b722-4a66-abfe-5a2c0cd7a210"}, "09f0d0cb-8b8d-43ea-8152-01f88106866e": {"doc_hash": "401b91a22264f093924d7dd898e2665c4e46dd4931128f0a2d18ad4b1a9e8653", "ref_doc_id": "12bf5697-b722-4a66-abfe-5a2c0cd7a210"}, "af78efb8-3b17-460a-9278-f47d8e3259a8": {"doc_hash": "81a17d9a33e187bb6f92fde2af91baced8e1d5ee1cf4e432cd9d5b69cfa39421", "ref_doc_id": "357c5ce4-1a1e-488c-806f-0fe3c21ead3d"}, "51c159ad-a39a-4f9a-b14b-3f2ea89a4931": {"doc_hash": "544eb3ee0df1d21a4c97d375ca01f46895bb9422d1be781aeb2176e55df42a4c", "ref_doc_id": "357c5ce4-1a1e-488c-806f-0fe3c21ead3d"}, "2cc51665-6bf8-4c8b-82c4-11e934f6a80b": {"doc_hash": "42ad7f3ee79baf7dcfd95d3967a817e9c2b8d0ac78f54d5bf29347e4d69c323f", "ref_doc_id": "54006636-f6ea-4e39-a7b4-a9dc57da7e11"}, "a45f3a47-22ad-4803-8571-9b3c1844458c": {"doc_hash": "43dabbd31ce7fa7f528c61679f4041cb0b701130896bb24cb91364d966f3ea8f", "ref_doc_id": "54006636-f6ea-4e39-a7b4-a9dc57da7e11"}, "15b59042-1268-4e02-8382-94f041cb7065": {"doc_hash": "d1f4c7dfec063c7b26d71e2f3588d4ba0073ba71d1ba0fab063413503306a9b9", "ref_doc_id": "ddc1d98d-bf62-468b-894e-b849e9a6b9ad"}, "8ed9e86b-1148-4e9a-82b0-de31aa6ae89b": {"doc_hash": "205ff7edabb5cfad77410c563c52eff4c81bb430ce9235ef23fa96dab194682a", "ref_doc_id": "ddc1d98d-bf62-468b-894e-b849e9a6b9ad"}, "854dffa9-c3f4-4ac8-bfbf-6ccbf37cc901": {"doc_hash": "339d4399c7f06b37e92989806b45618ea2967ec456979f37eaf6839b14b4d887", "ref_doc_id": "15ccc356-f37e-4f74-a25c-ee88b5b46988"}, "19606cec-3788-4874-bc1b-5b140b43590d": {"doc_hash": "1b40ef676e5b232359313b308fe734e9e5c03b97c6d8e2b1bd6c03c90e7b8124", "ref_doc_id": "9108b43a-3b89-4065-acbd-3eddee4838f2"}, "ecd26caf-e4b2-4a75-a68b-289c137ecced": {"doc_hash": "ae08041f0d4de85372d0437dde3ca9ca68688688f29ccaeb49820db48849a249", "ref_doc_id": "9108b43a-3b89-4065-acbd-3eddee4838f2"}, "348117be-6056-47fa-9972-e0832661091e": {"doc_hash": "934009745c3badf0b83c7419419dc5a8ef39117506aa3a286a05d213bf2e4360", "ref_doc_id": "57c4c09d-5583-4a41-9140-bdaa07b6914b"}, "2bb163c2-1346-437a-b4d2-87df6d392fd2": {"doc_hash": "881e299976a418b0dee14b044cd7a4796c2cf04e8354c493b76dc5ff852449aa", "ref_doc_id": "de4c71d5-55b7-4c50-aca0-ad9edf8f235f"}, "e4e7f813-6792-4a02-9a87-413aae75d4f3": {"doc_hash": "b745a6f79ba4b81e945546693e9ca10390f1c873df3520e795d0c17c3e9815f3", "ref_doc_id": "de4c71d5-55b7-4c50-aca0-ad9edf8f235f"}, "004844b6-73ce-4118-900f-9e55d473f026": {"doc_hash": "d88e1193443f09685dfd3ab381d811c0585102d928f859e94d8a4d51d361e901", "ref_doc_id": "2887afae-bb2d-4c89-b8f5-f29c1f0429ac"}, "3655a0e8-3122-46f8-857a-733977eb248d": {"doc_hash": "7d0136fe2cdf6b3bb7e6811e69fd927a3da7b7ba01f6e94e0f0b2ba620824fd3", "ref_doc_id": "2887afae-bb2d-4c89-b8f5-f29c1f0429ac"}, "a08edb53-116d-4571-a306-26200ada4ab7": {"doc_hash": "1131e0c78279124879ff7588f5f17f787e05341647c982ce8a11b54ee80d89b0", "ref_doc_id": "385c6838-b164-4a93-8280-3d97b0baa7ee"}, "9103aa5b-2310-4cdf-9bfd-b5d463ad8300": {"doc_hash": "2669abeb171f6eb7abebbe581d6b20ddae059bac3f332e4ba52ffcd4433b1c41", "ref_doc_id": "117fb19b-9133-4e78-91ae-3219ab301ff5"}, "9c59e168-4bd3-42bd-a564-313d743dc145": {"doc_hash": "21a42d30ac9a76fbfcf530437225c7bb5e1a46a19eba5a4630bc30545c23cf1d", "ref_doc_id": "117fb19b-9133-4e78-91ae-3219ab301ff5"}, "546f5a97-8507-4787-9c34-8928940717de": {"doc_hash": "bb61ed48703be69a9810c2c57ba66f0c8e9c912ae7013f1f486d2b8f62c36d43", "ref_doc_id": "77150e98-9717-436e-ae5b-6a129f54ba46"}, "2f3c3b61-92d7-43b7-9c84-7aad8e54b1e8": {"doc_hash": "a88140377cfdc5814663228dc85c4f3bd1fac92baad3c07ae2b93c8c2551e620", "ref_doc_id": "9884a721-51fb-4520-aef5-602714a6b320"}, "332d04b4-9dc0-48d9-8e8d-0975e41f845a": {"doc_hash": "52b5ea7cfa97f65d605a299423dbf331d09cc30a3ecdc57c2447318190c88c30", "ref_doc_id": "9884a721-51fb-4520-aef5-602714a6b320"}, "c44bdd3a-aff2-425d-95a7-fd08b8242213": {"doc_hash": "d20ec0968be489bdfe1508cedbe2e6a51ddd35b44782a37ba1c26a479c6070f3", "ref_doc_id": "0dfca31d-11fa-4be7-b596-c950092a1e09"}, "137ebd01-093b-4e2e-9b1f-62cec712cea7": {"doc_hash": "0181574cdff95848a28146bf208036b8fadeda21ceccee874222f36cbc53bdcb", "ref_doc_id": "0dfca31d-11fa-4be7-b596-c950092a1e09"}, "29ab00cb-208b-4bd7-b997-fcbd1c018c5f": {"doc_hash": "c58601fbe68b7f9ef3a6d56a79fe80b75be29c73e061e1bed2bfc761e60336db", "ref_doc_id": "903e504e-69e1-45e9-b8ae-aadc78b49a1e"}, "89513234-739b-4778-8376-860a0b474d4e": {"doc_hash": "f7e8b3254d9061ab2126d6aade2ee025829848e097a2318ebee32202f55af075", "ref_doc_id": "903e504e-69e1-45e9-b8ae-aadc78b49a1e"}, "5d2f5171-035e-4b8a-8185-aee1a914a176": {"doc_hash": "a7b5412b8954db2655bd5aefbe903e4f1df626a43d0d960d0bd30568d89ddeef", "ref_doc_id": "5c24a704-442c-4149-8eb8-871e561e53e9"}, "b6469387-448e-47c3-8560-de5a347e6ec7": {"doc_hash": "7c9c5ec2e146288eb54b413a99f453645247f3349edacebdd8f65c993bd277fa", "ref_doc_id": "1ed8ac25-fddd-442c-9f25-afb056379dd7"}, "ca8c82e1-bc82-4e95-b1e6-f4eaee669d30": {"doc_hash": "d694fb8c861345abd9b4d1f09a575e0fdddb3eece125c8760169e57765d1e2a8", "ref_doc_id": "1ed8ac25-fddd-442c-9f25-afb056379dd7"}, "c7dddfe8-e6cf-4f06-be3d-ac314dede628": {"doc_hash": "9b57de3f35f7839933eaf5f196b1933219a6bdd7c6eec480a6c2cee1a905aadd", "ref_doc_id": "1ed8ac25-fddd-442c-9f25-afb056379dd7"}, "b513de80-4830-44db-b523-f17ac4828de8": {"doc_hash": "c09bacab7aecf512ecc90a95f2cb9bdeda188553b6ee7542f6cb94e0af8345b0", "ref_doc_id": "1ed8ac25-fddd-442c-9f25-afb056379dd7"}, "8b43bc5d-c5d5-4482-8a0b-0f185a60bd27": {"doc_hash": "5f1f2a4a4d8d9a242feaea8cee9da1811f43aa93c40fc07b07ee3f7eb0fedd5b", "ref_doc_id": "ede94ee4-5ba2-4357-985f-918ccacb55fc"}, "7a8a3624-477a-450a-b541-162557327e20": {"doc_hash": "1793ac7280476d55b1aa3b1a9b6bc0a8b36bb06d4360068f2ca57f29f013ce77", "ref_doc_id": "ede94ee4-5ba2-4357-985f-918ccacb55fc"}, "545ee71e-6f4c-4d7c-92c4-cae9de47b2e2": {"doc_hash": "3498073744703dd09ab6eafbcdabd9c4ea779dc9e117d9ad8e7ea97a69d21aea", "ref_doc_id": "ede94ee4-5ba2-4357-985f-918ccacb55fc"}, "b3e455d4-b3d6-467b-ba8a-05bd4ab1667f": {"doc_hash": "5a3b11bca2e48021e8d002b9587c6c953f52c93169844f745bcb84475a89dd02", "ref_doc_id": "ede94ee4-5ba2-4357-985f-918ccacb55fc"}, "c87cfef0-4b2b-4820-a773-dea71addb5a1": {"doc_hash": "aa04d0678067737d09e4253d7750c08fddbdf7beaedd244215ee932144e65cb6", "ref_doc_id": "22c9cb55-fb0b-40d5-a2c3-dc0e7fb86bc5"}, "8a183db3-f2a2-4a7b-b319-c96c85721fc9": {"doc_hash": "a1490c46803c669c4056cd74537557e988f03fee721e35b1180f7900f6c62873", "ref_doc_id": "4f21dbc5-e2f9-4d66-9b0f-1e30d61ae0f3"}, "acbc312f-e494-4431-aa07-d919370dd880": {"doc_hash": "4bc3d711d7204f5737eae85c3563b349678bd8b251912eeb8f118b69c04e02e8", "ref_doc_id": "4f21dbc5-e2f9-4d66-9b0f-1e30d61ae0f3"}, "984aad14-89e1-450e-afc0-e9bde19f09b2": {"doc_hash": "eddc5fbffbe57bf704c095c65c304f83d09edfcf73788c07d73e85b3e9aee58b", "ref_doc_id": "a3fa06fd-1be4-43bc-913f-fff5e8cc0bff"}, "84c98189-1c2c-4dda-be3b-3d9857853ee8": {"doc_hash": "23f315b5fea567eb3b9de95a98d56b8acded0d67c714cdee809e3b7b8a058383", "ref_doc_id": "d29bf1b9-63ef-473b-b7a0-60751ce3ef65"}, "b5b2585e-3357-4f63-af6c-e9b93ae7daac": {"doc_hash": "a3001e3f2fdc303c1068c37816394bc9eced7020cb8aaa038d08d3c17d031a5d", "ref_doc_id": "d29bf1b9-63ef-473b-b7a0-60751ce3ef65"}, "860ac099-0927-4e81-b893-51fbb4f13357": {"doc_hash": "a555864745d1274f9d7c66535e67c0f35f51a7a4d6f6c680de2d61b4c7e45158", "ref_doc_id": "65c1b426-4c93-4cd0-a8f2-9a0ba2a297f6"}, "34bbbd54-a3c2-48a6-a741-8968bbde7a47": {"doc_hash": "b176e5e576283d532efe77a3b31550ab0d5e8503f4ce7d4ba5b7b06a238c12f4", "ref_doc_id": "284a764a-ff44-4c5f-a25b-1ae6d960e950"}, "9d414dac-d17f-49d8-b42b-1f0e85a4892b": {"doc_hash": "18e295246c8ef6364aa564591b13cb28c2d06d64f56f231dc56648e800b678df", "ref_doc_id": "284a764a-ff44-4c5f-a25b-1ae6d960e950"}, "bf1e5b89-e812-40f2-9848-57a5cd28a0d4": {"doc_hash": "7bcbdd3a6e5b94d1a713deb7f919a186e7901e1f9082c1d3548633d7b9c7f917", "ref_doc_id": "5cac06f1-0ae3-4569-874e-baf9050667fa"}, "976d5496-0701-4939-af98-7e4b09bd16b2": {"doc_hash": "583228fe3fa396acbbf2949f807ac3c8f9cd90c777c5cb8f8f56e5b69e42fefd", "ref_doc_id": "5cac06f1-0ae3-4569-874e-baf9050667fa"}, "1dd041fb-bad0-4262-91d3-5b6e19b81acd": {"doc_hash": "fce395ba9e30d69ef573084f51dd267ab87a4f0dfe83b4be43441540317062c2", "ref_doc_id": "31293a19-82d0-407e-9178-224274d45777"}, "79bf663c-f150-4670-9ea5-c65108d71feb": {"doc_hash": "2f2ce94cea2435fe3a84338b26affc6b13e0d20e9c97a8908b2e7674f4332438", "ref_doc_id": "1c189957-56b9-4c3b-9555-71ac1653ea86"}, "b14e7d51-e1e2-4ece-9952-e2d931a89ade": {"doc_hash": "b4d8ed513bb5afa56e1c9f387c3d1e92f1c2b7714b22752b2461a7377f0105cf", "ref_doc_id": "1c189957-56b9-4c3b-9555-71ac1653ea86"}, "c6a7f455-7e96-4562-8819-f16d387a044d": {"doc_hash": "ceb78e9c020a65f133eafaf4fa104b64a171e77c6cf99828fefe37ae294b3540", "ref_doc_id": "34204317-873a-40ce-8b59-7a28761ad12e"}, "ccc0ab10-ec56-43d4-b8b6-15ebc74007b5": {"doc_hash": "a71046b8a559612aaef93b454fd9bd952cab154e6bfb4c05072b004723cb987b", "ref_doc_id": "34204317-873a-40ce-8b59-7a28761ad12e"}, "b9d15f14-a72b-4700-9a4f-2652f60724f3": {"doc_hash": "05d939533637a96ff4872fa0bce82668bdc259ac892ab227b408dc5a9db57a01", "ref_doc_id": "e8739237-8fac-421e-96ce-4803352e6dac"}, "eea88fd6-e41f-41e0-b010-ab0685a16214": {"doc_hash": "f175a6cd014c0e4cf865748c84cf42019b292bc9ee68b23fa458ff97b1fd6bec", "ref_doc_id": "e8739237-8fac-421e-96ce-4803352e6dac"}, "0506cb3f-8d69-4359-9d66-e86d9cd6d5fa": {"doc_hash": "49a76834f32509483a9510f1596a5661ca191830b44411525e0b8c5d18a31a35", "ref_doc_id": "a0463727-fb3f-4c02-a387-c30181bb402b"}, "79c922a5-e561-472a-a0dc-e16552e12519": {"doc_hash": "4dbc391b9724335e20e31369b0836af9cdbd4bf6be1562f6d482bd171d1ab27e", "ref_doc_id": "a0463727-fb3f-4c02-a387-c30181bb402b"}, "1513af57-27a1-4f99-a2c2-a7689189ed86": {"doc_hash": "9f93c9e8c04895dca81a513636163afa7907a6728ead6d805bf718ba0657a7d8", "ref_doc_id": "dbb9e7c4-c1eb-4046-907e-ce6f1edf0055"}, "94bd3fe8-abed-4389-a2f3-af084f8c9ea5": {"doc_hash": "07b64d9315c5f5bb713db17b5566446019d6a4191bb14d27bb6cdfb2155b1e66", "ref_doc_id": "9b4acfd2-7037-4b98-a3a4-16ba85722dc5"}, "09e2ee9f-9b50-4979-a2dd-81a7451facf2": {"doc_hash": "caa07fadc1ec90e282f473adc94a6f913a05c096078453dea61c496ab35163e2", "ref_doc_id": "9b4acfd2-7037-4b98-a3a4-16ba85722dc5"}, "af920663-3044-4bbb-be92-8e01fe9fc462": {"doc_hash": "81ce9493172f82024b2ef52d470d769991e2170d47bb6a03014b1d9cc202f19d", "ref_doc_id": "85547109-727e-44e5-93d9-7e1caeab8f52"}, "befb18be-ce0c-4528-ba06-fc93610141b1": {"doc_hash": "a9bd27e381c72fb2f38c9bf00fe358441d93302f02215f76b50020fb0b7f6b2a", "ref_doc_id": "85547109-727e-44e5-93d9-7e1caeab8f52"}, "fee1393d-0186-4ba5-9ca6-3376cc6a51e8": {"doc_hash": "7d1991b1b3b9073df1114526e8ce847d4cc2391b9d16e555a1268507c76ec578", "ref_doc_id": "6326afcc-6ede-41f9-a5d8-182d84531875"}, "09195cb6-8e00-49b3-9511-128723cf91a5": {"doc_hash": "f433ae05b5c086ad5877f9e1352c887eef7280fc4f32babbabd076bb010312df", "ref_doc_id": "6326afcc-6ede-41f9-a5d8-182d84531875"}, "fd523efc-07b6-4f1c-8ccf-75fa01c673dc": {"doc_hash": "05002c1a0b66d0e7419abf31b9763191905fba230b178e95a7ea6f4208758158", "ref_doc_id": "14c36e9f-1905-4b0a-a759-fcc756229fbd"}, "9fbe7372-daeb-4d8d-bd5d-22d33019d238": {"doc_hash": "ab55c651a3ddd4cba44d69239d585429920a2b5af6112a9a2afd000b1efc314f", "ref_doc_id": "14c36e9f-1905-4b0a-a759-fcc756229fbd"}, "2c465a4b-32aa-4a7e-af31-16869e33329d": {"doc_hash": "f909412bbb37ff72674e2eea6ccba1b0f6f92839bbdd514e31c7662ac59cd5bb", "ref_doc_id": "bf990af5-6233-407a-8bd1-e22ec627665b"}, "13968090-73e3-4933-8a15-156433863dbb": {"doc_hash": "43db694207ff801f291db7d111ea63cbf54ead5b17369fc7ced8fdb14a1fa110", "ref_doc_id": "bf990af5-6233-407a-8bd1-e22ec627665b"}, "090d0783-b85e-4dce-9363-ac85dbc1fc7c": {"doc_hash": "e2a24ae24d51e150d82d0f64659543a2f3b1d190d156163a3a7875d33785e8e5", "ref_doc_id": "ead3175a-de46-47c5-9b0a-98b7426e92b4"}, "cacb447d-e9b5-4cc1-96b4-67959be152b7": {"doc_hash": "ebb4f75830546202563bc345947eb87c0630ebaa7274038de5f4d10604125f97", "ref_doc_id": "3ea7d4a4-4e08-4437-83ff-984656b7ab96"}, "14cb28e6-672b-4f8c-b9a6-9fa4d58ff27b": {"doc_hash": "c1680c4babeb6377ff3bb53ac609b8d4f44ce79e9895ea1701ee7dc47326ed7e", "ref_doc_id": "f2b00d9d-9d43-4e7c-b5dc-2936e1593e83"}, "f993dcce-43df-4a99-835b-a8209911a77d": {"doc_hash": "08574347a59010ea796ce8d160b93f205709e00fe98e7f9daab9aa05e278c64a", "ref_doc_id": "f8791b4e-8766-4301-b573-4a596d1579a8"}, "b3c3e748-96a2-46b1-ba99-eca82b0ad438": {"doc_hash": "232c006f62dc455657a2b2fd4d52b998260bf988cf373e8726033efda6af7f1f", "ref_doc_id": "4c0aec2f-6acb-4932-a30a-4e742b6d8098"}, "688bb219-2321-47a5-b918-ea87a6886353": {"doc_hash": "589fc7a811a466354050751e412e87c9d87fd4222636191e3924862450f77f15", "ref_doc_id": "81736daa-03d5-4dcd-880b-6e598a65dc2c"}, "2e92d666-f28b-47cc-9d8a-a7a0ed582f72": {"doc_hash": "9249b1cdb3bc2956db2916819f99b91516065f3d9b14d3fd83321526bdc9ff01", "ref_doc_id": "fd56c657-6f9d-4353-a79a-3f27c16a1b3e"}, "3ea1a944-d30d-4ee0-bcba-56aaef7c5b4f": {"doc_hash": "9b4d6f1de6e4017585c5c926196eb7c22e61a5938bb9199c07477459cdda254f", "ref_doc_id": "be1835b3-5068-4017-99b4-6e3087ef228c"}, "b3b33dc6-10d7-4dfd-baed-72018c62235a": {"doc_hash": "3c172775927d84d4710f6867c78d76f3226529ef58d31af4e4261e0178661e02", "ref_doc_id": "be1835b3-5068-4017-99b4-6e3087ef228c"}, "04040956-e2ef-42d0-b2b4-eb0d5af6f47e": {"doc_hash": "44e3ecce9da612a1be9bbe7b7802fcd364e460d8a913a1eb41cd8de22a647f08", "ref_doc_id": "be1835b3-5068-4017-99b4-6e3087ef228c"}, "6c52e001-c46d-4f65-a29d-23401d889f90": {"doc_hash": "9f608854fface43b3db09044e326d83ca823ac9411b9a93c130312cb239d429f", "ref_doc_id": "ca37cb9f-d742-468d-83f7-b1d662174765"}, "45fef1dd-f6df-4a43-a22e-42328b2cea28": {"doc_hash": "377c12380db0cd9397d463b1f479f471bafd543329d382cce152604b2ff2954e", "ref_doc_id": "ca37cb9f-d742-468d-83f7-b1d662174765"}, "9c2a26b2-b97e-4aaa-836c-237c4cac047b": {"doc_hash": "9848b9b5dedd7c314a62b00b02639a803f2de2b013aa44e046b99742a58a3b4b", "ref_doc_id": "ca37cb9f-d742-468d-83f7-b1d662174765"}, "1cd39d53-341c-4d6d-bb04-fab514dbc75b": {"doc_hash": "239f54cd2633115ea8b33a131c47fb0707ad0725696f1862c517d74b3b321dfe", "ref_doc_id": "ca37cb9f-d742-468d-83f7-b1d662174765"}, "07e3284d-2036-41b7-8338-7eb47f917a8f": {"doc_hash": "98ff612273e715d18178a14e654ba4392e6b6c923e0505a878d8afbc77f71216", "ref_doc_id": "58281e9d-3016-4bd6-8543-84b37d6738ef"}, "c8486019-afe5-44dc-8ef5-361c556e92bc": {"doc_hash": "1e05d29eb474546a8eac22afe8e2989696a3b09e174918d7c9944ca1b54bc882", "ref_doc_id": "837aa0bb-62a7-4ef8-a435-de2d6175c693"}, "46ff6b04-9796-455c-9378-3364f7887752": {"doc_hash": "61b030ce9c1836d1379f086811cf096b7dcf77d124f7107f64590e1cf09f6396", "ref_doc_id": "0066c18d-7575-4518-9778-f463c3fbc6f2"}, "e9ace022-2621-463d-a96b-fd6ca7b091da": {"doc_hash": "ac8938eb7cfbae041b3e1a89d10695bcdf9c9b98eeb5ed650eb820e891738a9e", "ref_doc_id": "e6ae766b-6aa2-4374-8151-b9922797a28e"}, "5e886250-4496-4ec8-af40-a70ebeddb4f2": {"doc_hash": "2e306ad870732eaa140650c2c5ad7cb25850ad40efc87640f84ed3e3f07f5a09", "ref_doc_id": "c90690b7-074b-4193-80fa-1137ecdf2a65"}, "c7197765-1277-4bed-843d-bf0c3a207c86": {"doc_hash": "8d483039a0c2b457ac24a70e9a8726dd7a19f2cead3f824a5e028a8c339068f3", "ref_doc_id": "47031e43-a8b6-491c-af45-7175b518a947"}, "c06a8182-120c-4d16-96c3-f31e870f3980": {"doc_hash": "8458b9784874b5ab237919b1cfb636dea6e3184186be57a5d03ad5e17be8e24c", "ref_doc_id": "f294f5e3-9039-4b1e-84d0-ff0e3bced4e1"}, "7e433823-8165-4d4c-9cfd-8cf92c727d83": {"doc_hash": "ad85f65548b3be9e717e7498b86bf453bbfd16ea69342eb3d4698fcd0621efb8", "ref_doc_id": "b3250294-a38e-475a-b6b8-38731a10396f"}, "1ae1289e-e6dc-4db8-96b8-78049850c1a3": {"doc_hash": "1e1ee8300bcdae5ca40c967133c63742eea2ac4824737e28b133ec849d91e0ca", "ref_doc_id": "b3250294-a38e-475a-b6b8-38731a10396f"}, "5d3cee47-c328-4a04-89b7-f9575f45bbf1": {"doc_hash": "7c52995a47c3e0b4b5b92dc720a9c258e2e7ce22844682841d2a09adb4c6b959", "ref_doc_id": "c09fb578-7439-4068-9a3a-cdf1db2853dd"}, "97886079-ce98-424c-8a66-54f0a8c3f029": {"doc_hash": "2bd3a8e7830afede408dd3c052dc79ebd9719dc58573cbbb8b341c424f8403e4", "ref_doc_id": "2e0969a7-f48e-4621-b395-0a7e7d27f070"}, "8b1be2c8-7aab-4e4b-b8b3-832fd0804aea": {"doc_hash": "10cc31b06617dc962d056c1731b35b5f97c5c9075af8756cd7631de327d373e1", "ref_doc_id": "180835dc-f3d1-47df-b0c2-bbfa13e1dbe2"}, "250ecdce-5663-437b-8843-cd2b20679529": {"doc_hash": "6171c0c9eff80aad8d586b8613b28f97e9e77899856aef4d3426987b6bcc882a", "ref_doc_id": "146fff57-fa20-4071-b0c8-2589e0628b4e"}, "51ae1889-dd9f-4b28-9f95-9578f425e5a9": {"doc_hash": "133976881df821d85c3b6fded8b56b53e22a6c50fc19ed248274279a3db6ba93", "ref_doc_id": "ae61ca21-7832-493d-ac68-b05c6bd7cb89"}, "7d03f622-7d3f-45e8-aa20-c9e6579587fc": {"doc_hash": "e0c48cca565c1a887dd66c1d84043d50b8f6d612e8008ed9cef2aedb5dc54f0d", "ref_doc_id": "534e30a4-9ae8-4b82-b022-0b7913584e96"}, "8c58cc64-726d-4398-a1f2-7ae8968399e2": {"doc_hash": "8c8f1bc4425a9a0997e4362f6021d0309083d0627b47b46c5908cffd91fb39d9", "ref_doc_id": "07c0cb8c-da65-4fb5-80af-03dff48ac169"}, "9c454712-be28-4210-8adb-f1cfb0597384": {"doc_hash": "c9200c2c34bed28b09bb69f48ae0468c3e80497f76fbd6e1f130db460bd3197d", "ref_doc_id": "af83969f-87d4-4922-be17-29d61bf5888a"}, "848f8a01-46d9-4805-9aef-6235e648ca02": {"doc_hash": "aea4b3d40f29516e773b5538faa94413f6aeed181cdf1574a2800db09bbb0fc6", "ref_doc_id": "77119e37-7cfe-4444-b343-010a3fd45017"}, "ad029d46-7ad0-4d6e-a34c-78179ebb34a1": {"doc_hash": "53ba31b4e594d24ce1d1cdaef46a1491fbeaee79a06d353f3d0042ceceab6f3c", "ref_doc_id": "6eb261d5-1394-4504-b06c-82fe149f968b"}, "c0123d73-c672-47d0-bacf-66036e4b1271": {"doc_hash": "87e0df6c016e87c54f5b8d7015ab307812c2ec3082025944eb8ff3315cbef2e3", "ref_doc_id": "6d9b7cce-8710-4be7-a9ad-8d17040bf954"}, "81cf5756-a1e6-4f44-bbdd-65bac704f2b0": {"doc_hash": "ae89a40ced2ff0d81fa38998dc1700c94a06bc4f6e613eb32cf88e0b2853ae68", "ref_doc_id": "e748c262-8a76-4882-9ce8-75102957223e"}, "e40dea1c-7d8f-4482-a850-28a6e65ce753": {"doc_hash": "ddd2ab093565309f7b846ba64fd5d61c1e89b69842fc7d3c08c14dab04d9e8ad", "ref_doc_id": "224112b9-91e4-4d1e-921c-cdfba587d1f0"}, "8d5150fe-4b65-4a4f-98df-e20bc2d4fdbd": {"doc_hash": "953b6cb8caf4ae7f6ee5fc5fbc22bb1904891017e6ea841df10799ee6e5a9b47", "ref_doc_id": "2dfdbf72-4d71-479e-b4c7-95220a59601d"}, "94297160-4f87-4ee8-9bc6-5ebbac51ea0e": {"doc_hash": "ad81f62c957f5e63ad3dcb2155b13d640a4aba8281d33650e8306e455d773bff", "ref_doc_id": "e049ab43-5135-4e93-ab71-033f2c046407"}, "b5bd3892-b4c8-42e6-80fa-e8332d00494f": {"doc_hash": "5f50a2147f682993dda39ea95f7d03aa80e55a67ef16e6f5f0dbea1f457cf933", "ref_doc_id": "02ce231c-4951-4dcb-96d7-64e5f549634b"}, "e3c4e192-24a3-4976-ae8f-e6cfcd89ef55": {"doc_hash": "f1fa2abeae060a88b81f41bcca819226b52fb908ca3c523c6ab1c8993cf3f70a", "ref_doc_id": "a9072a7b-604f-482b-ae5b-afefdef942d7"}, "977ca7bc-f3ba-44a6-8044-49efc81573fd": {"doc_hash": "706bcb16de54be986e1e62174eb2ea3b56588dc3f2d9af01244ee665e6f71695", "ref_doc_id": "9437165b-4bd4-4b18-a8e1-7150372fdd84"}, "01d288d2-d5da-4d51-ae15-4c6f73282ea8": {"doc_hash": "1dc66082e29602ba6d627305982fecf686c848c0aa04482b5110fc507732f93a", "ref_doc_id": "d906264a-5ec3-4226-ad62-592b5571dae2"}, "29b520de-f59a-4f73-8ac7-419b5da3b476": {"doc_hash": "2886bddc770c3026a76dbfa5c0ed9751098fe09f33ed40bdf6a43f4de8606d0d", "ref_doc_id": "ffa271c5-8bc3-4b61-a40a-091ee8682ee7"}, "e9f60308-fcc2-48ff-923b-a3e091cc91c4": {"doc_hash": "5d2ecb42e6174cc78c5d02e73c3f6f46b9f036ed1fd7f797cffd8fe974c93a0d", "ref_doc_id": "bd8c8b96-25b7-4cb2-8542-ca5d73805814"}, "e342c38d-e596-4b53-8ba3-95138a53f5f2": {"doc_hash": "d21c0fe21c342acece0fc53b02bc9b1b5b67773e162bc31fdc192a6b8338a1c7", "ref_doc_id": "5467a511-b4b2-425c-aa73-a7ce7d243d4e"}, "53d2416d-b154-4cb2-bb9c-aa6cc01230a1": {"doc_hash": "5e4b09512de3c73d7a21dcf9e035c962e2c3cb481e56e101cfef06648c306d1e", "ref_doc_id": "4166a2df-0187-4828-9e27-9d1f69ec66f9"}, "b4211bb3-5fd9-48da-a674-8cecafa1f7d4": {"doc_hash": "beb4ab9b88dcaca27c0c583f1a4e73ad997ca7032c1f9953d67551cd6943a19a", "ref_doc_id": "196447c9-6a7c-4687-bf71-c8f3a8667a2f"}, "e2fc7f30-d87a-4866-b4af-4ea4a430b4a8": {"doc_hash": "d3da5aa72d49be1a12ea38cf7d54dc5289f2fc53d9e512571027c35b2e2c99df", "ref_doc_id": "62aef9fa-972f-4dc6-bd3b-58c57cd2c79b"}, "a67bc556-adf3-4343-899b-5bdd256b9000": {"doc_hash": "4d08798c277df30a64a6ace140c44a4a6fd1b3c19b93a0a316e336b93bb0d694", "ref_doc_id": "5f782e5f-6270-4cff-b298-3f862f470c3d"}, "60f4e947-5ab7-4165-ac08-90b38e4b4d92": {"doc_hash": "b2a758fcbe58569ca5310d358ca0d3ee924110d62cc53e981b9efdfee1e11fea", "ref_doc_id": "850b1b48-179e-4c13-a894-a04ef2a6cd89"}, "b4572031-b2b0-458e-bd40-c6cfc4f83cce": {"doc_hash": "65cf21bdc5c17b6d15e81e888d06983d1f2d21165eda15e69dc724fc45cbf7e1", "ref_doc_id": "05492b40-b08e-4709-8047-b5d30f6356fb"}, "ab752029-64a7-4e81-a171-7e04f3c8f181": {"doc_hash": "a64fa13b542c33e9c8e0ffba98a05daa9ae2805b102df31d557571b22da177a2", "ref_doc_id": "05492b40-b08e-4709-8047-b5d30f6356fb"}, "0ecf9c66-737b-48b8-b8ae-392a5d9424f3": {"doc_hash": "279c504fe12f0eb215d27393a570fe3a2cb4748ba0767869ed50ab85805a36ba", "ref_doc_id": "0c249186-652f-4df9-9788-742cf249f6f2"}, "0f89079e-6026-42be-9196-92a6ca105e37": {"doc_hash": "4a6e3bfe33052fc48dc895e86d8d560b9b682eb3f901271d84e4a6347a3fa418", "ref_doc_id": "0c249186-652f-4df9-9788-742cf249f6f2"}, "3b2893dc-8d82-45be-be40-69ea4b2a3b4b": {"doc_hash": "4f74c974565cfbfc119b2a21403e694b5190184f4b7fdc72f7b824733683da66", "ref_doc_id": "0c249186-652f-4df9-9788-742cf249f6f2"}, "6120b71a-0f1d-44d1-a333-e0fc89ae11c0": {"doc_hash": "f4f8c2a8378aa5c6ba6e1c0b16722618ce29e009131bb83e401250cb03b53a39", "ref_doc_id": "16889032-d35e-4f4e-920b-2cf6e2a2d318"}, "0d116391-5be9-4ab9-ab2c-297327d5e9f7": {"doc_hash": "9ea5c0518a50c5ce25a2e68b039cfbb8d48ff58c8864717371d06ca40e03e95a", "ref_doc_id": "fc7c6253-26e6-4595-b74e-be84dcf3022d"}, "d64ba844-0496-465b-878f-c9aec4226937": {"doc_hash": "4640338a8cdb847e003abe775755adeae95e1008aca620d6b00e5afdd7d4c647", "ref_doc_id": "e70249ae-2bef-4b5e-ada3-80914942a563"}, "ac901eff-b5cc-4010-962f-41e32052059f": {"doc_hash": "a79b5d3e10a15156a6cbb3bd94d85db4c5e81bbf08586aabcd980ea3aa679339", "ref_doc_id": "d624c26f-78d7-4a76-8d3d-772059739a2f"}, "afbb872d-adb3-471e-acaa-7e4e97758a2d": {"doc_hash": "d0a03a0e1049004a5d27b6ea3c9bcc324fcb6ad0c5f9821441c47e6f1f811897", "ref_doc_id": "022dff2e-75e0-42b0-b889-c42da654ea8c"}, "7116f30b-c980-424d-883d-2b42c4a0260a": {"doc_hash": "f1b63b76c1889a548a7c217037962a5d074eed5696554765f525758e2ee0622b", "ref_doc_id": "8509d6b2-a0ff-4c48-9ddf-bfbd29119087"}, "9985bb51-c74f-4295-85cd-aa83067572d6": {"doc_hash": "35a5c5534f68f262abf3072a79ed0b00772b9a4043e7d32a9fe27c3a0543f26b", "ref_doc_id": "8509d6b2-a0ff-4c48-9ddf-bfbd29119087"}, "c1a3f5b9-75da-48d8-81c7-c29a7793523a": {"doc_hash": "4e91dff57cc3b251d7d6b9613e0e5d877252db6ec9f216afec2c2793308be7ac", "ref_doc_id": "b4906c56-ea0b-41b1-a86e-d2fa9ad64737"}, "abcbd0ff-e5f4-4ae3-a731-757328b12fd3": {"doc_hash": "396cf60dbc08775e8e1701aec8bd397f01d13ec862b23d6bc9b9b8036a5bf8cf", "ref_doc_id": "5874d69f-e639-4389-bf95-a4fef0609af6"}, "8e1b5253-6995-4c33-be7a-407cda31a8bb": {"doc_hash": "f9624a24891f6b8f1266653b453579ac3d13acd8a82fcc2a55321b9baa90a61f", "ref_doc_id": "5874d69f-e639-4389-bf95-a4fef0609af6"}, "df10fc44-108a-4209-a61e-75aebf12ce21": {"doc_hash": "6d1d7e99df168aaa0d3493be4c7576239c263b1d1d6ae98f6b25e3e6a1134637", "ref_doc_id": "61a7f0d6-6450-4229-b840-dac0e48ebbc0"}, "f1f25a89-e345-4078-9849-7b9fd774c3b1": {"doc_hash": "16dc23b827e8561097e805c3c245e7cc93ac8db65e2ed96e3b936894f49b4ebe", "ref_doc_id": "61a7f0d6-6450-4229-b840-dac0e48ebbc0"}, "84570f84-d7f2-4911-9623-38e391228e77": {"doc_hash": "402ff2a9c66c101194049c3b417cd7ed3b86ea8197b5269c7f2e4f6fb8b98ade", "ref_doc_id": "be0ed1b7-277b-4d61-83f0-3fc34c85cc2d"}, "d7dad901-7c6f-4925-b2a6-6905b4e835d0": {"doc_hash": "f4fbe8a0c66424746f80a40feee276efdac8fe0c4a51900e4f96d5321941d322", "ref_doc_id": "be0ed1b7-277b-4d61-83f0-3fc34c85cc2d"}, "06394022-8d9b-460f-8d12-b8c7c87f9953": {"doc_hash": "3d49e3308a25f9ba421b1a161c2e6e15caabe3105a7f96d2ad796d6b036a4afc", "ref_doc_id": "66ac7d25-2069-48c3-a014-70d939bb643f"}, "0467941c-4c18-4949-9767-1a57bc193a52": {"doc_hash": "ff61d650d8a9722d5e608a1eb0268f9f625f00cc839262320ffcdf3e7a92783c", "ref_doc_id": "66ac7d25-2069-48c3-a014-70d939bb643f"}, "4642d456-7afb-402b-b66c-1aadaa703c04": {"doc_hash": "104ba93bb30b9daf498eb8e555bd4199083f5d082a3f7cf7daf914323a2e977d", "ref_doc_id": "1f663f28-5b73-466e-b9ac-78da5972a78e"}, "79eecf99-558e-46ea-a542-bb15eea2fe50": {"doc_hash": "a40a4854c7b3ce197d8a118215497fcb690b9746d77e4284af5a8c703ee6b092", "ref_doc_id": "1f663f28-5b73-466e-b9ac-78da5972a78e"}, "6f5f745b-bdae-4841-a53c-3dbf06020fcb": {"doc_hash": "cba33fad61ce56a57f43c1754a03d9e334907e690b6fb452d4013e01a30cdb5b", "ref_doc_id": "ca835ce7-c718-41ec-b221-7068087f69ed"}, "9b05d3c8-5293-4c3e-9e33-fd2356dcc275": {"doc_hash": "969aa4eab05472866b1e30039eed5b30a3990a1cdae367257632c0f5a1707958", "ref_doc_id": "3487f585-7221-4adc-a6f0-2ca981300209"}, "9e7a655f-786f-4c19-8f05-680d45397cc7": {"doc_hash": "4a15d35af094ee918cfbfce27b6168213bbb75960e7a4b269497f2f59a737d52", "ref_doc_id": "b1816f85-d6ac-44b8-8397-25bc70fecb34"}, "b91e12ad-1ef9-4e54-935a-c4bd5d5413e6": {"doc_hash": "ee9cc729e3f270596cc0a74755ff303a9d1dfdb0e4b310363f9edc2ea925746f", "ref_doc_id": "4abf18cd-6ca2-4431-99c4-1270dd3c14d3"}, "63006cf3-3c31-4755-a6e3-e8b0e225ffe6": {"doc_hash": "8db268909b5edd74545795ee55846046103c29d9c8b7ad6ab02634b64120a1d7", "ref_doc_id": "cadeaa97-1ed5-4985-abfa-b50a7617b044"}, "53e7254c-3345-4562-b205-578a6f5f1b40": {"doc_hash": "971c6f5e8a3963b840952b42e862686578935de9a42a4dc3aa3790408f094b6c", "ref_doc_id": "ab659f33-9ad3-4346-99d9-db60a47fb277"}, "e6f484ee-08d1-4d2c-acf5-de024571696a": {"doc_hash": "f33ad3108cccadbba7c47f9e9249575ccc5b3e1451d18567c724f8a9ee4ae590", "ref_doc_id": "1efd0ef9-1b4d-4f22-a896-9332bbb96506"}, "7d452641-94d6-4033-a67f-21279355620e": {"doc_hash": "8dd4423b572baa143ad436e95b89e18e9a85cf477c4f7af8e4741e89e2969851", "ref_doc_id": "077a5dff-766e-47b1-bd89-2430a61d24bd"}, "cc6ff32d-04f0-4f00-826a-3df174e4635c": {"doc_hash": "e0e90e72fd7a4ab8268a68193ce2362e825c9e6221ceca221ca5e347944976f0", "ref_doc_id": "1231a601-c0f1-426c-944b-bb0bbdf60aa7"}, "c706cdd7-8333-4f43-862d-ee5631692759": {"doc_hash": "c1fdade7ac9e99545b4305d2610d2303692136ebdc121a72fbfb06cfb2b55b35", "ref_doc_id": "bf43e2df-4b45-4fb2-b73b-8031ffbab3ab"}, "32d401cc-58e3-4429-96f5-3d48c95cab8b": {"doc_hash": "624b9735d917bcaba6ce6f2d3cecea0cdec5e3534513e1a504e7190b8a3ca2a0", "ref_doc_id": "851d4b83-5891-417e-ba47-e567b286a375"}, "2ba98f45-63dc-429f-928c-40f4fbb37c1c": {"doc_hash": "115ab81f13e2dfd80b8847d4fe45b6d27b007ada6b5ae7c3c4d3f91c35278f95", "ref_doc_id": "851d4b83-5891-417e-ba47-e567b286a375"}, "804e74dc-6476-4ca6-9054-3fc86a9030f7": {"doc_hash": "2e12577c2b86b6bf644e130fc579f01a372a3b5fdd16b1e726790f64f591f183", "ref_doc_id": "851d4b83-5891-417e-ba47-e567b286a375"}, "f812c74c-2457-44b4-8731-1f8c33406026": {"doc_hash": "a19d7a6b098bf2ff6f9bbcc64d0b2f5e75de6a45b0761b0a02561a4f9a7ed429", "ref_doc_id": "ca98da3d-9123-4b95-9201-7d2a57a73ead"}, "d2ff1071-3f4f-4513-bb40-9233b1860c55": {"doc_hash": "fd74463a5d704be889afb6755cf67835c15eb636091c4110656f52df869d0425", "ref_doc_id": "ca98da3d-9123-4b95-9201-7d2a57a73ead"}, "ad2325e9-4a7a-47e2-8369-8aa8795ab031": {"doc_hash": "a76721e809a5e43bfd716ea5dae1aae3c8909bcccd2aa8102dc4ff3994668a44", "ref_doc_id": "d195a567-24fd-49cd-8066-59fd78454ca1"}, "39c8be5f-4427-4c03-bcd7-7364e47575f7": {"doc_hash": "ac296d1c0b9dff26953994d62c720e5703249150e782eab8eec43bbd85f2e4cd", "ref_doc_id": "d195a567-24fd-49cd-8066-59fd78454ca1"}, "54da89d2-b94e-41a8-aa2e-1c641c49bce0": {"doc_hash": "bdee4c9ca3c3fc9092d159b2a3cd3f9537c5a2ea38a1018ef483cdff3527959e", "ref_doc_id": "d4243e59-b8ef-4df9-91a7-57642d7b152c"}, "a78c8a1a-95ad-4f3e-a65a-3f864cb4e4cf": {"doc_hash": "f4fe77139782492e4d9aaee8554cc97cc2f16c00c9c8c5617b8cb5a436af6071", "ref_doc_id": "d4243e59-b8ef-4df9-91a7-57642d7b152c"}, "da231f08-1936-4fbf-b3e1-64569b16f8fb": {"doc_hash": "aa7933cb13edfdaa936e275efe48805c315f54f569c4bb810c04290c03d11ed6", "ref_doc_id": "f67acc2f-221d-412b-a722-bfff43ee31bb"}, "4adce80a-a47d-4983-90e8-2a1b35ec6d54": {"doc_hash": "16eb1a5ecc874443dcddb2e417d7af5781de5fdb7bd686c6199135d497cacab9", "ref_doc_id": "f67acc2f-221d-412b-a722-bfff43ee31bb"}, "45774988-1d0d-47f5-bc9b-a1c45e5a6e6d": {"doc_hash": "f976c0594659da298b80e3c6ca73b27914ea30558f2b60ab65745f4cd9aa1c0a", "ref_doc_id": "8216ea82-d3d6-4717-8668-230c8071509f"}, "135242e9-46a0-4f29-b834-5d74b00b7636": {"doc_hash": "d8d7ba65d7c14922a2a048495513a3c310100365844dd26e7be026975442484e", "ref_doc_id": "8216ea82-d3d6-4717-8668-230c8071509f"}, "195ba108-a512-40c9-99e6-6cf3e87a961e": {"doc_hash": "e136459cd7f8066ca04e27fa62d83091dddadb40923703d15b580be1a5ef8279", "ref_doc_id": "8216ea82-d3d6-4717-8668-230c8071509f"}, "1f8254d4-923a-4c7a-866d-88999c9f7420": {"doc_hash": "c659933b01c08a6b85b78d6772d701241a30487f23e54a28fbdc8900a066a757", "ref_doc_id": "d3a898da-94ed-477a-9931-9f6ae930ae49"}, "4e61d6d3-0f30-452b-bbb6-1b3165f1bb86": {"doc_hash": "8fe0abb70d1232165ed51036dd5d247764c3f7be61ba82adac71c4dbbf0a6f4e", "ref_doc_id": "d3a898da-94ed-477a-9931-9f6ae930ae49"}, "9cb4c9aa-f83e-43fe-8e1e-eef03cc2a67c": {"doc_hash": "51c38bc16d5fc19e119cacb07137a4c4453daafa1135f6355059d85dbca19df0", "ref_doc_id": "d3a898da-94ed-477a-9931-9f6ae930ae49"}, "b7c66650-7b80-41f6-ad3f-c6db15a88001": {"doc_hash": "063730ba2916eb7e5d196aca737484bc5163fdb62a928b8e294b439874455839", "ref_doc_id": "d5d9cd94-11b8-48dc-b20f-1d4c6f697296"}, "442c0c49-243c-4a73-9c61-fd52500f93b6": {"doc_hash": "8426c7f191f85b3d5bc82d01d06ecdd6b60783b9abc6acce9429b9f7d42fd0f0", "ref_doc_id": "9831a442-860c-4d42-80be-452420dc3575"}, "02e26e92-73c6-4a04-90e9-263f242bc9ae": {"doc_hash": "8f88d5069c6cb57603a274d5600dc9fa0218e8f90eb879172c56c240dff86197", "ref_doc_id": "9831a442-860c-4d42-80be-452420dc3575"}, "7e1547c1-d0f8-4d8f-851e-29b29e647a59": {"doc_hash": "13c5d528ce028ed04cfab9f6da1d3b8813b12a7081f4ca1d3d4e0e6a3e4da571", "ref_doc_id": "9831a442-860c-4d42-80be-452420dc3575"}, "2a0788ae-6724-4469-9868-884a786f154a": {"doc_hash": "f52eab674b410f96210bf364247ce2d73cdefc6ff2e5f8599195ac8fe2b010ca", "ref_doc_id": "58b7659b-9e72-4c6f-843c-25065d34c049"}, "3a63c0f7-6f7a-45ea-96f4-029231a56b2d": {"doc_hash": "645d544c203d7bf7703a101fdc6f3cb7917654df3423ca9a240c8f0b5b6a4e7b", "ref_doc_id": "58b7659b-9e72-4c6f-843c-25065d34c049"}, "e2a691cb-b4ae-46a4-99c9-c50f3d00f1ad": {"doc_hash": "6a10b5b1666d156c41d1454da76a183f4fc35a91e90f23b72b0aee665ad5d294", "ref_doc_id": "58b7659b-9e72-4c6f-843c-25065d34c049"}, "f36e9340-6c9c-4742-ba99-6c55e651fc6d": {"doc_hash": "249ca53e70d07cfad9a59b99935e6c419dc9ab70ced700e8c6a38e847e114c36", "ref_doc_id": "790264fe-15dc-49c1-b185-a73e0edef92b"}, "5b3d7a70-146e-4187-8f8a-f8824991eaef": {"doc_hash": "bbb92826d62e7499c196b58746501ac7e27ece6a7aec8a9a3e93daa0e1956318", "ref_doc_id": "48803f8a-3b97-49e6-aa8b-1f1907feba63"}, "d9213185-ce37-447c-8679-45fe54b3d241": {"doc_hash": "489ee4212f116c121111d5c2d7137ba362938f6b5adde337d35428b9754da2d6", "ref_doc_id": "48803f8a-3b97-49e6-aa8b-1f1907feba63"}, "105a7552-d0c0-477c-abd0-03ada12281c9": {"doc_hash": "a9640f28aadec7cacaca0f5b9807b56a21f5eb9ae1d2c3bbbf6abc834b647159", "ref_doc_id": "48803f8a-3b97-49e6-aa8b-1f1907feba63"}, "51eb65f3-3e06-4007-9483-1e04262dbae2": {"doc_hash": "03f1e6a0b304f9a99100f0a7a092ea34273e2f2337b869415ff8c8887faa7155", "ref_doc_id": "e781dc12-4ead-4dd3-b4e1-6dbcc6907fb4"}, "057841b4-df78-48e8-9b29-42f9653c31e3": {"doc_hash": "e4660657acc69183a007ac550649c35e0bbcdfcf291bf5deca93cc8d96c91182", "ref_doc_id": "e781dc12-4ead-4dd3-b4e1-6dbcc6907fb4"}, "da51da45-0658-4df5-ae3b-85a72224de9c": {"doc_hash": "4b7b9941be879f5a0cd87c4ff15e6629cb42aedf218c53e0e3518592b13a4698", "ref_doc_id": "e781dc12-4ead-4dd3-b4e1-6dbcc6907fb4"}, "5e9991bf-653b-4f69-9044-9b4fa42fe50b": {"doc_hash": "265666011392e755d590cf6dbd81f86f66c1752e329dcc55b7a53a23f66ae77d", "ref_doc_id": "28f3484e-dcd8-4148-95ba-6fe7b0b89284"}, "412031a4-2043-4843-95a2-6cd6d8c5dfc8": {"doc_hash": "a7c262456b4b71be9b6b48f58247f242dc7ea97354e7d280b654ff04f40549b6", "ref_doc_id": "f91cd471-cce3-4f26-9e0f-7d656e596eba"}, "1fa7ce8c-2a1c-48ef-9515-07f0d3f5a39b": {"doc_hash": "525ce45b83dd32c3b195406fc05f899eada1aa73ed9d8fa26950308a4ddc336c", "ref_doc_id": "f91cd471-cce3-4f26-9e0f-7d656e596eba"}, "56a6c8ac-ec85-4f83-b1b5-83e568d1a357": {"doc_hash": "8102f35b7d319efde669d2525d73a0533ad6bc168bab95fcb850ac072db6851b", "ref_doc_id": "12d91bc8-e76d-4b96-8f38-9ce5fc8d8bae"}, "9e8c5977-e749-490d-92fc-0eabbcb9bc55": {"doc_hash": "fb88365d5743993b79a4a14fd4b372431b826d0463e523c69b92765d89ed41e7", "ref_doc_id": "12d91bc8-e76d-4b96-8f38-9ce5fc8d8bae"}, "be956667-0536-46da-a359-62a1e2601052": {"doc_hash": "1ddfcf87685f92bc5a9fefcb8a458e75db732835011756a9fc8d50cb2afc27e3", "ref_doc_id": "adfdc12e-a7af-45c4-a37b-8271000964fd"}, "1bf1751f-8a11-48d5-a550-e91d14ce784c": {"doc_hash": "8bd5a299d787ba39bdc7cf2ca68b27cf1b0372f69535f984bb51d903db02a183", "ref_doc_id": "adfdc12e-a7af-45c4-a37b-8271000964fd"}, "43a77424-4b39-415b-b880-e7fae77ac002": {"doc_hash": "b13f644fa3c35e8a9d66c34ec0530100e1b14b1e25af1fa55da19b4c2c36b879", "ref_doc_id": "39fe5a42-e5de-4532-8b89-3f6abcbdeee7"}, "c80bf8b8-90b6-4aae-8ff7-31afcb553107": {"doc_hash": "2c3be20f52cd134da2d9bbf08a973a4522f408d5664dc4a8abd8102ec5d50b62", "ref_doc_id": "39fe5a42-e5de-4532-8b89-3f6abcbdeee7"}, "2e5c7582-ad80-440c-bde2-0e594d8abca1": {"doc_hash": "1da2ccb6f51613b9487d8cfced1d72cf884fed307cb5c18eee4d36ad103f04c1", "ref_doc_id": "e27c9ab3-6745-4bce-9b2c-9d247a6f7946"}, "3ce2dc4d-9dcb-4830-9e8c-096904af2e18": {"doc_hash": "53267901698d55e0ace254c470204ecae7ec27ebefdaa74a6b5d88fec8c3fa11", "ref_doc_id": "e27c9ab3-6745-4bce-9b2c-9d247a6f7946"}, "11d4d2dd-67e1-4464-9053-928b032b8d48": {"doc_hash": "74bb300840479031e5062d5bc8120fe48086bad148d69c435e6b672826d3a6f1", "ref_doc_id": "11d35be0-dbf0-44cb-acdb-2fac43d7f241"}, "953bf429-a1a4-462f-82f7-6a4d3ec3c340": {"doc_hash": "f6067b03141c695f0b762ab68a0c7d9fd558b7a22776989b6a0d4ead4bfc2e54", "ref_doc_id": "0fc9370b-c299-4d51-b02b-a3a2b70cdc57"}, "c38b4c8d-2fdf-48b0-b36a-7b62ea33323b": {"doc_hash": "d3e924e177cf19a417bd40697b9e49d926ca8a89d0a0ca1f150cb5e0e193613c", "ref_doc_id": "dcbb194b-4b50-49f2-ae3b-35593ab90181"}, "ce5e8db4-d114-4390-bdc1-0c9b44b53052": {"doc_hash": "2415d6dfd3a8ab553a0c0d3b37a3df1ef1542c3679532f41bab9b084cc889cbb", "ref_doc_id": "ccc85c77-be47-4234-bdb5-df0f9354a378"}, "f885a386-184a-4266-b6d3-2993a9eebeae": {"doc_hash": "ad98ec12891f088934baafe71a972dbc05a8ac21131e5e36f2e00e085f8f223b", "ref_doc_id": "ac0c2c7c-01f2-4eca-8bac-e54409c8cd37"}, "7a9f0c15-a946-4d9e-8836-b3a524a216d6": {"doc_hash": "6e6c61d276aa2d91a2c2bf87c88ffa030c37762fdccffe4fa007faa10c0b3d94", "ref_doc_id": "50825653-8065-4fb1-8fba-8c86bb9b61ac"}, "46aee766-74a1-43e3-b569-2761f005ece4": {"doc_hash": "58d52a41d2151cf9f68ad14bbfd4b1c2be4840d87e89751f68ee1ea5ca0d98da", "ref_doc_id": "e8313524-2bcb-4dfd-a7f3-6b64929ab14f"}, "f4f3d963-746f-4879-96d6-9b7ea597a1b3": {"doc_hash": "5996319decdec5e817c1adabc08b2dbbd313d1e3ddefd6671068c9b834aceb44", "ref_doc_id": "636371f3-6b59-4f02-bc2c-d38f7c790d57"}, "875add49-3f01-4b30-bafc-9517c1656aac": {"doc_hash": "8b0cef6781adf72fb3c58a74feaf8532d4acd7c0bc8d61792542fad6ee9ff42d", "ref_doc_id": "636371f3-6b59-4f02-bc2c-d38f7c790d57"}, "9e1c5743-a9cd-453b-83df-20b28f8b2603": {"doc_hash": "4d8b84cce7468a85e786384bccd3474d7355f33fd3f1d82476687106407933cc", "ref_doc_id": "6a261c19-7abd-4440-bb8f-b73c547b338d"}, "3c9d8868-e327-4616-bb97-78742fa949bd": {"doc_hash": "6545877d9addab034056914560765715c3a8e3f3e7fe06178b637886b520cbc7", "ref_doc_id": "6a261c19-7abd-4440-bb8f-b73c547b338d"}, "2a725a3e-a6e5-41b6-b7d1-1c2521603bdb": {"doc_hash": "595aa9c0b70b4ac14303861101a354666807ff7b351eb7968d576796bcf57bd0", "ref_doc_id": "fdf1f935-4173-4cea-bb38-dd8972d6f371"}, "44fd2725-7b55-4de5-b096-1835ec9c161a": {"doc_hash": "e9ec47173457f63dae3c99783e80c9198ca7b32390ebd55662c2409e0c37eaf2", "ref_doc_id": "fdf1f935-4173-4cea-bb38-dd8972d6f371"}, "d59522b9-9d21-49a5-9b10-1127e4d023ba": {"doc_hash": "39233a66df256622a842aee079d1902d927e5c4b8caa5739d3887ed1f3afeebb", "ref_doc_id": "6cc15f68-cf3c-4a52-abf2-c1223ad10617"}, "30707f22-7d50-4e27-82d9-76f693be17a5": {"doc_hash": "b069bf6b3c3ecca477a48be2765b4b92d619fe9028ac2fa2b6e72ce36c4b2263", "ref_doc_id": "0049559a-77f4-4cb5-ade2-75fd5413b5dd"}, "49eb4586-ba1c-4edb-b977-a48a88fb2e6f": {"doc_hash": "5af9ade9ee3299a246400eb08badfd6e6f32f9da8f91217022b1bd5a630c0176", "ref_doc_id": "0049559a-77f4-4cb5-ade2-75fd5413b5dd"}, "5def7a88-70f4-46eb-98bb-bdeb3e1a5464": {"doc_hash": "cee56156b78f4bb471917b0d70fd26aed619c439f93ebf85ea0cf06fcf991147", "ref_doc_id": "6ad2f737-7d46-4997-81ca-bf3e9bad9ca5"}, "dc65e377-520e-407c-99fa-1113cbebc0c7": {"doc_hash": "57c9bc501ce4faf10eee857068dd39f3c40ef71331a1e6a5f8c3911620057e7d", "ref_doc_id": "6ad2f737-7d46-4997-81ca-bf3e9bad9ca5"}, "371f0627-7ff8-4fe8-9a59-bb4f974a2ef9": {"doc_hash": "0131b0fc2903828a82c6ab696c3f15d826ce28b6057266a7a4619eb775c0c728", "ref_doc_id": "aca046ca-5a30-4c57-8305-7be3a2365069"}, "d5268f87-4dcd-4409-a097-aed5ccaa8e63": {"doc_hash": "b4add4a6c1a7d9dc44644b71aa13e591ac5239b4b7e16777b90e7a7d0515af74", "ref_doc_id": "aca046ca-5a30-4c57-8305-7be3a2365069"}, "f60f66c1-691f-467d-bb33-eca818c58492": {"doc_hash": "b6dd27c883b22b34e659abc406882170f96f69bdd1be4444c6bfefdd2284aa2e", "ref_doc_id": "897b6679-3267-4bc9-8b80-a2cfe236d67d"}, "dbc89dc6-3a79-418b-8104-1ec494f75c7c": {"doc_hash": "e519b61653c9dbcdcd43cabb59253d788c4ecd18dfd4e52d7374cbcce7953f94", "ref_doc_id": "dd5d13cd-55a3-4381-938a-a6446337c7f9"}, "6fbbacb2-6db6-43f1-8617-c222e274ccce": {"doc_hash": "eadab7953b9f166f6f16e2aa36ca3ef713ebc30698a566cd6ca5807d98fe8be0", "ref_doc_id": "a18f6a85-0883-4e33-976f-179135859ada"}, "e78ec48c-a453-47b1-a6e9-758840dfe22b": {"doc_hash": "e444a3a347cc7d4f77854b1f320acd6977f81bde0bae71e72f5d434b2a767860", "ref_doc_id": "0573f79f-96c2-429e-81b2-18333869bb9f"}, "5ddf69a5-21f9-454d-9928-a179ce5517fc": {"doc_hash": "c7810cbf62e85723baf6073af4cc53280c74415ec97b9a23c3a8cfe4e6dafdf0", "ref_doc_id": "0573f79f-96c2-429e-81b2-18333869bb9f"}, "76515d7e-e3ee-4544-8302-a662a1207651": {"doc_hash": "88751a186ac0e82d205b07e717791d48c8e0caac1a0558c8d8d221f60ba28af2", "ref_doc_id": "c679ec3a-77fa-43c5-809c-7139dbad247a"}, "78ee7abd-2a39-4586-9332-5ecf12c55283": {"doc_hash": "36e928955b34b1bd5e2e2536ad23b8a80a7959456290bb1f96d85fa6fe354ba0", "ref_doc_id": "bd9ea46f-f4df-469e-930e-22dc8921e85e"}, "d6354800-d9f7-4c0e-ba99-df33b6554ac4": {"doc_hash": "f5690522cd264651cb4e1a78f23e38a56f9b7405fc0f921bc5ea4a1dbd4b581d", "ref_doc_id": "d9621b70-0205-4af1-ab94-9552f5581fd1"}, "276e0850-e483-4b5f-b009-3e1ef9da40a2": {"doc_hash": "97ab42828c2727c6b99532775d89c07c97dc6aa5e81e4b6a0cbf0db5b453814d", "ref_doc_id": "87d2a4c7-ed99-47de-ba57-407d010dc2a6"}, "b5bfb05a-d7b9-4cf8-a255-422299284d98": {"doc_hash": "aa7d34aa4d1f9d96fba042fcfd4b04ca0206e34017757fba5d2582d335ec3350", "ref_doc_id": "dee0496d-78fe-41f8-b5c8-53cdeb488bcd"}, "51765ee9-6dc6-4ecf-a6e6-808e1e0ffaff": {"doc_hash": "3c3edcd98c622173d4c3b33746ac3e3c2e9deee369294cddb7294b5b5015abc1", "ref_doc_id": "46101aaa-5584-4139-8b93-58e3b270c390"}, "c2c5a3ba-e4b3-4ef2-acca-9af108e54224": {"doc_hash": "906d0636f5a2dd792608d4ba96b39f644921c3da04d718a7018beca3b91dac47", "ref_doc_id": "e91d9423-0028-4f02-9b8f-1f666879d1e6"}, "9717d46b-ddd4-475a-ae3f-725dc541023b": {"doc_hash": "d754b93dde550c14d9bcc16b78ae80000d6dc8ae0c7c749157553e845b7b905e", "ref_doc_id": "02e02b10-65f8-41d5-a179-6ff25bdbd003"}, "4a99ab5a-2450-4414-ba97-6cfb9b6dc36f": {"doc_hash": "28c94aad6916ca1d4e736464b9b4c0c7525503dabb507813895573fa0971fe98", "ref_doc_id": "170ff836-ac26-4ab8-bef4-54faf54bb6b9"}, "8193f68f-a56d-4b62-8f0b-6c9ce055fd43": {"doc_hash": "9e49df74ab5369f32fb315b14efb28f7682cb670938eccf46c797a691dbce342", "ref_doc_id": "a5c68f11-2106-4e30-9aed-c0f175a9d6cc"}, "4c20b2e5-1c8d-451c-8dad-3b721e2b3bcf": {"doc_hash": "6f6d1ebefd3f970826d3e4595e62f1f4fdaf7e1981a678c61d6e33fc579da41a", "ref_doc_id": "9789d345-c228-47fd-89f0-436c7d1d7b84"}, "384a48aa-760a-4457-ad4c-cdc4e3b964fa": {"doc_hash": "5244e09aa71dab94b40ccafdf2caceee34798cddbecab9bdbb976aab1d5cbca9", "ref_doc_id": "9789d345-c228-47fd-89f0-436c7d1d7b84"}, "e1a6c14c-efae-4f8f-bedc-dd6fe5dc56e7": {"doc_hash": "9a8c245009c21cff6fe711f4022b450ebdd15ee7af785a038a93466eec7ae2c7", "ref_doc_id": "ce7278ea-66eb-429f-bd20-12b04f6d67a2"}, "dfb48ec1-0270-4e03-8e6e-c67158e3b436": {"doc_hash": "9312fd1788454305fec41b93dc3458bc99e01ac7cbc278cf7a5fb74cab13f9cc", "ref_doc_id": "ce7278ea-66eb-429f-bd20-12b04f6d67a2"}, "503c243f-c32d-42a5-9053-2ca44d5f0757": {"doc_hash": "fb55b848120a35d3981947a3e2258cc54b64b9187f0e5d24d271e665de1a225d", "ref_doc_id": "ca53e90c-8285-49b8-af6a-69794cc8bd68"}, "268804e8-5ddc-4ce7-930b-cfef8b9b6c19": {"doc_hash": "c336000b51affe2641039bcbd89458ba2b39795deda43be89a891c77da90b9ab", "ref_doc_id": "ca53e90c-8285-49b8-af6a-69794cc8bd68"}, "ce6b4a27-a50d-4eea-b16a-de22875cf63a": {"doc_hash": "45db0db9b49b98b4b85a83c0226809f3119f3140d39b55d293d1c5ff4fd85229", "ref_doc_id": "28e1917d-e8cf-4e89-b8ba-89dabead36d4"}, "9818001e-53a7-4cb2-b62c-d517db3ead0f": {"doc_hash": "397cb238307c77f069e8521feb5253cd646f7b914ff26afb86572c7d8ca14794", "ref_doc_id": "3be146d2-bbc0-4967-b795-d7e16b067861"}, "5419bc1e-89bb-4ccb-aa45-9992cabb40db": {"doc_hash": "7cadd243dcaf5f113a55a7d70c82cada1cc608b67b502c49802228b3bc74e024", "ref_doc_id": "3be146d2-bbc0-4967-b795-d7e16b067861"}, "9d810208-af30-4af2-8afe-5560e676e50e": {"doc_hash": "1d4627f93405cc91133cd49cb0a401ad957dea92519b97e605013311c39561c5", "ref_doc_id": "95595593-3501-4404-890f-4bc88a6e1e20"}, "70c13757-8248-420f-886f-11e58efd908f": {"doc_hash": "d5a519e0f5654dba32ffeb4094904eee66383790609d727887cdeb197beb92e2", "ref_doc_id": "95595593-3501-4404-890f-4bc88a6e1e20"}, "4a8d67fa-3b75-4a2c-98de-ee579e5fb529": {"doc_hash": "205e592af51294b5d302f6350a5135f40d25eed18bbdb726af45f52fe3f87ae9", "ref_doc_id": "1a79c130-3f9c-41a6-8220-c19b4bb4523f"}, "c989a9b8-ee07-4ebb-af25-42ecc401e2b8": {"doc_hash": "a29e1b2e188034cc93a3b4187dca8830214da0e63b1a44c32726dba4e10b4d99", "ref_doc_id": "083a40d5-71b6-4cd8-bc44-ce0842bf5834"}, "0ded33eb-c6ac-4914-9862-4271e8248f7b": {"doc_hash": "cf0d2de51c43d3d730fc79ec7960d10f5a7b38e3e7070a7fd94288c0183ee260", "ref_doc_id": "234c0449-cb1f-4345-a903-23d62d94ac12"}, "973e8382-100c-4eeb-ae25-175179d0d53e": {"doc_hash": "b1e6c9a7414d38ce18669039885d2427fcaae066c77a2fc29cd3c29bc6bb29de", "ref_doc_id": "d586f953-027c-4f70-b7db-04fa13a546e6"}, "953d3004-36a3-48ae-ae62-909320142837": {"doc_hash": "12d36e146363ef74d388ce7abb732eff6cb8cd6de824e443ae784ecfaf9d2db6", "ref_doc_id": "2f6a0a0f-780a-4d3a-9730-17f9a41200dc"}, "0aac08e7-2a90-4143-a110-e688ca5507c4": {"doc_hash": "01129c33b66f3bc50d03f071f91fb049fbefe3d45bf17a50204e50f5d8611bf4", "ref_doc_id": "4b4c7c41-d269-4c5f-9185-c669441d1062"}, "a2acad43-6e57-4fa6-9edb-3420c2c8bd6b": {"doc_hash": "016e5b37c0b4d6738a19be15e569bed90d78fad93b3a723936406a50d6aadc67", "ref_doc_id": "d8a59c8d-d77a-43d6-8976-a856459fe07f"}, "337b1d01-ff37-44fa-af98-0837610be230": {"doc_hash": "447ab5dc61640b28e32465f43594f378b32189f9b2e9ccc3b4c7098e6fb2fe4d", "ref_doc_id": "d8a59c8d-d77a-43d6-8976-a856459fe07f"}, "e81e507e-85fa-42e8-968d-6c4bfd4515d4": {"doc_hash": "f3ef795f0e75c4d270f1923d4639fb791110687780a1bdd254cff82074d5531c", "ref_doc_id": "921c0272-ed93-4218-be54-f138a10a87a7"}, "e032ab53-d058-4e0e-9864-d63b3f7a0ef5": {"doc_hash": "866eeed07789a874b26d85bbd3f647b24813f8567af3304d4ac7bdbbcd981540", "ref_doc_id": "0f428bfc-1b65-4406-b095-1c5e398960f8"}, "f664593d-6d52-427f-bd53-dd5239b51b9b": {"doc_hash": "d4edca29e19275b42597efa1eb117738060e96260ba0533b4ad1f33a6bb6334a", "ref_doc_id": "2c77557f-3e0d-4767-96c3-a468a290760a"}, "9a4f4c38-d7d5-4357-b345-3bd86b028ede": {"doc_hash": "3f264151969891a1c9113498ff349bbb9d9aabe91967bed9807a72db032895c6", "ref_doc_id": "dc734550-480b-4437-9e9e-e54439352817"}, "24320d04-1ca4-4836-a3d7-4b7a7fddfea0": {"doc_hash": "2125f6eed795ba78d4b022986beb231bbca492cf5215a26fbbba28b08822d44d", "ref_doc_id": "425fcd81-d7b1-4a13-8c46-55adbcff2ef4"}, "16ef36b5-dc18-4454-b2bc-4905b9734137": {"doc_hash": "fe5113e3d9fa2f09d9d844bda73a6c563eff0eb15b290e7b36ff2d7f9f510627", "ref_doc_id": "06f20a7e-c8a6-45f6-8a96-203d3351d2dd"}, "f8f76594-5328-4748-abb9-2ebe4b1cf54e": {"doc_hash": "951f6fdf69ae03ad607d9de41b04564d0c078605d58cb3442ee670374c51fab5", "ref_doc_id": "06f20a7e-c8a6-45f6-8a96-203d3351d2dd"}, "5dd01787-b77b-4618-bfbc-62c09b58f0fc": {"doc_hash": "916018c9a5ad1b43bdfba0fc2b981fe9b80b50b029a783827a31792bb73a9c0f", "ref_doc_id": "ee554bda-b280-4f5b-9605-5a77ffd9974d"}, "e8508ffe-1c27-405e-b8fa-f5fe011a22e0": {"doc_hash": "69330534400d59eab40afe9d0c9474a2121d4ad5052ffec4628af8f315d5c21b", "ref_doc_id": "ee554bda-b280-4f5b-9605-5a77ffd9974d"}, "8aa08596-f931-4aaa-af2c-4b601b059cc6": {"doc_hash": "dfb6f9cda741d916c23b42f1126af7b853b12aa135e7f6decb9b0178442bffb8", "ref_doc_id": "ee554bda-b280-4f5b-9605-5a77ffd9974d"}, "f1f5b8cd-1688-4469-a1f1-78cf34769262": {"doc_hash": "08a6caf64a70d3d8bc005dbdfd6cb41f4eb0014b5506c0f87f528b988eb83eaa", "ref_doc_id": "cf4951a1-0e6b-4185-a9b3-fc404b11c0b9"}, "532229ed-8f7a-4924-89c0-88d550ac2fd3": {"doc_hash": "5dc67c39cfb2cbd5872c3db733b09f15c287dbb8bc24e41cc75a4d8aba1a32b7", "ref_doc_id": "cf4951a1-0e6b-4185-a9b3-fc404b11c0b9"}, "db8b5414-98f3-4012-9570-7f57ad341147": {"doc_hash": "5ea09ba729ad81426aff1097288255eb1730f98c5ce9eed4f6c497f8f78f1ee6", "ref_doc_id": "cf4951a1-0e6b-4185-a9b3-fc404b11c0b9"}, "3f1f9f55-208b-4739-b28a-1c4c4a2519e8": {"doc_hash": "91e639a633f07c9176e0ad6e99a309dc3949b79f6873374d446535603791eac2", "ref_doc_id": "85d3aaa6-8ba8-4b91-a142-c0a109aab745"}, "ebdd22d4-a168-45c2-bae5-dc391c1162cd": {"doc_hash": "8783237c6a86afa3bed01c5d3a4910181a760c897c476af6fd064852873cfebc", "ref_doc_id": "85d3aaa6-8ba8-4b91-a142-c0a109aab745"}, "45e3ad74-1721-4dcb-bae8-375346dc94ca": {"doc_hash": "b064b0d048499788783c58d242697f4b0d6389f2749684248f86d9cb5fc96920", "ref_doc_id": "85d3aaa6-8ba8-4b91-a142-c0a109aab745"}, "0c377f69-3f04-43ad-b957-64039950e275": {"doc_hash": "edca389018a01f6c322aebaaf122b3e811358cc6153fbaa0b3902c2b55b596f3", "ref_doc_id": "5c0ca706-f1dc-42be-9d9c-2a187148fc6b"}, "2d1974d7-2d48-43a8-b237-4e9b8a3d8b02": {"doc_hash": "585dc655b0773d8f86bb3f4fec206dcbbe5d981f013699dc133b0857a6b5310b", "ref_doc_id": "5c0ca706-f1dc-42be-9d9c-2a187148fc6b"}, "89fa5270-86c0-446c-9662-e4e72cebfb23": {"doc_hash": "bbd76a749789bb620e06fb81b7eecf7b313745e5260a82b330aab2c2959cdea7", "ref_doc_id": "5c0ca706-f1dc-42be-9d9c-2a187148fc6b"}, "e794825a-14c1-4370-a8ce-d343562e291b": {"doc_hash": "325b7334d1f0f21f7a6f3f5de72db884b4fafaeb239e3614140c3ff8d3001780", "ref_doc_id": "be661258-2bd1-4019-924d-e6aa631ca982"}, "ba032d5e-ea91-4003-b58d-82a9ea458f3a": {"doc_hash": "b5628bc292f5e368158c95ad01b9d58583938330b4b69a89903cd311b246353b", "ref_doc_id": "be661258-2bd1-4019-924d-e6aa631ca982"}, "1e2d60e0-f9f5-49ce-a2aa-f2c835b8d856": {"doc_hash": "10f4de70b2b97403de3e97bb7d3f92e20f2f870f6c16fbec20877d59c579beb7", "ref_doc_id": "be661258-2bd1-4019-924d-e6aa631ca982"}, "bec9114c-e55a-471d-895f-0570c41c0530": {"doc_hash": "342b9635e2acece761e4e700f7bfe9ca17b091c870193aecbccc5f4b240e8ced", "ref_doc_id": "a94a0c06-768e-4cc0-b542-049c964b11de"}, "57c59627-8c09-4516-b8f7-ed8aa7774754": {"doc_hash": "fc8f8e61112812bee5e486f9bcc68c66b0e3b206c079b44ca0030ce6c1373d04", "ref_doc_id": "a94a0c06-768e-4cc0-b542-049c964b11de"}, "93629bd7-c736-4584-8555-bda2753252c4": {"doc_hash": "02bc907ef2da8b0a91ea1c225f0447932dd85e64bc77ce3d96441d974c727583", "ref_doc_id": "c646f8de-d8d0-4033-86a6-d6d74a7f23fc"}, "bd1d9d39-7e41-4340-9a93-ce26a9de28a9": {"doc_hash": "5dad34e25534f9e7e745ab7a3d710a049f3baf4b33a6cdbfeaebeb6f63156466", "ref_doc_id": "775b54ea-5567-41ab-974f-aa3335796041"}, "cca2a079-785f-45ff-bb74-b74c333efbb1": {"doc_hash": "05930703d0e233b0b5a4cae3ace79b8fc6124b0536453a00615ed247708d7a73", "ref_doc_id": "b1a09b81-e97c-46b4-8219-f169d8249b38"}, "fd7ab557-298a-48dc-aebb-c597bf26a0b4": {"doc_hash": "8b9eacea7bb7dc4d21a6d7246760cfd562b9b8ba65c8d49f8497e675d3e20685", "ref_doc_id": "f7d882b9-6173-4ff9-918f-ec406ccea0d8"}, "ce5e05b2-26e0-4c79-8f8e-2b7e7e6bd9e8": {"doc_hash": "7230cd2b5c1d3c36eefd1a3d63464df148991bd9a7ede2c2841652b981f32f56", "ref_doc_id": "f77565f6-0359-48ef-8bbe-d9f6f96fe6db"}, "f585792c-aa98-46af-b366-35039065f8b6": {"doc_hash": "0cdb8d0771a5439cd60e539a0eda37f85b180d13c0b9d9a10c04006c62a06805", "ref_doc_id": "f77565f6-0359-48ef-8bbe-d9f6f96fe6db"}, "aae9153a-0f0e-4c38-a0a6-ec44b45a5791": {"doc_hash": "b74ea077299011b5764cc43767883ec722a17a5c35272dbf7f633402fdff6413", "ref_doc_id": "bc72bd0b-9340-4c36-87bb-261b67d94989"}, "1a164456-4c34-476d-a7d8-a7f15912b8a8": {"doc_hash": "64688ec1d958f69dd231c6d3190b804224e3ec688ba4af13f2dd4e860ba86b96", "ref_doc_id": "bc72bd0b-9340-4c36-87bb-261b67d94989"}, "eb30cb3c-0f99-4135-aa6c-76502b100aaf": {"doc_hash": "85b2f4e96df77ca688cebbccd37b76d994d86c232c231cf36dab73340a73f4d0", "ref_doc_id": "f59e0007-e6ff-4c11-bb25-772c0b47af9d"}, "e3934546-344c-446b-b9da-8537f1aa5a20": {"doc_hash": "7d8c23f0611b6899c6d7324da299ac65611493611ef200382ded6f5777e23bca", "ref_doc_id": "f59e0007-e6ff-4c11-bb25-772c0b47af9d"}, "8ba0e1d2-11de-493c-9ede-5c3aacf03bad": {"doc_hash": "4ea0ff15fe72456c8686e219f3de8fab4481ac5da21cda461e7ca7404c21fffd", "ref_doc_id": "1922f186-6e73-444b-ae8b-b28f5184331d"}, "69526e9a-3e4e-4cc4-baed-bef3a4256456": {"doc_hash": "70f723468196b946bed3482e891e9338d6f7ec0143ba5ab88907a54c3557a477", "ref_doc_id": "1922f186-6e73-444b-ae8b-b28f5184331d"}, "7438f099-b8fd-459b-8369-960745b0bda3": {"doc_hash": "2ec4d3a66b45de74d749ad17b698d3db798e5fc193645a5d7990bfbd0b44dc14", "ref_doc_id": "3b275cf1-f139-4263-b401-b501bc83c8c9"}, "4d138c82-1ee1-49fd-a5fc-9630e2e913d6": {"doc_hash": "95e24de6ffcf70856e7ef0ec872356a198d14d4b3aabc5f34619a71bc1cf60c1", "ref_doc_id": "d643ac5d-35fa-4dc3-8379-8057711c0d76"}, "303e9f88-cc85-4163-b631-061c39aec275": {"doc_hash": "45b515ea390971a4700f791bea24a50a3dccb119de856b313001eec216ff8bf1", "ref_doc_id": "7df68562-d35c-4110-bf60-f512b3b0788f"}, "f16982fc-9f21-49d8-b2c9-eb81827bb2a5": {"doc_hash": "81128f104561a304f9d0fb0f1f13b307d704c0fb6dadf520688a32646825485c", "ref_doc_id": "a9244289-13e7-4001-9d8e-49f53f49aa67"}, "e1839a7d-73a0-4ef8-8017-a53fdc07440f": {"doc_hash": "7c32c9933c0b537effd0cf896ce6594f8d75c12775c1c2699975929247bb85cf", "ref_doc_id": "5cb54a7a-39c1-4b53-aa40-a74732532525"}, "0394dbe8-35f8-4f1d-af79-06efd16cf817": {"doc_hash": "b41ef67e43803c70c4586504ff81aa57ccdf70ae449b3ef300158eea0e3f89cd", "ref_doc_id": "ed8e5b08-2cc9-4e9c-a2f4-f017c3fe58a0"}, "5870bf2a-6b64-4dd1-ab71-bb9308cfa90b": {"doc_hash": "7b2bf88fc111dfd28b278a9462f155b8ee1bcea79db22140f481f3cb52a00cd2", "ref_doc_id": "421693c2-4526-4469-9ce0-1bd0d1176943"}, "75558ccd-1573-41d2-98bf-ae637fa314f2": {"doc_hash": "42552cd97571a7100a3fa0a30a159855d883ff91f808c658a3894deda5d18ae0", "ref_doc_id": "421693c2-4526-4469-9ce0-1bd0d1176943"}, "84ddd6ae-4053-4ccf-b3d9-2d0e12c15f04": {"doc_hash": "bab2331eabdd2c08bfcdc023b03eb5f9ae8a3f679118dae6600bcbe65372a8a9", "ref_doc_id": "421693c2-4526-4469-9ce0-1bd0d1176943"}, "b6862bf2-ef1a-4a0e-8d06-ac4a856b99c0": {"doc_hash": "456b62222dddff81cec8063e49a8dfc7828748dd7e4fae6a81116f24f2c9e2ce", "ref_doc_id": "3405c67c-ee88-4fa7-849b-45f62ca0315a"}, "35847642-fa18-4abe-af7f-7478c1f24251": {"doc_hash": "c9b2226a78671825b3de31b82ce26d57af3cd4d04612c0c3b7c6cf974c8878d1", "ref_doc_id": "3405c67c-ee88-4fa7-849b-45f62ca0315a"}, "25c58ab6-cc63-4595-ae07-50555e419a35": {"doc_hash": "c85876aac71d200702284482255b92a6d9588d07edb59847baa7c590a40c8138", "ref_doc_id": "8401c088-705b-4463-a213-997ac3b63c28"}, "c37f575b-2241-4815-9fc3-c1ec0c5acfb4": {"doc_hash": "b5b8a5673f2cc1209ca2622c8dfb1ebed45fe931e9988a4880e1116a4b4f8756", "ref_doc_id": "ee3931b9-632a-4556-bd68-a29e3ae2e9e2"}, "90bde5d9-3dd5-43f3-83c7-e71069131683": {"doc_hash": "e6d2b37dbf08ad64c93b122659598249ee0d8823b3e2a35ff53af4001148e327", "ref_doc_id": "ee3931b9-632a-4556-bd68-a29e3ae2e9e2"}, "0c5f4a06-cef0-4111-9885-72a470fb2d79": {"doc_hash": "7bcdc7985fcc4e3a052ee871434633047f1e5f6b78e383d7c349a8f078eb78d3", "ref_doc_id": "216d3c89-5566-411e-8eb9-a8273ea2d283"}, "ac191482-0594-4173-9109-c66c8a9bf415": {"doc_hash": "871c35a2a445bfd7b322668b1e5dd4ff9679d8a2738c8849fbf329931ad1b6ca", "ref_doc_id": "216d3c89-5566-411e-8eb9-a8273ea2d283"}, "a858f1e9-fea2-40d3-a952-00d9b641652f": {"doc_hash": "e2045ae79d3080e69579c7462c1933eda1041ad953a2d458a7516ad10a8639c4", "ref_doc_id": "602a71b8-6c70-474f-8805-eb620c229423"}, "64504566-f6a0-4519-a9d3-b96adaec0cb9": {"doc_hash": "9bf948bb059d3c2ef49f92c9838d88ed1fea79fff0e12533ffdea1bef42914b8", "ref_doc_id": "602a71b8-6c70-474f-8805-eb620c229423"}, "e0361bc8-4e92-4f33-b0c3-c3bd1043c979": {"doc_hash": "866303ca5fa6953b32800431d83a16d3ac1d83f987017713dc91dacd84d349e5", "ref_doc_id": "aeeb624e-c3f3-46be-b9a3-10f9fafdaf83"}, "f7fe8066-d1f9-49cc-a9ce-0cbc69033f50": {"doc_hash": "64edc6d3cdf92c660acaed74b5b193e09c5d734fc6ccabc232ab37f91316badf", "ref_doc_id": "aeeb624e-c3f3-46be-b9a3-10f9fafdaf83"}, "c101b0d9-6ce8-4760-a84a-ebef44df93bd": {"doc_hash": "eba97273dc9bfe8052c358b9ff2d61df2de70c6ffad92b2641da78af7ba9665d", "ref_doc_id": "aeeb624e-c3f3-46be-b9a3-10f9fafdaf83"}, "51a7accb-6c81-4040-be97-fea4f665f7d9": {"doc_hash": "b9790272220c5d0bd377ccfd0a30b71b0e85ea6e4d7770d65475956a97bfb1ab", "ref_doc_id": "91cf89d6-d60a-438f-a2b9-023262f98c9e"}, "357cf8a8-0cc0-49e7-a17e-409c3ce68566": {"doc_hash": "ee51019cf5442a091ebc6aadb5337a0147096e0d81a1acd2726114e0717b1642", "ref_doc_id": "91cf89d6-d60a-438f-a2b9-023262f98c9e"}, "9de29564-4579-435d-9a09-732af1bb9893": {"doc_hash": "fea0c7f0915172808b2869b48c89facd75bd6d7e92ac9121e278e5552fdebaed", "ref_doc_id": "45aac0c9-d716-4bf6-af63-3fe2b4cf06a6"}, "a0ec3121-e7b1-4c2d-b9d5-983f1df408b0": {"doc_hash": "9ab3dcb4d6eb2972e85c7ee29a5d7f3f3c002e9574be9d242f9776353e8dbf50", "ref_doc_id": "22eeda53-78cf-40e6-9842-f83dbb45844a"}, "8356ec45-c682-4996-891d-e1b9a31b540d": {"doc_hash": "5c114370b750cae9c359994c62ef7bea7e05ba621cdbe0ceaa241729352b29f3", "ref_doc_id": "22eeda53-78cf-40e6-9842-f83dbb45844a"}, "06ef60cf-20c3-4ca7-a75d-06ac78da4745": {"doc_hash": "4bbd699a84fd2d59baaccdea100f17b29f89f93375308c5b2768e7cd903b8258", "ref_doc_id": "22eeda53-78cf-40e6-9842-f83dbb45844a"}, "7220941e-0382-4e8c-8938-485ad7978eb3": {"doc_hash": "de5b36ee77bdd282142a3530f97599c38bb249bcf330d3eacd0ad74631b131a8", "ref_doc_id": "63a1f3d8-06dd-47e0-8495-d78b5fdac9f6"}, "9f0e78b0-799b-4bc2-8790-c632a2b4ae9f": {"doc_hash": "6e3fc7897926f8a72c01cb3275facd5f9ba43a594a66f11546b45363a3dfe6da", "ref_doc_id": "63a1f3d8-06dd-47e0-8495-d78b5fdac9f6"}, "f1dba7a8-fa8a-4b5d-8395-9282ae261196": {"doc_hash": "b1a6b2f99b6d10e5c4ef3a5ddff3db79c29aa1fa5824926b21174a5d6e43db84", "ref_doc_id": "63a1f3d8-06dd-47e0-8495-d78b5fdac9f6"}, "58b7167d-0417-4c51-8c66-1b36861d1433": {"doc_hash": "1da90c79da2fe28e709f9783b02e6705c5a1712a21299f8622db218b1ce3b4d2", "ref_doc_id": "2cd1ebdf-75e7-4223-a4c1-b7491664d6d3"}, "5ad6fdb7-963b-4986-b0c6-278ca588c119": {"doc_hash": "57a1e2330c32999b27f68762e199c1ec9ed092d3bb2c9f74035a45756d64b0b6", "ref_doc_id": "2cd1ebdf-75e7-4223-a4c1-b7491664d6d3"}, "cbf253ae-4450-4861-b04a-f956ade37b42": {"doc_hash": "4e7b30bd130108c48941d418445385af9d3d0901620dea0045409766f63fde00", "ref_doc_id": "d11daa53-8c99-49eb-abe5-4483b02ac317"}, "201215ff-7581-4f28-8155-0274381b9ed8": {"doc_hash": "bc6988cb47925d5ffe5059cc74b2656c883a5189068a8f8882b031a1154f56ec", "ref_doc_id": "d11daa53-8c99-49eb-abe5-4483b02ac317"}, "6685157d-afd1-42da-8aeb-32e2b41c74c2": {"doc_hash": "a43956103aa2a6bc0093a2bb2f56a44561561292f9afd90da7febfaa797bccde", "ref_doc_id": "57965d55-c1ad-4d7f-90a1-a3791a2a78c0"}, "bcdf0afa-b938-44ad-8cb3-ba4b1b5fbfed": {"doc_hash": "71b2f4727d1b3c6a73d80f9e5a86be980a01ca129ea49a5b7692b583d0d81df3", "ref_doc_id": "57965d55-c1ad-4d7f-90a1-a3791a2a78c0"}, "5c6097f1-60c2-41b0-8707-603bb4af8a8a": {"doc_hash": "8370f7eeb5d450e05d6c4cb092af9edb57241d190bd532b3a4e88559bec4ccae", "ref_doc_id": "31df4760-baa6-4df8-b6a3-ad6e87d4178d"}, "6b8f641e-f7cc-4ccb-89da-b58b94963d60": {"doc_hash": "46b4f6a02e909df984f49a551efeb3c5e326d0458f8255a3a1357f3e18145319", "ref_doc_id": "6b582910-a64c-418a-a7c9-bc493f745ad5"}, "a50d4f16-6e5d-4dd6-b32f-22ee22cd58cc": {"doc_hash": "742b34b0e14fca0e66fed1e6fc85de18dfbd21d8175d85bd16aa285232d611a5", "ref_doc_id": "d93a2112-147a-4f5d-8fdf-5af9cd17b893"}, "1a9202a2-1801-4cce-9b33-ff97502bee53": {"doc_hash": "a553f65458860157b0045c355694c52a2326b5150c7681e5c1295c06cea844f6", "ref_doc_id": "f5ea06cc-02bd-4020-a102-5e446b0b6966"}, "7ffe8459-978b-41bc-ae67-0e612bbbc966": {"doc_hash": "57481d649d2acf5b21c3138c36d7fa6f8002cab502e1806519109a363aeefcaa", "ref_doc_id": "f5ea06cc-02bd-4020-a102-5e446b0b6966"}, "46f15ac8-a103-4000-a730-aa518e327da8": {"doc_hash": "ab47164acbfcc0d9a90bf174928e8d2a2cedda68a11a2074cc62a2a1e4afa454", "ref_doc_id": "6a1fe64d-f4a9-4062-863f-37cf1a17576a"}, "e8298082-52c3-437b-9dea-b4002529c28d": {"doc_hash": "4835b1c6f30ffe94aae423ca82c0e4b21e418f6b0694d741e23a9863016d5775", "ref_doc_id": "6a1fe64d-f4a9-4062-863f-37cf1a17576a"}, "f15204e8-67de-4de4-a3a1-c7c410b7d484": {"doc_hash": "919f8a869ea097be201fbc111d389b383e271559e9503326e291a37e802e066c", "ref_doc_id": "d38ee834-7582-4bf7-84ec-a68555bd2bc2"}, "c704a46c-c5d4-4a95-bb64-ce171ed9f1a6": {"doc_hash": "1fd268d2a2a3a43cc5a25d51f4bba93f6da8b0e577b40f5cee125dbc30d94828", "ref_doc_id": "ceb135aa-8c1b-4cff-ba92-5561e4591ed8"}, "1af2ca28-450c-489c-b8de-93e20b9b6985": {"doc_hash": "e73071589d847afa70b3982e0e6ddd2c2cdafd9cb4ac7112d03795ad0ef67f00", "ref_doc_id": "733581aa-97e5-431c-9e31-485d6245edbd"}, "d21ace7d-02bd-47c4-9773-9ccb39443137": {"doc_hash": "9f4325585cf74df599a254dfc0198945118da39bbe74a734c3293a35b6bb1043", "ref_doc_id": "733581aa-97e5-431c-9e31-485d6245edbd"}, "32e34bdf-ca80-40df-a185-fcd682ff3449": {"doc_hash": "07a20c6908226a8b0e032823b3f83e5837f13f28a391566f98a92b6f7ed305b7", "ref_doc_id": "0b1318a3-f7b1-4622-9b3d-2e42f66e5d8d"}, "e8699fb6-d147-4c39-a9e1-cbb6691beb64": {"doc_hash": "040b06d73ed6e0b28b129b957ea81f144391d020b10e0f02de81c3ec53a32d6e", "ref_doc_id": "0b1318a3-f7b1-4622-9b3d-2e42f66e5d8d"}, "16c7fd2e-7386-4a4a-86f9-8f22504dadbe": {"doc_hash": "c7e06c680c4d2b386fd0e6fb002b51bcb3ca68ac90d4fdeefd3aeee06dee9130", "ref_doc_id": "4c2b9b37-0d6a-4241-99fd-d6c85afaa8c4"}, "5a855c2b-dc5f-46d1-9a69-8f11427ac120": {"doc_hash": "a787c63b6f9265ed815192895a7a535cd83260000e46da9b1a617b2d1e108012", "ref_doc_id": "ae0db44a-ba09-4b74-b4e2-566d71094900"}, "394abb19-2ff6-4a77-86c2-197c707570ed": {"doc_hash": "f1761777621a4c3c81cc212330039cb617080754954f90dc0d3c050841dbb107", "ref_doc_id": "ae0db44a-ba09-4b74-b4e2-566d71094900"}, "63bd4f1e-4881-4252-a923-33877ce14f91": {"doc_hash": "9839a58cd0cc148999bd5dfd668e62726b92da7b32efe101f6ad6f277a2bbabe", "ref_doc_id": "16372890-a5f1-4c5e-8b81-8134278494a1"}, "127225ef-a33d-4812-a0d7-3ccf9d0fe1f2": {"doc_hash": "8fef004035c1a834b6d56484affaf44a7e0e6aa3e5e8d86ae2bdab1599ec23f0", "ref_doc_id": "16372890-a5f1-4c5e-8b81-8134278494a1"}, "593161fd-cc36-4d60-8076-43a77e720a5b": {"doc_hash": "c82e68a815f8956b6447ff0959dfa27c2d278bc83d88b5569d6dfaba9684ff24", "ref_doc_id": "0ae89faf-3ec0-40cd-a36e-2ff6a194988a"}, "7fa7c3c0-428a-45b1-aae5-7845e63fa64f": {"doc_hash": "c9ae13d03c7de596fe6cb7fb539962bc66eeff55be0aa7ed1cf7bb61ca6138d4", "ref_doc_id": "26a2de5a-37ca-4993-be72-f3451e471d09"}, "371f9c81-42a1-467b-873e-5f1c973a4e23": {"doc_hash": "3d2b86b3076308969b267abdf414e6c25494edff600ff99370fa2cea6b2cd723", "ref_doc_id": "26a2de5a-37ca-4993-be72-f3451e471d09"}, "c2b85f8c-8a07-483b-b508-3281943203d2": {"doc_hash": "e8f5b4b8e94e9974b2ecf1d974480ce6217250bc5f6d7e60f87e7de2e91affe5", "ref_doc_id": "1bbbc91e-59c6-4d9a-86ee-93fb7ffac84b"}, "c45cf6a7-82f5-41ea-9da2-fb8bc4eed9d5": {"doc_hash": "b6b7b225a9f0c6991ff64bfc1e4ac1cb8200880ab1cf5dfc510204a7a1c11b90", "ref_doc_id": "1bbbc91e-59c6-4d9a-86ee-93fb7ffac84b"}, "7fb996dd-3fe5-4e1a-b691-31100987adfd": {"doc_hash": "b2b72b353f87b7fed7874a46875d9a0948fe0b52c89d55d7fd144003d49fa26f", "ref_doc_id": "2bac64ee-5976-45ec-b2e0-7819b43e2d68"}, "a93ea63e-1a7c-4f2d-a32e-1bde74c958da": {"doc_hash": "465b8f91b683a5e27b222f84eba67ec96dbafb4c9aa3311d401e1ed898d02a16", "ref_doc_id": "2bac64ee-5976-45ec-b2e0-7819b43e2d68"}, "994440a2-f7c5-4ee0-a524-be2174b43d25": {"doc_hash": "aeacce8e2a21a3a0eb9591cbccc73ddc2a1fd8d9f9fb44e4c2824a665d8059db", "ref_doc_id": "45f14817-c099-4e06-935e-244fb3622c55"}, "ffd41f7c-1b9f-403c-83df-97b902e4db8b": {"doc_hash": "194cc1a5b693c5b4e5173cc6a1714887a129eef317f9a25b2c6a1b7bed015a5b", "ref_doc_id": "45f14817-c099-4e06-935e-244fb3622c55"}, "c95931ed-76e8-4477-8e3d-9f2eda4d33d7": {"doc_hash": "b56d3a41241baafa0f1c18cbf900b21386ea76514564a1d4e32dc6d86a1221b2", "ref_doc_id": "81ef302a-8dc0-4838-910b-2908b0b0489c"}, "d9963c07-b0c2-47b5-93a6-10c1ad6b65bf": {"doc_hash": "83e20a5c94245ee481f9dba0ce92cd432e2dbd2f7b9c70fcb4a60d3dade024da", "ref_doc_id": "81ef302a-8dc0-4838-910b-2908b0b0489c"}, "b7a06797-c66f-4ad0-b2ca-ee350668a3fb": {"doc_hash": "2be57ba16c68fa6381392611e9d47e87c04e61bc0a37701a1e6bc4e6424814ef", "ref_doc_id": "8277e6f2-c090-4bdf-ba6f-d4c3730d6597"}, "6d7d3942-5f62-4e06-8cc7-1b0ffc0df501": {"doc_hash": "0138f8939b500085e012704331f3c8141aab29a8741377d1d5d7100194b8c5d6", "ref_doc_id": "8277e6f2-c090-4bdf-ba6f-d4c3730d6597"}, "a57342b8-1361-4d8a-80b7-91a4f8a15a7f": {"doc_hash": "732f4bb980cbf933f8806cc45f2b4332345d1c56700c3950e71c3b5f2548c903", "ref_doc_id": "76d20f18-e95d-4500-92c1-bea0f5a9eae7"}, "fb33f237-6e7a-4081-acbd-47dd0949fd4d": {"doc_hash": "cb2fa8e72d54b76dd1e9b9cfca91ffdbdd7fcbfffb9245f5162292a73f0ef4ac", "ref_doc_id": "76d20f18-e95d-4500-92c1-bea0f5a9eae7"}, "6acce295-5e15-4a0b-8e60-2731719660eb": {"doc_hash": "ce8700cd4f460b5f8ff4b89c79734fa5142a01877c76d42d69887cf1e68a78fd", "ref_doc_id": "a54d56db-33a2-4a37-8cb7-d478e2ef5510"}, "92358d77-c67d-48ea-8a63-85a2d12ae106": {"doc_hash": "25f13a1bd6a0d5e30363359b4f235b417538454e1854de195134c6d9bc2ab427", "ref_doc_id": "f8609595-4f2f-4262-affc-75255774868f"}, "ef86c120-5d25-49f4-a096-58bf968df9a3": {"doc_hash": "3f726bb3bf8a75469d528fdc9832288a5efa9e7b40e16e9c572d09cd829354e8", "ref_doc_id": "f8609595-4f2f-4262-affc-75255774868f"}, "876d6d4e-9aec-4b95-90a2-cc3219fa18aa": {"doc_hash": "e4397d68320e14db7ca0471bca71a4503c0312d1b7e72624c8c23cb3a5400d48", "ref_doc_id": "9e2a9d2c-9026-4764-a237-af4877be3604"}, "776f5a90-a5f7-49d7-96c6-5d6c4031af00": {"doc_hash": "abdc68f6ba070aeaba6da98e81398acb31a0dd927c720f36ec2e9965aab534fc", "ref_doc_id": "9e2a9d2c-9026-4764-a237-af4877be3604"}, "e2a0d222-980d-4170-b46b-283029ec6078": {"doc_hash": "d203a2930013f8e23e359e9ac62b2c192a188078b7623ae8ea83c7cd12e23c98", "ref_doc_id": "4fb76642-c6a1-4af3-bea3-5ce3ec162acf"}, "59309db5-e341-4d7f-93d0-ebc057a0f7a6": {"doc_hash": "d3be88cb6a42dd79c19d797ef0351d4c1d2c34d7a8a592d116e479bfcc069842", "ref_doc_id": "b5bb01f8-34ed-4001-a1de-5d393d12d3bc"}, "64aa1fef-73d2-4c8d-912d-2ce58773c2aa": {"doc_hash": "39aeb3829ddbab95052f62e380f998b17e0d25ee72445bc37d9fe71f1eea6a12", "ref_doc_id": "b5bb01f8-34ed-4001-a1de-5d393d12d3bc"}, "30ca29fe-09be-4def-aa71-1bc526746362": {"doc_hash": "838350f4892df98101329e083b0539e7784bdaef84db8d1d63ab5ebe1b47d521", "ref_doc_id": "dc40b0e1-c5f9-428a-86a2-10dd95b17f94"}, "2584ffab-4c58-457b-a821-b2ea10e5d595": {"doc_hash": "a8c051f2f0042242fcafdbe4139bb0f0bc6a5e588e45915586837b372a73723e", "ref_doc_id": "dc40b0e1-c5f9-428a-86a2-10dd95b17f94"}, "79650cfb-edc2-4554-9124-ab2cb1e2f297": {"doc_hash": "bd1f60f9149e070f93c4423c6ca4d35de30b52988914a94d4c7b2516242b19b9", "ref_doc_id": "b0f95f32-a136-4524-a344-14ef4e6fd677"}, "3ab7061e-3ca9-4e2f-84b4-3183ffcac7c1": {"doc_hash": "c9a018c9c817fdcf6e4feff7bb8e1eaf7ce8a835016c76c08bd13ba7eab08fd7", "ref_doc_id": "da24a0bd-ea7d-4e60-951c-f458c0d2a6e1"}, "225cf31b-aa81-499a-95ab-eba9d3d2f3df": {"doc_hash": "b461760cca8860d4261bad60962925dfac7dcbe6cb8dd6c5038323135ab0d8ae", "ref_doc_id": "1982e495-a119-4fc3-80f2-9642414896f8"}, "af693991-a2fb-4594-9d83-10a0e9484e72": {"doc_hash": "a6cf43a13d1d8face78b03be6b07023a1b5a9e5d004d137fb2d2cc0b78c14795", "ref_doc_id": "1982e495-a119-4fc3-80f2-9642414896f8"}, "70c28908-3544-4945-9cb5-9927bc3f42aa": {"doc_hash": "8e9824bac7145af610730f303223c776680c719abef2202bbcdf4ebe11df0803", "ref_doc_id": "24d7e45c-607a-4d62-9587-bf023879a73c"}, "6abd2204-9b78-4ddb-b46b-53ff0aeec16a": {"doc_hash": "3b4dca525abe241f1a4571b742d41524e269b18cee8e987a2a59b339644e5097", "ref_doc_id": "24d7e45c-607a-4d62-9587-bf023879a73c"}, "96425a16-fce6-484c-a152-b64c7a26169f": {"doc_hash": "dec83a2f7577c86278d7f567023973b39d45f265035fa30283b65dd39825d7b6", "ref_doc_id": "e395f3db-f03c-498e-8192-9970c56d21f1"}, "39341ce7-f9ee-4f64-a053-538d99b8ff7d": {"doc_hash": "85a85fc420ca89970252f66b67c37fc6057b1985bbf96b94de4beb4b97dec9f2", "ref_doc_id": "e395f3db-f03c-498e-8192-9970c56d21f1"}, "20132331-989a-44cc-85c8-e63a8a9ed346": {"doc_hash": "38c837db7bd2d113eb878909dcc4532e1c5ba431b56d06d584162221cfe77db4", "ref_doc_id": "46927469-ee86-4e08-9017-b52723046954"}, "d21e99c2-f858-446b-b0d9-9ba3ba035648": {"doc_hash": "5a419b71cd08fdf18daed1f853ef91e78c195ab7ddf4fec01b62b5b720e498da", "ref_doc_id": "46927469-ee86-4e08-9017-b52723046954"}, "bf5551ac-1edb-44a6-9cc3-b436e7d92108": {"doc_hash": "1373d1b45e013f3c91faf584437bb197dc90c4dfea6536a980768d30889a118c", "ref_doc_id": "9ed85387-4afd-4709-b45a-9141a7c0e4e6"}, "6e041b12-1da7-43ef-82e7-e6432a0d54f1": {"doc_hash": "e949358aab4db80bc92596aa895a867223f2e89d9b2848de960d5140659ba8c5", "ref_doc_id": "0ea08a38-eccf-4460-8ad9-5fbe5bb43b41"}, "164fba56-d7c8-46db-bc43-c0a3abf915b3": {"doc_hash": "5db730e72e61f45c03f94e1d879321f5dee30f3d842a3b6e4cec2edec9879e5c", "ref_doc_id": "d8c0ec17-137a-42d1-bd12-adf8fb061db1"}, "32ac11a2-eb6d-4ec1-9290-2cb649a8182b": {"doc_hash": "17da9b8577eb3422336d4401c93e628ca982656c015173d921d6f12f259303ca", "ref_doc_id": "d8c0ec17-137a-42d1-bd12-adf8fb061db1"}, "03cb6b5f-7015-4480-bd69-450e853c09a7": {"doc_hash": "c1dc151e131dc157c2243339af7069d146ee84928306b67a5ad28e2f6d42541b", "ref_doc_id": "26cdb1e4-9a7c-4f4d-86a2-b3ad0da865cf"}, "fc6d92fc-a933-43cd-84f4-203af63a99c9": {"doc_hash": "437bf1dce52248f2130a36820672fb3eaf81de451fc251d1d972177f882fff74", "ref_doc_id": "6f282b2e-ba44-46e9-adfd-35761c9b68d2"}, "61a9ea69-13bd-477c-9ca6-804d7e2f1d83": {"doc_hash": "3f5165dda2109b2af0b042eefbc4102d0a6be5452c1f80c7c446b8a9420fd4bd", "ref_doc_id": "6eb113ae-4d87-4781-801b-6550e06b2f92"}, "09f30451-29ea-4911-9add-396bf3e487b9": {"doc_hash": "3d0e851030734472e6a6b2dc02471514d79da11eab14d13b11d73ec8009c0d96", "ref_doc_id": "6eb113ae-4d87-4781-801b-6550e06b2f92"}, "8f94f0a4-c77a-4c50-a075-1edcbe1a10d3": {"doc_hash": "386e357273bddab020d5275c787333b03b43a60c89fff0ca9828d18696425b86", "ref_doc_id": "b615bd25-1ae2-4a7a-9d48-836752fae871"}, "1d2c524c-19e9-4aa6-bd74-ed099e3550f0": {"doc_hash": "4433cf5047e071abe7fc6a8a2688a65d2e386f6a75368b6669b6ff7cc43f23ff", "ref_doc_id": "b615bd25-1ae2-4a7a-9d48-836752fae871"}, "aa59dd89-5997-46e3-98aa-14ae0fb2741a": {"doc_hash": "fbce28379ebc64d03b35803b92702cfffe590637574337d7d1e6c4da6738dd1a", "ref_doc_id": "3ac0ffdf-af59-4b99-94fe-8af07b0a4149"}, "7d8ac91f-8d9e-4a15-b0c1-ec89cba2bf1b": {"doc_hash": "70797ce0876e2db2222ab8872ee37dc33111f2c9f194920d6c709fffe0021c94", "ref_doc_id": "3ac0ffdf-af59-4b99-94fe-8af07b0a4149"}, "291071e9-fd52-4bf3-b86a-ebd05b935d1c": {"doc_hash": "bb9315509129d1cebc48c127a39e2747623c32ca82c8306c01fe43a1e9146361", "ref_doc_id": "e70268a6-e9cf-41f4-884f-3f9ad1300828"}, "f0afa10c-2d24-413b-92b4-9f0d213e46ab": {"doc_hash": "5b033f45137ea5cf8d2cfede38f9c0d29452f792b5575dc9e04c753f0f206389", "ref_doc_id": "e70268a6-e9cf-41f4-884f-3f9ad1300828"}, "b66f6201-8f85-4fc0-adb9-6661f2ed23da": {"doc_hash": "015c2670af162fbbb6ba21097fb65db27b81ada1543d26e04ba06666c4d27dc9", "ref_doc_id": "e0d0b33e-84c7-4e76-811f-98b1bfd619f4"}, "92a90b77-df1c-4ad7-ac7d-b051a9911306": {"doc_hash": "01009db80e5649432f3ffdc3cef1169336bb0f24b1177ada438c75e781282c6e", "ref_doc_id": "e0d0b33e-84c7-4e76-811f-98b1bfd619f4"}, "68a887b8-6b2e-45cc-b34b-ec4cd9a6c4a5": {"doc_hash": "11fdff80aaf6a85a15983a04b17e2d12ae2dcd55f0448fcfd435140a0341615d", "ref_doc_id": "ea5abddb-c16a-4a92-a021-d6c7e380e39b"}, "f89336ed-d7e0-490d-8581-706965ab4141": {"doc_hash": "1f6af824b685201bc0571ce9a0f8d35660c747f7d2290261331135f3508f4748", "ref_doc_id": "c1343274-5a38-4f0b-820a-2b11e2ea0c53"}, "55228acf-59c3-406c-8468-9b57982c816f": {"doc_hash": "e09e63b1a1199fb440614d97de31083f07be6dd41d2ecb1608e4c98484becbc6", "ref_doc_id": "c1343274-5a38-4f0b-820a-2b11e2ea0c53"}, "9ce2028b-2002-4131-a2a5-b5ab0ac25a4f": {"doc_hash": "36c002c20bf08275e643bccee57b95c5009d9cd735b5de5cf2fec4ffdb894fa9", "ref_doc_id": "7bc34106-b4ef-451e-999e-779866b856b2"}, "60b5bc34-5919-4b89-be63-59ec4594bd64": {"doc_hash": "5c32c3ededc0c9a775f87dcae7cdbc6784aee513530219dd086e0b215b54d6b6", "ref_doc_id": "7bc34106-b4ef-451e-999e-779866b856b2"}, "58001648-9d8d-448e-883f-f8c1874d28bc": {"doc_hash": "0237d99b44ee5840c990aa391174547cbc007806153640f5b9b18cf8608ee438", "ref_doc_id": "6e0bd672-07d5-46d1-b421-b037e5ab783b"}, "c1d7d178-e9f0-4717-ae1a-9f4e66f8f36c": {"doc_hash": "5e492d72a7e389ff14eaa8cb499c2c6c822daa4dbeb410dd5f9005c2eee621ae", "ref_doc_id": "aadb65dc-3cb9-4f52-a6a8-3a3eaf220142"}, "c38889ea-fdf6-4907-940c-26e5f1320012": {"doc_hash": "4ef011ddb3768ded3018da266e72028b592a722f427bcc0a439facbb2edad40a", "ref_doc_id": "aadb65dc-3cb9-4f52-a6a8-3a3eaf220142"}, "2eee5f44-52fd-4dd5-80e6-938ef12658ad": {"doc_hash": "9f2de22c1534e8807c0d331e4f737327f9c11b270ad35a2ec1a0d6bf29109499", "ref_doc_id": "aadb65dc-3cb9-4f52-a6a8-3a3eaf220142"}, "75edba8f-6a73-4dbf-b53e-7aea5a81659e": {"doc_hash": "412b0614e0e13117814a13fa47e6c3ac0cef05707761398f57793437b5d51fb0", "ref_doc_id": "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f"}, "05a12eaa-49c8-4379-a329-267057e3df58": {"doc_hash": "81eeebd832cbb277f1bcd6172329ea70f41bbf1a3c4f88d334a1ad7ff0e5875f", "ref_doc_id": "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f"}, "dc3e0fd5-5514-494b-82a2-90754486553c": {"doc_hash": "3cb1fa89060ab687fecc6b7ac95d51e6bb081e895c833ab41b157cf97497a47d", "ref_doc_id": "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f"}, "30a0d08e-c923-4553-89cb-744b440ba3ed": {"doc_hash": "78ed2af6232778df1820e0d3945bdbf0e7e0e1436e7e9f67f11089d4bbae5c3b", "ref_doc_id": "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f"}, "6f48087c-0815-426b-a511-f5c96eaa4862": {"doc_hash": "3a79500a3c87e2a4df01dd7d3c939a5aae19187be536763b92c9ef4a72cc31e9", "ref_doc_id": "6f62a57b-a8b0-4ff4-b5c3-ccf8c967ff65"}, "7f49d108-4b8e-4077-a3f9-9f82c68674ae": {"doc_hash": "d3daf5157fb64f1bc19006bd8a41d14b5773d644474869dbbca8278eb7ea13bd", "ref_doc_id": "6f62a57b-a8b0-4ff4-b5c3-ccf8c967ff65"}, "3710586d-0764-421e-b90a-3b79b31619d6": {"doc_hash": "f9b327e2a8910a9f2eb77a25af6a2270c6c5c43edc95b010f0d84ffca7e938d3", "ref_doc_id": "6f62a57b-a8b0-4ff4-b5c3-ccf8c967ff65"}, "1d63eb5d-21d0-4a4e-8fcf-733ff6280d8d": {"doc_hash": "79534342bbb530e4f7c45946a3b6eec7a2d02db86eaabad7b1e1c0b1627e51b9", "ref_doc_id": "9b9cffea-5a56-4a6e-bbf2-47f6875d941c"}, "b2881837-3687-4c2f-a859-dd7534e5cf62": {"doc_hash": "987d3171e2a13955d5b7a78bcf1431b02966062c0131198d801aa4897d519541", "ref_doc_id": "9b9cffea-5a56-4a6e-bbf2-47f6875d941c"}, "3e8b3962-c1d6-4bd0-aef2-9fd61b6824cb": {"doc_hash": "5353fe6de6ceef5afa894246b1553baeb8a25fabfa7b0c4b10c87a79fff67359", "ref_doc_id": "9b9cffea-5a56-4a6e-bbf2-47f6875d941c"}, "2b8a97a7-99a6-4424-bcb5-d7bc28b34505": {"doc_hash": "72e5ecd3de64976fb51571b58b173ccbf1d3ca7503ae9882c41c048aee4406bb", "ref_doc_id": "9b9cffea-5a56-4a6e-bbf2-47f6875d941c"}, "c6ac6818-6634-46c3-93af-3314b548283a": {"doc_hash": "730bd70ed87bc017289fd558ee162e8616228e5044559306999320af8e4600fc", "ref_doc_id": "3262b4aa-55a3-4633-b9e4-090add93b670"}, "91ac189b-8735-45bf-b645-cc6d12d42449": {"doc_hash": "93924976f7897fe941ffdbf98c796f46e41f8a62fea08dc91efe54aaaad6d2e9", "ref_doc_id": "3fcae6e8-660a-41c5-abd3-6141943b9ee7"}, "e2ff06b3-8ccd-454b-9e5d-2534203d4293": {"doc_hash": "635eaced849f135fb1a0aa41ff7fab69a34eb5d6bb1c29e8dfa8f97c9be5557b", "ref_doc_id": "3fcae6e8-660a-41c5-abd3-6141943b9ee7"}, "edd689e2-65e6-40ad-9698-f94a88b834b6": {"doc_hash": "b1c883a1f2dc73130ffedace1ec9eb8b0e06bc4f977d10650b96ea832f1e90f5", "ref_doc_id": "3fcae6e8-660a-41c5-abd3-6141943b9ee7"}, "81e00488-7f7a-4432-8694-884d4e42fecc": {"doc_hash": "963143466093fd80651d002268004f5ff1e6a0bb302b2ac729244a897f6267bb", "ref_doc_id": "72c1dd8d-45a7-4d98-9f36-a4df747f287f"}, "43305226-919f-4482-bded-bb24c05b01de": {"doc_hash": "95b06610530893cee9a1289e15c5631a94a98763f1491561845aa7d44f68e640", "ref_doc_id": "72c1dd8d-45a7-4d98-9f36-a4df747f287f"}, "ee721241-c50a-4db6-bdbe-7b65e9f51bf5": {"doc_hash": "0a9b648cfd025ce575ab14fbe67d70ee8c68913835b81fcfef4f14846b7619a5", "ref_doc_id": "596286fc-7286-42d6-a2be-460997c2e1bd"}, "b987f275-5caa-4210-a84e-63efefe1989a": {"doc_hash": "62a44283eb2d16ad95ba830db22f1f4e8ee5db0ff16c5941e7a98a77df4b582e", "ref_doc_id": "cd5669f0-8768-45a2-8700-6e00aa39eb54"}, "16b5490c-2e08-4422-b297-1080381e4f44": {"doc_hash": "46409fdb9c1d9bc1184012a24635a5ca7f6aa27a5410425c18c2c454a68ec57c", "ref_doc_id": "696df7ff-0499-40e1-856a-611c9a8c0f21"}, "fa5b3d69-c24c-4b78-b9d0-665b394f770a": {"doc_hash": "e4d472f7b26c3bba48ec79b136c19f6c99b115a43bc153a497094563197ae334", "ref_doc_id": "696df7ff-0499-40e1-856a-611c9a8c0f21"}, "c2768d1b-1714-4b42-8d0d-33bfb337707e": {"doc_hash": "6a5145828cb0c6a6dce390b572b905ee96f13028d83bf44d73c624646c309436", "ref_doc_id": "cad38abf-5546-45a3-be24-40dce9faf12e"}, "dbaf2a3d-2126-4603-a7fb-f52338a4c4fa": {"doc_hash": "2678118a2e8487b37e5cff7f6bb17c068654e2eb4afdf972d66158469f0d2245", "ref_doc_id": "d383be07-84e4-479a-b226-4de6a2076450"}, "54f63d7b-3c68-46b2-9c38-70963a04a713": {"doc_hash": "92ab0e050466097c5f78e978a127eb9fd8bcee5b6d456b3749fc1eb02decfd10", "ref_doc_id": "4eafe6cb-6cd5-4d54-b898-55ad86b3c703"}, "47097f74-f345-4bc9-b920-c3dd1f4c2e94": {"doc_hash": "5926d8c24ab3bfe99f2cc1642ba8d64c6db4a0ed93e272f25eda3a6d2c80bce9", "ref_doc_id": "4eafe6cb-6cd5-4d54-b898-55ad86b3c703"}, "32fe5c3a-f7fa-4472-a983-c1c15cba0e5e": {"doc_hash": "d0716788a82e1f710e501305c7751357162ee91206c6d28faaf8b6c2175d26cd", "ref_doc_id": "70d0aa84-bacc-45ff-bac4-996c43a41502"}, "8a292ec8-d7da-47eb-8f5e-6e6a0548a649": {"doc_hash": "c97d27ba662db4f047b794f57b7383fb2eee7a0f779b9cd295da86af3c4420dc", "ref_doc_id": "70d0aa84-bacc-45ff-bac4-996c43a41502"}, "895ae7c1-75c2-4ea6-a4ba-daf13e6558f0": {"doc_hash": "fb05a56b32e46f32f6da278432ee18184bc75a67c2da1cfb3d9b1040287ab210", "ref_doc_id": "b458fdf1-2816-4b83-9ec7-042a7edf93b7"}, "63168e92-d50c-493b-a895-92e3e403d304": {"doc_hash": "d6d2016294f77fa51c923b009ba584f21e8af48f47abb5b75b71dcd4e4d6fc95", "ref_doc_id": "e665bed8-e9dd-46e9-840d-beb5a980d49b"}, "d2b138d0-4e4f-45f5-bdc3-96f57eaa4550": {"doc_hash": "18c270c825c1f5d860df311a55174d2714f8923e21add3190b6ae2a30151178f", "ref_doc_id": "e665bed8-e9dd-46e9-840d-beb5a980d49b"}, "fbaa295a-3898-4b8a-9640-53e81f07ec39": {"doc_hash": "4a350ca471fa160bff56c7d6e9c4f6afa20325b4087821cb1fae21dcabb1b210", "ref_doc_id": "5ac04188-968b-4cc7-b7a4-541ee3c04d6b"}, "6c0c7cf6-cc27-41c0-b95e-702c266c4239": {"doc_hash": "16b33f58620fb892b35d3a8b21e69989134e2e307dff689e038196463ac89003", "ref_doc_id": "5ac04188-968b-4cc7-b7a4-541ee3c04d6b"}, "04bd2ccf-75c5-4d58-b62c-2998811f3594": {"doc_hash": "8d1a0e1e778b4b121ad2d6a9d402056bd838f04448035b4aff717b80b798c7ab", "ref_doc_id": "dd5d93fd-28dd-46cc-90c9-01dd1e1d3e04"}, "5591579c-ed00-40c4-b04d-9e6fcc2b9f62": {"doc_hash": "10550ad18af51c96ca6e2efd11f3cd5194e65641caedd526ad7e3da1f326721d", "ref_doc_id": "8fadd21e-73f2-4359-933e-93e650849acf"}, "c7e440f3-7f84-4a56-bb6a-063a43eb9b5e": {"doc_hash": "eb4ae70815aa60cb2810281da58121576da15e721d05159991e8139fe42be649", "ref_doc_id": "8fadd21e-73f2-4359-933e-93e650849acf"}, "00520418-f8a5-4a8c-94c4-767cb0be8f6b": {"doc_hash": "625a22513b1a2eb3bb00fbd03d36d1f28959114436256ed00de5549cd8521d99", "ref_doc_id": "a8815e0d-98d5-454e-9e85-c15431126bb0"}, "17130685-c381-4613-b806-8da43a5217d3": {"doc_hash": "aafbb4ff49039c613e80dd6edb82e492fbe71206a1ea065773dbacbba29735d6", "ref_doc_id": "a8815e0d-98d5-454e-9e85-c15431126bb0"}, "b2b7e769-373b-4927-9dea-d30fdcdfd771": {"doc_hash": "ccda3714eec8527c0aa2519cdae1713d73f6e32cecd70577c4b5368802a16ffe", "ref_doc_id": "7b6ca58d-df3d-4106-ad32-b03493eb6fec"}, "44f3426f-45fa-431a-b8ce-68ef23ff2c26": {"doc_hash": "6dbba1954174ce670a8254049f27effda01da4da2940a1a597176a14be3d28b6", "ref_doc_id": "7b6ca58d-df3d-4106-ad32-b03493eb6fec"}, "686e050e-30ed-4a2a-88fd-35dfa54422e4": {"doc_hash": "7e9c983d7f9c6226edcc0095626855bf99c01a656338a8766382cbb4ac7a9f5b", "ref_doc_id": "3c121948-25a6-4b3a-b850-4202c2c55b4d"}, "73cce467-b727-4bf3-b1d3-5cfadae82f3b": {"doc_hash": "5fab261151516efb6546e51cf92d0d5e28a7df3d52afe1fed634660a72dc2936", "ref_doc_id": "3c121948-25a6-4b3a-b850-4202c2c55b4d"}, "a9fa2a83-47dd-47bb-b4b5-4f356e0c29c4": {"doc_hash": "6e6f783d5ad0aa1057a913c6b3e794f78bab1803c562a118a7654ab640850869", "ref_doc_id": "a22cebfd-4862-4be0-a6cf-22e0c45997af"}, "6beb1b5a-249e-4324-9dba-b2fe75268449": {"doc_hash": "e525864ba64b2d9165336c804d2743acac2d30effb85f6c9cea0df4f97b81a57", "ref_doc_id": "a22cebfd-4862-4be0-a6cf-22e0c45997af"}, "8096ff3c-fb27-44d8-a6d0-75bb5d2f01e5": {"doc_hash": "e9fb180a66970a17bf3e6ffe27cf9b985d978a06c27a43f1d8cc91a561c8a90b", "ref_doc_id": "097b9294-3483-44bc-b101-44cfd738ab31"}, "ab5f8423-b2ec-4cab-8cc3-80ef50ccba50": {"doc_hash": "64095ad4c180b2dedc224474d845f95db5de3719c11affa22bc4f8716e4c1b0a", "ref_doc_id": "097b9294-3483-44bc-b101-44cfd738ab31"}, "5f2496d1-e65d-47dd-a0ae-ebf612c7e735": {"doc_hash": "dc7efdfdd7e284ccd749e72bbd9634b9284c44cfd446b576130d385e3ff01874", "ref_doc_id": "6f1c5cd5-4958-4f61-92ea-e165808eda85"}, "d8fab46a-c8cc-4626-a1fb-7f871eaf74f0": {"doc_hash": "fca5cb63eb7692d5bb6e6750fcfa1a39997089ad21bfa2283d8c2b77ed68ad13", "ref_doc_id": "66f2466b-3464-4c59-9f94-5592c3cec3b9"}, "23a3456d-aeec-4b43-ac66-cdb2ad50d88c": {"doc_hash": "3bdbb61e24547f384acf44e5766eaeea782486ba08e2f59fbc67b130113ac866", "ref_doc_id": "6c76a2ef-6994-4224-8b60-08f89a7b58ce"}, "24765497-6050-4698-9f57-e0ab3cb76644": {"doc_hash": "8d6d61787e16b53e690f59e1a947d0d93e3afb9f4989af0d793dbe8bbd39d1b7", "ref_doc_id": "a1366068-f121-4afc-b703-7b6c9c5bbd82"}, "7f853707-02b5-482b-9151-eeada1258310": {"doc_hash": "983146c98198ca6db7d1b6c3791e391aab32f65fa16be3b6eeaa551267bb18e8", "ref_doc_id": "fff33bcc-3118-4ccb-a956-b733a4aea3fa"}, "54eccbdb-cf9c-4749-86d6-6fdbd3176c29": {"doc_hash": "891714b1a690116ca53a9136569cce70273db582046dd562333926711c8f2b99", "ref_doc_id": "fff33bcc-3118-4ccb-a956-b733a4aea3fa"}, "523bd2bf-ab78-401a-bc23-90d6f91b72be": {"doc_hash": "feb860fd28bb6b0a30b9454746079ad97a6839e83d4e3d41e3aa98d3f46a4de2", "ref_doc_id": "4294a3da-1df4-4124-8f1d-2ca8a9524bcf"}, "56671b4e-1d36-43d9-9fdd-227e98f8ddb7": {"doc_hash": "0b4092cb42084ca0fd6347a5f3acab08e3cc7629679ec844fb8cf55f48221047", "ref_doc_id": "338921a6-dc4c-46aa-a742-86ed7e8ac4d4"}, "47b8a49d-ffce-410c-bf2b-f27d004ed9fa": {"doc_hash": "0905ed36b363cef887bd9fc5f7f48d66328549372436d82ec6dc77a73502e9f0", "ref_doc_id": "614859aa-9e47-4098-b7cb-c7c492c867a0"}, "ec4b4a11-3780-417d-bc0f-486a1fccc241": {"doc_hash": "3d913bb7e9041d5a7e30f55531d1656d87dba79ec3a9a8f4364833c480ba9a08", "ref_doc_id": "997361f6-035d-494b-b53c-589467c8286c"}, "fd57999b-5b74-41a9-b803-8de4edcfb5f8": {"doc_hash": "d998f2e813172afacd9d44459f46fffa9a378d55e2fb243923e1aaf42ad35399", "ref_doc_id": "ccf944c1-e7f6-4113-8e94-e1ef5d8804a9"}, "d7efdacb-77fc-49f9-8e9e-2fb1f07d478d": {"doc_hash": "ae6a14596324998c627c6eafe70ab0941f57d69f3cd6c4cbc5e56ae5b5daf195", "ref_doc_id": "6368d491-2054-4793-91ba-0335accbb817"}, "498a709a-6e6b-4bda-82eb-00346e1f9cf8": {"doc_hash": "1e826302d98db1ac78165259204224d2d6adc0e59b2c73470e7842e18a98bd26", "ref_doc_id": "fbfe30ea-c738-4a9c-b738-7202a960de77"}, "9a7e298c-062a-41a8-a352-c11ad5084fd9": {"doc_hash": "e9e0c3ec4383f52375ec1d56683a51b2a1231af1a11b384f2e5db757f243977e", "ref_doc_id": "fbfe30ea-c738-4a9c-b738-7202a960de77"}, "39ad5baf-20e7-4df2-b5cd-8d23b36f883a": {"doc_hash": "34f36f9af9f85d73901c1bd2fd93a38e77bac38c29d8cbc31025ef41308f9b4c", "ref_doc_id": "13d96e67-c91f-47b4-a53f-4d39e6db72fa"}, "7ddecaf4-becf-4386-8277-42393c3631ea": {"doc_hash": "a9f810baef171c22f28bb52c41dbf397c24a6b0dda6e05dbbf9f090724b2a9bf", "ref_doc_id": "13d96e67-c91f-47b4-a53f-4d39e6db72fa"}, "963c3759-e86c-46e8-894b-0eb831d6e7e6": {"doc_hash": "92771bc87252273d49da3b5c69c2a9a207dd007be19cc0b1519a80a60d126cf9", "ref_doc_id": "cb1bbc6a-73b6-4c93-aa25-fb451e1dc895"}, "101169e9-73cc-4605-9375-6c9ae1ed78f8": {"doc_hash": "cc6717a36e6f88f0dcaa7b387ea1e51abb466e6ed4e6a00490d08af5c2a75112", "ref_doc_id": "a5b57957-05c1-4162-8bc2-2a45988523d1"}, "30206999-ea0e-4449-aafa-015f5e5d09d8": {"doc_hash": "9308e298757bb520826e8267bb0e08fef190924b83f0fbb8975714baeaece64f", "ref_doc_id": "6b5a9268-49a8-4e11-8eb4-afd0ef9a7e57"}, "5daa80c2-7885-4185-ac33-4fc5d0f3382c": {"doc_hash": "c68f3e9342eae9a16821e21b5fcf884b9d63199fbe6a5ccd0a7fc9382ef8cdf6", "ref_doc_id": "6b5a9268-49a8-4e11-8eb4-afd0ef9a7e57"}, "ca8f9d13-f352-486a-820c-c63fd5f390dc": {"doc_hash": "ecefe0f982889ff8b92156c49013dd98e59b0df43b1ca563a11d2b9624a5f6fb", "ref_doc_id": "8f1e48d9-1b7c-4e7b-baf2-112029fe5bec"}, "a2d3cc83-b087-4db1-a8e9-736ac757efe4": {"doc_hash": "f26b09c5463609cd930f5488f50b4613a9cb8e914624c3d103ff36cf4c7e9f89", "ref_doc_id": "c7a08a80-3f9f-4fcb-9bd9-76f5d31703f3"}, "6fb9b602-0d48-4d41-9b2c-0563e62faf9f": {"doc_hash": "708551fc1a81b8fb5b27d8c81bcf71338589969db1748c8928fab2f98380e364", "ref_doc_id": "c7a08a80-3f9f-4fcb-9bd9-76f5d31703f3"}, "b8d68078-4dfd-400a-af31-76253ead4126": {"doc_hash": "e530b7ba1fee07eb4d9d121716aed1bacdbb843f220c36b9a8bcda528956b348", "ref_doc_id": "a1a3e470-290c-42c6-a9ec-c0739f49daa7"}, "6f40bab6-f003-41ff-a5c2-b993497cb8c0": {"doc_hash": "dac73d4cf8e100cc3370da5355644edd924ea6b29b0db0d38d7d3a302f51bb0c", "ref_doc_id": "aee496cd-8833-4126-9076-61ff13f1f550"}, "241b2168-f0aa-4a50-a34c-9cba732e1e47": {"doc_hash": "0e12d81daa9e06d7df3681c9af26b41b9cd031f98c43874c952d05195f025b79", "ref_doc_id": "3c9d15e8-677a-4f33-9955-9d5005325156"}, "8b4afa60-269f-45d3-919f-c306f0a54508": {"doc_hash": "7785d5b6f8202da0a3bbc0b842e98d472ced7b396de03a81424d6584f7554f2d", "ref_doc_id": "3c9d15e8-677a-4f33-9955-9d5005325156"}, "cf82c8a0-3593-4796-8067-2502fdfe0694": {"doc_hash": "53d50867aad619c6eef3c984e6860042bd0a85d1ff470e0b3dd7ebc525e1e3e2", "ref_doc_id": "642faa24-463a-4fc7-aeb4-538c958acf80"}, "ec397fb9-9f63-4e4c-9673-d1f58975379a": {"doc_hash": "bee139f0afcf0e3a3131e275a7db5af2fd5797621cf96cfff0f532bc3bcab485", "ref_doc_id": "ea94f67f-0fcb-448c-a732-57b2d9f9d071"}, "14ddef11-ddec-45be-a6eb-b33eaf1d07e3": {"doc_hash": "c6c59f8d86124f1ba4d28ac156d123361ec640ccd8483d4441f3d7e093b94abc", "ref_doc_id": "ea94f67f-0fcb-448c-a732-57b2d9f9d071"}, "8914e95b-3de1-4797-9f2e-4b10a44267f0": {"doc_hash": "aa45d85cbbff6305162de733c4524830c9757b4929c503618a27cb549b3a1b95", "ref_doc_id": "f988e311-6937-47d3-bdbe-1fbd26cf9e6b"}, "bf0ca4d3-db94-42d4-bd50-e2efc6b053e1": {"doc_hash": "00dc057c5214e73bb2fdd3cf88192e5f097f56d3c9d7a0667f32d614dcbf3f7a", "ref_doc_id": "fdd49707-f4e0-4201-b243-aaad2e013138"}, "6c52ed2d-9d3b-482b-a26b-fa2dc26550bd": {"doc_hash": "59347124e6689a1084ad815cb66962b3be1cd315a9bfb838683527b846561b9b", "ref_doc_id": "a044a364-08a8-49b3-8489-990c6a3b1800"}, "eb9f5ef9-8c4a-4074-82a8-5ba958174a70": {"doc_hash": "5b49f1eb60f3e5eb06ff44fbc1058a3666fa4f3340f6f8cbd5726dec11dd9129", "ref_doc_id": "a044a364-08a8-49b3-8489-990c6a3b1800"}, "5539d1ca-34c5-4f60-a5f2-a33925328ba6": {"doc_hash": "618ed881a59c6dbca57e41d1dc6264593ecec205443f73f497fc7ca321fcdae4", "ref_doc_id": "e1e88af1-f877-4e13-bd8f-7f4a59693384"}, "d3643e2c-c5e8-4786-a8be-ec3f6f1116ee": {"doc_hash": "6c848b44c411df51a807d34bda03985094d12ca3ad1e0c46636ab7c3748c8730", "ref_doc_id": "2eb720d0-f96f-4905-ad66-a7e3af10f15e"}, "8d8630f4-a5ce-48bf-b98e-797373d318a6": {"doc_hash": "6fecb0ef89e29d5e362e573257290866aff7feedd738b40afbf40e1dd033a9aa", "ref_doc_id": "264ed794-faa5-40e2-96b8-4f2188d47be5"}, "b66ae480-77b0-4cb2-9351-ce2809433e74": {"doc_hash": "04d1a6b28e103ccf84ce492ac0097882b691f8dc33bcd08b11fc4ee1ae6b03ba", "ref_doc_id": "73d7d395-d05c-485f-a718-5c80d619654b"}, "3e7cd9bb-78fb-4a10-96e7-0d3beb23eefe": {"doc_hash": "b6dc0e25f26634ccac9dca80e41748a79dbbf8d8f409193332cb5a26050bd3d2", "ref_doc_id": "73d7d395-d05c-485f-a718-5c80d619654b"}, "50b631fe-efd5-4f4f-bb6e-e3feec05ce9e": {"doc_hash": "cf0def1133ea6c8175f470851952a16ca85d6cc758a25559444cb0fbf8d2bbe4", "ref_doc_id": "3b31322e-6d70-4a44-bb20-63b367c09a8c"}, "fcbf8dfb-6b0e-4a4e-9011-e536f31d2328": {"doc_hash": "aaa54a8405ed1d1a9d9f1a732b6b87e0d5b81f3128a34700e618f6b5daf0c1a5", "ref_doc_id": "3b31322e-6d70-4a44-bb20-63b367c09a8c"}, "81b5ccb4-8c44-4a89-9464-4be324161a64": {"doc_hash": "585b67b5296cc42abc42682be93d878fab97c832f7bb572185d11af4f05a0d89", "ref_doc_id": "b310ff1e-bd1b-4c31-83f7-98b40eebc7ec"}, "801b7f4c-8770-48f3-b224-23b429d498fd": {"doc_hash": "e6fdff32d72782edf35ec9d95b4dd990fc71eaaf72706479c6cb00b5a2b69555", "ref_doc_id": "a89a33d6-519d-43c2-a121-aa43525fa1e6"}, "0a7e6ae5-d0a3-4481-b279-9e1ca5667c1f": {"doc_hash": "5f521cddf856cd8a0931292ab5d5d97491d4164f234521a5292680268c601766", "ref_doc_id": "a89a33d6-519d-43c2-a121-aa43525fa1e6"}, "fd051930-5238-44eb-aa78-d495ac0ec520": {"doc_hash": "4b05f40da46d090764f88f6a1c4833851bf634c0f64e7889281b63f1a3b313a3", "ref_doc_id": "e3992249-d474-42a9-bb87-0b1d0562a364"}, "66741ebf-4b45-4106-9ad4-1d677fd55924": {"doc_hash": "4f93b986f29d8199e93368d7c329b5e6fdc4ddec6d7bfbb8637ed7209bc5ed4b", "ref_doc_id": "8ff9594a-be99-4026-8121-9b6d5df6eee7"}, "73019f38-55c1-4bce-8cd8-820febeefb78": {"doc_hash": "ccc3634d493d503a3b3972eafe24dc2930d8f531af9cbfd1ad6ab5bab786d084", "ref_doc_id": "ba81448f-0442-4c2f-b16c-bce67bc8038b"}, "68b8ca25-04ad-4468-9102-e00ae27cc392": {"doc_hash": "6518c2a65ef8af95eb138a8fd3a7bab34cf338408b5ec780ea3f4fd25e6fee4e", "ref_doc_id": "ba81448f-0442-4c2f-b16c-bce67bc8038b"}, "aab7b970-e50a-48a7-8ba3-0305e7aa66e8": {"doc_hash": "2b13c4e80530f6a0169c03be7c6fd6e8faa9dfaa42dcb0f6dc7642485c520a75", "ref_doc_id": "8aa0ac21-e820-487b-9349-d7228e05c00c"}, "00d2203b-ebf3-408b-9cc0-851346acaed3": {"doc_hash": "54cc833879b74e579b6238f880451d5c8927749d48c9dd5e7fb0a05660d8dcbd", "ref_doc_id": "5cf35a21-4456-4129-9c6d-8c3e26a936f8"}, "a28ae5ab-fb8e-47cc-8eac-2a6bfecc0482": {"doc_hash": "301f224f748e13fbe5c4f3e02a33c1a7effa9c32b30960608fe3975fdee57250", "ref_doc_id": "a4831223-b50a-4dcf-862c-49bffc3222ed"}, "c5b705a4-aac7-4165-b7b9-dd0caa25675f": {"doc_hash": "188318adb30e107976216d1731a9d1a86e4c3bde2762260286fe065ae67f3b44", "ref_doc_id": "a4831223-b50a-4dcf-862c-49bffc3222ed"}, "2a32b7e8-4aaf-40e7-9771-672d129e34a5": {"doc_hash": "2f64b927e0ad51a4b6e21232ae3a7b977f39f03ffb8e036544f6b97cb8051094", "ref_doc_id": "9f18c7dd-0b93-45c7-84b2-f815311531d8"}, "dc4bf212-f3b8-483b-9c87-57b402559beb": {"doc_hash": "0454c3e781c9fd410db67532b197c84c0adcad9ecbb05c1361da4818f5c26f3b", "ref_doc_id": "a35cbd3c-cf26-4161-80d7-3901f6c2c469"}, "6dfce659-fe14-453e-963c-f790ba2c34df": {"doc_hash": "d3dd96a47e336fdd5d295899fcdf546957acc279e2fd0c66c7b9cb8ca94c2eda", "ref_doc_id": "6a92d3ed-1101-4ca6-8ea5-92e9555cafb3"}, "837959cd-503d-4937-8c2e-19c3945f3b74": {"doc_hash": "276a6b4c7f47a31aa53f42527e9fecfd74c4a62fee4d1464a8b87f9a69d68309", "ref_doc_id": "0cc2738d-c326-411e-aa7b-6dbdae135a46"}, "dc1c10c5-0257-4ec9-b3d0-7126799e6bd7": {"doc_hash": "58bb706e8309c1dec77cda1249fae7793e9eeced873b12e56fb416e7ef061025", "ref_doc_id": "59bce370-ead3-48a0-a98a-c4141d6550e1"}, "a4114a8f-3167-4f8c-b1dc-bc53cccd5777": {"doc_hash": "af7b0fedbae10a6ee67501cb6dae5b7f1a87038591e191bcf4f0ca56dc1e526f", "ref_doc_id": "b9d06f77-becf-422f-a203-8ecd0c070ec7"}, "d183174d-db5e-46de-bbd6-52c410347a90": {"doc_hash": "5e27291221a4fb5d08fa9e40b3b68467f9dc897751f4d30806223a23d1b9b32e", "ref_doc_id": "b9d06f77-becf-422f-a203-8ecd0c070ec7"}, "e3f08d88-bf64-491f-8fa1-a919e50e8ef0": {"doc_hash": "e511b7abe9d7a85962724493ec84b6fa6ddf037c686f12e976b091e7cf41ff1d", "ref_doc_id": "4da47ca7-499e-46d6-8e45-7f8b50eef566"}, "e348beee-8b20-4022-82e2-1a96f4e9cacd": {"doc_hash": "a7e02bc5f3b624bc467563f6445b880ecef1f70dc695a7696b8c056c2a7384fa", "ref_doc_id": "d781a0f7-a106-4e74-9761-12264b5d0ca0"}, "54b4c65c-9cf2-4c68-9c31-d01dcb805f8a": {"doc_hash": "b21b21e1cbd38e8bf50062e2667d9bc944d4b921f5bde5608759dec7de70494e", "ref_doc_id": "d781a0f7-a106-4e74-9761-12264b5d0ca0"}, "c5f916c0-867c-44bf-a52a-0023b1f66555": {"doc_hash": "9492b6d0af1986a269013eb7fde2664e92d2bb82632c4c20c59da55ddc4f32fe", "ref_doc_id": "2fc404a3-0b9c-46c3-bd1c-80e5760176e8"}, "0338220d-15e0-486e-a3ba-5f686756c094": {"doc_hash": "190ccffa4581783ad1f428604ab1278f7a3c952d20813a7907329b5dffe92d0e", "ref_doc_id": "2fc404a3-0b9c-46c3-bd1c-80e5760176e8"}, "c6a5d138-c5c0-4b14-a1cf-2d6422d137d7": {"doc_hash": "52e92d1d7def9838512f12e73f72586b8d4464557d238731f1bd7e167c7737fe", "ref_doc_id": "28ae9adb-4011-451d-a9cd-b9dca6dcbadb"}, "6ac07c39-00bb-40b5-b09c-8c46b18486f1": {"doc_hash": "67b0a3e97428bb1d2f1e2a17ee0963329e446ddc789da2e560079a54cc6313bc", "ref_doc_id": "28ae9adb-4011-451d-a9cd-b9dca6dcbadb"}, "93693f54-fe50-4e74-bee5-c0babcf61ad5": {"doc_hash": "b8cfaaafc77c8941d0629cecbf357f6bc68b589710db2b339f0cfd5efee0763d", "ref_doc_id": "a88af453-b979-4a38-9136-3d4d40ffea01"}, "de499c9d-a799-4906-ad5d-45c8505ce538": {"doc_hash": "43e6f57e2b5b75c9fcf27f77696c1f8486b3e077ff953934bd2515040dd2ae6c", "ref_doc_id": "a88af453-b979-4a38-9136-3d4d40ffea01"}, "40ff5d0c-4924-4f9a-b1aa-944557e5a9a7": {"doc_hash": "9edba40d5e0b2c62c07639510771533d1a36e11c682da83a963039231883ed46", "ref_doc_id": "6a3252ef-d6bb-4ab5-a290-65a2405fe179"}, "5aed8f39-bf4b-45f9-9623-ee680f6955a1": {"doc_hash": "d7d0e3af790d86557b526cf8289bfe6f9c7487c4ee911f9a7a918f6c512e8184", "ref_doc_id": "6a3252ef-d6bb-4ab5-a290-65a2405fe179"}, "660cff5d-bb06-4377-b87c-e8d18c65c74f": {"doc_hash": "437519e69c6981289e635df7e8e1e3054770c457b90ef6b1b8aff8fcb2a01283", "ref_doc_id": "6d46bc92-2755-4d0b-90f3-7f006a9355f0"}, "92625e3f-078a-4863-8457-2ff1fda52318": {"doc_hash": "b17980cc63449a8377d318f2de02e47c461dbfac333eb33ad9bd75adb5026a26", "ref_doc_id": "334840fe-c0d9-44ac-ad83-e7814c616fbe"}, "82646e5a-a7c4-485d-91f8-73f67dde9d26": {"doc_hash": "532f584d83c971ded76e9561c66e96da6018b22805b33b1efa82800686151c02", "ref_doc_id": "334840fe-c0d9-44ac-ad83-e7814c616fbe"}, "3bdc97fe-1a41-4f7f-b80b-c395945e6d12": {"doc_hash": "870a879cd4c6e4266ac5c45f9c1636bcc071153fb243fca511371f1655dfb255", "ref_doc_id": "41107b66-0840-4c4e-9e5b-c86eee3aa48c"}, "9a7d948f-0a0d-4e9a-814a-4511f18fdd00": {"doc_hash": "989e34701e7e2333dde4bc98a72dc1e17759bc14886358a99fa3f434848a9687", "ref_doc_id": "c5d758aa-9d5f-4e07-bca2-9e66dc661ed7"}, "3ffb4b22-d482-4815-b419-8c6e2245ae5c": {"doc_hash": "f42422f87d9005f99bae45a4f483c6e51d481c200451a737e0ab10c88d23e372", "ref_doc_id": "6bdd3480-78e3-4e1b-8a2f-56082cd10f98"}, "f453061d-c379-4dc4-8e36-d78e58496ac1": {"doc_hash": "1127d17ff06f9018394a8374896bc94debbdd81d8266517a4db7602cc1579507", "ref_doc_id": "6bdd3480-78e3-4e1b-8a2f-56082cd10f98"}, "b4712b0f-fae9-47e8-a9f3-03b6d0cb39cd": {"doc_hash": "f8a0f7dfc06a552c790c2a60a205b13c326339d9567cc549c3dd364e9ff6de7a", "ref_doc_id": "7bb5fbf9-72e1-4185-a112-a35bc5d08029"}, "a17f9368-24e4-48f7-b4cf-1f562953191a": {"doc_hash": "956cfc4a545ef55ef319675dd8a1b888e731cc678fdf944ce7c4ae3efc29dfd5", "ref_doc_id": "fd6ecb25-da29-4603-8c7c-847d48028560"}, "0e974173-447e-4f5e-8258-4ef90159864c": {"doc_hash": "56e0918480d52e9bf344e6fcf7b49daad0471242db2fe6ff02ea9a74830f2de8", "ref_doc_id": "c4df8cc3-4a95-4ac8-9876-61aa3c88fe72"}, "0e3da09d-c538-46f8-80ac-eeed4a321867": {"doc_hash": "807c68fd813d8a256d087d5ab462a5f725ba40f8f8c469920d80e10d48b41a6f", "ref_doc_id": "c6c3138d-c4ea-41c5-82a0-9d6cbba3976b"}, "a8c1ed72-e745-4273-acb6-91deaf16c3af": {"doc_hash": "09e462b1b3a96828e461afffb13cea50c351956596256bb57c36f31ceeb32824", "ref_doc_id": "0a0b2be5-12d8-4c32-80b0-fbc723405f61"}, "bf6400e9-68e4-432d-8258-2a9e01fa2e0f": {"doc_hash": "6be8bd278e8f82fb256e72a49f4d0a49de28053ace716f8c444ec57d4a3ecf41", "ref_doc_id": "32696bea-6ff2-4b60-a5da-5c5b7d62f06c"}, "8a474dd1-d275-44f7-a397-ab3b350ca041": {"doc_hash": "962d08c4816a86c6bb15bbc0b745aa20286912cb0ea6e99c9271fefe93357033", "ref_doc_id": "3e773a27-c45f-4d6b-a1ec-12225542f4db"}, "d280de3c-49f4-4441-b1d2-ff9ec2bc9db0": {"doc_hash": "6eb4a17ab20cbe2063ee513f07f4a9e273dbb2bc8405ed12a1364307acde9c83", "ref_doc_id": "e8e02b64-8d30-4aff-ab71-9b7bb0a3376c"}, "715d5b7e-9743-484b-b0fc-d9d569461a00": {"doc_hash": "a9d0d025c5249cbbfccf9bea5d35f2a4074d1029ac108d6878d15fe5774aa0fb", "ref_doc_id": "09e342e1-1ebc-4272-8ad5-8c06e7d9778a"}, "9da83d00-c20c-4e4b-bf4e-e71ddd618dcc": {"doc_hash": "457640d09abe5676019531e000bccdc80521c58f4b0f7df6a9da1fd14cd19070", "ref_doc_id": "97f2c2de-83a2-49f0-8d33-62717964451d"}, "725356ed-7b47-4c1b-83fd-af18b53537a4": {"doc_hash": "0d75bb95bfd30acdfdf35b799c73137d01f451b096cb27572f6ca95fd91214d3", "ref_doc_id": "be350762-028d-4c47-a398-24816b706c87"}, "07aff125-6b7c-4414-b261-82582d482709": {"doc_hash": "eba10a0828014264780471f37d0fc738e6042af3ecbcea05b329bf95c59d4780", "ref_doc_id": "f6d2e636-1c20-4db5-b1ce-26059ec0e8f3"}, "272250f2-8c85-47c6-9d67-898267e3c5b1": {"doc_hash": "95788b4dbc470dda8d76524f376a73b7433ff822150eb881c26f7cedddfa07ec", "ref_doc_id": "b839f269-0355-4f87-9f73-81ead996a694"}, "b81e596e-f3a2-4184-9f21-2c9f0dc7355b": {"doc_hash": "58fd86b798cb3622b8c576e8037ab31236cd67d7cbf6f1daeac05d71669da70d", "ref_doc_id": "dbf97873-d5a8-4f59-85e8-a491f7808f0e"}, "b770b72a-34fc-40b4-ad4e-8c66bf22c76c": {"doc_hash": "b16ab0cce82371420131c438161d547297da196b16d86c13daaba33f85eb0d5b", "ref_doc_id": "f81cb997-ad85-4462-a817-eb6293923ace"}, "60ee5fe7-08b3-43f6-9ef8-2d0dc127e5f4": {"doc_hash": "4386b07159939d509c56556ecf0238e3683b1b085af182d58ddc96d0d5df93e3", "ref_doc_id": "c0fed31f-5e8c-4f33-a2e3-ad634048ba78"}, "731f1637-f8ee-4f89-9f47-0d2fe69fd9ad": {"doc_hash": "8168a3a595771d89e3892e0329177a62fffadc2b82f0993252ef7eb6af6e4fec", "ref_doc_id": "6e18cf07-cbd2-4513-8156-635a63f903e9"}, "37b12b78-518a-4f05-b55d-49772679d9d4": {"doc_hash": "d89387d1897f7786e1eff8958ad77e8307155fbc8beda288a462dce959999076", "ref_doc_id": "6e18cf07-cbd2-4513-8156-635a63f903e9"}, "77e0fc29-1fd4-48ab-a376-b4c4a41bee91": {"doc_hash": "4ca9fc1164b330d6c2e2397d59933ffc5c32fd2b264c3f340fe1f140960a55aa", "ref_doc_id": "bae113e6-52f4-42e2-a3ff-19ad468b9545"}, "99b9bb89-c201-4910-8c73-c56fc5292e66": {"doc_hash": "5d0fea8b44e200b645b93e3e3d5bbaf5b4da3806b5ddef43b40620624bd5f36c", "ref_doc_id": "1242d105-7922-49c2-b69e-0b57fa3319ee"}, "02f90e2f-2c94-4f3f-8158-4c6861c607ca": {"doc_hash": "86dfed7283c52a44738f1e980870348c04e180b24273aa37f4e06afa3f101134", "ref_doc_id": "1242d105-7922-49c2-b69e-0b57fa3319ee"}, "90c99896-2a8f-4a76-a5ad-6c1756874a2c": {"doc_hash": "172cb29512c4ec8e22c60768df1266149458cf365e2ccba02a83335cce308ff3", "ref_doc_id": "92c2d505-353a-40a3-8599-07f8b0c5b82a"}, "ac7ded5a-4b28-49fb-b742-167b07a3ffba": {"doc_hash": "b494b780b9db287dc6f498edcbb2a18d7551f973175e78807312f7555d3fe51b", "ref_doc_id": "35b4a361-67a7-4fc9-8357-01978184fd31"}, "467056a7-088b-46ef-b02d-ac1b37a2e8e4": {"doc_hash": "9a9562582467f0178b216a855d637ebdf1637eb7e32b3667fcc5e2e2b2859fa5", "ref_doc_id": "279062c8-1cdd-40d6-945f-eb9542299ca4"}, "27de4ff4-fe81-4524-a852-b4c088d73bdd": {"doc_hash": "c5e49f3a8327d032d1b255a7460ac66320ca09df7700c2f9a3177805dddb122b", "ref_doc_id": "c41c8e6b-2663-49c0-a442-06d0d1b5c040"}, "3af8991d-21d4-4422-b792-dcfa186bd97f": {"doc_hash": "2a84f5f3b08cf2626724b3dc9ca1fce54ec04d937e62ef8ba08f74da245e8e31", "ref_doc_id": "a9b12e86-8640-49fb-851b-93d641a9c67f"}, "ec4d78d7-0318-414e-8098-1efc7b9c820e": {"doc_hash": "c1576014c0c43cb1db0d78c928ebb7a58cedaaf9cc87c524e8a8781e691e5a2e", "ref_doc_id": "a9b12e86-8640-49fb-851b-93d641a9c67f"}, "7d4ca857-8b7e-4f5e-a867-4acd71a4cb36": {"doc_hash": "00fa3a657f341b305391472acf6d73ccdf5ca60c0424dca23a21fe24e40b793d", "ref_doc_id": "1867539c-3c6c-44ac-9580-729cb3b3960f"}, "06ca7e49-a752-4218-8e77-2e5200b1af89": {"doc_hash": "e13db02edad7e5560cf0c90ff585d1cea8a7670a0e14bce00a85987eb52ab7a1", "ref_doc_id": "4eadccd5-73ee-4d1f-8dcc-11083f33e74a"}, "49586917-3323-4a56-8bfd-ad68360d5476": {"doc_hash": "b73324d4df0c5a871928eaf9b6dc04740bbb5d7fd3d784ae7eed13883d667000", "ref_doc_id": "be246367-1e4b-4bc6-954b-9769289b3cd9"}, "903402fd-5433-4111-beb3-e88b70913c91": {"doc_hash": "898826f7ea97d47c672f2633fa1e715f4f99109bcc12fde3d77e307630a53e28", "ref_doc_id": "94698283-d8a7-4477-b7b2-80eef423f4c6"}, "09ed455a-0e41-43dc-ac61-7ac03f666e92": {"doc_hash": "6602a48da8d5c84220a105c0deb835be3d58013ea461e9fd5594b378828d4827", "ref_doc_id": "a018680b-ab0e-40b9-a1dc-e47944555193"}, "8549aaec-1dec-48ea-9838-09a2cfdd1081": {"doc_hash": "c1d10c8b66341817735b3365ef4fd158b75389d40a921ded069a63d168d1390b", "ref_doc_id": "548505ec-72a0-4728-9ea6-34b61841854b"}, "a8d9715d-07fb-4362-876b-28363f910c00": {"doc_hash": "e22628423e427d1885c1b4ab8c4165b6d4759bd3f3c1a35ade527e676c4dfe8b", "ref_doc_id": "0c5503f8-88e0-48ab-bafe-cf95ce3bf302"}, "7e96ec9b-4a6b-4757-b32f-d329c15a6a61": {"doc_hash": "bdc926e1e6b2117ed1b568ea194881ad1189548295ccfaf04e740135ccd0b9c2", "ref_doc_id": "94dc4d92-1732-4f79-8445-a5e9ea858543"}, "4682e043-fb9c-442f-ba3e-529b15264515": {"doc_hash": "83425e3d4106d9f50b06b261ffc97a9e60b5b3ca1ca6a7be75870d6f67b3f439", "ref_doc_id": "d4880f8c-df20-47a7-a667-60e16aafd687"}, "73f0dac6-26d9-4c4f-8ad6-c15376a5e74c": {"doc_hash": "8bd6bd613b3a84ea128a774ab2361b4e79df17f12102d607deded3fc70dba7aa", "ref_doc_id": "e6a0d757-1805-4e21-8884-f50e8a2ad757"}, "9f308a24-f1a9-40ee-b16a-c439b3e3ad03": {"doc_hash": "e70686ad5599f7289eb76627ed1012be15db977de7d8bbe674ed2f146c8d3767", "ref_doc_id": "7468d813-627c-47d7-9a67-7b323b1585a7"}, "6946da5e-0491-4088-855d-16d374afed9a": {"doc_hash": "b40afe582bcd11da58335193532189b79cb7f39092eb773b09d4fb5e5d2c346d", "ref_doc_id": "d3b377d4-ea13-4932-99ed-46011b7560b9"}, "7029ed75-ff46-44e7-a287-d9f8a15f0291": {"doc_hash": "745a3cadfbba17c66b102ddab9a20a7e6f6edba30698427cb23e9843b8b325b5", "ref_doc_id": "85e91e75-16a5-4840-9510-30fd5f8c08fc"}, "7e3988ae-0ba0-40c4-840b-0d65f98a25e5": {"doc_hash": "5d0371ef7bb8e07b9127c357130fa254c65c417fda82876fd14c14ad47294862", "ref_doc_id": "7f42ea25-2d20-479d-a851-e11a7ebcef30"}, "49ea0a44-1b86-4582-b98e-c9dbf90216a4": {"doc_hash": "9e8b0208de2c0f14b2fb71e4945aeca551ccf4e8c9c66386060819b9d9247453", "ref_doc_id": "1ae502f1-b57f-45ad-8c63-d88edec4926f"}, "e4f09c23-f037-4354-9c61-2fc3e1c711cb": {"doc_hash": "8a7a11c43666950e91f774d9ea8c0239430ff9e4a97d146286c89690ad62e426", "ref_doc_id": "581d55a6-14c8-4fd2-b318-fd118d719471"}, "70b1f75b-86a6-488f-b81a-aea1224ed1a5": {"doc_hash": "8662ae1ac0ec4d50e652ff8b4a80a7cab8b1c73e61f9fa7d41c6504de3feead2", "ref_doc_id": "76ef005e-8281-4cdd-b0c6-d0f7232a253c"}, "09877178-09dd-443a-9a44-3c2e8f7cde77": {"doc_hash": "f69716fbfc344357640f297e31ed76a54ea8242990530c7cab63b369a7b7fa1b", "ref_doc_id": "1a8548d5-5e01-4e8d-8c2b-f86719163755"}, "b6f869a1-fa5c-470e-9c4e-9e490e27db41": {"doc_hash": "0968f8ecdc09320a5e353f23cc9c81ca9cb0566b539537f18c8d8894fc10bdc2", "ref_doc_id": "74c4fa35-756a-4fce-9a6d-a95a3206c06f"}, "363cf67f-a4ad-4c15-92f0-ee91e1b65fd5": {"doc_hash": "f015c143a35460668dfc0fcc8d2563995419a53e8e4d2be70102ed02fe019ea9", "ref_doc_id": "ce584bb2-c431-4af9-9e30-17f4589b697c"}, "bc4e36c9-3a7a-40b5-8802-f1e2797829f4": {"doc_hash": "c2b6e1a05f06f1853ad9c3be46f4290b5792551b16ecec80e4386580c8bbfe8c", "ref_doc_id": "38df8e15-792e-411c-8293-8fb13275554a"}, "bb3b1534-bfc7-43f9-b28b-5cc48119c40f": {"doc_hash": "e3ea9f8580e29b27270182bcd6ae0e37c14d0ac1bb725a5eeb18eb4f7aa5d560", "ref_doc_id": "d49960a7-3881-47dd-894b-1fdaa340b827"}, "7be75279-72a5-48f0-8e43-53115ed64ed9": {"doc_hash": "5c66be1ad8db0c1c3ace75628e58bba81273befb03655da81df2fd4bda2de252", "ref_doc_id": "4b1b81ae-94d2-4aaa-8811-1cc911043e3a"}, "84caa7f0-c9a5-49f0-99f2-736f0d2399e7": {"doc_hash": "0451bfca3f5283187f0bab2fd5cab0f3e4521b211437393645f3cc145ca9af61", "ref_doc_id": "6ea5f5c6-1dfb-4b57-b9f1-4eb7aa99eae9"}, "71d61065-7623-4dc7-baf9-0563b4b10bd6": {"doc_hash": "a69ef0778a9e39239b4c5ec8a8566f285931ca94b46542960a91527639778247", "ref_doc_id": "c60fd9ed-145a-4951-b9d2-bd917600cda8"}, "e9e0f646-07d8-4406-a8c6-833bd666ce30": {"doc_hash": "e171f580a1a8667c2c54f3341d60c73d1a027ea5448dc7725275deb7a86fbe60", "ref_doc_id": "4216e4eb-e5eb-4db5-baf7-aa111da14c00"}, "ebd520d3-b4eb-47fb-af15-3adc59174c75": {"doc_hash": "acfdca7c01d173707c730ae51fd71a641dd6524d1939c46bcf071c3f23dd91c2", "ref_doc_id": "b11c04ae-d94b-43a3-bdd1-d10080e96ebf"}, "897248a9-dc50-4b49-aba8-152fadeedead": {"doc_hash": "d75ca94cccf72165a8df64fdde62e190622096037b1b32e74bffc5eb692029b1", "ref_doc_id": "ce867913-2ac3-4052-a73e-aa31979f7199"}, "6051e6c7-2e78-4c8f-bc04-8a5c5fe7b8e6": {"doc_hash": "9fc9b1039f4f3afe2fcc92c5417a95bb927dc6007f5a4730d7cf713397ef70f5", "ref_doc_id": "ba9dc1b5-5a61-4730-af41-ffd126776388"}, "df43d9a9-16aa-4102-87b3-cbd9d13aa6d8": {"doc_hash": "eb86fbf2813fc6291f530ff685944692d7b6ffeeb98d931b1d27ba5fedcc2e72", "ref_doc_id": "3498c175-c3e5-4b1b-ad43-f1307428850e"}, "23655168-60e7-4e0e-9284-d05f20aca781": {"doc_hash": "25e413a6fa4bf1205595bf9fadecb89dc4a9344442bbde1c5d3a9a733f22d19a", "ref_doc_id": "3bbdeba5-f3a4-4835-8b71-7746d59293c8"}, "47a1f889-3023-44f8-b86c-23b2073a5ef4": {"doc_hash": "ecc702a5d53aaa67be216e7de1c1b0231b6f13a09c3dbbf59899345334c6f7c2", "ref_doc_id": "d54ea398-3832-4835-8095-c0d8dbf16de0"}, "a84e826a-5cea-4797-a050-0f75d449aec3": {"doc_hash": "d7f268528859fcf595e4fa8bf4dfd8d536e21836906210820f6c4c4bf323384c", "ref_doc_id": "99e79fd2-7517-44b4-ac93-fa99dc4d26d9"}, "237c9d01-f4a4-4062-aa99-8759a3258ba0": {"doc_hash": "f9330ba7c788f4e2fea28ff2aa8529d49ea997c118a86a86ba54244a456c1755", "ref_doc_id": "a412e7eb-0d6a-4655-a2e1-fdac112f27bc"}, "34ef93f8-cfdf-4d83-a827-bb7d36dcdaed": {"doc_hash": "4c1a201c6b7f4a5938498df43a845d79e112efc5a9d4f18809c0564f5ecd7673", "ref_doc_id": "ac318338-13ed-41d2-a783-42df447ea166"}, "b96527d5-9fd5-4b94-8663-1327a4b815c5": {"doc_hash": "3db6b2aefe9d507b09d76a0d5b889802c67aa15e67e0a11563bbb3d670cf6942", "ref_doc_id": "32df3d74-c677-4e4e-9b11-e1a719b7a1bc"}, "37f00e35-f698-4aaf-848d-df38e71e6913": {"doc_hash": "7cf706756f4ef5ed296ad47b47880767d3db9a26eaefdac844cffc16824d8a61", "ref_doc_id": "1d479855-bc36-4d95-b5dc-04d096634c6d"}, "18b6362b-1019-48a3-8134-097aaa900b65": {"doc_hash": "e1a3167e0cda777f91f9b5ac90f700638c1c8316d25e5c487a1acabde666aa90", "ref_doc_id": "1d479855-bc36-4d95-b5dc-04d096634c6d"}}, "docstore/ref_doc_info": {"86a336fa-a90d-4907-8629-775794e88f62": {"node_ids": ["e4b1b799-2fb1-44a4-a48a-236ae2791027"], "metadata": {"source": "SDTMIG v3.4", "page": 5, "section": "9.2 NON-HOST ORGANISM IDENTIFIERS (OI) ........................................................................................................... 441"}}, "961a8292-db8c-4db5-963b-7d864a0838c0": {"node_ids": ["f57361d4-6a24-47c5-804b-481ee74724d5"], "metadata": {"source": "SDTMIG v3.4", "page": 6, "section": "UNSPECIFIED"}}, "78be0d88-c369-4c8e-9d91-1800e4926fdd": {"node_ids": ["f4d6cebc-8919-41bf-98bc-fd359cd69adc"], "metadata": {"source": "SDTMIG v3.4", "page": 7, "section": "1.1 Purpose"}}, "62eb10f9-ce2b-43f2-9318-bc0a18912e28": {"node_ids": ["c0669caa-cc8f-4b2e-b0ce-0e85f08997dc"], "metadata": {"source": "SDTMIG v3.4", "page": 7, "section": "1.2 Organization of this Document"}}, "c3522668-be88-41f2-9480-faef9d189d32": {"node_ids": ["31e88b75-cf7f-4477-a7ad-b6f33acabd9e"], "metadata": {"source": "SDTMIG v3.4", "page": 9, "section": "1.4.1 How to Read a Domain Specification"}}, "f8e9ae21-a651-4afa-8e36-4a233be2a449": {"node_ids": ["f095d34f-8b4f-4e20-9b9f-e62e3ce80934"], "metadata": {"source": "SDTMIG v3.4", "page": 10, "section": "1.5 Known Issues"}}, "2bb0d21c-ce1d-477d-940d-5a3f611d683b": {"node_ids": ["18afac45-cecd-4237-97e0-764810c8aa67"], "metadata": {"source": "SDTMIG v3.4", "page": 11, "section": "2.1 Observations and Variables"}}, "b93a38d9-3c56-4f55-834f-4a93ceec77a5": {"node_ids": ["33bc2f95-a781-4ce5-8289-b2ce542c2136"], "metadata": {"source": "SDTMIG v3.4", "page": 11, "section": "2.2 Datasets and Domains"}}, "ff689c30-a77b-45df-a972-859622dd69c0": {"node_ids": ["bee71f84-e212-4f64-aec3-842db521d9cd"], "metadata": {"source": "SDTMIG v3.4", "page": 12, "section": "2.3 The General Observation Classes"}}, "21f404ae-13ec-48a6-925e-b8871340ef92": {"node_ids": ["fb9be06b-95bd-46c2-b767-eff959e08014"], "metadata": {"source": "SDTMIG v3.4", "page": 12, "section": "2.4 Datasets Other than General Observation Class Domains"}}, "67af4b81-ecbb-46cc-9233-b353304ee704": {"node_ids": ["a4ba4867-190a-42df-9888-087277f72ec7"], "metadata": {"source": "SDTMIG v3.4", "page": 13, "section": "2.5 The SDTM Standard Domain Models"}}, "9198468a-1196-4456-b38e-e81572af7560": {"node_ids": ["b09d27ca-3433-434c-a11a-cd99ad8e8bbc"], "metadata": {"source": "SDTMIG v3.4", "page": 13, "section": "2.6 Creating a New Domain"}}, "6bc8af54-6469-4faa-add4-ee5b9ce80431": {"node_ids": ["171e6a50-9b28-46f3-a9f2-de76be1cf63b", "678fb24e-5ec2-400f-8cba-7286f5786914"], "metadata": {"source": "SDTMIG v3.4", "page": 14, "section": "UNSPECIFIED"}}, "e6e61283-0840-4dd4-884c-0ebefae6bec2": {"node_ids": ["a375298c-8d31-4a02-97e5-283b716d321e"], "metadata": {"source": "SDTMIG v3.4", "page": 15, "section": "2.7 SDTM Variables Not Allowed in the SDTMIG"}}, "0f1fda67-d6a8-4cdb-bf97-4ba7f6c3fdbd": {"node_ids": ["2927bf33-5aed-444c-9f12-e4b5a9d1f3d7"], "metadata": {"source": "SDTMIG v3.4", "page": 16, "section": "UNSPECIFIED"}}, "2b1bb312-c026-42ee-8a17-1fad8143f1d0": {"node_ids": ["0510bbb4-c156-4d83-aea9-bc8913313865"], "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.1 Standard Metadata for Dataset Contents and Attributes"}}, "bb81f289-a8c7-4488-9c4d-1021fb19d53c": {"node_ids": ["59b0fd3e-a249-4ab1-bfd3-c387eb3fd75f"], "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.2 Using the CDISC Domain Models in Regulatory"}}, "26eaa4bc-6103-41d7-a12c-30a698609ff3": {"node_ids": ["8d792a9f-baea-4cc1-9b06-7682edcc8158"], "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.2.1 Dataset-level Metadata"}}, "b113ab81-802f-449b-9db6-3ee5f72033a2": {"node_ids": ["6c772066-41c6-4d4a-8013-4ade07dc3ec7", "e476c539-b38a-472e-9a8a-da62a8f8b36d", "900bd886-e07d-4431-9355-a03ecedd49f6"], "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}}, "00325f72-794d-4e9b-882d-c29ef0e4448f": {"node_ids": ["117eb082-65ae-4692-9ea1-da9985187517", "5debdcfe-33ce-41c7-9c13-a0b00a362e6f"], "metadata": {"source": "SDTMIG v3.4", "page": 19, "section": "UNSPECIFIED"}}, "7e0567e9-06a3-4ca2-b2b9-c55cbf644f69": {"node_ids": ["df27b1af-962f-4fe4-82cd-c3a3c4f6f1d7"], "metadata": {"source": "SDTMIG v3.4", "page": 20, "section": "3.2.1.1 Primary Keys"}}, "84687bc1-ed51-4ed6-9317-9b43e4a38b9c": {"node_ids": ["37eea7be-b7d4-4bf3-8040-3f8a292e49f0"], "metadata": {"source": "SDTMIG v3.4", "page": 20, "section": "3.2.1.2 CDISC Submission Value-level Metadata"}}, "7baa544f-5bc2-4628-9681-a43bf5e76965": {"node_ids": ["4090f594-71a2-4615-9bae-2fa59b3d4354"], "metadata": {"source": "SDTMIG v3.4", "page": 21, "section": "3.2.2 Conformance"}}, "823f7865-6a1f-42a0-8a62-38ef5969acb7": {"node_ids": ["931e04f8-1c4d-4f9a-a667-ec50d6bdad87"], "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.3 Additional Timing Variables"}}, "d553eb02-b777-43de-a92f-3fc3213102f4": {"node_ids": ["9196c4de-297d-4896-bd7d-9894f9dd5bc8"], "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.3.1 EPOCH Variable Guidance"}}, "39a662a1-e0ff-4e04-9fc1-c48c3a61c16a": {"node_ids": ["35cf1243-be53-42bb-8da8-2925efa3d3bc"], "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.4 Order of the Variables"}}, "39fe581c-3c10-4bb8-8919-1ed4a5fbe707": {"node_ids": ["b4bb0665-64d6-424d-8070-1477e41aacb9"], "metadata": {"source": "SDTMIG v3.4", "page": 23, "section": "4.1.6 Additional Guidance on Dataset Naming"}}, "3217b7f5-32db-48c6-a93b-f985b6b300a7": {"node_ids": ["57f2e0cf-dce7-4625-825c-a7b176cd2963"], "metadata": {"source": "SDTMIG v3.4", "page": 23, "section": "4.1.7 Splitting Domains"}}, "ec27e265-2d91-48a2-8280-e1f8ee2d7da3": {"node_ids": ["64363041-b4f3-47d4-ac95-6ea4c32e6032"], "metadata": {"source": "SDTMIG v3.4", "page": 24, "section": "4.1.7.1 Example of Splitting Questionnaires"}}, "ac918cfc-a1eb-40a4-bfa7-5958a6edeb13": {"node_ids": ["90f9ea2f-37cd-4130-bcb7-17b935456e51", "396c1f40-d6cc-4df2-87a5-39578cd25395", "45ba85ce-819e-4370-b463-22b9226bd92a"], "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}}, "52c97290-6409-450f-b721-1d681b9f120e": {"node_ids": ["3684f11b-0477-419f-9fef-98a073e4dba7"], "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.8.1 Origin Metadata for Variables"}}, "529f86b4-666a-4f51-b47d-a1976b2efe68": {"node_ids": ["9eafdd91-7c02-4adf-86a9-d1f74ce6a0bf"], "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.8.2 Origin Metadata for Records"}}, "445909e9-5f8d-419a-ab85-b6216db79d9e": {"node_ids": ["4ce49949-9fa9-44fc-8d92-e0d82ba20150"], "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.9 Assigning Natural Keys in the Metadata"}}, "08838fff-1123-4e92-ae96-c719f5412ae5": {"node_ids": ["40b1af4b-6630-4fd6-8eff-1b5f5f95f258", "23a7c845-8511-4f98-9703-893052036c06"], "metadata": {"source": "SDTMIG v3.4", "page": 27, "section": "UNSPECIFIED"}}, "7fb8eaab-4b53-40da-bf24-87d9d54aee3d": {"node_ids": ["6d670b1e-3b9a-4aec-9fb0-da3bdc2e8b54"], "metadata": {"source": "SDTMIG v3.4", "page": 28, "section": "4.2.1 Variable-naming Conventions"}}, "b23807e2-193f-4f4e-a0e4-cd4dc812ea79": {"node_ids": ["ee1e3af4-2d8b-4614-81f2-728cdc88bebb"], "metadata": {"source": "SDTMIG v3.4", "page": 28, "section": "4.2.2 Two-character Domain Identifier"}}, "f66c3632-a5c9-4a2e-a889-c71dc1288dd6": {"node_ids": ["945159ff-2093-42ca-939a-8e1054b1d701"], "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.3 Use of \"Subject\" and USUBJID"}}, "3f46645f-a667-4ee6-8eba-de6e382515fe": {"node_ids": ["f4cc50e0-6713-4aca-bfef-cd21204cbca7"], "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.4 Text Case in Submitted Data"}}, "00564d05-b1f7-454d-8a1f-0d692061ae2b": {"node_ids": ["f9c1cbcc-82de-4ad8-819b-f19e0169a29d"], "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.6 Grouping Variables and Categorization"}}, "d8e07c12-cea3-495b-89ee-f3afcb526622": {"node_ids": ["11d253aa-3ce4-41a5-8062-3d8fdbc772fc"], "metadata": {"source": "SDTMIG v3.4", "page": 30, "section": "UNSPECIFIED"}}, "6ec35928-2310-45b3-9da2-99cd68215bd5": {"node_ids": ["8f519c6e-8b28-4fe0-8ae6-64734a22f348"], "metadata": {"source": "SDTMIG v3.4", "page": 31, "section": "4.2.7.1 \"Specify\" Values for Non-result Qualifier Variables"}}, "0ed4567d-4935-44e9-a34b-df78b3c15084": {"node_ids": ["a6ec59a2-35ae-4dd0-9c14-0db1a94414e2"], "metadata": {"source": "SDTMIG v3.4", "page": 32, "section": "UNSPECIFIED"}}, "2534cc9a-18f5-41f0-a729-92fac4ba474f": {"node_ids": ["16d74c8b-e437-4aef-99b0-a62a6d462481"], "metadata": {"source": "SDTMIG v3.4", "page": 33, "section": "4.2.7.2 \"Specify\" Values for Result Qualifier Variables"}}, "1efaafc0-e785-4612-8d00-e7b5673de348": {"node_ids": ["c8e81117-0215-43c3-aa7c-a8a04b3e85e2"], "metadata": {"source": "SDTMIG v3.4", "page": 33, "section": "4.2.7.3 \"Specify\" Values for Topic Variables"}}, "09480d51-21b1-44c5-a447-1ffd05fc03d5": {"node_ids": ["b102b94f-d992-45fe-9e1a-270b474dff09"], "metadata": {"source": "SDTMIG v3.4", "page": 34, "section": "4.2.7.4 \"Specify\" Values for --OBJ"}}, "f0ae9030-e6d8-4e4d-8202-31301c93e593": {"node_ids": ["0999b84f-94f1-40e1-ba7a-9213ea49a456"], "metadata": {"source": "SDTMIG v3.4", "page": 34, "section": "4.2.8.1 Multiple Values for an Intervention or Event Topic Variable"}}, "70711c2a-68ad-45d6-a017-5852ab1f8924": {"node_ids": ["1faaf82b-64ab-45b0-aef3-6882bcc931ab"], "metadata": {"source": "SDTMIG v3.4", "page": 35, "section": "4.2.8.3 Multiple Values for a Non-result Qualifier Variable"}}, "6457b30f-c01e-4d9f-8a94-a8fe5ca848f6": {"node_ids": ["ae905cd9-debd-4e60-bdec-daf328ec3e3c"], "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.2.8.4 Multiple Values for a Parameter"}}, "6357e222-3151-462c-a667-8015c9b9f16c": {"node_ids": ["024d1b23-17ee-47b2-aa64-4d1ff684e43a"], "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.2.9 Variable Lengths"}}, "d1807b48-048f-4fd6-8bfb-02f4e1f187d8": {"node_ids": ["f681b665-5ee6-4702-97d0-cbbf254e6e9c"], "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.3.1 Controlled Terms, Codelist or Format Column"}}, "00715498-e154-41e0-ab3a-e806b74dfd54": {"node_ids": ["9a0059ce-08de-4d28-a1a7-257ea5415776"], "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.3 Controlled Terminology Values"}}, "2a6746c3-b56d-446d-8ccd-b2fc4669bc40": {"node_ids": ["60c5f9b3-c7e1-4e28-95e1-fc1ccd76e11f"], "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.4 Use of Controlled Terminology and Arbitrary Number Codes"}}, "3a60f030-3eb5-413e-9598-241e34b9bec9": {"node_ids": ["b9a80bbe-14d7-47bc-b013-a0de228e02d8"], "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.5 Storing Controlled Terminology for Synonym Qualifier Variables"}}, "5c186084-fb71-45d3-b855-a98736e1a95a": {"node_ids": ["37006fbc-f106-4a8d-ade7-f047cdd02493"], "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.6 Storing Topic Variables for General Domain Models"}}, "1c9a8830-ff62-4803-8be1-4ac6234ce2cf": {"node_ids": ["cbc1b00b-8845-47c4-9596-bf6e167000d4"], "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.3.7 Use of \"Yes\" and \"No\" Values"}}, "a1deb375-951e-4e71-bf42-6a4ab6a57b5c": {"node_ids": ["77848daa-bb84-4593-b329-38b3f2c28a63"], "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.4 Actual and Relative Time Assumptions"}}, "0250c001-0c1e-42fa-88b0-5aca1a293795": {"node_ids": ["dbfadd46-7c34-496f-88c8-b8bc918efd75"], "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.4.1 Formats for Date/Time Variables"}}, "a7645330-70b0-414f-8bb2-e6e11dcee001": {"node_ids": ["543487de-2d70-41b7-8aee-e1ed1f645887"], "metadata": {"source": "SDTMIG v3.4", "page": 39, "section": "4.4.2 Date/Time Precision"}}, "b28a0ebc-7d27-4fbd-90df-81c2068607f3": {"node_ids": ["e6c7af14-063e-420f-9e85-4c2693d757dc"], "metadata": {"source": "SDTMIG v3.4", "page": 40, "section": "4.4.3.1 Intervals of Time and Use of Duration"}}, "d8d90c88-2534-4a46-bc16-4e73697c8299": {"node_ids": ["1c59e99d-7b15-4004-a449-92ee7376016f"], "metadata": {"source": "SDTMIG v3.4", "page": 41, "section": "4.4.3.2 Interval with Uncertainty"}}, "071b3c18-eb34-4c8a-999c-71c77d9991f5": {"node_ids": ["703f6845-eef5-426e-bd7c-c01a3c3cf753"], "metadata": {"source": "SDTMIG v3.4", "page": 41, "section": "4.4.4 Use of the Study Day Variables"}}, "54dc9f07-3b07-4ed7-9871-d316f031969c": {"node_ids": ["e526f18e-0157-4319-ad71-4a873a0bdd84"], "metadata": {"source": "SDTMIG v3.4", "page": 42, "section": "4.4.5 Clinical Encounters and Visits"}}, "2a0685c0-8452-4277-b1ec-fdf56d91bd6a": {"node_ids": ["8b7eb893-1478-4859-80ca-b8e2024124d8"], "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.6 Representing Additional Study Days"}}, "42c595fe-0797-4aec-8287-5573da8ed21c": {"node_ids": ["b1286474-7973-48c6-95e9-42c67c42603e", "d38d0319-b90d-4f01-b6d8-a928f722fa5b"], "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.7 Use of Relative Timing Variables"}}, "1daf1db6-3e62-416a-b184-aa491a24914b": {"node_ids": ["6341cc52-3023-4b49-a260-f4981f127bab"], "metadata": {"source": "SDTMIG v3.4", "page": 44, "section": "UNSPECIFIED"}}, "3620d4e0-f216-4393-be81-593694e12ce2": {"node_ids": ["4aff8cd1-3025-47fd-97c9-136422e4ab30"], "metadata": {"source": "SDTMIG v3.4", "page": 45, "section": "4.4.8 Date and Time Reported in a Domain Based on Findings"}}, "43a053a5-09a6-4740-b6e3-2cfcfda8ac27": {"node_ids": ["eaeb9a68-745f-40c1-ad19-fbbbda0354e5"], "metadata": {"source": "SDTMIG v3.4", "page": 45, "section": "4.4.9 Use of Dates as Result Variables"}}, "961ba8b2-405c-4cf0-b5ac-4602557430b6": {"node_ids": ["7ea5efa6-f1dd-4a1c-8d17-0d45d6cb7666"], "metadata": {"source": "SDTMIG v3.4", "page": 46, "section": "4.4.10 Representing Time Points"}}, "d6f48eae-aed5-454e-868e-6e4d9d442115": {"node_ids": ["d1286d1a-32db-4636-84d0-e828654815ca", "4af4abf8-4d3d-4bc6-8be2-a6f372711257"], "metadata": {"source": "SDTMIG v3.4", "page": 47, "section": "UNSPECIFIED"}}, "6a37f4af-9884-4314-8d70-77d5027e0251": {"node_ids": ["8ce251f5-ee42-475d-b193-46141c72dca7"], "metadata": {"source": "SDTMIG v3.4", "page": 48, "section": "4.4.11 Disease Milestones and Disease Milestone Timing Variables"}}, "38ae3605-b002-4eb6-89b3-86d45fab1ed6": {"node_ids": ["8e412429-b2c4-4c7b-8d97-91c51abeb527", "aafbd5f8-4ef1-44ff-8141-2b0ad2e401b9"], "metadata": {"source": "SDTMIG v3.4", "page": 49, "section": "UNSPECIFIED"}}, "567aae79-a880-408a-939e-99c8b5133ffb": {"node_ids": ["05b8f910-d422-49c4-a386-7707d8c6cc83", "efc16f7b-51c3-48bd-b52f-bb9b289b02c1"], "metadata": {"source": "SDTMIG v3.4", "page": 50, "section": "UNSPECIFIED"}}, "64ca66dc-833e-456e-8668-4b0007d264ab": {"node_ids": ["3b2cfcf4-06ac-495b-9f1d-4c1bfe00b683"], "metadata": {"source": "SDTMIG v3.4", "page": 51, "section": "4.5.1.1 Original and Standardized Results"}}, "ca8b6516-71b5-4584-bab5-6bb43bfa518c": {"node_ids": ["90c9f6c6-4cc0-4957-944a-ba3e4d987348"], "metadata": {"source": "SDTMIG v3.4", "page": 52, "section": "4.5.1.2 Tests Not Done"}}, "67b42b9a-3c8c-4249-9f2f-743d9b496ff4": {"node_ids": ["e63fb069-ddfb-4919-9cb4-0f1466175c1d"], "metadata": {"source": "SDTMIG v3.4", "page": 52, "section": "4.5.1.3 Examples of Original and Standard Units and Test Not Done"}}, "ea11876b-0b66-4938-b379-08e830fd937b": {"node_ids": ["fa913110-6ee6-4b6e-8825-ba62c029224a"], "metadata": {"source": "SDTMIG v3.4", "page": 53, "section": "33.8 33.8"}}, "c4168171-6853-4beb-a468-13566f547133": {"node_ids": ["4b42c3b1-657d-49e7-ae80-2f0159947b8a"], "metadata": {"source": "SDTMIG v3.4", "page": 54, "section": "4.5.3.1 Test Name (--TEST) Greater than 40 Characters"}}, "a35e87cc-f90b-43ff-845c-0740974e82f9": {"node_ids": ["dbc8844e-13a6-48e8-9d53-f6362402c8b8"], "metadata": {"source": "SDTMIG v3.4", "page": 55, "section": "4.5.3.2 Text Strings Greater than 200 Characters in Other Variables"}}, "ef8db99f-97c7-4e0a-9670-e9500e645146": {"node_ids": ["cf49409d-89c0-4587-96d0-5c92aa7701d9"], "metadata": {"source": "SDTMIG v3.4", "page": 56, "section": "4.5.4 Evaluators in the Interventions and Events Observation Classes"}}, "eb6608a4-59f1-43ab-91db-3eb8fddf552c": {"node_ids": ["85d6ecb0-4c1c-4e25-aae8-d609b04d6506"], "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.5 Clinical Significance for Findings Observation Class Data"}}, "e47042cc-6ebc-4b6a-9d65-76c51768896b": {"node_ids": ["741d6354-3615-43ab-bbe6-9223c4183fc5"], "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.6 Supplemental Reason Variables"}}, "b9b7a13e-e917-4f2e-8bad-8ea72792d992": {"node_ids": ["1c548914-935f-4c06-bb04-dde918cd414f"], "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.7 Presence or Absence of Prespecified Interventions and Events"}}, "7213ac2f-3f81-4703-bc33-afcaeba8def5": {"node_ids": ["e4c0a39d-df69-4006-91cc-4a7a85d19c01"], "metadata": {"source": "SDTMIG v3.4", "page": 58, "section": "4.5.8 Accounting for Long-term Follow-up"}}, "4645bd29-25b7-4eb1-8486-47d9cd13cae8": {"node_ids": ["c9d3311e-db07-4c25-98d0-ac53c1ba90d7"], "metadata": {"source": "SDTMIG v3.4", "page": 59, "section": "4.5.9 Baseline Values"}}, "a6a35f7f-de88-4414-9c1d-0dad120b1252": {"node_ids": ["fcdcc07d-e08b-47df-ae2d-210ed3151033"], "metadata": {"source": "SDTMIG v3.4", "page": 60, "section": "5.1 Comments (CO)"}}, "59aafca2-8010-4c9d-b176-84a2b5af7711": {"node_ids": ["5d47da65-9233-4002-a5f7-be65e19bccb5", "860aae7d-cab2-4867-ad30-7d2540b49808"], "metadata": {"source": "SDTMIG v3.4", "page": 61, "section": "UNSPECIFIED"}}, "82229160-01fb-44c6-87b1-8234a9b16f11": {"node_ids": ["e02de7f5-89bc-44a9-baf4-e32504fa1560"], "metadata": {"source": "SDTMIG v3.4", "page": 62, "section": "5.2 Demographics (DM)"}}, "b2b7336b-f795-4a53-aade-de2970d7f8d6": {"node_ids": ["7b9a2e42-d8b2-469d-8b80-df03c4c28ba3", "eb51e895-a882-4ef5-b029-c141fc964f48"], "metadata": {"source": "SDTMIG v3.4", "page": 63, "section": "UNSPECIFIED"}}, "90dd798a-7795-4067-a885-9cbda366f052": {"node_ids": ["e091b3d4-62e8-49d5-b3e2-491625306acb", "ed7504d5-3e4b-416b-8a0a-adbbf5f4ae5e"], "metadata": {"source": "SDTMIG v3.4", "page": 64, "section": "UNSPECIFIED"}}, "f26f4991-ddd8-4aa9-8242-e8ea2539b0eb": {"node_ids": ["1c3f8e7e-f540-4f01-8f59-be1f8e75b0b3", "6fbc33f8-ef27-4fd9-b9cc-ce5b93902d2f"], "metadata": {"source": "SDTMIG v3.4", "page": 65, "section": "UNSPECIFIED"}}, "f3e364a2-7276-42ab-b342-f57a9662bf9e": {"node_ids": ["1ac74132-9760-4bb2-a942-1a65d51d8199", "af0b47e9-7222-440a-b9ac-dbaf0dae0b51"], "metadata": {"source": "SDTMIG v3.4", "page": 66, "section": "UNSPECIFIED"}}, "2dbd0238-2671-4eb1-9eae-60c1ed39957c": {"node_ids": ["b7a9452c-44a1-4f7f-b83a-7f2be4543d4d"], "metadata": {"source": "SDTMIG v3.4", "page": 67, "section": "UNSPECIFIED"}}, "ef474a01-1f60-413a-b6ac-e40a87c78422": {"node_ids": ["6b8d89df-eb45-4a45-ab50-f06f674b3855", "e58ca28a-d2b7-4f5a-81f6-63b8d78ff532", "44fe929c-c611-4ca7-92fd-d26d33919d11"], "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}}, "2021a54a-2bb1-4fce-82fa-d7d8c486c349": {"node_ids": ["5d32116e-0195-48d4-9662-3ed3d344872d", "1d6ca227-c350-471c-9edf-3b3f35244805"], "metadata": {"source": "SDTMIG v3.4", "page": 69, "section": "UNSPECIFIED"}}, "c6a0330a-39c8-4a52-bd30-0ea44b2e721b": {"node_ids": ["7cf5c4f7-d1d0-4a7c-a940-e179b1c009c2"], "metadata": {"source": "SDTMIG v3.4", "page": 70, "section": "UNSPECIFIED"}}, "857c5ffa-e12d-4566-9528-ec2fb6ff725f": {"node_ids": ["354fb203-52c3-469a-bb29-1c610e62b8db"], "metadata": {"source": "SDTMIG v3.4", "page": 71, "section": "UNSPECIFIED"}}, "bc49b419-b2d6-416a-a664-c6aa53cac0ec": {"node_ids": ["33bd77b8-f474-4ba1-b249-6db422c20c78"], "metadata": {"source": "SDTMIG v3.4", "page": 72, "section": "UNSPECIFIED"}}, "30007ce5-93e8-4522-aaa8-24663ed54454": {"node_ids": ["35e3b8f3-394c-4ade-8d52-93112aa726b2", "7ef19325-dc96-4a04-9297-725fe6201250"], "metadata": {"source": "SDTMIG v3.4", "page": 73, "section": "UNSPECIFIED"}}, "263e6387-9325-4935-913b-8a009ab2821b": {"node_ids": ["669a8ce0-fe2a-4020-9479-47cad68024ba", "f70e1e86-477d-4f58-8e02-a2f6e24c2e72"], "metadata": {"source": "SDTMIG v3.4", "page": 74, "section": "UNSPECIFIED"}}, "09bb8409-4ec8-4fe4-a249-9669bafbc766": {"node_ids": ["6354e179-af48-4d7f-acc9-aa3dc71f1112"], "metadata": {"source": "SDTMIG v3.4", "page": 75, "section": "UNSPECIFIED"}}, "eb8680e4-92e4-44b4-8964-e1ba7e3a68c6": {"node_ids": ["c9809e7e-8b60-424e-b199-72a201c0f308"], "metadata": {"source": "SDTMIG v3.4", "page": 76, "section": "UNSPECIFIED"}}, "6bc349b6-01ff-4fb9-8add-ffba755e658e": {"node_ids": ["564d01d5-09b8-45bb-ac4a-9656e5590f1b", "295032d6-5a07-404b-9948-e61ae0dde624"], "metadata": {"source": "SDTMIG v3.4", "page": 77, "section": "UNSPECIFIED"}}, "dbddadaf-9e36-44af-bde8-a20134fc72eb": {"node_ids": ["0e2ccbe5-d0c1-4520-9bdd-20a3d6b6742b"], "metadata": {"source": "SDTMIG v3.4", "page": 78, "section": "UNSPECIFIED"}}, "ea74c41a-6a95-489a-ae0f-232b07b85682": {"node_ids": ["8986bf2f-4afa-4cc3-9565-e7bcd98b85c6"], "metadata": {"source": "SDTMIG v3.4", "page": 79, "section": "5.3 Subject Elements (SE)"}}, "6db64d16-215e-4c86-9d1f-d35886ba5b13": {"node_ids": ["196ce6d5-0f3f-479e-8888-ee3b896a0552", "cbd59b0a-c9d9-419e-a873-34911320b057"], "metadata": {"source": "SDTMIG v3.4", "page": 80, "section": "UNSPECIFIED"}}, "483b3245-feb1-4e0b-8577-ee318f7c56e1": {"node_ids": ["7c28b978-5a7a-4cda-9985-ae33c6435d82", "ed6dfe1f-c3e8-4f0f-ac00-3ba9bd5d9f42"], "metadata": {"source": "SDTMIG v3.4", "page": 81, "section": "UNSPECIFIED"}}, "dc0cb0dc-03ab-47d6-999e-ebf0f5f5222a": {"node_ids": ["c5c27b8f-9fe7-45d1-8fcd-dbe24ea84940", "f8f127ac-845d-4ef8-bbd5-2ab57106ed7a", "4fdce03c-9dd6-43d8-a1ef-da8f3b14a24b"], "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}}, "572b00b7-ccfc-488d-9f06-4a27f53371da": {"node_ids": ["caac29ff-734a-4157-a642-d8208024f7f6", "9358f729-1da2-4093-b91c-134ac7ce7340"], "metadata": {"source": "SDTMIG v3.4", "page": 83, "section": "UNSPECIFIED"}}, "19cd7d97-9d91-4aec-8963-80931e2ff5f4": {"node_ids": ["846f8ffd-22fb-4ced-bddf-714de99cda7c"], "metadata": {"source": "SDTMIG v3.4", "page": 84, "section": "5.4 Subject Disease Milestones (SM)"}}, "b7eb73f8-0128-4489-ba25-62852c1fcd40": {"node_ids": ["ef9fea72-145a-4950-93c7-fec4c1958461", "c8d60c44-acce-4332-bdb9-be64403ab179"], "metadata": {"source": "SDTMIG v3.4", "page": 85, "section": "UNSPECIFIED"}}, "6dd1751b-fdf3-4cd2-a9bc-ee2907f2e2f5": {"node_ids": ["6870f6c5-887d-41b8-bf2f-022b531f2fc5"], "metadata": {"source": "SDTMIG v3.4", "page": 86, "section": "5.5 Subject Visits (SV)"}}, "b6bd8a6b-4248-424a-993c-2b36da7c0c3b": {"node_ids": ["a02a8944-9b73-4ebf-899c-ad95b47f39d3", "548b213c-3948-479a-9b5f-4c3340730335"], "metadata": {"source": "SDTMIG v3.4", "page": 87, "section": "UNSPECIFIED"}}, "6554d30b-8467-4fd2-9a7c-96c89d0b82aa": {"node_ids": ["d5ca1f8a-8aff-4660-a519-d40120779c93", "21e78b45-62dd-42a1-80d4-b49021b29fd5"], "metadata": {"source": "SDTMIG v3.4", "page": 88, "section": "UNSPECIFIED"}}, "52f25532-a246-4af2-9b90-83d86d828033": {"node_ids": ["b8be10e6-d7b8-414d-8255-0ea6e9263680", "48f6f390-7e84-4e86-b763-be9d72cb6a5d"], "metadata": {"source": "SDTMIG v3.4", "page": 89, "section": "UNSPECIFIED"}}, "3554a06b-78d7-42ea-8ed5-b3ae6ad64807": {"node_ids": ["71395785-1b4c-42c7-834c-0eed7c11a6b2", "bdd2ef22-8908-4c94-af9c-0dd72b417369"], "metadata": {"source": "SDTMIG v3.4", "page": 90, "section": "UNSPECIFIED"}}, "32273914-fe91-4464-8012-1f1d9e0e764c": {"node_ids": ["943af8fc-7557-4ad0-a56e-b757f3a426ef"], "metadata": {"source": "SDTMIG v3.4", "page": 92, "section": "6.1.1 Procedure Agents (AG)"}}, "27d2d277-ba42-4135-85f3-d91d9f77978c": {"node_ids": ["7f1e1ac2-3f3c-435e-abef-a1dbbd33e6ac", "e8f2aa13-b179-43b2-adf1-00d2675c4422"], "metadata": {"source": "SDTMIG v3.4", "page": 93, "section": "UNSPECIFIED"}}, "2fbdd8c6-7a1b-4435-8c09-7cc3f493e9b2": {"node_ids": ["85d02767-e85f-4f7d-b494-d0c0d979b74d", "388fbaea-6420-46a5-a675-d2a8521f0303"], "metadata": {"source": "SDTMIG v3.4", "page": 94, "section": "UNSPECIFIED"}}, "30fa772d-f408-4e2c-9898-dc79fed670e8": {"node_ids": ["6dfaa4aa-7ea4-4f37-821c-50826e213213", "053b006f-9de9-45f8-9f51-8a273a0fd8f8"], "metadata": {"source": "SDTMIG v3.4", "page": 95, "section": "UNSPECIFIED"}}, "c8334b17-fb1a-4ba1-822b-f92b2bd3c5d2": {"node_ids": ["44fa9db8-7cfd-487f-8e12-f88329dfc1a8", "cb583312-cebd-45ae-989e-aafc91d4d829"], "metadata": {"source": "SDTMIG v3.4", "page": 96, "section": "UNSPECIFIED"}}, "80f3e14a-d82e-4007-bce5-067537fd8d75": {"node_ids": ["79b2a2d2-1bba-41e0-8514-f56a83f47e90"], "metadata": {"source": "SDTMIG v3.4", "page": 97, "section": "13.99 13.99"}}, "4c8c58fb-249f-4fd6-8e2b-dc06481d3b5d": {"node_ids": ["57280cd2-aa43-4f9f-a6dc-199e07687f85", "3c810dde-7f05-46e9-bb94-cf9029d55007"], "metadata": {"source": "SDTMIG v3.4", "page": 98, "section": "6.1.2 Concomitant/Prior Medications (CM)"}}, "d79d0dff-436d-4679-ab1c-cf1acd850ba7": {"node_ids": ["b5a22ecd-71b4-431b-a671-dd60be6ff602", "af802285-8e90-4bc9-8ecb-443b471cc9a5"], "metadata": {"source": "SDTMIG v3.4", "page": 99, "section": "UNSPECIFIED"}}, "b05bec41-f59d-401f-8e8d-3b4cb88e40c5": {"node_ids": ["82aacd6d-89d9-4099-8b30-51b4aee75422", "d87b03dd-f423-45ca-a00b-f80dbe2ed906"], "metadata": {"source": "SDTMIG v3.4", "page": 100, "section": "UNSPECIFIED"}}, "68cc3412-3d3f-426b-bcf7-76c0e52f4033": {"node_ids": ["1a6842c6-daaa-4cda-b17b-45b342f92889", "e3bd06c5-80fc-48cc-923e-663643301926"], "metadata": {"source": "SDTMIG v3.4", "page": 101, "section": "UNSPECIFIED"}}, "0f56290c-df58-47b9-aa54-6d16d79c6be7": {"node_ids": ["0f2d82c6-d394-48b3-86da-ce691e6e52eb", "61cb07fc-2449-4421-b86c-5c98f89f6db6"], "metadata": {"source": "SDTMIG v3.4", "page": 102, "section": "UNSPECIFIED"}}, "54d61ee5-a1e1-469e-8778-122a82f431ca": {"node_ids": ["9d60c064-a6ca-4438-8552-80b74a1ebcb5"], "metadata": {"source": "SDTMIG v3.4", "page": 103, "section": "6.1.3 Exposure Domains"}}, "f4281936-1faa-44ff-b84f-3748f479f753": {"node_ids": ["eef859e3-99e3-4c1a-98f0-26badf4a22e3", "db3506cd-f2a4-400f-a5ea-d6b9149b05ee"], "metadata": {"source": "SDTMIG v3.4", "page": 104, "section": "6.1.3.1 Exposure (EX)"}}, "738c000c-3b99-4a92-ade6-bc365a8004bd": {"node_ids": ["16642a76-ea58-4d42-8ee0-0c3dec63fa79", "8a6ae6ef-e362-4643-8e86-7dda45b3d82f"], "metadata": {"source": "SDTMIG v3.4", "page": 105, "section": "UNSPECIFIED"}}, "51afbf85-25b8-4372-b629-872f5163f1bf": {"node_ids": ["d61ce06c-efd3-4dd0-95b3-36add1340209", "3a8e5bd2-4538-4e6a-b20e-df0617af0d96"], "metadata": {"source": "SDTMIG v3.4", "page": 106, "section": "UNSPECIFIED"}}, "deed3837-5ab1-4ecf-8dfb-7e8a2600747b": {"node_ids": ["fb01c8aa-353a-49b1-949a-c48e49fc8e88"], "metadata": {"source": "SDTMIG v3.4", "page": 107, "section": "6.1.3.2 Exposure as Collected (EC)"}}, "8bdedb7b-5632-4426-87c7-87f6991f6858": {"node_ids": ["60c03d05-a1b3-4e08-8553-4fd768d4eb57", "558e5df4-f91a-4dc8-91f3-3dda4ec44980"], "metadata": {"source": "SDTMIG v3.4", "page": 108, "section": "UNSPECIFIED"}}, "f159d177-63f9-494c-8654-d2311e041997": {"node_ids": ["943e7dc7-6b09-40d3-9867-d76c3038b2e4", "0f44d399-0620-4cfc-8481-de5b0464f5cc"], "metadata": {"source": "SDTMIG v3.4", "page": 109, "section": "UNSPECIFIED"}}, "415cabc4-4fd5-40d0-a1ec-43027e005c5a": {"node_ids": ["c3b94105-77e6-4f61-9bdd-07dd6054a63d", "a2b13742-b59f-4d94-8efe-9fe299835dc4"], "metadata": {"source": "SDTMIG v3.4", "page": 110, "section": "UNSPECIFIED"}}, "1715f803-3dc9-4eab-8cb5-c6e2f6717ffc": {"node_ids": ["b298f532-6687-4624-9a32-6dfdf9c05961", "6fa67bfe-7bc0-46a3-9619-1afcaf29c7eb"], "metadata": {"source": "SDTMIG v3.4", "page": 111, "section": "6.1.3.3 Exposure/Exposure as Collected Examples"}}, "a0341ccc-be28-40db-b729-b2978a76b542": {"node_ids": ["a8e97bc5-b4a3-462f-b135-d6cd6a66e176", "cdefad4b-4d92-4846-a3a4-f521644c2df0"], "metadata": {"source": "SDTMIG v3.4", "page": 112, "section": "UNSPECIFIED"}}, "27faa2c5-9909-4f3b-b969-fa3e07644e06": {"node_ids": ["67f95f4f-bac7-471e-bdd1-012b91119233", "1456a941-acea-45a6-b048-1bee1a4944d7"], "metadata": {"source": "SDTMIG v3.4", "page": 113, "section": "UNSPECIFIED"}}, "719e9f14-ba21-4bd9-9a19-066dc540f630": {"node_ids": ["0425d687-d8b6-48f6-8f11-618c1dcc33e6", "2c06198c-4739-4500-973d-0a423e3f85f1"], "metadata": {"source": "SDTMIG v3.4", "page": 114, "section": "UNSPECIFIED"}}, "55b2c449-4125-43a3-9c00-fc45068338a0": {"node_ids": ["881c5ba4-6399-4b73-ad3c-4a3d3ed67464", "b387b71b-c3f0-4f15-9e95-26d1f004b933", "2b95c9d5-ac74-472a-a0e5-5e41176b9fdd"], "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}}, "36a0db1e-82b4-4c30-8398-8ed401fcb8ce": {"node_ids": ["df7d66a5-b505-403b-af57-2568261e02d5", "b84acfdd-e056-41a7-b442-c4d6249bffdb", "4e737e77-ade2-4e91-9458-c7d3a5cbf336", "f42b0f24-c93c-4884-8c0b-d101df5a642f", "0d1c6acb-fa59-4261-a80c-5f3b94f41d01"], "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}}, "60c57d1c-8d19-4093-932d-a9815ba261fe": {"node_ids": ["f6060ff4-1839-4fd4-9148-2130500640a7", "30b6c504-ba72-4a83-9bf6-a7c6c17ce387", "107e1e12-b1b9-40a5-908d-937e24fec5bb", "f9787003-1c53-4fed-a586-dc7633b42999"], "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}}, "d46b86a2-f2c0-475d-b314-cfc38a52041d": {"node_ids": ["62a02373-3035-4f58-b814-c0ecfe1842db"], "metadata": {"source": "SDTMIG v3.4", "page": 118, "section": "4.12 mg/mL"}}, "a6b66fa6-b561-4c69-b766-978830e9454c": {"node_ids": ["46e1dc06-5a72-4655-93ff-97c51fce9572"], "metadata": {"source": "SDTMIG v3.4", "page": 118, "section": "4.12 mg/mL"}}, "804457bb-87a6-4b4e-8cdc-d18d5fe87127": {"node_ids": ["88b76e76-a62a-4ccd-9ea2-bd258310ff74"], "metadata": {"source": "SDTMIG v3.4", "page": 119, "section": "2.6 mg/kg"}}, "863bb77b-2dc7-449b-91fd-1520b23a7a82": {"node_ids": ["a94f8c32-e9c4-499c-93c3-6c8e147cf82a"], "metadata": {"source": "SDTMIG v3.4", "page": 120, "section": "UNSPECIFIED"}}, "264604a1-8180-484d-91ac-4ebca56f333d": {"node_ids": ["b4fdb5b6-53d2-4e79-996a-a1f5cda2afbe", "4b6504ef-64e2-45e0-b824-324151127f34"], "metadata": {"source": "SDTMIG v3.4", "page": 121, "section": "6.1.4 Meal Data (ML)"}}, "745d1c63-e052-4f64-b3f6-be386b6d40fd": {"node_ids": ["15f1617c-fd19-4c81-987e-23000c57db58", "ea48ae73-3034-424e-9150-091dfb6a999d"], "metadata": {"source": "SDTMIG v3.4", "page": 122, "section": "UNSPECIFIED"}}, "e85369e5-6c58-45a3-be8e-dce4eb419f49": {"node_ids": ["a1c559a1-00d6-48c1-b98a-6001ed911aba"], "metadata": {"source": "SDTMIG v3.4", "page": 123, "section": "UNSPECIFIED"}}, "af9e273f-eed2-4486-944a-2c1af1339bd1": {"node_ids": ["a9ac55ce-6430-43f3-b93d-a15c0590f45c", "616837f4-1ac1-45ee-9156-574e3d796c47"], "metadata": {"source": "SDTMIG v3.4", "page": 124, "section": "UNSPECIFIED"}}, "ccf102f9-e88f-4d29-be07-e92f42b7b1d6": {"node_ids": ["cca838dc-e537-4d6a-bca3-872c2eb7827b", "70ea6496-5447-45c5-9958-7fd22e913d72"], "metadata": {"source": "SDTMIG v3.4", "page": 125, "section": "6.1.5 Procedures (PR)"}}, "07e4b533-c2b4-49a4-a034-15dabd7c7e3a": {"node_ids": ["54f2ebd3-face-459d-bcc8-b41736d470f1", "dbf30eb8-8cde-4235-a20f-286749cf1940"], "metadata": {"source": "SDTMIG v3.4", "page": 126, "section": "UNSPECIFIED"}}, "48d35682-eb3f-4915-8b06-9ee157a3fbbc": {"node_ids": ["fa6d9118-32fb-4c7a-965e-551670d4aebc", "c36481dc-3fb8-4345-8d11-e961cf0d9e14"], "metadata": {"source": "SDTMIG v3.4", "page": 127, "section": "UNSPECIFIED"}}, "19f35486-7398-482a-8e54-27fcdf03cbcb": {"node_ids": ["d3eb32fc-147d-437c-9b73-f5b1e8b8029b", "37aeff13-d27c-4e70-b089-b1ecf27bfbfd"], "metadata": {"source": "SDTMIG v3.4", "page": 128, "section": "UNSPECIFIED"}}, "983da09d-ba54-429d-a948-d560d34e0296": {"node_ids": ["64e6460a-140b-4575-8f11-f7eb7963ca9b", "6d686cd7-5f30-4e33-8770-74f06f4c50c0"], "metadata": {"source": "SDTMIG v3.4", "page": 129, "section": "6.1.6 Substance Use (SU)"}}, "f9373df2-55be-4a05-949e-771fa578692b": {"node_ids": ["3e096d5a-294a-4d4f-a035-2499adccf46a", "cd789ae6-075f-48b7-8ee6-ef29e4e134e1"], "metadata": {"source": "SDTMIG v3.4", "page": 130, "section": "UNSPECIFIED"}}, "7d5024f8-d8a4-449e-b420-752f59e058a9": {"node_ids": ["07e24637-d937-4678-8a86-157ac391ec38"], "metadata": {"source": "SDTMIG v3.4", "page": 131, "section": "UNSPECIFIED"}}, "148f5249-29aa-4f19-8e1c-f8eb619f17f0": {"node_ids": ["96a108ac-c086-4222-b8ec-3b6f32e82ff1"], "metadata": {"source": "SDTMIG v3.4", "page": 132, "section": "UNSPECIFIED"}}, "eeaae70e-8bf2-4d5e-aa65-18464b168555": {"node_ids": ["f1a9dcb1-a013-4b3c-8b41-3f563244f750"], "metadata": {"source": "SDTMIG v3.4", "page": 133, "section": "6.2 Models for Events Domains"}}, "cf70586c-3ecf-460b-95af-531cbdf007af": {"node_ids": ["c7773769-b664-4807-a96c-bb5bc4ef6764", "a60db4d2-2354-49fa-a8e2-b4c4c07a58ff"], "metadata": {"source": "SDTMIG v3.4", "page": 134, "section": "UNSPECIFIED"}}, "b666503f-2dcc-4c92-a1bd-ba8d92062a38": {"node_ids": ["8c782232-abee-49f9-b91c-14eff4cb929d", "c6e0f797-f675-49a9-a913-326d96136e05"], "metadata": {"source": "SDTMIG v3.4", "page": 135, "section": "UNSPECIFIED"}}, "66daea96-6cb5-442a-ab53-9b0c13410d5d": {"node_ids": ["78ba2d80-7631-4bfe-8e2f-ac91651265c8", "8316e18a-ca4d-4832-91c3-02a4ec0f8685"], "metadata": {"source": "SDTMIG v3.4", "page": 136, "section": "UNSPECIFIED"}}, "5d337e49-a9c5-4c97-9f3f-ceb234dae7d7": {"node_ids": ["3a2c24c2-123c-4bb9-b897-afe23c2d2c88", "d6b7a500-7025-4871-89a5-149b48a681c3"], "metadata": {"source": "SDTMIG v3.4", "page": 137, "section": "UNSPECIFIED"}}, "1f970326-be3a-4a32-ae04-0396010ba790": {"node_ids": ["5fc7f427-2660-4f7c-9600-87264ad2c65c", "2ccbf18f-aca1-4935-90bc-56d8e440d6bb"], "metadata": {"source": "SDTMIG v3.4", "page": 138, "section": "UNSPECIFIED"}}, "627af751-5bbd-4a44-9a21-db2733c16094": {"node_ids": ["3877fbdb-6554-4135-a190-6ae51c66667f", "c36178db-5099-4218-acf7-a35c43c5a6e3"], "metadata": {"source": "SDTMIG v3.4", "page": 139, "section": "UNSPECIFIED"}}, "0ec8f58b-20f4-4c09-937c-921c63ba514d": {"node_ids": ["3b624330-d1d5-4714-89db-2a5d59a1b1c1", "ccbbfa8c-1754-4a0e-8df9-1499bbf1b80a"], "metadata": {"source": "SDTMIG v3.4", "page": 140, "section": "UNSPECIFIED"}}, "550155b8-03cc-47b2-9f92-0ba4dc52593b": {"node_ids": ["6864ea02-bcd8-4f7f-9e07-bab5a02dbb40", "ea6d9ee6-b61f-4bfa-a0e0-cc8489244dcc", "aadd2bad-c37c-499b-8a71-e03ca4ab1f0c"], "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}}, "016ad7e7-e76c-421c-a6c1-120b648afe74": {"node_ids": ["52a5f4e0-9162-45ac-a53f-f92124a03edd", "8e6b068d-1c7d-4729-84fd-1a06fdebe0b8", "8c3d02c6-46e2-4d00-b10c-8682504ec8ff"], "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}}, "3c85ca06-1a84-4825-ac52-3c4027cf587c": {"node_ids": ["91df385e-c944-4c07-8271-2700fc358ddb", "c43f0a11-303e-4364-98f0-8d6b5aa9a08f"], "metadata": {"source": "SDTMIG v3.4", "page": 143, "section": "6.2.2 Biospecimen Events (BE)"}}, "95381874-e431-4e61-ad84-35cd9828b11b": {"node_ids": ["d3d58bab-a95e-42e8-a6bc-87adaa96157d", "5b17253f-ebdb-4553-b5a1-6c7c35d5e093"], "metadata": {"source": "SDTMIG v3.4", "page": 144, "section": "UNSPECIFIED"}}, "48461c68-32d2-41f0-a052-a1108d006fc5": {"node_ids": ["14ad805b-4ee8-48f0-aa19-40418d073ed8"], "metadata": {"source": "SDTMIG v3.4", "page": 145, "section": "1148.267 BESPEC"}}, "26712588-e6d0-469a-93a7-26957b2a1c10": {"node_ids": ["e80413f3-c327-4b9e-97b3-7995edbfc33f", "66f6ed12-f106-4c33-8e07-a486e3d8e7d4"], "metadata": {"source": "SDTMIG v3.4", "page": 146, "section": "1148.267 FFRZMAT"}}, "134e2e1e-cae3-4af2-990b-7985a34472b4": {"node_ids": ["ff48fa85-b768-4caf-baac-e984797965d3"], "metadata": {"source": "SDTMIG v3.4", "page": 147, "section": "9.3 RNA"}}, "29111159-cbcd-4a15-a9f8-094ffffe6ffb": {"node_ids": ["3c5b649f-3a2a-41e8-a288-1b3fbd848e6e"], "metadata": {"source": "SDTMIG v3.4", "page": 148, "section": "6.2.3 Clinical Events (CE)"}}, "90592ea5-e9c9-47c7-9062-c2c19921c837": {"node_ids": ["3eb716e4-b1ef-48a0-9c43-924273b2b6a8", "28625096-67eb-440e-9c51-8af9262f907e"], "metadata": {"source": "SDTMIG v3.4", "page": 149, "section": "UNSPECIFIED"}}, "d140e481-7a14-447d-a413-c1d4b8eadedd": {"node_ids": ["42fe300f-8bf2-4385-883a-bc6f801d0d98", "ee49c7f4-023a-4346-998b-4b249bc62dad"], "metadata": {"source": "SDTMIG v3.4", "page": 150, "section": "UNSPECIFIED"}}, "26a76724-19a6-4202-bc5c-fb0c0134bf2d": {"node_ids": ["73de97f8-492c-4657-a4f7-72301bd95c08"], "metadata": {"source": "SDTMIG v3.4", "page": 151, "section": "UNSPECIFIED"}}, "65a949e0-67e0-4c09-96f4-2fe13e99c73f": {"node_ids": ["a3f34d5a-d1d7-4ea3-bdf9-0f681eabc7d7", "4f285986-e1a9-4a01-88ac-f64153137bb4"], "metadata": {"source": "SDTMIG v3.4", "page": 152, "section": "UNSPECIFIED"}}, "0285bdcf-301c-47da-8431-7e14df23702f": {"node_ids": ["7023d4fd-2a0f-46f6-abc8-b845aa4393cb"], "metadata": {"source": "SDTMIG v3.4", "page": 153, "section": "UNSPECIFIED"}}, "f3451a8f-2f63-4dce-aaa7-a0d00322d516": {"node_ids": ["925ff65c-8101-4be5-9dc1-510d83aaead7", "377b8d0f-bc2b-4990-9269-20fa1deab0a5"], "metadata": {"source": "SDTMIG v3.4", "page": 154, "section": "UNSPECIFIED"}}, "e25b858f-c3cc-4010-928c-72d772296afb": {"node_ids": ["ff918a55-b9be-4f88-a925-138e567e9395"], "metadata": {"source": "SDTMIG v3.4", "page": 155, "section": "6.2.4 Disposition (DS)"}}, "70f2c6f1-c01f-43ed-98a8-7c05b1286c70": {"node_ids": ["234350b2-67ea-4fe0-86fc-bdafb2c75cdc", "f31c1c28-ebf8-45bf-84d6-b327e6b95d9e"], "metadata": {"source": "SDTMIG v3.4", "page": 156, "section": "UNSPECIFIED"}}, "42dac78a-62f5-4058-b218-0018e75ec054": {"node_ids": ["2cbc488f-1f31-4b83-a907-ad542a5abbe8", "8e466b71-4cff-42ed-b703-87a5b7edb8b9"], "metadata": {"source": "SDTMIG v3.4", "page": 157, "section": "UNSPECIFIED"}}, "dce9115a-8c6e-4887-bf76-cd49da79c16f": {"node_ids": ["f1bd0024-733a-4d78-98a2-7089d831494b", "089420f5-fe9c-48fc-bb7b-365908e3ced0"], "metadata": {"source": "SDTMIG v3.4", "page": 158, "section": "UNSPECIFIED"}}, "1f74f35a-6580-4a14-988b-b2f4c616e656": {"node_ids": ["7429ad74-c24e-40a6-a19a-e321c8e49548", "bfd54050-5ba9-458b-a7fc-a863c1d91750"], "metadata": {"source": "SDTMIG v3.4", "page": 159, "section": "UNSPECIFIED"}}, "3dbf7c93-7227-4e6a-b7c0-c7096558be9b": {"node_ids": ["d905d2fe-346e-48b7-acc9-452772404f84", "aace67bc-59c5-47b7-b05e-c6647db75743"], "metadata": {"source": "SDTMIG v3.4", "page": 160, "section": "UNSPECIFIED"}}, "d31d96b4-731b-4e3a-9ec5-dc1877642053": {"node_ids": ["ddc951df-83c8-454b-a629-4f458eb58077", "959480ac-5bbd-459e-ae2c-54950e15bbd8"], "metadata": {"source": "SDTMIG v3.4", "page": 161, "section": "UNSPECIFIED"}}, "eabd1301-d510-4ef9-80db-ce018b3b5dbc": {"node_ids": ["de491dbb-30f1-422e-8fad-3e29f57999bc", "9ac75c51-c2da-485b-8b3d-9a3c23f20bc8"], "metadata": {"source": "SDTMIG v3.4", "page": 162, "section": "UNSPECIFIED"}}, "e6e4e9fc-aa49-44e8-b5b0-55b80dc1f717": {"node_ids": ["69feaeb6-e0e9-4f68-89d7-274dbb52a589", "af372453-493a-4562-8e42-8a0db46f2b41"], "metadata": {"source": "SDTMIG v3.4", "page": 163, "section": "UNSPECIFIED"}}, "1cbb64c6-6a5e-4efe-931b-02abdc7d5f20": {"node_ids": ["6c46be72-fb42-4c87-9fae-719eb60ed9f0", "a39134be-16f8-4fe4-8ea3-392dffcab1b5"], "metadata": {"source": "SDTMIG v3.4", "page": 164, "section": "UNSPECIFIED"}}, "82de0c19-acc7-4f7c-8bd7-4353054f5668": {"node_ids": ["bf73776e-1e25-4e58-9bb0-8b11c44805a0", "3414ac39-2162-465d-bcd3-71d36bb2d979", "411fc571-22bb-44de-9cda-2c740695d7b7"], "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}}, "df64b0a0-fcd9-4faa-aae8-dd157031b0d7": {"node_ids": ["a0f62625-7125-4813-9341-8492d15e6d84", "82b901ec-bbcc-4f48-965c-aed9aa713ad3"], "metadata": {"source": "SDTMIG v3.4", "page": 166, "section": "UNSPECIFIED"}}, "0bb35961-a35f-4a8a-a858-415fc3e963fe": {"node_ids": ["f8bb1d97-d0a8-4f64-bbbc-d6b19dfcb32f"], "metadata": {"source": "SDTMIG v3.4", "page": 167, "section": "6.2.5 Healthcare Encounters (HO)"}}, "1be6e8f2-0252-4f6a-96ef-6c30d75ffeca": {"node_ids": ["0a3dba9f-1538-42b4-b622-b10cb9ff9879", "69726ad5-9ded-4bb8-8047-161666385162"], "metadata": {"source": "SDTMIG v3.4", "page": 168, "section": "UNSPECIFIED"}}, "eb4c1063-ad6b-431d-8a20-8e9b2e468626": {"node_ids": ["44997148-b73c-4986-880a-03bb4554d839", "4c61a8a9-0b87-446e-aebc-1ba93746df55"], "metadata": {"source": "SDTMIG v3.4", "page": 169, "section": "UNSPECIFIED"}}, "e2757759-a170-4e87-8219-8169c2f9cc39": {"node_ids": ["6ba046cf-5060-4a37-94ef-28891316eafb", "c3e17cd6-d273-48f7-b3d3-7d4351b4c45f", "2fdc476f-2084-4d55-bb07-de85204447f0"], "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}}, "b38c7021-cb3e-43de-901c-53ac3a0acd17": {"node_ids": ["207e3ebc-4d1f-4866-82c3-b2a4194e6550"], "metadata": {"source": "SDTMIG v3.4", "page": 171, "section": "6.2.6 Medical History (MH)"}}, "ec762da1-86de-4027-9501-9716c7ffaf90": {"node_ids": ["35fd706e-af26-421c-b8b3-97fcdbb5f04f", "59e8903e-f509-4160-ba0a-5a70cbf17e47"], "metadata": {"source": "SDTMIG v3.4", "page": 172, "section": "UNSPECIFIED"}}, "cacf2cf2-a20e-4779-8c26-d16c4eb5b5b4": {"node_ids": ["1d5926e2-2da7-4e2f-be65-516fac2eed1a", "5fe54bbf-9233-4808-b6ca-76433d402382"], "metadata": {"source": "SDTMIG v3.4", "page": 173, "section": "UNSPECIFIED"}}, "12bf5697-b722-4a66-abfe-5a2c0cd7a210": {"node_ids": ["45ac3c09-16bc-47ef-81b9-9f7daa2944a9", "09f0d0cb-8b8d-43ea-8152-01f88106866e"], "metadata": {"source": "SDTMIG v3.4", "page": 174, "section": "UNSPECIFIED"}}, "357c5ce4-1a1e-488c-806f-0fe3c21ead3d": {"node_ids": ["af78efb8-3b17-460a-9278-f47d8e3259a8", "51c159ad-a39a-4f9a-b14b-3f2ea89a4931"], "metadata": {"source": "SDTMIG v3.4", "page": 175, "section": "UNSPECIFIED"}}, "54006636-f6ea-4e39-a7b4-a9dc57da7e11": {"node_ids": ["2cc51665-6bf8-4c8b-82c4-11e934f6a80b", "a45f3a47-22ad-4803-8571-9b3c1844458c"], "metadata": {"source": "SDTMIG v3.4", "page": 176, "section": "UNSPECIFIED"}}, "ddc1d98d-bf62-468b-894e-b849e9a6b9ad": {"node_ids": ["15b59042-1268-4e02-8382-94f041cb7065", "8ed9e86b-1148-4e9a-82b0-de31aa6ae89b"], "metadata": {"source": "SDTMIG v3.4", "page": 177, "section": "UNSPECIFIED"}}, "15ccc356-f37e-4f74-a25c-ee88b5b46988": {"node_ids": ["854dffa9-c3f4-4ac8-bfbf-6ccbf37cc901"], "metadata": {"source": "SDTMIG v3.4", "page": 178, "section": "6.2.7 Protocol Deviations (DV)"}}, "9108b43a-3b89-4065-acbd-3eddee4838f2": {"node_ids": ["19606cec-3788-4874-bc1b-5b140b43590d", "ecd26caf-e4b2-4a75-a68b-289c137ecced"], "metadata": {"source": "SDTMIG v3.4", "page": 179, "section": "UNSPECIFIED"}}, "57c4c09d-5583-4a41-9140-bdaa07b6914b": {"node_ids": ["348117be-6056-47fa-9972-e0832661091e"], "metadata": {"source": "SDTMIG v3.4", "page": 180, "section": "6.3.1 Product Accountability (DA)"}}, "de4c71d5-55b7-4c50-aca0-ad9edf8f235f": {"node_ids": ["2bb163c2-1346-437a-b4d2-87df6d392fd2", "e4e7f813-6792-4a02-9a87-413aae75d4f3"], "metadata": {"source": "SDTMIG v3.4", "page": 181, "section": "UNSPECIFIED"}}, "2887afae-bb2d-4c89-b8f5-f29c1f0429ac": {"node_ids": ["004844b6-73ce-4118-900f-9e55d473f026", "3655a0e8-3122-46f8-857a-733977eb248d"], "metadata": {"source": "SDTMIG v3.4", "page": 182, "section": "UNSPECIFIED"}}, "385c6838-b164-4a93-8280-3d97b0baa7ee": {"node_ids": ["a08edb53-116d-4571-a306-26200ada4ab7"], "metadata": {"source": "SDTMIG v3.4", "page": 183, "section": "6.3.2 Death Details (DD)"}}, "117fb19b-9133-4e78-91ae-3219ab301ff5": {"node_ids": ["9103aa5b-2310-4cdf-9bfd-b5d463ad8300", "9c59e168-4bd3-42bd-a564-313d743dc145"], "metadata": {"source": "SDTMIG v3.4", "page": 184, "section": "UNSPECIFIED"}}, "77150e98-9717-436e-ae5b-6a129f54ba46": {"node_ids": ["546f5a97-8507-4787-9c34-8928940717de"], "metadata": {"source": "SDTMIG v3.4", "page": 185, "section": "6.3.3 ECG Test Results (EG)"}}, "9884a721-51fb-4520-aef5-602714a6b320": {"node_ids": ["2f3c3b61-92d7-43b7-9c84-7aad8e54b1e8", "332d04b4-9dc0-48d9-8e8d-0975e41f845a"], "metadata": {"source": "SDTMIG v3.4", "page": 186, "section": "UNSPECIFIED"}}, "0dfca31d-11fa-4be7-b596-c950092a1e09": {"node_ids": ["c44bdd3a-aff2-425d-95a7-fd08b8242213", "137ebd01-093b-4e2e-9b1f-62cec712cea7"], "metadata": {"source": "SDTMIG v3.4", "page": 187, "section": "UNSPECIFIED"}}, "903e504e-69e1-45e9-b8ae-aadc78b49a1e": {"node_ids": ["29ab00cb-208b-4bd7-b997-fcbd1c018c5f", "89513234-739b-4778-8376-860a0b474d4e"], "metadata": {"source": "SDTMIG v3.4", "page": 188, "section": "UNSPECIFIED"}}, "5c24a704-442c-4149-8eb8-871e561e53e9": {"node_ids": ["5d2f5171-035e-4b8a-8185-aee1a914a176"], "metadata": {"source": "SDTMIG v3.4", "page": 189, "section": "UNSPECIFIED"}}, "1ed8ac25-fddd-442c-9f25-afb056379dd7": {"node_ids": ["b6469387-448e-47c3-8560-de5a347e6ec7", "ca8c82e1-bc82-4e95-b1e6-f4eaee669d30", "c7dddfe8-e6cf-4f06-be3d-ac314dede628", "b513de80-4830-44db-b523-f17ac4828de8"], "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}}, "ede94ee4-5ba2-4357-985f-918ccacb55fc": {"node_ids": ["8b43bc5d-c5d5-4482-8a0b-0f185a60bd27", "7a8a3624-477a-450a-b541-162557327e20", "545ee71e-6f4c-4d7c-92c4-cae9de47b2e2", "b3e455d4-b3d6-467b-ba8a-05bd4ab1667f"], "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}}, "22c9cb55-fb0b-40d5-a2c3-dc0e7fb86bc5": {"node_ids": ["c87cfef0-4b2b-4820-a773-dea71addb5a1"], "metadata": {"source": "SDTMIG v3.4", "page": 192, "section": "UNSPECIFIED"}}, "4f21dbc5-e2f9-4d66-9b0f-1e30d61ae0f3": {"node_ids": ["8a183db3-f2a2-4a7b-b319-c96c85721fc9", "acbc312f-e494-4431-aa07-d919370dd880"], "metadata": {"source": "SDTMIG v3.4", "page": 193, "section": "6.3.4 Inclusion/Exclusion Criteria Not Met (IE)"}}, "a3fa06fd-1be4-43bc-913f-fff5e8cc0bff": {"node_ids": ["984aad14-89e1-450e-afc0-e9bde19f09b2"], "metadata": {"source": "SDTMIG v3.4", "page": 194, "section": "6.3.5 Specimen-based Findings Domains"}}, "d29bf1b9-63ef-473b-b7a0-60751ce3ef65": {"node_ids": ["84c98189-1c2c-4dda-be3b-3d9857853ee8", "b5b2585e-3357-4f63-af6c-e9b93ae7daac"], "metadata": {"source": "SDTMIG v3.4", "page": 195, "section": "UNSPECIFIED"}}, "65c1b426-4c93-4cd0-a8f2-9a0ba2a297f6": {"node_ids": ["860ac099-0927-4e81-b893-51fbb4f13357"], "metadata": {"source": "SDTMIG v3.4", "page": 196, "section": "6.3.5.2 Biospecimen Findings (BS)"}}, "284a764a-ff44-4c5f-a25b-1ae6d960e950": {"node_ids": ["34bbbd54-a3c2-48a6-a741-8968bbde7a47", "9d414dac-d17f-49d8-b42b-1f0e85a4892b"], "metadata": {"source": "SDTMIG v3.4", "page": 197, "section": "UNSPECIFIED"}}, "5cac06f1-0ae3-4569-874e-baf9050667fa": {"node_ids": ["bf1e5b89-e812-40f2-9848-57a5cd28a0d4", "976d5496-0701-4939-af98-7e4b09bd16b2"], "metadata": {"source": "SDTMIG v3.4", "page": 198, "section": "UNSPECIFIED"}}, "31293a19-82d0-407e-9178-224274d45777": {"node_ids": ["1dd041fb-bad0-4262-91d3-5b6e19b81acd"], "metadata": {"source": "SDTMIG v3.4", "page": 199, "section": "6.3.5.3 Cell Phenotype Findings (CP)"}}, "1c189957-56b9-4c3b-9555-71ac1653ea86": {"node_ids": ["79bf663c-f150-4670-9ea5-c65108d71feb", "b14e7d51-e1e2-4ece-9952-e2d931a89ade"], "metadata": {"source": "SDTMIG v3.4", "page": 200, "section": "UNSPECIFIED"}}, "34204317-873a-40ce-8b59-7a28761ad12e": {"node_ids": ["c6a7f455-7e96-4562-8819-f16d387a044d", "ccc0ab10-ec56-43d4-b8b6-15ebc74007b5"], "metadata": {"source": "SDTMIG v3.4", "page": 201, "section": "UNSPECIFIED"}}, "e8739237-8fac-421e-96ce-4803352e6dac": {"node_ids": ["b9d15f14-a72b-4700-9a4f-2652f60724f3", "eea88fd6-e41f-41e0-b010-ab0685a16214"], "metadata": {"source": "SDTMIG v3.4", "page": 202, "section": "UNSPECIFIED"}}, "a0463727-fb3f-4c02-a387-c30181bb402b": {"node_ids": ["0506cb3f-8d69-4359-9d66-e86d9cd6d5fa", "79c922a5-e561-472a-a0dc-e16552e12519"], "metadata": {"source": "SDTMIG v3.4", "page": 203, "section": "UNSPECIFIED"}}, "dbb9e7c4-c1eb-4046-907e-ce6f1edf0055": {"node_ids": ["1513af57-27a1-4f99-a2c2-a7689189ed86"], "metadata": {"source": "SDTMIG v3.4", "page": 204, "section": "UNSPECIFIED"}}, "9b4acfd2-7037-4b98-a3a4-16ba85722dc5": {"node_ids": ["94bd3fe8-abed-4389-a2f3-af084f8c9ea5", "09e2ee9f-9b50-4979-a2dd-81a7451facf2"], "metadata": {"source": "SDTMIG v3.4", "page": 205, "section": "UNSPECIFIED"}}, "85547109-727e-44e5-93d9-7e1caeab8f52": {"node_ids": ["af920663-3044-4bbb-be92-8e01fe9fc462", "befb18be-ce0c-4528-ba06-fc93610141b1"], "metadata": {"source": "SDTMIG v3.4", "page": 206, "section": "UNSPECIFIED"}}, "6326afcc-6ede-41f9-a5d8-182d84531875": {"node_ids": ["fee1393d-0186-4ba5-9ca6-3376cc6a51e8", "09195cb6-8e00-49b3-9511-128723cf91a5"], "metadata": {"source": "SDTMIG v3.4", "page": 207, "section": "UNSPECIFIED"}}, "14c36e9f-1905-4b0a-a759-fcc756229fbd": {"node_ids": ["fd523efc-07b6-4f1c-8ccf-75fa01c673dc", "9fbe7372-daeb-4d8d-bd5d-22d33019d238"], "metadata": {"source": "SDTMIG v3.4", "page": 208, "section": "UNSPECIFIED"}}, "bf990af5-6233-407a-8bd1-e22ec627665b": {"node_ids": ["2c465a4b-32aa-4a7e-af31-16869e33329d", "13968090-73e3-4933-8a15-156433863dbb"], "metadata": {"source": "SDTMIG v3.4", "page": 209, "section": "UNSPECIFIED"}}, "ead3175a-de46-47c5-9b0a-98b7426e92b4": {"node_ids": ["090d0783-b85e-4dce-9363-ac85dbc1fc7c"], "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "25.8 QUANTITATIVE NUMBER FRACTION"}}, "3ea7d4a4-4e08-4437-83ff-984656b7ab96": {"node_ids": ["cacb447d-e9b5-4cc1-96b4-67959be152b7"], "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "6.1 QUANTITATIVE NUMBER FRACTION"}}, "f2b00d9d-9d43-4e7c-b5dc-2936e1593e83": {"node_ids": ["14cb28e6-672b-4f8c-b9a6-9fa4d58ff27b"], "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "64.8 QUANTITATIVE NUMBER FRACTION"}}, "f8791b4e-8766-4301-b573-4a596d1579a8": {"node_ids": ["f993dcce-43df-4a99-835b-a8209911a77d"], "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "38.4 QUANTITATIVE NUMBER FRACTION"}}, "4c0aec2f-6acb-4932-a30a-4e742b6d8098": {"node_ids": ["b3c3e748-96a2-46b1-ba99-eca82b0ad438"], "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "61.6 QUANTITATIVE NUMBER FRACTION"}}, "81736daa-03d5-4dcd-880b-6e598a65dc2c": {"node_ids": ["688bb219-2321-47a5-b918-ea87a6886353"], "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "9.3 QUANTITATIVE NUMBER FRACTION"}}, "fd56c657-6f9d-4353-a79a-3f27c16a1b3e": {"node_ids": ["2e92d666-f28b-47cc-9d8a-a7a0ed582f72"], "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "0.62 0.62"}}, "be1835b3-5068-4017-99b4-6e3087ef228c": {"node_ids": ["3ea1a944-d30d-4ee0-bcba-56aaef7c5b4f", "b3b33dc6-10d7-4dfd-baed-72018c62235a", "04040956-e2ef-42d0-b2b4-eb0d5af6f47e"], "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}}, "ca37cb9f-d742-468d-83f7-b1d662174765": {"node_ids": ["6c52e001-c46d-4f65-a29d-23401d889f90", "45fef1dd-f6df-4a43-a22e-42328b2cea28", "9c2a26b2-b97e-4aaa-836c-237c4cac047b", "1cd39d53-341c-4d6d-bb04-fab514dbc75b"], "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}}, "58281e9d-3016-4bd6-8543-84b37d6738ef": {"node_ids": ["07e3284d-2036-41b7-8338-7eb47f917a8f"], "metadata": {"source": "SDTMIG v3.4", "page": 213, "section": "0.15 QUANTITATIVE"}}, "837aa0bb-62a7-4ef8-a435-de2d6175c693": {"node_ids": ["c8486019-afe5-44dc-8ef5-361c556e92bc"], "metadata": {"source": "SDTMIG v3.4", "page": 213, "section": "5.00 QUANTITATIVE"}}, "0066c18d-7575-4518-9778-f463c3fbc6f2": {"node_ids": ["46ff6b04-9796-455c-9378-3364f7887752"], "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "2.9 2.9"}}, "e6ae766b-6aa2-4374-8151-b9922797a28e": {"node_ids": ["e9ace022-2621-463d-a96b-fd6ca7b091da"], "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "2.6 2.6"}}, "c90690b7-074b-4193-80fa-1137ecdf2a65": {"node_ids": ["5e886250-4496-4ec8-af40-a70ebeddb4f2"], "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "3.5 3.5"}}, "47031e43-a8b6-491c-af45-7175b518a947": {"node_ids": ["c7197765-1277-4bed-843d-bf0c3a207c86"], "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "55.3 55.3"}}, "f294f5e3-9039-4b1e-84d0-ff0e3bced4e1": {"node_ids": ["c06a8182-120c-4d16-96c3-f31e870f3980"], "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "83.9 83.9"}}, "b3250294-a38e-475a-b6b8-38731a10396f": {"node_ids": ["7e433823-8165-4d4c-9cfd-8cf92c727d83", "1ae1289e-e6dc-4db8-96b8-78049850c1a3"], "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "50.2 50.2"}}, "c09fb578-7439-4068-9a3a-cdf1db2853dd": {"node_ids": ["5d3cee47-c328-4a04-89b7-f9575f45bbf1"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "6.70 6.70"}}, "2e0969a7-f48e-4621-b395-0a7e7d27f070": {"node_ids": ["97886079-ce98-424c-8a66-54f0a8c3f029"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "31.20 31.20"}}, "180835dc-f3d1-47df-b0c2-bbfa13e1dbe2": {"node_ids": ["8b1be2c8-7aab-4e4b-b8b3-832fd0804aea"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.76 2.76"}}, "146fff57-fa20-4071-b0c8-2589e0628b4e": {"node_ids": ["250ecdce-5663-437b-8843-cd2b20679529"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 DCPSDCP"}}, "ae61ca21-7832-493d-ac68-b05c6bd7cb89": {"node_ids": ["51ae1889-dd9f-4b28-9f95-9578f425e5a9"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 DCPS"}}, "534e30a4-9ae8-4b82-b022-0b7913584e96": {"node_ids": ["7d03f622-7d3f-45e8-aa20-c9e6579587fc"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 CD83X"}}, "07c0cb8c-da65-4fb5-80af-03dff48ac169": {"node_ids": ["8c58cc64-726d-4398-a1f2-7ae8968399e2"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 CD83X"}}, "af83969f-87d4-4922-be17-29d61bf5888a": {"node_ids": ["9c454712-be28-4210-8adb-f1cfb0597384"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 DCPSDCP"}}, "77119e37-7cfe-4444-b343-010a3fd45017": {"node_ids": ["848f8a01-46d9-4805-9aef-6235e648ca02"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 DCPS"}}, "6eb261d5-1394-4504-b06c-82fe149f968b": {"node_ids": ["ad029d46-7ad0-4d6e-a34c-78179ebb34a1"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 CD80X"}}, "6d9b7cce-8710-4be7-a9ad-8d17040bf954": {"node_ids": ["c0123d73-c672-47d0-bacf-66036e4b1271"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 CD80X"}}, "e748c262-8a76-4882-9ce8-75102957223e": {"node_ids": ["81cf5756-a1e6-4f44-bbdd-65bac704f2b0"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 DCPSDCP"}}, "224112b9-91e4-4d1e-921c-cdfba587d1f0": {"node_ids": ["e40dea1c-7d8f-4482-a850-28a6e65ce753"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 DCPS"}}, "2dfdbf72-4d71-479e-b4c7-95220a59601d": {"node_ids": ["8d5150fe-4b65-4a4f-98df-e20bc2d4fdbd"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 CD40X"}}, "e049ab43-5135-4e93-ab71-033f2c046407": {"node_ids": ["94297160-4f87-4ee8-9bc6-5ebbac51ea0e"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 CD40X"}}, "02ce231c-4951-4dcb-96d7-64e5f549634b": {"node_ids": ["b5bd3892-b4c8-42e6-80fa-e8332d00494f"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "5.25 5.25"}}, "a9072a7b-604f-482b-ae5b-afefdef942d7": {"node_ids": ["e3c4e192-24a3-4976-ae8f-e6cfcd89ef55"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 DCPSDCP"}}, "9437165b-4bd4-4b18-a8e1-7150372fdd84": {"node_ids": ["977ca7bc-f3ba-44a6-8044-49efc81573fd"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 DCPS"}}, "d906264a-5ec3-4226-ad62-592b5571dae2": {"node_ids": ["01d288d2-d5da-4d51-ae15-4c6f73282ea8"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 CD83X"}}, "ffa271c5-8bc3-4b61-a40a-091ee8682ee7": {"node_ids": ["29b520de-f59a-4f73-8ac7-419b5da3b476"], "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 CD83X"}}, "bd8c8b96-25b7-4cb2-8542-ca5d73805814": {"node_ids": ["e9f60308-fcc2-48ff-923b-a3e091cc91c4"], "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 DCPSDCP"}}, "5467a511-b4b2-425c-aa73-a7ce7d243d4e": {"node_ids": ["e342c38d-e596-4b53-8ba3-95138a53f5f2"], "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 DCPS"}}, "4166a2df-0187-4828-9e27-9d1f69ec66f9": {"node_ids": ["53d2416d-b154-4cb2-bb9c-aa6cc01230a1"], "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 CD80X"}}, "196447c9-6a7c-4687-bf71-c8f3a8667a2f": {"node_ids": ["b4211bb3-5fd9-48da-a674-8cecafa1f7d4"], "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 CD80X"}}, "62aef9fa-972f-4dc6-bd3b-58c57cd2c79b": {"node_ids": ["e2fc7f30-d87a-4866-b4af-4ea4a430b4a8"], "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 DCPSDC"}}, "5f782e5f-6270-4cff-b298-3f862f470c3d": {"node_ids": ["a67bc556-adf3-4343-899b-5bdd256b9000"], "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 DCPS"}}, "850b1b48-179e-4c13-a894-a04ef2a6cd89": {"node_ids": ["60f4e947-5ab7-4165-ac08-90b38e4b4d92"], "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}}, "05492b40-b08e-4709-8047-b5d30f6356fb": {"node_ids": ["b4572031-b2b0-458e-bd40-c6cfc4f83cce", "ab752029-64a7-4e81-a171-7e04f3c8f181"], "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}}, "0c249186-652f-4df9-9788-742cf249f6f2": {"node_ids": ["0ecf9c66-737b-48b8-b8ae-392a5d9424f3", "0f89079e-6026-42be-9196-92a6ca105e37", "3b2893dc-8d82-45be-be40-69ea4b2a3b4b"], "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}}, "16889032-d35e-4f4e-920b-2cf6e2a2d318": {"node_ids": ["6120b71a-0f1d-44d1-a333-e0fc89ae11c0"], "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "24.6 24.6"}}, "fc7c6253-26e6-4595-b74e-be84dcf3022d": {"node_ids": ["0d116391-5be9-4ab9-ab2c-297327d5e9f7"], "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "31.7 31.7"}}, "e70249ae-2bef-4b5e-ada3-80914942a563": {"node_ids": ["d64ba844-0496-465b-878f-c9aec4226937"], "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "28.15 28.15"}}, "d624c26f-78d7-4a76-8d3d-772059739a2f": {"node_ids": ["ac901eff-b5cc-4010-962f-41e32052059f"], "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "33.9 33.9"}}, "022dff2e-75e0-42b0-b889-c42da654ea8c": {"node_ids": ["afbb872d-adb3-471e-acaa-7e4e97758a2d"], "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "33.9 33.9"}}, "8509d6b2-a0ff-4c48-9ddf-bfbd29119087": {"node_ids": ["7116f30b-c980-424d-883d-2b42c4a0260a", "9985bb51-c74f-4295-85cd-aa83067572d6"], "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "137.1 137.1"}}, "b4906c56-ea0b-41b1-a86e-d2fa9ad64737": {"node_ids": ["c1a3f5b9-75da-48d8-81c7-c29a7793523a"], "metadata": {"source": "SDTMIG v3.4", "page": 220, "section": "6.3.5.4 Genomics Findings (GF)"}}, "5874d69f-e639-4389-bf95-a4fef0609af6": {"node_ids": ["abcbd0ff-e5f4-4ae3-a731-757328b12fd3", "8e1b5253-6995-4c33-be7a-407cda31a8bb"], "metadata": {"source": "SDTMIG v3.4", "page": 221, "section": "UNSPECIFIED"}}, "61a7f0d6-6450-4229-b840-dac0e48ebbc0": {"node_ids": ["df10fc44-108a-4209-a61e-75aebf12ce21", "f1f25a89-e345-4078-9849-7b9fd774c3b1"], "metadata": {"source": "SDTMIG v3.4", "page": 222, "section": "UNSPECIFIED"}}, "be0ed1b7-277b-4d61-83f0-3fc34c85cc2d": {"node_ids": ["84570f84-d7f2-4911-9623-38e391228e77", "d7dad901-7c6f-4925-b2a6-6905b4e835d0"], "metadata": {"source": "SDTMIG v3.4", "page": 223, "section": "UNSPECIFIED"}}, "66ac7d25-2069-48c3-a014-70d939bb643f": {"node_ids": ["06394022-8d9b-460f-8d12-b8c7c87f9953", "0467941c-4c18-4949-9767-1a57bc193a52"], "metadata": {"source": "SDTMIG v3.4", "page": 224, "section": "UNSPECIFIED"}}, "1f663f28-5b73-466e-b9ac-78da5972a78e": {"node_ids": ["4642d456-7afb-402b-b66c-1aadaa703c04", "79eecf99-558e-46ea-a542-bb15eea2fe50"], "metadata": {"source": "SDTMIG v3.4", "page": 225, "section": "0.63 SOMATIC"}}, "ca835ce7-c718-41ec-b221-7068087f69ed": {"node_ids": ["6f5f745b-bdae-4841-a53c-3dbf06020fcb"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.5679 0.5679"}}, "3487f585-7221-4adc-a6f0-2ca981300209": {"node_ids": ["9b05d3c8-5293-4c3e-9e33-fd2356dcc275"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.0523 1.0523"}}, "b1816f85-d6ac-44b8-8397-25bc70fecb34": {"node_ids": ["9e7a655f-786f-4c19-8f05-680d45397cc7"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.9935 1.9935"}}, "4abf18cd-6ca2-4431-99c4-1270dd3c14d3": {"node_ids": ["b91e12ad-1ef9-4e54-935a-c4bd5d5413e6"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.37 0.37"}}, "cadeaa97-1ed5-4985-abfa-b50a7617b044": {"node_ids": ["63006cf3-3c31-4755-a6e3-e8b0e225ffe6"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "148.6268 148.6268"}}, "ab659f33-9ad3-4346-99d9-db60a47fb277": {"node_ids": ["53e7254c-3345-4562-b205-578a6f5f1b40"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "691.5607 691.5607"}}, "1efd0ef9-1b4d-4f22-a896-9332bbb96506": {"node_ids": ["e6f484ee-08d1-4d2c-acf5-de024571696a"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "521.716 521.716"}}, "077a5dff-766e-47b1-bd89-2430a61d24bd": {"node_ids": ["7d452641-94d6-4033-a67f-21279355620e"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.99 0.99"}}, "1231a601-c0f1-426c-944b-bb0bbdf60aa7": {"node_ids": ["cc6ff32d-04f0-4f00-826a-3df174e4635c"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.046787999 GRCh38.p12"}}, "bf43e2df-4b45-4fb2-b73b-8031ffbab3ab": {"node_ids": ["c706cdd7-8333-4f43-862d-ee5631692759"], "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.126819661 GRCh38.p12"}}, "851d4b83-5891-417e-ba47-e567b286a375": {"node_ids": ["32d401cc-58e3-4429-96f5-3d48c95cab8b", "2ba98f45-63dc-429f-928c-40f4fbb37c1c", "804e74dc-6476-4ca6-9054-3fc86a9030f7"], "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}}, "ca98da3d-9123-4b95-9201-7d2a57a73ead": {"node_ids": ["f812c74c-2457-44b4-8731-1f8c33406026", "d2ff1071-3f4f-4513-bb40-9233b1860c55"], "metadata": {"source": "SDTMIG v3.4", "page": 229, "section": "UNSPECIFIED"}}, "d195a567-24fd-49cd-8066-59fd78454ca1": {"node_ids": ["ad2325e9-4a7a-47e2-8369-8aa8795ab031", "39c8be5f-4427-4c03-bcd7-7364e47575f7"], "metadata": {"source": "SDTMIG v3.4", "page": 230, "section": "UNSPECIFIED"}}, "d4243e59-b8ef-4df9-91a7-57642d7b152c": {"node_ids": ["54da89d2-b94e-41a8-aa2e-1c641c49bce0", "a78c8a1a-95ad-4f3e-a65a-3f864cb4e4cf"], "metadata": {"source": "SDTMIG v3.4", "page": 231, "section": "UNSPECIFIED"}}, "f67acc2f-221d-412b-a722-bfff43ee31bb": {"node_ids": ["da231f08-1936-4fbf-b3e1-64569b16f8fb", "4adce80a-a47d-4983-90e8-2a1b35ec6d54"], "metadata": {"source": "SDTMIG v3.4", "page": 232, "section": "UNSPECIFIED"}}, "8216ea82-d3d6-4717-8668-230c8071509f": {"node_ids": ["45774988-1d0d-47f5-bc9b-a1c45e5a6e6d", "135242e9-46a0-4f29-b834-5d74b00b7636", "195ba108-a512-40c9-99e6-6cf3e87a961e"], "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}}, "d3a898da-94ed-477a-9931-9f6ae930ae49": {"node_ids": ["1f8254d4-923a-4c7a-866d-88999c9f7420", "4e61d6d3-0f30-452b-bbb6-1b3165f1bb86", "9cb4c9aa-f83e-43fe-8e1e-eef03cc2a67c"], "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}}, "d5d9cd94-11b8-48dc-b20f-1d4c6f697296": {"node_ids": ["b7c66650-7b80-41f6-ad3f-c6db15a88001"], "metadata": {"source": "SDTMIG v3.4", "page": 235, "section": "4.7 4.7"}}, "9831a442-860c-4d42-80be-452420dc3575": {"node_ids": ["442c0c49-243c-4a73-9c61-fd52500f93b6", "02e26e92-73c6-4a04-90e9-263f242bc9ae", "7e1547c1-d0f8-4d8f-851e-29b29e647a59"], "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}}, "58b7659b-9e72-4c6f-843c-25065d34c049": {"node_ids": ["2a0788ae-6724-4469-9868-884a786f154a", "3a63c0f7-6f7a-45ea-96f4-029231a56b2d", "e2a691cb-b4ae-46a4-99c9-c50f3d00f1ad"], "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}}, "790264fe-15dc-49c1-b185-a73e0edef92b": {"node_ids": ["f36e9340-6c9c-4742-ba99-6c55e651fc6d"], "metadata": {"source": "SDTMIG v3.4", "page": 238, "section": "260.5 260.5"}}, "48803f8a-3b97-49e6-aa8b-1f1907feba63": {"node_ids": ["5b3d7a70-146e-4187-8f8a-f8824991eaef", "d9213185-ce37-447c-8679-45fe54b3d241", "105a7552-d0c0-477c-abd0-03ada12281c9"], "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}}, "e781dc12-4ead-4dd3-b4e1-6dbcc6907fb4": {"node_ids": ["51eb65f3-3e06-4007-9483-1e04262dbae2", "057841b4-df78-48e8-9b29-42f9653c31e3", "da51da45-0658-4df5-ae3b-85a72224de9c"], "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}}, "28f3484e-dcd8-4148-95ba-6fe7b0b89284": {"node_ids": ["5e9991bf-653b-4f69-9044-9b4fa42fe50b"], "metadata": {"source": "SDTMIG v3.4", "page": 241, "section": "0.19 0.19"}}, "f91cd471-cce3-4f26-9e0f-7d656e596eba": {"node_ids": ["412031a4-2043-4843-95a2-6cd6d8c5dfc8", "1fa7ce8c-2a1c-48ef-9515-07f0d3f5a39b"], "metadata": {"source": "SDTMIG v3.4", "page": 242, "section": "UNSPECIFIED"}}, "12d91bc8-e76d-4b96-8f38-9ce5fc8d8bae": {"node_ids": ["56a6c8ac-ec85-4f83-b1b5-83e568d1a357", "9e8c5977-e749-490d-92fc-0eabbcb9bc55"], "metadata": {"source": "SDTMIG v3.4", "page": 243, "section": "UNSPECIFIED"}}, "adfdc12e-a7af-45c4-a37b-8271000964fd": {"node_ids": ["be956667-0536-46da-a359-62a1e2601052", "1bf1751f-8a11-48d5-a550-e91d14ce784c"], "metadata": {"source": "SDTMIG v3.4", "page": 244, "section": "UNSPECIFIED"}}, "39fe5a42-e5de-4532-8b89-3f6abcbdeee7": {"node_ids": ["43a77424-4b39-415b-b880-e7fae77ac002", "c80bf8b8-90b6-4aae-8ff7-31afcb553107"], "metadata": {"source": "SDTMIG v3.4", "page": 245, "section": "UNSPECIFIED"}}, "e27c9ab3-6745-4bce-9b2c-9d247a6f7946": {"node_ids": ["2e5c7582-ad80-440c-bde2-0e594d8abca1", "3ce2dc4d-9dcb-4830-9e8c-096904af2e18"], "metadata": {"source": "SDTMIG v3.4", "page": 246, "section": "UNSPECIFIED"}}, "11d35be0-dbf0-44cb-acdb-2fac43d7f241": {"node_ids": ["11d4d2dd-67e1-4464-9053-928b032b8d48"], "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "3.5 5"}}, "0fc9370b-c299-4d51-b02b-a3a2b70cdc57": {"node_ids": ["953bf429-a1a4-462f-82f7-6a4d3ec3c340"], "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "0.5 10"}}, "dcbb194b-4b50-49f2-ae3b-35593ab90181": {"node_ids": ["c38b4c8d-2fdf-48b0-b36a-7b62ea33323b"], "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "2.5 35741-8"}}, "ccc85c77-be47-4234-bdb5-df0f9354a378": {"node_ids": ["ce5e8db4-d114-4390-bdc1-0c9b44b53052"], "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "9.00 5803-2"}}, "ac0c2c7c-01f2-4eca-8bac-e54409c8cd37": {"node_ids": ["f885a386-184a-4266-b6d3-2993a9eebeae"], "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "5.9 5.9"}}, "50825653-8065-4fb1-8fba-8c86bb9b61ac": {"node_ids": ["7a9f0c15-a946-4d9e-8836-b3a524a216d6"], "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "0.1 0.8"}}, "e8313524-2bcb-4dfd-a7f3-6b64929ab14f": {"node_ids": ["46aee766-74a1-43e3-b569-2761f005ece4"], "metadata": {"source": "SDTMIG v3.4", "page": 248, "section": "6.3.5.7 Microbiology Domains"}}, "636371f3-6b59-4f02-bc2c-d38f7c790d57": {"node_ids": ["f4f3d963-746f-4879-96d6-9b7ea597a1b3", "875add49-3f01-4b30-bafc-9517c1656aac"], "metadata": {"source": "SDTMIG v3.4", "page": 249, "section": "UNSPECIFIED"}}, "6a261c19-7abd-4440-bb8f-b73c547b338d": {"node_ids": ["9e1c5743-a9cd-453b-83df-20b28f8b2603", "3c9d8868-e327-4616-bb97-78742fa949bd"], "metadata": {"source": "SDTMIG v3.4", "page": 250, "section": "UNSPECIFIED"}}, "fdf1f935-4173-4cea-bb38-dd8972d6f371": {"node_ids": ["2a725a3e-a6e5-41b6-b7d1-1c2521603bdb", "44fd2725-7b55-4de5-b096-1835ec9c161a"], "metadata": {"source": "SDTMIG v3.4", "page": 251, "section": "UNSPECIFIED"}}, "6cc15f68-cf3c-4a52-abf2-c1223ad10617": {"node_ids": ["d59522b9-9d21-49a5-9b10-1127e4d023ba"], "metadata": {"source": "SDTMIG v3.4", "page": 252, "section": "6.3.5.7.2 Microbiology Susceptibility (MS)"}}, "0049559a-77f4-4cb5-ade2-75fd5413b5dd": {"node_ids": ["30707f22-7d50-4e27-82d9-76f693be17a5", "49eb4586-ba1c-4edb-b977-a48a88fb2e6f"], "metadata": {"source": "SDTMIG v3.4", "page": 253, "section": "UNSPECIFIED"}}, "6ad2f737-7d46-4997-81ca-bf3e9bad9ca5": {"node_ids": ["5def7a88-70f4-46eb-98bb-bdeb3e1a5464", "dc65e377-520e-407c-99fa-1113cbebc0c7"], "metadata": {"source": "SDTMIG v3.4", "page": 254, "section": "UNSPECIFIED"}}, "aca046ca-5a30-4c57-8305-7be3a2365069": {"node_ids": ["371f0627-7ff8-4fe8-9a59-bb4f974a2ef9", "d5268f87-4dcd-4409-a097-aed5ccaa8e63"], "metadata": {"source": "SDTMIG v3.4", "page": 255, "section": "UNSPECIFIED"}}, "897b6679-3267-4bc9-8b80-a2cfe236d67d": {"node_ids": ["f60f66c1-691f-467d-bb33-eca818c58492"], "metadata": {"source": "SDTMIG v3.4", "page": 256, "section": "6.3.5.7.3 Microbiology Specimen/Microbiology Susceptibility Examples"}}, "dd5d13cd-55a3-4381-938a-a6446337c7f9": {"node_ids": ["dbc89dc6-3a79-418b-8104-1ec494f75c7c"], "metadata": {"source": "SDTMIG v3.4", "page": 257, "section": "0.25 0.25"}}, "a18f6a85-0883-4e33-976f-179135859ada": {"node_ids": ["6fbbacb2-6db6-43f1-8617-c222e274ccce"], "metadata": {"source": "SDTMIG v3.4", "page": 257, "section": "0.5 ug/dL"}}, "0573f79f-96c2-429e-81b2-18333869bb9f": {"node_ids": ["e78ec48c-a453-47b1-a6e9-758840dfe22b", "5ddf69a5-21f9-454d-9928-a179ce5517fc"], "metadata": {"source": "SDTMIG v3.4", "page": 258, "section": "UNSPECIFIED"}}, "c679ec3a-77fa-43c5-809c-7139dbad247a": {"node_ids": ["76515d7e-e3ee-4544-8302-a662a1207651"], "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.004 0.004"}}, "bd9ea46f-f4df-469e-930e-22dc8921e85e": {"node_ids": ["78ee7abd-2a39-4586-9332-5ecf12c55283"], "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.023 0.023"}}, "d9621b70-0205-4af1-ab94-9552f5581fd1": {"node_ids": ["d6354800-d9f7-4c0e-ba99-df33b6554ac4"], "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.125 0.125"}}, "87d2a4c7-ed99-47de-ba57-407d010dc2a6": {"node_ids": ["276e0850-e483-4b5f-b009-3e1ef9da40a2"], "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.023 0.023"}}, "dee0496d-78fe-41f8-b5c8-53cdeb488bcd": {"node_ids": ["b5bfb05a-d7b9-4cf8-a255-422299284d98"], "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.026 0.026"}}, "46101aaa-5584-4139-8b93-58e3b270c390": {"node_ids": ["51765ee9-6dc6-4ecf-a6e6-808e1e0ffaff"], "metadata": {"source": "SDTMIG v3.4", "page": 260, "section": "100.1 Concentrating"}}, "e91d9423-0028-4f02-9b8f-1f666879d1e6": {"node_ids": ["c2c5a3ba-e4b3-4ef2-acca-9af108e54224"], "metadata": {"source": "SDTMIG v3.4", "page": 260, "section": "100.5 BESPEC"}}, "02e02b10-65f8-41d5-a179-6ff25bdbd003": {"node_ids": ["9717d46b-ddd4-475a-ae3f-725dc541023b"], "metadata": {"source": "SDTMIG v3.4", "page": 261, "section": "100.5 LAVAGE FLUID"}}, "170ff836-ac26-4ab8-bef4-54faf54bb6b9": {"node_ids": ["4a99ab5a-2450-4414-ba97-6cfb9b6dc36f"], "metadata": {"source": "SDTMIG v3.4", "page": 262, "section": "100.3 MTB"}}, "a5c68f11-2106-4e30-9aed-c0f175a9d6cc": {"node_ids": ["8193f68f-a56d-4b62-8f0b-6c9ce055fd43"], "metadata": {"source": "SDTMIG v3.4", "page": 262, "section": "100.3 MBMEDTYP"}}, "9789d345-c228-47fd-89f0-436c7d1d7b84": {"node_ids": ["4c20b2e5-1c8d-451c-8dad-3b721e2b3bcf", "384a48aa-760a-4457-ad4c-cdc4e3b964fa"], "metadata": {"source": "SDTMIG v3.4", "page": 264, "section": "UNSPECIFIED"}}, "ce7278ea-66eb-429f-bd20-12b04f6d67a2": {"node_ids": ["e1a6c14c-efae-4f8f-bedc-dd6fe5dc56e7", "dfb48ec1-0270-4e03-8e6e-c67158e3b436"], "metadata": {"source": "SDTMIG v3.4", "page": 265, "section": "UNSPECIFIED"}}, "ca53e90c-8285-49b8-af6a-69794cc8bd68": {"node_ids": ["503c243f-c32d-42a5-9053-2ca44d5f0757", "268804e8-5ddc-4ce7-930b-cfef8b9b6c19"], "metadata": {"source": "SDTMIG v3.4", "page": 266, "section": "UNSPECIFIED"}}, "28e1917d-e8cf-4e89-b8ba-89dabead36d4": {"node_ids": ["ce6b4a27-a50d-4eea-b16a-de22875cf63a"], "metadata": {"source": "SDTMIG v3.4", "page": 267, "section": "6.3.5.9.1 Pharmacokinetics Concentrations (PC)"}}, "3be146d2-bbc0-4967-b795-d7e16b067861": {"node_ids": ["9818001e-53a7-4cb2-b62c-d517db3ead0f", "5419bc1e-89bb-4ccb-aa45-9992cabb40db"], "metadata": {"source": "SDTMIG v3.4", "page": 268, "section": "UNSPECIFIED"}}, "95595593-3501-4404-890f-4bc88a6e1e20": {"node_ids": ["9d810208-af30-4af2-8afe-5560e676e50e", "70c13757-8248-420f-886f-11e58efd908f"], "metadata": {"source": "SDTMIG v3.4", "page": 269, "section": "UNSPECIFIED"}}, "1a79c130-3f9c-41a6-8220-c19b4bb4523f": {"node_ids": ["4a8d67fa-3b75-4a2c-98de-ee579e5fb529"], "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "2.00 500"}}, "083a40d5-71b6-4cd8-bc44-ce0842bf5834": {"node_ids": ["c989a9b8-ee07-4ebb-af25-42ecc401e2b8"], "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "0.10 20"}}, "234c0449-cb1f-4345-a903-23d62d94ac12": {"node_ids": ["0ded33eb-c6ac-4914-9862-4271e8248f7b"], "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "2.00 500"}}, "d586f953-027c-4f70-b7db-04fa13a546e6": {"node_ids": ["973e8382-100c-4eeb-ae25-175179d0d53e"], "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "2.00 3"}}, "2f6a0a0f-780a-4d3a-9730-17f9a41200dc": {"node_ids": ["953d3004-36a3-48ae-ae62-909320142837"], "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "2.00 4"}}, "4b4c7c41-d269-4c5f-9185-c669441d1062": {"node_ids": ["0aac08e7-2a90-4143-a110-e688ca5507c4"], "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "6.3.5.9.2 Pharmacokinetics Parameters (PP)"}}, "d8a59c8d-d77a-43d6-8976-a856459fe07f": {"node_ids": ["a2acad43-6e57-4fa6-9edb-3420c2c8bd6b", "337b1d01-ff37-44fa-af98-0837610be230"], "metadata": {"source": "SDTMIG v3.4", "page": 272, "section": "UNSPECIFIED"}}, "921c0272-ed93-4218-be54-f138a10a87a7": {"node_ids": ["e81e507e-85fa-42e8-968d-6c4bfd4515d4"], "metadata": {"source": "SDTMIG v3.4", "page": 273, "section": "0.88 0.88"}}, "0f428bfc-1b65-4406-b095-1c5e398960f8": {"node_ids": ["e032ab53-d058-4e0e-9864-d63b3f7a0ef5"], "metadata": {"source": "SDTMIG v3.4", "page": 274, "section": "0.52 PLASMA"}}, "2c77557f-3e0d-4767-96c3-a468a290760a": {"node_ids": ["f664593d-6d52-427f-bd53-dd5239b51b9b"], "metadata": {"source": "SDTMIG v3.4", "page": 275, "section": "7.6 7.6"}}, "dc734550-480b-4437-9e9e-e54439352817": {"node_ids": ["9a4f4c38-d7d5-4357-b345-3bd86b028ede"], "metadata": {"source": "SDTMIG v3.4", "page": 275, "section": "6.3.5.9.3 Relating PP Records to PC Records"}}, "425fcd81-d7b1-4a13-8c46-55adbcff2ef4": {"node_ids": ["24320d04-1ca4-4836-a3d7-4b7a7fddfea0"], "metadata": {"source": "SDTMIG v3.4", "page": 277, "section": "1.75 1.75"}}, "06f20a7e-c8a6-45f6-8a96-203d3351d2dd": {"node_ids": ["16ef36b5-dc18-4454-b2bc-4905b9734137", "f8f76594-5328-4748-abb9-2ebe4b1cf54e"], "metadata": {"source": "SDTMIG v3.4", "page": 278, "section": "UNSPECIFIED"}}, "ee554bda-b280-4f5b-9605-5a77ffd9974d": {"node_ids": ["5dd01787-b77b-4618-bfbc-62c09b58f0fc", "e8508ffe-1c27-405e-b8fa-f5fe011a22e0", "8aa08596-f931-4aaa-af2c-4b601b059cc6"], "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}}, "cf4951a1-0e6b-4185-a9b3-fc404b11c0b9": {"node_ids": ["f1f5b8cd-1688-4469-a1f1-78cf34769262", "532229ed-8f7a-4924-89c0-88d550ac2fd3", "db8b5414-98f3-4012-9570-7f57ad341147"], "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}}, "85d3aaa6-8ba8-4b91-a142-c0a109aab745": {"node_ids": ["3f1f9f55-208b-4739-b28a-1c4c4a2519e8", "ebdd22d4-a168-45c2-bae5-dc391c1162cd", "45e3ad74-1721-4dcb-bae8-375346dc94ca"], "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}}, "5c0ca706-f1dc-42be-9d9c-2a187148fc6b": {"node_ids": ["0c377f69-3f04-43ad-b957-64039950e275", "2d1974d7-2d48-43a8-b237-4e9b8a3d8b02", "89fa5270-86c0-446c-9662-e4e72cebfb23"], "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}}, "be661258-2bd1-4019-924d-e6aa631ca982": {"node_ids": ["e794825a-14c1-4370-a8ce-d343562e291b", "ba032d5e-ea91-4003-b58d-82a9ea458f3a", "1e2d60e0-f9f5-49ce-a2aa-f2c835b8d856"], "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}}, "a94a0c06-768e-4cc0-b542-049c964b11de": {"node_ids": ["bec9114c-e55a-471d-895f-0570c41c0530", "57c59627-8c09-4516-b8f7-ed8aa7774754"], "metadata": {"source": "SDTMIG v3.4", "page": 284, "section": "UNSPECIFIED"}}, "c646f8de-d8d0-4033-86a6-d6d74a7f23fc": {"node_ids": ["93629bd7-c736-4584-8555-bda2753252c4"], "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.6 Morphology (MO)"}}, "775b54ea-5567-41ab-974f-aa3335796041": {"node_ids": ["bd1d9d39-7e41-4340-9a93-ce26a9de28a9"], "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.7 Morphology/Physiology Domains"}}, "b1a09b81-e97c-46b4-8219-f169d8249b38": {"node_ids": ["cca2a079-785f-45ff-bb74-b74c333efbb1"], "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.7.1 Generic Morphology/Physiology Specification"}}, "f7d882b9-6173-4ff9-918f-ec406ccea0d8": {"node_ids": ["fd7ab557-298a-48dc-aebb-c597bf26a0b4"], "metadata": {"source": "SDTMIG v3.4", "page": 286, "section": "6.3.7.2 Cardiovascular System Findings (CV)"}}, "f77565f6-0359-48ef-8bbe-d9f6f96fe6db": {"node_ids": ["ce5e05b2-26e0-4c79-8f8e-2b7e7e6bd9e8", "f585792c-aa98-46af-b366-35039065f8b6"], "metadata": {"source": "SDTMIG v3.4", "page": 287, "section": "UNSPECIFIED"}}, "bc72bd0b-9340-4c36-87bb-261b67d94989": {"node_ids": ["aae9153a-0f0e-4c38-a0a6-ec44b45a5791", "1a164456-4c34-476d-a7d8-a7f15912b8a8"], "metadata": {"source": "SDTMIG v3.4", "page": 288, "section": "UNSPECIFIED"}}, "f59e0007-e6ff-4c11-bb25-772c0b47af9d": {"node_ids": ["eb30cb3c-0f99-4135-aa6c-76502b100aaf", "e3934546-344c-446b-b9da-8537f1aa5a20"], "metadata": {"source": "SDTMIG v3.4", "page": 290, "section": "6.3.7.3 Musculoskeletal System Findings (MK)"}}, "1922f186-6e73-444b-ae8b-b28f5184331d": {"node_ids": ["8ba0e1d2-11de-493c-9ede-5c3aacf03bad", "69526e9a-3e4e-4cc4-baed-bef3a4256456"], "metadata": {"source": "SDTMIG v3.4", "page": 291, "section": "UNSPECIFIED"}}, "3b275cf1-f139-4263-b401-b501bc83c8c9": {"node_ids": ["7438f099-b8fd-459b-8369-960745b0bda3"], "metadata": {"source": "SDTMIG v3.4", "page": 292, "section": "UNSPECIFIED"}}, "d643ac5d-35fa-4dc3-8379-8057711c0d76": {"node_ids": ["4d138c82-1ee1-49fd-a5fc-9630e2e913d6"], "metadata": {"source": "SDTMIG v3.4", "page": 293, "section": "2.5 2.5"}}, "7df68562-d35c-4110-bf60-f512b3b0788f": {"node_ids": ["303e9f88-cc85-4163-b631-061c39aec275"], "metadata": {"source": "SDTMIG v3.4", "page": 293, "section": "3.5 3.5"}}, "a9244289-13e7-4001-9d8e-49f53f49aa67": {"node_ids": ["f16982fc-9f21-49d8-b2c9-eb81827bb2a5"], "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "3.5 3.5"}}, "5cb54a7a-39c1-4b53-aa40-a74732532525": {"node_ids": ["e1839a7d-73a0-4ef8-8017-a53fdc07440f"], "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "1.5 1.5"}}, "ed8e5b08-2cc9-4e9c-a2f4-f017c3fe58a0": {"node_ids": ["0394dbe8-35f8-4f1d-af79-06efd16cf817"], "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "6.3.7.4 Nervous System Findings (NV)"}}, "421693c2-4526-4469-9ce0-1bd0d1176943": {"node_ids": ["5870bf2a-6b64-4dd1-ab71-bb9308cfa90b", "75558ccd-1573-41d2-98bf-ae637fa314f2", "84ddd6ae-4053-4ccf-b3d9-2d0e12c15f04"], "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}}, "3405c67c-ee88-4fa7-849b-45f62ca0315a": {"node_ids": ["b6862bf2-ef1a-4a0e-8d06-ac4a856b99c0", "35847642-fa18-4abe-af7f-7478c1f24251"], "metadata": {"source": "SDTMIG v3.4", "page": 297, "section": "UNSPECIFIED"}}, "8401c088-705b-4463-a213-997ac3b63c28": {"node_ids": ["25c58ab6-cc63-4595-ae07-50555e419a35"], "metadata": {"source": "SDTMIG v3.4", "page": 298, "section": "4.78 12.7"}}, "ee3931b9-632a-4556-bd68-a29e3ae2e9e2": {"node_ids": ["c37f575b-2241-4815-9fc3-c1ec0c5acfb4", "90bde5d9-3dd5-43f3-83c7-e71069131683"], "metadata": {"source": "SDTMIG v3.4", "page": 299, "section": "UNSPECIFIED"}}, "216d3c89-5566-411e-8eb9-a8273ea2d283": {"node_ids": ["0c5f4a06-cef0-4111-9885-72a470fb2d79", "ac191482-0594-4173-9109-c66c8a9bf415"], "metadata": {"source": "SDTMIG v3.4", "page": 300, "section": "UNSPECIFIED"}}, "602a71b8-6c70-474f-8805-eb620c229423": {"node_ids": ["a858f1e9-fea2-40d3-a952-00d9b641652f", "64504566-f6a0-4519-a9d3-b96adaec0cb9"], "metadata": {"source": "SDTMIG v3.4", "page": 301, "section": "UNSPECIFIED"}}, "aeeb624e-c3f3-46be-b9a3-10f9fafdaf83": {"node_ids": ["e0361bc8-4e92-4f33-b0c3-c3bd1043c979", "f7fe8066-d1f9-49cc-a9ce-0cbc69033f50", "c101b0d9-6ce8-4760-a84a-ebef44df93bd"], "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}}, "91cf89d6-d60a-438f-a2b9-023262f98c9e": {"node_ids": ["51a7accb-6c81-4040-be97-fea4f665f7d9", "357cf8a8-0cc0-49e7-a17e-409c3ce68566"], "metadata": {"source": "SDTMIG v3.4", "page": 304, "section": "UNSPECIFIED"}}, "45aac0c9-d716-4bf6-af63-3fe2b4cf06a6": {"node_ids": ["9de29564-4579-435d-9a09-732af1bb9893"], "metadata": {"source": "SDTMIG v3.4", "page": 305, "section": "6.3.7.6 Reproductive System Findings (RP)"}}, "22eeda53-78cf-40e6-9842-f83dbb45844a": {"node_ids": ["a0ec3121-e7b1-4c2d-b9d5-983f1df408b0", "8356ec45-c682-4996-891d-e1b9a31b540d", "06ef60cf-20c3-4ca7-a75d-06ac78da4745"], "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}}, "63a1f3d8-06dd-47e0-8495-d78b5fdac9f6": {"node_ids": ["7220941e-0382-4e8c-8938-485ad7978eb3", "9f0e78b0-799b-4bc2-8790-c632a2b4ae9f", "f1dba7a8-fa8a-4b5d-8395-9282ae261196"], "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}}, "2cd1ebdf-75e7-4223-a4c1-b7491664d6d3": {"node_ids": ["58b7167d-0417-4c51-8c66-1b36861d1433", "5ad6fdb7-963b-4986-b0c6-278ca588c119"], "metadata": {"source": "SDTMIG v3.4", "page": 308, "section": "6.3.7.7 Respiratory System Findings (RE)"}}, "d11daa53-8c99-49eb-abe5-4483b02ac317": {"node_ids": ["cbf253ae-4450-4861-b04a-f956ade37b42", "201215ff-7581-4f28-8155-0274381b9ed8"], "metadata": {"source": "SDTMIG v3.4", "page": 309, "section": "UNSPECIFIED"}}, "57965d55-c1ad-4d7f-90a1-a3791a2a78c0": {"node_ids": ["6685157d-afd1-42da-8aeb-32e2b41c74c2", "bcdf0afa-b938-44ad-8cb3-ba4b1b5fbfed"], "metadata": {"source": "SDTMIG v3.4", "page": 310, "section": "UNSPECIFIED"}}, "31df4760-baa6-4df8-b6a3-ad6e87d4178d": {"node_ids": ["5c6097f1-60c2-41b0-8707-603bb4af8a8a"], "metadata": {"source": "SDTMIG v3.4", "page": 311, "section": "7.33 4"}}, "6b582910-a64c-418a-a7c9-bc493f745ad5": {"node_ids": ["6b8f641e-f7cc-4ccb-89da-b58b94963d60"], "metadata": {"source": "SDTMIG v3.4", "page": 311, "section": "1.57 L"}}, "d93a2112-147a-4f5d-8fdf-5af9cd17b893": {"node_ids": ["a50d4f16-6e5d-4dd6-b32f-22ee22cd58cc"], "metadata": {"source": "SDTMIG v3.4", "page": 312, "section": "6.3.7.8 Urinary System Findings (UR)"}}, "f5ea06cc-02bd-4020-a102-5e446b0b6966": {"node_ids": ["1a9202a2-1801-4cce-9b33-ff97502bee53", "7ffe8459-978b-41bc-ae67-0e612bbbc966"], "metadata": {"source": "SDTMIG v3.4", "page": 313, "section": "UNSPECIFIED"}}, "6a1fe64d-f4a9-4062-863f-37cf1a17576a": {"node_ids": ["46f15ac8-a103-4000-a730-aa518e327da8", "e8298082-52c3-437b-9dea-b4002529c28d"], "metadata": {"source": "SDTMIG v3.4", "page": 314, "section": "UNSPECIFIED"}}, "d38ee834-7582-4bf7-84ec-a68555bd2bc2": {"node_ids": ["f15204e8-67de-4de4-a3a1-c7c410b7d484"], "metadata": {"source": "SDTMIG v3.4", "page": 315, "section": "12.6 cm"}}, "ceb135aa-8c1b-4cff-ba92-5561e4591ed8": {"node_ids": ["c704a46c-c5d4-4a95-bb64-ce171ed9f1a6"], "metadata": {"source": "SDTMIG v3.4", "page": 315, "section": "6.3.8 Physical Examination (PE)"}}, "733581aa-97e5-431c-9e31-485d6245edbd": {"node_ids": ["1af2ca28-450c-489c-b8de-93e20b9b6985", "d21ace7d-02bd-47c4-9773-9ccb39443137"], "metadata": {"source": "SDTMIG v3.4", "page": 316, "section": "UNSPECIFIED"}}, "0b1318a3-f7b1-4622-9b3d-2e42f66e5d8d": {"node_ids": ["32e34bdf-ca80-40df-a185-fcd682ff3449", "e8699fb6-d147-4c39-a9e1-cbb6691beb64"], "metadata": {"source": "SDTMIG v3.4", "page": 317, "section": "UNSPECIFIED"}}, "4c2b9b37-0d6a-4241-99fd-d6c85afaa8c4": {"node_ids": ["16c7fd2e-7386-4a4a-86f9-8f22504dadbe"], "metadata": {"source": "SDTMIG v3.4", "page": 318, "section": "6.3.9 Questionnaires, Ratings, and Scales (QRS) Domains (FT, QS, RS)"}}, "ae0db44a-ba09-4b74-b4e2-566d71094900": {"node_ids": ["5a855c2b-dc5f-46d1-9a69-8f11427ac120", "394abb19-2ff6-4a77-86c2-197c707570ed"], "metadata": {"source": "SDTMIG v3.4", "page": 319, "section": "6.3.9.1 Functional Tests (FT)"}}, "16372890-a5f1-4c5e-8b81-8134278494a1": {"node_ids": ["63bd4f1e-4881-4252-a923-33877ce14f91", "127225ef-a33d-4812-a0d7-3ccf9d0fe1f2"], "metadata": {"source": "SDTMIG v3.4", "page": 320, "section": "UNSPECIFIED"}}, "0ae89faf-3ec0-40cd-a36e-2ff6a194988a": {"node_ids": ["593161fd-cc36-4d60-8076-43a77e720a5b"], "metadata": {"source": "SDTMIG v3.4", "page": 321, "section": "UNSPECIFIED"}}, "26a2de5a-37ca-4993-be72-f3451e471d09": {"node_ids": ["7fa7c3c0-428a-45b1-aae5-7845e63fa64f", "371f9c81-42a1-467b-873e-5f1c973a4e23"], "metadata": {"source": "SDTMIG v3.4", "page": 322, "section": "UNSPECIFIED"}}, "1bbbc91e-59c6-4d9a-86ee-93fb7ffac84b": {"node_ids": ["c2b85f8c-8a07-483b-b508-3281943203d2", "c45cf6a7-82f5-41ea-9da2-fb8bc4eed9d5"], "metadata": {"source": "SDTMIG v3.4", "page": 323, "section": "UNSPECIFIED"}}, "2bac64ee-5976-45ec-b2e0-7819b43e2d68": {"node_ids": ["7fb996dd-3fe5-4e1a-b691-31100987adfd", "a93ea63e-1a7c-4f2d-a32e-1bde74c958da"], "metadata": {"source": "SDTMIG v3.4", "page": 324, "section": "6.3.9.2 Questionnaires (QS)"}}, "45f14817-c099-4e06-935e-244fb3622c55": {"node_ids": ["994440a2-f7c5-4ee0-a524-be2174b43d25", "ffd41f7c-1b9f-403c-83df-97b902e4db8b"], "metadata": {"source": "SDTMIG v3.4", "page": 325, "section": "UNSPECIFIED"}}, "81ef302a-8dc0-4838-910b-2908b0b0489c": {"node_ids": ["c95931ed-76e8-4477-8e3d-9f2eda4d33d7", "d9963c07-b0c2-47b5-93a6-10c1ad6b65bf"], "metadata": {"source": "SDTMIG v3.4", "page": 326, "section": "UNSPECIFIED"}}, "8277e6f2-c090-4bdf-ba6f-d4c3730d6597": {"node_ids": ["b7a06797-c66f-4ad0-b2ca-ee350668a3fb", "6d7d3942-5f62-4e06-8cc7-1b0ffc0df501"], "metadata": {"source": "SDTMIG v3.4", "page": 327, "section": "UNSPECIFIED"}}, "76d20f18-e95d-4500-92c1-bea0f5a9eae7": {"node_ids": ["a57342b8-1361-4d8a-80b7-91a4f8a15a7f", "fb33f237-6e7a-4081-acbd-47dd0949fd4d"], "metadata": {"source": "SDTMIG v3.4", "page": 328, "section": "UNSPECIFIED"}}, "a54d56db-33a2-4a37-8cb7-d478e2ef5510": {"node_ids": ["6acce295-5e15-4a0b-8e60-2731719660eb"], "metadata": {"source": "SDTMIG v3.4", "page": 329, "section": "6.3.9.3 Disease Response and Clin Classification (RS)"}}, "f8609595-4f2f-4262-affc-75255774868f": {"node_ids": ["92358d77-c67d-48ea-8a63-85a2d12ae106", "ef86c120-5d25-49f4-a096-58bf968df9a3"], "metadata": {"source": "SDTMIG v3.4", "page": 330, "section": "UNSPECIFIED"}}, "9e2a9d2c-9026-4764-a237-af4877be3604": {"node_ids": ["876d6d4e-9aec-4b95-90a2-cc3219fa18aa", "776f5a90-a5f7-49d7-96c6-5d6c4031af00"], "metadata": {"source": "SDTMIG v3.4", "page": 331, "section": "UNSPECIFIED"}}, "4fb76642-c6a1-4af3-bea3-5ce3ec162acf": {"node_ids": ["e2a0d222-980d-4170-b46b-283029ec6078"], "metadata": {"source": "SDTMIG v3.4", "page": 332, "section": "6.3.9.3.1 Disease Response Use Case"}}, "b5bb01f8-34ed-4001-a1de-5d393d12d3bc": {"node_ids": ["59309db5-e341-4d7f-93d0-ebc057a0f7a6", "64aa1fef-73d2-4c8d-912d-2ce58773c2aa"], "metadata": {"source": "SDTMIG v3.4", "page": 333, "section": "UNSPECIFIED"}}, "dc40b0e1-c5f9-428a-86a2-10dd95b17f94": {"node_ids": ["30ca29fe-09be-4def-aa71-1bc526746362", "2584ffab-4c58-457b-a821-b2ea10e5d595"], "metadata": {"source": "SDTMIG v3.4", "page": 334, "section": "UNSPECIFIED"}}, "b0f95f32-a136-4524-a344-14ef4e6fd677": {"node_ids": ["79650cfb-edc2-4554-9124-ab2cb1e2f297"], "metadata": {"source": "SDTMIG v3.4", "page": 335, "section": "1.1 PD"}}, "da24a0bd-ea7d-4e60-951c-f458c0d2a6e1": {"node_ids": ["3ab7061e-3ca9-4e2f-84b4-3183ffcac7c1"], "metadata": {"source": "SDTMIG v3.4", "page": 336, "section": "6.3.9.3.2 Clinical Classifications Use Case"}}, "1982e495-a119-4fc3-80f2-9642414896f8": {"node_ids": ["225cf31b-aa81-499a-95ab-eba9d3d2f3df", "af693991-a2fb-4594-9d83-10a0e9484e72"], "metadata": {"source": "SDTMIG v3.4", "page": 337, "section": "UNSPECIFIED"}}, "24d7e45c-607a-4d62-9587-bf023879a73c": {"node_ids": ["70c28908-3544-4945-9cb5-9927bc3f42aa", "6abd2204-9b78-4ddb-b46b-53ff0aeec16a"], "metadata": {"source": "SDTMIG v3.4", "page": 338, "section": "UNSPECIFIED"}}, "e395f3db-f03c-498e-8192-9970c56d21f1": {"node_ids": ["96425a16-fce6-484c-a152-b64c7a26169f", "39341ce7-f9ee-4f64-a053-538d99b8ff7d"], "metadata": {"source": "SDTMIG v3.4", "page": 340, "section": "UNSPECIFIED"}}, "46927469-ee86-4e08-9017-b52723046954": {"node_ids": ["20132331-989a-44cc-85c8-e63a8a9ed346", "d21e99c2-f858-446b-b0d9-9ba3ba035648"], "metadata": {"source": "SDTMIG v3.4", "page": 341, "section": "UNSPECIFIED"}}, "9ed85387-4afd-4709-b45a-9141a7c0e4e6": {"node_ids": ["bf5551ac-1edb-44a6-9cc3-b436e7d92108"], "metadata": {"source": "SDTMIG v3.4", "page": 342, "section": "13.1 20-17-"}}, "0ea08a38-eccf-4460-8ad9-5fbe5bb43b41": {"node_ids": ["6e041b12-1da7-43ef-82e7-e6432a0d54f1"], "metadata": {"source": "SDTMIG v3.4", "page": 342, "section": "6.3.11 Subject Status (SS)"}}, "d8c0ec17-137a-42d1-bd12-adf8fb061db1": {"node_ids": ["164fba56-d7c8-46db-bc43-c0a3abf915b3", "32ac11a2-eb6d-4ec1-9290-2cb649a8182b"], "metadata": {"source": "SDTMIG v3.4", "page": 343, "section": "UNSPECIFIED"}}, "26cdb1e4-9a7c-4f4d-86a2-b3ad0da865cf": {"node_ids": ["03cb6b5f-7015-4480-bd69-450e853c09a7"], "metadata": {"source": "SDTMIG v3.4", "page": 344, "section": "6.3.12 Tumor/Lesion Domains"}}, "6f282b2e-ba44-46e9-adfd-35761c9b68d2": {"node_ids": ["fc6d92fc-a933-43cd-84f4-203af63a99c9"], "metadata": {"source": "SDTMIG v3.4", "page": 344, "section": "6.3.12.1 Tumor/Lesion Identification (TU)"}}, "6eb113ae-4d87-4781-801b-6550e06b2f92": {"node_ids": ["61a9ea69-13bd-477c-9ca6-804d7e2f1d83", "09f30451-29ea-4911-9add-396bf3e487b9"], "metadata": {"source": "SDTMIG v3.4", "page": 345, "section": "UNSPECIFIED"}}, "b615bd25-1ae2-4a7a-9d48-836752fae871": {"node_ids": ["8f94f0a4-c77a-4c50-a075-1edcbe1a10d3", "1d2c524c-19e9-4aa6-bd74-ed099e3550f0"], "metadata": {"source": "SDTMIG v3.4", "page": 346, "section": "UNSPECIFIED"}}, "3ac0ffdf-af59-4b99-94fe-8af07b0a4149": {"node_ids": ["aa59dd89-5997-46e3-98aa-14ae0fb2741a", "7d8ac91f-8d9e-4a15-b0c1-ec89cba2bf1b"], "metadata": {"source": "SDTMIG v3.4", "page": 347, "section": "UNSPECIFIED"}}, "e70268a6-e9cf-41f4-884f-3f9ad1300828": {"node_ids": ["291071e9-fd52-4bf3-b86a-ebd05b935d1c", "f0afa10c-2d24-413b-92b4-9f0d213e46ab"], "metadata": {"source": "SDTMIG v3.4", "page": 348, "section": "UNSPECIFIED"}}, "e0d0b33e-84c7-4e76-811f-98b1bfd619f4": {"node_ids": ["b66f6201-8f85-4fc0-adb9-6661f2ed23da", "92a90b77-df1c-4ad7-ac7d-b051a9911306"], "metadata": {"source": "SDTMIG v3.4", "page": 349, "section": "UNSPECIFIED"}}, "ea5abddb-c16a-4a92-a021-d6c7e380e39b": {"node_ids": ["68a887b8-6b2e-45cc-b34b-ec4cd9a6c4a5"], "metadata": {"source": "SDTMIG v3.4", "page": 350, "section": "6.3.12.2 Tumor/Lesion Results (TR)"}}, "c1343274-5a38-4f0b-820a-2b11e2ea0c53": {"node_ids": ["f89336ed-d7e0-490d-8581-706965ab4141", "55228acf-59c3-406c-8468-9b57982c816f"], "metadata": {"source": "SDTMIG v3.4", "page": 351, "section": "UNSPECIFIED"}}, "7bc34106-b4ef-451e-999e-779866b856b2": {"node_ids": ["9ce2028b-2002-4131-a2a5-b5ab0ac25a4f", "60b5bc34-5919-4b89-be63-59ec4594bd64"], "metadata": {"source": "SDTMIG v3.4", "page": 352, "section": "UNSPECIFIED"}}, "6e0bd672-07d5-46d1-b421-b037e5ab783b": {"node_ids": ["58001648-9d8d-448e-883f-f8c1874d28bc"], "metadata": {"source": "SDTMIG v3.4", "page": 353, "section": "6.3.12.3 Tumor Identification/Tumor Results Examples"}}, "aadb65dc-3cb9-4f52-a6a8-3a3eaf220142": {"node_ids": ["c1d7d178-e9f0-4717-ae1a-9f4e66f8f36c", "c38889ea-fdf6-4907-940c-26e5f1320012", "2eee5f44-52fd-4dd5-80e6-938ef12658ad"], "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}}, "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f": {"node_ids": ["75edba8f-6a73-4dbf-b53e-7aea5a81659e", "05a12eaa-49c8-4379-a329-267057e3df58", "dc3e0fd5-5514-494b-82a2-90754486553c", "30a0d08e-c923-4553-89cb-744b440ba3ed"], "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}}, "6f62a57b-a8b0-4ff4-b5c3-ccf8c967ff65": {"node_ids": ["6f48087c-0815-426b-a511-f5c96eaa4862", "7f49d108-4b8e-4077-a3f9-9f82c68674ae", "3710586d-0764-421e-b90a-3b79b31619d6"], "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}}, "9b9cffea-5a56-4a6e-bbf2-47f6875d941c": {"node_ids": ["1d63eb5d-21d0-4a4e-8fcf-733ff6280d8d", "b2881837-3687-4c2f-a859-dd7534e5cf62", "3e8b3962-c1d6-4bd0-aef2-9fd61b6824cb", "2b8a97a7-99a6-4424-bcb5-d7bc28b34505"], "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}}, "3262b4aa-55a3-4633-b9e4-090add93b670": {"node_ids": ["c6ac6818-6634-46c3-93af-3314b548283a"], "metadata": {"source": "SDTMIG v3.4", "page": 358, "section": "6.3.13 Vital Signs (VS)"}}, "3fcae6e8-660a-41c5-abd3-6141943b9ee7": {"node_ids": ["91ac189b-8735-45bf-b645-cc6d12d42449", "e2ff06b3-8ccd-454b-9e5d-2534203d4293", "edd689e2-65e6-40ad-9698-f94a88b834b6"], "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}}, "72c1dd8d-45a7-4d98-9f36-a4df747f287f": {"node_ids": ["81e00488-7f7a-4432-8694-884d4e42fecc", "43305226-919f-4482-bded-bb24c05b01de"], "metadata": {"source": "SDTMIG v3.4", "page": 360, "section": "UNSPECIFIED"}}, "596286fc-7286-42d6-a2be-460997c2e1bd": {"node_ids": ["ee721241-c50a-4db6-bdbe-7b65e9f51bf5"], "metadata": {"source": "SDTMIG v3.4", "page": 361, "section": "90.5 90.5"}}, "cd5669f0-8768-45a2-8700-6e00aa39eb54": {"node_ids": ["b987f275-5caa-4210-a84e-63efefe1989a"], "metadata": {"source": "SDTMIG v3.4", "page": 361, "section": "6.4.1 When to Use Findings About Events or Interventions"}}, "696df7ff-0499-40e1-856a-611c9a8c0f21": {"node_ids": ["16b5490c-2e08-4422-b297-1080381e4f44", "fa5b3d69-c24c-4b78-b9d0-665b394f770a"], "metadata": {"source": "SDTMIG v3.4", "page": 362, "section": "UNSPECIFIED"}}, "cad38abf-5546-45a3-be24-40dce9faf12e": {"node_ids": ["c2768d1b-1714-4b42-8d0d-33bfb337707e"], "metadata": {"source": "SDTMIG v3.4", "page": 363, "section": "6.4.2 Naming Findings About Domains"}}, "d383be07-84e4-479a-b226-4de6a2076450": {"node_ids": ["dbaf2a3d-2126-4603-a7fb-f52338a4c4fa"], "metadata": {"source": "SDTMIG v3.4", "page": 364, "section": "6.4.3 Variables Unique to Findings About"}}, "4eafe6cb-6cd5-4d54-b898-55ad86b3c703": {"node_ids": ["54f63d7b-3c68-46b2-9c38-70963a04a713", "47097f74-f345-4bc9-b920-c3dd1f4c2e94"], "metadata": {"source": "SDTMIG v3.4", "page": 365, "section": "UNSPECIFIED"}}, "70d0aa84-bacc-45ff-bac4-996c43a41502": {"node_ids": ["32fe5c3a-f7fa-4472-a983-c1c15cba0e5e", "8a292ec8-d7da-47eb-8f5e-6e6a0548a649"], "metadata": {"source": "SDTMIG v3.4", "page": 366, "section": "UNSPECIFIED"}}, "b458fdf1-2816-4b83-9ec7-042a7edf93b7": {"node_ids": ["895ae7c1-75c2-4ea6-a4ba-daf13e6558f0"], "metadata": {"source": "SDTMIG v3.4", "page": 367, "section": "UNSPECIFIED"}}, "e665bed8-e9dd-46e9-840d-beb5a980d49b": {"node_ids": ["63168e92-d50c-493b-a895-92e3e403d304", "d2b138d0-4e4f-45f5-bdc3-96f57eaa4550"], "metadata": {"source": "SDTMIG v3.4", "page": 368, "section": "UNSPECIFIED"}}, "5ac04188-968b-4cc7-b7a4-541ee3c04d6b": {"node_ids": ["fbaa295a-3898-4b8a-9640-53e81f07ec39", "6c0c7cf6-cc27-41c0-b95e-702c266c4239"], "metadata": {"source": "SDTMIG v3.4", "page": 369, "section": "UNSPECIFIED"}}, "dd5d93fd-28dd-46cc-90c9-01dd1e1d3e04": {"node_ids": ["04bd2ccf-75c5-4d58-b62c-2998811f3594"], "metadata": {"source": "SDTMIG v3.4", "page": 370, "section": "2.5 IN"}}, "8fadd21e-73f2-4359-933e-93e650849acf": {"node_ids": ["5591579c-ed00-40c4-b04d-9e6fcc2b9f62", "c7e440f3-7f84-4a56-bb6a-063a43eb9b5e"], "metadata": {"source": "SDTMIG v3.4", "page": 371, "section": "UNSPECIFIED"}}, "a8815e0d-98d5-454e-9e85-c15431126bb0": {"node_ids": ["00520418-f8a5-4a8c-94c4-767cb0be8f6b", "17130685-c381-4613-b806-8da43a5217d3"], "metadata": {"source": "SDTMIG v3.4", "page": 372, "section": "UNSPECIFIED"}}, "7b6ca58d-df3d-4106-ad32-b03493eb6fec": {"node_ids": ["b2b7e769-373b-4927-9dea-d30fdcdfd771", "44f3426f-45fa-431a-b8ce-68ef23ff2c26"], "metadata": {"source": "SDTMIG v3.4", "page": 373, "section": "UNSPECIFIED"}}, "3c121948-25a6-4b3a-b850-4202c2c55b4d": {"node_ids": ["686e050e-30ed-4a2a-88fd-35dfa54422e4", "73cce467-b727-4bf3-b1d3-5cfadae82f3b"], "metadata": {"source": "SDTMIG v3.4", "page": 374, "section": "UNSPECIFIED"}}, "a22cebfd-4862-4be0-a6cf-22e0c45997af": {"node_ids": ["a9fa2a83-47dd-47bb-b4b5-4f356e0c29c4", "6beb1b5a-249e-4324-9dba-b2fe75268449"], "metadata": {"source": "SDTMIG v3.4", "page": 376, "section": "UNSPECIFIED"}}, "097b9294-3483-44bc-b101-44cfd738ab31": {"node_ids": ["8096ff3c-fb27-44d8-a6d0-75bb5d2f01e5", "ab5f8423-b2ec-4cab-8cc3-80ef50ccba50"], "metadata": {"source": "SDTMIG v3.4", "page": 377, "section": "UNSPECIFIED"}}, "6f1c5cd5-4958-4f61-92ea-e165808eda85": {"node_ids": ["5f2496d1-e65d-47dd-a0ae-ebf612c7e735"], "metadata": {"source": "SDTMIG v3.4", "page": 378, "section": "0.20 BAU/mL"}}, "66f2466b-3464-4c59-9f94-5592c3cec3b9": {"node_ids": ["d8fab46a-c8cc-4626-a1fb-7f871eaf74f0"], "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "0.5 mg"}}, "6c76a2ef-6994-4224-8b60-08f89a7b58ce": {"node_ids": ["23a3456d-aeec-4b43-ac66-cdb2ad50d88c"], "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "1.5 mg"}}, "a1366068-f121-4afc-b703-7b6c9c5bbd82": {"node_ids": ["24765497-6050-4698-9f57-e0ab3cb76644"], "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "1.5 mg"}}, "fff33bcc-3118-4ccb-a956-b733a4aea3fa": {"node_ids": ["7f853707-02b5-482b-9151-eeada1258310", "54eccbdb-cf9c-4749-86d6-6fdbd3176c29"], "metadata": {"source": "SDTMIG v3.4", "page": 380, "section": "UNSPECIFIED"}}, "4294a3da-1df4-4124-8f1d-2ca8a9524bcf": {"node_ids": ["523bd2bf-ab78-401a-bc23-90d6f91b72be"], "metadata": {"source": "SDTMIG v3.4", "page": 381, "section": "UNSPECIFIED"}}, "338921a6-dc4c-46aa-a742-86ed7e8ac4d4": {"node_ids": ["56671b4e-1d36-43d9-9fdd-227e98f8ddb7"], "metadata": {"source": "SDTMIG v3.4", "page": 382, "section": "7.1.1 Purpose of the Trial Design Model"}}, "614859aa-9e47-4098-b7cb-c7c492c867a0": {"node_ids": ["47b8a49d-ffce-410c-bf2b-f27d004ed9fa"], "metadata": {"source": "SDTMIG v3.4", "page": 382, "section": "7.1.2 Definitions of Trial Design Concepts"}}, "997361f6-035d-494b-b53c-589467c8286c": {"node_ids": ["ec4b4a11-3780-417d-bc0f-486a1fccc241"], "metadata": {"source": "SDTMIG v3.4", "page": 383, "section": "7.1.3 Current and Future Contents of the Trial Design Model"}}, "ccf944c1-e7f6-4113-8e94-e1ef5d8804a9": {"node_ids": ["fd57999b-5b74-41a9-b803-8de4edcfb5f8"], "metadata": {"source": "SDTMIG v3.4", "page": 384, "section": "7.2 Experimental Design (TA and TE)"}}, "6368d491-2054-4793-91ba-0335accbb817": {"node_ids": ["d7efdacb-77fc-49f9-8e9e-2fb1f07d478d"], "metadata": {"source": "SDTMIG v3.4", "page": 384, "section": "7.2.1 Trial Arms (TA)"}}, "fbfe30ea-c738-4a9c-b738-7202a960de77": {"node_ids": ["498a709a-6e6b-4bda-82eb-00346e1f9cf8", "9a7e298c-062a-41a8-a352-c11ad5084fd9"], "metadata": {"source": "SDTMIG v3.4", "page": 385, "section": "UNSPECIFIED"}}, "13d96e67-c91f-47b4-a53f-4d39e6db72fa": {"node_ids": ["39ad5baf-20e7-4df2-b5cd-8d23b36f883a", "7ddecaf4-becf-4386-8277-42393c3631ea"], "metadata": {"source": "SDTMIG v3.4", "page": 386, "section": "UNSPECIFIED"}}, "cb1bbc6a-73b6-4c93-aa25-fb451e1dc895": {"node_ids": ["963c3759-e86c-46e8-894b-0eb831d6e7e6"], "metadata": {"source": "SDTMIG v3.4", "page": 387, "section": "UNSPECIFIED"}}, "a5b57957-05c1-4162-8bc2-2a45988523d1": {"node_ids": ["101169e9-73cc-4605-9375-6c9ae1ed78f8"], "metadata": {"source": "SDTMIG v3.4", "page": 388, "section": "UNSPECIFIED"}}, "6b5a9268-49a8-4e11-8eb4-afd0ef9a7e57": {"node_ids": ["30206999-ea0e-4449-aafa-015f5e5d09d8", "5daa80c2-7885-4185-ac33-4fc5d0f3382c"], "metadata": {"source": "SDTMIG v3.4", "page": 389, "section": "UNSPECIFIED"}}, "8f1e48d9-1b7c-4e7b-baf2-112029fe5bec": {"node_ids": ["ca8f9d13-f352-486a-820c-c63fd5f390dc"], "metadata": {"source": "SDTMIG v3.4", "page": 390, "section": "UNSPECIFIED"}}, "c7a08a80-3f9f-4fcb-9bd9-76f5d31703f3": {"node_ids": ["a2d3cc83-b087-4db1-a8e9-736ac757efe4", "6fb9b602-0d48-4d41-9b2c-0563e62faf9f"], "metadata": {"source": "SDTMIG v3.4", "page": 391, "section": "UNSPECIFIED"}}, "a1a3e470-290c-42c6-a9ec-c0739f49daa7": {"node_ids": ["b8d68078-4dfd-400a-af31-76253ead4126"], "metadata": {"source": "SDTMIG v3.4", "page": 392, "section": "UNSPECIFIED"}}, "aee496cd-8833-4126-9076-61ff13f1f550": {"node_ids": ["6f40bab6-f003-41ff-a5c2-b993497cb8c0"], "metadata": {"source": "SDTMIG v3.4", "page": 393, "section": "UNSPECIFIED"}}, "3c9d15e8-677a-4f33-9955-9d5005325156": {"node_ids": ["241b2168-f0aa-4a50-a34c-9cba732e1e47", "8b4afa60-269f-45d3-919f-c306f0a54508"], "metadata": {"source": "SDTMIG v3.4", "page": 394, "section": "UNSPECIFIED"}}, "642faa24-463a-4fc7-aeb4-538c958acf80": {"node_ids": ["cf82c8a0-3593-4796-8067-2502fdfe0694"], "metadata": {"source": "SDTMIG v3.4", "page": 395, "section": "UNSPECIFIED"}}, "ea94f67f-0fcb-448c-a732-57b2d9f9d071": {"node_ids": ["ec397fb9-9f63-4e4c-9673-d1f58975379a", "14ddef11-ddec-45be-a6eb-b33eaf1d07e3"], "metadata": {"source": "SDTMIG v3.4", "page": 396, "section": "UNSPECIFIED"}}, "f988e311-6937-47d3-bdbe-1fbd26cf9e6b": {"node_ids": ["8914e95b-3de1-4797-9f2e-4b10a44267f0"], "metadata": {"source": "SDTMIG v3.4", "page": 397, "section": "UNSPECIFIED"}}, "fdd49707-f4e0-4201-b243-aaad2e013138": {"node_ids": ["bf0ca4d3-db94-42d4-bd50-e2efc6b053e1"], "metadata": {"source": "SDTMIG v3.4", "page": 398, "section": "UNSPECIFIED"}}, "a044a364-08a8-49b3-8489-990c6a3b1800": {"node_ids": ["6c52ed2d-9d3b-482b-a26b-fa2dc26550bd", "eb9f5ef9-8c4a-4074-82a8-5ba958174a70"], "metadata": {"source": "SDTMIG v3.4", "page": 399, "section": "UNSPECIFIED"}}, "e1e88af1-f877-4e13-bd8f-7f4a59693384": {"node_ids": ["5539d1ca-34c5-4f60-a5f2-a33925328ba6"], "metadata": {"source": "SDTMIG v3.4", "page": 400, "section": "UNSPECIFIED"}}, "2eb720d0-f96f-4905-ad66-a7e3af10f15e": {"node_ids": ["d3643e2c-c5e8-4786-a8be-ec3f6f1116ee"], "metadata": {"source": "SDTMIG v3.4", "page": 401, "section": "UNSPECIFIED"}}, "264ed794-faa5-40e2-96b8-4f2188d47be5": {"node_ids": ["8d8630f4-a5ce-48bf-b98e-797373d318a6"], "metadata": {"source": "SDTMIG v3.4", "page": 402, "section": "7.2.1.1 Trial Arms Issues"}}, "73d7d395-d05c-485f-a718-5c80d619654b": {"node_ids": ["b66ae480-77b0-4cb2-9351-ce2809433e74", "3e7cd9bb-78fb-4a10-96e7-0d3beb23eefe"], "metadata": {"source": "SDTMIG v3.4", "page": 403, "section": "UNSPECIFIED"}}, "3b31322e-6d70-4a44-bb20-63b367c09a8c": {"node_ids": ["50b631fe-efd5-4f4f-bb6e-e3feec05ce9e", "fcbf8dfb-6b0e-4a4e-9011-e536f31d2328"], "metadata": {"source": "SDTMIG v3.4", "page": 404, "section": "UNSPECIFIED"}}, "b310ff1e-bd1b-4c31-83f7-98b40eebc7ec": {"node_ids": ["81b5ccb4-8c44-4a89-9464-4be324161a64"], "metadata": {"source": "SDTMIG v3.4", "page": 405, "section": "7.2.2.1 Trial Elements Issues"}}, "a89a33d6-519d-43c2-a121-aa43525fa1e6": {"node_ids": ["801b7f4c-8770-48f3-b224-23b429d498fd", "0a7e6ae5-d0a3-4481-b279-9e1ca5667c1f"], "metadata": {"source": "SDTMIG v3.4", "page": 406, "section": "UNSPECIFIED"}}, "e3992249-d474-42a9-bb87-0b1d0562a364": {"node_ids": ["fd051930-5238-44eb-aa78-d495ac0ec520"], "metadata": {"source": "SDTMIG v3.4", "page": 407, "section": "7.3 Schedule for Assessments (TV, TD, and TM)"}}, "8ff9594a-be99-4026-8121-9b6d5df6eee7": {"node_ids": ["66741ebf-4b45-4106-9ad4-1d677fd55924"], "metadata": {"source": "SDTMIG v3.4", "page": 407, "section": "7.3.1 Trial Visits (TV)"}}, "ba81448f-0442-4c2f-b16c-bce67bc8038b": {"node_ids": ["73019f38-55c1-4bce-8cd8-820febeefb78", "68b8ca25-04ad-4468-9102-e00ae27cc392"], "metadata": {"source": "SDTMIG v3.4", "page": 408, "section": "UNSPECIFIED"}}, "8aa0ac21-e820-487b-9349-d7228e05c00c": {"node_ids": ["aab7b970-e50a-48a7-8ba3-0305e7aa66e8"], "metadata": {"source": "SDTMIG v3.4", "page": 409, "section": "7.3.1.1 Trial Visits Issues"}}, "5cf35a21-4456-4129-9c6d-8c3e26a936f8": {"node_ids": ["00d2203b-ebf3-408b-9cc0-851346acaed3"], "metadata": {"source": "SDTMIG v3.4", "page": 410, "section": "7.3.2 Trial Disease Assessments (TD)"}}, "a4831223-b50a-4dcf-862c-49bffc3222ed": {"node_ids": ["a28ae5ab-fb8e-47cc-8eac-2a6bfecc0482", "c5b705a4-aac7-4165-b7b9-dd0caa25675f"], "metadata": {"source": "SDTMIG v3.4", "page": 411, "section": "UNSPECIFIED"}}, "9f18c7dd-0b93-45c7-84b2-f815311531d8": {"node_ids": ["2a32b7e8-4aaf-40e7-9771-672d129e34a5"], "metadata": {"source": "SDTMIG v3.4", "page": 412, "section": "UNSPECIFIED"}}, "a35cbd3c-cf26-4161-80d7-3901f6c2c469": {"node_ids": ["dc4bf212-f3b8-483b-9c87-57b402559beb"], "metadata": {"source": "SDTMIG v3.4", "page": 413, "section": "UNSPECIFIED"}}, "6a92d3ed-1101-4ca6-8ea5-92e9555cafb3": {"node_ids": ["6dfce659-fe14-453e-963c-f790ba2c34df"], "metadata": {"source": "SDTMIG v3.4", "page": 414, "section": "UNSPECIFIED"}}, "0cc2738d-c326-411e-aa7b-6dbdae135a46": {"node_ids": ["837959cd-503d-4937-8c2e-19c3945f3b74"], "metadata": {"source": "SDTMIG v3.4", "page": 415, "section": "7.3.3 Trial Disease Milestones (TM)"}}, "59bce370-ead3-48a0-a98a-c4141d6550e1": {"node_ids": ["dc1c10c5-0257-4ec9-b3d0-7126799e6bd7"], "metadata": {"source": "SDTMIG v3.4", "page": 415, "section": "7.4 Trial Eligibility and Summary (TI and TS)"}}, "b9d06f77-becf-422f-a203-8ecd0c070ec7": {"node_ids": ["a4114a8f-3167-4f8c-b1dc-bc53cccd5777", "d183174d-db5e-46de-bbd6-52c410347a90"], "metadata": {"source": "SDTMIG v3.4", "page": 416, "section": "7.4.1 Trial Inclusion/Exclusion Criteria (TI)"}}, "4da47ca7-499e-46d6-8e45-7f8b50eef566": {"node_ids": ["e3f08d88-bf64-491f-8fa1-a919e50e8ef0"], "metadata": {"source": "SDTMIG v3.4", "page": 417, "section": "2.2 7.4.2 Trial Summary (TS)"}}, "d781a0f7-a106-4e74-9761-12264b5d0ca0": {"node_ids": ["e348beee-8b20-4022-82e2-1a96f4e9cacd", "54b4c65c-9cf2-4c68-9c31-d01dcb805f8a"], "metadata": {"source": "SDTMIG v3.4", "page": 418, "section": "UNSPECIFIED"}}, "2fc404a3-0b9c-46c3-bd1c-80e5760176e8": {"node_ids": ["c5f916c0-867c-44bf-a52a-0023b1f66555", "0338220d-15e0-486e-a3ba-5f686756c094"], "metadata": {"source": "SDTMIG v3.4", "page": 419, "section": "UNSPECIFIED"}}, "28ae9adb-4011-451d-a9cd-b9dca6dcbadb": {"node_ids": ["c6a5d138-c5c0-4b14-a1cf-2d6422d137d7", "6ac07c39-00bb-40b5-b09c-8c46b18486f1"], "metadata": {"source": "SDTMIG v3.4", "page": 420, "section": "UNSPECIFIED"}}, "a88af453-b979-4a38-9136-3d4d40ffea01": {"node_ids": ["93693f54-fe50-4e74-bee5-c0babcf61ad5", "de499c9d-a799-4906-ad5d-45c8505ce538"], "metadata": {"source": "SDTMIG v3.4", "page": 421, "section": "UNSPECIFIED"}}, "6a3252ef-d6bb-4ab5-a290-65a2405fe179": {"node_ids": ["40ff5d0c-4924-4f9a-b1aa-944557e5a9a7", "5aed8f39-bf4b-45f9-9623-ee680f6955a1"], "metadata": {"source": "SDTMIG v3.4", "page": 422, "section": "UNSPECIFIED"}}, "6d46bc92-2755-4d0b-90f3-7f006a9355f0": {"node_ids": ["660cff5d-bb06-4377-b87c-e8d18c65c74f"], "metadata": {"source": "SDTMIG v3.4", "page": 423, "section": "0.5 27"}}, "334840fe-c0d9-44ac-ad83-e7814c616fbe": {"node_ids": ["92625e3f-078a-4863-8457-2ff1fda52318", "82646e5a-a7c4-485d-91f8-73f67dde9d26"], "metadata": {"source": "SDTMIG v3.4", "page": 424, "section": "7.4.2.1 Use of Null Flavor"}}, "41107b66-0840-4c4e-9e5b-c86eee3aa48c": {"node_ids": ["3bdc97fe-1a41-4f7f-b80b-c395945e6d12"], "metadata": {"source": "SDTMIG v3.4", "page": 425, "section": "7.5 How to Model the Design of a Clinical Trial"}}, "c5d758aa-9d5f-4e07-bca2-9e66dc661ed7": {"node_ids": ["9a7d948f-0a0d-4e9a-814a-4511f18fdd00"], "metadata": {"source": "SDTMIG v3.4", "page": 426, "section": "UNSPECIFIED"}}, "6bdd3480-78e3-4e1b-8a2f-56082cd10f98": {"node_ids": ["3ffb4b22-d482-4815-b419-8c6e2245ae5c", "f453061d-c379-4dc4-8e36-d78e58496ac1"], "metadata": {"source": "SDTMIG v3.4", "page": 427, "section": "UNSPECIFIED"}}, "7bb5fbf9-72e1-4185-a112-a35bc5d08029": {"node_ids": ["b4712b0f-fae9-47e8-a9f3-03b6d0cb39cd"], "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "8.1 Relating Groups of Records Within a Domain Using the --"}}, "fd6ecb25-da29-4603-8c7c-847d48028560": {"node_ids": ["a17f9368-24e4-48f7-b4cf-1f562953191a"], "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "8.1.1 --GRPID Example"}}, "c4df8cc3-4a95-4ac8-9876-61aa3c88fe72": {"node_ids": ["0e974173-447e-4f5e-8258-4ef90159864c"], "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "37.5 mg"}}, "c6c3138d-c4ea-41c5-82a0-9d6cbba3976b": {"node_ids": ["0e3da09d-c538-46f8-80ac-eeed4a321867"], "metadata": {"source": "SDTMIG v3.4", "page": 429, "section": "8.2 Relating Peer Records"}}, "0a0b2be5-12d8-4c32-80b0-fbc723405f61": {"node_ids": ["a8c1ed72-e745-4273-acb6-91deaf16c3af"], "metadata": {"source": "SDTMIG v3.4", "page": 429, "section": "8.2.1 Related Records (RELREC)"}}, "32696bea-6ff2-4b60-a5da-5c5b7d62f06c": {"node_ids": ["bf6400e9-68e4-432d-8258-2a9e01fa2e0f"], "metadata": {"source": "SDTMIG v3.4", "page": 430, "section": "8.2.2 RELREC Dataset Examples"}}, "3e773a27-c45f-4d6b-a1ec-12225542f4db": {"node_ids": ["8a474dd1-d275-44f7-a397-ab3b350ca041"], "metadata": {"source": "SDTMIG v3.4", "page": 430, "section": "8.3 Relating Datasets"}}, "e8e02b64-8d30-4aff-ab71-9b7bb0a3376c": {"node_ids": ["d280de3c-49f4-4441-b1d2-ff9ec2bc9db0"], "metadata": {"source": "SDTMIG v3.4", "page": 431, "section": "8.3.1 RELREC Dataset Relationship Example"}}, "09e342e1-1ebc-4272-8ad5-8c06e7d9778a": {"node_ids": ["715d5b7e-9743-484b-b0fc-d9d569461a00"], "metadata": {"source": "SDTMIG v3.4", "page": 431, "section": "8.4 Relating Non-standard Variable Values to a Parent"}}, "97f2c2de-83a2-49f0-8d33-62717964451d": {"node_ids": ["9da83d00-c20c-4e4b-bf4e-e71ddd618dcc"], "metadata": {"source": "SDTMIG v3.4", "page": 432, "section": "8.4.1 Supplemental Qualifiers (SUPP--)"}}, "be350762-028d-4c47-a398-24816b706c87": {"node_ids": ["725356ed-7b47-4c1b-83fd-af18b53537a4"], "metadata": {"source": "SDTMIG v3.4", "page": 433, "section": "8.4.2 Submitting Supplemental Qualifiers in Separate Datasets"}}, "f6d2e636-1c20-4db5-b1ce-26059ec0e8f3": {"node_ids": ["07aff125-6b7c-4414-b261-82582d482709"], "metadata": {"source": "SDTMIG v3.4", "page": 433, "section": "8.4.3 SUPP-- Examples"}}, "b839f269-0355-4f87-9f73-81ead996a694": {"node_ids": ["272250f2-8c85-47c6-9d67-898267e3c5b1"], "metadata": {"source": "SDTMIG v3.4", "page": 434, "section": "8.4.4 When Not to Use Supplemental Qualifiers"}}, "dbf97873-d5a8-4f59-85e8-a491f7808f0e": {"node_ids": ["b81e596e-f3a2-4184-9f21-2c9f0dc7355b"], "metadata": {"source": "SDTMIG v3.4", "page": 434, "section": "8.5 Relating Comments to a Parent Domain"}}, "f81cb997-ad85-4462-a817-eb6293923ace": {"node_ids": ["b770b72a-34fc-40b4-ad4e-8c66bf22c76c"], "metadata": {"source": "SDTMIG v3.4", "page": 435, "section": "8.6.1 Guidelines for Determining the General Observation Class"}}, "c0fed31f-5e8c-4f33-a2e3-ad634048ba78": {"node_ids": ["60ee5fe7-08b3-43f6-9ef8-2d0dc127e5f4"], "metadata": {"source": "SDTMIG v3.4", "page": 435, "section": "8.6.2 Guidelines for Forming New Domains"}}, "6e18cf07-cbd2-4513-8156-635a63f903e9": {"node_ids": ["731f1637-f8ee-4f89-9f47-0d2fe69fd9ad", "37b12b78-518a-4f05-b55d-49772679d9d4"], "metadata": {"source": "SDTMIG v3.4", "page": 436, "section": "8.6.3 Guidelines for Differentiating Between Interventions, Events,"}}, "bae113e6-52f4-42e2-a3ff-19ad468b9545": {"node_ids": ["77e0fc29-1fd4-48ab-a376-b4c4a41bee91"], "metadata": {"source": "SDTMIG v3.4", "page": 437, "section": "8.7 Related Subjects (RELSUB)"}}, "1242d105-7922-49c2-b69e-0b57fa3319ee": {"node_ids": ["99b9bb89-c201-4910-8c73-c56fc5292e66", "02f90e2f-2c94-4f3f-8158-4c6861c607ca"], "metadata": {"source": "SDTMIG v3.4", "page": 438, "section": "UNSPECIFIED"}}, "92c2d505-353a-40a3-8599-07f8b0c5b82a": {"node_ids": ["90c99896-2a8f-4a76-a5ad-6c1756874a2c"], "metadata": {"source": "SDTMIG v3.4", "page": 439, "section": "8.8 Related Specimens (RELSPEC)"}}, "35b4a361-67a7-4fc9-8357-01978184fd31": {"node_ids": ["ac7ded5a-4b28-49fb-b742-167b07a3ffba"], "metadata": {"source": "SDTMIG v3.4", "page": 440, "section": "UNSPECIFIED"}}, "279062c8-1cdd-40d6-945f-eb9542299ca4": {"node_ids": ["467056a7-088b-46ef-b02d-ac1b37a2e8e4"], "metadata": {"source": "SDTMIG v3.4", "page": 441, "section": "9.1 Device Identifiers"}}, "c41c8e6b-2663-49c0-a442-06d0d1b5c040": {"node_ids": ["27de4ff4-fe81-4524-a852-b4c088d73bdd"], "metadata": {"source": "SDTMIG v3.4", "page": 441, "section": "9.2 Non-host Organism Identifiers (OI)"}}, "a9b12e86-8640-49fb-851b-93d641a9c67f": {"node_ids": ["3af8991d-21d4-4422-b792-dcfa186bd97f", "ec4d78d7-0318-414e-8098-1efc7b9c820e"], "metadata": {"source": "SDTMIG v3.4", "page": 442, "section": "UNSPECIFIED"}}, "1867539c-3c6c-44ac-9580-729cb3b3960f": {"node_ids": ["7d4ca857-8b7e-4f5e-a867-4acd71a4cb36"], "metadata": {"source": "SDTMIG v3.4", "page": 443, "section": "UNSPECIFIED"}}, "4eadccd5-73ee-4d1f-8dcc-11083f33e74a": {"node_ids": ["06ca7e49-a752-4218-8e77-2e5200b1af89"], "metadata": {"source": "SDTMIG v3.4", "page": 444, "section": "UNSPECIFIED"}}, "be246367-1e4b-4bc6-954b-9769289b3cd9": {"node_ids": ["49586917-3323-4a56-8bfd-ad68360d5476"], "metadata": {"source": "SDTMIG v3.4", "page": 445, "section": "UNSPECIFIED"}}, "94698283-d8a7-4477-b7b2-80eef423f4c6": {"node_ids": ["903402fd-5433-4111-beb3-e88b70913c91"], "metadata": {"source": "SDTMIG v3.4", "page": 446, "section": "UNSPECIFIED"}}, "a018680b-ab0e-40b9-a1dc-e47944555193": {"node_ids": ["09ed455a-0e41-43dc-ac61-7ac03f666e92"], "metadata": {"source": "SDTMIG v3.4", "page": 447, "section": "UNSPECIFIED"}}, "548505ec-72a0-4728-9ea6-34b61841854b": {"node_ids": ["8549aaec-1dec-48ea-9838-09a2cfdd1081"], "metadata": {"source": "SDTMIG v3.4", "page": 448, "section": "UNSPECIFIED"}}, "0c5503f8-88e0-48ab-bafe-cf95ce3bf302": {"node_ids": ["a8d9715d-07fb-4362-876b-28363f910c00"], "metadata": {"source": "SDTMIG v3.4", "page": 449, "section": "UNSPECIFIED"}}, "94dc4d92-1732-4f79-8445-a5e9ea858543": {"node_ids": ["7e96ec9b-4a6b-4757-b32f-d329c15a6a61"], "metadata": {"source": "SDTMIG v3.4", "page": 450, "section": "UNSPECIFIED"}}, "d4880f8c-df20-47a7-a667-60e16aafd687": {"node_ids": ["4682e043-fb9c-442f-ba3e-529b15264515"], "metadata": {"source": "SDTMIG v3.4", "page": 451, "section": "UNSPECIFIED"}}, "e6a0d757-1805-4e21-8884-f50e8a2ad757": {"node_ids": ["73f0dac6-26d9-4c4f-8ad6-c15376a5e74c"], "metadata": {"source": "SDTMIG v3.4", "page": 452, "section": "UNSPECIFIED"}}, "7468d813-627c-47d7-9a67-7b323b1585a7": {"node_ids": ["9f308a24-f1a9-40ee-b16a-c439b3e3ad03"], "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "2.5 The SDTM Standard Domain Models"}}, "d3b377d4-ea13-4932-99ed-46011b7560b9": {"node_ids": ["6946da5e-0491-4088-855d-16d374afed9a"], "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "2.7 SDTM Variables Not Allowed in the"}}, "85e91e75-16a5-4840-9510-30fd5f8c08fc": {"node_ids": ["7029ed75-ff46-44e7-a287-d9f8a15f0291"], "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "3.2 Using the CDISC Domain Models in"}}, "7f42ea25-2d20-479d-a851-e11a7ebcef30": {"node_ids": ["7e3988ae-0ba0-40c4-840b-0d65f98a25e5"], "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "4.2 General Variable Assumptions"}}, "1ae502f1-b57f-45ad-8c63-d88edec4926f": {"node_ids": ["49ea0a44-1b86-4582-b98e-c9dbf90216a4"], "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.4 Actual and Relative Time Assumptions"}}, "581d55a6-14c8-4fd2-b318-fd118d719471": {"node_ids": ["e4f09c23-f037-4354-9c61-2fc3e1c711cb"], "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.5 Original and Standardized Results"}}, "76ef005e-8281-4cdd-b0c6-d0f7232a253c": {"node_ids": ["70b1f75b-86a6-488f-b81a-aea1224ed1a5"], "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.1 General Domain Assumptions"}}, "1a8548d5-5e01-4e8d-8c2b-f86719163755": {"node_ids": ["09877178-09dd-443a-9a44-3c2e8f7cde77"], "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "5.1 Comments (CO)"}}, "74c4fa35-756a-4fce-9a6d-a95a3206c06f": {"node_ids": ["b6f869a1-fa5c-470e-9c4e-9e490e27db41"], "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "5.2 Demographics (DM)"}}, "ce584bb2-c431-4af9-9e30-17f4589b697c": {"node_ids": ["363cf67f-a4ad-4c15-92f0-ee91e1b65fd5"], "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "5.5 Subject Visits (SV)"}}, "38df8e15-792e-411c-8293-8fb13275554a": {"node_ids": ["bc4e36c9-3a7a-40b5-8802-f1e2797829f4"], "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.1.3 Exposure Domains"}}, "d49960a7-3881-47dd-894b-1fdaa340b827": {"node_ids": ["bb3b1534-bfc7-43f9-b28b-5cc48119c40f"], "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.1.5 Procedures (PR)"}}, "4b1b81ae-94d2-4aaa-8811-1cc911043e3a": {"node_ids": ["7be75279-72a5-48f0-8e43-53115ed64ed9"], "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.2.1 Adverse Events (AE)"}}, "6ea5f5c6-1dfb-4b57-b9f1-4eb7aa99eae9": {"node_ids": ["84caa7f0-c9a5-49f0-99f2-736f0d2399e7"], "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3 Models for Findings Domains"}}, "c60fd9ed-145a-4951-b9d2-bd917600cda8": {"node_ids": ["71d61065-7623-4dc7-baf9-0563b4b10bd6"], "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.1 Product Accountability (DA)"}}, "4216e4eb-e5eb-4db5-baf7-aa111da14c00": {"node_ids": ["e9e0f646-07d8-4406-a8c6-833bd666ce30"], "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.5.2 Biospecimen Findings (BS)"}}, "b11c04ae-d94b-43a3-bdd1-d10080e96ebf": {"node_ids": ["ebd520d3-b4eb-47fb-af15-3adc59174c75"], "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.5.5 Immunogenicity Specimen Assessments"}}, "ce867913-2ac3-4052-a73e-aa31979f7199": {"node_ids": ["897248a9-dc50-4b49-aba8-152fadeedead"], "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.3.5.6 Laboratory Test Results (LB)"}}, "ba9dc1b5-5a61-4730-af41-ffd126776388": {"node_ids": ["6051e6c7-2e78-4c8f-bc04-8a5c5fe7b8e6"], "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.4.1 When to Use Findings About Events or"}}, "3498c175-c3e5-4b1b-ad43-f1307428850e": {"node_ids": ["df43d9a9-16aa-4102-87b3-cbd9d13aa6d8"], "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.4.4 Findings About Events or Interventions"}}, "3bbdeba5-f3a4-4835-8b71-7746d59293c8": {"node_ids": ["23655168-60e7-4e0e-9284-d05f20aca781"], "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "6.4.5 Skin Response (SR)"}}, "d54ea398-3832-4835-8095-c0d8dbf16de0": {"node_ids": ["47a1f889-3023-44f8-b86c-23b2073a5ef4"], "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "7.2 Experimental Design (TA and TE)"}}, "99e79fd2-7517-44b4-ac93-fa99dc4d26d9": {"node_ids": ["a84e826a-5cea-4797-a050-0f75d449aec3"], "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "7.4.2 Trial Summary (TS)"}}, "a412e7eb-0d6a-4655-a2e1-fdac112f27bc": {"node_ids": ["237c9d01-f4a4-4062-aa99-8759a3258ba0"], "metadata": {"source": "SDTMIG v3.4", "page": 459, "section": "8.6.3 Guidelines for Differentiating Between"}}, "ac318338-13ed-41d2-a783-42df447ea166": {"node_ids": ["34ef93f8-cfdf-4d83-a827-bb7d36dcdaed"], "metadata": {"source": "SDTMIG v3.4", "page": 459, "section": "8.8 Related Specimens (RELSPEC)"}}, "32df3d74-c677-4e4e-9b11-e1a719b7a1bc": {"node_ids": ["b96527d5-9fd5-4b94-8663-1327a4b815c5"], "metadata": {"source": "SDTMIG v3.4", "page": 460, "section": "UNSPECIFIED"}}, "1d479855-bc36-4d95-b5dc-04d096634c6d": {"node_ids": ["37f00e35-f698-4aaf-848d-df38e71e6913", "18b6362b-1019-48a3-8134-097aaa900b65"], "metadata": {"source": "SDTMIG v3.4", "page": 461, "section": "UNSPECIFIED"}}}, "docstore/data": {"e4b1b799-2fb1-44a4-a48a-236ae2791027": {"__data__": {"id_": "e4b1b799-2fb1-44a4-a48a-236ae2791027", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 5, "section": "9.2 NON-HOST ORGANISM IDENTIFIERS (OI) ........................................................................................................... 441"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "86a336fa-a90d-4907-8629-775794e88f62", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 5, "section": "9.2 NON-HOST ORGANISM IDENTIFIERS (OI) ........................................................................................................... 441"}, "hash": "b94216e695900f945da8585d9f211218c5989f2c92f9089ec5f79f49c5ef5dd4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "10 APPENDICES .................................................................................................................... 444 \nAPPENDIX A: CDISC SDS TEAM ............................................................................................................................... 444 \nAPPENDIX B: GLOSSARY AND ABBREVIATIONS ......................................................................................................... 446 \nAPPENDIX C: CONTROLLED TERMINOLOGY ............................................................................................................... 448 \nAPPENDIX D: CDISC VARIABLE-NAMING FRAGMENTS ............................................................................................. 449", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 739, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f57361d4-6a24-47c5-804b-481ee74724d5": {"__data__": {"id_": "f57361d4-6a24-47c5-804b-481ee74724d5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 6, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "961a8292-db8c-4db5-963b-7d864a0838c0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 6, "section": "UNSPECIFIED"}, "hash": "abec106fb2960b1f75df50c608d5a67566bc5c230c51ed184541399305e5e16b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 6 \n2021-11-29 \nAPPENDIX E: REVISION HISTORY ............................................................................................................................... 452 \nAPPENDIX F: REPRESENTATIONS AND WARRANTIES, LIMITATIONS OF LIABILITY, AND DISCLAIMERS ...................... 461", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 468, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f4d6cebc-8919-41bf-98bc-fd359cd69adc": {"__data__": {"id_": "f4d6cebc-8919-41bf-98bc-fd359cd69adc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 7, "section": "1.1 Purpose"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "78be0d88-c369-4c8e-9d91-1800e4926fdd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 7, "section": "1.1 Purpose"}, "hash": "072fe1742f0da641535f096c36d3c0498e3cfdc0969b9be2d60c2024e9f80532", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Study Data Tabulation Model Implementation Guide for Human Clinical Trials (SDTMIG) Version 3.4 has \nbeen prepared by the Submissions Data Standards (SDS) team of the Clinical Data Interchange Standards \nConsortium (CDISC). Like its predecessors, v3.4 is intended to guide the organization, structure, and format of \nstandard clinical trial tabulation datasets submitted to a regulatory authority. Version 3.4 supersedes all prior \nversions of the SDTMIG. \nThe SDTMIG should be used in close concert with Version 2.0 of the CDISC Study Data Tabulation Model \n(SDTM, available at https://www.cdisc.org/standards/foundational/sdtm), which describes the general conceptual \nmodel for representing clinical study data that is submitted to regulatory authorities and should be read prior to \nreading the SDTMIG. SDTMIG Version 3.4 provides specific domain models, assumptions, business rules, and \nexamples for preparing standard tabulation datasets that are based on the SDTM. \nThis document is intended for companies and individuals involved in the collection, preparation, and analysis of \nclinical data that will be submitted to regulatory authorities.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1155, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c0669caa-cc8f-4b2e-b0ce-0e85f08997dc": {"__data__": {"id_": "c0669caa-cc8f-4b2e-b0ce-0e85f08997dc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 7, "section": "1.2 Organization of this Document"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "62eb10f9-ce2b-43f2-9318-bc0a18912e28", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 7, "section": "1.2 Organization of this Document"}, "hash": "b0322a21b9a408e91fafa980a5c367c86a824bd56388ffe51ca45eeb92efc29a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This document is organized into the following sections: \n\u2022 \nSection 1, Introduction, provides an overall introduction to the v3.4 models and describes changes from \nprior versions. \n\u2022 \nSection 2, Fundamentals of the SDTM, recaps the basic concepts of the SDTM, and describes how this \nimplementation guide should be used in concert with the SDTM. \n\u2022 \nSection 3, Submitting Data in Standard Format, explains how to describe metadata for regulatory \nsubmissions, and how to assess conformance with the standards. \n\u2022 \nSection 4, Assumptions for Domain Models, describes basic concepts, business rules, and assumptions that \nshould be taken into consideration before applying the domain models. \n\u2022 \nSection 5, Models for Special-purpose Domains, describes special-purpose domains, including \nDemographics, Comments, Subject Visits, and Subject Elements. \n\u2022 \nSection 6, Domain Models Based on the General Observation Classes, provides specific metadata models \nbased on the 3 general observation classes, along with assumptions and example data. \n\u2022 \nSection 7, Trial Design Model Datasets, describes domains for trial-level data, with assumptions and \nexamples. \n\u2022 \nSection 8, Representing Relationships and Data, describes how to represent relationships between separate \ndomains, datasets, and/or records, and provides information to help sponsors determine where data belong \nin the SDTM. \n\u2022 \nSection 9, Study References, provides structures for representing study-specific terminology used in subject \ndata. \n\u2022 \nAppendices provide additional background material and describe other supplemental material relevant \nto implementation.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1630, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "31e88b75-cf7f-4477-a7ad-b6f33acabd9e": {"__data__": {"id_": "31e88b75-cf7f-4477-a7ad-b6f33acabd9e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 9, "section": "1.4.1 How to Read a Domain Specification"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c3522668-be88-41f2-9480-faef9d189d32", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 9, "section": "1.4.1 How to Read a Domain Specification"}, "hash": "3a7d62fe3d3e821a1190266d139edd9c567349777c921b2d91f42eeef97b025e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A domain specification table includes rows for all required and expected variables for a domain and for a set of \npermissible variables. The permissible variables do not include all the variables that are allowed for the domain; \nthey are a set of variables that the SDS Team considered likely to be included. The columns of the table are: \n\u2022 \nVariable Name \no \nFor variables that do not include a domain prefix, this name is taken directly from the SDTM. \no \nFor variables with a \"--\" placeholder in the SDTM, the \"--\" is replaced by the 2-character domain code. \n\u2022 \nVariable Label: A longer name for the variable   \no \nThis may be the same as the label in the SDTM, or it may be customized for the domain. \no \nSponsors should create an appropriate label if they include in a dataset an allowable variable not in the \ndomain specification. \n\u2022 \nType: One of the 2 SAS datatypes, \"Num\" or \"Char\".  These values are taken directly from the SDTM. \n\u2022 \nControlled Terms, Codelist, or Format \no \nControlled Terms \n\u25aa \nAs noted in the table note, an asterisk (*) indicates that the variable may be subject to controlled \nterminology.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1125, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f095d34f-8b4f-4e20-9b9f-e62e3ce80934": {"__data__": {"id_": "f095d34f-8b4f-4e20-9b9f-e62e3ce80934", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 10, "section": "1.5 Known Issues"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f8e9ae21-a651-4afa-8e36-4a233be2a449", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 10, "section": "1.5 Known Issues"}, "hash": "0d9b46923050a255b6af74523d95a6950717c0ae597eddd6d65fc843995f74d7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Derived Records and the use of --DRVFL \nAlthough it is implicit in the general concept of a derived record that there is no collected result (--ORRES should \nbe null), this is not an explicit requirement currently stated in published CDISC material.  This is being evaluated for \nclarification in a future release of the SDTMIG and/or Model document. \nUse of --LNKID and --LNKGRP \nThe definition of --LNKID says that it is \"used to identify a record,\" and the definition of --LNKGRP says that it is \n\"used to identify a group of records.\" This implies that when setting up a relationship in RELREC, a row where \nRELTYPE = ONE will have an IDVAR of --LNKID (and not --LNKGRP); a row where RELTYPE = MANY will \nhave an IDVAR of --LNKID (and not --LNKGRP). The examples in this version of the SDTMIG have not been \nsystematically reviewed to implement this distinction between --LNKID and --LNKGRP. This distinction between -\n-LNKID and --LNKGRP, and the appropriateness of using other identification variables for linking, will be clarified \nin a future release of the SDTMIG and/or Model document, and at that time examples in the SDTMIG will be \nsystematically reviewed and updated to reflect that clarification.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1212, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "18afac45-cecd-4237-97e0-764810c8aa67": {"__data__": {"id_": "18afac45-cecd-4237-97e0-764810c8aa67", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 11, "section": "2.1 Observations and Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2bb0d21c-ce1d-477d-940d-5a3f611d683b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 11, "section": "2.1 Observations and Variables"}, "hash": "4343201e0a142e3b640aea5f0af50a798d33f16ffcb2d0dc93884a0b8262305d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The SDTMIG for Human Clinical Trials is based on the SDTM\u2019s general framework for organizing clinical trial \ninformation that is to be submitted to regulatory authorities. The SDTM is built around the concept of observations \ncollected about subjects who participated in a clinical study. Each observation can be described by a series of \nvariables, corresponding to a row in a dataset. Each variable can be classified according to its role. A role \ndetermines the type of information conveyed by the variable about each distinct observation and how it can be used. \nVariables can be classified into 5 major roles:  \n\u2022 \nIdentifier variables, such as those that identify the study, subject, domain, and sequence number of the \nrecord \n\u2022 \nTopic variables, which specify the focus of the observation (e.g., the name of a lab test) \n\u2022 \nTiming variables, which describe the timing of the observation (e.g., start date and end date) \n\u2022 \nQualifier variables, which include additional illustrative text or numeric values that describe the results or \nadditional traits of the observation (e.g., units, descriptive adjectives) \n\u2022 \nRule variables, which describe the condition to start, end, branch, or loop in the Trial Design Model \nThe set of Qualifier variables can be further categorized into 5 subclasses: \n\u2022 \nGrouping Qualifiers are used to group together a collection of observations within the same domain. \nExamples include --CAT and --SCAT. \n\u2022 \nResult Qualifiers describe the specific results associated with the topic variable in a Findings dataset. They \nanswer the question raised by the topic variable. Result Qualifiers are --ORRES, --STRESC, and --\nSTRESN. \n\u2022 \nSynonym Qualifiers specify an alternative name for a particular variable in an observation. Examples \ninclude \u2011\u2011MODIFY and --DECOD, which are equivalent terms for a --TRT or --TERM topic variable, and -\n-TEST and \u2011\u2011LOINC, which are equivalent terms for a --TESTCD. \n\u2022 \nRecord Qualifiers define additional attributes of the observation record as a whole (rather than describing a \nparticular variable within a record). Examples include --REASND, AESLIFE, and all other serious adverse \nevent (SAE) flag variables in the AE domain; AGE, SEX, and RACE in the DM domain; and --BLFL, --\nPOS, --LOC, --SPEC and --NAM in a Findings domain \n\u2022 \nVariable Qualifiers are used to further modify or describe a specific variable within an observation and are \nonly meaningful in the context of the variable they qualify. Examples include --ORRESU, --ORNRHI, and \n\u2011\u2011ORNRLO, all of which are Variable Qualifiers of --ORRES; and --DOSU, which is a Variable Qualifier \nof \u2011\u2011DOSE. \nFor example, in the observation, \"Subject 101 had mild nausea starting on study day 6,\" the Topic variable value is \nthe term for the adverse event, \"NAUSEA\". The Identifier variable is the subject identifier, \"101\". The Timing \nvariable is the study day of the start of the event, which captures the information, \"starting on study day 6,\" whereas \nan example of a Record Qualifier is the severity, the value for which is \"MILD\". Additional Timing and Qualifier \nvariables could be included to provide the necessary detail to adequately describe an observation.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3193, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "33bc2f95-a781-4ce5-8289-b2ce542c2136": {"__data__": {"id_": "33bc2f95-a781-4ce5-8289-b2ce542c2136", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 11, "section": "2.2 Datasets and Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b93a38d9-3c56-4f55-834f-4a93ceec77a5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 11, "section": "2.2 Datasets and Domains"}, "hash": "e9ecbabcc19ac0e3b743db830c317b358b05f8ee3481e5e17f13876c3f60c7a8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Observations about study subjects are normally collected for all subjects in a series of domains. A domain is defined \nas a collection of logically related observations with a common topic. The logic of the relationship may pertain to \nthe scientific subject matter of the data or to its role in the trial. Each domain is represented by a single dataset. \nEach domain dataset is distinguished by a unique, 2-character code that should be used consistently throughout the \nsubmission. This code, which is stored in the SDTM variable named DOMAIN, is used in 4 ways: as the dataset", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 579, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bee71f84-e212-4f64-aec3-842db521d9cd": {"__data__": {"id_": "bee71f84-e212-4f64-aec3-842db521d9cd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 12, "section": "2.3 The General Observation Classes"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ff689c30-a77b-45df-a972-859622dd69c0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 12, "section": "2.3 The General Observation Classes"}, "hash": "b8c8c1783ef773e5e6da3c4a2341b708872990d9fd5d06c0ea17cb4391b4ae23", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Most subject-level observations collected during the study should be represented according to 1 of the 3 SDTM \ngeneral observation classes: Interventions, Events, or Findings. The lists of variables allowed to be used in each of \nthese can be found in the SDTM. \n\u2022 \nThe Interventions class captures investigational, therapeutic, and other treatments that are administered to \nthe subject (with some actual or expected physiological effect) either as specified by the study protocol \n(e.g., exposure to study drug), coincident with the study assessment period (e.g., concomitant medications), \nor self\u2011administered by the subject (e.g., use of alcohol, tobacco, or caffeine). \n\u2022 \nThe Events class captures planned protocol milestones such as randomization and study completion, and \noccurrences, conditions, or incidents independent of planned study evaluations occurring during the trial \n(e.g., adverse events) or prior to the trial (e.g., medical history). \n\u2022 \nThe Findings class captures the observations resulting from planned evaluations to address specific tests or \nquestions (e.g., laboratory tests, ECG testing, questions listed on questionnaires). \nIn most cases, the choice of observation class appropriate to a specific collection of data can be easily determined \naccording to these descriptions. The majority of data, which typically consists of measurements or responses to \nquestions, usually at specific visits or time points, will fit the Findings general observation class. Additional \nguidance on choosing the appropriate general observation class is provided in Section 8.6.1, Guidelines for \nDetermining the General Observation Class. \nGeneral assumptions for use with all domain models and custom domains based on the general observation classes \nare described in Section 4, Assumptions for Domain Models; specific assumptions for individual domains are \nincluded with the domain models.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1910, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fb9be06b-95bd-46c2-b767-eff959e08014": {"__data__": {"id_": "fb9be06b-95bd-46c2-b767-eff959e08014", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 12, "section": "2.4 Datasets Other than General Observation Class Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "21f404ae-13ec-48a6-925e-b8871340ef92", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 12, "section": "2.4 Datasets Other than General Observation Class Domains"}, "hash": "7df49dc239e245605feeed789be5b0c9cd9b281292e8ab7dce9b85a40b00461b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The SDTM includes 4 types of datasets other than those based on the general observation classes: \n\u2022 \nDomain datasets with subject-level data that do not conform to 1 of the 3 general observation classes. \nThese include Demographics (DM), Comments (CO), Subject Elements (SE), and Subject Visits (SV), and \nare described in Section 5, Models for Special-purpose Domains. \n\u2022 \nTrial Design Model (TDM) datasets, which represent information about the study design but do not contain \nsubject data. These include datasets such as Trial Arms (TA) and Trial Elements (TE) and are described in \nSection 7, Trial Design Model Datasets. \n\u2022 \nRelationship datasets, such as the RELREC and SUPP-- datasets. These are described in Section \n8, Representing Relationships and Data.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 765, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a4ba4867-190a-42df-9888-087277f72ec7": {"__data__": {"id_": "a4ba4867-190a-42df-9888-087277f72ec7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 13, "section": "2.5 The SDTM Standard Domain Models"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "67af4b81-ecbb-46cc-9233-b353304ee704", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 13, "section": "2.5 The SDTM Standard Domain Models"}, "hash": "4ad758a6a46a0bbd6bb3909adbee0be91657a6836ccd5f8b814b228e71fff1b1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A sponsor should only submit domain datasets that were actually collected (or directly derived from the collected \ndata) for a given study. Decisions on what data to collect should be based on the scientific objectives of the study, \nrather than the SDTM. Note that any data collected that will be submitted in an analysis (ADaM) dataset must be \ntraceable to a source in a tabulation (SDTM) dataset. \nThe collected data for a given study may use standard domains from this and other SDTM implementation guides as \nwell as additional custom domains based on the 3 general observation classes. A list of standard domains is provided \nin Section 3.2.1, Dataset-level Metadata. Final domains will be published only in an SDTM implementation guide \n(this guide or another implementation guide, e.g., SDTMIG for Medical Devices). Therapeutic-area standards \nprojects and other projects may develop proposals for additional domains. Draft versions of these domains may be \nmade available in the CDISC wiki in the SDTM Draft Domains space \n(https://wiki.cdisc.org/display/SDD/SDTM+Draft+Domains+Home). \nThese general rules apply when determining which variables to include in a domain: \n\u2022 \nThe Identifier variables, STUDYID, USUBJID, DOMAIN, and --SEQ are required in all domains based on \nthe general observation classes. Other Identifiers may be added as needed. \n\u2022 \nAny Timing variables are permissible for use in any submission dataset based on a general observation \nclass except where restricted by specific domain assumptions. \n\u2022 \nAny additional Qualifier variables from the same general observation class may be added to a domain \nmodel except where restricted by specific domain assumptions. \n\u2022 \nSponsors may not add any variables other than those described in the preceding 3 bullets. The SDTM \nallows for the inclusion of a sponsor's non-SDTM variables using the Supplemental Qualifiers special-\npurpose dataset structure, described in Section 8.4, Relating Non-standard Variable Values to a Parent \nDomain. As the SDTM continues to evolve, certain additional standard variables may be added to the \ngeneral observation classes.  \n\u2022 \nStandard variables must not be renamed or modified for novel usage. Their metadata should not be \nchanged. \n\u2022 \nA Permissible variable should be used in an SDTM dataset wherever appropriate.   \no \nIf a study includes a data item that would be represented in a Permissible variable, then \nthat variable must be included in the SDTM dataset, even if null. Refer to the Define-XML standard \n(available at https://www.cdisc.org/standards/data-exchange/define-xml) for additional details on how \nto manage no data availability. \no \nIf a study did not include a data item that would be represented in a Permissible variable, then that \nvariable should not be included in the SDTM dataset and should not be declared in the Define-XML \ndocument.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2874, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b09d27ca-3433-434c-a11a-cd99ad8e8bbc": {"__data__": {"id_": "b09d27ca-3433-434c-a11a-cd99ad8e8bbc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 13, "section": "2.6 Creating a New Domain"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9198468a-1196-4456-b38e-e81572af7560", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 13, "section": "2.6 Creating a New Domain"}, "hash": "f2cb8c6c15d8a577e9b41685bdbc1f4cc7a510017df7ea459fcb518192848bd5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This section describes the overall process for creating a custom domain, which must be based on 1 of the 3 SDTM \ngeneral observation classes. The number of domains submitted should be based on the specific requirements of the \nstudy. To create a custom domain, \n1. Confirm that none of the existing published domains will fit the need. A custom domain may only be \ncreated if the data are different in nature and do not fit into an existing published domain. \no \nEstablish a domain of a common topic; that is, where the nature of the data is the same rather than by a \nspecific method of collection (e.g., electrocardiogram). Group and separate data within the domain \nusing --CAT, --SCAT, --METHOD, --SPEC, --LOC, and so on, as appropriate. Examples of different", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 763, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "171e6a50-9b28-46f3-a9f2-de76be1cf63b": {"__data__": {"id_": "171e6a50-9b28-46f3-a9f2-de76be1cf63b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 14, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bc8af54-6469-4faa-add4-ee5b9ce80431", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 14, "section": "UNSPECIFIED"}, "hash": "db07b7a7c967e2e72c1846a198dbf3dccce49c24de0eaa456a90261612f86e95", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "678fb24e-5ec2-400f-8cba-7286f5786914", "node_type": "1", "metadata": {}, "hash": "dea6dffc321fdb06302a6d3255fc8b474c25eccfd4e1e4171be87928bda0b2ff", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 14 \n2021-11-29 \ntopics are: microbiology, tumor measurements, pathology/histology, vital signs, and physical exam \nresults. \no \nDo not create separate domains based on time; rather, represent both prior and current observations in \na domain (e.g., CM for all non-study medications). Note that Adverse Events (AE) and Medical \nHistory (MH) are an exception to this best practice because of regulatory reporting needs. \no \nHow collected data are used (e.g., to support analyses and/or efficacy endpoints) must not result in the \ncreation of a custom domain. For example, if blood pressure measurements are endpoints in a \nhypertension study, they must still be represented in the Vital Signs (VS) domain, as opposed to a \ncustom \u201cefficacy\u201d domain. Similarly, if liver function test results are of special interest, they must still \nbe represented in the Laboratory Tests (LB) domain. \no \nData that were collected on separate CRF modules or pages may fit into an existing domain (e.g., as \nseparate questionnaires into the QS domain, prior and concomitant medications in the CM domain). \no \nIf it is necessary to represent relationships between data that are hierarchical in nature (e.g., a parent \nrecord must be observed before child records), then establish a domain pair (e.g., MB/MS, PC/PP). \nNote: Domain pairs have been modeled for microbiology data (MB/MS domains) and \npharmacokinetics (PK) data (PC/PP domains) to enable dataset-level relationships to be described \nusing RELREC. The domain pair uses DOMAIN as an identifier to group parent records (e.g., MB) \nfrom child records (e.g., MS) and enables a dataset-level relationship to be described in RELREC. \nWithout using DOMAIN to facilitate description of the data relationships, RELREC, as currently \ndefined, could not be used without introducing a variable that would group data like DOMAIN. \n2. Check the SDTM Draft Domains area of the CDISC wiki \n(https://wiki.cdisc.org/display/SDD/SDTM+Draft+Domains+Home) for proposed domains developed since \nthe last published version of the SDTMIG. These proposed domains may be used as custom domains in a \nsubmission. \n3. Look for an existing, relevant domain model to serve as a prototype. If no existing model seems \nappropriate, choose the general observation class (Interventions, Events, or Findings) that best fits the data \nby considering the topic of the observation. As illustrated in the following figure, the general approach \nfor selecting variables for a custom domain is: \na. \nSelect and include the required identifier variables (e.g., STUDYID, DOMAIN, USUBJID, --SEQ) and \nany permissible Identifier variables from the SDTM.  \nb. Include the topic variable from the identified general observation class (e.g., --TESTCD for Findings) \nin the SDTM.  \nc. \nSelect and include the relevant qualifier variables from the identified general observation class in the \nSDTM. Variables belonging to other general observation classes must not be added. \nd. Select and include the applicable timing variables in the SDTM.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3210, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "678fb24e-5ec2-400f-8cba-7286f5786914": {"__data__": {"id_": "678fb24e-5ec2-400f-8cba-7286f5786914", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 14, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bc8af54-6469-4faa-add4-ee5b9ce80431", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 14, "section": "UNSPECIFIED"}, "hash": "db07b7a7c967e2e72c1846a198dbf3dccce49c24de0eaa456a90261612f86e95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "171e6a50-9b28-46f3-a9f2-de76be1cf63b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 14, "section": "UNSPECIFIED"}, "hash": "89dcff9c8c6dd74dae0a74b075827bde9547c936a61b0516e80ba60f7be08d54", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3. Look for an existing, relevant domain model to serve as a prototype. If no existing model seems \nappropriate, choose the general observation class (Interventions, Events, or Findings) that best fits the data \nby considering the topic of the observation. As illustrated in the following figure, the general approach \nfor selecting variables for a custom domain is: \na. \nSelect and include the required identifier variables (e.g., STUDYID, DOMAIN, USUBJID, --SEQ) and \nany permissible Identifier variables from the SDTM.  \nb. Include the topic variable from the identified general observation class (e.g., --TESTCD for Findings) \nin the SDTM.  \nc. \nSelect and include the relevant qualifier variables from the identified general observation class in the \nSDTM. Variables belonging to other general observation classes must not be added. \nd. Select and include the applicable timing variables in the SDTM. \ne. \nDetermine the domain code, one that is not a domain code in the CDISC Controlled Terminology \nSDTM Domain Abbreviations codelist (see  https://datascience.cancer.gov/resources/cancer-\nvocabulary/cdisc-terminology). If it is desired to have this domain code be part of CDISC Controlled \nTerminology, submit a request at https://ncitermform.nci.nih.gov/ncitermform/?version=cdisc. The \nsponsor-selected, 2\u2011character domain code should be used consistently throughout the submission. AD, \nAX, AP, SQ, and SA may not be used as custom domain codes. \nf. \nApply the 2-character domain code to the appropriate variables in the domain. Replace all variable \nprefixes (shown in the models as \u201c--\u201c) with the domain code. \ng. Set the order of variables consistent with the order defined in the SDTM for the general observation \nclass. \nh. Adjust the labels of the variables only as appropriate to properly convey the meaning in the context of \nthe data being submitted in the newly created domain. Use title case for all labels (title case means to \ncapitalize the first letter of every word except for articles, prepositions, and conjunctions).", "mimetype": "text/plain", "start_char_idx": 2305, "end_char_idx": 4350, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a375298c-8d31-4a02-97e5-283b716d321e": {"__data__": {"id_": "a375298c-8d31-4a02-97e5-283b716d321e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 15, "section": "2.7 SDTM Variables Not Allowed in the SDTMIG"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6e61283-0840-4dd4-884c-0ebefae6bec2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 15, "section": "2.7 SDTM Variables Not Allowed in the SDTMIG"}, "hash": "6f9e52cfadea7571101f0e59fa3b57ba09663342b1d1fa70fedb181a8ac8c25e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This section identifies those SDTM variables that either (1) should not be used in SDTM-compliant data tabulations \nof clinical trials data or (2) have not yet been evaluated for use in human clinical trials. \nThe following SDTM variables, defined for use in nonclinical studies (SEND), must NEVER be used in the \nsubmission of SDTM-based data for human clinical trials: \n\u2022 \n--USCHFL (Interventions, Events, Findings) \n\u2022 \n--METHOD (Interventions) \n\u2022 \n--RSTIND (Interventions, Findings) \n\u2022 \n--RSTMOD (Interventions, Findings) \n\u2022 \n--IMPLBL (Findings) \n\u2022 \n--RESLOC (Findings) \n\u2022 \n--DTHREL (Findings) \n\u2022 \n--EXCLFL (Findings) \n\u2022 \n--REASEX (Findings) \n\u2022 \nFETUSID (Identifiers) \n\u2022 \nRPHASE (Timing Variables) \n\u2022 \nRPPLDY (Timing Variables) \n\u2022 \nRPPLSTDY (Timing Variables) \n\u2022 \nRPPLENDY (Timing Variables)", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 794, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2927bf33-5aed-444c-9f12-e4b5a9d1f3d7": {"__data__": {"id_": "2927bf33-5aed-444c-9f12-e4b5a9d1f3d7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 16, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0f1fda67-d6a8-4cdb-bf97-4ba7f6c3fdbd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 16, "section": "UNSPECIFIED"}, "hash": "5d3e0ef3e8f7b524e0f1fd4a77c9a341a4a10b0f00c7bbbe2c3409712d3b7878", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 16 \n2021-11-29 \n\u2022 \n--NOMDY (Timing Variables) \n\u2022 \n--NOMLBL (Timing Variables) \n\u2022 \n--RPDY (Timing Variables) \n\u2022 \n--RPSTDY (Timing Variables) \n\u2022 \n--RPENDY (Timing Variables) \n\u2022 \n--DETECT (Timing Variables) \nThe following variables can be used for nonclinical studies (SEND) but must NEVER be used in the Demographics \n(DM) domain for human clinical trials, where all subjects are human. See Section 9.2, Non-host Organism \nIdentifiers, for information about representing taxonomic information for non-host organisms such as bacteria and \nviruses. \n\u2022 \nSPECIES (Demographics) \n\u2022 \nSTRAIN (Demographics) \n\u2022 \nSBSTRAIN (Demographics) \n\u2022 \nRPATHCD (Demographics) \nThe following variables have not been evaluated for use in human clinical trials and must therefore be used with \nextreme caution:    \n\u2022 \n--ANTREG (Findings) \n\u2022 \n--CHRON (Findings) \n\u2022 \n--DISTR (Findings) \n\u2022 \nSETCD (Demographics) \nThe use of SETCD additionally requires the use of the Trials Sets domain. \nThe following identifier variable can be used for nonclinical studies (SEND), and may be used in human clinical \ntrials when appropriate: \n\u2022 \nPOOLID \nThe use of POOLID additionally requires the use of the Pool Definition dataset. \nOther variables defined in the SDTM are allowed for use as defined in this SDTMIG except when explicitly stated. \nCustom domains, created following the guidance in Section 2.6, Creating a New Domain, may utilize any \nappropriate qualifier variables from the selected general observation class.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1662, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0510bbb4-c156-4d83-aea9-bc8913313865": {"__data__": {"id_": "0510bbb4-c156-4d83-aea9-bc8913313865", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.1 Standard Metadata for Dataset Contents and Attributes"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2b1bb312-c026-42ee-8a17-1fad8143f1d0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.1 Standard Metadata for Dataset Contents and Attributes"}, "hash": "3e2897afc0b9e559debdd94acb0da850bb94c1dd1f5777d64205d098ef779c06", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The SDTMIG provides standard descriptions of some of the most commonly used data domains, with metadata \nattributes. These include descriptive metadata attributes that should be included in a Define-XML document. In \naddition, the CDISC domain models include 2 shaded columns that are not sent to the FDA, but which assist \nsponsors in preparing their datasets: \n\u2022 \nThe CDISC Notes column provides information regarding the relevant use of each variable. \n\u2022 \nThe Core column indicates how a variable is classified (see Section 4.1.5, SDTM Core Designations). \nThe domain models in Section 6, Domain Models Based on the General Observation Classes, illustrate how to apply \nthe SDTM when creating a specific domain dataset. In particular, these models illustrate the selection of a subset of \nthe variables offered in 1 of the general observation classes, along with applicable timing variables. The models also \nshow how a standard variable from a general observation class should be adjusted to meet the specific content needs \nof a particular domain, including making the label more meaningful, specifying controlled terminology, and creating \ndomain-specific notes and examples. Thus, the domain models not only demonstrate how to apply the model for the \nmost common domains but also give insight on how to apply general model concepts to other domains not yet \ndefined by CDISC.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1383, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "59b0fd3e-a249-4ab1-bfd3-c387eb3fd75f": {"__data__": {"id_": "59b0fd3e-a249-4ab1-bfd3-c387eb3fd75f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.2 Using the CDISC Domain Models in Regulatory"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bb81f289-a8c7-4488-9c4d-1021fb19d53c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.2 Using the CDISC Domain Models in Regulatory"}, "hash": "e0b83b552cd9f0be17b703811ade3b7685a1f7812ec856a08478b92592290ef6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Submissions \u2013 Dataset Metadata \nThe Define-XML document that accompanies a submission should also describe each dataset that is included in the \nsubmission and describe the natural key structure of each dataset. Most studies will include Demographics (DM) and \na set of safety domains based on the 3 general observation classes\u2014typically including Exposure (EX), Concomitant \nand Prior Medications (CM), Adverse Events (AE), Disposition (DS), Medical History (MH), Laboratory Test \nResults (LB), and Vital Signs (VS). However, choosing which data to submit will depend on the protocol and the \nneeds of the regulatory review division or agency. Dataset definition metadata should include the dataset filenames, \ndescriptions, locations, structures, class, purpose, and keys, as shown in Section 3.2.1, Dataset-level Metadata. In \naddition, comments can also be provided where needed.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 883, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8d792a9f-baea-4cc1-9b06-7682edcc8158": {"__data__": {"id_": "8d792a9f-baea-4cc1-9b06-7682edcc8158", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.2.1 Dataset-level Metadata"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26eaa4bc-6103-41d7-a12c-30a698609ff3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 17, "section": "3.2.1 Dataset-level Metadata"}, "hash": "ffe7d87cb4ce68a8e2c45e232292e8edee62debe1dad4d3a199fc8077143b206", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Note that the key variables shown in this table are examples only. A sponsor\u2019s actual key structure may be \ndifferent. The order of classes and datasets in this table is not intended as a normative order of datasets in a \nsubmission. \n \nDataset \nDescription \nClass \nStructure \nPurpose \nKeys \nLocation \nCO \nComments \nSpecial \nPurpose \nOne record per comment per \nsubject \nTabulation STUDYID, USUBJID, \nIDVAR, COREF, CODTC \nco.xpt \nDM \nDemographics \nSpecial \nPurpose \nOne record per subject \nTabulation STUDYID, USUBJID \ndm.xpt \nSE \nSubject Elements \nSpecial \nPurpose \nOne record per actual Element per \nsubject \nTabulation STUDYID, USUBJID, \nETCD, SESTDTC \nse.xpt \nSM \nSubject Disease \nMilestones \nSpecial \nPurpose \nOne record per Disease Milestone \nper subject \nTabulation STUDYID, USUBJID, \nMIDS \nsm.xpt \nSV \nSubject Visits \nSpecial \nPurpose \nOne record per actual or planned \nvisit per subject \nTabulation STUDYID, USUBJID, \nSVTERM \nsv.xpt \nAG \nProcedure Agents \nInterventions One record per recorded \nintervention occurrence per subject \nTabulation STUDYID, USUBJID, \nAGTRT, AGSTDTC \nag.xpt \nCM \nConcomitant/Prior \nMedications \nInterventions One record per recorded \nintervention occurrence or constant-\ndosing interval per subject \nTabulation STUDYID, USUBJID, \nCMTRT, CMSTDTC \ncm.xpt \nEC \nExposure as \nCollected \nInterventions One record per protocol-specified \nstudy treatment, collected-dosing \ninterval, per subject, per mood \nTabulation STUDYID, USUBJID, \nECTRT, ECSTDTC, \nECMOOD \nec.xpt", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1496, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c772066-41c6-4d4a-8013-4ade07dc3ec7": {"__data__": {"id_": "6c772066-41c6-4d4a-8013-4ade07dc3ec7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b113ab81-802f-449b-9db6-3ee5f72033a2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}, "hash": "126892f2f7bca20dfa48a908c70c4c00f97b29bcd0739184f5d8fa577c9f695c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e476c539-b38a-472e-9a8a-da62a8f8b36d", "node_type": "1", "metadata": {}, "hash": "314880c29907daf0ef22613375e4da5b794df9d7ccb43fc52d760c3173c4c79c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 18 \n2021-11-29 \nDataset \nDescription \nClass \nStructure \nPurpose \nKeys \nLocation \nEX \nExposure \nInterventions One record per protocol-specified \nstudy treatment, constant-dosing \ninterval, per subject \nTabulation STUDYID, USUBJID, \nEXTRT, EXSTDTC \nex.xpt \nML \nMeal Data \nInterventions One record per food product \noccurrence or constant intake \ninterval per subject \nTabulation STUDYID, USUBJID, \nMLTRT, MLSTDTC \nml.xpt \nPR \nProcedures \nInterventions One record per recorded procedure \nper occurrence per subject \nTabulation STUDYID, USUBJID, \nPRTRT, PRSTDTC \npr.xpt \nSU \nSubstance Use \nInterventions One record per substance type per \nreported occurrence per subject \nTabulation STUDYID, USUBJID, \nSUTRT, SUSTDTC \nsu.xpt \nAE \nAdverse Events \nEvents \nOne record per adverse event per \nsubject \nTabulation STUDYID, USUBJID, \nAEDECOD, AESTDTC \nae.xpt \nBE \nBiospecimen Events \nEvents \nOne record per instance per \nbiospecimen event per biospecimen \nidentifier per subject \nTabulation STUDYID, USUBJID, \nBEREFID, BETERM, \nBESDTC \nbe.xpt \nCE \nClinical Events \nEvents \nOne record per event per subject \nTabulation STUDYID, USUBJID, \nCETERM, CESTDTC \nce.xpt \nDS \nDisposition \nEvents \nOne record per disposition status or \nprotocol milestone per subject \nTabulation STUDYID, USUBJID, \nDSDECOD, DSSTDTC \nds.xpt \nDV \nProtocol Deviations \nEvents \nOne record per protocol deviation \nper subject \nTabulation STUDYID, USUBJID, \nDVTERM, DVSTDTC \ndv.xpt \nHO \nHealthcare \nEncounters \nEvents \nOne record per healthcare \nencounter per subject \nTabulation STUDYID, USUBJID, \nHOTERM, HOSTDTC \nho.xpt \nMH \nMedical History \nEvents \nOne record per medical history \nevent per subject \nTabulation STUDYID, USUBJID, \nMHDECOD \nmh.xpt \nBS \nBiospecimen \nFindings \nFindings \nOne record per measurement per \nbiospecimen identifier per subject \nTabulation STUDYID, USUBJID, \nBSREFID, BSTESTCD \nbs.xpt \nCP \nCell Phenotype \nFindings \nFindings \nOne record per test per specimen \nper timepoint per visit per subject \nTabulation STUDYID, USUBJID, \nCPTESTCD, CPSPEC, \nVISITNUM, CPTPTREF, \nCPTPTNUM \ncp.xpt \nCV \nCardiovascular \nSystem Findings \nFindings \nOne record per finding or result per \ntime point per visit per subject \nTabulation STUDYID, USUBJID, \nVISITNUM, CVTESTCD, \nCVTPTREF, CVTPTNUM \ncv.xpt \nDA \nProduct \nAccountability \nFindings \nOne record per product \naccountability finding per subject \nTabulation STUDYID, USUBJID,", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2571, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e476c539-b38a-472e-9a8a-da62a8f8b36d": {"__data__": {"id_": "e476c539-b38a-472e-9a8a-da62a8f8b36d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b113ab81-802f-449b-9db6-3ee5f72033a2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}, "hash": "126892f2f7bca20dfa48a908c70c4c00f97b29bcd0739184f5d8fa577c9f695c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c772066-41c6-4d4a-8013-4ade07dc3ec7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}, "hash": "45fbdc08ae513151dab062238dbf6413635b7e2e23756c6845ccdb5397dcbb4c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "900bd886-e07d-4431-9355-a03ecedd49f6", "node_type": "1", "metadata": {}, "hash": "10978c8fb4797be519bf25c9b08215f107eb41820cd99d07daf1ea44363cd438", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "USUBJID, \nBSREFID, BSTESTCD \nbs.xpt \nCP \nCell Phenotype \nFindings \nFindings \nOne record per test per specimen \nper timepoint per visit per subject \nTabulation STUDYID, USUBJID, \nCPTESTCD, CPSPEC, \nVISITNUM, CPTPTREF, \nCPTPTNUM \ncp.xpt \nCV \nCardiovascular \nSystem Findings \nFindings \nOne record per finding or result per \ntime point per visit per subject \nTabulation STUDYID, USUBJID, \nVISITNUM, CVTESTCD, \nCVTPTREF, CVTPTNUM \ncv.xpt \nDA \nProduct \nAccountability \nFindings \nOne record per product \naccountability finding per subject \nTabulation STUDYID, USUBJID, \nDATESTCD, DADTC \nda.xpt \nDD \nDeath Details \nFindings \nOne record per finding per subject \nTabulation STUDYID, USUBJID, \nDDTESTCD, DDDTC \ndd.xpt \nEG \nECG Test Results \nFindings \nOne record per ECG observation \nper replicate per time point or one \nrecord per ECG observation per \nbeat per visit per subject \nTabulation STUDYID, USUBJID, \nEGTESTCD, VISITNUM, \nEGTPTREF, \nEGTPTNUM \neg.xpt \nFT \nFunctional Tests \nFindings \nOne record per Functional Test \nfinding per time point per visit per \nsubject \nTabulation STUDYID, USUBJID, \nTESTCD, VISITNUM, \nFTTPTREF, FTTPTNUM \nft.xpt \nGF \nGenomics Findings \nFindings \nOne record per finding per \nobservation per biospecimen per \nsubject \nTabulation STUDYID, USUBJID, \nGFTESTCD, GFSPEC, \nVISITNUM, GFTPTREF, \nGFTPTNUM \ngf.xpt \nIE \nInclusion/Exclusion \nCriteria Not Met \nFindings \nOne record per inclusion/exclusion \ncriterion not met per subject \nTabulation STUDYID, USUBJID, \nIETESTCD \nie.xpt \nIS \nImmunogenicity \nSpecimen \nAssessments \nFindings \nOne record per test per visit per \nsubject \nTabulation STUDYID, USUBJID, \nISTESTCD, ISBDAGNT, \nISSCMBCL, ISTSTOPO, \nVISITNUM \nis.xpt \nLB \nLaboratory Test \nResults \nFindings \nOne record per lab test per time \npoint per visit per subject \nTabulation STUDYID, USUBJID, \nLBTESTCD, LBSPEC, \nVISITNUM, LBTPTREF, \nLBTPTNUM \nlb.xpt \nMB \nMicrobiology \nSpecimen \nFindings \nOne record per microbiology \nspecimen finding per time point per \nvisit per subject \nTabulation STUDYID, USUBJID, \nMBTESTCD, VISITNUM, \nMBTPTREF, \nMBTPTNUM \nmb.xpt \nMI \nMicroscopic Findings Findings \nOne record per finding per \nspecimen per subject \nTabulation STUDYID, USUBJID, \nMISPEC, MITESTCD \nmi.xpt \nMK \nMusculoskeletal \nSystem Findings \nFindings \nOne record per assessment per visit \nper subject \nTabulation STUDYID, USUBJID, \nVISITNUM, MKTESTCD, \nMKLOC,", "mimetype": "text/plain", "start_char_idx": 2010, "end_char_idx": 4383, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "900bd886-e07d-4431-9355-a03ecedd49f6": {"__data__": {"id_": "900bd886-e07d-4431-9355-a03ecedd49f6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b113ab81-802f-449b-9db6-3ee5f72033a2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}, "hash": "126892f2f7bca20dfa48a908c70c4c00f97b29bcd0739184f5d8fa577c9f695c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e476c539-b38a-472e-9a8a-da62a8f8b36d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 18, "section": "UNSPECIFIED"}, "hash": "b838b062648129d5406e6c83bf33ea309591bc7650f17fafa3165ede8d7f72b0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "USUBJID, \nLBTESTCD, LBSPEC, \nVISITNUM, LBTPTREF, \nLBTPTNUM \nlb.xpt \nMB \nMicrobiology \nSpecimen \nFindings \nOne record per microbiology \nspecimen finding per time point per \nvisit per subject \nTabulation STUDYID, USUBJID, \nMBTESTCD, VISITNUM, \nMBTPTREF, \nMBTPTNUM \nmb.xpt \nMI \nMicroscopic Findings Findings \nOne record per finding per \nspecimen per subject \nTabulation STUDYID, USUBJID, \nMISPEC, MITESTCD \nmi.xpt \nMK \nMusculoskeletal \nSystem Findings \nFindings \nOne record per assessment per visit \nper subject \nTabulation STUDYID, USUBJID, \nVISITNUM, MKTESTCD, \nMKLOC, MKLAT \nmk.xpt \nMS \nMicrobiology \nSusceptibility \nFindings \nOne record per microbiology \nsusceptibility test (or other \norganism-related finding) per \norganism found in MB \nTabulation STUDYID, USUBJID, \nMSTESTCD, VISITNUM, \nMSTPTREF, \nMSTPTNUM \nms.xpt", "mimetype": "text/plain", "start_char_idx": 3816, "end_char_idx": 4634, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "117eb082-65ae-4692-9ea1-da9985187517": {"__data__": {"id_": "117eb082-65ae-4692-9ea1-da9985187517", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 19, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "00325f72-794d-4e9b-882d-c29ef0e4448f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 19, "section": "UNSPECIFIED"}, "hash": "9e7ebac4a19e1d310df27c8ed70668096b63a34700081825459cfb385f26d9fc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5debdcfe-33ce-41c7-9c13-a0b00a362e6f", "node_type": "1", "metadata": {}, "hash": "ea59aed1888c427c3f4147c8580de16d7452d181491b1a43aa8ef10f49da9176", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 19 \n2021-11-29 \nDataset \nDescription \nClass \nStructure \nPurpose \nKeys \nLocation \nNV \nNervous System \nFindings \nFindings \nOne record per finding per location \nper time point per visit per subject \nTabulation STUDYID, USUBJID, \nVISITNUM, NVTPTNUM, \nNVLOC, NVTESTCD \nnv.xpt \nOE \nOphthalmic \nExaminations \nFindings \nOne record per ophthalmic finding \nper method per location, per time \npoint per visit per subject \nTabulation STUDYID, USUBJID, \nFOCID, OETESTCD, \nOETSTDTL, \nOEMETHOD, OELOC, \nOELAT, OEDIR, \nVISITNUM, OEDTC, \nOETPTREF, \nOETPTNUM, \nOEREPNUM \noe.xpt \nPC \nPharmacokinetics \nConcentrations \nFindings \nOne record per sample \ncharacteristic or time-point \nconcentration per reference time \npoint or per analyte per subject \nTabulation STUDYID, USUBJID, \nPCTESTCD, VISITNUM, \nPCTPTREF, PCTPTNUM \npc.xpt \nPE \nPhysical \nExamination \nFindings \nOne record per body system or \nabnormality per visit per subject \nTabulation STUDYID, USUBJID, \nPETESTCD, VISITNUM \npe.xpt \nPP \nPharmacokinetics \nParameters \nFindings \nOne record per PK parameter per \ntime-concentration profile per \nmodeling method per subject \nTabulation STUDYID, USUBJID, \nPPTESTCD, PPCAT, \nVISITNUM, PPRFTDTC \npp.xpt \nQS \nQuestionnaires \nFindings \nOne record per questionnaire per \nquestion per time point per visit per \nsubject \nTabulation STUDYID, USUBJID, \nQSCAT, QSSCAT, \nVISITNUM, QSTESTCD \nqs.xpt \nRE \nRespiratory System \nFindings \nFindings \nOne record per finding or result per \ntime point per visit per subject \nTabulation STUDYID, USUBJID, \nVISITNUM, RETESTCD, \nRETPTNUM, \nREREPNUM \nre.xpt \nRP \nReproductive \nSystem Findings \nFindings \nOne record per finding or result per \ntime point per visit per subject \nTabulation STUDYID, DOMAIN, \nUSUBJID, RPTESTCD, \nVISITNUM \nrp.xpt \nRS \nDisease Response \nand Clin \nClassification \nFindings \nOne record per response \nassessment or clinical classification \nassessment per time point per visit \nper subject per assessor per \nmedical evaluator \nTabulation STUDYID, USUBJID, \nRSTESTCD, VISITNUM, \nRSTPTREF, \nRSTPTNUM, RSEVAL, \nRSEVALID \nrs.xpt \nSC \nSubject \nCharacteristics \nFindings \nOne record per characteristic per \nvisit per subject.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2329, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5debdcfe-33ce-41c7-9c13-a0b00a362e6f": {"__data__": {"id_": "5debdcfe-33ce-41c7-9c13-a0b00a362e6f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 19, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "00325f72-794d-4e9b-882d-c29ef0e4448f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 19, "section": "UNSPECIFIED"}, "hash": "9e7ebac4a19e1d310df27c8ed70668096b63a34700081825459cfb385f26d9fc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "117eb082-65ae-4692-9ea1-da9985187517", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 19, "section": "UNSPECIFIED"}, "hash": "fe913146fc2d990b6dbaa9da101df561e95b9cfed06483d8fe12c47831839c32", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Tabulation STUDYID, USUBJID, \nSCTESTCD, VISITNUM \nsc.xpt \nSS \nSubject Status \nFindings \nOne record per status per visit per \nsubject \nTabulation STUDYID, USUBJID, \nSSTESTCD, VISITNUM \nss.xpt \nTR \nTumor/Lesion \nResults \nFindings \nOne record per tumor \nmeasurement/assessment per visit \nper subject per assessor \nTabulation STUDYID, USUBJID, \nTRTESTCD, TREVALID, \nVISITNUM \ntr.xpt \nTU \nTumor/Lesion \nIdentification \nFindings \nOne record per identified tumor per \nsubject per assessor \nTabulation STUDYID, USUBJID, \nTUEVALID, TULNKID \ntu.xpt \nUR \nUrinary System \nFindings \nFindings \nOne record per finding per location \nper per visit per subject \nTabulation STUDYID, USUBJID, \nVISITNUM, URTESTCD, \nURLOC, URLAT, URDIR \nur.xpt \nVS \nVital Signs \nFindings \nOne record per vital sign \nmeasurement per time point per \nvisit per subject \nTabulation STUDYID, USUBJID, \nVSTESTCD, VISITNUM, \nVSTPTREF, VSTPTNUM \nvs.xpt \nFA \nFindings About \nEvents or \nInterventions \nFindings \nAbout \nOne record per finding, per object, \nper time point, per visit per subject \nTabulation STUDYID, USUBJID, \nFATESTCD, FAOBJ, \nVISITNUM, FATPTREF, \nFATPTNUM \nfa.xpt \nSR \nSkin Response \nFindings \nAbout \nOne record per finding, per object, \nper time point, per visit per subject \nTabulation STUDYID, USUBJID, \nSRTESTCD, SROBJ, \nVISITNUM, SRTPTREF, \nSRTPTNUM \nsr.xpt \nTA \nTrial Arms \nTrial Design \nOne record per planned Element \nper Arm \nTabulation STUDYID, ARMCD, \nTAETORD \nta.xpt \nTD \nTrial Disease \nAssessments \nTrial Design \nOne record per planned constant \nassessment period \nTabulation STUDYID, TDORDER \ntd.xpt \nTE \nTrial Elements \nTrial Design \nOne record per planned Element \nTabulation STUDYID, ETCD \nte.xpt \nTI \nTrial \nInclusion/Exclusion \nCriteria \nTrial Design \nOne record per I/E criterion \nTabulation STUDYID, IETESTCD \nti.xpt \nTM \nTrial Disease \nMilestones \nTrial Design \nOne record per Disease Milestone \ntype \nTabulation STUDYID, MIDSTYPE \ntm.xpt \nTS \nTrial Summary \nTrial Design \nOne record per trial summary \nparameter value \nTabulation STUDYID, TSPARMCD, \nTSSEQ \nts.xpt", "mimetype": "text/plain", "start_char_idx": 2331, "end_char_idx": 4386, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "df27b1af-962f-4fe4-82cd-c3a3c4f6f1d7": {"__data__": {"id_": "df27b1af-962f-4fe4-82cd-c3a3c4f6f1d7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 20, "section": "3.2.1.1 Primary Keys"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7e0567e9-06a3-4ca2-b2b9-c55cbf644f69", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 20, "section": "3.2.1.1 Primary Keys"}, "hash": "3fa573628b0a64fa67861a9913c2204acec562b2aa1f3066d49a37bac2e0600e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The table in Section 3.2.1, Dataset-level Metadata, shows examples of what a sponsor might submit as variables that \ncomprise the primary key for SDTM datasets. Because the purpose of the Keys column is to aid reviewers in \nunderstanding the structure of a dataset, sponsors should list all of the natural keys for the dataset. These keys should \ndefine uniqueness for records within a dataset, and may define a record sort order. The identified keys for each \ndataset should be consistent with the description of the dataset structure as described in the Define-XML document. \nFor all the general observation-class domains (and for some special-purpose domains), the --SEQ variable was \ncreated so that a unique record could be identified consistently across all of these domains via its use, along with \nSTUDYID, USUBJID, and DOMAIN. In most domains, --SEQ will be a surrogate key for a set of variables that \ncomprise the natural key. In certain instances, a supplemental qualifier (SUPP--) variable might also contribute to \nthe natural key of a record for a particular domain. See Section 4.1.9, Assigning Natural Keys in the Metadata, for \nhow this should be represented, and for additional information on keys. \nDefinitions \nA natural key is a set of data (1 or more columns of an entity) that uniquely identifies that entity and distinguishes it \nfrom any other row in the table. The advantage of natural keys is that they exist already; one does not need to \nintroduce a new, \u201cunnatural\u201d value to the data schema. One of the difficulties in choosing a natural key is that just \nabout any natural key one can think of has the potential to change. Because they have business meaning, natural \nkeys are effectively coupled to the business, and they may need to be reworked when business requirements change. \nAn example of such a change in clinical trials data would be the addition of a position or location that becomes a \nkey in a new study, but which was not collected in previous studies. \nA surrogate key is a single-part, artificially established identifier for a record. Surrogate key assignment is a special \ncase of derived data, one where a portion of the primary key is derived. A surrogate key is immune to changes in \nbusiness needs. In addition, the key depends on only 1 field, so it is compact. A common way of deriving surrogate \nkey values is to assign integer values sequentially. The --SEQ variable in the SDTM datasets is an example of a \nsurrogate key for most datasets; in some instances, however, --SEQ might be a part of a natural key as a replacement \nfor what might have been a key (e.g., a repeat sequence number) in the sponsor's database.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2675, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "37eea7be-b7d4-4bf3-8040-3f8a292e49f0": {"__data__": {"id_": "37eea7be-b7d4-4bf3-8040-3f8a292e49f0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 20, "section": "3.2.1.2 CDISC Submission Value-level Metadata"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "84687bc1-ed51-4ed6-9317-9b43e4a38b9c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 20, "section": "3.2.1.2 CDISC Submission Value-level Metadata"}, "hash": "21afe4c105ecffd5ef21c512e7d5e5e0a3eeea938566ea453be8845c24245386", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In general, findings data models are closely related to normalized, relational data models in a vertical structure of 1 \nrecord per observation. Because general observation class data structures are fixed, sometimes information that \nmight appear as columns in a more horizontal (denormalized) structure in presentations and reports will instead be \nrepresented as rows in an SDTM Findings structure. Because many different types of observations are all presented \nin the same structure, there is a need to provide additional metadata to describe expected properties that differentiate \n(e.g., hematology lab results from serum chemistry lab results in terms of data type, standard units, and other \nattributes). \nFor example, the Vital Signs (VS) data domain could contain subject records related to diastolic and systolic blood \npressure, height, weight, and body mass index (BMI). These data are all submitted in the normalized SDTM", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 935, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4090f594-71a2-4615-9bae-2fa59b3d4354": {"__data__": {"id_": "4090f594-71a2-4615-9bae-2fa59b3d4354", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 21, "section": "3.2.2 Conformance"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7baa544f-5bc2-4628-9681-a43bf5e76965", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 21, "section": "3.2.2 Conformance"}, "hash": "cc6049f4f8fe409391db4a6af88ff4f96560826d4a8793a944986ffbff38afdc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Conformance with the SDTMIG domain models is minimally indicated by: \n\u2022 \nFollowing the complete metadata structure for data domains \n\u2022 \nFollowing SDTMIG domain models wherever applicable \n\u2022 \nUsing SDTM-specified standard domain names and prefixes where applicable \n\u2022 \nUsing SDTM-specified standard variable names \n\u2022 \nUsing SDTM-specified data types for all variables \n\u2022 \nFollowing SDTM-specified controlled terminology and format guidelines for variables, when provided \n\u2022 \nIncluding all collected and relevant derived data in one of the standard domains, special-purpose datasets, \nor general observation class structures \n\u2022 \nIncluding all Required and Expected variables as columns in standard domains, and ensuring that all \nRequired variables are populated \n\u2022 \nEnsuring that each record in a dataset includes the appropriate Identifier and Timing variables, as well as a \nTopic variable \n\u2022 \nConforming to all business rules described in the CDISC Notes column and general and domain-specific \nassumptions", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1008, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "931e04f8-1c4d-4f9a-a667-ec50d6bdad87": {"__data__": {"id_": "931e04f8-1c4d-4f9a-a667-ec50d6bdad87", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.3 Additional Timing Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "823f7865-6a1f-42a0-8a62-38ef5969acb7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.3 Additional Timing Variables"}, "hash": "79fb686b8ba47d55e3ea771b5ea1cc10378318e98f85af3c4c51952f59658c4f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Additional Timing variables can be added as needed to a standard domain model based on the 3 general observation \nclasses, except for the cases specified in Assumption 4.4.8, Date and Time Reported in a Domain Based on \nFindings. Timing variables can be added to special-purpose domains only where specified in the SDTMIG domain \nmodel assumptions. Timing variables cannot be added to SUPPQUAL datasets or to RELREC (described in Section \n8, Representing Relationships and Data).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 479, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9196c4de-297d-4896-bd7d-9894f9dd5bc8": {"__data__": {"id_": "9196c4de-297d-4896-bd7d-9894f9dd5bc8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.3.1 EPOCH Variable Guidance"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d553eb02-b777-43de-a92f-3fc3213102f4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.3.1 EPOCH Variable Guidance"}, "hash": "b2554075f719683a2cb48e5df75480e4d75c4f0081ec448059dba030cf604cf7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When EPOCH is included in a Findings class domain, it should be based on the --DTC variable, since this is the \ndate/time of the test or, for tests performed on specimens, the date/time of specimen collection. For observations in \nInterventions or Events class domains, EPOCH should be based on the --STDTC variable, since this is the start of \nthe intervention or event. A possible, though unlikely, exception would be a finding based on an interval specimen \ncollection that started in one epoch but ended in another.  --ENDTC might be a more appropriate basis for EPOCH \nin such a case. \nSponsors should not impute EPOCH values, but should, where possible, assign EPOCH values on the basis of CRF \ninstructions and structure, even if EPOCH was not directly collected and date/time data was not collected with \nsufficient precision to permit assignment of an observation to an EPOCH on the basis of date/time data alone. If it is \nnot possible to determine the epoch of an observation, then EPOCH should be null. Methods for assigning EPOCH \nvalues can be described in the Define-XML document. \nBecause EPOCH is a study-design construct, it is not applicable to interventions or events that started before the \nsubject's participation in a study, nor to findings performed before participation in a study. For such records, \nEPOCH should be null. Note that a subject's participation in a study includes screening, which generally occurs \nbefore the reference start date (RFSTDTC) in the Demographics (DM) domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1514, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "35cf1243-be53-42bb-8da8-2925efa3d3bc": {"__data__": {"id_": "35cf1243-be53-42bb-8da8-2925efa3d3bc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.4 Order of the Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "39a662a1-e0ff-4e04-9fc1-c48c3a61c16a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 22, "section": "4.1.4 Order of the Variables"}, "hash": "c782d969becd2ada9ddce4bce7e6adee9e0d0e58e9f44097f151710aead525e6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The order of variables in the Define-XML document must reflect the order of variables in the dataset. The order of \nvariables in CDISC domain models has been chosen to facilitate the review of the models and application of the \nmodels. Variables for the 3 general observation classes must be ordered with Identifiers variables first, followed by \nTopic, Qualifier, and Timing variables. Within each role, variables must be ordered as shown in SDTM Sections \n3.1.1, The Interventions Observation Class; 3.1.2, The Events Observation Class; 3.1.3, The Findings Observation \nClass; 3.1.3.1, Findings About Events or Interventions; 3.1.4, Identifiers for All Classes; and 3.1.5, Timing \nVariables for All Classes.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 709, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b4bb0665-64d6-424d-8070-1477e41aacb9": {"__data__": {"id_": "b4bb0665-64d6-424d-8070-1477e41aacb9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 23, "section": "4.1.6 Additional Guidance on Dataset Naming"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "39fe581c-3c10-4bb8-8919-1ed4a5fbe707", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 23, "section": "4.1.6 Additional Guidance on Dataset Naming"}, "hash": "4392145601a34f7335c0f9577011b4c0ebd172e065a77ee0d97f9a98783720bb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SDTM datasets are normally named to be consistent with the domain code; for example, the Demographics dataset \n(DM) is named dm.xpt. (See the SDTM Domain Abbreviation codelist, C66734, in CDISC Controlled Terminology \n(https://www.cancer.gov/research/resources/terminology/cdisc) for standard domain codes). Exceptions to this rule \nare described in Section 4.1.7, Splitting Domains, for general observation class datasets and in Section 8, \nRepresenting Relationships and Data, for RELREC and SUPP-- datasets. \nIn some cases, sponsors may need to define new custom domains and may be concerned that CDISC domain codes \ndefined in the future will conflict with those they choose to use. To eliminate any risk of a sponsor using a name that \nCDISC later determines to have a different meaning, domain codes beginning with the letters X, Y, and Z have been \nreserved for the creation of custom domains. Any letter or number may be used in the second position. Note the use \nof codes beginning with X, Y, or Z is optional, and not required for custom domains.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1056, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "57f2e0cf-dce7-4625-825c-a7b176cd2963": {"__data__": {"id_": "57f2e0cf-dce7-4625-825c-a7b176cd2963", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 23, "section": "4.1.7 Splitting Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3217b7f5-32db-48c6-a93b-f985b6b300a7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 23, "section": "4.1.7 Splitting Domains"}, "hash": "154e1e11852a469c50c3aceb8e6c1fbbb588a68cccde5eb36338a4b2c15cf165", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sponsors may choose to split a domain of topically related information into physically separate datasets. \n\u2022 \nA domain based on a general observation class may be split according to values in --CAT. When a domain \nis split on --CAT, --CAT must not be null. \n\u2022 \nThe Findings About (FA) domain (see Section 6.4.4, Findings About Events or Interventions) may \nalternatively be split based on the domain of the value in --OBJ. For example, FACM would store findings \nabout Concomitant/Prior Medications (CM) records. See Section 6.4.2, Naming Findings About Domains, \nfor more details. \nThe following rules must be adhered to when splitting a domain into separate datasets to ensure they can be \nappended back into 1 domain dataset: \n1. The value of DOMAIN must be consistent across the separate datasets as it would have been if they had not \nbeen split (e.g., QS, FA). \n2. All variables that require a domain prefix (e.g., --TESTCD, --LOC) must use the value of DOMAIN as the \nprefix value (e.g., QS, FA). \n3. --SEQ must be unique within USUBJID for all records across all the split datasets. If there are 1000 records \nfor a USUBJID across the separate datasets, all 1000 records need unique values for --SEQ.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1208, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "64363041-b4f3-47d4-ac95-6ea4c32e6032": {"__data__": {"id_": "64363041-b4f3-47d4-ac95-6ea4c32e6032", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 24, "section": "4.1.7.1 Example of Splitting Questionnaires"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ec27e265-2d91-48a2-8280-e1f8ee2d7da3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 24, "section": "4.1.7.1 Example of Splitting Questionnaires"}, "hash": "cbd6c3a01acd439e9d3ef6207754fd0c213cb960d95f83215f54f5385f6da5d5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "QRS datasets are routinely created and reviewed for the individual QRS instrument. This example shows the QS \ndomain data split into 3 datasets: Clinical Global Impression (QSCG), Pain Intensity (QSPI), and Satisfaction of \nLife Scale (QSSW). Each dataset represents a subset of the QS domain data and has only 1 value of QSCAT.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 328, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "90f9ea2f-37cd-4130-bcb7-17b935456e51": {"__data__": {"id_": "90f9ea2f-37cd-4130-bcb7-17b935456e51", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ac918cfc-a1eb-40a4-bfa7-5958a6edeb13", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}, "hash": "d6250f0ec1857b3f86385bebf44575b75d06f36f625d4c97474e33633cf7ed5d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "396c1f40-d6cc-4df2-87a5-39578cd25395", "node_type": "1", "metadata": {}, "hash": "b730cba7e9802df6d91d3b0ba22626050351551af633dba34bbcccea73725389", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 25 \n2021-11-29 \nQS Domains \nDataset for Clinical Global Impressions \nqscg.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nQSSEQ \nQSTESTCD \nQSTEST \nQSCAT \nQSORRES \nQSSTRESC \nQSSTRESN \nQSLOBXFL \nVISITNUM \nVISIT \nVISITDY \nQSDTC \nQSDY \n1 \nCDISC01 \nQS \nCDISC01.100008 \n1 \nCGI0201 \nCGI02-Severity \nCGI \nModerate \n4 \n4 \nY \n1 \nWEEK 1 \n1 \n2003-04-15 \n1 \n2 \nCDISC01 \nQS \nCDISC01.100008 \n2 \nCGI0201 \nCGI02-Severity \nCGI \nMild \n3 \n3 \n \n2 \nWEEK 2 \n7 \n2003-04-21 \n7 \n3 \nCDISC01 \nQS \nCDISC01.100008 \n3 \nCGI0202 \nCGI02-Change \nCGI \nMinimally Improved \n3 \n3 \n \n2 \nWEEK 2 \n7 \n2003-04-21 \n7 \n4 \nCDISC01 \nQS \nCDISC01.100008 \n4 \nCGI0203 \nCGI02-Improvement \nCGI \nA little better \n3 \n3 \n \n2 \nWEEK 2 \n7 \n2003-04-21 \n7 \n5 \nCDISC01 \nQS \nCDISC01.100014 \n1 \nCGI0201 \nCGI02-Severity \nCGI \nModerate \n4 \n4 \nY \n1 \nWEEK 1 \n1 \n2003-04-15 \n1 \n6 \nCDISC01 \nQS \nCDISC01.100014 \n2 \nCGI0201 \nCGI02-Severity \nCGI \nMild \n3 \n3 \n \n2 \nWEEK 2 \n7 \n2003-04-21 \n7 \n7 \nCDISC01 \nQS \nCDISC01.100014 \n3 \nCGI0202 \nCGI02-Change \nCGI \nMinimally Improved \n3 \n3 \n \n2 \nWEEK 2 \n7 \n2003-04-21 \n7 \n8 \nCDISC01 \nQS \nCDISC01.100014 \n4 \nCGI0203 \nCGI02-Improvement \nCGI \nA little better \n3 \n3 \n \n2 \nWEEK 2 \n7 \n2003-04-21 \n7 \nDataset for Pain Intensity \nqspi.xpt \nRow STUDYID DOMAIN USUBJID \nQSSEQ QSTESTCD QSTEST \nQSCAT QSSCAT \nQSORRES \nQSORRESU QSSTRESC QSSTRESN QSSTRESU QSLOC QSMETHOD \nQSLOBXFL VISITNUM QSDTC \nQSDY QSEVLINT \n1 \nCDISC01 QS \nCDISC01.100008 1 \nPI0101 \nPI01-Pain \nIntensity \nPI \nFIBROMYALGIA WORST PAIN \nIMAGINABLE \n \n100 \n100 \n \nBACK \nVISUAL ANALOG \nSCALE (100 MM) \nY \n1 \n2003-04-\n15 \n1 \n-PT24H \n2 \nCDISC01 QS \nCDISC01.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1737, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "396c1f40-d6cc-4df2-87a5-39578cd25395": {"__data__": {"id_": "396c1f40-d6cc-4df2-87a5-39578cd25395", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ac918cfc-a1eb-40a4-bfa7-5958a6edeb13", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}, "hash": "d6250f0ec1857b3f86385bebf44575b75d06f36f625d4c97474e33633cf7ed5d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "90f9ea2f-37cd-4130-bcb7-17b935456e51", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}, "hash": "f9b81efae6fd451f75e412808fbbc1dd73326acedbb9d1bf218cfb17c89763b8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45ba85ce-819e-4370-b463-22b9226bd92a", "node_type": "1", "metadata": {}, "hash": "25c53518bc6e540c4e5520d77cf54ff6f9876ac45022e84908863049e7c92f6e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "xpt \nRow STUDYID DOMAIN USUBJID \nQSSEQ QSTESTCD QSTEST \nQSCAT QSSCAT \nQSORRES \nQSORRESU QSSTRESC QSSTRESN QSSTRESU QSLOC QSMETHOD \nQSLOBXFL VISITNUM QSDTC \nQSDY QSEVLINT \n1 \nCDISC01 QS \nCDISC01.100008 1 \nPI0101 \nPI01-Pain \nIntensity \nPI \nFIBROMYALGIA WORST PAIN \nIMAGINABLE \n \n100 \n100 \n \nBACK \nVISUAL ANALOG \nSCALE (100 MM) \nY \n1 \n2003-04-\n15 \n1 \n-PT24H \n2 \nCDISC01 QS \nCDISC01.100008 2 \nPI0101 \nPI01-Pain \nIntensity \nPI \nFIBROMYALGIA 50 \nmm \n50 \n50 \nmm \nBACK \nVISUAL ANALOG \nSCALE (100 MM) \n \n2 \n2003-04-\n21 \n7 \n-PT24H \n3 \nCDISC01 QS \nCDISC01.100008 3 \nPI0101 \nPI01-Pain \nIntensity \nPI \nFIBROMYALGIA 60 \nmm \n60 \n60 \nmm \nBACK \nVISUAL ANALOG \nSCALE (100 MM) \n \n3 \n2003-04-\n28 \n14 \n-PT24H \n4 \nCDISC01 QS \nCDISC01.100014 4 \nPI0101 \nPI01-Pain \nIntensity \nPI \nFIBROMYALGIA WORST PAIN \nIMAGINABLE \n \n100 \n100 \n \nBACK \nVISUAL ANALOG \nSCALE (100 MM) \nY \n1 \n2003-04-\n15 \n1 \n-PT24H \n5 \nCDISC01 QS \nCDISC01.100014 5 \nPI0101 \nPI01-Pain \nIntensity \nPI \nFIBROMYALGIA 50 \nmm \n50 \n50 \nmm \nBACK \nVISUAL ANALOG \nSCALE (100 MM) \n \n2 \n2003-04-\n21 \n7 \n-PT24H \n6 \nCDISC01 QS \nCDISC01.100014 6 \nPI0101 \nPI01-Pain \nIntensity \nPI \nFIBROMYALGIA 60 \nmm \n60 \n60 \nmm \nBACK \nVISUAL ANALOG \nSCALE (100 MM) \n \n3 \n2003-04-\n28 \n14 \n-PT24H \nDataset for Satisfaction of Life Scale \nqssw.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nQSSEQ \nQSTESTCD \nQSTEST \nQSCAT \nQSORRES \nQSSTRESC \nQSSTRESN \nQSLOBXFL \nVISITNUM \nQSDTC \nQSDY \n1 \nCDISC01 \nQS \nCDISC01.100008 \n1 \nSWLS0101 \nSWLS01-My Life is Close to Ideal \nSWLS \nSlightly agree \n5 \n5 \nY \n1 \n2003-04-15 \n1 \n2 \nCDISC01 \nQS \nCDISC01.100008 \n2 \nSWLS0102 \nSWLS01-My Life Conditions are Excellent \nSWLS \nNeither agree nor disagree \n4 \n4 \nY \n1 \n2003-04-15 \n1 \n3 \nCDISC01 \nQS \nCDISC01.", "mimetype": "text/plain", "start_char_idx": 1358, "end_char_idx": 3039, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45ba85ce-819e-4370-b463-22b9226bd92a": {"__data__": {"id_": "45ba85ce-819e-4370-b463-22b9226bd92a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ac918cfc-a1eb-40a4-bfa7-5958a6edeb13", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}, "hash": "d6250f0ec1857b3f86385bebf44575b75d06f36f625d4c97474e33633cf7ed5d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "396c1f40-d6cc-4df2-87a5-39578cd25395", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 25, "section": "UNSPECIFIED"}, "hash": "234fbf33dca9fe96dcbbeac0741a8e4a7ca182ba3d1404f27c364debb60349b0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nQSSEQ \nQSTESTCD \nQSTEST \nQSCAT \nQSORRES \nQSSTRESC \nQSSTRESN \nQSLOBXFL \nVISITNUM \nQSDTC \nQSDY \n1 \nCDISC01 \nQS \nCDISC01.100008 \n1 \nSWLS0101 \nSWLS01-My Life is Close to Ideal \nSWLS \nSlightly agree \n5 \n5 \nY \n1 \n2003-04-15 \n1 \n2 \nCDISC01 \nQS \nCDISC01.100008 \n2 \nSWLS0102 \nSWLS01-My Life Conditions are Excellent \nSWLS \nNeither agree nor disagree \n4 \n4 \nY \n1 \n2003-04-15 \n1 \n3 \nCDISC01 \nQS \nCDISC01.100008 \n3 \nSWLS0103 \nSWLS01-I Am Satisfied with My Life \nSWLS \nAgree \n6 \n6 \nY \n1 \n2003-04-15 \n1 \n4 \nCDISC01 \nQS \nCDISC01.100008 \n4 \nSWLS0104 \nSWLS01-Have Gotten Important Things \nSWLS \nDisagree \n2 \n2 \nY \n1 \n2003-04-15 \n1 \n5 \nCDISC01 \nQS \nCDISC01.100008 \n5 \nSWLS0105 \nSWLS01-Live Life Over Change Nothing \nSWLS \nStrongly disagree \n1 \n1 \nY \n1 \n2003-04-15 \n1 \n6 \nCDISC01 \nQS \nCDISC01.100014 \n6 \nSWLS0101 \nSWLS01-My Life is Close to Ideal \nSWLS \nSlightly agree \n5 \n5 \nY \n1 \n2003-04-15 \n1 \n7 \nCDISC01 \nQS \nCDISC01.100014 \n7 \nSWLS0102 \nSWLS01-My Life Conditions are Excellent \nSWLS \nNeither agree nor disagree \n4 \n4 \nY \n1 \n2003-04-15 \n1 \n8 \nCDISC01 \nQS \nCDISC01.100014 \n8 \nSWLS0103 \nSWLS01-I Am Satisfied with My Life \nSWLS \nAgree \n6 \n6 \nY \n1 \n2003-04-15 \n1 \n9 \nCDISC01 \nQS \nCDISC01.100014 \n9 \nSWLS0104 \nSWLS01-Have Gotten Important Things \nSWLS \nDisagree \n2 \n2 \nY \n1 \n2003-04-15 \n1 \n10 \nCDISC01 \nQS \nCDISC01.100014 \n10 \nSWLS0105 \nSWLS01-Live Life Over Change Nothing \nSWLS \nStrongly disagree \n1 \n1 \nY \n1 \n2003-04-15 \n1 \nSUPPQS Domains \nSupplemental Qualifiers for QSCG \nsuppqscg.xpt \nRow STUDYID RDOMAIN USUBJID \nIDVAR \nIDVARVAL QNAM \nQLABEL \nQVAL \nQORIG QEVAL \n1 \nCDISC01 QS \nCDISC01.100008 QSCAT CGI \nQSLANG Questionnaire Language GERMAN CRF \n \n2 \nCDISC01 QS \nCDISC01.100014 QSCAT CGI \nQSLANG Questionnaire Language FRENCH CRF", "mimetype": "text/plain", "start_char_idx": 2610, "end_char_idx": 4362, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3684f11b-0477-419f-9fef-98a073e4dba7": {"__data__": {"id_": "3684f11b-0477-419f-9fef-98a073e4dba7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.8.1 Origin Metadata for Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "52c97290-6409-450f-b721-1d681b9f120e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.8.1 Origin Metadata for Variables"}, "hash": "1f755166f95d53a8ce4679641f8681bebd2f3bae310cf631f570c2fe006caafe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The origin element in the Define-XML document file is used to indicate where the data originated. Its purpose is to \nunambiguously communicate to the reviewer the origin of the data source. For example, data could be collected (on \nthe CRF, from a vendor, or from a device), derived, or assigned; CRF data should be traceable to an annotated CRF \nand derived data should be traceable to some derivation algorithm. The Define-XML specification is the definitive \nsource of allowable origin values. Additional guidance and supporting examples can be referenced using the \nMetadata Submission Guidelines (MSG) for SDTMIG.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 618, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9eafdd91-7c02-4adf-86a9-d1f74ce6a0bf": {"__data__": {"id_": "9eafdd91-7c02-4adf-86a9-d1f74ce6a0bf", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.8.2 Origin Metadata for Records"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "529f86b4-666a-4f51-b47d-a1976b2efe68", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.8.2 Origin Metadata for Records"}, "hash": "f6e1e9b2a0c12d5d159bfabeabab61c85c45aa0b4c352ebd195f8aadc20f2d73", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sponsors are cautioned to recognize that a derived origin means that all values for that variable were derived, and \nthat collected on the CRF applies to all values as well. In some cases, both collected and derived values may be \nreported in the same field. For example, some records in a Findings dataset such as Questionnaires (QS) contain \nvalues collected from the CRF; other records may contain derived values, such as a total score. When both derived \nand collected values are reported in a variable, the origin is to be described using value-level metadata in the Define-\nXML document.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 593, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4ce49949-9fa9-44fc-8d92-e0d82ba20150": {"__data__": {"id_": "4ce49949-9fa9-44fc-8d92-e0d82ba20150", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.9 Assigning Natural Keys in the Metadata"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "445909e9-5f8d-419a-ab85-b6216db79d9e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 26, "section": "4.1.9 Assigning Natural Keys in the Metadata"}, "hash": "c58aa3e138da7c2e3190fcb5ad3c4616049fdbaacd201cb85e645c9fef30ae13", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Section 3.2, Using the CDISC Domain Models in Regulatory Submissions \u2013 Dataset Metadata, indicates that a \nsponsor should include in the metadata the variables that contribute to the natural key for a domain. In a case where \na dataset includes a mix of records with different natural keys, the natural key that provides the most granularity is \nthe one that should be provided. The following example illustrates how to do this, and include a case where a \nSupplemental Qualifier variable is referenced because it forms part of the natural key. \nMusculoskeletal System Findings (MK) Domain Example \nSponsor A chooses the following natural key for the MK domain: \nSTUDYID, USUBJID, VISTNUM, MKTESTCD \nSponsor B collects data in such a way that the location (MKLOC and MKLAT) and method (MKMETHOD) \nvariables need to be included in the natural key to identify a unique row. Sponsor B then defines the following \nnatural key for the MK domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 940, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "40b1af4b-6630-4fd6-8eff-1b5f5f95f258": {"__data__": {"id_": "40b1af4b-6630-4fd6-8eff-1b5f5f95f258", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 27, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08838fff-1123-4e92-ae96-c719f5412ae5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 27, "section": "UNSPECIFIED"}, "hash": "0e11187b1712859c6e5365235301b51d0d1615207d06969cd743fca801792478", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "23a7c845-8511-4f98-9703-893052036c06", "node_type": "1", "metadata": {}, "hash": "1f2fceb2d3f32902a92534b2c5560c21bf253a6716571a0bbf07f99586a794de", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 27 \n2021-11-29 \nSTUDYID, USUBJID, VISITNUM, MKTESTCD, MKLOC, MKLAT, MKMETHOD \nIn certain instances a Supplemental Qualifier variable (i.e., a QNAM value; see Section 8.4, Relating Non-standard \nVariable Values to a Parent Domain) might also contribute to the natural key of a record, and therefore needs to be \nreferenced as part of the natural key for a domain. The important concept here is that a domain is not limited by \nphysical structure. A domain may comprise more than 1 physical dataset (e.g., the main domain dataset and its \nassociated Supplemental Qualifiers dataset). Supplemental Qualifier variables should be referenced in the natural \nkey by using a 2-part name. The word QNAM must be used as the first part of the name to indicate that the \ncontributing variable exists in a domain-specific SUPP--; the second part is the value of QNAM that ultimately \nbecomes a column reference when the SUPPQUAL records are joined on to the main domain dataset (e.g., \nQNAM.XVAR when the SUPP-- record has a QNAM of \"XVAR\") . \nIn this example, sponsor B might have collected data that used different imaging methods, using imaging devices \nwith different makes and models, and using different hand positions. The sponsor considers the make and model \ninformation and hand position to be essential data that contributes to the uniqueness of the test result, and so \nincludes a device identifier (SPDEVID) in the data and creates a Supplemental Qualifier variable for hand position \n(QNAM = \"MKHNDPOS\"). The natural key is then defined as follows: \nSTUDYID, USUBJID, SPDEVID, VISITNUM, MKTESTCD, MKLOC, MKLAT, MKMETHOD, \nQNAM.MKHNDPOS \nwhere the notation \"QNAM.MKHNDPOS\" means the Supplemental Qualifier whose QNAM \nis \"MKHNDPOS\".This approach becomes very useful in a Findings domain when --TESTCD values are \"generic\" \nand rely on other variables to completely describe the test. The use of generic test codes helps to create distinct lists \nof manageable controlled terminology for --TESTCD. In studies where multiple repetitive tests or measurements are \nbeing made, for example in a rheumatoid arthritis study where repetitive measurements of bone erosion in the hands \nand wrists might be made using both X-ray and MRI equipment, the generic MKTEST \"Sharp/Genant Bone Erosion \nScore\" would be used in combination with other variables to fully identify the result. \nTaking just the phalanges, a sponsor might want to express the following in a test in order to make it unique: \n\u2022 \nLeft or right hand \n\u2022 \nPhalangeal joint position (which finger, which joint) \n\u2022 \nRotation of the hand \n\u2022 \nMethod of measurement (x-ray or MRI) \n\u2022 \nMachine make and model \nWhen CDISC Controlled Terminology for a test is not available, and a sponsor creates --TEST and --TESTCD \nvalues, trying to encapsulate all information about a test within a unique value of a --TESTCD is not a \nrecommended approach for the following reasons: \n\u2022 \nIt results in the creation of a potentially large number of test codes. \n\u2022 \nThe 8-character values of --TESTCD become less intuitively meaningful.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3247, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "23a7c845-8511-4f98-9703-893052036c06": {"__data__": {"id_": "23a7c845-8511-4f98-9703-893052036c06", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 27, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "08838fff-1123-4e92-ae96-c719f5412ae5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 27, "section": "UNSPECIFIED"}, "hash": "0e11187b1712859c6e5365235301b51d0d1615207d06969cd743fca801792478", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40b1af4b-6630-4fd6-8eff-1b5f5f95f258", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 27, "section": "UNSPECIFIED"}, "hash": "41f945e4cfc469d056c1604998e5e7b4313f4b3ea28b57983d672a4b48d6e350", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Taking just the phalanges, a sponsor might want to express the following in a test in order to make it unique: \n\u2022 \nLeft or right hand \n\u2022 \nPhalangeal joint position (which finger, which joint) \n\u2022 \nRotation of the hand \n\u2022 \nMethod of measurement (x-ray or MRI) \n\u2022 \nMachine make and model \nWhen CDISC Controlled Terminology for a test is not available, and a sponsor creates --TEST and --TESTCD \nvalues, trying to encapsulate all information about a test within a unique value of a --TESTCD is not a \nrecommended approach for the following reasons: \n\u2022 \nIt results in the creation of a potentially large number of test codes. \n\u2022 \nThe 8-character values of --TESTCD become less intuitively meaningful. \n\u2022 \nMultiple test codes are essentially representing the same test or measurement simply to accommodate \nattributes of a test within the --TESTCD value itself (e.g., to represent a body location at which a \nmeasurement was taken). \nAs a result, the preferred approach would be to use a generic (or simple) test code that requires associated qualifier \nvariables to fully express the test detail. This approach was used in creating the CDISC Controlled Terminology \nused in this example: \nThe MKTESTCD value \"SGBESCR\" is a generic test code, and additional information about the test is provided by \nseparate qualifier variables. The variables that completely specify a test may include domain variables and \nsupplemental qualifier variables. Expressing the natural key becomes very important in this situation in order to \ncommunicate the variables that contribute to the uniqueness of a test. \nThe following variables would be used to fully describe the test. The natural key for this domain includes \nboth parent dataset variables and a supplemental qualifier variable that contribute to the natural key of each row and \nto describe the uniqueness of the test.", "mimetype": "text/plain", "start_char_idx": 2552, "end_char_idx": 4410, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d670b1e-3b9a-4aec-9fb0-da3bdc2e8b54": {"__data__": {"id_": "6d670b1e-3b9a-4aec-9fb0-da3bdc2e8b54", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 28, "section": "4.2.1 Variable-naming Conventions"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7fb8eaab-4b53-40da-bf24-87d9d54aee3d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 28, "section": "4.2.1 Variable-naming Conventions"}, "hash": "330fb852319f466ca9802aadd795bdb3ef00d9ee5b2319a6777f18d111862abe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SDTM variables are named according to a set of conventions, using fragment names (see Appendix D, CDISC \nVariable-naming Fragments). Variables with names ending in \"CD\" are \"short\" versions of associated variables that \ndo not include the \"CD\" suffix (e.g., --TESTCD is the short version of --TEST). \nValues of --TESTCD must be limited to 8 characters and cannot start with a number, nor can they contain characters \nother than letters, numbers, or underscores. This is to avoid possible incompatibility with SAS v5 transport files. \nThis limitation will be in effect until the use of other formats (e.g., Dataset-XML) becomes acceptable to regulatory \nauthorities. \nBecause QNAM serves the same purpose as --TESTCD within supplemental qualifier datasets, values of QNAM are \nsubject to the same restrictions as values of --TESTCD. \nValues of other \"CD\" variables are not subject to the same restrictions as --TESTCD: \n\u2022\nETCD (the companion to ELEMENT) and TSPARMCD (the companion to TSPARM) are limited to 8\ncharacters and do not have the character restrictions that apply to --TESTCD. These values should be short\nfor ease of use in programming, but it is not expected that they will need to serve as variable names.\n\u2022\nARMCD is limited to 20 characters and does not have the character restrictions that apply to --TESTCD.\nThe maximum length of ARMCD is longer than for other \"short\" variables to accommodate the kind of\nvalues that are likely to be needed for crossover trials. For example, if ARMCD values for a 7-period\ncrossover were constructed using 2-character abbreviations for each treatment and separating hyphens, the\nlength of ARMCD values would be 20. This same rule applies to the ACTARMCD variable.\nVariable descriptive names (labels), up to 40 characters, should be provided as data variable labels for all variables, \nincluding Supplemental Qualifier variables. \nUse of variable names (other than domain prefixes), formats, decodes, terminology, and data types for the same type \nof data (even for custom domains and Supplemental Qualifiers) should be consistent within and across studies \nwithin a submission.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2128, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ee1e3af4-2d8b-4614-81f2-728cdc88bebb": {"__data__": {"id_": "ee1e3af4-2d8b-4614-81f2-728cdc88bebb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 28, "section": "4.2.2 Two-character Domain Identifier"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b23807e2-193f-4f4e-a0e4-cd4dc812ea79", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 28, "section": "4.2.2 Two-character Domain Identifier"}, "hash": "6be7c3346c3ceb696a21dfc4cfa18e46445019fc907e8e8bf7cf20f0a235eaf7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In order to minimize the risk of difficulty when merging/joining domains for reporting purposes, the 2-character \ndomain identifier is used as a prefix in most variable names. \nVariables in domain specification tables (see Section 5, Models for Special-purpose Domains; Section 6, Domain \nModels Based on the General Observation Classes; Section 7, Trial Design Model Datasets; Section 8, Representing \nRelationships and Data; and Section 9, Study References) already specify the complete variable names. When \nadding variables from the SDTM to standard domains or creating custom domains based on the general observation \nclasses, sponsors must replace the \"--\" prefix in the SDTM tables of General Observation Class, Timing, and \nIdentifier variables with the 2-character domain identifier (DOMAIN) value for that domain/dataset. The 2-character \ndomain code is limited to A-Z for the first character, and A-Z, 0-9 for the second character. No other characters are \nallowed. This is for compatibility with SAS v5 transport files and with file naming requirements as part of the \nElectronic Common Technical Document (eCTD). \nThe following variables are exceptions to the philosophy that all variable names are prefixed with the domain \nidentifier: \n\u2022\nRequired Identifiers (STUDYID, DOMAIN, USUBJID)\n\u2022\nCommonly used grouping and merge keys (e.g., VISIT, VISITNUM, VISITDY)\n\u2022\nAll Demographics (DM) domain variables other than DMDTC and DMDY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1440, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "945159ff-2093-42ca-939a-8e1054b1d701": {"__data__": {"id_": "945159ff-2093-42ca-939a-8e1054b1d701", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.3 Use of \"Subject\" and USUBJID"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f66c3632-a5c9-4a2e-a889-c71dc1288dd6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.3 Use of \"Subject\" and USUBJID"}, "hash": "0123b8388404e9012c9ad10455ee755cdaf0ad8ad963e755ffa7fb834951f959", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\"Subject\" is used to generically refer to both patients and healthy volunteers in order to be consistent with the \nrecommendation in FDA guidance. The term \"subject\" should be used consistently in all labels and Define-XML \ndocument comments. To identify a subject uniquely across all studies for all applications or submissions involving \nthe product, a unique identifier (USUBJID) should be assigned and included in all datasets. \nThe unique subject identifier (USUBJID) is required in all datasets containing subject-level data. USUBJID values \nmust be unique for each trial participant (subject) across all trials in the submission. This means that no 2 or more \nsubjects, across all trials in the submission, may have the same USUBJID. In addition, the same person who \nparticipates in multiple clinical trials (when this is known) must be assigned the same USUBJID value in all trials. \nCDISC does not recommend any specific format for the values of USUBJID, only that the values need to be unique \nfor all subjects in the submission, and across multiple submissions for the same compound. Many sponsors \nconcatenate values for the study, site, and subject into USUBJID, but this is not a requirement. It is acceptable to use \nany format for USUBJID, as long as the values are unique across all subjects. \nThe following dm.xpt sample rows illustrate a single subject who participates in 2 studies, first in ACME01 and \nlater in ACME14. Note that this is only one example of the possible values for USUBJID.  \ndm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSUBJID \nSITEID \nINVNAM \n1 \nACME01 \nDM \nACME01-05-001 \n001 \n05 \nJohn Doe \n \ndm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSUBJID \nSITEID \nINVNAM \n1 \nACME14 \nDM \nACME01-05-001 \n017 \n14 \nMary Smith", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1741, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f4cc50e0-6713-4aca-bfef-cd21204cbca7": {"__data__": {"id_": "f4cc50e0-6713-4aca-bfef-cd21204cbca7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.4 Text Case in Submitted Data"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3f46645f-a667-4ee6-8eba-de6e382515fe", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.4 Text Case in Submitted Data"}, "hash": "f232e8ae092a634f95e92bbbe9016e0d8a4b2decd13362bfeea0717a79e1e6d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It is recommended that text data be submitted in text that is all upper case (e.g., NEGATIVE). Exceptions may \ninclude long text data (e.g., comment text) and values of --TEST in Findings datasets (which may be more readable \nin title case if used as labels in transposed views). Values from CDISC Controlled Terminology or external code \nsystems (e.g., MedDRA, SNOMED) or response values for QRS instruments specified by the instrument \ndocumentation should be in the case specified by those sources, which may be mixed case. The case used in the text \ndata must match the case used in the controlled terminology provided in the Define-XML document.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 650, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f9c1cbcc-82de-4ad8-819b-f19e0169a29d": {"__data__": {"id_": "f9c1cbcc-82de-4ad8-819b-f19e0169a29d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.6 Grouping Variables and Categorization"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "00564d05-b1f7-454d-8a1f-0d692061ae2b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 29, "section": "4.2.6 Grouping Variables and Categorization"}, "hash": "21f7d8b5833a474122717785bc11e72729e79a51f473148d8313695bdb413577", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Grouping variables are Identifiers and Qualifiers variables\u2014such as the --CAT (Category) and --SCAT \n(Subcategory)\u2014that group records in the SDTM domains/datasets and can be assigned by sponsors to categorize \ntopic-variable values. For example, a lab record with LBTEST = \"SODIUM\" might have LBCAT = \"CHEMISTRY\" \nand LBSCAT = \"ELECTROLYTES\". Values for --CAT and --SCAT should not be redundant with the domain \nname or dictionary classification provided by --DECOD and --BODSYS.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 479, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "11d253aa-3ce4-41a5-8062-3d8fdbc772fc": {"__data__": {"id_": "11d253aa-3ce4-41a5-8062-3d8fdbc772fc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 30, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d8e07c12-cea3-495b-89ee-f3afcb526622", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 30, "section": "UNSPECIFIED"}, "hash": "2b3bb3595a0288378d10e5f24b3a8de4f773af474a24ec45ece8167966e66820", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 30 \n2021-11-29 \nHierarchy of Grouping Variables \nSTUDYID \nDOMAIN \n--CAT \n--SCAT \n \n   USUBJID \n \n \n--GRPID \n \n \n--LNKID \n \n \n--LNKGRP \nHow Grouping Variables Group Data \nFor the subject \n1. All records with the same USUBJID value are a group of records that describe that subject. \nAcross subjects (records with different USUBJID values) \n1. All records with the same STUDYID value are a group of records that describe that study. \n2. All records with the same DOMAIN value are a group of records that describe that domain. \n3. --CAT (Category) and --SCAT (Sub-category) values further subset groups within the domain. Generally, -\n-CAT/--SCAT values have meaning within a particular domain. However, it is possible to use the same \nvalues for --CAT/--SCAT in related domains (e.g., MH and AE). When values are used across domains, the \nmeanings should be the same. Examples of where --CAT/--SCAT may have meaning across \ndomains/datasets include: \na. \nCases where different domains in the same general observation class contain similar conceptual \ninformation. Adverse Events (AE), Medical History (MH), and Clinical Events (CE), for example, are \nconceptually the same data, the only differences being when the event started relative to the study start \nand whether the event is considered a regulatory-reportable adverse event in the study. Neurotoxicities \ncollected in oncology trials both as separate Medical History CRFs (MH domain) and Adverse Event \nCRFs (AE domain) could both identify/collect \"Paresthesia of the left arm\". In both domains, the --\nCAT variable could have the value of \"NEUROTOXICITY\". \nb. Cases where multiple datasets are necessary to capture data about the same topic. Following the \noncology example, the existence and start and stop date of paresthesia of the left arm may be reported \nas an adverse event (AE domain), whereas the severity of the event is captured at multiple visits and \nrecorded as Findings About (FA dataset). In both cases the --CAT variable could have a value of \n\"NEUROTOXICITY\". \nc. \nCases where multiple domains are necessary to capture data that were collected together and have an \nimplicit relationship, perhaps identified in the Related Records (RELREC) special-purpose dataset.  \nStress-test data collection may capture the following: \ni. Information about the occurrence, start, stop, and duration of the test (in the Procedures (PR) \ndomain) \nii. Vital Signs recorded during the stress test (VS domain) \niii. Treatments (e.g., oxygen) administered during the stress test (in an Interventions domain) \nIn such cases, the data collected during the stress tests recorded in 3 separate domains may all have  \n--CAT/--SCAT values (STRESS TEST) that identify that data were collected during the stress test. \nWithin subjects (records with the same USUBJID values) \n1. --GRPID values further group (subset) records within USUBJID. All records in the same domain with the \nsame --GRPID value are a group of records within USUBJID. Unlike --CAT and --SCAT, --GRPID values \nare not intended to have any meaning across subjects and are usually assigned during or after data \ncollection.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3318, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8f519c6e-8b28-4fe0-8ae6-64734a22f348": {"__data__": {"id_": "8f519c6e-8b28-4fe0-8ae6-64734a22f348", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 31, "section": "4.2.7.1 \"Specify\" Values for Non-result Qualifier Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ec35928-2310-45b3-9da2-99cd68215bd5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 31, "section": "4.2.7.1 \"Specify\" Values for Non-result Qualifier Variables"}, "hash": "c7c4e4005c6203fbf4dc9338c684ddd2a7c3db0a6ff0f1c4a7ad32f412e8dd10", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When free-text information is collected to supplement a standard non-result qualifier field, the free-text value should \nbe placed in the SUPP-- dataset described in Section 8.4, Relating Non-standard Variable Values to a Parent \nDomain. When applicable, controlled terminology should be used for SUPP-- field names (QNAM) and their \nassociated labels (QLABEL; see Section 8.4, Relating Non-standard Variable Values to a Parent Domain, and \nAppendix C1, Supplemental Qualifiers Name Codes). \nFor example, when a description of \"Other Medically Important Serious Adverse Event\" category is collected on a \nCRF, the free-text description should be stored in the SUPPAE dataset. \n\u2022 \nAESMIE = \"Y\" \n\u2022 \nSUPPAE QNAM = \"AESOSP\", QLABEL = \"Other Medically Important SAE\", QVAL = \"HIGH RISK \nFOR ADDITIONAL THROMBOSIS\"", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 808, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a6ec59a2-35ae-4dd0-9c14-0db1a94414e2": {"__data__": {"id_": "a6ec59a2-35ae-4dd0-9c14-0db1a94414e2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 32, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0ed4567d-4935-44e9-a34b-df78b3c15084", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 32, "section": "UNSPECIFIED"}, "hash": "bcd57264645c34a2db27ab8d0a56289818cb140e1e72830339e660305e0b0c85", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 32 \n2021-11-29 \nAnother example is a CRF that collects reason for dose adjustment with additional free-text description: \nReason for Dose Adjustment (EXADJ) Describe \n\uf0b7 \nAdverse Event \n \n\uf0b7 \nInsufficient Response \n \n\uf0b7 \nNon-medical Reason \n \nThe free-text description should be stored in the SUPPEX dataset. \n\u2022 \nEXADJ = \"NONMEDICAL REASON\" \n\u2022 \nSUPPEX QNAM = \"EXADJDSC\", QLABEL = \"Reason For Dose Adjustment Description\", QVAL = \n\"PATIENT MISUNDERSTOOD INSTRUCTIONS\" \nNote that QNAM references the \"parent\" variable name with the addition of \"DSC\". Likewise, the label \nis a modification of the parent variable label. \nWhen the CRF includes a list of values for a qualifier field that includes \"Other\" and the \"Other\" is supplemented \nwith a \"Specify\" free-text field, then the manner in which the free-text \"Specify\" value is submitted will vary based \non the sponsor's coding practice and analysis requirements. \nFor example, consider a CRF that collects the indication for an analgesic concomitant medication (CMINDC) using \na list of prespecified values and an \"Other, specify\" field : \nIndication for analgesic \no Post-operative pain \no Headache \no Menstrual pain \no Myalgia \no Toothache \no Other, \nspecify:  ________________ \nAn investigator has selected \"OTHER\" and specified \"Broken arm\". Several options are available for submission of \nthis data: \n1. If the sponsor wishes to maintain controlled terminology for the CMINDC field and limit the terminology \nto the 5 prespecified choices, then the free text is placed in SUPPCM. \nCMINDC \nOTHER \n \nQNAM \nQLABEL \nQVAL \nCMINDOTH \nOther Indication \nBROKEN ARM \n2. If the sponsor wishes to maintain controlled terminology for CMINDC but will expand the terminology \nbased on values seen in the \"Other, specify\" field, then the value of CMINDC will reflect the sponsor's \ncoding decision and SUPPCM could be used to store the verbatim text. \nCMINDC \nFRACTURE \n \nQNAM \nQLABEL \nQVAL \nCMINDOTH \nOther Indication \nBROKEN ARM \nNote that the sponsor might choose a different value for CMINDC (e.g., \"BONE FRACTURE\") depending \non the sponsor's coding practice and analysis requirements. \n3. If the sponsor does not require that controlled terminology be maintained and wishes for all responses to be \nstored in a single variable, then CMINDC will be used and SUPPCM is not required. \nCMINDC \nBROKEN ARM", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2524, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16d74c8b-e437-4aef-99b0-a62a6d462481": {"__data__": {"id_": "16d74c8b-e437-4aef-99b0-a62a6d462481", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 33, "section": "4.2.7.2 \"Specify\" Values for Result Qualifier Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2534cc9a-18f5-41f0-a729-92fac4ba474f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 33, "section": "4.2.7.2 \"Specify\" Values for Result Qualifier Variables"}, "hash": "d03152126eb69c91209bd3301e34c2b404838d649505ea6c188751f1811d0882", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When the CRF includes a list of values for a result field that includes \"Other\" and the \"Other\" is supplemented with \na \"Specify\" free-text field, then the manner in which the free-text \"Specify\" value is submitted will vary based on the \nsponsor's coding practice and analysis requirements. \nFor example, consider a CRF where the sponsor requests the subject's eye color: \nEye Color \no Brown \no Black \no Blue \no Green \no Other, specify:  ________________ \nAn investigator has selected \"OTHER\" and specified \"BLUEISH GRAY\". As in the preceding discussion for non-\nresult qualifier values, the sponsor has several options for submission: \n1. If the sponsor wishes to maintain controlled terminology in the standard result field and limit the \nterminology to the 5 prespecified choices, then the free text is placed in --ORRES and the controlled \nterminology in --STRESC. \nSCTEST \nSCORRES \nSCSTRESC \nEye Color \nBLUEISH GRAY \nOTHER \n2. If the sponsor wishes to maintain controlled terminology in the standard result field, but will expand the \nterminology based on values seen in the \"Other, specify\" field, then the free text is placed in --ORRES and \nthe value of --STRESC will reflect the sponsor's coding decision. \nSCTEST \nSCORRES \nSCSTRESC \nEye Color \nBLUEISH GRAY \nGRAY \n3. If the sponsor does not require that controlled terminology be maintained, the verbatim value will be copied \nto --STRESC. \nSCTEST \nSCORRES \nSCSTRESC \nEye Color \nBLUEISH GRAY \nBLUEISH GRAY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1466, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c8e81117-0215-43c3-aa7c-a8a04b3e85e2": {"__data__": {"id_": "c8e81117-0215-43c3-aa7c-a8a04b3e85e2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 33, "section": "4.2.7.3 \"Specify\" Values for Topic Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1efaafc0-e785-4612-8d00-e7b5673de348", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 33, "section": "4.2.7.3 \"Specify\" Values for Topic Variables"}, "hash": "3e4f4317c376981ce8392be69f7c61e2ab70585c0eac70b11d5127f25721baf0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Interventions \nIf a list of specific treatments is provided along with \"Other, Specify\", --TRT should be populated with the name of \nthe treatment found in the specified text. If the sponsor wishes to distinguish between the prespecified list of \ntreatments and those recorded in \"Other, Specify,\" the --PRESP variable could be used. For example: \nIndicate which of the following \nconcomitant medications \nwas used to treat the subject\u2019s \nheadaches: \no Acetaminophen \no Aspirin \no Ibuprofen \no Naproxen \no Other, \nspecify:  ________________ \nIf ibuprofen and diclofenac were reported, the CM dataset would include the following: \nCMTRT \nCMPRESP \nIBUPROFEN \nY \nDICLOFENAC  \nEvents \n\"Other, Specify\" for events may be handled similarly to Interventions. --TERM should be populated with the \ndescription of the event found in the specified text and --PRESP could be used to distinguish between prespecified \nand free-text responses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 929, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b102b94f-d992-45fe-9e1a-270b474dff09": {"__data__": {"id_": "b102b94f-d992-45fe-9e1a-270b474dff09", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 34, "section": "4.2.7.4 \"Specify\" Values for --OBJ"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "09480d51-21b1-44c5-a447-1ffd05fc03d5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 34, "section": "4.2.7.4 \"Specify\" Values for --OBJ"}, "hash": "3a96bd1bfb2e964aa9a99ff71987646e81ff74561bc908468ce9beacb898580c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As illustrated in the following figure, when findings are collected about an event or intervention, and the name of the \nevent or intervention is collected in an \"Other, specify\" CRF field, the value in --OBJ variable depends on whether \nthe Findings record has a parent record and whether the \"Other, specify\" value was coded. See also Section 6.4.3, \nVariables Unique to Findings About. \nFigure. Decision Tree for Populating --OBJ", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 432, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0999b84f-94f1-40e1-ba7a-9213ea49a456": {"__data__": {"id_": "0999b84f-94f1-40e1-ba7a-9213ea49a456", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 34, "section": "4.2.8.1 Multiple Values for an Intervention or Event Topic Variable"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f0ae9030-e6d8-4e4d-8202-31301c93e593", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 34, "section": "4.2.8.1 Multiple Values for an Intervention or Event Topic Variable"}, "hash": "29aa1455a2377a6d6db898c63b4cc02af15cd27d94c781ba33d6fc0426a7139f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If multiple values are reported for an intervention or event topic variable (e.g., --TRT in an Interventions general \nobservation-class dataset or --TERM in an Events general observation-class dataset), it is expected that the sponsor \nwill split the values into multiple records or otherwise resolve the multiplicity per the sponsor's data management \nstandard operating procedures. For example, if an adverse event term of \"Headache and nausea\" or a concomitant \nmedication of \"Tylenol and Benadryl\" is reported, sponsors will often split the original report into separate records \nand/or query the site for clarification. By the time of submission, datasets should be in conformance with the record \nstructures described in the SDTMIG. \nNote: The Disposition (DS) dataset is an exception to the general rule of splitting multiple topic values into separate \nrecords. For DS, 1 record for each disposition or protocol milestone is permitted according to the domain structure. \nFor cases of multiple reasons for discontinuation see Section 6.2.4, Disposition, assumption 5 for additional \ninformation.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1102, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1faaf82b-64ab-45b0-aef3-6882bcc931ab": {"__data__": {"id_": "1faaf82b-64ab-45b0-aef3-6882bcc931ab", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 35, "section": "4.2.8.3 Multiple Values for a Non-result Qualifier Variable"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70711c2a-68ad-45d6-a017-5852ab1f8924", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 35, "section": "4.2.8.3 Multiple Values for a Non-result Qualifier Variable"}, "hash": "15afb631e5d497bfd9feab6653f914ced08c0b1fdeb2ed3b55f7fd60f5214ba7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The SDTM permits 1 value for each qualifier variable per record. If multiple values exist (e.g., due to a \"Check all \nthat apply\" instruction on a CRF), then the value for the qualifier variable should be \"MULTIPLE\" and SUPP-- \nshould be used to store the individual responses. It is recommended that the SUPP-- QNAM value reference the \ncorresponding standard domain variable with an appended number or letter. In some cases, the standard variable \nname will be shortened to meet the 8-character variable name requirement, or it may be clearer to append a \nmeaningful character string as shown in the second Adverse Events (AE) example below, where the first 3 \ncharacters of the drug name are appended. Likewise, the QLABEL value should be similar to the standard label. The \nvalues stored in QVAL should be consistent with the controlled terminology associated with the standard variable. \nSee Section 8.4, Relating Non-standard Variable Values to a Parent Domain, for additional guidance on maintaining \nappropriately unique QNAM values. \nThe following example includes selected variables from the ae.xpt and suppae.xpt datasets for a rash with locations \non the face, neck, and chest. \nae.xpt \nAETERM \nAELOC \nRASH \nMULTIPLE \nsuppae.xpt \nQNAM \nQLABEL \nQVAL \nAELOC1 \nLocation of the Reaction 1 \nFACE \nAELOC2 \nLocation of the Reaction 2 \nNECK \nAELOC3 \nLocation of the Reaction 3 \nCHEST \nIn some cases, values for QNAM and QLABEL more specific than these may be needed. \nFor example, a sponsor might conduct a study with 2 study drugs (e.g., open-label study of Abcicin + Xyzamin), and \nmay require the investigator assess causality and describe action taken for each drug for the rash: \nae.xpt \nAETERM \nAEREL \nAEACN \nRASH \nMULTIPLE \nMULTIPLE \nsuppae.xpt \nQNAM \nQLABEL \nQVAL \nAERELABC \nCausality of Abcicin \nPOSSIBLY RELATED \nAERELXYZ \nCausality of Xyzamin \nUNLIKELY RELATED \nAEACNABC \nAction Taken with Abcicin \nDOSE REDUCED \nAEACNXYZ \nAction Taken with Xyzamin \nDOSE NOT CHANGED \nIn each of these examples, the use of SUPPAE should be documented in the Define-XML document and the \nannotated CRF. The controlled terminology used should be documented as part of value-level metadata. \nIf the sponsor has clearly documented that one response is of primary interest (e.g., in the CRF, protocol, or analysis \nplan), the standard domain variable may be populated with the primary response and SUPP-- may be used to store \nthe secondary response(s). \nFor example, if Abcicin is designated as the primary study drug in the example above: \nae.xpt \nAETERM \nAEREL \nAEACN \nRASH \nPOSSIBLY RELATED \nDOSE REDUCED", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2601, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ae905cd9-debd-4e60-bdec-daf328ec3e3c": {"__data__": {"id_": "ae905cd9-debd-4e60-bdec-daf328ec3e3c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.2.8.4 Multiple Values for a Parameter"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6457b30f-c01e-4d9f-8a94-a8fe5ca848f6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.2.8.4 Multiple Values for a Parameter"}, "hash": "53215f19a0c8f870e3fbaf2ab112623908929d7321911f9258848105ac5e139c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If multiple values (--VAL) are reported for a parameter in a Trial Design or Study Reference dataset (e.g., TS, OI), \nmultiple records should be submitted for that --PARMCD. \nFor example, \n\u2022 \nTSPARMCD = \"TTYPE\", TSPARM = \"Trial Type\", TSVAL = \"EFFICACY\" \n\u2022 \nTSPARMCD = \"TTYPE\", TSPARM = \"Trial Type\", TSVAL = \"SAFETY\" \nWhen a parameter can have multiple values, the key structure for the dataset must be adequate to distinguish \nbetween the multiple records. See Section 4.1.9, Assigning Natural Keys in the Metadata.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 517, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "024d1b23-17ee-47b2-aa64-4d1ff684e43a": {"__data__": {"id_": "024d1b23-17ee-47b2-aa64-4d1ff684e43a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.2.9 Variable Lengths"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6357e222-3151-462c-a667-8015c9b9f16c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.2.9 Variable Lengths"}, "hash": "0357f85efb208872135440bcf8a38253d2127c1127007048725886e564127a35", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When variable length is referenced in the SDTMIG, this refers to the length in bytes of ASCII character strings. \nVery large transport files have become an issue for certain regulatory authorities (e.g., US FDA) to process. One of \nthe main contributors to large file sizes has been sponsors using the maximum length of 200 for character variables. \nTo help rectify this situation: \n\u2022 \nThe maximum SAS v5 transport file character variable length of 200 characters should not be used unless \nnecessary. \n\u2022 \nSponsors should consider the nature of the data and apply reasonable, appropriate lengths to variables. For \nexample: \no \nThe length of flags will always be 1. \no \n--TESTCD and IDVAR will never be more than 8, so the length can always be set to 8. \no \nThe length for variables that use controlled terminology can be set to the length of the longest term.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 860, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f681b665-5ee6-4702-97d0-cbbf254e6e9c": {"__data__": {"id_": "f681b665-5ee6-4702-97d0-cbbf254e6e9c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.3.1 Controlled Terms, Codelist or Format Column"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d1807b48-048f-4fd6-8bfb-02f4e1f187d8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 36, "section": "4.3.1 Controlled Terms, Codelist or Format Column"}, "hash": "b1731a1da5ed1ab49ad85e80ddb76793ca49393eaf71163ca8ae4a1a57d29315", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As of SDTMIG v3.3, controlled terminology is represented in the following ways: \n\u2022 \nA single asterisk (*) when CDISC Controlled Terminology is not currently available but the SDS Team \nexpects that sponsors may have their own controlled terminology and/or the CDISC Controlled \nTerminology Team may develop controlled terminology in the future \n\u2022 \nThe single applicable value for the variable DOMAIN (e.g., \"PR\") \n\u2022 \nThe name of a CDISC codelist, represented as a hyperlink in parentheses (e.g., \"(NY)\") \n\u2022 \nA short reference to an external terminology (e.g., \"MedDRA\", \"ISO 3166-1 alpha-3\") \nIn addition, the Controlled Terms, Codelist or Format column has been used to indicate variables that use an ISO \n8601 format.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 719, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9a0059ce-08de-4d28-a1a7-257ea5415776": {"__data__": {"id_": "9a0059ce-08de-4d28-a1a7-257ea5415776", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.3 Controlled Terminology Values"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "00715498-e154-41e0-ab3a-e806b74dfd54", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.3 Controlled Terminology Values"}, "hash": "0b68b54a89a6b9571d23bda39daee572822b73e9113ef121383ca16670d7385e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The controlled terminology or a reference to the controlled terminology should be included in the Define-XML \ndocument file wherever applicable. All values in the permissible value set for the study should be included, whether \nor not they are represented in the submitted data. Note that a null value should not be included in the permissible \nvalue set. A null value is implied for any list of controlled terms unless the variable is \"Required\" (see Section 4.1.5, \nSDTM Core Designations). \nWhen a domain or dataset specification includes a codelist for a variable, not every value in that codelist may have \nbeen part of planned data collection; only values that were part of planned data collection should be included in the \nDefine-XML document. For example, --PRESP variables are associated with the NY codelist, but only the value \n\"Y\" is allowed in --PRESP variables. Future versions of the Define-XML specification are expected to include \ninformation on representing subsets of controlled terminology.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1012, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "60c5f9b3-c7e1-4e28-95e1-fc1ccd76e11f": {"__data__": {"id_": "60c5f9b3-c7e1-4e28-95e1-fc1ccd76e11f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.4 Use of Controlled Terminology and Arbitrary Number Codes"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2a6746c3-b56d-446d-8ccd-b2fc4669bc40", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.4 Use of Controlled Terminology and Arbitrary Number Codes"}, "hash": "fdc3202bd0fa59f9f6212f99e4c7ef16c763805244fdb7f21eb9df753be0abc9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Controlled terminology or human-readable text should be used instead of arbitrary number codes in order to reduce \nambiguity for submission reviewers. For example, CMDECOD would contain human-readable dictionary text rather \nthan a numeric code. Numeric code values may be submitted as Supplemental Qualifiers if necessary.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 323, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b9a80bbe-14d7-47bc-b013-a0de228e02d8": {"__data__": {"id_": "b9a80bbe-14d7-47bc-b013-a0de228e02d8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.5 Storing Controlled Terminology for Synonym Qualifier Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3a60f030-3eb5-413e-9598-241e34b9bec9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.5 Storing Controlled Terminology for Synonym Qualifier Variables"}, "hash": "5e1a4893414c1a20fe454cf64ff9d5ad1349004d0928973e2701b63867b6ab33", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 \nFor events such as adverse events and medical history, populate --DECOD with the dictionary's preferred \nterm and populate --BODSYS with the preferred body system name. If a dictionary is multi-axial, the value \nin --BODSYS should represent the system organ class (SOC) used for the sponsor's analysis and summary \ntables, which may not necessarily be the primary SOC. Populate --SOC with the dictionary-derived primary \nSOC. In cases where the primary SOC was used for analysis, --BODSYS and --SOC are the same. \n\u2022 \nIf MedDRA is used to code events, the intermediate levels in the MedDRA hierarchy should also be \nrepresented in the dataset. A pair of variables has been defined for each of the levels of the hierarchy other \nthan SOC and Preferred Term (PT): one to represent the text description and the other to represent the code \nvalue associated with it. For example, --LLT should be used to represent the Lowest Level Term text \ndescription and --LLTCD should be used to represent the Lowest Level Term code value. \n\u2022 \nFor concomitant medications, populate CMDECOD with the drug's generic name and populate CMCLAS \nwith the drug class used for the sponsor's analysis and summary tables. If coding to multiple classes, follow \nSection 4.2.8.1, Multiple Values for an Intervention or Event Topic Variable, or omit CMCLAS. \n\u2022 \nFor concomitant medications, supplemental qualifiers may be used to represent additional coding \ndictionary information (e.g., a drug's ATC codes from the WHO Drug Dictionary; see Section 8.4, Relating \nNon-standard Variable Values to a Parent Domain). \nThe sponsor is expected to provide the dictionary name and version used to map the terms by utilizing the Define-\nXML external codelist attributes.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1736, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "37006fbc-f106-4a8d-ade7-f047cdd02493": {"__data__": {"id_": "37006fbc-f106-4a8d-ade7-f047cdd02493", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.6 Storing Topic Variables for General Domain Models"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c186084-fb71-45d3-b855-a98736e1a95a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 37, "section": "4.3.6 Storing Topic Variables for General Domain Models"}, "hash": "0d9c388ebbf55d64720d9b0bd6b4698abc40a1a59316c1acef3dd0ce8a1657e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The topic variable for the Interventions and Events general observation-class models is often stored as verbatim text. \nFor an Events domain, the topic variable is --TERM. For an Interventions domain, the topic variable is --TRT. For a \nFindings domain, the topic variable --TESTCD should use controlled terminology (e.g., \"SYSBP\" for systolic blood \npressure). If CDISC Controlled Terminology exists, it should be used; otherwise, sponsors should define their own \ncontrolled list of terms. If the verbatim topic variable in an Interventions or Event domain is modified to facilitate \ncoding, the modified text is stored in --MODIFY. In most cases\u2014other than Physical Examination (PE)\u2014the", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 689, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cbc1b00b-8845-47c4-9596-bf6e167000d4": {"__data__": {"id_": "cbc1b00b-8845-47c4-9596-bf6e167000d4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.3.7 Use of \"Yes\" and \"No\" Values"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1c9a8830-ff62-4803-8be1-4ac6234ce2cf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.3.7 Use of \"Yes\" and \"No\" Values"}, "hash": "3a1a5ba227364c42b32ec7b0618c20d2be24adea0d4b8b059e64a5884dccd551", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Variables where the response is \"Yes\" or \"No\" (\"Y\" or \"N\") should normally be populated for both \"Y\" and \"N\" \nresponses. This eliminates confusion regarding whether a blank response indicates \"N\" or is a missing value. \nHowever, some variables are collected or derived in a manner that allows only 1 response, such as when a single \ncheckbox indicates \"Yes\". In situations such as these, where it is unambiguous to populate only the response of \ninterest, it is permissible to populate only 1 value (\"Y\" or \"N\") and leave the alternate value blank. An example of \nwhen it would be acceptable to use only a value of \"Y\" would be for Last Observation Before Exposure Flag (--\nLOBXFL) variables, where \"N\" is not necessary to indicate that a value is not the last observation before exposure. \nNote: Permissible values for variables with controlled terms of \"Y\" or \"N\" may be extended to include \"U\" or \n\"NA\" if it is the sponsor's practice to explicitly collect or derive values indicating \"Unknown\" or \"Not Applicable\" \nfor that variable.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1037, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "77848daa-bb84-4593-b329-38b3f2c28a63": {"__data__": {"id_": "77848daa-bb84-4593-b329-38b3f2c28a63", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.4 Actual and Relative Time Assumptions"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a1deb375-951e-4e71-bf42-6a4ab6a57b5c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.4 Actual and Relative Time Assumptions"}, "hash": "4830690741293dcc83c64c46bc971958eb37c964cee4c36b6414a436c0850f69", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Timing variables (SDTM Section 3.1.5, Timing Variables for All Classes) are an essential component of all SDTM \nsubject-level domain datasets. In general, all domains based on the 3 general observation classes should have at least \n1 timing variable. In the Events or Interventions general observation class, this could be the start date of the event or \nintervention. In the Findings observation class, where data are usually collected at multiple visits, at least 1 timing \nvariable must be used. \nThe SDTMIG requires dates and times of day to be stored according to the international standard ISO 8601 \n(http://www.iso.org). ISO 8601 provides a text-based representation of dates and/or times, intervals of time, and \ndurations of time.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 739, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbfadd46-7c34-496f-88c8-b8bc918efd75": {"__data__": {"id_": "dbfadd46-7c34-496f-88c8-b8bc918efd75", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.4.1 Formats for Date/Time Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0250c001-0c1e-42fa-88b0-5aca1a293795", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 38, "section": "4.4.1 Formats for Date/Time Variables"}, "hash": "cd0ec97068584f525e0730f9c13e1aa5747c9572d391c34be7a4e45ef6a097b5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "An SDTM DTC variable may include data that is represented in ISO 8601 format as a complete date/time, a partial \ndate/time, or an incomplete date/time. \nThe SDTMIG template uses ISO 8601 for calendar dates and times of day, which are expressed as follows: \n\u2022 \nYYYY-MM-DDThh:mm:ss(.n+)?(((+|-)hh:mm)|Z)? \nwhere: \n\u2022 \n[YYYY] = four-digit year \n\u2022 \n[MM] = two-digit representation of the month (01-12, 01=January, etc.) \n\u2022 \n[DD] = two-digit day of the month (01 through 31) \n\u2022 \n[T] = (time designator) indicates time information follows \n\u2022 \n[hh] = two digits of hour (00 through 23) (am/pm is NOT allowed) \n\u2022 \n[mm] = two digits of minute (00 through 59) \n\u2022 \n[ss] = two digits of second (00 through 59) \nThe last two components, indicated in the format pattern with a question mark, are optional:", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 790, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "543487de-2d70-41b7-8aee-e1ed1f645887": {"__data__": {"id_": "543487de-2d70-41b7-8aee-e1ed1f645887", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 39, "section": "4.4.2 Date/Time Precision"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a7645330-70b0-414f-8bb2-e6e11dcee001", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 39, "section": "4.4.2 Date/Time Precision"}, "hash": "637d455197d0d0bf8463b934c59a010cbdda769b8aa9e94a7fec1df7b3cbd2f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The concept of representing date/time precision is handled through use of the ISO 8601 standard. According to ISO \n8601, precision (also referred to by ISO 8601 as \"completeness\" or \"representations with reduced accuracy\") can be \ninferred from the presence or absence of components in the date and/or time values. Missing components are \nrepresented by right truncation or a hyphen (for intermediate components that are missing). If the date and time \nvalues are completely missing, the SDTM date field should be null. Every component except year is represented as 2 \ndigits. Years are represented as 4 digits; for all other components, 1-digit numbers are always padded with a leading \nzero. \nThe following table provides examples of ISO 8601 representations of complete and truncated date/time values \nusing ISO 8601 \"appropriate right truncations\" of incomplete date/time representations. Note that if no time \ncomponent is represented, the [T] time designator (in addition to the missing time) must be omitted in ISO 8601 \nrepresentation. \n \nDate and Time as Originally Recorded Precision \nISO 8601 Date/Time \n1 December 15, 2003 13:14:17.123 \nDate/time, including fractional seconds 2003-12-15T13:14:17.123 \n2 December 15, 2003 13:14:17 \nDate/time to the nearest second \n2003-12-15T13:14:17 \n3 December 15, 2003 13:14 \nUnknown seconds \n2003-12-15T13:14 \n4 December 15, 2003 13 \nUnknown minutes and seconds \n2003-12-15T13 \n5 December 15, 2003 \nUnknown time \n2003-12-15 \n6 December, 2003 \nUnknown day and time \n2003-12 \n7 2003 \nUnknown month, day, and time \n2003 \nThis date and date/time model also provides for imprecise or estimated dates, such as those commonly seen in \nMedical History. To represent these intervals while applying the ISO 8601 standard, it is recommended that the \nsponsor concatenate the date/time values (using the most complete representation of the date/time known) that \ndescribe the beginning and the end of the interval of uncertainty and separate them with a solidus, as shown in the \nfollowing table.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2034, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e6c7af14-063e-420f-9e85-4c2693d757dc": {"__data__": {"id_": "e6c7af14-063e-420f-9e85-4c2693d757dc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 40, "section": "4.4.3.1 Intervals of Time and Use of Duration"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b28a0ebc-7d27-4fbd-90df-81c2068607f3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 40, "section": "4.4.3.1 Intervals of Time and Use of Duration"}, "hash": "224acf82033db3f94943c5665e081411e7e8e553baed2348ecba3b42dd89d1e5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As defined by ISO 8601, an interval of time is the part of a time axis, limited by 2 time \"instants\" such as the times \nrepresented in SDTM by the variables --STDTC and --ENDTC. These variables represent the 2 instants that bound \nan interval of time; the duration is the quantity of time that is equal to the difference between these time points. \nISO 8601 allows an interval to be represented in multiple ways. One representation, shown below, uses 2 dates in \nthe format: \nYYYY-MM-DDThh:mm:ss/YYYY-MM-DDThh:mm:ss \nAlthough this example represents the interval (by providing the start date/time and end date/time to bound the \ninterval of time), it does not provide the value of the duration (the quantity of time). \nDuration is frequently used during a review; however, the duration timing variable (--DUR) should generally be \nused in a domain if it was collected in lieu of a start date/time (--STDTC) and end date/time (--ENDTC). If both --\nSTDTC and --ENDTC are collected, durations can be calculated by the difference in these 2 values, and need not be \nin the submission dataset. \nBoth duration and duration units can be provided in the single --DUR variable, in accordance with the ISO 8601 \nstandard. The values provided in --DUR should follow 1 of the following ISO 8601 duration formats: \nPnYnMnDTnHnMnS \n- or - \nPnW \nwhere the letter designation is defined as: \n\u2022 \n[P] (duration designator): precedes the alphanumeric text string that represents the duration. Note that the \nuse of the character \"P\" is based on the historical use of the term \"period\" for duration.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1579, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1c59e99d-7b15-4004-a449-92ee7376016f": {"__data__": {"id_": "1c59e99d-7b15-4004-a449-92ee7376016f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 41, "section": "4.4.3.2 Interval with Uncertainty"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d8d90c88-2534-4a46-bc16-4e73697c8299", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 41, "section": "4.4.3.2 Interval with Uncertainty"}, "hash": "194c001b893c0122fd36e768ef9990e7b1e99b5da8e5e9199cac5afd33c4de5a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When an interval of time is an amount of time (duration) following an event whose start date/time is recorded (with \nsome level of precision, e.g., when one knows the start date/time and the duration following the start date/time), the \ncorrect ISO 8601 usage to represent this interval is: \nYYYY-MM-DDThh:mm:ss/PnYnMnDTnHnMnS \nwhere the start date/time is represented before the solidus or foreword slash [/], the \"Pn\u2026\" following the solidus \nrepresents a \"duration,\" and the entire representation is known as an \"interval.\" Note that this is the recommended \nrepresentation of elapsed time, given a start date/time and the duration elapsed. \nWhen an interval of time is an amount of time (duration) measured prior to an event whose start date/time is \nrecorded (with some level of precision, e.g., where one knows the end date/time and the duration preceding that end \ndate/time), the syntax is: \nPnYnMnDTnHnMnS/YYYY-MM-DDThh:mm:ss \nwhere the duration, \"Pn\u2026\", is represented before the solidus [/], the end date/time is represented following the \nsolidus, and the entire representation is known as an \"interval.\"", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1114, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "703f6845-eef5-426e-bd7c-c01a3c3cf753": {"__data__": {"id_": "703f6845-eef5-426e-bd7c-c01a3c3cf753", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 41, "section": "4.4.4 Use of the Study Day Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "071b3c18-eb34-4c8a-999c-71c77d9991f5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 41, "section": "4.4.4 Use of the Study Day Variables"}, "hash": "2d76598ecc834427de3669b53d88e8978e70b4ee6e0af1f79e682edc55634257", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The permissible study day variables (i.e., --DY, --STDY, --ENDY) describe the relative day of the observation \nstarting with the reference date as day 1. They are determined by comparing the date portion of the respective \ndate/time variables (--DTC, --STDTC, and --ENDTC) to the date portion of the subject reference start date \n(RFSTDTC from the Demographics domain).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 369, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e526f18e-0157-4319-ad71-4a873a0bdd84": {"__data__": {"id_": "e526f18e-0157-4319-ad71-4a873a0bdd84", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 42, "section": "4.4.5 Clinical Encounters and Visits"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "54dc9f07-3b07-4ed7-9871-d316f031969c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 42, "section": "4.4.5 Clinical Encounters and Visits"}, "hash": "c6b0f021e7c6142211ab98055dbe05ab3be1a569ae62bbd2231ae568d3f507db", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All domains based on the 3 general observation classes should have at least 1 timing variable. For domains in the \nEvents or Interventions observation classes, and for domains in the Findings observation class, for which data are \ncollected only once during the study, the most appropriate timing variable may be a date (e.g., --DTC, --STDTC) or \nsome other timing variable. For studies that are designed with a prospectively defined schedule of visit-based \nactivities, domains for data that are to be collected more than once per subject (e.g., labs, ECG, vital signs) are \nexpected to include VISITNUM as a timing variable. \nClinical encounters are described by the CDISC visit variables. For planned visits, values of VISIT, VISITNUM, \nand VISITDY must be those defined in the Trial Visits (TV) dataset (see Section 7.3.1, Trial Visits). For planned \nvisits: \n\u2022 \nValues of VISITNUM are used for sorting and should, wherever possible, match the planned chronological \norder of visits. Occasionally, a protocol will define a planned visit whose timing is unpredictable (e.g., \nplanned in response to an adverse event, a threshold test value, or a disease event), and completely \nchronological values of VISITNUM may not be possible in such cases. \n\u2022 \nThere should be a one-to-one relationship between values of VISIT and VISITNUM. \n\u2022 \nFor visits that may last more than 1 calendar day, VISITDY should be the planned day of the start of the \nvisit. \nSponsor practices for populating visit variables for unplanned visits may vary. \n\u2022 \nVISITNUM should generally be populated, even for unplanned visits, as it is expected in many Findings \ndomains, as described above. The easiest method of populating VISITNUM for unplanned visits is to \nassign the same value (e.g., 99) to all unplanned visits, although this method provides no differentiation \nbetween the unplanned visits and does not provide chronological sorting. Methods that provide a one-to-\none relationship between visits and values of VISITNUM, that are consistent across domains, and that \nassign VISITNUM values that sort chronologically require more work and must be applied after all of a \nsubject's unplanned visits are known. \n\u2022 \nVISIT may be left null or may be populated with a generic value (e.g., \"Unscheduled\") for all unplanned \nvisits, or individual values may be assigned to different unplanned visits. \n\u2022 \nVISITDY must not be populated for unplanned visits; VISITDY is, by definition, the planned study day of \nvisit. The actual study day of an unplanned visit belongs in a --DY variable. \nThe following lb.xpt sample rows show how visit identifiers might be used for lab data. \nlb.xpt \nUSUBJID VISIT \nVISITNUM VISITDY LBDY \n001 \nWeek 1 \n2 \n7 \n7 \n001 \nWeek 2 \n3 \n14 \n13 \n001 \nWeek 2 Unscheduled 3.1 \n \n17", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2779, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8b7eb893-1478-4859-80ca-b8e2024124d8": {"__data__": {"id_": "8b7eb893-1478-4859-80ca-b8e2024124d8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.6 Representing Additional Study Days"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2a0685c0-8452-4277-b1ec-fdf56d91bd6a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.6 Representing Additional Study Days"}, "hash": "8f547fb063d3950edc6018a7dc9f6687a1f63079fd15f7004b54e1054f3c55d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The SDTM allows for the representation of study days relative to the RFSTDTC reference start date variable in the \nDM dataset, using variables --DY, as described in Section 4.4.4, Use of the \"Study Day\" Variables. The calculation \nof additional study days within subdivisions of time in a clinical trial may be based on 1 or more sponsor-defined \nreference dates not represented by RFSTDTC. In such cases, the sponsor may define supplemental qualifier \nvariables and the Define-XML document should reflect the reference dates used to calculate such study days. If the \nsponsor wishes to define \"day within element\" or \"day within epoch\", the reference date/time will be an element \nstart date/time in the Subject Elements (SE) dataset (see Section 5.3, Subject Elements).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 771, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b1286474-7973-48c6-95e9-42c67c42603e": {"__data__": {"id_": "b1286474-7973-48c6-95e9-42c67c42603e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.7 Use of Relative Timing Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "42c595fe-0797-4aec-8287-5573da8ed21c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.7 Use of Relative Timing Variables"}, "hash": "436979242de42058cb2d12a94c63bff05157141fe70d7e82273bf40421b119ed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d38d0319-b90d-4f01-b6d8-a928f722fa5b", "node_type": "1", "metadata": {}, "hash": "1a0b1c954cda548d92a10b5969543989c8733331af634bde4a54c5ff8d735bf2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "--STRF and --ENRF \nThe variables --STRF and --ENRF represent the timing of an observation relative to the sponsor-defined study \nreference period, when information such as \"BEFORE\", \"PRIOR\", \"ONGOING\"', or \"CONTINUING\" is collected \nin lieu of a date and this collected information is in relation to the sponsor-defined study reference period. The \nsponsor-defined study reference period is the continuous period of time defined by the discrete starting point, \nRFSTDTC, and the discrete ending point, RFENDTC, for each subject in the Demographics (DM) dataset. \n--STRF is used to identify the start of an observation relative to the sponsor-defined study reference period. \n--ENRF is used to identify the end of an observation relative to the sponsor-defined study reference period. \nAllowable values for --STRF are \"BEFORE\", \"DURING\", \"DURING/AFTER\", \"AFTER\", and \"UNKNOWN\". \nAlthough \"COINCIDENT\" and \"ONGOING\" are in the STENRF codelist, they describe timing relative to a point in \ntime rather than an interval of time, so are not appropriate for use with --STRF variables. It would be unusual for an \nevent or intervention to be recorded as starting \"AFTER\" the study reference period, but could be possible, \ndepending on how the study reference period is defined in a particular study. \nAllowable values for --ENRF are \"BEFORE\", \"DURING\", \"DURING/AFTER\", \"AFTER\" and \"UNKNOWN\". If --\nENRF is used, then --ENRF = \"AFTER\" means that the event did not end before or during the study reference \nperiod. Although \"COINCIDENT\" and \"ONGOING\" are in the STENRF codelist, they describe timing relative to a \npoint in time rather than an interval of time, so are not appropriate for use with --ENRF variables.As an example, a \nCRF checkbox that identifies concomitant medication use that began prior to the study reference period would \ntranslate into CMSTRF = \"BEFORE\", if selected. Note that in this example, the information collected is with \nrespect to the start of the concomitant medication use only, and therefore the collected data corresponds to variable \nCMSTRF, not CMENRF. Note also that the information collected is relative to the study reference period, which \nmeets the definition of CMSTRF.Some sponsors may wish to derive --STRF and --ENRF for analysis or reporting \npurposes even when dates are collected. Sponsors are cautioned that doing so in conjunction with directly collecting \nor mapping data such as \"BEFORE\", \"PRIOR\", and \"ONGOING\" to --STRF and --ENRF will blur the distinction \nbetween collected and derived values within the domain. Sponsors wishing to do such derivations are instead \nencouraged to use analysis datasets for this derived data. \nIn general, sponsors are cautioned that representing information using variables --STRF and --ENRF may not be as \nprecise as other methods, particularly because information is often collected relative to a point in time or to a period \nof time other than the one defined as the study reference period. SDTMIG v3.1.2 attempted to address these \nlimitations by the addition of 4 new relative timing variables, which are described in the following section. Sponsors \nshould use the set of variables that allows for accurate representation of collected data. In many cases, this will mean \nusing these new relative timing variables in place of --STRF and --ENRF.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3333, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d38d0319-b90d-4f01-b6d8-a928f722fa5b": {"__data__": {"id_": "d38d0319-b90d-4f01-b6d8-a928f722fa5b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.7 Use of Relative Timing Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "42c595fe-0797-4aec-8287-5573da8ed21c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.7 Use of Relative Timing Variables"}, "hash": "436979242de42058cb2d12a94c63bff05157141fe70d7e82273bf40421b119ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b1286474-7973-48c6-95e9-42c67c42603e", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 43, "section": "4.4.7 Use of Relative Timing Variables"}, "hash": "21c1fc6dd6adc3bef62ec698cb214dd452789744947a88d2d84f565a1fc61826", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sponsors wishing to do such derivations are instead \nencouraged to use analysis datasets for this derived data. \nIn general, sponsors are cautioned that representing information using variables --STRF and --ENRF may not be as \nprecise as other methods, particularly because information is often collected relative to a point in time or to a period \nof time other than the one defined as the study reference period. SDTMIG v3.1.2 attempted to address these \nlimitations by the addition of 4 new relative timing variables, which are described in the following section. Sponsors \nshould use the set of variables that allows for accurate representation of collected data. In many cases, this will mean \nusing these new relative timing variables in place of --STRF and --ENRF. \n--STRTPT, --STTPT, --ENRTPT, and --ENTPT \nAlthough the variables --STRF and --ENRF are useful in the case when relative timing assessments are made \ncoincident with the start and end of the study reference period, they may not be suitable for expressing relative \ntiming assessments (e.g., \"Prior\", \"Ongoing\") that are collected at other times of the study. As a result, 4 new timing \nvariables were added in SDTMIG v3.1.2 to express a similar concept at any point in time. The variables --STRTPT \nand --ENRTPT contain values similar to --STRF and --ENRF, but may be anchored with any timing description or \ndate/time value expressed in the respective --STTPT and --ENTPT variables, and are not limited to the study \nreference period. Unlike the variables --STRF and --ENRF, which for all domains are defined relative to one study", "mimetype": "text/plain", "start_char_idx": 2562, "end_char_idx": 4165, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6341cc52-3023-4b49-a260-f4981f127bab": {"__data__": {"id_": "6341cc52-3023-4b49-a260-f4981f127bab", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 44, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1daf1db6-3e62-416a-b184-aa491a24914b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 44, "section": "UNSPECIFIED"}, "hash": "78177b89465291e2c7e5ce54e825684e7e0e24fe6cb170a3db6cb443284ce934", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 44 \n2021-11-29 \nreference period, the timing variables --STRTPT, --STTPT, --ENRTPT, and --ENTPT are defined by each sponsor \nfor each study. Allowable values for --STRTPT and --ENRTPT are as follows. \nIf the reference time point corresponds to the date of collection or assessment: \n\u2022\nStart values: An observation can start BEFORE that time point, can start COINCIDENT with that time\npoint, or it can be UNKNOWN when it started.\n\u2022\nEnd values: An observation can end BEFORE that time point, can end COINCIDENT with that time point,\ncan be known that it did not end but was ONGOING, or it can be UNKNOWN when it ended or if it was\nongoing.\n\u2022\nAFTER is not a valid value in this case because it would represent an event after the date of collection.\nIf the reference time point is prior to the date of collection or assessment: \n\u2022\nStart values: An observation can start BEFORE the reference point, can start COINCIDENT with the\nreference point, can start AFTER the reference point, or it can be UNKNOWN when it started.\n\u2022\nEnd values: An observation can end BEFORE the reference point, can end COINCIDENT with the\nreference point, can end AFTER the reference point, can be known that it did not end but was ONGOING,\nor it can be UNKNOWN when it ended or if it was ongoing.\nAlthough \"DURING\" and \"DURING/AFTER\" are in the STENRF codelist, they describe timing relative to an \ninterval of time rather than a point in time, so are not allowable for use with --STRTPT and --ENRTPT variables. \nExamples of --STRTPT, --STTPT, --ENRTPT, and --ENTPT \nExample 1: Medical History \nAssumptions: \n\u2022\nCRF contains \"Year Started\" and checkbox for \"Active\"\n\u2022\n\"Date of Assessment\" is collected\nExample when \"Active\" is checked: \n\u2022\nMHDTC = date of assessment value (e.g., \"2006-11-02\")\n\u2022\nMHSTDTC = year of condition start (e.g., \"2002\")\n\u2022\nMHENRTPT = \"ONGOING\"\n\u2022\nMHENTPT = date of assessment value (e.g., \"2006-11-02\")\nFigure. Example of --ENRTPT and --ENTPT for Medical History", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2132, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4aff8cd1-3025-47fd-97c9-136422e4ab30": {"__data__": {"id_": "4aff8cd1-3025-47fd-97c9-136422e4ab30", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 45, "section": "4.4.8 Date and Time Reported in a Domain Based on Findings"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3620d4e0-f216-4393-be81-593694e12ce2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 45, "section": "4.4.8 Date and Time Reported in a Domain Based on Findings"}, "hash": "0152e1ee7082bfb07ceef32a66d2ee02b160f097fd1aa327d69ef60851cd3ea9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When the date/time of collection is reported in any domain, the date/time should go into the --DTC field (e.g., \nEGDTC for Date/Time of ECG). For any domain based on the Findings general observation class (e.g., lab tests \nbased on a specimen), the collection date is likely to be tied to when the source of the finding was captured, not \nnecessarily when the data were recorded. In order to ensure that the critical timing information is always represented \nin the same variable, the --DTC variable is used to represent the time of specimen collection. For example, in the \nLaboratory Test Results (LB) domain, the LBDTC variable would be used for all single-point blood collections or \nspot urine collections. For timed lab collections (e.g., 24-hour urine collections) the LBDTC variable would be used \nfor the start date/time of the collection and LBENDTC for the end date/time of the collection. This approach allows \nthe single-point and interval collections to use the same date/time variables consistently across all datasets for the \nFindings general observation class. The following table illustrates the proper use of these variables. Note that --\nSTDTC should not be used in the Findings general observation class and is therefore blank in this table. \nCollection Type \n--DTC --STDTC --ENDTC \nSingle-point Collection X \n \n \nInterval Collection \nX \n \nX", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1363, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eaeb9a68-745f-40c1-ad19-fbbbda0354e5": {"__data__": {"id_": "eaeb9a68-745f-40c1-ad19-fbbbda0354e5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 45, "section": "4.4.9 Use of Dates as Result Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "43a053a5-09a6-4740-b6e3-2cfcfda8ac27", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 45, "section": "4.4.9 Use of Dates as Result Variables"}, "hash": "564820bab72d72ec5c0e199b941053f09754286f35b070a2e3f975ffc7a881cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dates are generally used only as timing variables to describe the timing of an event, intervention, or collection \nactivity, but there may be occasions when it may be preferable to model a date as a result (--ORRES) in a Findings \ndataset. Note that using a date as a result to a Findings question is unusual and atypical, and should be approached", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 347, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7ea5efa6-f1dd-4a1c-8d17-0d45d6cb7666": {"__data__": {"id_": "7ea5efa6-f1dd-4a1c-8d17-0d45d6cb7666", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 46, "section": "4.4.10 Representing Time Points"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "961ba8b2-405c-4cf0-b5ac-4602557430b6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 46, "section": "4.4.10 Representing Time Points"}, "hash": "24e34464afe50d4ff624e26624827234ebaf2c7c19c52a5a1b7903215b9e3bd4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Time points can be represented using the time point variables --TPT, --TPTNUM, --ELTM, and the time-point \nanchors --TPTREF (text description) and --RFTDTC (the date/time). Note that time-point data will usually have an \nassociated --DTC value. The interrelationship of these variables is shown in the following figure. \nFigure. Representing Time Points \nValues for these variables for vital signs measurements taken at 30, 60, and 90 minutes after dosing would look like \nthe following. \nVSTPTNUM \nVSTPT \nVSELTM \nVSTPTREF \nVSRFTDTC \nVSDTC \n1 \n30 MIN \nPT30M \nDOSE ADMINISTRATION \n2006-08-01T08:00 \n2006-08-01T08:30 \n2 \n60 MIN \nPT1H \nDOSE ADMINISTRATION \n2006-08-01T08:00 \n2006-08-01T09:01 \n3 \n90 MIN \nPT1H30M \nDOSE ADMINISTRATION \n2006-08-01T08:00 \n2006-08-01T09:32 \nNote that VSELTM is the planned elapsed time, not the actual elapsed time. The actual elapsed time could be \nderived in an analysis dataset, if desired, as VSDTC-VSRFTDTC. \nValues for these variables for urine collections taken pre-dose, and from 0-12 hours and 12-24 hours after dosing \nwould look like the following. \nLBTPTNUM \nLBTPT \nLBELTM \nLBTPTREF \nLBRFTDTC \nLBDTC \n1 \n15 MIN PRE-DOSE \n-PT15M\nDOSE ADMINISTRATION \n2006-08-01T08:00 \n2006-08-01T07:45 \n2 \n0-12 HOURS\nPT12H \nDOSE ADMINISTRATION \n2006-08-01T08:00 \n2006-08-01T20:35 \n3 \n12-24 HOURS\nPT24H \nDOSE ADMINISTRATION \n2006-08-01T08:00 \n2006-08-02T08:40 \nNote that the value in LBELTM represents the end of the specimen collection interval. \nWhen time points are represented in SDTMIG domains, both --TPT and --TPTNUM must be used. Time points may \nor may not have an associated --TPTREF. Sometimes, --TPTNUM may be used as a key for multiple values \ncollected for the same test within a visit; as such, there is no dependence upon an anchor such as --TPTREF, but \nthere will be a dependency upon VISITNUM. In such cases, VISITNUM will be required to confer uniqueness to \nvalues of --TPTNUM.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1917, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d1286d1a-32db-4636-84d0-e828654815ca": {"__data__": {"id_": "d1286d1a-32db-4636-84d0-e828654815ca", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 47, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d6f48eae-aed5-454e-868e-6e4d9d442115", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 47, "section": "UNSPECIFIED"}, "hash": "a2af5b27d8a9182cf1a228acbe18bfffb38bc3ae100c2dbee4137fd9f12238ab", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4af4abf8-4d3d-4bc6-8be2-a6f372711257", "node_type": "1", "metadata": {}, "hash": "00ca5f09feceaeb409b9f97c701e82855295a77ae24b7905a21eae7d8ed504db", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 47 \n2021-11-29 \nIf the protocol describes the scheduling of a dose using a reference intervention or assessment, then --TPTREF \nshould be populated, even if it does not contribute to uniqueness. The fact that time points are related to a reference \ntime point, and what that reference time point is, are important for interpreting the data collected at the time point. \nNot all time points will require all 3 variables to provide uniqueness. In fact, in some cases a time point may be \nuniquely identified without the use of VISIT, or without the use of --TPTREF, or without the use of either. For \ninstance: \n\u2022 \nA trial might have time points only within 1 visit, so that the contribution of VISITNUM to uniqueness is \ntrivial. (VISITNUM would be populated, but would not contribute to uniqueness.) \n\u2022 \nA trial might have time points that do not relate to any visit, such as time points relative to a dose of drug \nself-administered by the subject at home. (Visit variables would not be included, but --TPTREF and other \ntime point variables would be populated.) \n\u2022 \nA trial may have only 1 reference time point per visit, and all reference time points may be similar, so that \nonly 1 value of --TPTREF (e.g., \"DOSE\") is needed. (--TPTREF would be populated, but would not \ncontribute to uniqueness.) \n\u2022 \nA trial may have time points not related to a reference time point. For instance, --TPTNUM values could be \nused to distinguish first, second, and third repeats of a measurement scheduled without any relationship to \ndosing (\u2013TPTREF and --ELTM would not be included.) In this case, where the protocol calls for repeated \nmeasurements but does not specify timing of the measurements, the --REPNUM variable could be used \ninstead of time-point variables. \nFor trials with many time points, the requirement to provide uniqueness using only VISITNUM, --TPTREF, and --\nTPTNUM may lead to a scheme where multiple natural keys are combined into the values of one of these variables. \nFor instance, in a crossover trial with multiple doses on multiple days within each period, either of the following \noptions could be used. \n1. VISITNUM might be used to designate period, --TPTREF might be used to designate the day and the dose, \nand --TPTNUM might be used to designate the timing relative to the reference time point. \n2. VISITNUM might be used to designate period and day within period, --TPTREF might be used to \ndesignate the dose within the day, and --TPTNUM might be used to designate the timing relative to the \nreference time point.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2719, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4af4abf8-4d3d-4bc6-8be2-a6f372711257": {"__data__": {"id_": "4af4abf8-4d3d-4bc6-8be2-a6f372711257", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 47, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d6f48eae-aed5-454e-868e-6e4d9d442115", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 47, "section": "UNSPECIFIED"}, "hash": "a2af5b27d8a9182cf1a228acbe18bfffb38bc3ae100c2dbee4137fd9f12238ab", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d1286d1a-32db-4636-84d0-e828654815ca", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 47, "section": "UNSPECIFIED"}, "hash": "ed7b7bae9b2300147b7c281115eae6d1554736839ea2db1ddad6c2b60d7d46e5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For trials with many time points, the requirement to provide uniqueness using only VISITNUM, --TPTREF, and --\nTPTNUM may lead to a scheme where multiple natural keys are combined into the values of one of these variables. \nFor instance, in a crossover trial with multiple doses on multiple days within each period, either of the following \noptions could be used. \n1. VISITNUM might be used to designate period, --TPTREF might be used to designate the day and the dose, \nand --TPTNUM might be used to designate the timing relative to the reference time point. \n2. VISITNUM might be used to designate period and day within period, --TPTREF might be used to \ndesignate the dose within the day, and --TPTNUM might be used to designate the timing relative to the \nreference time point. \nOption 1 \nVISIT \nVISITNUM --TPT \n--TPTNUM --TPTREF \nPERIOD 1 3 \nPRE-DOSE 1 \nDAY 1, AM DOSE \n1H \n2 \n4H \n3 \nPRE-DOSE 1 \nDAY 1, PM DOSE \n1H \n2 \n4H \n3 \nPRE-DOSE 1 \nDAY 5, AM DOSE \n1H \n2 \n4H \n3 \nPRE-DOSE 1 \nDAY 5, PM DOSE \n1H \n2 \n4H \n3 \nPERIOD 2 4 \nPRE-DOSE 1 \nDAY 1, AM DOSE \n1H \n2 \n4H \n3 \nPRE-DOSE 1 \nDAY 1, PM DOSE \n1H \n2 \n4H \n3", "mimetype": "text/plain", "start_char_idx": 1939, "end_char_idx": 3047, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8ce251f5-ee42-475d-b193-46141c72dca7": {"__data__": {"id_": "8ce251f5-ee42-475d-b193-46141c72dca7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 48, "section": "4.4.11 Disease Milestones and Disease Milestone Timing Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a37f4af-9884-4314-8d70-77d5027e0251", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 48, "section": "4.4.11 Disease Milestones and Disease Milestone Timing Variables"}, "hash": "57401ddb071074c881cd061bf62d7e531adaa72a010bf5078846e86e8a240b36", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A disease milestone is an event or activity that can be anticipated in the course of a disease, but whose timing is not \ncontrolled by the study schedule. A disease milestone may be something that occurred pre-study, but which \nrepresents a time at which data would have been collected (e.g., diagnosis of the disease under study). A disease \nmilestone may also be something which is anticipated to occur during a study and which, if it occurs, triggers the \ncollection of related data outside the regular schedule of visits (e.g., adverse event of interest). The types of disease \nmilestones for a study are defined in the study-level Trial Disease Milestones (TM) dataset (see Section 7.3.3, Trial \nDisease Milestones). The times at which disease milestones occurred for a particular subject are summarized in the \nspecial-purpose Subject Disease Milestones (SM) domain (see Section 5.4, Subject Disease Milestones), a domain \nsimilar in structure to the Subject Visits (SV) and Subject Elements (SE) domains. \nNot all studies will have disease milestones. If a study does not have disease milestones, the TM and SM domains \nwill not be present and the disease milestones timing variables may not be included in other domains.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1228, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8e412429-b2c4-4c7b-8d97-91c51abeb527": {"__data__": {"id_": "8e412429-b2c4-4c7b-8d97-91c51abeb527", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 49, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "38ae3605-b002-4eb6-89b3-86d45fab1ed6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 49, "section": "UNSPECIFIED"}, "hash": "695c0a8f27d128fa2c1a21e6361215c3d7a4c197aed85f0d7111c3c40246cfe2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aafbd5f8-4ef1-44ff-8141-2b0ad2e401b9", "node_type": "1", "metadata": {}, "hash": "a51f62c92c35b5f83485615aee6369ba47a54668ddec764262c8e9c7e0b2793b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 49 \n2021-11-29 \nDisease Milestone Naming \nInstances of disease milestones are given names at a subject level. The name of a disease milestone is composed of a \ncharacter string that depends on the disease milestone type (MIDSTYPE in TM and SM) and, if the type of disease \nmilestone is one that may occur multiple times, a chronological sequence number for this disease milestone among \nother instances of the same type for the subject. The character string used in the name of a disease milestone is \nusually a short form of the disease milestone type. For example, if the type of disease milestone is \"EPISODE OF \nDISEASE UNDER STUDY\", the values of MIDS for instances of this type of event could include \"EPISODE1\", \n\"EPISODE2\"; or \"EPISODE01\", \"EPISODE02\", and so on. The association between the longer text in MIDSTYPE \nand the shorter text in MIDS can be seen in SM, which includes both variables. \nDisease Milestone Name (MIDS) \nIf something that has been defined as a disease milestone for a particular study occurrs for a particular subject, it is \nrepresented as usual: in the appropriate findings, intervention, or events class record. In addition, this record will \ninclude the MIDS timing variable, populated with the name of the disease milestone. The timing of a disease \nmilestone is also represented in the special-purpose SM domain. \nThe record that represents a disease milestone does not include values for the timing variables RELMIDS and \nMIDSDTC, which are used to represent the timing of other observations relative to a disease milestone. The usual \ntiming variables in the record for a disease milestone (e.g., --DTC, --STDTC, --ENDTC) provide the needed timing \nfor this observation and for the timing information represented in the SM domain. \nTiming Relative to a Disease Milestone (MIDS, RELMIDS, MIDSDTC) \nFor an observation triggered by the occurrence of a disease milestone, the relationship of the observation to the \ndisease milestone can be represented using the disease milestones timing variables MIDS, RELMIDS, and \nMIDSDTC to describe the timing of the observation. \n\u2022 \nMIDS is populated with the name of a disease milestone for this subject. MIDS is the \u201canchor\u201d for \ndescribing the timing of the observation relative to the disease milestone. In this sense, its function is \nsimilar to --TPTREF for time points. \n\u2022 \nRELMIDS is usually populated with a textual description of the temporal relationship between the \nobservation and the disease milestone named in MIDS. Controlled Terminology has not yet been developed \nfor RELMIDS, but is likely to include terms such as \"IMMEDIATELY BEFORE\", \"AT START OF\", \n\"DURING\", \"AT END OF\", and \"SHORTLY AFTER\". It is similar to --ELTM, except that --ELTM is \nrepresented ISO 8601 duration. \n\u2022 \nMIDSDTC is populated with the date/time of the disease milestone. This is the --DTC for a finding, or the -\n-STDTC for an event or intervention, and is the date recorded in SMSTDTC in the SM domain. Its function \nis similar to --RFTDTC for time points. \nIn some cases, data collected in conjunction with a disease milestone do not include the collection of a separate date \nfor the related observation.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3358, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aafbd5f8-4ef1-44ff-8141-2b0ad2e401b9": {"__data__": {"id_": "aafbd5f8-4ef1-44ff-8141-2b0ad2e401b9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 49, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "38ae3605-b002-4eb6-89b3-86d45fab1ed6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 49, "section": "UNSPECIFIED"}, "hash": "695c0a8f27d128fa2c1a21e6361215c3d7a4c197aed85f0d7111c3c40246cfe2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8e412429-b2c4-4c7b-8d97-91c51abeb527", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 49, "section": "UNSPECIFIED"}, "hash": "681a8ad56331eba9cf1649920554db0f8842766622beccb43dd2c19382c632f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Controlled Terminology has not yet been developed \nfor RELMIDS, but is likely to include terms such as \"IMMEDIATELY BEFORE\", \"AT START OF\", \n\"DURING\", \"AT END OF\", and \"SHORTLY AFTER\". It is similar to --ELTM, except that --ELTM is \nrepresented ISO 8601 duration. \n\u2022 \nMIDSDTC is populated with the date/time of the disease milestone. This is the --DTC for a finding, or the -\n-STDTC for an event or intervention, and is the date recorded in SMSTDTC in the SM domain. Its function \nis similar to --RFTDTC for time points. \nIn some cases, data collected in conjunction with a disease milestone do not include the collection of a separate date \nfor the related observation. This is particularly common for pre-study disease milestones, but may occur with on-\nstudy disease milestones as well. In such cases, MIDSDTC provides a related date/time in records that would not \notherwise contain any date. In records that do contain date/time(s) of the observation, MIDSDTC allows easy \ncomparison of the date(s) of the observation to the (start) date of the disease milestone. In such cases, it functions \nmuch like the reference time point date/time (--RFTDTC) in observations at time points. \nWhen a disease milestone is an event or intervention, some data triggered by the disease milestone may be modeled \nas findings about the disease milestone (i.e., FAOBJ is the disease milestone). In such cases, RELMIDS should be \nused to describe the temporal relationship between the disease milestone and the subject of the question being asked \nin the finding, rather than as describing when the question was asked. \n\u2022 \nWhen the subject of the question is the disease milestone itself, RELMIDS may be populated with a value \nsuch as \u201cENTIRE EVENT\u201d or \u201cENTIRE TREATMENT\u201d. \n\u2022 \nWhen the subject of the question is a question about the occurrence of some activity or event related to the \ndisease milestone, RELMIDS acts like an evaluation interval, describing the period of time on which the \nquestion is focused.", "mimetype": "text/plain", "start_char_idx": 2688, "end_char_idx": 4687, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "05b8f910-d422-49c4-a386-7707d8c6cc83": {"__data__": {"id_": "05b8f910-d422-49c4-a386-7707d8c6cc83", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 50, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "567aae79-a880-408a-939e-99c8b5133ffb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 50, "section": "UNSPECIFIED"}, "hash": "8d516bf40cdd5df5482890c3df5340ac093e9ea72b990312e9c939d4ee1d3e9f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "efc16f7b-51c3-48bd-b52f-bb9b289b02c1", "node_type": "1", "metadata": {}, "hash": "072651f4b0c2fed591cff3c2a0f856fcb0036de54361f9f3708a5290d930dc09", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 50 \n2021-11-29 \no \nFor questions about a possible cause of an event or about the indication for a treatment, RELMIDS \nwould have a value such as \u201cWEEK PRIOR\u201d or \u201cIMMEDIATELY BEFORE\u201d, or even just \n\u201cBEFORE\u201d. \no \nRELMIDS would be \u201cDURING\u201d for questions about things that may have occurred while an event or \nintervention disease milestone was in progress. \no \nFor sequelae of a disease milestone, RELMIDS would have a value such as \u201cAT DISCHARGE\u201d or \n\u201cWEEK AFTER\u201d, or simply \u201cAFTER\u201d. \nUse of Disease Milestone Timing Variables with Other Timing Variables \nThe disease milestone timing variables provide timing relative to an activity or event that has been identified, for the \nparticular study, as a disease milestone. Their use does not preclude the use of variables that collect actual date/times \nor timing relative to the study schedule. \n\u2022 \nThe use of actual date/times is unaffected. The disease milestone timing variables may provide timing \ninformation in cases where actual date/times are unavailable, particularly for pre-study disease milestones. \nWhen the question text for an observation references a disease milestone but a separate date for the \nobservation is not collected, the disease milestone timing variables should be populated but the actual \ndate/s should not be imputed by populating them with the date of the disease milestone. Examples of such \nquestions include disease stage at initial diagnosis of disease under study, or treatment for most recent \ndisease episode. \n\u2022 \nStudy-day variables should be populated wherever complete actual date/times are populated. This includes \nnegative study days for pre-study observations. \n\u2022 \nThe timing variables EPOCH and TAETORD (Planned Order of Element within Arm) may be populated \nfor on-study observations associated with disease milestones. However, pre-study disease milestones\u2014\nthose which occur before the start of study participation when informed consent is obtained\u2014by definition \ndo not have an associated EPOCH or TAETORD. \n\u2022 \nVisit variables are expected in many Findings domains, but findings triggered by the occurrence of a study \nmilestone might not occur at a scheduled visit. \no \nFindings associated with pre-study disease milestones are often collected at a screening visit, although \nthe test was not performed at that visit. \no \nFor findings associated with on-study disease milestones but not conducted at a scheduled visit, \npractices for populating VISITNUM as for an unscheduled visit should be followed. \n\u2022 \nThe use of time-point variables with disease milestone variables may occur in cases where a disease \nmilestone triggers treatment, and time points relative to treatment are part of the study schedule. For \ninstance, a migraine trial may call for assessments of symptom severity at prescribed times after treatment \nof the migraine. If the migraine episodes were treated as disease milestones, then the disease milestone \ntiming variables might be populated in the exposure and symptom-severity records. If the study planned to \ntreat multiple migraine episodes, the MIDS variable would provide a convenient way to determine the \nepisode with which data were associated. \no \nAn evaluation interval variable (--EVLINT or --EVINTX) can be used in conjunction with disease \nmilestone variables. For instance, patient-reported outcome (PRO) instruments might be administered \nat the time of a disease milestone, and the questions in the instrument might include an evaluation \ninterval.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3664, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "efc16f7b-51c3-48bd-b52f-bb9b289b02c1": {"__data__": {"id_": "efc16f7b-51c3-48bd-b52f-bb9b289b02c1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 50, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "567aae79-a880-408a-939e-99c8b5133ffb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 50, "section": "UNSPECIFIED"}, "hash": "8d516bf40cdd5df5482890c3df5340ac093e9ea72b990312e9c939d4ee1d3e9f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "05b8f910-d422-49c4-a386-7707d8c6cc83", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 50, "section": "UNSPECIFIED"}, "hash": "fb22e430a0d6a073b7e4e13c9336f77ad61666d1f2829440f0c589522a28a017", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 \nThe use of time-point variables with disease milestone variables may occur in cases where a disease \nmilestone triggers treatment, and time points relative to treatment are part of the study schedule. For \ninstance, a migraine trial may call for assessments of symptom severity at prescribed times after treatment \nof the migraine. If the migraine episodes were treated as disease milestones, then the disease milestone \ntiming variables might be populated in the exposure and symptom-severity records. If the study planned to \ntreat multiple migraine episodes, the MIDS variable would provide a convenient way to determine the \nepisode with which data were associated. \no \nAn evaluation interval variable (--EVLINT or --EVINTX) can be used in conjunction with disease \nmilestone variables. For instance, patient-reported outcome (PRO) instruments might be administered \nat the time of a disease milestone, and the questions in the instrument might include an evaluation \ninterval. \n\u2022 \nThe timing variables for start and end of an event or intervention relative to the study reference period (--\nSTRF and --ENRF) or relative to a reference time point (--STRTPT and --STTPT, --ENRTPT and --\nENTPT) can be used in conjunction with disease milestone variables. For example, a concomitant \nmedication could be collected in association with a disease milestone, so that the disease milestone timing \nvariables were populated but relative timing variables used for the start or end of the concomitant \nmedication.", "mimetype": "text/plain", "start_char_idx": 2680, "end_char_idx": 4190, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3b2cfcf4-06ac-495b-9f1d-4c1bfe00b683": {"__data__": {"id_": "3b2cfcf4-06ac-495b-9f1d-4c1bfe00b683", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 51, "section": "4.5.1.1 Original and Standardized Results"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "64ca66dc-833e-456e-8668-4b0007d264ab", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 51, "section": "4.5.1.1 Original and Standardized Results"}, "hash": "0ec797356bd2a73a56feca15a8853a64a90963a93194a54cea77c3c24c297bad", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The --ORRES variable contains the result of the measurement or finding as originally received or collected. --\nORRES is an expected variable and should always be populated, except (1) when --STAT = \"NOT DONE\" (because \nthere is no result for such a record) or (2) for derived records. \nNote: Records with --DRVFL = \"Y\" may combine data collected at more than 1 visit. In such cases, sponsors must \ndefine the value for VISITNUM, addressing the correct temporal sequence. If a new record is derived for a dataset \nby the sponsor or their agent (e.g., a CRO), then that new record should be flagged as derived.For example, in \nelectrocardiogram (ECG) data, if a corrected QT interval value derived in-house by the sponsor were represented in \nan SDTM record, then EGDRVFL would be \"Y\". If a corrected QT interval value was received from a vendor or \nwas produced by the ECG machine, the derived flag would be null. \nWhen --ORRES is populated, --STRESC must also be populated, regardless of whether the data values are character \nor numeric. The variable --STRESC is populated either by the conversion of values in --ORRES to values with \nstandard units, or by the assignment of the value of --ORRES, as in the Physical Examination (PE) domain, where --\nSTRESC could contain a dictionary-derived term. A further step is necessary when --STRESC contains numeric \nvalues. These are converted to numeric type and written to --STRESN. Because --STRESC may contain a mixture of \nnumeric and character values, --STRESN may contain null values, as shown in the following figure. \nFigure. Original to Standardized Results \nWhen the original measurement or finding is a selection from a defined codelist, in general, the --ORRES and --\nSTRESC variables contain results in decoded format (i.e., the textual interpretation of whichever code was selected \nfrom the codelist). In some cases where the code values in the codelist are statistically meaningful standardized \nvalues or scores, which are defined by sponsors or by valid methodologies such as SF36 questionnaires, the --\nORRES variables will contain the decoded format, whereas the --STRESC variables as well as the --STRESN \nvariables will contain the standardized values or scores. \nOccasionally data that are intended to be numeric are collected with characters attached that cause the character-to-\nnumeric conversion to fail. For example, numeric cell counts in the source data may be specified with a greater than \n(>) or less than (<) sign attached (e.g., >10,000, <1). In these cases, the value with the greater than (>) or less than \n(<) sign attached should be moved to the --STRESC variable, and --STRESN should be null. The rules for", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2690, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "90c9f6c6-4cc0-4957-944a-ba3e4d987348": {"__data__": {"id_": "90c9f6c6-4cc0-4957-944a-ba3e4d987348", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 52, "section": "4.5.1.2 Tests Not Done"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca8b6516-71b5-4584-bab5-6bb43bfa518c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 52, "section": "4.5.1.2 Tests Not Done"}, "hash": "26dae6669aa9490bdec8e07ffb287858b4f63afac818339196bc1cdee74af5b2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If the data on the CRF is missing and \"Yes/No\" or \"Done/Not Done\" was not explicitly captured, a record should not \nbe created to indicate that the data was not collected, with the exception of QRS. Regulatory agencies may require a \nrecord for all items on a CRF in QRS datasets (e.g., FT, QS, and clinical classifications in RS).  \nIf a record is created for a test not done, --REASND is populated only if a reason was explicitly collected except for \nQRS logically skipped items. \nWhen an entire examination (e.g., laboratory draw, ECG, vital signs, physical examination), a group of tests (e.g., \nhematology, urinalysis), or an individual test (e.g., glucose, PR interval, blood pressure, hearing) is not done, and \nthis information is explicitly captured with a \"Yes/No\" or \"Done/Not Done\" question, this information should be \nrepresented in the dataset. The reason for the missing information may or may not have been collected. \nA sponsor has the following options: \n1. Submit individual records for each test not done. \n2. Submit 1 record for a group of tests that were not done. \nThe following example illustrates the single-record approach for representing a group of tests not done. \nIf a single record is used to represent a group of tests were not done: \n\u2022 \n--TESTCD should be --ALL \n\u2022 \n--TEST should be <Domain description> \n\u2022 \n--CAT should be <Name of group of tests> \n\u2022 \n--ORRES should be null \n\u2022 \n--STAT should be \"NOT DONE\" \n\u2022 \n--REASND, if collected, might be \"Specimen lost\" \nFor example, if urinalysis tests were not done, then: \n\u2022 \nLBTESTCD would be \"LBALL\" \n\u2022 \nLBTEST would be \"Laboratory Test Results\" \n\u2022 \nLBCAT would be \"URINALYSIS\" \n\u2022 \nLBORRES would be null \n\u2022 \nLBSTAT would be \"NOT DONE\" \n\u2022 \nLBREASND, if collected, might be \"Subject could not void\"", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1777, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e63fb069-ddfb-4919-9cb4-0f1466175c1d": {"__data__": {"id_": "e63fb069-ddfb-4919-9cb4-0f1466175c1d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 52, "section": "4.5.1.3 Examples of Original and Standard Units and Test Not Done"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "67b42b9a-3c8c-4249-9f2f-743d9b496ff4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 52, "section": "4.5.1.3 Examples of Original and Standard Units and Test Not Done"}, "hash": "63bc8acc3eb6e377b0a04387069ac18433eedfd3e7a3d5e0179a42fe1f02ce4a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The following examples are meant to illustrate the use of Findings results variables, and are not meant as \ncomprehensive domain examples. Certain required and expected variables are omitted (e.g., USUBJID), and the \nsamples may represent data for more than 1 subject. \nExample 1 \nRow 1: \nA numeric value was converted to the standard unit. \nRow 2: \nA numeric value was copied; the original unit was the standard unit so conversion was not needed. \nRows 3-4: \nA character result was copied from the LBORRES to LBSTRESC. Since this is not a numeric result, \nLBSTRESN is null. \nRow 5: \nA character result was converted to a standardized format.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 642, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fa913110-6ee6-4b6e-8825-ba62c029224a": {"__data__": {"id_": "fa913110-6ee6-4b6e-8825-ba62c029224a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 53, "section": "33.8 33.8"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea11876b-0b66-4938-b379-08e830fd937b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 53, "section": "33.8 33.8"}, "hash": "57132b17d11451070c8ccbd5ca9f385ea0b7ae9d31bb5e2c91e550540600ae47", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "g/dL \n \nY \n3 \n2016-02-15 \n8 \nHCT \nHEMATOLOGY \n \n \n \n \n \nNOT DONE \n \n2 \n2016-02-08 \n9 \nLBALL \nHEMATOLOGY \n \n \n \n \n \nNOT DONE \n \n3 \n2016-02-29 \n10 \nLBALL \n \n \n \n \n \n \nNOT DONE \n \n4 \n2016-02-22 \n11 \nWBC \nHEMATOLOGY \n<4, 000 \n10^6/L \n<4,000 \n \n10^6/L \n \n \n6 \n2016-02-07 \n12 \nBILI \nCHEMISTRY \n<0.1 \nmg/dL \n<1.71 \n \numol/L \n \n \n6 \n2016-02-07 \nExample 2 \nRow 1: \nA numeric result was collected in standard units. Because no conversion was necessary, the result was copied into LBSTRESC and LBSTRESN. \nRows 2-3: \nNumeric results were converted to standard units. \nRow 4: \nCharacter values were copied to EGSTRESC. EGSTRESN is null. \nRow 5: \nThe overall interpretation of the ECG is represented as a separate test. \nRow 6: \nThe result for EGTESTCD = \"PRAG\" was missing at visit 2, as indicated by EGSTAT = \"NOT DONE\"; neither EGORRES nor EGSTRESC is \npopulated. \nRow 7: \nAt visit 3, there were no ECG results, as indicated by EGTESTCD = \"EGALL\" and EGSTAT = \"NOT DONE\". \neg.xpt \nRow EGTESTCD EGTEST \nEGORRES \nEGORRESU EGSTRESC \nEGSTRESN EGSTRESU EGSTAT \nVISITNUM EGDTC \n1 \nQRSAG \nPR Interval, Aggregate", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1093, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4b42c3b1-657d-49e7-ae80-2f0159947b8a": {"__data__": {"id_": "4b42c3b1-657d-49e7-ae80-2f0159947b8a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 54, "section": "4.5.3.1 Test Name (--TEST) Greater than 40 Characters"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c4168171-6853-4beb-a468-13566f547133", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 54, "section": "4.5.3.1 Test Name (--TEST) Greater than 40 Characters"}, "hash": "d513730b6e882ee92f957ea4cdeba04a0b6e3d3ac745a7dfcc1075aea63884f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sponsors may have test descriptions (--TEST) longer than 40 characters in their operational database. Because the --TEST variable is meant to serve as a label \nfor a --TESTCD when a Findings dataset is transposed to a more horizontal format, the length of --TEST is limited to 40 characters (except as noted below) to \nconform to the limitations of the SAS V5 transport file format (https://documentation.sas.com/). Therefore, sponsors have the choice to either insert the first 40 \ncharacters or a text string abbreviated to 40 characters in --TEST. Sponsors have the following options for including the full description for these variables in the \nstudy metadata: \n\u2022 \nIf the annotated CRF contains the full text, provide a reference to the aCRF page containing the full test description in the Define-XML document origin \ndefinition for --TEST. \n\u2022 \nIf the annotated CRF does not specify the full text, then the full text should be documented in the Define-XML document and/or other submission \nmaterials (e.g., the clinical study data reviewer's guide).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1055, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbc8844e-13a6-48e8-9d53-f6362402c8b8": {"__data__": {"id_": "dbc8844e-13a6-48e8-9d53-f6362402c8b8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 55, "section": "4.5.3.2 Text Strings Greater than 200 Characters in Other Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a35e87cc-f90b-43ff-845c-0740974e82f9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 55, "section": "4.5.3.2 Text Strings Greater than 200 Characters in Other Variables"}, "hash": "79d3de02edb8f76ef4f40afe37ba72d19ea13152bf2cad979e748f196e6b15fc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Some sponsors may collect data values longer than 200 characters for some variables. Because of the current \nrequirement for the SAS V5 transport file format, it is not possible to store long text strings using only 1 variable. \nTherefore, the SDTMIG has defined conventions for storing long text strings using multiple variables. \nFor general observation-class variables and supplemental qualifiers (i.e., non-standard variables, NSVs), \nthe conventions are as follows: \n\u2022 \nThe first 200 characters of text should be stored in the parent domain variable and each additional 200 \ncharacters of text should be stored in a record in the SUPP-- dataset (see Section 8.4, Relating Non-\nstandard Variable Values to a Parent Domain). \n\u2022 \nWhen splitting a text string into several records, the text should be split between words to improve \nreadability. \n\u2022 \nWhen the text longer than 200 characters is for a supplemental qualifier, the first QNAM should describe \nthe NSV without any numeric suffix.  \n\u2022 \nThe value for QNAMs for additional text (>200 characters) should contain a sequential variable name, \nwhich is formed by appending a 1-digit integer, beginning with 1, to the original domain variable name. \n\u2022 \nThe value for QLABEL should be the original domain variable label. \no \nThe reason a digit integer or suffix is not appended to the label is because the long text string \nrepresents a single value for a variable. The physical representation (i.e., SAS V5 transport file format) \ndoes not change the concept described by the label. \no \nThis is different conceptually from when there are multiple values for a non-result qualifier variable \nand values are individually stored in SUPP--.  In that case, both QNAM and QLABEL must be \nuniquely named (see Section 4.2.8.3, Multiple Values for a Non-result Qualifier Variable) because \nthey represent multiple values for a single variable. \no \nIn cases where the standard domain variable name is already 8 characters in length, sponsors should \nreplace the last character with a digit when creating values for QNAM. As an example, for Other \nAction Taken in Adverse Events (AEACNOTH), values for QNAM for the SUPPAE records would \nhave the values AEACNOT1, AEACNOT2, and so on. \nExample 1 \nIn this example, the text entered for MHTERM was longer than 200 characters and required 2 supplemental qualifier \nvariables for the text that extended beyond what could be represented in the standard variable. \nmh.xpt \nRow STUDYID DOMAIN USUBJID MHSEQ MHTERM \n1 \n12345 \nMH \n99-123 \n6 \n1st ~200 chars of text, split between words \n \nsuppmh.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL QNAM \nQLABEL \nQVAL \nQORIG QEVAL \n1 \n12345 \nMH \n99-123 \nMHSEQ 6 \nMHTERM1 Reported Term for the \nMedical History \n2nd ~200 chars of text, \nsplit between words \nCRF \n \n2 \n12345 \nMH \n99-123 \nMHSEQ 6 \nMHTERM2 Reported Term for the \nMedical History \nlast 100 or more chars of \ntext \nCRF \n \nExample 2 \nIn this example, the text entered for AEACNOTH was longer than 200 characters, but required only 1 supplemental \nqualifier for the text that extended beyond what could be represented in the standard variable.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3132, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cf49409d-89c0-4587-96d0-5c92aa7701d9": {"__data__": {"id_": "cf49409d-89c0-4587-96d0-5c92aa7701d9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 56, "section": "4.5.4 Evaluators in the Interventions and Events Observation Classes"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ef8db99f-97c7-4e0a-9670-e9500e645146", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 56, "section": "4.5.4 Evaluators in the Interventions and Events Observation Classes"}, "hash": "de1172661f28e09242c011a72dd61e638858191421d6571527035181a5fb1ba6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Because observations may originate from more than 1 source (e.g., investigator, independent assessor), observations \nrecorded in the Findings class include the --EVAL qualifier. For the Interventions and Events observation classes, \nwhich do not include the --EVAL variable, all data are assumed to be attributed to the principal investigator. The \nQEVAL variable can be used to describe the evaluator for any data item in a SUPP-- dataset (see Section 8.4.1, \nSupplemental Qualifiers \u2013 SUPP-- Datasets), but is not required when the data are objective. For observations that \nhave primary and secondary evaluations of specific qualifier variables, sponsors should put data from the primary \nevaluation into the standard domain dataset and data from the secondary evaluation into the Supplemental Qualifier \ndatasets (SUPP--). Within each SUPP-- record, the value for QNAM should be formed by appending a \"1\" to the \ncorresponding standard domain variable name. In cases where the standard domain variable name is already 8 \ncharacters in length, sponsors should replace the last character with a \"1\" (incremented for each additional \nattribution). \nThis example illustrates a case where an adjudication committee evaluated an adverse event. The evaluations of the \nadverse event by the primary investigator were represented in the standard AE dataset. The evaluations of the \nadjudication committee were represented in SUPPAE. See Section 8.4, Relating Non-standard Variable Values to a", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1487, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "85d6ecb0-4c1c-4e25-aae8-d609b04d6506": {"__data__": {"id_": "85d6ecb0-4c1c-4e25-aae8-d609b04d6506", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.5 Clinical Significance for Findings Observation Class Data"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eb6608a4-59f1-43ab-91db-3eb8fddf552c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.5 Clinical Significance for Findings Observation Class Data"}, "hash": "8ab694b01c2a214f8cae256f0814d8125f6ad10e509ac0cf6d67a165ea838758", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For assessments of clinical significance when the overall interpretation is a record in the domain, use the --CLSIG \n(Clinically Significant) variable on the record that contains the overall interpretation or a particular result. For \nexample, EGCLSIG = \"Y\" indicates that an ECG result of \"ATRIAL FIBRILLATION\" was clinically significant. \nSeparate from clinical significance are results of \"NORMAL\" or \"ABNORMAL\", or lab values that are out of \nnormal range. Examples of the latter include: \n\u2022\nAn ECG test with EGTESTCD = \"INTP\" (which addresses the ECG as a whole) should have a result or of\n\"NORMAL\" or \"ABNORMAL\". A record for EGTESTCD = \"INTP\" may also have EGCLSIG indicating\nwhether the result is clinically significant.\n\u2022\nA record for a vital signs measurement (e.g., systolic blood pressure) or a lab test (e.g., hematocrit) that\ncontains a measurement may have a normal range and a normal range indicator. It could also have --CLSIG\nindicating whether the result was clinically significant.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1001, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "741d6354-3615-43ab-bbe6-9223c4183fc5": {"__data__": {"id_": "741d6354-3615-43ab-bbe6-9223c4183fc5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.6 Supplemental Reason Variables"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e47042cc-6ebc-4b6a-9d65-76c51768896b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.6 Supplemental Reason Variables"}, "hash": "5748aa4541cd060fda2c4b9e582965927ca3e512ad6e1ae4c7527da87b221f40", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The SDTM general observation classes include the --REASND variable to submit the reason a response is not \npresent (a result in a findings class or an --OCCUR value in an events or interventions variable). For Events and \nInterventions domains where prespecified occurrences have a reason for the \"Y\" or \"N\" value of --OCCUR, the \nreason can be represented with the variable --REASOC. However, sponsors sometimes collect the reason that \nsomething was done. For the Interventions general observation class, --INDC is available to represent the medical \ncondition for which the intervention was given, and --ADJ is available to represent the reason for a dose adjustment. \nFor the Findings general observation class, --REASPF is available to represent the reason a test was performed. If \nthe sponsor collects a reason for performing an activity represented in an Events domain where the topic is not a \nmedical condition, or a reason for an intervention other than a medical indication, the reason can be represented in \nthe SUPP-- dataset (as described in Section 8.4.1, Supplemental Qualifiers \u2013 SUPP-- Datasets) using the \nsupplemental qualifier with QNAM  of \"--REAS\" listed in Appendix C1, Supplemental Qualifiers Name Codes. If \nmultiple reasons are reported, refer to Section 4.2.8.3, Multiple Values for a Non-result Qualifier Variable. \nFor example, if the sponsor collected the reason for admission to a nursing home was for rehabilitation, a SUPPHO \nrecord might be populated as follows.  \nsuppho.xpt\nRow STUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \n1 \n12345 \nHO \n99-123\nHOSEQ \n3 \nHOREAS \nReason \nREHABILITATION \nCRF", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1653, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1c548914-935f-4c06-bb04-dde918cd414f": {"__data__": {"id_": "1c548914-935f-4c06-bb04-dde918cd414f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.7 Presence or Absence of Prespecified Interventions and Events"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b9b7a13e-e917-4f2e-8bad-8ea72792d992", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 57, "section": "4.5.7 Presence or Absence of Prespecified Interventions and Events"}, "hash": "ab69aa58155f02df2ba7bffc5e1a7589a64a0060185d1bba36e86e4955b8d9f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Interventions (e.g., concomitant medications) and events (e.g., medical history) can generally be collected in 2 \ndifferent ways, by recording either verbatim free text or the responses to a prespecified list of treatments or terms. \nBecause the method of solicitation for information on treatments and terms may affect the frequency at which they \nare reported, whether they were prespecified may be of interest to reviewers. The --PRESP variable is used to \nindicate whether a specific intervention (--TRT) or event (--TERM) was solicited. The --PRESP variable has \ncontrolled terminology of \"Y\" (for \"Yes\") or a null value. It is a permissible variable, and should only be used when \nthe topic variable values come from a prespecified list. Questions such as \"Did the subject have any concomitant \nmedications?\" or \"Did the subject have any medical history?\" should not have records in an SDTM domain because", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 911, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e4c0a39d-df69-4006-91cc-4a7a85d19c01": {"__data__": {"id_": "e4c0a39d-df69-4006-91cc-4a7a85d19c01", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 58, "section": "4.5.8 Accounting for Long-term Follow-up"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7213ac2f-3f81-4703-bc33-afcaeba8def5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 58, "section": "4.5.8 Accounting for Long-term Follow-up"}, "hash": "839fd4c3e08090459ab9717c887d5f3efcd8ea80a39913bff78a9d5bb62e6641", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Studies often include long-term follow-up assessments to monitor a subject's condition. Use cases include studies in \nterminally ill populations that periodically assess survival and studies involving chronic disease that include follow-\nup to assess relapse. Long-term follow-up is often conducted via telephone calls rather than clinic visits. Regardless \nof the method of contact, the information should be stored in the appropriate topic-based domain. \nOverall study conclusion in the Disposition (DS) domain occurs once all contact with the subject ceases. If a study \nhas a clinical treatment phase followed by a long-term follow-up phase, these 2 segments of the study can be \nrepresented as separate epochs within the overall study, each with its own epoch disposition record. \nThe following example illustrates the recommended SDTM approach to storing these data. \nAn oncology study encompasses 2 months of clinical treatment and assessments followed by once-monthly \ntelephone contacts. The contacts continue until the subject dies. During the telephone contact, the investigator \ncollects information on the subject's survival status and medication use. The answers to certain questions may \ntrigger other data collection. For example, if the subject's survival status is \"dead\", then this indicates that the subject \nhas ceased participation in the study, so a study discontinuation record would need to be created. In SDTM, the data \nrelated to these follow-up telephone contacts should be stored as follows: \n1. Concomitant medications reported during the contact should be stored in the CM domain. \n2. The subject's survival status should be stored in the Subject Status (SS) domain. \n3. The disposition of the subject at the time of the final follow-up contact should be stored in DS. Note that \noverall study conclusion is the point where any contact with the subject ceases, which in this example is \nalso the conclusion of long-term follow-up. The disposition of the subject at the conclusion of the 2-month \nclinical treatment phase would be stored in DS as the conclusion to that epoch. Long-term follow-up would \nbe represented as a separate epoch. Therefore, in this example the subject could have 3 disposition records \nin DS, with both the follow-up epoch disposition and the overall study conclusion disposition being \ncollected at the final telephone contact. See Section 6.2.4, Disposition, for detailed assumptions and \nexamples. \n4. If the subject's survival status is \"dead\", the Demographics (DM) variables DTHDTC and DTHFL must be \nappropriately populated.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2589, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c9d3311e-db07-4c25-98d0-ac53c1ba90d7": {"__data__": {"id_": "c9d3311e-db07-4c25-98d0-ac53c1ba90d7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 59, "section": "4.5.9 Baseline Values"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4645bd29-25b7-4eb1-8486-47d9cd13cae8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 59, "section": "4.5.9 Baseline Values"}, "hash": "ab418b46e772c9a6a2c059f0321779df0ab888939d71cc9685dd529c42102659", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The variable --LOBXFL was introduced in SDTMIG v3.3 to address the need for a consistent definition of a value \nthat can serve as a reference with which to compare post-treatment values. This generic definition approximates the \nconcept of baseline and can be used to calculate post-treatment changes. In domains where --BLFL was expected, its \ncore value was changed from expected to permissible and the variable --LOBXFL, with a core value of expected, \nwas added to contain the consistent definition. In domains where --BLFL was permissible, the variable --LOBXFL \nwas added with a core value of permissible. \nThe following table shows a set of similar flag variables and their usage across the SDTM and ADaM. \nVariable Structure \nWhere It Is \nDefined \nRequirement in That \nStructure \nDefinition \nIntended Use \n--\nLOBXFL \nSDTM \nFindings \nExpected or \nPermissible \nLast non-missing value prior to RFXSTDTC \n(operationally derived) \nConsistent pre-treatment \nreference value baseline for \nuse across all studies and \nsponsors \nABLFL \nADaM BDS \nConditionally \nRequired \nFlags the record that is the source of the baseline \nvalue for a given parameter specified in the statistical \nanalysis plan (SAP; may differ both across and within \nstudies and datasets) \nBaseline for ADaM analysis \nas specified in the SAP \n--BLFL \nSDTM \nFindings \nPermissible (formerly \nExpected in some \ndomains) \nA baseline defined by the sponsor (could be derived in \nthe same manner as --LOBXFL or ABLFL, but is not \nrequired to be) \nAny sponsor-defined baseline \nuse \nAs shown in the table, each variable serves a specific need. The SDTM variable --LOBXFL (and/or --BLFL, if used) \ncan be copied to ADaM for traceability and transparency, but only the ADaM variable ABLFL would be used to \nsignify baseline for analysis. The content of --LOBXFL and ABLFL will be exactly the same when the SAP \nspecifies that the baseline used for analysis is the last non-missing value prior to RFXSTDTC.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1965, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fcdcc07d-e08b-47df-ae2d-210ed3151033": {"__data__": {"id_": "fcdcc07d-e08b-47df-ae2d-210ed3151033", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 60, "section": "5.1 Comments (CO)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a6a35f7f-de88-4414-9c1d-0dad120b1252", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 60, "section": "5.1 Comments (CO)"}, "hash": "4faf1e525f5c0fae28cf739067b1b96260fd981626d6ce1d20ae2e17d0a480ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CO \u2013 Description/Overview \nA special-purpose domain that contains comments that may be collected alongside other data. \nCO \u2013 Specification \nco.xpt, Comments \u2014 Special Purpose. One record per comment per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar CO \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nRDOMAIN \nRelated Domain \nAbbreviation \nChar (DOMAIN) \nRecord \nQualifier \nTwo-character abbreviation for the domain of the parent record(s). Null for comments collected on a \ngeneral comments or additional information CRF page. \nPerm \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nCOSEQ \nSequence Number Num  \nIdentifier \nSequence Number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nIDVAR \nIdentifying \nVariable \nChar * \nRecord \nQualifier \nIdentifying variable in the parent dataset that identifies the record(s) to which the comment applies. \nExamples AESEQ or CMGRPID. Used only when individual comments are related to domain records. \nNull for comments collected on separate CRFs. \nPerm \nIDVARVAL \nIdentifying \nVariable Value \nChar  \nRecord \nQualifier \nValue of identifying variable of the parent record(s). Used only when individual comments are related to \ndomain records. Null for comments collected on separate CRFs. \nPerm \nCOREF \nComment \nReference \nChar  \nRecord \nQualifier \nSponsor-defined reference associated with the comment. May be the CRF page number (e.g., 650), or a \nmodule name (e.g., DEMOG), or a combination of information that identifies the reference (e.g. 650-\nVITALS-VISIT 2). \nPerm \nCOVAL \nComment \nChar  \nTopic \nThe text of the comment. Text over 200 characters can be added to additional columns COVAL1-\nCOVALn. See Assumption 3. \nReq \nCOEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned \nby a person or a group). Example: \"INVESTIGATOR\". \nPerm \nCOEVALID \nEvaluator Identifier Char (MEDEVAL) \nRecord \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in --EVAL. Examples: \n\"RADIOLOGIST\", \"RADIOLOGIST 1\", \"RADIOLOGIST 2\". \nPerm \nCODTC \nDate/Time of \nComment \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time of comment on dedicated comment form. Should be null if this is a child record of another \ndomain or if comment date was not collected. \nPerm \nCODY \nStudy Day of \nComment \nNum  \nTiming \nStudy day of the comment, in integer days. The algorithm for calculations must be relative to the sponsor-\ndefined RFSTDTC variable in the Demographics (DM) domain. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3092, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d47da65-9233-4002-a5f7-be65e19bccb5": {"__data__": {"id_": "5d47da65-9233-4002-a5f7-be65e19bccb5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 61, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "59aafca2-8010-4c9d-b176-84a2b5af7711", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 61, "section": "UNSPECIFIED"}, "hash": "a05d34330262bb3351debcd69efe829f7e7f00ff94d8a3db02ff5cbf671ef525", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "860aae7d-cab2-4867-ad30-7d2540b49808", "node_type": "1", "metadata": {}, "hash": "fed80eb2da5507be9a502df9f213c080eac89b0ed34bcca5162204b29c9cb07b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 61 \n2021-11-29 \nCO \u2013 Assumptions \n1. The Comments special-purpose domain provides a solution for submitting free-text comments related to data in 1 or more SDTM domains (as described \nin Section 8.5, Relating Comments to a Parent Domain) or collected on a separate CRF page dedicated to comments. Comments are generally not \nresponses to specific questions; instead, comments usually consist of voluntary free-text or unsolicited observations. \n2. Although the structure for the Comments domain in the SDTM is \"One record per comment\", USUBJID is required in the comments domain for human \nclinical trials, so the structure of the Comments domain in the SDTMIG is \"One record per comment per subject.\" \n3. The CO dataset accommodates 3 sources of comments: \na. \nThose unrelated to a specific domain or parent record(s), in which case the values of the variables RDOMAIN, IDVAR, and IDVARVAL are null. \nCODTC should be populated if captured. See Example 1, row 1. \nb. Those related to a domain but not to specific parent record(s), in which case the value of the variable RDOMAIN is set to the DOMAIN code of the \nparent domain and the variables IDVAR and IDVARVAL are null. CODTC should be populated if captured. See Example 1, row 2. \nc. \nThose related to a specific parent record or group of parent records, in which case the value of the variable RDOMAIN is set to the DOMAIN code \nof the parent record(s) and the variables IDVAR and IDVARVAL are populated with the key variable name and value of the parent record(s). \nAssumptions for populating IDVAR and IDVARVAL are further described in Section 8.5, Relating Comments to a Parent Domain. CODTC should \nbe null because the timing of the parent record(s) is inherited by the comment record. See Example 1, rows 3-5. \n4. When the comment text is longer than 200 characters, the first 200 characters of the comment will be in COVAL, the next 200 in COVAL1, and \nadditional text stored as needed to COVALn. See Example 1, rows 3-4. Additional information about how to relate comments to parent SDTM records \nis provided in Section 8.5, Relating Comments to a Parent Domain. \n5. The variable COREF may be null unless it is used to identify the source of the comment. See Example 1, rows 1 and 5. \n6. Identifier variables and Timing variables may be added to the CO domain, but the following qualifiers would generally not be used in CO: --GRPID, --\nREFID, --SPID, TAETORD, --TPT, --TPTNUM, --ELTM, --TPTREF, --RFTDTC. \nCO \u2013 Examples \nExample 1 \nRow 1: \nShows a comment collected on a separate comments page. Since it was unrelated to any specific domain or record, RDOMAIN, IDVAR, and \nIDVARVAL are null. \nRow 2: \nShows a comment that was collected on the bottom of the PE page for Visit 7, without any indication of specific records it applied to. Since the \ncomment related to a specific domain, RDOMAIN is populated.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3049, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "860aae7d-cab2-4867-ad30-7d2540b49808": {"__data__": {"id_": "860aae7d-cab2-4867-ad30-7d2540b49808", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 61, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "59aafca2-8010-4c9d-b176-84a2b5af7711", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 61, "section": "UNSPECIFIED"}, "hash": "a05d34330262bb3351debcd69efe829f7e7f00ff94d8a3db02ff5cbf671ef525", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d47da65-9233-4002-a5f7-be65e19bccb5", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 61, "section": "UNSPECIFIED"}, "hash": "b6f05212b28b899bb44b6df093669115e2d991380e1e5998470a7da3b7a8aeb3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "See Example 1, rows 1 and 5. \n6. Identifier variables and Timing variables may be added to the CO domain, but the following qualifiers would generally not be used in CO: --GRPID, --\nREFID, --SPID, TAETORD, --TPT, --TPTNUM, --ELTM, --TPTREF, --RFTDTC. \nCO \u2013 Examples \nExample 1 \nRow 1: \nShows a comment collected on a separate comments page. Since it was unrelated to any specific domain or record, RDOMAIN, IDVAR, and \nIDVARVAL are null. \nRow 2: \nShows a comment that was collected on the bottom of the PE page for Visit 7, without any indication of specific records it applied to. Since the \ncomment related to a specific domain, RDOMAIN is populated. Since it was related to a specific visit, VISIT, COREF is \"VISIT 7\". However, \nsince it does not relate to a specific record, IDVAR and IDVARVAL are null. \nRow 3: \nShows a comment related to a single AE record having its AESEQ=7. \nRow 4: \nShows a comment related to multiple EX records with EXGRPID = \"COMBO1\". \nRow 5: \nShows a comment related to multiple VS records with VSGRPID = \"VS2\".", "mimetype": "text/plain", "start_char_idx": 2397, "end_char_idx": 3438, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e02de7f5-89bc-44a9-baf4-e32504fa1560": {"__data__": {"id_": "e02de7f5-89bc-44a9-baf4-e32504fa1560", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 62, "section": "5.2 Demographics (DM)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "82229160-01fb-44c6-87b1-8234a9b16f11", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 62, "section": "5.2 Demographics (DM)"}, "hash": "a47cc32b0a5c3d5e1ab40cc69193d25ed71a63a3b19df7920ae94fc5d98c0336", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DM \u2013 Description/Overview \nA special-purpose domain that includes a set of essential standard variables that describe each subject in a clinical study. It is the parent domain for all other \nobservations for human clinical subjects. \nDM \u2013 Specification \ndm.xpt, Demographics \u2014 Special Purpose. One record per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar DM \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the \nproduct. This must be a unique value, and could be a compound identifier formed by concatenating \nSTUDYID-SITEID-SUBJID. \nReq \nSUBJID \nSubject Identifier \nfor the Study \nChar  \nTopic \nSubject identifier, which must be unique within the study. Often the ID of the subject as recorded on a CRF. \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1087, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7b9a2e42-d8b2-469d-8b80-df03c4c28ba3": {"__data__": {"id_": "7b9a2e42-d8b2-469d-8b80-df03c4c28ba3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 63, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b2b7336b-f795-4a53-aade-de2970d7f8d6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 63, "section": "UNSPECIFIED"}, "hash": "837bdfccacc4093a7cdb2f40e7033b9b3c73355d853e23d545c0a643ede40b90", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb51e895-a882-4ef5-b029-c141fc964f48", "node_type": "1", "metadata": {}, "hash": "56b69c2128621349ae802a7a048641297966021ebc4acf8cb9271235c6c5effe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 63 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nRFSTDTC \nSubject Reference \nStart Date/Time \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nReference start date/time for the subject in ISO 8601 character format. Usually equivalent to date/time when \nsubject was first exposed to study treatment. See assumption 9 for additional detail on when RFSTDTC may \nbe null. \nExp \nRFENDTC \nSubject Reference \nEnd Date/Time \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nReference end date/time for the subject in ISO 8601 character format. Usually equivalent to the date/time \nwhen subject was determined to have ended the trial, and often equivalent to date/time of last exposure to \nstudy treatment. Required for all randomized subjects; null for screen failures or unassigned subjects. \nExp \nRFXSTDTC \nDate/Time of First \nStudy Treatment \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nFirst date/time of exposure to any protocol-specified treatment or therapy, equal to the earliest value of \nEXSTDTC. \nExp \nRFXENDTC \nDate/Time of Last \nStudy Treatment \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nLast date/time of exposure to any protocol-specified treatment or therapy, equal to the latest value of \nEXENDTC (or the latest value of EXSTDTC if EXENDTC was not collected or is missing). \nExp \nRFCSTDTC \nDate/Time of First \nChallenge Agent \nAdmin \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nUsed only when protocol specifies a challenge agent to induce a condition that the investigational treatment \nis intended to cure, mitigate, treat, or prevent. Equal to the earliest value of AGSTDTC for the challenge \nagent. \nPerm \nRFCENDTC \nDate/Time of Last \nChallenge Agent \nAdmin \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nUsed only when protocol specifies a challenge agent to induce a condition that the investigational treatment \nis intended to cure, mitigate, treat, or prevent. Equal to the latest value of AGENDTC for the challenge agent \n(or the latest value of AGSTDTC if AGENDTC was not collected or is missing). \nPerm \nRFICDTC \nDate/Time of \nInformed Consent \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nDate/time of informed consent in ISO 8601 character format. This will be the same as the date of informed \nconsent in the Disposition domain, if that protocol milestone is documented. Would be null only in studies not \ncollecting the date of informed consent. \nExp \nRFPENDTC \nDate/Time of End \nof Participation \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nDate/time when subject ended participation or follow-up in a trial, as defined in the protocol, in ISO 8601 \ncharacter format. Should correspond to the last known date of contact. Examples include completion date, \nwithdrawal date, last follow-up, date recorded for lost to follow up, and death date. \nExp \nDTHDTC \nDate/Time of \nDeath \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nDate/time of death for any subject who died, in ISO 8601 format.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3255, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb51e895-a882-4ef5-b029-c141fc964f48": {"__data__": {"id_": "eb51e895-a882-4ef5-b029-c141fc964f48", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 63, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b2b7336b-f795-4a53-aade-de2970d7f8d6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 63, "section": "UNSPECIFIED"}, "hash": "837bdfccacc4093a7cdb2f40e7033b9b3c73355d853e23d545c0a643ede40b90", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7b9a2e42-d8b2-469d-8b80-df03c4c28ba3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 63, "section": "UNSPECIFIED"}, "hash": "4d960adc08359354c810b30d66bff24b4314c0478cf500ca83255f4e317e07c7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This will be the same as the date of informed \nconsent in the Disposition domain, if that protocol milestone is documented. Would be null only in studies not \ncollecting the date of informed consent. \nExp \nRFPENDTC \nDate/Time of End \nof Participation \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nDate/time when subject ended participation or follow-up in a trial, as defined in the protocol, in ISO 8601 \ncharacter format. Should correspond to the last known date of contact. Examples include completion date, \nwithdrawal date, last follow-up, date recorded for lost to follow up, and death date. \nExp \nDTHDTC \nDate/Time of \nDeath \nChar ISO 8601 datetime \nor interval \nRecord \nQualifier \nDate/time of death for any subject who died, in ISO 8601 format. Should represent the date/time that is \ncaptured in the clinical-trial database. \nExp \nDTHFL \nSubject Death \nFlag \nChar (NY) \nRecord \nQualifier \nIndicates the subject died. Should be \"Y\" or null. Should be populated even when the death date is unknown. Exp \nSITEID \nStudy Site \nIdentifier \nChar * \nRecord \nQualifier \nUnique identifier for a site within a study. \nReq \nINVID \nInvestigator \nIdentifier \nChar \nRecord \nQualifier \nAn identifier to describe the Investigator for the study. May be used in addition to SITEID. Not needed if \nSITEID is equivalent to INVID. \nPerm \nINVNAM \nInvestigator Name Char \nSynonym \nQualifier \nName of the investigator for a site. \nPerm \nBRTHDTC \nDate/Time of Birth Char ISO 8601 datetime \nor interval \nRecord \nQualifier \nDate/time of birth of the subject. \nPerm \nAGE \nAge \nNum \nRecord \nQualifier \nAge expressed in AGEU. May be derived from RFSTDTC and BRTHDTC, but BRTHDTC may not be \navailable in all cases (due to subject privacy concerns). \nExp \nAGEU \nAge Units \nChar (AGEU) \nVariable \nQualifier \nUnits associated with AGE. \nExp \nSEX \nSex \nChar (SEX) \nRecord \nQualifier \nSex of the subject. \nReq \nRACE \nRace \nChar (RACE) \nRecord \nQualifier \nRace of the subject. Sponsors should refer to the FDA guidance2 regarding the collection of race. See \nassumption below regarding RACE. \nExp \nETHNIC \nEthnicity \nChar (ETHNIC) \nRecord \nQualifier \nThe ethnicity of the subject. Sponsors should refer to the FDA guidance1 regarding the collection of ethnicity. \nPerm \nARMCD \nPlanned Arm \nCode \nChar * \nRecord \nQualifier \nARMCD is limited to 20 characters. It is not subject to the character restrictions that apply to TESTCD. The \nmaximum length of ARMCD is longer than for other \"short\" variables to accommodate the kind of values that \nare likely to be needed for crossover trials. For example, if ARMCD values for a 7-period crossover were \nconstructed using 2-character abbreviations for each treatment and separating hyphens, the length of \nExp", "mimetype": "text/plain", "start_char_idx": 2491, "end_char_idx": 5226, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e091b3d4-62e8-49d5-b3e2-491625306acb": {"__data__": {"id_": "e091b3d4-62e8-49d5-b3e2-491625306acb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 64, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90dd798a-7795-4067-a885-9cbda366f052", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 64, "section": "UNSPECIFIED"}, "hash": "08b6dcf6ec7bcd9b04f07977bdb5e2a04a8f2d2dc33190c1606e1a14a58d2b3d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed7504d5-3e4b-416b-8a0a-adbbf5f4ae5e", "node_type": "1", "metadata": {}, "hash": "b1b7be988f3815210403c713d5b97b39ae2c8b84cbe96bba6ec67c7f31f9230e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 64 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nARMCD values would be 20. If the subject was not assigned to a trial arm, ARMCD is null and ARMNRS is \npopulated. \nWith the exception of studies which use multistage arm assignments, must be a value of ARMCD in the Trial \nArms dataset. \nARM \nDescription of \nPlanned Arm \nChar * \nSynonym \nQualifier \nName of the arm to which the subject was assigned. If the subject was not assigned to an arm, ARM is null \nand ARMNRS is populated. \nWith the exception of studies which use multistage arm assignments, must be a value of ARM in the Trial \nArms dataset. \nExp \nACTARMCD Actual Arm Code \nChar * \nRecord \nQualifier \nCode of actual arm. ACTARMCD is limited to 20 characters. It is not subject to the character restrictions that \napply to TESTCD. The maximum length of ACTARMCD is longer than for other short variables to \naccommodate the kind of values that are likely to be needed for crossover trials. \nWith the exception of studies which use multistage arm assignments, must be a value of ARMCD in the Trial \nArms dataset. \nIf the subject was not assigned to an arm or followed a course not described by any planned arm, \nACTARMCD is null and ARMNRS is populated. \nExp \nACTARM \nDescription of \nActual Arm \nChar * \nSynonym \nQualifier \nDescription of actual arm. \nWith the exception of studies which use multistage arm assignments, must be a value of ARM in the Trial \nArms dataset. \nIf the subject was not assigned to an arm or followed a course not described by any planned arm, ACTARM \nis null and ARMNRS is populated. \nExp \nARMNRS \nReason Arm \nand/or Actual Arm \nis Null \nChar (ARMNULRS) \nRecord \nQualifier \nA coded reason that arm variables (ARM and ARMCD) and/or actual arm variables (ACTARM and \nACTARMCD) are null. Examples: \"SCREEN FAILURE\", \"NOT ASSIGNED\", \"ASSIGNED, NOT TREATED\", \n\"UNPLANNED TREATMENT\". It is assumed that if the arm and actual arm variables are null, the same \nreason applies to both arm and actual arm. \nExp \nACTARMUD Description of \nUnplanned Actual \nArm \nChar \nRecord \nQualifier \nA description of actual treatment for a subject who did not receive treatment described in a planned trial arm. \nExp \nCOUNTRY \nCountry \nChar \nRecord \nQualifier \nCountry of the investigational site in which the subject participated in the trial. \nGenerally represented using ISO 3166-1 Alpha-3. Note that regulatory agency specific requirements (e.g., \nUS FDA) may require other terminologies; in such cases, follow regulatory requirements. \nReq \nDMDTC \nDate/Time of \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of demographic data collection. \nPerm \nDMDY \nStudy Day of \nCollection \nNum \nTiming \nStudy day of collection measured as integer days. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3136, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ed7504d5-3e4b-416b-8a0a-adbbf5f4ae5e": {"__data__": {"id_": "ed7504d5-3e4b-416b-8a0a-adbbf5f4ae5e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 64, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90dd798a-7795-4067-a885-9cbda366f052", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 64, "section": "UNSPECIFIED"}, "hash": "08b6dcf6ec7bcd9b04f07977bdb5e2a04a8f2d2dc33190c1606e1a14a58d2b3d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e091b3d4-62e8-49d5-b3e2-491625306acb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 64, "section": "UNSPECIFIED"}, "hash": "6387d569f59c042a9ffabe3a8143752d7b25c9bda721476073ac054f36e737bc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Exp \nCOUNTRY \nCountry \nChar \nRecord \nQualifier \nCountry of the investigational site in which the subject participated in the trial. \nGenerally represented using ISO 3166-1 Alpha-3. Note that regulatory agency specific requirements (e.g., \nUS FDA) may require other terminologies; in such cases, follow regulatory requirements. \nReq \nDMDTC \nDate/Time of \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of demographic data collection. \nPerm \nDMDY \nStudy Day of \nCollection \nNum \nTiming \nStudy day of collection measured as integer days. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n2Food and Drug Administration. Collection of Race and Ethnicity Data in Clinical Trials. US Department of Health and Human Services;2016. Accessed January 8, \n2020. https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf)", "mimetype": "text/plain", "start_char_idx": 2417, "end_char_idx": 3379, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1c3f8e7e-f540-4f01-8f59-be1f8e75b0b3": {"__data__": {"id_": "1c3f8e7e-f540-4f01-8f59-be1f8e75b0b3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 65, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f26f4991-ddd8-4aa9-8242-e8ea2539b0eb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 65, "section": "UNSPECIFIED"}, "hash": "915b42f7d9a0e7efaee2f2f3f743d77d3ffaafeaae6712cebc4db54c400a0e64", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6fbc33f8-ef27-4fd9-b9cc-ce5b93902d2f", "node_type": "1", "metadata": {}, "hash": "f038b2f131b2e80431654403be6435e8fde67b4df26fad1dc8f3200880344559", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 65 \n2021-11-29 \nDM \u2013Assumptions \n1. Investigator and site identification: Companies use different methods to distinguish sites and investigators. \nCDISC assumes that SITEID will always be present, with INVID and INVNAM used as necessary. This \nshould be done consistently and the meaning of the variable made clear in the Define-XML document. \n2. Every subject in a study must have a subject identifier (SUBJID). In some cases a subject may participate \nin more than 1 study. To identify a subject uniquely across all studies for all applications or submissions \ninvolving the product, a unique identifier (USUBJID) must be included in all datasets. Subjects \noccasionally change sites during the course of a clinical trial. Sponsors must decide how to populate \nvariables such as USUBJID, SUBJID and SITEID based on their operational and analysis needs, but only 1 \nDM record should be submitted for each subject. The Supplemental Qualifiers dataset may be used if \nappropriate to provide additional information. \n3. Concerns for subject privacy suggest caution regarding the collection of variables like BRTHDTC. This \nvariable is included in the Demographics model in the event that a sponsor intends to submit it; however, \nsponsors should follow regulatory guidelines and guidance as appropriate. \n4. With the exception of trials that use multistage processes to assign subjects to arms described below, ARM \nand ACTARM must be populated with ARM values from the Trial Arms (TA) dataset and ARMCD and \nACTARMCD must be populated with ARMCD values from the TA dataset or be null. The ARM and \nARMCD values in the TA dataset have a one-to-one relationship, and that one-to-one relationship must be \npreserved in the values used to populate ARM and ARMCD in DM, and to populate the values of \nACTARM and ACTARMCD in DM. \na. \nRules for the arm-related variables:  \ni. If ARMCD is null, then ARM must be null and ARMNRS must be populated with the reason \nARMCD is null. \nii. If ACTARMCD is null, then ACTARM must be null and ARMNRS must be populated with the \nreason ACTARMCD is null. Both ARMCD and ACTARMCD will be null for subjects who were \nnot assigned to treatment. The same reason will provide the reason that both are null. \niii. ARMNRS may not be populated if both ARMCD and ACTARMCD are populated. ARMCD and \nACTARMCD will be populated if the subject was assigned to an arm and received treatment \nconsistent with 1 of the arms in the TA dataset. If ARMCD and ACTARMCD are not the same, \nthat is sufficient to explain the situation; ARMNRS should not be populated. \niv. If ARMNRS is populated with \"UNPLANNED TREATMENT\", ACTARMUD should be \npopulated with a description of the unplanned treatment received. \nb. Multistage assignment to treatment: Some trials use a multistage process for assigning a subject to an \narm (see Section 7.2.1, Trial Arms, Example Trial 3). In such a case, best practice is to create ARMCD \nvalues composed of codes representing the results of the multiple stages of the treatment assignment \nprocess.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3218, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6fbc33f8-ef27-4fd9-b9cc-ce5b93902d2f": {"__data__": {"id_": "6fbc33f8-ef27-4fd9-b9cc-ce5b93902d2f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 65, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f26f4991-ddd8-4aa9-8242-e8ea2539b0eb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 65, "section": "UNSPECIFIED"}, "hash": "915b42f7d9a0e7efaee2f2f3f743d77d3ffaafeaae6712cebc4db54c400a0e64", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1c3f8e7e-f540-4f01-8f59-be1f8e75b0b3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 65, "section": "UNSPECIFIED"}, "hash": "367d5846b981acca75d90f76c5003f6283cdb6905ddb1b186610207e54bf2d11", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ARMNRS may not be populated if both ARMCD and ACTARMCD are populated. ARMCD and \nACTARMCD will be populated if the subject was assigned to an arm and received treatment \nconsistent with 1 of the arms in the TA dataset. If ARMCD and ACTARMCD are not the same, \nthat is sufficient to explain the situation; ARMNRS should not be populated. \niv. If ARMNRS is populated with \"UNPLANNED TREATMENT\", ACTARMUD should be \npopulated with a description of the unplanned treatment received. \nb. Multistage assignment to treatment: Some trials use a multistage process for assigning a subject to an \narm (see Section 7.2.1, Trial Arms, Example Trial 3). In such a case, best practice is to create ARMCD \nvalues composed of codes representing the results of the multiple stages of the treatment assignment \nprocess. If a subject is partially assigned, then truncated codes representing the stages completed can \nbe used in ARMCD, and similar truncated codes can be used in ACTARMCD. The descriptions used \nto populate ARM and ACTARM should be similarly truncated, and the one-to-one relationship \nbetween these truncated codes should be maintained for all affected subjects in the trial. Example 3 \nbelow provides an example of this situation; see also Section 5.3, Subject Elements, Example 2. Note \nthat this use of values not in the TA dataset is allowable only for trials with multistage assignment to \narms and to subjects in those trials who do not complete all stages of the assignment. \nc. \nExamples illustrating the arm-related variables \ni. Example 1 below shows how to handle a subject who was a screen failure and was never treated. \nii. The Subject Elements (SE) dataset records the series of elements a subject passed through in the \ncourse of a trial, and these determine the value of ACTARMCD. The following examples include \nsample data for both datasets to illustrate this relationship. \n1. Example 2 below shows how subjects who started the trial but were never assigned to an arm \nwould be handled.", "mimetype": "text/plain", "start_char_idx": 2417, "end_char_idx": 4421, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1ac74132-9760-4bb2-a942-1a65d51d8199": {"__data__": {"id_": "1ac74132-9760-4bb2-a942-1a65d51d8199", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 66, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f3e364a2-7276-42ab-b342-f57a9662bf9e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 66, "section": "UNSPECIFIED"}, "hash": "86df2dea8ef19b1221748c0b6e1db6104e832a9f031841e5b2d7261b27e3f66e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af0b47e9-7222-440a-b9ac-dbaf0dae0b51", "node_type": "1", "metadata": {}, "hash": "fa9808cb4a506002ca8edf4464711c70a2fe314a7709f3dc8d85432a7b052021", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 66 \n2021-11-29 \n2. Section 5.3, Subject Elements, Example 1 illustrates a situation for a subject who received a \ntreatment that was not the one to which they were assigned. \n3. Section 5.3, Subject Elements, Example 2 illustrates a situation in which a subject received a \nset of treatments different from that for any of the planned arms. \n5. Study population flags should not be included in SDTM data. The standard supplemental qualifiers \nincluded in previous versions of the SDTMIG (COMPLT, FULLSET, ITT, PPROT, SAFETY) should not \nbe used. Note: The ADaM Subject-level Analysis Dataset (ADSL) specifies standard variable names for \nthe most common populations and requires the inclusion of these flags when necessary for analysis; consult \nthe ADaMIG for more information about these variables. \n6. Submission of multiple race responses should be represented in the Demographics (DM) domain and \nSupplemental Qualifiers (SUPPDM) dataset as described in Section 4.2.8.3, Multiple Values for a Non-\nresult Qualifier Variable. If multiple races are collected, then the value of RACE should be \u201cMULTIPLE\u201d \nand the additional information will be included in the Supplemental Qualifiers dataset. Controlled \nterminology for RACE should be used in both DM and SUPPDM so that consistent values are available for \nsummaries regardless of whether the data are found in a column or row. If multiple races were collected \nand 1 was designated as primary, RACE in DM should be the primary race and additional races should be \nreported in SUPPDM. When additional free-text information is reported about subject's race using \u201cOther, \nSpecify\u201d, sponsors should refer to Section 4.2.7.1, \"Specify\" Values for Non-Result Qualifier Variables. If \nrace was collected via an \"Other, Specify\" field and the sponsor chooses not to map the value as described \nin the current FDA guidance (see CDISC Notes for RACE in the domain specification), then the value of \nRACE should be \u201cOTHER\u201d. For subjects who refuse to provide or do not know their race information, the \nvalue of RACE could be \u201cUNKNOWN\u201d. See DM Example 4, DM Example 5, DM Example 6, and DM \nExample 7. \na. \nThe Racec-Ethnicc Codetable (available at https://www.cdisc.org/standards/terminology/controlled-\nterminology) represents associations between collected race values and published race Controlled \nTerminology, as well as collected ethnicity values and published ethnicity Controlled Terminology.  \n7. RFSTDTC, RFENDTC, RFXSTDTC, RFXENDTC, RFCSTDTC, RFCENDTC, RFICDTC, RFPENDTC, \nDTHDTC, and BRTHDTC represent date/time values, but they are considered to have a record qualifier \nrole in DM. They are not considered to be timing variables because they are not intended for use in the \ngeneral observation classes. \n8. Additional permissible identifier, qualifier, and timing variables: \na. \nOnly the following timing variables are permissible and may be added as appropriate: VISITNUM, \nVISIT, VISITDY.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3131, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af0b47e9-7222-440a-b9ac-dbaf0dae0b51": {"__data__": {"id_": "af0b47e9-7222-440a-b9ac-dbaf0dae0b51", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 66, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f3e364a2-7276-42ab-b342-f57a9662bf9e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 66, "section": "UNSPECIFIED"}, "hash": "86df2dea8ef19b1221748c0b6e1db6104e832a9f031841e5b2d7261b27e3f66e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ac74132-9760-4bb2-a942-1a65d51d8199", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 66, "section": "UNSPECIFIED"}, "hash": "39bce997310d100d0addc312a74788548fa1835bcfa3c8b1a4da0323041ff4f7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "7. RFSTDTC, RFENDTC, RFXSTDTC, RFXENDTC, RFCSTDTC, RFCENDTC, RFICDTC, RFPENDTC, \nDTHDTC, and BRTHDTC represent date/time values, but they are considered to have a record qualifier \nrole in DM. They are not considered to be timing variables because they are not intended for use in the \ngeneral observation classes. \n8. Additional permissible identifier, qualifier, and timing variables: \na. \nOnly the following timing variables are permissible and may be added as appropriate: VISITNUM, \nVISIT, VISITDY. The record qualifier DMXFN (External File Name) is the only additional qualifier \nvariable that may be added, which is adopted from the Findings general observation class, may also be \nused to refer to an external file, such as a patient narrative. \nb. The order of these additional variables within the domain should follow the rules as described in \nSection 4.1.4, Order of the Variables, and the order described in Section 4.2, General Variable \nAssumptions. \n9. As described in Section 4.1.4, Order of the Variables, RFSTDTC is used to calculate study day variables. \nRFSTDTC is usually defined as the date/time when a subject was first exposed to study drug. This \ndefinition applies for most interventional studies, when the start of treatment is the natural and preferred \nstarting point for study day variables and thus the logical value for RFSTDTC. In such studies, when data \nare submitted for subjects who are ineligible for treatment (e.g., screen failures with ARMNRS = \n\"SCREEN FAILURE\"), subjects who were enrolled but not assigned to an arm (e.g., ARMNRS = \"NOT \nASSIGNED\"), or subjects who were randomized but not treated (e.g., ARMNRS = \"NOT TREATED\"), \nRFSTDTC will be null. For studies with designs that include a substantial portion of subjects who are not \nexpected to be treated, a different protocol milestone may be chosen as the starting point for study day \nvariables. Some examples include non-interventional or observational studies, studies with a no-treatment \narm, and studies where there is a delay between randomization and treatment. \n10. The DM domain contains several pairs of reference period variables: RFSTDTC and RFENDTC, \nRFXSTDTC and RFXENDTC, RFCSTDTC and RFCENDTC, and RFICDTC and RFPENDTC. There are \n4 sets of reference variables to accommodate distinct reference-period definitions and there are instances", "mimetype": "text/plain", "start_char_idx": 2628, "end_char_idx": 4986, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b7a9452c-44a1-4f7f-b83a-7f2be4543d4d": {"__data__": {"id_": "b7a9452c-44a1-4f7f-b83a-7f2be4543d4d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 67, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2dbd0238-2671-4eb1-9eae-60c1ed39957c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 67, "section": "UNSPECIFIED"}, "hash": "9cb59b92337e9ccd8f54928a93014066577a2a5cb6f26c8045dde3077cdf7529", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 67 \n2021-11-29 \nwhen the values of the variables may be exactly the same, particularly with RFSTDTC-RFENDTC and \nRFXSTDTC-RFXENDTC.  \na. \nRFSTDTC and RFENDTC: This pair of variables is sponsor-defined, but usually represents the \ndate/time of first and last study exposure. However, there are certain study designs where the start of \nthe reference period is defined differently, such as studies that have a washout period before \nrandomization or have a medical procedure required during screening (e.g., biopsy). In these cases, \nRFSTDTC may be the enrollment date, which is prior to first dose. Because study day values are \ncalculated using RFSTDTC, in this case study days would not be based on the date of first dose.      \nb. RFXSTDTC and RFXENDTC: This pair of variables defines a consistent reference period for all \ninterventional studies and is not open to customization. RFXSTDTC and RFXENDTC always \nrepresent the date/time of first and last study exposure. The study reference period often duplicates the \nreference period defined in RFSTDTC and RFENDTC, but not always. Therefore, this pair of \nvariables is important as they guarantee that a reviewer will always be able to reference the first and \nlast study exposure reference period. RFXSTDTC should be the same as SESTDTC for the first \ntreatment element described in the SE dataset. RFXENDTC may often be the same as the SEENDTC \nfor the last treatment element described in the SE dataset. \nc. \nRFCSTDTC and RFCENDTC: This pair of variables is used only when the study uses a protocol-\nspecified challenge agent to induce a condition that the investigational treatment is intended to cure, \nmitigate, treat, or prevent. RFCSTDTC and RFCENDTC always represent the date/time of first and \nlast exposure to the challenge agent. \nd. RFICDTC and RFPENDTC: The definitions of this pair of variables are consistent in every study in \nwhich they are used: They represent the entire period of a subject\u2019s involvement in a study, from \nproviding informed consent through the last participation event or activity. There may be times when \nthis period coincides with other reference periods but that is unusual. An example of when these \nperiods might coincide with the study reference period, RFSTDTC to RFENDTC, might be an \nobservational trial where no study intervention is administered. RFICDTC should correspond to the \ndate of the informed consent protocol milestone in Disposition (DS), if that protocol milestone is \ndocumented in DS. In the event that there are multiple informed consents, this will be the date of the \nfirst. RFPENDTC will be the last date of participation for a subject for data included in a submission. \nThis should be the last date of any record for the subject in the database at the time it is locked for \nsubmission. As such, it may not be the last date of participation in the study if the submission includes \ninterim data.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3098, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6b8d89df-eb45-4a45-ab50-f06f674b3855": {"__data__": {"id_": "6b8d89df-eb45-4a45-ab50-f06f674b3855", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ef474a01-1f60-413a-b6ac-e40a87c78422", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}, "hash": "a8b123f2498e0040b74adb40b0546edf5416b2b3820df0dab78f296579729128", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e58ca28a-d2b7-4f5a-81f6-63b8d78ff532", "node_type": "1", "metadata": {}, "hash": "1c24a49a1cfe7852f65c952f8473d5f2d5125163af4f39b7ad1abe3c25e6f983", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 150, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e58ca28a-d2b7-4f5a-81f6-63b8d78ff532": {"__data__": {"id_": "e58ca28a-d2b7-4f5a-81f6-63b8d78ff532", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ef474a01-1f60-413a-b6ac-e40a87c78422", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}, "hash": "a8b123f2498e0040b74adb40b0546edf5416b2b3820df0dab78f296579729128", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6b8d89df-eb45-4a45-ab50-f06f674b3855", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}, "hash": "c4ea88b57977da3c0d2dc2c201aec916481a063e846b9fab71cbf743264a5354", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "44fe929c-c611-4ca7-92fd-d26d33919d11", "node_type": "1", "metadata": {}, "hash": "3ccab17aa819f968b116728ec42b0477823c1b1cbbec7909c201a7e767152191", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All rights reserved  \n Page 68 \n2021-11-29 \nDM \u2013 Examples \nExample 1 \ndm.xpt \nRow STUDYID DOMAIN USUBJID \nSUBJID RFSTDTC RFENDTC RFXSTDTC RFXENDTC RFICDTC RFPENDTC SITEID INVNAM \nBRTHDTC AGE AGEU \nSEX RACE \nETHNIC \nARMCD ARM \nACTARMCD ACTARM ARMNRS \nACTARMUD COUNTRY \n1 \nABC123 \nDM \nABC12301001 01001 \n2006-01-\n12 \n2006-03-\n10 \n2006-01-12 \n2006-03-10 \n2006-01-\n03 \n2006-04-01 \n01 \nJOHNSON, \nM \n1948-12-\n13 \n57 \nYEARS M \nWHITE \nHISPANIC \nOR LATINO \nA \nDrug A \nA \nDrug A \n \n \nUSA \n2 \nABC123 \nDM \nABC12301002 01002 \n2006-01-\n15 \n2006-02-\n28 \n2006-01-15 \n2006-02-28 \n2006-01-\n04 \n2006-03-26 \n01 \nJOHNSON, \nM \n1955-03-\n22 \n50 \nYEARS M \nWHITE \nNOT \nHISPANIC \nOR LATINO \nP \nPlacebo P \nPlacebo \n \n \nUSA \n3 \nABC123 \nDM \nABC12301003 01003 \n2006-01-\n16 \n2006-03-\n19 \n2006-01-16 \n2006-03-19 \n2006-01-\n02 \n2006-03-19 \n01 \nJOHNSON, \nM \n1938-01-\n19 \n68 \nYEARS F \nBLACK OR \nAFRICAN \nAMERICAN \nNOT \nHISPANIC \nOR LATINO \nP \nPlacebo P \nPlacebo \n \n \nUSA \n4 \nABC123 \nDM \nABC12301004 01004 \n \n \n \n \n2006-01-\n07 \n2006-01-08 \n01 \nJOHNSON, \nM \n1941-07-\n02 \n \n \nM \nASIAN \nNOT \nHISPANIC \nOR LATINO \n \n \n \n \nSCREEN \nFAILURE \n \nUSA \n5 \nABC123 \nDM \nABC12302001 02001 \n2006-02-\n02 \n2006-03-\n31 \n2006-02-02 \n2006-03-31 \n2006-01-\n15 \n2006-04-12 \n02 \nGONZALEZ, \nE \n1950-06-\n23 \n55 \nYEARS F \nAMERICAN \nINDIAN OR \nALASKA \nNATIVE \nNOT \nHISPANIC \nOR LATINO \nP \nPlacebo P \nPlacebo \n \n \nUSA \n6 \nABC123 \nDM \nABC12302002 02002 \n2006-02-\n03 \n2006-04-\n05 \n2006-02-03 \n2006-04-05 \n2006-01-\n10 \n2006-04-25 \n02 \nGONZALEZ, \nE \n1956-05-\n05 \n49 \nYEARS F \nNATIVE \nHAWAIIAN OR \nOTHER \nPACIFIC \nISLANDERS \nNOT \nHISPANIC \nOR LATINO \nA \nDrug A \nA \nDrug A \n \n \nUSA \nExample 2 \nThis example Demographics dataset does not include all the DM required and expected variables, only those that illustrate the variables that represent arm information.", "mimetype": "text/plain", "start_char_idx": 151, "end_char_idx": 1939, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "44fe929c-c611-4ca7-92fd-d26d33919d11": {"__data__": {"id_": "44fe929c-c611-4ca7-92fd-d26d33919d11", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ef474a01-1f60-413a-b6ac-e40a87c78422", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}, "hash": "a8b123f2498e0040b74adb40b0546edf5416b2b3820df0dab78f296579729128", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e58ca28a-d2b7-4f5a-81f6-63b8d78ff532", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 68, "section": "UNSPECIFIED"}, "hash": "b4d09860db3e4944ad356065fe2eb7fd42814c3cebcf55a5a093241baf705b8e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The following example illustrates values of \nARMCD for subjects in Example Trial 1, described in Section 7.2.1, Trial Arms. This study included 2 elements, screen and run-in, before subjects were randomized to treatment. For this study, \nthe sponsor submitted data on all subjects, including screen-failure subjects. \nRow 1: \nSubject 001 was randomized to arm \"Drug A\". As shown in the SE dataset, this subject completed the \"Drug A\" element, so their actual arm was also \"Drug A\". \nRow 2: \nSubject 002 was randomized to arm \"Drug B\". As shown in the SE dataset, their actual arm was consistent with their randomization. \nRow 3: \nSubject 003 was a screen failure, so they were not assigned to an arm or treated. The arm actual arm variables are null, and ARMNRS=\"SCREEN FAILURE\". \nRow 4: \nSubject 004 withdrew during the run-in element. Like subject 003, they were not assigned to an arm or treated. However, they were not considered a screen failure, and ARMNRS=\"NOT ASSIGNED\". \nRow 5: \nSubject 005 was randomized but dropped out before being treated. Thus, the actual arm variables are not populated and ARMNRS=\"ASSIGNED, NOT TREATED\". \ndm.xpt \nRow STUDYID DOMAIN USUBJID ARMCD ARM \nACTARMCD ACTARM ARMNRS \nACTARMUD \n1 \nABC \nDM \n001 \nA \nDrug A A \nDrug A \n \n \n2 \nABC \nDM \n002 \nB \nDrug B B \nDrug B \n \n \n3 \nABC \nDM \n003 \n \n \n \n \nSCREEN FAILURE \n \n4 \nABC \nDM \n004 \n \n \n \n \nNOT ASSIGNED \n \n5 \nABC \nDM \n005 \nA \nDrug A  \n \nASSIGNED, NOT TREATED", "mimetype": "text/plain", "start_char_idx": 1940, "end_char_idx": 3379, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d32116e-0195-48d4-9662-3ed3d344872d": {"__data__": {"id_": "5d32116e-0195-48d4-9662-3ed3d344872d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 69, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2021a54a-2bb1-4fce-82fa-d7d8c486c349", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 69, "section": "UNSPECIFIED"}, "hash": "108d28ebe17d91c9004f979b963faba3b0d69c13845a8cabbdd89675ed840f97", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d6ca227-c350-471c-9edf-3b3f35244805", "node_type": "1", "metadata": {}, "hash": "bbd3d74862feff6c48b4dcc6fdc94c6bfe18e8d30557d1e1a8edc6c6c30a97ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 69 \n2021-11-29 \nRows 1-3: \nSubject 001 completed all the elements for arm A. \nRows 4-6: \nSubject 002 completed all the elements for arm B. \nRow 7: \nSubject 003 was a screen failure, who participated only in the \"Screen\" element. \nRows 8-9: \nSubject 004 withdrew during the \"Run-in\" element, before they could be randomized. \nRows 10-11: Subject 005 withdrew after they were randomized, but did not start treatment. \nse.xpt\nRow STUDYID \nDOMAIN \nUSUBJID \nSESEQ \nETCD \nELEMENT \nSESTDTC \nSEENDTC \n1 \nABC \nSE \n001 \n1 \nSCRN Screen \n2006-06-01 \n2006-06-07 \n2 \nABC \nSE \n001 \n2 \nRI \nRun-In \n2006-06-07 \n2006-06-21 \n3 \nABC \nSE \n001 \n3 \nA \nDrug A \n2006-06-21 \n2006-07-05 \n4 \nABC \nSE \n002 \n1 \nSCRN Screen \n2006-05-03 \n2006-05-10 \n5 \nABC \nSE \n002 \n2 \nRI \nRun-In \n2006-05-10 \n2006-05-24 \n6 \nABC \nSE \n002 \n3 \nB \nDrug B \n2006-05-24 \n2006-06-07 \n7 \nABC \nSE \n003 \n1 \nSCRN Screen \n2006-06-27 \n2006-06-30 \n8 \nABC \nSE \n004 \n1 \nSCRN Screen \n2006-05-14 \n2006-05-21 \n9 \nABC \nSE \n004 \n2 \nRI \nRun-In \n2006-05-21 \n2006-05-26 \n10 \nABC \nSE \n005 \n1 \nSCRN Screen \n2006-05-14 \n2006-05-21 \n11 \nABC \nSE \n005 \n2 \nRI \nRun-In \n2006-05-21 \n2006-05-26 \nExample 3\nRow 1: \nSubject 001 was randomized to drug A. At the end of the double-blind treatment epoch, they were \nassigned to open label A; thus, their ARMCD is \"AA\". They received the treatment to which they were \nassigned, so ACTRMCD is also \"AA\". \nRow 2: \nSubject 002 was randomized to drug A. They were lost to follow-up during the double-blind treatment \nepoch, so never reached the open label epoch, when they would have been assigned to either the open \ndrug A or the rescue element. Their ARMCD is \"A\". This case illustrates the exception to the rule that \nARMCD, ARM, ACTARMCD, and ACTARM must be populated with values from the TA dataset. \nRow 3: \nSubject \"003\" was randomized to drug A, but received drug B. At the end of the double-blind \ntreatment epoch, they were assigned to rescue treatment. ARMCD shows the result of their \nassignments, \"AR\"; ACTARMCD shows their actual treatment, \"BR\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2197, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d6ca227-c350-471c-9edf-3b3f35244805": {"__data__": {"id_": "1d6ca227-c350-471c-9edf-3b3f35244805", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 69, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2021a54a-2bb1-4fce-82fa-d7d8c486c349", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 69, "section": "UNSPECIFIED"}, "hash": "108d28ebe17d91c9004f979b963faba3b0d69c13845a8cabbdd89675ed840f97", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5d32116e-0195-48d4-9662-3ed3d344872d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 69, "section": "UNSPECIFIED"}, "hash": "7a5811e690320490f2a12ad6c0b65c05e2e3398883e8065a132dfe6cf1645613", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "They received the treatment to which they were \nassigned, so ACTRMCD is also \"AA\". \nRow 2: \nSubject 002 was randomized to drug A. They were lost to follow-up during the double-blind treatment \nepoch, so never reached the open label epoch, when they would have been assigned to either the open \ndrug A or the rescue element. Their ARMCD is \"A\". This case illustrates the exception to the rule that \nARMCD, ARM, ACTARMCD, and ACTARM must be populated with values from the TA dataset. \nRow 3: \nSubject \"003\" was randomized to drug A, but received drug B. At the end of the double-blind \ntreatment epoch, they were assigned to rescue treatment. ARMCD shows the result of their \nassignments, \"AR\"; ACTARMCD shows their actual treatment, \"BR\". \ndm.xpt\nRow STUDYID DOMAIN USUBJID ARMCD ARM \nACTARMCD ACTARM \nARMNRS ACTARMUD \n1 \nDEF \nDM \n001 \nAA \nA-OPEN A\nAA \nA-OPEN A\n2 \nDEF \nDM \n002 \nA \nA \nA \nA \n3 \nDEF \nDM \n003 \nAR \nA-RESCUE\nBR \nB-RESCUE\nThe following example illustrates values of ARMCD for subjects in Example Trial 3, described in Section \n7.2.1, Trial Arms. \nRows 1-3: \nShow that the subject passed through all 3 elements for the AA arm. \nRows 4-5: \nShow the 2 elements (\"Screen\" and \"Treatment A\") the subject passed through. \nRows 6-8: \nShow that the subject passed through the 3 elements associated with the \"B-Rescue\" arm. \nse.xpt\nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSESEQ \nETCD \nELEMENT \nSESTDTC \nSEENDTC \n1 \nDEF \nSE \n001 \n1 \nSCRN \nScreen \n2006-01-07 \n2006-01-12 \n2 \nDEF \nSE \n001 \n2 \nDBA \nTreatment A \n2006-01-12 \n2006-04-10 \n3 \nDEF \nSE \n001 \n3 \nOA \nOpen Drug A \n2006-04-10 \n2006-07-05 \n4 \nDEF \nSE \n002 \n1 \nSCRN \nScreen \n2006-02-03 \n2006-02-10 \n5 \nDEF \nSE \n002 \n2 \nDBA \nTreatment A \n2006-02-10 \n2006-03-24 \n6 \nDEF \nSE \n003 \n1 \nSCRN \nScreen \n2006-02-22 \n2006-03-01 \n7 \nDEF \nSE \n003 \n2 \nDBB \nTreatment B \n2006-03-01 \n2006-06-27 \n8 \nDEF \nSE \n003 \n3 \nRSC \nRescue \n2006-06-27 \n2006-09-24", "mimetype": "text/plain", "start_char_idx": 1460, "end_char_idx": 3341, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7cf5c4f7-d1d0-4a7c-a940-e179b1c009c2": {"__data__": {"id_": "7cf5c4f7-d1d0-4a7c-a940-e179b1c009c2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 70, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c6a0330a-39c8-4a52-bd30-0ea44b2e721b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 70, "section": "UNSPECIFIED"}, "hash": "4f2a3dfedc6e044b0a413b32d21a07368caee496693644f48e2543ef0791b8e3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 70 \n2021-11-29 \nExample 4\nThe CRF in this example is annotated to show the CDASH variable name and the target SDTMIG variable. Data \nthat are collected using the same variable name as defined in the SDTMIG are in  RED . If the CDASHIG variable \ndiffers from the one defined in the SDTMIG, the CDASHIG variable is in  GREY .   \nSee the CDASH Model and Implementation Guide for additional \ninformation: https://www.cdisc.org/standards/foundational/cdash. \nThis example shows multiple race categories and subcategories. Only a subset of options is shown for this \ninstrument due to space constraints. \nDemographics Sample aCRF for Race with Additional Granularity \nIf the study participant answered: AMERICAN INDIAN OR ALASKA NATIVE", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 907, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "354fb203-52c3-469a-bb29-1c610e62b8db": {"__data__": {"id_": "354fb203-52c3-469a-bb29-1c610e62b8db", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 71, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "857c5ffa-e12d-4566-9528-ec2fb6ff725f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 71, "section": "UNSPECIFIED"}, "hash": "e5350071dba4fa434357730b45f0d32b1b85c220ac69bdf82d4a71b4ca08e2e2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 71 \n2021-11-29 \nIf the study participant answered: BLACK OR AFRICAN AMERICAN \nIf the study participant answered: WHITE \nIf the study participant answered: ASIAN", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 338, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "33bd77b8-f474-4ba1-b249-6db422c20c78": {"__data__": {"id_": "33bd77b8-f474-4ba1-b249-6db422c20c78", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 72, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bc49b419-b2d6-416a-a664-c6aa53cac0ec", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 72, "section": "UNSPECIFIED"}, "hash": "128ed15a60429b416d3d9967b16098f3f3aaab76c386b9fd3197db7b6206f268", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 72 \n2021-11-29 \nCRF Metadata \nCDASH \nVariable \nOrder Question Text \nPrompt CRF \nCompletion \nInstructions \nType SDTMIG Target \nVariable \nSDTM Target \nMapping \nControlled \nTerminology \nCode List \nName \nPermissible Values \nPre-\nspecified \nValue \nQuery \nDisplay \nList \nStyle \nHidden \nRACE01 \n1 \nWhich of the following \nracial designations \nbest describes you? \n(More than one \nchoice is acceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, with \nrace being \nasked about \nafter ethnicity. \nText \nRACE \n(RACE) \nAMERICAN INDIAN OR \nALASKA NATIVE \ncheckbox \nRACE02 \n2 \nWhich of the following \nracial  designations \nbest describes you? \n(More than one \nchoice is acceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, with \nrace being \nasked about \nafter ethnicity. \nText \nRACE \n(RACE) \nASIAN \ncheckbox \nRACE03 \n3 \nWhich of the following \nracial designations \nbest describes you? \n(More than one \nchoice is acceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, with \nrace being \nasked about \nafter ethnicity. \nText \nRACE \n(RACE) \nBLACK OR AFRICAN \nAMERICAN \ncheckbox \nRACE04 \n4 \nWhich of the following \nracial designations \nbest describes you? \n(More than one \nchoice is acceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, with \nrace being \nasked about \nafter ethnicity. \nText \nRACE \n(RACE) \nNATIVE HAWAIIAN OR \nOTHER PACIFIC ISLANDER \ncheckbox \nRACE05 \n5 \nWhich of the following \nracial designations \nbest describes you? \n(More than one \nchoice is acceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, with \nrace being \nasked about \nafter ethnicity. \nText \nRACE \n(RACE) \nWHITE \ncheckbox \nRACE06 \n6 \nWhich of the following \nracial designations \nbest describes you? \n(More than one \nchoice is acceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, with \nrace being \nasked about \nafter ethnicity. \nText \nRACE \n(RACE) \nNOT REPORTED \ncheckbox \nRACE07 \n7 \nWhich of the following \nracial designations \nbest describes you? \n(More than one \nchoice is acceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, with \nrace being \nasked about \nafter ethnicity. \nText \nRACE \n(RACE) \nUNKNOWN \ncheckbox \nIf study participant answered: AMERICAN INDIAN OR ALASKA NATIVE \nCRACE01-\nCRACE04 \n10 \nWhich of the following \nracial designations \nbest describes you? \nRace \nSelect each \nvalue that \napplies if the \nsubject \nanswered \nText \nSUPPDM.QVAL For each value that \napplies, \nSUPPDM.QVAL where \nSUPPDM.QNAM \n=\"CRACEn\" and \n(RACEC) \nALASKA NATIVE; AMERICAN \nINDIAN; CARIBBEAN INDIAN; \nCENTRAL AMERICAN \nINDIAN; \ncheckbox", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2757, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "35e3b8f3-394c-4ade-8d52-93112aa726b2": {"__data__": {"id_": "35e3b8f3-394c-4ade-8d52-93112aa726b2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 73, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "30007ce5-93e8-4522-aaa8-24663ed54454", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 73, "section": "UNSPECIFIED"}, "hash": "a07a147f655dbec5e3894ea7397f6e92b9479bc62402e5130d13721c45131078", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ef19325-dc96-4a04-9297-725fe6201250", "node_type": "1", "metadata": {}, "hash": "886a67ee6a10afa3be328f34bdec4258b10b35c620b41acea166de316028df23", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 73 \n2021-11-29 \nCDASH \nVariable \nOrder Question Text \nPrompt CRF \nCompletion \nInstructions \nType SDTMIG Target \nVariable \nSDTM Target \nMapping \nControlled \nTerminology \nCode List \nName \nPermissible Values \nPre-\nspecified \nValue \nQuery \nDisplay \nList \nStyle \nHidden \n\"AMERICAN \nINDIAN OR \nALASKA \nNATIVE\". Check \nall that apply. \nSUPPDM.QLABEL = \n\"Collected Race \nn\"  where n is the \nchoice value. \nIf study participant answered: ASIAN \nCRACE05-\nCRACE10 \n11 \nWhich of the following \nracial designations \nbest describes you?  \nRace \nSelect each \nvalue that \napplies if the \nsubject \nanswered \n\"ASIAN\". Check \nall that apply. \nText \nSUPPDM.QVAL For each value that \napplies, \nSUPPDM.QVAL where \nSUPPDM.QNAM \n=\"CRACEn\" and \nSUPPDM.QLABEL = \n\"Collected Race n\" \nwhere n is the choice \nvalue. \n(RACEC) \nASIAN AMERICAN; ASIAN \nINDIAN; \nBANGLADESHI;  CHINESE; \nJAPANESE; KOREAN; \n \n \n \ncheckbox CRACE05-\nCRACE10 \nIf study participant answered: BLACK OR AFRICAN AMERICAN \nCRACE11-\nCRACE17 \n12 \nWhich of the following \nracial designations \nbest describes you?  \nRace \nSelect each \nvalue that \napplies if the \nsubject \nanswered \n\"BLACK OR \nAFRICAN \nAMERICAN\". \nCheck all that \napply. \nText \nSUPPDM.QVAL For each value that \napplies, \nSUPPDM.QVAL where \nSUPPDM.QNAM \n=\"CRACEn\" and \nSUPPDM.QLABEL = \n\"Collected Race n\" \nwhere n is the choice \nvalue. \n(RACEC) \nAFRICAN; AFRICAN \nAMERICAN; AFRICAN \nCARIBBEAN; BAHAMIAN; \nBARBADIAN; BLACK; BLACK \nCENTRAL AMERICAN; \n \n \n \ncheckbox  \nIf study participant answered: WHITE \nCRACE18-\nCRACE21 \n13 \nWhich of the following \nracial designations \nbest describes you?  \nRace \nSelect each \nvalue that \napplies if the \nsubject \nanswered \n\"WHITE\". Check \nall that apply. \nText \nSUPPDM.QVAL For each value that \napplies, \nSUPPDM.QVAL where \nSUPPDM.QNAM \n=\"CRACEn\" and \nSUPPDM.QLABEL = \n\"Collected Race n\" \nwhere n is the choice \nvalue. \n(RACEC) \nARAB; EUROPEAN; MIDDLE \nEASTERN; RUSSIAN; \n \n \n \ncheckbox  \nThe value of RACE is used to represent the high-level racial designation as a single collected value per CDISC Controlled Terminology in dm.xpt. When more \nthan 1 choice is selected, the value is represented with \"MULTIPLE\" as shown in this example. Note: Only those variables relevant to this example are shown. \nRow 1: \nShows that USUBJID ABC789-010-045 designated 1 race, \"WHITE\", as the value that best describes their race.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2533, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7ef19325-dc96-4a04-9297-725fe6201250": {"__data__": {"id_": "7ef19325-dc96-4a04-9297-725fe6201250", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 73, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "30007ce5-93e8-4522-aaa8-24663ed54454", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 73, "section": "UNSPECIFIED"}, "hash": "a07a147f655dbec5e3894ea7397f6e92b9479bc62402e5130d13721c45131078", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "35e3b8f3-394c-4ade-8d52-93112aa726b2", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 73, "section": "UNSPECIFIED"}, "hash": "48ee7de543c8043adff0e96d9734f98d06bf751501556506d5f6ed2fcb21bb68", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Check \nall that apply. \nText \nSUPPDM.QVAL For each value that \napplies, \nSUPPDM.QVAL where \nSUPPDM.QNAM \n=\"CRACEn\" and \nSUPPDM.QLABEL = \n\"Collected Race n\" \nwhere n is the choice \nvalue. \n(RACEC) \nARAB; EUROPEAN; MIDDLE \nEASTERN; RUSSIAN; \n \n \n \ncheckbox  \nThe value of RACE is used to represent the high-level racial designation as a single collected value per CDISC Controlled Terminology in dm.xpt. When more \nthan 1 choice is selected, the value is represented with \"MULTIPLE\" as shown in this example. Note: Only those variables relevant to this example are shown. \nRow 1: \nShows that USUBJID ABC789-010-045 designated 1 race, \"WHITE\", as the value that best describes their race. \nRow 2: \nShows that USUBJID ABC789-010-046 designated 1 race, \"ASIAN\", as the value that best describes their race. \nRow 3: \nShows that USUBJID ABC789-010-047 designated multiple races as the values that best describe their race. \"MULTIPLE\" is assigned in RACE. \ndm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSUBJID \nRACE \n1 \nABC789 \nDM \nABC789-010-045 \n010-045 \nWHITE \n2 \nABC789 \nDM \nABC789-010-046 \n010-046 \nASIAN \n3 \nABC789 \nDM \nABC789-010-047 \n010-047 \nMULTIPLE", "mimetype": "text/plain", "start_char_idx": 1848, "end_char_idx": 2992, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "669a8ce0-fe2a-4020-9479-47cad68024ba": {"__data__": {"id_": "669a8ce0-fe2a-4020-9479-47cad68024ba", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 74, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "263e6387-9325-4935-913b-8a009ab2821b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 74, "section": "UNSPECIFIED"}, "hash": "d470f304438280f6f6c42bd0d735c382037516ef279c80c3345a142233dd2d42", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f70e1e86-477d-4f58-8e02-a2f6e24c2e72", "node_type": "1", "metadata": {}, "hash": "428f35cec6f15ce784bcede937aff6d60f1a29ee3339e43f6af5dbf9114bc2c8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 74 \n2021-11-29 \nWhen a subject selects multiple race values, as USUBJID ABC789-010-047 did, the values selected are represented \nin SUPPDM. Collected race, which is the specific race subcategory (or subcategories) selected by each subject, is \nrepresented in SUPPDM to ensure subject self-identification and/or country-specific requirements are available for \nreference. CDASH recommended QNAM-QLABEL values have been provided.suppdm.xpt \nRows 1, 2: Show that USUBJID ABC789-010-047 selected 2 RACE values, \"ASIAN\" and \"WHITE\". CDASH \nrecommended QNAM-QLABEL values have been provided. \nRows 3-5: \nShow that USUBJID ABC789-010-047 selected 3 collected race (CRACE) values, \"CHINESE\", \n\"KOREAN\", and \"RUSSIAN\". CDASH recommended QNAM-QLABEL values have been provided. \nsuppdm.xpt\nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \nQEVAL \n1 \nABC789 \nDM \nABC789-010-047 \nRACE2 \nRace 2 \nASIAN \nCRF \n2 \nABC789 \nDM \nABC789-010-047 \nRACE5 \nRace 5 \nWHITE \nCRF \n3 \nABC789 \nDM \nABC789-010-047 \nCRACE8 \nCollected Race 8 \nCHINESE \nCRF \n4 \nABC789 \nDM \nABC789-010-047 \nCRACE10 \nCollected Race 10 \nKOREAN \nCRF \n5 \nABC789 \nDM \nABC789-010-047 \nCRACE21 \nCollected Race 21 \nRUSSIAN \nCRF \nExample 5\nThis example shows different Chinese regional ethnicity subcategorizations (majority and minority). \nCRF Mock Example \nIn this CRF example, subcategorizations of ethnicity are made available. \nRACE is identified as \"ASIAN\" and ETHNIC as \"NOT HISPANIC OR LATINO\". \ndm.xpt\nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSUBJID \nAGE \nAGEU \nSEX \nRACE \nETHNIC \n1 \nABC789 \nDM \nABC789-010-045 \n010-045\n20 \nYEARS \nM \nASIAN \nNOT HISPANIC OR LATINO \n2 \nABC789 \nDM \nABC789-010-047 \n010-047\n24 \nYEARS \nF \nASIAN \nNOT HISPANIC OR LATINO \nRow 1: \nEthnicity subcategorization of subject self-identification being \"HAN CHINESE\". CDASH \nrecommended QNAM-QLABEL values have been provided. \nRows 2-3: \nEthnicity subcategorization of subject self-identification being \"MIAO\" and \"ZHUANG\". CDASH \nrecommended QNAM-QLABEL values have been provided.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2191, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f70e1e86-477d-4f58-8e02-a2f6e24c2e72": {"__data__": {"id_": "f70e1e86-477d-4f58-8e02-a2f6e24c2e72", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 74, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "263e6387-9325-4935-913b-8a009ab2821b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 74, "section": "UNSPECIFIED"}, "hash": "d470f304438280f6f6c42bd0d735c382037516ef279c80c3345a142233dd2d42", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "669a8ce0-fe2a-4020-9479-47cad68024ba", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 74, "section": "UNSPECIFIED"}, "hash": "0033af75fbca5926d95bcafcc22dc70a6915393dd7dc09ddacc73fdafbab9645", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "dm.xpt\nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSUBJID \nAGE \nAGEU \nSEX \nRACE \nETHNIC \n1 \nABC789 \nDM \nABC789-010-045 \n010-045\n20 \nYEARS \nM \nASIAN \nNOT HISPANIC OR LATINO \n2 \nABC789 \nDM \nABC789-010-047 \n010-047\n24 \nYEARS \nF \nASIAN \nNOT HISPANIC OR LATINO \nRow 1: \nEthnicity subcategorization of subject self-identification being \"HAN CHINESE\". CDASH \nrecommended QNAM-QLABEL values have been provided. \nRows 2-3: \nEthnicity subcategorization of subject self-identification being \"MIAO\" and \"ZHUANG\". CDASH \nrecommended QNAM-QLABEL values have been provided. \nsuppdm.xpt\nRow STUDYID \nRDOMAIN \nUSUBJID \nIDVAR IDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \nQEVAL \n1 \nABC789 \nDM \nABC789-010-045 \nETHNIC1 \nCollected Ethnicity 1 \nHAN CHINESE \nCRF \n2 \nABC789 \nDM \nABC789-010-047 \nETHNIC1 \nCollected Ethnicity 1 \nMIAO \nCRF \n3 \nABC789 \nDM \nABC789-010-047 \nETHNIC2 \nCollected Ethnicity 2 \nZHUANG \nCRF \nExample 6\nThe CRF in this example is annotated to show the CDASH variable name and the target SDTMIG variable. Data \nthat are collected using the same variable name as defined in the SDTMIG are in  RED . If the CDASHIG variable \ndiffers from the one defined in the SDTMIG, the CDASHIG variable is in  GREY .  \nSee the CDASH Model and Implementation Guide for additional \ninformation: https://www.cdisc.org/standards/foundational/cdash.", "mimetype": "text/plain", "start_char_idx": 1646, "end_char_idx": 2951, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6354e179-af48-4d7f-acc9-aa3dc71f1112": {"__data__": {"id_": "6354e179-af48-4d7f-acc9-aa3dc71f1112", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 75, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "09bb8409-4ec8-4fe4-a249-9669bafbc766", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 75, "section": "UNSPECIFIED"}, "hash": "73ca4d14c00d0ea1ed5064e6d3aad65346246474e6dd45794476b5b44ac5da68", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 75 \n2021-11-29 \nThis example shows race categories and subcategories. Only a subset of options are shown for this instrument due to \nspace constraints. For a complete aCRF example see the CDASHIG v2.1, Section 7.3. \nDemographics Sample aCRF for Race with Additional Granularity \nIf the study participant answered: ASIAN \nIf the study participant answered: BLACK OR AFRICAN AMERICAN", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 559, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c9809e7e-8b60-424e-b199-72a201c0f308": {"__data__": {"id_": "c9809e7e-8b60-424e-b199-72a201c0f308", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 76, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eb8680e4-92e4-44b4-8964-e1ba7e3a68c6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 76, "section": "UNSPECIFIED"}, "hash": "bde2cc14fe4293de2bdc96eb023450b1056acfb6edf6f2767a08e91407ceb95f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 76 \n2021-11-29 \nCRF Metadata \nCDASH \nVariable \nOrder Question Text \nPrompt CRF \nCompletion \nInstructions \nType SDTMIG Target \nVariable \nSDTM Target \nMapping \nControlled \nTerminology \nCode List \nName \nPermissible Values \nPre-\nspecified \nValue \nQuery \nDisplay \nList \nStyle \nHidden \nRACE01 \n3 \nWhich of the \nfollowing racial \ndesignations best \ndescribes you? \n(More than one \nchoice is \nacceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, \nwith race \nbeing asked \nabout after \nethnicity. \nText \nRACE \n(RACE) \nAMERICAN INDIAN OR \nALASKA NATIVE \ncheckbox \nRACE02 \n4 \nWhich of the \nfollowing \nracial  designations \nbest describes you? \n(More than one \nchoice is \nacceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, \nwith race \nbeing asked \nabout after \nethnicity. \nText \nRACE \n(RACE) \nASIAN \ncheckbox \nRACE03 \n5 \nWhich of the \nfollowing racial \ndesignations best \ndescribes you? \n(More than one \nchoice is \nacceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, \nwith race \nbeing asked \nabout after \nethnicity. \nText \nRACE \n(RACE) \nBLACK OR AFRICAN \nAMERICAN \ncheckbox \nRACE04 \n6 \nWhich of the \nfollowing racial \ndesignations best \ndescribes you? \n(More than one \nchoice is \nacceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, \nwith race \nbeing asked \nabout after \nethnicity. \nText \nRACE \n \n(RACE) \nNATIVE HAWAIIAN OR \nOTHER PACIFIC ISLANDER \n \n \ncheckbox \n \nRACE05 \n7 \nWhich of the \nfollowing racial \ndesignations best \ndescribes you? \n(More than one \nchoice is \nacceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, \nwith race \nbeing asked \nabout after \nethnicity. \nText \nRACE \n(RACE) \nWHITE \ncheckbox \nRACE06 \n8 \nWhich of the \nfollowing racial \ndesignations best \ndescribes you? \n(More than one \nchoice is \nacceptable.) \nRace \nStudy \nparticipants \nshould self-\nreport race, \nwith race \nbeing asked \nabout after \nethnicity. \nText \nRACE \n(RACE) \nNOT REPORTED \ncheckbox \nRACE07 \n9 \nWhich of the \nfollowing racial \ndesignations best \nRace \nStudy \nparticipants \nshould self-\nText \nRACE \n(RACE) \nUNKNOWN \ncheckbox", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2254, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "564d01d5-09b8-45bb-ac4a-9656e5590f1b": {"__data__": {"id_": "564d01d5-09b8-45bb-ac4a-9656e5590f1b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 77, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bc349b6-01ff-4fb9-8add-ffba755e658e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 77, "section": "UNSPECIFIED"}, "hash": "adb2ea79853e0eb01edb3a41fb19796c79b0f714491b35f5317373a5149b6909", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "295032d6-5a07-404b-9948-e61ae0dde624", "node_type": "1", "metadata": {}, "hash": "96bf86978aa0987a0980d26e2e21e1c56d96466e6ed878ddc268f7e447918553", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 77 \n2021-11-29 \nCDASH \nVariable \nOrder Question Text \nPrompt CRF \nCompletion \nInstructions \nType SDTMIG Target \nVariable \nSDTM Target \nMapping \nControlled \nTerminology \nCode List \nName \nPermissible Values \nPre-\nspecified \nValue \nQuery \nDisplay \nList \nStyle \nHidden \ndescribes you? \n(More than one \nchoice is \nacceptable.) \nreport race, \nwith race \nbeing asked \nabout after \nethnicity. \nIf the study participant answered: ASIAN \nCRACE05-\nCRACE10 \n11 \nWhich of the \nfollowing racial \ndesignations best \ndescribes you?  \nRace \nSelect each \nvalue that \napplies if the \nsubject \nanswered \n\"ASIAN\". \nCheck all that \napply. \nText \nSUPPDM.QVAL For each value that \napplies, \nSUPPDM.QVAL \nwhere \nSUPPDM.QNAM \n=\"CRACEn\" and \nSUPPDM.QLABEL \n= \"Collected Race \nn\" where n is the \nchoice value. \n(RACEC) \nASIAN AMERICAN; ASIAN \nINDIAN; \nBANGLADESHI;  CHINESE; \nJAPANESE; KOREAN; \n \n \n \ncheckbox  \nIf the study participant answered: BLACK OR AFRICAN AMERICAN \nCRACE11-\nCRACE17 \n12 \nWhich of the \nfollowing racial \ndesignations best \ndescribes you?  \nRace \nSelect each \nvalue that \napplies if the \nsubject \nanswered \n\"BLACK OR \nAFRICAN \nAMERICAN\". \nCheck all that \napply. \nText \nSUPPDM.QVAL For each value that \napplies, \nSUPPDM.QVAL \nwhere \nSUPPDM.QNAM \n=\"CRACEn\" and \nSUPPDM.QLABEL \n= \"Collected Race \nn\" where n is the \nchoice value. \n(RACEC) \nAFRICAN; AFRICAN \nAMERICAN; AFRICAN \nCARIBBEAN; BAHAMIAN; \nBARBADIAN; BLACK; \nBLACK CENTRAL \nAMERICAN; \n \n \n \ncheckbox  \nThe value of RACE is used to represent the high-level racial designation as a single collected value per CDISC Controlled Terminology in dm.xpt. In this \nexample, subjects chose to select 1 high-level racial designation. \nNote: Only those variables relevant to this example are shown. \nRow 1: \nShows that USUBJID ABC789-010-001 designated 1 race, \"ASIAN\", as the value that best describes their race. \n \nRow 2: \nShows that USUBJID ABC789-010-002 designated 1 race, \"BLACK OR AFRICAN AMERICAN\", as the value that best describes their race. \nRow 3: \nShows that USUBJID ABC789-010-003 designated 1 race, \"BLACK OR AFRICAN AMERICAN\", as the value that best describes their race.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2306, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "295032d6-5a07-404b-9948-e61ae0dde624": {"__data__": {"id_": "295032d6-5a07-404b-9948-e61ae0dde624", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 77, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bc349b6-01ff-4fb9-8add-ffba755e658e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 77, "section": "UNSPECIFIED"}, "hash": "adb2ea79853e0eb01edb3a41fb19796c79b0f714491b35f5317373a5149b6909", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "564d01d5-09b8-45bb-ac4a-9656e5590f1b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 77, "section": "UNSPECIFIED"}, "hash": "6441823e629b019391a9baa5e79bdda7478a9bc17c1281c4ce065e70424cb419", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In this \nexample, subjects chose to select 1 high-level racial designation. \nNote: Only those variables relevant to this example are shown. \nRow 1: \nShows that USUBJID ABC789-010-001 designated 1 race, \"ASIAN\", as the value that best describes their race. \n \nRow 2: \nShows that USUBJID ABC789-010-002 designated 1 race, \"BLACK OR AFRICAN AMERICAN\", as the value that best describes their race. \nRow 3: \nShows that USUBJID ABC789-010-003 designated 1 race, \"BLACK OR AFRICAN AMERICAN\", as the value that best describes their race. \ndm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSUBJID \nRACE \n1 \nABC789 \nDM \nABC789-010-001 \n010-001 \nASIAN \n2 \nABC789 \nDM \nABC789-010-002 \n010-002 \nBLACK OR AFRICAN AMERICAN \n3 \nABC789 \nDM \nABC789-010-003 \n010-003 \nBLACK OR AFRICAN AMERICAN \nCollected race, which is the specific race subcategory for each subject, is represented in SUPPDM to ensure subject self-identification and/or country-specific \nrequirements are available for reference. In this example, each subject selected 1 race and 1 race subcategory.  CDASH recommended QNAM-QLABEL values \nhave been provided.", "mimetype": "text/plain", "start_char_idx": 1777, "end_char_idx": 2873, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0e2ccbe5-d0c1-4520-9bdd-20a3d6b6742b": {"__data__": {"id_": "0e2ccbe5-d0c1-4520-9bdd-20a3d6b6742b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 78, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dbddadaf-9e36-44af-bde8-a20134fc72eb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 78, "section": "UNSPECIFIED"}, "hash": "2c967a2a2f8a0040785712a1c9ea0aa11e5f578d63064d515026e518e0237338", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 78 \n2021-11-29 \nRow 1: \nShows USUBJID ABC789-010-001 selected \"JAPANESE\" as the specific ASIAN race collected. \nRow 2: \nShows USUBJID ABC789-010-002 selected \"AFRICAN AMERICAN\" as the specific BLACK OR AFRICAN AMERICAN race collected. \nRow 3: \nShows USUBJID ABC789-010-003 selected \"BLACK\" as the specific BLACK OR AFRICAN AMERICAN race collected. \nsuppdm.xpt\nRow STUDYID RDOMAIN USUBJID \nIDVAR IDVARVAL QNAM \nQLABEL \nQVAL \nQORIG QEVAL \n1 \nABC789 \nDM \nABC789-010-001 \nCRACE3 Collected Race 3 \nJAPANESE \nCRF \n2 \nABC789 \nDM \nABC789-010-002 \nCRACE5 Collected Race 5 \nAFRICAN AMERICAN \nCRF \n3 \nABC789 \nDM \nABC789-010-003 \nCRACE8 Collected Race 8 \nBLACK \nCRF \nExample 7 \nCRF Mock Example \nRows 1-2:  Subjects self-identify to 1 of the first 5 race options on the CRF form. \nRow 3: \nSubject did not self-identify to 1 of the existing race options and selected \"Other\". RACE was populated with \"OTHER\" in this case. \nRow 4: \nSubject could not self-identify to any of the race options including identification of an \"Other\". RACE was populated with \"UNKNOWN\" in this \ncase. \nNote: Not all DM variables are shown. \ndm.xpt\nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSUBJID \nAGE \nAGEU \nSEX \nRACE \nETHNIC \n1 \nABC789 \nDM \nABC789-010-045 \n010-045\n20 \nYEARS \nM \nWHITE \nHISPANIC OR LATINO \n2 \nABC789 \nDM \nABC789-010-046 \n010-046\n21 \nYEARS \nF \nASIAN \nNOT HISPANIC OR LATINO \n3 \nABC789 \nDM \nABC789-010-047 \n010-047\n24 \nYEARS \nF \nOTHER \nHISPANIC OR LATINO \n3 \nABC789 \nDM \nABC789-010-048 \n010-048\n33 \nYEARS \nM \nUNKNOWN \nHISPANIC OR LATINO", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1684, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8986bf2f-4afa-4cc3-9565-e7bcd98b85c6": {"__data__": {"id_": "8986bf2f-4afa-4cc3-9565-e7bcd98b85c6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 79, "section": "5.3 Subject Elements (SE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea74c41a-6a95-489a-ae0f-232b07b85682", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 79, "section": "5.3 Subject Elements (SE)"}, "hash": "5502b0e33a7ab5a48239bb966bd3cf05790d9769c21ee1fb4be324d17718980e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SE \u2013 Description/Overview \nA special-purpose domain that contains the actual order of elements followed by the subject, together with the start date/time and end date/time for each element. \nThe Subject Elements dataset consolidates information about the timing of each subject\u2019s progress through the epochs and elements of the trial. For elements that \ninvolve study treatments, the identification of which element the subject passed through (e.g., drug X vs. placebo) is likely to derive from data in the Exposure \ndomain or another Interventions domain. The dates of a subject\u2019s transition from one element to the next will be taken from the Interventions domain(s) and from \nother relevant domains, according to the definitions (TESTRL values) in the Trial Elements (TE) dataset (see Section 7.2.2, Trial Elements). \nThe SE dataset is particularly useful for studies with multiple treatment periods, such as crossover studies. The SE dataset contains the date/times at which a \nsubject moved from one element to another, so when this dataset, the Trial Arms (TA; see Section 7.2.1, Trial Arms) dataset, and the Trial Elements (TE;  see \nSection 7.2.2, Trial Elements) dataset are included in a submission, reviewers can relate all observations made about a subject to that subject\u2019s progression \nthrough the trial. \n\u2022 \nComparison of the --DTC of a finding observation to the element transition dates (values of SESTDTC and SEENDTC) identifies which element the \nsubject was in at the time of the finding. Similarly, one can determine the element during which an event or intervention started or ended. \n\u2022 \n\u201cDay within Element\u201d or \u201cDay within Epoch\u201d can be derived. Such variables relate an observation to the start of an element or epoch in the same \nway that study day (--DY) variables relate it to the reference start date (RFSTDTC) for the study as a whole. See Section 4.4.4, Use of the \"Study Day\" \nVariables. \n\u2022 \nHaving knowledge of SE start and end dates can be helpful in the determination of baseline values. \nSE \u2013 Specification \nse.xpt, Subject Elements \u2014 Special Purpose. One record per actual Element per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation Char SE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nSESEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. Should be assigned \nto be consistent chronological order. \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2797, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "196ce6d5-0f3f-479e-8888-ee3b896a0552": {"__data__": {"id_": "196ce6d5-0f3f-479e-8888-ee3b896a0552", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 80, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6db64d16-215e-4c86-9d1f-d35886ba5b13", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 80, "section": "UNSPECIFIED"}, "hash": "2db560872ae6af8f2f0e648ef9aa5b9638f210321b134d47dd07049b511c7030", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cbd59b0a-c9d9-419e-a873-34911320b057", "node_type": "1", "metadata": {}, "hash": "1ad8ce8fb788d602a6f7b168e6bb0c997fd378dc19b71fce3ffa0cdb060cfcaf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 80 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nETCD \nElement Code \nChar * \nTopic \n1. \nETCD (the companion to ELEMENT) is limited to 8 characters and does not have special \ncharacter restrictions. These values should be short for ease of use in programming, but it is \nnot expected that ETCD will need to serve as a variable name. \n2. \nIf an encountered element differs from the planned element to the point that it is considered a \nnew element, then use \"UNPLAN\" as the value for ETCD to represent this element. \nReq \nELEMENT \nDescription of \nElement \nChar * \nSynonym \nQualifier \nThe name of the element. If ETCD has a value of \"UNPLAN\", then ELEMENT should be null. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the subject's assigned trial arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the element in the planned sequence of elements for the arm to which the subject \nwas assigned. \nPerm \nSESTDTC \nStart Date/Time of \nElement \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time for an element for each subject. \nReq \nSEENDTC \nEnd Date/Time of \nElement \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time for an element for each subject. \nExp \nSESTDY \nStudy Day of Start of \nElement \nNum  \nTiming \nStudy day of start of element relative to the sponsor-defined RFSTDTC. \nPerm \nSEENDY \nStudy Day of End of \nElement \nNum  \nTiming \nStudy day of end of element relative to the sponsor-defined RFSTDTC. \nPerm \nSEUPDES \nDescription of \nUnplanned Element \nChar  \nSynonym \nQualifier \nDescription of what happened to the subject during an unplanned element. Used only if ETCD has the \nvalue of \"UNPLAN\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nSE \u2013 Assumptions \nSubmission of the SE dataset is strongly recommended, as it provides information needed by reviewers to place observations in context within the study. As \nnoted in the SE - Description/Overview, the TE and TA datasets should also be submitted, as these define the design and the terms referenced by the SE dataset. \nThe SE domain allows the submission of data on the timing of the trial elements a subject actually passed through in their participation in the trial. Section \n7.2.2, Trial Elements, and Section 7.2.1, Trial Arms, provide additional information on these datasets, which define a trial's planned elements and describe the \nplanned sequences of elements for the arms of the trial. \n1. For any particular subject, the dates in the SE table are the dates when the transition events identified in the TE table occurred. Judgment may be needed \nto match actual events in a subject's experience with the definitions of transition events (i.e., events that mark the start of new elements) in the TE table; \nactual events may vary from the plan.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3207, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cbd59b0a-c9d9-419e-a873-34911320b057": {"__data__": {"id_": "cbd59b0a-c9d9-419e-a873-34911320b057", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 80, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6db64d16-215e-4c86-9d1f-d35886ba5b13", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 80, "section": "UNSPECIFIED"}, "hash": "2db560872ae6af8f2f0e648ef9aa5b9638f210321b134d47dd07049b511c7030", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "196ce6d5-0f3f-479e-8888-ee3b896a0552", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 80, "section": "UNSPECIFIED"}, "hash": "029d0e6f2cb19f6eade03872f821670156b15d5da3ecfdcfbd47b7cda875d315", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "As \nnoted in the SE - Description/Overview, the TE and TA datasets should also be submitted, as these define the design and the terms referenced by the SE dataset. \nThe SE domain allows the submission of data on the timing of the trial elements a subject actually passed through in their participation in the trial. Section \n7.2.2, Trial Elements, and Section 7.2.1, Trial Arms, provide additional information on these datasets, which define a trial's planned elements and describe the \nplanned sequences of elements for the arms of the trial. \n1. For any particular subject, the dates in the SE table are the dates when the transition events identified in the TE table occurred. Judgment may be needed \nto match actual events in a subject's experience with the definitions of transition events (i.e., events that mark the start of new elements) in the TE table; \nactual events may vary from the plan. For instance, in a single-dose pharmacokinetics (PK) study, the transition events might correspond to study drug \ndoses of 5 and 10 mg. If a subject actually received a dose of 7 mg when they were scheduled to receive 5 mg, a decision will have to be made on how \nto represent this in the SE domain. \n2. If the date/time of a transition element was not collected directly, the method used to infer the element start date/time should be explained in the \nComments column of the Define-XML document. \n3. Judgment will also have to be used in deciding how to represent a subject's experience if an element does not proceed or end as planned. For instance, \nthe plan might identify a trial element that is to start with the first of a series of 5 daily doses and end after 1 week, when the subject transitions to the \nnext treatment element. If the subject actually started the next treatment epoch (see Section 7.1, Introduction to Trial Design Model Datasets, and \nSection 7.1.2, Definitions of Trial Design Concepts) after 4 weeks, the sponsor would have to decide whether to represent this as an abnormally long \nelement, or as a normal element plus an unplanned non-treatment element.", "mimetype": "text/plain", "start_char_idx": 2306, "end_char_idx": 4393, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7c28b978-5a7a-4cda-9985-ae33c6435d82": {"__data__": {"id_": "7c28b978-5a7a-4cda-9985-ae33c6435d82", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 81, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "483b3245-feb1-4e0b-8577-ee318f7c56e1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 81, "section": "UNSPECIFIED"}, "hash": "a72eec2e7c1f347b1406a05cf3eed3d84ebe36299e0b0f2b25025c5a4a94130b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ed6dfe1f-c3e8-4f0f-ac00-3ba9bd5d9f42", "node_type": "1", "metadata": {}, "hash": "dd7849a28410381e613a75aef0ecd065998fe953f9e404d8039ff9fdbf36c00a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 81 \n2021-11-29 \n4. If the sponsor decides that the subject's experience for a particular period of time cannot be represented with one of the planned elements, then that \nperiod of time should be represented as an unplanned element. The value of ETCD for an unplanned element is \u201cUNPLAN\u201d and SEUPDES should be \npopulated with a description of the unplanned element. \n5. The values of SESTDTC provide the chronological order of the actual subject elements. SESEQ should be assigned to be consistent with the \nchronological order. Note that the requirement that SESEQ be consistent with chronological order is more stringent than in most other domains, where -\n-SEQ values need only be unique within subject. \n6. When TAETORD is included in the SE domain, it represents the planned order of an element in an arm. This should not be confused with the actual \norder of the elements, which will be represented by their chronological order and SESEQ. TAETORD will not be populated for subject elements that are \nnot planned for the arm to which the subject was assigned. Thus, TAETORD will not be populated for any element with an ETCD value of \u201cUNPLAN\u201d. \nTAETORD also will not be populated if a subject passed through an element that, although defined in the TE dataset, was out of place for the arm to \nwhich the subject was assigned. For example, if a subject in a parallel study of drug A vs. drug B was assigned to receive drug A but received drug B \ninstead, then TAETORD would be left blank for the SE record for their drug B element. If a subject was assigned to receive the sequence of elements A, \nB, C, D, and instead received A, D, B, C, then the sponsor would have to decide for which of these SE records TAETORD should be populated. The \nrationale for this decision should be documented in the Comments column of the Define-XML document. \n7. For subjects who follow the planned sequence of elements for the arm to which they were assigned, the values of EPOCH in the SE domain will match \nthose associated with the elements for the subject's arm in the TA dataset. The sponsor will have to decide what value, if any, of EPOCH to assign SE \nrecords for unplanned elements and in other cases where the subject's actual elements deviate from the plan. The sponsor's methods for such decisions \nshould be documented in the Define-XML document, in the row for EPOCH in the SE dataset table. \n8. Because there are, by definition, no gaps between elements, the value of SEENDTC for one element will always be the same as the value of SESTDTC \nfor the next element. \n9. Note that SESTDTC is required, although --STDTC is not required in any other subject-level dataset. The purpose of the dataset is to record the \nelements a subject actually passed through. If it is known that a subject passed through a particular element, then there must be some information \n(perhaps imprecise) on when it started. Thus, SESTDTC may not be null, although some records may not have all the components (e.g., year, month, \nday, hour, minute) of the date/time value collected. \n10. The following identifier variables are permissible and may be added as appropriate: --GRPID, --REFID, --SPID. \n11.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3360, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ed6dfe1f-c3e8-4f0f-ac00-3ba9bd5d9f42": {"__data__": {"id_": "ed6dfe1f-c3e8-4f0f-ac00-3ba9bd5d9f42", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 81, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "483b3245-feb1-4e0b-8577-ee318f7c56e1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 81, "section": "UNSPECIFIED"}, "hash": "a72eec2e7c1f347b1406a05cf3eed3d84ebe36299e0b0f2b25025c5a4a94130b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7c28b978-5a7a-4cda-9985-ae33c6435d82", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 81, "section": "UNSPECIFIED"}, "hash": "11324c5603908df333ee97a0f93880a4248ebce4167554fe7fca75e7401c5a3e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "8. Because there are, by definition, no gaps between elements, the value of SEENDTC for one element will always be the same as the value of SESTDTC \nfor the next element. \n9. Note that SESTDTC is required, although --STDTC is not required in any other subject-level dataset. The purpose of the dataset is to record the \nelements a subject actually passed through. If it is known that a subject passed through a particular element, then there must be some information \n(perhaps imprecise) on when it started. Thus, SESTDTC may not be null, although some records may not have all the components (e.g., year, month, \nday, hour, minute) of the date/time value collected. \n10. The following identifier variables are permissible and may be added as appropriate: --GRPID, --REFID, --SPID. \n11. Care should be taken in adding additional timing variables:  \na. \nThe purpose of --DTC and --DY is to record the date and study day on which data was collected. Elements are generally \u201cderived\u201d in the sense that \nthey are a secondary use of data collected elsewhere; it is not generally useful to know when those date/times were recorded. \nb. --DUR could be added only if the duration of an element was collected, not derived. \nc. \nIt would be inappropriate to add the variables that support time points (--TPT, --TPTNUM, --ELTM, --TPTREF, and --RFTDTC), because the topic \nof this dataset is elements. \nSE \u2013 Examples \nSTUDYID and DOMAIN, which are required in the SE and Demographics (DM) domains, have not been included in the following examples, to improve \nreadability.", "mimetype": "text/plain", "start_char_idx": 2574, "end_char_idx": 4134, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c5c27b8f-9fe7-45d1-8fcd-dbe24ea84940": {"__data__": {"id_": "c5c27b8f-9fe7-45d1-8fcd-dbe24ea84940", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dc0cb0dc-03ab-47d6-999e-ebf0f5f5222a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}, "hash": "c2d29b2f547aa6339aad3303d0ca14d931378242b65bfb5e5de49ad84936521e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f8f127ac-845d-4ef8-bbd5-2ab57106ed7a", "node_type": "1", "metadata": {}, "hash": "e3500340ab51bebb6fe1e3924bee5a273d998747338bde8e8a2a020acfe120dc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 82 \n2021-11-29 \nExample 1 \nThis example shows data for 2 subjects for a crossover trial with 4 epochs. \nRow 1: \nThe record for the SCREEN element for subject 789. Note that only the date of the start of the SCREEN element was collected, whereas for the end \nof the element (which corresponds to the start of IV dosing) both date and time were collected. \nRow 2: \nThe record for the IV element for subject 789. The IV element started with the start of IV dosing and ended with the start of oral dosing, and full \ndate/times were collected for both. \nRow 3: \nThe record for the ORAL element for subject 789. Only the date, and not the time, of the start of follow-up was collected. \nRow 4: \nThe FOLLOWUP element for subject 789 started and ended on the same day. Presumably, the element had a positive duration, but no times were \ncollected. \nRows 5-8: \nSubject 790 was treated incorrectly. This subject entered the IV element before the ORAL element, although the planned order of elements for this \nsubject was ORAL, then IV. The sponsor has assigned EPOCH values for this subject according to the actual order of elements, rather than the \nplanned order. Per Assumption 6, TAETORD is missing for the elements that were out of order. The correct order of elements is the subject's \nARMCD, shown in the DM dataset. \nRows 9-10: Subject 791 was screened, randomized to the IV-ORAL arm, and received the IV treatment, but did not return to the unit for the treatment epoch or \nfollow-up.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1662, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f8f127ac-845d-4ef8-bbd5-2ab57106ed7a": {"__data__": {"id_": "f8f127ac-845d-4ef8-bbd5-2ab57106ed7a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dc0cb0dc-03ab-47d6-999e-ebf0f5f5222a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}, "hash": "c2d29b2f547aa6339aad3303d0ca14d931378242b65bfb5e5de49ad84936521e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c5c27b8f-9fe7-45d1-8fcd-dbe24ea84940", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}, "hash": "ca6dfdde30bc47528b7c3b4d976323cdc2739b3ce0c81fe3e44ca133e46c8f5a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4fdce03c-9dd6-43d8-a1ef-da8f3b14a24b", "node_type": "1", "metadata": {}, "hash": "77ebe9beaade9a80430d02efc0ed985341344ab9b616a693d3d45c90b845b54a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Row 4: \nThe FOLLOWUP element for subject 789 started and ended on the same day. Presumably, the element had a positive duration, but no times were \ncollected. \nRows 5-8: \nSubject 790 was treated incorrectly. This subject entered the IV element before the ORAL element, although the planned order of elements for this \nsubject was ORAL, then IV. The sponsor has assigned EPOCH values for this subject according to the actual order of elements, rather than the \nplanned order. Per Assumption 6, TAETORD is missing for the elements that were out of order. The correct order of elements is the subject's \nARMCD, shown in the DM dataset. \nRows 9-10: Subject 791 was screened, randomized to the IV-ORAL arm, and received the IV treatment, but did not return to the unit for the treatment epoch or \nfollow-up. \nse.xpt \nRow \nUSUBJID \nSESEQ \nETCD \nSESTDTC \nSEENDTC \nSEUPDES \nTAETORD \nEPOCH \n1 \n789 \n1 \nSCREEN \n2006-06-01 \n2006-06-03T10:32 \n \n1 \nSCREENING \n2 \n789 \n2 \nIV \n2006-06-03T10:32 \n2006-06-10T09:47 \n \n2 \nTREATMENT 1 \n3 \n789 \n3 \nORAL \n2006-06-10T09:47 \n2006-06-17 \n \n3 \nTREATMENT 2 \n4 \n789 \n4 \nFOLLOWUP \n2006-06-17 \n2006-06-17 \n \n4 \nFOLLOW-UP \n5 \n790 \n1 \nSCREEN \n2006-06-01 \n2006-06-03T10:14 \n \n1 \nSCREENING \n6 \n790 \n2 \nIV \n2006-06-03T10:14 \n2006-06-10T10:32 \n \n \nTREATMENT 1 \n7 \n790 \n3 \nORAL \n2006-06-10T10:32 \n2006-06-17 \n \n \nTREATMENT 2 \n8 \n790 \n4 \nFOLLOWUP \n2006-06-17 \n2006-06-17 \n \n4 \nFOLLOW-UP \n9 \n791 \n1 \nSCREEN \n2006-06-01 \n2006-06-03T10:17 \n \n1 \nSCREENING \n10 \n791 \n2 \nIV \n2006-06-03T10:17 \n2006-06-07 \n \n2 \nTREATMENT 1 \n \nRow 1: \nSubject 789 was assigned to the IV-ORAL arm and was treated accordingly. \nRow 2: \nSubject 790 was assigned to the ORAL-IV arm, but their actual treatment was IV, then oral. \nRow 3: \nSubject 791 was assigned to the IV-ORAL arm, received the first of the 2 planned treatment elements, and were following the assigned treatment \nwhen they withdrew early. The actual arm variables are populated with the values for the arm to which subject 791 was assigned.", "mimetype": "text/plain", "start_char_idx": 860, "end_char_idx": 2852, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4fdce03c-9dd6-43d8-a1ef-da8f3b14a24b": {"__data__": {"id_": "4fdce03c-9dd6-43d8-a1ef-da8f3b14a24b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dc0cb0dc-03ab-47d6-999e-ebf0f5f5222a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}, "hash": "c2d29b2f547aa6339aad3303d0ca14d931378242b65bfb5e5de49ad84936521e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f8f127ac-845d-4ef8-bbd5-2ab57106ed7a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 82, "section": "UNSPECIFIED"}, "hash": "9939d0a31c87e2ba964d9661eb7215d1411979b77462817850689aac8366e17c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Row 2: \nSubject 790 was assigned to the ORAL-IV arm, but their actual treatment was IV, then oral. \nRow 3: \nSubject 791 was assigned to the IV-ORAL arm, received the first of the 2 planned treatment elements, and were following the assigned treatment \nwhen they withdrew early. The actual arm variables are populated with the values for the arm to which subject 791 was assigned. \ndm.xpt \nRow USUBJID SUBJID RFSTDTC RFENDTC SITEID INVNAM BIRTHDTC AGE AGEU \nSEX RACE \nETHNIC \nARMCD ARM \nACTARMCD ACTARM ARMNRS ACTARMUD COUNTRY \n1 \n789 \n001 \n2006-06-\n03 \n2006-06-\n17 \n01 \nSMITH, \nJ \n1948-12-13 57 \nYEARS M \nWHITE HISPANIC OR \nLATINO \nIO \nIV-\nORAL \nIO \nIV-ORAL \n \n \nUSA \n2 \n790 \n002 \n2006-06-\n03 \n2006-06-\n17 \n01 \nSMITH, \nJ \n1955-03-22 51 \nYEARS M \nWHITE NOT \nHISPANIC OR \nLATINO \nOI \nORAL-\nIV \nIO \nIV-ORAL \n \n \nUSA", "mimetype": "text/plain", "start_char_idx": 2473, "end_char_idx": 3285, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "caac29ff-734a-4157-a642-d8208024f7f6": {"__data__": {"id_": "caac29ff-734a-4157-a642-d8208024f7f6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 83, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "572b00b7-ccfc-488d-9f06-4a27f53371da", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 83, "section": "UNSPECIFIED"}, "hash": "72543859a45098cef57498e24c5aff43d40da885ab43f79706b99cbf633935a2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9358f729-1da2-4093-b91c-134ac7ce7340", "node_type": "1", "metadata": {}, "hash": "9d087a9b175e9291fd245350b4eb27ba5b369a9750098a25f944b4422c5464cb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 83 \n2021-11-29 \nRow USUBJID SUBJID RFSTDTC RFENDTC SITEID INVNAM BIRTHDTC AGE AGEU \nSEX RACE \nETHNIC \nARMCD ARM \nACTARMCD ACTARM ARMNRS ACTARMUD COUNTRY \n3 \n791 \n003 \n2006-06-\n03 \n2006-06-\n07 \n01 \nSMITH, \nJ \n1956-07-17 49 \nYEARS M \nWHITE NOT \nHISPANIC OR \nLATINO \nIO \nIV-\nORAL \nIO \nIV-ORAL \n \n \nUSA \nExample 2 \nThe following data represent 2 subjects enrolled in a trial in which assignment to an arm occurs in 2 stages. \nSee Section 7.2.1, Trial Arms, Example Trial 3. In this trial, subjects were randomized at the beginning of the blinded treatment epoch, then assigned to treatment \nfor the open treatment epoch according to their response to treatment in the blinded treatment epoch. See Section 5.2, Demographics, for other examples of ARM \nand ARMCD values for this trial. \nIn this trial, start of dosing was recorded as dates without times, so SESTDTC values include only dates.  Epochs could not be assigned to observations that \noccurred on epoch transition dates on the basis of the SE dataset alone, so the sponsor's algorithms for dealing with this ambiguity were documented in the \nDefine-XML document. \nRows 1-2: \nShow data for a subject who completed only 2 elements of the trial. \nRows 3-6: \nShow data for a subject who completed the trial, but received the wrong drug for the last 2 weeks of the double-blind treatment period. This has \nbeen represented by treating the period when the subject received the wrong drug as an unplanned element. Note that TAETORD, which represents \nthe planned order of elements within an arm, has not been populated for this unplanned element. Even though this element was unplanned, the \nsponsor assigned a value of BLINDED TREATMENT to EPOCH. \nse.xpt \nRow USUBJID \nSESEQ \nETCD \nSESTDTC \nSEENDTC \nSEUPDES \nTAETORD \nEPOCH \n1 \n123 \n1 \nSCRN \n2006-06-01 \n2006-06-03 \n \n1 \nSCREENING \n2 \n123 \n2 \nDBA \n2006-06-03 \n2006-06-10 \n \n2 \nBLINDED TREATMENT \n3 \n456 \n1 \nSCRN \n2006-05-01 \n2006-05-03 \n \n1 \nSCREENING \n4 \n456 \n2 \nDBA \n2006-05-03 \n2006-05-31 \n \n2 \nBLINDED TREATMENT \n5 \n456 \n3 \nUNPLAN \n2006-05-31 \n2006-06-13 \nDrug B dispensed in error \n \nBLINDED TREATMENT \n6 \n456 \n4 \nRSC \n2006-06-13 \n2006-07-30 \n \n3 \nOPEN LABEL TREATMENT \n \nRow 1: \nShows the record for a subject who was randomized to blinded treatment A, but withdrew from the trial before the open treatment epoch and did not \nhave a second treatment assignment. They were thus incompletely assigned to an arm.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2592, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9358f729-1da2-4093-b91c-134ac7ce7340": {"__data__": {"id_": "9358f729-1da2-4093-b91c-134ac7ce7340", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 83, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "572b00b7-ccfc-488d-9f06-4a27f53371da", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 83, "section": "UNSPECIFIED"}, "hash": "72543859a45098cef57498e24c5aff43d40da885ab43f79706b99cbf633935a2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "caac29ff-734a-4157-a642-d8208024f7f6", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 83, "section": "UNSPECIFIED"}, "hash": "ed861c29cd0695df295f486210a853cc25db22bb57efe068049a9f9927b455c2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "They were thus incompletely assigned to an arm. The code used to represent this incomplete assignment, \"A\", \nis not in the TA table for this trial design, but is the first part of the codes for the 2 arms to which subject 123 could have been assigned (\"AR\" or \n\"AO\"). \nRow 2: \nShows the record for a subject who was randomized to blinded treatment A, but was erroneously treated with drug B for part of the blinded \ntreatment epoch. ARM and ARMCD for this subject reflect the planned treatment and are not affected by the fact that treatment deviated from plan. \nThe subject's assignment to Rescue treatment for the open treatment epoch proceeded as planned. The sponsor decided that the subject's treatment, \nwhich consisted partly of drug A and partly of drug B, did not match any planned arm, so ACTARMCD and ACTARM were left null. ARMNRS \nwas populated with \"UNPLANNED TREATMENT\" and the way in which this treatment was unplanned was described in ACTARMUD. \ndm.xpt \nRow USUBJID SUBJID RFSTDTC RFENDTC SITEID INVNAM BIRTHDTC AGE AGEU \nSEX RACE \nETHNIC \nARMCD ARM \nACTARMCD ACTARM ARMNRS \nACTARMUD COUNTRY \n1 \n123 \n012 \n2006-06-\n03 \n2006-06-\n10 \n01 \nJONES, \nD \n1943-12-08 62 \nYEARS M \nASIAN \nHISPANIC \nOR \nLATINO \nA \nA \nA \nA \n \n \nUSA", "mimetype": "text/plain", "start_char_idx": 2545, "end_char_idx": 3780, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "846f8ffd-22fb-4ced-bddf-714de99cda7c": {"__data__": {"id_": "846f8ffd-22fb-4ced-bddf-714de99cda7c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 84, "section": "5.4 Subject Disease Milestones (SM)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "19cd7d97-9d91-4aec-8963-80931e2ff5f4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 84, "section": "5.4 Subject Disease Milestones (SM)"}, "hash": "e30502d1f02faf1910a55ef019eb085d1223ee3a0df2b7d5e59a005ad0310c31", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SM \u2013 Description/Overview \nA special-purpose domain that is designed to record the timing, for each subject, of disease milestones that have been defined in the Trial Disease Milestones \n(TM) domain. \nSM \u2013 Specification \nsm.xpt, Subject Disease Milestones \u2014 Special Purpose. One record per Disease Milestone per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar SM \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nSMSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of subject records. Should be assigned to be \nconsistent chronological order. \nReq \nMIDS \nDisease Milestone \nInstance Name \nChar * \nTopic \nName of the specific disease milestone. For types of disease milestones that can occur multiple \ntimes, the name will end with a sequence number. Example: \"HYPO1\". \nReq \nMIDSTYPE \nDisease Milestone \nType \nChar * \nRecord \nQualifier \nThe type of disease milestone. Example: \"HYPOGLYCEMIC EVENT\". \nReq \nSMSTDTC \nStart Date/Time of \nMilestone \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time of milestone instance (if milestone is an intervention or event) or date of \nmilestone (if Milestone is a finding). \nExp \nSMENDTC \nEnd Date/Time of \nMilestone \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time of disease milestone instance. \nExp \nSMSTDY \nStudy Day of Start of \nMilestone \nNum  \nTiming \nStudy day of start of disease milestone instance, relative to the sponsor-defined RFSTDTC. \nExp \nSMENDY \nStudy Day of End of \nMilestone \nNum  \nTiming \nStudy day of end of disease milestone instance, relative to the sponsor-defined RFSTDTC. \nExp \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n \nSM \u2013 Assumptions \n1. Disease milestones are observations or activities whose timings are of interest in the study. The types of disease milestones are defined at the study level \nin the TM dataset. The purpose of the SM dataset is to provide a summary timeline of the milestones for a particular subject. \n2. The name of the disease milestone is recorded in MIDS. \na. \nFor disease milestones that can occur only once (TMRPT = \"N\"), the value of MIDS may be the value in MIDSTYPE or may an abbreviated \nversion.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2654, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ef9fea72-145a-4950-93c7-fec4c1958461": {"__data__": {"id_": "ef9fea72-145a-4950-93c7-fec4c1958461", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 85, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b7eb73f8-0128-4489-ba25-62852c1fcd40", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 85, "section": "UNSPECIFIED"}, "hash": "0548bd46c95a3ab7da33757a04e462afe49d89f91f23e552f1d091ca0abece02", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c8d60c44-acce-4332-bdb9-be64403ab179", "node_type": "1", "metadata": {}, "hash": "5858116d8bb85dd919f3ab39e1ceea8bf1f589b570c44fcf16db73aa8ccfa5fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 85 \n2021-11-29 \nb. For types of disease milestones that can occur multiple times, MIDS will usually be an abbreviated version of MIDSTYPE and will always end with \na sequence number. Sequence numbers should start with 1 and indicate the chronological order of the instances of this type of disease milestone. \n3. The timing variables SMSTDTC and SMENDTC hold start and end date/times of data collected for the disease milestone(s) for each subject. SMSTDY \nand SMENDY represent the corresponding study day variables. \na. \nThe start date/time of the disease milestone is the critical date/time, and must be populated. If the disease milestone is an event, then the meaning of \n\u201cstart date\u201d for the event may need to be defined. \nb. The start study day will not be populated if the start date/time includes only a year or only a year and month. \nc. \nThe end date/time for the disease milestone is less important than the start date/time. It will not be populated if the disease milestone is a finding \nwithout an end date/time or if it is an event or intervention for which an end date/time has not yet occurred or was not collected. \nd. The end study day will not be populated if the end date/time includes only a year or only a year and month. \nSM \u2013 Examples \nExample 1 \nIn this study, the disease milestones of interest were initial diagnosis and hypoglycemic events, as shown in Section 7.3.3, Trial Disease Milestones, Example 1. \nRow 1: \nShows that subject 001's initial diagnosis of diabetes occurred in October 2005. Because this is a partial date, SMDY is not populated. No end \ndate/time was recorded for this milestone. \nRows 2-3: \nShow that subject 001 had 2 hypoglycemic events. In this case, only start date/times have been collected. Because these date/times include full \ndates, SMSTDY has been populated in each case. \nRow 4: \nShows that subject 002\u2019s initial diagnosis of diabetes occurred on May 15, 2010. Because a full date was collected, the study day of this milestone \nwas populated. Diagnosis was pre-study, so the study day of the disease milestone is negative. No hypoglycemic events were recorded for this \nsubject. \nsm.xpt \nRow STUDYID DOMAIN USUBJID SMSEQ MIDS \nMIDSTYPE \nSMSTDTC \nSMENDTC SMSTDY SMENDY \n1 \nXYZ \nSM \n001 \n1 \nDIAG \nDIAGNOSIS \n2005-10 \n \n \n \n2 \nXYZ \nSM \n001 \n2 \nHYPO1 HYPOGLYCEMIC EVENT \n2013-09-01T11:00 \n \n25 \n \n3 \nXYZ \nSM \n001 \n3 \nHYPO2 HYPOGLYCEMIC EVENT \n2013-09-24T8:48 \n \n50 \n \n4 \nXYZ \nSM \n002 \n1 \nDIAG \nDIAGNOSIS \n2010-05-15 \n \n-1046 \n \nInformation in SM is taken from records in other domains. In this study, diagnosis was represented in the Medical History (MH) domain, and hyypoglycemic \nevents were represented in the Clinical Events (CE) domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2879, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c8d60c44-acce-4332-bdb9-be64403ab179": {"__data__": {"id_": "c8d60c44-acce-4332-bdb9-be64403ab179", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 85, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b7eb73f8-0128-4489-ba25-62852c1fcd40", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 85, "section": "UNSPECIFIED"}, "hash": "0548bd46c95a3ab7da33757a04e462afe49d89f91f23e552f1d091ca0abece02", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ef9fea72-145a-4950-93c7-fec4c1958461", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 85, "section": "UNSPECIFIED"}, "hash": "f6cfcebb430068d171cef4089db195ede3c36c8e5ce00c4cb1f5734240297a20", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In this study, diagnosis was represented in the Medical History (MH) domain, and hyypoglycemic \nevents were represented in the Clinical Events (CE) domain. \nThe MH  records for diabetes (MHEVDTYP = \"DIAGNOSIS\") are the records which represent the disease milestones for the defined MIDSTYPE of \n\"DIAGNOSIS\", so these records include the MIDS variable with the value \"DIAG\".  Because these are records for disease milestones rather than associated \nrecords, the variables RELMIDS and MIDSDTC are not needed. \nmh.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nMHSEQ \nMHTERM \nMHDECOD \nMHEVDTYP \nMHPRESP \nMHOCCUR \nMHDTC \nMHSTDTC \nMHENDTC \nMHDY \nMIDS \n1 \nXYZ \nMH \n001 \n1 \nTYPE 2 DIABETES \nType 2 diabetes mellitus \nDIAGNOSIS \nY \nY \n2013-08-06 \n2005-10 \n \n1 \nDIAG \n2 \nXYZ \nMH \n002 \n1 \nTYPE 2 DIABETES \nType 2 diabetes mellitus \nDIAGNOSIS \nY \nY \n2013-08-06 \n2010-05-15 \n \n1 \nDIAG", "mimetype": "text/plain", "start_char_idx": 2724, "end_char_idx": 3584, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6870f6c5-887d-41b8-bf2f-022b531f2fc5": {"__data__": {"id_": "6870f6c5-887d-41b8-bf2f-022b531f2fc5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 86, "section": "5.5 Subject Visits (SV)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6dd1751b-fdf3-4cd2-a9bc-ee2907f2e2f5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 86, "section": "5.5 Subject Visits (SV)"}, "hash": "e70f780f810aea100375542b13e5d056b8780d61072a8cab315d1192b221686c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SV \u2013 Description/Overview \nA special purpose domain that contains information for each subject's actual and planned visits. \nThe Subject Visits domain consolidates information about the timing of subject visits that is otherwise spread over domains that include the visit variables \n(VISITNUM and possibly VISIT and/or VISITDY). Unless the beginning and end of each visit is collected, populating the SV dataset will involve derivations. \nIn a simple case, where, for each subject visit, exactly 1 date appears in every such domain, the SV dataset can be created easily by populating both SVSTDTC \nand SVENDTC with the single date for a visit. When there are multiple dates and/or date/times for a visit for a particular subject, the derivation of values for \nSVSTDTC and SVENDTC may be more complex. The method for deriving these values should be consistent with the visit definitions in the Trial Visits (TV) \ndataset (see Section 7.3.1, Trial Visits). For some studies, a visit may be defined to correspond with a clinic visit that occurs within 1 day, whereas for other \nstudies, a visit may reflect data collection over a multiday period. \nThe SV dataset provides reviewers with a summary of a subject\u2019s visits over the course of their participation in a study. Comparison of an individual subject\u2019s \nSV dataset with the TV dataset, which describes the planned visits for the trial, supports the identification of planned but not expected visits due to a subject not \ncompleting the study. Comparison of the values of SVSTDY and SVENDY to VISIT and/or VISITDY can often highlight departures from the planned timing of \nvisits. \nSV \u2013 Specification \nsv.xpt, Subject Visits \u2014 Special Purpose. One record per actual or planned visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar SV \nIdentifier \nTwo-character abbreviation for the domain most relevant to the observation. The domain \nabbreviation is also used as a prefix for variables to ensure uniqueness when datasets are \nmerged. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or \nsubmissions involving the product. \nReq \nVISITNUM \nVisit Number \nNum  \nTopic \nClinical encounter number. Numeric version of VISIT, used for sorting. \nReq \nVISIT \nVisit Name \nChar  \nSynonym \nQualifier \nProtocol-defined description of a clinical encounter. \nPerm \nSVPRESP \nPre-specified \nChar (NY) \nVariable \nQualifier \nUsed to indicate whether the visit was planned (i.e., visits specified in the TV domain). Value \nis \"Y\" for planned visits, null for unplanned visits. \nExp \nSVOCCUR \nOccurrence \nChar (NY) \nRecord \nQualifier \nUsed to record whether a planned visit occurred. The value is null for unplanned visits. \nExp \nSVREASOC \nReason for Occur Value \nChar  \nRecord \nQualifier \nThe reason for the value in SVOCCUR. If SVOCCUR=\"N\", SVREASOC is the reason the \nvisit did not occur. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3123, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a02a8944-9b73-4ebf-899c-ad95b47f39d3": {"__data__": {"id_": "a02a8944-9b73-4ebf-899c-ad95b47f39d3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 87, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b6bd8a6b-4248-424a-993c-2b36da7c0c3b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 87, "section": "UNSPECIFIED"}, "hash": "89fe3c1b0b2dfb718132ee15d2231a3fd8f30fc7b9a733a6e698cec76a33c4c4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "548b213c-3948-479a-9b5f-4c3340730335", "node_type": "1", "metadata": {}, "hash": "7790e2b427795690b808c73d4c8072c0a27050f4adefece48960aaeb2878b026", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 87 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSVCNTMOD \nContact Mode \nChar (CNTMODE) \nRecord \nQualifier \nThe way in which the visit was conducted. Examples: \"IN PERSON\", \"TELEPHONE CALL\", \n\"IVRS\". \nPerm \nSVEPCHGI \nEpi/Pandemic Related \nChange Indicator \nChar (NY) \nRecord \nQualifier \nIndicates whether the visit was changed due to an epidemic or pandemic. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nSVSTDTC \nStart Date/Time of \nObservation \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time of an observation represented in IS0 8601 character format. \nExp \nSVENDTC \nEnd Date/Time of \nObservation \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time of the observation represented in IS0 8601 character format. \nExp \nSVSTDY \nStudy Day of Start of \nObservation \nNum  \nTiming \nActual study day of start of observation expressed in integer days relative to the sponsor-\ndefined RFSTDTC in Demographics. \nPerm \nSVENDY \nStudy Day of End of \nObservation \nNum  \nTiming \nActual study day of end of observation expressed in integer days relative to the sponsor-\ndefined RFSTDTC in Demographics. \nPerm \nSVUPDES \nDescription of Unplanned \nVisit \nChar  \nRecord \nQualifier \nDescription of what happened to the subject during an unplanned visit. Only populated for \nunplanned visits. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nSV \u2013 Assumptions \n1. The Subject Visits domain allows the submission of data on the timing of the trial visits for a subject, including both those visits they actually passed \nthrough in their participation in the trial and those visits that did not occur. Refer to Section 7.3.1, Trial Visits (TV), as the TV dataset defines the \nplanned visits for the trial. \n2. Subjects can have 1 and only 1 record per VISITNUM. \n3. Subjects who screen fail, withdraw, die, or otherwise discontinue study participation will not have records for planned visits subsequent to their final \ndisposition event. \n4. Planned and unplanned visits with a subject, whether or not they are physical visits to the investigational site, are represented in this domain.  \na. \nSVPRESP = \"Y\" identifies rows for planned visits. \nb. For planned visits, SVOCCUR indicates whether the visit occurred. \nc. \nFor unplanned visits, SVPRESP and SVOCCUR are null. \nd. See Section 4.5.7, Presence or Absence of Prespecified Interventions and Events, for more information on the use of --PRESP and --OCCUR. \n5. The identification of an actual visit with a planned visit sometimes calls for judgment. In general, data collection forms are prepared for particular visits, \nand the fact that data was collected on a form labeled with a planned visit is sufficient to make the association.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3123, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "548b213c-3948-479a-9b5f-4c3340730335": {"__data__": {"id_": "548b213c-3948-479a-9b5f-4c3340730335", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 87, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b6bd8a6b-4248-424a-993c-2b36da7c0c3b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 87, "section": "UNSPECIFIED"}, "hash": "89fe3c1b0b2dfb718132ee15d2231a3fd8f30fc7b9a733a6e698cec76a33c4c4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a02a8944-9b73-4ebf-899c-ad95b47f39d3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 87, "section": "UNSPECIFIED"}, "hash": "7777ee83c784bfb18f87ff5aa5585a42adb9990665b45a16dc42ed41ab7d7d80", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4. Planned and unplanned visits with a subject, whether or not they are physical visits to the investigational site, are represented in this domain.  \na. \nSVPRESP = \"Y\" identifies rows for planned visits. \nb. For planned visits, SVOCCUR indicates whether the visit occurred. \nc. \nFor unplanned visits, SVPRESP and SVOCCUR are null. \nd. See Section 4.5.7, Presence or Absence of Prespecified Interventions and Events, for more information on the use of --PRESP and --OCCUR. \n5. The identification of an actual visit with a planned visit sometimes calls for judgment. In general, data collection forms are prepared for particular visits, \nand the fact that data was collected on a form labeled with a planned visit is sufficient to make the association. Occasionally, the association will not be \nso clear, and the sponsor will need to make decisions about how to label actual visits. The sponsor's rules for making such decisions should be \ndocumented in the Define-XML document. \n6. Records for unplanned visits should be included in the SV dataset. For unplanned visits, SVUPDES can be populated with a description of the reason \nfor the unplanned visit. Some judgment may be required to determine what constitutes an unplanned visit. When data are collected outside a planned \nvisit, that act of collecting data may or may not be described as a \"visit.\" The encounter should generally be treated as a visit if data from the encounter \nare included in any domain for which VISITNUM is included; a record with a missing value for VISITNUM is generally less useful than a record with", "mimetype": "text/plain", "start_char_idx": 2372, "end_char_idx": 3954, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d5ca1f8a-8aff-4660-a519-d40120779c93": {"__data__": {"id_": "d5ca1f8a-8aff-4660-a519-d40120779c93", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 88, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6554d30b-8467-4fd2-9a7c-96c89d0b82aa", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 88, "section": "UNSPECIFIED"}, "hash": "3abff4b0a575576d25044b9acfc56a257365c9ff26c53775eb82f74d217eb2e3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "21e78b45-62dd-42a1-80d4-b49021b29fd5", "node_type": "1", "metadata": {}, "hash": "7424ef6d5382142818ab8b3571b9aa8d4314c7eec39afa8175da49c7270f80a3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 88 \n2021-11-29 \nVISITNUM populated. If the occasion is considered a visit, its date/times must be included in the SV table and a value of VISITNUM must be assigned. \nRefer to Section 4.4.5, Clinical Encounters and Visits, for information on the population of visit variables for unplanned visits. \n7. The variable SVCNTMOD is used to record the way in which the visit was conducted. For example, for visits to a clinic, SVCNTMOD = \"IN \nPERSON\", visits conducted remotely might have values such as \"TELEPHONE\", \"REMOTE AUDIO VIDEO\", or \"IVRS\". If there are multiple contact \nmodes, refer to Section 4.2.8.3, Multiple Values for a Non-result Qualifier Variable. \n8. The planned study day of visit variable (VISITDY) should not be populated for unplanned visits. \n9. If SVSTDY is included, it is the actual study day corresponding to SVSTDTC. In studies for which VISITDY has been populated, it may be desirable to \npopulate SVSTDY, as this will facilitate the comparison of planned (VISITDY) and actual (SVSTDY) study days for the start of a visit. \n10. If SVENDY is included, it is the actual day corresponding to SVENDTC. \n11. For many studies, all visits are assumed to occur within 1 calendar day, and only 1 date is collected for the visit. In such a case, the values for \nSVENDTC duplicate values in SVSTDTC. However, if the data for a visit is actually collected over several physical visits and/or over several days, \nthen SVSTDTC and SVENDTC should reflect this fact. Note that it is fairly common for screening data to be collected over several days, but for the \ndata to be treated as belonging to a single planned screening visit, even in studies for which all other visits are single-day visits. \n12. Differentiating between planned and unplanned visits may be challenging if unplanned assessments (e.g., repeat labs) are performed during the time \nperiod of a planned visit. \n13. Algorithms for populating SVSTDTC and SVENDTC from the dates of assessments performed at a visit may be particularly challenging for screening \nvisits, since baseline values collected at a screening visit are sometimes historical data from tests performed before the subject started screening for the \ntrial. Therefore dates prior to informed consent are not part of the determination of SVSTDTC. \n14. The following Identifier variables are permissible and may be added as appropriate: --SEQ, --GRPID, --REFID, and --SPID. \n15. Care should be taken in adding additional timing variables: \na. \nIf TAETORD and/or EPOCH are added, then the values must be those at the start of the visit. \nb. The purpose of --DTC and --DY in other domains with start and end dates (Event and Intervention Domains) is to record the date on which \ndata was collected. For a visit that occurred, it is not necessary to submit the date on which information about the visit was recorded. When \nSVPRESP = \"Y\" and SVOCCUR = \"N\", --DTC and --DY are available for use to represent the date on which it was recorded that the visit did \nnot take place. \nc.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3196, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "21e78b45-62dd-42a1-80d4-b49021b29fd5": {"__data__": {"id_": "21e78b45-62dd-42a1-80d4-b49021b29fd5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 88, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6554d30b-8467-4fd2-9a7c-96c89d0b82aa", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 88, "section": "UNSPECIFIED"}, "hash": "3abff4b0a575576d25044b9acfc56a257365c9ff26c53775eb82f74d217eb2e3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d5ca1f8a-8aff-4660-a519-d40120779c93", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 88, "section": "UNSPECIFIED"}, "hash": "c41667c275393d8c82cda08858f5ce1c1864433b12242749fa519a675b2cec00", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "14. The following Identifier variables are permissible and may be added as appropriate: --SEQ, --GRPID, --REFID, and --SPID. \n15. Care should be taken in adding additional timing variables: \na. \nIf TAETORD and/or EPOCH are added, then the values must be those at the start of the visit. \nb. The purpose of --DTC and --DY in other domains with start and end dates (Event and Intervention Domains) is to record the date on which \ndata was collected. For a visit that occurred, it is not necessary to submit the date on which information about the visit was recorded. When \nSVPRESP = \"Y\" and SVOCCUR = \"N\", --DTC and --DY are available for use to represent the date on which it was recorded that the visit did \nnot take place. \nc. \n--DUR could be added if the duration of a visit was collected. \nd. It would be inappropriate to add the variables that support time points (--TPT, --TPTNUM, --ELTM, --TPTREF, and --RFTDTC), because the \ntopic of this dataset is visits. \ne. \n--STRF and --ENRF could be used to say whether a visit started and ended before, during, or after the study reference period, although this \nseems unnecessary. \nf. \n--STRTPT, --STTPT, --ENRTPT, and --ENTPT could be used to say that a visit started or ended before or after particular dates, although this \nseems unnecessary. \n16. SVOCCUR = \"N\" records are only to be created for planned visits that were expected to occur before the end of the subject's participation.", "mimetype": "text/plain", "start_char_idx": 2469, "end_char_idx": 3907, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b8be10e6-d7b8-414d-8255-0ea6e9263680": {"__data__": {"id_": "b8be10e6-d7b8-414d-8255-0ea6e9263680", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 89, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "52f25532-a246-4af2-9b90-83d86d828033", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 89, "section": "UNSPECIFIED"}, "hash": "36e7148f3f5d902dac9b3b773ec2623a95a022261eaa8bc007a2334092c198d9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "48f6f390-7e84-4e86-b763-be9d72cb6a5d", "node_type": "1", "metadata": {}, "hash": "6bdbc0305af4c72df7f6d1ab27e431c1a673386e97d784430b656877b5aa71ee", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 89 \n2021-11-29 \nSV \u2013 Examples \nExample 1 \nThis example shows the planned visit schedule for a study, along with disposition and study events data for 3 subjects. For this study, data on screen failures \nwere submitted. The study was disrupted by the COVID-19 pandemic after many subjects had completed the study. \nThis is the planned schedule of visits for the study in this example. \nRow 1: \nThe activities for the SCREEN visit may occur over up to 7 days. \nRow 2: \nThe day 1 visit is planned to start before the start of treatment and end after the start of treatment. \nRows 3-7: \nThese visits are scheduled relative to the start of the treatment epoch. \nRow 8: \nThe follow-up visit is generally scheduled relative to the start of the treatment epoch, but may occur earlier if treatment is stopped early. \ntv.xpt \nRow STUDYID DOMAIN VISITNUM VISIT \nVISITDY TVSTRL \nTVENRL \n1 \n123456 \nTV \n1 \nSCREEN \n \nStart of Screening Epoch \nUp to 7 days after start of the Screening Epoch \n2 \n123456 \nTV \n2 \nDAY 1 \n1 \nOn the day of, but before, the end of the Screen Epoch \nOn the day of, but after, the start of the \nTreatment Epoch \n3 \n123456 \nTV \n3 \nWEEK 1 \n8 \n1 week after the start of the Treatment Epoch \n \n4 \n123456 \nTV \n4 \nWEEK 2 \n15 \n2 weeks after the start of the Treatment Epoch \n \n5 \n123456 \nTV \n5 \nWEEK 4 \n29 \n4 weeks after the start of the Treatment Epoch \n \n6 \n123456 \nTV \n6 \nWEEK 6 \n43 \n6 weeks after the start of the Treatment Epoch \n \n7 \n123456 \nTV \n7 \nWEEK 8 \n57 \n8 weeks after the start of the Treatment Epoch \n \n8 \n123456 \nTV \n8 \nFOLLOW-\nUP \n \nThe earlier of 14 days after the last dose of treatment and 10 weeks after the start of the \nTreatment Epoch \nAt Trial Exit \nThis table shows the disposition records for the subjects in this example. \nRow 1: \nShows informed consent for subject 37. \nRow 2: \nShows the subject 37 was discontinued due to screen failure. Note that because the subject did not start treatment, DSSTDY is not populated in their \nrecords. \nRow 3: \nShows informed consent for subject 85. \nRow 4: \nShows that subject 85 completed the study. \nRow 5: \nShows informed consent for subject 101 \nRow 6: \nShows that subject 101 chose to withdraw early.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2352, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "48f6f390-7e84-4e86-b763-be9d72cb6a5d": {"__data__": {"id_": "48f6f390-7e84-4e86-b763-be9d72cb6a5d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 89, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "52f25532-a246-4af2-9b90-83d86d828033", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 89, "section": "UNSPECIFIED"}, "hash": "36e7148f3f5d902dac9b3b773ec2623a95a022261eaa8bc007a2334092c198d9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b8be10e6-d7b8-414d-8255-0ea6e9263680", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 89, "section": "UNSPECIFIED"}, "hash": "91751ce2aef1b886d8da59bb85766bfb4c1b002124be2dcf0e426098c2a106fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Row 1: \nShows informed consent for subject 37. \nRow 2: \nShows the subject 37 was discontinued due to screen failure. Note that because the subject did not start treatment, DSSTDY is not populated in their \nrecords. \nRow 3: \nShows informed consent for subject 85. \nRow 4: \nShows that subject 85 completed the study. \nRow 5: \nShows informed consent for subject 101 \nRow 6: \nShows that subject 101 chose to withdraw early. \nds.xpt \nRow STUDYID DOMAIN USUBJID DSSEQ DSTERM \nDSDECOD \nDSCAT \nDSSCAT \nEPOCH \nDSDTC \nDSSTDTC \nDSSTDY \n1 \n123456 \nDS \n37 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2019-09-\n10 \n2019-09-\n10 \n \n2 \n123456 \nDS \n37 \n2 \nSCREEN FAILURE \nSCREEN FAILURE \nDISPOSITION EVENT \nSTUDY \nPARTICIPATION \nSCREENING 2019-09-\n16 \n2019-09-\n16 \n \n3 \n123456 \nDS \n85 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2019-12-\n13 \n2019-12-\n13 \n-6 \n4 \n123456 \nDS \n85 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY \nPARTICIPATION \nTREATMENT 2020-02-\n27 \n2020-02-\n27 \n72", "mimetype": "text/plain", "start_char_idx": 1933, "end_char_idx": 2994, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "71395785-1b4c-42c7-834c-0eed7c11a6b2": {"__data__": {"id_": "71395785-1b4c-42c7-834c-0eed7c11a6b2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 90, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3554a06b-78d7-42ea-8ed5-b3ae6ad64807", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 90, "section": "UNSPECIFIED"}, "hash": "93517bd6a3cf5a1b3a3abd57d7f1d99bb02f4dcd57c9f7717561e5be3f49b7b1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bdd2ef22-8908-4c94-af9c-0dd72b417369", "node_type": "1", "metadata": {}, "hash": "087d1b8b70281161d8d906b1130eedefdf9a028740e2bfb9c9aa5853d9a07937", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 90 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID DSSEQ DSTERM \nDSDECOD \nDSCAT \nDSSCAT \nEPOCH \nDSDTC \nDSSTDTC \nDSSTDY \n5 \n123456 \nDS \n101 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2020-02-\n13 \n2020-02-\n13 \n-6 \n6 \n123456 \nDS \n101 \n2 \nWITHDRAWAL BY SUBJECT \nWITHDRAWAL BY SUBJECT \nDISPOSITION EVENT \nSTUDY \nPARTICIPATION \nTREATMENT 2020-03-\n16 \n2020-03-\n16 \n26 \nBecause the study in this example was disrupted by an epidemic, the permissible variable SVEPCHGI (Epi/Pandemic Related Change Indicator) was included in \nthe SV dataset. As originally planned, visits were to be conducted in person, but pandemic disruption included conducting some visits remotely. When the \nchange to a remote visit was a change due to the pandemic, SVEPCHGI = \"Y\". \nRow 1: \nShows that screening data for subject 37 was collected during a period of 4 days. This subject is shown as a screen failure in ds.xpt and therefore \nwould have a null DM.RFSTDTC, hence the study day values in SVSTDY and SVENDY, which are based on the sponsor-defined reference start \ndate, are null. \nRows 2-3: \nShow normal completion of the first 2 visits for subject 85. \nRow 4: \nShows that for subject 85, the visit called \"WEEK 1\" did not occur; the reason it did not occur is represented in SVREASOC. \nRows 5-9: \nNormal completion of remaining visits for subject 85. \nRow 10: \nData for the screening visit was gathered over the course of six days. For this and subsequent visits, SVPRESP = \"Y\" indicates that a visit was \nplanned and SVOCCUR = \"Y\" indicates that the visit occurred. \nRow 11: \nThe visit called \"DAY 1\" started and ended as planned, on Day 1. \nRow 12: \nThe visit scheduled for Day 8 occurred one day early, on Day 7. \nRow 13: \nThe visit called \"WEEK 2\" did not occur due to clinic closure. SVOCCUR = \"N\" and SVREASOC contains the reason the visit did not occur. \nRow 14: \nShows an unscheduled visit. SVUPDES provides the information that this visit dealt with evaluation of an adverse event. Since this visit was not \nplanned, VISITDY was not populated, SVPRESP and SVOCCUR are both null. VISITNUM is populated as required, but the sponsor chose not to \npopulate VISIT. Data collected at this encounter may be in a Findings domain such as EG, LB, or VS, in which VISITNUM is treated as an \nimportant timing variable. This visit was over remote audio video due to having an adverse event during a pandemic. \nRow 15: \nThis subject had their last visit, a follow-up visit on study day 26, eight days after the unscheduled visit.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2721, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bdd2ef22-8908-4c94-af9c-0dd72b417369": {"__data__": {"id_": "bdd2ef22-8908-4c94-af9c-0dd72b417369", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 90, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3554a06b-78d7-42ea-8ed5-b3ae6ad64807", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 90, "section": "UNSPECIFIED"}, "hash": "93517bd6a3cf5a1b3a3abd57d7f1d99bb02f4dcd57c9f7717561e5be3f49b7b1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "71395785-1b4c-42c7-834c-0eed7c11a6b2", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 90, "section": "UNSPECIFIED"}, "hash": "4c425b19e0eda4466ca6264b77d1bd9ddc6adf00973d059dce32f4f39d64bbd6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SVOCCUR = \"N\" and SVREASOC contains the reason the visit did not occur. \nRow 14: \nShows an unscheduled visit. SVUPDES provides the information that this visit dealt with evaluation of an adverse event. Since this visit was not \nplanned, VISITDY was not populated, SVPRESP and SVOCCUR are both null. VISITNUM is populated as required, but the sponsor chose not to \npopulate VISIT. Data collected at this encounter may be in a Findings domain such as EG, LB, or VS, in which VISITNUM is treated as an \nimportant timing variable. This visit was over remote audio video due to having an adverse event during a pandemic. \nRow 15: \nThis subject had their last visit, a follow-up visit on study day 26, eight days after the unscheduled visit. \nsv.xpt \nRow STUDYID DOMAIN USUBJID VISITNUM VISIT \nSVPRESP SVOCCUR SVREASOC \nSVCNTMOD \nSVEPCHGI VISITDY SVSTDTC SVENDTC SVSTDY SVENDY SVUPDES \n1 \n123456 \nSV \n37 \n1 \nSCREEN \nY \nY \n \nIN PERSON \n \n \n2019-09-\n10 \n2019-09-\n16 \n \n \n \n2 \n123456 \nSV \n85 \n1 \nSCREEN \nY \nY \n \nIN PERSON \n \n \n2019-12-\n13 \n2019-12-\n18 \n-6 \n-1 \n \n3 \n123456 \nSV \n85 \n2 \nDAY 1 \nY \nY \n \nIN PERSON \n \n1 \n2019-12-\n19 \n2019-12-\n19 \n1 \n1 \n \n4 \n123456 \nSV \n85 \n3 \nWEEK 1 \nY \nN \nSUBJECT LACKED \nTRANSPORTATION \n \n \n8 \n \n \n \n \n \n5 \n123456 \nSV \n85 \n4 \nWEEK 2 \nY \nY \n \nIN PERSON \n \n15 \n2020-01-\n02 \n2020-01-\n02 \n15 \n15 \n \n6 \n123456 \nSV \n85 \n5 \nWEEK 4 \nY \nY \n \nIN PERSON \n \n29 \n2020-01-\n16 \n2020-01-\n16 \n30 \n30 \n \n7 \n123456 \nSV \n85 \n6 \nWEEK 6 \nY \nY \n \nIN PERSON \n \n43 \n2020-01-\n30 \n2020-01-\n30 \n43 \n43 \n \n8 \n123456 \nSV \n85 \n7 \nWEEK 8 \nY \nY \n \nIN PERSON \n \n57 \n2020-02-\n13 \n2020-02-\n13 \n57 \n57", "mimetype": "text/plain", "start_char_idx": 1986, "end_char_idx": 3572, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "943af8fc-7557-4ad0-a56e-b757f3a426ef": {"__data__": {"id_": "943af8fc-7557-4ad0-a56e-b757f3a426ef", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 92, "section": "6.1.1 Procedure Agents (AG)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "32273914-fe91-4464-8012-1f1d9e0e764c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 92, "section": "6.1.1 Procedure Agents (AG)"}, "hash": "377c69b4c20eef84b005f3181716cb8f1dc7a6852d70cb00d98ff80d28bf40e6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "AG \u2013 Description/Overview \nAn interventions domain that contains the agents administered to the subject as part of a procedure or assessment, as opposed to drugs, medications and therapies \nadministered with therapeutic intent. \nAG \u2013 Specification \nag.xpt, Procedure Agents \u2014 Interventions. One record per recorded intervention occurrence per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar AG \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the \nproduct. \nReq \nAGSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid number. Req \nAGGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nAGSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined in \nthe sponsor's operational database. Example: Line number from the procedure or test page. \nPerm \nAGLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains.This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nAGLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains.This will usually be a many-to-one relationship. \nPerm \nAGTRT \nReported Agent \nName \nChar  \nTopic \nVerbatim medication name that is either preprinted or collected on a CRF. \nReq \nAGMODIFY \nModified Reported \nName \nChar  \nSynonym \nQualifier \nIf AGTRT is modified to facilitate coding, then AGMODIFY will contain the modified text. \nPerm \nAGDECOD \nStandardized Agent \nName \nChar * \nSynonym \nQualifier \nStandardized or dictionary-derived text description of AGTRT or AGMODIFY. Equivalent to the generic \nmedication name in WHO Drug. The sponsor is expected to provide the dictionary name and version used to \nmap the terms utilizing the external codelist element in the Define-XML document. If an intervention term \ndoes not have a decode value in the dictionary, then AGDECOD will be left blank. \nPerm \nAGCAT \nCategory for Agent \nChar * \nGrouping \nQualifier \nUsed to define a category of agent. Examples: \"CHALLENGE AGENT\", \"PET TRACER\". \nPerm \nAGSCAT \nSubcategory for \nAgent \nChar * \nGrouping \nQualifier \nFurther categorization of agent. \nPerm \nAGPRESP \nAG Pre-Specified \nChar (NY) \nVariable \nQualifier \nUsed to indicate whether (\"Y\"/null) information about the use of a specific agent was solicited on the CRF. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2850, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7f1e1ac2-3f3c-435e-abef-a1dbbd33e6ac": {"__data__": {"id_": "7f1e1ac2-3f3c-435e-abef-a1dbbd33e6ac", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 93, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27d2d277-ba42-4135-85f3-d91d9f77978c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 93, "section": "UNSPECIFIED"}, "hash": "ec4281fd30241df18651cda6bf127b77b8c4949420f5e27e6ba6259fe5d4db5f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8f2aa13-b179-43b2-adf1-00d2675c4422", "node_type": "1", "metadata": {}, "hash": "9008a640db9ead4698933b5b7fdb6aba6c03ee5a6366cbd5a801673d7420ceae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 93 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nAGOCCUR \nAG Occurrence \nChar (NY) \nRecord \nQualifier \nWhen the use of specific agent is solicited, AGOCCUR is used to indicate whether (\"Y\"/\"N\") use of the agent \noccurred. Values are null for agents not specifically solicited. \nPerm \nAGSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question about a prespecified agent was not answered. Should be null or have a \nvalue of \"NOT DONE\". \nPerm \nAGREASND \nReason Procedure \nAgent Not \nCollected \nChar  \nRecord \nQualifier \nDescribes the reason a response to a question about the occurrence of a procedure agent was not collected. \nUsed in conjunction with AGSTAT when value is \"NOT DONE\". \nPerm \nAGCLAS \nAgent Class \nChar * \nVariable \nQualifier \nDrug class. May be obtained from coding. When coding to a single class, populate with class value. If using \na dictionary and coding to multiple classes, follow guidance in Section 4.2.8.3, Multiple Values for a Non-\nresult Qualifier Variable, or omit AGCLAS. \nPerm \nAGCLASCD \nAgent Class Code \nChar * \nVariable \nQualifier \nClass code corresponding to AGCLAS. Drug class. May be obtained from coding. When coding to a single \nclass, populate with class code. If using a dictionary and coding to multiple classes, follow guidance in \nSection 4.2.8.3, Multiple Values for a Non-result Qualifier Variable, or omit AGCLASCD. \nPerm \nAGDOSE \nDose per \nAdministration \nNum  \nRecord \nQualifier \nAmount of AGTRT taken. \nPerm \nAGDOSTXT \nDose Description \nChar  \nRecord \nQualifier \nDosing amounts or a range of dosing information collected in text form. Units may be stored in AGDOSU. \nExamples: \"200-400\", \"15-20\". \nPerm \nAGDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for AGDOSE and AGDOSTXT. Examples: \"ng\", \"mg\", \"mg/kg\". \nPerm \nAGDOSFRM Dose Form \nChar (FRM) \nVariable \nQualifier \nDose form for AGTRT. Examples: \"TABLET\", \"AEROSOL\". \nPerm \nAGDOSFRQ \nDosing Frequency \nper Interval \nChar (FREQ) \nRecord \nQualifier \nUsually expressed as the number of repeated administrations of AGDOSE within a specific time period. \nExample: \"ONCE\". \nPerm \nAGROUTE \nRoute of \nAdministration \nChar (ROUTE) \nVariable \nQualifier \nRoute of administration for AGTRT. Example: \"ORAL\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \n1. \nClinical encounter number. \n2. \nNumeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \n1. \nProtocol-defined description of clinical encounter. \n2. \nMay be used in addition to VISITNUM and/or VISITDY.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2767, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e8f2aa13-b179-43b2-adf1-00d2675c4422": {"__data__": {"id_": "e8f2aa13-b179-43b2-adf1-00d2675c4422", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 93, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27d2d277-ba42-4135-85f3-d91d9f77978c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 93, "section": "UNSPECIFIED"}, "hash": "ec4281fd30241df18651cda6bf127b77b8c4949420f5e27e6ba6259fe5d4db5f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7f1e1ac2-3f3c-435e-abef-a1dbbd33e6ac", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 93, "section": "UNSPECIFIED"}, "hash": "a8df11e7a5ad8fd0226b954df43045a364b61aaa7e80318925151915772b5c82", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"TABLET\", \"AEROSOL\". \nPerm \nAGDOSFRQ \nDosing Frequency \nper Interval \nChar (FREQ) \nRecord \nQualifier \nUsually expressed as the number of repeated administrations of AGDOSE within a specific time period. \nExample: \"ONCE\". \nPerm \nAGROUTE \nRoute of \nAdministration \nChar (ROUTE) \nVariable \nQualifier \nRoute of administration for AGTRT. Example: \"ORAL\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \n1. \nClinical encounter number. \n2. \nNumeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \n1. \nProtocol-defined description of clinical encounter. \n2. \nMay be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day \nof Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the agent \nadministration started. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the agent administration started. \nPerm \nAGSTDTC \nStart Date/Time of \nAgent \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nThe date/time when administration of the treatment indicated by AGTRT and the dosing variables began. \nPerm \nAGENDTC \nEnd Date/Time of \nAgent \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nThe date/time when administration of the treatment indicated by AGTRT and the dosing variables ended. \nPerm \nAGSTDY \nStudy Day of Start \nof Agent \nNum  \nTiming \nStudy day of start of agent relative to the sponsor-defined RFSTDTC. \nPerm \nAGENDY \nStudy Day of End \nof Agent \nNum  \nTiming \nStudy day of end of agent relative to the sponsor-defined RFSTDTC. \nPerm \nAGDUR \nDuration of Agent \nChar ISO 8601 \nduration \nTiming \nCollected duration for an agent episode. Used only if collected on the CRF and not derived from start and \nend date/times. \nPerm \nAGSTRF \nStart Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the start of the agent relative to sponsor-defined reference period. The sponsor-defined reference \nperiod is a continuous period of time defined by a discrete starting point and a discrete ending point \nPerm", "mimetype": "text/plain", "start_char_idx": 2130, "end_char_idx": 4324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "85d02767-e85f-4f7d-b494-d0c0d979b74d": {"__data__": {"id_": "85d02767-e85f-4f7d-b494-d0c0d979b74d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 94, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2fbdd8c6-7a1b-4435-8c09-7cc3f493e9b2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 94, "section": "UNSPECIFIED"}, "hash": "a046c696dcde3b65b944b4c2c3d8e66887fd8f3d988be542ee773f192cc2f66b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "388fbaea-6420-46a5-a675-d2a8521f0303", "node_type": "1", "metadata": {}, "hash": "97a2754446aaba937a1fb4c1446fa6bbabb2bece5435b69ce51f1a7b016fab26", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 94 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \n(represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\", \"ONGOING\", \nor \"CONTINUING\" was collected, this information may be translated into AGSTRF. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nAGENRF \nEnd Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the end of the agent relative to the sponsor-defined reference period. The sponsor-defined \nreference period is a continuous period of time defined by a discrete starting point and a discrete ending \npoint (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\", \n\"ONGOING\", or \"CONTINUING\" was collected, this information may be translated into AGENRF. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nAGSTRTPT \nStart Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the start of the agent as being before or after the sponsor-defined reference time point defined by \nvariable AGSTTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nAGSTTPT \nStart Reference \nTime Point \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the reference point referred to by AGSTRTPT. \nExamples: \"2003-12-15\", \"VISIT 1\". \nPerm \nAGENRTPT \nEnd Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the end of the agent as being before or after the reference time point defined by variable \nAGENTPT. Identifies the end of the agent as being before or after the sponsor-defined reference time point \ndefined by variable AGENTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nAGENTPT \nEnd Reference \nTime Point \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the reference point referred to by AGENRTPT. \nExamples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nAG \u2013 Assumptions \n1. Purpose of the domain: Some tests involve administration of substances, and it has been unclear in which domain these should be represented. \na. \nThe Concomitant/Prior Medications (CM) domain seemed particularly inappropriate when the substance was one that would never be given as a \nmedication. Even substances that are medications are not being used as such when they are given as part of a testing procedure. \nb. The Exposure (EX) domain also seemed inappropriate; although the testing procedure might be part of the study plan, these data would not be used \nor analyzed in the same way as data about study treatments.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3146, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "388fbaea-6420-46a5-a675-d2a8521f0303": {"__data__": {"id_": "388fbaea-6420-46a5-a675-d2a8521f0303", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 94, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2fbdd8c6-7a1b-4435-8c09-7cc3f493e9b2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 94, "section": "UNSPECIFIED"}, "hash": "a046c696dcde3b65b944b4c2c3d8e66887fd8f3d988be542ee773f192cc2f66b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "85d02767-e85f-4f7d-b494-d0c0d979b74d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 94, "section": "UNSPECIFIED"}, "hash": "226e2a1f34c230e611ac33a5038aabce2d1e4277703a28606a4e3bd9d2fe4b74", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nAG \u2013 Assumptions \n1. Purpose of the domain: Some tests involve administration of substances, and it has been unclear in which domain these should be represented. \na. \nThe Concomitant/Prior Medications (CM) domain seemed particularly inappropriate when the substance was one that would never be given as a \nmedication. Even substances that are medications are not being used as such when they are given as part of a testing procedure. \nb. The Exposure (EX) domain also seemed inappropriate; although the testing procedure might be part of the study plan, these data would not be used \nor analyzed in the same way as data about study treatments. The AG domain was created to fill this gap. \nc. \nThe AG domain has advantages over the Procedures (PR) domain for this purpose. It allows recording of multiple substance administrations for a \nsingle testing procedure. It also separates data about substance administrations from data about procedures that do not involve substance \nadministration. \nd. Information about the conduct of the procedure with which the procedure agent administration was associated, if collected, should be represented in \nthe PR domain. \n2. Examples and structure \na. \nExamples of agents administered as part of a procedure include a short-acting bronchodilator administered as part of a reversibility assessment and \ncontrast agents or radio-labeled substances used in imaging studies.", "mimetype": "text/plain", "start_char_idx": 2302, "end_char_idx": 3912, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6dfaa4aa-7ea4-4f37-821c-50826e213213": {"__data__": {"id_": "6dfaa4aa-7ea4-4f37-821c-50826e213213", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 95, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "30fa772d-f408-4e2c-9898-dc79fed670e8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 95, "section": "UNSPECIFIED"}, "hash": "ebef4fb4fb75dc2c684439f86d019a2b52ea59f0c7e94df1b81fe23ff3aadbc1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "053b006f-9de9-45f8-9f51-8a273a0fd8f8", "node_type": "1", "metadata": {}, "hash": "fd7aaf1e373ea5342aca6439db9b7ce118c65b83798bacf98f9cf13c42afe03d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 95 \n2021-11-29 \nb. The structure of the AG domain is 1 record per agent intervention episode, or prespecified agent assessment per subject. It is the sponsor's \nresponsibility to define an intervention episode. This definition may vary based on the sponsor's requirements for review and analysis. \n3. AG description and coding \na. \nAGTRT captures the name of the agent and it is the topic variable. It is a required variable and must have a value. AGTRT should include only the \nagent name, and should not include dosage, formulation, or other qualifying information. For example, \"ALBUTEROL 2 PUFF\" is not a valid value \nfor AGTRT. This example should be expressed as AGTRT = \"ALBUTEROL\", AGDOSE = \"2\", AGDOSU = \"PUFF\", and AGDOSFRM = \n\"AEROSOL\". \nb. AGMODIFY should be included if the sponsor's procedure permits modification of a verbatim term for coding. \nc. \nAGDECOD is the standardized agent term derived by the sponsor from the coding dictionary. It is possible that the reported term (AGTRT) or the \nmodified term (AGMODIFY) can be coded using a standard dictionary. In such cases, sponsors are expected to provide the dictionary name and \nversion used to map the terms utilizing the external codelist element in the Define-XML document. \n4. Prespecified terms; presence or absence of procedure agents \na. \nAGPRESP is used to indicate whether an agent was prespecified. \nb. AGOCCUR is used to indicate whether a prespecified agent was used. A value of \"Y\" indicates that the agent was used and \"N\" indicates that it \nwas not. \nc. \nIf an agent was not prespecified, the value of AGOCCUR should be null. AGPRESP and AGOCCUR are permissible fields and may be omitted \nfrom the dataset if all agents were collected as free text. Values of AGOCCUR may also be null for prespecified agents if no Y/N response was \ncollected; in this case, AGSTAT = \"NOT DONE\", and AGREASND could be used to describe the reason the answer was missing. \n5. Any identifier variables, timing variables, or interventions general observation-class qualifiers may be added to the AG domain. \na. \nHowever, --INDC, although allowed, would not generally be used because substance administrations represented in AG are given as part of a \ntesting procedure rather than with therapeutic intent.  \nb. The variables --DOSTOT and --DOSRGM, although allowed, would generally not be used because procedure agents are likely to be recorded at the \nlevel of single administrations. \nAG \u2013 Examples \nExample 1 \nThis example captures data about the allergen administered to the subject as part of a bronchial allergen challenge (BAC) test. Prior to the BAC, the subject had a \nskin-prick allergen test to help identify the allergen to be used for the BAC test. The skin-prick test identified grass as the allergen to be used in the BAC test. \nData from the allergen skin test are not shown, but the CRF for the BAC includes collection of the allergen chosen for use in the BAC.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3119, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "053b006f-9de9-45f8-9f51-8a273a0fd8f8": {"__data__": {"id_": "053b006f-9de9-45f8-9f51-8a273a0fd8f8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 95, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "30fa772d-f408-4e2c-9898-dc79fed670e8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 95, "section": "UNSPECIFIED"}, "hash": "ebef4fb4fb75dc2c684439f86d019a2b52ea59f0c7e94df1b81fe23ff3aadbc1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6dfaa4aa-7ea4-4f37-821c-50826e213213", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 95, "section": "UNSPECIFIED"}, "hash": "6c9c9d1358f36bd9ea85c3629ae1062c200a8d39f9e7d3b20022b4ae8d7d9f51", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b. The variables --DOSTOT and --DOSRGM, although allowed, would generally not be used because procedure agents are likely to be recorded at the \nlevel of single administrations. \nAG \u2013 Examples \nExample 1 \nThis example captures data about the allergen administered to the subject as part of a bronchial allergen challenge (BAC) test. Prior to the BAC, the subject had a \nskin-prick allergen test to help identify the allergen to be used for the BAC test. The skin-prick test identified grass as the allergen to be used in the BAC test. \nData from the allergen skin test are not shown, but the CRF for the BAC includes collection of the allergen chosen for use in the BAC. A predetermined set of \nascending doses of the chosen allergen was used in the screening BAC test. The results of the screening BAC are not shown, but would be represented in the \nRespiratory System Findings (RE) domain. \nRow 1: \nThe first dose given in the BAC was saline. \nRows 2-4: \nThree successively higher doses of grass allergen were given.", "mimetype": "text/plain", "start_char_idx": 2449, "end_char_idx": 3467, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "44fa9db8-7cfd-487f-8e12-f88329dfc1a8": {"__data__": {"id_": "44fa9db8-7cfd-487f-8e12-f88329dfc1a8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 96, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c8334b17-fb1a-4ba1-822b-f92b2bd3c5d2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 96, "section": "UNSPECIFIED"}, "hash": "1fd2ca20ef128507811e27286048d5b4358252ae1540a754b0fbb305b64b18c4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cb583312-cebd-45ae-989e-aafc91d4d829", "node_type": "1", "metadata": {}, "hash": "c2cf88ecde42fab8623a9a07bee02964e94ea11e0a428eb1a313d771fafd3fcd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 96 \n2021-11-29 \nag.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nAGSEQ \nAGTRT \nAGPRESP \nAGOCCUR \nAGDOSE \nAGDOSU \nAGROUTE \nVISIT \nAGENDTC \n1 \nXYZ \nAG \nXYZ-001-001 \n1 \nSALINE \nY \nY \n0 \nSQ-u/mL \nRESPIRATORY (INHALATION) \nSCREENING \n2010-11-07T10:56:00 \n2 \nXYZ \nAG \nXYZ-001-001 \n2 \nGRASS \nY \nY \n250 \nSQ-u/mL \nRESPIRATORY (INHALATION) \nSCREENING \n2010-11-07T11:19:00 \n3 \nXYZ \nAG \nXYZ-001-001 \n3 \nGRASS \nY \nY \n1000 \nSQ-u/mL \nRESPIRATORY (INHALATION) \nSCREENING \n2010-11-07T11:43:00 \n4 \nXYZ \nAG \nXYZ-001-001 \n4 \nGRASS \nY \nY \n2000 \nSQ-u/mL \nRESPIRATORY (INHALATION) \nSCREENING \n2010-11-07T12:06:00 \nExample 2 \nIn this example, first there was a check that the subject had not taken a short-acting bronchodilator in the previous 4 hours (Concomitant/Prior Medications (CM) \ndomain). Then the procedure agent (AG domain) was given as part of a reversibility assessment. Spirometry measurements (RE domain) were obtained before \nand after agent administration. An identifier was assigned to the reversibility test and this identifier was used to be link data across the multiple SDTM domains \nin which the data are represented. \nThe question as to whether a short-acting bronchodilator was administered in the 4 hours prior to the reversibility assessment is represented in the CM domain \nbecause this prior administration would have been for therapeutic effect, not as part of the procedure. The question asked was about the administration of any \nshort-acting bronchodilator, rather than a specific medication, so both CMTRT and CMCAT are populated with \"SHORT-ACTING BRONCHODILATOR\", \nwhich describes a group of medications. The CMSPID value RV1 was used to indicate that this question was associated with the reversibility test. \ncm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCMSEQ \nCMSPID \nCMTRT \nCMCAT \nCMPRESP \nCMOCCUR \nCMEVLINT \n1 \nXYZ \nCM \nXYZ-001-001 \n1 \nRV1 \nSHORT-ACTING BRONCHODILATOR \nSHORT-ACTING BRONCHODILATOR \nY \nN \n-PT4H \nThe administration of albuterol as part of the reversibility procedure is represented in the AG domain. The AGSPID value RV1 was used to indicate that this \nadministration was associated with the reversibility test.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2307, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cb583312-cebd-45ae-989e-aafc91d4d829": {"__data__": {"id_": "cb583312-cebd-45ae-989e-aafc91d4d829", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 96, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c8334b17-fb1a-4ba1-822b-f92b2bd3c5d2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 96, "section": "UNSPECIFIED"}, "hash": "1fd2ca20ef128507811e27286048d5b4358252ae1540a754b0fbb305b64b18c4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "44fa9db8-7cfd-487f-8e12-f88329dfc1a8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 96, "section": "UNSPECIFIED"}, "hash": "2441c2e2bc398750bb15feeb5b58689c175b5f085f8dc060e56f818b45d7e4e0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The CMSPID value RV1 was used to indicate that this question was associated with the reversibility test. \ncm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCMSEQ \nCMSPID \nCMTRT \nCMCAT \nCMPRESP \nCMOCCUR \nCMEVLINT \n1 \nXYZ \nCM \nXYZ-001-001 \n1 \nRV1 \nSHORT-ACTING BRONCHODILATOR \nSHORT-ACTING BRONCHODILATOR \nY \nN \n-PT4H \nThe administration of albuterol as part of the reversibility procedure is represented in the AG domain. The AGSPID value RV1 was used to indicate that this \nadministration was associated with the reversibility test. \nag.xpt \nRow STUDYID DOMAIN USUBJID \nAGSEQ AGSPID AGTRT \nAGPRESP AGOCCUR AGDOSE AGDOSU AGDOSFRM AGDOSFRQ AGROUTE \nVISIT \nAGSTDTC \n1 \nXYZ \nAG \nXYZ-001-\n001 \n1 \nRV1 \nALBUTEROL Y \nY \n2 \nPUFF \nAEROSOL \nONCE \nRESPIRATORY \n(INHALATION) \nVISIT \n2 \n2013-06-\n18T10:05 \nThe sponsor populated REGRPID with RV1 to indicate that these pulmonary function tests were associated with the reversibility test. The spirometer used in the \ntesting is identified in SPDEVID. See the SDTMIG-MD (available at https://www.cdisc.org/standards/foundational/medical-devices-sdtmig/) for information \nabout representing device-related information. \nRow 1: \nShows the results for the pre-bronchodilator FEV1 test performed as part of a reversibility assessment. The timing reference variables RETPT, \nRETPTNUM, REELTM, RETPTREF, and RERFTDTC show that this test was performed 5 minutes before the bronchodilator challenge. \nRow 2: \nShows the results for FEV1 test performed 20 minutes after the bronchodilator challenge. \nRow 3: \nBecause the percentage reversibility was collected on the CRF, it is included in the SDTM dataset.", "mimetype": "text/plain", "start_char_idx": 1786, "end_char_idx": 3407, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79b2a2d2-1bba-41e0-8514-f56a83f47e90": {"__data__": {"id_": "79b2a2d2-1bba-41e0-8514-f56a83f47e90", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 97, "section": "13.99 13.99"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "80f3e14a-d82e-4007-bce5-067537fd8d75", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 97, "section": "13.99 13.99"}, "hash": "48312c8612251a0fafdd29f3845b72be8603e7822b1c20cab2291903a4cdd944", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nVISIT \n2 \n2013-06-\n18T10:00 \n \n \n \nBRONCHODILATOR \nADMINISTRATION \n2013-06-\n18T10:05 \nThe identifier for the device used in the test was established in the Device Identifier (DI) domain. \ndi.xpt \nRow \nSTUDYID DOMAIN SPDEVID DISEQ DIPARMCD DIPARM \nDIVAL \n1 \nXYZ \nDI \nABC001 \n1 \nTYPE \nDevice Type SPIROMETER \nThe relationship of the test agent to the spirometry measurements obtained before and after its administration and to the prior occurrence of short acting bronchodilator administration is recorded by means of a \nrelationship in RELREC. \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nXYZ \nAG \nXYZ-001-001 \nAGSPID \nRV1 \n \n1 \n2 \nXYZ \nRE \nXYZ-001-001 \nREGRPID \nRV1 \n \n1 \n3 \nXYZ \nCM \nXYZ-001-001 \nCMSPID \nRV1 \n \n1", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 752, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "57280cd2-aa43-4f9f-a6dc-199e07687f85": {"__data__": {"id_": "57280cd2-aa43-4f9f-a6dc-199e07687f85", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 98, "section": "6.1.2 Concomitant/Prior Medications (CM)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4c8c58fb-249f-4fd6-8e2b-dc06481d3b5d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 98, "section": "6.1.2 Concomitant/Prior Medications (CM)"}, "hash": "450178f2da99d9fa484ee4b52a25984faa83477bae5ad9e8210441aa4e6b0d26", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3c810dde-7f05-46e9-bb94-cf9029d55007", "node_type": "1", "metadata": {}, "hash": "45a710c7b229b701f0e7b3862b47b69d115ac99da5f49573fc8e666f98cd9a83", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CM \u2013 Description/Overview \nAn interventions domain that contains concomitant and prior medications used by the subject, such as those given on an as needed basis or condition-appropriate \nmedications. \nCM \u2013 Specification \ncm.xpt, Concomitant/Prior Medications \u2014 Interventions. One record per recorded intervention occurrence or constant-dosing interval \nper subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar CM \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nCMSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of subject records within a domain. May be any valid number. \nReq \nCMGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nCMSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. Example: a number preprinted on the CRF as an explicit line identifier \nor record identifier defined in the sponsor's operational database. Example: line number on a concomitant \nmedication page. \nPerm \nCMTRT \nReported Name of \nDrug, Med, or \nTherapy \nChar  \nTopic \nVerbatim medication name that is either preprinted or collected on a CRF. \nReq \nCMMODIFY \nModified Reported \nName \nChar  \nSynonym \nQualifier \nIf CMTRT is modified to facilitate coding, then CMMODIFY will contain the modified text. \nPerm \nCMDECOD \nStandardized \nMedication Name \nChar  \nSynonym \nQualifier \nStandardized or dictionary-derived text description of CMTRT or CMMODIFY. Equivalent to the generic \ndrug name in WHO Drug. The sponsor is expected to provide the dictionary name and version used to map \nthe terms utilizing the external codelist element in the Define-XML document. If an intervention term does \nnot have a decode value in the dictionary, then CMDECOD will be left blank. \nPerm \nCMCAT \nCategory for \nMedication \nChar  \nGrouping \nQualifier \nUsed to define a category of medications/treatment. Examples: \"PRIOR\", \"CONCOMITANT\", \"ANTI-\nCANCER MEDICATION\", \"GENERAL CONMED\". \nPerm \nCMSCAT \nSubcategory for \nMedication \nChar  \nGrouping \nQualifier \nA further categorization of medications/treatment. Examples: \"CHEMOTHERAPY\", \"HORMONAL \nTHERAPY\", \"ALTERNATIVE THERAPY\". \nPerm \nCMPRESP \nCM Pre-specified \nChar (NY) \nVariable \nQualifier \nUsed to indicate whether (\"Y\"/null) information about the use of a specific medication was solicited on the \nCRF. \nPerm \nCMOCCUR \nCM Occurrence \nChar (NY) \nRecord \nQualifier \nWhen the use of a specific medication is solicited. CMOCCUR is used to indicate whether (\"Y\"/\"N\") use of \nthe medication occurred. Values are null for medications not specifically solicited.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2999, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3c810dde-7f05-46e9-bb94-cf9029d55007": {"__data__": {"id_": "3c810dde-7f05-46e9-bb94-cf9029d55007", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 98, "section": "6.1.2 Concomitant/Prior Medications (CM)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4c8c58fb-249f-4fd6-8e2b-dc06481d3b5d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 98, "section": "6.1.2 Concomitant/Prior Medications (CM)"}, "hash": "450178f2da99d9fa484ee4b52a25984faa83477bae5ad9e8210441aa4e6b0d26", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "57280cd2-aa43-4f9f-a6dc-199e07687f85", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 98, "section": "6.1.2 Concomitant/Prior Medications (CM)"}, "hash": "aaa140dc4ce8b749969ac55759d2907d56cc1b1dd45bae0436fc8bb934918f04", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"PRIOR\", \"CONCOMITANT\", \"ANTI-\nCANCER MEDICATION\", \"GENERAL CONMED\". \nPerm \nCMSCAT \nSubcategory for \nMedication \nChar  \nGrouping \nQualifier \nA further categorization of medications/treatment. Examples: \"CHEMOTHERAPY\", \"HORMONAL \nTHERAPY\", \"ALTERNATIVE THERAPY\". \nPerm \nCMPRESP \nCM Pre-specified \nChar (NY) \nVariable \nQualifier \nUsed to indicate whether (\"Y\"/null) information about the use of a specific medication was solicited on the \nCRF. \nPerm \nCMOCCUR \nCM Occurrence \nChar (NY) \nRecord \nQualifier \nWhen the use of a specific medication is solicited. CMOCCUR is used to indicate whether (\"Y\"/\"N\") use of \nthe medication occurred. Values are null for medications not specifically solicited. \nPerm \nCMSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question about the occurrence of a prespecified intervention was not answered. \nShould be null or have a value of \"NOT DONE\". \nPerm \nCMREASND \nReason Medication \nNot Collected \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with CMSTAT when value is \"NOT DONE\". \nPerm \nCMINDC \nIndication \nChar  \nRecord \nQualifier \nDenotes why a medication was taken or administered. Examples: \"NAUSEA\", \"HYPERTENSION\". \nPerm \nCMCLAS \nMedication Class \nChar  \nVariable \nQualifier \nDrug class. May be obtained from coding. When coding to a single class, populate with class value. If using \na dictionary and coding to multiple classes, then follow Section 4.2.8.3, Multiple Values for a Non-result \nQualifier Variable, or omit CMCLAS. \nPerm", "mimetype": "text/plain", "start_char_idx": 2296, "end_char_idx": 3826, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5a22ecd-71b4-431b-a671-dd60be6ff602": {"__data__": {"id_": "b5a22ecd-71b4-431b-a671-dd60be6ff602", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 99, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d79d0dff-436d-4679-ab1c-cf1acd850ba7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 99, "section": "UNSPECIFIED"}, "hash": "330b48e5c205c476893b463042d0a35450b1cdee755d324f4cedde1ecad5f46a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af802285-8e90-4bc9-8ecb-443b471cc9a5", "node_type": "1", "metadata": {}, "hash": "a1110272d73957f29d6d942d98a408250aefc013c719a46168ba810de458bc5f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 99 \n2021-11-29 \nCMCLASCD \nMedication Class \nCode \nChar  \nVariable \nQualifier \nClass code corresponding to CMCLAS. Drug class. May be obtained from coding. When coding to a single \nclass, populate with class code. If using a dictionary and coding to multiple classes, then follow Section \n4.2.8.3, Multiple Values for a Non-result Qualifier Variable, or omit CMCLASCD. \nPerm \nCMDOSE \nDose per \nAdministration \nNum  \nRecord \nQualifier \nAmount of CMTRT given. Not populated when CMDOSTXT is populated. \nPerm \nCMDOSTXT \nDose Description \nChar  \nRecord \nQualifier \nDosing amounts or a range of dosing information collected in text form. Units may be stored in CMDOSU. \nExamples: \"200-400\", \"15-20\". Not populated when CMDOSE is populated. \nPerm \nCMDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for CMDOSE, CMDOSTOT, or CMDOSTXT. Examples: \"ng\", \"mg\", \"mg/kg\". \nPerm \nCMDOSFRM \nDose Form \nChar (FRM) \nVariable \nQualifier \nDose form for CMTRT. Examples: \"TABLET\", \"LOTION\". \nPerm \nCMDOSFRQ \nDosing Frequency \nper Interval \nChar (FREQ) \nRecord \nQualifier \nUsually expressed as the number of repeated administrations of CMDOSE within a specific time period. \nExamples: \"BID\" (twice daily), \"Q12H\" (every 12 hours). \nPerm \nCMDOSTOT \nTotal Daily Dose \nNum  \nRecord \nQualifier \nTotal daily dose of CMTRT using the units in CMDOSU. Used when dosing is collected as total daily dose. \nTotal dose over a period other than day could be recorded in a separate supplemental qualifier variable. \nPerm \nCMDOSRGM Intended Dose \nRegimen \nChar  \nRecord \nQualifier \nText description of the (intended) schedule or regimen for the Intervention. Example: \"TWO WEEKS ON, \nTWO WEEKS OFF\". \nPerm \nCMROUTE \nRoute of \nAdministration \nChar (ROUTE) \nVariable \nQualifier \nRoute of administration for the intervention. Examples: \"ORAL\", \"INTRAVENOUS\". \nPerm \nCMADJ \nReason for Dose \nAdjustment \nChar  \nRecord \nQualifier \nDescribes reason or explanation of why a dose is adjusted. Examples: \"ADVERSE EVENT\", \n\"INSUFFICIENT RESPONSE\", \"NON-MEDICAL REASON\". \nPerm \nCMRSDISC \nReason the \nIntervention Was \nDiscontinued \nChar  \nRecord \nQualifier \nWhen dosing of a treatment is recorded over multiple successive records, this variable is applicable only for \nthe (chronologically) last record for the treatment. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the medication \nadministration started. Null for medications that started before study participation. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the medication administration. Null for medications that started \nbefore study participation.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2903, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af802285-8e90-4bc9-8ecb-443b471cc9a5": {"__data__": {"id_": "af802285-8e90-4bc9-8ecb-443b471cc9a5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 99, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d79d0dff-436d-4679-ab1c-cf1acd850ba7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 99, "section": "UNSPECIFIED"}, "hash": "330b48e5c205c476893b463042d0a35450b1cdee755d324f4cedde1ecad5f46a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b5a22ecd-71b4-431b-a671-dd60be6ff602", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 99, "section": "UNSPECIFIED"}, "hash": "561eaa6bc646ca88c96cf4f89117ada65fad4dd9a7d85ad89739c047a94552ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"ADVERSE EVENT\", \n\"INSUFFICIENT RESPONSE\", \"NON-MEDICAL REASON\". \nPerm \nCMRSDISC \nReason the \nIntervention Was \nDiscontinued \nChar  \nRecord \nQualifier \nWhen dosing of a treatment is recorded over multiple successive records, this variable is applicable only for \nthe (chronologically) last record for the treatment. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the medication \nadministration started. Null for medications that started before study participation. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the medication administration. Null for medications that started \nbefore study participation. \nPerm \nCMSTDTC \nStart Date/Time of \nMedication \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nStart date/time of the medication administration represented in ISO 8601 character format. \nPerm \nCMENDTC \nEnd Date/Time of \nMedication \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nEnd date/time of the medication administration represented in ISO 8601 character format. \nPerm \nCMSTDY \nStudy Day of Start \nof Medication \nNum  \nTiming \nStudy day of start of medication relative to the sponsor-defined RFSTDTC. \nPerm \nCMENDY \nStudy Day of End of \nMedication \nNum  \nTiming \nStudy day of end of medication relative to the sponsor-defined RFSTDTC. \nPerm \nCMDUR \nDuration \nChar ISO 8601 \nduration \nTiming \nCollected duration for a treatment episode. Used only if collected on the CRF and not derived from start and \nend date/times. \nPerm \nCMSTRF \nStart Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the start of the medication relative to sponsor-defined reference period. The sponsor-defined \nreference period is a continuous period of time defined by a discrete starting point and a discrete ending \npoint (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\" was \ncollected, this information may be translated into CMSTRF. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nCMENRF \nEnd Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the end of the medication relative to the sponsor-defined reference period. The sponsor-defined \nreference period is a continuous period of time defined by a discrete starting point and a discrete ending \npoint (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\", \n\"ONGOING, or \"CONTINUING\" was collected, this information may be translated into CMENRF. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm", "mimetype": "text/plain", "start_char_idx": 2135, "end_char_idx": 4881, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "82aacd6d-89d9-4099-8b30-51b4aee75422": {"__data__": {"id_": "82aacd6d-89d9-4099-8b30-51b4aee75422", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 100, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b05bec41-f59d-401f-8e8d-3b4cb88e40c5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 100, "section": "UNSPECIFIED"}, "hash": "c4d73d9d7f78dfbcbd71823b23c3c4850c800860fc521a36ada32577a13a000d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d87b03dd-f423-45ca-a00b-f80dbe2ed906", "node_type": "1", "metadata": {}, "hash": "3681e5c77bc5ae8077e4df8298297418912974d27658aa7b4a4ae2079a52c548", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 100 \n2021-11-29 \nCMSTRTPT \nStart Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the start of the medication as being before or after the sponsor-defined reference time point \ndefined by variable CMSTTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nCMSTTPT \nStart Reference \nTime Point \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the sponsor-defined reference point referred to by \nCMSTRTPT. Examples: \"2003-12-15\", \"VISIT 1\". \nPerm \nCMENRTPT \nEnd Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the end of the medication as being before or after the sponsor-defined reference time point \ndefined by variable CMENTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nCMENTPT \nEnd Reference \nTime Point \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the sponsor-defined reference point referred to by \nCMENRTPT. Examples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n \nCM \u2013 Assumptions \n1. The structure of the CM domain is 1 record per medication intervention episode, constant-dosing interval, or prespecified medication assessment per \nsubject. It is the sponsor's responsibility to define an intervention episode. This definition may vary based on the sponsor's requirements for review and \nanalysis. The submission dataset structure may differ from the structure used for collection. One common approach is to submit a new record when there \nis a change in the dosing regimen. Another approach is to collapse all records for a medication to a summary level with either a dose range or the highest \ndose level. Other approaches may also be reasonable as long as they meet the sponsor's evaluation requirements. \n2. CM description and coding \na. \nCMTRT is the topic variable and captures the name of the concomitant medication/therapy or the prespecified term used to collect information \nabout the occurrence of any of a group of medications and/or therapies. It is a required variable and must have a value. CMTRT only includes the \nmedication/therapy name and does not include dosage, formulation, or other qualifying information. For example, \u201cASPIRIN 100MG TABLET\u201d is \nnot a valid value for CMTRT. This example should be expressed as CMTRT= \u201cASPIRIN\u201d, CMDOSE= \u201c100\u201d, CMDOSU= \u201cMG\u201d, and \nCMDOSFRM= \u201cTABLET\u201d. When referring to a prespecified group of medications/therapies, CMTRT contains the description of the group used to \nsolicit the occurrence response. \nb. CMMODIFY should be included if the sponsor\u2019s procedure permits modification of a verbatim term for coding. \nc. \nCMDECOD is the standardized medication/therapy term derived by the sponsor from the coding dictionary.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3165, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d87b03dd-f423-45ca-a00b-f80dbe2ed906": {"__data__": {"id_": "d87b03dd-f423-45ca-a00b-f80dbe2ed906", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 100, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b05bec41-f59d-401f-8e8d-3b4cb88e40c5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 100, "section": "UNSPECIFIED"}, "hash": "c4d73d9d7f78dfbcbd71823b23c3c4850c800860fc521a36ada32577a13a000d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "82aacd6d-89d9-4099-8b30-51b4aee75422", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 100, "section": "UNSPECIFIED"}, "hash": "2a42096834e1f58d1fb70d71d6637030634b8a4952ae8f90798753bb793283b9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It is a required variable and must have a value. CMTRT only includes the \nmedication/therapy name and does not include dosage, formulation, or other qualifying information. For example, \u201cASPIRIN 100MG TABLET\u201d is \nnot a valid value for CMTRT. This example should be expressed as CMTRT= \u201cASPIRIN\u201d, CMDOSE= \u201c100\u201d, CMDOSU= \u201cMG\u201d, and \nCMDOSFRM= \u201cTABLET\u201d. When referring to a prespecified group of medications/therapies, CMTRT contains the description of the group used to \nsolicit the occurrence response. \nb. CMMODIFY should be included if the sponsor\u2019s procedure permits modification of a verbatim term for coding. \nc. \nCMDECOD is the standardized medication/therapy term derived by the sponsor from the coding dictionary. It is expected that the reported term \n(CMTRT) or the modified term (CMMODIFY) will be coded using a standard dictionary. The sponsor is expected to provide the dictionary name \nand version used to map the terms utilizing the external codelist element in the Define-XML document. \nd. When CMDECOD values from the WHODrug Dictionary are longer than 200 characters, split the values at semicolons rather than spaces when \nimplementing guidance in Section 4.5.3.2, Text Strings Greater than 200 Characters. \n3. Prespecified terms; presence or absence of concomitant medications \na. \nInformation on concomitant medications is generally collected in 2 different ways, either by recording free text or using a prespecified list of terms. \nBecause the solicitation of information on specific concomitant medications may affect the frequency at which they are reported, the fact that a \nspecific medication was solicited may be of interest to reviewers. CMPRESP and CMOCCUR are used together to indicate whether the intervention \nin CMTRT was prespecified and whether it occurred, respectively.", "mimetype": "text/plain", "start_char_idx": 2446, "end_char_idx": 4252, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1a6842c6-daaa-4cda-b17b-45b342f92889": {"__data__": {"id_": "1a6842c6-daaa-4cda-b17b-45b342f92889", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 101, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "68cc3412-3d3f-426b-bcf7-76c0e52f4033", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 101, "section": "UNSPECIFIED"}, "hash": "f642849e702b8ff8d5943498fd194874ec37704d5275c19c4067d93b79fc61c7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e3bd06c5-80fc-48cc-923e-663643301926", "node_type": "1", "metadata": {}, "hash": "f54f997726906a55c65781e73b735863fb803ad7bfdcc3c891888b0e2a7e4663", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 101 \n2021-11-29 \nb. CMOCCUR is used to indicate whether a prespecified medication was used. A value of \"Y\" indicates that the medication was used and \"N\" \nindicates that it was not. \nc. \nIf a medication was not prespecified, the value of CMOCCUR should be null. CMPRESP and CMOCCUR are permissible fields and may be \nomitted from the dataset if all medications were collected as free text. Values of CMOCCUR may also be null for prespecified medications if \nno Y/N response was collected; in such cases, CMSTAT = \"NOT DONE\", and CMREASND could be used to describe the reason the answer \nwas missing. \n4. Variables for timing relative to a time point \na. \nCMSTRTPT, CMSTTPT, CMENRTPT, and CMENTPT may be populated as necessary to indicate when a medication was used relative to \nspecified time points. For example, assume a subject uses birth control medication. The subject has used the same medication for many years and \ncontinues to do so. The date the subject began using the medication (or at least a partial date) would be stored in CMSTDTC. CMENDTC is null \nbecause the end date is unknown/has not yet happened. This fact can be recorded by setting CMENTPT = \"2007-04-30\" (the date the assessment \nwas made) and CMENRTPT = \"ONGOING\". \n5. Although any identifier variables, timing variables, or interventions general observation-class qualifiers may be added to the CM domain, the following \nqualifiers would generally not be used: --MOOD, --LOT. \nCM \u2013 Examples \nExample 1 \nSponsors collect the timing of concomitant medication use with varying specificity, depending on the pattern of use; the type, purpose, and importance of the \nmedication; and the needs of the study. It is often unnecessary to record every unique instance of medication use, since the same information can be conveyed \nwith start and end dates and frequency of use. If appropriate, medications taken as needed (intermittently or sporadically over a time period) may be reported \nwith a start and end date and a frequency of \u201cPRN\u201d. \nThe example below shows 3 subjects who took the same medication on the same day. \nRows 1-6: \nFor subject ABC-0001, each instance of aspirin use was recorded separately, and the frequency in each record is (CMDOSFRQ) is \"ONCE\". \nRows 7-9: \nFor subject ABC-0002, frequency was once a day (\"QD\") in the first and third records (where CMSEQ is \"1\" and \"3\"), but twice a day in the \nsecond record (CMSEQ = \"2\"). \nRow 10: \nRecords for subject ABC-0003 are collapsed into a single entry that spans the relevant time period, with a frequency of \"PRN\". This is shown as an \nexample only, not as a recommendation. This approach assumes that knowing exactly when aspirin was used is not important for evaluating safety \nand efficacy in this study.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e3bd06c5-80fc-48cc-923e-663643301926": {"__data__": {"id_": "e3bd06c5-80fc-48cc-923e-663643301926", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 101, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "68cc3412-3d3f-426b-bcf7-76c0e52f4033", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 101, "section": "UNSPECIFIED"}, "hash": "f642849e702b8ff8d5943498fd194874ec37704d5275c19c4067d93b79fc61c7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a6842c6-daaa-4cda-b17b-45b342f92889", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 101, "section": "UNSPECIFIED"}, "hash": "af9a3739e7d9e4b3b50f4c64fcf4126ad855f4d212a44949de04f953e6c1a0d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The example below shows 3 subjects who took the same medication on the same day. \nRows 1-6: \nFor subject ABC-0001, each instance of aspirin use was recorded separately, and the frequency in each record is (CMDOSFRQ) is \"ONCE\". \nRows 7-9: \nFor subject ABC-0002, frequency was once a day (\"QD\") in the first and third records (where CMSEQ is \"1\" and \"3\"), but twice a day in the \nsecond record (CMSEQ = \"2\"). \nRow 10: \nRecords for subject ABC-0003 are collapsed into a single entry that spans the relevant time period, with a frequency of \"PRN\". This is shown as an \nexample only, not as a recommendation. This approach assumes that knowing exactly when aspirin was used is not important for evaluating safety \nand efficacy in this study. \ncm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCMSEQ \nCMTRT \nCMDOSE \nCMDOSU \nCMDOSFRQ \nCMSTDTC \nCMENDTC \n1 \nABC \nCM \nABC-0001 \n1 \nASPIRIN \n100 \nmg \nONCE \n2004-01-01 \n2004-01-01 \n2 \nABC \nCM \nABC-0001 \n2 \nASPIRIN \n100 \nmg \nONCE \n2004-01-02 \n2004-01-02 \n3 \nABC \nCM \nABC-0001 \n3 \nASPIRIN \n100 \nmg \nONCE \n2004-01-03 \n2004-01-03 \n4 \nABC \nCM \nABC-0001 \n4 \nASPIRIN \n100 \nmg \nONCE \n2004-01-07 \n2004-01-07 \n5 \nABC \nCM \nABC-0001 \n5 \nASPIRIN \n100 \nmg \nONCE \n2004-01-07 \n2004-01-07 \n6 \nABC \nCM \nABC-0001 \n6 \nASPIRIN \n100 \nmg \nONCE \n2004-01-09 \n2004-01-09 \n7 \nABC \nCM \nABC-0002 \n1 \nASPIRIN \n100 \nmg \nQD \n2004-01-01 \n2004-01-03 \n8 \nABC \nCM \nABC-0002 \n2 \nASPIRIN \n100 \nmg \nBID \n2004-01-07 \n2004-01-07", "mimetype": "text/plain", "start_char_idx": 2190, "end_char_idx": 3604, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0f2d82c6-d394-48b3-86da-ce691e6e52eb": {"__data__": {"id_": "0f2d82c6-d394-48b3-86da-ce691e6e52eb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 102, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0f56290c-df58-47b9-aa54-6d16d79c6be7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 102, "section": "UNSPECIFIED"}, "hash": "c8f6a64158acf724fea9cd3b67746fa07e9f95a6f7da1d85f41417489f964632", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "61cb07fc-2449-4421-b86c-5c98f89f6db6", "node_type": "1", "metadata": {}, "hash": "c6b67301a236c8125e7eb1b82d6ea0680c87353124d2e09d92fc6d38a5ee759c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 102 \n2021-11-29 \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCMSEQ \nCMTRT \nCMDOSE \nCMDOSU \nCMDOSFRQ \nCMSTDTC \nCMENDTC \n9 \nABC \nCM \nABC-0002 \n3 \nASPIRIN \n100 \nmg \nQD \n2004-01-09 \n2004-01-09 \n10 \nABC \nCM \nABC-0003 \n1 \nASPIRIN \n100 \nmg \nPRN \n2004-01-01 \n2004-01-09 \nExample 2 \nIn this example study, it was of particular interest whether subjects use any anticonvulsant medications. The medication history, dosing, and so on was not of \ninterest; the study only asked for the anticonvulsants to which subjects were exposed. \ncm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCMSEQ \nCMTRT \nCMCAT \n1 \nABC123 \nCM \n1 \n1 \nLITHIUM \nANTI-CONVULSANT \n2 \nABC123 \nCM \n2 \n1 \nVPA \nANTI-CONVULSANT \nExample 3 \nSponsors often are interested in whether subjects are exposed to specific concomitant medications, and collect this information using a checklist. This example is \nfor a study that had a particular interest in the antidepressant medications that subjects used. For the study\u2019s purposes, absence is just as important as presence of \na medication. This can be clearly shown using CMOCCUR. \nIn this example, CMPRESP shows that the subjects were specifically asked if they use any of 3 antidepressants (Zoloft, Prozac, and Paxil). The value of \nCMOCCUR indicates the response to the prespecified medication question. CMSTAT indicates whether the response was missing for a prespecified medication, \nand CMREASND shows the reason for missing response. The medication details (e.g., dose, frequency) were not of interest in this study. \nRow 1: \nMedication use was solicited and the medication was taken. \nRow 2: \nMedication use was solicited and the medication was not taken. \nRow 3: \nMedication use was solicited, but data were not collected. The reason for the lack of a response was collected and is represented in CMREASND. \ncm.xpt \nRow STUDYID DOMAIN USUBJID CMSEQ CMTRT \nCMPRESP \nCMOCCUR \nCMSTAT \nCMREASND \n1 \nABC123 \nCM \n1 \n1 \nZOLOFT \nY \nY \n \n \n2 \nABC123 \nCM \n1 \n2 \nPROZAC Y \nN \n \n \n3 \nABC123 \nCM \n1 \n3 \nPAXIL \nY \n \nNOT DONE \nDidn't ask due to interruption \nExample 4 \nIn this hepatitis C study, collection of data on prior treatments included reason for discontinuation. Because hepatitis C is usually treated with a combinations of \nmedications, CMGRPID was used to group records into regimens. \nRows 1-3: \nThis subject's treatment consisted of the 3 medications grouped by means of CMGRPID = \"1\". The subject completed the scheduled treatment. \nRows 4-6: \nAnother subject received the same set of 3 medications.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2664, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "61cb07fc-2449-4421-b86c-5c98f89f6db6": {"__data__": {"id_": "61cb07fc-2449-4421-b86c-5c98f89f6db6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 102, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0f56290c-df58-47b9-aa54-6d16d79c6be7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 102, "section": "UNSPECIFIED"}, "hash": "c8f6a64158acf724fea9cd3b67746fa07e9f95a6f7da1d85f41417489f964632", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0f2d82c6-d394-48b3-86da-ce691e6e52eb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 102, "section": "UNSPECIFIED"}, "hash": "5f11a783e8cac26ef5a8f4fcdbcdc406deeb2be8c23538021fde0c5fa6216292", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Because hepatitis C is usually treated with a combinations of \nmedications, CMGRPID was used to group records into regimens. \nRows 1-3: \nThis subject's treatment consisted of the 3 medications grouped by means of CMGRPID = \"1\". The subject completed the scheduled treatment. \nRows 4-6: \nAnother subject received the same set of 3 medications. The medications for this subject are also grouped using CMGRPID = \"1\". Note, however, \nthat the fact that the same CMGRPID value has been used for the same set of medications for subjects \"ABC123-765\" and \"ABC123-899\" is \ncoincidence; CMGRPID groups records only within a subject. This subject stopped the regimen due to side effects. \ncm.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCMSEQ \nCMGRPID \nCMTRT \nCMCAT \nCMDOSFRM \nCMROUTE \nCMRSDISC \n1 \nABC123 \nCM \nABC123-765 \n1 \n1 \nPEGINTRON \nHCV TREATMENT \nINJECTION \nSUBCUTANEOUS \nCOMPLETED SCHEDULED TREATMENT \n2 \nABC123 \nCM \nABC123-765 \n2 \n1 \nRIBAVIRIN \nHCV TREATMENT \nTABLET \nORAL \nCOMPLETED SCHEDULED TREATMENT \n3 \nABC123 \nCM \nABC123-765 \n3 \n1 \nBOCEPREVIR \nHCV TREATMENT \nTABLET \nORAL \nCOMPLETED SCHEDULED TREATMENT", "mimetype": "text/plain", "start_char_idx": 2322, "end_char_idx": 3421, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9d60c064-a6ca-4438-8552-80b74a1ebcb5": {"__data__": {"id_": "9d60c064-a6ca-4438-8552-80b74a1ebcb5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 103, "section": "6.1.3 Exposure Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "54d61ee5-a1e1-469e-8778-122a82f431ca", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 103, "section": "6.1.3 Exposure Domains"}, "hash": "5030d2cc8c681a7603790f887558c07937ac150cceaf15ba3526b71dac40d64a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Clinical trial study designs can range from open label (where subjects and investigators know which product each subject is receiving) to blinded (where the \nsubject, investigator, or anyone assessing the outcome is unaware of the treatment assignment(s) to reduce potential for bias). To support standardization of \nvarious collection methods and details, as well as process differences between open-label and blinded studies, 2 SDTM domains based on the Interventions \nGeneral Observation Class are available to represent details of subject exposure to protocol-specified study treatment(s): Exposure (EX) and Exposure as \nCollected (EC).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 640, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eef859e3-99e3-4c1a-98f0-26badf4a22e3": {"__data__": {"id_": "eef859e3-99e3-4c1a-98f0-26badf4a22e3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 104, "section": "6.1.3.1 Exposure (EX)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f4281936-1faa-44ff-b84f-3748f479f753", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 104, "section": "6.1.3.1 Exposure (EX)"}, "hash": "3efb2ed00c4eb617e5fe7e6016b748ee399bf3a40ee7b217eaec4494cbfdb675", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "db3506cd-f2a4-400f-a5ea-d6b9149b05ee", "node_type": "1", "metadata": {}, "hash": "d623294f0e621ac18c19e9de16d01b13d81b3cf009e09ae9983e8aea20ccbba7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "EX \u2013 Description/Overview \nAn interventions domain that contains the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is \nprospectively defined as a test material within a study, and is typically but not always supplied to the subject. \nEX \u2013 Specification \nex.xpt, Exposure \u2014 Interventions. One record per protocol-specified study treatment, constant-dosing interval, per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar EX \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nEXSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nEXGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nEXREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier (e.g., kit number, bottle label, vial identifier). \nPerm \nEXSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Example: Line number on a CRF page. \nPerm \nEXLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. \nPerm \nEXLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related, grouped records across domains. \nPerm \nEXTRT \nName of Treatment \nChar * \nTopic \nName of the protocol-specified study treatment given during the dosing period for the observation. \nReq \nEXCAT \nCategory of Treatment Char * \nGrouping \nQualifier \nUsed to define a category of EXTRT values. \nPerm \nEXSCAT \nSubcategory of \nTreatment \nChar * \nGrouping \nQualifier \nA further categorization of EXCAT values. \nPerm \nEXDOSE \nDose \nNum  \nRecord \nQualifier \nAmount of EXTRT when numeric. Not populated when EXDOSTXT is populated. \nExp \nEXDOSTXT \nDose Description \nChar  \nRecord \nQualifier \nAmount of EXTRT when non-numeric. Dosing amounts or a range of dosing information collected in text \nform. Example: \"200-400\". Not populated when EXDOSE is populated. \nPerm \nEXDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for EXDOSE, EXDOSTOT, or EXDOSTXT representing protocol-specified values. Examples: \n\"ng\", \"mg\", \"mg/kg\", \"mg/m2\". \nExp \nEXDOSFRM \nDose Form \nChar (FRM) \nVariable \nQualifier \nDose form for EXTRT. Examples: \"TABLET\", \"LOTION\". \nExp \nEXDOSFRQ \nDosing Frequency per \nInterval \nChar (FREQ) \nRecord \nQualifier \nUsually expressed as the number of repeated administrations of EXDOSE within a specific time period. \nExamples: \"Q2H\", \"QD\", \"BID\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3015, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "db3506cd-f2a4-400f-a5ea-d6b9149b05ee": {"__data__": {"id_": "db3506cd-f2a4-400f-a5ea-d6b9149b05ee", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 104, "section": "6.1.3.1 Exposure (EX)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f4281936-1faa-44ff-b84f-3748f479f753", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 104, "section": "6.1.3.1 Exposure (EX)"}, "hash": "3efb2ed00c4eb617e5fe7e6016b748ee399bf3a40ee7b217eaec4494cbfdb675", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eef859e3-99e3-4c1a-98f0-26badf4a22e3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 104, "section": "6.1.3.1 Exposure (EX)"}, "hash": "1877bef6e499a4197510bc0f60a7db56eecc3ff8df06ee9de739f7e638609947", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dosing amounts or a range of dosing information collected in text \nform. Example: \"200-400\". Not populated when EXDOSE is populated. \nPerm \nEXDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for EXDOSE, EXDOSTOT, or EXDOSTXT representing protocol-specified values. Examples: \n\"ng\", \"mg\", \"mg/kg\", \"mg/m2\". \nExp \nEXDOSFRM \nDose Form \nChar (FRM) \nVariable \nQualifier \nDose form for EXTRT. Examples: \"TABLET\", \"LOTION\". \nExp \nEXDOSFRQ \nDosing Frequency per \nInterval \nChar (FREQ) \nRecord \nQualifier \nUsually expressed as the number of repeated administrations of EXDOSE within a specific time period. \nExamples: \"Q2H\", \"QD\", \"BID\". \nPerm \nEXDOSRGM Intended Dose \nRegimen \nChar  \nRecord \nQualifier \nText description of the intended schedule or regimen for the Intervention. Example: \"TWO WEEKS ON, \nTWO WEEKS OFF\". \nPerm \nEXROUTE \nRoute of \nAdministration \nChar (ROUTE) \nVariable \nQualifier \nRoute of administration for the intervention. Examples: \"ORAL\", \"INTRAVENOUS\". \nPerm \nEXLOT \nLot Number \nChar  \nRecord \nQualifier \nLot number of the intervention product. \nPerm \nEXLOC \nLocation of Dose \nAdministration \nChar (LOC) \nRecord \nQualifier \nSpecifies location of administration. Examples: \"ARM\", \"LIP\". \nPerm \nEXLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location further detailing laterality of the intervention administration. Examples: \n\"LEFT\", \"RIGHT\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2378, "end_char_idx": 3778, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16642a76-ea58-4d42-8ee0-0c3dec63fa79": {"__data__": {"id_": "16642a76-ea58-4d42-8ee0-0c3dec63fa79", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 105, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "738c000c-3b99-4a92-ade6-bc365a8004bd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 105, "section": "UNSPECIFIED"}, "hash": "78cebb273bd4a677e77712dae8fadb797713d6c2f496f01e770f4294d137183d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a6ae6ef-e362-4643-8e86-7dda45b3d82f", "node_type": "1", "metadata": {}, "hash": "6ac68e67d5ac8c746b0d5bea6a97c25e215522420e35c532da4dbf10335de911", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 105 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nEXDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location further detailing directionality. Examples: \"ANTERIOR\", \"LOWER\", \n\"PROXIMAL\", \"UPPER\". \nPerm \nEXFAST \nFasting Status \nChar (NY) \nRecord \nQualifier \nIndicator used to identify fasting status. Examples: \"Y\", \"N\". \nPerm \nEXADJ \nReason for Dose \nAdjustment \nChar * \nRecord \nQualifier \nDescribes reason or explanation of why a dose is adjusted. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nTrial epoch of the exposure record. Examples: \"RUN-IN\", \"TREATMENT\". \nPerm \nEXSTDTC \nStart Date/Time of \nTreatment \nChar ISO 8601 datetime \nor interval \nTiming \nThe date/time when administration of the treatment indicated by EXTRT and EXDOSE began. \nExp \nEXENDTC \nEnd Date/Time of \nTreatment \nChar ISO 8601 datetime \nor interval \nTiming \nThe date/time when administration of the treatment indicated by EXTRT and EXDOSE ended. For \nadministrations considered given at a point in time (e.g., oral tablet, pre-filled syringe injection), where \nonly an administration date/time is collected, EXSTDTC should be copied to EXENDTC as the standard \nrepresentation. \nExp \nEXSTDY \nStudy Day of Start of \nTreatment \nNum  \nTiming \nStudy day of EXSTDTC relative to DM.RFSTDTC. \nPerm \nEXENDY \nStudy Day of End of \nTreatment \nNum  \nTiming \nStudy day of EXENDTC relative to DM.RFSTDTC. \nPerm \nEXDUR \nDuration of Treatment Char ISO 8601 duration \nTiming \nCollected duration of administration. Used only if collected on the CRF and not derived from start and \nend date/times. \nPerm \nEXTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when administration should occur. This may be represented as an elapsed time \nrelative to a fixed reference point, such as time of last dose. See EXTPTNUM and EXTPTREF. \nPerm \nEXTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of EXTPT to aid in sorting. \nPerm \nEXELTM \nPlanned Elapsed \nTime from Time Point \nRef \nChar ISO 8601 duration \nTiming \nPlanned elapsed time relative to the planned fixed reference (EXTPTREF). This variable is useful where \nthere are repetitive measures. Not a clock time. \nPerm \nEXTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by EXELTM, EXTPTNUM, and EXTPT. Examples: \nPREVIOUS DOSE, PREVIOUS MEAL. \nPerm \nEXRFTDTC \nDate/Time of \nReference Time Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point defined by EXTPTREF.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2897, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8a6ae6ef-e362-4643-8e86-7dda45b3d82f": {"__data__": {"id_": "8a6ae6ef-e362-4643-8e86-7dda45b3d82f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 105, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "738c000c-3b99-4a92-ade6-bc365a8004bd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 105, "section": "UNSPECIFIED"}, "hash": "78cebb273bd4a677e77712dae8fadb797713d6c2f496f01e770f4294d137183d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16642a76-ea58-4d42-8ee0-0c3dec63fa79", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 105, "section": "UNSPECIFIED"}, "hash": "0420104b895520637f4665fea620d319135c889f6c304ae5bd6e7e40eb99c9eb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "See EXTPTNUM and EXTPTREF. \nPerm \nEXTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of EXTPT to aid in sorting. \nPerm \nEXELTM \nPlanned Elapsed \nTime from Time Point \nRef \nChar ISO 8601 duration \nTiming \nPlanned elapsed time relative to the planned fixed reference (EXTPTREF). This variable is useful where \nthere are repetitive measures. Not a clock time. \nPerm \nEXTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by EXELTM, EXTPTNUM, and EXTPT. Examples: \nPREVIOUS DOSE, PREVIOUS MEAL. \nPerm \nEXRFTDTC \nDate/Time of \nReference Time Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point defined by EXTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nEX \u2013 Assumptions \n1. EX structure and use \na. \nExamples of treatments represented in the EX domain include but are not limited to placebo, active comparators, and investigational products. \nTreatments that are not protocol-specified should be represented in the Concomitant/Prior Medications (CM) or another Interventions domain as \nappropriate. \nb. The EX domain is recognized in most cases as a derived dataset where EXDOSU reflects the protocol-specified unit per study treatment. Collected \ndata points (e.g., number of tablets, total volume infused) along with additional inputs (e.g., randomization file, concentration, dosage strength, \nproduct accountability) are used to derive records in the EX domain.", "mimetype": "text/plain", "start_char_idx": 2187, "end_char_idx": 3776, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d61ce06c-efd3-4dd0-95b3-36add1340209": {"__data__": {"id_": "d61ce06c-efd3-4dd0-95b3-36add1340209", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 106, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "51afbf85-25b8-4372-b629-872f5163f1bf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 106, "section": "UNSPECIFIED"}, "hash": "116ea44af1b562d4c49422921d1821e82dd6bdc348b9f931ed95c2b73bc48849", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3a8e5bd2-4538-4e6a-b20e-df0617af0d96", "node_type": "1", "metadata": {}, "hash": "f50d8ca3240acc87e404ea8c8cec679c287071c07999a53db87462af3cce5a9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 106 \n2021-11-29 \nc. \nThe EX domain is required for all studies that include protocol-specified study treatment. Exposure records may be directly or indirectly \ndetermined; metadata should describe how the records were derived. Common methods for determining exposure (from most direct to least direct) \ninclude the following: \ni. Derived from actual observation of the administration of drug by the investigator \nii. Derived from automated dispensing device that records administrations \niii. Derived from subject recall \niv. Derived from product accountability data \nv. Derived from the protocol. When a study is still masked and protocol-specified study treatment doses cannot yet be reflected in the protocol-\nspecified unit due to blinding requirements, then the EX domain is not expected to be populated. \nd. The EX domain should contain 1 record per constant-dosing interval per subject. Sponsors define the constant-dosing interval, which may include \nany period of time that can be described in terms of a known treatment given at a consistent dose, frequency, infusion rate, and so on. For example, \nfor a study with once-a-week administration of a standard dose for 6 weeks, exposure may be represented as: \ni. a single record per subject, spanning the entire 6-week treatment phase, if information about each dose is not collected; or \nii. up to 6 records (1 for each weekly administration), if the sponsor monitors each treatment administration. \n2. Exposure treatment description \na. \nEXTRT captures the name of the protocol-specified study treatment and is the topic variable. It is a required variable and must have a value. \nEXTRT must include only the treatment name and must not include dosage, formulation, or other qualifying information. For example, \"ASPIRIN \n100MG TABLET\" is not a valid value for EXTRT. This example should be expressed as EXTRT = \"ASPIRIN\", EXDOSE = \"100\", EXDOSU = \n\"mg\", and EXDOSFRM = \"TABLET\". \nb. Doses of placebo should be represented by EXTRT = \"PLACEBO\" and EXDOSE = \"0\" (indicating 0 mg of active ingredient was taken or \nadministered). \n3. Categorization and grouping \na. \nEXCAT and EXSCAT may be used when appropriate to categorize treatments into categories and subcategories. For example, if a study contains \nseveral active comparator medications, EXCAT may be set to \"ACTIVE COMPARATOR\". Such categorization may not be useful in all studies, so \nthese variables are permissible. \n4. Timing variables \na. \nThe timing of exposure to study treatment is captured by the start/end date and start/end time of each constant-dosing interval. If the subject is only \nexposed to study medication within a clinical encounter (e.g., if an injection is administered at the clinic), VISITNUM may be added to the domain \nas an additional timing variable. VISITDY and VISIT would then also be permissible qualifiers. However, if the beginning and end of a constant-\ndosing interval is not confined within the time limits of a clinical encounter (e.g., if a subject takes pills at home), then it is not appropriate to \ninclude VISITNUM in the EX domain. This is because EX is designed to capture the timing of exposure to treatment, not the timing of dispensing \ntreatment.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3392, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3a8e5bd2-4538-4e6a-b20e-df0617af0d96": {"__data__": {"id_": "3a8e5bd2-4538-4e6a-b20e-df0617af0d96", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 106, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "51afbf85-25b8-4372-b629-872f5163f1bf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 106, "section": "UNSPECIFIED"}, "hash": "116ea44af1b562d4c49422921d1821e82dd6bdc348b9f931ed95c2b73bc48849", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d61ce06c-efd3-4dd0-95b3-36add1340209", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 106, "section": "UNSPECIFIED"}, "hash": "31da7ec9d7f8023cf138d932712afd6a6274acb695241208ca2a71d8ec277a64", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Such categorization may not be useful in all studies, so \nthese variables are permissible. \n4. Timing variables \na. \nThe timing of exposure to study treatment is captured by the start/end date and start/end time of each constant-dosing interval. If the subject is only \nexposed to study medication within a clinical encounter (e.g., if an injection is administered at the clinic), VISITNUM may be added to the domain \nas an additional timing variable. VISITDY and VISIT would then also be permissible qualifiers. However, if the beginning and end of a constant-\ndosing interval is not confined within the time limits of a clinical encounter (e.g., if a subject takes pills at home), then it is not appropriate to \ninclude VISITNUM in the EX domain. This is because EX is designed to capture the timing of exposure to treatment, not the timing of dispensing \ntreatment. Further, VISITNUM should not be used to indicate that treatment began at a particular visit and continued for a period of time. The \nSDTM does not have any provision for recording \"start visit\" and \"end visit\" of exposure.", "mimetype": "text/plain", "start_char_idx": 2524, "end_char_idx": 3615, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fb01c8aa-353a-49b1-949a-c48e49fc8e88": {"__data__": {"id_": "fb01c8aa-353a-49b1-949a-c48e49fc8e88", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 107, "section": "6.1.3.2 Exposure as Collected (EC)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "deed3837-5ab1-4ecf-8dfb-7e8a2600747b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 107, "section": "6.1.3.2 Exposure as Collected (EC)"}, "hash": "0d453c1c5617587aee6eaf0177314ebc00cb42835b57bf19bd3026a256b21097", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "EC \u2013 Description/Overview \nAn interventions domain that contains information about protocol-specified study treatment administrations, as collected. \nEC \u2013 Specification \nec.xpt, Exposure as Collected \u2014 Interventions. One record per protocol-specified study treatment, collected-dosing interval, per \nsubject, per mood, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar EC \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nECSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nECGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nECREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier (e.g., kit number, bottle label, vial identifier). \nPerm \nECSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Example: Line number on a CRF page. \nPerm \nECLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. \nPerm \nECLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related, grouped records across domains. \nPerm \nECTRT \nName of Treatment \nChar * \nTopic \nName of the intervention treatment known to the subject and/or administrator. \nReq \nECMOOD \nMood \nChar (BRDGMOOD) \nRecord \nQualifier \nMode or condition of the record specifying whether the intervention (activity) is intended to happen or \nhas happened. Values align with BRIDG pillars (e.g., scheduled context, performed context) and HL7 \nactivity moods (e.g., intent, event). Examples: \"SCHEDULED\", \"PERFORMED\". \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2135, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "60c03d05-a1b3-4e08-8553-4fd768d4eb57": {"__data__": {"id_": "60c03d05-a1b3-4e08-8553-4fd768d4eb57", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 108, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8bdedb7b-5632-4426-87c7-87f6991f6858", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 108, "section": "UNSPECIFIED"}, "hash": "8bd7bed0cdf660cefbe2361ae00d39174522b538428f76f1422f95e9685cd84c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "558e5df4-f91a-4dc8-91f3-3dda4ec44980", "node_type": "1", "metadata": {}, "hash": "b0d6b8244a40dc89f5402a0cfa4beb96633ff88a53ae30ab8ced3fd6221f7f1b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 108 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nECCAT \nCategory of Treatment Char * \nGrouping \nQualifier \nUsed to define a category of related ECTRT values. \nPerm \nECSCAT \nSubcategory of \nTreatment \nChar * \nGrouping \nQualifier \nA further categorization of ECCAT values. \nPerm \nECPRESP \nPre-Specified \nChar (NY) \nVariable \nQualifier \nUsed when a specific intervention is prespecified. Values should be \"Y\" or null. \nPerm \nECOCCUR \nOccurrence \nChar (NY) \nRecord \nQualifier \nUsed to indicate whether a treatment occurred when information about the occurrence is solicited. \nECOCCUR = \"N\" when a treatment was not taken, not given, or missed. \nPerm \nECREASOC \nReason for Occur \nValue \nChar  \nRecord \nQualifier \nThe reason for the value in --OCCUR. If --OCCUR = \"N\", this is the reason the exposure did not \noccur. \nPerm \nECDOSE \nDose \nNum  \nRecord \nQualifier \nAmount of ECTRT when numeric. Not populated when ECDOSTXT is populated. \nExp \nECDOSTXT \nDose Description \nChar  \nRecord \nQualifier \nAmount of ECTRT when non-numeric. Dosing amounts or a range of dosing information collected in \ntext form. Example: \"200-400\". Not populated when ECDOSE is populated. \nPerm \nECDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for ECDOSE, ECDOSTOT, or ECDOSTXT. \nExp \nECDOSFRM \nDose Form \nChar (FRM) \nVariable \nQualifier \nDose form for ECTRT. Examples: \"TABLET\", \"LOTION\". \nExp \nECDOSFRQ \nDosing Frequency per \nInterval \nChar (FREQ) \nRecord \nQualifier \nUsually expressed as the number of repeated administrations of ECDOSE within a specific time \nperiod. Examples: \"Q2H\", \"QD\", \"BID\". \nPerm \nECDOSTOT \nTotal Daily Dose \nNum  \nRecord \nQualifier \nTotal daily dose of ECTRT using the units in ECDOSU. Used when dosing is collected as total daily \ndose. \nPerm \nECDOSRGM Intended Dose \nRegimen \nChar  \nRecord \nQualifier \nText description of the intended schedule or regimen for the Intervention. Example: \"TWO WEEKS \nON\", \"TWO WEEKS OFF\". \nPerm \nECROUTE \nRoute of \nAdministration \nChar (ROUTE) \nVariable \nQualifier \nRoute of administration for the intervention. Examples: \"ORAL\", \"INTRAVENOUS\". \nPerm \nECLOT \nLot Number \nChar  \nRecord \nQualifier \nLot number of the ECTRT product. \nPerm \nECLOC \nLocation of Dose \nAdministration \nChar (LOC) \nRecord \nQualifier \nSpecifies location of administration. Example: \"ARM\", \"LIP\". \nPerm \nECLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location further detailing laterality of the intervention administration. \nExamples: \"LEFT\", \"RIGHT\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2745, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "558e5df4-f91a-4dc8-91f3-3dda4ec44980": {"__data__": {"id_": "558e5df4-f91a-4dc8-91f3-3dda4ec44980", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 108, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8bdedb7b-5632-4426-87c7-87f6991f6858", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 108, "section": "UNSPECIFIED"}, "hash": "8bd7bed0cdf660cefbe2361ae00d39174522b538428f76f1422f95e9685cd84c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "60c03d05-a1b3-4e08-8553-4fd768d4eb57", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 108, "section": "UNSPECIFIED"}, "hash": "b68fc4413f6c72f2341cae7da76dd5a07b5c20fb025e62c26b8f589b153d2c88", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nECDOSRGM Intended Dose \nRegimen \nChar  \nRecord \nQualifier \nText description of the intended schedule or regimen for the Intervention. Example: \"TWO WEEKS \nON\", \"TWO WEEKS OFF\". \nPerm \nECROUTE \nRoute of \nAdministration \nChar (ROUTE) \nVariable \nQualifier \nRoute of administration for the intervention. Examples: \"ORAL\", \"INTRAVENOUS\". \nPerm \nECLOT \nLot Number \nChar  \nRecord \nQualifier \nLot number of the ECTRT product. \nPerm \nECLOC \nLocation of Dose \nAdministration \nChar (LOC) \nRecord \nQualifier \nSpecifies location of administration. Example: \"ARM\", \"LIP\". \nPerm \nECLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location further detailing laterality of the intervention administration. \nExamples: \"LEFT\", \"RIGHT\". \nPerm \nECDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location further detailing directionality. Examples: \"ANTERIOR\", \"LOWER\", \n\"PROXIMAL\", \"UPPER\". \nPerm \nECPORTOT \nPortion or Totality \nChar (PORTOT) \nVariable \nQualifier \nQualifier for anatomical location further detailing distribution (i.e., arrangement of, apportioning of). \nExamples: \"ENTIRE\", \"SINGLE\", \"SEGMENT\". \nPerm \nECFAST \nFasting Status \nChar (NY) \nRecord \nQualifier \nIndicator used to identify fasting status. Examples: \"Y\", \"N\". \nPerm \nECPSTRG \nPharmaceutical \nStrength \nNum  \nRecord \nQualifier \nAmount of an active ingredient expressed quantitatively per dosage unit, per unit of volume, or per \nunit of weight, according to the pharmaceutical dose form. \nPerm \nECPSTRGU \nPharmaceutical \nStrength Units \nChar (UNIT) \nVariable \nQualifier \nUnit for ECPSTRG. Examples: \"mg/TABLET\", \"mg/mL\". \nPerm \nECADJ \nReason for Dose \nAdjustment \nChar  \nRecord \nQualifier \nDescribes reason or explanation of why a dose is adjusted. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nTrial epoch of the exposure as collected record. Examples: \"RUN-IN\", \"TREATMENT\". \nPerm \nECSTDTC \nStart Date/Time of \nTreatment \nChar ISO 8601 datetime or \ninterval \nTiming \nThe date/time when administration of the treatment indicated by ECTRT and ECDOSE began. \nExp", "mimetype": "text/plain", "start_char_idx": 1996, "end_char_idx": 4208, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "943e7dc7-6b09-40d3-9867-d76c3038b2e4": {"__data__": {"id_": "943e7dc7-6b09-40d3-9867-d76c3038b2e4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 109, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f159d177-63f9-494c-8654-d2311e041997", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 109, "section": "UNSPECIFIED"}, "hash": "f2a35e0782daefc16b9105e00c7404f9d71ddf2b42a0d1fbfc2abd6ae0d08d9a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0f44d399-0620-4cfc-8481-de5b0464f5cc", "node_type": "1", "metadata": {}, "hash": "bc693b9e720a68fa3f7d0ffefcb4b7abd6154373e87b379d1dd1708bbfa9d1dc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 109 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nECENDTC \nEnd Date/Time of \nTreatment \nChar ISO 8601 datetime or \ninterval \nTiming \nThe date/time when administration of the treatment indicated by ECTRT and ECDOSE ended. For \nadministrations considered given at a point in time (e.g., oral tablet, pre-filled syringe injection), \nwhere only an administration date/time is collected, ECSTDTC should be copied to ECENDTC as the \nstandard representation. \nExp \nECSTDY \nStudy Day of Start of \nTreatment \nNum  \nTiming \nStudy day of ECSTDTC relative to the sponsor-defined DM.RFSTDTC. \nPerm \nECENDY \nStudy Day of End of \nTreatment \nNum  \nTiming \nStudy day of ECENDTC relative to the sponsor-defined DM.RFSTDTC. \nPerm \nECDUR \nDuration of Treatment \nChar ISO 8601 duration \nTiming \nCollected duration of administration. Used only if collected on the CRF and not derived from start and \nend date/times. \nPerm \nECTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when administration should occur. This may be represented as an elapsed \ntime relative to a fixed reference point, such as time of last dose. See ECTPTNUM and ECTPTREF. \nPerm \nECTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of ECTPT to aid in sorting. \nPerm \nECELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time relative to the planned fixed reference (ECTPTREF). This variable is useful \nwhere there are repetitive measures. Not a clock time. \nPerm \nECTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by ECELTM, ECTPTNUM, and ECTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nECRFTDTC \nDate/Time of \nReference Time Point \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by ECTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nEC \u2013 Assumptions \n1. The EC domain model reflects protocol-specified study treatment administrations, as collected. \na. \nEC should be used in all cases where collected exposure information cannot or should not be directly represented in the Exposure (EX) domain. For \nexample, administrations collected in tablets when the protocol-specified unit is mg, or administrations collected in mL when the protocol-specified \nunit is mg/kg. Product accountability details (e.g., amount dispensed, amount returned) are represented in the DA domain, not in EC. \nb. Collected exposure data are in most cases represented in a combination of 1 or more of EC, DA, or Findings About Events or Interventions (FA) \ndomains. If the entire EC dataset is an exact duplicate of the entire EX dataset, then EC is optional and at the sponsor's discretion.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3079, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0f44d399-0620-4cfc-8481-de5b0464f5cc": {"__data__": {"id_": "0f44d399-0620-4cfc-8481-de5b0464f5cc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 109, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f159d177-63f9-494c-8654-d2311e041997", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 109, "section": "UNSPECIFIED"}, "hash": "f2a35e0782daefc16b9105e00c7404f9d71ddf2b42a0d1fbfc2abd6ae0d08d9a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "943e7dc7-6b09-40d3-9867-d76c3038b2e4", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 109, "section": "UNSPECIFIED"}, "hash": "f83b586d731ef3520727017fa8ce5396cffe4faaf308cb45bae81d5c9ae70bc6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC/NCI codelist values are enclosed in parentheses. \n  \nEC \u2013 Assumptions \n1. The EC domain model reflects protocol-specified study treatment administrations, as collected. \na. \nEC should be used in all cases where collected exposure information cannot or should not be directly represented in the Exposure (EX) domain. For \nexample, administrations collected in tablets when the protocol-specified unit is mg, or administrations collected in mL when the protocol-specified \nunit is mg/kg. Product accountability details (e.g., amount dispensed, amount returned) are represented in the DA domain, not in EC. \nb. Collected exposure data are in most cases represented in a combination of 1 or more of EC, DA, or Findings About Events or Interventions (FA) \ndomains. If the entire EC dataset is an exact duplicate of the entire EX dataset, then EC is optional and at the sponsor's discretion. \nc. \nCollected exposure log data points descriptive of administrations typically reflect amounts at the product-level (e.g., number of tablets, number of \nmL). \n2. Treatment description (ECTRT) is sponsor-defined and should reflect how the protocol-specified study treatment is known or referred to in data \ncollection. In an open-label study, ECTRT should store the treatment name. In a masked study, if treatment is collected and known as tablet A to the \nsubject or administrator, then ECTRT = \"TABLET A\". If, in a masked study, the treatment is not known by a synonym and the data are to be exchanged \nbetween sponsors, partners, and/or regulatory agency(s), then assign ECTRT the value of \"MASKED\". \n3. ECMOOD is permissible; when implemented, it must be populated for all records. \na. \nValues of ECMOOD, to date include: \ni. \"SCHEDULED\" (for collected subject-level intended dose records) \nii. \"PERFORMED\" (for collected subject-level actual dose records)", "mimetype": "text/plain", "start_char_idx": 2188, "end_char_idx": 4041, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c3b94105-77e6-4f61-9bdd-07dd6054a63d": {"__data__": {"id_": "c3b94105-77e6-4f61-9bdd-07dd6054a63d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 110, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "415cabc4-4fd5-40d0-a1ec-43027e005c5a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 110, "section": "UNSPECIFIED"}, "hash": "1b13d37dbce8d2986e80d8bf39882a5e7af5c0162d8851ddae6307663d1aebd5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a2b13742-b59f-4d94-8efe-9fe299835dc4", "node_type": "1", "metadata": {}, "hash": "285b7486a1b321ea4b7e9f4b91398ae6fe42bc4fed6e3ef9ceea84de920a54ae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 110 \n2021-11-29 \nb. Qualifier variables should be populated with equal granularity across scheduled and performed records when known. For example, if ECDOSU and \nECDOSFRQ are known at scheduling and administration, then the variables would be populated on both records. If ECLOC is determined at the \ntime of administration, then it would be populated on the Performed record only. \nc. \nAppropriate timing variable(s) should be populated. Note: Details on Scheduled records may describe timing at a higher level than Performed \nrecords. \nd. ECOCCUR is generally not applicable for Scheduled records. \ne. \nAn activity may be rescheduled or modified multiple times before being performed. Representation of Scheduled records is dependent on the \ncollected, available data. If each rescheduled or modified activity is collected, then multiple Scheduled records may be represented. If only the final \nscheduled activity is collected, then it would be the only Scheduled record represented. \n4. Doses not taken, not given, or missed \na. \nThe record qualifier --OCCUR, with value of \"N\", is available in domains based on the Interventions and Events General Observation Classes as \nthe standard way to represent whether an intervention or event did not happen. In the EC domain, ECOCCUR value of \"N\" indicates a dose was not \ntaken, not given, or missed. For example, if zero tablets are taken within a timeframe or zero mL is infused at a visit, then ECOCCUR = \"N\" is the \nstandard representation of the collected doses not taken, not given, or missed. Dose amount variables (e.g., ECDOSE, ECDOSTXT) must not be set \nto zero (0) as an alternative method for indicating doses not taken, not given, or missed. \nb. The population of qualifier variables (e.g., grouping, record) and additional timing variables (e.g., date of collection, visit, time point) for records \nrepresenting information collected about doses not taken, not given, or missed should be populated with equal granularity as administered records, \nwhen known and/or applicable. Qualifiers that indicate dose amount (e.g., ECDOSE, ECDOSTXT) may be populated with positive (non-zero) \nvalues in cases where the sponsor feels it is necessary and/or appropriate to represent specific dose amounts not taken, not given, or missed. \nc. \nIf a reason why a dose was not given is collected, it is represented in ECREASOC, the reason why ECOCCUR = \"N\". \n5. Timing variables \na. \nTiming variables in the EC domain should reflect administrations by the intervals they were collected (e.g., constant-dosing intervals, visits, \ntargeted dates like first dose, last dose). \nb. For administrations considered given at a point in time (e.g., oral tablet, pre-filled syringe injection), where only an administration date/time is \ncollected, ECSTDTC should be copied to ECENDTC. \n6. The degree of summarization of records from EC to EX is sponsor-defined to support study purpose and analysis. When the relationship between EC \nand EX records can be described in RELREC, then it should be defined. EX derivations must be described in the Define-XML document. \n7. Additional interventions qualifiers \na.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3323, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a2b13742-b59f-4d94-8efe-9fe299835dc4": {"__data__": {"id_": "a2b13742-b59f-4d94-8efe-9fe299835dc4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 110, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "415cabc4-4fd5-40d0-a1ec-43027e005c5a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 110, "section": "UNSPECIFIED"}, "hash": "1b13d37dbce8d2986e80d8bf39882a5e7af5c0162d8851ddae6307663d1aebd5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c3b94105-77e6-4f61-9bdd-07dd6054a63d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 110, "section": "UNSPECIFIED"}, "hash": "333a2f7953574541aff0836f75c0d9e5d4f71743d59a71b9df966f0e77aa0e7c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "5. Timing variables \na. \nTiming variables in the EC domain should reflect administrations by the intervals they were collected (e.g., constant-dosing intervals, visits, \ntargeted dates like first dose, last dose). \nb. For administrations considered given at a point in time (e.g., oral tablet, pre-filled syringe injection), where only an administration date/time is \ncollected, ECSTDTC should be copied to ECENDTC. \n6. The degree of summarization of records from EC to EX is sponsor-defined to support study purpose and analysis. When the relationship between EC \nand EX records can be described in RELREC, then it should be defined. EX derivations must be described in the Define-XML document. \n7. Additional interventions qualifiers \na. \n--DOSTOT is under evaluation for potential deprecation and replacement with a mechanism to describe total dose over any interval of time (e.g., \nday, week, month). Sponsors considering ECDOSTOT may want to consider using other dose amount variables (ECDOSE or ECDOSTXT) in \ncombination with frequency (ECDOSFRQ) and timing variables to represent the data. \nb.  Any identifier variables, timing variables, or findings general observation-class qualifiers may be added to the EC domain, but the following \nqualifiers would generally not be used:  --STAT and --REASND.", "mimetype": "text/plain", "start_char_idx": 2584, "end_char_idx": 3890, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b298f532-6687-4624-9a32-6dfdf9c05961": {"__data__": {"id_": "b298f532-6687-4624-9a32-6dfdf9c05961", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 111, "section": "6.1.3.3 Exposure/Exposure as Collected Examples"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1715f803-3dc9-4eab-8cb5-c6e2f6717ffc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 111, "section": "6.1.3.3 Exposure/Exposure as Collected Examples"}, "hash": "7c96707b4b9a6cc3e32e026e28ac8de2e54a5b2bfa40f1e494da11b3bd9b3fbc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6fa67bfe-7bc0-46a3-9619-1afcaf29c7eb", "node_type": "1", "metadata": {}, "hash": "c6bf579e66a45f65eb36851fa4e5b1e894a961311c754bb442b6a0d8965e112a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example 1 \nThis is an example of a double-blind study comparing drug X extended release (ER; 2 500-mg tablets once daily) vs. drug Z (2 250-mg tablets once daily). Per \nexample CRFs, subject ABC1001 took 2 tablets from 2011-01-14 to 2011-01-28 and subject ABC2001 took 2 tablets within the same timeframe but missed \ndosing on 2011-01-24. \nExposure CRF: \nSubject: ABC1001 \nBottle Number of Tablets Taken Daily \nReason for Variation \nStart Date \nEnd Date \nA \n2 \n \n2011-01-14 2011-01-28 \nSubject: ABC2001 \nBottle Number of Tablets Taken Daily \nReason for Variation \nStart Date \nEnd Date \nA \n2 \n \n2011-01-14 2011-01-23 \nA \n0 \nPatient mistake \n2011-01-24 2011-01-24 \nA \n2 \n \n2011-01-25 2011-01-28 \nUpon unmasking, it became known that subject ABC1001 received drug X and Subject ABC2001 received drug Z. The EC dataset shows the administrations of \nstudy treatment as collected. \nRows 1-2, 4: Show treatments administered. \nRow 3: \nShows that the zero for Number of Tablets Taken Daily on the CRF was represented as ECOCCUR = \"N\". The reason this treatment did not occur \nis represented in ECREASOC. \nec.xpt \nRow STUDYID DOMAIN USUBJID ECSEQ ECLNKID \nECTRT \nECPRESP ECOCCUR ECREASOC \nECDOSE ECDOSU ECDOSFRQ EPOCH \nECSTDTC \nECENDTC ECSTDY ECENDY \n1 \nABC \nEC \nABC1001 1 \nA2-\n20110114 \nBOTTLE \nA \nY \nY \n \n2 \nTABLET \nQD \nTREATMENT 2011-01-\n14 \n2011-01-\n28 \n1 \n15 \n2 \nABC \nEC \nABC2001 1 \nA2-\n20110114 \nBOTTLE \nA \nY \nY \n \n2 \nTABLET \nQD \nTREATMENT 2011-01-\n14 \n2011-01-\n23 \n1 \n10 \n3 \nABC \nEC \nABC2001 2 \nA0-\n20110124 \nBOTTLE \nA \nY \nN \nPATIENT \nMISTAKE \n \nTABLET \nQD \nTREATMENT 2011-01-\n24 \n2011-01-\n24 \n11 \n11 \n4 \nABC \nEC \nABC2001 3 \nA2-\n20110125 \nBOTTLE \nA \nY \nY \n \n2 \nTABLET \nQD \nTREATMENT 2011-01-\n25 \n2011-01-\n28 \n12 \n15 \nThe EX dataset shows the unmasked administrations. Two tablets from bottle A became 1000 mg of drug X extended release for subject ABC1001, but 500 mg \nof drug Z for subject ABC2001. Note that there is no record in the EX dataset for non-occurrence of study treatment.  The non-occurrence of study drug for \nsubject ABC2001 is reflected in the gap in time between the 2 EX records.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2096, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6fa67bfe-7bc0-46a3-9619-1afcaf29c7eb": {"__data__": {"id_": "6fa67bfe-7bc0-46a3-9619-1afcaf29c7eb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 111, "section": "6.1.3.3 Exposure/Exposure as Collected Examples"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1715f803-3dc9-4eab-8cb5-c6e2f6717ffc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 111, "section": "6.1.3.3 Exposure/Exposure as Collected Examples"}, "hash": "7c96707b4b9a6cc3e32e026e28ac8de2e54a5b2bfa40f1e494da11b3bd9b3fbc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b298f532-6687-4624-9a32-6dfdf9c05961", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 111, "section": "6.1.3.3 Exposure/Exposure as Collected Examples"}, "hash": "837643dfbc149e2308bd58726100f10c52fc1a17c38c543684ce6b70d5f7ebab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Two tablets from bottle A became 1000 mg of drug X extended release for subject ABC1001, but 500 mg \nof drug Z for subject ABC2001. Note that there is no record in the EX dataset for non-occurrence of study treatment.  The non-occurrence of study drug for \nsubject ABC2001 is reflected in the gap in time between the 2 EX records. \nex.xpt \nRow STUDYID DOMAIN USUBJID EXSEQ EXLNKID \nEXTRT \nEXDOSE EXDOSU EXDOSFRM \nEXDOSFRQ EXROUTE EPOCH \nEXSTDTC \nEXENDTC \nEXSTDY EXENDY \n1 \nABC \nEX \nABC1001 1 \nA2-\n20110114 \nDRUG \nX \n1000 \nmg \nTABLET, EXTENDED \nRELEASE \nQD \nORAL \nTREATMENT 2011-01-\n14 \n2011-01-\n28 \n1 \n15 \n2 \nABC \nEX \nABC2001 1 \nA2-\n20110114 \nDRUG \nZ \n500 \nmg \nTABLET \nQD \nORAL \nTREATMENT 2011-01-\n14 \n2011-01-\n23 \n1 \n10 \n3 \nABC \nEX \nABC2001 2 \nA2-\n20110125 \nDRUG \nZ \n500 \nmg \nTABLET \nQD \nORAL \nTREATMENT 2011-01-\n25 \n2011-01-\n28 \n12 \n15", "mimetype": "text/plain", "start_char_idx": 1766, "end_char_idx": 2603, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a8e97bc5-b4a3-462f-b135-d6cd6a66e176": {"__data__": {"id_": "a8e97bc5-b4a3-462f-b135-d6cd6a66e176", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 112, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a0341ccc-be28-40db-b729-b2978a76b542", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 112, "section": "UNSPECIFIED"}, "hash": "a07d1e09893eb21d4b03b0c5200c2ffe88c7f76bb0b0412be533727d47a4348e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cdefad4b-4d92-4846-a3a4-f521644c2df0", "node_type": "1", "metadata": {}, "hash": "a8ed9004096c45173779f3a63b4f48ca0ca6348acb2d57674cd6c16cbabe8356", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 112 \n2021-11-29 \nThe relrec.xpt example reflects a one-to-one dataset-level relationship between EC and EX using --LNKID. \nrelrec.xpt \nRow STUDYID RDOMAIN \nUSUBJID IDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC \nEC \n \nECLNKID  \nONE \n1 \n2 \nABC \nEX \n \nEXLNKID \n \nONE \n1 \nExample 2 \nThis example shows data from an open-label study. A subject received drug X as a 20 mg/mL solution administered across 3 injection sites to deliver a total dose of 3 mg/kg. The subject's weight was 100 kg. \nExposure CRF \nVisit \n3 \nDate \n2009-05-10 \nInjection 1 \n \nVolume Given (mL) 5 \nLocation \nABDOMEN \nSide \nLEFT \nInjection 2 \n \nVolume Given (mL) 5 \nLocation \nABDOMEN \nSide \nCENTER \nInjection 3 \n \nVolume Given (mL) 5 \nLocation \nABDOMEN \nSide \nRIGHT \nThe collected administration amounts, in mL, and their locations are represented in the EC dataset. \nec.xpt \nRow STUDYID DOMAIN USUBJID ECSEQ ECSPID ECLNKID ECTRT \nECPRESP ECOCCUR ECDOSE ECDOSU ECDOSFRM ECDOSFRQ ECROUTE \nECLOC \nECLAT \nVISITNUM VISIT \nEPOCH \nECSTDTC ECENDTC ECSTDY ECENDY \n1 \nABC \nEC \nABC3001 1 \nINJ1 \nV3 \nDRUG \nX \nY \nY \n5 \nmL \nINJECTION \nONCE \nSUBCUTANEOUS ABDOMINAL \nCAVITY \nLEFT \n3 \nVISIT \n3 \nTREATMENT 2009-05-\n10 \n2009-05-\n10 \n21 \n21 \n2 \nABC \nEC \nABC3001 2 \nINJ2 \nV3 \nDRUG \nX \nY \nY \n5 \nmL \nINJECTION \nONCE \nSUBCUTANEOUS ABDOMINAL \nCAVITY \nCENTER 3 \nVISIT \n3 \nTREATMENT 2009-05-\n10 \n2009-05-\n10 \n21 \n21 \n3 \nABC \nEC \nABC3001 3 \nINJ3 \nV3 \nDRUG \nX \nY \nY \n5 \nmL \nINJECTION \nONCE \nSUBCUTANEOUS ABDOMINAL \nCAVITY \nRIGHT \n3 \nVISIT \n3 \nTREATMENT 2009-05-\n10 \n2009-05-\n10 \n21 \n21 \nThe sponsor considered the 3 injections to constitute a single administration, so the EX dataset shows the total dose given in the protocol-specified unit, mg/kg. EXLOC = \"ABDOMEN\" is included because this \nlocation was common to all injections, but EXLAT was not included. If the sponsor had chosen to represent laterality in the EX record, this would have been handled as described in Section 4.2.8.3, Multiple Values \nfor a Non-result Qualifier Variable.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2154, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cdefad4b-4d92-4846-a3a4-f521644c2df0": {"__data__": {"id_": "cdefad4b-4d92-4846-a3a4-f521644c2df0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 112, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a0341ccc-be28-40db-b729-b2978a76b542", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 112, "section": "UNSPECIFIED"}, "hash": "a07d1e09893eb21d4b03b0c5200c2ffe88c7f76bb0b0412be533727d47a4348e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a8e97bc5-b4a3-462f-b135-d6cd6a66e176", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 112, "section": "UNSPECIFIED"}, "hash": "c64ca4b3fb7917c7cbd69ac565b82401a6019e94160623dbd30aa35d5953cba9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "EXLOC = \"ABDOMEN\" is included because this \nlocation was common to all injections, but EXLAT was not included. If the sponsor had chosen to represent laterality in the EX record, this would have been handled as described in Section 4.2.8.3, Multiple Values \nfor a Non-result Qualifier Variable. \nex.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nEXSEQ \nEXSPID \nEXLNKID \nEXTRT \nEXDOSE \nEXDOSU \nEXDOSFRM \nEXDOSFRQ \nEXROUTE \nEXLOC \nVISITNUM \nVISIT \nEPOCH \nEXSTDTC \nEXENDTC \nEXSTDY \nEXENDY \n1 \nABC \nEX \nABC3001 \n1 \n \nV3 \nDRUG X \n3 \nmg/kg \nINJECTION \nONCE \nSUBCUTANEOUS \nABDOMEN \n3 \nVISIT 3 \nTREATMENT \n2009-05-10 \n2009-05-10 \n21 \n21", "mimetype": "text/plain", "start_char_idx": 1860, "end_char_idx": 2477, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "67f95f4f-bac7-471e-bdd1-012b91119233": {"__data__": {"id_": "67f95f4f-bac7-471e-bdd1-012b91119233", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 113, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27faa2c5-9909-4f3b-b969-fa3e07644e06", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 113, "section": "UNSPECIFIED"}, "hash": "74ce487bb087e4dfd4ff1aa066384cbf4446b71862a0766db57057dba4c1ee2a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1456a941-acea-45a6-b048-1bee1a4944d7", "node_type": "1", "metadata": {}, "hash": "09f8986ad8c9caaca083f07bedbe2bbf6a9b8906f1a4a14e26af7071563bf84a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 113 \n2021-11-29 \nThe relrec.xpt example reflects a many-to-one dataset-level relationship between EC and EX using --LNKID. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC \nEC \n \nECLNKID  \nMANY \n1 \n2 \nABC \nEX \n \nEXLNKID  \nONE \n1 \nExample 3 \nThe study in this example was a double-blind study comparing 10, 20, and 30 mg of Drug X once daily vs. placebo. Study treatment was given as 1 tablet each \nfrom bottles A, B, and C taken together once daily. The subject in this example took: \n\u2022 \n1 tablet from bottles A, B and C from 2011-01-14 to 2011-01-20 \n\u2022 \n0 tablets from bottle B on 2011-01-21, then 2 tablets on 2011-01-22 \n\u2022 \n1 tablet from bottles A and C on 2011-01-21 and 2011-01-22 \n\u2022 \n1 tablet from ottles A, B and C from 2011-01-23 to 2011-01-28 \nThe EC dataset shows administrations as collected, in tablets. \nec.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nECSEQ \nECTRT \nECPRESP \nECOCCUR \nECDOSE \nECDOSU \nECDOSFRQ \nEPOCH \nECSTDTC \nECENDTC \nECSTDY \nECENDY \n1 \nABC \nEC \nABC4001 \n1 \nBOTTLE A \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2011-01-14 \n2011-01-28 \n1 \n15 \n2 \nABC \nEC \nABC4001 \n2 \nBOTTLE C \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2011-01-14 \n2011-01-28 \n1 \n15 \n3 \nABC \nEC \nABC4001 \n3 \nBOTTLE B \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2011-01-14 \n2011-01-20 \n1 \n7 \n4 \nABC \nEC \nABC4001 \n4 \nBOTTLE B \nY \nN \n \nTABLET \nQD \nTREATMENT \n2011-01-21 \n2011-01-21 \n8 \n8 \n5 \nABC \nEC \nABC4001 \n5 \nBOTTLE B \nY \nY \n2 \nTABLET \nQD \nTREATMENT \n2011-01-22 \n2011-01-22 \n9 \n9 \n6 \nABC \nEC \nABC4001 \n6 \nBOTTLE B \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2011-01-23 \n2011-01-28 \n10 \n15 \nUpon unmasking, it became known that the subject was randomized to drug X 20 mg and that: \n\u2022 \nBottle A contained 10 mg/tablet \n\u2022 \nBottle B contained 10 mg/tablet \n\u2022 \nBottle C contained placebo (i.e., 0 mg of active ingredient/tablet) \nThe EX dataset shows the doses administered in the protocol-specified unit (mg).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2058, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1456a941-acea-45a6-b048-1bee1a4944d7": {"__data__": {"id_": "1456a941-acea-45a6-b048-1bee1a4944d7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 113, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "27faa2c5-9909-4f3b-b969-fa3e07644e06", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 113, "section": "UNSPECIFIED"}, "hash": "74ce487bb087e4dfd4ff1aa066384cbf4446b71862a0766db57057dba4c1ee2a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "67f95f4f-bac7-471e-bdd1-012b91119233", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 113, "section": "UNSPECIFIED"}, "hash": "9984f9e6166a3552639ce253059e9c2041c8e4172e325515ceadf02420f5f8cf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The sponsor considered an administration to consist of the total amount for \nbottles A, B, and C. The derivation of EX records from multiple EC records should be shown in the Define-XML document. \nex.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nEXSEQ \nEXTRT \nEXDOSE \nEXDOSU \nEXDOSFRM \nEXDOSFRQ \nEXROUTE \nEPOCH \nEXSTDTC \nEXENDTC \nEXSTDY \nEXENDY \n1 \nABC \nEX \nABC4001 \n1 \nDRUG X \n20 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2011-01-14 \n2011-01-20 \n1 \n7 \n2 \nABC \nEX \nABC4001 \n2 \nDRUG X \n10 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2011-01-21 \n2011-01-21 \n8 \n8 \n3 \nABC \nEX \nABC4001 \n3 \nDRUG X \n30 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2011-01-22 \n2011-01-22 \n9 \n9 \n4 \nABC \nEX \nABC4001 \n4 \nDRUG X \n20 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2011-01-23 \n2011-01-28 \n10 \n15", "mimetype": "text/plain", "start_char_idx": 2059, "end_char_idx": 2791, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0425d687-d8b6-48f6-8f11-618c1dcc33e6": {"__data__": {"id_": "0425d687-d8b6-48f6-8f11-618c1dcc33e6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 114, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "719e9f14-ba21-4bd9-9a19-066dc540f630", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 114, "section": "UNSPECIFIED"}, "hash": "8f0669ff5074752dad9b34741a710d526a92a61c18f5b4625594eb80de12f949", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2c06198c-4739-4500-973d-0a423e3f85f1", "node_type": "1", "metadata": {}, "hash": "d1e99a8c672dd136da0ec217ba62063cd9594c1a224346b0ee7047993f6ccd42", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 114 \n2021-11-29 \nExample 4 \nThe study in this example was an open-label study examining the tolerability of different doses of drug A. The study drug was taken orally, daily for 3 months. \nDose adjustments were allowed as needed in response to tolerability or efficacy issues. \nThe EX dataset shows administrations collected in the protocol-specified unit, mg. No EC dataset was needed because the open-label administrations were \ncollected in the protocol-specified unit; EC would be an exact duplicate of the entire EX domain. \nex.xpt \nRow STUDYID DOMAIN USUBJID EXSEQ EXTRT \nEXDOSE EXDOSU EXDOSFRM EXDOSFRQ EXROUTE EXADJ \nEPOCH \nEXSTDTC \nEXENDTC \n1 \n37841 \nEX \n37841001 1 \nDRUG A 20 \nmg \nTABLET \nQD \nORAL \n \nTREATMENT 2002-07-01 2002-10-01 \n2 \n37841 \nEX \n37841002 1 \nDRUG A 20 \nmg \nTABLET \nQD \nORAL \n \nTREATMENT 2002-04-02 2002-04-21 \n3 \n37841 \nEX \n37841002 2 \nDRUG A 15 \nmg \nTABLET \nQD \nORAL \nReduced due to toxicity \nTREATMENT 2002-04-22 2002-07-01 \n4 \n37841 \nEX \n37841003 1 \nDRUG A 20 \nmg \nTABLET \nQD \nORAL \n \nTREATMENT 2002-05-09 2002-06-01 \n5 \n37841 \nEX \n37841003 2 \nDRUG A 25 \nmg \nTABLET \nQD \nORAL \nIncreased due to suboptimal efficacy TREATMENT 2002-06-02 2002-07-01 \n6 \n37841 \nEX \n37841003 3 \nDRUG A 30 \nmg \nTABLET \nQD \nORAL \nIncreased due to suboptimal efficacy TREATMENT 2002-07-02 2002-08-01 \nExample 5 \nThis is an example of a double-blind study design comparing 10 and 20 mg of drug X vs. placebo taken daily, morning and evening, for a week. \nSubject ABC5001 \nBottle Time Point \nNumber of Tablets Taken \nStart Date \nEnd Date \nA \nAM \n1 \n2012-01-01 \n2012-01-08 \nB \nPM \n1 \n2012-01-01 \n2012-01-08 \nSubject ABC5002 \nBottle Time Point \nNumber of Tablets Taken \nStart Date \nEnd Date \nA \nAM \n1 \n2012-02-01 \n2012-02-08 \nB \nPM \n1 \n2012-02-01 \n2012-02-08 \nSubject ABC5003 \nBottle Time Point \nNumber of Tablets Taken \nStart Date \nEnd Date \nA \nAM \n1 \n2012-03-01 \n2012-03-08 \nB \nPM \n1 \n2012-03-01 \n2012-03-08 \nThe EC dataset shows the administrations as collected. The time-point variables ECTPT and ECTPTNUM were used to describe the time of day of \nadministration.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2248, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2c06198c-4739-4500-973d-0a423e3f85f1": {"__data__": {"id_": "2c06198c-4739-4500-973d-0a423e3f85f1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 114, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "719e9f14-ba21-4bd9-9a19-066dc540f630", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 114, "section": "UNSPECIFIED"}, "hash": "8f0669ff5074752dad9b34741a710d526a92a61c18f5b4625594eb80de12f949", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0425d687-d8b6-48f6-8f11-618c1dcc33e6", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 114, "section": "UNSPECIFIED"}, "hash": "632b2c26d15c4aad563cede8952180d96027f2640be03d56e144f2ecafc5cd59", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The time-point variables ECTPT and ECTPTNUM were used to describe the time of day of \nadministration. This use of time-point variables is novel, representing data about multiple time points, 1 on each day of administration, rather than data for a \nsingle time point.", "mimetype": "text/plain", "start_char_idx": 2147, "end_char_idx": 2413, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "881c5ba4-6399-4b73-ad3c-4a3d3ed67464": {"__data__": {"id_": "881c5ba4-6399-4b73-ad3c-4a3d3ed67464", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "55b2c449-4125-43a3-9c00-fc45068338a0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}, "hash": "b0eb4b34d75406bde91cffd203ad01b9370ff9ee97b7867e7426a0dcd3676374", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b387b71b-c3f0-4f15-9e95-26d1f004b933", "node_type": "1", "metadata": {}, "hash": "4583de8f41188a9c09e9242b2021b01e38cffb6a97fa1065d9d2e1b5fe441c0c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 115 \n2021-11-29 \nec.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nECSEQ \nECLNKID \nECTRT \nECPRESP \nECOCCUR \nECDOSE \nECDOSU \nECDOSFRQ \nEPOCH \nECSTDTC \nECENDTC \nECSTDY \nECENDY \nECTPT \nECTPTNUM \n1 \nABC \nEC \nABC5001 \n1 \n20120101-20120108-AM \nBOTTLE A \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2012-01-01 \n2012-01-08 \n1 \n8 \nAM \n1 \n2 \nABC \nEC \nABC5001 \n2 \n20120101-20120108-PM \nBOTTLE B \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2012-01-01 \n2012-01-08 \n1 \n8 \nPM \n2 \n3 \nABC \nEC \nABC5002 \n1 \n20120201-20120208-AM \nBOTTLE A \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2012-02-01 \n2012-02-08 \n1 \n8 \nAM \n1 \n4 \nABC \nEC \nABC5002 \n2 \n20120201-20120208-PM \nBOTTLE B \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2012-02-01 \n2012-02-08 \n1 \n8 \nPM \n2 \n5 \nABC \nEC \nABC5003 \n1 \n20120301-20120308-AM \nBOTTLE A \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2012-03-01 \n2012-03-08 \n1 \n8 \nAM \n1 \n6 \nABC \nEC \nABC5003 \n2 \n20120301-20120308-PM \nBOTTLE B \nY \nY \n1 \nTABLET \nQD \nTREATMENT \n2012-03-01 \n2012-03-08 \n1 \n8 \nPM \n2 \nThe EX dataset shows the unmasked administrations in the protocol specified unit, mg. Amount of placebo was represented as 0 mg. The sponsor chose to represent the administrations at the time-point level. \nRows 1-2: \nShow administrations for a subject who was randomized to the 20 mg drug X arm. \nRows 3-4: \nShow administrations for a subject who was randomized to the 10 mg drug X arm. \nRows 5-6: \nShow administrations for a subject who was randomized to the placebo arm.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1582, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b387b71b-c3f0-4f15-9e95-26d1f004b933": {"__data__": {"id_": "b387b71b-c3f0-4f15-9e95-26d1f004b933", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "55b2c449-4125-43a3-9c00-fc45068338a0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}, "hash": "b0eb4b34d75406bde91cffd203ad01b9370ff9ee97b7867e7426a0dcd3676374", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "881c5ba4-6399-4b73-ad3c-4a3d3ed67464", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}, "hash": "7515ac4ec15ae63aa9f9ad03c7b386854c6a130eee7e72dc3c9d4422f7ff5877", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b95c9d5-ac74-472a-a0e5-5e41176b9fdd", "node_type": "1", "metadata": {}, "hash": "ab2f6c61af83ebc0a2fbb57e2ae9bbe20dc261703a7a914327bf8b32432508b6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Amount of placebo was represented as 0 mg. The sponsor chose to represent the administrations at the time-point level. \nRows 1-2: \nShow administrations for a subject who was randomized to the 20 mg drug X arm. \nRows 3-4: \nShow administrations for a subject who was randomized to the 10 mg drug X arm. \nRows 5-6: \nShow administrations for a subject who was randomized to the placebo arm. \nex.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nEXSEQ \nEXLNKID \nEXTRT \nEXDOSE \nEXDOSU \nEXDOSFRM \nEXDOSFRQ \nEXROUTE \nEPOCH \nEXSTDTC \nEXENDTC \nEXSTDY \nEXENDY \nEXTPT \nEXTPTNUM \n1 \nABC \nEX \nABC5001 \n1 \n20120101-20120108-AM \nDRUG X \n10 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2012-01-01 \n2012-01-08 \n1 \n8 \nAM \n1 \n2 \nABC \nEX \nABC5001 \n2 \n20120101-20120108-PM \nDRUG X \n10 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2012-01-01 \n2012-01-08 \n1 \n8 \nPM \n2 \n3 \nABC \nEX \nABC5002 \n1 \n20120201-20120208-AM \nDRUG X \n10 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2012-02-01 \n2012-02-08 \n1 \n8 \nAM \n1 \n4 \nABC \nEX \nABC5002 \n2 \n20120201-20120208-PM \nPLACEBO \n0 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2012-02-01 \n2012-02-08 \n1 \n8 \nPM \n2 \n5 \nABC \nEX \nABC5003 \n1 \n20120301-20120308-AM \nPLACEBO \n0 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2012-03-01 \n2012-03-08 \n1 \n8 \nAM \n1 \n6 \nABC \nEX \nABC5003 \n2 \n20120301-20120308-PM \nPLACEBO \n0 \nmg \nTABLET \nQD \nORAL \nTREATMENT \n2012-03-01 \n2012-03-08 \n1 \n8 \nPM \n2 \nThe relrec.xpt example reflects a one-to-one dataset-level relationship between EC and EX using --LNKID. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC \nEC \n \nECLNKID  \nONE \n1 \n2 \nABC \nEX \n \nEXLNKID  \nONE \n1 \nExample 6 \nThe study in this example was a single-crossover study comparing once-daily oral administration of drug A 20 mg capsules with drug B 30 mg coated tablets. The study drug was taken for 3 consecutive mornings, 30 \nminutes prior to a standardized breakfast. There was a 6-day washout period between treatments. \nThe following CRFs show data for 2 subjects.", "mimetype": "text/plain", "start_char_idx": 1196, "end_char_idx": 3122, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b95c9d5-ac74-472a-a0e5-5e41176b9fdd": {"__data__": {"id_": "2b95c9d5-ac74-472a-a0e5-5e41176b9fdd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "55b2c449-4125-43a3-9c00-fc45068338a0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}, "hash": "b0eb4b34d75406bde91cffd203ad01b9370ff9ee97b7867e7426a0dcd3676374", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b387b71b-c3f0-4f15-9e95-26d1f004b933", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 115, "section": "UNSPECIFIED"}, "hash": "be427315abcfbaecc5a68a7672228771bbab4b0c3f279f0a9d92d007a7b6dbe8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "relrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC \nEC \n \nECLNKID  \nONE \n1 \n2 \nABC \nEX \n \nEXLNKID  \nONE \n1 \nExample 6 \nThe study in this example was a single-crossover study comparing once-daily oral administration of drug A 20 mg capsules with drug B 30 mg coated tablets. The study drug was taken for 3 consecutive mornings, 30 \nminutes prior to a standardized breakfast. There was a 6-day washout period between treatments. \nThe following CRFs show data for 2 subjects. \nSubject 56789001 \nPeriod 1 \nPeriod 2 \nDay Bottle 1 \n# of capsules \nBottle 2 \n# of tablets \nStart Date/Time \nEnd Date/Time \nDay Bottle 1 \n# of capsules \nBottle 2 \n# of tablets \nStart Date/Time \nEnd Date/Time \n1 \n1 \n1 \n2002-07-01T07:30 2002-07-01T07:30 1 \n1 \n1 \n2002-07-09T07:30 2002-07-09T07:30 \n2 \n1 \n1 \n2002-07-02T07:30 2002-07-02T07:30 2 \n1 \n1 \n2002-07-10T07:30 2002-07-10T07:30 \n3 \n1 \n1 \n2002-07-03T07:32 2002-07-03T07:32 3 \n1 \n1 \n2002-07-11T07:34 2002-07-11T07:34", "mimetype": "text/plain", "start_char_idx": 2623, "end_char_idx": 3591, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "df7d66a5-b505-403b-af57-2568261e02d5": {"__data__": {"id_": "df7d66a5-b505-403b-af57-2568261e02d5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "5759b92532c7f310129dee4912b4a4386db59102429ac048a46a802f9e0c6063", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b84acfdd-e056-41a7-b442-c4d6249bffdb", "node_type": "1", "metadata": {}, "hash": "893f9963f90888200bac88eb141eee21d9ed4fcde20c491855a0e09cd0a725b8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 116 \n2021-11-29 \nSubject 56789003 \nPeriod 1 \nPeriod 2 \nDay Bottle 1 \n# of capsules \nBottle 2 \n# of tablets \nStart Date/Time \nEnd Date/Time \nDay Bottle 1 \n# of capsules \nBottle 2 \n# of tablets \nStart Date/Time \nEnd Date/Time \n1 \n1 \n1 \n2002-07-03T07:30 2002-07-03T07:30 1 \n1 \n1 \n2002-07-11T07:30 2002-07-11T07:30 \n2 \n1 \n1 \n2002-07-04T07:24 2002-07-04T07:24 2 \n1 \n1 \n2002-07-12T07:43 2002-07-12T07:43 \n3 \n1 \n1 \n2002-07-05T07:24 2002-07-05T07:24 3 \n1 \n1 \n2002-07-13T07:38 2002-07-13T07:38 \nThe EC dataset shows administrations as collected. \nec.xpt \nRow STUDYID DOMAIN USUBJID ECSEQ ECTRT \nECPRESP ECOCCUR ECDOSE ECDOSU \nECDOSFRM \nECDOSFRQ ECROUTE EPOCH \nECSTDTC \nECENDTC \nECSTDY ECENDY ECTPT \nECELTM ECTPTREF \n1 \n56789 \nEC \n56789001 1 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n01T07:30 \n2002-07-\n01T07:30 \n1 \n1 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n2 \n56789 \nEC \n56789001 2 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n01T07:30 \n2002-07-\n01T07:30 \n1 \n1 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n3 \n56789 \nEC \n56789001 3 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n02T07:30 \n2002-07-\n02T07:30 \n2 \n2 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n4 \n56789 \nEC \n56789001 4 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET,", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1497, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b84acfdd-e056-41a7-b442-c4d6249bffdb": {"__data__": {"id_": "b84acfdd-e056-41a7-b442-c4d6249bffdb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "5759b92532c7f310129dee4912b4a4386db59102429ac048a46a802f9e0c6063", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "df7d66a5-b505-403b-af57-2568261e02d5", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "fc80017227c1e1f7145b65a6d63b4aa4b1b106dca1dca7bac9733dfc6788ac24", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e737e77-ade2-4e91-9458-c7d3a5cbf336", "node_type": "1", "metadata": {}, "hash": "f736415dc87a0a312d71036d6810dbd05375416ec60f03a30df9354bbb19e3fc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "COATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n01T07:30 \n2002-07-\n01T07:30 \n1 \n1 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n3 \n56789 \nEC \n56789001 3 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n02T07:30 \n2002-07-\n02T07:30 \n2 \n2 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n4 \n56789 \nEC \n56789001 4 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n02T07:30 \n2002-07-\n02T07:30 \n2 \n2 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n5 \n56789 \nEC \n56789001 5 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n03T07:32 \n2002-07-\n03T07:32 \n3 \n3 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n6 \n56789 \nEC \n56789001 6 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n03T07:32 \n2002-07-\n03T07:32 \n3 \n3 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n7 \n56789 \nEC \n56789001 7 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n09T07:30 \n2002-07-\n09T07:30 \n9 \n9 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n8 \n56789 \nEC \n56789001 8 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n09T07:30 \n2002-07-\n09T07:30 \n9 \n9 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n9 \n56789 \nEC \n56789001 9 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n10T07:30 \n2002-07-\n10T07:30 \n10 \n10 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n10 \n56789 \nEC \n56789001 10 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET,", "mimetype": "text/plain", "start_char_idx": 1116, "end_char_idx": 2599, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4e737e77-ade2-4e91-9458-c7d3a5cbf336": {"__data__": {"id_": "4e737e77-ade2-4e91-9458-c7d3a5cbf336", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "5759b92532c7f310129dee4912b4a4386db59102429ac048a46a802f9e0c6063", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b84acfdd-e056-41a7-b442-c4d6249bffdb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "28b8c875de6713c9ab70a3c0a50433c17c8e21c9b3fa52e340c6fcee2b0842d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f42b0f24-c93c-4884-8c0b-d101df5a642f", "node_type": "1", "metadata": {}, "hash": "f92ef3f3406c5f57bf037b7048038447b637d0b53fa7be81d63a650bc7191d26", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "COATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n09T07:30 \n2002-07-\n09T07:30 \n9 \n9 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n9 \n56789 \nEC \n56789001 9 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n10T07:30 \n2002-07-\n10T07:30 \n10 \n10 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n10 \n56789 \nEC \n56789001 10 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n10T07:30 \n2002-07-\n10T07:30 \n10 \n10 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n11 \n56789 \nEC \n56789001 11 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n11T07:34 \n2002-07-\n11T07:34 \n11 \n11 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n12 \n56789 \nEC \n56789001 12 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n11T07:34 \n2002-07-\n11T07:34 \n11 \n11 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n13 \n56789 \nEC \n56789003 1 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n03T07:30 \n2002-07-\n03T07:30 \n1 \n1 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n14 \n56789 \nEC \n56789003 2 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n03T07:30 \n2002-07-\n03T07:30 \n1 \n1 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n15 \n56789 \nEC \n56789003 3 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n04T07:24 \n2002-07-\n04T07:24 \n2 \n2 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n16 \n56789 \nEC \n56789003 4 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET,", "mimetype": "text/plain", "start_char_idx": 2214, "end_char_idx": 3711, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f42b0f24-c93c-4884-8c0b-d101df5a642f": {"__data__": {"id_": "f42b0f24-c93c-4884-8c0b-d101df5a642f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "5759b92532c7f310129dee4912b4a4386db59102429ac048a46a802f9e0c6063", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e737e77-ade2-4e91-9458-c7d3a5cbf336", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "4a1dd9f2df5f4fd185bc774ee4e5558a6436b499a7e09f8d9d373a32d4f841bd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0d1c6acb-fa59-4261-a80c-5f3b94f41d01", "node_type": "1", "metadata": {}, "hash": "a96c0c82f8e594f3d0b842032d42fd26b1ad7c454c62cec29e1792329a0edb8d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "COATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n03T07:30 \n2002-07-\n03T07:30 \n1 \n1 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n15 \n56789 \nEC \n56789003 3 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n04T07:24 \n2002-07-\n04T07:24 \n2 \n2 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n16 \n56789 \nEC \n56789003 4 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n04T07:24 \n2002-07-\n04T07:24 \n2 \n2 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n17 \n56789 \nEC \n56789003 5 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n05T07:24 \n2002-07-\n05T07:24 \n3 \n3 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n18 \n56789 \nEC \n56789003 6 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n1 \n2002-07-\n05T07:24 \n2002-07-\n05T07:24 \n3 \n3 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n19 \n56789 \nEC \n56789003 7 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n11T07:30 \n2002-07-\n11T07:30 \n9 \n9 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n20 \n56789 \nEC \n56789003 8 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n11T07:30 \n2002-07-\n11T07:30 \n9 \n9 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n21 \n56789 \nEC \n56789003 9 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n12T07:43 \n2002-07-\n12T07:43 \n10 \n10 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n22 \n56789 \nEC \n56789003 10 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET,", "mimetype": "text/plain", "start_char_idx": 3328, "end_char_idx": 4818, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0d1c6acb-fa59-4261-a80c-5f3b94f41d01": {"__data__": {"id_": "0d1c6acb-fa59-4261-a80c-5f3b94f41d01", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "36a0db1e-82b4-4c30-8398-8ed401fcb8ce", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "5759b92532c7f310129dee4912b4a4386db59102429ac048a46a802f9e0c6063", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f42b0f24-c93c-4884-8c0b-d101df5a642f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 116, "section": "UNSPECIFIED"}, "hash": "e245713853664889a77a73e15e4429bf02efdf94f31f14924ce1808a3856aea0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "COATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n11T07:30 \n2002-07-\n11T07:30 \n9 \n9 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n21 \n56789 \nEC \n56789003 9 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n12T07:43 \n2002-07-\n12T07:43 \n10 \n10 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n22 \n56789 \nEC \n56789003 10 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n12T07:43 \n2002-07-\n12T07:43 \n10 \n10 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST", "mimetype": "text/plain", "start_char_idx": 4432, "end_char_idx": 4939, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f6060ff4-1839-4fd4-9148-2130500640a7": {"__data__": {"id_": "f6060ff4-1839-4fd4-9148-2130500640a7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "60c57d1c-8d19-4093-932d-a9815ba261fe", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "hash": "e69d29c853158f59caf8445ba0142a47b13d6aecf0f4de8c90a94f3b9bd29bad", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "30b6c504-ba72-4a83-9bf6-a7c6c17ce387", "node_type": "1", "metadata": {}, "hash": "924d751446ecdec68afe044299cac8d91ea91c7f3166a17a59de05bc23e40182", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 117 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID ECSEQ ECTRT \nECPRESP ECOCCUR ECDOSE ECDOSU \nECDOSFRM \nECDOSFRQ ECROUTE EPOCH \nECSTDTC \nECENDTC \nECSTDY ECENDY ECTPT \nECELTM ECTPTREF \n23 \n56789 \nEC \n56789003 11 \nBOTTLE \n1 \nY \nY \n1 \nCAPSULE \nCAPSULE \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n13T07:38 \n2002-07-\n13T07:38 \n11 \n11 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \n24 \n56789 \nEC \n56789003 12 \nBOTTLE \n2 \nY \nY \n1 \nTABLET, \nCOATED \nTABLET, \nCOATED \nQD \nORAL \nTREATMENT \n2 \n2002-07-\n13T07:38 \n2002-07-\n13T07:38 \n11 \n11 \n30 MINUTES \nPRIOR \n-PT30M \nSTD \nBREAKFAST \nThe EX dataset shows the unblinded administrations. \nRows 1-12: \nUnblinding revealed that subject 56789001 received placebo-coated tablets during the first treatment epoch and placebo capsules during the second treatment epoch. \nRows 13-24: Unblinding revealed that subject 56789003 received placebo capsules during the first treatment epoch and placebo-coated tablets during the second treatment epoch. \nex.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nEXSEQ \nEXTRT \nEXDOSE \nEXDOSU \nEXDOSFRM \nEXDOSFRQ \nEXROUTE \nEPOCH \nEXSTDTC \nEXENDTC \nEXSTDY \nEXENDY \nEXTPT \nEXELTM \nEXTPTREF \n1 \n56789 \nEX \n56789001 \n1 \nDRUG A \n20 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 1 \n2002-07-01T07:30 \n \n1 \n1 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n2 \n56789 \nEX \n56789001 \n2 \nPLACEBO \n0 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 1 \n2002-07-01T07:30 \n \n1 \n1 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n3 \n56789 \nEX \n56789001 \n3 \nDRUG A \n20 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 1 \n2002-07-02T07:30 \n \n2 \n2 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n4 \n56789 \nEX \n56789001 \n4 \nPLACEBO \n0 \nmg \nTABLET,", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1782, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30b6c504-ba72-4a83-9bf6-a7c6c17ce387": {"__data__": {"id_": "30b6c504-ba72-4a83-9bf6-a7c6c17ce387", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "60c57d1c-8d19-4093-932d-a9815ba261fe", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "hash": "e69d29c853158f59caf8445ba0142a47b13d6aecf0f4de8c90a94f3b9bd29bad", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f6060ff4-1839-4fd4-9148-2130500640a7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "hash": "7ddb2d0d48dbf0785cbed55c855e0a5b65857f597ed95b10547a90a76e3d58bd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "107e1e12-b1b9-40a5-908d-937e24fec5bb", "node_type": "1", "metadata": {}, "hash": "de8eafa2eb8cd84e6f36f0ef8a18f0d73630d9ec0a5c757bb17c7dbe6c0685d8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "COATED \nQD \nORAL \nTREATMENT 1 \n2002-07-01T07:30 \n \n1 \n1 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n3 \n56789 \nEX \n56789001 \n3 \nDRUG A \n20 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 1 \n2002-07-02T07:30 \n \n2 \n2 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n4 \n56789 \nEX \n56789001 \n4 \nPLACEBO \n0 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 1 \n2002-07-02T07:30 \n \n2 \n2 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n5 \n56789 \nEX \n56789001 \n5 \nDRUG A \n20 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 1 \n2002-07-03T07:32 \n \n3 \n3 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n6 \n56789 \nEX \n56789001 \n6 \nPLACEBO \n0 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 1 \n2002-07-03T07:32 \n \n3 \n3 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n7 \n56789 \nEX \n56789001 \n7 \nPLACEBO \n0 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 2 \n2002-07-09T07:30 \n \n9 \n9 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n8 \n56789 \nEX \n56789001 \n8 \nDRUG B \n30 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 2 \n2002-07-09T07:30 \n \n9 \n9 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n9 \n56789 \nEX \n56789001 \n9 \nPLACEBO \n0 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 2 \n2002-07-10T07:30 \n \n10 \n10 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n10 \n56789 \nEX \n56789001 \n10 \nDRUG B \n30 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 2 \n2002-07-10T07:30 \n \n10 \n10 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n11 \n56789 \nEX \n56789001 \n11 \nPLACEBO \n0 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 2 \n2002-07-11T07:34 \n \n11 \n11 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n12 \n56789 \nEX \n56789001 \n12 \nDRUG B \n30 \nmg \nTABLET,", "mimetype": "text/plain", "start_char_idx": 1492, "end_char_idx": 2958, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "107e1e12-b1b9-40a5-908d-937e24fec5bb": {"__data__": {"id_": "107e1e12-b1b9-40a5-908d-937e24fec5bb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "60c57d1c-8d19-4093-932d-a9815ba261fe", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "hash": "e69d29c853158f59caf8445ba0142a47b13d6aecf0f4de8c90a94f3b9bd29bad", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30b6c504-ba72-4a83-9bf6-a7c6c17ce387", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "hash": "9d7533d0860fadd373d5e07547bbf0d6870bcb81da1d4f482e4724f0243d981a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f9787003-1c53-4fed-a586-dc7633b42999", "node_type": "1", "metadata": {}, "hash": "0909c0c0c4564a1ecbef7527da4bb16a745cd4a4b28c190ea250067a6efa4f5a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "COATED \nQD \nORAL \nTREATMENT 2 \n2002-07-10T07:30 \n \n10 \n10 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n11 \n56789 \nEX \n56789001 \n11 \nPLACEBO \n0 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 2 \n2002-07-11T07:34 \n \n11 \n11 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n12 \n56789 \nEX \n56789001 \n12 \nDRUG B \n30 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 2 \n2002-07-11T07:34 \n \n11 \n11 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n13 \n56789 \nEX \n56789003 \n1 \nPLACEBO \n0 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 1 \n2002-07-03T07:30 \n \n1 \n1 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n14 \n56789 \nEX \n56789003 \n2 \nDRUG B \n30 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 1 \n2002-07-03T07:30 \n \n1 \n1 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n15 \n56789 \nEX \n56789003 \n3 \nPLACEBO \n0 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 1 \n2002-07-04T07:24 \n \n2 \n2 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n16 \n56789 \nEX \n56789003 \n4 \nDRUG B \n30 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 1 \n2002-07-04T07:24 \n \n2 \n2 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n17 \n56789 \nEX \n56789003 \n5 \nPLACEBO \n0 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 1 \n2002-07-05T07:24 \n \n3 \n3 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n18 \n56789 \nEX \n56789003 \n6 \nDRUG B \n30 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 1 \n2002-07-05T07:24 \n \n3 \n3 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n19 \n56789 \nEX \n56789003 \n7 \nDRUG A \n20 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 2 \n2002-07-11T07:30 \n \n9 \n9 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n20 \n56789 \nEX \n56789003 \n8 \nPLACEBO \n0 \nmg \nTABLET,", "mimetype": "text/plain", "start_char_idx": 2660, "end_char_idx": 4132, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f9787003-1c53-4fed-a586-dc7633b42999": {"__data__": {"id_": "f9787003-1c53-4fed-a586-dc7633b42999", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "60c57d1c-8d19-4093-932d-a9815ba261fe", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "hash": "e69d29c853158f59caf8445ba0142a47b13d6aecf0f4de8c90a94f3b9bd29bad", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "107e1e12-b1b9-40a5-908d-937e24fec5bb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 117, "section": "UNSPECIFIED"}, "hash": "c1bf8c7245470e2f3fd8b1df399471d8fc441df26662a4878b1735e391ff2fd2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "COATED \nQD \nORAL \nTREATMENT 1 \n2002-07-05T07:24 \n \n3 \n3 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n19 \n56789 \nEX \n56789003 \n7 \nDRUG A \n20 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 2 \n2002-07-11T07:30 \n \n9 \n9 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n20 \n56789 \nEX \n56789003 \n8 \nPLACEBO \n0 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 2 \n2002-07-11T07:30 \n \n9 \n9 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n21 \n56789 \nEX \n56789003 \n9 \nDRUG A \n20 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 2 \n2002-07-12T07:43 \n \n10 \n10 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n22 \n56789 \nEX \n56789003 \n10 \nPLACEBO \n0 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 2 \n2002-07-12T07:43 \n \n10 \n10 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n23 \n56789 \nEX \n56789003 \n11 \nDRUG A \n20 \nmg \nCAPSULE \nQD \nORAL \nTREATMENT 2 \n2002-07-13T07:38 \n \n11 \n11 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \n24 \n56789 \nEX \n56789003 \n12 \nPLACEBO \n0 \nmg \nTABLET, COATED \nQD \nORAL \nTREATMENT 2 \n2002-07-13T07:38 \n \n11 \n11 \n30 MINUTES PRIOR \n-PT30M \nSTD BREAKFAST \nExample 7 \nThe study in this example involved weekly infusions of drug Z 10 mg/kg. If a subject experienced a dose-limiting toxicity (DLT), the intended dose could be reduced to 7.5 mg/kg. \nThe example CRF below was for subject ABC123-0201, who weighed 55 kg. The CRF shows that: \n\u2022 \nThe subject's first administration of drug Z was on 2009-02-13; the intended dose was 10 mg/kg, but the actual amount given was 99 mL at 5.5 mg/mL, so the actual dose was 9.9 mg/kg. \n\u2022 \nThe subject's second administration of drug Z occurred on 2009-02-20; the intended dose was reduced to 7.5 mg/kg due to dose-limiting toxicity, and the infusion was stopped early due to an injection site \nreaction. However, the actual amount given was 35 mL at a concentration of 4.12 mg/mL, so the calculated actual dose was 2.6 mg/kg. \n\u2022 \nThe subject's third administration was intended to occur on 2009-02-27; the intended dose was 7.5 mg/kg but, due to a personal reason, the administration did not occur.", "mimetype": "text/plain", "start_char_idx": 3840, "end_char_idx": 5807, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "62a02373-3035-4f58-b814-c0ecfe1842db": {"__data__": {"id_": "62a02373-3035-4f58-b814-c0ecfe1842db", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 118, "section": "4.12 mg/mL"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d46b86a2-f2c0-475d-b314-cfc38a52041d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 118, "section": "4.12 mg/mL"}, "hash": "0f986d855e5b28792c08c99b77d706106ddf9e87b7c68f46dbdcb9db35204f5d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If dose was adjusted, what was the reason: \n\u2022 Injection site reaction \n\u2022 Adverse event \n\u2022 Other, specify: ______________________ \n\u2022 Injection site reaction \n\u2022 Adverse event \n\u2022 Other, specify: ____________________ \n\u2022 Injection site reaction \n\u2022 Adverse event \n\u2022 Other, specify: ______________________ \nThe EC dataset shows both intended and actual doses of Drug Z, as collected. \nRows 1, 3, 5: Show the collected intended dose levels (mg/kg) and ECMOOD is \"SCHEDULED\". Scheduled dose is represented in mg/mL. \nRows 2, 4: \nShow the collected actual administration amounts (mL) and ECMOOD is \"PERFORMED\". Actual doses are represented using dose in mL and concentration (pharmaceutical strength) in mg/mL. \nRow 6: \nShows a dose that was not given. ECREASOC shows the reason that ECOCCUR = \"N\", and ECDOSE is null. \nec.xpt \nRow STUDYID DOMAIN USUBJID \nECSEQ ECLNKID \nECLNKGRP ECTRT ECMOOD \nECPRESP ECOCCUR ECREASOC \nECDOSE ECDOSU ECPSTRG ECPSTRGU ECADJ \nVISITNUM VISIT EPOCH \nECSTDTC \nECENDTC \nECSTDY ECENDY \n1 \nABC123 \nEC \nABC123-\n0201 \n1 \n \nV1 \nDRUG \nZ \nSCHEDULED \n \n \n \n10 \nmg/kg \n \n \n \n1 \nVISIT \n1 \nTREATMENT 2009-02-13 \n2009-02-13 \n1 \n1 \n2 \nABC123 \nEC \nABC123-\n0201 \n2 \n20090213 \nT1000 \nV1 \nDRUG \nZ \nPERFORMED Y \nY \n \n99 \nmL", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1223, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "46e1dc06-5a72-4655-93ff-97c51fce9572": {"__data__": {"id_": "46e1dc06-5a72-4655-93ff-97c51fce9572", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 118, "section": "4.12 mg/mL"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a6b66fa6-b561-4c69-b766-978830e9454c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 118, "section": "4.12 mg/mL"}, "hash": "fa863cabb1ec4913f5a6557972e1abf50f66fd00f1f639e405546a064d1beaf7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3 \nVISIT \n3 \nTREATMENT 2009-02-27 \n2009-02-27 \n15 \n15 \nThe EX dataset shows the administrations in protocol-specified unit (mg/kg). There is no record for the intended third dose that was not given. Intended doses in EC (records with ECMOOD = \"SCHEDULED\") can \nbe compared with actual doses in EX. \nRow 1: \nShows the subject's first dose. \nRow 2: \nShows the subject's second dose. The collected explanation for the adjusted dose amount administered at visit 2 is in EXADJ.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 472, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "88b76e76-a62a-4ccd-9ea2-bd258310ff74": {"__data__": {"id_": "88b76e76-a62a-4ccd-9ea2-bd258310ff74", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 119, "section": "2.6 mg/kg"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "804457bb-87a6-4b4e-8cdc-d18d5fe87127", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 119, "section": "2.6 mg/kg"}, "hash": "8d15bc618aaf7a4635de0143f531efe9668c300daa394bb1230e7af60c4b18cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SOLUTION \nCONTINUOUS INTRAVENOUS Injection site \nreaction \n2 \nVISIT \n2 \nTREATMENT 2009-02-\n20T11:00 \n2009-02-\n20T11:00 \n8 \n8 \nTo complete this example the relevant records from the Vital Signs domain are represented below, to show the collected weight of the subject which was used for the dosing calculations. \nvs.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nVSSEQ \nVSLNKID \nVSLNKGRP \nVSTESTCD \nVSTEST \nVSORRES \nVSORRESU \nVSSTRESC \nVSSTRESN \nVSSTRESU \nVSLOBXFL \nVISITNUM \nVISIT \nVSDTC \nEPOCH \n1 \nABC123 \nVS \nABC123-0201 \n1 \n20090213T1000 \nV1 \nWEIGHT \nWeight \n55 \nkg \n55 \n55 \nkg \nY \n1 \nVISIT 1 \n2009-02-13 \nTREATMENT \n2 \nABC123 \nVS \nABC123-0201 \n2 \n20090220T1100 \nV2 \nWEIGHT \nWeight \n55 \nkg \n55 \n55 \nkg \n \n2 \nVISIT 2 \n2009-02-20 \nTREATMENT \nThe RELREC dataset represents relationships between EC, EX, and VS. \nRows 1-3: \nRepresent the one-to-one-to-one relationship between \"PERFORMED\" records in EC, records in EX, and records in VS using --LNKID, . \nRows 4-6: \nRepresent the many-to-one-to-one relationship between many records in EC (both \"SCHEDULED\" and \"PERFORMED\"), one record in EX, and one record in VS (for each visit), using --LNKGRP. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC123 \nEC \n \nECLNKID \n \nONE \n1 \n2 \nABC123 \nEX \n \nEXLNKID \n \nONE \n1 \n6 \nABC123 \nVS \n \nVSLNKID \n \nONE \n1 \n3 \nABC123 \nEC \n \nECLNKGRP  \nMANY \n2 \n4 \nABC123 \nEX \n \nEXLNKGRP  \nONE \n2 \n6 \nABC123 \nVS \n \nVSLNKGRP  \nONE \n2 \nExample 8 \nIn this example, a 100 mg tablet is scheduled to be taken daily. Start and end of dosing were collected, along with deviations from the planned daily dosing. Note: This method of data collection design is not \nconsistent with current CDASH standards. \nFirst Dose Date \nLast Dose Date \n2012-01-13 \n2012-01-20 \n \nDate \nNumber of Doses Daily \nIf/When Deviated from Plan \n2012-01-15 0 \n2012-01-16 2 \nThe EC dataset shows administrations as collected. \nRow 1: \nShows the overall dosing interval from first dose date to last dose date. \nRow 2: \nShows the missed dose on 2012-01-15, which falls within the overall dosing interval. \nRow 3: \nShows a doubled dose on 2012-01-16, which also falls within the overall dosing interval.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2157, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a94f8c32-e9c4-499c-93c3-6c8e147cf82a": {"__data__": {"id_": "a94f8c32-e9c4-499c-93c3-6c8e147cf82a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 120, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "863bb77b-2dc7-449b-91fd-1520b23a7a82", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 120, "section": "UNSPECIFIED"}, "hash": "711068810b9347b338383c540de16e8081d4fe03e2e466f0bf192d5dd26b3bbb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 120 \n2021-11-29 \nec.xpt \nRow STUDYID DOMAIN USUBJID ECSEQ ECTRT \nECCAT \nECPRESP ECOCCUR ECDOSE ECDOSU ECDOSFRQ EPOCH \nECSTDTC \nECENDTC \nECSTDY ECENDY \n1 \nABC \nEC \nABC7001 1 \nBOTTLE A FIRST TO LAST DOSE INTERVAL Y \nY \n1 \nTABLET \nQD \nTREATMENT 2012-01-13 2012-01-20 1 \n8 \n2 \nABC \nEC \nABC7001 2 \nBOTTLE A EXCEPTION DOSE \nY \nN \n \nTABLET \nQD \nTREATMENT 2012-01-15 2012-01-15 3 \n3 \n3 \nABC \nEC \nABC7001 3 \nBOTTLE A EXCEPTION DOSE \nY \nY \n2 \nTABLET \nQD \nTREATMENT 2012-01-16 2012-01-16 4 \n4 \nThe EX dataset shows the unmasked treatment for this subject, \"DRUG X\", and represents dosing in nonoverlapping intervals of time. There is no EX record for the missed dose, but the missed dose is reflected in a \ngap between dates in the EX records. \nRow 1: \nShows the administration from first dose date to the day before the missed dose. \nRow 2: \nShows the doubled dose. \nRow 3: \nShows the remaining administrations to the last dose date. \nex.xpt \nRow STUDYID DOMAIN USUBJID EXSEQ EXTRT \nEXDOSE EXDOSU EXDOSFRM EXDOSFRQ EXROUTE EPOCH \nEXSTDTC \nEXENDTC \nEXSTDY EXENDY \n1 \nABC \nEX \nABC7001 1 \nDRUG X 100 \nmg \nTABLET \nQD \nORAL \nTREATMENT 2012-01-13 2012-01-14 1 \n2 \n2 \nABC \nEX \nABC7001 2 \nDRUG X 200 \nmg \nTABLET \nQD \nORAL \nTREATMENT 2012-01-16 2012-01-16 4 \n4 \n3 \nABC \nEX \nABC7001 3 \nDRUG X 100 \nmg \nTABLET \nQD \nORAL \nTREATMENT 2012-01-17 2012-01-20 5 \n8", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1515, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b4fdb5b6-53d2-4e79-996a-a1f5cda2afbe": {"__data__": {"id_": "b4fdb5b6-53d2-4e79-996a-a1f5cda2afbe", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 121, "section": "6.1.4 Meal Data (ML)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "264604a1-8180-484d-91ac-4ebca56f333d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 121, "section": "6.1.4 Meal Data (ML)"}, "hash": "950d82a7d4f84f5d8ee922d2097adc7fe0334c1e7e29704f33ff0bbf3a7eedb7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4b6504ef-64e2-45e0-b824-324151127f34", "node_type": "1", "metadata": {}, "hash": "83d35f6524d7ac75c17a3ec71a78b30324c8146860ed2c49a29f00966a084d58", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ML \u2013 Description/Overview \nAn interventions domain that contains information describing a subject's food product consumption. \nML \u2013 Specification \nml.xpt, Meal Data \u2014 Interventions. One record per food product occurrence or constant intake interval per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar ML \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or \nsubmissions involving the product. \nReq \nMLSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be \nany valid number. \nReq \nMLGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nMLSPID \nSponsor-Defined Identifier \nChar  \nIdentifier \nSponsor-defined reference number. Examples: a number preprinted on the CRF as an explicit \nline identifier, record identifier defined in the sponsor's operational database. \nPerm \nMLTRT \nName of Meal \nChar * \nTopic \nVerbatim food product name that is either preprinted or collected on a CRF. \nReq \nMLCAT \nCategory for Meal \nChar * \nGrouping \nQualifier \nUsed to define a category of MLTRT values. \nPerm \nMLSCAT \nSubcategory for Meal \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of MLCAT values. \nPerm \nMLPRESP \nML Pre-specified \nChar (NY) \nVariable \nQualifier \nUsed when a specific meal is prespecified on a CRF. Values should be \"Y\" or null. \nPerm \nMLOCCUR \nML Occurrence \nChar (NY) \nRecord \nQualifier \nUsed to record whether a prespecified meal occurred when information about the occurrence \nof a specific meal is solicited. \nPerm \nMLSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate when a question about the occurrence of a prespecified meal was not \nanswered. Should be null or have a value of \"NOT DONE\". \nPerm \nMLREASND \nReason Meal Not Collected \nChar  \nRecord \nQualifier \nDescribes the reason a response to a question about the occurrence of a meal was not \ncollected. Used in conjunction with MLSTAT when value is \"NOT DONE\". \nPerm \nMLDOSE \nDose \nNum  \nRecord \nQualifier \nAmount of MLTRT consumed. Not populated when MLDOSTXT is populated. \nPerm \nMLDOSTXT \nDose Description \nChar  \nRecord \nQualifier \nAmount description of MLTRT consumed, collected in text form. Not populated when \nMLDOSE is populated. Examples: \"<1 per day\", \"200-400\". \nPerm \nMLDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for MLDOSE, MLDOSTOT, or MLDOSTXT. \nPerm \nMLDOSFRM \nDose Form \nChar (FRM) \nVariable \nQualifier \nDosage form for MLTRT. Example: \"BAR, CHEWABLE\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3004, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4b6504ef-64e2-45e0-b824-324151127f34": {"__data__": {"id_": "4b6504ef-64e2-45e0-b824-324151127f34", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 121, "section": "6.1.4 Meal Data (ML)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "264604a1-8180-484d-91ac-4ebca56f333d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 121, "section": "6.1.4 Meal Data (ML)"}, "hash": "950d82a7d4f84f5d8ee922d2097adc7fe0334c1e7e29704f33ff0bbf3a7eedb7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b4fdb5b6-53d2-4e79-996a-a1f5cda2afbe", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 121, "section": "6.1.4 Meal Data (ML)"}, "hash": "55242c4cd45f5de20b307d79d08cd98b78cef6875792a267bf68b2274d0de870", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nMLDOSE \nDose \nNum  \nRecord \nQualifier \nAmount of MLTRT consumed. Not populated when MLDOSTXT is populated. \nPerm \nMLDOSTXT \nDose Description \nChar  \nRecord \nQualifier \nAmount description of MLTRT consumed, collected in text form. Not populated when \nMLDOSE is populated. Examples: \"<1 per day\", \"200-400\". \nPerm \nMLDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for MLDOSE, MLDOSTOT, or MLDOSTXT. \nPerm \nMLDOSFRM \nDose Form \nChar (FRM) \nVariable \nQualifier \nDosage form for MLTRT. Example: \"BAR, CHEWABLE\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nPerm \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of Visit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of Element \nwithin Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which \nthe meal started. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the meal. \nPerm \nMLDTC \nDate/Time of Collection \nChar ISO 8601 datetime or \ninterval \nTiming \nCollection date and time of the meal represented in ISO 8601 character format. \nPerm", "mimetype": "text/plain", "start_char_idx": 2365, "end_char_idx": 3652, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "15f1617c-fd19-4c81-987e-23000c57db58": {"__data__": {"id_": "15f1617c-fd19-4c81-987e-23000c57db58", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 122, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "745d1c63-e052-4f64-b3f6-be386b6d40fd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 122, "section": "UNSPECIFIED"}, "hash": "0581b8fa019e327c722bd7ae788a09cac1f3e0efe572d6e32081f1602786ac59", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ea48ae73-3034-424e-9150-091dfb6a999d", "node_type": "1", "metadata": {}, "hash": "eb2042d7db0645017c1d885b74924c165d215cff4141c98156a51a5703c22905", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 122 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nMLSTDTC \nStart Date/Time of Meal \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time of the meal represented in ISO 8601 character format. \nPerm \nMLENDTC \nEnd Date/Time of Meal \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time of the meal represented in ISO 8601 character format. \nPerm \nMLDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of the visit/collection expressed in integer days relative to the sponsor-\ndefined RFSTDTC in Demographics. \nPerm \nMLSTDY \nStudy Day of Start of Meal \nNum  \nTiming \nActual study day of start of the meal expressed in integer days relative to sponsor-defined \nRFSTDTC in Demographics. \nPerm \nMLENDY \nStudy Day of End of Meal \nNum  \nTiming \nActual study day of end of the meal expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nMLDUR \nDuration of Meal \nChar ISO 8601 duration \nTiming \nCollected duration of the meal represented in ISO 8601 character format. Used only if \ncollected on the CRF and not derived. \nPerm \nMLTPT \nPlanned Time Point Name \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in \nthe protocol. This may be represented as an elapsed time relative to a fixed reference point. \nSee MLTPTNUM and MLTPTREF. \nPerm \nMLTPTNUM \nPlanned Time Point Number \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nMLELTM \nPlanned Elapsed Time from \nTime Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to the planned fixed reference (MLTPTREF). This \nvariable is useful when there are repetitive measures. Not a clock time or a date/time variable. \nRepresented as an ISO 8601 duration. \nPerm \nMLTPTREF \nTime Point Reference \nChar  \nTiming \nDescription of the fixed reference point referred to by MLELTM, MLTPTNUM, and MLTPT. \nPerm \nMLRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by MLTPTREF in ISO 8601 character \nformat. \nPerm \nMIDS \nDisease Milestone Instance \nName \nChar  \nTiming \nThe name of a specific instance of a disease milestone type (MIDSTYPE) described in the \nTrial Disease Milestones dataset. This should be unique within a subject. Used only in \nconjunction with RELMIDS and MIDSDTC. \nPerm \nRELMIDS \nTemporal Relation to \nMilestone Instance \nChar  \nTiming \nThe temporal relationship of the observation to the disease milestone instance name in MIDS. \nExamples: \"IMMEDIATELY BEFORE\", \"AT TIME OF\", \"AFTER\". \nPerm \nMIDSDTC \nDisease Milestone Instance \nDate/Time \nChar ISO 8601 datetime or \ninterval \nTiming \nThe start date/time of the disease milestone instance name in MIDS, in ISO 8601 format.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3041, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ea48ae73-3034-424e-9150-091dfb6a999d": {"__data__": {"id_": "ea48ae73-3034-424e-9150-091dfb6a999d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 122, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "745d1c63-e052-4f64-b3f6-be386b6d40fd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 122, "section": "UNSPECIFIED"}, "hash": "0581b8fa019e327c722bd7ae788a09cac1f3e0efe572d6e32081f1602786ac59", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "15f1617c-fd19-4c81-987e-23000c57db58", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 122, "section": "UNSPECIFIED"}, "hash": "98bad48eebc366328e291018267d124eb548bd96c9cfcc9f2e9ca74105f3fe4f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nMIDS \nDisease Milestone Instance \nName \nChar  \nTiming \nThe name of a specific instance of a disease milestone type (MIDSTYPE) described in the \nTrial Disease Milestones dataset. This should be unique within a subject. Used only in \nconjunction with RELMIDS and MIDSDTC. \nPerm \nRELMIDS \nTemporal Relation to \nMilestone Instance \nChar  \nTiming \nThe temporal relationship of the observation to the disease milestone instance name in MIDS. \nExamples: \"IMMEDIATELY BEFORE\", \"AT TIME OF\", \"AFTER\". \nPerm \nMIDSDTC \nDisease Milestone Instance \nDate/Time \nChar ISO 8601 datetime or \ninterval \nTiming \nThe start date/time of the disease milestone instance name in MIDS, in ISO 8601 format. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nML \u2013 Assumptions \n1. The ML domain is used to represent consumption of any food or nutritional item that would not be represented in the exposure domains (EC/EX), \nConcomitant/Prior Medications (CM), Procedure Agents (AG), or Substance Use (SU). Examples of nutritional items that would be represented in other \ndomains include: \na. \nInvestigational nutritional products (represented in EC/EX) \nb. Food or drink used to treat hypoglycemic events (represented in CM) \nc. \nGlucose given as part of a glucose tolerance test (represented in AG) \nd. Caffeinated drinks (represented in SU) \nThe nutritional items represented in ML may be prospectively defined within a protocol, collected retrospectively as potential precipitants of clinical \nevents, and/or to describe nutritional intake. \n2. Additional timing variables", "mimetype": "text/plain", "start_char_idx": 2356, "end_char_idx": 4024, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a1c559a1-00d6-48c1-b98a-6001ed911aba": {"__data__": {"id_": "a1c559a1-00d6-48c1-b98a-6001ed911aba", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 123, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e85369e5-6c58-45a3-be8e-dce4eb419f49", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 123, "section": "UNSPECIFIED"}, "hash": "1a296e6b1a46fa8d2aa254935215691803d8f78a8e58a2a7cdc0415fae5f2a97", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 123 \n2021-11-29 \na. \nAny additional timing variables may be added to this domain. \nb. Consumption of a food product is considered to occur over an interval of time (as opposed to a point in time). If start and end date/times are \ncollected, they should be represented in MLSTDTC and MLENDTC, respectively. If only a start date/time is collected, it should not be copied to \nMLENDTC. \n3. Any identifier variables, timing variables, or findings general observation-class qualifiers may be added to the ML domain, but the following qualifiers \nwould generally not be used: --MOOD, --LOT, --LOC, --LAT, --DIR, --PORTOT. \nML \u2013 Examples \nExample 1 \nThis example shows meal data collected in an effort to understand the causes of 2 different kinds of events. \n\u2022 \nData was collected about the last meal before each hypoglycemic event \n\u2022 \nData was collected about the occurrence of of prespecified foods prior to a suspected event of drug-induced liver injury (DILI). \nMeal Log CRF \nRecord the last type of meal/food consumption prior to the hypoglycemic event: \nType \nIf Nutritional Drink, Volume (ounces) \nStart Date \nStart Time Event ID \nX Snack \nNutritional drink \nMeal  \n2015 Jun 03 14:15 \nCE001 \nSnack X  Nutritional drink \nMeal 8 oz \n2015 Sep 03 8:30 \nCE002 \nSnack \nNutritional drink X Meal  \n2015 Dec 31 19:00 \nCE003 \nClick here to add a row:  ADD ROW  \nDILI Meal CRF \nIf suspected DILI, did you consume any of the following in the past week? \nType \nOccurrence \nIf yes, Date \nWild mushrooms X Yes \nNo 2015  DEC 24 \nAckee fruit \nYes X No  \nCycad seeds \nYes X No  \nNote that in this example MLENDTC is null. Because no end date was collected, the meal was represented as a point-in-time event, as described in Assumption \n2b. \nRows 1-3: \nShow the last meal data for 3 hypoglycemic events. \nRows 4-6: \nShow the meal data collected relative to the suspected DILI. \nml.xpt \nRow STUDYID DOMAIN USUBJID MLSEQ MLTRT \nMLCAT \nMLPRESP MLOCCUR MLDOSE MLDOSU MLDTC MLSTDTC MLENDTC MLEVLINT RELMIDS \nMIDS \nMIDSDTC \n1 \nXYZ \nML \nXYZ-001-\n001 \n1 \nSNACK \nHYPOGLYCEMIA \nEVALUATION \nY \nY \n \n \n \n2015-06-\n03T14:15 \n \n \nLAST \nMEAL \nPRIOR \nTO \nHYPO1 2015-06-\n03T19:20", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2322, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a9ac55ce-6430-43f3-b93d-a15c0590f45c": {"__data__": {"id_": "a9ac55ce-6430-43f3-b93d-a15c0590f45c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 124, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "af9e273f-eed2-4486-944a-2c1af1339bd1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 124, "section": "UNSPECIFIED"}, "hash": "1a47935f2a8f93442685b78b0522f8a9bdcb16dabbb135d7b0f5498e68fa3811", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "616837f4-1ac1-45ee-9156-574e3d796c47", "node_type": "1", "metadata": {}, "hash": "9f8cca62ea8669c798ae61380eb0a4eb1199ae7167b83ddc94eec6c689de0b4d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 124 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID MLSEQ MLTRT \nMLCAT \nMLPRESP MLOCCUR MLDOSE MLDOSU MLDTC MLSTDTC MLENDTC MLEVLINT RELMIDS \nMIDS \nMIDSDTC \n2 \nXYZ \nML \nXYZ-001-\n001 \n2 \nNUTRITIONAL \nDRINK \nHYPOGLYCEMIA \nEVALUATION \nY \nY \n8 \noz \n \n2015-09-\n03T08:30 \n \n \nLAST \nMEAL \nPRIOR \nTO \nHYPO2 2015-09-\n03T17:00 \n3 \nXYZ \nML \nXYZ-001-\n001 \n3 \nMEAL \nHYPOGLYCEMIA \nEVALUATION \nY \nY \n \n \n \n2015-12-\n31T19:00 \n \n \nLAST \nMEAL \nPRIOR \nTO \nHYPO3 2016-01-\n01T10:30 \n4 \nXYZ \nML \nXYZ-001-\n001 \n4 \nWILD \nMUSHROOMS \nDILI \nEVALUATION \nY \nY \n \n \n2015-\n12-27 \n2015-12-\n24 \n \n-P1W \n \n \n \n5 \nXYZ \nML \nXYZ-001-\n001 \n5 \nACKEE FRUIT \nDILI \nEVALUATION \nY \nN \n \n \n2015-\n12-27 \n \n \n-P1W \n \n \n \n6 \nXYZ \nML \nXYZ-001-\n001 \n6 \nCYCAD \nSEEDS \nDILI \nEVALUATION \nY \nN \n \n \n2015-\n12-27 \n \n \n-P1W \n \n \n \nExample 2 \nThis example describes a study that examines the effect of physical modifications in a cafeteria on selection/consumption among school students. \nGroup \nArms \nDetails \n1 \nControl \nStudents received standard meals in a standard cafeteria environment. \n2 \nExperimental: choice \narchitecture \nStudents were exposed to modifications to the physical environment in the cafeteria to \u201cnudge\u201d students towards \nhealthier choices. Physical modifications included: \n\u2022 Placing vegetables at the beginning of the lunch line \n\u2022 Placing fruits in attractive bowls, trays lined with appealing fabric, and fruit options next to cash registers \n\u2022 Promoting fruits and vegetables with prominently displayed signage and images \n\u2022 Placing white milk selection more predominantly than chocolate milk (e.g., white milk displayed in front \nof chocolate milk) \nFood-card data was collected over a 7-month period by students receiving a school meal 1 day per week. Students who brought a lunch from home or those not \neating lunch in the cafeteria on a study day were excluded. \nThe dataset below shows the food-card data collected for the first 3 weeks for a subject.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2100, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "616837f4-1ac1-45ee-9156-574e3d796c47": {"__data__": {"id_": "616837f4-1ac1-45ee-9156-574e3d796c47", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 124, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "af9e273f-eed2-4486-944a-2c1af1339bd1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 124, "section": "UNSPECIFIED"}, "hash": "1a47935f2a8f93442685b78b0522f8a9bdcb16dabbb135d7b0f5498e68fa3811", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a9ac55ce-6430-43f3-b93d-a15c0590f45c", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 124, "section": "UNSPECIFIED"}, "hash": "dc851bbb3ed6f92c99a2030f84411a89cef679541d13e6df866ff8394a683e78", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2 \nExperimental: choice \narchitecture \nStudents were exposed to modifications to the physical environment in the cafeteria to \u201cnudge\u201d students towards \nhealthier choices. Physical modifications included: \n\u2022 Placing vegetables at the beginning of the lunch line \n\u2022 Placing fruits in attractive bowls, trays lined with appealing fabric, and fruit options next to cash registers \n\u2022 Promoting fruits and vegetables with prominently displayed signage and images \n\u2022 Placing white milk selection more predominantly than chocolate milk (e.g., white milk displayed in front \nof chocolate milk) \nFood-card data was collected over a 7-month period by students receiving a school meal 1 day per week. Students who brought a lunch from home or those not \neating lunch in the cafeteria on a study day were excluded. \nThe dataset below shows the food-card data collected for the first 3 weeks for a subject. \nml.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nMLSEQ \nMLTRT \nVISITNUM \nVISIT \nMLSTDTC \n1 \nABC123 \nML \nABC123-001 \n1 \nFRUIT ROLLUP \n1 \nWEEK 1 \n2015-09-09 \n2 \nABC123 \nML \nABC123-001 \n2 \nWHTE MILK \n1 \nWEEK 1 \n2015-09-09 \n3 \nABC123 \nML \nABC123-001 \n3 \nPEANUT BUTTER SANDWICH \n1 \nWEEK 1 \n2015-09-09 \n4 \nABC123 \nML \nABC123-001 \n4 \nBANANA \n2 \nWEEK 2 \n2015-09-17 \n5 \nABC123 \nML \nABC123-001 \n5 \nCHOCOLATE MILK \n2 \nWEEK 2 \n2015-09-17 \n6 \nABC123 \nML \nABC123-001 \n6 \nPIZZA \n2 \nWEEK 2 \n2015-09-17 \n7 \nABC123 \nML \nABC123-001 \n7 \nAPPLE \n3 \nWEEK 3 \n2015-09-22 \n8 \nABC123 \nML \nABC123-001 \n8 \nWHITE MILK \n3 \nWEEK 3 \n2015-09-22 \n9 \nABC123 \nML \nABC123-001 \n9 \nSALAD \n3 \nWEEK 3 \n2015-09-22", "mimetype": "text/plain", "start_char_idx": 1208, "end_char_idx": 2762, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cca838dc-e537-4d6a-bca3-872c2eb7827b": {"__data__": {"id_": "cca838dc-e537-4d6a-bca3-872c2eb7827b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 125, "section": "6.1.5 Procedures (PR)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ccf102f9-e88f-4d29-be07-e92f42b7b1d6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 125, "section": "6.1.5 Procedures (PR)"}, "hash": "ff3877558a6c479e25c615e88e0b630447859dde946d52a22fc8692fe3f7449a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "70ea6496-5447-45c5-9958-7fd22e913d72", "node_type": "1", "metadata": {}, "hash": "cfdb4acec1322973ae10fb8dfc446cc5301c3d59774d3f42c88700a2c999f96d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PR \u2013 Description/Overview \nAn interventions domain that contains interventional activity intended to have diagnostic, preventive, therapeutic, or palliative effects. \nPR \u2013 Specification \npr.xpt, Procedures \u2014 Interventions. One record per recorded procedure per occurrence per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar PR \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nPRSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nPRGRPID \nGroup ID \nChar  \nIdentifier \nUsed to link together a block of related records within a subject in a domain. \nPerm \nPRSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. Example: preprinted line identifier on a CRF, record identifier defined in the \nsponsor's operational database. \nPerm \nPRLNKID \nLink ID \nChar  \nIdentifier \nUsed to facilitate identification of relationships between records. \nPerm \nPRLNKGRP \nLink Group ID \nChar  \nIdentifier \nUsed to facilitate identification of relationships between records. \nPerm \nPRTRT \nReported Name of \nProcedure \nChar  \nTopic \nName of procedure performed, either preprinted or collected on a CRF. \nReq \nPRDECOD \nStandardized \nProcedure Name \nChar (PROCEDUR) \nSynonym \nQualifier \nStandardized or dictionary-derived name of PRTRT. If the codelist \"PROCEDUR\" is not used, the \nsponsor is expected to provide the dictionary name and version used to map the terms in the external \ncodelist element in the Define-XML document. If an intervention term does not have a decode value, \nthen PRDECOD will be null. \nPerm \nPRCAT \nCategory \nChar * \nGrouping \nQualifier \nUsed to define a category of procedure values. \nPerm \nPRSCAT \nSubcategory \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of PRCAT values. \nPerm \nPRPRESP \nPre-specified \nChar (NY) \nVariable \nQualifier \nUsed when a specific procedure is pre-specified on a CRF. Values should be \"Y\" or null. \nPerm \nPROCCUR \nOccurrence \nChar (NY) \nRecord \nQualifier \nUsed to record whether a prespecified procedure occurred when information about the occurrence of \na specific procedure is solicited. \nPerm \nPRINDC \nIndication \nChar  \nRecord \nQualifier \nDenotes the indication for the procedure (e.g., why the procedure was performed). \nPerm \nPRDOSE \nDose \nNum  \nRecord \nQualifier \nAmount of PRTRT administered. Not populated when PRDOSTXT is populated. \nPerm \nPRDOSTXT \nDose Description \nChar  \nRecord \nQualifier \nDosing information collected in text form. Examples: \"<1\", \"200-400\". Not populated when PRDOSE is \npopulated. \nPerm \nPRDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for PRDOSE, PRDOSTOT, or PRDOSTXT.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3090, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "70ea6496-5447-45c5-9958-7fd22e913d72": {"__data__": {"id_": "70ea6496-5447-45c5-9958-7fd22e913d72", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 125, "section": "6.1.5 Procedures (PR)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ccf102f9-e88f-4d29-be07-e92f42b7b1d6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 125, "section": "6.1.5 Procedures (PR)"}, "hash": "ff3877558a6c479e25c615e88e0b630447859dde946d52a22fc8692fe3f7449a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cca838dc-e537-4d6a-bca3-872c2eb7827b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 125, "section": "6.1.5 Procedures (PR)"}, "hash": "2f0a52fff1a165c49f099e2c2548f31e2f92899b5832f0d4b48152c9320595d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nPROCCUR \nOccurrence \nChar (NY) \nRecord \nQualifier \nUsed to record whether a prespecified procedure occurred when information about the occurrence of \na specific procedure is solicited. \nPerm \nPRINDC \nIndication \nChar  \nRecord \nQualifier \nDenotes the indication for the procedure (e.g., why the procedure was performed). \nPerm \nPRDOSE \nDose \nNum  \nRecord \nQualifier \nAmount of PRTRT administered. Not populated when PRDOSTXT is populated. \nPerm \nPRDOSTXT \nDose Description \nChar  \nRecord \nQualifier \nDosing information collected in text form. Examples: \"<1\", \"200-400\". Not populated when PRDOSE is \npopulated. \nPerm \nPRDOSU \nDose Units \nChar (UNIT) \nVariable \nQualifier \nUnits for PRDOSE, PRDOSTOT, or PRDOSTXT. \nPerm \nPRDOSFRM \nDose Form \nChar (FRM) \nVariable \nQualifier \nDose form for PRTRT. \nPerm \nPRDOSFRQ \nDosing Frequency per \nInterval \nChar (FREQ) \nRecord \nQualifier \nUsually expressed as the number of doses given per a specific interval. \nPerm \nPRDOSRGM Intended Dose \nRegimen \nChar  \nRecord \nQualifier \nText description of the intended schedule or regimen for the procedure. \nPerm \nPRROUTE \nRoute of \nAdministration \nChar (ROUTE) \nVariable \nQualifier \nRoute of administration for PRTRT. \nPerm", "mimetype": "text/plain", "start_char_idx": 2373, "end_char_idx": 3581, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "54f2ebd3-face-459d-bcc8-b41736d470f1": {"__data__": {"id_": "54f2ebd3-face-459d-bcc8-b41736d470f1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 126, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "07e4b533-c2b4-49a4-a034-15dabd7c7e3a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 126, "section": "UNSPECIFIED"}, "hash": "0f7e82a8bd5436802a4a686b6531672332e0da3c15e34a92e0dcbc1376242d9a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dbf30eb8-8cde-4235-a20f-286749cf1940", "node_type": "1", "metadata": {}, "hash": "9a25c8cfacd28f7302d06eb91ccd26fe40db77f6ca03725c8aad71bb6dd2e4b6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 126 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nPRLOC \nLocation of Procedure Char (LOC) \nRecord \nQualifier \nAnatomical location of a procedure. \nPerm \nPRLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. \nPerm \nPRDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. \nPerm \nPRPORTOT \nPortion or Totality \nChar (PORTOT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing the distribution, which means \narrangement of, apportioning of. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nPerm \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the procedure. \nPerm \nPRSTDTC \nStart Date/Time of \nProcedure \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time of the procedure represented in ISO 8601 character format. \nExp \nPRENDTC \nEnd Date/Time of \nProcedure \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time of the procedure represented in ISO 8601 character format. \nPerm \nPRSTDY \nStudy Day of Start of \nProcedure \nNum  \nTiming \nStudy day of start of procedure expressed in integer days relative to the sponsor-defined RFSTDTC in \nDemographics. \nPerm \nPRENDY \nStudy Day of End of \nProcedure \nNum  \nTiming \nStudy day of end of procedure expressed in integer days relative to the sponsor-defined RFSTDTC in \nDemographics. \nPerm \nPRDUR \nDuration of Procedure Char ISO 8601 duration \nTiming \nCollected duration of a procedure represented in ISO 8601 character format. Used only if collected on \nthe CRF and not derived from start and end date/times. \nPerm \nPRTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a procedure should be performed. This may be represented as an \nelapsed time relative to a fixed reference point, such as time of last dose. See PRTPTNUM and \nPRTPTREF. \nPerm \nPRTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of planned time point used in sorting. \nPerm \nPRELTM \nPlanned Elapsed \nTime from Time Point \nRef \nChar ISO 8601 duration \nTiming \nPlanned elapsed time in ISO 8601 format relative to a planned fixed reference (PRTPTREF). This \nvariable is useful where there are repetitive measures. Not a clock time or a date/time variable, but an \ninterval, represented as ISO duration.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3042, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbf30eb8-8cde-4235-a20f-286749cf1940": {"__data__": {"id_": "dbf30eb8-8cde-4235-a20f-286749cf1940", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 126, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "07e4b533-c2b4-49a4-a034-15dabd7c7e3a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 126, "section": "UNSPECIFIED"}, "hash": "0f7e82a8bd5436802a4a686b6531672332e0da3c15e34a92e0dcbc1376242d9a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "54f2ebd3-face-459d-bcc8-b41736d470f1", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 126, "section": "UNSPECIFIED"}, "hash": "d029fa1bbad300f887fb7a33e5833cf87fb381ee076f6cdc0a9333af68bc79a4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Used only if collected on \nthe CRF and not derived from start and end date/times. \nPerm \nPRTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a procedure should be performed. This may be represented as an \nelapsed time relative to a fixed reference point, such as time of last dose. See PRTPTNUM and \nPRTPTREF. \nPerm \nPRTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of planned time point used in sorting. \nPerm \nPRELTM \nPlanned Elapsed \nTime from Time Point \nRef \nChar ISO 8601 duration \nTiming \nPlanned elapsed time in ISO 8601 format relative to a planned fixed reference (PRTPTREF). This \nvariable is useful where there are repetitive measures. Not a clock time or a date/time variable, but an \ninterval, represented as ISO duration. \nPerm \nPRTPTREF \nTime Point Reference Char  \nTiming \nDescription of the fixed reference point referred to by PRELTM, PRTPTNUM, and PRTPT. \nPerm \nPRRFTDTC \nDate/Time of \nReference Time Point \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by PRTRTREF in ISO 8601 character format. \nPerm \nPRSTRTPT \nStart Relative to \nReference Time Point \nChar (STENRF) \nTiming \nIdentifies the start of the observation as being before or after the sponsor-defined reference time point \ndefined by variable PRSTTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nPRSTTPT \nStart Reference Time \nPoint \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the sponsor-defined reference point referred \nto by PRSTRTPT. Examples: \"2003-12-15\", \"VISIT 1\". \nPerm \nPRENRTPT \nEnd Relative to \nReference Time Point \nChar (STENRF) \nTiming \nIdentifies the end of the observation as being before or after the sponsor-defined reference time point \ndefined by variable PRENTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nPRENTPT \nEnd Reference Time \nPoint \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the sponsor-defined reference point referred \nto by PRENRTPT. Examples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.", "mimetype": "text/plain", "start_char_idx": 2259, "end_char_idx": 4630, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fa6d9118-32fb-4c7a-965e-551670d4aebc": {"__data__": {"id_": "fa6d9118-32fb-4c7a-965e-551670d4aebc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 127, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48d35682-eb3f-4915-8b06-9ee157a3fbbc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 127, "section": "UNSPECIFIED"}, "hash": "dad501f00feaed36f5cfecb286484793ececf080dd6344c434da5e010d049af0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c36481dc-3fb8-4345-8d11-e961cf0d9e14", "node_type": "1", "metadata": {}, "hash": "4bb8b18b190c98ef81760020bbc4f33cf52e40be3fd5c0273c33a4559af06dd5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 127 \n2021-11-29 \nPR \u2013 Assumptions \n1. Some examples of procedures, by type, include the following: \na. \nDisease screening (e.g., mammogram, pap smear) \nb. Endoscopic examinations (e.g., arthroscopy, diagnostic colonoscopy, therapeutic colonoscopy, diagnostic laparoscopy, therapeutic laparoscopy) \nc. \nDiagnostic tests (e.g., amniocentesis, biopsy, catheterization, cutaneous oximetry, finger stick, fluorophotometry, imaging techniques (e.g., DXA \nscan, CT scan, MRI), phlebotomy, pulmonary function test, skin test, stress test, tympanometry) \nd. Therapeutic procedures (e.g., ablation therapy, catheterization, cryotherapy, mechanical ventilation, phototherapy, radiation therapy/radiotherapy, \nthermotherapy) \ne. \nSurgical procedures (e.g., curative surgery, diagnostic surgery, palliative surgery, therapeutic surgery, prophylactic surgery, resection, stenting, \nhysterectomy, tubal ligation, implantation) \n \nThe Procedures domain is based on the Interventions observation class. The extent of physiological effect may range from observable to microscopic. \nRegardless of the extent of effect or whether it is collected in the study, all collected procedures are represented in this domain. The protocol design \nshould specify whether procedure information will be collected.Measurements obtained from procedures are to be represented in their respective \nFindings domain(s). For example, a biopsy may be performed to obtain a tissue sample that is then evaluated histopathologically. In this case, details of \nthe biopsy procedure can be represented in the PR domain and the histopathology findings in the Microscopic Findings (MI) domain. Describing the \nrelationship between PR and MI records (in RELREC) in this example is dependent on whether the relationship is collected, either explicitly or \nimplicitly. \n2. In the Findings Observation Class, the test method is represented in the --METHOD variable (e.g., electrophoresis, gram stain, polymerase chain \nreaction). At times, the test method overlaps with diagnostic/therapeutic procedures (e.g., ultrasound, MRI, x-ray) in-scope for the PR domain. The \nfollowing is recommended: If timing (start, end or duration) or an indicator populating PROCCUR, PRSTAT, or PRREASND is collected, then a PR \nrecord should be created. If only the findings from a procedure are collected, then --METHOD in the Findings domain(s) may be sufficient to reflect the \nprocedure and a related PR record is optional. It is at the sponsor\u2019s discretion whether to represent the procedure as both a test method (--METHOD) \nand related PR record. \n3. PRINDC is used to represent a medical indication, a medical condition which makes a treatment advisable. The reason for a procedure may be \nsomething other than a medical indication. For example, an x-ray might be taken to determine whether a fracture was present. Reasons other than \nmedical indications should be represented using the supplemental qualifier PRREAS (see Appendix C1, Supplemental Qualifiers Name Codes). \n4. Any identifier variables, timing variables, or interventions general observation-class qualifiers may be added to the PR domain, but the following \nqualifiers would generally not be used: --MOOD, --LOT.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3396, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c36481dc-3fb8-4345-8d11-e961cf0d9e14": {"__data__": {"id_": "c36481dc-3fb8-4345-8d11-e961cf0d9e14", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 127, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48d35682-eb3f-4915-8b06-9ee157a3fbbc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 127, "section": "UNSPECIFIED"}, "hash": "dad501f00feaed36f5cfecb286484793ececf080dd6344c434da5e010d049af0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fa6d9118-32fb-4c7a-965e-551670d4aebc", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 127, "section": "UNSPECIFIED"}, "hash": "73155b5ca7303f0ba8f6f00f43157499a1aab875a4a5778dede7f4dd1209bb0e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If only the findings from a procedure are collected, then --METHOD in the Findings domain(s) may be sufficient to reflect the \nprocedure and a related PR record is optional. It is at the sponsor\u2019s discretion whether to represent the procedure as both a test method (--METHOD) \nand related PR record. \n3. PRINDC is used to represent a medical indication, a medical condition which makes a treatment advisable. The reason for a procedure may be \nsomething other than a medical indication. For example, an x-ray might be taken to determine whether a fracture was present. Reasons other than \nmedical indications should be represented using the supplemental qualifier PRREAS (see Appendix C1, Supplemental Qualifiers Name Codes). \n4. Any identifier variables, timing variables, or interventions general observation-class qualifiers may be added to the PR domain, but the following \nqualifiers would generally not be used: --MOOD, --LOT. \nPR \u2013 Examples \nExample 1 \nA procedures log CRF may collect verbatim values (procedure names) and dates performed. This example shows a subject who had 5 procedures collected and \nrepresented in the PR domain. In this study, the sponsor chose to consider verbatim text in PRTRT as long text represented in mixed case. See Section 4.2.4, Text \nCase in Submitted Data.", "mimetype": "text/plain", "start_char_idx": 2464, "end_char_idx": 3763, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d3eb32fc-147d-437c-9b73-f5b1e8b8029b": {"__data__": {"id_": "d3eb32fc-147d-437c-9b73-f5b1e8b8029b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 128, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "19f35486-7398-482a-8e54-27fcdf03cbcb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 128, "section": "UNSPECIFIED"}, "hash": "ed4946deee65d745d6971cb4684477d518d94fc8424395936864fc152bffa827", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "37aeff13-d27c-4e70-b089-b1ecf27bfbfd", "node_type": "1", "metadata": {}, "hash": "3e35f8c91b5bcf90b9b87257b4853942964759c42d758fb41f485cd57f754563", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 128 \n2021-11-29 \npr.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nPRSEQ \nPRTRT \nPRSTDTC \nPRENDTC \n1 \nXYZ \nPR \nXYZ789-002 \n1 \nWisdom Teeth Extraction \n2010-06-08 \n2010-06-08 \n2 \nXYZ \nPR \nXYZ789-002 \n2 \nReset Broken Arm \n2010-08-06 \n2010-08-06 \n3 \nXYZ \nPR \nXYZ789-002 \n3 \nProstate Examination \n2010-12-12 \n2010-12-12 \n4 \nXYZ \nPR \nXYZ789-002 \n4 \nEndoscopy \n2010-12-12 \n2010-12-12 \n5 \nXYZ \nPR \nXYZ789-002 \n5 \nHeart Transplant \n2011-08-29 \n2011-08-29 \nExample 2 \nThis example shows data from a 24-hour Holter monitor, an ambulatory electrocardiography device that records a continuous electrocardiographic rhythm \npattern. \nThe start and end of the Holter monitoring procedure are represented in the PR domain. \npr.xpt \nRow STUDYID DOMAIN USUBJID \nPRSEQ PRLNKID \nPRTRT \nPRDECOD \nPRPRESP PROCCUR PRSTDTC \nPRENDTC \n1 \nABC123 \nPR \nABC123-\n001 \n1 \n20110101_20110102 24-HOUR HOLTER \nMONITOR \nHOLTER CONTINUOUS ECG \nRECORDING \nY \nY \n2011-01-\n01T08:00 \n2011-01-\n02T09:45 \nThe heart rate findings from the procedure are represented in the ECG Test Results (EG) domain. \neg.xpt \nRow STUDYID DOMAIN USUBJID \nEGSEQ EGLNKID \nEGTESTCD \nEGTEST \nEGORRES EGORRESU EGMETHOD \nEGDTC \nEGENDTC \n1 \nABC123 \nEG \nABC123-\n001 \n1 \n20110101_20110102 EGHRMIN \nECG Minimum \nHeart Rate \n70 \nbeats/min \nHOLTER CONTINUOUS ECG \nRECORDING \n2011-01-\n01T08:00 \n2011-01-\n02T09:45 \n2 \nABC123 \nEG \nABC123-\n001 \n2 \n20110101_20110102 EGHRMAX \nECG Maximum \nHeart Rate \n100 \nbeats/min \nHOLTER CONTINUOUS ECG \nRECORDING \n2011-01-\n01T08:00 \n2011-01-\n02T09:45 \n3 \nABC123 \nEG \nABC123-\n001 \n3 \n20110101_20110102 EGHRMEAN ECG Mean Heart \nRate \n75 \nbeats/min \nHOLTER CONTINUOUS ECG \nRECORDING \n2011-01-\n01T08:00 \n2011-01-\n02T09:45 \nThe relrec.xpt reflects a one-to-many dataset-level relationship between PR and EG using --LNKID.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1943, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "37aeff13-d27c-4e70-b089-b1ecf27bfbfd": {"__data__": {"id_": "37aeff13-d27c-4e70-b089-b1ecf27bfbfd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 128, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "19f35486-7398-482a-8e54-27fcdf03cbcb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 128, "section": "UNSPECIFIED"}, "hash": "ed4946deee65d745d6971cb4684477d518d94fc8424395936864fc152bffa827", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d3eb32fc-147d-437c-9b73-f5b1e8b8029b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 128, "section": "UNSPECIFIED"}, "hash": "841275c61b5a38515ec9d0b5dfdffba3263c2d58f4984733e8b18bb16d307e04", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "relrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC123 \nPR \n \nPRLNKID  \nONE \n1 \n2 \nABC123 \nEG \n \nEGLNKID  \nMANY \n1 \nExample 3 \nThis example shows data for 3 subjects who had on-study radiotherapy. Dose, dose unit, location, and timing are represented. In this study, the sponsor chose to \nconsider verbatim text in PRTRT as long text represented in mixed case. See Section 4.2.4, Text Case in Submitted Data. \npr.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nPRSEQ \nPRTRT \nPRDOSE \nPRDOSU \nPRLOC \nPRLAT \nPRSTDTC \nPRENDTC \n1 \nABC123 \nPR \nABC123-1001 \n1 \nExternal beam radiation therapy \n70 \nGy \nBREAST \nRIGHT \n2011-06-01 \n2011-06-25 \n2 \nABC123 \nPR \nABC123-2002 \n1 \nBrachytherapy \n25 \nGy \nPROSTATE \n \n2011-07-15 \n2011-07-15 \n3 \nABC123 \nPR \nABC123-3003 \n1 \nRadiotherapy \n300 \ncGy \nBONE \n \n2011-08-19 \n2011-08-22", "mimetype": "text/plain", "start_char_idx": 1945, "end_char_idx": 2767, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "64e6460a-140b-4575-8f11-f7eb7963ca9b": {"__data__": {"id_": "64e6460a-140b-4575-8f11-f7eb7963ca9b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 129, "section": "6.1.6 Substance Use (SU)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "983da09d-ba54-429d-a948-d560d34e0296", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 129, "section": "6.1.6 Substance Use (SU)"}, "hash": "1514c1a329a2cb6595d9194fa5bfb3cfcaae034d84e258308ad148d4e4948b26", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d686cd7-5f30-4e33-8770-74f06f4c50c0", "node_type": "1", "metadata": {}, "hash": "66332a161070bc17f930c440e6c21df0d7bb67b2e125c43b880fa248e6b3f265", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SU \u2013 Description/Overview \nAn interventions domain that contains substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects \nof chronic substance use. \nSU \u2013 Specification \nsu.xpt, Substance Use \u2014 Interventions. One record per substance type per reported occurrence per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar SU \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the \nproduct. \nReq \nSUSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid number. Req \nSUGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nSUSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined in \nthe sponsor's operational database. Example: Line number on a Tobacco & Alcohol Use CRF page. \nPerm \nSUTRT \nReported Name of \nSubstance \nChar  \nTopic \nSubstance name. Examples: \"CIGARETTES\", \"COFFEE\". \nReq \nSUMODIFY \nModified Substance \nName \nChar  \nSynonym \nQualifier \nIf SUTRT is modified, then the modified text is placed here. \nPerm \nSUDECOD \nStandardized \nSubstance Name \nChar * \nSynonym \nQualifier \nStandardized or dictionary-derived text description of SUTRT or SUMODIFY if the sponsor chooses to code \nthe substance use. The sponsor is expected to provide the dictionary name and version used to map the \nterms utilizing the external codelist element in the Define-XML document. \nPerm \nSUCAT \nCategory for \nSubstance Use \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. Examples: \"TOBACCO\", \"ALCOHOL\", or \"CAFFEINE\". \nPerm \nSUSCAT \nSubcategory for \nSubstance Use \nChar * \nGrouping \nQualifier \nA further categorization of substance use. Examples: \"CIGARS\", \"CIGARETTES\", \"BEER\", \"WINE\". \nPerm \nSUPRESP \nSU Pre-Specified \nChar (NY) \nVariable \nQualifier \nUsed to indicate whether (\"Y\"/null) information about the use of a specific substance was solicited on the \nCRF. \nPerm \nSUOCCUR \nSU Occurrence \nChar (NY) \nRecord \nQualifier \nWhen the use of specific substances is solicited, SUOCCUR is used to indicate whether (\"Y\"/\"N\") a particular \nprespecified substance was used. Values are null for substances not specifically solicited. \nPerm \nSUSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nWhen the use of prespecified substances is solicited, the completion status indicates that there was no \nresponse to the question about the prespecified substance. When there is no prespecified list on the CRF, \nthen the completion status indicates that substance use was not assessed for the subject.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3104, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d686cd7-5f30-4e33-8770-74f06f4c50c0": {"__data__": {"id_": "6d686cd7-5f30-4e33-8770-74f06f4c50c0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 129, "section": "6.1.6 Substance Use (SU)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "983da09d-ba54-429d-a948-d560d34e0296", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 129, "section": "6.1.6 Substance Use (SU)"}, "hash": "1514c1a329a2cb6595d9194fa5bfb3cfcaae034d84e258308ad148d4e4948b26", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "64e6460a-140b-4575-8f11-f7eb7963ca9b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 129, "section": "6.1.6 Substance Use (SU)"}, "hash": "6283ba8b2a998fbadfa8fcd4072ac36c665dbe43c8602ee0de4248f4981dfc56", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nSUPRESP \nSU Pre-Specified \nChar (NY) \nVariable \nQualifier \nUsed to indicate whether (\"Y\"/null) information about the use of a specific substance was solicited on the \nCRF. \nPerm \nSUOCCUR \nSU Occurrence \nChar (NY) \nRecord \nQualifier \nWhen the use of specific substances is solicited, SUOCCUR is used to indicate whether (\"Y\"/\"N\") a particular \nprespecified substance was used. Values are null for substances not specifically solicited. \nPerm \nSUSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nWhen the use of prespecified substances is solicited, the completion status indicates that there was no \nresponse to the question about the prespecified substance. When there is no prespecified list on the CRF, \nthen the completion status indicates that substance use was not assessed for the subject. \nPerm \nSUREASND \nReason Substance \nUse Not Collected \nChar  \nRecord \nQualifier \nDescribes the reason substance use was not collected. Used in conjunction with SUSTAT when value of \nSUSTAT is \"NOT DONE\". \nPerm \nSUCLAS \nSubstance Use \nClass \nChar * \nVariable \nQualifier \nSubstance use class. May be obtained from coding. When coding to a single class, populate with class \nvalue. If using a dictionary and coding to multiple classes, then follow Section 4.2.8.3, Multiple Values for a \nNon-result Qualifier Variable, or omit SUCLAS. \nPerm \nSUCLASCD \nSubstance Use \nClass Code \nChar * \nVariable \nQualifier \nCode corresponding to SUCLAS. May be obtained from coding. \nPerm \nSUDOSE \nSubstance Use \nConsumption \nNum  \nRecord \nQualifier \nAmount of SUTRT consumed. Not populated if SUDOSTXT is populated. \nPerm", "mimetype": "text/plain", "start_char_idx": 2298, "end_char_idx": 3907, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3e096d5a-294a-4d4f-a035-2499adccf46a": {"__data__": {"id_": "3e096d5a-294a-4d4f-a035-2499adccf46a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 130, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f9373df2-55be-4a05-949e-771fa578692b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 130, "section": "UNSPECIFIED"}, "hash": "a4e61c898a2db3281be208aac462c5ccd3f2b11832ae907694d08ad0504dc5cf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "cd789ae6-075f-48b7-8ee6-ef29e4e134e1", "node_type": "1", "metadata": {}, "hash": "f22a46f784ce3c6d12f5e41234397c798213733489f845af561612c0758a14f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 130 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSUDOSTXT \nSubstance Use \nConsumption Text \nChar  \nRecord \nQualifier \nSubstance use consumption amounts or a range of consumption information collected in text form. Not \npopulated if SUDOSE is populated. \nPerm \nSUDOSU \nConsumption Units \nChar (UNIT) \nVariable \nQualifier \nUnits for SUDOSE, SUDOSTOT, or SUDOSTXT. Examples: \"oz\", \"CIGARETTE\", \"PACK\", \"g\". \nPerm \nSUDOSFRM Dose Form \nChar (FRM) \nVariable \nQualifier \nDose form for SUTRT. Examples: \"INJECTABLE\", \"LIQUID\", \"POWDER\". \nPerm \nSUDOSFRQ \nUse Frequency Per \nInterval \nChar (FREQ) \nVariable \nQualifier \nUsually expressed as the number of repeated administrations of SUDOSE within a specific time period. \nExample: \"Q24H\" (every day). \nPerm \nSUDOSTOT \nTotal Daily \nConsumption \nNum  \nRecord \nQualifier \nTotal daily use of SUTRT using the units in SUDOSU. Used when dosing is collected as total daily dose. If a \nsponsor needs to aggregate the data over a period other than daily, then the aggregated total could be \nrecorded in a supplemental qualifier variable. \nPerm \nSUROUTE \nRoute of \nAdministration \nChar (ROUTE) \nVariable \nQualifier \nRoute of administration for SUTRT. Examples: \"ORAL\", \"INTRAVENOUS\". \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the substance \nuse started. Null for substances that started before study participation. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the substance use. Null for substances that started before study \nparticipation. \nPerm \nSUSTDTC \nStart Date/Time of \nSubstance Use \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nStart date/time of the substance use represented in ISO 8601 character format. \nPerm \nSUENDTC \nEnd Date/Time of \nSubstance Use \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nEnd date/time of the substance use represented in ISO 8601 character format. \nPerm \nSUSTDY \nStudy Day of Start \nof Substance Use \nNum  \nTiming \nStudy day of start of substance use relative to the sponsor-defined RFSTDTC. \nPerm \nSUENDY \nStudy Day of End \nof Substance Use \nNum  \nTiming \nStudy day of end of substance use relative to the sponsor-defined RFSTDTC. \nPerm \nSUDUR \nDuration of \nSubstance Use \nChar ISO 8601 \nduration \nTiming \nCollected duration of substance use in ISO 8601 format. Used only if collected on the CRF and not derived \nfrom start and end date/times. \nPerm \nSUSTRF \nStart Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the start of the substance use relative to the sponsor-defined reference period.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2890, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cd789ae6-075f-48b7-8ee6-ef29e4e134e1": {"__data__": {"id_": "cd789ae6-075f-48b7-8ee6-ef29e4e134e1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 130, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f9373df2-55be-4a05-949e-771fa578692b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 130, "section": "UNSPECIFIED"}, "hash": "a4e61c898a2db3281be208aac462c5ccd3f2b11832ae907694d08ad0504dc5cf", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3e096d5a-294a-4d4f-a035-2499adccf46a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 130, "section": "UNSPECIFIED"}, "hash": "e75b31c807bc5d765f8a454c29247bdbd1305649bf0c54c3223fcc27ad3ba7e1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nSUSTDY \nStudy Day of Start \nof Substance Use \nNum  \nTiming \nStudy day of start of substance use relative to the sponsor-defined RFSTDTC. \nPerm \nSUENDY \nStudy Day of End \nof Substance Use \nNum  \nTiming \nStudy day of end of substance use relative to the sponsor-defined RFSTDTC. \nPerm \nSUDUR \nDuration of \nSubstance Use \nChar ISO 8601 \nduration \nTiming \nCollected duration of substance use in ISO 8601 format. Used only if collected on the CRF and not derived \nfrom start and end date/times. \nPerm \nSUSTRF \nStart Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the start of the substance use relative to the sponsor-defined reference period. The sponsor-\ndefined reference period is a continuous period of time defined by a discrete starting point and a discrete \nending point (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\" \nwas collected, this information may be translated into SUSTRF. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nSUENRF \nEnd Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the end of the substance use with relative to the sponsor-defined reference period. The sponsor-\ndefined reference period is a continuous period of time defined by a discrete starting point and a discrete \nending point (represented by RFSTDTC and RFENDTC in Demographics). If information such as \"PRIOR\", \n\"ONGOING\", or \"CONTINUING\" was collected, this information may be translated into SUENRF. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nSUSTRTPT \nStart Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the start of the substance as being before or after the reference time point defined by variable \nSUSTTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7 , Use of Relative Timing \nVariables. \nPerm \nSUSTTPT \nStart Reference \nTime Point \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the reference point referred to by SUSTRTPT. \nExamples: \"2003-12-15\", \"VISIT 1\". \nPerm \nSUENRTPT \nEnd Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the end of the substance as being before or after the reference time point defined by variable \nSUENTPT. \nPerm", "mimetype": "text/plain", "start_char_idx": 2229, "end_char_idx": 4611, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "07e24637-d937-4678-8a86-157ac391ec38": {"__data__": {"id_": "07e24637-d937-4678-8a86-157ac391ec38", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 131, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7d5024f8-d8a4-449e-b420-752f59e058a9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 131, "section": "UNSPECIFIED"}, "hash": "6f64754554b93ef286063d3a4b441bdb19c97834947bb22917cfdef89632fe89", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 131 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nNot all values of the codelist are allowable for this variable. See Section 4.4.7 , Use of Relative Timing \nVariables. \nSUENTPT \nEnd Reference \nTime Point \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the reference point referred to by SUENRTPT. \nExamples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nSU \u2013 Assumptions \n1. Substance use information may be independent of planned study evaluations, or may be a key outcome (e.g., planned evaluation) of a clinical trial. \na. \nIn many clinical trials, detailed substance use information as provided for in the domain model above may not be required (e.g., the only \ninformation collected may be a response to the question \u201cHave you ever smoked tobacco?\u201d); in such cases, many of the qualifier variables would \nnot be submitted. \nb. SU may contain responses to questions about use of prespecified substances as well as records of substance use collected as free text. \n2. SU description and coding \na. \nSUTRT captures the verbatim or the prespecified text collected for the substance. It is the topic variable for the SU dataset. SUTRT is a required \nvariable and must have a value. \nb. SUMODIFY is a permissible variable and should be included if coding is performed and the sponsor\u2019s procedure permits modification of a \nverbatim substance use term for coding. The modified term is listed in SUMODIFY. The variable may be populated as per the sponsor\u2019s \nprocedures. \nc. \nSUDECOD is the preferred term derived by the sponsor from the coding dictionary if coding is performed. It is a permissible variable. Where \ndeemed necessary by the sponsor, the verbatim term (SUTRT) should be coded using a standard dictionary such as WHO Drug. The sponsor is \nexpected to provide the dictionary name and version used to map the terms utilizing the external codelist element in the Define-XML document. \n3. Additional categorization and grouping \na. \nSUCAT and SUSCAT should not be redundant with the domain code or dictionary classification provided by SUDECOD, or with SUTRT. That is, \nthey should provide a different means of defining or classifying SU records. For example, a sponsor may be interested in identifying all substances \nthat the investigator feels might represent opium use, and to collect such use on a separate CRF page. This categorization might differ from the \ncategorization derived from the coding dictionary. \nb. SUGRPID may be used to link (or associate) different records together to form a block of related records within SU at the subject level (see Section \n4.2.6, Grouping Variables and Categorization). It should not be used in place of SUCAT or SUSCAT. \n4. Timing variables \na. \nSUSTDTC and SUENDTC may be populated as required. \nb. If substance use information is collected more than once within the CRF (indicating that the data are visit-based) then VISITNUM would be added \nto the domain as an additional timing variable. VISITDY and VISIT would then be permissible variables.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3425, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "96a108ac-c086-4222-b8ec-3b6f32e82ff1": {"__data__": {"id_": "96a108ac-c086-4222-b8ec-3b6f32e82ff1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 132, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "148f5249-29aa-4f19-8e1c-f8eb619f17f0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 132, "section": "UNSPECIFIED"}, "hash": "b8e1224ee1112017dae92f5fe730c728afb98a7e33b4d453cf1cf30c7894dc3b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 132 \n2021-11-29 \n5. Any additional qualifiers from the Interventions class may be added to the SU domain, but the following qualifiers would generally not be used: --\nMOOD, --LOT. \nSU \u2013 Examples \nExample 1 \nThis example illustrates how typical SU data could be populated. Here, the CRF collected: \n\u2022 \nSmoking data \no \nSmoking status of \"previous\", \"current\", or \"never\" \no \nIf a current or past smoker, number of packs per day \no \nIf a former smoker, the year the subject quit \n\u2022 \n Current caffeine use \no \nWhat caffeine drinks subjects consumed today \no \nHow many cups today \nSUCAT allows the records to be grouped into smoking-related data and caffeine-related data. In this example, the treatments are prespecified on the CRF page, \nso SUTRT does not require a standardized SUDECOD equivalent. \nNot shown: A subject who never smoked does not have a tobacco record. Alternatively, a row for the subject could have been included with SUOCCUR = \"N\" \nand null dosing and timing fields; the interpretation would be the same. A subject who did not drink any caffeinated drinks on the day of the assessment does not \nhave any caffeine records. A subject who never smoked and did not drink caffeinated drinks on the day of the assessment does not appear in the dataset. \nRow 1: \nSubject 1234005 is a 2-pack/day current smoker. \u201cCurrent\u201d implies that smoking started sometime before the time the question was asked \n(SUSTTPT = \"2006-01-01\", SUSTRTPT = \"BEFORE\") and had not ended as of that date (SUENTTP = \"2006-01-01\", SUENRTPT = \n\"ONGOING\"). See Section 4.4.7, Use of Relative Timing Variables for the use of these variables. Both the beginning and ending reference time \npoints for this question are the date of the assessment. \nRow 2: \nSubject 1234005 drank 3 cups of coffee on the day of the assessment. \nRow 3: \nSubject 1234006 is a former smoker. The date this subject began smoking is unknown, but it was sometime before the assessment date; this is \nshown by the values of SUSTTPT and SUSTRTPT. The end date of smoking was collected, so SUENTPT and SUENRTPT are not populated. \nInstead, the end date is in SUENDTC. \nRow 4: \nSubject 1234006 drank tea on the day of the assessment. \nRow 5: \nSubject 1234006 drank coffee on the day of the assessment. \nRow 6: \nSubject 1234007 had missing data for the smoking questions; this is indicated by SUSTAT = \"NOT DONE\". The reason is in SUREASND. \nRow 7: \nSubject 1234007 also had missing data for all of the caffeine questions.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2650, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f1a9dcb1-a013-4b3c-8b41-3f563244f750": {"__data__": {"id_": "f1a9dcb1-a013-4b3c-8b41-3f563244f750", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 133, "section": "6.2 Models for Events Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eeaae70e-8bf2-4d5e-aa65-18464b168555", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 133, "section": "6.2 Models for Events Domains"}, "hash": "5e71a1b750d7b63d224bf57abf7b28940ff79c1ef8b2fc861db78a25b84ae842", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Most subject-level observations collected during the study should be represented according to one of the 3 SDTM general observation classes. The following \ndomains correspond to the Events class: \nAdverse Events (AE) \nBiospecimen Events (BE) \nClinical Events (CE) \nDisposition (DS) \nHealthcare Encounters (HO) \nMedical History (MH) \nProtocol Deviations (DV)", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 357, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c7773769-b664-4807-a96c-bb5bc4ef6764": {"__data__": {"id_": "c7773769-b664-4807-a96c-bb5bc4ef6764", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 134, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cf70586c-3ecf-460b-95af-531cbdf007af", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 134, "section": "UNSPECIFIED"}, "hash": "13c8895342a04536a652dd9f3f00bc30d8bbb1416f78b7608bb21fc6cad8798d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a60db4d2-2354-49fa-a8e2-b4c4c07a58ff", "node_type": "1", "metadata": {}, "hash": "63811de0ecfeb91e739c45e9e3e30e1d23ab31ba38e3f86964ec412acd2d8594", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 134 \n2021-11-29 \nAE \u2013 Specification \nae.xpt, Adverse Events \u2014 Events. One record per adverse event per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar AE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nSPDEVID \nSponsor Device \nIdentifier \nChar  \nIdentifier \nA sequence of characters used by the sponsor to uniquely identify a specific device. Used to represent a \ndevice associated in some way with the adverse event. SPDEVID values are defined in the Device \nIdentifiers (DI) domain. \nPerm \nAESEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nAEGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nAEREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier such as a serial number on an SAE reporting form. \nPerm \nAESPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. It may be preprinted on the CRF as an explicit line identifier or defined in the \nsponsor's operational database. Example: Line number on an Adverse Events CRF page. \nPerm \nAETERM \nReported Term for the \nAdverse Event \nChar  \nTopic \nVerbatim name of the event. \nReq \nAEMODIFY \nModified Reported \nTerm \nChar  \nSynonym \nQualifier \nIf AETERM is modified to facilitate coding, then AEMODIFY will contain the modified text. \nPerm \nAELLT \nLowest Level Term \nChar MedDRA \nVariable \nQualifier \nDictionary-derived text description of the lowest level term. \nExp \nAELLTCD \nLowest Level Term \nCode \nNum MedDRA \nVariable \nQualifier \nDictionary-derived code for the lowest level term. \nExp \nAEDECOD \nDictionary-Derived \nTerm \nChar MedDRA \nSynonym \nQualifier \nDictionary-derived text description of AETERM or AEMODIFY. Equivalent to the Preferred Term (PT in \nMedDRA). The sponsor is expected to provide the dictionary name and version used to map the terms \nutilizing the external codelist element in the Define-XML document. \nReq \nAEPTCD \nPreferred Term Code \nNum MedDRA \nVariable \nQualifier \nDictionary-derived code for the preferred term. \nExp \nAEHLT \nHigh Level Term \nChar MedDRA \nVariable \nQualifier \nDictionary-derived text description of the high level term for the primary system organ class (SOC). \nExp \nAEHLTCD \nHigh Level Term Code \nNum MedDRA \nVariable \nQualifier \nDictionary-derived code for the high level term for the primary SOC. \nExp \nAEHLGT \nHigh Level Group Term Char MedDRA \nVariable \nQualifier \nDictionary-derived text description of the high level group term for the primary SOC.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3150, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a60db4d2-2354-49fa-a8e2-b4c4c07a58ff": {"__data__": {"id_": "a60db4d2-2354-49fa-a8e2-b4c4c07a58ff", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 134, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cf70586c-3ecf-460b-95af-531cbdf007af", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 134, "section": "UNSPECIFIED"}, "hash": "13c8895342a04536a652dd9f3f00bc30d8bbb1416f78b7608bb21fc6cad8798d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c7773769-b664-4807-a96c-bb5bc4ef6764", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 134, "section": "UNSPECIFIED"}, "hash": "1da7b8a01909aa8b86c6b08f0cd256af8f25915963b47c81ca041aee36a4624d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Equivalent to the Preferred Term (PT in \nMedDRA). The sponsor is expected to provide the dictionary name and version used to map the terms \nutilizing the external codelist element in the Define-XML document. \nReq \nAEPTCD \nPreferred Term Code \nNum MedDRA \nVariable \nQualifier \nDictionary-derived code for the preferred term. \nExp \nAEHLT \nHigh Level Term \nChar MedDRA \nVariable \nQualifier \nDictionary-derived text description of the high level term for the primary system organ class (SOC). \nExp \nAEHLTCD \nHigh Level Term Code \nNum MedDRA \nVariable \nQualifier \nDictionary-derived code for the high level term for the primary SOC. \nExp \nAEHLGT \nHigh Level Group Term Char MedDRA \nVariable \nQualifier \nDictionary-derived text description of the high level group term for the primary SOC. \nExp \nAEHLGTCD \nHigh Level Group Term \nCode \nNum MedDRA \nVariable \nQualifier \nDictionary-derived code for the high level group term for the primary SOC. \nExp \nAECAT \nCategory for Adverse \nEvent \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. Examples: \"BLEEDING\", \"NEUROPSYCHIATRIC\". \nPerm \nAESCAT \nSubcategory for \nAdverse Event \nChar * \nGrouping \nQualifier \nA further categorization of adverse event. Example: \"NEUROLOGIC\". \nPerm \nAEPRESP \nPre-Specified Adverse \nEvent \nChar (NY) \nVariable \nQualifier \nA value of \"Y\" indicates that this adverse event was prespecified on the CRF. Values are null for \nspontaneously reported events (i.e., those collected as free-text verbatim terms). \nPerm \nAEBODSYS Body System or Organ \nClass \nChar * \nRecord \nQualifier \nDictionary derived. Body system or organ class used by the sponsor from the coding dictionary (e.g., \nMedDRA). When using a multi-axial dictionary such as MedDRA, this should contain the SOC used for \nthe sponsor's analyses and summary tables, which may not necessarily be the primary SOC. \nExp", "mimetype": "text/plain", "start_char_idx": 2367, "end_char_idx": 4231, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8c782232-abee-49f9-b91c-14eff4cb929d": {"__data__": {"id_": "8c782232-abee-49f9-b91c-14eff4cb929d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 135, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b666503f-2dcc-4c92-a1bd-ba8d92062a38", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 135, "section": "UNSPECIFIED"}, "hash": "527adb8a064b900c090fc75fb8561bc0ace5822b544e699d80a3b85c0ce0b957", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c6e0f797-f675-49a9-a913-326d96136e05", "node_type": "1", "metadata": {}, "hash": "1cbc476ddfb8804d67461b1d3420e103170cb498d00e33f2ed32537d16be0567", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 135 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nAEBDSYCD Body System or Organ \nClass Code \nNum MedDRA \nVariable \nQualifier \nDictionary derived. Code for the body system or organ class used by the sponsor. When using a multi-\naxial dictionary such as MedDRA, this should contain the SOC used for the sponsor's analyses and \nsummary tables, which may not necessarily be the primary SOC. \nExp \nAESOC \nPrimary System Organ \nClass \nChar MedDRA \nVariable \nQualifier \nDictionary-derived text description of the primary SOC. Will be the same as AEBODSYS if the primary \nSOC was used for analysis. \nExp \nAESOCCD \nPrimary System Organ \nClass Code \nNum MedDRA \nVariable \nQualifier \nDictionary-derived code for the primary SOC. Will be the same as AEBDSYCD if the primary SOC was \nused for analysis. \nExp \nAELOC \nLocation of Event \nChar (LOC) \nRecord \nQualifier \nDescribes anatomical location relevant for the event (e.g., \"ARM\" for skin rash). \nPerm \nAESEV \nSeverity/Intensity \nChar (AESEV) \nRecord \nQualifier \nThe severity or intensity of the event. Examples: \"MILD\", \"MODERATE\", \"SEVERE\". \nPerm \nAESER \nSerious Event \nChar (NY) \nRecord \nQualifier \nIs this a serious event? Valid values are \"Y\" and \"N\". \nExp \nAEACN \nAction Taken with \nStudy Treatment \nChar (ACN) \nRecord \nQualifier \nDescribes changes to the study treatment as a result of the event. AEACN is specifically for the \nrelationship to study treatment. AEACNOTH is for actions unrelated to dose adjustments of study \ntreatment. Examples of AEACN values include ICH E2B values: \"DRUG WITHDRAWN\", \"DOSE \nREDUCED\", \"DOSE INCREASED\", \"DOSE NOT CHANGED\", \"UNKNOWN\" and \"NOT APPLICABLE\". \nExp \nAEACNOTH Other Action Taken \nChar  \nRecord \nQualifier \nDescribes other actions taken as a result of the event that are unrelated to dose adjustments of study \ntreatment. Usually reported as free text. Example: \"TREATMENT UNBLINDED. PRIMARY CARE \nPHYSICIAN NOTIFIED\". \nPerm \nAEACNDEV Action Taken with \nDevice \nChar (DEACNDEV) \nRecord \nQualifier \nAn action taken with a device as the result of the event. The device may or may not be a device under \nstudy. \nPerm \nAEREL \nCausality \nChar * \nRecord \nQualifier \nRecords the investigator's opinion as to the causality of the event to the treatment. ICH does not \nestablish any required or recommended terms for non-device relatedness. ICH E2A and E2B examples \ninclude (up-cased here for alignment to SDTM conventions) terms such as \"NOT RELATED\", \"UNLIKELY \nRELATED\", \"POSSIBLY RELATED\", \"RELATED\", but these example terms do not establish any \nconventions or expectations. Controlled terminology may be defined in the future. Check with regulatory \nauthority for population of this variable.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2929, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c6e0f797-f675-49a9-a913-326d96136e05": {"__data__": {"id_": "c6e0f797-f675-49a9-a913-326d96136e05", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 135, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b666503f-2dcc-4c92-a1bd-ba8d92062a38", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 135, "section": "UNSPECIFIED"}, "hash": "527adb8a064b900c090fc75fb8561bc0ace5822b544e699d80a3b85c0ce0b957", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8c782232-abee-49f9-b91c-14eff4cb929d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 135, "section": "UNSPECIFIED"}, "hash": "2f14ee8744f1d7011f73dee07b8eeb63d6632b061c151186a9c3898983499bd5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PRIMARY CARE \nPHYSICIAN NOTIFIED\". \nPerm \nAEACNDEV Action Taken with \nDevice \nChar (DEACNDEV) \nRecord \nQualifier \nAn action taken with a device as the result of the event. The device may or may not be a device under \nstudy. \nPerm \nAEREL \nCausality \nChar * \nRecord \nQualifier \nRecords the investigator's opinion as to the causality of the event to the treatment. ICH does not \nestablish any required or recommended terms for non-device relatedness. ICH E2A and E2B examples \ninclude (up-cased here for alignment to SDTM conventions) terms such as \"NOT RELATED\", \"UNLIKELY \nRELATED\", \"POSSIBLY RELATED\", \"RELATED\", but these example terms do not establish any \nconventions or expectations. Controlled terminology may be defined in the future. Check with regulatory \nauthority for population of this variable. \nExp \nAERLDEV \nRelationship of Event \nto Device \nChar * \nRecord \nQualifier \nA judgment as to the likelihood that the device caused the adverse event. The relationship is to a device \nidentified in the data (i.e., has an SPDEVID). The device may be ancillary or under study. \nTerminology: \n\u2022 \nIn the EU, follow the European Commission Guidelines on Medical Devices, Clinical \nInvestigations: SAE Reporting (MEDDEV 2.7/3) (e.g., Not Related, Unlikely, Possible, \nProbable, Causal Relationship), with device-specific definitions. \n\u2022 \nNo required Controlled Terminology in US. \nPerm \nAERELNST \nRelationship to Non-\nStudy Treatment \nChar  \nRecord \nQualifier \nRecords the investigator's opinion as to whether the event may have been due to a treatment other than \nstudy drug. May be reported as free text. Example: \"MORE LIKELY RELATED TO ASPIRIN USE\". \nPerm \nAEPATT \nPattern of Adverse \nEvent \nChar * \nRecord \nQualifier \nUsed to indicate the pattern of the event over time. Examples: \"INTERMITTENT\", \"CONTINUOUS\", \n\"SINGLE EVENT\". \nPerm \nAEOUT \nOutcome of Adverse \nEvent \nChar (OUT) \nRecord \nQualifier \nDescription of the outcome of an event. \nPerm \nAESCAN \nInvolves Cancer \nChar (NY) \nRecord \nQualifier \nWas the serious event associated with the development of cancer? Valid values are \"Y\" and \"N\". This is a \nlegacy seriousness criterion. It is not included in ICH E2A or E2B. \nPerm \nAESCONG \nCongenital Anomaly or \nBirth Defect \nChar (NY) \nRecord \nQualifier \nWas the serious event associated with congenital anomaly or birth defect? Valid values are \"Y\" and \"N\". \nPerm \nAESDISAB \nPersist or Signif \nDisability/Incapacity \nChar (NY) \nRecord \nQualifier \nDid the serious event result in persistent or significant disability/incapacity? Valid values are \"Y\" and \"N\". \nPerm \nAESDTH \nResults in Death \nChar (NY) \nRecord \nQualifier \nDid the serious event result in death? Valid values are \"Y\" and \"N\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2123, "end_char_idx": 4828, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "78ba2d80-7631-4bfe-8e2f-ac91651265c8": {"__data__": {"id_": "78ba2d80-7631-4bfe-8e2f-ac91651265c8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 136, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "66daea96-6cb5-442a-ab53-9b0c13410d5d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 136, "section": "UNSPECIFIED"}, "hash": "a75939d31566c33277e73fe57804116537c820c8622a1a7a375e2666cd8a86e2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8316e18a-ca4d-4832-91c3-02a4ec0f8685", "node_type": "1", "metadata": {}, "hash": "e8393321b498f12dcea8f62eaca5d810b41a851e244e343f85944c19ee0c5836", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 136 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nAESHOSP \nRequires or Prolongs \nHospitalization \nChar (NY) \nRecord \nQualifier \nDid the serious event require or prolong hospitalization? Valid values are \"Y\" and \"N\". \nPerm \nAESLIFE \nIs Life Threatening \nChar (NY) \nRecord \nQualifier \nWas the serious event life-threatening? Valid values are \"Y\" and \"N\". \nPerm \nAESOD \nOccurred with \nOverdose \nChar (NY) \nRecord \nQualifier \nDid the serious event occur with an overdose? Valid values are \"Y\" and \"N\". This is a legacy seriousness \ncriterion. It is not included in ICH E2A or E2B. \nPerm \nAESMIE \nOther Medically \nImportant Serious \nEvent \nChar (NY) \nRecord \nQualifier \nDo additional categories for seriousness apply? Valid values are \"Y\" and \"N\". \nPerm \nAESINTV \nNeeds Intervention to \nPrevent Impairment \nChar (NY) \nRecord \nQualifier \nRecords whether medical or surgical intervention was necessary to preclude permanent impairment of a \nbody function, or to prevent permanent damage to a body structure, with either situation suspected to be \ndue to the use of a medical product. This variable is used in conjunction with the other \"seriousness\" \nvariables (e.g., fatal, life-threatening). It is part of the US federal government definition of a serious \nadverse event; see 21 CFR Part 803.3(w)(3). \nPerm \nAEUNANT \nUnanticipated Adverse \nDevice Effect \nChar (NY) \nRecord \nQualifier \nAny serious adverse effect on health or safety or any life-threatening problem or death caused by or \nassociated with a device, if that effect, problem, or death was not previously identified in nature, severity, \nor degree of incidence in the investigational plan or application (including a supplementary plan or \napplication), \nor \nany other unanticipated serious problem associated with a device that relates to the rights, safety, or \nwelfare of subjects. (21 CFR Part 812.3(s)). \nThis variable applies only to serious AEs and should hold collected data; if the value is derived, it should \nbe held in ADaM. \nPerm \nAERLPRT \nRel of AE to Non-Dev-\nRel Study Activity \nChar * \nRecord \nQualifier \nThe investigator's opinion as to the causality of the event as related to other protocol-required activities, \nactions, or assessments (e.g., medication changes, tests/assessments, other procedures). The \nrelationship is to a protocol-specified, non-device-related activity where the device is identified in the data \n(i.e., has an SPDEVID). The device may be ancillary or under study. \nTerminology: \n\u2022 \nIn the EU, follow the European Commission Guidelines on Medical Devices, Clinical \nInvestigations: SAE Reporting (MEDDEV 2.7/3) (e.g., Not Related, Unlikely, Possible, \nProbable, Causal Relationship), with device-specific definitions. \n\u2022 \nNo required Controlled Terminology in US.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3011, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8316e18a-ca4d-4832-91c3-02a4ec0f8685": {"__data__": {"id_": "8316e18a-ca4d-4832-91c3-02a4ec0f8685", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 136, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "66daea96-6cb5-442a-ab53-9b0c13410d5d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 136, "section": "UNSPECIFIED"}, "hash": "a75939d31566c33277e73fe57804116537c820c8622a1a7a375e2666cd8a86e2", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "78ba2d80-7631-4bfe-8e2f-ac91651265c8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 136, "section": "UNSPECIFIED"}, "hash": "4c53d5dea2067baac244dc7ba19c2c8ea1d7a4b701e03561bfece61b17a47525", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nAERLPRT \nRel of AE to Non-Dev-\nRel Study Activity \nChar * \nRecord \nQualifier \nThe investigator's opinion as to the causality of the event as related to other protocol-required activities, \nactions, or assessments (e.g., medication changes, tests/assessments, other procedures). The \nrelationship is to a protocol-specified, non-device-related activity where the device is identified in the data \n(i.e., has an SPDEVID). The device may be ancillary or under study. \nTerminology: \n\u2022 \nIn the EU, follow the European Commission Guidelines on Medical Devices, Clinical \nInvestigations: SAE Reporting (MEDDEV 2.7/3) (e.g., Not Related, Unlikely, Possible, \nProbable, Causal Relationship), with device-specific definitions. \n\u2022 \nNo required Controlled Terminology in US. \nPerm \nAERLPRC \nRel of AE to Device-\nRelated Procedure \nChar * \nRecord \nQualifier \nThe investigator's opinion as to the likelihood that the device-related study procedure (e.g., \nimplant/insertion, revision/adjustment, explant/removal) caused the AE. The relationship is to a device-\nrelated procedure where the device is identified in the data (i.e., has an SPDEVID). The device may be \nancillary or under study. \nTerminology: \n\u2022 \nIn the EU, follow the European Commission Guidelines on Medical Devices, Clinical \nInvestigations: SAE Reporting (MEDDEV 2.7/3) (e.g., Not Related, Unlikely, Possible, \nProbable, Causal Relationship), with device-specific definitions. \n\u2022 \nNo required Controlled Terminology in US. \nPerm \nAECONTRT Concomitant or \nAdditional Trtmnt Given \nChar (NY) \nRecord \nQualifier \nWas another treatment given because of the occurrence of the event? Valid values are \"Y\" and \"N\". \nPerm \nAETOXGR \nStandard Toxicity \nGrade \nChar * \nRecord \nQualifier \nToxicity grade according to a standard toxicity scale (e.g., Common Terminology Criteria for Adverse \nEvents, CTCAE). Sponsors should specify the name of the scale and version used in the metadata (see \nassumption 7d). If value is from a numeric scale, represent only the number (e.g., \"2\", not \"Grade 2\"). \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the adverse event. Examples: \"SCREENING\", \n\"TREATMENT\", \"FOLLOW-UP\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2243, "end_char_idx": 4583, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3a2c24c2-123c-4bb9-b897-afe23c2d2c88": {"__data__": {"id_": "3a2c24c2-123c-4bb9-b897-afe23c2d2c88", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 137, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5d337e49-a9c5-4c97-9f3f-ceb234dae7d7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 137, "section": "UNSPECIFIED"}, "hash": "68993d79c547589b7e8ce824f650c3cd39c0ac6219fc721244bb8db585ad619b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d6b7a500-7025-4871-89a5-149b48a681c3", "node_type": "1", "metadata": {}, "hash": "467e77d81bda059aca2f9dcbdfb51bc867f7dcbd0077054983194853452131f5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 137 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nAESTDTC \nStart Date/Time of \nAdverse Event \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nStart date/time of the adverse event represented in ISO 8601 character format. \nExp \nAEENDTC \nEnd Date/Time of \nAdverse Event \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nEnd date/time of the adverse event represented in ISO 8601 character format. \nExp \nAESTDY \nStudy Day of Start of \nAdverse Event \nNum  \nTiming \nStudy day of start of adverse event relative to the sponsor-defined RFSTDTC. \nPerm \nAEENDY \nStudy Day of End of \nAdverse Event \nNum  \nTiming \nStudy day of end of event relative to the sponsor-defined RFSTDTC. \nPerm \nAEDUR \nDuration of Adverse \nEvent \nChar ISO 8601 duration Timing \nCollected duration and unit of an adverse event. Used only if collected on the CRF and not derived from \nstart and end date/times. Example: \"P1DT2H\" (for 1 day, 2 hours). \nPerm \nAEENRF \nEnd Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the end of the event relative to the sponsor-defined reference period. The sponsor-defined \nreference period is a continuous period of time defined by a discrete starting point (RFSTDTC) and a \ndiscrete ending point (RFENDTC) of the trial. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nAEENRTPT \nEnd Relative to \nReference Time Point \nChar (STENRF) \nTiming \nIdentifies the end of the event as being before or after the reference time point defined by variable \nAEENTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nAEENTPT \nEnd Reference Time \nPoint \nChar  \nTiming \nDescription of date/time in ISO 8601 character format of the reference point referred to by AEENRTPT. \nExamples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nAE \u2013 Assumptions \n1. The Adverse Events dataset includes clinical data describing \"any untoward medical occurrence in a patient or clinical investigation subject \nadministered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment\" (ICH E2A). In \nconsultation with regulatory authorities, sponsors may extend or limit the scope of adverse event collection (e.g., collecting pre-treatment events related \nto trial conduct, not collecting events that are assessed as efficacy endpoints). The events included in the AE dataset should be consistent with the \nprotocol requirements. Adverse events may be captured either as free text or via a prespecified list of terms. \n2. AE description and coding \na. \nAETERM captures the verbatim term collected for the event. It is the topic variable for the AE dataset.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3135, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d6b7a500-7025-4871-89a5-149b48a681c3": {"__data__": {"id_": "d6b7a500-7025-4871-89a5-149b48a681c3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 137, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5d337e49-a9c5-4c97-9f3f-ceb234dae7d7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 137, "section": "UNSPECIFIED"}, "hash": "68993d79c547589b7e8ce824f650c3cd39c0ac6219fc721244bb8db585ad619b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3a2c24c2-123c-4bb9-b897-afe23c2d2c88", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 137, "section": "UNSPECIFIED"}, "hash": "154c0cf903af00a3e68cae0a628725bad73e8656aec5a081a841b6da3e536a60", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC/NCI codelist values are enclosed in parentheses. \n  \nAE \u2013 Assumptions \n1. The Adverse Events dataset includes clinical data describing \"any untoward medical occurrence in a patient or clinical investigation subject \nadministered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment\" (ICH E2A). In \nconsultation with regulatory authorities, sponsors may extend or limit the scope of adverse event collection (e.g., collecting pre-treatment events related \nto trial conduct, not collecting events that are assessed as efficacy endpoints). The events included in the AE dataset should be consistent with the \nprotocol requirements. Adverse events may be captured either as free text or via a prespecified list of terms. \n2. AE description and coding \na. \nAETERM captures the verbatim term collected for the event. It is the topic variable for the AE dataset. AETERM is a required variable and must \nhave a value. \nb.  AEMODIFY is a permissible variable and should be included if the sponsor\u2019s procedure permits modification of a verbatim term for coding. The \nmodified term is listed in AEMODIFY. The variable should be populated as per the sponsor\u2019s procedures. \nc. \nAEDECOD is the preferred term derived by the sponsor from the coding dictionary. It is a required variable and must have a value. It is expected \nthat the reported term (AETERM) will be coded using a standard dictionary such as MedDRA. The sponsor is expected to provide the dictionary \nname and version used to map the terms utilizing the external codelist element in the Define-XML document.", "mimetype": "text/plain", "start_char_idx": 2216, "end_char_idx": 3838, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5fc7f427-2660-4f7c-9600-87264ad2c65c": {"__data__": {"id_": "5fc7f427-2660-4f7c-9600-87264ad2c65c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 138, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1f970326-be3a-4a32-ae04-0396010ba790", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 138, "section": "UNSPECIFIED"}, "hash": "8ef5cae7bc32027f617b9f0224a0e4b1ff1fba5c3c9b25500ebdf69279104d1d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2ccbf18f-aca1-4935-90bc-56d8e440d6bb", "node_type": "1", "metadata": {}, "hash": "c3ac3d24d9030e00eaf812e763fd41f3b8f2a8dad798364b7e10a8c39e56ebb9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 138 \n2021-11-29 \nd. AEBODSYS is the system organ class (SOC) from the coding dictionary associated with the adverse event by the sponsor. This value may differ \nfrom the primary SOC designated in the coding dictionary's standard hierarchy. It is expected that this variable will be populated. \n3. Additional categorization and grouping \na. \nAECAT and AESCAT should not be redundant with the domain code or dictionary classification provided by AEDECOD and AEBODSYS (i.e., \nthey should provide a different means of defining or classifying AE records). AECAT and AESCAT are intended for categorizations that are \ndefined in advance. For example, a sponsor may have a CRF page for AEs of special interest and another page for all other AEs. AECAT and \nAESCAT should not be used for after-the-fact categorizations such as \"clinically significant.\" In cases where a category of AEs of special interest \nresembles a part of the dictionary hierarchy (e.g., \"CARDIAC EVENTS\"), the categorization represented by AECAT and AESCAT may differ \nfrom the categorization derived from the coding dictionary. \nb. AEGRPID may be used to link (or associate) different records together to form a block of related records at the subject level within the AE domain; \nsee Section 4.2.6, Grouping Variables and Categorization. \n4. Prespecified terms; presence or absence of events \na. \nAdverse events are generally collected in 2 different ways, either by recording free text or using a prespecified list of terms. In the latter case, the \nsolicitation of information on specific adverse events may affect the frequency at which they are reported; therefore, the fact that a specific adverse \nevent was solicited may be of interest to reviewers. An AEPRESP value of \u201cY\u201d is used to indicate that the event in AETERM was prespecified on \nthe CRF. \nb. If it is important to know which adverse events from a prespecified list were not reported as well as those that did occur, these data should be \nsubmitted in a Findings class dataset such as Findings About Events and Interventions (see Section 6.4, Findings About Events or Interventions). A \nrecord should be included in that Findings dataset for each prespecified adverse-event term. Records for adverse events that actually occurred \nshould also exist in the AE dataset with AEPRESP set to \u201cY.\u201d \nc. \nIf a study collects both prespecified adverse events and free-text events, the value of AEPRESP should be \u201cY\u201d for all prespecified events and null \nfor events reported as free text. AEPRESP is a permissible field and may be omitted from the dataset if all adverse events were collected as free \ntext. \nd. When adverse events are collected with the recording of free text, a record may be entered into the sponsor\u2019s data management system to indicate \n\u201cno adverse events\u201d for a specific subject. For these subjects, do not include a record in the AE submission dataset to indicate that there were no \nevents. Records should be included in the submission AE dataset only for adverse events that have actually occurred. \n5. Timing variables \na. \nRelative timing assessment \u201cOngoing\u201d is common in the collection of AE information.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3334, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2ccbf18f-aca1-4935-90bc-56d8e440d6bb": {"__data__": {"id_": "2ccbf18f-aca1-4935-90bc-56d8e440d6bb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 138, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1f970326-be3a-4a32-ae04-0396010ba790", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 138, "section": "UNSPECIFIED"}, "hash": "8ef5cae7bc32027f617b9f0224a0e4b1ff1fba5c3c9b25500ebdf69279104d1d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5fc7f427-2660-4f7c-9600-87264ad2c65c", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 138, "section": "UNSPECIFIED"}, "hash": "9a697c36581d4a710fd0042d6fae87496bdaa1b4571fae3a77354c901d4d0faf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "AEPRESP is a permissible field and may be omitted from the dataset if all adverse events were collected as free \ntext. \nd. When adverse events are collected with the recording of free text, a record may be entered into the sponsor\u2019s data management system to indicate \n\u201cno adverse events\u201d for a specific subject. For these subjects, do not include a record in the AE submission dataset to indicate that there were no \nevents. Records should be included in the submission AE dataset only for adverse events that have actually occurred. \n5. Timing variables \na. \nRelative timing assessment \u201cOngoing\u201d is common in the collection of AE information. AEENRF may be used when this relative timing assessment \nis made coincident with the end of the study reference period for the subject represented in the Demographics (DM) dataset (RFENDTC). \nAEENRTPT with AEENTPT may be used when \"Ongoing\" is relative to another date (e.g., the final safety follow-up visit date). See Section \n4.4.7, Use of Relative Timing Variables. \nb. Additional timing variables (e.g., AEDTC) may be used when appropriate. \n6. Actions taken", "mimetype": "text/plain", "start_char_idx": 2690, "end_char_idx": 3798, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3877fbdb-6554-4135-a190-6ae51c66667f": {"__data__": {"id_": "3877fbdb-6554-4135-a190-6ae51c66667f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 139, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "627af751-5bbd-4a44-9a21-db2733c16094", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 139, "section": "UNSPECIFIED"}, "hash": "aff739183311d0ee3355e7fe9a910842ee195e3c08214f0d4079907cca359c11", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c36178db-5099-4218-acf7-a35c43c5a6e3", "node_type": "1", "metadata": {}, "hash": "7b2f896f295fe8833262b9f8a377d9a1fac83eeda4dab218903b73a5a3b09d98", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 139 \n2021-11-29 \na. \nAECONTRT is a Y/N variable. If the non-study treatment is collected, the name and other information about the treatment should be represented in \nthe appropriate Interventions domain\u2014usually Concomitant/Prior Medications (CM) or Procedures (PR)\u2014and linked to the AE record with \nRELREC. \nb. Actions other than concomitant treatments are recorded in: \n\u25aa \nAEACN, only for actions taken with study treatment \n\u25aa \nAEACNDEV, for actions with a device \n\u25aa \nAEACNOTH, for actions that do not involve treatment or a device \n7. Other qualifier variables \na. \nIf categories of serious events are collected secondarily to a leading question the values of the variables that capture reasons an event is considered \nserious (e.g., AESCAN, AESCONG) may be null: \n \nFor example, if \"Serious?\" is answered \"No\", the values for these variables may be null. However, if \"Serious?\" is answered \"Yes\", at least one of \nthem will have a \u201cY\u201d response. Others may be \"N\" or null, according to the sponsor\u2019s convention. \nSerious? \n[ ] Yes [ ] No \nIf yes, check all that apply \n[ ] Fatal [ ] Life-threatening [ ] Inpatient hospitalization\u2026 [ ] etc. \nOn the other hand, if the CRF is structured so that a response is collected for each seriousness category, all category variables (e.g., AESDTH, \nAESHOSP) would be populated and AESER would be derived. \nb. The serious categories \u201cInvolves cancer\u201d (AESCAN) and \u201cOccurred with overdose\u201d (AESOD) are not part of the ICH definition of a serious \nadverse event, but these categories are available for use in studies conducted under guidelines that existed prior to the FDA\u2019s adoption of the ICH \ndefinition. \nc. \nWhen a description of \"Other Medically Important Serious Adverse Events\" category is collected on a CRF, sponsors should place the description \nin the SUPPAE dataset using the standard supplemental qualifier name code AESOSP as described in Section 8.4, Relating Non-Standard Variables \nValues to a Parent Domain, and in Appendix C1, Supplemental Qualifiers Name Codes. \nd. In studies using toxicity grade according to a standard toxicity scale such as the Common Terminology Criteria for Adverse Events v3.0 (CTCAE), \npublished by the National Cancer Institute (NCI; available at https://ctep.cancer.gov/protocoldevelopment/), AETOXGR should be used instead of \nAESEV. In most cases, either AESEV or AETOXGR is populated but not both. There may be cases when a sponsor may need to populate both \nvariables. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the external codelist element in the \nDefine-XML document. \ne. \nThe structure of the AE domain is 1 record per adverse event per subject. It is the sponsor's responsibility to define an event. This definition may \nvary based on the sponsor's requirements for characterizing and reporting product safety and is usually described in the protocol. For example, the \nsponsor may submit 1 record that covers an adverse event from start to finish.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3179, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c36178db-5099-4218-acf7-a35c43c5a6e3": {"__data__": {"id_": "c36178db-5099-4218-acf7-a35c43c5a6e3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 139, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "627af751-5bbd-4a44-9a21-db2733c16094", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 139, "section": "UNSPECIFIED"}, "hash": "aff739183311d0ee3355e7fe9a910842ee195e3c08214f0d4079907cca359c11", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3877fbdb-6554-4135-a190-6ae51c66667f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 139, "section": "UNSPECIFIED"}, "hash": "2243da499586351499e8a3811548e9526d813a8d9a56af30da9130ae783da72b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In most cases, either AESEV or AETOXGR is populated but not both. There may be cases when a sponsor may need to populate both \nvariables. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the external codelist element in the \nDefine-XML document. \ne. \nThe structure of the AE domain is 1 record per adverse event per subject. It is the sponsor's responsibility to define an event. This definition may \nvary based on the sponsor's requirements for characterizing and reporting product safety and is usually described in the protocol. For example, the \nsponsor may submit 1 record that covers an adverse event from start to finish. Alternatively, if there is a need to evaluate AEs at a more granular \nlevel, a sponsor may submit a new record when severity, causality, or seriousness changes or worsens. By submitting these individual records, the \nsponsor indicates that each is considered to represent a different event. The submission dataset structure may differ from the structure at the time of \ncollection. For example, a sponsor might collect data at each visit in order to meet operational needs, but submit records that summarize the event \nand contain the highest level of severity, causality, seriousness, and so on. Examples of dataset structure include:", "mimetype": "text/plain", "start_char_idx": 2501, "end_char_idx": 3815, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3b624330-d1d5-4714-89db-2a5d59a1b1c1": {"__data__": {"id_": "3b624330-d1d5-4714-89db-2a5d59a1b1c1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 140, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0ec8f58b-20f4-4c09-937c-921c63ba514d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 140, "section": "UNSPECIFIED"}, "hash": "457c3278f41cb96ac48bff1e3c37615557b156aa8806a1db8d0eff2751f12bd7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ccbbfa8c-1754-4a0e-8df9-1499bbf1b80a", "node_type": "1", "metadata": {}, "hash": "e8000a52016a28c85e0693e18c19c3ea7cf5f088d2992760618ba4ce1aeda471", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 140 \n2021-11-29 \ni. One record per adverse event per subject for each unique event. Multiple adverse event records reported by the investigator are submitted as \nsummary records \u201ccollapsed\u201d to the highest level of severity, causality, seriousness, and the final outcome. \nii. One record per adverse event per subject. Changes over time in severity, causality, or seriousness are submitted as separate events. \nAlternatively, these changes may be submitted in a separate dataset based on the Findings About Events and Interventions model (see Section \n6.4, Findings About Events or Interventions). \niii. Other approaches may also be reasonable as long as they meet the sponsor's safety evaluation requirements and each submitted record \nrepresents a unique event. The domain-level metadata (see Section 3.2, Using the CDISC Domain Models in Regulatory Submissions \u2013 \nDataset Metadata) should clarify the structure of the dataset. \n8. Use of EPOCH and TAETORD: When EPOCH is included in the AE domain, it should be the epoch of the start of the adverse event. In other words, it \nshould be based on AESTDTC, rather than AEENDTC. The computational method for EPOCH in the Define-XML document should describe any \nassumptions made to handle cases where an adverse event starts on the same day that a subject starts an epoch, if AESTDTC and SESTDTC are not \ncaptured with enough precision to determine the epoch of the onset of the adverse event unambiguously. Similarly, if TAETORD is included in the AE \ndomain, it should be the value for the start of the adverse event, and the computational method in the Define-XML document should describe any \nassumptions. \n9. Any additional identifier variables may be added to the AE domain. \n10. The following qualifiers would not be used in AE: --OCCUR, --STAT, and--REASND. They are the only qualifiers from the SDTM Events class not in \nthe AE domain. They are not permitted because the AE domain contains only records for adverse events that actually occurred. See Assumption 4b for \ninformation on how to deal with negative responses or missing responses to probing questions for prespecified adverse events. \n11. Variable order in the domain should follow the rules as described in Section 4.1.4, Order of the Variables, and the order described in Section 1.1, \nPurpose. \n12. The addition of AELLT, AELLTCD, AEPTCD, AEHLT, AEHLTCD, AEHLGT, AEHLGTCD, AEBDSYCD, AESOC, and AESOCCD is applicable to \nsubmissions coded in MedDRA only. Data items are not expected for non-MedDRA coding. \nAE \u2013 Examples \nExample 1 \nThis example illustrates data from an AE CRF that collected AE terms as free text. AEs were coded using MedDRA, and the sponsor\u2019s procedures include the \npossibility of modifying the reported term to aid in coding. The CRF was structured so that seriousness category variables (e.g., AESDTH, AESHOSP) were \nchecked only when AESER is answered \u201cY.\u201d In this study, the study reference period started at the start of study treatment. Three AEs were reported for this \nsubject.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3205, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ccbbfa8c-1754-4a0e-8df9-1499bbf1b80a": {"__data__": {"id_": "ccbbfa8c-1754-4a0e-8df9-1499bbf1b80a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 140, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0ec8f58b-20f4-4c09-937c-921c63ba514d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 140, "section": "UNSPECIFIED"}, "hash": "457c3278f41cb96ac48bff1e3c37615557b156aa8806a1db8d0eff2751f12bd7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3b624330-d1d5-4714-89db-2a5d59a1b1c1", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 140, "section": "UNSPECIFIED"}, "hash": "69c2c5d68eb51a5666e7a885e74e27e881f802b7c1c01da44fbe160454f19533", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "12. The addition of AELLT, AELLTCD, AEPTCD, AEHLT, AEHLTCD, AEHLGT, AEHLGTCD, AEBDSYCD, AESOC, and AESOCCD is applicable to \nsubmissions coded in MedDRA only. Data items are not expected for non-MedDRA coding. \nAE \u2013 Examples \nExample 1 \nThis example illustrates data from an AE CRF that collected AE terms as free text. AEs were coded using MedDRA, and the sponsor\u2019s procedures include the \npossibility of modifying the reported term to aid in coding. The CRF was structured so that seriousness category variables (e.g., AESDTH, AESHOSP) were \nchecked only when AESER is answered \u201cY.\u201d In this study, the study reference period started at the start of study treatment. Three AEs were reported for this \nsubject. \nRows 1-2: \nShow examples of modifying the reported term for coding purposes, with the modified term in AEMODIFY. These adverse events were not \nserious, so the seriousness criteria variables are null. Note that for the event in row 2, AESTDY = \"1\". Day 1 was the day treatment started; the AE \nstart and end times, as well as dates, were collected to allow comparison of the AE timing to the start of treatment. \nRow 3: \nShows an example of the overall seriousness question AESER answered with \"Y\" and the relevant corresponding seriousness category variables \n(AESHOSP and AESLIFE) answered \"Y\". The other seriousness category variables are left blank. This row also shows AEENRF being populated \nbecause the AE was marked as \u201cContinuing\u201d as of the end of the study reference period for the subject (see Section 4.4.7, Use of Relative Timing \nVariables).", "mimetype": "text/plain", "start_char_idx": 2495, "end_char_idx": 4062, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6864ea02-bcd8-4f7f-9e07-bab5a02dbb40": {"__data__": {"id_": "6864ea02-bcd8-4f7f-9e07-bab5a02dbb40", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "550155b8-03cc-47b2-9f92-0ba4dc52593b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}, "hash": "84e1f5be51dd681bc63477f60d53277ffde25c50a03dd13163a9316c764cfa3e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ea6d9ee6-b61f-4bfa-a0e0-cc8489244dcc", "node_type": "1", "metadata": {}, "hash": "529cc13f222baff87b8095d782376b4d7aa0a105d7c324cd6b482ced79bfb7a6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 141 \n2021-11-29 \nae.xpt \nRow STUDYID DOMAIN USUBJID AESEQ \nAETERM \nAEMODIFY \nAEDECOD \nAEBODSYS \nAESEV \nAESER AEACN \nAEREL \nAEOUT \nAESCONG AESDISAB AESDTH AESHOSP AESLIFE AESMIE EPOCH \nAESTDTC \nAEENDTC \nAESTDY AEENDY AEENRF \n1 \nABC123 \nAE \n123101 \n1 \nPOUNDING \nHEADACHE \nHEADACHE Headache \nNervous system \ndisorders \nSEVERE \nN \nNOT \nAPPLICABLE \nDEFINITELY \nNOT \nRELATED \nRECOVERED/ \nRESOLVED \n \n \n \n \n \n \nSCREENING \n2005-10-\n12 \n2005-10-\n12 \n-1 \n-1 \n \n2 \nABC123 \nAE \n123101 \n2 \nBACK PAIN \nFOR 6 \nHOURS \nBACK PAIN \nBack pain \nMusculoskeletal \nand connective \ntissue disorders \nMODERATE N \nDOSE \nREDUCED \nPROBABLY \nRELATED \nRECOVERED/ \nRESOLVED \n \n \n \n \n \n \nTREATMENT 2005-10-\n13T13:05 \n2005-10-\n13T19:00 \n1 \n1 \n \n3 \nABC123 \nAE \n123101 \n3 \nPULMONARY \nEMBOLISM \n \nPulmonary \nembolism \nVascular \ndisorders \nMODERATE Y \nDOSE \nREDUCED \nPROBABLY \nNOT \nRELATED \nRECOVERING/ \nRESOLVING \n \n \n \nY \nY \n \nTREATMENT 2005-10-\n21 \n \n9 \n \nAFTER \nExample 2 \nIn this example, a CRF module included at several visits asked whether nausea, vomiting, or diarrhea occurred. The responses to the probing questions \"Yes\", \"No\", or \"Not Done\" were represented in the Findings \nAbout (FA) domain (see Section 6.4, Findings About Events or Interventions). If \u201cYes\u201d, the investigator was instructed to complete the AE CRF. In the AE dataset, data on AEs solicited via prespecification on the \nCRF have an AEPRESP value of \"Y\". For AEs solicited by a general question, AEPRESP is null. RELREC may be used to relate AE records and FA records. \nRows 1-2: \nShow that nausea and vomiting were prespecified on a CRF, as indicated by AEPRESP = \"Y\". The subject did not experience diarrhea, so no record for that term exists in the AE dataset. \nRow 3: \nShows an example of an AE (headache) that was not prespecified on a CRF, as indicated by a null value for AEPRESP.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2008, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ea6d9ee6-b61f-4bfa-a0e0-cc8489244dcc": {"__data__": {"id_": "ea6d9ee6-b61f-4bfa-a0e0-cc8489244dcc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "550155b8-03cc-47b2-9f92-0ba4dc52593b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}, "hash": "84e1f5be51dd681bc63477f60d53277ffde25c50a03dd13163a9316c764cfa3e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6864ea02-bcd8-4f7f-9e07-bab5a02dbb40", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}, "hash": "bcf8fec1cbf96d9c5ca7c8842496c472f472bf6de86ceeff9683daeb36008f2a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aadd2bad-c37c-499b-8a71-e03ca4ab1f0c", "node_type": "1", "metadata": {}, "hash": "7313fc9df197ee640d41d8bf885da7943e7cd0ed29a20bf0072837c20591350b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If \u201cYes\u201d, the investigator was instructed to complete the AE CRF. In the AE dataset, data on AEs solicited via prespecification on the \nCRF have an AEPRESP value of \"Y\". For AEs solicited by a general question, AEPRESP is null. RELREC may be used to relate AE records and FA records. \nRows 1-2: \nShow that nausea and vomiting were prespecified on a CRF, as indicated by AEPRESP = \"Y\". The subject did not experience diarrhea, so no record for that term exists in the AE dataset. \nRow 3: \nShows an example of an AE (headache) that was not prespecified on a CRF, as indicated by a null value for AEPRESP. \nae.xpt \nRow STUDYID DOMAIN USUBJID AESEQ AETERM \nAEDECOD AEPRESP AEBODSYS \nAESEV \nAESER AEACN \nAEREL \nAEOUT \nEPOCH \nAESTDTC \nAEENDTC \nAESTDY AEENDY \n1 \nABC123 \nAE \n123101 \n1 \nNAUSEA \nNausea \nY \nGastrointestinal \ndisorders \nSEVERE \nN \nDOSE REDUCED \nRELATED \nRECOVERED/RESOLVED TREATMENT 2005-10-12 \n2005-10-13 \n2 \n3 \n2 \nABC123 \nAE \n123101 \n2 \nVOMITING \nVomiting \nY \nGastrointestinal \ndisorders \nMODERATE N \nDOSE REDUCED \nRELATED \nRECOVERED/RESOLVED TREATMENT 2005-10-\n13T13:00 \n2005-10-\n13T19:00 \n3 \n3 \n3 \nABC123 \nAE \n123101 \n3 \nHEADACHE Headache \n \nNervous system \ndisorders \nMILD \nN \nDOSE NOT \nCHANGED \nPOSSIBLY \nRELATED \nRECOVERED/RESOLVED TREATMENT 2005-10-21 \n2005-10-21 \n11 \n11 \nExample 3 \nIn this example, a CRF module that asked whether or not nausea, vomiting, or diarrhea occurred was included in the study only once. In the context of this study, the conditions that occurred were reportable as \nadverse events. No additional data about these events was collected. No other AE information was collected via general questions. The responses to the probing questions \"Yes\", \"No\", or \"Not Done\" were \nrepresented in the FA domain (see Section 6.4, Findings About Events or Interventions). This is an example of unusually sparse AE data collection; the AE dataset is populated with the term and the flag indicating \nthat it was prespecified, but timing information is limited to the date of collection, and other expected qualifiers are not available. RELREC may be used to relate AE records and FA records. \nThe subject shown in this example experienced nausea and vomiting. The subject did not experience diarrhea, so no record for that term exists in the AE dataset.", "mimetype": "text/plain", "start_char_idx": 1406, "end_char_idx": 3685, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aadd2bad-c37c-499b-8a71-e03ca4ab1f0c": {"__data__": {"id_": "aadd2bad-c37c-499b-8a71-e03ca4ab1f0c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "550155b8-03cc-47b2-9f92-0ba4dc52593b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}, "hash": "84e1f5be51dd681bc63477f60d53277ffde25c50a03dd13163a9316c764cfa3e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ea6d9ee6-b61f-4bfa-a0e0-cc8489244dcc", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 141, "section": "UNSPECIFIED"}, "hash": "db00832ec69344b8398d4ea794beb1dfa97c839dfa6976f8aa9711aab8277acd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the context of this study, the conditions that occurred were reportable as \nadverse events. No additional data about these events was collected. No other AE information was collected via general questions. The responses to the probing questions \"Yes\", \"No\", or \"Not Done\" were \nrepresented in the FA domain (see Section 6.4, Findings About Events or Interventions). This is an example of unusually sparse AE data collection; the AE dataset is populated with the term and the flag indicating \nthat it was prespecified, but timing information is limited to the date of collection, and other expected qualifiers are not available. RELREC may be used to relate AE records and FA records. \nThe subject shown in this example experienced nausea and vomiting. The subject did not experience diarrhea, so no record for that term exists in the AE dataset. \nae.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nAESEQ \nAETERM \nAEDECOD \nAEPRESP \nAEBODSYS \nAESER \nAEACN \nAEREL \nAEDTC \nAESTDTC \nAEENDTC \nAEDY \n1 \nABC123 \nAE \n123101 \n1 \nNAUSEA \nNausea \nY \nGastrointestinal disorders \n \n \n \n2005-10-29 \n \n \n19 \n2 \nABC123 \nAE \n123101 \n2 \nVOMITING \nVomiting \nY \nGastrointestinal disorders \n \n \n \n2005-10-29 \n \n \n19 \nExample 4 \nIn this example, the investigator was instructed to create a new AE record each time the severity of an adverse event changed. The sponsor used AEGRPID to identify the group of records related to a single event for \na subject. \nRow 1: \nShows an adverse event of nausea, for which severity was moderate. \nRows 2-4: \nShow AEGRPID used to group records related to a single event of \"VOMITING\". \nRows 5-6: \nShow AEGRPID used to group records related to a single event of \"DIARRHEA\".", "mimetype": "text/plain", "start_char_idx": 2837, "end_char_idx": 4512, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "52a5f4e0-9162-45ac-a53f-f92124a03edd": {"__data__": {"id_": "52a5f4e0-9162-45ac-a53f-f92124a03edd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "016ad7e7-e76c-421c-a6c1-120b648afe74", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}, "hash": "f6f459d7b3e39d95e4af14fdca89afcb67fcf5f6d11a7b06227e04fb9232b009", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8e6b068d-1c7d-4729-84fd-1a06fdebe0b8", "node_type": "1", "metadata": {}, "hash": "676c93d7f5a2468f56585a4641b26a3c810ee34a92383e92452fe2ac7a44762e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 142 \n2021-11-29 \nae.xpt \nRow STUDYID DOMAIN USUBJID AESEQ AEGRPID AETERM \nAEBODSYS \nAESEV \nAESER AEACN \nAEREL \nAESTDTC \nAEENDTC \n1 \nABC123 \nAE \n123101 \n1 \n \nNAUSEA \nGastrointestinal disorders MODERATE N \nDOSE NOT CHANGED RELATED \n2005-10-13 2005-10-14 \n2 \nABC123 \nAE \n123101 \n2 \n1 \nVOMITING Gastrointestinal disorders MILD \nN \nDOSE NOT CHANGED POSSIBLY RELATED 2005-10-14 2005-10-16 \n3 \nABC123 \nAE \n123101 \n3 \n1 \nVOMITING Gastrointestinal disorders SEVERE \nN \nDOSE NOT CHANGED POSSIBLY RELATED 2005-10-16 2005-10-17 \n4 \nABC123 \nAE \n123101 \n4 \n1 \nVOMITING Gastrointestinal disorders MILD \nN \nDOSE NOT CHANGED POSSIBLY RELATED 2005-10-17 2005-10-20 \n5 \nABC123 \nAE \n123101 \n5 \n2 \nDIARRHEA Gastrointestinal disorders SEVERE \nN \nDOSE NOT CHANGED POSSIBLY RELATED 2005-10-16 2005-10-17 \n6 \nABC123 \nAE \n123101 \n6 \n2 \nDIARRHEA Gastrointestinal disorders MODERATE N \nDOSE NOT CHANGED POSSIBLY RELATED 2005-10-17 2005-10-21 \nExample 5 \nThis study was evaluating artificial hip joints made of a novel material. The protocol specified that only 1 hip could be replaced in a subject, and that subjects should be encouraged to begin walking within 2 days \nafter surgery. This subject was walking on day 5 and tripped and sprained her left ankle. A few days later, she developed an infection in the hip bone adjacent to the implant. The implant was removed and replaced \nby a different product. She never regained full use of her hip, and was left with a limp. This example shows the use of the device-related variables indicating if the AE was unanticipated (AEUNANT), if it was \nrelated to the procedure that implanted the device rather than the device itself (AERLPRC), or if it was related to some other procedure or activity required by the protocol (AERLPRT). These are used to determine if \nthe AE was an unanticipated serious device event, a designation required by some regulatory authorities. Device Identifiers (DI) and other related device domains have not been modeled here; for more information \nabout device domains, see the SDTMIG-MD (https://www.cdisc.org/standards/foundational/medical-devices). \nRow 1: \nShows an AE of \"Twisted left ankle\". The location and laterality are specified as it may be important to know if it occurred on the same or opposite side of the body. \nRow 2: \nShows an AE of \"Osteomyelitis right hip\". The location and laterality are specified and it is considered a serious adverse event. The device was removed as the AE was probably related to the event.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2660, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8e6b068d-1c7d-4729-84fd-1a06fdebe0b8": {"__data__": {"id_": "8e6b068d-1c7d-4729-84fd-1a06fdebe0b8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "016ad7e7-e76c-421c-a6c1-120b648afe74", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}, "hash": "f6f459d7b3e39d95e4af14fdca89afcb67fcf5f6d11a7b06227e04fb9232b009", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "52a5f4e0-9162-45ac-a53f-f92124a03edd", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}, "hash": "9c760355b9fa4767986eb0ad932a8b201bab87e66d741c6ad061cfe93602a452", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8c3d02c6-46e2-4d00-b10c-8682504ec8ff", "node_type": "1", "metadata": {}, "hash": "99cbee54d2af484fc8e9e17d517c4e2117ccbe93ae7c9bf130755e5ed5a240ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These are used to determine if \nthe AE was an unanticipated serious device event, a designation required by some regulatory authorities. Device Identifiers (DI) and other related device domains have not been modeled here; for more information \nabout device domains, see the SDTMIG-MD (https://www.cdisc.org/standards/foundational/medical-devices). \nRow 1: \nShows an AE of \"Twisted left ankle\". The location and laterality are specified as it may be important to know if it occurred on the same or opposite side of the body. \nRow 2: \nShows an AE of \"Osteomyelitis right hip\". The location and laterality are specified and it is considered a serious adverse event. The device was removed as the AE was probably related to the event. \nae.xpt \n \nSTUDYID \nDOMAIN \nUSUBJID \nSPDEVID \nAESEQ \nAESPID \nAETERM \nAEDECOD \nAELOC \nAELAT \nAESER \nAESEV \nAEACNDEV \nAERLDEV \nAEOUT \nAESCONG \nAESHOSP \nAESDISAB \nAESDTH \nAESLIFE \nAESMIE \nAESINTV \nAEUNANT \nAERLPRC \nAERLPRT \nAESTDTC \nAEENDTC \nAESTDY \nAEENDY \n1 \nT002 \nAE \n002 \nHipX22 \n1 \nAE0099 \nTwisted left \nankle \nSPRAIN \nANKLE \nJOINT \nLEFT \nN \nMILD \nNONE \nNOT \nRELATED \nRECOVERED/ \nRESOLVED \nN \nN \nN \nN \nN \nN \nN \nY \nN \nY \n2018-04-\n21 \n2014-04-\n26 \n5 \n10 \n2 \nT002 \nAE \n002 \nHipX22 \n2 \nAE0033 \nOsteomyelitis \nright hip \nOSTEOMYELITIS \nHIP \nRIGHT \nY \nMODERATE \nREMOVED \nPROBABLE \nRECOVERED/ \nRESOLVED \nWITH \nSEQUELLAE \nN \nY \nY \nN \nN \nN \nY \nY \nN \nN \n2018-05-\n01 \n2018-05-\n10 \n15 \n25 \nExample 6 \nThis study was testing an implanted cardiac pacemaker that was paired with a transmitting sensor that was attached to the participant's skin.  The sensor picked up transmitted measurements from the pacemaker and \nrelayed them to a cell network and then to the subject's and investigator's smart phones. The devices were the focus of the study. The DI domain and other related device domains have not been modeled here; for \nfurther information about the device domains, see the SDTMIG-MD. \nRow 1: \nShows the use of the variables for the relationship of the device to the AE (AERLDEV), and the action taken with the device as a result of the AE (AEACNDEV). The sponsor has chosen to use the ISO \n14155 controlled terminology for Relationship of AE to Device. The sensor attachment to the skin caused some skin irritation, which was considered to be caused by the device; the action taken was to \nreposition the device, and the subject recovered. \nRow 2: \nShows an adverse event of infection at the sensor site. In the Microbiology Specimen (MB) domain (not shown), a record shows that the infection was caused by a microbe with partial resistance to \ncommon antibiotics, and so the subject was hospitalized to receive intravenous treatment.", "mimetype": "text/plain", "start_char_idx": 1930, "end_char_idx": 4591, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8c3d02c6-46e2-4d00-b10c-8682504ec8ff": {"__data__": {"id_": "8c3d02c6-46e2-4d00-b10c-8682504ec8ff", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "016ad7e7-e76c-421c-a6c1-120b648afe74", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}, "hash": "f6f459d7b3e39d95e4af14fdca89afcb67fcf5f6d11a7b06227e04fb9232b009", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8e6b068d-1c7d-4729-84fd-1a06fdebe0b8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 142, "section": "UNSPECIFIED"}, "hash": "d0cc0f1d81aef4132c4e78c98a91df266fac46dbbdc07bae0f7d7b6417cc19b1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Row 1: \nShows the use of the variables for the relationship of the device to the AE (AERLDEV), and the action taken with the device as a result of the AE (AEACNDEV). The sponsor has chosen to use the ISO \n14155 controlled terminology for Relationship of AE to Device. The sensor attachment to the skin caused some skin irritation, which was considered to be caused by the device; the action taken was to \nreposition the device, and the subject recovered. \nRow 2: \nShows an adverse event of infection at the sensor site. In the Microbiology Specimen (MB) domain (not shown), a record shows that the infection was caused by a microbe with partial resistance to \ncommon antibiotics, and so the subject was hospitalized to receive intravenous treatment. The event was considered to be probably related to the device, and was serious. The seriousness criteria \nincluded hospitalization, and the device-specific criterion of requiring intervention to prevent progression to life-threatening or fatal conditions (AESINTV). \nae.xpt \nRow STUDYID DOMAIN USUBJID SPDEVID \nAESEQ AESPID AETERM \nAEDECOD \nAESER AESEV \nAEACNDEV \nAERLDEV \nAEOUT \nAESCONG AESHOSP AESDISAB AESDTH AESLIFE AESMIE AESINTV AESTDTC AEENDTC AESTDY AEENDY \n1 \nT001 \nAE \n002 \nSensor123 1 \nAE0007 \nSkin \nredness \nERYTHEMA N \nMILD \nSENSOR \nREPOSITIONED \nCAUSAL \nRECOVERED/ \nRESOLVED \nN \nN \nN \nN \nN \nN \nN \n2018-09-\n01 \n2018-09-\n07 \n27 \n33 \n2 \nT001 \nAE \n001 \nSensor123 2 \nAE0049 \nInfection at \nsensor site \nINFECTION \nY \nMODERATE SENSOR REPLACED \nAND REPOSITIONED \nPROBABLE RECOVERED/ \nRESOLVED \nN \nY \nN \nN \nN \nN \nY \n2018-10-\n24 \n2014-11-\n27 \n78 \n113", "mimetype": "text/plain", "start_char_idx": 3842, "end_char_idx": 5446, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "91df385e-c944-4c07-8271-2700fc358ddb": {"__data__": {"id_": "91df385e-c944-4c07-8271-2700fc358ddb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 143, "section": "6.2.2 Biospecimen Events (BE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3c85ca06-1a84-4825-ac52-3c4027cf587c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 143, "section": "6.2.2 Biospecimen Events (BE)"}, "hash": "01d2ea64f21f93e9987d062fbcd0664e9c0ca6207641a06d4d4880e6198e83f4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c43f0a11-303e-4364-98f0-8d6b5aa9a08f", "node_type": "1", "metadata": {}, "hash": "05b5e926b52ee6df14abea9534bfcc5ef0db5e8c858532423f594de307128309", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BE, BS, and RELSPEC domain specifications, assumptions, and examples were copied and minimally updated from the provisional SDTMIG-PGx, published \n2015-05-26. This was done in preparation for the retirement of the SDTMIG-PGx upon publication of SDTMIG v3.4. These domains are currently under \nextensive revision for inclusion in a future SDTMIG publication, after v3.4. \nBE \u2013 Description/Overview \nAn events domain that documents actions taken that affect or may affect a specimen (e.g., specimen collection, freezing and thawing, aliquoting, transportation). \nBE \u2013 Specification \nbe.xpt, Biospecimen Events \u2014 Events. One record per instance per biospecimen event per biospecimen identifier per subject, \nTabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar BE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nSPDEVID \nSponsor Device \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier for a device. \nPerm \nBESEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid number \n(including decimals) and does not have to start at 1. \nReq \nBEGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nPerm \nBEREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier for the specimen affected or created by the event. \nExp \nBESPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nOptional sponsor-defined reference number. Example: Line number on a CRF page. \nPerm \nBETERM \nReported Term for \nthe Biospecimen \nEvent \nChar  \nTopic \nTopic variable for an event observation, which is the verbatim or pre-specified name of the event. \nReq \nBEMODIFY \nModified Reported \nTerm \nChar  \nSynonym \nQualifier \nIf the value for BETERM is modified for coding purposes, then the modified text is placed here. \nPerm \nBEDECOD \nDictionary-Derived \nTerm \nChar (BEDECOD) \nSynonym \nQualifier \nDictionary-derived text description of BETERM or BEMODIFY, if applicable. \nPerm \nBECAT \nCategory for \nBiospecimen Event \nChar  \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Example: COLLECTION, PREPARATION, \nTRANSPORT. \nPerm \nBESCAT \nSubcategory for \nBiospecimen Event \nChar  \nGrouping \nQualifier \nA further categorization of BECAT values. \nPerm \nBELOC \nAnatomical Location \nof Event \nChar (LOC) \nRecord \nQualifier \nDescribes the anatomical location relevant for the event (e.g. BRAIN, LUNG). \nPerm \nBEPARTY \nAccountable Party \nChar * \nRecord \nQualifier \nParty accountable for the transferable object (e.g. specimen) as a result of the activity performed in the \nassociated BETERM variable.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3051, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c43f0a11-303e-4364-98f0-8d6b5aa9a08f": {"__data__": {"id_": "c43f0a11-303e-4364-98f0-8d6b5aa9a08f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 143, "section": "6.2.2 Biospecimen Events (BE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3c85ca06-1a84-4825-ac52-3c4027cf587c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 143, "section": "6.2.2 Biospecimen Events (BE)"}, "hash": "01d2ea64f21f93e9987d062fbcd0664e9c0ca6207641a06d4d4880e6198e83f4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "91df385e-c944-4c07-8271-2700fc358ddb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 143, "section": "6.2.2 Biospecimen Events (BE)"}, "hash": "45c914eed022f916bc4b31f6ba95b461d7f3a1ef22432a02d08d8cdd2a030461", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nBECAT \nCategory for \nBiospecimen Event \nChar  \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Example: COLLECTION, PREPARATION, \nTRANSPORT. \nPerm \nBESCAT \nSubcategory for \nBiospecimen Event \nChar  \nGrouping \nQualifier \nA further categorization of BECAT values. \nPerm \nBELOC \nAnatomical Location \nof Event \nChar (LOC) \nRecord \nQualifier \nDescribes the anatomical location relevant for the event (e.g. BRAIN, LUNG). \nPerm \nBEPARTY \nAccountable Party \nChar * \nRecord \nQualifier \nParty accountable for the transferable object (e.g. specimen) as a result of the activity performed in the \nassociated BETERM variable. The party could be an individual (e.g., subject), an organization (e.g., \nsponsor), or a location that is a proxy for an individual or organization (e.g., site). It is usually a somewhat \ngeneral term that is further identified in the BEPRTYID variable. \nPerm \nBEPRTYID \nIdentification of \nAccountable Party \nChar  \nRecord \nQualifier \nIdentification of the specific party accountable for the transferable object (e.g. Specimen) after the action in \nBETERM is taken. Used in conjunction with BEPARTY. \nPerm", "mimetype": "text/plain", "start_char_idx": 2408, "end_char_idx": 3557, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d3d58bab-a95e-42e8-a6bc-87adaa96157d": {"__data__": {"id_": "d3d58bab-a95e-42e8-a6bc-87adaa96157d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 144, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95381874-e431-4e61-ad84-35cd9828b11b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 144, "section": "UNSPECIFIED"}, "hash": "9f4dcdd84a8bfdb387c70fbfc2146436a96e228cbdbe9845d53f47e3689b5abe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5b17253f-ebdb-4553-b5a1-6c7c35d5e093", "node_type": "1", "metadata": {}, "hash": "b2c3bc62831d9be5f2f367282a6e71a0cf81aa61dfc98f5e378534e8e98cf928", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 144 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. \nPerm \nVISITDY \nPlanned Study Day \nof Visit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nBEDTC \nDate/Time of \nSpecimen \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nDate and time of specimen collection. \nExp \nBESTDTC \nStart Date/Time of \nBiospecimen Event \nChar ISO 8601 datetime \nor interval \nTiming \nStart date/time of the event. \nExp \nBEENDTC \nEnd Date/Time of \nBiospecimen Event \nChar ISO 8601 datetime \nor interval \nTiming \nEnd date/time of the event. \nExp \nBESTDY \nStudy Day of Start \nof Biospecimen \nEvent \nNum  \nTiming \nActual study day of start of observation expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nBEENDY \nStudy Day of End of \nBiospecimen Event \nNum  \nTiming \nActual study day of end of observation expressed in integer days relative to the sponsor-defined RFSTDTC \nin Demographics. \nPerm \nBEDUR \nDuration of \nBiospecimen Event \nChar ISO 8601 duration \nTiming \nCollected duration and unit of a biospecimen event. Used only if collected on the CRF and not derived from \nstart and end date/times. Example: P1DT2H (for 1 day, 2 hours). \nPerm \nBE \u2013 Assumptions \n1. The BE domain contains data about actions taken that affect or may affect a specimen, such as specimen collection, freezing and thawing, aliquoting, \nand transportation. This domain is intended to be applicable to any specimen tracking data, regardless of the reason for specimen collection. \n2. The value in BEREFID identifies the specimen most affected by the event. For aliquoting, this would be the child specimen(s) created by the event, \nrather than the parent specimen. BEREFID should not contain any identifiers other than specimen IDs. \n3. BELOC holds the relevant anatomic location of the subject, so it should only be populated when the subject participates in and is directly affected by the \nevent given in BETERM. \n4. BEPARTY and BEPRTYID together identify the individual or organization that takes responsibility for the biospecimen as a result of the action in \nBETERM. For example, if BETERM is COLLECTED, BEPARTY would be a general term defining the type of responsible party, such as SITE, and \nBEPRTYID would contain the site identifier, such as 02. If BEPARTY is sufficient to uniquely identify the party (such as SPONSOR in a single-\nsponsor study), then BEPRTYID may be null. \n5. Usually BEPARTY and BEPRTYID refer to who has possession of the biospecimen after the action in BETERM.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2968, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5b17253f-ebdb-4553-b5a1-6c7c35d5e093": {"__data__": {"id_": "5b17253f-ebdb-4553-b5a1-6c7c35d5e093", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 144, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95381874-e431-4e61-ad84-35cd9828b11b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 144, "section": "UNSPECIFIED"}, "hash": "9f4dcdd84a8bfdb387c70fbfc2146436a96e228cbdbe9845d53f47e3689b5abe", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d3d58bab-a95e-42e8-a6bc-87adaa96157d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 144, "section": "UNSPECIFIED"}, "hash": "3b647adbfe8928c35246f47e369b4f7b937e49eec9c74bfed4727402a534e433", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3. BELOC holds the relevant anatomic location of the subject, so it should only be populated when the subject participates in and is directly affected by the \nevent given in BETERM. \n4. BEPARTY and BEPRTYID together identify the individual or organization that takes responsibility for the biospecimen as a result of the action in \nBETERM. For example, if BETERM is COLLECTED, BEPARTY would be a general term defining the type of responsible party, such as SITE, and \nBEPRTYID would contain the site identifier, such as 02. If BEPARTY is sufficient to uniquely identify the party (such as SPONSOR in a single-\nsponsor study), then BEPRTYID may be null. \n5. Usually BEPARTY and BEPRTYID refer to who has possession of the biospecimen after the action in BETERM. In the cases where a biospecimen is \nlost or destroyed for example, BEPARTY and BEPRTYID may be null. \n6. Timing variables: \na. \nBESTDTC and BEENDTC hold the start and end date/times for the event given in BETERM. If the end date/time is the same as the start date/time \nfor the event, then BEENDTC is null. \nb. Unlike other Events domains, BEDTC does not hold the date/time of data collection. Instead, it holds the date/time of specimen collection, in \nalignment with the use of --DTC for specimen-related findings. BEDTC values for extracted or otherwise derived specimens are copied from that of \nthe parent specimen.", "mimetype": "text/plain", "start_char_idx": 2208, "end_char_idx": 3590, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "14ad805b-4ee8-48f0-aa19-40418d073ed8": {"__data__": {"id_": "14ad805b-4ee8-48f0-aa19-40418d073ed8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 145, "section": "1148.267 BESPEC"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48461c68-32d2-41f0-a052-a1108d006fc5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 145, "section": "1148.267 BESPEC"}, "hash": "e86867c6289f364777a65a96e88d4ee97750cb400c4b5f96eb7cfbe3b48c1f83", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SPECIMEN TYPE \nTISSUE \nCRF \n \nFindings related to specimen handling processes are stored in the Biospecimen (BS) domain. These processes can be important to maintain the integrity of the \nspecimens used in genetic variation and gene expression testing. Depending on how a study is designed, there might be very specific specimen handling \nspecifications contained in the protocol for all labs to follow. Other protocols may let the labs determine the processes to follow. This example illustrates the \nlatter approach. \nRow 1: \nShows the volume of the biospecimen. \nRows 2-3: \nShow the flash freeze temperature and material, associated via RELREC with BE row 2.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 661, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e80413f3-c327-4b9e-97b3-7995edbfc33f": {"__data__": {"id_": "e80413f3-c327-4b9e-97b3-7995edbfc33f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 146, "section": "1148.267 FFRZMAT"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26712588-e6d0-469a-93a7-26957b2a1c10", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 146, "section": "1148.267 FFRZMAT"}, "hash": "0a9e705fe461a8a89de276bf52126823792a17471deb1e0e611e09d150e21a96", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "66f6ed12-f106-4c33-8e07-a486e3d8e7d4", "node_type": "1", "metadata": {}, "hash": "7dc033abc4ba36635548a1f88c0d8c5b2e94b486dda4e57f7b5092b89e2792b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Flash Freeze \nMaterial \nSPECIMEN HANDLING \nDRY \nICE/ISOPOPANOL \n \nDRY \nICE/ISOPOPANOL \n \n \nBRAIN \nCEREBRAL \nAQUEDUCT \n1 \n5-0 \nThe Device Identifiers (DI) dataset (required with the use of SPDEVID) is not shown in this example. \nRELREC relates the records in BE and BS to each other. \nRows 1-2: \nTie the specimen's volume to its collection, when the measurement was made. \nRows 3-4: \nTie the temperature to which the specimen was flash frozen to the event of its occurrence. \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC134 \nBE \n43871 \nBESEQ \n1 \n \n1 \n2 \nABC134 \nBS \n43871 \nBSSEQ \n1 \n \n1 \n3 \nABC134 \nBE \n43871 \nBESEQ \n2 \n \n2 \n4 \nABC134 \nBS \n43871 \nBSGRPID \n267FF \n \n2 \nExample 2 \nCell-free RNA, which can be obtained from plasma, may be useful for some tumor-specific cancer detection,[1] but has poor integrity.[2]In this example, a blood sample was drawn, centrifuged to get plasma, and \nstored in a pretreated container before being shipped to the lab. The lab then extracted and purified RNA from the plasma, divided the RNA into 3 aliquots, and sequenced 1 aliquot immediately while freezing and \nstoring the other 2 for later use.  \nRow 1: \nShows the collection of the blood sample. \nRow 2: \nShows the extraction of the plasma via centrifuge. BESPDEVID holds the identifier for the container into which the plasma is placed. (Not shown: any preservatives with which the container comes \npretreated, which would be stored in the Device Properties (DO) domain.) \nRow 3: \nShows the transportation of the plasma from the site to the lab. \nRow 4: \nShows the extraction of the RNA, which includes purification and quality control testing to make sure the sample is of a high enough quality to be viable. BESPDEVID holds the identifier for the \npurification kit. \nRows 5-7: \nShow the aliquoting of the RNA. \nRow 8: \nShows the sequencing of the first RNA aliquot. (Not shown: results from sequencing, which would be stored in the Pharmacogenomics Findings (PF) domain.) \nRows 9-10: Show the freezing of the second and third RNA aliquots.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2072, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "66f6ed12-f106-4c33-8e07-a486e3d8e7d4": {"__data__": {"id_": "66f6ed12-f106-4c33-8e07-a486e3d8e7d4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 146, "section": "1148.267 FFRZMAT"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26712588-e6d0-469a-93a7-26957b2a1c10", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 146, "section": "1148.267 FFRZMAT"}, "hash": "0a9e705fe461a8a89de276bf52126823792a17471deb1e0e611e09d150e21a96", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e80413f3-c327-4b9e-97b3-7995edbfc33f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 146, "section": "1148.267 FFRZMAT"}, "hash": "918d5d2b4d480fcff7f786d0b7edf57ee6a4d8b1049a1373c15d4f444389fe9a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BESPDEVID holds the identifier for the container into which the plasma is placed. (Not shown: any preservatives with which the container comes \npretreated, which would be stored in the Device Properties (DO) domain.) \nRow 3: \nShows the transportation of the plasma from the site to the lab. \nRow 4: \nShows the extraction of the RNA, which includes purification and quality control testing to make sure the sample is of a high enough quality to be viable. BESPDEVID holds the identifier for the \npurification kit. \nRows 5-7: \nShow the aliquoting of the RNA. \nRow 8: \nShows the sequencing of the first RNA aliquot. (Not shown: results from sequencing, which would be stored in the Pharmacogenomics Findings (PF) domain.) \nRows 9-10: Show the freezing of the second and third RNA aliquots. \nbe.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nSPDEVID \nBESEQ \nBEREFID \nBETERM \nBEDECOD \nBEPARTY \nBEPRTYID \nBECAT \nVISITNUM \nBEDTC \nBESTDTC \nBEENDTC \n1 \n3441271 \nBE \nMU-298 \n \n1 \n298B1 \nCollecting \nCOLLECTING \nSITE \n05 \nCOLLECTION \n2 \n2010-04-01T11:50 \n2010-04-01T11:50 \n \n2 \n3441271 \nBE \nMU-298 \n293USHE8 \n2 \n298B1-1 \nExtracting \nEXTRACTING \nSITE \n05 \nEXTRACTION \n2 \n2010-04-01T11:50 \n2010-04-01T12:10 \n \n3 \n3441271 \nBE \nMU-298 \n \n3 \n298B1-1 \nShipping \nSHIPPING \nABC LAB \n \nTRANSPORT \n2 \n2010-04-01T11:50 \n2010-04-01T15:00 \n2010-04-02T8:00 \n4 \n3441271 \nBE \nMU-298 \nPURKIT \n4 \n298R1-1R0 \nExtracting \nEXTRACTING \nABC LAB \n \nEXTRACTION \n2 \n2010-04-01T11:50 \n2010-04-02T9:00 \n2010-04-05T13:50 \n5 \n3441271 \nBE \nMU-298 \n \n5 \n298R1-1R1 \nAliquoting \nALIQUOTING \nABC LAB \n \nPREPARATION \n2 \n2010-04-01T11:50 \n2010-04-05T13:50 \n \n6 \n3441271 \nBE \nMU-298 \n \n6 \n298R1-1R2 \nAliquoting \nALIQUOTING \nABC LAB \n \nPREPARATION \n2 \n2010-04-01T11:50 \n2010-04-05T13:50", "mimetype": "text/plain", "start_char_idx": 1286, "end_char_idx": 3010, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ff48fa85-b768-4caf-baac-e984797965d3": {"__data__": {"id_": "ff48fa85-b768-4caf-baac-e984797965d3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 147, "section": "9.3 RNA"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "134e2e1e-cae3-4af2-990b-7985a34472b4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 147, "section": "9.3 RNA"}, "hash": "14355efa3dd2416162e206a8e48f77946fc48ad163ba029f6213dc5087d46856", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2 \n2010-04-01T11:50 \n5 \n3441271 \nBS \nMU-298 \n5 \n298R1-1R1 \nVOLUME \nVolume \nSPECIMEN MEASUREMENT \n2 \nmL \n2 \n2 \nmL \nRNA \n2 \n2010-04-01T11:50 \n6 \n3441271 \nBS \nMU-298 \n6 \n298R1-1R2 \nVOLUME \nVolume \nSPECIMEN MEASUREMENT \n2 \nmL \n2 \n2 \nmL \nRNA \n2 \n2010-04-01T11:50 \n7 \n3441271 \nBS \nMU-298 \n7 \n298R1-1R3 \nVOLUME \nVolume \nSPECIMEN MEASUREMENT \n2 \nmL \n2 \n2 \nmL \nRNA \n2 \n2010-04-01T11:50 \nThe results from the sequencing procedure are stored in the PF domain, which is not shown in this example. See GF examples for examples of GF datasets. \nThe RELSPEC dataset preserves the specimen hierarchy. \nrelspec.xpt \nRow \nSTUDYID \nUSUBJID \nREFID \nSPEC \nPARENT \nLEVEL \n1 \n3441271 \nMU-298 \n298B1 \nBLOOD \n \n1 \n2 \n3441271 \nMU-298 \n298B1-1 \nPLASMA \n298B1 \n2 \n3 \n3441271 \nMU-298 \n298R1-1R0 \nRNA \n298B1-1 \n3 \n4 \n3441271 \nMU-298 \n298R1-1R1 \nRNA \n298R1-1R0 \n4 \n5 \n3441271 \nMU-298 \n298R1-1R2 \nRNA \n298R1-1R0 \n4 \n6 \n3441271 \nMU-298 \n298R1-1R3 \nRNA \n298R1-1R0 \n4", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 932, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3c5b649f-3a2a-41e8-a288-1b3fbd848e6e": {"__data__": {"id_": "3c5b649f-3a2a-41e8-a288-1b3fbd848e6e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 148, "section": "6.2.3 Clinical Events (CE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "29111159-cbcd-4a15-a9f8-094ffffe6ffb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 148, "section": "6.2.3 Clinical Events (CE)"}, "hash": "238ef03f3589dedda0572b8e43702a11366be02a160f42a92dd81cd4b14d7d2c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CE \u2013 Description/Overview \nAn events domain that contains clinical events of interest that would not be classified as adverse events. \nCE \u2013 Specification \nce.xpt, Clinical Events \u2014 Events. One record per event per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar CE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nCESEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nCEGRPID \nGroup ID \nChar  \nIdentifier \nUsed to link together a block of related records for a subject within a domain. \nPerm \nCEREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier (e.g., lab specimen ID, UUID for an ECG waveform or medical image). \nPerm \nCESPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. \nPerm \nCETERM \nReported Term for the \nClinical Event \nChar  \nTopic \nTerm for the medical condition or event. Most likely preprinted on CRF. \nReq \nCEDECOD \nDictionary-Derived \nTerm \nChar * \nSynonym \nQualifier \nControlled terminology for the name of the clinical event. The sponsor is expected to provide the \ndictionary name and version used to map the terms utilizing the external codelist element in the Define-\nXML document. \nPerm \nCECAT \nCategory for the \nClinical Event \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1775, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3eb716e4-b1ef-48a0-9c43-924273b2b6a8": {"__data__": {"id_": "3eb716e4-b1ef-48a0-9c43-924273b2b6a8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 149, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90592ea5-e9c9-47c7-9062-c2c19921c837", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 149, "section": "UNSPECIFIED"}, "hash": "82605ba8863fb57adecda4e931a36ba0fc92becc7e1eb055081b411c09a5f1ef", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "28625096-67eb-440e-9c51-8af9262f907e", "node_type": "1", "metadata": {}, "hash": "02d6010d34baf30e14911b42a748fe0ed6b04d85f258c903e42f86f2648b3b1a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 149 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nCESCAT \nSubcategory for the \nClinical Event \nChar * \nGrouping \nQualifier \nA further categorization of the condition or event. \nPerm \nCEPRESP \nClinical Event Pre-\nspecified \nChar (NY) \nVariable \nQualifier \nUsed to indicate whether the event in CETERM was prespecified. Value is \"Y\" for prespecified events \nand null for spontaneously reported events. \nPerm \nCEOCCUR \nClinical Event \nOccurrence \nChar (NY) \nRecord \nQualifier \nUsed when the occurrence of specific events is solicited, to indicate whether or not a clinical event \noccurred. Values are null for spontaneously reported events. \nPerm \nCESTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nThe status indicates that a question from a prespecified list was not answered. \nPerm \nCEREASND \nReason Clinical Event \nNot Collected \nChar  \nRecord \nQualifier \nDescribes the reason clinical event data was not collected. Used in conjunction with CESTAT when \nvalue is \"NOT DONE\". \nPerm \nCEBODSYS \nBody System or Organ \nClass \nChar * \nRecord \nQualifier \nDictionary-derived. Body system or organ class that is involved in an event or measurement from a \nstandard hierarchy (e.g., MedDRA). When using a multi-axial dictionary such as MedDRA, this should \ncontain the SOC used for the sponsor's analyses and summary tables, which may not necessarily be \nthe primary SOC. \nPerm \nCESEV \nSeverity/Intensity \nChar (SEVRS) \nRecord \nQualifier \nThe severity or intensity of the event. Examples: \"MILD\", \"MODERATE\", \"SEVERE\". \nPerm \nCETOXGR \nStandard Toxicity \nGrade \nChar * \nRecord \nQualifier \nToxicity grade according to a standard toxicity scale (e.g., Common Terminology Criteria for Adverse \nEvents (CTCAE) v3.0). Sponsor should specify name of the scale and version used in the metadata. If \nvalue is from a numeric scale, represent only the number (e.g., \"2\", not \"Grade 2\"). \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the clinical \nevent started. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the clinical event. \nPerm \nCEDTC \nDate/Time of Event \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time for the clinical event observation represented in ISO 8601 character format. \nPerm \nCESTDTC \nStart Date/Time of \nClinical Event \nChar ISO 8601 datetime \nor interval \nTiming \nStart date/time of the clinical event represented in ISO 8601 character format. \nPerm \nCEENDTC \nEnd Date/Time of \nClinical Event \nChar ISO 8601 datetime \nor interval \nTiming \nEnd date/time of the clinical event, represented in ISO 8601 character format. \nPerm \nCEDY \nStudy Day of Event \nCollection \nNum  \nTiming \nStudy day of clinical event collection, measured as integer days.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3086, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "28625096-67eb-440e-9c51-8af9262f907e": {"__data__": {"id_": "28625096-67eb-440e-9c51-8af9262f907e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 149, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "90592ea5-e9c9-47c7-9062-c2c19921c837", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 149, "section": "UNSPECIFIED"}, "hash": "82605ba8863fb57adecda4e931a36ba0fc92becc7e1eb055081b411c09a5f1ef", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3eb716e4-b1ef-48a0-9c43-924273b2b6a8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 149, "section": "UNSPECIFIED"}, "hash": "50132f13b72062df714a870f6da12bbc61c5f567d2fe639ea114c3ca85cf914a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the clinical event. \nPerm \nCEDTC \nDate/Time of Event \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time for the clinical event observation represented in ISO 8601 character format. \nPerm \nCESTDTC \nStart Date/Time of \nClinical Event \nChar ISO 8601 datetime \nor interval \nTiming \nStart date/time of the clinical event represented in ISO 8601 character format. \nPerm \nCEENDTC \nEnd Date/Time of \nClinical Event \nChar ISO 8601 datetime \nor interval \nTiming \nEnd date/time of the clinical event, represented in ISO 8601 character format. \nPerm \nCEDY \nStudy Day of Event \nCollection \nNum  \nTiming \nStudy day of clinical event collection, measured as integer days. Algorithm for calculations must be \nrelative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent \nacross the submission. \nPerm \nCESTDY \nStudy Day of Start of \nEvent \nNum  \nTiming \nActual study day of start of the clinical event expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nCEENDY \nStudy Day of End of \nEvent \nNum  \nTiming \nActual study day of end of the clinical event expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nCESTRF \nStart Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the start of the clinical event relative to the sponsor-defined reference period. The sponsor-\ndefined reference period is a continuous period of time defined by a discrete starting point and a \ndiscrete ending point (represented by RFSTDTC and RFENDTC in Demographics). \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nCEENRF \nEnd Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the end of the event relative to the sponsor-defined reference period. The sponsor-defined \nreference period is a continuous period of time defined by a discrete starting point and a discrete \nending point (represented by RFSTDTC and RFENDTC in Demographics). \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nCESTRTPT \nStart Relative to \nReference Time Point \nChar (STENRF) \nTiming \nIdentifies the start of the observation as being before or after the reference time point defined by \nvariable CESTTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm", "mimetype": "text/plain", "start_char_idx": 2311, "end_char_idx": 4887, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "42fe300f-8bf2-4385-883a-bc6f801d0d98": {"__data__": {"id_": "42fe300f-8bf2-4385-883a-bc6f801d0d98", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 150, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d140e481-7a14-447d-a413-c1d4b8eadedd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 150, "section": "UNSPECIFIED"}, "hash": "fe509fef1104092369f95cc42dd737299b8df45cec3d70b2fa2f1b267b80c60d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ee49c7f4-023a-4346-998b-4b249bc62dad", "node_type": "1", "metadata": {}, "hash": "a0e4aa2db6817363dd3ec82778e99d6dc5179a0c00ee62dae764cd5c65365b23", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 150 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nCESTTPT \nStart Reference Time \nPoint \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the sponsor-defined reference point referred to \nby --STRTPT. Examples: \"2003-12-15\", \"VISIT 1\". \nPerm \nCEENRTPT \nEnd Relative to \nReference Time Point \nChar (STENRF) \nTiming \nIdentifies the end of the observation as being before or after the sponsor-defined reference time point \ndefined by variable CEENTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nCEENTPT \nEnd Reference Time \nPoint \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the reference point referred to by CEENRTPT. \nExamples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nCE \u2013 Assumptions \n1. The determination of events to be considered clinical events versus adverse events should be done carefully and with reference to regulatory guidelines \nor consultation with a regulatory review division. Events of clinical interest as defined by the protocol that are not considered AEs should be reflected as \nCEs. \na. \nEvents considered to be clinical events may include episodes of symptoms of the disease under study (often known as \"signs and symptoms\"), or \nevents that do not constitute adverse events in themselves, though they might lead to the identification of an adverse event. For example, in a study \nof an investigational treatment for migraine headaches, migraine headaches may not be considered to be adverse events per protocol. The \noccurrence of migraines or associated signs and symptoms might be reported in CE. \nb. In vaccine trials, certain adverse events may be considered to be signs or symptoms and accordingly determined to be clinical events. If any event is \nconsidered serious, then the serious variable (--SER) and the serious adverse event flags (--SCAN, --SCONG, --SDTH, --SHOSP, --SDISAB, --\nSLIFE, --SOD, --SMIE) would be required in the CE domain. \nc. \nOther studies might track the occurrence of specific events as efficacy endpoints. For example, in a study of an investigational treatment for \nprevention of ischemic stroke, all occurrences of TIA, stroke, and death might be captured as clinical events and assessed as to whether they meet \nendpoint criteria. Note that other information about these events may be reported in other datasets. For example, the event leading to death would be \nreported in AE; death would also be a reason for study discontinuation in the Disposition (DS) domain. \n2. CEOCCUR and CEPRESP are used together to indicate whether the event in CETERM was prespecified and whether it occurred. CEPRESP can be \nused to separate records that correspond to probing questions for prespecified events from those that represent spontaneously reported events, whereas \nCEOCCUR contains the responses to such questions. The following table shows how these variables are populated in various situations.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3381, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ee49c7f4-023a-4346-998b-4b249bc62dad": {"__data__": {"id_": "ee49c7f4-023a-4346-998b-4b249bc62dad", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 150, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d140e481-7a14-447d-a413-c1d4b8eadedd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 150, "section": "UNSPECIFIED"}, "hash": "fe509fef1104092369f95cc42dd737299b8df45cec3d70b2fa2f1b267b80c60d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "42fe300f-8bf2-4385-883a-bc6f801d0d98", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 150, "section": "UNSPECIFIED"}, "hash": "ce86d48aceedc228ad3cf137222ed2d556f6a05e1cd082081d572e6c1e214c91", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "c. \nOther studies might track the occurrence of specific events as efficacy endpoints. For example, in a study of an investigational treatment for \nprevention of ischemic stroke, all occurrences of TIA, stroke, and death might be captured as clinical events and assessed as to whether they meet \nendpoint criteria. Note that other information about these events may be reported in other datasets. For example, the event leading to death would be \nreported in AE; death would also be a reason for study discontinuation in the Disposition (DS) domain. \n2. CEOCCUR and CEPRESP are used together to indicate whether the event in CETERM was prespecified and whether it occurred. CEPRESP can be \nused to separate records that correspond to probing questions for prespecified events from those that represent spontaneously reported events, whereas \nCEOCCUR contains the responses to such questions. The following table shows how these variables are populated in various situations. \nSituation \nValue of \nCEPRESP \nValue of \nCEOCCUR \nValue of \nCESTAT \nSpontaneously reported event occurrence \n \n \n \nPrespecified event occurred \nY \nY \n \nPrespecified event did not occur \nY \nN \n \nPrespecified event has no response \nY \n \nNOT DONE \n3. The collection of write-in events on a CE CRF should be considered with caution. Sponsors must ensure that all adverse events are recorded in the AE \ndomain. \n4. Any identifier variable may be added to the CE domain.", "mimetype": "text/plain", "start_char_idx": 2407, "end_char_idx": 3846, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "73de97f8-492c-4657-a4f7-72301bd95c08": {"__data__": {"id_": "73de97f8-492c-4657-a4f7-72301bd95c08", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 151, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26a76724-19a6-4202-bc5c-fb0c0134bf2d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 151, "section": "UNSPECIFIED"}, "hash": "24134df23d0a5daecd418a170a3c2afff271c5321f2d9ffd770ba472f0c62e58", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 151 \n2021-11-29 \n5. Timing variables \na. \nRelative timing assessments \"Prior\" or \u201cOngoing\u201d are common in the collection of CE information. CESTRF or CEENRF may be used when this \ntiming assessment is relative to the study reference period for the subject represented in the Demographics (DM) dataset (RFENDTC). CESTRTPT \nwith CESTTPT and/or CEENRTPT with CEENTPT may be used when \"Prior\" or \"Ongoing\" are relative to specific dates other than the start and \nend of the study reference period. See Section 4.4.7, Use of Relative Timing Variables. \nb. Additional timing variables may be used when appropriate. \n6. The clinical events domain is based on the Events general observation class and thus can use any variables in the Events class, including those found in \nthe AE domain specification table. \nCE \u2013 Examples \nExample 1 \nIn this example, data were collected about prespecified events that, in the context of this study, were not reportable as AEs. The data were collected in a log \nindependent of visits, rather than in visit-based CRF modules, so visit and date of collection (CEDTC) data were not collected. \nCRF \nRecord start dates of any of the following signs that occurred during the study. \nClinical Sign \nDid it occur? \nStart Date of First Episode \nRash \nNo \nYes \n \nWheezing \nNo \nYes \n \nEdema \nNo \nYes \n \nConjunctivitis \nNo \nYes \n \nRows 1-3: \nShow 3 symptoms which occurred and their start dates. \nRow 4: \nShows that conjunctivitis did not occur. Because there was no event, there is no start date. \nce.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCESEQ \nCETERM \nCEPRESP \nCEOCCUR \nCESTDTC \n1 \nABC123 \nCE \n123 \n1 \nRash \nY \nY \n2006-05-03 \n2 \nABC123 \nCE \n123 \n2 \nWheezing \nY \nY \n2006-05-03 \n3 \nABC123 \nCE \n123 \n3 \nEdema \nY \nY \n2006-05-03 \n4 \nABC123 \nCE \n123 \n4 \nConjunctivitis \nY \nN \n \nExample 2 \nIn this example, the CRF included both questions about prespecified clinical events (events not reportable as AEs in the context of this study) and places for \nspecifying additional clinical events. No explicit evaluation interval is given, but the implicit time frame for the question is \"during the study.\" Although this \nexample CRF shows only 1 row for each symptom, if a symptom occurred more than once, data would be collected for each time it occurred. \nThese data are about the event as a whole, so they are represented in the CE domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2524, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a3f34d5a-d1d7-4ea3-bdf9-0f681eabc7d7": {"__data__": {"id_": "a3f34d5a-d1d7-4ea3-bdf9-0f681eabc7d7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 152, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "65a949e0-67e0-4c09-96f4-2fe13e99c73f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 152, "section": "UNSPECIFIED"}, "hash": "5827f193fafef4eceaaf5044fd10a7f3f47223a9dc841f30a5ae34fd7d750392", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4f285986-e1a9-4a01-88ac-f64153137bb4", "node_type": "1", "metadata": {}, "hash": "5ae97226a844503939bb1ebf96e9a0753a3645a65b2def6af8cf25ed786070f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 152 \n2021-11-29 \nIn this example, the use of \"Other, Specify\" for clinical events is likely to require manual review of the data, to be sure that none of the write-in terms should \nhave been reported as adverse events based on the sponsor's criteria for this study. \n \nCRF \nEvent \nDate Started \nDate Ended \nSeverity \nNausea \no Yes \no No \n_ _ / _ _ _ / _ _ _ _ \n(dd/mmm/yyyy) \n_ _ / _ _ _ / _ _ _ _ \n(dd/mmm/yyyy) \no Mild \no Moderate \no Severe \nVomit \no Yes \no No \n_ _ / _ _ _ / _ _ _ _ \n(dd/mmm/yyyy) \n_ _ / _ _ _ / _ _ _ _ \n(dd/mmm/yyyy) \no Mild \no Moderate \no Severe \nDiarrhea \no Yes \no No \n_ _ / _ _ _ / _ _ _ _ \n(dd/mmm/yyyy) \n_ _ / _ _ _ / _ _ _ _ \n(dd/mmm/yyyy) \no Mild \no Moderate \no Severe \nOther, Specify: _____________ _ _ / _ _ _ / _ _ _ _ \n(dd/mmm/yyyy) \n_ _ / _ _ _ / _ _ _ _ \n(dd/mmm/yyyy) \no Mild \no Moderate \no Severe \n \nRows 1-2: \nShow records for 2 instances of the prespecified clinical event, nausea. The CEPRESP value of \"Y\" indicates that there was a probing question; the \nresponse to the probe (CEOCCUR) was \"Yes\". CEPRESP and CEOCCUR are included in both records for \"Nausea\". The record includes \nadditional data about the event. \nRow 3: \nShows a record for the prespecified clinical event, vomit. The CEPRESP value of \"Y\" indicates that there was a probing question; the response to \nthe question (CEOCCUR) was \"No\". Because there was no event, severity and start and end dates are null. \nRow 4: \nShows a record for the prespecified clinical event, diarrhea. The value \"Y\" for CEPRESP indicates it was prespecified. The CESTAT value of NOT \nDONE indicates that the probing question was not asked or that there was no answer. \nRow 5: \nShows a record for a write-in clinical event recorded in the \"Other, Specify\" space. Because this event was not prespecified, CEPRESP and \nCEOCCUR are null. See Section 4.2.7.3, \"Specify\" Values for Topic Variables,for further information on populating the topic variable when \n\"Other, Specify\" is used on the CRF.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2154, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4f285986-e1a9-4a01-88ac-f64153137bb4": {"__data__": {"id_": "4f285986-e1a9-4a01-88ac-f64153137bb4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 152, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "65a949e0-67e0-4c09-96f4-2fe13e99c73f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 152, "section": "UNSPECIFIED"}, "hash": "5827f193fafef4eceaaf5044fd10a7f3f47223a9dc841f30a5ae34fd7d750392", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a3f34d5a-d1d7-4ea3-bdf9-0f681eabc7d7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 152, "section": "UNSPECIFIED"}, "hash": "faafd61217df1d71519b412c42aeaea468194c3b520c62baae0f0d016c98a9c1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The CEPRESP value of \"Y\" indicates that there was a probing question; the response to \nthe question (CEOCCUR) was \"No\". Because there was no event, severity and start and end dates are null. \nRow 4: \nShows a record for the prespecified clinical event, diarrhea. The value \"Y\" for CEPRESP indicates it was prespecified. The CESTAT value of NOT \nDONE indicates that the probing question was not asked or that there was no answer. \nRow 5: \nShows a record for a write-in clinical event recorded in the \"Other, Specify\" space. Because this event was not prespecified, CEPRESP and \nCEOCCUR are null. See Section 4.2.7.3, \"Specify\" Values for Topic Variables,for further information on populating the topic variable when \n\"Other, Specify\" is used on the CRF. \nce.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCESEQ \nCETERM \nCEDECOD \nCEPRESP \nCEOCCUR \nCESTAT \nCESEV \nCESTDTC \nCEENDTC \n1 \nABC123 \nCE \n123 \n1 \nNAUSEA \nNausea \nY \nY \n \nMODERATE \n2005-10-12 \n2005-10-12 \n2 \nABC123 \nCE \n123 \n2 \nNAUSEA \nNausea \nY \nY \n \nMODERATE \n2005-10-14 \n2005-10-15 \n3 \nABC123 \nCE \n123 \n3 \nVOMIT \nVomiting \nY \nN \n \n \n \n \n4 \nABC123 \nCE \n123 \n4 \nDIARRHEA \nDiarrhoea \nY \n \nNOT DONE \n \n \n \n5 \nABC123 \nCE \n123 \n5 \nSEVERE HEAD PAIN \nHeadache \n \n \n \nSEVERE \n2005-10-09 \n2005-10-11 \nExample 3 \nIn this study, a prior fracture in the previous 5 years was a requirement for study entry. Details about bone-fracture events were collected about pre-study \nfractures in the previous 5 years, and about any fracture events that occurred during the study.", "mimetype": "text/plain", "start_char_idx": 1403, "end_char_idx": 2905, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7023d4fd-2a0f-46f6-abc8-b845aa4393cb": {"__data__": {"id_": "7023d4fd-2a0f-46f6-abc8-b845aa4393cb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 153, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0285bdcf-301c-47da-8431-7e14df23702f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 153, "section": "UNSPECIFIED"}, "hash": "b6bd15589a88e3ceee3b7806f57f499b94bab122d2022086434de9f3ec7fa92e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 153 \n2021-11-29 \nBone Fracture Assessment \nWhich fracture? \n\u25cb Pre-study fracture, reference number_____ \n\u25cb On-study fracture, reference number_____ \nDate of collection \n--/---/-- \nDate of fracture \n--/---/-- \nHow did fracture occur? \n\u25cb Pathologic \n\u25cb Fall \n\u25cb Other trauma \n\u25cb Unknown \nWhat was the location of the fracture? \n_____ \nWhat was the laterality? \n\u25cb Left \n\u25cb Right \n\u25cb Not applicable \nWere therapeutic measures required? \n\u25cb Yes \n\u25cb No \n\u25cb Unknown \nIf therapeutic measures were required, select all that apply. \u25a1 Casting/immobilization \n\u25a1 Traction \n\u25a1 Surgery \nWere there any complications of the fracture? \n\u25cb Yes \n\u25cb No \n\u25cb Unknown \nIf there were complications, select all that apply. \n\u25a1 Infection of fracture site \n\u25a1 Improper healing requiring bone reset \n\u25a1 Soft tissue damage, specify location ______ \nThe collected data do not meet criteria for representation in FA. Data about the most recent pre-study fracture were represented in the Medical History (MH) \ndomain, and data about fractures during the study were represented in the CE domain. \nThe supplemental qualifier MHCAUSE or CECAUSE (depending on domain) was used to represent the response to the question, \"How did the fracture occur?\" \nThe supplemental qualifier MHCPLIND or CECPLIND (depending on domain) was used to represent the response to the question, \"Were there any \ncomplications of the fracture?\" \nThe codelist used for AECONTRT (NY) was used for MHCONTRT and CECONTRT. \nRow 1: \nThe subject had only 1 fracture in the last 5 years. This fracture required treatment (MHCONTRT = \"Y\"). \nRow 2: \nThis subject had a complication (see supplemental qualifier MHCPLIND in suppmh.xpt dataset), which was represented as a separate medical \nhistory event. MHGRPID was used to group this with the fracture for which it was a complication. No separate start date for this complication was \ncollected, so MHSTDTC is blank. \nmh.xpt \nRow STUDYID DOMAIN USUBJID \nMHSEQ MHGRPID MHSPID MHTERM \nMHCAT \nMHSCAT \nMHPRESP MHOCCUR MHLOC MHLAT MHCONTRT MHDTC MHSTDTC MHEVLINT \n1 \nABC \nMH \nABC -US-\n701-002 \n1 \n1 \nMH1 \nFracture \nFRACTURE-\nRELATED \nEVENTS \n \nY \nY \nRIB 3 \nRIGHT \nY \n2006-\n05-13 \n2005-08-\n18 \n-P5Y", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2337, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "925ff65c-8101-4be5-9dc1-510d83aaead7": {"__data__": {"id_": "925ff65c-8101-4be5-9dc1-510d83aaead7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 154, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f3451a8f-2f63-4dce-aaa7-a0d00322d516", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 154, "section": "UNSPECIFIED"}, "hash": "86c24eea3c20a610670dec65217f752c5492f68455ffd441d75efcacdae64d9e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "377b8d0f-bc2b-4990-9269-20fa1deab0a5", "node_type": "1", "metadata": {}, "hash": "333436d01b5f15ef5c9dbb6c794234db2beeb03d654873b43119a813ebc0e8c2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 154 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID \nMHSEQ MHGRPID MHSPID MHTERM \nMHCAT \nMHSCAT \nMHPRESP MHOCCUR MHLOC MHLAT MHCONTRT MHDTC MHSTDTC MHEVLINT \n2 \nABC \nMH \nABC -US-\n701-002 \n2 \n1 \n \nSoft \nTissue \nDamage \nFRACTURE-\nRELATED \nEVENTS \nCOMPLICATIONS Y \nY \nLUNG \n \n \n2006-\n05-13 \n \n \nThe cause of the fracture and whether there were complications were represented as supplemental qualifiers. \nsuppmh.xpt \nRow STUDYID RDOMAIN \nUSUBJID IDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG QEVAL \n1 \nABC \nMH \n001-001 \nMHSEQ 1 \nMHCAUSE \nCause of Event \nOTHER TRAUMA \nCRF \n \n2 \nABC \nMH \n001-001 \nMHSEQ 1 \nMHCPLIND \nComplications Indicator \nY \nCRF \n \nThe subject had 2 on-study fractures. \nRow 1: \nShows the subject's first on-study fracture. Although it healed normally (as indicated by the lack of complications, supplemental qualifier \nCECPLIND = \"N\"), it required additional treatment, as indicated by CECONTRT = \"Y\". \nRows 2-3: \nShow the subject's second fracture and its associated complication. The 2 events were linked using CEGRPID. \nce.xpt \nRow STUDYID DOMAIN USUBJID CESEQ CEGRPID CESPID CETERM \nCECAT \nCESCAT \nCEPRESP CEOCCUR CELOC \nCELAT CECONTRT CEDTC CESTDTC \n1 \nABC \nCE \nABC -US-\n701-002 \n1 \n \nCE1 \nFracture \nFRACTURE-\nRELATED \nEVENTS \n \nY \nY \nHUMERUS RIGHT Y \n2006-\n07-09 \n2006-07-\n03 \n2 \nABC \nCE \nABC -US-\n701-002 \n2 \n1 \nCE2 \nFracture \nFRACTURE-\nRELATED \nEVENTS \n \nY \nY \nFIBULA \nLEFT \nN \n2006-\n10-23 \n2006-10-\n15 \n3 \nABC \nCE \nABC -US-\n701-002 \n3 \n1 \nCE3 \nInfection \nof fracture \nsite \nFRACTURE-\nRELATED \nEVENTS \nCOMPLICATIONS Y \nY \n \n \n \n2006-\n10-23 \n \nThe causes of the fractures and whether there were complications were represented as supplemental qualifiers.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1843, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "377b8d0f-bc2b-4990-9269-20fa1deab0a5": {"__data__": {"id_": "377b8d0f-bc2b-4990-9269-20fa1deab0a5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 154, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f3451a8f-2f63-4dce-aaa7-a0d00322d516", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 154, "section": "UNSPECIFIED"}, "hash": "86c24eea3c20a610670dec65217f752c5492f68455ffd441d75efcacdae64d9e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "925ff65c-8101-4be5-9dc1-510d83aaead7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 154, "section": "UNSPECIFIED"}, "hash": "f37550f0d49d14766067e3236e6fa21473f427095b9e81c24ccd1bbf3c7b451a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "suppce.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL QNAM \nQLABEL \nQVAL \nQORIG QEVAL \n1 \nABC \nCE \n001-001 \nCESEQ 1 \nCECAUSE Cause of Event \nFALL \nCRF \n \n2 \nABC \nCE \n001-001 \nCESEQ 1 \nCECPLIND Complications Indicator N \nCRF \n \n3 \nABC \nCE \n001-001 \nCESEQ 2 \nCECAUSE Cause of Event \nOTHER TRAUMA CRF \n \n4 \nABC \nCE \n001-001 \nCESEQ 2 \nCECPLIND Complications Indicator Y \nCRF \n \nThe therapeutic measures in this example were procedures represented in the Procedures (PR) domain.  PRSTDTC is an expected variable, so it is included in the \ndataset, although it was not collected in this study. \nRow 1: \nThe subject's pre-study fracture required one of the prespecified therapeutic procedures. The sponsor populated PRSPID with the value in MHSPID \nfor the fracture. PRDTC is populated with the date on which medical history was collected, which also appeared in MHDTC. \nRows 2-3: \nThe subject's first on-study fracture required 2 of the prespecified therapeutic procedures. For these procedures, PRSPID was populated with a \nCESPID value. PRDTC is the same as CEDTC for the associated fracture. \npr.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nPRSEQ \nPRSPID \nPRTRT \nPRCAT \nPRPRESP \nPROCCUR \nPRDTC \nPRSTDTC \n1 \nABC \nPR \nABC -US-701-002 \n1 \nMH1 \nCasting/Immobilization \nFRACTURE TREATMENTS \nY \nY \n2006-05-13 \n \n2 \nABC \nPR \nABC -US-701-002 \n2 \nCE1 \nSurgery \nFRACTURE TREATMENTS \nY \nY \n2006-07-09", "mimetype": "text/plain", "start_char_idx": 1845, "end_char_idx": 3223, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ff918a55-b9be-4f88-a925-138e567e9395": {"__data__": {"id_": "ff918a55-b9be-4f88-a925-138e567e9395", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 155, "section": "6.2.4 Disposition (DS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e25b858f-c3cc-4010-928c-72d772296afb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 155, "section": "6.2.4 Disposition (DS)"}, "hash": "1411a3502af3e4b42de27c117368e5a72515bd6978d00464e1ee347c4a91fb52", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DS \u2013 Description/Overview \nAn events domain that contains information encompassing and representing data related to subject disposition. \nDS \u2013 Specification \nds.xpt, Disposition \u2014 Events. One record per disposition status or protocol milestone per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, Codelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar DS \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or \nsubmissions involving the product. \nReq \nDSSEQ \nSequence \nNumber \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be \nany valid number. \nReq \nDSGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nDSREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier. \nPerm \nDSSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line \nidentifier or defined in the sponsor's operational database. Example: Line number on a \nDisposition page. \nPerm \nDSTERM \nReported Term \nfor the \nDisposition Event \nChar  \nTopic \nVerbatim name of the event or protocol milestone. Some terms in DSTERM will match \nDSDECOD, but others, such as \"Subject moved\", will map to controlled terminology in \nDSDECOD, such as \"LOST TO FOLLOW-UP\". \nReq \nDSDECOD \nStandardized \nDisposition Term \nChar (NCOMPLT)(PROTMLST)(OTHEVENT) Synonym \nQualifier \nControlled terminology for the name of disposition event or protocol milestone. Examples \nof protocol milestones: \"INFORMED CONSENT OBTAINED\", \"RANDOMIZED\". There are \nseparate codelists used for DSDECOD where the choice depends on the value of DSCAT. \nCodelist \"NCOMPLT\" is used for disposition events, codelist \"PROTMLST\" is used for \nprotocol milestones, and codelist \"OTHEVENT\" is used for other events. \nReq \nDSCAT \nCategory for \nDisposition Event \nChar (DSCAT) \nGrouping \nQualifier \nUsed to define a category of related records. \nExp", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2271, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "234350b2-67ea-4fe0-86fc-bdafb2c75cdc": {"__data__": {"id_": "234350b2-67ea-4fe0-86fc-bdafb2c75cdc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 156, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70f2c6f1-c01f-43ed-98a8-7c05b1286c70", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 156, "section": "UNSPECIFIED"}, "hash": "03dbbc243ea8e9b0f47afd52c402788ac60aa59274754c1cd6d25e4d9f38bc17", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f31c1c28-ebf8-45bf-84d6-b327e6b95d9e", "node_type": "1", "metadata": {}, "hash": "d654f81cbef4281eae8e60abb711c7f723ff6e2a2e79fa4051e6ee8f01d419fa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 156 \n2021-11-29 \nDSSCAT \nSubcategory for \nDisposition Event \nChar (DSSCAT) \nGrouping \nQualifier \nA further categorization of DSCAT (e.g., \"STUDY PARTICIPATION\", \"STUDY \nTREATMENT\" when DSCAT = \"DISPOSITION EVENT\"). The variable may be subject to \ncontrolled terminology for other categories of disposition event records. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the event. \nPerm \nDSDTC \nDate/Time of \nCollection \nChar ISO 8601 datetime or interval \nTiming \nCollection date and time of the disposition observation represented in ISO 8601 character \nformat. \nPerm \nDSSTDTC \nStart Date/Time \nof Disposition \nEvent \nChar ISO 8601 datetime or interval \nTiming \nStart date/time of the disposition event in ISO 8601 character format. \nExp \nDSDY \nStudy Day of \nCollection \nNum  \nTiming \nStudy day of collection of event relative to the sponsor-defined RFSTDTC. \nPerm \nDSSTDY \nStudy Day of \nStart of \nDisposition Event \nNum  \nTiming \nStudy day of start of event relative to the sponsor-defined RFSTDTC. \nExp \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nDS \u2013 Assumptions \n1. The Disposition (DS) dataset provides an accounting for all subjects who entered the study and may include protocol milestones, such as randomization, \nas well as the subject's completion status or reason for discontinuation for the entire study or each phase or segment of the study, including screening \nand post-treatment follow-up. Sponsors may choose which disposition events and milestones to submit for a study. See ICH E3, Section 10.1, for \ninformation about disposition events. \n2. Categorization \na. \nDSCAT is used to distinguish between disposition events, protocol milestones, and other events. The controlled terminology for DSCAT consists of \n\"DISPOSITION EVENT\", \"PROTOCOL MILESTONE\", and \"OTHER EVENT\". \nb. An event with DSCAT = \u201cDISPOSITION EVENT\u201d describes either disposition of study participation or of a study treatment. It describes whether a \nsubject completed study participation or a study treatment and, if not, the reason they did not complete it. Dispositions may be described for each \nepoch (e.g., screening, initial treatment, washout, cross-over treatment, follow-up) or for the study as a whole. If disposition events for both study \nparticipation and study treatment(s) are to be represented, then DSSCAT provides this distinction. For records with DSCAT = \"DISPOSITION \nEVENT\", \ni. DSSCAT = \"STUDY PARTICIPATION\" is used to represent disposition of study participation. \nii. DSSCAT = \"STUDY TREATMENT\" is used when a study has only a single treatment. \niii. If a study has multiple treatments, then DSSCAT should name the individual treatment. \nc. \nDSSCAT may be used when DSCAT = \"PROTOCOL MILESTONE\" or \"OTHER EVENT\", but would be subject to additional CDISC Controlled \nTerminology.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3127, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f31c1c28-ebf8-45bf-84d6-b327e6b95d9e": {"__data__": {"id_": "f31c1c28-ebf8-45bf-84d6-b327e6b95d9e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 156, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70f2c6f1-c01f-43ed-98a8-7c05b1286c70", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 156, "section": "UNSPECIFIED"}, "hash": "03dbbc243ea8e9b0f47afd52c402788ac60aa59274754c1cd6d25e4d9f38bc17", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "234350b2-67ea-4fe0-86fc-bdafb2c75cdc", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 156, "section": "UNSPECIFIED"}, "hash": "8ccdc49fff5b537fe04cbb2e04ab6c4d6d6c0a2b34648b020a5ea00d1ec858da", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dispositions may be described for each \nepoch (e.g., screening, initial treatment, washout, cross-over treatment, follow-up) or for the study as a whole. If disposition events for both study \nparticipation and study treatment(s) are to be represented, then DSSCAT provides this distinction. For records with DSCAT = \"DISPOSITION \nEVENT\", \ni. DSSCAT = \"STUDY PARTICIPATION\" is used to represent disposition of study participation. \nii. DSSCAT = \"STUDY TREATMENT\" is used when a study has only a single treatment. \niii. If a study has multiple treatments, then DSSCAT should name the individual treatment. \nc. \nDSSCAT may be used when DSCAT = \"PROTOCOL MILESTONE\" or \"OTHER EVENT\", but would be subject to additional CDISC Controlled \nTerminology. \nd. An event with DSCAT = \u201cPROTOCOL MILESTONE\u201d is a protocol-specified, point-in-time event. Common protocol milestones include \n\u201cINFORMED CONSENT OBTAINED\u201d and \u201cRANDOMIZED.\u201d DSSCAT may be used for subcategories of protocol milestones. \ne. \nAn event with DSCAT = \"OTHER EVENT\" is another important event that occurred during a trial, but was not driven by protocol requirements \nand was not captured in another Events or Interventions class dataset. \u201cTREATMENT UNBLINDED\u201d is an example of an event that would be \nrepresented with DSCAT = \u201cOTHER EVENT\u201d.", "mimetype": "text/plain", "start_char_idx": 2382, "end_char_idx": 3680, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2cbc488f-1f31-4b83-a907-ad542a5abbe8": {"__data__": {"id_": "2cbc488f-1f31-4b83-a907-ad542a5abbe8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 157, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "42dac78a-62f5-4058-b218-0018e75ec054", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 157, "section": "UNSPECIFIED"}, "hash": "a58993a57e2faa930395c5989de6862d037773dba2d613e108bb62dcefd589a9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8e466b71-4cff-42ed-b703-87a5b7edb8b9", "node_type": "1", "metadata": {}, "hash": "6127aaa376c1dab4885019df1a89a0920d16e449047b69450bf0697ca1e9132a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 157 \n2021-11-29 \nf. \nAssociations between DSCAT and some DSDECOD codelist values are described in the DS Codetable (available \nat https://www.cdisc.org/standards/terminology/controlled-terminology). \n3. DS description and coding \na. \nDSDECOD values are drawn from controlled terminology. The controlled terminology depends on the value of DSCAT. \nb. When DSCAT = \"DISPOSITION EVENT\" DSTERM contains either \"COMPLETED\" or, if the subject did not complete, specific verbatim \ninformation about the reason for non-completion. \ni. When DSTERM = \"COMPLETED\", DSDECOD is the term \"COMPLETED\" from the Controlled Terminology codelist NCOMPLT. \nii. When DSTERM contains verbatim text, DSDECOD will use the extensible Controlled Terminology codelist NCOMPLT. For example, \nDSTERM = \"Subject moved\" might be coded to DSDECOD = \"LOST TO FOLLOW-UP\". \nc. \nWhen DSCAT = \"PROTOCOL MILESTONE\", DSTERM contains the verbatim (as collected) and/or standardized text, DSDECOD will use the \nextensible Controlled Terminology codelist PROTMLST. \nd. When DSCAT = \u201cOTHER EVENT\u201d, DSDECOD uses sponsor terminology. \ni. If a reason for the event was collected, the reason for the event is in DSTERM and the DSDECOD is a term from sponsor terminology. For \nexample, if treatment was unblinded due to investigator error, this might be represented in a record with DSTERM = \"INVESTIGATOR \nERROR\" and DSDECOD = \"TREATMENT UNBLINDED\". \nii. If no reason was collected, then DSTERM should be populated with the value in DSDECOD. \n4. Timing variables \na. \nDSSTDTC is expected and is used for the date/time of the disposition event. Events represented in the DS domain do not have end dates; \ndisposition events do not span an interval, but rather occur at a single date/time (e.g., randomization date, disposition of study participation or study \ntreatment). \nb. DSSTDTC documents the date/time that a protocol milestone, disposition event, or other event occurred. For an event with DSCAT = \n\"DISPOSITION EVENT\" where DSTERM is not \"COMPLETED\", the reason for non-completion may be related to an observation reported in \nanother dataset. DSSTDTC is the date/time that the Epoch was completed and is not necessarily the same as the date/time, start date/time, or end \ndate/time of the observation that led to discontinuation. \n \nFor example, a subject reported severe vertigo on June 1, 2006 (AESTDTC). After ruling out other possible causes, the investigator decided to \ndiscontinue study treatment on June 6, 2006 (DSSTDTC). The subject reported that the vertigo had resolved on June 8, 2006 (AEENDTC). \nc. \nEPOCH may be included as a timing variable as in other general observation-class domains. In DS, EPOCH is based on DSSTDTC. The values of \nEPOCH are drawn from the Trial Arms (TA) dataset (see Section 7.2.1, Trial Arms). \n5.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2978, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8e466b71-4cff-42ed-b703-87a5b7edb8b9": {"__data__": {"id_": "8e466b71-4cff-42ed-b703-87a5b7edb8b9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 157, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "42dac78a-62f5-4058-b218-0018e75ec054", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 157, "section": "UNSPECIFIED"}, "hash": "a58993a57e2faa930395c5989de6862d037773dba2d613e108bb62dcefd589a9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2cbc488f-1f31-4b83-a907-ad542a5abbe8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 157, "section": "UNSPECIFIED"}, "hash": "fceb00aaf3d5af1e8db551093ff2f259be70a875343d376802fca0e29cd9cce8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DSSTDTC is the date/time that the Epoch was completed and is not necessarily the same as the date/time, start date/time, or end \ndate/time of the observation that led to discontinuation. \n \nFor example, a subject reported severe vertigo on June 1, 2006 (AESTDTC). After ruling out other possible causes, the investigator decided to \ndiscontinue study treatment on June 6, 2006 (DSSTDTC). The subject reported that the vertigo had resolved on June 8, 2006 (AEENDTC). \nc. \nEPOCH may be included as a timing variable as in other general observation-class domains. In DS, EPOCH is based on DSSTDTC. The values of \nEPOCH are drawn from the Trial Arms (TA) dataset (see Section 7.2.1, Trial Arms). \n5. Reasons for termination: ICH E3 Section 10.1 indicates that \u201cthe specific reason for discontinuation\u201d should be presented, and that summaries should be \n\u201cgrouped by treatment and by major reason.\u201d The CDISC SDS Team interprets this guidance as requiring 1 standardized disposition term (DSDECOD) \nper disposition event. If multiple reasons are reported, the sponsor should identify a primary reason and use that to populate DSTERM and DSDECOD. \nAdditional reasons should be submitted in SUPPDS.", "mimetype": "text/plain", "start_char_idx": 2283, "end_char_idx": 3473, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f1bd0024-733a-4d78-98a2-7089d831494b": {"__data__": {"id_": "f1bd0024-733a-4d78-98a2-7089d831494b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 158, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dce9115a-8c6e-4887-bf76-cd49da79c16f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 158, "section": "UNSPECIFIED"}, "hash": "ed936a2320c8266830b8e2e09a74ce9caf084f0de6ea577589fc93de11b0a584", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "089420f5-fe9c-48fc-bb7b-365908e3ced0", "node_type": "1", "metadata": {}, "hash": "4a5a0df0e7798cfb5512a6ff817df4ea6c74959fd72c3f61deb527e815bc85d8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 158 \n2021-11-29 \nFor example, in a case where DSTERM = \"SEVERE NAUSEA\" and DSDECOD = \"ADVERSE EVENT\", the supplemental qualifiers dataset might \ninclude records with \n \nSUPPDS QNAM = \"DSTERM1\", SUPPDS QLABEL = \"Reported Term for Disposition Event 1\", and SUPPDS QVAL = \"SUBJECT REFUSED \nFURTHER TREATMENT\" \n \nSUPPDS QNAM = \"DSDECOD1\", SUPPDS QLABEL = \"Standardized Disposition Term 1\", and SUPPDS QVAL = \"WITHDREW CONSENT\" \n6. Any identifier variables, timing variables, or Events general observation-class qualifiers may be added to the DS domain, but the following Qualifiers \nwould generally not be used: --PRESP, --OCCUR, --STAT, --REASND, --BODSYS, --LOC, --SEV, --SER, \u2011\u2011ACN, \u2011\u2011ACNOTH, --REL, --RELNST, --\nPATT, --OUT, --SCAN, --SCONG, --SDISAB, --SDTH, --SHOSP, --SLIFE, --SOD, --SMIE, \u2011\u2011CONTRT, --TOXGR. \nDS \u2013 Examples \nExample 1 \nIn this example, disposition of study participation was collected for each epoch of a trial. Disposition of study participation is indicated by DSCAT = \n\"DISPOSITION EVENT\". EPOCH was taken from the CRF, which asked about completion of each epoch of the study. Data about disposition of study \ntreatment was not collected, but the sponsor populated DSSCAT with \"STUDY PARTICIPATION\" to emphasize that these represent disposition of study \nparticipation. \nData were also collected about several protocol milestones represented with DSCAT = \"PROTOCOL MILESTONE\". \nRows 1, 2, 6, 8, 9, 12, 13, 17, 18: Show records for protocol milestones. DSTERM and DSDECOD are populated with the same value, the name of the \nmilestone. Note that for randomization events, EPOCH = \"SCREENING\", because randomization occurred before the start of \ntreatment, during the screening epoch. \nRows 3-5: \nShow 3 records for a subject who completed 3 stages of the study (\"SCREENING\", \"TREATMENT\", \"FOLLOW-UP\"). \nRow 7: \nShows disposition of a subject who was a screen failure. The verbatim reason the subject was a screen failure is represented \nin DSTERM. Because the subject did not complete the screening epoch, DSDECOD is not \u201cCOMPLETED\u201d but another \nappropriate controlled term, \"PROTOCOL VIOLATION\". The date of discontinuation is in DSSTDTC. The protocol \ndeviation event itself would be represented in the DV dataset. \nRows 10-11: \nShow disposition of a subject who completed the screening stage but did not complete the treatment stage. For completed \nepochs, both DSTERM and DSDECOD are \"COMPLETED\". For epochs that were not completed, the verbatim reason for \nnon-completion of the treatment epoch is in DSTERM, while the value from controlled terminology is in DSDECOD.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2772, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "089420f5-fe9c-48fc-bb7b-365908e3ced0": {"__data__": {"id_": "089420f5-fe9c-48fc-bb7b-365908e3ced0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 158, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dce9115a-8c6e-4887-bf76-cd49da79c16f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 158, "section": "UNSPECIFIED"}, "hash": "ed936a2320c8266830b8e2e09a74ce9caf084f0de6ea577589fc93de11b0a584", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f1bd0024-733a-4d78-98a2-7089d831494b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 158, "section": "UNSPECIFIED"}, "hash": "8c30ac2fd62c40269c6ad2c837da63d6977bd330cafe33a8cd58276da3a14d8c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Row 7: \nShows disposition of a subject who was a screen failure. The verbatim reason the subject was a screen failure is represented \nin DSTERM. Because the subject did not complete the screening epoch, DSDECOD is not \u201cCOMPLETED\u201d but another \nappropriate controlled term, \"PROTOCOL VIOLATION\". The date of discontinuation is in DSSTDTC. The protocol \ndeviation event itself would be represented in the DV dataset. \nRows 10-11: \nShow disposition of a subject who completed the screening stage but did not complete the treatment stage. For completed \nepochs, both DSTERM and DSDECOD are \"COMPLETED\". For epochs that were not completed, the verbatim reason for \nnon-completion of the treatment epoch is in DSTERM, while the value from controlled terminology is in DSDECOD. \nRows 14-16: \nShow disposition of a subject who completed treatment, but did not complete follow-up. Note that for final disposition event, \nthe date of collection of the event information, DSDTC, was different from the date of the disposition event (the subject's \ndeath), DSSTDTC. \nRows 19-21: \nShow disposition of a subject who discontinued the treatment epoch due to an adverse event, but who went on to complete \nthe follow-up phase of the trial.", "mimetype": "text/plain", "start_char_idx": 2003, "end_char_idx": 3224, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7429ad74-c24e-40a6-a19a-e321c8e49548": {"__data__": {"id_": "7429ad74-c24e-40a6-a19a-e321c8e49548", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 159, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1f74f35a-6580-4a14-988b-b2f4c616e656", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 159, "section": "UNSPECIFIED"}, "hash": "1bbe3a4b67f2ba58440e07086d2ebab858763f24726ed501e87d851c35e0b564", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bfd54050-5ba9-458b-a7fc-a863c1d91750", "node_type": "1", "metadata": {}, "hash": "d6f450412169ab0fb317e7169957303b68a819352ccaa0e06b8ad3fb97ae1fac", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 159 \n2021-11-29 \nds.xpt \nRow STUDYID DOMAIN USUBJID DSSEQ DSTERM \nDSDECOD \nDSCAT \nDSSCAT \nEPOCH \nDSDTC \nDSSTDTC \n1 \nABC123 \nDS \n123101 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n21 \n2003-09-\n21 \n2 \nABC123 \nDS \n123101 \n2 \nRANDOMIZED \nRANDOMIZED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n30 \n2003-09-\n30 \n3 \nABC123 \nDS \n123101 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nSCREENING 2003-09-\n30 \n2003-09-\n29 \n4 \nABC123 \nDS \n123101 \n4 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nTREATMENT 2003-10-\n31 \n2003-10-\n31 \n5 \nABC123 \nDS \n123101 \n5 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nFOLLOW-UP 2003-11-\n15 \n2003-11-\n15 \n6 \nABC123 \nDS \n123102 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-11-\n21 \n2003-11-\n21 \n7 \nABC123 \nDS \n123102 \n2 \nSUBJECT DENIED MRI \nPROCEDURE \nPROTOCOL VIOLATION \nDISPOSITION EVENT STUDY \nPARTICIPATION \nSCREENING 2003-11-\n22 \n2003-11-\n20 \n8 \nABC123 \nDS \n123103 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n15 \n2003-09-\n15 \n9 \nABC123 \nDS \n123103 \n2 \nRANDOMIZED \nRANDOMIZED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n30 \n2003-09-\n30 \n10 \nABC123 \nDS \n123103 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nSCREENING 2003-09-\n30 \n2003-09-\n22 \n11 \nABC123 \nDS \n123103 \n4 \nSUBJECT MOVED \nLOST TO FOLLOW-UP \nDISPOSITION EVENT STUDY \nPARTICIPATION \nTREATMENT 2003-10-\n31 \n2003-10-\n31 \n12 \nABC123 \nDS \n123104 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n15 \n2003-09-\n15 \n13 \nABC123 \nDS \n123104 \n3 \nRANDOMIZED \nRANDOMIZED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n30 \n2003-09-\n30 \n14 \nABC123 \nDS \n123104 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nSCREENING", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2070, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bfd54050-5ba9-458b-a7fc-a863c1d91750": {"__data__": {"id_": "bfd54050-5ba9-458b-a7fc-a863c1d91750", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 159, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1f74f35a-6580-4a14-988b-b2f4c616e656", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 159, "section": "UNSPECIFIED"}, "hash": "1bbe3a4b67f2ba58440e07086d2ebab858763f24726ed501e87d851c35e0b564", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7429ad74-c24e-40a6-a19a-e321c8e49548", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 159, "section": "UNSPECIFIED"}, "hash": "39bb7e6ced68ec0820f681c1e366d5e747872563e21cc85f34c705a6106ba879", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2003-09-\n30 \n2003-09-\n22 \n11 \nABC123 \nDS \n123103 \n4 \nSUBJECT MOVED \nLOST TO FOLLOW-UP \nDISPOSITION EVENT STUDY \nPARTICIPATION \nTREATMENT 2003-10-\n31 \n2003-10-\n31 \n12 \nABC123 \nDS \n123104 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n15 \n2003-09-\n15 \n13 \nABC123 \nDS \n123104 \n3 \nRANDOMIZED \nRANDOMIZED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n30 \n2003-09-\n30 \n14 \nABC123 \nDS \n123104 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nSCREENING 2003-09-\n30 \n2003-09-\n22 \n15 \nABC123 \nDS \n123104 \n4 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nTREATMENT 2003-10-\n15 \n2003-10-\n15 \n16 \nABC123 \nDS \n123104 \n5 \nAUTOMOBILE ACCIDENT \nDEATH \nDISPOSITION EVENT STUDY \nPARTICIPATION \nFOLLOW-UP 2003-10-\n31 \n2003-10-\n29 \n17 \nABC123 \nDS \n123105 \n1 \nINFORMED CONSENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-09-\n28 \n2003-09-\n28 \n18 \nABC123 \nDS \n123105 \n2 \nRANDOMIZED \nRANDOMIZED \nPROTOCOL \nMILESTONE \n \nSCREENING 2003-10-\n02 \n2003-10-\n02 \n19 \nABC123 \nDS \n123105 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nSCREENING 2003-10-\n02 \n2003-10-\n02 \n20 \nABC123 \nDS \n123105 \n4 \nANEMIA \nADVERSE EVENT \nDISPOSITION EVENT STUDY \nPARTICIPATION \nTREATMENT 2003-10-\n17 \n2003-10-\n17 \n21 \nABC123 \nDS \n123105 \n5 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT STUDY \nPARTICIPATION \nFOLLOW-UP 2003-11-\n02 \n2003-11-\n02 \nExample 2 \nIn this example, the sponsor has chosen to simply submit whether or not subjects completed the study, so there is only 1 record per subject. The sponsor did not \ncollect disposition of treatment and did not include DSSCAT. EPOCH was populated as a timing variable, and represents the epoch during which the subject \ndiscontinued. \nRow 1: \nSubject 456101 completed the study. EPOCH = \"FOLLOW-UP\", which was the last epoch in the design of this study. \nRows 2-3: \nSubjects 456102 and 456103 discontinued. Both discontinued participation during the treatment epoch.", "mimetype": "text/plain", "start_char_idx": 1557, "end_char_idx": 3554, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d905d2fe-346e-48b7-acc9-452772404f84": {"__data__": {"id_": "d905d2fe-346e-48b7-acc9-452772404f84", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 160, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3dbf7c93-7227-4e6a-b7c0-c7096558be9b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 160, "section": "UNSPECIFIED"}, "hash": "34f01abc7b1f571a32ac8b1a3de210a59c72bdab8875ca77bbe26d6c6bd8b5f9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "aace67bc-59c5-47b7-b05e-c6647db75743", "node_type": "1", "metadata": {}, "hash": "84da0c76c3e3412825d95582da9a98705ccd87145ae2f4e87da79e06abd3ade4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 160 \n2021-11-29 \nds.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nDSSEQ \nDSTERM \nDSDECOD \nDSCAT \nEPOCH \nDSSTDTC \n1 \nABC456 \nDS \n456101 \n1 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nFOLLOW-UP \n2003-09-21 \n2 \nABC456 \nDS \n456102 \n1 \nSUBJECT TAKING STUDY MED ERRATICALLY \nPROTOCOL VIOLATION \nDISPOSITION EVENT \nTREATMENT \n2003-09-29 \n3 \nABC456 \nDS \n456103 \n1 \nLOST TO FOLLOW-UP \nLOST TO FOLLOW-UP \nDISPOSITION EVENT \nTREATMENT \n2003-10-15 \nExample 3 \nIn this study, disposition of study participation was collected for the treatment and follow-up epochs. For these records, the value in EPOCH was taken from the \nCRF. Data on screen failures were not submitted for this study, so all submitted subjects completed screening; the sponsor chose not to collect data on disposition \nof the screening epoch.  \nData on protocol milestones were not collected, but data were collected if a subject's treatment was unblinded. For these records, EPOCH represents the epoch \nduring which the blind was broken. \nRows 1, 2: Subject 789101 completed the treatment and follow-up phases. \nRows 3, 5: Subject 789102 did not complete the treatment phase but did complete the follow-up phase. \nRow 4: \nSubject 789102\u2019s treatment was unblinded. The date of the unblinding is represented in DSSTDTC. Maintaining the blind as per protocol was not \nconsidered to be an \"event\" because there was no change in the subject\u2019s state. \nds.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nDSSEQ \nDSTERM \nDSDECOD \nDSCAT \nEPOCH \nDSSTDTC \n1 \nABC789 \nDS \n789101 \n1 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nTREATMENT \n2004-09-12 \n2 \nABC789 \nDS \n789101 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nFOLLOW-UP \n2004-12-20 \n3 \nABC789 \nDS \n789102 \n1 \nSKIN RASH \nADVERSE EVENT \nDISPOSITION EVENT \nTREATMENT \n2004-09-30 \n4 \nABC789 \nDS \n789102 \n2 \nSUBJECT HAD SEVERE RASH \nTREATMENT UNBLINDED \nOTHER EVENT \nTREATMENT \n2004-10-01 \n5 \nABC789 \nDS \n789102 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nFOLLOW-UP \n2004-12-28 \nExample 4 \nIn this example, the CRF included collection of an AE number when study participation was incomplete due to an adverse event. The relationship between the \nDS record and in the AE record was represented in a RELREC dataset. \nThe DS domain represents the end of the subject's participation in the study, due to their death from heart failure. In this case, the disposition was collected \n(DSDTC) on the same day that death occurred and the subject's study participation ended. (DSDTDTC).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2625, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aace67bc-59c5-47b7-b05e-c6647db75743": {"__data__": {"id_": "aace67bc-59c5-47b7-b05e-c6647db75743", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 160, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3dbf7c93-7227-4e6a-b7c0-c7096558be9b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 160, "section": "UNSPECIFIED"}, "hash": "34f01abc7b1f571a32ac8b1a3de210a59c72bdab8875ca77bbe26d6c6bd8b5f9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d905d2fe-346e-48b7-acc9-452772404f84", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 160, "section": "UNSPECIFIED"}, "hash": "a8b819e687bb0b7bda548b77c45982bfe7c639d152815765dd50f50b077621c4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The relationship between the \nDS record and in the AE record was represented in a RELREC dataset. \nThe DS domain represents the end of the subject's participation in the study, due to their death from heart failure. In this case, the disposition was collected \n(DSDTC) on the same day that death occurred and the subject's study participation ended. (DSDTDTC). \nds.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nDSSEQ \nDSTERM \nDSDECOD \nDSCAT \nEPOCH \nDSDTC \nDSSTDTC \n1 \nABC123 \nDS \n123102 \n1 \nHeart Failure \nDEATH \nDISPOSITION EVENT \nTREATMENT \n2003-09-29 \n2003-09-29 \nThe heart failure is represented as an adverse event. In order to save space, only 2 of the MedDRA coding variables for the adverse event have been included.", "mimetype": "text/plain", "start_char_idx": 2265, "end_char_idx": 2979, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ddc951df-83c8-454b-a629-4f458eb58077": {"__data__": {"id_": "ddc951df-83c8-454b-a629-4f458eb58077", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 161, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d31d96b4-731b-4e3a-9ec5-dc1877642053", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 161, "section": "UNSPECIFIED"}, "hash": "2dd8a9d7d455cecee78d5303bbcc9d22deae88ae8d665a1ebf4150decff997ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "959480ac-5bbd-459e-ae2c-54950e15bbd8", "node_type": "1", "metadata": {}, "hash": "6de98388baa4e4b1a3e72768e8282ee893d650e36ecf174ff235f8ab4d4c9e24", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 161 \n2021-11-29 \nae.xpt \nRow STUDYID DOMAIN USUBJID AESEQ AETERM \nAESTDTC AEENDTC AEDECOD \nAESOC \nAESEV \nAESER AEACN \nAEREL \nAEOUT AESCAN AESCONG AESDISAB AESDTH AESHOSP AESLIFE AESOD AESMIE \n1 \nABC123 \nAE \n123102 \n1 \nHeart \nFailure \n2003-09-\n29 \n2003-09-\n29 \nHEART \nFAILURE \nCARDIOVASCULAR \nSYSTEM \nSEVERE Y \nNOT \nAPPLICABLE \nDEFINITELY NOT \nRELATED \nFATAL \nN \nN \nN \nY \nN \nN \nN \nN \nThe relationship between the DS and AE records is represented in RELREC. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC123 \nDS \n123102 \nDSSEQ 1 \n \n1 \n2 \nABC123 \nAE \n123102 \nAESEQ 1 \n \n1 \nThe subject's DM record is not shown, but included DTHFL = \"Y\" and the date of death. \nExample 5 \nThis below represents a multidrug (isoniazid and levofloxacin) investigational treatment trial for multidrug-resistant tuberculosis (MDR-TB). The protocol allows for a subject to discontinue levofloxacin \nand continue single treatment of isoniazid throughout the remainder of the study. Disposition of study participation and disposition of each drug was collected.  Whether a record with DSCAT = \"DISPOSITION \nEVENT\" represents disposition of the subject's participation in the study or disposition of a study treatment is represented in DSSCAT. In this example, disposition of the study and of each drug a subject received for \neach of the study's 2 treatment epochs. \nRow 1: \nIndicates that the physician, per protocol, removed levofloxacin treatment due to high-level positive cultures. This record represents the treatment discontinuation for levofloxacin, for the first treatment \nepocch. Note that because this subject did not receive levofloxacin during the second treatment epoch, there is no record for DSSCAT = \"LEVOFLOXACIN\" with EPOCH = \"TREATMENT 2\". \nRows 2, 4: Represent the treatment continuation and completion for isoniazid each treatment epoch, as indicated by DSSCAT = \"ISONIAZID\". \nRows 3, 5: Represent the study disposition for each treatment epoch, as indicated by DSSCAT = \"STUDY PARTICIPATION\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2199, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "959480ac-5bbd-459e-ae2c-54950e15bbd8": {"__data__": {"id_": "959480ac-5bbd-459e-ae2c-54950e15bbd8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 161, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d31d96b4-731b-4e3a-9ec5-dc1877642053", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 161, "section": "UNSPECIFIED"}, "hash": "2dd8a9d7d455cecee78d5303bbcc9d22deae88ae8d665a1ebf4150decff997ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ddc951df-83c8-454b-a629-4f458eb58077", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 161, "section": "UNSPECIFIED"}, "hash": "1894ff907b328cf8230776018ab1963efd4334cf8393a9434e386ef567e8356e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In this example, disposition of the study and of each drug a subject received for \neach of the study's 2 treatment epochs. \nRow 1: \nIndicates that the physician, per protocol, removed levofloxacin treatment due to high-level positive cultures. This record represents the treatment discontinuation for levofloxacin, for the first treatment \nepocch. Note that because this subject did not receive levofloxacin during the second treatment epoch, there is no record for DSSCAT = \"LEVOFLOXACIN\" with EPOCH = \"TREATMENT 2\". \nRows 2, 4: Represent the treatment continuation and completion for isoniazid each treatment epoch, as indicated by DSSCAT = \"ISONIAZID\". \nRows 3, 5: Represent the study disposition for each treatment epoch, as indicated by DSSCAT = \"STUDY PARTICIPATION\". \nds.xpt \nRow STUDYID DOMAIN USUBJID \nDSSEQ DSTERM \nDSDECOD \nDSCAT \nDSSCAT \nEPOCH \nDSSTDTC \n1 \nXXX \nDS \nXXX-767-\n001 \n1 \nPERSISTENT HIGH-LEVEL POSITIVE CULTURES, PER \nPROTOCOL, LEVOFLOXACIN REMOVAL RECOMMENDED \nPHYSICIAN \nDECISION \nDISPOSITION \nEVENT \nLEVOFLOXACIN \nTREATMENT \n1 \n2016-02-\n15 \n2 \nXXX \nDS \nXXX-767-\n001 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION \nEVENT \nISONIAZID \nTREATMENT \n1 \n2016-02-\n15 \n3 \nXXX \nDS \nXXX-767-\n001 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION \nEVENT \nSTUDY \nPARTICIPATION \nTREATMENT \n1 \n2016-02-\n25 \n4 \nXXX \nDS \nXXX-767-\n001 \n4 \nCOMPLETED \nCOMPLETED \nDISPOSITION \nEVENT \nISONIAZID \nTREATMENT \n2 \n2016-03-\n14 \n5 \nXXX \nDS \nXXX-767-\n001 \n5 \nCOMPLETED \nCOMPLETED \nDISPOSITION \nEVENT \nSTUDY \nPARTICIPATION \nTREATMENT \n2 \n2016-03-\n24 \nExample 6 \nThis example is for a study of a multidrug (isoniazid and levofloxacin) investigational treatment for MDR-TB. The protocol allowed a subject to discontinue levofloxacin and continue single treatment of \nisoniazid throughout the remainder of the study. Disposition of study participation and of each study treatment was collected. For records of disposition of the subject's participation in the study DSSCAT = \"STUDY \nPARTICIPATION\", whereas for records of disposition of a study treatment DSSCAT is the name of the treatment. \nRow 1: \nRepresents the final treatment disposition for levofloxacin, as indicated by DSSCAT = \"LEVOFLOXACIN\". The physician removed levofloxacin treatment due to high-level positive cultures, as \nallowed by the protocol. \nRow 2: \nRepresents the final treatment completion of isoniazid within the trial, which is indicated by DSSCAT = \"ISONIAZID\".", "mimetype": "text/plain", "start_char_idx": 1426, "end_char_idx": 3835, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "de491dbb-30f1-422e-8fad-3e29f57999bc": {"__data__": {"id_": "de491dbb-30f1-422e-8fad-3e29f57999bc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 162, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eabd1301-d510-4ef9-80db-ce018b3b5dbc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 162, "section": "UNSPECIFIED"}, "hash": "557cfe93e0d0abcedd2cd2083282f403cc1ed0da7b97634411d9cfe698377d38", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9ac75c51-c2da-485b-8b3d-9a3c23f20bc8", "node_type": "1", "metadata": {}, "hash": "c13829fd7f742bc16f749ffbf6465dae646b2ca6cf585d57fb462108216cd9d5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 162 \n2021-11-29 \nRow 3: \nRepresents the final study completion within the trial, which is indicated by DSSCAT = \"STUDY PARTICIPATION\". \nds.xpt \nRow STUDYID DOMAIN USUBJID \nDSSEQ DSTERM \nDSDECOD \nDSCAT \nDSSCAT \nEPOCH \nDSSTDTC \n1 \nXXX \nDS \nXXX-767-\n001 \n1 \nPERSISTENT HIGH-LEVEL POSITIVE CULTURES, PER \nPROTOCOL, LEVOFLOXACIN REMOVAL RECOMMENDED \nPHYSICIAN \nDECISION \nDISPOSITION \nEVENT \nLEVOFLOXACIN \nTREATMENT \n1 \n2016-02-\n15 \n2 \nXXX \nDS \nXXX-767-\n001 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION \nEVENT \nISONIAZID \nTREATMENT \n2 \n2016-03-\n14 \n3 \nXXX \nDS \nXXX-767-\n001 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION \nEVENT \nSTUDY \nPARTICIPATION \nTREATMENT \n2 \n2016-03-\n24 \nExample 7 \nThis is an example of a trial with a single investigative treatment. The sponsor used the generic DSSCAT value \"STUDY TREATMENT\" rather than the name \nof the treatment. This subject discontinued both treatment and study participation due to an adverse event. \nRows 1, 3: Represent the disposition of treatment for each treatment epoch, as indicated by DSSCAT = \"STUDY TREATMENT\". \nRows 2, 4: Represent the disposition of study participation continuation for each treatment epoch, as indicated by DSSCAT = \"STUDY PARTICIPATION\". \nds.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nDSSEQ \nDSTERM \nDSDECOD \nDSCAT \nDSSCAT \nEPOCH \nDSSTDTC \n1 \nXXX \nDS \nXXX-767-001 \n1 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY TREATMENT \nTREATMENT 1 \n2016-02-15 \n2 \nXXX \nDS \nXXX-767-001 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nTREATMENT 1 \n2016-02-15 \n3 \nXXX \nDS \nXXX-767-001 \n3 \nSKIN RASH \nADVERSE EVENT \nDISPOSITION EVENT \nSTUDY TREATMENT \nTREATMENT 2 \n2016-03-14 \n4 \nXXX \nDS \nXXX-767-001 \n4 \nSKIN RASH \nADVERSE EVENT \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nTREATMENT 2 \n2016-03-14 \nExample 8 \nThis example represents data for an ongoing blinded study in which each subject received 2 treatments, identified by the sponsor as \"BLINDED DRUG A\" and \n\"BLINDED DRUG B\". Disposition of study participation and of each of the 2 blinded treatments was collected for each of the 2 treatment epochs in the study. \nThe subject in this example completed study participation and both treatments for both treatment epochs.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2355, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9ac75c51-c2da-485b-8b3d-9a3c23f20bc8": {"__data__": {"id_": "9ac75c51-c2da-485b-8b3d-9a3c23f20bc8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 162, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eabd1301-d510-4ef9-80db-ce018b3b5dbc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 162, "section": "UNSPECIFIED"}, "hash": "557cfe93e0d0abcedd2cd2083282f403cc1ed0da7b97634411d9cfe698377d38", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "de491dbb-30f1-422e-8fad-3e29f57999bc", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 162, "section": "UNSPECIFIED"}, "hash": "e91b3591afce19a095f2b3035b6a16432ff50aaede4de1c137d4458a2dd1ed44", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Disposition of study participation and of each of the 2 blinded treatments was collected for each of the 2 treatment epochs in the study. \nThe subject in this example completed study participation and both treatments for both treatment epochs. \nRows 1, 2, 4, 5: Represent the disposition of the blinded treatments for each of the 2 treatment epochs for each of the 2 treatments, indicated by DSSCAT = \n\"BLINDED DRUG A\" and DSSCAT = \"BLINDED DRUG B\". \nRows 3, 6: \nRepresent the disposition of study participation for each of the 2 treatment epochs, as indicated by DSSCAT = \"STUDY PARTICIPATION\". \nds.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nDSSEQ \nDSTERM \nDSDECOD \nDSCAT \nDSSCAT \nEPOCH \nDSSTDTC \n1 \nXXX \nDS \nXXX-767-001 \n1 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nBLINDED DRUG A \nTREATMENT 1 \n2016-02-15 \n2 \nXXX \nDS \nXXX-767-001 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nBLINDED DRUG B \nTREATMENT 1 \n2016-02-15 \n3 \nXXX \nDS \nXXX-767-001 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nTREATMENT 1 \n2016-02-25 \n4 \nXXX \nDS \nXXX-767-001 \n4 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nBLINDED DRUG A \nTREATMENT 2 \n2016-03-14 \n5 \nXXX \nDS \nXXX-767-001 \n5 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nBLINDED DRUG B \nTREATMENT 2 \n2016-03-14 \n6 \nXXX \nDS \nXXX-767-001 \n6 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nTREATMENT 2 \n2016-03-24", "mimetype": "text/plain", "start_char_idx": 2112, "end_char_idx": 3471, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "69feaeb6-e0e9-4f68-89d7-274dbb52a589": {"__data__": {"id_": "69feaeb6-e0e9-4f68-89d7-274dbb52a589", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 163, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6e4e9fc-aa49-44e8-b5b0-55b80dc1f717", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 163, "section": "UNSPECIFIED"}, "hash": "38eb330d4ad09ebd6830c45a18901b92907fb9f0b2492ffe1a42f42bed24d296", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af372453-493a-4562-8e42-8a0db46f2b41", "node_type": "1", "metadata": {}, "hash": "66b3810c7f36a8f0731edc565b03894e888943c8cc270162bc15eff6fa0e4f2a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 163 \n2021-11-29 \nExample 9 \nThis example is for a study in which multiple informed consents were collected. DSTERM is populated with a full description of the informed \nconsent. DSDECOD is populated with the standardized value \"INFORMED CONSENT OBTAINED\" from the Protocol Milestone (PROTMLST) codelist. For \nall informed consent records, DSCAT = \"PROTOCOL MILESTONE\". The sponsor chose to include the EPOCH timing variable, to indicate the epoch during \nwhich each protocol milestone occurred.  \nRow 1: \nShows the obtaining of the initial study informed consent. \nRow 2: \nShows randomization, another event with DSCAT = \"PROTOCOL MILESTONE\". \nRows 3-5: \nShow 3 additional informed consents obtained during the trial. \nds.xpt \nRow STUDYID DOMAIN USUBJID \nDSSEQ DSTERM \nDSDECOD \nDSCAT \nEPOCH \nDSSTDTC \n1 \nXXX \nDS \nXXX-767-\n001 \n1 \nINFORMED CONSENT FOR STUDY ENROLLMENT \nOBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \nSCREENING \n2016-02-\n22 \n2 \nXXX \nDS \nXXX-767-\n001 \n2 \nRANDOMIZED \nRANDOMIZED \nPROTOCOL \nMILESTONE \nSCREENING \n2016-02-\n26 \n3 \nXXX \nDS \nXXX-767-\n001 \n3 \nINFORMED CONSENT FOR AMENDMENT ONE OBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \nTREATMENT \n1 \n2016-04-\n12 \n4 \nXXX \nDS \nXXX-767-\n001 \n4 \nINFORMED CONSENT FOR PHARMACOGENETIC \nRESEARCH OBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \nTREATMENT \n2 \n2016-06-\n08 \n5 \nXXX \nDS \nXXX-767-\n001 \n5 \nINFORMED CONSENT FOR PK SUB-STUDY OBTAINED \nINFORMED CONSENT \nOBTAINED \nPROTOCOL \nMILESTONE \nTREATMENT \n2 \n2016-06-\n23 \nExample 10 \nThe example represents data for 2 subjects who participated in a study with multiple treatment periods. During the first treatment period, subjects were \nrandomized to drug 1 or drug 2. The second treatment phase added the investigational drug to drug 1 and drug 2. Disposition of study drugs and study \nparticipation was collected at the end of each epoch. DSSCAT was used to distinguish between disposition of study drugs vs. study participation. The supporting \nDemographics (DM), Exposure (EX), Trial Elements (TE), Trial Arms (TA), and Subject Elements (SE) datasets have been provided for additional context. Not \nall records are shown in the supporting example datasets. \nThe elements used in the TA dataset are defined in the TE dataset. \nRow 1: \nShows the screening element. \nRows 2, 3: Show the elements for treatment (either \"DRUG1\" or \"DRUG2\"). These appear in the first treatment epoch in the TA dataset. \nRows 4, 5: Show the elements for treatment (either \"DG1INDG\" or \"DG2INDG\").", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2696, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af372453-493a-4562-8e42-8a0db46f2b41": {"__data__": {"id_": "af372453-493a-4562-8e42-8a0db46f2b41", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 163, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6e4e9fc-aa49-44e8-b5b0-55b80dc1f717", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 163, "section": "UNSPECIFIED"}, "hash": "38eb330d4ad09ebd6830c45a18901b92907fb9f0b2492ffe1a42f42bed24d296", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "69feaeb6-e0e9-4f68-89d7-274dbb52a589", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 163, "section": "UNSPECIFIED"}, "hash": "f597d6cd63d5b12feeb25c8ab1d8009ed92f5ca4cdcc0f5664bd87d5d38f3143", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The second treatment phase added the investigational drug to drug 1 and drug 2. Disposition of study drugs and study \nparticipation was collected at the end of each epoch. DSSCAT was used to distinguish between disposition of study drugs vs. study participation. The supporting \nDemographics (DM), Exposure (EX), Trial Elements (TE), Trial Arms (TA), and Subject Elements (SE) datasets have been provided for additional context. Not \nall records are shown in the supporting example datasets. \nThe elements used in the TA dataset are defined in the TE dataset. \nRow 1: \nShows the screening element. \nRows 2, 3: Show the elements for treatment (either \"DRUG1\" or \"DRUG2\"). These appear in the first treatment epoch in the TA dataset. \nRows 4, 5: Show the elements for treatment (either \"DG1INDG\" or \"DG2INDG\"). These appear in the second treatment epoch in the TA dataset. \nRow 6: \nShows the follow-up element. \nte.xpt \nRow STUDYID \nDOMAIN \nETCD \nELEMENT \nTESTRL \nTEENRL \nTEDUR \n1 \nXYZ \nTE \nSCRN \nScreen \nInformed Consent \n1 week after start of Element \nP7D \n2 \nXYZ \nTE \nDRUG1 \nDrug 1 \nFirst dose of Drug 1 \n4 weeks after start of Element \nP28D \n3 \nXYZ \nTE \nDRUG2 \nDrug 2 \nFirst dose of Drug 2 \n4 weeks after start of Element \nP28D \n4 \nXYZ \nTE \nDG1INDG \nDrug 1 + Investigation Drug \nFirst dose of Investigational Drug, where Investigational Drug is given with Drug 1. \n1 week after start of Element \nP7D \n5 \nXYZ \nTE \nDG2INDG \nDrug 2 + Investigation Drug \nFirst dose of Investigational Drug, where Investigational Drug is given with Drug 2. \n1 week after start of Element \nP7D \n6 \nXYZ \nTE \nFU \nFollow-up \nOne day after last administration of study drug.", "mimetype": "text/plain", "start_char_idx": 1888, "end_char_idx": 3538, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c46be72-fb42-4c87-9fae-719eb60ed9f0": {"__data__": {"id_": "6c46be72-fb42-4c87-9fae-719eb60ed9f0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 164, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1cbb64c6-6a5e-4efe-931b-02abdc7d5f20", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 164, "section": "UNSPECIFIED"}, "hash": "10ff0d674fc1e2ce1c30e50c07d9e902788472d920e508c136fed762caa95386", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a39134be-16f8-4fe4-8ea3-392dffcab1b5", "node_type": "1", "metadata": {}, "hash": "7c83506c7243264d84114a0bbe0ecb6ebd43f2bb4b01e56aee141e0b9ff276fa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 164 \n2021-11-29 \nThe TA dataset describes the design of the study. \nRows 1, 5: Screening portion of the trial arm. \nRows 2, 6: Represents the planned initial treatment arm of either \"DRUG1\" or \"DRUG2\". \nRows 3, 7: Represents the planned second treatment arm of either \"DG1INDG\" or \" DG2INDG\". \nRows 4, 8: Follow-up portion of the trial arm. \nta.xpt \nRow \nSTUDYID \nDOMAIN \nARMCD \nARM \nTAETORD \nETCD \nELEMENT \nTABRANCH \nTATRANS \nEPOCH \n1 \nXYZ \nTA \nDG1INDG \nDrug-1+Investigation-Drug \n1 \nSCRN \nScreen \nRandomized to DG1INDG \n \nSCREENING \n2 \nXYZ \nTA \nDG1INDG \nDrug-1+Investigation-Drug \n2 \nDRUG1 \nDrug-1 \n \n \nTREATMENT 1 \n3 \nXYZ \nTA \nDG1INDG \nDrug-1+Investigation-Drug \n3 \nDG1INDG \nDrug 1 + Investigation Drug \n \n \nTREATMENT 2 \n4 \nXYZ \nTA \nDG1INDG \nDrug-1+Investigation-Drug \n4 \nFU \nFollow-up \n \n \nFOLLOW-UP \n5 \nXYZ \nTA \nDG2INDG \nDrug-2+Investigation-Drug \n1 \nSCRN \nScreen \nRandomized to DG2INDG \n \nSCREENING \n6 \nXYZ \nTA \nDG2INDG \nDrug-2+Investigation-Drug \n2 \nDRUG2 \nDrug-2 \n \n \nTREATMENT 1 \n7 \nXYZ \nTA \nDG2INDG \nDrug-2+Investigation-Drug \n3 \nDG2INDG \nDrug 2 + Investigation Drug \n \n \nTREATMENT 2 \n8 \nXYZ \nTA \nDG2INDG \nDrug-2+Investigation-Drug \n4 \nFU \nFollow-up \n \n \nFOLLOW-UP \nThe DM dataset includes the arm to which the subjects were randomized, and the dates of informed consent, start of study treatment, end of study treatment, and \nend of study participation. \ndm.xpt \nRow STUDYID DOMAIN USUBJID \nSUBJID RFXSTDTC RFXENDTC RFICDTC \nRFPENDTC SITEID INVNAM \nARMCD \nARM \nACTARMCD ACTARM \nARMNRS ACTARMUD \n1 \nXYZ \nDM \nXYZ-767-\n001 \n001 \n2016-02-14 \n2016-04-19 \n2016-02-\n02 \n2016-04-24 \n01 \nADAMS, \nM \nDG1INDG Drug-\n1+Investigation-\nDrug \nDG1INDG \nDrug-\n1+Investigation-\nDrug \n \n \n3 \nXYZ \nDM \nXYZ-767-\n002 \n002 \n2016-02-21 \n2016-04-24 \n2016-02-\n04 \n2016-04-29 \n01 \nADAMS, \nM \nDG2INDG Drug-\n2+Investigation-\nDrug \nDG2INDG \nDrug-\n2+Investigation-\nDrug \n \n \nThe EX dataset shows the administration of study treatments.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2093, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a39134be-16f8-4fe4-8ea3-392dffcab1b5": {"__data__": {"id_": "a39134be-16f8-4fe4-8ea3-392dffcab1b5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 164, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1cbb64c6-6a5e-4efe-931b-02abdc7d5f20", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 164, "section": "UNSPECIFIED"}, "hash": "10ff0d674fc1e2ce1c30e50c07d9e902788472d920e508c136fed762caa95386", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c46be72-fb42-4c87-9fae-719eb60ed9f0", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 164, "section": "UNSPECIFIED"}, "hash": "0e3ce021ae4a05da9dce159539279e14e35bb2edccf41e640d8c1b2d881a0ce8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ex.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nEXSEQ \nEXTRT \nEXDOSE \nEXDOSU \nEPOCH \nEXSTDTC \nEXENDTC \n1 \nXYZ \nEX \nXYZ-767-001 \n1 \nDrug 1 \n500 \nmg \nTREATMENT 1 \n2016-02-14 \n2016-03-13 \n2 \nXYZ \nEX \nXYZ-767-001 \n2 \nDrug 1 \n500 \nmg \nTREATMENT 2 \n2016-03-14 \n2016-04-19 \n3 \nXYZ \nEX \nXYZ-767-001 \n3 \nInvestigational Drug \n1000 \nmg \nTREATMENT 2 \n2016-03-14 \n2016-04-19 \n4 \nXYZ \nEX \nXYZ-767-002 \n1 \nDrug 2 \n500 \nmg \nTREATMENT 1 \n2016-02-21 \n2016-03-23 \n5 \nXYZ \nEX \nXYZ-767-002 \n2 \nDrug 2 \n500 \nmg \nTREATMENT 2 \n2016-03-24 \n2016-04-24 \n6 \nXYZ \nEX \nXYZ-767-002 \n3 \nInvestigational Drug \n1000 \nmg \nTREATMENT 2 \n2016-03-24 \n2016-04-24 \nThe SE dataset shows the dates for the elements for each subject. \nRows 1, 5: Represent the subjects' actual screening elements. \nRows 2, 6: Represent the subjects' actual first treatment epochs. The 2 subjects were in different elements in the first treatment epoch. \nRows 3, 7: Represent the subjects' actual second treatment epochs. \nRows 4, 8: Represent the subjects' actual follow-up elements.", "mimetype": "text/plain", "start_char_idx": 2095, "end_char_idx": 3109, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf73776e-1e25-4e58-9bb0-8b11c44805a0": {"__data__": {"id_": "bf73776e-1e25-4e58-9bb0-8b11c44805a0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "82de0c19-acc7-4f7c-8bd7-4353054f5668", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}, "hash": "02777ea59b0687f8e6d74e31193c7543edc57e97d762efa0673c547e000518bb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3414ac39-2162-465d-bcd3-71d36bb2d979", "node_type": "1", "metadata": {}, "hash": "e03e1f4d12fbfc6d5e2aad448ddde8274fb4a18ad5da809b34a6b911e3a393b5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 165 \n2021-11-29 \nse.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSDSEQ \nETCD \nELEMENT \nSESTDTC \nSEENDTC \nTAETORD \nEPOCH \n1 \nXYZ \nSE \nXYZ-767-001 \n1 \nSCREEN \nScreen \n2016-02-02 \n2016-02-14 \n1 \nSCREENING \n2 \nXYZ \nSE \nXYZ-767-001 \n2 \nDRUG1 \nDrug-1 \n2016-02-14 \n2016-03-14 \n2 \nTREATMENT 1 \n3 \nXYZ \nSE \nXYZ-767-001 \n3 \nDG1INDG \nDrug 1 + Investigational Drug \n2016-03-14 \n2016-04-24 \n3 \nTREATMENT 2 \n4 \nXYZ \nSE \nXYZ-767-001 \n4 \nFU \nFollow-up \n2016-04-24 \n2016-04-24 \n4 \nFOLLOW-UP \n5 \nXYZ \nSE \nXYZ-767-002 \n1 \nSCREEN \nScreen \n2016-02-04 \n2016-02-21 \n1 \nSCREENING \n6 \nXYZ \nSE \nXYZ-767-002 \n2 \nDRUG2 \nDrug-2 \n2016-02-21 \n2016-03-24 \n2 \nTREATMENT 1 \n7 \nXYZ \nSE \nXYZ-767-002 \n3 \nDG2INDG \nDrug 2 + Investigational Drug \n2016-03-24 \n2016-04-29 \n3 \nTREATMENT 2 \n8 \nXYZ \nSE \nXYZ-767-002 \n4 \nFU \nFollow-up \n2016-04-29 \n2016-04-29 \n4 \nFOLLOW-UP \nThe DS dataset shows the disposition events and protocol milestones for each subject. \nRows 1, 8: \nShow randomization to either DRUG 1 or DRUG 2 in the study. \nRows 2, 9: \nRepresent the completion of the screening phase of the study. Note that although a form describing disposition of the screening epoch may \nbe filled out before treatment starts, the screening epoch does not end until treatment begins. \nRows 3, 5, 10, 12: \nRepresent the completion of drug for each EPOCH, where DSSCAT has the name of the drug(s). The DSSTDTC is the end date of study \ntreatment for the epoch. \nRows 4, 6, 11, 13: \nRepresent the completion of study participation for each epoch, where DSSCAT has the name of \"STUDY PARTICIPATION\". The \nDSSTDTC is the end date of study participation for the epoch. There was a 1-day evaluation post-treatment. \nRows 7, 14: \nRepresent the completion of the study participation follow-up epoch, where DSSCAT has the name of \"STUDY PARTICIPATION\". The \nDSSTDTC is the end date of study participation for the epoch.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2031, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3414ac39-2162-465d-bcd3-71d36bb2d979": {"__data__": {"id_": "3414ac39-2162-465d-bcd3-71d36bb2d979", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "82de0c19-acc7-4f7c-8bd7-4353054f5668", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}, "hash": "02777ea59b0687f8e6d74e31193c7543edc57e97d762efa0673c547e000518bb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bf73776e-1e25-4e58-9bb0-8b11c44805a0", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}, "hash": "4f9a217984b16e2c0c341bad84a36052b8f11edec95aa21136297ae1200c61a5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "411fc571-22bb-44de-9cda-2c740695d7b7", "node_type": "1", "metadata": {}, "hash": "6ffdbfc81e80f61340578f9d72fbdba37afa04b55c12f3b698ab1f3b318c2da7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rows 4, 6, 11, 13: \nRepresent the completion of study participation for each epoch, where DSSCAT has the name of \"STUDY PARTICIPATION\". The \nDSSTDTC is the end date of study participation for the epoch. There was a 1-day evaluation post-treatment. \nRows 7, 14: \nRepresent the completion of the study participation follow-up epoch, where DSSCAT has the name of \"STUDY PARTICIPATION\". The \nDSSTDTC is the end date of study participation for the epoch. \nds.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nDSSEQ \nDSTERM \nDSDECOD \nDSCAT \nDSSCAT \nEPOCH \nDSSTDTC \n1 \nXYZ \nDS \nXYZ-767-001 \n1 \nRANDOMIZED \nRANDOMIZED \nPROTOCOL MILESTONE \n \nSCREENING \n2016-02-13 \n2 \nXYZ \nDS \nXYZ-767-001 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nSCREENING \n2016-02-13 \n3 \nXYZ \nDS \nXYZ-767-001 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nDRUG1 \nTREATMENT 1 \n2016-03-13 \n4 \nXYZ \nDS \nXYZ-767-001 \n4 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nTREATMENT 1 \n2016-03-14 \n5 \nXYZ \nDS \nXYZ-767-001 \n5 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nDG1INDG \nTREATMENT 2 \n2016-04-19 \n6 \nXYZ \nDS \nXYZ-767-001 \n6 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nTREATMENT 2 \n2016-04-20 \n7 \nXYZ \nDS \nXYZ-767-001 \n7 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nFOLLOW-UP \n2016-04-24 \n8 \nXYZ \nDS \nXYZ-767-002 \n1 \nRANDOMIZED \nRANDOMIZED \nPROTOCOL MILESTONE \n \nSCREENING \n2016-02-20 \n9 \nXYZ \nDS \nXYZ-767-002 \n2 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nSCREENING \n2016-02-20 \n10 \nXYZ \nDS \nXYZ-767-002 \n3 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nDRUG2 \nTREATMENT 1 \n2016-03-23 \n11 \nXYZ \nDS \nXYZ-767-002 \n4 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nTREATMENT 1 \n2016-03-24 \n12 \nXYZ \nDS \nXYZ-767-002 \n5 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nDG2INDG \nTREATMENT 2 \n2016-04-24 \n13 \nXYZ \nDS \nXYZ-767-002 \n6 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nTREATMENT 2 \n2016-04-25 \n14 \nXYZ \nDS \nXYZ-767-002 \n7 \nCOMPLETED \nCOMPLETED \nDISPOSITION EVENT \nSTUDY PARTICIPATION \nFOLLOW-UP \n2016-04-29 \nExample 11 \nThe study in this example had 4 cycles of treatment within the treatment epoch, and each cycle was represented as an element.", "mimetype": "text/plain", "start_char_idx": 1582, "end_char_idx": 3783, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "411fc571-22bb-44de-9cda-2c740695d7b7": {"__data__": {"id_": "411fc571-22bb-44de-9cda-2c740695d7b7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "82de0c19-acc7-4f7c-8bd7-4353054f5668", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}, "hash": "02777ea59b0687f8e6d74e31193c7543edc57e97d762efa0673c547e000518bb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3414ac39-2162-465d-bcd3-71d36bb2d979", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 165, "section": "UNSPECIFIED"}, "hash": "3fff40df39692001d7a7e00e76a23f7c63e2bd30f3325f662ad7c5c8c59e7ba0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although it is not a general \nrequirement that each cycle is represented as a distinct element, doing so was important for this study. The study compared a current standard treatment with \ndrugs A and B to treatment with drugs A, B, and C. The protocol allowed for drug doses to be reduced under specified criteria. For drug C, these dose \nmodifications could include dropping the drug. When drug C is dropped, the subject may transition to treatment with drugs A and B or to follow-up. \nThe TE dataset shows the elements of the trial.", "mimetype": "text/plain", "start_char_idx": 3784, "end_char_idx": 4319, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a0f62625-7125-4813-9341-8492d15e6d84": {"__data__": {"id_": "a0f62625-7125-4813-9341-8492d15e6d84", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 166, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "df64b0a0-fcd9-4faa-aae8-dd157031b0d7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 166, "section": "UNSPECIFIED"}, "hash": "985f3cb7ded1a8889f739779416f381b216e3c2812b1eeb234076b33b7ba211d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82b901ec-bbcc-4f48-965c-aed9aa713ad3", "node_type": "1", "metadata": {}, "hash": "b379842278e5a2a1f54d848f1076abafb730cceb0694fc8f830553ec5ab6a7d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 166 \n2021-11-29 \nte.xpt \nRow STUDYID \nDOMAIN \nETCD \nELEMENT \nTESTRL \nTEENRL \nTEDUR \n1 \nDS10 \nTE \nSCRN \nScreen \nInformed Consent \nScreening assessments are complete, up to 2 weeks after start of Element \n \n2 \nDS10 \nTE \nAB \nTrt AB \nFirst dose of treatment Element, where treatment is AB \n4 weeks after start of Element \nP4W \n3 \nDS10 \nTE \nABC \nTrt ABC \nFirst dose of treatment Element, where treatment AB +C \n4 weeks after start of Element \nP4W \n4 \nDS10 \nTE \nFU \nFollow-up \nFour weeks after start of last treatment element \nDeath, withdrawal of consent, or loss to follow-up. \n \nThe TA dataset shows the trial design. The sponsor chose to number elements starting with zero for the screening element. For the AB arm, the TAETORD \nvalues match the cycle numbers. For the ABC arm, if drug C is dropped, the subject may transition to an AB element or follow-up. TAETORD values are not \nchronological for this arm such that elements with TAETORD values of \"2\" or \"5\" would be during \"Cycle 2\", elements with TAETORD values of \"3\" or \"6\" \nwould be during \"Cycle 3\", and elements with TAETORD values of \"4\" or \"7\" would be during \"Cycle 4\". \nta.xpt \nRow STUDYID DOMAIN ARMCD ARM TAETORD ETCD ELEMENT TABRANCH \nTATRANS \nEPOCH \n1 \nDS10 \nTA \nAB \nAB \n0 \nSCRN Screen \nRandomized to AB  \nSCREENING \n2 \nDS10 \nTA \nAB \nAB \n1 \nAB \nTrt AB \n \nIf disease progression, go to follow-up epoch. \nTREATMENT \n3 \nDS10 \nTA \nAB \nAB \n2 \nAB \nTrt AB \n \nIf disease progression, go to follow-up epoch. \nTREATMENT \n4 \nDS10 \nTA \nAB \nAB \n3 \nAB \nTrt AB \n \nIf disease progression, go to follow-up epoch. \nTREATMENT \n5 \nDS10 \nTA \nAB \nAB \n4 \nAB \nTrt AB \n \n \nTREATMENT \n6 \nDS10 \nTA \nAB \nAB \n5 \nFU \nFollow-up \n \n \nFOLLOW-UP \n7 \nDS10 \nTA \nABC \nABC 0 \nSCRN Screen \nRandomized to \nABC \n \nSCREENING \n8 \nDS10 \nTA \nABC \nABC 1 \nABC \nTrt ABC \n \nIf disease progression, go to follow-up epoch. If drug C is dropped, go to element with \nTAETORD = \"5\". \nTREATMENT \n9 \nDS10 \nTA \nABC \nABC 2 \nABC \nTrt ABC \n \nIf disease progression, go to follow-up epoch. If drug C is dropped, go to element with \nTAETORD = \"6\". \nTREATMENT \n10 \nDS10 \nTA \nABC \nABC 3 \nABC \nTrt ABC \n \nIf disease progression, go to follow-up epoch. If drug C is dropped, go to element with \nTAETORD = \"7\". \nTREATMENT \n11 \nDS10 \nTA \nABC \nABC 4 \nABC \nTrt ABC \n \nGo to follow-up epoch.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2466, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "82b901ec-bbcc-4f48-965c-aed9aa713ad3": {"__data__": {"id_": "82b901ec-bbcc-4f48-965c-aed9aa713ad3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 166, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "df64b0a0-fcd9-4faa-aae8-dd157031b0d7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 166, "section": "UNSPECIFIED"}, "hash": "985f3cb7ded1a8889f739779416f381b216e3c2812b1eeb234076b33b7ba211d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a0f62625-7125-4813-9341-8492d15e6d84", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 166, "section": "UNSPECIFIED"}, "hash": "aa12b6d5284ee4093ce58f64d13c17b5ee417809c8aeeb60cbda42f4a06e2ee4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If drug C is dropped, go to element with \nTAETORD = \"5\". \nTREATMENT \n9 \nDS10 \nTA \nABC \nABC 2 \nABC \nTrt ABC \n \nIf disease progression, go to follow-up epoch. If drug C is dropped, go to element with \nTAETORD = \"6\". \nTREATMENT \n10 \nDS10 \nTA \nABC \nABC 3 \nABC \nTrt ABC \n \nIf disease progression, go to follow-up epoch. If drug C is dropped, go to element with \nTAETORD = \"7\". \nTREATMENT \n11 \nDS10 \nTA \nABC \nABC 4 \nABC \nTrt ABC \n \nGo to follow-up epoch. \nTREATMENT \n12 \nDS10 \nTA \nABC \nABC 5 \nAB \nTrt AB \n \n \nTREATMENT \n13 \nDS10 \nTA \nABC \nABC 6 \nAB \nTrt AB \n \n \nTREATMENT \n14 \nDS10 \nTA \nABC \nABC 7 \nAB \nTrt AB \n \n \nTREATMENT \n15 \nDS10 \nTA \nABC \nABC 8 \nFU \nFollow-up \n \n \nFOLLOW-UP \nThis example shows data for a subject who was randomized to treatment ABC. Drug C was dropped after cycle 2 due to toxicity associated with drug C. \nTreatment with drugs A and B was stopped after cycle 3 due to disease progression. The subject died during follow-up. \nThe SE dataset records the elements this subject experienced. \nRows 1-4: \nThe subject participated in the screening epoch and 3 elements of the treatment epoch. \nRow 5: \nThe subject's fifth element was not \"ABC\" or \"AB\", as would have been expected if they recieved all 4 cycles of therapy, but \"FU\". \nse.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSESEQ \nETCD \nSESTDTC \nSEENDTC \nSEUPDES \nTAETORD \nEPOCH \n1 \nDS10 \nSE \n101 \n1 \nSCRN \n2015-01-21 \n2015-02-01 \n \n0 \nSCREENING \n2 \nDS10 \nSE \n101 \n2 \nABC \n2015-02-01 \n2015-03-01 \n \n1 \nTREATMENT \n3 \nDS10 \nSE \n101 \n3 \nABC \n2015-03-01 \n2015-03-29 \n \n2 \nTREATMENT \n4 \nDS10 \nSE \n101 \n4 \nAB \n2015-03-29 \n2015-04-26 \n \n6 \nTREATMENT \n5 \nDS10 \nSE \n101 \n5 \nFU \n2015-04-26 \n2015-09-19 \n \n8 \nFOLLOW-UP", "mimetype": "text/plain", "start_char_idx": 2018, "end_char_idx": 3686, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f8bb1d97-d0a8-4f64-bbbc-d6b19dfcb32f": {"__data__": {"id_": "f8bb1d97-d0a8-4f64-bbbc-d6b19dfcb32f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 167, "section": "6.2.5 Healthcare Encounters (HO)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0bb35961-a35f-4a8a-a858-415fc3e963fe", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 167, "section": "6.2.5 Healthcare Encounters (HO)"}, "hash": "f54cc6817c504a3625d34f1af1f387eeac80ed20a21e14cf66f9c2db4ecfc2b9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "HO \u2013 Description/Overview \nAn events domain that contains data for inpatient and outpatient healthcare events (e.g., hospitalization, nursing home stay, rehabilitation facility stay, \nambulatory surgery). \nHO \u2013 Specification \nho.xpt, Healthcare Encounters \u2014 Events. One record per healthcare encounter per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar HO \nIdentifier \nTwo-character abbreviation for the domain. \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 610, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0a3dba9f-1538-42b4-b622-b10cb9ff9879": {"__data__": {"id_": "0a3dba9f-1538-42b4-b622-b10cb9ff9879", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 168, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1be6e8f2-0252-4f6a-96ef-6c30d75ffeca", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 168, "section": "UNSPECIFIED"}, "hash": "a54f8b644d99764400b254b5fa45a27efc704b55bcf91e74b3cb4946e4aefa4b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "69726ad5-9ded-4bb8-8047-161666385162", "node_type": "1", "metadata": {}, "hash": "c5f1bfddade57175bf9737b8ea2c073c09194cf2da6f801dfdd2627c7c1dd45e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 168 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or \nsubmissions involving the product. \nReq \nHOSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be \nany valid number. \nReq \nHOGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nHOREFID \nReference ID \nChar  \nIdentifier \nInternal or external healthcare encounter identifier. \nPerm \nHOSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Example: Line number on a Healthcare \nEncounters CRF page. \nPerm \nHOTERM \nHealthcare Encounter \nTerm \nChar  \nTopic \nVerbatim or preprinted CRF term for the healthcare encounter. \nReq \nHODECOD \nDictionary-Derived Term \nChar (HODECOD) \nSynonym \nQualifier \nDictionary or sponsor-defined derived text description of HOTERM or the modified topic \nvariable (HOMODIFY). \nPerm \nHOCAT \nCategory for Healthcare \nEncounter \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-related values. \nPerm \nHOSCAT \nSubcategory for \nHealthcare Encounter \nChar * \nGrouping \nQualifier \nA further categorization of HOCAT values. \nPerm \nHOPRESP \nPre-Specified Healthcare \nEncounter \nChar (NY) \nVariable \nQualifier \nA value of \"Y\" indicates that this healthcare encounter event was prespecified on the CRF. \nValues are null for spontaneously reported events (i.e., those collected as free-text verbatim \nterms). \nPerm \nHOOCCUR \nHealthcare Encounter \nOccurrence \nChar (NY) \nRecord \nQualifier \nUsed when the occurrence of specific healthcare encounters is solicited, to indicate whether \nan encounter occurred. Values are null for spontaneously reported events. \nPerm \nHOSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nThe status indicates that the prespecified question was not answered. \nPerm \nHOREASND \nReason Healthcare \nEncounter Not Done \nChar  \nRecord \nQualifier \nDescribes the reason data for a prespecified event were not collected. Used in conjunction \nwith HOSTAT when value is \"NOT DONE\". \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the healthcare encounter. Examples: \n\"SCREENING\", \"TREATMENT\", \"FOLLOW-UP\". \nPerm \nHODTC \nDate/Time of Event \nCollection \nChar ISO 8601 datetime or \ninterval \nTiming \nCollection date and time of the healthcare encounter. \nPerm \nHOSTDTC \nStart Date/Time of \nHealthcare Encounter \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time of the healthcare encounter (e.g., date of admission).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3173, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "69726ad5-9ded-4bb8-8047-161666385162": {"__data__": {"id_": "69726ad5-9ded-4bb8-8047-161666385162", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 168, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1be6e8f2-0252-4f6a-96ef-6c30d75ffeca", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 168, "section": "UNSPECIFIED"}, "hash": "a54f8b644d99764400b254b5fa45a27efc704b55bcf91e74b3cb4946e4aefa4b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0a3dba9f-1538-42b4-b622-b10cb9ff9879", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 168, "section": "UNSPECIFIED"}, "hash": "6bfacb97239c11ab97d7f8271bd20fe718f5f9385d0b2fbb15fc718956805048", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Used in conjunction \nwith HOSTAT when value is \"NOT DONE\". \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the healthcare encounter. Examples: \n\"SCREENING\", \"TREATMENT\", \"FOLLOW-UP\". \nPerm \nHODTC \nDate/Time of Event \nCollection \nChar ISO 8601 datetime or \ninterval \nTiming \nCollection date and time of the healthcare encounter. \nPerm \nHOSTDTC \nStart Date/Time of \nHealthcare Encounter \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time of the healthcare encounter (e.g., date of admission). \nExp \nHOENDTC \nEnd Date/Time of \nHealthcare Encounter \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time of the healthcare encounter (e.g., date of discharge). \nPerm \nHODY \nStudy Day of Event \nCollection \nNum  \nTiming \nStudy day of event collection relative to the sponsor-defined RFSTDTC. \nPerm \nHOSTDY \nStudy Day of Start of \nEncounter \nNum  \nTiming \nStudy day of the start of the healthcare encounter relative to the sponsor-defined RFSTDTC. \nPerm \nHOENDY \nStudy Day of End of \nHealthcare Encounter \nNum  \nTiming \nStudy day of the end of the healthcare encounter relative to the sponsor-defined RFSTDTC. \nPerm \nHODUR \nDuration of Healthcare \nEncounter \nChar ISO 8601 duration \nTiming \nCollected duration of the healthcare encounter. Used only if collected on the CRF and not \nderived from the start and end date/times. Example: \"P1DT2H\" (for 1 day, 2 hours). \nPerm \nHOSTRTPT \nStart Relative to \nReference Time Point \nChar (STENRF) \nTiming \nIdentifies the start of the observation as being before or after the sponsor-defined reference \ntime point defined by variable --STTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative \nTiming Variables. \nPerm \nHOSTTPT \nStart Reference Time \nPoint \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the sponsor-defined reference point \nreferred to by STRTPT. Examples: \"2003-12-15\", \"VISIT 1\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2497, "end_char_idx": 4598, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "44997148-b73c-4986-880a-03bb4554d839": {"__data__": {"id_": "44997148-b73c-4986-880a-03bb4554d839", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 169, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eb4c1063-ad6b-431d-8a20-8e9b2e468626", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 169, "section": "UNSPECIFIED"}, "hash": "7e683713cd8e6276f7a63e2cddbd6bb81b6d7e2e7a3b7cd7be3d71f1f0f9a7db", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4c61a8a9-0b87-446e-aebc-1ba93746df55", "node_type": "1", "metadata": {}, "hash": "c0f0d273315b592b04c0bbb5b537faa32f4038dcf5385a77fcdf9436601006a2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 169 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nHOENRTPT \nEnd Relative to \nReference Time Point \nChar (STENRF) \nTiming \nIdentifies the end of the event as being before or after the reference time point defined by \nvariable HOENTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative \nTiming Variables. \nPerm \nHOENTPT \nEnd Reference Time \nPoint \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the reference point referred to by \nHOENRTPT. Examples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nHO \u2013 Assumptions \n1. The Healthcare Encounters (HO) dataset includes inpatient and outpatient healthcare events (e.g., hospitalizations, nursing home stays, rehabilitation \nfacility stays, ambulatory surgery). \n2. Values of HOTERM typically describe the location or place of the healthcare encounter (e.g., \"HOSPITAL\" rather than \"HOSPITALIZATION\"). \nHOSTDTC should represent the start or admission date and HOENDTC the end or discharge date. \n3. Data collected about healthcare encounters may include the reason for the encounter. The following supplemental qualifiers may be appropriate for \nrepresenting such data: \na. \nThe supplemental qualifier with QNAM = \"HOINDC\" would be used to represent the indication/medical condition for the encounter (e.g., stroke). \nNote that --INDC is an Interventions class variable, so is not a standard variable for HO, which is an Events class domain. \nb. The supplemental qualifier with QNAM = \"HOREAS\" would be used to represent a reason for the encounter other than a medical condition (e.g., \nannual checkup). \n4. If collected data includes the name of the provider or the facility where the encounter took place, this may be represented using the supplemental \nqualifier with QNAM = \"HONAM\". Note that --NAM is a Findings class variable, so is not a standard variable for HO, which is an Events class \ndomain. \n5. Any identifier variables, timing variables, or Events general observation-class qualifiers may be added to the HO domain, but the following Qualifiers \nwould generally not be used: \u2011\u2011SER, --ACN, --ACNOTH, --REL, --RELNST, --SCAN, --SCONG, --SDISAB, \u2011\u2011SDTH, --SHOSP, --SLIFE, --SOD, --\nSMIE, \u2011\u2011BODSYS, \u2011\u2011LOC, \u2011\u2011SEV, --TOX, --TOXGR, --PATT, --CONTRT. \nHO \u2013 Examples \nExample 1 \nIn this example, a healthcare encounter CRF collects verbatim descriptions of the encounter. \nRows 1-2: \nSubject ABC123101 was hospitalized and then moved to a nursing home. \nRows 3-5: \nSubject ABC123102 was in a hospital in the general ward and then in the intensive care unit. This same subject was transferred to a rehabilitation \nfacility.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3042, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4c61a8a9-0b87-446e-aebc-1ba93746df55": {"__data__": {"id_": "4c61a8a9-0b87-446e-aebc-1ba93746df55", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 169, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "eb4c1063-ad6b-431d-8a20-8e9b2e468626", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 169, "section": "UNSPECIFIED"}, "hash": "7e683713cd8e6276f7a63e2cddbd6bb81b6d7e2e7a3b7cd7be3d71f1f0f9a7db", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "44997148-b73c-4986-880a-03bb4554d839", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 169, "section": "UNSPECIFIED"}, "hash": "1dbcd23651237063c6c305699928fc034fd50245cff62c6e5a0234d8280ed295", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "HO \u2013 Examples \nExample 1 \nIn this example, a healthcare encounter CRF collects verbatim descriptions of the encounter. \nRows 1-2: \nSubject ABC123101 was hospitalized and then moved to a nursing home. \nRows 3-5: \nSubject ABC123102 was in a hospital in the general ward and then in the intensive care unit. This same subject was transferred to a rehabilitation \nfacility. \nRows 6-7: \nSubject ABC123103 has 2 hospitalization records. \nRow 8: \nSubject ABC123104 was seen in the cardiac catheterization laboratory.", "mimetype": "text/plain", "start_char_idx": 2673, "end_char_idx": 3182, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6ba046cf-5060-4a37-94ef-28891316eafb": {"__data__": {"id_": "6ba046cf-5060-4a37-94ef-28891316eafb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e2757759-a170-4e87-8219-8169c2f9cc39", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}, "hash": "dba0bd1d45be960c689f808eb379d696b78ae7f7a93a5e3d35380790325919fe", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c3e17cd6-d273-48f7-b3d3-7d4351b4c45f", "node_type": "1", "metadata": {}, "hash": "29d8d815ec970a4d22342e170fa82211fe1a03a2ba78b738c191dbc9ffe1debe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 170 \n2021-11-29 \nRows 9-12: Subject ABC123105 and subject ABC123106 were each seen in the cardiac catheterization laboratory and then transferred to another hospital. \nho.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nHOSEQ \nHOTERM \nEPOCH \nHOSTDTC \nHOENDTC \nHODUR \n1 \nABC \nHO \nABC123101 \n1 \nHOSPITAL \nTREATMENT \n2011-06-08 \n2011-06-13 \n \n2 \nABC \nHO \nABC123101 \n2 \nNURSING HOME \nTREATMENT \n \n \nP6D \n3 \nABC \nHO \nABC123102 \n1 \nGENERAL WARD \nTREATMENT \n2011-08-06 \n2011-08-08 \n \n4 \nABC \nHO \nABC123102 \n2 \nINTENSIVE CARE \nTREATMENT \n2011-08-08 \n2011-08-15 \n \n5 \nABC \nHO \nABC123102 \n3 \nREHABILIATION FACILITY \nTREATMENT \n2011-08-15 \n2011-08-20 \n \n6 \nABC \nHO \nABC123103 \n1 \nHOSPITAL \nTREATMENT \n2011-09-09 \n2011-09-11 \n \n7 \nABC \nHO \nABC123103 \n2 \nHOSPITAL \nTREATMENT \n2011-09-11 \n2011-09-15 \n \n8 \nABC \nHO \nABC123104 \n1 \nCARDIAC CATHETERIZATION LABORATORY \nTREATMENT \n2011-10-10 \n2011-10-10 \n \n9 \nABC \nHO \nABC123105 \n1 \nCARDIAC CATHETERIZATION LABORATORY \nTREATMENT \n2011-10-11 \n2011-10-11 \n \n10 \nABC \nHO \nABC123105 \n2 \nHOSPITAL \nTREATMENT \n2011-10-11 \n2011-10-15 \n \n11 \nABC \nHO \nABC123106 \n1 \nCARDIAC CATHETERIZATION LABORATORY \nFOLLOW-UP \n2011-11-07 \n2011-11-07 \n \n12 \nABC \nHO \nABC123106 \n2 \nHOSPITAL \nFOLLOW-UP \n2011-11-07 \n2011-11-09 \n \n \nRow 1: \nFor the first encounter recorded for subject ABC123101, the indication/medical condition for hospitalization was recorded. \nRow 2: \nFor the second encounter recorded for subject ABC123101, the reason for admission to a nursing home was for rehabilitation. \nRows 3-4: \nFor the 2 encounters recorded for subject ABC123103, the names of the facilities were recorded. \nRow 5: \nFor the first encounter for subject ABC123105, the indication/medical condition for the hospitalization was recorded. \nRow 6: \nFor the second encounter for subject ABC123105, the name of the hospital was recorded.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1997, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c3e17cd6-d273-48f7-b3d3-7d4351b4c45f": {"__data__": {"id_": "c3e17cd6-d273-48f7-b3d3-7d4351b4c45f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e2757759-a170-4e87-8219-8169c2f9cc39", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}, "hash": "dba0bd1d45be960c689f808eb379d696b78ae7f7a93a5e3d35380790325919fe", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6ba046cf-5060-4a37-94ef-28891316eafb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}, "hash": "6ca3c9e90bbc06608b4dce6612f4f5b46ce110f0b2a26229970ef8f1fdbf54e1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2fdc476f-2084-4d55-bb07-de85204447f0", "node_type": "1", "metadata": {}, "hash": "11292ee0fa4738d754c94384c552e7b7f64e4ca9fb3e6287b4732a41997be181", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Row 2: \nFor the second encounter recorded for subject ABC123101, the reason for admission to a nursing home was for rehabilitation. \nRows 3-4: \nFor the 2 encounters recorded for subject ABC123103, the names of the facilities were recorded. \nRow 5: \nFor the first encounter for subject ABC123105, the indication/medical condition for the hospitalization was recorded. \nRow 6: \nFor the second encounter for subject ABC123105, the name of the hospital was recorded. \nsuppho.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \nQEVAL \n1 \nABC \nHO \nABC123101 \nHOSEQ \n1 \nHOINDC \nIndication \nCONGESTIVE HEART FAILURE \nCRF \n \n2 \nABC \nHO \nABC123101 \nHOSEQ \n2 \nHOREAS \nReason \nREHABILITATION \nCRF \n \n3 \nABC \nHO \nABC123103 \nHOSEQ \n1 \nHONAM \nProvider Name \nGENERAL HOSPITAL \nCRF \n \n4 \nABC \nHO \nABC123103 \nHOSEQ \n2 \nHONAM \nProvider Name \nEMERSON HOSPITAL \nCRF \n \n5 \nABC \nHO \nABC123105 \nHOSEQ \n1 \nHOINDC \nIndication \nATRIAL FIBRILLATION \nCRF \n \n6 \nABC \nHO \nABC123105 \nHOSEQ \n2 \nHONAM \nProvider Name \nROOSEVELT HOSPITAL \nCRF \n \nExample 2 \nIn this example, the dates of an initial hospitalization are collected as well as the date/time of ICU stay.  Subsequent to discharge from the initial hospitalization, \nfollow-up healthcare encounters, including admission to a rehabilitation facility, visits with healthcare providers, and home nursing visits were collected.  Repeat \nhospitalizations are categorized separately.", "mimetype": "text/plain", "start_char_idx": 1535, "end_char_idx": 2965, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2fdc476f-2084-4d55-bb07-de85204447f0": {"__data__": {"id_": "2fdc476f-2084-4d55-bb07-de85204447f0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e2757759-a170-4e87-8219-8169c2f9cc39", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}, "hash": "dba0bd1d45be960c689f808eb379d696b78ae7f7a93a5e3d35380790325919fe", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c3e17cd6-d273-48f7-b3d3-7d4351b4c45f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 170, "section": "UNSPECIFIED"}, "hash": "a32c72526a97afd2a2d88184574d13a272fd92ec57201ed2761e8ec36cc39242", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Subsequent to discharge from the initial hospitalization, \nfollow-up healthcare encounters, including admission to a rehabilitation facility, visits with healthcare providers, and home nursing visits were collected.  Repeat \nhospitalizations are categorized separately. \nho.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nHOSEQ HOTERM \nHOCAT \nHOSTDTC \nHOENDTC \nHOENRTPT \nHOENTPT \n1 \nABC \nHO \nABC123101 \n1 \nHOSPITAL \nINITIAL HOSPITALIZATION \n2011-06-08 \n2011-06-12 \n \n \n2 \nABC \nHO \nABC123101 \n2 \nICU \nINITIAL HOSPITALIZATION \n2011-06-08T11:00 \n2011-06-09T14:30 \n \n \n3 \nABC \nHO \nABC123101 \n3 \nREHABILITATION FACILITY \nFOLLOW-UP CARE \n2011-06-12 \n2011-06-22 \n \n \n4 \nABC \nHO \nABC123101 \n4 \nCARDIOLOGY UNIT \nFOLLOW-UP CARE \n2011-06-25 \n2011-06-25 \n \n \n5 \nABC \nHO \nABC123101 \n5 \nOUTPATIENT PHYSICAL THERAPY \nFOLLOW-UP CARE \n2011-06-27 \n2011-06-27 \n \n \n6 \nABC \nHO \nABC123101 \n6 \nOUTPATIENT PHYSICAL THERAPY \nFOLLOW-UP CARE \n2011-07-12 \n2011-07-12 \n \n \n7 \nABC \nHO \nABC123101 \n7 \nHOSPITAL \nREPEAT HOSPITALIZATION \n2011-07-23 \n2011-07-24 \n \n \n8 \nABC \nHO \nABC123102 \n1 \nHOSPITAL \nINITIAL HOSPITALIZATION \n2011-06-19 \n2011-07-02", "mimetype": "text/plain", "start_char_idx": 2696, "end_char_idx": 3799, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "207e3ebc-4d1f-4866-82c3-b2a4194e6550": {"__data__": {"id_": "207e3ebc-4d1f-4866-82c3-b2a4194e6550", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 171, "section": "6.2.6 Medical History (MH)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b38c7021-cb3e-43de-901c-53ac3a0acd17", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 171, "section": "6.2.6 Medical History (MH)"}, "hash": "36c4d33b262d424cab93de6c2e615b6deb39d6f3fbe67276605440b05e4175eb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MH \u2013 Description/Overview \nAn events domain that contains data that includes the subject's prior medical history at the start of the trial. \nMH \u2013 Specification \nmh.xpt, Medical History \u2014 Events. One record per medical history event per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar MH \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nMHSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nMHGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nMHREFID \nReference ID \nChar  \nIdentifier \nInternal or external medical history identifier. \nPerm \nMHSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Example: Line number on a Medical History CRF page. \nPerm \nMHTERM \nReported Term for \nthe Medical History \nChar  \nTopic \nVerbatim or preprinted CRF term for the medical condition or event. \nReq \nMHMODIFY \nModified Reported \nTerm \nChar  \nSynonym \nQualifier \nIf MHTERM is modified to facilitate coding, then MHMODIFY will contain the modified text. \nPerm \nMHDECOD \nDictionary-Derived \nTerm \nChar * \nSynonym \nQualifier \nDictionary-derived text description of MHTERM or MHMODIFY. Equivalent to the Preferred Term (PT in \nMedDRA). The sponsor is expected to provide the dictionary name and version used to map the terms \nutilizing the external codelist element in the Define-XML document. \nPerm \nMHEVDTYP \nMedical History \nEvent Date Type \nChar (MHEDTTYP) \nVariable \nQualifier \nSpecifies the aspect of the medical condition or event by which MHSTDTC and/or the MHENDTC is \ndefined. Examples: \"DIAGNOSIS\", \"SYMPTOMS\", \"RELAPSE\", \"INFECTION\". \nPerm \nMHCAT \nCategory for \nMedical History \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. Examples: \"CARDIAC\", \"GENERAL\". \nPerm \nMHSCAT \nSubcategory for \nMedical History \nChar * \nGrouping \nQualifier \nA further categorization of the condition or event. \nPerm \nMHPRESP \nMedical History \nEvent Pre-Specified \nChar (NY) \nVariable \nQualifier \nA value of \"Y\" indicates that this medical history event was prespecified on the CRF. Values are null for \nspontaneously reported events (i.e., those collected as free-text verbatim terms). \nPerm \nMHOCCUR \nMedical History \nOccurrence \nChar (NY) \nRecord \nQualifier \nUsed when the occurrence of specific medical history conditions is solicited, to indicate whether \n(\"Y\"/\"N\") a medical condition (MHTERM) had ever occurred. Values are null for spontaneously reported \nevents. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3093, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "35fd706e-af26-421c-b8b3-97fcdbb5f04f": {"__data__": {"id_": "35fd706e-af26-421c-b8b3-97fcdbb5f04f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 172, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ec762da1-86de-4027-9501-9716c7ffaf90", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 172, "section": "UNSPECIFIED"}, "hash": "0193c66f0e3d71fd2ecef36e6eb0405a7291d24d2c5473af584e571579bc29de", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "59e8903e-f509-4160-ba0a-5a70cbf17e47", "node_type": "1", "metadata": {}, "hash": "93cd6e0cbb62be8c0c8233cdeeac22a203ab7f49846d72e2fa372083f5248961", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 172 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nMHSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nThe status indicates that the prespecified question was not asked/answered. \nPerm \nMHREASND \nReason Medical \nHistory Not \nCollected \nChar  \nRecord \nQualifier \nDescribes the reason why data for a prespecified condition was not collected. Used in conjunction with \nMHSTAT when value is \"NOT DONE\". \nPerm \nMHBODSYS \nBody System or \nOrgan Class \nChar * \nRecord \nQualifier \nDictionary-derived. Body system or organ class that is involved in an event or measurement from a \nstandard hierarchy (e.g., MedDRA). When using a multi-axial dictionary such as MedDRA, this should \ncontain the SOC used for the sponsor's analyses and summary tables which may not necessarily be the \nprimary SOC. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the medical history event. \nPerm \nMHDTC \nDate/Time of History \nCollection \nChar ISO 8601 datetime or \ninterval \nTiming \nCollection date and time of the medical history observation represented in ISO 8601 character format. \nPerm \nMHSTDTC \nStart Date/Time of \nMedical History \nEvent \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time of the medical history event represented in ISO 8601 character format. \nPerm \nMHENDTC \nEnd Date/Time of \nMedical History \nEvent \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time of the medical history event. \nPerm \nMHDY \nStudy Day of History \nCollection \nNum  \nTiming \nStudy day of medical history collection, measured as integer day. Algorithm for calculations must be \nrelative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent \nacross the submission. \nPerm \nMHENRF \nEnd Relative to \nReference Period \nChar (STENRF) \nTiming \nDescribes the end of the event relative to the sponsor-defined reference period. The sponsor-defined \nreference period is a continuous period of time defined by a discrete starting point and a discrete ending \npoint (represented by RFSTDTC and RFENDTC in Demographics). \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nMHENRTPT \nEnd Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the end of the event as being before or after the reference time point defined by variable \nMHENTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nMHENTPT \nEnd Reference Time \nPoint \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the reference point referred to by MHENRTPT. \nExamples: \"2003-12-25\", \"VISIT 2\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3126, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "59e8903e-f509-4160-ba0a-5a70cbf17e47": {"__data__": {"id_": "59e8903e-f509-4160-ba0a-5a70cbf17e47", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 172, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ec762da1-86de-4027-9501-9716c7ffaf90", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 172, "section": "UNSPECIFIED"}, "hash": "0193c66f0e3d71fd2ecef36e6eb0405a7291d24d2c5473af584e571579bc29de", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "35fd706e-af26-421c-b8b3-97fcdbb5f04f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 172, "section": "UNSPECIFIED"}, "hash": "76921fec1bba86e7827f2b481c142e1fccdf71c94494cc21ccb10fcd3f434f7b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Not all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nMHENRTPT \nEnd Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the end of the event as being before or after the reference time point defined by variable \nMHENTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nMHENTPT \nEnd Reference Time \nPoint \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the reference point referred to by MHENRTPT. \nExamples: \"2003-12-25\", \"VISIT 2\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nMH \u2013 Assumptions \n1. Prior treatments, including prior medications and procedures, should be submitted in an appropriate dataset from the Interventions class (e.g., \nConcomitant/Prior Medications (CM) or Procedures (PR)). \n2. MH description and coding \na. \nMHTERM is the topic variable and captures the verbatim term collected for the condition or event or the prespecified term used to collect \ninformation about the occurrence of any of a group of conditions or events. MHTERM is a required variable and must have a value. \nb. MHMODIFY is a permissible variable and should be included if the sponsor\u2019s procedure permits modification of a verbatim term for coding. The \nmodified term is listed in MHMODIFY. The variable should be populated as per the sponsor\u2019s procedures; null values are permitted.", "mimetype": "text/plain", "start_char_idx": 2502, "end_char_idx": 4096, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d5926e2-2da7-4e2f-be65-516fac2eed1a": {"__data__": {"id_": "1d5926e2-2da7-4e2f-be65-516fac2eed1a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 173, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cacf2cf2-a20e-4779-8c26-d16c4eb5b5b4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 173, "section": "UNSPECIFIED"}, "hash": "3629e5a1849504e668ed88fefba3d6b88cb95e1388d1ffd27bb1c1ef62938eb1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5fe54bbf-9233-4808-b6ca-76433d402382", "node_type": "1", "metadata": {}, "hash": "5bf676f18923f6cf49c0cc738dfb7c3febc56f075e2c9c23ccabe3d28da1091a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 173 \n2021-11-29 \nc. \nIf the sponsor codes the reported term (MHTERM) using a standard dictionary, then MHDECOD will be populated with the preferred term derived \nfrom the dictionary. The sponsor is expected to provide the dictionary name and version used to map the terms utilizing the external codelist \nelement in the Define-XML document. \nd. MHBODSYS is the system organ class (SOC) from the coding dictionary associated with the adverse event by the sponsor. This value may differ \nfrom the primary SOC designated in the coding dictionary's standard hierarchy. \ne. \nIf a CRF collects medical history by prespecified body systems and the sponsor also codes reported terms using a standard dictionary, then \nMHDECOD and MHBODSYS are populated using the standard dictionary. MHCAT and MHSCAT should be used for the prespecified body \nsystems. \n3. Additional categorization and grouping \na. \nMHCAT and MHSCAT may be populated with the sponsor's predefined categorization of medical history events, which are often prespecified on \nthe CRF. Note that even if the sponsor uses the body system terminology from the standard dictionary, MHBODSYS and MHCAT may differ; \nMHBODSYS is derived from the coding system, whereas MHCAT is effectively assigned when the investigator records a condition under the \nprespecified category. \ni. This categorization should not group all records (within the MH domain) into one generic group such as \u201cMedical History\u201d or \u201cGeneral \nMedical History\u201d because this is redundant information with the domain code. If no smaller categorization can be applied, then it is not \nnecessary to include or populate this variable. \nii. Examples of MHCAT could include \u201cGeneral Medical History\u201c (see above assumption; if \u201cGeneral Medical History\u201d is an MHCAT value, \nthen there should be other MHCAT values), \u201cAllergy Medical History, \u201c and \u201cReproductive Medical History\u201d. \nb. MHGRPID may be used to link (or associate) different records together to form a block of related records at the subject level within the MH \ndomain. It should not be used in place of MHCAT or MHSCAT, which are used to group data across subjects. For example, if a group of \nsyndromes reported for a subject were related to a particular disease, then the MHGRPID variable could be populated with the appropriate text. \n4. Prespecified terms; presence or absence of events \na. \nInformation on medical history is generally collected in 2 different ways, either by recording free text or using a prespecified list of terms. The \nsolicitation of information on specific medical history events may affect the frequency at which they are reported; therefore, the fact that a specific \nmedical history event was solicited may be of interest to reviewers. MHPRESP and MHOCCUR are used together to indicate whether the condition \nin MHTERM was prespecified and whether it occurred, respectively. A value of \u201cY\u201d in MHPRESP indicates that the term was prespecified. \nb. MHOCCUR is used to indicate whether a prespecified medical condition occurred; a value of \"Y\" indicates that the event occurred and \"N\" \nindicates that it did not. \nc. \nIf a medical history event was reported using free text, the values of MHPRESP and MHOCCUR should be null.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5fe54bbf-9233-4808-b6ca-76433d402382": {"__data__": {"id_": "5fe54bbf-9233-4808-b6ca-76433d402382", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 173, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cacf2cf2-a20e-4779-8c26-d16c4eb5b5b4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 173, "section": "UNSPECIFIED"}, "hash": "3629e5a1849504e668ed88fefba3d6b88cb95e1388d1ffd27bb1c1ef62938eb1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d5926e2-2da7-4e2f-be65-516fac2eed1a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 173, "section": "UNSPECIFIED"}, "hash": "2077033ea0b2226182aa9b56f6bcc5316db64aee35e8e1c36d15222b1e95b4b4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The \nsolicitation of information on specific medical history events may affect the frequency at which they are reported; therefore, the fact that a specific \nmedical history event was solicited may be of interest to reviewers. MHPRESP and MHOCCUR are used together to indicate whether the condition \nin MHTERM was prespecified and whether it occurred, respectively. A value of \u201cY\u201d in MHPRESP indicates that the term was prespecified. \nb. MHOCCUR is used to indicate whether a prespecified medical condition occurred; a value of \"Y\" indicates that the event occurred and \"N\" \nindicates that it did not. \nc. \nIf a medical history event was reported using free text, the values of MHPRESP and MHOCCUR should be null. MHPRESP and MHOCCUR are \npermissible fields and may be omitted from the dataset if all medical history events were collected as free text. \nd. MHSTAT and MHREASND provide information about prespecified medical history questions for which no response was collected. MHSTAT and \nMHREASND are permissible fields and may be omitted from the dataset if all medications were collected as free text or if all prespecified \nconditions had responses in MHOCCUR.", "mimetype": "text/plain", "start_char_idx": 2691, "end_char_idx": 3857, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45ac3c09-16bc-47ef-81b9-9f7daa2944a9": {"__data__": {"id_": "45ac3c09-16bc-47ef-81b9-9f7daa2944a9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 174, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12bf5697-b722-4a66-abfe-5a2c0cd7a210", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 174, "section": "UNSPECIFIED"}, "hash": "b374746e2f1fb1861eddfe1a56e5b5993417c5f05cd56b6c4dd6cc367944c298", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "09f0d0cb-8b8d-43ea-8152-01f88106866e", "node_type": "1", "metadata": {}, "hash": "8f691cbd1810b60b9cfaec6695d08954c2a471ac82776b45df8e9eb51fb6df2a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 174 \n2021-11-29 \n \nSituation \nValue of \nMHPRESP \nValue of \nMHOCCUR \nValue of \nMHSTAT \nSpontaneously reported event occurred \n \n \n \nPre-specified event occurred \nY \nY \n \nPre-specified event did not occur \nY \nN \n \nPre-specified event has no response \nY \n \nNOT DONE \ne. \nWhen medical history events are collected with the recording of free text, a record may be entered into the data management system to indicate \u201cno \nmedical history\u201d for a specific subject or prespecified body system category (e.g., gastrointestinal). For these subjects or categories within subject, \ndo not include a record in the MH dataset to indicate that there were no events. \n5. Timing variables \na. \nRelative timing assessments such as \u201cOngoing\u201d or \"Active\" are common in the collection of MH information. MHENRF may be used when this \nrelative timing assessment is coincident with the start of the study reference period for the subject represented in the Demographics (DM) dataset \n(RFSTDTC). MHENRTPT and MHENTPT may be used when \"Ongoing\" is relative to another date such as the screening visit date. See the \nexamples in this section and in Section 4.4.7, Use of Relative Timing Variables. \nb. Additional timing variables (e.g., MHSTRF) may be used when appropriate. \n6. MH event date type \na. \nMHEVDTYP is a domain-specific variable that can be used to indicate the aspect of the event that is represented in the event start and/or end \ndate/times (MHSTDTC and/or MHENDTC). If a start date and/or end date is collected without further specification of what constitutes the start or \nend of the event, then MHEVDTYP is not needed. However, when data collection specifies how the start or end date is to be reported, \nMHEVDTYP can be used to provide this information. For example, when collecting the date of diagnosis, it would be used to populate \nMHSTDTC; MHEVDTYP would be populated with \"DIAGNOSIS\". If MHEVDTYP is not needed for any collected data, it need not be included \nin the dataset. If MHEVDTYP is included in the dataset, it should be populated only when the data collection specifies the aspect of the event that is \nto be used to populate the start and/or end date; otherwise, it should be null.  \nb. When data collected about an event includes 2 different dates that could be considered the start or end of an event, then an MH record will be \ncreated for each. For example, if data collection included both a date of onset of symptoms and a date of diagnosis, there would be 2 records for the \nevent, one with MHSTDTC the date of onset of symptoms and MHEVDTYP = \"SYMPTOMS\" and a second with MHSTDTC the date of diagnosis \nand MHENDTYP = \"DIAGNOSIS\". In such a case, it is recommended that the 2 records be linked by means such as a common value of MHSPID \nor MHGRPID. \n7.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2949, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "09f0d0cb-8b8d-43ea-8152-01f88106866e": {"__data__": {"id_": "09f0d0cb-8b8d-43ea-8152-01f88106866e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 174, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12bf5697-b722-4a66-abfe-5a2c0cd7a210", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 174, "section": "UNSPECIFIED"}, "hash": "b374746e2f1fb1861eddfe1a56e5b5993417c5f05cd56b6c4dd6cc367944c298", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45ac3c09-16bc-47ef-81b9-9f7daa2944a9", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 174, "section": "UNSPECIFIED"}, "hash": "79ac194e04d159c805de76d5057999f69b0c9e1eda55eaccf5546686d5219d59", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b. When data collected about an event includes 2 different dates that could be considered the start or end of an event, then an MH record will be \ncreated for each. For example, if data collection included both a date of onset of symptoms and a date of diagnosis, there would be 2 records for the \nevent, one with MHSTDTC the date of onset of symptoms and MHEVDTYP = \"SYMPTOMS\" and a second with MHSTDTC the date of diagnosis \nand MHENDTYP = \"DIAGNOSIS\". In such a case, it is recommended that the 2 records be linked by means such as a common value of MHSPID \nor MHGRPID. \n7. Any identifiers, timing variables, or Events general observation-class qualifiers may be added to the MH domain, but the following Qualifiers would \ngenerally not be used: --SER, --ACN, --ACNOTH, --REL, --RELNST, --OUT, --SCAN, --SCONG, --SDISAB, \u2011\u2011SDTH, --SHOSP, --SLIFE, --SOD, --\nSMIE.", "mimetype": "text/plain", "start_char_idx": 2373, "end_char_idx": 3238, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af78efb8-3b17-460a-9278-f47d8e3259a8": {"__data__": {"id_": "af78efb8-3b17-460a-9278-f47d8e3259a8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 175, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "357c5ce4-1a1e-488c-806f-0fe3c21ead3d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 175, "section": "UNSPECIFIED"}, "hash": "52bf5915bbc3a5281c36c3b63c149149fab33b336f6da0d7a47f2b59d3003db4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "51c159ad-a39a-4f9a-b14b-3f2ea89a4931", "node_type": "1", "metadata": {}, "hash": "c11f7847b746ad09a32ac9eb29ec3a532e81a77f2df667ebf08fd3e71cc8ae61", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 175 \n2021-11-29 \nMH \u2013 Examples \nExample 1 \nIn this example, a General Medical History CRF collected verbatim descriptions of conditions and events by body system (e.g., endocrine, metabolic), did not \ncollect start date, but asked whether or not the condition was ongoing at the time of the visit. Another CRF page was used for cardiac history events. This page \nasked for date of onset of symptoms and date of diagnosis, but did not include the ongoing question. \nRows 1-3: \nMHCAT indicates that these data were collected on the General Medical History CRF, and MHSCAT indicates the body system for which the \nevent was collected. The reported events were coded using a standard dictionary. MHDECOD and MHBODSYS display the preferred term and \nbody system assigned through the coding process. MHENRTPT was populated based on the response to the \"Ongoing\" question on the General \nMedical History CRF. MHENTPT displays the reference date for MHENRTPT, that is, the date the information was collected. If \"Yes\" was \nspecified for Ongoing, MHENRTPT = \"ONGOING\"; if \"No\" was checked, MHENRTPT = \"BEFORE\". See Section 4.4.7, Use of Relative Timing \nVariables, for further guidance. \nRows 4-5: \nMHCAT indicates that these data were collected on the Cardiac Medical History CRF. Because 2 kinds of start date were collected for congestive \nheart failure, there are 2 records for this event, with start dates of MHEVDTYP = \"SYMPTOM ONSET\" and MHEVDTYP = \"DIAGNOSIS\". The \nsponsor grouped these 2 records using the MHGRPID value \"CHF\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1706, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "51c159ad-a39a-4f9a-b14b-3f2ea89a4931": {"__data__": {"id_": "51c159ad-a39a-4f9a-b14b-3f2ea89a4931", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 175, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "357c5ce4-1a1e-488c-806f-0fe3c21ead3d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 175, "section": "UNSPECIFIED"}, "hash": "52bf5915bbc3a5281c36c3b63c149149fab33b336f6da0d7a47f2b59d3003db4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af78efb8-3b17-460a-9278-f47d8e3259a8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 175, "section": "UNSPECIFIED"}, "hash": "81a17d9a33e187bb6f92fde2af91baced8e1d5ee1cf4e432cd9d5b69cfa39421", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MHENTPT displays the reference date for MHENRTPT, that is, the date the information was collected. If \"Yes\" was \nspecified for Ongoing, MHENRTPT = \"ONGOING\"; if \"No\" was checked, MHENRTPT = \"BEFORE\". See Section 4.4.7, Use of Relative Timing \nVariables, for further guidance. \nRows 4-5: \nMHCAT indicates that these data were collected on the Cardiac Medical History CRF. Because 2 kinds of start date were collected for congestive \nheart failure, there are 2 records for this event, with start dates of MHEVDTYP = \"SYMPTOM ONSET\" and MHEVDTYP = \"DIAGNOSIS\". The \nsponsor grouped these 2 records using the MHGRPID value \"CHF\". \nmh.xpt \nRow STUDYID DOMAIN USUBJID MHSEQ MHGRPID MHTERM \nMHDECOD \nMHEVDTYP \nMHCAT \nMHSCAT \nMHBODSYS \nMHSTDTC MHENRTPT MHENTPT \n1 \nABC123 \nMH \n123101 \n1 \n \nASTHMA \nAsthma \n \nGENERAL \nMEDICAL \nHISTORY \nRESPIRATORY Respiratory system \ndisorders \n \nONGOING \n2004-09-\n18 \n2 \nABC123 \nMH \n123101 \n2 \n \nFREQUENT \nHEADACHES \nHeadache \n \nGENERAL \nMEDICAL \nHISTORY \nCNS \nCentral and \nperipheral nervous \nsystem disorders \n \nONGOING \n2004-09-\n18 \n3 \nABC123 \nMH \n123101 \n3 \n \nBROKEN LEG \nBone \nfracture \n \nGENERAL \nMEDICAL \nHISTORY \nOTHER \nMusculoskeletal \nsystem disorders \n \nBEFORE \n2004-09-\n18 \n4 \nABC123 \nMH \n123101 \n4 \nCHF \nCONGESTIVE \nHEART \nFAILURE \nCardiac \nfailure \ncongestive \nSYMPTOM \nONSET \nCARDIAC \nMEDICAL \nHISTORY \n \nCardiac disorders \n2004-09-\n17 \n \n \n5 \nABC123 \nMH \n123101 \n5 \nCHF \nCONGESTIVE \nHEART \nFAILURE \nCardiac \nfailure \ncongestive \nDIAGNOSIS \nCARDIAC \nMEDICAL \nHISTORY \n \nCardiac disorders \n2004-09-\n19 \n \n \nExample 2 \nIn this example, data from 3 CRF modules related to medical history were collected: \n\u2022 \nA General Medical History CRF collected descriptions of conditions and events by body system (e.g., endocrine, metabolic) and asked whether the \nconditions were ongoing at study start. The reported events were coded using a standard dictionary. \n\u2022 \nA second CRF collected stroke history. Terms were selected from a list of terms taken from the standard dictionary. \n\u2022 \nA third CRF asked whether the subject had any of a list of 4 specific risk factors. \nIn all of the records shown below, MHCAT is populated with the CRF module (general medical history, stroke history, or risk factors) through which the data \nwere collected. MHPRESP and MHOCCUR were populated only when the term was prespecified, in keeping with MH assumption 4.", "mimetype": "text/plain", "start_char_idx": 1081, "end_char_idx": 3458, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2cc51665-6bf8-4c8b-82c4-11e934f6a80b": {"__data__": {"id_": "2cc51665-6bf8-4c8b-82c4-11e934f6a80b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 176, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "54006636-f6ea-4e39-a7b4-a9dc57da7e11", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 176, "section": "UNSPECIFIED"}, "hash": "c29cf16036d29bf24607ff67d776894fb595a5d21ad561512c834e2184371a38", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a45f3a47-22ad-4803-8571-9b3c1844458c", "node_type": "1", "metadata": {}, "hash": "d255c5cd10de16b9034e3abcce238dd00dd39da778356c05332c798913e75aa6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 176 \n2021-11-29 \nRows 1-3: \nShow records from the General Medical History CRF. MHSCAT displays the body systems specified on the CRF. The coded terms are represented \nin MHDECOD. MHENRF has been populated based on the response to the \"Ongoing at Study Start\" question on the CRF. If \"Yes\" was specified, \nMHENRF = \"DURING/AFTER\"; if \"No\" was checked, MHENRF = \"BEFORE\". See Section 4.4.7, Use of Relative Timing Variables, for further \nguidance on using --STRF and --ENRF. \nRow 4: \nShows the record from the Stroke History CRF. MHSTDTC was populated with the date and time at which the event occurred. \nRows 5-8: \nShow records from the Risk Factors CRF. MHPRESP values of \u201cY\u201d indicate that each risk factor was prespecified on the CRF. MHOCCUR is \npopulated with \"Y\" or \"N\", corresponding to the CRF response to the questions for the 4 prespecified risk factors. The terms used to describe these \nrisk factors were chosen to have associated codes in the standard dictionary. \nmh.xpt \nRow STUDYID DOMAIN USUBJID MHSEQ MHTERM \nMHDECOD \nMHCAT \nMHSCAT \nMHPRESP MHOCCUR MHBODSYS \nMHSTDTC \nMHENRF \n1 \nABC123 \nMH \n123101 \n1 \nASTHMA \nAsthma \nGENERAL \nMEDICAL \nHISTORY \nRESPIRATORY  \n \nRespiratory system \ndisorders \n \nDURING/AFTER \n2 \nABC123 \nMH \n123101 \n2 \nFREQUENT HEADACHES \nHeadache \nGENERAL \nMEDICAL \nHISTORY \nCNS \n \n \nCentral and \nperipheral nervous \nsystem disorders \n \nDURING/AFTER \n3 \nABC123 \nMH \n123101 \n3 \nBROKEN LEG \nBone fracture \nGENERAL \nMEDICAL \nHISTORY \nOTHER \n \n \nMusculoskeletal \nsystem disorders \n \nBEFORE \n4 \nABC123 \nMH \n123101 \n4 \nISCHEMIC STROKE \nIschaemic Stroke \nSTROKE \nHISTORY \n \n \n \n \n2004-09-\n17T07:30 \n \n5 \nABC123 \nMH \n123101 \n5 \nDIABETES \nDiabetes mellitus \nRISK \nFACTORS \n \nY \nY \n \n \n \n6 \nABC123 \nMH \n123101 \n6 \nHYPERCHOLESTEROLEMIA Hypercholesterolemia \nRISK \nFACTORS \n \nY \nY \n \n \n \n7 \nABC123 \nMH \n123101 \n7 \nHYPERTENSION \nHypertension \nRISK \nFACTORS \n \nY \nY \n \n \n \n8 \nABC123 \nMH \n123101 \n8 \nTIA \nTransient ischaemic \nattack \nRISK \nFACTORS \n \nY \nN \n \n \n \nExample 3 \nThis is an example of a medical history CRF where the history of specific (prespecified) conditions is solicited. The conditions were not coded using a standard \ndictionary. The data were collected as part of the screening visit. \nRows 1-9: \nMHPRESP = \"Y\" indicates that these conditions were specifically queried. Presence or absence of the condition is represented in MHOCCUR.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2548, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a45f3a47-22ad-4803-8571-9b3c1844458c": {"__data__": {"id_": "a45f3a47-22ad-4803-8571-9b3c1844458c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 176, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "54006636-f6ea-4e39-a7b4-a9dc57da7e11", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 176, "section": "UNSPECIFIED"}, "hash": "c29cf16036d29bf24607ff67d776894fb595a5d21ad561512c834e2184371a38", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2cc51665-6bf8-4c8b-82c4-11e934f6a80b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 176, "section": "UNSPECIFIED"}, "hash": "42ad7f3ee79baf7dcfd95d3967a817e9c2b8d0ac78f54d5bf29347e4d69c323f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The conditions were not coded using a standard \ndictionary. The data were collected as part of the screening visit. \nRows 1-9: \nMHPRESP = \"Y\" indicates that these conditions were specifically queried. Presence or absence of the condition is represented in MHOCCUR. \nRow 10: \nThere was also a specific question about asthma, as indicated by MHPRESP = \"Y\", but this question was not asked. Because the question was not \nasked, MHOCCUR is null and MHSTAT = \"NOT DONE\". In this case, a reason for the absence of a response was collected, and this is represented \nin MHREASND. \nmh.xpt \nRow STUDYID DOMAIN USUBJID MHSEQ MHTERM \nMHDECOD \nMHPRESP MHOCCUR MHSTAT \nMHREASND \nVISITNUM VISIT \nMHDTC \nMHDY \n1 \nABC123 \nMH \n101002 \n1 \nHISTORY OF EARLY CORONARY \nARTERY DISEASE (<55 YEARS OF \nAGE) \nCoronary Artery \nDisease \nY \nN \n \n \n1 \nSCREEN 2006-04-\n22 \n-5 \n2 \nABC123 \nMH \n101002 \n2 \nCONGESTIVE HEART FAILURE \nCongestive Heart \nFailure \nY \nN \n \n \n1 \nSCREEN 2006-04-\n22 \n-5", "mimetype": "text/plain", "start_char_idx": 2284, "end_char_idx": 3244, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "15b59042-1268-4e02-8382-94f041cb7065": {"__data__": {"id_": "15b59042-1268-4e02-8382-94f041cb7065", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 177, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ddc1d98d-bf62-468b-894e-b849e9a6b9ad", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 177, "section": "UNSPECIFIED"}, "hash": "0eb80b59da4f89f0beaf0e3cf59bc649921cfcf284e462e159a7d9372c1d3264", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8ed9e86b-1148-4e9a-82b0-de31aa6ae89b", "node_type": "1", "metadata": {}, "hash": "969dc08171b96d5b15f38b5941e764a8b5ca645e2ba689607e0697a6298c241c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 177 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID MHSEQ MHTERM \nMHDECOD \nMHPRESP MHOCCUR MHSTAT \nMHREASND \nVISITNUM VISIT \nMHDTC \nMHDY \n3 \nABC123 \nMH \n101002 \n3 \nPERIPHERAL VASCULAR \nDISEASE \nPeripheral \nVascular \nDisease \nY \nN \n \n \n1 \nSCREEN 2006-04-\n22 \n-5 \n4 \nABC123 \nMH \n101002 \n4 \nTRANSIENT ISCHEMIC ATTACK \nTransient \nIschemic Attack \nY \nY \n \n \n1 \nSCREEN 2006-04-\n22 \n-5 \n5 \nABC123 \nMH \n101002 \n5 \nASTHMA \nAsthma \nY \nY \n \n \n1 \nSCREEN 2006-04-\n22 \n-5 \n6 \nABC123 \nMH \n101003 \n1 \nHISTORY OF EARLY CORONARY \nARTERY DISEASE (<55 YEARS OF \nAGE) \nCoronary Artery \nDisease \nY \nY \n \n \n1 \nSCREEN 2006-05-\n03 \n-3 \n7 \nABC123 \nMH \n101003 \n2 \nCONGESTIVE HEART FAILURE \nCongestive Heart \nFailure \nY \nN \n \n \n1 \nSCREEN 2006-05-\n03 \n-3 \n8 \nABC123 \nMH \n101003 \n3 \nPERIPHERAL VASCULAR \nDISEASE \nPeripheral \nVascular \nDisease \nY \nY \n \n \n1 \nSCREEN 2006-05-\n03 \n-3 \n9 \nABC123 \nMH \n101003 \n4 \nTRANSIENT ISCHEMIC ATTACK \nTransient \nIschemic Attack \nY \nN \n \n \n1 \nSCREEN 2006-05-\n03 \n-3 \n10 \nABC123 \nMH \n101003 \n5 \nASTHMA \nAsthma \nY \n \nNOT \nDONE \nFORGOT TO \nASK \n1 \nSCREEN 2006-05-\n03 \n-3 \nExample 4 \nThis diabetes study included subjects with both type 1 diabetes and type 2 diabetes. Data collection included which kind of diabetes the subject had and the date \nof diagnosis of the condition. \nRows 1-2: \nShow that subject XYZ-001-001 had type 1 diabetes, and did not have type 2 diabetes. The start date in row 1 is the date of diagnosis, as indicated \nby MHEVDTYP=\"DIAGNOSIS\". Because this subject did not have type 2 diabetes, no start date for type 2 diabetes was collected, so \nMHEVDTYP in row 2 is blank. \nRows 3-4: \nShow that subject XYZ-001-002 had type 2 diabetes, and did not have type 1 diabetes. The start date in row 4 is the date of diagnosis, as indicated \nby MHEVDTYP=\"DIAGNOSIS\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1950, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8ed9e86b-1148-4e9a-82b0-de31aa6ae89b": {"__data__": {"id_": "8ed9e86b-1148-4e9a-82b0-de31aa6ae89b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 177, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ddc1d98d-bf62-468b-894e-b849e9a6b9ad", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 177, "section": "UNSPECIFIED"}, "hash": "0eb80b59da4f89f0beaf0e3cf59bc649921cfcf284e462e159a7d9372c1d3264", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "15b59042-1268-4e02-8382-94f041cb7065", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 177, "section": "UNSPECIFIED"}, "hash": "d1f4c7dfec063c7b26d71e2f3588d4ba0073ba71d1ba0fab063413503306a9b9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Data collection included which kind of diabetes the subject had and the date \nof diagnosis of the condition. \nRows 1-2: \nShow that subject XYZ-001-001 had type 1 diabetes, and did not have type 2 diabetes. The start date in row 1 is the date of diagnosis, as indicated \nby MHEVDTYP=\"DIAGNOSIS\". Because this subject did not have type 2 diabetes, no start date for type 2 diabetes was collected, so \nMHEVDTYP in row 2 is blank. \nRows 3-4: \nShow that subject XYZ-001-002 had type 2 diabetes, and did not have type 1 diabetes. The start date in row 4 is the date of diagnosis, as indicated \nby MHEVDTYP=\"DIAGNOSIS\". \nmh.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nMHSEQ \nMHTERM \nMHDECOD \nMHEVDTYP \nMHCAT \nMHPRESP \nMHOCCUR \nMHDTC \nMHSTDTC \n1 \nXYZ \nMH \nXYZ-001-001 \n1 \nTYPE 1 DIABETES MELLITUS \nType 1 diabetes mellitus \nDIAGNOSIS \nDIABETES \nY \nY \n2010-09-26 \n2010-03-25 \n2 \nXYZ \nMH \nXYZ-001-001 \n2 \nTYPE 2 DIABETES MELLITUS \nType 2 diabetes mellitus \n \nDIABETES \nY \nN \n2010-09-26 \n \n3 \nXYZ \nMH \nXYZ-001-002 \n1 \nTYPE 1 DIABETES MELLITUS \nType 1 diabetes mellitus \n \nDIABETES \nY \nN \n2010-10-26 \n \n4 \nXYZ \nMH \nXYZ-001-002 \n2 \nTYPE 2 DIABETES MELLITUS \nType 2 diabetes mellitus \nDIAGNOSIS \nDIABETES \nY \nY \n2010-10-26 \n2010-04-25 \nExample 5 \nThis example shows data from a study in which data were collected about whether subjects had had any respiratory infections in the prior 6 months and, if they \nhad, collected data on those respiratory infections. The example shows data for 2 subjects. \nRow 1: \nShows that subject 203 had no respiratory infections during the evaluation interval (the prior 6 months). The same value (\"Respiratory Infections\") \nin both MHTERM and MHCAT indicates that the occurrence question was about a group of medical conditions rather than a specific single \nmedical condition. \nRow 2: \nShows that subject 204 did have at least 1 respiratory infection during the evaluation interval.", "mimetype": "text/plain", "start_char_idx": 1338, "end_char_idx": 3231, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "854dffa9-c3f4-4ac8-bfbf-6ccbf37cc901": {"__data__": {"id_": "854dffa9-c3f4-4ac8-bfbf-6ccbf37cc901", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 178, "section": "6.2.7 Protocol Deviations (DV)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "15ccc356-f37e-4f74-a25c-ee88b5b46988", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 178, "section": "6.2.7 Protocol Deviations (DV)"}, "hash": "c09696483001bc09041ec67a5700652f83a5517788bb32f5596cf0d1a5e56a79", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DV \u2013 Description/Overview \nAn events domain that contains protocol violations and deviations during the course of the study. \nDV \u2013 Specification \ndv.xpt, Protocol Deviations \u2014 Events. One record per protocol deviation per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar DV \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nDVSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nDVREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier. \nPerm \nDVSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Example: Line number on a CRF page. \nPerm \nDVTERM \nProtocol Deviation \nTerm \nChar  \nTopic \nVerbatim name of the protocol deviation criterion. Example: \"IVRS PROCESS DEVIATION - NO \nDOSE CALL PERFORMED\". DVTERM values will map to the controlled terminology in DVDECOD \n(e.g., \"TREATMENT DEVIATION\"). \nReq \nDVDECOD \nProtocol Deviation \nCoded Term \nChar * \nSynonym \nQualifier \nControlled terminology for the name of the protocol deviation. Examples: \"SUBJECT NOT \nWITHDRAWN AS PER PROTOCOL\", \"SELECTION CRITERIA NOT MET\", \"EXCLUDED \nCONCOMITANT MEDICATION\", \"TREATMENT DEVIATION\". \nPerm \nDVCAT \nCategory for Protocol \nDeviation \nChar * \nGrouping \nQualifier \nCategory of the protocol deviation criterion. \nPerm \nDVSCAT \nSubcategory for \nProtocol Deviation \nChar * \nGrouping \nQualifier \nA further categorization of the protocol deviation. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the deviation. Examples: \"TREATMENT\", \"SCREENING\", \n\"FOLLOW-UP\". \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2279, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "19606cec-3788-4874-bc1b-5b140b43590d": {"__data__": {"id_": "19606cec-3788-4874-bc1b-5b140b43590d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 179, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9108b43a-3b89-4065-acbd-3eddee4838f2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 179, "section": "UNSPECIFIED"}, "hash": "80564cd900c273d54c3505b0cfc47485f52ea4c2f276aaeb72fb9f9cb5bebd27", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ecd26caf-e4b2-4a75-a68b-289c137ecced", "node_type": "1", "metadata": {}, "hash": "f34c226361b6083a86cf2b09f23ed09f9182ccf5b895cb18bed88f9f777914f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 179 \n2021-11-29 \nDVSTDTC \nStart Date/Time of \nDeviation \nChar ISO 8601 datetime or \ninterval \nTiming \nStart date/time of deviation represented in ISO 8601 character format. \nPerm \nDVENDTC \nEnd Date/Time of \nDeviation \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time of deviation represented in ISO 8601 character format. \nPerm \nDVSTDY \nStudy Day of Start of \nDeviation Event \nNum  \nTiming \nStudy day of start of event relative to the sponsor-defined RFSTDTC. \nPerm \nDVENDY \nStudy Day of End of \nDeviation Event \nNum  \nTiming \nStudy day of end of event relative to the sponsor-defined RFSTDTC. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nDV \u2013 Assumptions \n1. The DV domain is an Events model for collected protocol deviations and not for derived protocol deviations that are more likely to be part of analysis. \nEvents typically include what the event was, captured in --TERM (the topic variable), and when it happened (captured in its start and/or end dates). The \nintent of the domain model is to capture protocol deviations that occurred during the course of the study (see ICH E3, Section 10.2[1]). Usually these are \ndeviations that occur after the subject has been randomized or received the first treatment. \n2. This domain should not be used to collect entry-criteria information. Violated inclusion/exclusion criteria are stored in IE. The Deviations domain is for \nmore general deviation data. A protocol may indicate that violating an inclusion/exclusion criterion during the course of the study (after first dose) is a \nprotocol violation. In this case, this information would go into DV. \n3. Any identifier variables, timing variables, or Events general observation-class qualifiers may be added to the DV domain, but the following qualifiers \nwould generally not be used: --PRESP, --OCCUR, --STAT, --REASND, --BODSYS, --LOC, --SEV, --SER, --ACN, \u2011\u2011ACNOTH, --REL, --RELNST, --\nPATT, --OUT, --SCAN, --SCONG, --SDISAB, --SDTH, --SHOSP, --SLIFE, --SOD, --SMIE, --CONTRT, --TOXGR. \nDV \u2013 Examples \nExample 1 \nThis is an example of data that was collected on a protocol-deviations CRF. The DVDECOD column is for controlled terminology, whereas the DVTERM is free \ntext. \nRows 1, 3: Show examples of a TREATMENT DEVIATION type of protocol deviation. \nRow 2: \nShows an example of a deviation due to the subject taking a prohibited concomitant medication. \nRow 4: \nShows an example of a medication that should not be taken during the study. \ndv.xpt \nRow STUDYID \nDOMAIN USUBJID \nDVSEQ DVTERM \nDVDECOD \nEPOCH \nDVSTDTC \n1 \nABC123 \nDV \n123101 \n1 \nIVRS PROCESS DEVIATION - NO DOSE CALL PERFORMED.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2910, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ecd26caf-e4b2-4a75-a68b-289c137ecced": {"__data__": {"id_": "ecd26caf-e4b2-4a75-a68b-289c137ecced", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 179, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9108b43a-3b89-4065-acbd-3eddee4838f2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 179, "section": "UNSPECIFIED"}, "hash": "80564cd900c273d54c3505b0cfc47485f52ea4c2f276aaeb72fb9f9cb5bebd27", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "19606cec-3788-4874-bc1b-5b140b43590d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 179, "section": "UNSPECIFIED"}, "hash": "1b40ef676e5b232359313b308fe734e9e5c03b97c6d8e2b1bd6c03c90e7b8124", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DV \u2013 Examples \nExample 1 \nThis is an example of data that was collected on a protocol-deviations CRF. The DVDECOD column is for controlled terminology, whereas the DVTERM is free \ntext. \nRows 1, 3: Show examples of a TREATMENT DEVIATION type of protocol deviation. \nRow 2: \nShows an example of a deviation due to the subject taking a prohibited concomitant medication. \nRow 4: \nShows an example of a medication that should not be taken during the study. \ndv.xpt \nRow STUDYID \nDOMAIN USUBJID \nDVSEQ DVTERM \nDVDECOD \nEPOCH \nDVSTDTC \n1 \nABC123 \nDV \n123101 \n1 \nIVRS PROCESS DEVIATION - NO DOSE CALL PERFORMED. \nTREATMENT DEVIATION \nTREATMENT \n2003-09-21 \n2 \nABC123 \nDV \n123103 \n1 \nDRUG XXX ADMINISTERED DURING STUDY TREATMENT PERIOD \nEXCLUDED CONCOMITANT MEDICATION \nTREATMENT \n2003-10-30 \n3 \nABC123 \nDV \n123103 \n2 \nVISIT 3 DOSE <15 MG \nTREATMENT DEVIATION \nTREATMENT \n2003-10-30 \n4 \nABC123 \nDV \n123104 \n1 \nTOOK ASPIRIN \nPROHIBITED MEDS \nTREATMENT \n2003-11-30 \nReferences \n1. European Medicines Agency. ICH E3: Structure and Content of Clinical Study Reports. European Medicines Agency; 1996. Accessed February 22, \n2021. https://www.ema.europa.eu/en/ich-e3-structure-content-clinical-study-reports", "mimetype": "text/plain", "start_char_idx": 2305, "end_char_idx": 3499, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "348117be-6056-47fa-9972-e0832661091e": {"__data__": {"id_": "348117be-6056-47fa-9972-e0832661091e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 180, "section": "6.3.1 Product Accountability (DA)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "57c4c09d-5583-4a41-9140-bdaa07b6914b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 180, "section": "6.3.1 Product Accountability (DA)"}, "hash": "f82c72a718ba0b882b9e4e499bdfef35cddeb22893ddfc342f4bcbecea6ce12d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DA \u2013 Description/Overview \nA findings domain that contains the accountability of study products, such as information on the receipt, dispensing, return, and packaging. \nDA \u2013 Specification \nda.xpt, Product Accountability \u2014 Findings. One record per product accountability finding per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study within the submission. \nReq \nDOMAIN \nDomain Abbreviation \nChar DA \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nDASEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any \nvalid number. \nReq \nDAGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nDAREFID \nReference ID \nChar  \nIdentifier \nOptional internal or external identifier such as a code from the product packaging (e.g., bottle \nlabel, package label, kit label). \nPerm \nDASPID \nSponsor-Defined Identifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Examples: Line number on the Product \nAccountability CRF page, a code from the product packaging (e.g., bottle label, package label, kit \nlabel). \nPerm \nDALNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nDALNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one \nrelationship. \nPerm \nDATESTCD \nShort Name of \nAccountability Assessment \nChar (DATESTCD) \nTopic \nShort character value for DATEST used as a column name when converting a dataset from a \nvertical format to a horizontal format. The short value can be up to 8 characters and cannot begin \nwith a number or contain characters other than letters, numbers, or underscores. Examples: \n\"DISPAMT\", \"RETAMT\". \nReq \nDATEST \nName of Accountability \nAssessment \nChar (DATEST) \nSynonym \nQualifier \nVerbatim name corresponding to the topic variable of the test or examination used to obtain the \nproduct accountability assessment. The value in DATEST cannot be longer than 40 characters. \nExamples: \"Dispensed Amount\", \"Returned Amount\". \nReq \nDACAT \nCategory \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Examples: \"STUDY MEDICATION\", \"RESCUE \nMEDICATION\". \nPerm \nDASCAT \nSubcategory \nChar * \nGrouping \nQualifier \nUsed to define a further categorization level for a group of related records. \nPerm \nDAORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the product accountability assessment as originally received or collected. \nExp \nDAORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nUnit for DAORRES. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3172, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2bb163c2-1346-437a-b4d2-87df6d392fd2": {"__data__": {"id_": "2bb163c2-1346-437a-b4d2-87df6d392fd2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 181, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "de4c71d5-55b7-4c50-aca0-ad9edf8f235f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 181, "section": "UNSPECIFIED"}, "hash": "b3f3e1b94e683eaf141cd5fc6d4ef88c5b422c9120f8c1437d5da783255a752f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e4e7f813-6792-4a02-9a87-413aae75d4f3", "node_type": "1", "metadata": {}, "hash": "ab88b30101c5cf3fcb82622e522bd474d8817f3372507302b7abab2c4f12d11a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 181 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nDASTRESC \nResult or Finding in \nStandard Format \nChar  \nResult \nQualifier \nContains the result value for all product accountability assessments copied or derived from \nDAORRES, in a standard format or in standard units. DASTRESC should store all results or \nfindings in character format; if results are numeric, they should also be stored in numeric format in \nDASTRESN. \nExp \nDASTRESN \nNumeric Result/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format \nfrom DASTRESC. DASTRESN should store all numeric test results or findings. \nPerm \nDASTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for DASTRESC and DASTRESN. \nPerm \nDASTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a product accountability assessment was not done. Should be null or have a \nvalue of \"NOT DONE\". \nPerm \nDAREASND \nReason Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with DASTAT when value is \"NOT DONE\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of Visit Num  \nTiming \nPlanned study day of the visit, based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of Element \nwithin Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm (see Section 7.2.1, Trial Arms). Perm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the observation, or the date/time of collection if start \ndate/time is not collected. \nPerm \nDADTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nDate and time of the product accountability assessment represented in ISO 8601 character \nformat. \nExp \nDADY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nStudy day of product accountability assessment, measured in integer days. Algorithm for \ncalculations must be relative to the sponsor-defined RFSTDTC in Demographics. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nDA \u2013 Assumptions \n1. This domain records the amount of study product transferred to or from the study subject. \na. \nTransfers of devices are not represented in this domain, but in the Device Tracking and Disposition (DT) domain. See the SDTMIG for Medical \nDevices (available at https://www.cdisc.org/standards/foundational/medical-devices-sdtmig/). \nb. For drugs, transfers are usually recorded using the tests \"Dispensed Amount\" and \"Returned Amount\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3123, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e4e7f813-6792-4a02-9a87-413aae75d4f3": {"__data__": {"id_": "e4e7f813-6792-4a02-9a87-413aae75d4f3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 181, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "de4c71d5-55b7-4c50-aca0-ad9edf8f235f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 181, "section": "UNSPECIFIED"}, "hash": "b3f3e1b94e683eaf141cd5fc6d4ef88c5b422c9120f8c1437d5da783255a752f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2bb163c2-1346-437a-b4d2-87df6d392fd2", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 181, "section": "UNSPECIFIED"}, "hash": "881e299976a418b0dee14b044cd7a4796c2cf04e8354c493b76dc5ff852449aa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Algorithm for \ncalculations must be relative to the sponsor-defined RFSTDTC in Demographics. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nDA \u2013 Assumptions \n1. This domain records the amount of study product transferred to or from the study subject. \na. \nTransfers of devices are not represented in this domain, but in the Device Tracking and Disposition (DT) domain. See the SDTMIG for Medical \nDevices (available at https://www.cdisc.org/standards/foundational/medical-devices-sdtmig/). \nb. For drugs, transfers are usually recorded using the tests \"Dispensed Amount\" and \"Returned Amount\". \nc. \nTest terminology for other products may be different; for example, for nutrition, the tests might be \"Prepared Amount\" and \"Unused Amount\". \n2. DACAT may be used to differentiate transfers of different groups of products (e.g., rescue medications vs. investigational medications). \n3. DAREFID and DASPID are both available for capturing label information. \n4. The following qualifiers would not generally be used in DA: --MODIFY, --POS, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --\nSTNRC, --NRIND, --RESCAT, --XFN, --NAM, --LOINC, --SPEC, --SPCCND, --METHOD, --BLFL, --FAST, --DRVRL, --TOX, --TOXGR, --SEV.", "mimetype": "text/plain", "start_char_idx": 2408, "end_char_idx": 3743, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "004844b6-73ce-4118-900f-9e55d473f026": {"__data__": {"id_": "004844b6-73ce-4118-900f-9e55d473f026", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 182, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2887afae-bb2d-4c89-b8f5-f29c1f0429ac", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 182, "section": "UNSPECIFIED"}, "hash": "12772074bd8160b0d0ac3f2a8636f88b9734a0a8f29d2b578519a9952f8fca83", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3655a0e8-3122-46f8-857a-733977eb248d", "node_type": "1", "metadata": {}, "hash": "934e57937f5ef1df99fb5a3e45d175bfb6a2a0a75b2c77b6cb0a06b5f5378003", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 182 \n2021-11-29 \nDA \u2013 Examples \nExample 1 \nThis example shows drug accounting for a study with 2 study medications and one rescue medication, all of which were measured in tablets. The sponsor chose to add EPOCH from the list of timing variables and to \nuse DASPID and DAREFID for code numbers that appeared on the label. \nda.xpt \nRow STUDYID DOMAIN USUBJID \nDASEQ DAREFID \nDASPID \nDATESTCD \nDATEST \nDACAT \nDASCAT DAORRES \nDAORRESU \nDASTRESC \nDASTRESN \nDASTRESU \nVISITNUM EPOCH \nDADTC \n1 \nABC \nDA \nABC-01001 \n1 \nXBYCC-E990A \nA375827 DISPAMT \nDispensed Amount \nStudy Medication \nBottle A \n30 \nTABLET \n30 \n30 \nTABLET \n1 \nStudy Med Period 1 \n2004-06-15 \n2 \nABC \nDA \nABC-01001 \n2 \nXBYCC-E990A \nA375827 RETAMT \nReturned Amount \nStudy Medication \nBottle A \n5 \nTABLET \n5 \n5 \nTABLET \n2 \nStudy Med Period 1 \n2004-07-15 \n3 \nABC \nDA \nABC-01001 \n3 \nXBYCC-E990B \nA227588 DISPAMT \nDispensed Amount \nStudy Medication \nBottle B \n15 \nTABLET \n15 \n15 \nTABLET \n1 \nStudy Med Period 1 \n2004-06-15 \n4 \nABC \nDA \nABC-01001 \n4 \nXBYCC-E990B \nA227588 RETAMT \nReturned Amount \nStudy Medication \nBottle B \n0 \nTABLET \n0 \n0 \nTABLET \n2 \nStudy Med Period 1 \n2004-07-15 \n5 \nABC \nDA \nABC-01001 \n5 \n \n \nDISPAMT \nDispensed Amount \nRescue Medication \n \n10 \nTABLET \n10 \n10 \nTABLET \n1 \nStudy Med Period 1 \n2004-06-15 \n6 \nABC \nDA \nABC-01001 \n6 \n \n \nRETAMT \nReturned Amount \nRescue Medication \n \n10 \nTABLET \n10 \n10 \nTABLET \n2 \nStudy Med Period 1 \n2004-07-15 \nExample 2 \nIn this study, drug containers, rather than their contents, were being accounted for and the sponsor did not track returns. In this case, the purpose of the accountability tracking is to verify that the containers dispensed \nwere consistent with the randomization. The sponsor chose to use DASPID to record the identifying number of the container dispensed.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1963, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3655a0e8-3122-46f8-857a-733977eb248d": {"__data__": {"id_": "3655a0e8-3122-46f8-857a-733977eb248d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 182, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2887afae-bb2d-4c89-b8f5-f29c1f0429ac", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 182, "section": "UNSPECIFIED"}, "hash": "12772074bd8160b0d0ac3f2a8636f88b9734a0a8f29d2b578519a9952f8fca83", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "004844b6-73ce-4118-900f-9e55d473f026", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 182, "section": "UNSPECIFIED"}, "hash": "d88e1193443f09685dfd3ab381d811c0585102d928f859e94d8a4d51d361e901", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In this case, the purpose of the accountability tracking is to verify that the containers dispensed \nwere consistent with the randomization. The sponsor chose to use DASPID to record the identifying number of the container dispensed. \nda.xpt \nRow STUDYID DOMAIN USUBJID \nDASEQ DASPID DATESTCD DATEST \nDACAT \nDASCAT DAORRES DAORRESU \nDASTRESC DASTRESN DASTRESU \nVISITNUM DADTC \n1 \nABC \nDA \nABC-01001 1 \nAB001 \nDISPAMT \nDispensed Amount Study Medication Drug A \n1 \nCONTAINER 1 \n1 \nCONTAINER 1 \n2004-06-15 \n2 \nABC \nDA \nABC-01001 2 \nAB002 \nDISPAMT \nDispensed Amount Study Medication Drug B \n1 \nCONTAINER 1 \n1 \nCONTAINER 1 \n2004-06-15 \nExample 3 \nThis example shows, for a nutrition study, the volume of infant feeding formula prepared and the volume remaining after feeding. \nRows 1-2: \nShow the volume of formula prepared and the volume of formula left after feeding for the first feed of the diary (day 1). \nRows 3-4: \nShow the volume of formula prepared and the volume of formula left after feeding for the second feed of the diary (day 1). \nRows 5-6: \nShow the volume of formula prepared and the volume of formula left after feeding for the third feed of the diary (day 2). \nda.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nDASEQ \nDAGRPID \nDASPID \nDATESTCD \nDATEST \nDACAT \nDAORRES \nDAORRESU \nDASTRESC \nDASTRESN \nDASTRESU \nDADTC \nDADY \n 1 \nABC \nDA \n101 \n1 \n1 \n1 \nPREPAMT \nPrepared Amount \nStudy Product \n100 \nmL \n100 \n100 \nmL \n2017-05-19  \n 1 \n 2 \nABC \nDA \n101 \n2 \n1 \n1 \nREMAMT \nRemaining Amount \nStudy Product \n15 \nmL \n15 \n15 \nmL \n2017-05-19 \n 1 \n3 \nABC \nDA \n101 \n3 \n2 \n2 \nPREPAMT \nPrepared Amount \nStudy Product \n100 \nmL \n100 \n100 \nmL \n2017-05-19 \n 1 \n4 \nABC \nDA \n101 \n4 \n2 \n2 \nREMAMT \nRemaining Amount \nStudy Product \n25 \nmL \n25 \n25 \nmL \n2017-05-19 \n 1 \n5 \nABC \nDA \n101 \n5 \n3 \n1 \nPREPAMT \n \nPrepared Amount \nStudy Product \n100 \nmL \n100 \n100 \nmL \n2017-05-20 \n2 \n6 \nABC \nDA \n101 \n6 \n3 \n1 \nREMAMT \nRemaining Amount \nStudy Product \n10 \nmL \n10 \n10 \nmL \n2017-05-20 \n2", "mimetype": "text/plain", "start_char_idx": 1730, "end_char_idx": 3682, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a08edb53-116d-4571-a306-26200ada4ab7": {"__data__": {"id_": "a08edb53-116d-4571-a306-26200ada4ab7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 183, "section": "6.3.2 Death Details (DD)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "385c6838-b164-4a93-8280-3d97b0baa7ee", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 183, "section": "6.3.2 Death Details (DD)"}, "hash": "e971829dfbb915ea25886f63d5792fcec90272ca77c7a24c5a7dc1a6073bd974", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DD \u2013 Description/Overview \nA findings domain that contains the diagnosis of the cause of death for a subject. \nThe domain is designed to hold supplemental data that are typically collected when a death occurs, such as the official cause of death. It does not replace existing \ndata such as serious adverse event details in AE. Further, it does not introduce a new requirement to collect information that is not already indicated as good \nclinical practice or defined in regulatory guidelines. Instead, it provides a consistent place within the SDTM to hold information that previously did not have a \nclearly defined home. \nDD \u2013 Specification \ndd.xpt, Death Details \u2014 Findings. One record per finding per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar DD \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nDDSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nDDTESTCD \nDeath Detail \nAssessment Short \nName \nChar (DTHDXCD) \nTopic \nShort name of the measurement, test, or examination described in DDTEST. It can be used as a column \nname when converting a dataset from a vertical to a horizontal format. The value in DDTESTCD cannot be \nlonger than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). DDTESTCD cannot \ncontain characters other than letters, numbers, or underscores. Examples: \"PRCDTH\", \"SECDTH\". \nReq \nDDTEST \nDeath Detail \nAssessment Name \nChar (DTHDX) \nSynonym \nQualifier \nLong name for DDTESTCD. The value in DDTEST cannot be longer than 40 characters. Examples: \"Primary \nCause of Death\", \"Secondary Cause of Death\". \nReq \nDDORRES \nResult or Finding \nas Collected \nChar  \nResult \nQualifier \nResult of the test defined in DDTEST, as originally received or collected. \nExp \nDDSTRESC \nCharacter \nResult/Finding in \nStd Format \nChar  \nResult \nQualifier \nContains the result or finding copied or derived from DDORRES in a standard format. \nExp \nDDRESCAT \nResult Category \nChar * \nVariable \nQualifier \nUsed to categorize the result of a finding. Examples: \"TREATMENT RELATED\", \"NONTREATMENT \nRELATED\", \"UNDETERMINED\", \"ACCIDENTAL\". \nPerm \nDDEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. \nPerm \nDDDTC \nDate/Time of \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of collection of the diagnosis or other death assessment data in ISO 8601 format. This is not \nnecessarily the date of death. \nExp \nDDDY \nStudy Day of \nCollection \nNum  \nTiming \nStudy day of the collection, in integer days. The algorithm for calculations must be relative to the sponsor-\ndefined RFSTDTC variable in the Demographics (DM) domain. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3273, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9103aa5b-2310-4cdf-9bfd-b5d463ad8300": {"__data__": {"id_": "9103aa5b-2310-4cdf-9bfd-b5d463ad8300", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 184, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "117fb19b-9133-4e78-91ae-3219ab301ff5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 184, "section": "UNSPECIFIED"}, "hash": "fa92b8864994800b9733dd34caffb9066f7efa508afd4e51b803bda59c0e925a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9c59e168-4bd3-42bd-a564-313d743dc145", "node_type": "1", "metadata": {}, "hash": "c0e2e440ea6bc8ba9589401a4080ea3e314f4f75eaa137feaeadb22d1ee0c346", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 184 \n2021-11-29 \nDD \u2013 Assumptions \n1. There may be more than 1 cause of death. If so, these may be separated into primary and secondary causes and/or other appropriate designations. DD \nmay also include other details about the death, such as where the death occurred and whether it was witnessed. \n2. Death details are typically collected on designated CRF pages. The DD domain is not intended to collate data that are collected in standard variables in \nother domains, such as AE.AEOUT (Outcome of Adverse Event), AE.AESDTH (Results in Death) or DS.DSTERM (Reported Term for the Disposition \nEvent). Data from other domains that relates to the death can be linked to DD using RELREC. \n3. This domain is not intended to include data obtained from autopsy. An autopsy is a procedure from which there will usually be findings. Autopsy \ninformation should be handled as per recommendations in the Procedures (PR) domain. \n4. There are separate codelists for DD tests and responses. Associations between the DD tests and response codelists are described in the DD codetable \n(available at https://www.cdisc.org/standards/terminology/controlled-terminology). \n5. Any identifiers, timing variables, or findings general observation-class qualifiers may be added to the DD domain, but the following qualifiers would \nnot generally be used: --MODIFY, --POS, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STNRC, --NRIND, --NAM, --LOINC, --\nSPEC, --SPCCND, --LOBXFL, --BLFL, --FAST, --DRVFL, --TOX, --TOXGR, --SEV. \nDD \u2013 Examples \nExample 1 \nThis example shows the primary cause of death for 3 subjects. The CRF also collected the location of the subject\u2019s death and a secondary cause of death. \nRows 1-2: \nShow the primary cause of death and location of death for a subject. DDDTC is the date of assessment. \nRows 3-4: \nShow records for primary cause of death and location of death for another subject for whom the information was not known. \nRows 5-7: \nShow primary and secondary cause of death and location of death for a third subject.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2213, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9c59e168-4bd3-42bd-a564-313d743dc145": {"__data__": {"id_": "9c59e168-4bd3-42bd-a564-313d743dc145", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 184, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "117fb19b-9133-4e78-91ae-3219ab301ff5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 184, "section": "UNSPECIFIED"}, "hash": "fa92b8864994800b9733dd34caffb9066f7efa508afd4e51b803bda59c0e925a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9103aa5b-2310-4cdf-9bfd-b5d463ad8300", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 184, "section": "UNSPECIFIED"}, "hash": "2669abeb171f6eb7abebbe581d6b20ddae059bac3f332e4ba52ffcd4433b1c41", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DD \u2013 Examples \nExample 1 \nThis example shows the primary cause of death for 3 subjects. The CRF also collected the location of the subject\u2019s death and a secondary cause of death. \nRows 1-2: \nShow the primary cause of death and location of death for a subject. DDDTC is the date of assessment. \nRows 3-4: \nShow records for primary cause of death and location of death for another subject for whom the information was not known. \nRows 5-7: \nShow primary and secondary cause of death and location of death for a third subject. \ndd.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nDDSEQ \nDDTESTCD \nDDTEST \nDDORRES \nDDSTRESC \nDDDTC \n1 \nABC123 \nDD \nABC12301001 \n1 \nPRCDTH \nPrimary Cause of Death \nSUDDEN CARDIAC DEATH \nSUDDEN CARDIAC DEATH \n2011-01-12 \n2 \nABC123 \nDD \nABC12301001 \n2 \nLOCDTH \nLocation of Death \nHOME \nHOME \n2011-01-12 \n3 \nABC123 \nDD \nABC12301002 \n1 \nPRCDTH \nPrimary Cause of Death \nUNKNOWN \nUNKNOWN \n2011-03-15 \n4 \nABC123 \nDD \nABC12301002 \n2 \nLOCDTH \nLocation of Death \nUNKNOWN \nUNKNOWN \n2011-03-15 \n5 \nABC123 \nDD \nABC12301023 \n1 \nPRCDTH \nPrimary Cause of Death \nCARDIAC ARRHYTHMIA \nCARDIAC ARRHYTHMIA \n2011-09-09 \n6 \nABC123 \nDD \nABC12301023 \n2 \nSECDTH \nSecondary Cause of Death \nCHF \nCONGESTIVE HEART FAILURE \n2011-09-09 \n7 \nABC123 \nDD \nABC12301023 \n3 \nLOCDTH \nLocation of Death \nMEMORIAL HOSPITAL \nHOSPITAL \n2011-09-09 \nExample 2 \nThis example illustrates how the DD, Disposition (DS), and AE data for a subject were linked using RELREC. Note that each of these domains serves a different \npurpose, even though the information is related. This subject had a fatal adverse event, represented in the AE domain. \nae.xpt \nRow STUDYID DOMAIN USUBJID \nAESEQ AETERM \nAESTDTC \nAEENDTC \nAEDECOD \nAEBODSYS \nAEOUT AESER AESDTH \n1 \nABC123 \nAE \nABC12301001 6 \nSUDDEN CARDIAC DEATH 2011-01-10 2011-01-10 SUDDEN CARDIAC DEATH CARDIOVASCULAR SYSTEM FATAL \nY \nY \nThe primary cause of death was collected and is represented in DD. In this case, the result for primary cause of death is the same as the term in the AE record.", "mimetype": "text/plain", "start_char_idx": 1690, "end_char_idx": 3695, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "546f5a97-8507-4787-9c34-8928940717de": {"__data__": {"id_": "546f5a97-8507-4787-9c34-8928940717de", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 185, "section": "6.3.3 ECG Test Results (EG)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "77150e98-9717-436e-ae5b-6a129f54ba46", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 185, "section": "6.3.3 ECG Test Results (EG)"}, "hash": "5f9234e185db89b060c7fa750134909a36613e202c8bb7249cff798bc3c7d3c6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "EG \u2013 Description/Overview \nA findings domain that contains ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG \nincluding an overall interpretation if collected or derived. \nEG \u2013 Specification \neg.xpt, ECG Test Results \u2014 Findings. One record per ECG observation per replicate per time point or one record per ECG observation \nper beat per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, Codelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar EG \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or \nsubmissions involving the product. \nReq \nSPDEVID \nSponsor Device \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier for a device. \nPerm \nEGSEQ \nSequence \nNumber \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. \nMay be any valid number. \nReq \nEGGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nEGREFID \nECG Reference \nID \nChar  \nIdentifier \nInternal or external ECG identifier. Example: \"334PT89\". \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1405, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2f3c3b61-92d7-43b7-9c84-7aad8e54b1e8": {"__data__": {"id_": "2f3c3b61-92d7-43b7-9c84-7aad8e54b1e8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 186, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9884a721-51fb-4520-aef5-602714a6b320", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 186, "section": "UNSPECIFIED"}, "hash": "81acf0ca5cda721f188a0a498e3528a1bbbeb814c169fcf3a39f30628272d820", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "332d04b4-9dc0-48d9-8e8d-0975e41f845a", "node_type": "1", "metadata": {}, "hash": "27dac485930545e4a31d1ebfd2f7d698b8e4a1db25b21b44673c9ee5964409c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 186 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, Codelist or Format1 \nRole \nCDISC Notes \nCore \nEGSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be printed on the CRF as an explicit line \nidentifier or defined in the sponsor's operational database. Example: Line number on \nthe ECG page. \nPerm \nEGBEATNO \nECG Beat \nNumber \nNum  \nIdentifier \nA sequence number that identifies the beat within an ECG. \nPerm \nEGTESTCD \nECG Test or \nExamination Short \nName \nChar (EGTESTCD)(HETESTCD) \nTopic \nShort name of the measurement, test, or examination described in EGTEST. It can be \nused as a column name when converting a dataset from a vertical to a horizontal \nformat. The value in EGTESTCD cannot be longer than 8 characters, nor can it start \nwith a number (e.g., \"1TEST\" is not valid). EGTESTCD cannot contain characters \nother than letters, numbers, or underscores. Examples: \"PRAG\", \"QRSAG\". \nTest codes are in 2 separate codelists, 1 for tests based on regular 10-second ECGs \n(EGTESTCD) and one 1 tests based on Holter monitoring (HETESTCD). \nReq \nEGTEST \nECG Test or \nExamination \nName \nChar (EGTEST)(HETEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. \nThe value in EGTEST cannot be longer than 40 characters. Examples: \"PR Interval, \nAggregate\", \"QRS Duration, Aggregate\". \nTest names are in 2 separate codelists, 1 for tests based on regular 10-second ECGs \n(EGTEST) and 1 for tests based on Holter monitoring (HETEST). \nReq \nEGCAT \nCategory for ECG \nChar * \nGrouping \nQualifier \nUsed to categorize ECG observations across subjects. Examples: \"MEASUREMENT\", \n\"FINDING\", \"INTERVAL\". \nPerm \nEGSCAT \nSubcategory for \nECG \nChar * \nGrouping \nQualifier \nA further categorization of the ECG. \nPerm \nEGPOS \nECG Position of \nSubject \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during a measurement or examination. Examples: \"SUPINE\", \n\"STANDING\", \"SITTING\". \nPerm \nEGORRES \nResult or Finding \nin Original Units \nChar  \nResult \nQualifier \nResult of the ECG measurement or finding as originally received or collected. \nExamples of expected values are \"62\" or \"0.151\" when the result is an interval or \nmeasurement, or \"ATRIAL FIBRILLATION\" or \"QT PROLONGATION\" when the result \nis a finding. \nExp \nEGORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for EGORRES. Examples: \n\"sec\", \"msec\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2669, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "332d04b4-9dc0-48d9-8e8d-0975e41f845a": {"__data__": {"id_": "332d04b4-9dc0-48d9-8e8d-0975e41f845a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 186, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9884a721-51fb-4520-aef5-602714a6b320", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 186, "section": "UNSPECIFIED"}, "hash": "81acf0ca5cda721f188a0a498e3528a1bbbeb814c169fcf3a39f30628272d820", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2f3c3b61-92d7-43b7-9c84-7aad8e54b1e8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 186, "section": "UNSPECIFIED"}, "hash": "a88140377cfdc5814663228dc85c4f3bd1fac92baad3c07ae2b93c8c2551e620", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nEGPOS \nECG Position of \nSubject \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during a measurement or examination. Examples: \"SUPINE\", \n\"STANDING\", \"SITTING\". \nPerm \nEGORRES \nResult or Finding \nin Original Units \nChar  \nResult \nQualifier \nResult of the ECG measurement or finding as originally received or collected. \nExamples of expected values are \"62\" or \"0.151\" when the result is an interval or \nmeasurement, or \"ATRIAL FIBRILLATION\" or \"QT PROLONGATION\" when the result \nis a finding. \nExp \nEGORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for EGORRES. Examples: \n\"sec\", \"msec\". \nPerm \nEGSTRESC \nCharacter \nResult/Finding in \nStd Format \nChar (EGSTRESC)(HESTRESC)(NORMABNM) Result \nQualifier \nContains the result value for all findings copied or derived from EGORRES, in a \nstandard format or standard units. EGSTRESC should store all results or findings in \ncharacter format; if results are numeric, they should also be stored in numeric format \nin EGSTRESN. For example, if a test has results of 62 beats/min, then EGORRES = \n\"62\", EGORRESU = \"beats/min\", EGSTRESC = \"62\", EGSTRESN = 62, and \nEGSTRESU = \"beats/min\" . For other examples, see Original and Standardized \nResults. Additional examples of result data: \"SINUS BRADYCARDIA\", \"ATRIAL \nFLUTTER\", \"ATRIAL FIBRILLATION\". \nTest results are in 3 separate codelists: EGSTRESC for abnormal test results based \non regular 10-second ECGs; HESTRESC for abnormal test results based on Holter \nmonitoring, and NORMABNM for generic test results and/or responses to EGTEST = \n\"Interpretation\". \nExp \nEGSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in \nnumeric format from EGSTRESC. EGSTRESN should store all numeric test results or \nfindings. \nPerm \nEGSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for EGSTRESC and EGSTRESN. \nPerm \nEGSTAT \nCompletion Status Char (ND) \nRecord \nQualifier \nUsed to indicate an ECG was not done, or an ECG measurement was not taken. \nShould be null if a result exists in EGORRES. \nPerm \nEGREASND \nReason ECG Not \nDone \nChar  \nRecord \nQualifier \nDescribes why a measurement or test was not performed. Examples: \"BROKEN \nEQUIPMENT\", \"SUBJECT REFUSED\". Used in conjunction with EGSTAT when value \nis \"NOT DONE\". \nPerm", "mimetype": "text/plain", "start_char_idx": 1996, "end_char_idx": 4427, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c44bdd3a-aff2-425d-95a7-fd08b8242213": {"__data__": {"id_": "c44bdd3a-aff2-425d-95a7-fd08b8242213", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 187, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0dfca31d-11fa-4be7-b596-c950092a1e09", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 187, "section": "UNSPECIFIED"}, "hash": "8fe996671e37c710a5027280a4a205b72b1313c538a8b4de347a5fb540a6afd4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "137ebd01-093b-4e2e-9b1f-62cec712cea7", "node_type": "1", "metadata": {}, "hash": "75eedac63b1e98146bfb48977fc10e70720493828a9cf4eff2cfebec585aa91f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 187 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, Codelist or Format1 \nRole \nCDISC Notes \nCore \nEGXFN \nECG External File \nPath \nChar  \nRecord \nQualifier \nFile name and path for the external ECG waveform file. \nPerm \nEGNAM \nVendor Name \nChar  \nRecord \nQualifier \nName or identifier of the laboratory or vendor providing the test results. \nPerm \nEGMETHOD Method of Test or \nExamination \nChar (EGMETHOD) \nRecord \nQualifier \nMethod of the ECG test. Example: \"12-LEAD STANDARD\". \nPerm \nEGLEAD \nLead Location \nUsed for \nMeasurement \nChar (EGLEAD) \nRecord \nQualifier \nThe lead used for the measurement. Examples: \"LEAD 1\", \"LEAD 2\", \"LEAD rV2\", \n\"LEAD V1\". \nPerm \nEGLOBXFL \nLast Observation \nBefore Exposure \nFlag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to \nRFXSTDTC. The value should be \"Y\" or null. \nExp \nEGBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that EGBLFL is \nretained for backward compatibility. The authoritative baseline for statistical analysis is \nin an ADaM dataset. \nPerm \nEGDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Records that \nrepresent the average of other records, or that do not come from the CRF, or are not \nas originally collected or received are examples of records that would be derived for \nthe submission datasets. If EGDRVFL=\"Y\", then EGORRES could be null, with \nEGSTRESC and EGSTRESN (if the result is numeric) having the derived value. \nPerm \nEGEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are \nsubjective (e.g., assigned by a person or a group). Should be null for records that \ncontain collected or derived data. Examples: \"INVESTIGATOR\", \"ADJUDICATION \nCOMMITTEE\", \"VENDOR\". \nPerm \nEGEVALID \nEvaluator \nIdentifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in EGEVAL. \nExamples: \"RADIOLOGIST 1\" or \"RADIOLOGIST 2\". \nPerm \nEGCLSIG \nClinically \nSignificant, \nCollected \nChar (NY) \nRecord \nQualifier \nUsed to indicate whether a collected observation is clinically significant based on \njudgment. \nPerm \nEGREPNUM Repetition \nNumber \nNum  \nRecord \nQualifier \nThe incidence number of a test that is repeated within a given timeframe for the same \ntest. The level of granularity can vary (e.g., within a time point, within a visit). \nExamples: multiple measurements of blood pressure, multiple analyses of a sample. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2927, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "137ebd01-093b-4e2e-9b1f-62cec712cea7": {"__data__": {"id_": "137ebd01-093b-4e2e-9b1f-62cec712cea7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 187, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0dfca31d-11fa-4be7-b596-c950092a1e09", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 187, "section": "UNSPECIFIED"}, "hash": "8fe996671e37c710a5027280a4a205b72b1313c538a8b4de347a5fb540a6afd4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c44bdd3a-aff2-425d-95a7-fd08b8242213", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 187, "section": "UNSPECIFIED"}, "hash": "d20ec0968be489bdfe1508cedbe2e6a51ddd35b44782a37ba1c26a479c6070f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"RADIOLOGIST 1\" or \"RADIOLOGIST 2\". \nPerm \nEGCLSIG \nClinically \nSignificant, \nCollected \nChar (NY) \nRecord \nQualifier \nUsed to indicate whether a collected observation is clinically significant based on \njudgment. \nPerm \nEGREPNUM Repetition \nNumber \nNum  \nRecord \nQualifier \nThe incidence number of a test that is repeated within a given timeframe for the same \ntest. The level of granularity can vary (e.g., within a time point, within a visit). \nExamples: multiple measurements of blood pressure, multiple analyses of a sample. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to \nVISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study \nDay of Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within \nArm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in \nwhich the assessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nEGDTC \nDate/Time of ECG Char ISO 8601 datetime or interval \nTiming \nDate/Time of ECG. \nExp \nEGDY \nStudy Day of ECG Num  \nTiming \nStudy day of the ECG, measured as integer days. Algorithm for calculations must be \nrelative to the sponsor-defined RFSTDTC variable in Demographics. \nPerm \nEGTPT \nPlanned Time \nPoint Name \nChar  \nTiming \nText description of time when measurement should be taken. This may be \nrepresented as an elapsed time relative to a fixed reference point, such as time of last \ndose. See EGTPTNUM and EGTPTREF. Examples: \"Start\", \"5 min post\". \nPerm \nEGTPTNUM \nPlanned Time \nPoint Number \nNum  \nTiming \nNumerical version of EGTPT to aid in sorting. \nPerm", "mimetype": "text/plain", "start_char_idx": 2272, "end_char_idx": 4177, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "29ab00cb-208b-4bd7-b997-fcbd1c018c5f": {"__data__": {"id_": "29ab00cb-208b-4bd7-b997-fcbd1c018c5f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 188, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "903e504e-69e1-45e9-b8ae-aadc78b49a1e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 188, "section": "UNSPECIFIED"}, "hash": "ab60ad75c9f753e07792518592a5ff657adc3cfc10726e08b1fd65c5354d1a6d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89513234-739b-4778-8376-860a0b474d4e", "node_type": "1", "metadata": {}, "hash": "6cf45dfd08e6963420f0ead6b4a42a8dd9a5bda54755483f0fb71ccb0a4e0d01", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 188 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, Codelist or Format1 \nRole \nCDISC Notes \nCore \nEGELTM \nPlanned Elapsed \nTime from Time \nPoint Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a fixed time point reference \n(EGTPTREF). Not a clock time or a date time variable. Represented as an ISO 8601 \nduration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the \nreference point indicated by EGTPTREF, \"PT8H\" to represent the period of 8 hours \nafter the reference point indicated by EGTPTREF. \nPerm \nEGTPTREF \nTime Point \nReference \nChar  \nTiming \nName of the fixed reference point referred to by EGELTM, EGTPTNUM, and EGTPT. \nExamples: \"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nEGRFTDTC \nDate/Time of \nReference Time \nPoint \nChar ISO 8601 datetime or interval \nTiming \nDate/time for a fixed reference time point defined by EGTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nEG \u2013 Assumptions \n1. EGREFID is intended to store an identifier (e.g., UUID) for the associated ECG tracing. EGXFN is intended to store the name of and path to the \nelectrocardiogram (ECG) waveform file when it is submitted. \n2. There are separate codelists for tests and results based on regular 10-second ECGs and for tests and results based on Holter monitoring.  \na. \nAssociations between some ECG abnormality tests and response codelists are described in the ECG codetable (available \nat https://www.cdisc.org/standards/terminology/controlled-terminology). \n3. For non-individual ECG beat data and for aggregate ECG parameter results (e.g., \"QT interval\", \"RR\", \"PR\", \"QRS\"), EGREFID is populated for all \nunique ECGs, so that submitted SDTM data can be matched to the actual ECGs stored in the ECG warehouse. Therefore, this variable is expected for \nthese types of records. \n4. For individual-beat parameter results, waveform data will not be stored in the warehouse, so there will be no associated identifier for these beats. \n5. The method for QT interval correction is specified in the test name by controlled terminology: EGTESTCD = \"QTCFAG\" and EGTEST = \"QTcF \nInterval, Aggregate\" is used for Fridericia's formula; EGTESTCD = \"QTCBAG\" and EGTEST = \"QTcB Interval, Aggregate\", is used for Bazett's \nformula. \n6. EGBEATNO is used to differentiate between beats in beat-to-beat records. \n7. EGREPNUM is used to differentiate between multiple repetitions of a test within a given time frame. \n8. EGNRIND can be added to indicate where a result falls with respect to reference range defined by EGORNRLO and EGORNRHI. Examples: \"HIGH\", \n\"LOW\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2908, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89513234-739b-4778-8376-860a0b474d4e": {"__data__": {"id_": "89513234-739b-4778-8376-860a0b474d4e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 188, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "903e504e-69e1-45e9-b8ae-aadc78b49a1e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 188, "section": "UNSPECIFIED"}, "hash": "ab60ad75c9f753e07792518592a5ff657adc3cfc10726e08b1fd65c5354d1a6d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "29ab00cb-208b-4bd7-b997-fcbd1c018c5f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 188, "section": "UNSPECIFIED"}, "hash": "c58601fbe68b7f9ef3a6d56a79fe80b75be29c73e061e1bed2bfc761e60336db", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For individual-beat parameter results, waveform data will not be stored in the warehouse, so there will be no associated identifier for these beats. \n5. The method for QT interval correction is specified in the test name by controlled terminology: EGTESTCD = \"QTCFAG\" and EGTEST = \"QTcF \nInterval, Aggregate\" is used for Fridericia's formula; EGTESTCD = \"QTCBAG\" and EGTEST = \"QTcB Interval, Aggregate\", is used for Bazett's \nformula. \n6. EGBEATNO is used to differentiate between beats in beat-to-beat records. \n7. EGREPNUM is used to differentiate between multiple repetitions of a test within a given time frame. \n8. EGNRIND can be added to indicate where a result falls with respect to reference range defined by EGORNRLO and EGORNRHI. Examples: \"HIGH\", \n\"LOW\". Clinical significance would be represented as described in Section 4.5.5, Clinical Significance for Findings Observation Class Data, in \nEGCLSIG (see also EG Example 1). \n9. When \"QTcF Interval, Aggregate\" or \"QTcB Interval, Aggregate\" is derived by the sponsor, the derived flag (EGDRVFL) is set to \"Y\". However, when \nthe \"QTcF Interval, Aggregate\" or \"QTcB Interval, Aggregate\" is received from a central provider or vendor, the value would go into EGORRES and \nEGDRVFL would be null (see Section 4.1.8.1, Origin Metadata for Variables). \n10. If this domain is used in conjunction with the ECG QT Correction Model Data (QT) domain: \na. \nFor each QT correction method used in the study, values of EGTESTCD and EGTEST are assigned at the study level.", "mimetype": "text/plain", "start_char_idx": 2143, "end_char_idx": 3660, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d2f5171-035e-4b8a-8185-aee1a914a176": {"__data__": {"id_": "5d2f5171-035e-4b8a-8185-aee1a914a176", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 189, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c24a704-442c-4149-8eb8-871e561e53e9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 189, "section": "UNSPECIFIED"}, "hash": "b64623baf96d622b1d335b056b2a454116e4a7036a61d5ad50b0ebb72e0db003", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 189 \n2021-11-29 \nb. The sponsor should assign values for EGTESTCD/EGTEST appropriately with clear documentation on what each test code represents. For \nexample, if the protocol calls for computing the top two best fit models, the sponsor could choose to name the top best fit model QTCIAG1 and the \nsecond best fit model QTCIAG2, in rank order. \n11. Any identifiers, timing variables, or findings general observation-class qualifiers may be added to the EG domain, but the following qualifiers would not \ngenerally be used: --MODIFY, --BODSYS, --SPEC, --SPCCND, --FAST, --SEV. It is recommended that \u2011\u2011LOINC not be used. \nEG - Examples \nExample 1 \nThis example shows ECG measurements and other findings from one ECG for one subject. EGCAT has been used to group tests. \nRow 1: \nShows a measurement of ventricular rate. This result was assessed as not clinically significant (EGCLSIG = \"N\"). \nRow 2: \nShows a measurement of PR interval. This result was assessed as clinically significant (EGCLSIG = \"Y\"). \nRows 2-4: \nThese interval measurements were collected in seconds. However, in this submission, the standard unit for these tests was milliseconds, so the \nresults have been converted in EGSTRESC and EGSTRESN. \nRows 5-6: \nShow \"QTcB Interval, Aggregate\" and \"QTcF Interval, Aggregate\". These results were derived by the sponsor, as indicated by the \u201cY\u201d in the \nEGDRVFL column. Note that EGORRES is null for these derived records. \nRows 7-10: Show results from tests looking for certain kinds of abnormalities, which have been grouped using EGCAT = \"FINDINGS\". \nRow 11: \nShows a technical problem represented as the result of the test \"Technical Quality\". Results of this test can be important to the overall \nunderstanding of an ECG, but are not truly findings or interpretations about the subject's heart function. \nRow 12: \nShows the result of the TEST \"Interpretation\" (i.e., the interpretation of the ECG strip as a whole), which for this ECG was \"ABNORMAL\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2145, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b6469387-448e-47c3-8560-de5a347e6ec7": {"__data__": {"id_": "b6469387-448e-47c3-8560-de5a347e6ec7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ed8ac25-fddd-442c-9f25-afb056379dd7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "hash": "5c7eb9b8fb0ae5a0b28e14167c0467d64915d2ad42048c91ffc65b5de012d943", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ca8c82e1-bc82-4e95-b1e6-f4eaee669d30", "node_type": "1", "metadata": {}, "hash": "412e8eeb6df6d90e146968193ca747f2f505636274373c13220724b9915f53d4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 190 \n2021-11-29 \neg.xpt \nRow STUDYID DOMAIN USUBJID \nEGSEQ EGREFID EGTESTCD EGTEST \nEGCAT \nEGPOS \nEGORRES \nEGORRESU EGSTRESC \nEGSTRESN EGSTRESU EGXFN \nEGNAM EGLOBXFL EGDRVFL EGCLSIG VISITNUM VISIT \nEGDTC \nEGDY \n1 \nXYZ \nEG \nXYZ-US-\n701-002 \n1 \n334PT89 \nEGHRMN \nECG Mean Heart \nRate \nMEASUREMENT SUPINE 62 \nbeats/min \n62 \n62 \nbeats/min \nPQW436789-\n07.xml \nTest \nLab \n \n \nN \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n2 \nXYZ \nEG \nXYZ-US-\n701-002 \n2 \n334PT89 \nPRAG \nPR Interval, \nAggregate \nINTERVAL \nSUPINE 0.15 \nsec \n150 \n150 \nmsec \nPQW436789-\n07.xml \nTest \nLab \n \n \nY \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n3 \nXYZ \nEG \nXYZ-US-\n701-002 \n3 \n334PT89 \nQRSAG \nQRS Duration, \nAggregate \nINTERVAL \nSUPINE 0.103 \nsec \n103 \n103 \nmsec \nPQW436789-\n07.xml \nTest \nLab \n \n \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n4 \nXYZ \nEG \nXYZ-US-\n701-002 \n4 \n334PT89 \nQTAG \nQT Interval, \nAggregate \nINTERVAL \nSUPINE 0.406 \nsec \n406 \n406 \nmsec \nPQW436789-\n07.xml \nTest \nLab \n \n \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n5 \nXYZ \nEG \nXYZ-US-\n701-002 \n5 \n334PT89 \nQTCBAG \nQTcB Interval, \nAggregate \nINTERVAL \nSUPINE  \n \n469 \n469 \nmsec \nPQW436789-\n07.xml \nTest \nLab \n \nY \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n6 \nXYZ \nEG \nXYZ-US-\n701-002 \n6 \n334PT89 \nQTCFAG \nQTcF Interval, \nAggregate \nINTERVAL \nSUPINE  \n \n446 \n446 \nmsec \nPQW436789-\n07.xml \nTest \nLab \n \nY \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n7 \nXYZ \nEG \nXYZ-US-\n701-002 \n7 \n334PT89 \nSPRTARRY Supraventricular \nTachyarrhythmias \nFINDING \nSUPINE ATRIAL FIBRILLATION \n \nATRIAL FIBRILLATION \n \n \nPQW436789-\n07.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1722, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ca8c82e1-bc82-4e95-b1e6-f4eaee669d30": {"__data__": {"id_": "ca8c82e1-bc82-4e95-b1e6-f4eaee669d30", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ed8ac25-fddd-442c-9f25-afb056379dd7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "hash": "5c7eb9b8fb0ae5a0b28e14167c0467d64915d2ad42048c91ffc65b5de012d943", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b6469387-448e-47c3-8560-de5a347e6ec7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "hash": "7c9c5ec2e146288eb54b413a99f453645247f3349edacebdd8f65c993bd277fa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c7dddfe8-e6cf-4f06-be3d-ac314dede628", "node_type": "1", "metadata": {}, "hash": "4132d49655697a11e368fc72b5360bd340386661d577e2b51fe644507883b266", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "xml \nTest \nLab \n \nY \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n6 \nXYZ \nEG \nXYZ-US-\n701-002 \n6 \n334PT89 \nQTCFAG \nQTcF Interval, \nAggregate \nINTERVAL \nSUPINE  \n \n446 \n446 \nmsec \nPQW436789-\n07.xml \nTest \nLab \n \nY \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n7 \nXYZ \nEG \nXYZ-US-\n701-002 \n7 \n334PT89 \nSPRTARRY Supraventricular \nTachyarrhythmias \nFINDING \nSUPINE ATRIAL FIBRILLATION \n \nATRIAL FIBRILLATION \n \n \nPQW436789-\n07.xml \nTest \nLab \n \n \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n8 \nXYZ \nEG \nXYZ-US-\n701-002 \n8 \n334PT89 \nSPRTARRY Supraventricular \nTachyarrhythmias \nFINDING \nSUPINE ATRIAL FLUTTER \n \nATRIAL FLUTTER \n \n \nPQW436789-\n07.xml \nTest \nLab \n \n \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n9 \nXYZ \nEG \nXYZ-US-\n701-002 \n9 \n334PT89 \nSTSTWUW \nST Segment, T wave, \nand U wave \nFINDING \nSUPINE PROLONGED QT \n \nPROLONGED QT \n \n \nPQW436789-\n07.xml \nTest \nLab \n \n \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n10 \nXYZ \nEG \nXYZ-US-\n701-002 \n10 \n334PT89 \nCHYPTENL \nChamber Hypertrophy \nor Enlargement \nFINDING \nSUPINE LEFT VENTRICULAR \nHYPERTROPHY \n \nLEFT VENTRICULAR \nHYPERTROPHY \n \n \nPQW436789-\n07.xml \nTest \nLab \n \n \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n11 \nXYZ \nEG \nXYZ-US-\n701-002 \n11 \n334PT89 \nTECHQUAL Technical Quality \n \nSUPINE OTHER INCORRECT \nELECTRODE \nPLACEMENT \n \nOTHER INCORRECT \nELECTRODE \nPLACEMENT \n \n \nPQW436789-\n07.xml \nTest \nLab \n \n \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \n12 \nXYZ \nEG \nXYZ-US-\n701-002 \n12 \n334PT89 \nINTP \nInterpretation \n \nSUPINE ABNORMAL \n \nABNORMAL \n \n \n \n \n \n \n \n1 \nScreening \n1 \n2003-04-\n15T11:58 \n-36 \nExample 2 \nThis example shows ECG results where only the overall assessment was collected. Results are for one subject across multiple visits. In addition, the ECG interpretation was provided by the investigator and, when \nnecessary, by a cardiologist. EGGRPID is used to group the overall assessments collected on each ECG. \nRows 1-3: \nShow interpretations performed by the principal investigation on three different occasions. The ECG at Visit \"SCREEN 2\" has been flagged as the last observation before start of study treatment. \nRows 4-5: \nShow interpretations of the same ECG by both the investigator and a cardiologist.", "mimetype": "text/plain", "start_char_idx": 1303, "end_char_idx": 3479, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c7dddfe8-e6cf-4f06-be3d-ac314dede628": {"__data__": {"id_": "c7dddfe8-e6cf-4f06-be3d-ac314dede628", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ed8ac25-fddd-442c-9f25-afb056379dd7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "hash": "5c7eb9b8fb0ae5a0b28e14167c0467d64915d2ad42048c91ffc65b5de012d943", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ca8c82e1-bc82-4e95-b1e6-f4eaee669d30", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "hash": "d694fb8c861345abd9b4d1f09a575e0fdddb3eece125c8760169e57765d1e2a8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b513de80-4830-44db-b523-f17ac4828de8", "node_type": "1", "metadata": {}, "hash": "b10f703adb0ab2dbbda3343eb55a6deaac453d250e787ec5eeb71ae2522aa94c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Results are for one subject across multiple visits. In addition, the ECG interpretation was provided by the investigator and, when \nnecessary, by a cardiologist. EGGRPID is used to group the overall assessments collected on each ECG. \nRows 1-3: \nShow interpretations performed by the principal investigation on three different occasions. The ECG at Visit \"SCREEN 2\" has been flagged as the last observation before start of study treatment. \nRows 4-5: \nShow interpretations of the same ECG by both the investigator and a cardiologist. EGGRPID has been used to group these two records to emphasize their relationship. \neg.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nEGSEQ \nEGGRPID \nEGTESTCD \nEGTEST \nEGPOS \nEGORRES \nEGSTRESC \nEGSTRESN \nEGLOBXFL \nEGEVAL \nVISITNUM \nVISIT \nVISITDY \nEGDTC \nEGDY \n1 \nABC \nEG \nABC-99-CA-456 \n1 \n \nINTP \nInterpretation \nSUPINE \nNORMAL \nNORMAL \n \n \nPRINCIPAL INVESTIGATOR \n1 \nSCREEN I \n-2 \n2003-11-26 \n-2 \n2 \nABC \nEG \nABC-99-CA-456 \n2 \n \nINTP \nInterpretation \nSUPINE \nABNORMAL \nABNORMAL \n \nY \nPRINCIPAL INVESTIGATOR \n2 \nSCREEN II \n-1 \n2003-11-27 \n-1 \n3 \nABC \nEG \nABC-99-CA-456 \n3 \n \nINTP \nInterpretation \nSUPINE \nABNORMAL \nABNORMAL \n \n \nPRINCIPAL INVESTIGATOR \n3 \nDAY 10 \n10 \n2003-12-07T09:02 \n10 \n4 \nABC \nEG \nABC-99-CA-456 \n4 \nComp 1 \nINTP \nInterpretation \nSUPINE \nABNORMAL \nABNORMAL \n \n \nPRINCIPAL INVESTIGATOR \n4 \nDAY 15 \n15 \n2003-12-12 \n15 \n5 \nABC \nEG \nABC-99-CA-456 \n5 \nComp 1 \nINTP \nInterpretation \nSUPINE \nABNORMAL \nABNORMAL \n \n \nCARDIOLOGIST \n4 \nDAY 15 \n15 \n2003-12-12 \n15 \nExample 3 \nThis example shows 10-second ECG replicates extracted from a continuous recording. The example shows one subject\u2019s extracted 10-second ECG replicate results. Three replicates were extracted for planned time \npoints \"1 HR\" and \"2 HR\"; EGREPNUM is used to identify the replicates. Summary mean measurements are reported for the 10 seconds of extracted data for each replicate. EGDTC is the date/time of the first \nindividual beat in the extracted 10-second ECG. In order to save space, some permissible variables (EGREFID, VISITDY, EGTPTNUM, EGTPTREF, EGRFTDTC) have been omitted, as marked by ellipses.", "mimetype": "text/plain", "start_char_idx": 2946, "end_char_idx": 5056, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b513de80-4830-44db-b523-f17ac4828de8": {"__data__": {"id_": "b513de80-4830-44db-b523-f17ac4828de8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ed8ac25-fddd-442c-9f25-afb056379dd7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "hash": "5c7eb9b8fb0ae5a0b28e14167c0467d64915d2ad42048c91ffc65b5de012d943", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c7dddfe8-e6cf-4f06-be3d-ac314dede628", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 190, "section": "UNSPECIFIED"}, "hash": "9b57de3f35f7839933eaf5f196b1933219a6bdd7c6eec480a6c2cee1a905aadd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The example shows one subject\u2019s extracted 10-second ECG replicate results. Three replicates were extracted for planned time \npoints \"1 HR\" and \"2 HR\"; EGREPNUM is used to identify the replicates. Summary mean measurements are reported for the 10 seconds of extracted data for each replicate. EGDTC is the date/time of the first \nindividual beat in the extracted 10-second ECG. In order to save space, some permissible variables (EGREFID, VISITDY, EGTPTNUM, EGTPTREF, EGRFTDTC) have been omitted, as marked by ellipses. \neg.xpt \nRow STUDYID DOMAIN USUBJID \nEGSEQ \u2026 EGTESTCD EGTEST \nEGCAT \nEGPOS EGORRES EGORRESU EGSTRESC EGSTRESN EGSTRESU EGMETHOD \nEGLEAD EGLOBXFL VISITNUM VISIT \nEGDTC \nEGTPT \u2026 EGREPNUM \n1 \nSTUDY01 EG \n2324-\nP0001 \n1 \n\u2026 PRAG \nPR Interval, \nAggregate \nINTERVAL SUPINE 176 \nmsec \n176 \n176 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:00:21 \n1 HR \n\u2026 1 \n2 \nSTUDY01 EG \n2324-\nP0001 \n2 \n\u2026 RRAG \nRR Interval, \nAggregate \nINTERVAL SUPINE 658 \nmsec \n658 \n658 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:00:21 \n1 HR \n\u2026 1 \n3 \nSTUDY01 EG \n2324-\nP0001 \n3 \n\u2026 QRSAG \nQRS Duration, \nAggregate \nINTERVAL SUPINE 97 \nmsec \n97 \n97 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:00:21 \n1 HR \n\u2026 1", "mimetype": "text/plain", "start_char_idx": 4538, "end_char_idx": 5789, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8b43bc5d-c5d5-4482-8a0b-0f185a60bd27": {"__data__": {"id_": "8b43bc5d-c5d5-4482-8a0b-0f185a60bd27", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ede94ee4-5ba2-4357-985f-918ccacb55fc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "hash": "b90fb4ec97239a8f9280eb617795764e0a23a2ca1323ec96930c5124a4468960", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7a8a3624-477a-450a-b541-162557327e20", "node_type": "1", "metadata": {}, "hash": "d3db34f3c81b05bade09cef89383e5a949ac5900c330181940df399cb4230c5a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 191 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID \nEGSEQ \u2026 EGTESTCD EGTEST \nEGCAT \nEGPOS EGORRES EGORRESU EGSTRESC EGSTRESN EGSTRESU EGMETHOD \nEGLEAD EGLOBXFL VISITNUM VISIT \nEGDTC \nEGTPT \u2026 EGREPNUM \n4 \nSTUDY01 EG \n2324-\nP0001 \n4 \n\u2026 QTAG \nQT Interval, \nAggregate \nINTERVAL SUPINE 440 \nmsec \n440 \n440 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:00:21 \n1 HR \n\u2026 1 \n5 \nSTUDY01 EG \n2324-\nP0001 \n5 \n\u2026 PRAG \nPR Interval, \nAggregate \nINTERVAL SUPINE 176 \nmsec \n176 \n176 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:01:35 \n1 HR \n\u2026 2 \n6 \nSTUDY01 EG \n2324-\nP0001 \n6 \n\u2026 RRAG \nRR Interval, \nAggregate \nINTERVAL SUPINE 679 \nmsec \n679 \n679 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:01:35 \n1 HR \n\u2026 2 \n7 \nSTUDY01 EG \n2324-\nP0001 \n7 \n\u2026 QRSAG \nQRS Duration, \nAggregate \nINTERVAL SUPINE 95 \nmsec \n95 \n95 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:01:35 \n1 HR \n\u2026 2 \n8 \nSTUDY01 EG \n2324-\nP0001 \n8 \n\u2026 QTAG \nQT Interval, \nAggregate \nINTERVAL SUPINE 389 \nmsec \n389 \n389 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:01:35 \n1 HR \n\u2026 2 \n9 \nSTUDY01 EG \n2324-\nP0001 \n9 \n\u2026 PRAG \nPR Interval, \nAggregate \nINTERVAL SUPINE 169 \nmsec \n169 \n169 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:02:14 \n1 HR \n\u2026 3 \n10 \nSTUDY01 EG \n2324-\nP0001 \n10 \n\u2026 RRAG \nRR Interval, \nAggregate \nINTERVAL SUPINE 661 \nmsec \n661 \n661 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:02:14 \n1 HR \n\u2026 3 \n11 \nSTUDY01 EG \n2324-\nP0001 \n11 \n\u2026 QRSAG \nQRS Duration,", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1710, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7a8a3624-477a-450a-b541-162557327e20": {"__data__": {"id_": "7a8a3624-477a-450a-b541-162557327e20", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ede94ee4-5ba2-4357-985f-918ccacb55fc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "hash": "b90fb4ec97239a8f9280eb617795764e0a23a2ca1323ec96930c5124a4468960", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8b43bc5d-c5d5-4482-8a0b-0f185a60bd27", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "hash": "5f1f2a4a4d8d9a242feaea8cee9da1811f43aa93c40fc07b07ee3f7eb0fedd5b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "545ee71e-6f4c-4d7c-92c4-cae9de47b2e2", "node_type": "1", "metadata": {}, "hash": "7253d61664f5fb62a393efc285060946aa7ec9dbec5661370e2d0f73f1709597", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Aggregate \nINTERVAL SUPINE 169 \nmsec \n169 \n169 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:02:14 \n1 HR \n\u2026 3 \n10 \nSTUDY01 EG \n2324-\nP0001 \n10 \n\u2026 RRAG \nRR Interval, \nAggregate \nINTERVAL SUPINE 661 \nmsec \n661 \n661 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:02:14 \n1 HR \n\u2026 3 \n11 \nSTUDY01 EG \n2324-\nP0001 \n11 \n\u2026 QRSAG \nQRS Duration, \nAggregate \nINTERVAL SUPINE 90 \nmsec \n90 \n90 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:02:14 \n1 HR \n\u2026 3 \n12 \nSTUDY01 EG \n2324-\nP0001 \n12 \n\u2026 QTAG \nQT Interval, \nAggregate \nINTERVAL SUPINE 377 \nmsec \n377 \n377 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T10:02:14 \n1 HR \n\u2026 3 \n13 \nSTUDY01 EG \n2324-\nP0001 \n13 \n\u2026 PRAG \nPR Interval, \nAggregate \nINTERVAL SUPINE 176 \nmsec \n176 \n176 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:00:21 \n2 HR \n\u2026 1 \n14 \nSTUDY01 EG \n2324-\nP0001 \n14 \n\u2026 RRAG \nRR Interval, \nAggregate \nINTERVAL SUPINE 771 \nmsec \n771 \n771 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:00:21 \n2 HR \n\u2026 1 \n15 \nSTUDY01 EG \n2324-\nP0001 \n15 \n\u2026 QRSAG \nQRS Duration, \nAggregate \nINTERVAL SUPINE 100 \nmsec \n100 \n100 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:00:21 \n2 HR \n\u2026 1 \n16 \nSTUDY01 EG \n2324-\nP0001 \n16 \n\u2026 QTAG \nQT Interval, \nAggregate \nINTERVAL SUPINE 379 \nmsec \n379 \n379 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:00:21 \n2 HR \n\u2026 1 \n17 \nSTUDY01 EG \n2324-\nP0001 \n17 \n\u2026 PRAG \nPR Interval, \nAggregate \nINTERVAL SUPINE 179 \nmsec \n179 \n179 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:01:31 \n2 HR \n\u2026 2 \n18 \nSTUDY01 EG \n2324-\nP0001 \n18 \n\u2026 RRAG \nRR Interval,", "mimetype": "text/plain", "start_char_idx": 1340, "end_char_idx": 3004, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "545ee71e-6f4c-4d7c-92c4-cae9de47b2e2": {"__data__": {"id_": "545ee71e-6f4c-4d7c-92c4-cae9de47b2e2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ede94ee4-5ba2-4357-985f-918ccacb55fc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "hash": "b90fb4ec97239a8f9280eb617795764e0a23a2ca1323ec96930c5124a4468960", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7a8a3624-477a-450a-b541-162557327e20", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "hash": "1793ac7280476d55b1aa3b1a9b6bc0a8b36bb06d4360068f2ca57f29f013ce77", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3e455d4-b3d6-467b-ba8a-05bd4ab1667f", "node_type": "1", "metadata": {}, "hash": "abf024e745ef679afe9ac2c67877597a36cd59fc399280345fd3485c57b98c70", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Aggregate \nINTERVAL SUPINE 379 \nmsec \n379 \n379 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:00:21 \n2 HR \n\u2026 1 \n17 \nSTUDY01 EG \n2324-\nP0001 \n17 \n\u2026 PRAG \nPR Interval, \nAggregate \nINTERVAL SUPINE 179 \nmsec \n179 \n179 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:01:31 \n2 HR \n\u2026 2 \n18 \nSTUDY01 EG \n2324-\nP0001 \n18 \n\u2026 RRAG \nRR Interval, \nAggregate \nINTERVAL SUPINE 749 \nmsec \n749 \n749 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:01:31 \n2 HR \n\u2026 2 \n19 \nSTUDY01 EG \n2324-\nP0001 \n19 \n\u2026 QRSAG \nQRS Duration, \nAggregate \nINTERVAL SUPINE 103 \nmsec \n103 \n103 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:01:31 \n2 HR \n\u2026 2 \n20 \nSTUDY01 EG \n2324-\nP0001 \n20 \n\u2026 QTAG \nQT Interval, \nAggregate \nINTERVAL SUPINE 402 \nmsec \n402 \n402 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:01:31 \n2 HR \n\u2026 2 \n21 \nSTUDY01 EG \n2324-\nP0001 \n21 \n\u2026 PRAG \nPR Interval, \nAggregate \nINTERVAL SUPINE 175 \nmsec \n175 \n175 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:02:40 \n2 HR \n\u2026 3 \n22 \nSTUDY01 EG \n2324-\nP0001 \n22 \n\u2026 RRAG \nRR Interval, \nAggregate \nINTERVAL SUPINE 771 \nmsec \n771 \n771 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:02:40 \n2 HR \n\u2026 3 \n23 \nSTUDY01 EG \n2324-\nP0001 \n23 \n\u2026 QRSAG \nQRS Duration, \nAggregate \nINTERVAL SUPINE 98 \nmsec \n98 \n98 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:02:40 \n2 HR \n\u2026 3 \n24 \nSTUDY01 EG \n2324-\nP0001 \n24 \n\u2026 QTAG \nQT Interval, \nAggregate \nINTERVAL SUPINE 356 \nmsec \n356 \n356 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:02:40 \n2 HR \n\u2026 3 \nExample 4 \nThe example shows one subject\u2019s continuous beat-to-beat EG results. Only 3 beats are shown, but there could be measurements for, as an example, 101,000 complexes in 24 hours.", "mimetype": "text/plain", "start_char_idx": 2636, "end_char_idx": 4432, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b3e455d4-b3d6-467b-ba8a-05bd4ab1667f": {"__data__": {"id_": "b3e455d4-b3d6-467b-ba8a-05bd4ab1667f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ede94ee4-5ba2-4357-985f-918ccacb55fc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "hash": "b90fb4ec97239a8f9280eb617795764e0a23a2ca1323ec96930c5124a4468960", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "545ee71e-6f4c-4d7c-92c4-cae9de47b2e2", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 191, "section": "UNSPECIFIED"}, "hash": "3498073744703dd09ab6eafbcdabd9c4ea779dc9e117d9ad8e7ea97a69d21aea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Aggregate \nINTERVAL SUPINE 98 \nmsec \n98 \n98 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:02:40 \n2 HR \n\u2026 3 \n24 \nSTUDY01 EG \n2324-\nP0001 \n24 \n\u2026 QTAG \nQT Interval, \nAggregate \nINTERVAL SUPINE 356 \nmsec \n356 \n356 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n2 \nVISIT \n2 \n2014-03-\n22T11:02:40 \n2 HR \n\u2026 3 \nExample 4 \nThe example shows one subject\u2019s continuous beat-to-beat EG results. Only 3 beats are shown, but there could be measurements for, as an example, 101,000 complexes in 24 hours. The actual number of complexes in \n24 hours can be variable and depends on average heart rate. The results are mapped to the EG domain using EGBEATNO. If there is no result to be reported, then the row would not be included. \nRows 1-2: \nShow the first beat recorded. The first beat was considered to be the beat for which the recording contained a complete P-wave. It was assigned EGBEATNO = \"1\". There is no RR measurement for this \nbeat because RR is measured as the duration (time) between the peak of the R-wave in the reported single beat and peak of the R-wave in the preceding single beat, and the partial recording that \npreceded EGBEATNO = \"1\" did not contain an R-wave. EGDTC was the date/time of the individual beat. \nRows 3-5: \nEGBEATNO = \"2\" had an RR measurement, since the R-wave of the preceding beat (EGBEATNO = \"1\") was recorded. \nRows 6-8: \nThere is a 1-hour gap between beats 2 and 3 due to electrical interference or other artifacts that prevented measurements from being recorded. Note that EGBEATNO = \"3\" does have an RR \nmeasurement because the partial beat preceding EGBEATNO = \"3\" contained an R-wave.", "mimetype": "text/plain", "start_char_idx": 3935, "end_char_idx": 5560, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c87cfef0-4b2b-4820-a773-dea71addb5a1": {"__data__": {"id_": "c87cfef0-4b2b-4820-a773-dea71addb5a1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 192, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "22c9cb55-fb0b-40d5-a2c3-dc0e7fb86bc5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 192, "section": "UNSPECIFIED"}, "hash": "5a3a7a25014861c3c0e26d280a5adb779d03db731ab1bf2eb85fd8e38782d032", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 192 \n2021-11-29 \neg.xpt \nRow STUDYID DOMAIN USUBJID \nEGSEQ EGBEATNO EGTESTCD EGTEST \nEGCAT \nEGPOS EGORRES EGORRESU EGSTRESC EGSTRESN EGSTRESU EGMETHOD \nEGLEAD EGLOBXFL VISITNUM VISIT \nVISITDY EGDTC \n1 \nSTUDY01 EG \n2324-\nP0001 \n1 \n1 \nPRSB \nPR Interval, Single \nBeat \nINTERVAL SUPINE 176 \nmsec \n176 \n176 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n1 \nSCREENING -7 \n2014-02-\n11T14:32:12.3 \n2 \nSTUDY01 EG \n2324-\nP0001 \n2 \n1 \nQRSSB \nQRS Duration, \nSingle Beat \nINTERVAL SUPINE 97 \nmsec \n97 \n97 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n1 \nSCREENING -7 \n2014-02-\n11T14:32:12.3 \n3 \nSTUDY01 EG \n2324-\nP0001 \n3 \n2 \nPRSB \nPR Interval, Single \nBeat \nINTERVAL SUPINE 176 \nmsec \n176 \n176 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n1 \nSCREENING -7 \n2014-02-\n11T14:32:13.3 \n4 \nSTUDY01 EG \n2324-\nP0001 \n4 \n2 \nRRSM \nRR Interval, Single \nMeasurement \nINTERVAL SUPINE 679 \nmsec \n679 \n679 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n1 \nSCREENING -7 \n2014-02-\n11T14:32:13.3 \n5 \nSTUDY01 EG \n2324-\nP0001 \n5 \n2 \nQRSSB \nQRS Duration, \nSingle Beat \nINTERVAL SUPINE 95 \nmsec \n95 \n95 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n1 \nSCREENING -7 \n2014-02-\n11T14:32:13.3 \n6 \nSTUDY01 EG \n2324-\nP0001 \n6 \n3 \nPRSB \nPR Interval, Single \nBeat \nINTERVAL SUPINE 169 \nmsec \n169 \n169 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n1 \nSCREENING -7 \n2014-02-\n11T15:32:14.2 \n7 \nSTUDY01 EG \n2324-\nP0001 \n7 \n3 \nRRSM \nRR Interval, Single \nMeasurement \nINTERVAL SUPINE 661 \nmsec \n661 \n661 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n1 \nSCREENING -7 \n2014-02-\n11T15:32:14.2 \n8 \nSTUDY01 EG \n2324-\nP0001 \n8 \n3 \nQRSSB \nQRS Duration, \nSingle Beat \nINTERVAL SUPINE 90 \nmsec \n90 \n90 \nmsec \n12 LEAD \nSTANDARD \nLEAD II \n \n1 \nSCREENING -7 \n2014-02-\n11T15:32:14.2", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1835, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8a183db3-f2a2-4a7b-b319-c96c85721fc9": {"__data__": {"id_": "8a183db3-f2a2-4a7b-b319-c96c85721fc9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 193, "section": "6.3.4 Inclusion/Exclusion Criteria Not Met (IE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4f21dbc5-e2f9-4d66-9b0f-1e30d61ae0f3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 193, "section": "6.3.4 Inclusion/Exclusion Criteria Not Met (IE)"}, "hash": "819b5aeec44b488e3b99892f9f03d379c73a842775a2e19ba37031cc674eea75", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "acbc312f-e494-4431-aa07-d919370dd880", "node_type": "1", "metadata": {}, "hash": "f2404a3c882d76de8548ed87b03b3937ae40c3528cdcb17c6f5118aacdd2bb04", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "IE \u2013 Description/Overview \nA findings domain that contains those criteria that cause the subject to be in violation of the inclusion/exclusion criteria. \nIE \u2013 Specification \nie.xpt, Inclusion/Exclusion Criteria Not Met \u2014 Findings. One record per inclusion/exclusion criterion not met per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar IE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nIESEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nIESPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Example: Inclusion or exclusion criteria number from \nCRF. \nPerm \nIETESTCD \nInclusion/Exclusion \nCriterion Short Name \nChar * \nTopic \nShort name of the criterion described in IETEST. The value in IETESTCD cannot be longer than 8 \ncharacters, nor can it start with a number (e.g., \"1TEST\" is not valid). IETESTCD cannot contain \ncharacters other than letters, numbers, or underscores. Examples: \"IN01\", \"EX01\". \nReq \nIETEST \nInclusion/Exclusion \nCriterion \nChar  \nSynonym \nQualifier \nVerbatim description of the inclusion or exclusion criterion that was the exception for the subject \nwithin the study. IETEST cannot be longer than 200 characters. \nReq \nIECAT \nInclusion/Exclusion \nCategory \nChar (IECAT) \nGrouping \nQualifier \nUsed to define a category of related records across subjects. \nReq \nIESCAT \nInclusion/Exclusion \nSubcategory \nChar * \nGrouping \nQualifier \nA further categorization of the exception criterion. Can be used to distinguish criteria for a sub-study \nor for to categorize as a major or minor exceptions. Examples: \"MAJOR\", \"MINOR\". \nPerm \nIEORRES \nI/E Criterion Original \nResult \nChar (NY) \nResult \nQualifier \nOriginal response to inclusion/exclusion criterion question, i.e., whether the inclusion or exclusion \ncriterion was met. \nReq \nIESTRESC \nI/E Criterion Result in Std \nFormat \nChar (NY) \nResult \nQualifier \nResponse to inclusion/exclusion criterion result, in standard format. \nReq \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nPerm \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3112, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "acbc312f-e494-4431-aa07-d919370dd880": {"__data__": {"id_": "acbc312f-e494-4431-aa07-d919370dd880", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 193, "section": "6.3.4 Inclusion/Exclusion Criteria Not Met (IE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4f21dbc5-e2f9-4d66-9b0f-1e30d61ae0f3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 193, "section": "6.3.4 Inclusion/Exclusion Criteria Not Met (IE)"}, "hash": "819b5aeec44b488e3b99892f9f03d379c73a842775a2e19ba37031cc674eea75", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8a183db3-f2a2-4a7b-b319-c96c85721fc9", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 193, "section": "6.3.4 Inclusion/Exclusion Criteria Not Met (IE)"}, "hash": "a1490c46803c669c4056cd74537557e988f03fee721e35b1180f7900f6c62873", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Req \nIESTRESC \nI/E Criterion Result in Std \nFormat \nChar (NY) \nResult \nQualifier \nResponse to inclusion/exclusion criterion result, in standard format. \nReq \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nPerm \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the observation date/time of the inclusion/exclusion finding. \nPerm \nIEDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of the inclusion/exclusion criterion represented in ISO 8601 character \nformat. \nPerm \nIEDY \nStudy Day of Collection \nNum  \nTiming \nStudy day of collection of the inclusion/exclusion exceptions, measured as integer days. Algorithm \nfor calculations must be relative to the sponsor-defined RFSTDTC variable in Demographics. This \nformula should be consistent across the submission. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.", "mimetype": "text/plain", "start_char_idx": 2389, "end_char_idx": 3894, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "984aad14-89e1-450e-afc0-e9bde19f09b2": {"__data__": {"id_": "984aad14-89e1-450e-afc0-e9bde19f09b2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 194, "section": "6.3.5 Specimen-based Findings Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a3fa06fd-1be4-43bc-913f-fff5e8cc0bff", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 194, "section": "6.3.5 Specimen-based Findings Domains"}, "hash": "10589c3bd5fa8edd05231016bf426f89dc638cbf05f2d072752e3dfdd045f6e5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Individual domains (e.g., IS, LB, MB) for laboratory measurements, tests, or examinations performed on collected biological specimens (e.g., blood, urine, tumor \ntissue) are grouped together in this section. This grouping is not meant to imply that there is a single laboratory domain for all test methodologies. Additional \nlaboratory domains are expected to be added in future versions.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 388, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "84c98189-1c2c-4dda-be3b-3d9857853ee8": {"__data__": {"id_": "84c98189-1c2c-4dda-be3b-3d9857853ee8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 195, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d29bf1b9-63ef-473b-b7a0-60751ce3ef65", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 195, "section": "UNSPECIFIED"}, "hash": "6f56872866dd3afdada05a94b068023e514976e4a8ac92aca1d85e959f57c88b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b5b2585e-3357-4f63-af6c-e9b93ae7daac", "node_type": "1", "metadata": {}, "hash": "9310441ae8aa7b82b67a66e3c5e1dfddb79be57a6eced153d0a077aa8210ff31", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 195 \n2021-11-29 \n\u2022 \nThe SDTMIG includes several domains for representing clinical pathology laboratory measurements, tests, and examinations supporting safety and/or \nefficacy analyses. Each domain is defined to group measures of a common topic (e.g., microbiology susceptibility, microscopic findings, \npharmacokinetic concentrations). \n\u2022 \nIn the generic lab domain specification table that follows, \"--\" is used as a placeholder. In each individual laboratory findings domain specification, it is \nreplaced by the appropriate domain code. \n\u2022 \nThe variables in the generic domain specification table include required, expected, and permissible variables typically used across specimen-based \nlaboratory findings domains to uniquely describe a measurement, test, or examination of a biological specimen. \no \nIndividual domains include additional variables with specific Controlled Terminology codelists and domain-specific Core values. \no \nThe Findings general observation class includes additional permissible variables that may be added when representing specimen-based laboratory \nfindings. \no \nPermissible identifier and timing variables may be added to represent details (e.g., identifiers to describe related records, planned time points, actual \ntiming). \n--.xpt, Generic Specimen-Based Laboratory Findings \u2014 Findings, Version 1.0. One record per finding per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar -- \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the \nproduct. \nReq \n--SEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid number \n(including decimals) and does not have to start at 1. \nReq \n--GRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nPerm \n--REFID \nReference ID \nChar  \nIdentifier \nOptional internal or external identifier (e.g., lab specimen ID). \nPerm \n--TESTCD \nShort Name of \nMeasurement, Test or \nExam \nChar * \nTopic \nShort character value for --TEST used as a column name when converting a dataset from a vertical format to \na horizontal format. The short value can be up to 8 characters. Subject to domain-specific test code \ncontrolled terminology. \nReq \n--TEST \nName of Measurement, \nTest or Exam \nChar * \nSynonym \nQualifier \nLong name for --TESTCD. Subject to domain-specific test code controlled terminology. \nReq \n--CAT \nCategory \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. \nPerm \n--SCAT \nSubcategory \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of --CAT values. \nPerm \n--ORRES \nResult or Finding in Original \nUnits \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \n--ORRESU \nOriginal Units \nChar * \nVariable \nQualifier \nUnit for --ORRES and --ORREF. Subject to domain-specific test code controlled terminology.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3509, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5b2585e-3357-4f63-af6c-e9b93ae7daac": {"__data__": {"id_": "b5b2585e-3357-4f63-af6c-e9b93ae7daac", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 195, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d29bf1b9-63ef-473b-b7a0-60751ce3ef65", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 195, "section": "UNSPECIFIED"}, "hash": "6f56872866dd3afdada05a94b068023e514976e4a8ac92aca1d85e959f57c88b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "84c98189-1c2c-4dda-be3b-3d9857853ee8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 195, "section": "UNSPECIFIED"}, "hash": "23f315b5fea567eb3b9de95a98d56b8acded0d67c714cdee809e3b7b8a058383", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The short value can be up to 8 characters. Subject to domain-specific test code \ncontrolled terminology. \nReq \n--TEST \nName of Measurement, \nTest or Exam \nChar * \nSynonym \nQualifier \nLong name for --TESTCD. Subject to domain-specific test code controlled terminology. \nReq \n--CAT \nCategory \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. \nPerm \n--SCAT \nSubcategory \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of --CAT values. \nPerm \n--ORRES \nResult or Finding in Original \nUnits \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \n--ORRESU \nOriginal Units \nChar * \nVariable \nQualifier \nUnit for --ORRES and --ORREF. Subject to domain-specific test code controlled terminology. \nPerm \n--LLOD \nLower Limit of Detection \nChar  \nVariable \nQualifier \nThe lowest threshold (as originally received or collected) for reliably detecting the presence or absence of \nsubstance measured by a specific test. The value for the field will be as described in documentation from the \ninstrument or lab vendor. \nPerm \n--STRESC \nResult or Finding in \nStandard Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from --ORRES, in a standard format or in standard \nunits. --STRESC should store all results or findings in character format; if results are numeric, they should \nalso be stored in numeric format in --STRESN. \nExp \n--STRESN \nNumeric Result/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from --\nSTRESC. --STRESN should store all numeric test results or findings. \nPerm \n--STRESU \nStandard Units \nChar * \nVariable \nQualifier \nStandardized units used for --STRESC, --STRESN, --STREFC, and --STREFN. Subject to domain-specific \ntest code controlled terminology. \nPerm", "mimetype": "text/plain", "start_char_idx": 2718, "end_char_idx": 4634, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "860ac099-0927-4e81-b893-51fbb4f13357": {"__data__": {"id_": "860ac099-0927-4e81-b893-51fbb4f13357", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 196, "section": "6.3.5.2 Biospecimen Findings (BS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "65c1b426-4c93-4cd0-a8f2-9a0ba2a297f6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 196, "section": "6.3.5.2 Biospecimen Findings (BS)"}, "hash": "82b36d24118391a4d85fe1a65cc2549d1eb4cea30ccdb423018f4b78ba2071af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BE, BS, and RELSPEC domain specifications, assumptions, and examples were copied and minimally updated from the provisional SDTMIG-PGx, published \n2015-05-26. This was done in preparation for the retirement of the SDTMIG-PGx upon publication of SDTMIG v3.4. These domains are currently under \nextensive revision for inclusion in a future SDTMIG publication, after v3.4. \nBS \u2013 Description/Overview \nA findings domain that contains data related to biospecimen characteristics. \nBS \u2013 Specification \nbs.xpt, Biospecimen Findings \u2014 Findings. One record per measurement per biospecimen identifier per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar BS \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or \nsubmissions involving the product. \nReq \nSPDEVID \nSponsor Device \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier for a device. \nPerm \nBSSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness within a dataset for a subject. May be any valid \nnumber (including decimals) and does not have to start at 1. \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1393, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "34bbbd54-a3c2-48a6-a741-8968bbde7a47": {"__data__": {"id_": "34bbbd54-a3c2-48a6-a741-8968bbde7a47", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 197, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "284a764a-ff44-4c5f-a25b-1ae6d960e950", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 197, "section": "UNSPECIFIED"}, "hash": "73e23f46fd3a0f619c9e77090e6722ed1f1f8cad09619e6cbb388e6e7d0d1919", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9d414dac-d17f-49d8-b42b-1f0e85a4892b", "node_type": "1", "metadata": {}, "hash": "53dc873e162f456bbc6b7728a4592b484af3a6105d3ba93c0b8decdd5de6daf8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 197 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nBSGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a \ndomain. \nPerm \nBSREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier such as lab specimen ID. \nExp \nBSSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. \nPerm \nBSTESTCD \nBiospecimen Test \nShort Name \nChar (BSTESTCD) \nTopic \nShort character value for BSTEST used as a column name when converting a dataset from a \nvertical format to a horizontal format. The short value can be up to 8 characters. Examples: \nVOLUME, RIN. \nReq \nBSTEST \nBiospecimen Test \nName \nChar (BSTEST) \nSynonym \nQualifier \nLong name for BSTESTCD. Examples: Volume, RNA Integrity Number. \nReq \nBSCAT \nCategory for \nBiospecimen Test \nChar  \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Example: MEASUREMENT, QUALITY. \nExp \nBSSCAT \nSubcategory for \nBiospecimen Test \nChar  \nGrouping \nQualifier \nUsed to define a further categorization of BSCAT values. \nPerm \nBSORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nBSORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nUnit for BSORRES. Examples: mg, mL. \nExp \nBSSTRESC \nCharacter \nResult/Finding in Std \nFormat \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from BSORRES in a standard \nformat or standard units. BSSTRESC should store all results or findings in character format; if \nresults are numeric, they should also be stored in numeric format in BSSTRESN. \nExp \nBSSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format \nfrom BSSTRESC. BSSTRESN should store all numeric test results or findings. \nExp \nBSSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for BSSTRESC and BSSTRESN. \nExp \nBSSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a test was not done, or was attempted but did not generate a result. \nShould be null or have a value of NOT DONE. \nPerm \nBSREASND \nReason Test Not \nDone \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with BSSTAT when value is NOT DONE. \nPerm \nBSNAM \nVendor Name \nChar  \nRecord \nQualifier \nName or identifier of the vendor (e.g., laboratory) that provided the test results. \nPerm \nBSSPEC \nSpecimen Type \nChar (SPECTYPE)(GENSMP) \nRecord \nQualifier \nDefines the type of specimen used for a measurement. Examples: SERUM, PLASMA, URINE, \nSOFT TISSUE.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2959, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9d414dac-d17f-49d8-b42b-1f0e85a4892b": {"__data__": {"id_": "9d414dac-d17f-49d8-b42b-1f0e85a4892b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 197, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "284a764a-ff44-4c5f-a25b-1ae6d960e950", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 197, "section": "UNSPECIFIED"}, "hash": "73e23f46fd3a0f619c9e77090e6722ed1f1f8cad09619e6cbb388e6e7d0d1919", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "34bbbd54-a3c2-48a6-a741-8968bbde7a47", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 197, "section": "UNSPECIFIED"}, "hash": "b176e5e576283d532efe77a3b31550ab0d5e8503f4ce7d4ba5b7b06a238c12f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Exp \nBSSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a test was not done, or was attempted but did not generate a result. \nShould be null or have a value of NOT DONE. \nPerm \nBSREASND \nReason Test Not \nDone \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with BSSTAT when value is NOT DONE. \nPerm \nBSNAM \nVendor Name \nChar  \nRecord \nQualifier \nName or identifier of the vendor (e.g., laboratory) that provided the test results. \nPerm \nBSSPEC \nSpecimen Type \nChar (SPECTYPE)(GENSMP) \nRecord \nQualifier \nDefines the type of specimen used for a measurement. Examples: SERUM, PLASMA, URINE, \nSOFT TISSUE. \nPerm \nBSANTREG \nAnatomical Region of \nSpecimen \nChar * \nVariable \nQualifier \nDefines the specific anatomical or biological region of a tissue, organ specimen or the region \nfrom which the specimen is obtained, as defined in the protocol, such as a section or part of \nwhat is described in the BSSPEC variable. Examples: CORTEX, MEDULLA, MUCOSA. \nPerm \nBSSPCCND \nSpecimen Condition \nChar (SPECCOND) \nRecord \nQualifier \nDefines the condition of the specimen. Examples: HEMOLYZED, ICTERIC, LIPEMIC. \nPerm \nBSMETHOD \nMethod of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: SPECTROPHOTOMETRY, \nELECTROPHORESIS. \nPerm \nBSBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nBSDTC \nDate/Time of \nSpecimen Collection \nChar ISO 8601 datetime or \ninterval \nTiming \nDate and time of specimen collection. \nExp", "mimetype": "text/plain", "start_char_idx": 2313, "end_char_idx": 4180, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf1e5b89-e812-40f2-9848-57a5cd28a0d4": {"__data__": {"id_": "bf1e5b89-e812-40f2-9848-57a5cd28a0d4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 198, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5cac06f1-0ae3-4569-874e-baf9050667fa", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 198, "section": "UNSPECIFIED"}, "hash": "085ebf85858e66daaba84e7bcd134d05ba9a0853937d86702992a9d4d6a15a28", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "976d5496-0701-4939-af98-7e4b09bd16b2", "node_type": "1", "metadata": {}, "hash": "8d0efa8895968cf37d4704ca0495e2f157a00411dcd992a95917bd9860c73ab0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 198 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nBSDY \nStudy Day of \nSpecimen Collection \nNum  \nTiming \nStudy day of specimen collection relative to the sponsor-defined RFSTDTC. \nPerm \nBSTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point, such \nas time of last dose. See BSTPTNUM and BSTPTREF. \nPerm \nBSTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of BSTPT used in sorting. \nPerm \nBSELTM \nPlanned Elapsed \nTime from Time Point \nRef \nChar ISO 8601 duration \nTiming \nElapsed time relative to a planned fixed reference (BSTPTREF). This variable is useful where \nthere are repetitive measures. Not a clock time or a date time variable, but an interval, \nrepresented as ISO duration. \nPerm \nBSTPTREF \nTime Point Reference Char  \nTiming \nName of the fixed reference point referred to by BSELTM, BSTPTNUM, and BSTPT. \nExamples: PREVIOUS DOSE, PREVIOUS MEAL. \nPerm \nBSRFTDTC \nDate/Time of \nReference Time Point \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by BSTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nBS \u2013 Assumptions \n1. The BS domain is used to store findings related to specimen handling and specimen characteristics such as type, amount, or size. BS is not restricted to \nPGx-related specimens. \n2. For biospecimens of genetic material, BSSPEC values are drawn from the GENSMP (C111114) codelist. \n3. Non-genetic BSSPEC values are drawn from the SPEC (C77529) codelist, which is part the SEND terminology listing. BSANTREG is used to further \ndefine BSSPEC when it is desirable to identify a specific region within an organ. \n4. To adapt BS for use with the SDTMIG, use the SPECTYPE (C78734) codelist in BSSPEC, add --LOC, --LAT, --DIR, and --PORTOT as applicable, \nand remove BSANTREG. Values that would otherwise have gone in BSANTREG may be placed in a supplemental qualifier that is almost identical to \nthat variable, but which further qualifies BSLOC instead of BSSPEC. \n5. The following variables generally would not be used in BS: --POS, --ORNLO, --ORNHI, --STRNLO, --STNRHI, --STNRC, --NRIND, --LEAD, --\nCSTATE, --ACPTFL, --FAST, --TOX, --TOXGR, --SEV, --DTHREL. \nBS \u2013 Example \nExample 1 \nThis example shows data about RNA integrity. The data collected focus on the quality of the RNA sample being collected. It has been shown that improper \nstorage or isolation methods might compromise the usability of a sample.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2958, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "976d5496-0701-4939-af98-7e4b09bd16b2": {"__data__": {"id_": "976d5496-0701-4939-af98-7e4b09bd16b2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 198, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5cac06f1-0ae3-4569-874e-baf9050667fa", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 198, "section": "UNSPECIFIED"}, "hash": "085ebf85858e66daaba84e7bcd134d05ba9a0853937d86702992a9d4d6a15a28", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bf1e5b89-e812-40f2-9848-57a5cd28a0d4", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 198, "section": "UNSPECIFIED"}, "hash": "7bcbdd3a6e5b94d1a713deb7f919a186e7901e1f9082c1d3548633d7b9c7f917", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Values that would otherwise have gone in BSANTREG may be placed in a supplemental qualifier that is almost identical to \nthat variable, but which further qualifies BSLOC instead of BSSPEC. \n5. The following variables generally would not be used in BS: --POS, --ORNLO, --ORNHI, --STRNLO, --STNRHI, --STNRC, --NRIND, --LEAD, --\nCSTATE, --ACPTFL, --FAST, --TOX, --TOXGR, --SEV, --DTHREL. \nBS \u2013 Example \nExample 1 \nThis example shows data about RNA integrity. The data collected focus on the quality of the RNA sample being collected. It has been shown that improper \nstorage or isolation methods might compromise the usability of a sample. \nRows 1-2: \nThe A260/A280 and A260/A230 rations are used to determine the purity of the RNA sample. Any ratios outside of the accepted values may \nindicated contamination with protein or reagents used during the extraction process. \nRow 3: \nThe amounts of both 28S and 18S ribosomal RNA are measured and then a ratio is calculated. Because values in --TESTCD cannot begin with a \nnumber, the test code has been prefixed with an \"I\" for integrity. \nRow 4: \nThe RNA integrity number is a quality measurement calculated using a special algorithm and used to determine the usability of the RNA sample.", "mimetype": "text/plain", "start_char_idx": 2322, "end_char_idx": 3556, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1dd041fb-bad0-4262-91d3-5b6e19b81acd": {"__data__": {"id_": "1dd041fb-bad0-4262-91d3-5b6e19b81acd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 199, "section": "6.3.5.3 Cell Phenotype Findings (CP)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "31293a19-82d0-407e-9178-224274d45777", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 199, "section": "6.3.5.3 Cell Phenotype Findings (CP)"}, "hash": "3a66349ffa34a5184a8c908032c298a246d4686f90d56054d25534e53f3703c0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CP \u2013 Description/Overview \nA findings domain that contains data related to the characterization of cell phenotype, lineage, and function based on expression of specific markers in single cell or particle suspensions. \nThe CP domain is modeled for use with disseminated tissue specimens (e.g., blood and other body fluids, bone marrow aspirates) and cell suspensions, and is not currently modeled for evaluations of solid tissue \nspecimens. The domain is intended to support tests associated with a cell phenotyping component based on the use of markers and is not intended for tests that are not associated with marker-based phenotyping, \nwhich are more appropriate to include in another domain (e.g., Immunogenicity Specimen Assessments (IS), Laboratory Test Results (LB), Microscopic Findings (MI)). The CP domain is not intended to supplant \nuse of the LB domain for routine lab hematology (e.g., blood cell differentials), nor is it intended for findings originating from microscopic assessment of cells, including those employing immunohistochemical \n(IHC) techniques. \nThe modeled use cases include measurement of \n\u2022 \ncell populations identified, classified, and/or otherwise characterized based on the differential expression of phenotypic and/or cell state/function markers, as determined for both normal and abnormal cell \npopulations; \n\u2022 \nthe level of marker expression; \n\u2022 \nsubstances interacting with (e.g., binding to) a marker which is a target of interest (not limited to a pharmacologic target); and \n\u2022 \nother cell properties based on characterization of expression marker(s) and/or substances that interact with the marker(s). \nTo provide the flexibility needed to report cell marker expression data, which can range widely in complexity, several new SDTM variables have been created. Most of the new variables are permissible, and are \navailable as needed to fully define a test and/or to prevent ambiguity that could lead to misunderstanding or difficulty in interpreting the data. New variables include --SBMRKS (Sublineage Marker String), --\nCELSTA (Cell State), --CSMRKS (Cell State Marker String), --TSTCND (Test Condition), --CNDAGT (Test Condition Agent), --BNDAGT (Binding Agent), --ABCLID (Antibody Clone Identifier), --MRKSTR \n(Marker String), --GATE (Gate Name), --GATEDEF (Gate Definition), --SPTSTD (Sponsor Test Description), --TSTPNL (Test Panel), --RESSCL (Result Scale), and --RESTYP (Result Type). Definitions and \nappropriate use of these variables are provided in the Specification and Assumptions sections of this guidance and are illustrated in the examples for selected use cases. \nData submitters should work closely with laboratory data providers, analysts, and data receivers/users to determine the appropriate set of permissible variables to include in a dataset (i.e., the variables needed to fully \ndocument tests and associated findings for a particular use case).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2912, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79bf663c-f150-4670-9ea5-c65108d71feb": {"__data__": {"id_": "79bf663c-f150-4670-9ea5-c65108d71feb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 200, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1c189957-56b9-4c3b-9555-71ac1653ea86", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 200, "section": "UNSPECIFIED"}, "hash": "687f6510c6f561be94fbc5091fb739763a2c515220a6b35f548e6e6271cb4348", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b14e7d51-e1e2-4ece-9952-e2d931a89ade", "node_type": "1", "metadata": {}, "hash": "865e429890556b2648ba60e5002e39a7c25e80951909fcda264cb4e3175eb1a1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 200 \n2021-11-29 \nSponsors that previously chose to submit cell phenotyping data in the LB domain, where LBTEST was often used to populate cell marker information (e.g., \n\"CD4\" to indicate helper T lymphocytes), should note that the new variable --MRKSTR should be used to house the full marker string information used to define \nthe test in terms of markers; the --TEST variable is reserved for the name of the cell population. Several of the new variables (i.e., --SBMRKS, --CELSTA, --\nCSMRKS) are used to further subdivide the population reported in --TEST into more granular unnamed subpopulations based on 1 or more additional markers. \nThis approach provides a more easily understood test name in the --TEST variable and enables development of controlled terminology for --TEST and --\nTESTCD. The goal is to standardize, where possible, cell phenotype test names across studies so that it will be easier for users to understand and interpret the \ndata (e.g., when different marker sets are used across labs to define the same cell population). This approach also enhances the ability to integrate and compare \ndata across studies in a practicable manner that (in addition to being less error-prone) preserves the often subtle differences between tests, which are essential for \ndetermining whether tests are truly comparable. \nUsed in accordance with this guidance, the complete marker sting information provided in the --MRKSTR variable reflects the operational (i.e., laboratory-\nspecific) definition of the test measurement. Together with the gating information provided in the --GATE and --GATEDEF variables, --MRKSTR values help to \nensure that proper groupings and comparisons are made across tests by preserving nuanced details that may affect the interpretation of test results. To facilitate \nthese objectives and to enable accurate cross-study comparisons and data-mining efforts, it is recommended that --MRKSTR values conform as closely as \npossible to marker string formatting principles presented in the CP Assumptions section.  \nCP \u2013 Specificationcp.xpt, Cell Phenotype Findings \u2014 Findings. One record per test per specimen per timepoint per visit per subject, \nTabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar CP \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier Char  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nCPSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of subject records within a domain. May be any valid number. \nReq \nCPGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nCPREFID \nReference ID \nChar  \nIdentifier \nInternal or external specimen identifier. \nPerm \nCPSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Example: Line number on the lab page. \nPerm \nCPLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3547, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b14e7d51-e1e2-4ece-9952-e2d931a89ade": {"__data__": {"id_": "b14e7d51-e1e2-4ece-9952-e2d931a89ade", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 200, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1c189957-56b9-4c3b-9555-71ac1653ea86", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 200, "section": "UNSPECIFIED"}, "hash": "687f6510c6f561be94fbc5091fb739763a2c515220a6b35f548e6e6271cb4348", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "79bf663c-f150-4670-9ea5-c65108d71feb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 200, "section": "UNSPECIFIED"}, "hash": "2f2ce94cea2435fe3a84338b26affc6b13e0d20e9c97a8908b2e7674f4332438", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Req \nCPSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of subject records within a domain. May be any valid number. \nReq \nCPGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nCPREFID \nReference ID \nChar  \nIdentifier \nInternal or external specimen identifier. \nPerm \nCPSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. Example: Line number on the lab page. \nPerm \nCPLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nCPLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nCPTESTCD \nTest or Examination \nShort Name \nChar (CPTESTCD) \nTopic \nShort name of the measurement, test, or examination described in CPTEST. It can be used as a \ncolumn name when converting a dataset from a vertical to a horizontal format. The value in CPTESTCD \ncannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). \nCPTESTCD cannot contain characters other than letters, numbers, or underscores. Examples: \n\"MONO\", \"MNS\". \nReq \nCPTEST \nName of Measurement, \nTest or Examination \nChar (CPTEST) \nSynonym \nQualifier \nLong name for CPTESTCD. For cell phenotyping, the name (often abbreviated) of the cell population, \nas it is generally accepted by the scientific community, is populated (rather than a colloquial designation \nbased on a primary marker, e.g., TLym Help rather than CD4). When the test is for a sublineage which \ncan only be identified by specifying additional markers (i.e., has not been given a name) or which is \nfurther restricted to a subpopulation based on a particular cell state (e.g., activated, proliferating, \napoptotic), the Sublineage Marker String (CPSBMRKS), Cell State (CPCELSTA), and Cell State Marker \nString (CPCSMRKS) variables are additionally populated and the value in CPTEST is suffixed with \n\"Sub\" to denote that it is a subset of the population identified in CPTEST (e.g., Monocytes Sub). \nThe value in CPTEST cannot be longer than 40 characters. \nReq", "mimetype": "text/plain", "start_char_idx": 2840, "end_char_idx": 5201, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c6a7f455-7e96-4562-8819-f16d387a044d": {"__data__": {"id_": "c6a7f455-7e96-4562-8819-f16d387a044d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 201, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "34204317-873a-40ce-8b59-7a28761ad12e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 201, "section": "UNSPECIFIED"}, "hash": "89196cafc677dda13dd77655a91dd4214cc977d84695c83f4b0e6954f3b9c6af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ccc0ab10-ec56-43d4-b8b6-15ebc74007b5", "node_type": "1", "metadata": {}, "hash": "8d298ff65d3ff409831be443bb48846d4158169c73759d86ac5b84030dd2da4b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 201 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nCPSBMRKS \nSublineage Marker \nString \nChar  \nVariable \nQualifier \nUsed to further subset the cell population identified in CPTEST based on the use of additional marker(s) \nthat define a sublineage. The value in CPSBMRKS is used in combination with values in CPTEST and \nCPCELSTA to fully describe the cell population being measured. As such, it is an essential component \nof the full test name. \nFor example, three unnamed sublineages of monocytes have been identified as: CCR2+CD16-, CCR2-\nCD16+, and CCR2+CD16+. Whereas the entire monocyte cell population can be defined as CD14+ \ncells, the additional CCR2 and CD16 markers are used to differentiate one sublineage from another. As \nnone of these sublineages have been given names, they are only known by the CCR2 and CD16 \nmarker combinations. By associating the CPTEST value of \"Monocytes Sub\" with, for example, a value \nof \"CCR2+CD16-\" in CPSBMRKS, the full test is defined to be the CCR2+CD16- monocyte \nsubpopulation. \nPerm \nCPCELSTA \nCell State \nChar (CELSTATE) \nVariable \nQualifier \nA textual description of a subset of the cell population identified in CPTEST based on a particular \nfunctional and/or biological state (e.g., \"ACTIVATED\", \"PROLIFERATING\", \"SENESCENT\"). When \npopulated, the values in CPCELSTA and CPSMRKS, in combination with the values in CPTEST and \nCPSBMRKS, fully describe the cell population being measured. \nPerm \nCPCSMRKS Cell State Marker String \nChar  \nVariable \nQualifier \nIdentifies the marker(s) or indicator(s) used to define the cell state (i.e., the value in CPCELSTA). \nFor example, when Ki67 expression is used to determine that a cell population is in a proliferating state \n(i.e., CPCELSTA value=\"PROLIFERATING\"), the value \"Ki67+\" in CPCSMRKS indicates that positive \nexpression of Ki67 was used to define the population as proliferating. Similarly, a value of \"Ki67-\" in \nCPCSMRKS would indicate that lack of expression of Ki67 defined the \"NON-PROLIFERATING\" cell \nstate in CPCELSTA. The CPCSMRKS value is useful for quickly determining which marker(s) were \nused to classify (i.e., operationally define) a cell population based on a functional/biological state. \nPerm \nCPTSTCND \nTest Condition \nChar (TESTCOND) \nVariable \nQualifier \nIdentifies any planned condition imposed by the assay system on the specimen at the time the test is \nperformed. --TSTCND is generally used to distinguish between two or more records where the same \nassay is performed under varying (as opposed to fixed) conditions, usually for the purpose of making a \ncomparison. For example, when the same assay (identified in --TEST) is performed under stimulated \nand non-stimulated conditions, the --TSTCND variable is used distinguish between the records.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3027, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ccc0ab10-ec56-43d4-b8b6-15ebc74007b5": {"__data__": {"id_": "ccc0ab10-ec56-43d4-b8b6-15ebc74007b5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 201, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "34204317-873a-40ce-8b59-7a28761ad12e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 201, "section": "UNSPECIFIED"}, "hash": "89196cafc677dda13dd77655a91dd4214cc977d84695c83f4b0e6954f3b9c6af", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c6a7f455-7e96-4562-8819-f16d387a044d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 201, "section": "UNSPECIFIED"}, "hash": "ceb78e9c020a65f133eafaf4fa104b64a171e77c6cf99828fefe37ae294b3540", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The CPCSMRKS value is useful for quickly determining which marker(s) were \nused to classify (i.e., operationally define) a cell population based on a functional/biological state. \nPerm \nCPTSTCND \nTest Condition \nChar (TESTCOND) \nVariable \nQualifier \nIdentifies any planned condition imposed by the assay system on the specimen at the time the test is \nperformed. --TSTCND is generally used to distinguish between two or more records where the same \nassay is performed under varying (as opposed to fixed) conditions, usually for the purpose of making a \ncomparison. For example, when the same assay (identified in --TEST) is performed under stimulated \nand non-stimulated conditions, the --TSTCND variable is used distinguish between the records. \nPerm \nCPCNDAGT \nTest Condition Agent \nChar  \nRecord \nQualifier \nThe textual description of the agent, if applicable, used to impose the condition identified in \nCPTSTCND. For example, records might be produced for the same assay run under stimulating \n(CPTSTCND value = \"STIMULATED\") conditions produced by different stimulating agents (e.g., phorbol \nmyristate acetate, concanavalin A, PHA-P, TNF-alpha, Ionomycin, candida antigen). \nPerm \nCPBDAGNT \nBinding Agent \nChar  \nRecord \nQualifier \nThe textual description of the agent that is binding to the entity in the CPTEST variable. The \nCPBDAGNT variable is used to indicate that there is a binding relationship between the entities in the \nCPTEST and CPBDAGNT variables, regardless of direction. \nThe binding agent may be, but is not limited to, a test article; a portion of a test article; a substance \nrelated to a test article; an endogenous molecule; an allergen; an infectious agent; or a reagent (e.g., \nprimary antibody) that confers the binding specificity for the measurement defined in CPTEST when it is \nneeded to uniquely identify the test. \nPerm \nCPABCLID \nAntibody Clone Identifier Char  \nRecord \nQualifier \nIdentifies the antibody clone (e.g., supplier-provided catalog name) used to confer specificity for the \nbinding agent specified in CPBDAGNT. \nPerm \nCPMRKSTR \nMarker String \nChar  \nRecord \nQualifier \nThe text string identifying the full set of markers/indicators used by the laboratory to operationally define \nthe complete test based on the combination of CPTEST, CPSBMRKS, and CPCELSTA. Because \nlaboratories often use different markers/indicators to identify a cell population, the relationship between \na named cell population in CPTEST (as combined with CPSBMRKS and CPCELSTA values) and the \nset of markers used to identify that population is many-to-one. To ensure nuances important for \naccurately interpreting the data are accounted for and which arise from the use of different sets of \nmarkers, it is necessary to operationally define the test in terms of the complete set of \nmarkers/indicators used to perform that test. \nExp \nCPGATE \nGate \nChar  \nRecord \nQualifier \nThe sponsor-defined name assigned to a gate. Gates are electronic (i.e., a device setting or software-\ndefined) boundaries set by a user to virtually parse a specimen into discrete populations based on a set \nPerm", "mimetype": "text/plain", "start_char_idx": 2282, "end_char_idx": 5396, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b9d15f14-a72b-4700-9a4f-2652f60724f3": {"__data__": {"id_": "b9d15f14-a72b-4700-9a4f-2652f60724f3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 202, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e8739237-8fac-421e-96ce-4803352e6dac", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 202, "section": "UNSPECIFIED"}, "hash": "4d70ebde13b87db53f4597143237d03ddd9ef5c30d80af53b7efe2d0d96aa877", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eea88fd6-e41f-41e0-b010-ab0685a16214", "node_type": "1", "metadata": {}, "hash": "122242fbd7e4034bf82ea80aa611c1150a2e77de1d80846e6846228dc6f6b2e5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 202 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nof defined characteristics (e.g., presence, absence, or intensity of expression of various markers; \nphysical size; internal complexity or granularity). Gates are used to constrain data collection or analysis \nto a specific cell population or region of interest within the specimen. \nCPGATDEF \nGate Definition \nChar  \nRecord \nQualifier \nThe text string identifying the set of parameters and the order in which they are applied to define the \ngating strategy. In practice, a series of 2-dimensional sub-gates based on different cell characteristics \n(i.e., markers/indicators/physical properties) are most often combined until the cell population of interest \nis sufficiently resolved (i.e., electronically isolated) from other cell populations contained within the \nspecimen. \nFor complex analyses, differences in gating strategies can produce subtle differences in results \nobtained for a test. To ensure nuances important for accurately interpreting the data are accounted for \nand which arise from the use of different gating strategies, it is often necessary to qualify the test in \nterms of the gating strategy. For some purposes, however, and at the discretion of the sponsor, only the \nultimate or penultimate gate is identified. When specifying the gating strategy in CPGATDEF, each sub-\ngate should be listed in the order it was applied and separated from the next sub-gate using the \npipe/vertical line (\"|\") character. \nPerm \nCPSPTSTD \nSponsor Test \nDescription \nChar  \nRecord \nQualifier \nSponsor's description of a test. The variable is intended to contain highly structured test description \nmetadata used by a sponsor to unambiguously define (label) a test. Such values generally reside in a \nsponsor/laboratory test metadata repository. CPSPTSTD is not intended for unstructured (spontaneous) \nfree text. \nAn example of appropriate usage is when it is necessary to include identifying information for a target \ncell population on which a test is conducted when the target population is not part of the test name, e.g., \ntests for quantitative expression of a particular marker on a specific cell population. \nPerm \nCPCAT \nCategory \nChar (CPCAT) \nGrouping \nQualifier \nUsed to define a category of topic-variable values across subjects. Examples: \n\"IMMUNOPHENOTYPING\", \"CELL FUNCTION\", \"TARGET ENGAGEMENT\". \nPerm \nCPSCAT \nSubcategory \nChar  \nGrouping \nQualifier \nA further categorization of CPCAT. \nPerm \nCPTSTPNL \nTest Panel \nChar  \nGrouping \nQualifier \nSponsor-defined textual description used to group tests run together as part of a test panel. Can be \nused with --GRPID to ensure that relationships between associated tests are accurately identified. \nPerm \nCPORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nCPORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for CPORRES. Examples: \"10^6/L\", \"%\", \n\"MESF\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3291, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eea88fd6-e41f-41e0-b010-ab0685a16214": {"__data__": {"id_": "eea88fd6-e41f-41e0-b010-ab0685a16214", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 202, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e8739237-8fac-421e-96ce-4803352e6dac", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 202, "section": "UNSPECIFIED"}, "hash": "4d70ebde13b87db53f4597143237d03ddd9ef5c30d80af53b7efe2d0d96aa877", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b9d15f14-a72b-4700-9a4f-2652f60724f3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 202, "section": "UNSPECIFIED"}, "hash": "05d939533637a96ff4872fa0bce82668bdc259ac892ab227b408dc5a9db57a01", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \n\"IMMUNOPHENOTYPING\", \"CELL FUNCTION\", \"TARGET ENGAGEMENT\". \nPerm \nCPSCAT \nSubcategory \nChar  \nGrouping \nQualifier \nA further categorization of CPCAT. \nPerm \nCPTSTPNL \nTest Panel \nChar  \nGrouping \nQualifier \nSponsor-defined textual description used to group tests run together as part of a test panel. Can be \nused with --GRPID to ensure that relationships between associated tests are accurately identified. \nPerm \nCPORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nCPORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for CPORRES. Examples: \"10^6/L\", \"%\", \n\"MESF\". \nPerm \nCPRESSCL \nResult Scale \nChar (RSLSCLRS) \nRecord \nQualifier \nClassifies the scale of the original result value with respect to whether the result is quantitative, ordinal, \nnominal, or narrative. \nPerm \nCPRESTYP \nResult Type \nChar (RESTYPRS) \nRecord \nQualifier \nClassifies the kind of result (i.e., property type) originally reported for the test. Examples: \"NUMBER \nCONCENTRATION\", \"NUMBER FRACTION\", \"RATIO\". \nPerm \nCPCOLSRT \nCollected Summary \nResult Type \nChar (COLSTYP) \nRecord \nQualifier \nUsed to indicate the type of collected summary result. This includes source summary results collected \non a CRF or provided by an external vendor (e.g., central lab). If the summary result is derived using \nindividual source data records, this summary result should be represented in ADaM. If a sponsor has \nboth a collected summary result and a derived summary result, the collected summary result should be \nrepresented in SDTM and the derived summary result should be represented in ADaM. \nPerm \nCPORNRLO Reference Range Lower \nLimit in Orig Unit \nChar  \nVariable \nQualifier \nLower end of reference range for continuous measurement in original units. Should be populated only \nfor continuous results. \nPerm \nCPORNRHI \nReference Range Upper \nLimit in Orig Unit \nChar  \nVariable \nQualifier \nUpper end of reference range for continuous measurement in original units. Should be populated only \nfor continuous results. \nPerm \nCPSTRESC \nResult or Finding in \nStandard Format \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from CPORRES in a standard format or in \nstandard units. CPSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in CPSTRESN. \nExp \nCPSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nCPSTRESC. CPSTRESN should store all numeric test results or findings. \nPerm", "mimetype": "text/plain", "start_char_idx": 2549, "end_char_idx": 5322, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0506cb3f-8d69-4359-9d66-e86d9cd6d5fa": {"__data__": {"id_": "0506cb3f-8d69-4359-9d66-e86d9cd6d5fa", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 203, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a0463727-fb3f-4c02-a387-c30181bb402b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 203, "section": "UNSPECIFIED"}, "hash": "1747ace29dd0feaa77fad7f3a077f08ca817c3716634bd4c501edeafbdaeeea7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "79c922a5-e561-472a-a0dc-e16552e12519", "node_type": "1", "metadata": {}, "hash": "8b81b8185a1f159c07afd75414617bc3207d92eedb20eefc64e8c18351511d35", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 203 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nCPSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for CPSTRESC or CPSTRESN. \nPerm \nCPSTNRLO \nReference Range Lower \nLimit-Std Units \nNum  \nVariable \nQualifier \nLower end of reference range for continuous measurements for CPSTRESC/CPSTRESN in \nstandardized units. Should be populated only for continuous results. \nPerm \nCPSTNRHI \nReference Range Upper \nLimit-Std Units \nNum  \nVariable \nQualifier \nUpper end of reference range for continuous measurements in standardized units. Should be populated \nonly for continuous results. \nPerm \nCPNRIND \nReference Range \nIndicator \nChar (NRIND) \nVariable \nQualifier \nIndicates where the value falls with respect to reference range defined by CPORNRLO and \nCPORNRHI, CPSTNRLO and CPSTNRHI, or by CPSTNRC. Examples: \"NORMAL\", \"ABNORMAL\", \n\"HIGH\", \"LOW\". Sponsors should specify in the study metadata (Comments column in the Define-XML \ndocument) whether CPNRIND refers to the original or standard reference ranges and results. \nCPNRIND should not be used to indicate clinical significance. \nPerm \nCPSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that the test was not performed or that it was attempted but did not generate a result. \nShould be null if a result exists in CPORRES. \nPerm \nCPREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a test was not performed, e.g., \"BROKEN EQUIPMENT\", \"SUBJECT REFUSED\", \n\"SPECIMEN LOST\". Used in conjunction with CPSTAT when value is \"NOT DONE\". \nPerm \nCPNAM \nVendor Name \nChar  \nRecord \nQualifier \nThe name or identifier of the laboratory that performed the test. \nPerm \nCPLOINC \nLOINC Code \nChar LOINC \nSynonym \nQualifier \nCode for the test from the LOINC code system. The sponsor is expected to provide the dictionary name \nand version used to map the terms utilizing the Define-XML external codelist attributes. \nPerm \nCPSPEC \nSpecimen Type \nChar (SPECTYPE) \nRecord \nQualifier \nDefines the type of specimen used for a measurement. Examples: \"BLOOD\", \"BONE MARROW\". \nPerm \nCPSPCCND \nSpecimen Condition \nChar (SPECCOND) \nRecord \nQualifier \nThe physical state or quality of a specimen for an assessment. Example: \"CLOTTED\". \nPerm \nCPMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Example: \"FLOW CYTOMETRY\". \nPerm \nCPANMETH \nAnalysis Method \nChar  \nRecord \nQualifier \nAnalysis method applied to obtain a summarized result. Analysis method describes the method of \nsecondary processing applied to a complex observation result. \nPerm \nCPLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally-derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3051, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79c922a5-e561-472a-a0dc-e16552e12519": {"__data__": {"id_": "79c922a5-e561-472a-a0dc-e16552e12519", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 203, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a0463727-fb3f-4c02-a387-c30181bb402b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 203, "section": "UNSPECIFIED"}, "hash": "1747ace29dd0feaa77fad7f3a077f08ca817c3716634bd4c501edeafbdaeeea7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0506cb3f-8d69-4359-9d66-e86d9cd6d5fa", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 203, "section": "UNSPECIFIED"}, "hash": "49a76834f32509483a9510f1596a5661ca191830b44411525e0b8c5d18a31a35", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"BLOOD\", \"BONE MARROW\". \nPerm \nCPSPCCND \nSpecimen Condition \nChar (SPECCOND) \nRecord \nQualifier \nThe physical state or quality of a specimen for an assessment. Example: \"CLOTTED\". \nPerm \nCPMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Example: \"FLOW CYTOMETRY\". \nPerm \nCPANMETH \nAnalysis Method \nChar  \nRecord \nQualifier \nAnalysis method applied to obtain a summarized result. Analysis method describes the method of \nsecondary processing applied to a complex observation result. \nPerm \nCPLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally-derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nPerm \nCPBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. The value should be \"Y\" or null. \nPerm \nCPDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Records that represent the average \nof other records, or do not come from the CRF, or are not as originally received or collected are \nexamples of records that might be derived for the submission datasets. If CPDRVFL = \"Y\", then \nCPORRES may be null, with CPSTRESC and (if numeric) CPSTRESN having the derived value. \nPerm \nCPCLSIG \nClinically Significant, \nCollected \nChar (NY) \nRecord \nQualifier \nUsed to indicate whether a collected observation is clinically significant based on judgement. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nPerm \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the observation, or the date/time of collection if start \ndate/time is not collected. \nPerm \nCPDTC \nDate/Time of Collection \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nDate/time of specimen collection represented in ISO 8601 character format. \nExp", "mimetype": "text/plain", "start_char_idx": 2284, "end_char_idx": 4695, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1513af57-27a1-4f99-a2c2-a7689189ed86": {"__data__": {"id_": "1513af57-27a1-4f99-a2c2-a7689189ed86", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 204, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dbb9e7c4-c1eb-4046-907e-ce6f1edf0055", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 204, "section": "UNSPECIFIED"}, "hash": "a8cbd6967f37f3c291a1d04ecc130d1022f53ef9cadb6babcd6f054edade747e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 204 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nCPDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nStudy day of specimen collection, measured in integer days. Algorithm for calculations must be relative \nto the sponsor-defined RFSTDTC value in Demographics. \nPerm \nCPTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a specimen is to be taken, as defined in the protocol. This may be \nrepresented as an elapsed time relative to a fixed reference point (i.e., to the value in CPTPTREF). \nExample: \"1 hour post\". \nPerm \nCPTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of CPTPT to aid in sorting. When CPTPT is represented as an elapsed time relative \nto a fixed reference point (i.e., to the value in CPTPTREF), the values in CPTPTNUM should be \nassigned in ascending order relative to the value in CPTPTREF. For example, records for time points \nwhere CPTPT = \"5 minutes post\", 1 hour post\", and \"4 hours post\" could be represented in CPTPTNUM \nas \"1\", \"2\", and \"3\", which maintains the order between CPTPT and CPTPTNUM with respect to the \nfixed time point reference in CPTPTREF. \nPerm \nCPELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration Timing \nPlanned elapsed time relative to the planned fixed reference value in CPTPTREF, represented in ISO \n8601 duration format. Examples: \"-PT15M\" to represent 15 minutes prior to the reference time point \nindicated by CPTPTREF, \"T8H\" to represent 8 hours after the reference time point represented by \nCPTPTREF. \nPerm \nCPTPTREF \nTime Point Reference \nChar  \nTiming \nDescriptive name of the fixed reference point referred to by CPTPT, CPTPTNUM, and CPELTM. \nExamples: \"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nCPRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by CPTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2297, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "94bd3fe8-abed-4389-a2f3-af084f8c9ea5": {"__data__": {"id_": "94bd3fe8-abed-4389-a2f3-af084f8c9ea5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 205, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b4acfd2-7037-4b98-a3a4-16ba85722dc5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 205, "section": "UNSPECIFIED"}, "hash": "2503a4f8618c99d0feaef253d1e39b3aaec65dafd387ecdd5d55691a457d2cc8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "09e2ee9f-9b50-4979-a2dd-81a7451facf2", "node_type": "1", "metadata": {}, "hash": "a854c083f6264f9d374b65e0bb9affc8d4a1044e9ddb0683eea9ed12c8d6139f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 205 \n2021-11-29 \nCP \u2013 Assumptions \n1. The Cell Phenotype domain captures cell phenotyping and related data based on cell expression markers \nand other indicators (e.g., stains/dyes) in disseminated tissue specimens and cell suspensions. \n2. The CP domain is only used for tests which include a phenotyping component that relies on using cell \nmarkers to identify a specific population of cells (e.g., quantitative cell phenotyping), or on which the test is \nconducted (e.g., quantitative single marker expression, target/receptor occupancy). For example, a test \nwhich measures gamma-interferon expression in helper T lymphocytes defined as the \nCD45+CD3+CD4+CD8- population is an appropriate test for including in CP, whereas a test which \nmeasures gamma interferon secretion in an undefined \"PBMC\" (peripheral blood mononuclear cell) \npopulation is not appropriate. \n3. A value which is calculated and reported by a lab according to its procedures is considered collected rather \nthan derived; the Derived Flag (CPDRVFL) should be null for these results. \n4. CPCELSTA is used in conjunction with CPSCMRKS. When CPCELSTA is populated, CPSCMRKS must \nalso be populated. Conversely, when CPSCMRKS is populated, CPCELSTA must be populated. \n5. The combination of values in CPTEST, CPSBMRKS, CPCELSTA, and CPCSMRKS are used to uniquely \nidentify a test. When 1 or more of the variables CPSBMRKS, CPCELSTA, or CPCSMRKS are populated, \nthe Test Name (CPTEST) must be populated with the test name variant containing the \"Sub\" suffix to \nindicate that the finding/result pertains to a subpopulation of the cell type named in CPTEST.  \n6. Populating the CPTEST and CPMRKSTR variables: The general structure of CPTEST depends on the use \ncase (e.g., immunophenotyping, quantitative marker expression, target/receptor occupancy), which is \ngenerally conveyed by the CPCAT and/or CPSCAT value(s). Currently, CP supports the following use \ncases for which guidance on CPTEST and CPMRKSTR values are given:  \na. \nImmunophenotyping \ni. CPTEST is populated with the name of the cell type being measured, not with the set of markers \nused to define the cell type. \nii. It is expected that CPMRKSTR is populated, and that it contains the entire set of markers used to \ndefine the test, including those that are also present in CPSBMRKS and/or CPCSMRKS. \niii. Marker strings follow, as closely as possible, formatting recommendations presented in \nassumption 8. \nb. Quantitative single-marker expression \ni. CPTEST begins with the identity of the marker (e.g., CD99), followed by the word \"Expression\" \n(e.g., \"CD99 Expression\"). \nii. It is expected that CPMRKSTR is populated, and that it starts by identifying the marker being \nquantified (e.g. \"CD99\"). This is followed by a delimiter (described below) and then the entire \nmarker string used to define the cell population on which the marker is measured, including the \nmarker being quantified, since it also defines the cell population. \niii.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3158, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "09e2ee9f-9b50-4979-a2dd-81a7451facf2": {"__data__": {"id_": "09e2ee9f-9b50-4979-a2dd-81a7451facf2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 205, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b4acfd2-7037-4b98-a3a4-16ba85722dc5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 205, "section": "UNSPECIFIED"}, "hash": "2503a4f8618c99d0feaef253d1e39b3aaec65dafd387ecdd5d55691a457d2cc8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "94bd3fe8-abed-4389-a2f3-af084f8c9ea5", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 205, "section": "UNSPECIFIED"}, "hash": "07b64d9315c5f5bb713db17b5566446019d6a4191bb14d27bb6cdfb2155b1e66", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It is expected that CPMRKSTR is populated, and that it contains the entire set of markers used to \ndefine the test, including those that are also present in CPSBMRKS and/or CPCSMRKS. \niii. Marker strings follow, as closely as possible, formatting recommendations presented in \nassumption 8. \nb. Quantitative single-marker expression \ni. CPTEST begins with the identity of the marker (e.g., CD99), followed by the word \"Expression\" \n(e.g., \"CD99 Expression\"). \nii. It is expected that CPMRKSTR is populated, and that it starts by identifying the marker being \nquantified (e.g. \"CD99\"). This is followed by a delimiter (described below) and then the entire \nmarker string used to define the cell population on which the marker is measured, including the \nmarker being quantified, since it also defines the cell population. \niii. The general form of the delimiter used to separate the marker being quantified from the cell \npopulation on which it is measured is \"<space>xxxx<space>\", where \"xxxx\" represents a \ncharacter string used as delimiting text. It is recommended that the delimiting text is the \nabbreviation for the unit of measure used to report the level of expression of the quantified marker \n(e.g., \"MESF\", \"MdFI\"). An example which follows this guidance is: CPTEST = \"CD99 \nExpression\" and CPMRKSTR = \"CD99 MESF CD45+CD3-CD19+CD99+\", where \"MESF\" is \nthe text delimiter and is followed by the entire marker string defining the cell population on which \nCD99 was measured, which includes the CD99 marker itself. \niv. Marker strings follow, as closely as possible, formatting recommendations presented in \nassumption 8. \nc. \nOther use cases (e.g., target/receptor occupancy), refer to the examples section and to published \nControlled Terminology supporting CP. In the case of target/receptor occupancy a more generalized \ntest value is populated into CPTEST (e.g., \"Total Bound\") and the identity of the target/receptor is", "mimetype": "text/plain", "start_char_idx": 2332, "end_char_idx": 4265, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af920663-3044-4bbb-be92-8e01fe9fc462": {"__data__": {"id_": "af920663-3044-4bbb-be92-8e01fe9fc462", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 206, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85547109-727e-44e5-93d9-7e1caeab8f52", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 206, "section": "UNSPECIFIED"}, "hash": "d68adf44f4978c3dbdabcdfad09b9ec828ab1eca4d9f8916d421c69ead4090b5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "befb18be-ce0c-4528-ba06-fc93610141b1", "node_type": "1", "metadata": {}, "hash": "230c5a65fc54c80375deeb5b0a71f03fe1e97a433709672ad866daec8e09533a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 206 \n2021-11-29 \nincluded in another variable, such as CPBNDAGT and/or CPTSTPNL (refer to examples). CDISC will \ncontinue to develop examples for other use cases as they are identified and modeled. \n7. Specifying viability: \na. \nBecause the majority of cell phenotyping tests of interest are for viable cells, the word \"Viable\" is not \ngenerally included in the test name (CPTEST) and usually does not need to be explicitly stated in \nCPCELSTA. Because populating CPCELSTA and CSMRKS with viability information necessitates \nappending the \"Sub\" suffix to the value in CPTEST (assumption 5), it is recommended that \nCPCELSTA and CPCSMRKS generally not be used unless a selective viability stain was included in \nthe test in order to differentiate the record for viable cells from record(s) for cells in a different vital \nstate. For example, when viable cells are being compared to apoptotic and/or non-viable cells, it is \nnecessary to differentiate those records using CPCELSTA and CPCSMRKS. In such cases where \nCPCELSTA and CPCSMRKS are populated, the \"Sub\" suffix is appended to the value in CPTEST \n(assumption 5). \nb. Viability marker(s) used to define a test are included in the full marker string in CPMRKSTR \nregardless of whether the viability status is stated explicitly in CPCELSTA. Moreover, if viability is \nexplicitly stated in CPGATE, marker(s) used to designate viability are included in CPGATDEF. For \nexample, if the value in CPGATE is \"Lymphocytes, Viable\" and 7AAD- was used to define the viable \nstate, 7AAD- is included in CPGATDEF, in addition to being included in the complete marker string \nin CPMRKSTR. \n8. Recommended formatting of marker string variables CPMRKSTR, CPSBMRKS, and CPCSMRKS: The \nmarker string variables provide critical information for defining a test. Although there are no current plans \nto control their values through CDISC Controlled Terminology codelists, adherence to the following \nformatting guidelines helps to preclude ambiguities that can lead to uncertainty in uniquely understanding a \ntest and its associated result.    \na. \nMarker strings do not contain delimiting characters (e.g., \",\", space, \"/\", \"|\") to separate individual \nmarkers within the string, nor do they contain punctuation (e.g., hyphens) within individual markers, as \nthese can be confused with symbols used to designate levels of expression and/or make it difficult to \ndistinguish between the individual markers that comprise the string. For example, although the \nscientific literature often uses \"HLA-DR\", this is represented in CP marker strings as \"HLADR\".  \nb. Forward slash \"/\" is only used to separate the portion of the marker string defining a numerator from \nthe portion defining a denominator. \nc. \nWhen referring to a marker using the cluster of differentiation (CD) designation, \"CD\" should be \nincluded as part of the marker reference. For example, a marker string for helper T lymphocytes \ncomprising CD45, CD3, CD4, and CD8 markers would be \"CD45+CD3+CD4+CD8-\" (rather than \n\"45+3+4+8-\").", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3212, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "befb18be-ce0c-4528-ba06-fc93610141b1": {"__data__": {"id_": "befb18be-ce0c-4528-ba06-fc93610141b1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 206, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85547109-727e-44e5-93d9-7e1caeab8f52", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 206, "section": "UNSPECIFIED"}, "hash": "d68adf44f4978c3dbdabcdfad09b9ec828ab1eca4d9f8916d421c69ead4090b5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "af920663-3044-4bbb-be92-8e01fe9fc462", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 206, "section": "UNSPECIFIED"}, "hash": "81ce9493172f82024b2ef52d470d769991e2170d47bb6a03014b1d9cc202f19d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For example, although the \nscientific literature often uses \"HLA-DR\", this is represented in CP marker strings as \"HLADR\".  \nb. Forward slash \"/\" is only used to separate the portion of the marker string defining a numerator from \nthe portion defining a denominator. \nc. \nWhen referring to a marker using the cluster of differentiation (CD) designation, \"CD\" should be \nincluded as part of the marker reference. For example, a marker string for helper T lymphocytes \ncomprising CD45, CD3, CD4, and CD8 markers would be \"CD45+CD3+CD4+CD8-\" (rather than \n\"45+3+4+8-\"). \nd. The order of markers within a string is consistent across similar tests, generally proceeding in the order \nthat defines the cell hierarchy from highest to lowest, followed by additional non-lineage-defining \nmarkers, and ending with cell state and viability markers. This order maintains alignment with how a \ntest is identified using the ordered combination of CPTEST, CPSMRKS, and CPCELSTA. For \nexample, a test for proliferating viable activated central memory helper T-lymphocytes would be \noperationally defined in CPMRKSTR as similar to \"CD45+CD3+CD19-CD4+CD8-CD197+CD45RA-\nCD278+Ki67+7AAD-\", where the order of markers in the string is \"CD45\" (leukocyte), \"CD3+CD19- \n(T lymphocyte), \"CD4+CD8-\" (helper), \"CD197+CD45RA-\" (central memory), \"CD278+ (activated), \nKi67+ (proliferating), 7AAD- (viable). Corresponding to this marker-based definition of the test, and \nusing the appropriate Controlled Terminology terms, CPTEST is \"TLym Help Cen Mem Sub\", \nCPCELSTA is \"ACTIVATED; PROLIFERATING\", and CPCSMRKS is \"CD278+Ki67+\". If the \nsponsor also chose to include the viability status as a cell state in addition to the activation and \nproliferative states, CPCELSTA would be similar to \"ACTIVATED; PROLIFERATING; VIABLE\" \nand the corresponding CPCSMRKS value would be \"CD278+Ki67+7AAD-\". In this example, the \nnamed cell population in CPTEST has not been further divided into an unnamed sublineage based on \nadditional sublineage markers; therefore, CPSBMRKS is null.", "mimetype": "text/plain", "start_char_idx": 2646, "end_char_idx": 4690, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fee1393d-0186-4ba5-9ca6-3376cc6a51e8": {"__data__": {"id_": "fee1393d-0186-4ba5-9ca6-3376cc6a51e8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 207, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6326afcc-6ede-41f9-a5d8-182d84531875", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 207, "section": "UNSPECIFIED"}, "hash": "042cc02ebf4900a95a8f56261c3a0b3c4a963fd048e17e5d03c3fe03f552df54", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "09195cb6-8e00-49b3-9511-128723cf91a5", "node_type": "1", "metadata": {}, "hash": "71506bc1e638e21356a7eb80d81fe0f95aedaeaae43931c7741e3f8a793928c8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 207 \n2021-11-29 \ne. \nForward (FSC) and Side (SSC) light scatter: These parameters are generally used to perform initial \ngating to exclude debris non-singlets and are often reapplied to differentiate cell subpopulations in the \n\"inclusion\" gate. However, FSC and SSC are often not included in marker string definitions as it is \ngenerally taken for granted that they were used. In contrast, they are usually included in a descriptions \nof a gating strategy, and would generally be included in CPGATDEF when the full gating strategy is \nshown. Labs/sponsors may choose whether to include FSC and SSC parameters in CPMRKSTR. It is \nrecommended to include them when they are needed to differentiate one test from another. For \nexample, because there is no universal expression marker specific for lymphocytes, FSC and SSC are \nused to define the lymphocyte subpopulation within a CD45+ leukocyte population. A test of \n\"Lymphocytes/Leukocytes\" defined only in terms of CD45 expression would not make sense as it \nwould be \"CD45+/CD45+\". In this case, it makes sense to define lymphocytes as \"CD45+SSClo\" so \nthat the value in CPMRKSTR is \"CD45+SSClo/CD45+\".    \nf. \nIndicating the expression level of individual markers included in a marker string: A variety of formats \nare used in the scientific literature for indicating the level of expression of a marker on or within a cell. \nFor example, after identifying a marker such as CD4, its level of expression might be represented as 1 \nof the following:  \ni. neg, min, or - to denote the absence or minimal expression (e.g., CD4neg, CD4min, CD4-) \nii. pos or + to denote that the marker is expressed (e.g., CD4pos, CD4+) \niii. high, hi, or ++ to denote that the marker is expressed at a very high level relative to simply being \n\"positive\" (e.g., CD4high, CD4hi, CD4++) \niv. other formats (e.g., -/low, -/lo, low, lo, mid, -/+, +++) \ng. Because categories for expression levels are subjective in the sense that they are relative to one \nanother, various formats often overlap, which can create ambiguities. Some degree of consistency in \nformats used to represent relative expression levels is warranted to mitigate ambiguity, at least to the \nextent that relative expression levels used to define cell lineages/sublineages are similar across studies \nand laboratories in order to enable comparisons. Five designations are recommended for use in SDTM \ndatasets: \ni. \"-\" (the marker is not expressed; at times, the use of \"-lo\" may be justified to indicate that the \nmarker is either not expressed or is present in a negligible amount) \nii. \"lo\" (the marker is expressed at a low level) \niii. \"mid\" (the marker is expressed somewhere between a low and \"normal\" positive level for that cell \ntype) \niv. \"+\" (the marker is expressed at a normal positive level for that cell type) \nv.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3006, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "09195cb6-8e00-49b3-9511-128723cf91a5": {"__data__": {"id_": "09195cb6-8e00-49b3-9511-128723cf91a5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 207, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6326afcc-6ede-41f9-a5d8-182d84531875", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 207, "section": "UNSPECIFIED"}, "hash": "042cc02ebf4900a95a8f56261c3a0b3c4a963fd048e17e5d03c3fe03f552df54", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fee1393d-0186-4ba5-9ca6-3376cc6a51e8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 207, "section": "UNSPECIFIED"}, "hash": "7d1991b1b3b9073df1114526e8ce847d4cc2391b9d16e555a1268507c76ec578", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Some degree of consistency in \nformats used to represent relative expression levels is warranted to mitigate ambiguity, at least to the \nextent that relative expression levels used to define cell lineages/sublineages are similar across studies \nand laboratories in order to enable comparisons. Five designations are recommended for use in SDTM \ndatasets: \ni. \"-\" (the marker is not expressed; at times, the use of \"-lo\" may be justified to indicate that the \nmarker is either not expressed or is present in a negligible amount) \nii. \"lo\" (the marker is expressed at a low level) \niii. \"mid\" (the marker is expressed somewhere between a low and \"normal\" positive level for that cell \ntype) \niv. \"+\" (the marker is expressed at a normal positive level for that cell type) \nv. \"hi\" (the marker is expressed at a distinctly higher level than in cells that are \"+\", such that they \nare distinguishable from the \"+\" population and define their own subpopulation) \nvi. Although these designations are expected to be useful in the majority of cases, it is recognized \nthat designations not listed here may be more appropriate in some cases. The data provider must \ndetermine the best way to designate an expression level suited to the purpose of the test, while \nstriving to mitigate ambiguities resulting from lack of consistency of use. \nh. Explicitly indicating the cellular sublocation for a marker: In most cases, the location of a marker on or \nwithin a cell is not necessary; however, there are situations in which a marker can be expressed in \nmore than a single cellular compartment and there is a need for the test to distinguish between marker \nexpression in one compartment versus another. To accommodate this, using a lowercase letter in front \nof the marker is recommended. The cell sublocations are usually related to the cell surface (plasma \nmembrane), cytoplasm, and nucleus. Use m, c, or n in front of the marker to denote \"membrane\", \n\"cytoplasm\", and \"nucleus\", respectively. An example of a marker often associated with a need to \nindicate cell location is CD152 (CTLA4), where cytoplasmic expression may define a test to \ndistinguish it from whole cell expression. In this case, \"cCD152\" is used to denote that it is the \ncytoplasmic expression of CD152 that is measured for the test.", "mimetype": "text/plain", "start_char_idx": 2233, "end_char_idx": 4532, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fd523efc-07b6-4f1c-8ccf-75fa01c673dc": {"__data__": {"id_": "fd523efc-07b6-4f1c-8ccf-75fa01c673dc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 208, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "14c36e9f-1905-4b0a-a759-fcc756229fbd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 208, "section": "UNSPECIFIED"}, "hash": "c6e458051568a2813adf77841dc561d1a4fd3296813f9b899e53faa9d5572f77", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9fbe7372-daeb-4d8d-bd5d-22d33019d238", "node_type": "1", "metadata": {}, "hash": "ead4a26a92b587699f70132bb6a1a066794b14f718254d6a4596d1b0a74f4ed3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 208 \n2021-11-29 \n9. CPNRIND can be added to indicate where a result falls with respect to a reference range defined by \nCPORNRLO and CPORNRHI (e.g., \"HIGH\", \"LOW\"). \n10. The variable CPORRESU uses the UNIT codelist. This means that sponsors should be submitting a term \nfrom the CDISC Submission Value column in the published Controlled Terminology maintained for \nCDISC by NCI EVS. When sponsors have units that are not in this column, they should first check to see if \ntheir unit is mathematically synonymous with an existing unit and submit their lab values using that unit. If \nthis is not the case, then a request for a new term (see https://ncitermform.nci.nih.gov/) should be \nsubmitted. \nCP \u2013 Examples \nThe CP domain includes use of several new qualifier variables. The primary intent of the following examples is to \ndemonstrate the appropriate use of these new variables based on a selection of use cases for which they would \nordinarily be included in a well-structured CP dataset. Secondarily, the examples illustrate standardized formatting \nconcepts for variables that are not associated with a formal Controlled Terminology codelist. Although not \ncontrolled, the standardized formatting of content for these variables significantly aids understanding of the test and \nassociated data, making data review and comparisons much easier. To make the examples as easy to understand as \npossible, many of the other SDTM variables that would normally be included in the dataset and which are already \nfamiliar to the reader have not been included. \nThe following new SDTM variables are included in the examples: CPSBMRKS (Sublineage Marker String), \nCPCELSTA (Cell State), CPCSMRKS (Cell State Marker String), CPTSTCND (Test Condition), CPCNDAGT \n(Test Condition Agent), CPBDAGNT (Binding Agent), CPABCLID (Antibody Clone Identifier), CPMRKSTR \n(Marker String), CPGATE (Gate), CPGATDEF (Gate Definition), CPSPTSTD (Sponsor Test Description), \nCPTSTPNL (Test Panel), CPRESSCL (Result Scale), CPRESTYP (Result Type), and CPCOLSRT (Collected \nSummary Result Type). The proper use of each of these variables is illustrated in 1 or more of the examples, based \non the identified use case. \nExample 1 \nExample 1a illustrates use of the CPMRKSTR variable for an assay panel that enumerates several of the major \nnamed cell subpopulations of leukocytes. For most cases involving simple phenotyping, and when used in \naccordance with CP domain guidance, the CPMRKSTR variable is sufficient for providing the marker information \nneeded to fully describe a test. As such, CPMRKSTR is the only new CP test qualifier variable having a Core \ndesignation of \"Expected\". In such a case, the sponsor may determine whether to include other permissible CP test \nqualifier variables, based on the needs of the data recipient. This example presents records that might typically be \nreported for a panel of tests quantifying T-cell, B-cell, monocyte, and natural killer (NK) cell populations, and for \nsubtyping T-cells.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3186, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9fbe7372-daeb-4d8d-bd5d-22d33019d238": {"__data__": {"id_": "9fbe7372-daeb-4d8d-bd5d-22d33019d238", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 208, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "14c36e9f-1905-4b0a-a759-fcc756229fbd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 208, "section": "UNSPECIFIED"}, "hash": "c6e458051568a2813adf77841dc561d1a4fd3296813f9b899e53faa9d5572f77", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fd523efc-07b6-4f1c-8ccf-75fa01c673dc", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 208, "section": "UNSPECIFIED"}, "hash": "05002c1a0b66d0e7419abf31b9763191905fba230b178e95a7ea6f4208758158", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example 1 \nExample 1a illustrates use of the CPMRKSTR variable for an assay panel that enumerates several of the major \nnamed cell subpopulations of leukocytes. For most cases involving simple phenotyping, and when used in \naccordance with CP domain guidance, the CPMRKSTR variable is sufficient for providing the marker information \nneeded to fully describe a test. As such, CPMRKSTR is the only new CP test qualifier variable having a Core \ndesignation of \"Expected\". In such a case, the sponsor may determine whether to include other permissible CP test \nqualifier variables, based on the needs of the data recipient. This example presents records that might typically be \nreported for a panel of tests quantifying T-cell, B-cell, monocyte, and natural killer (NK) cell populations, and for \nsubtyping T-cells. In this example, the sponsor determined that none of the permissible CP test qualifier variables \nwere needed to accurately comprehend or distinguish among tests in the dataset, so chose to include only the \nCPMRKSTR (complete markers string) information. \nExample 1b, in addition to including the expected CPMRKSTR variable, introduces 2 additional variables: \nCPGATE and CPGATDEF. These variables convey gating information used in data collection and/or analyses, and \nare often needed to fully understand a test. Typically, either the full gating strategy or the penultimate gate is \nidentified. Because different gating strategies for the same test can yield somewhat different test results, the \nCPGATE and CPGATDEF variables provide the means for transmitting this information at the test (i.e., record) \nlevel. \nExample 1a \nRows 1-3: \nThe total leukocyte population is determined using positive expression of the CD45 marker as the \noperational definition of the test (CD45+ in the CPMRKSTR variable). The total leukocyte count is \nreported because it contains the value used as the denominator in several subsequent tests for \nleukocyte subpopulations. Row 2 contains the total lymphocyte count which, in addition to CD45, \nused Forward (FSC) and Side (SSC) Light Scatter properties to define the lymphocyte subpopulation \nof leukocytes. By convention, FSC and SSC are often not included as part of the marker string \ndefinition of a cell subpopulation since it is well-recognized that these physical properties are used as \nthe first gate in nearly all cell phenotyping applications. However, in the absence of a pan-lymphocyte \nmarker to distinguish them from other leukocytes, FSC and SSC are included in rows 2 and 3 to \nindicate that these parameters are used in addition to CD45, to differentiate lymphocytes from other", "mimetype": "text/plain", "start_char_idx": 2373, "end_char_idx": 5020, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2c465a4b-32aa-4a7e-af31-16869e33329d": {"__data__": {"id_": "2c465a4b-32aa-4a7e-af31-16869e33329d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 209, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bf990af5-6233-407a-8bd1-e22ec627665b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 209, "section": "UNSPECIFIED"}, "hash": "776643b769ce35f6554c099a4c83f429358b177a3c566bfd3db8336e350242bf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "13968090-73e3-4933-8a15-156433863dbb", "node_type": "1", "metadata": {}, "hash": "663192a393d820b7acee81817b1682b324f59f7d5284d019b03cb61dfdc2d91a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 209 \n2021-11-29 \nCD45+ leukocytes. Once they have been included in the marker string (CPMRKSTR) definition of \nlymphocytes, they can generally be dropped for any further subsetting of the lymphocytes population. \nRow 3 shows the proportion of lymphocytes as a percentage of total leukocytes. Note that the value in \nCPMRKSTR used a forward slash (\"/\") to separate the numerator marker string from the denominator \nmarker string. \nRows 4-5: \nThe B-lymphocyte lineage of lymphocytes is determined using a set of lineage-specific markers in \naddition to the CD45 leukocyte marker, to define the subpopulation both in terms of positive (i.e., \nCD19+) and negative (i.e., CD3-, CD14-, and CD56-) marker expression. Following a common \nconvention and CP domain guidance for ordering markers in CPMRKSTR, the marker(s) used to \ndefine the highest level of the lineage hierarchy are placed first (i.e., CD45+ defining the leukocyte \npopulation), followed by marker(s) that define each subsequently lower level of the hierarchy. The \nexample also follows a convention whereby the set of positive and negative markers used to identify \nthe major lineages of leukocytes are ordered by T-cell, B-cell, monocyte, and NK cell. In row 4, B \nlymphocytes are defined as leukocytes (CD45+), non-T-cell (CD3-), B-cell (CD19+), non-monocyte \n(CD14-), and non-NK cell (CD56-), resulting in a CPMRKSTR value of \"CD45+CD3-CD19+CD14-\nCD56-\". Row 5 shows that CPMRKSTR contains the full set of markers used to define both the \nnumerator and the denominator, separated by a forward slash \"/\". \nRows 6-7: \nThe T-lymphocyte lineage of lymphocytes is determined using a set of lineage-specific markers in \naddition to the CD45 leukocyte marker, to define the subpopulation both in terms of positive (i.e., \nCD3+) and negative (i.e., CD19-, CD14-, and CD56-) marker expression. The order of markers in \nCPMRKSTR follows the same convention described for B-lymphocytes in rows 4 and 5. \nRows 8-11: The T-lymphocyte lineage is divided further into T helper and T cytotoxic sublineages. In these \nexamples the laboratory does not use the negative lineage markers for B-cells, monocytes, and NK \ncells, but used the positive T-cell (CD3) marker to identify the T-lymphocyte population, and \nadditional markers to define subpopulations as either the T helper (CD4+CD8-) or T cytotoxic (CD4-\nCD8+) subpopulation. In rows 9 and 11, results are reported as a percentage of the total T-lymphocyte \npopulation. Using CPMRKSTR, the numerator is the marker string used to define the T helper \nsubpopulation (as shown in row 8) or the T cytotoxic subpopulation (as shown in row 10), and the \ndenominator consists of the marker string used to define the total T-lymphocyte population (as shown \nin row 6). A forward slash \"/\" is used to separate the numerator and denominator.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3011, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "13968090-73e3-4933-8a15-156433863dbb": {"__data__": {"id_": "13968090-73e3-4933-8a15-156433863dbb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 209, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bf990af5-6233-407a-8bd1-e22ec627665b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 209, "section": "UNSPECIFIED"}, "hash": "776643b769ce35f6554c099a4c83f429358b177a3c566bfd3db8336e350242bf", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2c465a4b-32aa-4a7e-af31-16869e33329d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 209, "section": "UNSPECIFIED"}, "hash": "f909412bbb37ff72674e2eea6ccba1b0f6f92839bbdd514e31c7662ac59cd5bb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In these \nexamples the laboratory does not use the negative lineage markers for B-cells, monocytes, and NK \ncells, but used the positive T-cell (CD3) marker to identify the T-lymphocyte population, and \nadditional markers to define subpopulations as either the T helper (CD4+CD8-) or T cytotoxic (CD4-\nCD8+) subpopulation. In rows 9 and 11, results are reported as a percentage of the total T-lymphocyte \npopulation. Using CPMRKSTR, the numerator is the marker string used to define the T helper \nsubpopulation (as shown in row 8) or the T cytotoxic subpopulation (as shown in row 10), and the \ndenominator consists of the marker string used to define the total T-lymphocyte population (as shown \nin row 6). A forward slash \"/\" is used to separate the numerator and denominator. \nRows 12-13: The monocyte lineage of leukocytes is determined using a set of lineage-specific markers in addition \nto the CD45 leukocyte marker, to define the subpopulation both in terms of positive (i.e., CD14+) and \nnegative (i.e., CD3-, CD19-, and CD56-) marker expression. The order of markers in CPMRKSTR \nfollows the same convention described for B-lymphocytes in rows 4 and 5. In addition, the sponsor \nchose to include the FSC and SSC properties as markers because they are used, in part, to differentiate \nthe monocyte and lymphocyte populations. Note that when FSC and SSC are used in a marker string, \nthey usually go last, whereas they often come first when showing a gating strategy. \nRows 14-15: The NK cell lineage of leukocytes is determined using a set of lineage-specific markers in addition to \nthe CD45 leukocyte marker, to define the subpopulation both in terms of positive (i.e., CD56+) and \nnegative (i.e., CD3-, CD19-, and CD14-) marker expression. The order of markers in CPMRKSTR \nfollows the same convention described for B-lymphocytes in rows 4 and 5. In addition, the sponsor \nchose to include the FSC and SSC properties as markers because they are used, in part, to differentiate \nthe natural killer cell and lymphocyte populations. Note that when FSC and SSC are used in a marker \nstring, they usually go last, whereas they often come first when showing a gating strategy. \nRow 16: \nThe ratio of T helper to T cytotoxic lymphocytes is calculated from the T helper (CD4+) cell count in \nrow 8 and the T cytotoxic (CD8+) cell count in row 10 and a unit of measure is not included because \nit is not reported by the lab for this type of test.", "mimetype": "text/plain", "start_char_idx": 2233, "end_char_idx": 4682, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "090d0783-b85e-4dce-9363-ac85dbc1fc7c": {"__data__": {"id_": "090d0783-b85e-4dce-9363-ac85dbc1fc7c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "25.8 QUANTITATIVE NUMBER FRACTION"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ead3175a-de46-47c5-9b0a-98b7426e92b4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "25.8 QUANTITATIVE NUMBER FRACTION"}, "hash": "ca04d31e35c2c5de7288c65ac04520c54e4b0876bb22e8cc361852f51df56bf4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n4 \nABCD \nCP \nABCD-\n001-001 \n4 \nBLYCE \nB-Lymphocytes \nCD45+CD3-CD19+CD14-CD56- \nIMMUNOPHENOTYPING 104 \n10^6/L \n104 \n10^6/L \n104 \nQUANTITATIVE NUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n5 \nABCD \nCP \nABCD-\n001-001 \n5 \nBLYCELY \nB-\nLymphocytes/Lymphocytes \nCD45+CD3-CD19+CD14-CD56-\n/CD45+FSC SSC \nIMMUNOPHENOTYPING 6.1 \n%", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 382, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cacb447d-e9b5-4cc1-96b4-67959be152b7": {"__data__": {"id_": "cacb447d-e9b5-4cc1-96b4-67959be152b7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "6.1 QUANTITATIVE NUMBER FRACTION"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3ea7d4a4-4e08-4437-83ff-984656b7ab96", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "6.1 QUANTITATIVE NUMBER FRACTION"}, "hash": "77f04ca5d34050777e99981993f91258816494c1bc0581ade350d86d6ab7c275", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n6 \nABCD \nCP \nABCD-\n001-001 \n6 \nTLYCE \nT-Lymphocytes \nCD45+CD3+CD19-CD14-CD56- \nIMMUNOPHENOTYPING 1108 \n10^6/L \n1108 \n10^6/L \n1108 \nQUANTITATIVE NUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n7 \nABCD \nCP \nABCD-\n001-001 \n7 \nTLYLY \nTLym/Lym \nCD45+CD3+CD19-CD14-CD56-\n/CD45+FSC SSC \nIMMUNOPHENOTYPING 64.8 \n%", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 366, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "14cb28e6-672b-4f8c-b9a6-9fa4d58ff27b": {"__data__": {"id_": "14cb28e6-672b-4f8c-b9a6-9fa4d58ff27b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "64.8 QUANTITATIVE NUMBER FRACTION"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f2b00d9d-9d43-4e7c-b5dc-2936e1593e83", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "64.8 QUANTITATIVE NUMBER FRACTION"}, "hash": "361f63cc61eaafd52745400944d0d898b1895237ec12e0e068797da7659624ea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n8 \nABCD \nCP \nABCD-\n001-001 \n8 \nTLYH \nTLym Help \nCD45+CD3+CD4+CD8- \nIMMUNOPHENOTYPING 425 \n10^6/L \n425 \n10^6/L \n425 \nQUANTITATIVE NUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n9 \nABCD \nCP \nABCD-\n001-001 \n9 \nTLYHTLY \nTLym Help/TLym \nCD45+CD3+CD4+CD8-\n/CD45+CD3+CD19-CD14-CD56- \nIMMUNOPHENOTYPING 38.4 \n%", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 364, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f993dcce-43df-4a99-835b-a8209911a77d": {"__data__": {"id_": "f993dcce-43df-4a99-835b-a8209911a77d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "38.4 QUANTITATIVE NUMBER FRACTION"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f8791b4e-8766-4301-b573-4a596d1579a8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "38.4 QUANTITATIVE NUMBER FRACTION"}, "hash": "adcf6cecbf425fda294cb7f5feadb547ef946ca85a5d1e873e55bcbf65dc01af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n10 \nABCD \nCP \nABCD-\n001-001 \n10 \nTLC \nTLym Cytx \nCD45+CD3+CD4-CD8+ \nIMMUNOPHENOTYPING 682 \n10^6/L \n682 \n10^6/L \n682 \nQUANTITATIVE NUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n11 \nABCD \nCP \nABCD-\n001-001 \n11 \nTLYCTLY \nTLym Cytx/TLym \nCD45+CD3+CD4-\nCD8+/CD45+CD3+CD19-CD14-\nCD56- \nIMMUNOPHENOTYPING 61.6 \n%", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 368, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b3c3e748-96a2-46b1-ba99-eca82b0ad438": {"__data__": {"id_": "b3c3e748-96a2-46b1-ba99-eca82b0ad438", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "61.6 QUANTITATIVE NUMBER FRACTION"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4c0aec2f-6acb-4932-a30a-4e742b6d8098", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "61.6 QUANTITATIVE NUMBER FRACTION"}, "hash": "382ac0d79ca68f93bbd424998c19be5dab09c688b603aefe7e0691dc8e32373f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n12 \nABCD \nCP \nABCD-\n001-001 \n12 \nMONO \nMonocytes \nCD45+CD3-CD19-CD14+CD56-\nFSC SSC \nIMMUNOPHENOTYPING 613 \n10^6/L \n613 \n10^6/L \n613 \nQUANTITATIVE NUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n13 \nABCD \nCP \nABCD-\n001-001 \n13 \nMONOLE \nMonocytes/Leukocytes \nCD45+CD3-CD19-CD14+CD56-\nFSC SSC/CD45+ \nIMMUNOPHENOTYPING 9.3 \n%", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 382, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "688bb219-2321-47a5-b918-ea87a6886353": {"__data__": {"id_": "688bb219-2321-47a5-b918-ea87a6886353", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "9.3 QUANTITATIVE NUMBER FRACTION"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "81736daa-03d5-4dcd-880b-6e598a65dc2c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "9.3 QUANTITATIVE NUMBER FRACTION"}, "hash": "5074563c07ff03f77e2acfd799b12a89ed5bf6b2b0fb61f03c15204aebda7692", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n14 \nABCD \nCP \nABCD-\n001-001 \n14 \nNKCE \nNatural Killer Cells \nCD45+CD3-CD19-CD14-\nCD56+FSC SSC \nIMMUNOPHENOTYPING 230 \n10^6/L \n230 \n10^6/L \n230 \nQUANTITATIVE NUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n15 \nABCD \nCP \nABCD-\n001-001 \n15 \nNKLE \nNK Cells/Leuk \nCD45+CD3-CD19-CD14-\nCD56+FSC SSC/CD45+ \nIMMUNOPHENOTYPING 3.5 \n%", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 384, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2e92d666-f28b-47cc-9d8a-a7a0ed582f72": {"__data__": {"id_": "2e92d666-f28b-47cc-9d8a-a7a0ed582f72", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "0.62 0.62"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fd56c657-6f9d-4353-a79a-3f27c16a1b3e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 210, "section": "0.62 0.62"}, "hash": "0d91703cc8f7606ae1fc27a4a61a8039bdf2daf0d7b3b291e6538f76dd1085fa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "QUANTITATIVE RATIO \nBLOOD \nCALCULATION \n2021-08-\n16T04:20 \nExample 1b \nRow 1: \nThe total leukocyte count is reported for a whole blood specimen in which the CD45 marker is used to identify the leukocyte population. FSC and SSC are used to exclude debris and non-singlets from \ndata collection events. Because FSC and SSC are nearly always used in this manner in the first data collection gate, they are usually assumed and are often not reported (i.e., the sponsor could have \nchosen to leave CPGATDEF null). \nRows 2-3: \nThe total lymphocyte subpopulation of leukocytes is reported in row 2 as an absolute cell count, and in row 3 as a percentage of leukocytes. In these cases, FSC and SSC were used as subgates to isolate \nthe lymphocyte lineage within the leukocyte (CD45+) population. Because FSC and SSC (in addition to the CD45 leukocyte marker) are used to define the lymphocyte lineage, they are included in \nCPMRKSTR, where they are used to distinguish between the lymphocyte and other leukocyte lineages. \nRow 4: \nIllustrates an alternative way a sponsor chose to construct the value of CPMRKSTR using the gate name in CPGATE (operationally defined in CPGATDEF) as the denominator. Although the preferred \nmethod for constructing CPMRKSTR is to use markers to define both the numerator and denominator, the method shown in this example for designating the denominator can be useful, particularly \nwhen the denominator string is merely a very long repeat of the majority of markers in the numerator. \ncp.xpt \nRow STUDYID DOMAIN USUBJID \nCPSEQ CPTESTCD CPTEST \nCPMRKSTR \nCPGATE CPGATDEF CPCAT \nCPORRES CPORRESU CPSTRESC CPSTRESU CPSTRESN CPRESSCL \nCPRESTYP \nCPSPEC CPMETHOD \nCPDTC \n1 \nABCD \nCP \nABCD-\n001-001 \n1 \nWBC \nLeukocytes \nCD45+ \n \nFSC SSC \nIMMUNOPHENOTYPING 6630 \n10^6/L \n6630 \n10^6/L \n6630 \nQUANTITATIVE NUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n2 \nABCD \nCP \nABCD-\n001-001 \n2 \nLYM \nLymphocytes \nCD45+FSC \nSSC \nLEUK \nCD45+ \nIMMUNOPHENOTYPING 1710 \n10^6/L \n1710 \n10^6/L \n1710 \nQUANTITATIVE NUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \n3 \nABCD \nCP \nABCD-\n001-001 \n3 \nLYMLE \nLymphocytes/Leukocytes CD45+FSC \nSSC/CD45+ \nLEUK \nCD45+ \nIMMUNOPHENOTYPING 25.8 \n%", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2214, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3ea1a944-d30d-4ee0-bcba-56aaef7c5b4f": {"__data__": {"id_": "3ea1a944-d30d-4ee0-bcba-56aaef7c5b4f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be1835b3-5068-4017-99b4-6e3087ef228c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}, "hash": "d05df0c88db6071e7b588ec405c28a59fe75b529615d1151f6dc6a4669805f6f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b3b33dc6-10d7-4dfd-baed-72018c62235a", "node_type": "1", "metadata": {}, "hash": "00019c4c740f824a14c15e06733a61783ad1d93031f8e081a32bd02329b24f31", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "FRACTION \nBLOOD \nFLOW \nCYTOMETRY \n2021-08-\n16T04:20 \nExample 2 \nThis example shows data from a lymphocyte apoptosis assay and how the new permissible variables CPCELSTA and CPCSMRKS are used to indicate the biological state of the cell population measured in the \ntest (e.g., viable, apoptotic, activated, exhausted, senescent, proliferating). Although in most cases only viable cells are measured in a test, making it unnecessary to specifically indicate their viability status in the \ndataset, there are other situations (e.g., when the ratio of viable to non-viable cells is of particular interest) when each cell state needs to be explicitly indicated in order to differentiate the tests. The principles \nillustrated in the example using CPCELSTA and CPCSMRKS variables also apply to more complex tests where the biological state of the cell population is considered to be integral to the test. \nRows 1-2: \nForward light scatter (FSC) and side scatter (SSC) are almost always applied as the first gating parameters to distinguish singlets and viable cells from doublets and debris. In row 1, a lymphocyte \n(LYM) count is reported which does not explicitly provide viability information. Nevertheless, it is generally assumed that FSC SSC gating is applied to exclude doublets, debris, and dead cells. \nSecondary FSC and SSC gating is then used to distinguish the lymphocyte population from other CD45+ leukocytes. In contrast, row 2 explicitly calls out cell viability based on the use of viability \nmarker 7AAD to exclude cells that are in the process of dying (7AAD+). This is indicated in the Marker String (CPMRKSTR) and Gate Definition (CPGATEDEF) variables. In addition, the term \n\"VIABLE\" is included in the gate name (CPGATE). \nRows 3-4: \nIllustrate using CPCELSTA and CPCSMRKS to provide (1) the cell state descriptor in CPCELSTA, and (2) the markers used to define the cell state in CPCSMRKS. These variables further define \nCPTEST to be a subset of cells named in CPTEST, therefore the suffix \"Sub\" is appended to the value in CPTEST. In this example, the sponsor is interested in contrasting viable cells with those in the \nprocess of dying (non-viable), so each population is reported and the records differentiated using CPCELSTA and CPCSMRKS. \nRows 5-6: \nIllustrate using CPCELSTA and CPCSMRKS for the apoptotic cell state. The sponsor is reporting the apoptotic lymphocyte subpopulation, both as a cell count (row 5) and as a percentage of total \nlymphocytes (row 6). The apoptotic cell state in CPCELSTA is defined as cells that are ANXV+ in CPCSMRKS. As in rows 3 and 4, the suffix \"Sub\" is added to the value in CPTEST to indicate that it \nis a subpopulation of lymphocytes (i.e., apoptotic) being measured. \nRows 7-8: \nIllustrate using CPTEST, CPCELSTA, and CPCSMRKS variables to present findings when the cell population has more than a single cell state of interest (e.g., both viable and apoptotic). In this case, \nviability marker 7AAD is used in combination with apoptosis marker ANXV.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3014, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b3b33dc6-10d7-4dfd-baed-72018c62235a": {"__data__": {"id_": "b3b33dc6-10d7-4dfd-baed-72018c62235a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be1835b3-5068-4017-99b4-6e3087ef228c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}, "hash": "d05df0c88db6071e7b588ec405c28a59fe75b529615d1151f6dc6a4669805f6f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3ea1a944-d30d-4ee0-bcba-56aaef7c5b4f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}, "hash": "9b4d6f1de6e4017585c5c926196eb7c22e61a5938bb9199c07477459cdda254f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "04040956-e2ef-42d0-b2b4-eb0d5af6f47e", "node_type": "1", "metadata": {}, "hash": "e1529e186adb0bb899ef402940c88ef849128dbc2a7f44f4bfac13c6a3a0c492", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The sponsor is reporting the apoptotic lymphocyte subpopulation, both as a cell count (row 5) and as a percentage of total \nlymphocytes (row 6). The apoptotic cell state in CPCELSTA is defined as cells that are ANXV+ in CPCSMRKS. As in rows 3 and 4, the suffix \"Sub\" is added to the value in CPTEST to indicate that it \nis a subpopulation of lymphocytes (i.e., apoptotic) being measured. \nRows 7-8: \nIllustrate using CPTEST, CPCELSTA, and CPCSMRKS variables to present findings when the cell population has more than a single cell state of interest (e.g., both viable and apoptotic). In this case, \nviability marker 7AAD is used in combination with apoptosis marker ANXV. \nRows 9-11: Illustrate a need to pre-coordinate information into the test name when the test incorporates results from two or more records (e.g., a ratio) in which key component(s) of the test are split across multiple \nvariables. In the example, rows 9 and 10 use the CPCELSTA variable to indicate that the measured lymphocyte subpopulation includes only viable cells (row 9) or dying (non-viable cells, row 10). The \nratio of viable to nonviable lymphocytes in row 11 is calculated using data from rows 9 and 10. \n \nBecause the ratio in row 11 is based on counts of both the viable (row 9) and the non-viable (row 10) lymphocyte subpopulations, it is not appropriate to use the CPCELSTA variable. Instead, the \nviability information is pre-coordinated into the value in CPTEST. Additionally, because the cell state (i.e., \"VIABLE\" or \"NON-VIABLE\") is pre-coordinated into the Test Name in row 11, the suffix \n\"Sub\" is no longer needed in CPTEST (i.e., the Test Name is \"Lymphocytes Viable/Lymphocytes NonViable\" rather than \"Lymphocytes Sub Viable/Lymphocytes Sub NonViable\". CPGRPID is used to \ngroup the related records for the ratio (row 11) with those used to calculate it (rows 9 and 10).", "mimetype": "text/plain", "start_char_idx": 2343, "end_char_idx": 4210, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "04040956-e2ef-42d0-b2b4-eb0d5af6f47e": {"__data__": {"id_": "04040956-e2ef-42d0-b2b4-eb0d5af6f47e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be1835b3-5068-4017-99b4-6e3087ef228c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}, "hash": "d05df0c88db6071e7b588ec405c28a59fe75b529615d1151f6dc6a4669805f6f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b3b33dc6-10d7-4dfd-baed-72018c62235a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 211, "section": "25.8 QUANTITATIVE NUMBER"}, "hash": "3c172775927d84d4710f6867c78d76f3226529ef58d31af4e4261e0178661e02", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CPGRPID is used to \ngroup the related records for the ratio (row 11) with those used to calculate it (rows 9 and 10). \ncp.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCPSEQ \nCPGRPID \nCPTESTCD \nCPTEST \nCPCELSTA \nCPCSMRKS \nCPMRKSTR \nCPGATE \nCPGATDEF \nCPCAT \nCPTSTPNL \nCPORRES \nCPORRESU \nCPSTRESC \nCPSTRESU \nCPSTRESN \nCPRESSCL \nCPRESTYP \nCPSPEC \nCPMETHOD \nCPDTC \n1 \nIM001-\n123 \nCP \n0005 \n00542 \n1 \n \nLYM \nLymphocytes \n \n \nCD45+FSC SSC \nLEUK \nCD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n3500 \n10^6/L \n3500 \n10^6/L \n3500 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n2 \nIM001-\n123 \nCP \n0005 \n00542 \n2 \n1 \nLYM \nLymphocytes \n \n \nCD45+7AAD-FSC SSC \nLEUK, \nVIABLE \nCD45+7AAD- \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n3325 \n10^6/L \n3325 \n10^6/L \n3325 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n3 \nIM001-\n123 \nCP \n0005 \n00542 \n3 \n1 \nLYS \nLym Sub \nVIABLE \n7AAD- \nCD45+7AAD- \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n3325 \n10^6/L \n3325 \n10^6/L \n3325 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n4 \nIM001-\n123 \nCP \n0005 \n00542 \n4 \n1 \nLYS \nLym Sub \nNON-\nVIABLE \n7AAD+ \nCD45+7AAD+ \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n175 \n10^6/L \n175 \n10^6/L \n175 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n5 \nIM001-\n123 \nCP \n0005 \n00542 \n5 \n1 \nLYS \nLym Sub \nAPOPTOTIC \nANXV+ \nCD45+ANXV+ \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n700 \n10^6/L \n700 \n10^6/L \n700 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20", "mimetype": "text/plain", "start_char_idx": 4093, "end_char_idx": 5716, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c52e001-c46d-4f65-a29d-23401d889f90": {"__data__": {"id_": "6c52e001-c46d-4f65-a29d-23401d889f90", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca37cb9f-d742-468d-83f7-b1d662174765", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "hash": "7b081e47528a92c7ec9f8ba2895031bf98b5a1e8851ca42daf4636e4de19db0b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45fef1dd-f6df-4a43-a22e-42328b2cea28", "node_type": "1", "metadata": {}, "hash": "9d6ef6dc9c6b420b5dd2f0be381478b37c7eadcf1c0c24f91a8cadbdf2f19b27", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 212 \n2021-11-29 \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCPSEQ \nCPGRPID \nCPTESTCD \nCPTEST \nCPCELSTA \nCPCSMRKS \nCPMRKSTR \nCPGATE \nCPGATDEF \nCPCAT \nCPTSTPNL \nCPORRES \nCPORRESU \nCPSTRESC \nCPSTRESU \nCPSTRESN \nCPRESSCL \nCPRESTYP \nCPSPEC \nCPMETHOD \nCPDTC \n6 \nIM001-\n123 \nCP \n0005 \n00542 \n6 \n1 \nLYSLY \nLym \nSub/Lym \nAPOPTOTIC \nANXV+ \nCD45+ANXV+/CD45+FSC \nSSC \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n21 \n% \n21 \n% \n21 \nQUANTITATIVE \nNUMBER \nFRACTION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T04:20 \n7 \nIM001-\n123 \nCP \n0005 \n00542 \n7 \n1 \nLYS \nLym Sub \nVIABLE; \nAPOPTOTIC \n7AAD-\nANXV+ \nCD45+7AAD-ANXV+ \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n665 \n10^6/L \n665 \n10^6/L \n665 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n8 \nIM001-\n123 \nCP \n0005 \n00542 \n8 \n1 \nLYSLY \nLym \nSub/Lym \nVIABLE;", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1021, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45fef1dd-f6df-4a43-a22e-42328b2cea28": {"__data__": {"id_": "45fef1dd-f6df-4a43-a22e-42328b2cea28", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca37cb9f-d742-468d-83f7-b1d662174765", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "hash": "7b081e47528a92c7ec9f8ba2895031bf98b5a1e8851ca42daf4636e4de19db0b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c52e001-c46d-4f65-a29d-23401d889f90", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "hash": "9f608854fface43b3db09044e326d83ca823ac9411b9a93c130312cb239d429f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9c2a26b2-b97e-4aaa-836c-237c4cac047b", "node_type": "1", "metadata": {}, "hash": "cfce9f321dc47497280e11c6f043a6599fd75f7be2ba3e0f97b4fa712b040059", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "APOPTOTIC \n7AAD-\nANXV+ \nCD45+7AAD-ANXV+ \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n665 \n10^6/L \n665 \n10^6/L \n665 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n8 \nIM001-\n123 \nCP \n0005 \n00542 \n8 \n1 \nLYSLY \nLym \nSub/Lym \nVIABLE; \nAPOPTOTIC \n7AAD-\nANXV+ \nCD45+7AAD-\nANXV+/CD45+FSC SSC \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n20 \n% \n20 \n% \n20 \nQUANTITATIVE \nNUMBER \nFRACTION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n9 \nIM001-\n123 \nCP \n0005 \n00542 \n9 \n2 \nLYS \nLym Sub \nVIABLE \n7AAD- \nCD45+7AAD- \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n3325 \n10^6/L \n3325 \n10^6/L \n3325 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n10 \nIM001-\n123 \nCP \n0005 \n00542 \n10 \n2 \nLYS \nLym Sub \nNON-\nVIABLE \n7AAD+ \nCD45+7AAD+ \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n175 \n10^6/L \n175 \n10^6/L \n175 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \n11 \nIM001-\n123 \nCP \n0005 \n00542 \n11 \n3 \nLYVLYNV \nLym \nViable/Lym \nNonViable \n \n \nCD45+7AAD-\n/CD45+7AAD+ \nLYM \nFSC \nSSC|CD45+ \nIMMUNOPHENOTYPING \nLYM \nAPOPTOSIS \nCOUNT \n19 \nRATIO \n19 \nRATIO \n19 \nQUANTITATIVE \nRATIO \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T12:20 \nExample 3 \nThis example shows data from a monocyte subset assay to highlight the use of new CP domain variables to capture cell sublineage information in CPSBMRKS, CPCELSTA and CPCSMRKS, and to illustrate how \nCPTEST is qualified by the content of those variables. \nCPTEST is used to identify named cell populations (i.e., those cell types assigned names established by the scientific community). However, simply naming a cell type in CPTEST is often not sufficient for \nidentifying or distinguishing among further subpopulations within that named population. In those cases, CPTEST alone does not contain the full complement of information needed to accurately define a test. For \nexample, a test might be specific for a cell population existing in a certain state (e.g., activated, proliferating, apoptotic).", "mimetype": "text/plain", "start_char_idx": 740, "end_char_idx": 2818, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9c2a26b2-b97e-4aaa-836c-237c4cac047b": {"__data__": {"id_": "9c2a26b2-b97e-4aaa-836c-237c4cac047b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca37cb9f-d742-468d-83f7-b1d662174765", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "hash": "7b081e47528a92c7ec9f8ba2895031bf98b5a1e8851ca42daf4636e4de19db0b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45fef1dd-f6df-4a43-a22e-42328b2cea28", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "hash": "377c12380db0cd9397d463b1f479f471bafd543329d382cce152604b2ff2954e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1cd39d53-341c-4d6d-bb04-fab514dbc75b", "node_type": "1", "metadata": {}, "hash": "33a2856d318668bd4471bfe27b6ee1c4b8efc3c59bdb99376102586d58678075", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CPCELSTA and CPCSMRKS, and to illustrate how \nCPTEST is qualified by the content of those variables. \nCPTEST is used to identify named cell populations (i.e., those cell types assigned names established by the scientific community). However, simply naming a cell type in CPTEST is often not sufficient for \nidentifying or distinguishing among further subpopulations within that named population. In those cases, CPTEST alone does not contain the full complement of information needed to accurately define a test. For \nexample, a test might be specific for a cell population existing in a certain state (e.g., activated, proliferating, apoptotic). Moreover, named populations can often be subdivided into sublineages which have not been \nassigned names; these may only be distinguishable by including the 1 or more additional markers used to define the sublineage. To accommodate the need for further subsetting, 3 new variables that qualify CPTEST \nhave been added to the CP domain specification for use when needed. Two of the variables, CPCELSTA and CPCSMRKS, support identifying a cell state. The third variable, CPSBMRKS, supports identifying \nadditional markers needed to subdivide the named population in CPTEST into further sublineages. \nIn order to make it clear that 1 or more of these variables have been used to further subdivide CPTEST, the value of the named cell population in CPTEST is appended with \"Sub\" to denote that the true test is a \nsubset, subpopulation, or sublineage of the parent population identified in CPTEST. \nWhen considering the need to use the CPSBMRKS variable, it is important to note that CPTEST is populated with the hierarchically lowest (most granular) named population, to which \"Sub\" is then appended. This \nensures that CPSBMRKS contains only those additional marker(s) required to further differentiate subset(s) within the named population identified in CPTEST. For example, if 2 additional markers, CDxx and \nCDyy, are used to further classify T lymphocyte helper 2 cells into CDxx+CDyy- and CDxx-CDyy+ sublineages, CPTEST would contain the most granular named population (TLymHelp 2) appended with \"Sub\" in \neach of the 2 records (i.e., \"TLym Help 2 Sub\"), and CPSBMRKS would contain \"CDxx+CDyy-\" in 1 of the records and \"CDxx-CDyy+\" in the other. \nRows 1-3: \nShow use of CPCELSTA and CPCSMRKS to further subset the named cell population in CPTEST. In row 1, the total monocyte population, based on expression of CD14, is measured without any \nfurther subsetting. Rows 2 and 3 show that the monocyte population is further subdivided, based on the cell state, into \"proliferating\" and \"non-proliferating\" subpopulations as indicated by the \nCPCELSTA value. The value \"Monocytes\" in CPTEST for these rows is appended with \"Sub\" to \"Monocytes Sub\" to indicate that the record pertains to a subpopulation of monocytes (i.e., proliferating \nor non-proliferating). CPCELSTA is used to indicate that row 2 contains data for the proliferating subpopulation and row 3 contains data for the non-proliferating subpopulation.", "mimetype": "text/plain", "start_char_idx": 2172, "end_char_idx": 5232, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1cd39d53-341c-4d6d-bb04-fab514dbc75b": {"__data__": {"id_": "1cd39d53-341c-4d6d-bb04-fab514dbc75b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca37cb9f-d742-468d-83f7-b1d662174765", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "hash": "7b081e47528a92c7ec9f8ba2895031bf98b5a1e8851ca42daf4636e4de19db0b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9c2a26b2-b97e-4aaa-836c-237c4cac047b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 212, "section": "UNSPECIFIED"}, "hash": "9848b9b5dedd7c314a62b00b02639a803f2de2b013aa44e046b99742a58a3b4b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rows 1-3: \nShow use of CPCELSTA and CPCSMRKS to further subset the named cell population in CPTEST. In row 1, the total monocyte population, based on expression of CD14, is measured without any \nfurther subsetting. Rows 2 and 3 show that the monocyte population is further subdivided, based on the cell state, into \"proliferating\" and \"non-proliferating\" subpopulations as indicated by the \nCPCELSTA value. The value \"Monocytes\" in CPTEST for these rows is appended with \"Sub\" to \"Monocytes Sub\" to indicate that the record pertains to a subpopulation of monocytes (i.e., proliferating \nor non-proliferating). CPCELSTA is used to indicate that row 2 contains data for the proliferating subpopulation and row 3 contains data for the non-proliferating subpopulation. The CPCSMRKS \nvariable is used to indicate that positive expression of the Ki67 marker (i.e., Ki67+) is used to identify the proliferating subpopulation and cells that do not express the Ki67 marker (i.e., Ki67-) is used to \nidentify the non-proliferating subpopulation. The full set of markers used for the test are included in CPMRKSTR, and the cell gating strategy is identified in CPGATE and CPGATEDEF using the pipe \ncharacter (|) to separate each level of the gate in CPGATEDEF. \nRows 4-5: \nShow the proliferating (from row 2) and non-proliferating (from row 3) monocyte subpopulations expressed as a percentage of total monocytes (from row 1). The numerators in CPTEST for rows 4-5 \nuse the named cell population appended with \"Sub\" (i.e., Monocytes Sub), and CPCELSTA and CPCSMRKS are used to differentiate the proliferating and the non-proliferating subpopulations. The \ngrouping value in CPGRPID indicates the data for monocytes in row 1 is used as the denominator for these tests. \n \nData from rows 1-3 are used to perform the additional measurements shown in the tests defined in rows 4-6; CPGRPID is used to indicate which records belong to the group.", "mimetype": "text/plain", "start_char_idx": 4468, "end_char_idx": 6397, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "07e3284d-2036-41b7-8338-7eb47f917a8f": {"__data__": {"id_": "07e3284d-2036-41b7-8338-7eb47f917a8f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 213, "section": "0.15 QUANTITATIVE"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "58281e9d-3016-4bd6-8543-84b37d6738ef", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 213, "section": "0.15 QUANTITATIVE"}, "hash": "b0e94f6435bf4388cef0bc09982b0ec5c4f27e3ea6569c9041e6cb3d0afa4103", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RATIO \nBLOOD \nCALCULATION \n2020-08-\n16T08:00 \n7 \nABC-123 \nCP \nABCD-\n001-001 \n7 \n2 \nMONO \nMonocytes \n \n \n \nCD14+ \nMONO \nFSC+SSC+|CD14+ \nIMMUNOPHENOTYPING \nMONOCYTE \nCD SUBSETS \n394 \n10^6/L \n394 \n10^6/L \n394 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T08:00 \n8 \nABC-123 \nCP \nABCD-\n001-001 \n8 \n2 \nMNS \nMono Sub \nCDxx+CDyy- \n \n \nCD14+CDxx+CDyy- \nMONO \nFSC+SSC+|CD14+ \nIMMUNOPHENOTYPING \nMONOCYTE \nCD SUBSETS \n366 \n10^6/L \n366 \n10^6/L \n366 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T08:00 \n9 \nABC-123 \nCP \nABCD-\n001-001 \n9 \n2 \nMNS \nMono Sub \nCDxx-CDyy+ \n \n \nCD14+CDxx-CDyy+ \nMONO \nFSC+SSC+|CD14+ \nIMMUNOPHENOTYPING \nMONOCYTE \nCD SUBSETS \n20 \n10^6/L \n20 \n10^6/L \n20 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T08:00 \n10 \nABC-123 \nCP \nABCD-\n001-001 \n10 \n2 \nMNSMN \nMono \nSub/Mono \nCDxx+CDyy- \n \n \nCD14+CDxx+CDyy-\n/CD14+ \nMONO \nFSC+SSC+|CD14+ \nIMMUNOPHENOTYPING \nMONOCYTE \nCD SUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 965, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c8486019-afe5-44dc-8ef5-361c556e92bc": {"__data__": {"id_": "c8486019-afe5-44dc-8ef5-361c556e92bc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 213, "section": "5.00 QUANTITATIVE"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "837aa0bb-62a7-4ef8-a435-de2d6175c693", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 213, "section": "5.00 QUANTITATIVE"}, "hash": "a802a829185916ab21c38cd528b07ef9d1ac987a757cba2abaa032feba24160f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "NUMBER \nFRACTION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T08:00 \n12 \nABC-123 \nCP \nABCD-\n001-001 \n12 \n3 \nMNS \nMono Sub \nCDxx+CDyy- \nAPOPTOTIC \nANXV+ \nCD14+CDxx+CDyy-\nANXV+ \nMONO \nFSC+SSC+|CD14+ \nIMMUNOPHENOTYPING \nMONOCYTE \nCD SUBSETS \n5 \n10^6/L \n5 \n10^6/L \n5 \nQUANTITATIVE \nNUMBER \nCONCENTRATION \nBLOOD \nFLOW \nCYTOMETRY \n2020-08-\n16T08:00 \n    \nExample 4 \nThis example shows data from a CCR5 cytotoxic T helper assay where test condition, stimulating agent, and replicate information is included to illustrate use of CPTSTCND, CPCNDAGT, CPREPNUM, and \nCPCOLSRT.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 557, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "46ff6b04-9796-455c-9378-3364f7887752": {"__data__": {"id_": "46ff6b04-9796-455c-9378-3364f7887752", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "2.9 2.9"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0066c18d-7575-4518-9778-f463c3fbc6f2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "2.9 2.9"}, "hash": "603461e5732eee8ca06e35e9851ec7086a82ffb1f354634c9e6f9acf3df7cf7e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n \n1 \n2021-03-\n20T09:52:00 \n5 \nABC-123 \nCP \nABCD-001-\n002 \n2 \n2 \nTLCSTLC \nTLym Cytx \nSub/TLym Cytx \nACTIVATED \npCCR5+ \nWITH \nSTIMULATING \nAGENT \nMACROPHAGE \nINFLAMMATORY PROTEIN \n1BETA \nCD3+CD8+pCCR5+/CD3+CD8+ \nTLym \nCytx \nFSC \nSSC|CD3+CD8+ \nCELL \nFUNCTION \npCCR5 T-\nLYMPHOCYTES", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 304, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e9ace022-2621-463d-a96b-fd6ca7b091da": {"__data__": {"id_": "e9ace022-2621-463d-a96b-fd6ca7b091da", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "2.6 2.6"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6ae766b-6aa2-4374-8151-b9922797a28e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "2.6 2.6"}, "hash": "3e1713e097c455c58976987453fd383d4f38ce0638865da04edd50cac87a41e2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n \n2 \n2021-03-\n20T09:52:00 \n6 \nABC-123 \nCP \nABCD-001-\n002 \n3 \n2 \nTLCSTLC \nTLym Cytx \nSub/TLym Cytx \nACTIVATED \npCCR5+ \nWITH \nSTIMULATING \nAGENT \nMACROPHAGE \nINFLAMMATORY PROTEIN \n1BETA \nCD3+CD8+pCCR5+/CD3+CD8+ \nTLym \nCytx \nFSC \nSSC|CD3+CD8+ \nCELL \nFUNCTION \npCCR5 T-\nLYMPHOCYTES", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 304, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5e886250-4496-4ec8-af40-a70ebeddb4f2": {"__data__": {"id_": "5e886250-4496-4ec8-af40-a70ebeddb4f2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "3.5 3.5"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c90690b7-074b-4193-80fa-1137ecdf2a65", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 214, "section": "3.5 3.5"}, "hash": "4f39cb62129f830fb00e7fd0531c5044240232e2254cbe483078ca51d11c8a50", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RATIO \nBLOOD \nCALCULATION \nSTIMULATED/UNSTIMULATED \n \n2021-03-\n20T09:52:00 \nExample 5 \nThis example shows data from a B-lymphocyte activation assay with single-marker quantitation of a cell state marker using the formatting guidance for CPTEST and CPMRKSTR. It also demonstrates the use of \nCPGATE and CPGATDEF for reporting a full gating strategy and for reporting the total number of events counted within a gate. \nRows 1-3: \nIncorporates both standard proportion analysis and single marker expression for a cell state marker in the B lymphocyte assay using CPGRPID to group the related record. In accordance with CP \nguidance for quantitative single marker expression, row 3 contains the marker being measured followed by \"Expression\". CPMRKSTR uses the recommended format of listing the marker being \nmeasured first, followed by the unit in which expression was quantified (median fluorescence intensity, MdFI in the example), and lastly by the complete marker string of the cell population on which \nexpression was measured. The analyte is repeated as part of the target cell population string (CD95+ in the example). GATE and GATEDEF show the gating strategy so it is clear which gate was used to \nmake the quantitative measurement of expression. \nRows 4-8: \nShow a set of tests similar to those in rows 1-3, except that the marker being quantified is more narrowly restricted to a subpopulation of B lymphocytes (i.e., naive B cells), which are identified using a \nricher set of markers. The sponsor chose, in row 6, to include the total number of events counted in the final gate to document that the data are reliable based on a sample size sufficient to reduce error to \nan appropriate level (e.g. 2-sigma).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1717, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c7197765-1277-4bed-843d-bf0c3a207c86": {"__data__": {"id_": "c7197765-1277-4bed-843d-bf0c3a207c86", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "55.3 55.3"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "47031e43-a8b6-491c-af45-7175b518a947", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "55.3 55.3"}, "hash": "5cec097351a37343b141b510a97c750509c6945c01762a06627e799927771a45", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n2021-10-\n20T09:20:00 \n3 \nABC-123 \nCP \nABCD-\n001-001 \n3 \n1 \nCD95X \nCD95 \nExpression \nAPOPTOTIC \nCD95+ \nCD95 MdFI CD45+CD19+CD95+ \nCD95+ \nBLym \nFSC+SSC+|CD45+|CD19+CD95+ \nIMMUNOPHENOTYPING \nB CELL \nACTIVATION \nCD95 Expr \nBLym \n100 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n100 \n100 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n2021-10-\n20T09:20:00 \n4 \nABC-123 \nCP \nABCD-\n001-002 \n1 \n2 \nBLYCELE \nBLym/Leuk \n \n \nCD45+CD19+/CD45+ \nBLym \nFSC+SSC+|CD45+|CD19+ \nIMMUNOPHENOTYPING \nB CELL \nACTIVATION \nCD95 Expr \nBLym", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 525, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c06a8182-120c-4d16-96c3-f31e870f3980": {"__data__": {"id_": "c06a8182-120c-4d16-96c3-f31e870f3980", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "83.9 83.9"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f294f5e3-9039-4b1e-84d0-ff0e3bced4e1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "83.9 83.9"}, "hash": "e97a7fdb6ace323a78ab02df019d7f03f1376608d98c6f63cf5fe23204616df4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n2021-10-\n20T09:20:00 \n6 \nABC-123 \nCP \nABCD-\n001-002 \n3 \n2 \nBLYN \nBLym Naive Sub \nAPOPTOTIC \nCD95+ \nCD45+CD19+IgD+CD27-\nCD95+/CD45+CD19+IgD+CD27- \nCD95+ \nBLym Naive \nFSC+SSC+|CD45+|CD19+|IgD+CD27-\n|CD95+ \nIMMUNOPHENOTYPING \nB CELL \nACTIVATION \nCD95 Expr \nBLym \n2946 \nEvents \nQUANTITATIVE \nNUMBER \n2946 \n2946 \nEvents \nBLOOD \nFLOW \nCYTOMETRY \n2021-10-\n20T09:20:00 \n7 \nABC-123 \nCP \nABCD-\n001-002 \n4 \n2 \nBNSBN \nBLym Naive \nSub/BLym Naive \nAPOPTOTIC \nCD95+ \nCD45+CD19+IgD+CD27-\nCD95+/CD45+CD19+IgD+CD27- \nCD95+ \nBLym Naive \nFSC+SSC+|CD45+|CD19+|IgD+CD27-\n|CD95+ \nIMMUNOPHENOTYPING \nB CELL \nACTIVATION \nCD95 Expr \nBLym", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 638, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e433823-8165-4d4c-9cfd-8cf92c727d83": {"__data__": {"id_": "7e433823-8165-4d4c-9cfd-8cf92c727d83", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "50.2 50.2"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3250294-a38e-475a-b6b8-38731a10396f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "50.2 50.2"}, "hash": "f3c5cc1c6e1620f355dc92c60f604c761f0e2ea5abc4c4dfe40260399e49a6ea", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1ae1289e-e6dc-4db8-96b8-78049850c1a3", "node_type": "1", "metadata": {}, "hash": "0d5c0ac055b981df55397b007f6233726fa553fc7ace0074df961b5fc62371bd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n2021-10-\n20T09:20:00 \n8 \nABC-123 \nCP \nABCD-\n001-002 \n5 \n2 \nCD95X \nCD95 \nExpression \nAPOPTOTIC \nCD95+ \nCD95 MdFI CD45+CD19+IgD+CD27-\nCD95+ \nCD95+ \nBLym Naive \nFSC+SSC+|CD45+|CD19+|IgD+CD27-\n|CD95+ \nIMMUNOPHENOTYPING \nB CELL \nACTIVATION \nCD95 Expr \nBLym \n89 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n89 \n89 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n2021-10-\n20T09:20:00 \nExample 6 \nThis example shows use of CPSPTSTD for the lab/sponsor to describe a test in detail using internal data repository/dictionary nomenclature which has been developed for the test. The example uses a complex \ndendritic cell (DC) assay panel to illustrate information appropriate for this variable. \nWith the advent of increasingly complex phenotypic assays used to measure proportions, counts, and expression levels on cell subpopulations, it is sometimes advantageous for a lab/sponsor to provide a more \nthorough test description in a format used internally to represent a test and/or that a data recipient can more readily understand. For example, when quantitative marker expression is reported, CPTEST does not \nindicate the cell population on which expression was measured. Although the marker string of the target cell population is included in CPMRKSTR, the actual name of the cell is lost unless it is included as part of the \ngate name in CPGATE or in CPSPTSTD. CPSPTSTD (Sponsor Test Description) provides the flexibility for combining pieces of information that make the test easier to understand and to track internally to \nlab/sponsor dictionaries using a single variable which is not managed by CDISC Controlled Terminology. \nRows 1-6: \nIllustrate how the sponsor uses CPSPTSTD to combine details of a test into a single variable to align with the lab/sponsor data repository or dictionary and to aid understanding of the test. Rows 1-4 \nintroduce CPSPTSTD using simple tests for dendritic cells to set the stage for the more complex tests shown in rows 5-6. Those rows incorporate an additional marker (CD1c-) to define the \nplasmacytoid sublineage, and a non-lineage, non-cell state marker (CD303+) that is of interest. Although the entire marker string is in CPMRKSTR, it is easy to miss that CD303+ was also used to \nsubdivide the population, even though it is not considered to define a sublineage. The lab/sponsor test nomenclature reinforces the use of CD303 by calling them a \"CD303+ Dendritic Cell \nPlasmacytoid Sub\" (subset) in the CPSPTSTD for rows 5-6. The information presented by the lab/sponsor helps the data recipient to quickly understand such nuances of a test at a glance, which is \nespecially useful as the complexity of a test increases. \nRows 7-10: \nIllustrate how CPSPTSTD might preface the name of a cell population with cell state marker(s) (e.g., CD83+ in rows 7-8) in addition to non-cell state, non-sublineage marker(s).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2861, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1ae1289e-e6dc-4db8-96b8-78049850c1a3": {"__data__": {"id_": "1ae1289e-e6dc-4db8-96b8-78049850c1a3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "50.2 50.2"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b3250294-a38e-475a-b6b8-38731a10396f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "50.2 50.2"}, "hash": "f3c5cc1c6e1620f355dc92c60f604c761f0e2ea5abc4c4dfe40260399e49a6ea", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7e433823-8165-4d4c-9cfd-8cf92c727d83", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 215, "section": "50.2 50.2"}, "hash": "ad85f65548b3be9e717e7498b86bf453bbfd16ea69342eb3d4698fcd0621efb8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although the entire marker string is in CPMRKSTR, it is easy to miss that CD303+ was also used to \nsubdivide the population, even though it is not considered to define a sublineage. The lab/sponsor test nomenclature reinforces the use of CD303 by calling them a \"CD303+ Dendritic Cell \nPlasmacytoid Sub\" (subset) in the CPSPTSTD for rows 5-6. The information presented by the lab/sponsor helps the data recipient to quickly understand such nuances of a test at a glance, which is \nespecially useful as the complexity of a test increases. \nRows 7-10: \nIllustrate how CPSPTSTD might preface the name of a cell population with cell state marker(s) (e.g., CD83+ in rows 7-8) in addition to non-cell state, non-sublineage marker(s). Rows 9-10 \nadditionally show that the lab/sponsor uses CPSPTSTD to identify the target cell population by name when it is not in CPTEST, such as when the test is for quantitative single marker expression \n(CD83 Expression in rows 9-10). \nRows 11-14: Same as rows 7-10, except here the cell state activation marker for the CD303+ pDC cell subset and the single marker expression measurement is CD80. \nRows 15-18: Illustrate how CPSPTSTD might preface the name of a cell population with cell sublineage marker(s) (e.g., CD40+ in rows 15-16 in addition to non-cell state, non-sublineage marker(s). Rows 17-18 \nadditionally show that the lab/sponsor uses CPSPTSTD to identify the target cell population by name when it is not in CPTEST, such as when the test is for quantitative single marker expression \n(CD40 Expression in rows 17-18). \nRows 19-32: No new concepts are introduced in these rows, but they are additional illustrations of using CPSBMRKS, CPCELSTA, CPCSMRKR and CPSPTSTD for a subset of pDC in which CD123+ is a marker \nof interest which is neither a cell sublineage nor cell state marker. These rows are included to reinforce the principles illustrated in rows 1-18.", "mimetype": "text/plain", "start_char_idx": 2134, "end_char_idx": 4040, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5d3cee47-c328-4a04-89b7-f9575f45bbf1": {"__data__": {"id_": "5d3cee47-c328-4a04-89b7-f9575f45bbf1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "6.70 6.70"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c09fb578-7439-4068-9a3a-cdf1db2853dd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "6.70 6.70"}, "hash": "0d8e56333027dbf2a7e11b032bd1120a33943bccd572e49319da6ae6d16ff449", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n2 \nABC-123 \nCP \nABCD-\n001-001 \n2 \n1 \nLYMONO \nLym+Mono \n \n \n \nCD45+SSCmid \nLYM+MONO \nSSCmid|CD45+ \nLym+Mono Count \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n663 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n663 \n663 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n3 \nABC-123 \nCP \nABCD-\n001-001 \n3 \n1 \nDCLYMONO \nDendritic \nCells/Lym+Mono \n \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+/CD45+SSCmid \nDENDRITIC \nCELLS \nSSCmid|CD45+LIN- \n|HLADR+ \n%Dendritic \nCells/Lym+Mono \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 557, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "97886079-ce98-424c-8a66-54f0a8c3f029": {"__data__": {"id_": "97886079-ce98-424c-8a66-54f0a8c3f029", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "31.20 31.20"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2e0969a7-f48e-4621-b395-0a7e7d27f070", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "31.20 31.20"}, "hash": "d5a15c5d6037dfc0017ad3b7d46bc60ec4f5f3d0b0e6bbeb807297207a2f010d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n4 \nABC-123 \nCP \nABCD-\n001-001 \n4 \n1 \nDC \nDendritic Cells \n \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+ \nDENDRITIC \nCELLS \nSSCmid|CD45+LIN-\n|HLADR+ \nDendritic Cells Count \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n156 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n156 \n156 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n5 \nABC-123 \nCP \nABCD-\n001-001 \n5 \n2 \nDCPDC \nDC \nPlasmacytoid/DC \n \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD303+CD1c-\n/CD45+CD3-CD19-CD20-CD56-\nHLADR+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45+LIN- \n|HLADR+|CD303+CD1c- \n%CD303+ Dendritic \nCells Plasmacytoid \nSub/DC \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 675, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8b1be2c8-7aab-4e4b-b8b3-832fd0804aea": {"__data__": {"id_": "8b1be2c8-7aab-4e4b-b8b3-832fd0804aea", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.76 2.76"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "180835dc-f3d1-47df-b0c2-bbfa13e1dbe2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.76 2.76"}, "hash": "2d4279d572cb85e9b14de099f40786068f4bb28e80f20e7f9da415bf00d9830c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n6 \nABC-123 \nCP \nABCD-\n001-001 \n6 \n2 \nDCP \nDC Plasmacytoid \n \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD303+CD1c- \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45+LIN-\n|HLADR+|CD303+CD1c- \nCD303+ Dendritic \nCells Plasmacytoid \nSub Count \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n430 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n430 \n430 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n7 \nABC-123 \nCP \nABCD-\n001-001 \n7", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 465, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "250ecdce-5663-437b-8843-cd2b20679529": {"__data__": {"id_": "250ecdce-5663-437b-8843-cd2b20679529", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 DCPSDCP"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "146fff57-fa20-4071-b0c8-2589e0628b4e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 DCPSDCP"}, "hash": "215905369f5e9f524f5118819acf9bb1464916503b6b530b1c9d1497dcd8fbc2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub/DC \nPlasmacytoid \n \nACTIVATED \nCD83+ \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD303+CD1c-\nCD83+/CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \n%CD83+CD303+ \nDendritic Cells \nPlasmacytoid \nSub/CD303+ DCPS \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 323, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "51ae1889-dd9f-4b28-9f95-9578f425e5a9": {"__data__": {"id_": "51ae1889-dd9f-4b28-9f95-9578f425e5a9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 DCPS"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ae61ca21-7832-493d-ac68-b05c6bd7cb89", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 DCPS"}, "hash": "56acc0ebc542d89f3fb5b43981cd14c1eed04907c8dd1e638e46d80c36b39787", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub \n \nACTIVATED \nCD83+ \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD303+CD1c-CD83+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD83+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nCount \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n2 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n2 \n2 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n9 \nABC-123 \nCP \nABCD-\n001-001 \n9", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 397, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d03f622-7d3f-45e8-aa20-c9e6579587fc": {"__data__": {"id_": "7d03f622-7d3f-45e8-aa20-c9e6579587fc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 CD83X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "534e30a4-9ae8-4b82-b022-0b7913584e96", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 CD83X"}, "hash": "cb228560bdcc0a6bb1bae9ff40b5943e7087ce1b1f48218485c70f11e7f5f9ee", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD83 Expression \n \n \n \nCD83 MdFI CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c-CD83+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD83 Expr MdFI \nCD83+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n500 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n500 \n500 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n10 \nABC-123 \nCP \nABCD-\n001-001 \n10", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8c58cc64-726d-4398-a1f2-7ae8968399e2": {"__data__": {"id_": "8c58cc64-726d-4398-a1f2-7ae8968399e2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 CD83X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "07c0cb8c-da65-4fb5-80af-03dff48ac169", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.1 CD83X"}, "hash": "7dcb8c6d534c37a108f6485c27f3b4f68d9b3327b8f84e6c57713b4d7afd10f5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD83 Expression \n \n \n \nCD83 MESF CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c-CD83+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD83 Expr MESF \nCD83+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n2000 \nMESF \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n2000 \n2000 \nMESF \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n11 \nABC-123 \nCP \nABCD-\n001-001 \n11", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 407, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9c454712-be28-4210-8adb-f1cfb0597384": {"__data__": {"id_": "9c454712-be28-4210-8adb-f1cfb0597384", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 DCPSDCP"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "af83969f-87d4-4922-be17-29d61bf5888a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 DCPSDCP"}, "hash": "b2d598eede24004efdc26bd8c6bae7ce39aaa8ac6e68c41df9faeed4d9bf0f55", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub/DC \nPlasmacytoid \n \nACTIVATED \nCD80+ \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD303+CD1c-\nCD80+/CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c- \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \n%CD80+CD303+ \nDendritic Cells \nPlasmacytoid \nSub/CD303+ DCPS \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "848f8a01-46d9-4805-9aef-6235e648ca02": {"__data__": {"id_": "848f8a01-46d9-4805-9aef-6235e648ca02", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 DCPS"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "77119e37-7cfe-4444-b343-010a3fd45017", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 DCPS"}, "hash": "af350faef8502fff3f939ca3942f2e52d3d20e0ba99d38f5ff4da5baff789a8c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub \n \nACTIVATED \nCD80+ \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD303+CD1c-CD80+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD80+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nCount \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n100 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n100 \n100 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n13 \nABC-123 \nCP \nABCD-\n001-001 \n13", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 405, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ad029d46-7ad0-4d6e-a34c-78179ebb34a1": {"__data__": {"id_": "ad029d46-7ad0-4d6e-a34c-78179ebb34a1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 CD80X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6eb261d5-1394-4504-b06c-82fe149f968b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 CD80X"}, "hash": "df16370b01af50cda512dbe7579216d6096e890f198491f2bf3b8711be265764", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD80 Expression \n \n \n \nCD80 MdFI CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c-CD80+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD80 Expr MdFI \nCD80+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n100 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n100 \n100 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n14 \nABC-123 \nCP \nABCD-\n001-001 \n14", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c0123d73-c672-47d0-bacf-66036e4b1271": {"__data__": {"id_": "c0123d73-c672-47d0-bacf-66036e4b1271", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 CD80X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6d9b7cce-8710-4be7-a9ad-8d17040bf954", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.2 CD80X"}, "hash": "a6e8c8651e827b1d87dd89b93646e2f2fffc25f3aa1a9c23c1ef7e52e2d098fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD80 Expression \n \n \n \nCD80 MESF CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c-CD80+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD80 Expr MESF \nCD80+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n400 \nMESF \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n400 \n400 \nMESF \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n15 \nABC-123 \nCP \nABCD-\n001-001 \n15", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "81cf5756-a1e6-4f44-bbdd-65bac704f2b0": {"__data__": {"id_": "81cf5756-a1e6-4f44-bbdd-65bac704f2b0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 DCPSDCP"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e748c262-8a76-4882-9ce8-75102957223e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 DCPSDCP"}, "hash": "56b2b17dbcd147f73b9cbbfd60cb3b5be6bfbaff52a673d7f7b0e573b77ef7d7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub/DC \nPlasmacytoid \nCD40+ \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD303+CD1c-\nCD40+/CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c- \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \n%CD40+CD303+ \nDendritic Cells \nPlasmacytoid \nSub/CD303+ DCPS \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 315, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e40dea1c-7d8f-4482-a850-28a6e65ce753": {"__data__": {"id_": "e40dea1c-7d8f-4482-a850-28a6e65ce753", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 DCPS"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "224112b9-91e4-4d1e-921c-cdfba587d1f0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 DCPS"}, "hash": "6c5b2da0bc31f2742716a9957c74eb68ee299c9a0ccfb15c62d7a87f992cea24", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub \nCD40+ \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD303+CD1c-CD40+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD40+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nCount \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n63 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n63 \n63 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n17 \nABC-123 \nCP \nABCD-\n001-001 \n17", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 393, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8d5150fe-4b65-4a4f-98df-e20bc2d4fdbd": {"__data__": {"id_": "8d5150fe-4b65-4a4f-98df-e20bc2d4fdbd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 CD40X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2dfdbf72-4d71-479e-b4c7-95220a59601d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 CD40X"}, "hash": "8e8d2bb6ea48bd5eb132ddc588278a7cfa484aa0dccc98045a105e750c6f2f0e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD40 Expression \n \n \n \nCD40 MdFI CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c-CD40+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD40 Expr MdFI \nCD40+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n300 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n300 \n300 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n18 \nABC-123 \nCP \nABCD-\n001-001 \n18", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "94297160-4f87-4ee8-9bc6-5ebbac51ea0e": {"__data__": {"id_": "94297160-4f87-4ee8-9bc6-5ebbac51ea0e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 CD40X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e049ab43-5135-4e93-ab71-033f2c046407", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "2.3 CD40X"}, "hash": "a27bb86a9d7ff13b81dc266db4fafc0f195366d751a67fb566ae4700d262abcf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD40 Expression \n \n \n \nCD40 MESF CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD303+CD1c-CD40+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD303+CD1c- \nCD40 Expr MESF \nCD40+CD303+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n1200 \nMESF \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n1200 \n1200 \nMESF \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n19 \nABC-123 \nCP \nABCD-\n001-001 \n19 \n3 \nDCPDC \nDC \nPlasmacytoid/DC \n \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD123+CD1c-\n/CD45+CD3-CD19-CD20-CD56-\nHLADR+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \n%CD123+ Dendritic \nCells Plasmacytoid \nSub/DC \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 679, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5bd3892-b4c8-42e6-80fa-e8332d00494f": {"__data__": {"id_": "b5bd3892-b4c8-42e6-80fa-e8332d00494f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "5.25 5.25"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "02ce231c-4951-4dcb-96d7-64e5f549634b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "5.25 5.25"}, "hash": "17ea14ee7f80bdf3e5fae37b8facd8857808856d0094db6e22f81f20b00f9aba", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n20 \nABC-123 \nCP \nABCD-\n001-001 \n20 \n3 \nDCP \nDC Plasmacytoid \n \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD123+CD1c- \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD123+ Dendritic \nCells Plasmacytoid \nSub Count \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n26 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n26 \n26 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n21 \nABC-123 \nCP \nABCD-\n001-001 \n21", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 465, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e3c4e192-24a3-4976-ae8f-e6cfcd89ef55": {"__data__": {"id_": "e3c4e192-24a3-4976-ae8f-e6cfcd89ef55", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 DCPSDCP"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9072a7b-604f-482b-ae5b-afefdef942d7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 DCPSDCP"}, "hash": "5433f88d9c72b76e4e60aa96b8ee8ea762e919a0ceef251b0429f8a96b9cb927", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub/DC \nPlasmacytoid \n \nACTIVATED \nCD83+ \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD123+CD1c-\nCD83+/CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c- \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \n%CD83+CD123+ \nDendritic Cells \nPlasmacytoid \nSub/CD123+ DCPS \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "977ca7bc-f3ba-44a6-8044-49efc81573fd": {"__data__": {"id_": "977ca7bc-f3ba-44a6-8044-49efc81573fd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 DCPS"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9437165b-4bd4-4b18-a8e1-7150372fdd84", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 DCPS"}, "hash": "b133e1eab5d84ad577b5d3bc5def06c08c1cbca91ddacd2bf75ef361906432a6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub \n \nACTIVATED \nCD83+ \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD123+CD1c-CD83+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD83+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nCount \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n8 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n8 \n8 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n23 \nABC-123 \nCP \nABCD-\n001-001 \n23", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 399, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "01d288d2-d5da-4d51-ae15-4c6f73282ea8": {"__data__": {"id_": "01d288d2-d5da-4d51-ae15-4c6f73282ea8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 CD83X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d906264a-5ec3-4226-ad62-592b5571dae2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 CD83X"}, "hash": "b1978fb311b478dcc035effa0e749f3eca958a81b427089494886cd66941ae4e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD83 Expression \n \n \n \nCD83 MdFI CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c-CD83+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD83 Expr MdFI \nCD83+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n200 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n200 \n200 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n24 \nABC-123 \nCP \nABCD-\n001-001 \n24", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "29b520de-f59a-4f73-8ac7-419b5da3b476": {"__data__": {"id_": "29b520de-f59a-4f73-8ac7-419b5da3b476", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 CD83X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ffa271c5-8bc3-4b61-a40a-091ee8682ee7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 216, "section": "3.1 CD83X"}, "hash": "7828aa59a9a3d221383247939fa9c4a03d5a37a4abcc9f9c091524a886d0bc93", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD83 Expression \n \n \n \nCD83 MESF CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c-CD83+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD83 Expr MESF \nCD83+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n800 \nMESF \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n800 \n800 \nMESF \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 368, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e9f60308-fcc2-48ff-923b-a3e091cc91c4": {"__data__": {"id_": "e9f60308-fcc2-48ff-923b-a3e091cc91c4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 DCPSDCP"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bd8c8b96-25b7-4cb2-8542-ca5d73805814", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 DCPSDCP"}, "hash": "341d4d7b9b3979c92c2f963799fd69af23136a8ccb98a8b30e3f0dc5fa7e57b5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub/DC \nPlasmacytoid \n \nACTIVATED \nCD80+ \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD123+CD1c-\nCD80+/CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c- \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \n%CD80+CD123+ \nDendritic Cells \nPlasmacytoid \nSub/CD123+ DCPS \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e342c38d-e596-4b53-8ba3-95138a53f5f2": {"__data__": {"id_": "e342c38d-e596-4b53-8ba3-95138a53f5f2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 DCPS"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5467a511-b4b2-425c-aa73-a7ce7d243d4e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 DCPS"}, "hash": "111e5a3999448e2b718e9cd72507aa5a869b79d94c5e151549c4b21bf98e4c3f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub \n \nACTIVATED \nCD80+ \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD123+CD1c-CD80+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD80+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nCount \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n4 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n4 \n4 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n27 \nABC-123 \nCP \nABCD-\n001-001 \n27", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 399, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "53d2416d-b154-4cb2-bb9c-aa6cc01230a1": {"__data__": {"id_": "53d2416d-b154-4cb2-bb9c-aa6cc01230a1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 CD80X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4166a2df-0187-4828-9e27-9d1f69ec66f9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 CD80X"}, "hash": "f19f5718138f8891aeab882b77602864e057636663316c51b59a51659a49d7f5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD80 Expression \n \n \n \nCD80 MdFI CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c-CD80+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD80 Expr MdFI \nCD80+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n50 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n50 \n50 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n28 \nABC-123 \nCP \nABCD-\n001-001 \n28", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 401, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b4211bb3-5fd9-48da-a674-8cecafa1f7d4": {"__data__": {"id_": "b4211bb3-5fd9-48da-a674-8cecafa1f7d4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 CD80X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "196447c9-6a7c-4687-bf71-c8f3a8667a2f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.2 CD80X"}, "hash": "ae16a283fbbd974f8bb8b6e477bf72a74e232beb67307995253b0f16db9df688", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD80 Expression \n \n \n \nCD80 MESF CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c-CD80+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD80 Expr MESF \nCD80+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n200 \nMESF \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n200 \n200 \nMESF \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n29 \nABC-123 \nCP \nABCD-\n001-001 \n29", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 404, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e2fc7f30-d87a-4866-b4af-4ea4a430b4a8": {"__data__": {"id_": "e2fc7f30-d87a-4866-b4af-4ea4a430b4a8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 DCPSDC"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "62aef9fa-972f-4dc6-bd3b-58c57cd2c79b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 DCPSDC"}, "hash": "3f0735aa0b3d83c21b284e333322c5e6a953fd68c7d9cd3cdf7a0dc1ca511230", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub/DC \nPlasmacytoid \nCD40+ \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD123+CD1c-\nCD40+/CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c- \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \n%CD40+CD123+ \nDendritic Cells \nPlasmacytoid \nSub/CD123+ DCPS \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 315, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a67bc556-adf3-4343-899b-5bdd256b9000": {"__data__": {"id_": "a67bc556-adf3-4343-899b-5bdd256b9000", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 DCPS"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5f782e5f-6270-4cff-b298-3f862f470c3d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 DCPS"}, "hash": "4bd2d704b85db169001093975cc04b1223799f6fe1f88730b346d45cc740b2e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DC Plasmacytoid \nSub \nCD40+ \n \n \nCD45+CD3-CD19-CD20-CD56-\nHLADR+CD123+CD1c-CD40+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD40+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nCount \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n6 \n10^6/L \nQUANTITATIVE \nNUMBER \nCONCENTRATION \n6 \n6 \n10^6/L \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n31 \nABC-123 \nCP \nABCD-\n001-001 \n31", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 390, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "60f4e947-5ab7-4165-ac08-90b38e4b4d92": {"__data__": {"id_": "60f4e947-5ab7-4165-ac08-90b38e4b4d92", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "850b1b48-179e-4c13-a894-a04ef2a6cd89", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}, "hash": "fbdf94b2e522a9aacafafa76da979ebfc4aae87ee091a3ac81d0f0b0a844c47d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD40 Expression \n \n \n \nCD40 MdFI CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c-CD40+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD40 MdFI \nCD40+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nCount \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n240 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n240 \n240 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \n32 \nABC-123 \nCP \nABCD-\n001-001 \n32", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 406, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b4572031-b2b0-458e-bd40-c6cfc4f83cce": {"__data__": {"id_": "b4572031-b2b0-458e-bd40-c6cfc4f83cce", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "05492b40-b08e-4709-8047-b5d30f6356fb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}, "hash": "2d263b57555dc004d99756aad7814a351d596092cbc36f9c7559ab84556c4a7e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab752029-64a7-4e81-a171-7e04f3c8f181", "node_type": "1", "metadata": {}, "hash": "e64d49d2e2e4b6f702819160cf7548407b6cda2e4b9d9fb4b9ce7ab8791550c2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CD40 Expression \n \n \n \nCD40 MESF CD45+CD3-CD19-\nCD20-CD56-\nHLADR+CD123+CD1c-CD40+ \nDENDRITIC \nCELLS \nPLASMACYTOID \nSSCmid|CD45LIN-\n|HLADR+|CD123+CD1c- \nCD40 Expr MESF \nCD40+CD123+ \nDendritic Cells \nPlasmacytoid Sub \nIMMUNOPHENOTYPING \nmDC AND \npDC \nSUBSETS \n535 \nMESF \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n535 \n535 \nMESF \nBLOOD \nFLOW \nCYTOMETRY \n2021-01-\n30T07:10:00 \nExample 7 \nThis example shows data from a monocyte target occupancy assay for which a cell surface marker of interest is bound to its specific protein or ligand (identified in CPBDAGNT) upon sample analysis. In addition, \nthree different ways for populating CPGATE and CPGATDEF are shown in the example. \nPrinciples related to cell phenotyping are often used to measure the extent of binding between two molecules of interest (e.g., ligand-receptor or protein-protein interactions). Substances involved in the binding \ninteraction can represent naturally occurring, pathological (i.e., disease-related), or therapeutic intervention processes. Quantification of these types of interactions is often used: (1) to aid in diagnosis and/or tracking \ndisease progression; (2) to determine whether a therapy operating through a binding mechanism works as intended at selected doses; and (3) to assess whether potential off-target interactions, particularly those \nassociated with undesirable side effects or safety risks, are likely to be a concern.  \nRow 1: \nThe sponsor chose to submit only the final calculated result for target occupancy as reported by the lab, i.e., records used for the calculation were not submitted. The CPMRKSTR variable includes \nmarkers identifying the cell population (CD45+CD14+) and the target of interest (CDxx) on which occupancy was measured. CPGATE contains the name of the gate used to virtually isolate the cell \npopulation of interest and CPGATEDEF contains the gate definition or gating strategy. Note in this example that the CDxx marker, although it is the target of interest for the test, is not part of the string \nused to formally identify the named portion of the cell population. As a result, the sponsor chose to report the penultimate gate, which does not include the target marker of interest (CDxx). Because the \ntarget of interest for which occupancy was measured is not part of the test name, it is identified in CPBDAGNT and/or another variable (e.g. CPTSTPNL). \nRow 2: \nSame as row 1 except that the sponsor chose to use CPGATE and CPGATDEF to report information for the final gate rather than the penultimate gate. In this example, the CDxx marker (the target of \ninterest for measuring occupancy) is not part of the marker string used to identify the named portion of the cell population on which the test was performed, so it was placed in front of the named portion \nof the gate to make it easily understood that the final gate was on CDxx-positive monocytes (i.e., CDxx+ MONOCYTES). Because the target of interest for which occupancy was measured is not part of \nthe test name, it is identified in CPBDAGNT and/or another variable (e.g. CPTSTPNL).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3069, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ab752029-64a7-4e81-a171-7e04f3c8f181": {"__data__": {"id_": "ab752029-64a7-4e81-a171-7e04f3c8f181", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "05492b40-b08e-4709-8047-b5d30f6356fb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}, "hash": "2d263b57555dc004d99756aad7814a351d596092cbc36f9c7559ab84556c4a7e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b4572031-b2b0-458e-bd40-c6cfc4f83cce", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 217, "section": "3.3 CD40X"}, "hash": "65cf21bdc5c17b6d15e81e888d06983d1f2d21165eda15e69dc724fc45cbf7e1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CPTSTPNL). \nRow 2: \nSame as row 1 except that the sponsor chose to use CPGATE and CPGATDEF to report information for the final gate rather than the penultimate gate. In this example, the CDxx marker (the target of \ninterest for measuring occupancy) is not part of the marker string used to identify the named portion of the cell population on which the test was performed, so it was placed in front of the named portion \nof the gate to make it easily understood that the final gate was on CDxx-positive monocytes (i.e., CDxx+ MONOCYTES). Because the target of interest for which occupancy was measured is not part of \nthe test name, it is identified in CPBDAGNT and/or another variable (e.g. CPTSTPNL). \nRow 3: \nThe target of interest is also a marker needed to identify the named portion of the cell population on which the occupancy was measured. For example, proinflammatory monocytes are distinguished \nfrom monocytes based on additional marker expression criteria as CD16+HLADRhi. In the example, the CD16 marker was also the target of interest for measuring occupancy. Because CD16 is \nincluded in the set of markers used to identify the named portion of the cell population on which the test was performed, it does not need to be explicitly called out in CPGATE.", "mimetype": "text/plain", "start_char_idx": 2367, "end_char_idx": 3636, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0ecf9c66-737b-48b8-b8ae-392a5d9424f3": {"__data__": {"id_": "0ecf9c66-737b-48b8-b8ae-392a5d9424f3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c249186-652f-4df9-9788-742cf249f6f2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}, "hash": "becf233a2bb66f95c521e268e87821243e1c552a9c8234011abc441aa62fd824", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0f89079e-6026-42be-9196-92a6ca105e37", "node_type": "1", "metadata": {}, "hash": "2b82c736af15d9c39a2b81867d3350c48448171ab5d0338410d8297d7c2c9531", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 218 \n2021-11-29 \ncp.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nCPSEQ \nCPTESTCD \nCPTEST \nCPBDAGNT \nCPMRKSTR \nCPGATE \nCPGATDEF \nCPCAT \nCPSCAT \nCPTSTPNL \nCPORRES \nCPORRESU \nCPRESSCL \nCPRESTYP \nCPSTRESC \nCPSTRESN \nCPSTRESU \nCPSPEC \nCPMETHOD \nCPDTC \n1 \nABC-123 \nCP \nABCD-\n001-001 \n1 \nTGOCC \nTarget \nOccupancy \nCDxx BINDING \nMOLECULE \nCD45+CD14+CDxx+ \nMONOCYTES \nFSC SSC|CD45+CD14+ \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nMONOCYTE \nCDxx RO \n83 \n% \nQUANTITATIVE \nNUMBER \nFRACTION \n83 \n83 \n% \nBLOOD \nFLOW \nCYTOMETRY \n2020-07-\n24T09:00 \n2 \nABC-123 \nCP \nABCD-\n001-001 \n1 \nTGOCC \nTarget \nOccupancy \nCDxx BINDING \nMOLECULE \nCD45+CD14+CDxx+ \nCDxx+ MONOCYTES \nFSC SSC|CD45+CD14+|CDxx+ \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nMONOCYTE \nCDxx RO \n83 \n% \nQUANTITATIVE \nNUMBER \nFRACTION \n83 \n83 \n% \nBLOOD \nFLOW \nCYTOMETRY \n2020-07-\n24T09:00 \n3 \nABC-123 \nCP \nABCD-\n001-001 \n1 \nTGOCC \nTarget \nOccupancy \nCD16 BINDING \nMOLECULE \nCD45+CD14+CD16+HLADRhi \nMONOCYTES, \nPROINFLAMMATORY \nFSC \nSSC|CD45+CD14+|CD16+HLADRhi \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nMONOCYTE \nCD16 RO \n83 \n% \nQUANTITATIVE \nNUMBER \nFRACTION \n83 \n83 \n% \nBLOOD \nFLOW \nCYTOMETRY \n2020-07-\n24T09:00 \nExample 8 \nThe example is a use case for data from a receptor occupancy study based on a direct cell-binding assay method to illustrate the use of several new variables.  \nIn the example, target engagement is assessed by measuring the extent to which a cell-associated target protein (the hypothetical cell marker CDxx) is occupied by a therapeutic antibody (CDxx antibody) intended to \ninteract with it. The assay uses a labeled detection antibody to the therapeutic antibody to measure the proportion of the target bound by the therapeutic antibody in an unaltered specimen (numerator), as compared to \nthe total amount of target available for binding (denominator). The total target available for binding is assessed by saturating the specimen with the therapeutic antibody before measuring the labeled detection \nantibody. To correct the numerator and denominator for non-specific (background) binding, labeled isotype controls are included which are subtracted to yield specific binding values.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2322, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0f89079e-6026-42be-9196-92a6ca105e37": {"__data__": {"id_": "0f89079e-6026-42be-9196-92a6ca105e37", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c249186-652f-4df9-9788-742cf249f6f2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}, "hash": "becf233a2bb66f95c521e268e87821243e1c552a9c8234011abc441aa62fd824", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0ecf9c66-737b-48b8-b8ae-392a5d9424f3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}, "hash": "279c504fe12f0eb215d27393a570fe3a2cb4748ba0767869ed50ab85805a36ba", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3b2893dc-8d82-45be-be40-69ea4b2a3b4b", "node_type": "1", "metadata": {}, "hash": "3ac13838459c58c1beac786bbc9025186ca6f6650d91d3582cdd7a99b368857e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the example, target engagement is assessed by measuring the extent to which a cell-associated target protein (the hypothetical cell marker CDxx) is occupied by a therapeutic antibody (CDxx antibody) intended to \ninteract with it. The assay uses a labeled detection antibody to the therapeutic antibody to measure the proportion of the target bound by the therapeutic antibody in an unaltered specimen (numerator), as compared to \nthe total amount of target available for binding (denominator). The total target available for binding is assessed by saturating the specimen with the therapeutic antibody before measuring the labeled detection \nantibody. To correct the numerator and denominator for non-specific (background) binding, labeled isotype controls are included which are subtracted to yield specific binding values. Although sponsors may elect to \nonly report the final calculated receptor occupancy (proportion of bound/total target occupied) as in Example 7, this example includes the various measured parameters generated in the assay which are then used to \nmake calculations for the final Receptor Occupancy value. \nSince the example is measuring binding and not a cell population per se, the Sublineage Marker String (CPSBMRKS), Cell State (CPCELSTA), and Cell State Marker String (CPCSMRKS) are not used and are not \nincluded. Other variables such as CPMRKSTR, CPGATE, and CPGATEDEF are used to identify the cell population on which the binding of interest was measured. In addition, the Sponsor Test Description \n(CPSPTSTD) and Test Panel (CPTSTPNL) variables may be helpful for identifying a specific cell population. \nRows 1-3: \nIllustrate how the test name (CPTEST), marker string (CPMRKSTR), binding agent (CPBDAGNT), replicates (CPREPNUM), and summary result type (CPCOLSRT) are populated for data from an \nassay used to assess target engagement by measuring the occupancy of the CDxx cell-associated target protein expressed on cytotoxic T-lymphocytes (defined as CD45+CD3+CD8+CDxx+). In this \ndirect assay, CPBDAGNT identifies the CDxx antibody (therapeutic antibody) as the target-bound substance of interest. Two replicate determinations and the mean extent of CDxx bound in the \nunaltered specimen are indicated using CPREPNUM and CPCOLSRT. \nRows 4-6: \nCPTEST, CPBDAGNT, REPNUM, and CPCOLSRT are used the same manner as they are in rows 1-3, except that CPTSTCND is now also used to indicate that the assay was conducted under a \nsaturating condition of CDxx antibody by adding an excess of this therapeutic antibody to the assay system. Under this condition, the labeled detection antibody reflects the maximum (total) amount of \nCDxx available to be occupied by the therapeutic antibody, \nRows 7-8: \nShow values for background (i.e. non-specific) binding of the labeled detection antibody to the CDxx-expressing cells of interest by using an isotype control belonging to the same immunoglobulin \nclass/subclass as the therapeutic antibody. This is indicated in CPBDAGNT and is also shown for how the sponsor chose to represent it in CPMRKSTR. \nRows 9-11: Rows 9 and 10 show values for specific binding of the therapeutic antibody (CDxx antibody) in the unaltered (native) specimen (Row 9) and the specimen to which excess CDxx antibody was added \n(saturated assay condition) (Row 10).", "mimetype": "text/plain", "start_char_idx": 1495, "end_char_idx": 4811, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3b2893dc-8d82-45be-be40-69ea4b2a3b4b": {"__data__": {"id_": "3b2893dc-8d82-45be-be40-69ea4b2a3b4b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c249186-652f-4df9-9788-742cf249f6f2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}, "hash": "becf233a2bb66f95c521e268e87821243e1c552a9c8234011abc441aa62fd824", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0f89079e-6026-42be-9196-92a6ca105e37", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 218, "section": "UNSPECIFIED"}, "hash": "4a6e3bfe33052fc48dc895e86d8d560b9b682eb3f901271d84e4a6347a3fa418", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Under this condition, the labeled detection antibody reflects the maximum (total) amount of \nCDxx available to be occupied by the therapeutic antibody, \nRows 7-8: \nShow values for background (i.e. non-specific) binding of the labeled detection antibody to the CDxx-expressing cells of interest by using an isotype control belonging to the same immunoglobulin \nclass/subclass as the therapeutic antibody. This is indicated in CPBDAGNT and is also shown for how the sponsor chose to represent it in CPMRKSTR. \nRows 9-11: Rows 9 and 10 show values for specific binding of the therapeutic antibody (CDxx antibody) in the unaltered (native) specimen (Row 9) and the specimen to which excess CDxx antibody was added \n(saturated assay condition) (Row 10). Specific binding was determined by subtracting the appropriate background measured in Rows 7 and 8 from the mean target bound (Row 3) and mean target total \n(Row 6). Row 11 shows the final result for CDxx antibody occupancy on the CDxx target protein as the quotient of the specific binding in the native specimen (Row 9) to the specific binding measuring \nthe total CDxx available for binding (Row 10).", "mimetype": "text/plain", "start_char_idx": 4063, "end_char_idx": 5215, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6120b71a-0f1d-44d1-a333-e0fc89ae11c0": {"__data__": {"id_": "6120b71a-0f1d-44d1-a333-e0fc89ae11c0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "24.6 24.6"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "16889032-d35e-4f4e-920b-2cf6e2a2d318", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "24.6 24.6"}, "hash": "684b3bbb157e463bb2813a54e9221275242c756ee9a8e7c4c6e86335490dd1b1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MdFI \nBLOOD \nFLOW \nCYTOMETRY \n \n1 \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n2 \nABC-123 \nCP \nABCD-\n001-001 \n2 \n1 \nTGB \nTarget \nBound \n \nANTI-CDxx \nANTIBODY \nCDxx MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Bound \nExpression MdFI \nT-Lymphocytes \nCytotoxic Rep 2 \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 345, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0d116391-5be9-4ab9-ab2c-297327d5e9f7": {"__data__": {"id_": "0d116391-5be9-4ab9-ab2c-297327d5e9f7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "31.7 31.7"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fc7c6253-26e6-4595-b74e-be84dcf3022d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "31.7 31.7"}, "hash": "316614df0f46a4a4a68a82db37bb0b73c2d99c264721025a492202244efb8e6c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MdFI \nBLOOD \nFLOW \nCYTOMETRY \n \n2 \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n3 \nABC-123 \nCP \nABCD-\n001-001 \n3 \n1 \nTGB \nTarget \nBound \n \nANTI-CDxx \nANTIBODY \nCDxx MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Bound \nExpression MdFI \nT-Lymphocytes \nCytotoxic Mean \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 344, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d64ba844-0496-465b-878f-c9aec4226937": {"__data__": {"id_": "d64ba844-0496-465b-878f-c9aec4226937", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "28.15 28.15"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e70249ae-2bef-4b5e-ada3-80914942a563", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "28.15 28.15"}, "hash": "52f814b4d66462292eb6431b7bb8e69dd4fa805c286e1f5b35bd43cfef53f5a9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MdFI \nBLOOD \nCALCULATION \n \n \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n4 \nABC-123 \nCP \nABCD-\n001-001 \n4 \n2 \nTGT \nTarget Total \nSATURATED \nCONDITION \nWITH BINDING \nAGENT \nANTI-CDxx \nANTIBODY \nCDxx MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Total \nExpression MdFI \nT-Lymphocytes \nCytotoxic Rep 1 \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO \n182 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n \n182 \n182 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n \n1 \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n5 \nABC-123 \nCP \nABCD-\n001-001 \n5 \n2 \nTGT \nTarget Total \nSATURATED \nCONDITION \nWITH BINDING \nAGENT \nANTI-CDxx \nANTIBODY \nCDxx MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Total \nExpression MdFI \nT-Lymphocytes \nCytotoxic Rep 2 \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO \n160 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n \n160 \n160 \nMdFI \nBLOOD \nFLOW \nCYTOMETRY \n \n2 \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n6 \nABC-123 \nCP \nABCD-\n001-001 \n6 \n2 \nTGT \nTarget Total \nSATURATED \nCONDITION \nWITH BINDING \nAGENT \nANTI-CDxx \nANTIBODY \nCDxx MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Total \nExpression MdFI \nT-Lymphocytes \nCytotoxic Mean \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO \n171 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \nMEAN \n171 \n171 \nMdFI \nBLOOD \nCALCULATION \n \n \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n7 \nABC-123 \nCP \nABCD-\n001-001 \n7 \n \nTGBBK \nTarget \nBound, \nBackground \n \nIGG1 \nISOTYPE \nISOTYPE MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Isotype \nControl \nExpression MdFI \nT-Lymphocytes \nCytotoxic \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1701, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ac901eff-b5cc-4010-962f-41e32052059f": {"__data__": {"id_": "ac901eff-b5cc-4010-962f-41e32052059f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "33.9 33.9"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d624c26f-78d7-4a76-8d3d-772059739a2f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "33.9 33.9"}, "hash": "381e6eccaad46c59a4e98cdf56a847fc858ec761d3ce1f0639f2f24faba49ad1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MdFI \nBLOOD \nFLOW \nCYTOMETRY \n \n \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n8 \nABC-123 \nCP \nABCD-\n001-001 \n8 \n \nTGTBK \nTarget Total, \nBackground \n \nIGG1 \nISOTYPE \nISOTYPE MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Isotype \nControl \nExpression MdFI \nT-Lymphocytes \nCytotoxic \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 359, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "afbb872d-adb3-471e-acaa-7e4e97758a2d": {"__data__": {"id_": "afbb872d-adb3-471e-acaa-7e4e97758a2d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "33.9 33.9"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "022dff2e-75e0-42b0-b889-c42da654ea8c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "33.9 33.9"}, "hash": "6cf3f07abdb31f6057b64667e950937bfecdf3d2dac626fa34f6cabcea170b19", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MdFI \nBLOOD \nFLOW \nCYTOMETRY \n \n \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n9 \nABC-123 \nCP \nABCD-\n001-001 \n9 \n3 \nTGBDBBK \nTarget \nBound, Delta \nBound \nBackground \n \nANTI-CDxx \nANTIBODY \nCDxx MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Delta \nBound \nExpression MdFI \nT-Lymphocytes \nCytotoxic \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO \n-5.75 \nMdFI \nQUANTITATIVE \nFLUORESCENCE \nINTENSITY \n \n-5.75 \n-5.75 \nMdFI \nBLOOD \nCALCULATION \n(Target Bound mean)-\n(Target Bound, Background) \n \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n10 \nABC-123 \nCP \nABCD-\n001-001 \n10 \n3 \nTGTDTBK \nTarget Total, \nDelta Total \nBackground \n \nANTI-CDxx \nANTIBODY \nCDxx MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \nCDxx Delta Total \nExpression MdFI \nT-Lymphocytes \nCytotoxic \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 863, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7116f30b-c980-424d-883d-2b42c4a0260a": {"__data__": {"id_": "7116f30b-c980-424d-883d-2b42c4a0260a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "137.1 137.1"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8509d6b2-a0ff-4c48-9ddf-bfbd29119087", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "137.1 137.1"}, "hash": "fde4d24cfa453ff98f01d1d36757cbafce043c193004efd6c5ed157a561f206e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9985bb51-c74f-4295-85cd-aa83067572d6", "node_type": "1", "metadata": {}, "hash": "170b40293b331dc7fd5f3047936098e06416b67fd30d68fa3b4890e451eef0d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MdFI \nBLOOD \nCALCULATION \n(Target Total mean)-(Target \nTotal, Background) \n \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \n11 \nABC-123 \nCP \nABCD-\n001-001 \n11 \n3 \nTGOCC \nTarget \nOccupancy \n \nANTI-CDxx \nANTIBODY \nCDxx MdFI \nCD45+CD3+CD8+CDxx+ \nTLym \nCytx \nFSC \nSSC|CD45+|CD3+CD8+ \n% CDxx \nReceptor \nOccupancy T-\nLymphocytes \nCytotoxic Direct \nMeasurement \nMdFI \nTARGET \nENGAGEMENT \nRECEPTOR \nOCCUPANCY \nCD8 T \nCELL CDxx \nRO \n-4.19 \n% \nQUANTITATIVE \nNUMBER \nFRACTION \n \n-4.19 \n-4.19 \nMdFI \nBLOOD \nCALCULATION \n(Target Bound, Delta Bound \nBackground)*100/(Target \nTotal, Delta Total \nBackground) \n \n2020-07-\n24T09:00 \nCYCLE \n1, DAY \n1 \n1 \nExample 9 \nThis example shows data from a monocyte receptor occupancy indirect detection assay for a target of interest relying upon externally applied assay conditions and several binding agents to measure the parameters \nreported. \nUnder certain circumstances, assessment of changes to free or unoccupied receptor (target) binding over the time-course of drug therapy or use of an indirect assay format may be more appropriate than direct \ndetection of a binding agent (e.g., drug, small molecule ligand, protein) to obtain information on the extent of target engagement. Indirect assays of this sort rely on measuring remaining free (unbound) binding site \nusing a labeled competitive detection probe (e.g., antibody or other ligand) that binds to the remaining available sites on the target; that is, those sites not already occupied by treating with the therapeutic. (Occupancy \nof the target by the therapeutic agent is then calculated as the difference between the total number of binding sites and the number of free binding sites detected by the probe.) In addition to measuring the free binding \nsites, a second labeled probe which binds to a non-interfering alternate site on the target (i.e., is non-competitive with the therapeutic molecule) may be used to assess the total amount of the target molecule expressed \non cells (not binding sites) in order to monitor whether therapy changed the number of targets available relative to baseline expression. This allows results to be interpreted as a change in occupancy as opposed to a \nchange in the number of targets available. \nSponsors may choose to report a single test for the final calculated occupancy, such as shown in row 1, or may elect to include results for the entire set of tests conducted which were then used to calculate the final \noccupancy result, such as shown in rows 2 through 14. \nIn the example showing the full set of tests, data are reported for free and total binding, background (non-specific) binding, and specific binding. CPBDAGNT is used to identify the probe (detection) antibody for \neach type of test (HA5-PE or 2D4-APC). Specific free binding (Target Free, Delta Free Background) is calculated as the difference in the probe signal (measured as MESF) between an untreated assay tube to a tube \ntreated with unlabeled probe antibody under saturating concentrations (to measure non-specific binding, which is not diminished under saturating conditions). CPTSTCND is used to capture the saturated condition \nimposed on the assay at runtime.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3162, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9985bb51-c74f-4295-85cd-aa83067572d6": {"__data__": {"id_": "9985bb51-c74f-4295-85cd-aa83067572d6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "137.1 137.1"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8509d6b2-a0ff-4c48-9ddf-bfbd29119087", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "137.1 137.1"}, "hash": "fde4d24cfa453ff98f01d1d36757cbafce043c193004efd6c5ed157a561f206e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7116f30b-c980-424d-883d-2b42c4a0260a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 219, "section": "137.1 137.1"}, "hash": "f1b63b76c1889a548a7c217037962a5d074eed5696554765f525758e2ee0622b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the example showing the full set of tests, data are reported for free and total binding, background (non-specific) binding, and specific binding. CPBDAGNT is used to identify the probe (detection) antibody for \neach type of test (HA5-PE or 2D4-APC). Specific free binding (Target Free, Delta Free Background) is calculated as the difference in the probe signal (measured as MESF) between an untreated assay tube to a tube \ntreated with unlabeled probe antibody under saturating concentrations (to measure non-specific binding, which is not diminished under saturating conditions). CPTSTCND is used to capture the saturated condition \nimposed on the assay at runtime. Receptor Occupancy is calculated as the difference between pre- and post-treatment binding of the labeled competitive probe (HA5) normalized to pre-treatment binding. \nRow 1: \nThe sponsor chose to submit only the final calculated result for target occupancy as reported by the lab; the data used in the calculation were not submitted. CPMRKSTR includes markers identifying the \ncell population (CD45+CD14+) and the target of interest (CD99) on which occupancy was measured. CPGATE contains the name of the gate used to virtually isolate the cell population of interest and", "mimetype": "text/plain", "start_char_idx": 2493, "end_char_idx": 3735, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c1a3f5b9-75da-48d8-81c7-c29a7793523a": {"__data__": {"id_": "c1a3f5b9-75da-48d8-81c7-c29a7793523a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 220, "section": "6.3.5.4 Genomics Findings (GF)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b4906c56-ea0b-41b1-a86e-d2fa9ad64737", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 220, "section": "6.3.5.4 Genomics Findings (GF)"}, "hash": "db04fea5a2def0de073d9bba13cab753be00e1e22425fe9c9dd630a64fc29a99", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "GF - Description/Overview \nA findings domain that contains data related to the structure, function, evolution, mapping, and editing of subject and non-host organism genomic material of interest. This domain includes but is not limited to \nassessments and results for genetic variation and transcription, and summary measures derived from these assessments. The GF domain is used for findings from characteristics assessed from nucleic acids and may \ninclude subsequent inferences and/or predictions about related proteins/amino acids.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 534, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "abcbd0ff-e5f4-4ae3-a731-757328b12fd3": {"__data__": {"id_": "abcbd0ff-e5f4-4ae3-a731-757328b12fd3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 221, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5874d69f-e639-4389-bf95-a4fef0609af6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 221, "section": "UNSPECIFIED"}, "hash": "0a07d049c2a0464c36a0f109043d4e48d16e174a24938717a29b57fcf6ca781b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8e1b5253-6995-4c33-be7a-407cda31a8bb", "node_type": "1", "metadata": {}, "hash": "513e04ed016bb3302b50e748c39552c53a94a6706ca2408c0737a2d812b8c538", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 221 \n2021-11-29 \nGF \u2013 Specification \ngf.xpt, Genomics Findings \u2014 Findings. One record per finding per observation per biospecimen per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar GF \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nSPDEVID \nSponsor Device \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier for a device. \nPerm \nNHOID \nNon-Host Organism \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier for a non-host organism which should only be used when the organism is \nthe subject of the TEST. This variable should be populated with an intuitive name based on the identity \nof the non-host organism as reported by a lab (e.g., \"A/California/7/2009 (H1N1)\"). It is not to be used \nas a qualifier of the result in the record on which it appears. \nPerm \nGFSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid \nnumber (including decimals) and does not have to start at 1. \nReq \nGFGRPID \nGroup ID \nChar  \nIdentifier \nUsed to link together a block of related records within a subject in a domain. \nPerm \nGFREFID \nReference ID \nChar  \nIdentifier \nA unique identifier for the assayed genetic specimen. \n \nExp \nGFSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. \nPerm \nGFLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nGFLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nGFTESTCD \nShort Name of Genomic \nMeasurement \nChar (GFTESTCD) \nTopic \nShort name of the measurement, test, or examination described in GFTEST. It can be used as a \ncolumn name when converting a dataset from a vertical to a horizontal format. The value in \nGFTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not \nvalid). GFTESTCD cannot contain characters other than letters, numbers, or underscores. \nReq \nGFTEST \nName of Genomic \nMeasurement \nChar (GFTEST) \nSynonym \nQualifier \nLong name for GFTESTCD. The value in GFTEST cannot be longer than 40 characters. \nReq \nGFTSTDTL \nMeasurement, Test, or \nExamination Detail \nChar (GFTSDTL) \nVariable \nQualifier \nDescription of a reportable qualifying the assessment in GFTESTCD and GFTEST. \nPerm \nGFCAT \nCategory for Genomic \nFinding \nChar  \nGrouping \nQualifier \nUsed to define a category of topic-variable values.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3090, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8e1b5253-6995-4c33-be7a-407cda31a8bb": {"__data__": {"id_": "8e1b5253-6995-4c33-be7a-407cda31a8bb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 221, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5874d69f-e639-4389-bf95-a4fef0609af6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 221, "section": "UNSPECIFIED"}, "hash": "0a07d049c2a0464c36a0f109043d4e48d16e174a24938717a29b57fcf6ca781b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "abcbd0ff-e5f4-4ae3-a731-757328b12fd3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 221, "section": "UNSPECIFIED"}, "hash": "396cf60dbc08775e8e1701aec8bd397f01d13ec862b23d6bc9b9b8036a5bf8cf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It can be used as a \ncolumn name when converting a dataset from a vertical to a horizontal format. The value in \nGFTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not \nvalid). GFTESTCD cannot contain characters other than letters, numbers, or underscores. \nReq \nGFTEST \nName of Genomic \nMeasurement \nChar (GFTEST) \nSynonym \nQualifier \nLong name for GFTESTCD. The value in GFTEST cannot be longer than 40 characters. \nReq \nGFTSTDTL \nMeasurement, Test, or \nExamination Detail \nChar (GFTSDTL) \nVariable \nQualifier \nDescription of a reportable qualifying the assessment in GFTESTCD and GFTEST. \nPerm \nGFCAT \nCategory for Genomic \nFinding \nChar  \nGrouping \nQualifier \nUsed to define a category of topic-variable values. \nPerm \nGFSCAT \nSubcategory for \nGenomic Finding \nChar  \nGrouping \nQualifier \nUsed to define a further categorization of GFCAT values. \nPerm \nGFORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nGFORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nUnit for GFORRES. \nPerm \nGFORREF \nReference Result in \nOriginal Units \nChar  \nVariable \nQualifier \nReference value for the result or finding as originally received or collected. GFORREF uses the same \nunits as GFORRES, if applicable. \nPerm \nGFSTRESC \nResult or Finding in \nStandard Format \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from GFORRES, in a standard format or in \nstandard units. GFSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in GFSTRESN. \nExp \nGFSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nGFSTRESC. GFSTRESN should store all numeric test results or findings. \nPerm \nGFSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for GFSTRESC, GFSTRESN, GFSTREFC, and GFSTREFN. \nPerm", "mimetype": "text/plain", "start_char_idx": 2332, "end_char_idx": 4431, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "df10fc44-108a-4209-a61e-75aebf12ce21": {"__data__": {"id_": "df10fc44-108a-4209-a61e-75aebf12ce21", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 222, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "61a7f0d6-6450-4229-b840-dac0e48ebbc0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 222, "section": "UNSPECIFIED"}, "hash": "2b923723203132097e6cf6ee5e109893531d343fc7ee3790c2a93bdc0c7b907a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f1f25a89-e345-4078-9849-7b9fd774c3b1", "node_type": "1", "metadata": {}, "hash": "d54d055ecba75f5926474cd263e79cb3b57578d81e91be96a2c8720258e076d1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 222 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nGFSTREFC \nReference Result in \nStandard Format \nChar  \nVariable \nQualifier \nReference value for the result or finding copied or derived from GFORREF in a standard format. \nPerm \nGFSTREFN \nNumeric Reference \nResult in Std Units \nNum  \nVariable \nQualifier \nReference value for continuous or numeric results or findings in standard format or in standard units. \nGFSTREFN uses the same units as GFSTRESN, if applicable. \nPerm \nGFRESCAT \nResult Category \nChar  \nVariable \nQualifier \nUsed to categorize the result of a finding. \nPerm \nGFINHERT \nInheritability \nChar (INHERTGF) \nVariable \nQualifier \nIdentifies whether the variation can be passed to the next generation. \nPerm \nGFGENREF \nGenome Reference \nChar  \nVariable \nQualifier \nAn identifier for the genome reference used to generate the reported result. For example, Genome \nReference Consortium Human Build 38 patch release 13 may be represented as \"GRCh38.p13\". \nPerm \nGFCHROM \nChromosome Identifier \nChar  \nVariable \nQualifier \nThe designation (name or number) of the chromosome or contig on which the variant or other feature \nappears (e.g., \"17\"; \"X\"). \nPerm \nGFSYM \nGenomic Symbol \nChar * \nVariable \nQualifier \nA published symbol for the portion of the genome serving as a locus for the experiment/test. \nPerm \nGFSYMTYP \nGenomic Symbol Type \nChar (SYMTYPGF) \nVariable \nQualifier \nA description of the type of genomic entity that is represented by the published symbol in GFSYM. \nPerm \nGFGENLOC \nGenetic Location \nChar  \nVariable \nQualifier \nSpecifies the location within a sequence for the observed value in GFORRES. \nPerm \nGFGENSR \nGenetic Sub-Region \nChar  \nVariable \nQualifier \nThe portion of the locus in which the variation was found. Examples: \"Exon 15\", \"Kinase domain\". \nPerm \nGFSEQID \nSequence Identifier \n \nChar  \nVariable \nQualifier \nA unique identifier for the sequence used as the reference to identify the genetic variation in the result. \nExamples: \"NM_001234\", \"ENSG00000182533\", \"ENST00000343849.2\". \nPerm \nGFPVRID \nPublished Variant \nIdentifier \nChar  \nVariable \nQualifier \nA unique identifier for the variation that has been publicly characterized in an external database. \nExamples: \"rs2231142\", \"COSM41596\". \nPerm \nGFCOPYID \nCopy Identifier \nChar  \nVariable \nQualifier \nAn arbitrary identifier used to differentiate between copies of a genetic target of interest present on \nhomologous chromosomes. \nPerm \nGFSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or a test was attempted but did \nnot generate a result. Should be null or have a value of \"NOT DONE\". \nPerm \nGFREASND \nReason Test Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with GFSTAT when value is \"NOT DONE\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3051, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f1f25a89-e345-4078-9849-7b9fd774c3b1": {"__data__": {"id_": "f1f25a89-e345-4078-9849-7b9fd774c3b1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 222, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "61a7f0d6-6450-4229-b840-dac0e48ebbc0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 222, "section": "UNSPECIFIED"}, "hash": "2b923723203132097e6cf6ee5e109893531d343fc7ee3790c2a93bdc0c7b907a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "df10fc44-108a-4209-a61e-75aebf12ce21", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 222, "section": "UNSPECIFIED"}, "hash": "6d1d7e99df168aaa0d3493be4c7576239c263b1d1d6ae98f6b25e3e6a1134637", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nGFPVRID \nPublished Variant \nIdentifier \nChar  \nVariable \nQualifier \nA unique identifier for the variation that has been publicly characterized in an external database. \nExamples: \"rs2231142\", \"COSM41596\". \nPerm \nGFCOPYID \nCopy Identifier \nChar  \nVariable \nQualifier \nAn arbitrary identifier used to differentiate between copies of a genetic target of interest present on \nhomologous chromosomes. \nPerm \nGFSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or a test was attempted but did \nnot generate a result. Should be null or have a value of \"NOT DONE\". \nPerm \nGFREASND \nReason Test Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with GFSTAT when value is \"NOT DONE\". \nPerm \nGFXFN \nExternal File Path \nChar  \nRecord \nQualifier \nThe filename and/or path to external data not stored in the same format and possibly not the same \nlocation as the other data for a study. \nPerm \nGFNAM \nLaboratory/Vendor \nName \nChar  \nRecord \nQualifier \nName or identifier of the vendor that provided the test result. When more than 1 vendor is involved in \nthe generation of the result, additional vendors should be represented as supplemental qualifiers. \nPerm \nGFSPEC \nSpecimen Material \nType \nChar (GENSMP) \nRecord \nQualifier \nIdentifies the type of genetic material used for the measurement. \nPerm \nGFMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nThe test method by which the examination is performed by the wet lab in order to yield the result \nreported in the dataset. \nExp \nGFRUNID \nRun ID \nChar  \nRecord \nQualifier \nA unique identifier for a particular run of a test performed by the wet lab on a particular batch of \nsamples. This identifier can be used to distinguish between records for the same test performed at \ndifferent times. \nPerm \nGFANMETH \nAnalysis Method \nChar (GFANMET) \nRecord \nQualifier \nThe method of secondary processing performed by the dry lab to yield the result reported in the \ndataset. \nPerm \nGFBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. \nPerm \nGFDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nGFLLOQ \nLower Limit of \nQuantitation \nNum  \nVariable \nQualifier \nIndicates the lower limit of quantitation for an assay. Units will be those used for GFSTRESU. \nPerm", "mimetype": "text/plain", "start_char_idx": 2273, "end_char_idx": 4817, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "84570f84-d7f2-4911-9623-38e391228e77": {"__data__": {"id_": "84570f84-d7f2-4911-9623-38e391228e77", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 223, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be0ed1b7-277b-4d61-83f0-3fc34c85cc2d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 223, "section": "UNSPECIFIED"}, "hash": "fa371cf7f32503be0bb7943d9299a4bb4dfa136de1c664d1b617564c80a541e1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d7dad901-7c6f-4925-b2a6-6905b4e835d0", "node_type": "1", "metadata": {}, "hash": "2223952f5364beee57dc904cad2d1dbe6df6d9ffaa9a09e1209cb199a328ae5b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 223 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nGFREPNUM Repetition Number \nNum  \nRecord \nQualifier \nThe instance number of a test that is repeated within a given timeframe for the same test performed by \nthe wet lab. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nGFDTC \nDate/Time of Specimen \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nDate and time of specimen collection. \nExp \nGFDY \nStudy Day of Specimen \nCollection \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nGFTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point, such as time \nof last dose. See GFTPTNUM and GFTPTREF. \nPerm \nGFTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of GFTPT used in sorting. \nPerm \nGFELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nElapsed time relative to a planned fixed reference (GFTPTREF). This variable is useful where there \nare repetitive measures. Not a clock time or a date time variable, but an interval, represented as ISO \nduration. \nPerm \nGFTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by GFELTM, GFTPTNUM, and GFTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nGFRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point defined by GFTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nGF \u2013 Assumptions \n1. The Genomics Findings domain is used to represent findings related to the structure, function, evolution, mapping, and editing of subject and non-host \norganism genomic material of interest. This domain includes but is not limited to assessments and results for genetic variation and transcription, and \nsummary measures derived from these assessments. The GF domain is used for findings from characteristics assessed from nucleic acids and may \ninclude subsequent inferences and/or predictions about related proteins/amino acids. However, direct assessments of proteins (e.g., assessments of \namino acids) are out of scope for this domain.  \n2.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2977, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d7dad901-7c6f-4925-b2a6-6905b4e835d0": {"__data__": {"id_": "d7dad901-7c6f-4925-b2a6-6905b4e835d0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 223, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be0ed1b7-277b-4d61-83f0-3fc34c85cc2d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 223, "section": "UNSPECIFIED"}, "hash": "fa371cf7f32503be0bb7943d9299a4bb4dfa136de1c664d1b617564c80a541e1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "84570f84-d7f2-4911-9623-38e391228e77", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 223, "section": "UNSPECIFIED"}, "hash": "402ff2a9c66c101194049c3b417cd7ed3b86ea8197b5269c7f2e4f6fb8b98ade", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nGF \u2013 Assumptions \n1. The Genomics Findings domain is used to represent findings related to the structure, function, evolution, mapping, and editing of subject and non-host \norganism genomic material of interest. This domain includes but is not limited to assessments and results for genetic variation and transcription, and \nsummary measures derived from these assessments. The GF domain is used for findings from characteristics assessed from nucleic acids and may \ninclude subsequent inferences and/or predictions about related proteins/amino acids. However, direct assessments of proteins (e.g., assessments of \namino acids) are out of scope for this domain.  \n2. Regarding genetic testing on non-host organisms (including but not limited to bacteria, viruses, and parasites), the following additional assumptions \napply: \na. \nTests that give genetic results (e.g., expressed in terms of genetic variation, specific sequence information) on non-host organisms that have been \nidentified in subject samples should be represented in GF. To distinguish these findings from subject genetic data, the variable NHOID must be \npopulated to identify the non-host organism as the focus of the record (see Section 9.2, Non-host Organism Identifiers, assumption 2 for more \ninformation). \nb. If the purpose of the test is to detect or determine the identity of a viable, non-host organism or infectious agent in a subject sample, data should be \nrepresented in the Microbiology Specimen (MB) domain. \nc. \nTests that are used to determine the resistance/susceptibility of a non-host organism to a drug on a genetic basis should be represented in the \nMicrobiology Susceptibility (MS) domain.", "mimetype": "text/plain", "start_char_idx": 2146, "end_char_idx": 3993, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "06394022-8d9b-460f-8d12-b8c7c87f9953": {"__data__": {"id_": "06394022-8d9b-460f-8d12-b8c7c87f9953", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 224, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "66ac7d25-2069-48c3-a014-70d939bb643f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 224, "section": "UNSPECIFIED"}, "hash": "627d589edeac7087f54ccea78fa234aa11058411e1b58b719fcd1d5de58744e3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0467941c-4c18-4949-9767-1a57bc193a52", "node_type": "1", "metadata": {}, "hash": "dc21784fce6ce76e811df65a0b4321800571e78fffa129515125637b3181f332", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 224 \n2021-11-29 \nd. If the test provides both genetic data and susceptibility/resistance data, genetic data should be represented in GF and the susceptibility/resistance \ndata should be represented in the MS domain (See Section 6.3.5.7.2, Microbiology Susceptibility, assumption 1b for more information).    \n3. The platform used to detect the finding may be represented in SPDEVID. Attributes used in conjunction with a platform (e.g., assay panel, reagents) \nmay be represented in the Device Identifiers (DI) domain and other associated device domains. See the SDTM Implementation Guide for Medical \nDevices (SDTMIG-MD) for further information about SPDEVID and the device domains. \n4. Values populated in GFCAT and GFSCAT are sponsor-defined and there is no CDISC Controlled Terminology for these variables.  \n5. Genomic symbols are represented in GFSYM.  \na. \nGFTESTCD and GFTEST should not include genomic names or symbols, including but not limited to official gene symbols.  \nb. For human genetic data, standard nomenclature populated in variable GFSYM must be obtained from the genomic symbol list maintained in the \nHUGO Gene Nomenclature Committee (HGNC) database (www.genenames.org). \n6. When populating GFGENSR, caution should be exercised for annotations of loci where more than 1 annotation applies. In such cases, the source of the \nannotation should be captured and documented in Define-XML. In addition, the value populated in GFGENSR may be dependent on the precision of the \nvalue populated in GFSEQID. \n7. Values populated in GFGENREF, GFSEQID, and GFPVRID should reflect the level of granularity collected (e.g., version, build, patch, release) to \nsupport interpretation of the reported result.  \n8. GFMETHOD lists wet lab techniques for the execution of genomics or genetic testing. Methods related to specimen processing or reagents are \nnot represented in GFMETHOD.  \n9. The following variables generally would not be used in GF: --POS, --BODSYS, --ORNRLO, ORNRHI,--STNRLO, --STNRHI, --STNRC, --NRIND, --\nCHRON, --DISTR, --ANTREG, --LOC, --LAT, --DIR, --PORTOT, --LEAD, --CSTATE, --SPCCND, --FAST, --TOX, --TOXGR, --SEV. \nGF \u2013 Examples \nExample 1 \nThis example shows findings from an assessment of single nucleotide and copy number variation generated from biocomputational analysis with wet laboratory \nmethodology targeted genome sequencing. Findings from this assessment show variation from DNA extracted from an individual's tumor tissue. As the DNA \nspecimen was extracted from tumor tissue, the inheritabilty of the variation is considered to be somatic.  \nRow 1: \nShows the predicted amino acid change due to the single nucleotide variant. \nRow 2: \nShows the predicted coding sequence change due to the single nucleotide variant. \nRow 3: \nShows the classification of the variant impact given the predicted amino acid change. \nRow 4: \nShows the number of times the locus specified in variables GFCHROM and GFGENLOC was observed. \nRow 5: \nShows the percent variant read depth to total read depth.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3205, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0467941c-4c18-4949-9767-1a57bc193a52": {"__data__": {"id_": "0467941c-4c18-4949-9767-1a57bc193a52", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 224, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "66ac7d25-2069-48c3-a014-70d939bb643f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 224, "section": "UNSPECIFIED"}, "hash": "627d589edeac7087f54ccea78fa234aa11058411e1b58b719fcd1d5de58744e3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "06394022-8d9b-460f-8d12-b8c7c87f9953", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 224, "section": "UNSPECIFIED"}, "hash": "3d49e3308a25f9ba421b1a161c2e6e15caabe3105a7f96d2ad796d6b036a4afc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "GF \u2013 Examples \nExample 1 \nThis example shows findings from an assessment of single nucleotide and copy number variation generated from biocomputational analysis with wet laboratory \nmethodology targeted genome sequencing. Findings from this assessment show variation from DNA extracted from an individual's tumor tissue. As the DNA \nspecimen was extracted from tumor tissue, the inheritabilty of the variation is considered to be somatic.  \nRow 1: \nShows the predicted amino acid change due to the single nucleotide variant. \nRow 2: \nShows the predicted coding sequence change due to the single nucleotide variant. \nRow 3: \nShows the classification of the variant impact given the predicted amino acid change. \nRow 4: \nShows the number of times the locus specified in variables GFCHROM and GFGENLOC was observed. \nRow 5: \nShows the percent variant read depth to total read depth. \nRow 6: \nShows the number of copies of the gene of interest within the genome of the tumor cell. \nRow 7: \nShows the number of altered exons within the gene of interest in the genome of the tumor cell.", "mimetype": "text/plain", "start_char_idx": 2326, "end_char_idx": 3406, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4642d456-7afb-402b-b66c-1aadaa703c04": {"__data__": {"id_": "4642d456-7afb-402b-b66c-1aadaa703c04", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 225, "section": "0.63 SOMATIC"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1f663f28-5b73-466e-b9ac-78da5972a78e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 225, "section": "0.63 SOMATIC"}, "hash": "c9dccfd584951e7874301aedf089511e3071aebcef5c828876fab05173c30669", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "79eecf99-558e-46ea-a542-bb15eea2fe50", "node_type": "1", "metadata": {}, "hash": "bf6f9ba7948bfd8bf40e0d839d19ea3d071f8b3144708e869d2c9c920ad37d66", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "VARIATION \nGRCh37.75 \n9 \nCDKN2A \nGENE WITH \nPROTEIN \nPRODUCT \n21967751 \nENST00000579755.1 \nCOSM12473 \n/compbio/analysis/120718_SN855_0084_AD13D5ACXX_LCNL-\n361/sampleAnalysis/sample18.TRF001338.01/TRF001338.01.vars.final.xml \nACME \nSEQUENCING \nLLC \nDNA \nTARGETED GENOME \nSEQUENCING \n1 \nDay \n1 \n1 \n2018-\n05-22 \n2 \n9 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n500 \n9 \n2 \nTRF001338 \nCPNUMVAR \nCopy Number \nVariation \nCOPY NUMBER \nALTERATION \nINTERPRETATION \nloss \n \nloss \n \n \nSOMATIC \nVARIATION \nGRCh37.75 \n9 \nCDKN2A \nGENE WITH \nPROTEIN \nPRODUCT \n21967751 \nENST00000579755.1 \nCOSM12473 \n/compbio/analysis/120718_SN855_0084_AD13D5ACXX_LCNL-\n361/sampleAnalysis/sample18.TRF001338.01/TRF001338.01.vars.final.xml \nACME \nSEQUENCING \nLLC \nDNA \nTARGETED GENOME \nSEQUENCING \n1 \nDay \n1 \n1 \n2018-\n05-22 \n2 \nIdentifying information for the gene panel used to generate the result is in the DI domain. The gene panel is represented in SDTM, as the panel used as part of the wet laboratory methodology may change and affects \ninterpretation of the result. The platform in which the gene panel was used is not represented, because it does not provide additional context for the result. \nThe DI example shows the device type and manufacturer for the device identified as ACME GenePanel 500. \ndi.xpt \nRow STUDYID DOMAIN SPDEVID \nDISEQ DIPARMCD DIPARM \nDIVAL \n1 \nABC-123 \nDI \nACME GenePanel 500 1 \nDEVTYPE \nDevice Type \nGene Panel \n2 \nABC-123 \nDI \nACME GenePanel 500 2 \nMANUF \nManufacturer ACME \nExample 2 \nThis example shows findings from an assessment of a known single nucleotide variant in gene ABCG2 using wet laboratory methodology real-time polymerase chain reaction. Findings from this assessment show the \ngenotypes from DNA extracted from the blood of 3 individuals, each with a different genotype at the genetic locus of interest. Because the DNA specimen was extracted from normal blood, the inheritability of the \nvariation is considered to be in the germline.  \nRow 1: \nShows a subject genotype which is homozygous for the variant nucleotide in the reference sequence. \nRow 2: \nShows a subject genotype which is heterozygous for the nucleotide in the reference sequence. \nRow 3: \nShows a subject genotype which is homozygous for the nucleotide in the reference sequence.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2258, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79eecf99-558e-46ea-a542-bb15eea2fe50": {"__data__": {"id_": "79eecf99-558e-46ea-a542-bb15eea2fe50", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 225, "section": "0.63 SOMATIC"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1f663f28-5b73-466e-b9ac-78da5972a78e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 225, "section": "0.63 SOMATIC"}, "hash": "c9dccfd584951e7874301aedf089511e3071aebcef5c828876fab05173c30669", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4642d456-7afb-402b-b66c-1aadaa703c04", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 225, "section": "0.63 SOMATIC"}, "hash": "104ba93bb30b9daf498eb8e555bd4199083f5d082a3f7cf7daf914323a2e977d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Findings from this assessment show the \ngenotypes from DNA extracted from the blood of 3 individuals, each with a different genotype at the genetic locus of interest. Because the DNA specimen was extracted from normal blood, the inheritability of the \nvariation is considered to be in the germline.  \nRow 1: \nShows a subject genotype which is homozygous for the variant nucleotide in the reference sequence. \nRow 2: \nShows a subject genotype which is heterozygous for the nucleotide in the reference sequence. \nRow 3: \nShows a subject genotype which is homozygous for the nucleotide in the reference sequence. \ngf.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nGFSEQ \nGFREFID \nGFTESTCD \nGFTEST \nGFTSTDTL \nGFORRES \nGFORREF \nGFSTRESC \nGFSTREFC \nGFINHERT \nGFGENREF \nGFCHROM \nGFSYM \nGFSYMTYP \nGFGENLOC \nGFSEQID \nGFPVRID \nGFNAM \nGFSPEC \nGFMETHOD \nVISITNUM \nVISIT \nVISITDY \nGFDTC \nGFDY \n1 \nC12345 \nGF \nC12345-\n001 \n1 \nNA18537 \nSNV \nSingle \nNucleotide \nVariation \nGENOTYPE \nT/T \nG/G \nT/T \nG/G \nGERMLINE \nVARIATION \nGRCh38.p13 \n4 \nABCG2 \nGENE WITH \nPROTEIN \nPRODUCT \n4:88131171 \nENSG00000118777 \nrs2231142 \nACME \nLABS \nDNA \nREAL_TIME \nPOLYMERASE CHAIN \nREACTION \n1 \nSCREENING \n-1 \n2020-06-\n25 \n-3 \n2 \nC12345 \nGF \nC12345-\n002 \n2 \nNA07000 \nSNV \nSingle \nNucleotide \nVariation \nGENOTYPE \nG/T \nG/G \nG/T \nG/G \nGERMLINE \nVARIATION \nGRCh38.p13 \n4 \nABCG2 \nGENE WITH \nPROTEIN \nPRODUCT \n4:88131171 \nENSG00000118777 \nrs2231142 \nACME \nLABS \nDNA \nREAL_TIME \nPOLYMERASE CHAIN \nREACTION \n1 \nSCREENING \n-1 \n2020-06-\n25 \n-3 \n3 \nC12345 \nGF \nC12345-\n003 \n3 \nNA00131 \nSNV \nSingle \nNucleotide \nVariation \nGENOTYPE \nG/G \nG/G \nG/G \nG/G \nGERMLINE \nVARIATION \nGRCh38.p13 \n4 \nABCG2 \nGENE WITH \nPROTEIN \nPRODUCT \n4:88131171 \nENSG00000118777 \nrs2231142 \nACME \nLABS \nDNA \nREAL_TIME \nPOLYMERASE CHAIN \nREACTION \n1 \nSCREENING \n-1 \n2020-06-\n25 \n-3 \nExample 3 \nThis example shows transcription levels of genes ACTB and GAPDH and summarized scores from the transcription levels. Transcription levels and scores were determined using biocomputational analysis with wet \nlaboratory methodology targeted transcriptome sequencing. Specific formulas used in biocomputational analyses to generate normalized and summarized score results are respresented when applicable.", "mimetype": "text/plain", "start_char_idx": 1649, "end_char_idx": 3859, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6f5f745b-bdae-4841-a53c-3dbf06020fcb": {"__data__": {"id_": "6f5f745b-bdae-4841-a53c-3dbf06020fcb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.5679 0.5679"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca835ce7-c718-41ec-b221-7068087f69ed", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.5679 0.5679"}, "hash": "1ed89c4f8f554414dcd288f49a8c0ad56694fcdd180dde71449deee822fe686c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/MBP \nhs37d5 \n7 \nACTB \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000646664.1 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nFRAGMENTS \nPER KILOBASE \nMILLION \nFORMULA \n1 \nVISIT \n1 \n1 \n2018-\n09-04 \n2 \n3 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n3 \n1 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nNORMALIZED \nLEVEL", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 329, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9b05d3c8-5293-4c3e-9e33-fd2356dcc275": {"__data__": {"id_": "9b05d3c8-5293-4c3e-9e33-fd2356dcc275", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.0523 1.0523"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3487f585-7221-4adc-a6f0-2ca981300209", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.0523 1.0523"}, "hash": "ea2a5d58af36294209c7e841e2596f23e556fc8ea870f085c3f93c2dfad99724", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/10^6 \nhs37d5 \n7 \nACTB \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000646664.1 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nCOUNTS PER \nMILLION \nFORMULA \n1 \nVISIT \n1 \n1 \n2018-\n09-04 \n2 \n4 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n4 \n1 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nNORMALIZED \nLEVEL", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 317, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9e7a655f-786f-4c19-8f05-680d45397cc7": {"__data__": {"id_": "9e7a655f-786f-4c19-8f05-680d45397cc7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.9935 1.9935"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b1816f85-d6ac-44b8-8397-25bc70fecb34", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.9935 1.9935"}, "hash": "d62c15f511eb44a227676b21cddaa15c68c509daae98b0ead86eedb739605690", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/MBP \nhs37d5 \n7 \nACTB \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000646664.1 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nTRANSCRIPTS \nPER MILLION \nFORMULA \n1 \nVISIT \n1 \n1 \n2018-\n09-04 \n2 \n5 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n5 \n1 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nPERCENTILE \nRANK", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 320, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b91e12ad-1ef9-4e54-935a-c4bd5d5413e6": {"__data__": {"id_": "b91e12ad-1ef9-4e54-935a-c4bd5d5413e6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.37 0.37"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4abf18cd-6ca2-4431-99c4-1270dd3c14d3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.37 0.37"}, "hash": "903f1319458b8245bd0f85d563fd840bef135a39d1e8d456307f68250411eb70", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nhs37d5 \n7 \nACTB \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000646664.1 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \n \n1 \nVISIT \n1 \n1 \n2018-\n09-04 \n2 \n6 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n6 \n1 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nGENETIC \nTRANSCRIPTION \nINDICATOR \nno \n \nno \n \n \nhs37d5 \n7 \nACTB \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000646664.1 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \n \n1 \nVISIT \n1 \n1 \n2018-\n09-04 \n2 \n7 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n7 \n2 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nFRAGMENT \nCOUNT \n23658 \n \n23658 \n23658 \n \nhs37d5 \n12 \nGAPDH \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000396861.5 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \n \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \n8 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n8 \n2 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nNORMALIZED \nLEVEL", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 908, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "63006cf3-3c31-4755-a6e3-e8b0e225ffe6": {"__data__": {"id_": "63006cf3-3c31-4755-a6e3-e8b0e225ffe6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "148.6268 148.6268"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cadeaa97-1ed5-4985-abfa-b50a7617b044", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "148.6268 148.6268"}, "hash": "206ad7045bc8812dd98d579bb075f86410dbc36cf45a6c4d4a60d6dd77f1e704", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/MBP \nhs37d5 \n12 \nGAPDH \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000396861.5 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nFRAGMENTS \nPER KILOBASE \nMILLION \nFORMULA \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \n9 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n9 \n2 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nNORMALIZED \nLEVEL", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 331, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "53e7254c-3345-4562-b205-578a6f5f1b40": {"__data__": {"id_": "53e7254c-3345-4562-b205-578a6f5f1b40", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "691.5607 691.5607"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ab659f33-9ad3-4346-99d9-db60a47fb277", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "691.5607 691.5607"}, "hash": "15fd6bc5c6d605658a6fe35817ad1b081b8262c4b9820556e8b1775246a03321", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/10^6 \nhs37d5 \n12 \nGAPDH \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000396861.5 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nCOUNTS PER \nMILLION \nFORMULA \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \n10 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n10 \n2 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nNORMALIZED \nLEVEL", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 321, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e6f484ee-08d1-4d2c-acf5-de024571696a": {"__data__": {"id_": "e6f484ee-08d1-4d2c-acf5-de024571696a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "521.716 521.716"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1efd0ef9-1b4d-4f22-a896-9332bbb96506", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "521.716 521.716"}, "hash": "8c3b88c7f9fff716283e720ab43f9e885f12aff14fc8f83d72f2c65d47e983b1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "/MBP \nhs37d5 \n12 \nGAPDH \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000396861.5 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nTRANSCRIPTS \nPER MILLION \nFORMULA \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \n11 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n11 \n2 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nPERCENTILE \nRANK", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 324, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d452641-94d6-4033-a67f-21279355620e": {"__data__": {"id_": "7d452641-94d6-4033-a67f-21279355620e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.99 0.99"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "077a5dff-766e-47b1-bd89-2430a61d24bd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.99 0.99"}, "hash": "37865348ae8790b3ceaba98590dcff94c14adb8df77268602598e2b293d959af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "% \nhs37d5 \n12 \nGAPDH \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000396861.5 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \n \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \n12 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n12 \n2 \nABU3908A52 \nAH749754 \nTRNSCPTN \nTranscription \nGENETIC \nTRANSCRIPTION \nINDICATOR \nyes \n \nyes \n \n \nhs37d5 \n12 \nGAPDH \nGENE WITH \nPROTEIN \nPRODUCT \nENST00000396861.5 \nAH749754.fastq.gz \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \n \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \n13 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n13 \n1 \nABC1234567 \nAP483910 \nTRNSCPTN \nTranscription \nNORMALIZED \nLEVEL \n-", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 612, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cc6ff32d-04f0-4f00-826a-3df174e4635c": {"__data__": {"id_": "cc6ff32d-04f0-4f00-826a-3df174e4635c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.046787999 GRCh38.p12"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1231a601-c0f1-426c-944b-bb0bbdf60aa7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "0.046787999 GRCh38.p12"}, "hash": "6cc433b85e13e826103b286230c6dc95f407e8d04481f939eaad4251158d688c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "GAPDH \nGENE WITH \nPROTEIN \nPRODUCT \nNM_001256799.3 \n \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nDIFFERENCES \nOF LOG2 \nINTENSITIES \nFORMULA \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \n15 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n15 \n2 \nABC1234567 \nAP483910 \nGENESIG \nGene \nSignature \nGENETIC \nTRANSCRIPTION \nINTERPRETATION \nLOW \n \nLOW \n \n \nGRCh38.p12 \n \nACTB \nGENE WITH \nPROTEIN \nPRODUCT \nNM_001101.5 \n \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nIFN-1 GENE \nSIGNATURE \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \n16 \nABC-123 \nGF \n123101 \nACME \nGenePanel \n250 \n16 \n3 \nABC1234567 \nAP483910 \nGENESIG \nGene \nSignature \nSCORE \n-", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 613, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c706cdd7-8333-4f43-862d-ee5631692759": {"__data__": {"id_": "c706cdd7-8333-4f43-862d-ee5631692759", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.126819661 GRCh38.p12"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bf43e2df-4b45-4fb2-b73b-8031ffbab3ab", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 226, "section": "1.126819661 GRCh38.p12"}, "hash": "12e506aaeda6c3306facc92087c5b2ccc34bfbfb6fded385edf6d0261d5c6e18", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ACTB \nGENE WITH \nPROTEIN \nPRODUCT \nNM_001101.5 \n \nACME \nRNA \nTARGETED \nTRANSCRIPTOME \nSEQUENCING \nIFN-1 GENE \nSIGNATURE \n1 \nVISIT \n1 \n1 \n2018-\n09-18 \n2 \nIdentifying information for the gene panel used to generate the result is in the DI domain. The gene panel is represented in SDTM, as the panel used as part of the wet laboratory methodology may change and affects \ninterpretation of the result. The platform in which the gene panel was used is not represented, because it does not provide additional context for the result. \nThe DI example shows the device type and manufacturer for the device identified as ACME GenePanel 250. \ndi.xpt \nRow \nSTUDYID \nDOMAIN \nSPDEVID \nDISEQ \nDIPARMCD \nDIPARM \nDIVAL \n1 \nABC-123 \nDI \nACME GenePanel 250 \n1 \nDEVTYPE \nDevice Type \nGene Panel \n2 \nABC-123 \nDI \nACME GenePanel 250 \n2 \nMANUF \nManufacturer \nACME", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 840, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "32d401cc-58e3-4429-96f5-3d48c95cab8b": {"__data__": {"id_": "32d401cc-58e3-4429-96f5-3d48c95cab8b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "851d4b83-5891-417e-ba47-e567b286a375", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}, "hash": "211cbabd70544215e814c4d3a61f1ecc23569421e5afb0150dcf224442898426", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2ba98f45-63dc-429f-928c-40f4fbb37c1c", "node_type": "1", "metadata": {}, "hash": "b2129168e49bd3d05b668629af410757d96d158fc6b53e7d039f8dbedb209349", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 227 \n2021-11-29 \nExample 4 \nThis example shows findings from an assessment of microsatellite instability for genetic subregions that are known to be unstable. DNA extracted from tumor tissue is amplified and the resulting amplicons are \nresolved using wet laboratory methodology capillary electrophoresis.  \nRow 1: \nShows the summarized interpretation of overall microsatellite instability. \nRows 2-6: \nShow whether microsatellite instability is detected in the genetic subregions indicated.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 670, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2ba98f45-63dc-429f-928c-40f4fbb37c1c": {"__data__": {"id_": "2ba98f45-63dc-429f-928c-40f4fbb37c1c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "851d4b83-5891-417e-ba47-e567b286a375", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}, "hash": "211cbabd70544215e814c4d3a61f1ecc23569421e5afb0150dcf224442898426", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "32d401cc-58e3-4429-96f5-3d48c95cab8b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}, "hash": "624b9735d917bcaba6ce6f2d3cecea0cdec5e3534513e1a504e7190b8a3ca2a0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "804e74dc-6476-4ca6-9054-3fc86a9030f7", "node_type": "1", "metadata": {}, "hash": "7b5b2ef766962f74f2ea424a42d37739e831d2769e53b2bba58f626f7ccc26bf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Row 1: \nShows the summarized interpretation of overall microsatellite instability. \nRows 2-6: \nShow whether microsatellite instability is detected in the genetic subregions indicated. \ngf.xpt \nRow STUDYID DOMAIN USUBJID GFSEQ GFREFID \nGFTESTCD GFTEST \nGFTSTDTL \nGFORRES \nGFSTRESC \nGFGENSR GFXFN \nGFNAM \nGFSPEC GFMETHOD \nGFRUNID \nVISITNUM VISIT \nVISITDY GFDTC \nGFDY \n1 \nABC123 \nGF \n123101 \n1 \n4401470-\n2-6 \nMICRISTB \nMicrosatellite \nInstability \nMICROSATELLITE INSTABILITY \nOVERALL STATUS \nMSI-Stable \nMSI-Stable \n \nmsi_abc_gf.csv ACME \nLaboratories \nDNA \nCAPILLARY \nELECTROPHORESIS \nMSI-\n010418 \n1 \nVISIT \n1 \n1 \n2020-02-\n04 \n-2 \n2 \nABC123 \nGF \n123101 \n2 \n4401470-\n2-6 \nMICRISTB \nMicrosatellite \nInstability \nDETECTION \nNot \nDetected \nNot \nDetected \nBAT-25 \nmsi_abc_gf.csv ACME \nLaboratories \nDNA \nCAPILLARY \nELECTROPHORESIS \nMSI-\n010418 \n1 \nVISIT \n1 \n1 \n2020-02-\n04 \n-2 \n3 \nABC123 \nGF \n123101 \n3 \n4401470-\n2-6 \nMICRISTB \nMicrosatellite \nInstability \nDETECTION \nNot \nDetected \nNot \nDetected \nBAT-26 \nmsi_abc_gf.csv ACME \nLaboratories \nDNA \nCAPILLARY \nELECTROPHORESIS \nMSI-\n010418 \n1 \nVISIT \n1 \n1 \n2020-02-\n04 \n-2 \n4 \nABC123 \nGF \n123101 \n4 \n4401470-\n2-6 \nMICRISTB \nMicrosatellite \nInstability \nDETECTION \nNot \nDetected \nNot \nDetected \nMONO-27 \nmsi_abc_gf.csv ACME \nLaboratories \nDNA \nCAPILLARY \nELECTROPHORESIS \nMSI-\n010418 \n1 \nVISIT \n1 \n1 \n2020-02-\n04 \n-2 \n5 \nABC123 \nGF \n123101 \n5 \n4401470-\n2-6 \nMICRISTB \nMicrosatellite \nInstability \nDETECTION \nNot \nDetected \nNot \nDetected \nNR-21 \nmsi_abc_gf.csv ACME \nLaboratories \nDNA \nCAPILLARY \nELECTROPHORESIS \nMSI-\n010418 \n1 \nVISIT \n1 \n1 \n2020-02-\n04 \n-2 \n6 \nABC123 \nGF \n123101 \n6 \n4401470-\n2-6 \nMICRISTB \nMicrosatellite \nInstability \nDETECTION \nNot \nDetected \nNot \nDetected \nNR-24 \nmsi_abc_gf.csv ACME \nLaboratories \nDNA \nCAPILLARY \nELECTROPHORESIS \nMSI-\n010418 \n1 \nVISIT \n1 \n1 \n2020-02-\n04 \n-2 \nExample 5 \nThis example includes 3 datasets (i.e., MB and MS in addition to GF).", "mimetype": "text/plain", "start_char_idx": 487, "end_char_idx": 2405, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "804e74dc-6476-4ca6-9054-3fc86a9030f7": {"__data__": {"id_": "804e74dc-6476-4ca6-9054-3fc86a9030f7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "851d4b83-5891-417e-ba47-e567b286a375", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}, "hash": "211cbabd70544215e814c4d3a61f1ecc23569421e5afb0150dcf224442898426", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2ba98f45-63dc-429f-928c-40f4fbb37c1c", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 227, "section": "UNSPECIFIED"}, "hash": "115ab81f13e2dfd80b8847d4fe45b6d27b007ada6b5ae7c3c4d3f91c35278f95", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The purpose of this 3-part example is to illustrate how these domains are appropriately used in cases where the concepts in each domain are \nvery closely related. Specifically, the example demonstrates the use of these domains by following a subject through a hypothetical scenario of influenza diagnosis, genetic evaluation of the virus, and interpretation \nof drug susceptibility resulting from genetic testing. \nTests that diagnose or identify the presence of an infectious agent in a subject sample are represented in the MB domain, regardless of the methodology used. In this example, the subject was diagnosed with influenza \nA H3N2 via a nucleic acid amplification test (NAAT) at the baseline visit. MBTEST = \"Microbial Organism Identification\" because the assay does not specifically test for the presence of 1 organism or subtype to the \nexclusion of all others. \nmb.xpt \nRow STUDYID DOMAIN USUBJID MBSEQ MBREFID \nMBTESTCD MBTEST \nMBORRES \nMBSTRESC \nMBSPEC MBLOC \nMBMETHOD \nVISITNUM VISIT \nMBDTC \n1 \nINFLU122 MB \nINF01-01 \n1 \nINFLU0101 MCORGIDN Microbial Organism \nIdenitifcation \nINFLUENZA A VIRUS SUBTYPE \nH3N2 \nINFLUENZA A VIRUS SUBTYPE \nH3N2 \nMUCUS \nNOSTRIL NUCLEIC ACID AMPLIFICATION \nTEST \n1 \nBASELINE 2020-06-\n11 \nNext, a series of virus samples extracted from the subject underwent targeted single nucleotide polymorphism (SNP) testing to determine the feasibility of using the neuraminidase inhibitor oseltamivir to treat the \ninfection (i.e., drug susceptibility testing). \nFindings from this testing provide both genetic data in the form of the genotype identified and the susceptibility/resistance data as inferred phenotype. Genotypic findings are represented in the GF domain, and \ninferred susceptibility/resistance in MS. \nThe GFTEST \"Single Nucleotide Variation\" is used for SNP tests. GFTSTDTL indicates that the results are expressed as predicted amino acid change instead of nucleotide change. GFSYM = \"NA\", the published \ngene symbol for the influenza neuraminidase gene. GFGENLOC represents the position in the protein sequence where the targeted variation which confers resistance to oseltamivir occurs. GFSEQID is the reference \nsequence/segment to which the results are compared. \nNote the use of NHOID, which is populated with the name of the organism to which the testing applies. Note: It is important to use this identifier to distinguish between tests that apply to a non-host organism \nand tests that apply to the study subject/host.", "mimetype": "text/plain", "start_char_idx": 2406, "end_char_idx": 4879, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f812c74c-2457-44b4-8731-1f8c33406026": {"__data__": {"id_": "f812c74c-2457-44b4-8731-1f8c33406026", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 229, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca98da3d-9123-4b95-9201-7d2a57a73ead", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 229, "section": "UNSPECIFIED"}, "hash": "fbeae9e15f9dbf71c13d0c821e2a29a0a8ef89ad18fe953bbbea77abe11f4a76", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d2ff1071-3f4f-4513-bb40-9233b1860c55", "node_type": "1", "metadata": {}, "hash": "1e8f0375b78d883e90a4453d5ef5303323f087750b396cdf60656ade7a82de87", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 229 \n2021-11-29 \nIS \u2013 Specification \nis.xpt, Immunogenicity Specimen Assessments \u2014 Findings. One record per test per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar IS \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier Char  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or \nsubmissions involving the product. \nReq \nNHOID \nNon-host Organism ID \nChar  \nIdentifier \nSponsor-defined identifier for a non-host organism which should only be used when the \norganism is the subject of the TEST. This variable should be populated with an intuitive name \nbased on the identity of the non-host organism as reported by a lab (e.g., \"A/California/7/2009 \n(H1N1)\"). It is not to be used as a qualifier of the result in the record on which it appears. \nPerm \nISSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any \nvalid number (including decimals) and does not have to start at 1. \nReq \nISGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nISREFID \nReference ID \nChar  \nIdentifier \nInternal or external specimen identifier. Example: \"458975-01\". \nPerm \nISSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. \nPerm \nISTESTCD \nImmunogenicity \nTest/Exam Short Name \nChar (ISTESTCD) \nTopic \nShort name of the measurement, test, or examination described in ISTEST. It can be used as \na column name when converting a dataset from a vertical to a horizontal format. The value in \nISTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is \nnot valid). ISTESTCD cannot contain characters other than letters, numbers, or underscores. \nReq \nISTEST \nImmunogenicity Test or \nExamination Name \nChar (ISTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The \nvalue in ISTEST cannot be longer than 40 characters. Example: \"Immunoglobulin E\". \nReq \nISTSTCND \nTest Condition \nChar (TESTCOND) \nVariable \nQualifier \nIdentifies any planned condition imposed by the assay system on the specimen at the time the \ntest is performed. \nPerm \nISCNDAGT \nTest Condition Agent \nChar  \nRecord \nQualifier \nThe textual description of the agent used to impose a test condition. Examples are different \nstimulating agents used in immunoassays such as those in the Interferon Gamma Response \nassay (e.g., Mycobacterium tuberculosis ESAT-6, CFP-10, TB 7.7, Mitogen).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2975, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d2ff1071-3f4f-4513-bb40-9233b1860c55": {"__data__": {"id_": "d2ff1071-3f4f-4513-bb40-9233b1860c55", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 229, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca98da3d-9123-4b95-9201-7d2a57a73ead", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 229, "section": "UNSPECIFIED"}, "hash": "fbeae9e15f9dbf71c13d0c821e2a29a0a8ef89ad18fe953bbbea77abe11f4a76", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f812c74c-2457-44b4-8731-1f8c33406026", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 229, "section": "UNSPECIFIED"}, "hash": "a19d7a6b098bf2ff6f9bbcc64d0b2f5e75de6a45b0761b0a02561a4f9a7ed429", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Req \nISTEST \nImmunogenicity Test or \nExamination Name \nChar (ISTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The \nvalue in ISTEST cannot be longer than 40 characters. Example: \"Immunoglobulin E\". \nReq \nISTSTCND \nTest Condition \nChar (TESTCOND) \nVariable \nQualifier \nIdentifies any planned condition imposed by the assay system on the specimen at the time the \ntest is performed. \nPerm \nISCNDAGT \nTest Condition Agent \nChar  \nRecord \nQualifier \nThe textual description of the agent used to impose a test condition. Examples are different \nstimulating agents used in immunoassays such as those in the Interferon Gamma Response \nassay (e.g., Mycobacterium tuberculosis ESAT-6, CFP-10, TB 7.7, Mitogen). \nPerm \nISBDAGNT \nBinding Agent \nChar (MICROORG)(ISBDAGT) \nVariable \nQualifier \nText description of the agent that is binding to the entity in the ISTEST variable. ISBDAGNT is \nused to indicate that there is a binding relationship between the entities in the ISTEST and \nISBDAGNT variables, regardless of direction. \nISBDAGNT is not a method qualifier. It should only be used when the actual interest of the \nmeasurement is the binding interaction between the 2 entities in ISTEST and ISBDAGNT. In \nother words, the combination of ISTEST and ISBDAGNT should describe the entity or the \nanalyte being measured, without the need for additional variables. \nThe binding agent may be (but is not limited to) a test article, a portion of the test article, a \nrelated compound, an endogenous molecule, an allergen, or an infectious agent. \nPerm \nISTSTOPO \nTest Operational \nObjective \nChar (TSTOPOBJ) \nVariable \nQualifier \nText description of the high-level purpose of the test at the operational level. If populated, valid \nvalues are \"SCREEN\", \"CONFIRM\", and \"QUANTIFY\". \nPerm \nISMSCBCE \nMolecule Secreted by \nCells \nChar  \nVariable \nQualifier \nText description of the entity secreted by the cells represented in ISTEST. The combination of \nISTEST and ISMSCBCE should describe the entity or the analyte being measured, without the \nneed for additional variables. \nPerm \nISTSTDTL \nTest Detail \nChar  \nVariable \nQualifier \nFurther description of ISTESTCD and ISTEST. \nPerm \nISCAT \nCategory for \nImmunogenicity Test \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values across subjects. Example: \"SEROLOGY\". \nPerm \nISSCAT \nSubcategory for \nImmunogenicity Test \nChar * \nGrouping \nQualifier \nA further categorization of ISCAT. \nPerm", "mimetype": "text/plain", "start_char_idx": 2211, "end_char_idx": 4724, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ad2325e9-4a7a-47e2-8369-8aa8795ab031": {"__data__": {"id_": "ad2325e9-4a7a-47e2-8369-8aa8795ab031", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 230, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d195a567-24fd-49cd-8066-59fd78454ca1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 230, "section": "UNSPECIFIED"}, "hash": "45d901050ee82f0fb04794ab80d783ea7d7e361be790c42e6c8cc4fc5d78bd10", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "39c8be5f-4427-4c03-bcd7-7364e47575f7", "node_type": "1", "metadata": {}, "hash": "cd4a06f5f9908a7b9a1de17eb82890f8567d76a2a0b2c22ebb67f5fb1eec8d21", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 230 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nISORRES \nResults or Findings in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nISORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for ISORRES. Examples: \"Index \nValue\", \"gpELISA\", \"unit/mL\". \nExp \nISORNRLO \nReference Range Lower \nLimit in Orig Unit \nChar  \nVariable \nQualifier \nLower end of reference range for continuous measurement in original units. Should be \npopulated only for continuous results. \nExp \nISORNRHI \nReference Range Upper \nLimit in Orig Unit \nChar  \nVariable \nQualifier \nUpper end of reference range for continuous measurement in original units. Should be \npopulated only for continuous results. \nExp \nISSTRESC \nCharacter Result/Finding \nin Std Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from ISORRES, in a standard format \nor in standard units. ISSTRESC should store all results or findings in character format; if \nresults are numeric, they should also be stored in numeric format in ISSTRESN. \nExp \nISSTRESN \nNumeric \nResults/Findings in Std. \nUnits \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format \nfrom ISSTRESC. ISSTRESN should store all numeric test results or findings. \nExp \nISSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for ISSTRESC and ISSTRESN. Examples: \"Index Value\", \"gpELISA\", \n\"unit/mL\". \nExp \nISSTNRLO \nReference Range Lower \nLimit-Std Units \nNum  \nVariable \nQualifier \nLower end of reference range for continuous measurements for ISSTRESC/ISSTRESN in \nstandardized units. Should be populated only for continuous results. \nExp \nISSTNRHI \nReference Range Upper \nLimit-Std Units \nNum  \nVariable \nQualifier \nUpper end of reference range for continuous measurements in standardized units. Should be \npopulated only for continuous results. \nExp \nISSTNRC \nReference Range for \nChar Rslt-Std Units \nChar  \nVariable \nQualifier \nFor normal range values that are character in ordinal scale or if categorical ranges were \nsupplied. Examples: \"-1 to +1\", \"NEGATIVE TO TRACE\". \nPerm \nISNRIND \nReference Range \nIndicator \nChar (NRIND) \nVariable \nQualifier \nIndicates where the value falls with respect to reference range defined by ISORNRLO and \nISORNRHI, ISSTNRLO and ISSTNRHI, or by ISSTNRC. Examples: \"NORMAL\", \n\"ABNORMAL\", \"HIGH\", \"LOW\". \nSponsors should specify in the study metadata (Comments column in the Define-XML \ndocument) whether ISNRIND refers to the original or standard reference ranges and results. \nShould not be used to indicate clinical significance. \nExp \nISSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate a test was not done. Should be null if a result exists in ISORRES.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3144, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "39c8be5f-4427-4c03-bcd7-7364e47575f7": {"__data__": {"id_": "39c8be5f-4427-4c03-bcd7-7364e47575f7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 230, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d195a567-24fd-49cd-8066-59fd78454ca1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 230, "section": "UNSPECIFIED"}, "hash": "45d901050ee82f0fb04794ab80d783ea7d7e361be790c42e6c8cc4fc5d78bd10", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ad2325e9-4a7a-47e2-8369-8aa8795ab031", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 230, "section": "UNSPECIFIED"}, "hash": "a76721e809a5e43bfd716ea5dae1aae3c8909bcccd2aa8102dc4ff3994668a44", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"-1 to +1\", \"NEGATIVE TO TRACE\". \nPerm \nISNRIND \nReference Range \nIndicator \nChar (NRIND) \nVariable \nQualifier \nIndicates where the value falls with respect to reference range defined by ISORNRLO and \nISORNRHI, ISSTNRLO and ISSTNRHI, or by ISSTNRC. Examples: \"NORMAL\", \n\"ABNORMAL\", \"HIGH\", \"LOW\". \nSponsors should specify in the study metadata (Comments column in the Define-XML \ndocument) whether ISNRIND refers to the original or standard reference ranges and results. \nShould not be used to indicate clinical significance. \nExp \nISSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate a test was not done. Should be null if a result exists in ISORRES. \nPerm \nISREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a measurement or test was not performed. Used in conjunction with ISSTAT \nwhen value is \"NOT DONE\". \nPerm \nISNAM \nVendor Name \nChar  \nRecord \nQualifier \nName or identifier of the laboratory or vendor who provided the test results. \nPerm \nISSPEC \nSpecimen Type \nChar (SPECTYPE) \nRecord \nQualifier \nDefines the types of specimen used for a measurement. Example: \"SERUM\". \nPerm \nISSPCCND \nSpecimen Condition \nChar (SPECCOND) \nRecord \nQualifier \nFree or standardized text describing the condition of the specimen. Examples: \"HEMOLYZED\", \n\"ICTERIC\", \"LIPEMIC\". \nPerm \nISSPCUFL \nSpecimen Usability for \nthe Test \nChar (NY) \nRecord \nQualifier \nDescribes the usability of the specimen for the test. The value will be \"N\" if the specimen is not \nusable, and null if the specimen is usable. \nPerm \nISMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"ELISA\", \"ELISPOT\". \nPerm \nISLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. \nThe value should be \"Y\" or null. \nPerm \nISBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that ISBLFL is retained \nfor backward compatibility. The authoritative baseline for statistical analysis is in an ADaM \ndataset. \nPerm \nISDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Examples of records that \nmight be derived for the submission datasets include those that represent the average of other \nrecords, do not come from the CRF, or are not as originally received or collected. If \nPerm", "mimetype": "text/plain", "start_char_idx": 2462, "end_char_idx": 4966, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "54da89d2-b94e-41a8-aa2e-1c641c49bce0": {"__data__": {"id_": "54da89d2-b94e-41a8-aa2e-1c641c49bce0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 231, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d4243e59-b8ef-4df9-91a7-57642d7b152c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 231, "section": "UNSPECIFIED"}, "hash": "916c23fb7ed2a52d07434a2ab0a12b7e536b6ad4c46314a89767dc5cc98b5819", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a78c8a1a-95ad-4f3e-a65a-3f864cb4e4cf", "node_type": "1", "metadata": {}, "hash": "7ddb73ecc50baede660b249fb43e536a6dc70455b4f843dcc08e1096dba84d94", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 231 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nISDRVFL=\"Y\", then ISORRES may be null, with ISSTRESC and (if numeric) ISSTRESN \nhaving the derived value. \nISLLOQ \nLower Limit of \nQuantitation \nNum  \nVariable \nQualifier \nIndicates the lower limit of quantitation for an assay. Units will be those used for ISSTRESU. \nExp \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. May be used in addition to VISITNUM \nand/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the observation, or the date/time of collection if \nstart date/time is not collected. \nPerm \nISDTC \nDate/Time of Collection \nChar ISO 8601 datetime or \ninterval \nTiming \nCollection date and time of an observation. \nExp \nISENDTC \nEnd Date/Time of \nSpecimen Collection \nChar ISO 8601 datetime or \ninterval \nTiming \nEnd date/time of the observation. \nPerm \nISDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to sponsor-defined \nRFSTDTC in Demographics. \nPerm \nISENDY \nStudy Day of End of \nSpecimen Collection \nNum  \nTiming \nActual study day of end of observation expressed in integer days relative to the sponsor-\ndefined RFSTDTC in Demographics. \nPerm \nISTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when specimen should be taken. This may be represented as an \nelapsed time relative to a fixed reference point, such as time of last dose. See ISTPTNUM and \nISTPTREF. Examples: \"Start\", \"5 min post\". \nPerm \nISTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of ISTPT to aid in sorting. \nPerm \nISELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a planned fixed reference (ISTPTREF). This \nvariable is useful where there are repetitive measures. Not a clock time or a date/time variable. \nRepresented as ISO 8601 duration. Examples: \"-PT15M\" to represent the period of 15 minutes \nprior to the reference point indicated by ISTPTREF, \"PT8H\" to represent the period of 8 hours \nafter the reference point indicated by ISTPTREF. \nPerm \nISTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by ISELTM, ISTPTNUM, and ISTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2980, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a78c8a1a-95ad-4f3e-a65a-3f864cb4e4cf": {"__data__": {"id_": "a78c8a1a-95ad-4f3e-a65a-3f864cb4e4cf", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 231, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d4243e59-b8ef-4df9-91a7-57642d7b152c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 231, "section": "UNSPECIFIED"}, "hash": "916c23fb7ed2a52d07434a2ab0a12b7e536b6ad4c46314a89767dc5cc98b5819", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "54da89d2-b94e-41a8-aa2e-1c641c49bce0", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 231, "section": "UNSPECIFIED"}, "hash": "bdee4c9ca3c3fc9092d159b2a3cd3f9537c5a2ea38a1018ef483cdff3527959e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nISELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a planned fixed reference (ISTPTREF). This \nvariable is useful where there are repetitive measures. Not a clock time or a date/time variable. \nRepresented as ISO 8601 duration. Examples: \"-PT15M\" to represent the period of 15 minutes \nprior to the reference point indicated by ISTPTREF, \"PT8H\" to represent the period of 8 hours \nafter the reference point indicated by ISTPTREF. \nPerm \nISTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by ISELTM, ISTPTNUM, and ISTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nISRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time of the reference time point, ISTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nIS \u2013 Assumptions \n1. The Immunogenicity Specimen Assessments (IS) domain holds assessments that describe whether a therapy (e.g., biologic, drug, vaccine) \nprovoked/caused/induced an immune response in a subject. The response can be either positive or negative. For example, a vaccine is expected to \ninduce a beneficial immune response, whereas a cellular therapy (e.g., erythropoiesis-stimulating agents) may cause an adverse immune response. \n2. The IS domain also holds assessments that describe whether an allergen, microorganism, or endogenous molecule provoked/caused/induced an immune \nresponse in a subject, such as a subject's antibody reaction (autoantibodies) against auto/self-antigens for autoimmune studies or antibody production in \nresponse to allergens in allergy trials. Expected outputs can be positive or negative, present or absent for the antibody of interest, as well as \nquantification of the antibody. Assessments pertaining to antibodies produced in response to microbial infection will also be represented in the IS \ndomain.", "mimetype": "text/plain", "start_char_idx": 2289, "end_char_idx": 4349, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "da231f08-1936-4fbf-b3e1-64569b16f8fb": {"__data__": {"id_": "da231f08-1936-4fbf-b3e1-64569b16f8fb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 232, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f67acc2f-221d-412b-a722-bfff43ee31bb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 232, "section": "UNSPECIFIED"}, "hash": "5ecc745969f0648f74c01bfdaefc97a1948446e5e9f58d84c215d9cb92a0b895", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4adce80a-a47d-4983-90e8-2a1b35ec6d54", "node_type": "1", "metadata": {}, "hash": "c29b683334f1d3146336ab0ae86e5f870e8400542bf75582eaff3f25bf309869", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 232 \n2021-11-29 \n3. Assessments about all other types of \"induced\" humoral (antibody) immune response in a subject (e.g., antibodies against human leukocyte antigen \n(HLA) proteins) will also be represented in the IS domain. \n4. Certain types of cellular immune responses will also be modeled in IS using non-flow cytometry techniques (see example 6). Flow cytometry data \nshould be modeled in the Cell Phenotype Findings (CP) domain, section 6.3.5.3. \n5. An exception is made to the class of antigen/antibody (Ag/Ab) combination assays. Microbial antigen/antibody (Ag/Ab) combination tests should be \nrepresented in the Microbiology Specimen (MB) domain. An example is fourth-generation HIV Ag/Ab combination tests, which are commonly seen as \nHIV identification or detection assays rather than tests that provide additional details on and characterization of a subject\u2019s immunological responses. \nThe outputs of these assays can be expected as reactive, non-reactive, or indeterminate. Whereas some tests generate separate outputs for antigen and \nantibody, others just indicate \u201creactive\u201d when either or both are detected. Output is generally based on relative light units, where a result of \n\"reactive\" typically requires the signal to cutoff ratio to be greater than 1. \n6. Measurements of cytokines, chemokines, and complement proteins should be represented in the Laboratory Test Results (LB) domain. \n7. The IS domain variable ISBDAGNT (Binding Agent) is currently supported by 2 Controlled Terminology codelists: Microorganism (MICROORG) and \nBinding Agent for Immunogenicity Tests (ISBDAGT). Controlled Terminology Rules for Immunogenicity Tests describes how and when to use each \ncodelist (see https://www.cdisc.org/standards/terminology/controlled-terminology).  \na. \nFor antidrug antibody (ADA) tests, the ISBDAGNT variable is used to represent the free-text description of the name/identity of the therapy \nthe antidrug antibody targets. CDISC does not control study therapy names (e.g., drugs, biologics). For ADA tests as a part of regulatory agency \nsubmissions, the proprietary binding study therapy name(s) should be considered as extended values of the ISBDAGT codelist when represented in \nDefine-XML. \nb. For mixed-allergens panel tests, submission values represented in the ISBDAGNT variable should follow this format: \u201cXXX, Multiple\u201d (e.g., Dairy \nMix Antigens, Multiple; Animal Mix Antigens, Multiple; use the plural form for the word \u201cantigen\u201d if needed). Should the sponsor wish to specify \nthe individual antigens in a mixed antigens panel (e.g., ISBDAGNT = \u201cAnimal Mix Antigens, Multiple\u201d), put the names of the specific antigens in \nSuppqual (e.g., Cat, Dog, Cow, Horse; see example 11). \n8. The IS domain variable ISTSTOPO (Test Operational Objective) is supported by a nonextensible Controlled Terminology codelist containing the values \nSCREEN, CONFIRM, and QUANTIFY. \n9.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3084, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4adce80a-a47d-4983-90e8-2a1b35ec6d54": {"__data__": {"id_": "4adce80a-a47d-4983-90e8-2a1b35ec6d54", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 232, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f67acc2f-221d-412b-a722-bfff43ee31bb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 232, "section": "UNSPECIFIED"}, "hash": "5ecc745969f0648f74c01bfdaefc97a1948446e5e9f58d84c215d9cb92a0b895", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "da231f08-1936-4fbf-b3e1-64569b16f8fb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 232, "section": "UNSPECIFIED"}, "hash": "aa7933cb13edfdaa936e275efe48805c315f54f569c4bb810c04290c03d11ed6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b. For mixed-allergens panel tests, submission values represented in the ISBDAGNT variable should follow this format: \u201cXXX, Multiple\u201d (e.g., Dairy \nMix Antigens, Multiple; Animal Mix Antigens, Multiple; use the plural form for the word \u201cantigen\u201d if needed). Should the sponsor wish to specify \nthe individual antigens in a mixed antigens panel (e.g., ISBDAGNT = \u201cAnimal Mix Antigens, Multiple\u201d), put the names of the specific antigens in \nSuppqual (e.g., Cat, Dog, Cow, Horse; see example 11). \n8. The IS domain variable ISTSTOPO (Test Operational Objective) is supported by a nonextensible Controlled Terminology codelist containing the values \nSCREEN, CONFIRM, and QUANTIFY. \n9. For vaccine studies, in order to distinguish collected data between study vaccine-induced immunogenicity and immunogenicity findings unrelated to the \nstudy vaccine (i.e., immunity as a result of natural infection or previous vaccination), the following ISCAT and ISSCAT values are recommended (see \nexample 5):  \na. \nFor immunological data pertaining to the study vaccine, ISCAT = STUDY VACCINE-RELATED IMMUNOGENICITY. \nb. For immunological data collected during the vaccine trial but which are not assessments about the study vaccine, ISCAT = NON-STUDY-\nRELATED IMMUNOGENICITY. \nc. \nFor assessments measuring the induced-antibody response, ISSCAT = HUMORAL IMMUNITY. \nd. For assessments measuring the induced-cellular response, ISSCAT = CELLULAR IMMUNITY. \n10. Any Identifier variables, Timing variables, or Findings general observation class qualifiers may be added to the IS domain.", "mimetype": "text/plain", "start_char_idx": 2404, "end_char_idx": 3971, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45774988-1d0d-47f5-bc9b-a1c45e5a6e6d": {"__data__": {"id_": "45774988-1d0d-47f5-bc9b-a1c45e5a6e6d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8216ea82-d3d6-4717-8668-230c8071509f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}, "hash": "e53cb80a41f86c2fe603fd81b37f732fa12969a004ed7f61a314a10cdfeaa5ed", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "135242e9-46a0-4f29-b834-5d74b00b7636", "node_type": "1", "metadata": {}, "hash": "3a851d99f4642303ab4c8fd7c847aea49c6f10ea5d0dd926c774ab9996e62fe8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 233 \n2021-11-29 \nIS \u2013 Examples \nExample 1 \nThis example shows data from tiered testing of antidrug antibody (ADA). \nTiered testing scheme for ADA evaluation generally includes the following steps: screening, confirmatory, and \"characterization\" of the antidrug antibody. In tier 1, all evaluable samples are run in a screening assay. \nSamples that are positive for ADA in the screen assay are then analyzed in a confirmatory assay (tier 2). The samples that are positive for ADA in both the screen and confirmatory tiers of testing are further tested in \ntier 3; this frequently includes analysis of antibody titer and neutralizing activity. In order to illustrate the distinctive differences between the 3 tiers of ADA testing, the standard variable ISTSTOPO is used to \nrepresent the controlled values SCREEN, CONFIRM, and QUANTIFY. These values help to describe the operational objective or the reason behind each testing step/tier, and also to provide uniqueness to each row \nof record. The study drug AZ-007, which induces the subject's production of, and is the target of the antidrug antibody, is represented by the variable ISBDAGNT. ISGRPID is used in this example to show that the \nrecords are related to each other; in this particular case, tests are done in a tiered, sequential manner from screen to confirm to quantification of the detected antidrug antibody. \nLastly, antibody titer is often defined as the reciprocal of the lowest dilution of a sample generating a signal that is above the assay cut-point. Alternatively, the titer is defined as the reciprocal of the dilution of a \nsample generating a signal that is equivalent to the assay cut-point, calculated by an interpolation formula provided in an assay specific bioanalytical method. \nRow 1: \nShows the screening of the presence of ADA to drug AZ-007. \nRow 2: \nShows the confirmation of the previously detected ADA to drug AZ-007. \nRow 3: \nShows the measurement of titer of the ADA from the screen and confirmatory steps.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2176, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "135242e9-46a0-4f29-b834-5d74b00b7636": {"__data__": {"id_": "135242e9-46a0-4f29-b834-5d74b00b7636", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8216ea82-d3d6-4717-8668-230c8071509f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}, "hash": "e53cb80a41f86c2fe603fd81b37f732fa12969a004ed7f61a314a10cdfeaa5ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "45774988-1d0d-47f5-bc9b-a1c45e5a6e6d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}, "hash": "f976c0594659da298b80e3c6ca73b27914ea30558f2b60ab65745f4cd9aa1c0a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "195ba108-a512-40c9-99e6-6cf3e87a961e", "node_type": "1", "metadata": {}, "hash": "11abdfe620d7b466d4f7ac67f13d8d636d33504e6e54699fe2654c05e859659e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ISGRPID is used in this example to show that the \nrecords are related to each other; in this particular case, tests are done in a tiered, sequential manner from screen to confirm to quantification of the detected antidrug antibody. \nLastly, antibody titer is often defined as the reciprocal of the lowest dilution of a sample generating a signal that is above the assay cut-point. Alternatively, the titer is defined as the reciprocal of the dilution of a \nsample generating a signal that is equivalent to the assay cut-point, calculated by an interpolation formula provided in an assay specific bioanalytical method. \nRow 1: \nShows the screening of the presence of ADA to drug AZ-007. \nRow 2: \nShows the confirmation of the previously detected ADA to drug AZ-007. \nRow 3: \nShows the measurement of titer of the ADA from the screen and confirmatory steps. \nis.xpt \nRow STUDYID DOMAIN USUBJID ISSEQ ISREFID  ISGRPID ISTESTCD ISTEST \nISBDAGNT ISTSTOPO ISCAT \nISSCAT \nISORRES \nISORRESU ISSTRESC ISSTRESN  ISSTRESU ISSPEC \nISMETHOD \nVISITNUM VISIT ISDTC \n 1 \n ABC \nIS  \n ABC-002  1 \n V555 \n1 \nADA_BAB \nBinding \nAntidrug \nAntibody \nDRUG AZ-\n007 \nSCREEN \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE   \nPOSITIVE   \n \nSERUM  ELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 2 \n ABC \nIS \n ABC-002  2 \n V555 \n1 \nADA_BAB \nBinding \nAntidrug \nAntibody \nDRUG AZ-\n007 \nCONFIRM \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE   \nPOSITIVE   \n \nSERUM \nELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 3 \n ABC \nIS  \n ABC-002  3 \n V555 \n1 \nADA_BAB \nBinding \nAntidrug \nAntibody \nDRUG AZ-\n007 \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n50 \ntiter \n50 \n50 \ntiter \nSERUM  ELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \nExample 2 \nThis example shows data from various subtypes of ADA tests.  \nAlthough most ADAs do not inhibit the pharmacodynamic activity of a drug, neutralizing antidrug antibodies (NAbs) can inhibit drug activity soon after a drug is administered. Most ADAs (those that are not \nclassified as NAbs) can lower the drug's systemic exposure by increasing the rate of drug clearance, resulting in a clinically similar outcome to that of NAbs (i.e., reduced clinical efficacy). \nIn this example, the administered drug is an analogue of an endogenous protein. The example data include ADA reactions against both the administered drug and the endogenous protein. Both the study drug and the \nendogenous protein are represented by the standard variable ISBDAGNT, which qualifies ISTEST. The variable ISTSTOPO, is also used in this dataset to describe the purpose of each testing step, and provides \nuniqueness among similar records.", "mimetype": "text/plain", "start_char_idx": 1321, "end_char_idx": 4011, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "195ba108-a512-40c9-99e6-6cf3e87a961e": {"__data__": {"id_": "195ba108-a512-40c9-99e6-6cf3e87a961e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8216ea82-d3d6-4717-8668-230c8071509f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}, "hash": "e53cb80a41f86c2fe603fd81b37f732fa12969a004ed7f61a314a10cdfeaa5ed", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "135242e9-46a0-4f29-b834-5d74b00b7636", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 233, "section": "UNSPECIFIED"}, "hash": "d8d7ba65d7c14922a2a048495513a3c310100365844dd26e7be026975442484e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although most ADAs do not inhibit the pharmacodynamic activity of a drug, neutralizing antidrug antibodies (NAbs) can inhibit drug activity soon after a drug is administered. Most ADAs (those that are not \nclassified as NAbs) can lower the drug's systemic exposure by increasing the rate of drug clearance, resulting in a clinically similar outcome to that of NAbs (i.e., reduced clinical efficacy). \nIn this example, the administered drug is an analogue of an endogenous protein. The example data include ADA reactions against both the administered drug and the endogenous protein. Both the study drug and the \nendogenous protein are represented by the standard variable ISBDAGNT, which qualifies ISTEST. The variable ISTSTOPO, is also used in this dataset to describe the purpose of each testing step, and provides \nuniqueness among similar records. ISGRPID is used to show which records are related in this dataset. \nNote that, in this example, even though only confirmatory records are reported and shown, it is assumed that the screening step has also been performed. \nRows 1-2: \nShow the confirmation and quantification of binding ADA to coagulation factor VIII analogue drug. A binding antidrug antibody is an antibody that binds to a drug. \nRows 3-4: \nShow the confirmation and quantification of the neutralizing binding ADA to coagulation factor VIII analogue drug. A neutralizing binding antidrug antibody is a type of ADA that binds to the \nfunctional portion of a drug, leading to diminished or negated pharmacological activity. The neutralizing ADAs are a subset of the total ADAs.", "mimetype": "text/plain", "start_char_idx": 3160, "end_char_idx": 4754, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1f8254d4-923a-4c7a-866d-88999c9f7420": {"__data__": {"id_": "1f8254d4-923a-4c7a-866d-88999c9f7420", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d3a898da-94ed-477a-9931-9f6ae930ae49", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}, "hash": "da7674436f404f13dd670e0d62d976dd1f9c6b85fc3672c1eb329a82f7cd49dc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "4e61d6d3-0f30-452b-bbb6-1b3165f1bb86", "node_type": "1", "metadata": {}, "hash": "743f59eb41d7c9373530d226227d2863be493495844dac591d289b8d84df842d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 234 \n2021-11-29 \nRows 5-6: \nShow the confirmation and quantification of the cross-reactive binding ADA to the endogenous coagulation factor VIII. A cross-reactive binding antidrug antibody is a type of ADA that binds to \nendogenous molecules, also a subset of the total ADAs. \nRows 7-8: \nShow the confirmation and quantification of the neutralizing cross-reactive binding ADA to the endogenous coagulation factor VIII. Neutralizing cross-reactive binding antidrug antibodies are a type of \nADA that bind to endogenous molecules, leading to diminished or negated function; in some cases, they may also bind and negate the function of the study drug. They are a subset of the total ADAs. \nis.xpt \nRow STUDYID DOMAIN USUBJID ISSEQ ISREFID ISGRPID ISTESTCD ISTEST \nISBDAGNT \nISTSTOPO ISCAT \nISSCAT  \nISORRES \nISORRESU ISSTRESC ISSTRESN  ISSTRESU ISSPEC \nISMETHOD \nVISITNUM VISIT \nISDTC \n 1 \n ABC \nIS  \n ABC-001  1 \nA42839 \n1 \nADA_BAB \nBinding \nAntidrug \nAntibody \nCOAGULATION \nFACTOR VIII \nANALOGUE DRUG \nCONFIRM \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY  \nPOSITIVE   \nPOSITIVE  \n \n \nSERUM  \nELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 2 \n ABC \nIS  \n ABC-001  2 \nA42839 \n1 \nADA_BAB \nBinding \nAntidrug \nAntibody \nCOAGULATION \nFACTOR VIII \nANALOGUE DRUG \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n30 \ntiter \n30  \n30  \ntiter \nSERUM  \nELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 3 \n ABC \nIS  \n ABC-001  3 \n A42839 \n2 \nADA_NAB \nNeutralizing \nBinding \nAntidrug \nAntibody \nCOAGULATION \nFACTOR VIII \nANALOGUE DRUG \nCONFIRM \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE   \nPOSITIVE  \n \n \nSERUM  \nHEMAGGLUTINATION INHIBITION \nASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 4 \n ABC \nIS  \n ABC-001  4 \n A42839 \n2 \nADA_NAB \nNeutralizing \nBinding \nAntidrug \nAntibody \nCOAGULATION \nFACTOR VIII \nANALOGUE DRUG \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n60 \ntiter \n60  \n60  \ntiter \nSERUM  \nHEMAGGLUTINATION INHIBITION \nASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 5 \n ABC \nIS  \n ABC-001", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2188, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4e61d6d3-0f30-452b-bbb6-1b3165f1bb86": {"__data__": {"id_": "4e61d6d3-0f30-452b-bbb6-1b3165f1bb86", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d3a898da-94ed-477a-9931-9f6ae930ae49", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}, "hash": "da7674436f404f13dd670e0d62d976dd1f9c6b85fc3672c1eb329a82f7cd49dc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1f8254d4-923a-4c7a-866d-88999c9f7420", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}, "hash": "c659933b01c08a6b85b78d6772d701241a30487f23e54a28fbdc8900a066a757", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9cb4c9aa-f83e-43fe-8e1e-eef03cc2a67c", "node_type": "1", "metadata": {}, "hash": "13d77fafb3f82d7947e28d26dc294fde76b086b075d98b705c1d97c095fe7a75", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CONFIRM \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE   \nPOSITIVE  \n \n \nSERUM  \nHEMAGGLUTINATION INHIBITION \nASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 4 \n ABC \nIS  \n ABC-001  4 \n A42839 \n2 \nADA_NAB \nNeutralizing \nBinding \nAntidrug \nAntibody \nCOAGULATION \nFACTOR VIII \nANALOGUE DRUG \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n60 \ntiter \n60  \n60  \ntiter \nSERUM  \nHEMAGGLUTINATION INHIBITION \nASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 5 \n ABC \nIS  \n ABC-001  5 \n A42839 \n3 \nADA_X \nCross-Reactive \nBinding \nAntidrug \nAntibody \nENDOGENOUS \nCOAGULATION \nFACTOR VIII \nCONFIRM \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE   \nPOSITIVE  \n \n \nSERUM   ELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 6 \n ABC \nIS  \n ABC-001  6 \n A42839 \n3 \nADA_X \nCross-Reactive \nBinding \nAntidrug \nAntibody \nENDOGENOUS \nCOAGULATION \nFACTOR VIII \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n90 \ntiter \n90 \n90 \ntiter \nSERUM   ELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 7 \n ABC \nIS  \n ABC-001  7 \n A42839 \n4 \nADA_NX \nNeutraliz \nCross-React \nBind Antidrug \nAB \nENDOGENOUS \nCOAGULATION \nFACTOR VIII \nCONFIRM \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE   \nPOSITIVE  \n \n \nSERUM  \nHEMAGGLUTINATION INHIBITION \nASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 8 \n ABC \nIS  \n ABC-001  8 \n A42839 \n4 \nADA_NX \nNeutraliz \nCross-React \nBind Antidrug \nAB \nENDOGENOUS \nCOAGULATION \nFACTOR VIII \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n150 \ntiter \n150 \n150 \ntiter \nSERUM  \nHEMAGGLUTINATION INHIBITION \nASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \nExample 3 \nThis example shows data about ADA reaction against drug components. \nThis example shows the production of ADA in response to both the prodrug and its active metabolite. A prodrug is a compound that, after administration, is metabolized into a pharmacologically active drug. Note \nthat, in this example, even though only confirmatory records are reported and shown, it is assumed that the screening step has also been performed.", "mimetype": "text/plain", "start_char_idx": 1735, "end_char_idx": 3720, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9cb4c9aa-f83e-43fe-8e1e-eef03cc2a67c": {"__data__": {"id_": "9cb4c9aa-f83e-43fe-8e1e-eef03cc2a67c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d3a898da-94ed-477a-9931-9f6ae930ae49", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}, "hash": "da7674436f404f13dd670e0d62d976dd1f9c6b85fc3672c1eb329a82f7cd49dc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4e61d6d3-0f30-452b-bbb6-1b3165f1bb86", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 234, "section": "UNSPECIFIED"}, "hash": "8fe0abb70d1232165ed51036dd5d247764c3f7be61ba82adac71c4dbbf0a6f4e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "8 \n A42839 \n4 \nADA_NX \nNeutraliz \nCross-React \nBind Antidrug \nAB \nENDOGENOUS \nCOAGULATION \nFACTOR VIII \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n150 \ntiter \n150 \n150 \ntiter \nSERUM  \nHEMAGGLUTINATION INHIBITION \nASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \nExample 3 \nThis example shows data about ADA reaction against drug components. \nThis example shows the production of ADA in response to both the prodrug and its active metabolite. A prodrug is a compound that, after administration, is metabolized into a pharmacologically active drug. Note \nthat, in this example, even though only confirmatory records are reported and shown, it is assumed that the screening step has also been performed. \nRows 1-2: \nShow the confirmation and quantification of the ADA against prodrug A. \nRows 3-4: \nShow the confirmation and quantification of the ADA against the active metabolite of prodrug A. \nis.xpt \nRow STUDYID DOMAIN USUBJID ISSEQ ISREFID  ISGRPID ISTESTCD ISTEST \nISBDAGNT \nISTSTOPO ISCAT \nISSCAT \nISORRES \nISORRESU ISSTRESC ISSTRESN  ISSTRESU ISSPEC \nISMETHOD \nVISITNUM VISIT \nISDTC \n 1 \n ABC \nIS  \n ABC-004  1 \n J123 \n1 \nADA_BAB \nBinding \nAntidrug \nAntibody \nPRODRUG A \nCONFIRM \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE   \nPOSITIVE  \n \n \nSERUM  ELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27 \n 2 \n ABC \nIS  \n ABC-004  2 \n J123 \n1 \nADA_BAB \nBinding \nAntidrug \nAntibody \nPRODRUG A \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n30 \ntiter \n30  \n30  \ntiter \nSERUM  ELECTROCHEMILUMINESCENCE \nIMMUNOASSAY \n 1 \nVISIT \n1 \n2017-\n07-27", "mimetype": "text/plain", "start_char_idx": 3028, "end_char_idx": 4582, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b7c66650-7b80-41f6-ad3f-c6db15a88001": {"__data__": {"id_": "b7c66650-7b80-41f6-ad3f-c6db15a88001", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 235, "section": "4.7 4.7"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d5d9cd94-11b8-48dc-b20f-1d4c6f697296", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 235, "section": "4.7 4.7"}, "hash": "38e613f3f3c46556959c9604579645d03cb3a05999d27e330a1e06994fd82ca2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "titer \nSERUM  REPORTER GENE \nIMMUNOASSAY \n1 \nVISIT \n1  \n2017-\n07-27  \n 6 \n ABC \nIS  \nABC-008 \n6 \n V4 \nADA_BAB \nBinding Antidrug \nAntibody \nACTIVE INTERFERON BETA \n1A \nSCREEN \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nNEGATIVE   \nNEGATIVE   \n \nSERUM  IMMUNOASSAY \n1 \nVISIT \n1 \n2017-\n08-27 \n 7 \n ABC \nIS  \nABC-008 \n7 \n V4 \nADA_BAB \nBinding Antidrug \nAntibody \nPEG EPITOPE OF \nPEGINTERFERON BETA1A \nSCREEN \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE  \n \nPOSITIVE  \n \n \nSERUM  ELISA \n1 \nVISIT \n1 \n2017-\n08-27 \n 8 \n ABC \nIS  \nABC-008  8  \n V4 \nADA_BAB  Binding Antidrug \nAntibody \nPEG EPITOPE OF \nPEGINTERFERON BETA1A  \nCONFIRM \nANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \nPOSITIVE  \n \nPOSITIVE  \n \n \n SERUM ELISA \n1  \nVISIT \n1  \n2017-\n08-27  \n 9 \n ABC \n IS \nABC-008  9  \n V4 \nADA_BAB  Binding Antidrug \nAntibody \nPEG EPITOPE OF \nPEGINTERFERON BETA1A  \nQUANTIFY ANTIDRUG \nANTIBODIES \nHUMORAL \nIMMUNITY \n40 \ntiter \n40  \n40 \ntiter \nSERUM  ELISA \n1 \nVISIT \n1  \n2017-\n08-27  \nExample 5 \nThis example illustrates how to represent both study vaccine-induced humoral (antibody) immunity, and immunogenicity responses not related to the study vaccine but which are also important for collection, \nspecifically in vaccine trials. \nIn this case, the subject was administered with a human respiratory syncytial virus (RSV) vaccine and his protective antibody production against the major component of the study vaccine, RSV-protein B, was \nassessed. Detection and quantification of the anti-RSV-protein B antibody data from baseline to post-vaccination were collected and are represented below. At baseline, antibody against RSV-protein Z was detected", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1638, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "442c0c49-243c-4a73-9c61-fd52500f93b6": {"__data__": {"id_": "442c0c49-243c-4a73-9c61-fd52500f93b6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9831a442-860c-4d42-80be-452420dc3575", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}, "hash": "4eea6a989c6870be20e73d7ef9379d54d04b9557a6fe2fe019ab0667a27a71cb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "02e26e92-73c6-4a04-90e9-263f242bc9ae", "node_type": "1", "metadata": {}, "hash": "7552386b0638371f12a3b8108d03873d1d85568eb93e5dccdd5f1b8b4f4a4f35", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 236 \n2021-11-29 \nin the same subject, which suggests either natural infection by or previous vaccination with RSV-protein B at the time of assessment. Even though immunity against RSV-protein B was not the interest of the RSV \nvaccine study, immunological data pertaining to RSV-protein B was collected for the subject. \nThis example illustrates the use of the CDISC-recommended ISCAT values \"STUDY VACCINE-RELATED IMMUNOGENICITY\" and \"NON-STUDY-RELATED IMMUNOGENICITY\" to distinguish between \nstudy vaccine-induced immunogenicity and immunogenicity findings unrelated to the study vaccine data collected during a vaccine study. ISCAT = \"NON-STUDY-RELATED IMMUNOGENICITY\" was \ndeveloped to explicitly and purposefully indicate whether an observed immunity toward an antigen was not related to the study vaccine but rather was a result of natural infection or previous vaccination. Oftentimes, \nit is simply impossible to tell whether the antibody found in a subject is due to a natural infection or previous vaccination (or both)\u2014yet this immunogenicity, unrelated to the study vaccine, is important for collection \nand assessment at the screening phase of the trial. \nIn this example, immune responses against RSV-protein Z were measured during the study. Because protein Z is not inserted into the vaccine vector, any immune response detected toward protein Z was not related \nto the study vaccine, although important for assessment and collected per the study protocol. In order to show that RSV-protein Z-induced antibody production was unrelated to the immunity solicited by the study \nvaccine RSV-protein B (ISCAT = \"STUDY VACCINE-RELATED IMMUNOGENICITY\"), the ISCAT for rows 3 and 4 is \u201cNON-STUDY-RELATED IMMUNOGENICITY\u201d (note: protein Z and protein B are \nexamples, refer to controlled terminology for standard terms associated with ISBDAGNT). \nRows 1-2: \nShow the screening and quantification of microbial-induced immunoglobulin G (IgG) antibody against the RSV-protein B at baseline, prior to the administration of the study vaccine. \nISBDAGNT=\"HUMAN RESPIRATORY SYNCYTIAL VIRUS-PROTEIN B\" is the immunogenic target in the study vaccine that could potentially stimulate the production of antibodies. Note: \nISCAT=\"STUDY VACCINE-RELATED IMMUNOGENICITY\", even though at this point the study vaccine has not been administered to the subject; this is done purposefully to enable the grouping of \nbaseline and treatment measurements. \nRows 3-4: \nShow the screening and quantification of microbial-induced IgG antibody against the RSV-protein Z at baseline. Note: Because RSV-protein Z is not the immunogenic target of interest in this vaccine \nstudy, ISCAT is populated with the value \"NON-STUDY RELATED IMMUNOGENICITY\". \nRows 5-7: \nShow the titer of microbial-induced IgG antibody against the RSV-protein B, post-vaccination at visits 1, 2, and 3. These 3 records show the antibody titers had increased post-vaccination, presumably \ndue to the stimulation from the RSV study vaccine. ISCAT is populated with the value \"STUDY VACCINE-RELATED IMMUNOGENICITY\". \nis.xpt \nRow", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3255, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "02e26e92-73c6-4a04-90e9-263f242bc9ae": {"__data__": {"id_": "02e26e92-73c6-4a04-90e9-263f242bc9ae", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9831a442-860c-4d42-80be-452420dc3575", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}, "hash": "4eea6a989c6870be20e73d7ef9379d54d04b9557a6fe2fe019ab0667a27a71cb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "442c0c49-243c-4a73-9c61-fd52500f93b6", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}, "hash": "8426c7f191f85b3d5bc82d01d06ecdd6b60783b9abc6acce9429b9f7d42fd0f0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7e1547c1-d0f8-4d8f-851e-29b29e647a59", "node_type": "1", "metadata": {}, "hash": "9e84bd46eaab41665afd06141482defd00e8da79d80a08938ad9a71038aae57f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rows 3-4: \nShow the screening and quantification of microbial-induced IgG antibody against the RSV-protein Z at baseline. Note: Because RSV-protein Z is not the immunogenic target of interest in this vaccine \nstudy, ISCAT is populated with the value \"NON-STUDY RELATED IMMUNOGENICITY\". \nRows 5-7: \nShow the titer of microbial-induced IgG antibody against the RSV-protein B, post-vaccination at visits 1, 2, and 3. These 3 records show the antibody titers had increased post-vaccination, presumably \ndue to the stimulation from the RSV study vaccine. ISCAT is populated with the value \"STUDY VACCINE-RELATED IMMUNOGENICITY\". \nis.xpt \nRow STUDYID DOMAIN USUBJID \nISSEQ ISREFID ISGRPID ISTESTCD ISTEST \nISBDAGNT \nISTSTOPO ISCAT \nISSCAT \nISORRES \nISSTRESC ISSTRESN ISSTRESU ISSPEC ISMETHOD VISITNUM VISIT \nISDTC \n1 \nRSV1230 \nIS \nRSV1230-\n011 \n1 \n13668 \n1 \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nB \nSCREEN \nSTUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \nPOSITIVE POSITIVE \n \n \nSERUM ELISA \n1 \nBASELINE 2017-\n05-27 \n2 \nRSV1230 \nIS \nRSV1230-\n011 \n2 \n13668 \n1 \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nB \nQUANTIFY STUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:25 \n25 \n25 \ntiter \nSERUM ELISA \n1 \nBASELINE 2017-\n05-27 \n3 \nRSV1230 \nIS \nRSV1230-\n011 \n1 \n13668 \n2 \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nZ \nSCREEN \nNON-STUDY-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \nPOSITIVE POSITIVE \n \n \nSERUM ELISA \n1 \nBASELINE 2017-\n05-27 \n4 \nRSV1230 \nIS \nRSV1230-\n011 \n2 \n13668 \n2 \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nZ \nQUANTIFY NON-STUDY-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:120 \n120 \n120 \ntiter \nSERUM ELISA \n1 \nBASELINE 2017-\n05-27 \n5 \nRSV1230 \nIS \nRSV1230-\n011 \n1 \n13669 \n \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nB \nQUANTIFY STUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:90 \n90 \n90 \ntiter", "mimetype": "text/plain", "start_char_idx": 2619, "end_char_idx": 4674, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e1547c1-d0f8-4d8f-851e-29b29e647a59": {"__data__": {"id_": "7e1547c1-d0f8-4d8f-851e-29b29e647a59", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9831a442-860c-4d42-80be-452420dc3575", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}, "hash": "4eea6a989c6870be20e73d7ef9379d54d04b9557a6fe2fe019ab0667a27a71cb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "02e26e92-73c6-4a04-90e9-263f242bc9ae", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 236, "section": "UNSPECIFIED"}, "hash": "8f88d5069c6cb57603a274d5600dc9fa0218e8f90eb879172c56c240dff86197", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "IS \nRSV1230-\n011 \n2 \n13668 \n2 \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nZ \nQUANTIFY NON-STUDY-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:120 \n120 \n120 \ntiter \nSERUM ELISA \n1 \nBASELINE 2017-\n05-27 \n5 \nRSV1230 \nIS \nRSV1230-\n011 \n1 \n13669 \n \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nB \nQUANTIFY STUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:90 \n90 \n90 \ntiter \nSERUM ELISA \n2 \nVISIT 1 \n2017-\n07-27 \n6 \nRSC1230 IS \nRSV1230-\n011 \n2 \n13670 \n \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nB \nQUANTIFY STUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:220 \n220 \n220 \ntiter \nSERUM ELISA \n3 \nVISIT 2 \n2017-\n08-27 \n7 \nRSC1230 IS \nRSV1230-\n011 \n3 \n13671 \n \nMBIGGAB \nMicrobial-induced \nIgG Antibody \nHUMAN RESPIRATORY \nSYNCYTIAL VIRUS-PROTEIN \nB \nQUANTIFY STUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:500 \n500 \n500 \ntiter \nSERUM ELISA \n4 \nVISIT 3 \n2017-\n09-27 \nThus far, all the IS tests illustrated are measurements of concentrations of a substance (e.g., antibody titer). However, some immunogenicity tests are actual counts of immune cells that secrete a particular substance. \nThese tests are described by the combination of ISTEST (Immunogenicity Test or Examination Name) and ISMSCBCE (Molecule Secreted by Cells), where ISTEST identifies the type of cells that secrete a specific", "mimetype": "text/plain", "start_char_idx": 4212, "end_char_idx": 5657, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2a0788ae-6724-4469-9868-884a786f154a": {"__data__": {"id_": "2a0788ae-6724-4469-9868-884a786f154a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "58b7659b-9e72-4c6f-843c-25065d34c049", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}, "hash": "fd5351de49b5a9a91f92edbc83e457dc42193142259e433cbee0232a441463bc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3a63c0f7-6f7a-45ea-96f4-029231a56b2d", "node_type": "1", "metadata": {}, "hash": "e6a0a2705306fd01e2bdef081697fd957aa880b969db528b62d02fe88b193ef4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 237 \n2021-11-29 \nsubstance (e.g., antibody-secreting cells, cytokine-secreting cells) and ISMSCBCE names the substance (e.g., IgG antibody, interferon-gamma). The following 2 examples introduce the IS domain-specific variable, \nISMSCBCE, and illustrate its use with ISTEST to represent a complete immunological analyte of interest. \nExample 6 \nThis example shows data about the assessment of antibody-secreting cells (ASCs). \nTraditional methods such as enzyme-linked immunosorbent assay (ELISA) that monitor humoral immune responses after immunization or infection typically only quantify specific antibody titers in serum. These \nmethods do not provide any information about the actual number and location of the immune cells that secrete antibodies or cytokines. \nThe enzyme-linked immunospot (ELISpot) assay is a method to detect and quantify analyte-secreting T or B cells. During ELISpot testing, a colored precipitate forms and appears as spots at the sites of analyte \nlocalization (analytes typically are cytokines or antibodies), with each individual spot representing an individual analyte-secreting cell. The spots can be counted with an automated ELISpot reader system or \nmanually, using a stereomicroscope. This example shows how to represent the quantification of ASCs as the number of spots per million peripheral blood mononuclear cells (PBMC) as determined by B-cell ELISpot \nfrom a vaccine trial. \nThe IS domain-specific variable ISMSCBCE introduced in this example allows flexibility in data representation and post-coordination of the various secreted antibody types and their respective ASCs. This approach \nliberates the ISTEST variable from having to house precoordinated and thus hyperspecific values crafted based on secretion and cell types. \nRow 1: \nShows the total number of IgG ASCs from a subject\u2019s blood sample. In this case, ISTEST=\"Antibody-secreting Cells\"; the entity secreted by the cells in ISTEST is represented by the variable \nISMSCBCE (i.e. IGG antibody non-specific to any antigen). \nRow 2: \nShows the number of H1-specific IgG ASCs from the same subject\u2019s blood sample. In this case, ISTEST=\"Antibody-secreting Cells\"; the entity secreted by the cells in ISTEST is in ISMSCBCE (i.e. \nIgG antibody specific to H1 antigen). \nRow 3: \nShows the number of H3-specific IgG ASCs from the same subject\u2019s blood sample. In this case, ISTEST=\"Antibody-secreting Cells\"; the entity secreted by the cells in ISTEST is in ISMSCBCE (i.e. \nIgG antibody specific to H3 antigen).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2685, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3a63c0f7-6f7a-45ea-96f4-029231a56b2d": {"__data__": {"id_": "3a63c0f7-6f7a-45ea-96f4-029231a56b2d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "58b7659b-9e72-4c6f-843c-25065d34c049", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}, "hash": "fd5351de49b5a9a91f92edbc83e457dc42193142259e433cbee0232a441463bc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2a0788ae-6724-4469-9868-884a786f154a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}, "hash": "f52eab674b410f96210bf364247ce2d73cdefc6ff2e5f8599195ac8fe2b010ca", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e2a691cb-b4ae-46a4-99c9-c50f3d00f1ad", "node_type": "1", "metadata": {}, "hash": "98cd1cdfa30ef30a07fe57c692ee2bfd70805f6938f2d6073fd30632ee79c018", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In this case, ISTEST=\"Antibody-secreting Cells\"; the entity secreted by the cells in ISTEST is represented by the variable \nISMSCBCE (i.e. IGG antibody non-specific to any antigen). \nRow 2: \nShows the number of H1-specific IgG ASCs from the same subject\u2019s blood sample. In this case, ISTEST=\"Antibody-secreting Cells\"; the entity secreted by the cells in ISTEST is in ISMSCBCE (i.e. \nIgG antibody specific to H1 antigen). \nRow 3: \nShows the number of H3-specific IgG ASCs from the same subject\u2019s blood sample. In this case, ISTEST=\"Antibody-secreting Cells\"; the entity secreted by the cells in ISTEST is in ISMSCBCE (i.e. \nIgG antibody specific to H3 antigen). \nis.xpt \nRow STUDYID DOMAIN USUBJID ISSEQ ISREFID \nISTESTCD ISTEST \nISMSCBCE \nISCAT \nISSCAT \nISORRES ISORRESU \nISSTRESC ISSTRESN ISSTRESU \nISSPEC \nISMETHOD ISDTC \n1 \nINFL456 \nIS \nINF02-01 \n1 \nSAMPBL0201 ABSCCL \nAntibody-\nsecreting Cells \nIGG ANTIBODY \nSTUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n2019 \nSFC/10^6 \nPBMC \n2019 \n2019 \nSFC/10^6 \nPBMC \nPERIPHERAL BLOOD \nMONONUCLEAR CELL \nELISPOT \n2011-08-\n08 \n2 \nINFL456 \nIS \nINF02-01 \n2 \nSAMPBL0201 ABSCCL \nAntibody-\nsecreting Cells \nINFLUENZA H1-SPECIFIC \nIGG ANTIBODY \nSTUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n626 \nSFC/10^6 \nPBMC \n626 \n626 \nSFC/10^6 \nPBMC \nPERIPHERAL BLOOD \nMONONUCLEAR CELL \nELISPOT \n2011-08-\n08 \n3 \nINFL456 \nIS \nINF02-01 \n3 \nSAMPBL0201 ABSCCL \nAntibody-\nsecreting Cells \nINFLUENZA H3-SPECIFIC \nIGG ANTIBODY \nSTUDY VACCINE-RELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n592 \nSFC/10^6 \nPBMC \n592 \n592 \nSFC/10^6 \nPBMC \nPERIPHERAL BLOOD \nMONONUCLEAR CELL \nELISPOT \n2011-08-\n08 \n \nExample 7 \nThis example shows data from the in vitro assessment and quantification of cytokine-secreting immune cells, expressed in number of spot-forming cells (SFC) per million peripheral blood mononuclear cells (PBMC) \nas determined by T-cell ELISpot from a vaccine trial. \nThrough vaccination, it is expected that cytokine secretion in immune cells is boosted whenever immune cells encounter the same virus and/or the previously exposed viral antigens. By increasing this cytokine \nsecretion, immune cells aid in the host defense and protection against (re-)infections.", "mimetype": "text/plain", "start_char_idx": 2024, "end_char_idx": 4229, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e2a691cb-b4ae-46a4-99c9-c50f3d00f1ad": {"__data__": {"id_": "e2a691cb-b4ae-46a4-99c9-c50f3d00f1ad", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "58b7659b-9e72-4c6f-843c-25065d34c049", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}, "hash": "fd5351de49b5a9a91f92edbc83e457dc42193142259e433cbee0232a441463bc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3a63c0f7-6f7a-45ea-96f4-029231a56b2d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 237, "section": "UNSPECIFIED"}, "hash": "645d544c203d7bf7703a101fdc6f3cb7917654df3423ca9a240c8f0b5b6a4e7b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Through vaccination, it is expected that cytokine secretion in immune cells is boosted whenever immune cells encounter the same virus and/or the previously exposed viral antigens. By increasing this cytokine \nsecretion, immune cells aid in the host defense and protection against (re-)infections. In vaccine trials, this can be measured by isolating immune cells (e.g., PBMCs) from subjects at multiple time points during the \ncourse of the trial and restimulating them with the virus or its viral antigens in vitro. \nIn this example, PBMCs were isolated from a subject participating a vaccine study for RSV and restimulated in vitro with either a RSV-antigen or without a stimulating agent. At baseline (i.e., before vaccination), \nthe RSV antigen-stimulated PBMCs produced minimal number of interferon gamma, as expressed in interferon gamma-secreting cells quantified in the number of SFC/10^6 PBMC (row 2), as compared to no \nstimulation (row 1). Three weeks after vaccination, RSV-antigen stimulated PBMCs (row 4) showed significant increase in the number of interferon-gamma secreting cells compared to no stimulation (row 3) or \nbaseline values (rows 1 and 2). This suggests immunological memory of the immune cells after encountering the same microorganism or its antigens, and the switch of cell state from resting to active.", "mimetype": "text/plain", "start_char_idx": 3933, "end_char_idx": 5267, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f36e9340-6c9c-4742-ba99-6c55e651fc6d": {"__data__": {"id_": "f36e9340-6c9c-4742-ba99-6c55e651fc6d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 238, "section": "260.5 260.5"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "790264fe-15dc-49c1-b185-a73e0edef92b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 238, "section": "260.5 260.5"}, "hash": "381cda1c3be1c202f5f2da0941e327f85ce74691746f5ef319ebd6898ff5113d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SFC/10^6 \nPBMC \nPERIPHERAL \nBLOOD \nMONONUCLEAR \nCELL \nELISPOT \n2 \nVISIT 1 \n2017-\n08-27 \nThe next 2 examples show data from microneutralization and opsonophagocytic killing (OPK) assays, which are used to measure vaccine efficacy and immunoprotectivity. \nExample 8 \nIn vaccine studies, microneutralization assays are commonly used in assays to quantify viral-specific neutralizing antibodies in a subject\u2019s specimen that can block viral infection in vitro, and therefore provide a \nmeasure of vaccine efficacy. A neutralizing antibody is an antibody that binds to, blocks, and prevents non-self agents from infecting cells. \nWhen immunizing a subject with a vaccine, the hope is that the vaccine will induce antiviral and humoral-protective antibody responses in the subject; with an effective vaccine, the quantity of virus-specific \nantibodies that are able to block viral infection are increased. To test the efficacy of a vaccine, a microneutralization test is performed by adding a vaccinated subject's serum and the virus of study interest to cell \ncultures in vitro. If neutralizing antibodies are present in the subject's serum post-vaccination, those antibodies will bind to, block, and prevent the virus from infecting cells in the culture plates. The neutralization \ntiter is the specific dilution of the antibody that blocks viral infection of the cells. The 50% neutralization titer (also known as NT50), in the context of microneutralization assays, is defined as the antiviral antibody \ntiter that blocks 50% of viral infection of the cells. Note: Some users may represent the 50% neutralization titer as \"IC50 titer\" or other test descriptors. CDISC recommends mapping all such values in the ISTSTDTL \nvariable. \nNHOID is populated with respiratory syncytial virus because this microorganism is the subject of the vaccine efficacy test. \nNHOID, defined by the Non-host Organism Identifiers (OI) domain, should be used to map microorganisms that have been either experimentally determined in the course of a study or are previously known (e.g., \nlab strains used as reference in the study). In other words, NHOID is used when the study subject is the microorganism, and when the microorganism is present in the testing sample. In vaccine efficacy studies, a \nsubject\u2019s post-immunization sera is often incubated with a microbial strain of interest, where the functional capacities of the vaccine-induced antibodies are measured through whether the antibodies can effectively \nstop (from infection), neutralize, and kill the study microorganism of interest, in vitro. Examples of such tests include microneutralization, hemagglutination inhibition, and opsonophagocytic-killing assays. These \nare tests that measure the direct effect of the antimicrobial antibodies on the microorganism; therefore, said microorganism is the study subject and should be mapped to NHOID. \nThis example uses data from the same RSV vaccine study, where the subject is being vaccinated with a viral vector containing RSV. The subject is tested before (baseline) and after vaccination (visits 1 and 2) to \ninvestigate whether the anti-RSV antibodies present in the subject\u2019s serum also have the ability to neutralize RSV infection in vitro.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3230, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5b3d7a70-146e-4187-8f8a-f8824991eaef": {"__data__": {"id_": "5b3d7a70-146e-4187-8f8a-f8824991eaef", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48803f8a-3b97-49e6-aa8b-1f1907feba63", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}, "hash": "d20c01881279b556ddb630dbbbb16a84e403aad84d90367427f9698deba91e7f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9213185-ce37-447c-8679-45fe54b3d241", "node_type": "1", "metadata": {}, "hash": "5b3bb308053ef0aa79b13a3a2642ba42356076f74a44f60f2d6590d27f01e948", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 239 \n2021-11-29 \nis.xpt \nRow STUDYID DOMAIN USUBJID \nNHOID \nISSEQ ISREFID ISTESTCD ISTEST \nISBDAGNT \nISTSTDTL \nISCAT \nISSCAT \nISORRES ISSTRESC ISSTRESN ISSTRESU ISSPEC ISMETHOD \nVISITNUM VISIT \nISDTC \n1 \nRSV1230 \nIS \nRSV1230-\n011 \nRESPIRATORY \nSYNCYTIAL \nVIRUS \n1 \n13668 \nMBNAB \nNeutralizing \nMicrobial-\ninduced \nAntibody \nRESPIRATORY \nSYNCYTIAL \nVIRUS \nNEUTRALIZING \nTITER 50% \nSTUDY VACCINE-\nRELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:40 \n40 \n40 \ntiter \nSERUM MICRONEUTRALIZATION \nASSAY \n1 \nBASELINE 2017-\n05-27 \n2 \nRSV1230 \nIS \nRSV1230-\n011 \nRESPIRATORY \nSYNCYTIAL \nVIRUS \n2 \n13668 \nMBNAB \nNeutralizing \nMicrobial-\ninduced \nAntibody \nRESPIRATORY \nSYNCYTIAL \nVIRUS \nNEUTRALIZING \nTITER 50% \nSTUDY VACCINE-\nRELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:80 \n80 \n80 \ntiter \nSERUM MICRONEUTRALIZATION \nASSAY \n2 \nVISIT 1 \n2017-\n07-27 \n3 \nRSV1230 \nIS \nRSV1230-\n011 \nRESPIRATORY \nSYNCYTIAL \nVIRUS \n3 \n13668 \nMBNAB \nNeutralizing \nMicrobial-\ninduced \nAntibody \nRESPIRATORY \nSYNCYTIAL \nVIRUS \nNEUTRALIZING \nTITER 50% \nSTUDY VACCINE-\nRELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1:200 \n200 \n200 \ntiter \nSERUM MICRONEUTRALIZATION \nASSAY \n3 \nVISIT 2 \n2017-\n08-27 \nExample 9 \nIn vaccine trials, the OPK assay is used as a correlate for immunoprotectivity against antigens, by measuring the functional capacities of vaccine-induced antibodies. \nTypically, this test is performed by incubating a subject's post-immunization sera with the bacterial strain of interest, phagocytes, and complement proteins. If antibacterial, functional antibodies are present in the \nsubject's serum, those antibodies will bind to the bacteria together with complement proteins. This subsequently targets the bacteria for opsonization, the ingestion and destruction of invading non-self \nagents by phagocytes. With vaccination, the quantity of bacterial-specific, functional antibodies are increased, leading to a decreased number of viable bacterial cells in the presence of phagocytes, functional \nantibodies, and complement. The assay read-out is expressed in by the opsonization index, which is calculated using linear interpolation of the serum dilution containing functional antibody killing the desired \npercentage (usually 50%) of the bacteria, using a specified algorithm.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2429, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d9213185-ce37-447c-8679-45fe54b3d241": {"__data__": {"id_": "d9213185-ce37-447c-8679-45fe54b3d241", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48803f8a-3b97-49e6-aa8b-1f1907feba63", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}, "hash": "d20c01881279b556ddb630dbbbb16a84e403aad84d90367427f9698deba91e7f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5b3d7a70-146e-4187-8f8a-f8824991eaef", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}, "hash": "bbb92826d62e7499c196b58746501ac7e27ece6a7aec8a9a3e93daa0e1956318", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "105a7552-d0c0-477c-abd0-03ada12281c9", "node_type": "1", "metadata": {}, "hash": "bc93f6c84aef617e8a8637181564857a75b839cc5f747d54105c73078aed7959", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Typically, this test is performed by incubating a subject's post-immunization sera with the bacterial strain of interest, phagocytes, and complement proteins. If antibacterial, functional antibodies are present in the \nsubject's serum, those antibodies will bind to the bacteria together with complement proteins. This subsequently targets the bacteria for opsonization, the ingestion and destruction of invading non-self \nagents by phagocytes. With vaccination, the quantity of bacterial-specific, functional antibodies are increased, leading to a decreased number of viable bacterial cells in the presence of phagocytes, functional \nantibodies, and complement. The assay read-out is expressed in by the opsonization index, which is calculated using linear interpolation of the serum dilution containing functional antibody killing the desired \npercentage (usually 50%) of the bacteria, using a specified algorithm. \nNHOID is populated with Staphylococcus aureus 04-02981 because this strain of S. aureus is the subject of the vaccine efficacy test. \nNHOID, defined by the Non-host Organism Identifiers (OI) domain, should be used to map microorganisms that have been either experimentally determined in the course of a study or are previously known (e.g., \nlab strains used as reference in the study). In other words, NHOID is used when the study subject is the microorganism, and when the microorganism is present in the testing sample. In vaccine efficacy studies, a \nsubject\u2019s post-immunization sera is often incubated with a microbial strain of interest, where the functional capacities of the vaccine-induced antibodies are measured through whether the antibodies can effectively \nstop (from infection), neutralize, and kill the study microorganism of interest, in vitro. Examples of such tests include microneutralization, hemagglutination inhibition, and opsonophagocytic-killing assays. These \nare tests that measure the direct effect of the antimicrobial antibodies on the microorganism; therefore, said microorganism is the study subject and should be mapped to NHOID. \nIn this vaccine-study example, the subject is vaccinated with a vector containing S. aureus-epitope X (note: epitope X is an example, refer to controlled terminology for standard terms associated with ISBDAGNT). \nThe subject is tested before (baseline) and after vaccination (visits 1 and 2) to investigate whether the vaccine-induced functional antibodies drive efficient complement deposition and subsequent opsonophagocytic \nkilling of S. aureus, in vitro. The assay read-out is expressed by the opsonization index (ISTSTDTL), which is a unit-less test.", "mimetype": "text/plain", "start_char_idx": 1513, "end_char_idx": 4151, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "105a7552-d0c0-477c-abd0-03ada12281c9": {"__data__": {"id_": "105a7552-d0c0-477c-abd0-03ada12281c9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "48803f8a-3b97-49e6-aa8b-1f1907feba63", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}, "hash": "d20c01881279b556ddb630dbbbb16a84e403aad84d90367427f9698deba91e7f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "d9213185-ce37-447c-8679-45fe54b3d241", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 239, "section": "UNSPECIFIED"}, "hash": "489ee4212f116c121111d5c2d7137ba362938f6b5adde337d35428b9754da2d6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples of such tests include microneutralization, hemagglutination inhibition, and opsonophagocytic-killing assays. These \nare tests that measure the direct effect of the antimicrobial antibodies on the microorganism; therefore, said microorganism is the study subject and should be mapped to NHOID. \nIn this vaccine-study example, the subject is vaccinated with a vector containing S. aureus-epitope X (note: epitope X is an example, refer to controlled terminology for standard terms associated with ISBDAGNT). \nThe subject is tested before (baseline) and after vaccination (visits 1 and 2) to investigate whether the vaccine-induced functional antibodies drive efficient complement deposition and subsequent opsonophagocytic \nkilling of S. aureus, in vitro. The assay read-out is expressed by the opsonization index (ISTSTDTL), which is a unit-less test. \nis.xpt \nRow STUDYID DOMAIN USUBJID \nNHOID \nISSEQ ISREFID ISTESTCD ISTEST \nISBDAGNT \nISTSTDTL \nISCAT \nISSCAT \nISORRES ISSTRESC ISSTRESN ISSPEC ISMETHOD \nVISITNUM VISIT \nISDTC \n1 \nSAU1230 \nIS \nSAU1230-\n011 \nSTAPHYLOCOCCUS \nAUREUS 04-02981 \n1 \n13668 \nMBFAB \nFunctional \nMicrobial-\ninduced \nAntibody \nSTAPHYLOCOCCUS \nAUREUS\u2013EPITOPE X \nOPSONIZATION \nINDEX \nSTUDY VACCINE-\nRELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n100 \n100 \n100 \nSERUM OPSONOPHAGOCYTIC \nKILLING ASSAY \n1 \nBASELINE 2017-\n05-27 \n2 \nSAU1230 \nIS \nSAU1230-\n011 \nSTAPHYLOCOCCUS \nAUREUS 04-02981 \n2 \n13668 \nMBFAB \nFunctional \nMicrobial-\ninduced \nAntibody \nSTAPHYLOCOCCUS \nAUREUS\u2013EPITOPE X \nOPSONIZATION \nINDEX \nSTUDY VACCINE-\nRELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n1000 \n1000 \n1000 \nSERUM OPSONOPHAGOCYTIC \nKILLING ASSAY \n2 \nVISIT 1 \n2017-\n07-27 \n3 \nSAU1230 \nIS \nSAU1230-\n011 \nSTAPHYLOCOCCUS \nAUREUS 04-02981 \n3 \n13668 \nMBFAB \nFunctional \nMicrobial-\ninduced \nAntibody \nSTAPHYLOCOCCUS \nAUREUS\u2013EPITOPE X \nOPSONIZATION \nINDEX \nSTUDY VACCINE-\nRELATED \nIMMUNOGENICITY \nHUMORAL \nIMMUNITY \n5000 \n5000 \n5000 \nSERUM OPSONOPHAGOCYTIC \nKILLING ASSAY \n3 \nVISIT 2 \n2017-\n09-27", "mimetype": "text/plain", "start_char_idx": 3292, "end_char_idx": 5277, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "51eb65f3-3e06-4007-9483-1e04262dbae2": {"__data__": {"id_": "51eb65f3-3e06-4007-9483-1e04262dbae2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e781dc12-4ead-4dd3-b4e1-6dbcc6907fb4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}, "hash": "1c177e9600fb7651c8415a57b6fc40e51c66f52ec7c3991762cdd71f5073de78", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "057841b4-df78-48e8-9b29-42f9653c31e3", "node_type": "1", "metadata": {}, "hash": "82fd5a792c0ffc0560af0aa26e6531a0eb099de9caa7a59dcf819f1688ef6463", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 240 \n2021-11-29 \nExample 10 \nThis example shows how to present data from an autoimmune disease study, specifically how to represent information from disease-specific autoantibody tests. \nSj\u00f6gren's syndrome (SS) is a systemic autoimmune disease characterized by dry eyes and dry mouth. Diagnosis of SS is generally based on the detection of antinuclear antibodies (ANAs), that is, anti-Ro (SS-A) and \nanti-La (SS-B) antibodies. \nRows 1-5: \nShow the screening (row 1) and quantification (rows 2, 4) of ANAs. Rows 2 and 3 are grouped together using ISGRPID=\"1a\"; this means the titer result in row 2 is specifically related to the particular \nnuclear staining pattern (i.e., speckled) finding in row 3. The speckled pattern of ANA is typically indicative of SS, systemic lupus, and mixed connective tissue disease. Rows 4 and 5 are grouped \ntogether using ISGRPID=\"1b\"; this means the titer result in row 4 is specifically related to the nuclear staining pattern (i.e., nucleoar) finding in row 5. Rows 1 to 5 are grouped together using ISGRPID \nwith values starting with the number \"1\", indicating that these records are related. The antinuclear antibodies test is post-coordinated and represented by both ISTEST=\"Autoantibody\" and \nISBDAGNT=\"NUCLEAR AUTOANTIGENS\". \nRows 6-11: Show the screening and quantification of the various SS-specific autoantibodies. SS autoantigens are represented by the ISBDAGNT variable, whereas the ISTEST=\"Autoantibody\". \nis.xpt \nRow STUDYID DOMAIN USUBJID ISSEQ ISREFID \nISGRPID ISTESTCD ISTEST \nISBDAGNT \nISTSTDTL \nISTSTOPO ISORRES \nISORRESU ISSTRESC \nISSTRESN ISSTRESU ISSPEC ISMETHOD \nVISITNUM VISIT \nISDTC \n1 \nXYZ \nIS \nXYZ1234 \n1 \n19283746 1 \nATAB \nAutoantibody NUCLEAR \nAUTOANTIGENS \n \nSCREEN \nPOSITIVE \n \nPOSITIVE \n \n \nSERUM FLUORESCENT \nIMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n2 \nXYZ \nIS \nXYZ1234 \n2 \n19283746 1a \nATAB \nAutoantibody NUCLEAR \nAUTOANTIGENS \n \nQUANTIFY 1:340 \n \n340 \n340 \ntiter \nSERUM FLUORESCENT \nIMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n3 \nXYZ \nIS \nXYZ1234 \n3 \n19283746 1a \nATAB \nAutoantibody NUCLEAR \nAUTOANTIGENS \nSTAINING \nPATTERN \n \nSPECKLED \nPATTERN \n \nSPECKLED \nPATTERN \n \n \nSERUM FLUORESCENT \nIMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n4 \nXYZ \nIS \nXYZ1234 \n4 \n19283746 1b \nATAB \nAutoantibody NUCLEAR \nAUTOANTIGENS \n \nQUANTIFY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2457, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "057841b4-df78-48e8-9b29-42f9653c31e3": {"__data__": {"id_": "057841b4-df78-48e8-9b29-42f9653c31e3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e781dc12-4ead-4dd3-b4e1-6dbcc6907fb4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}, "hash": "1c177e9600fb7651c8415a57b6fc40e51c66f52ec7c3991762cdd71f5073de78", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "51eb65f3-3e06-4007-9483-1e04262dbae2", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}, "hash": "03f1e6a0b304f9a99100f0a7a092ea34273e2f2337b869415ff8c8887faa7155", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "da51da45-0658-4df5-ae3b-85a72224de9c", "node_type": "1", "metadata": {}, "hash": "f85b5e07e124dbc3ed72ff23fe6295647fa0b2ccb0deb15b9d6c115df3ad4fb3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "XYZ1234 \n2 \n19283746 1a \nATAB \nAutoantibody NUCLEAR \nAUTOANTIGENS \n \nQUANTIFY 1:340 \n \n340 \n340 \ntiter \nSERUM FLUORESCENT \nIMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n3 \nXYZ \nIS \nXYZ1234 \n3 \n19283746 1a \nATAB \nAutoantibody NUCLEAR \nAUTOANTIGENS \nSTAINING \nPATTERN \n \nSPECKLED \nPATTERN \n \nSPECKLED \nPATTERN \n \n \nSERUM FLUORESCENT \nIMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n4 \nXYZ \nIS \nXYZ1234 \n4 \n19283746 1b \nATAB \nAutoantibody NUCLEAR \nAUTOANTIGENS \n \nQUANTIFY 1:170 \n \n170 \n170 \ntiter \nSERUM FLUORESCENT \nIMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n5 \nXYZ \nIS \nXYZ1234 \n5 \n19283746 1b \nATAB \nAutoantibody NUCLEAR \nAUTOANTIGENS \nSTAINING \nPATTERN \n \nNUCLEOLAR \nPATTERN \n \nNUCLEOLAR \nPATTERN \n \n \nSERUM FLUORESCENT \nIMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n6 \nXYZ \nIS \nXYZ1234 \n1 \n19283746 2 \nATAB \nAutoantibody SJOGRENS SS-A60 \nANTIGEN \n \nSCREEN \nPOSITIVE \n \nPOSITIVE \n \n \nSERUM MULTIPLEXED BEAD \nBASED IMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n7 \nXYZ \nIS \nXYZ1234 \n2 \n19283746 2 \nATAB \nAutoantibody SJOGRENS SS-A60 \nANTIGEN \n \nQUANTIFY 181 \nU/mL \n181 \n181 \nU/mL \nSERUM MULTIPLEXED BEAD \nBASED IMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n8 \nXYZ \nIS \nXYZ1234 \n3 \n19283746 3 \nATAB \nAutoantibody SJOGRENS SS-A52 \nANTIGEN \n \nSCREEN \nPOSITIVE \n \nPOSITIVE \n \n \nSERUM MULTIPLEXED BEAD \nBASED IMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n9 \nXYZ \nIS \nXYZ1234 \n4 \n19283746 3 \nATAB \nAutoantibody SJOGRENS SS-A52 \nANTIGEN \n \nQUANTIFY 51 \nU/mL \n51 \n51 \nU/mL \nSERUM MULTIPLEXED BEAD \nBASED IMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n10 \nXYZ \nIS \nXYZ1234 \n5 \n19283746 4 \nATAB \nAutoantibody SJOGRENS SS-B \nANTIGEN \n \nSCREEN \nPOSITIVE \n \nPOSITIVE \n \n \nSERUM MULTIPLEXED BEAD \nBASED IMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n11 \nXYZ \nIS \nXYZ1234 \n6 \n19283746 4 \nATAB \nAutoantibody SJOGRENS SS-B \nANTIGEN \n \nQUANTIFY 169 \nU/mL \n169 \n169 \nU/mL \nSERUM MULTIPLEXED", "mimetype": "text/plain", "start_char_idx": 2004, "end_char_idx": 3811, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "da51da45-0658-4df5-ae3b-85a72224de9c": {"__data__": {"id_": "da51da45-0658-4df5-ae3b-85a72224de9c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e781dc12-4ead-4dd3-b4e1-6dbcc6907fb4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}, "hash": "1c177e9600fb7651c8415a57b6fc40e51c66f52ec7c3991762cdd71f5073de78", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "057841b4-df78-48e8-9b29-42f9653c31e3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 240, "section": "UNSPECIFIED"}, "hash": "e4660657acc69183a007ac550649c35e0bbcdfcf291bf5deca93cc8d96c91182", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ATAB \nAutoantibody SJOGRENS SS-A52 \nANTIGEN \n \nQUANTIFY 51 \nU/mL \n51 \n51 \nU/mL \nSERUM MULTIPLEXED BEAD \nBASED IMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n10 \nXYZ \nIS \nXYZ1234 \n5 \n19283746 4 \nATAB \nAutoantibody SJOGRENS SS-B \nANTIGEN \n \nSCREEN \nPOSITIVE \n \nPOSITIVE \n \n \nSERUM MULTIPLEXED BEAD \nBASED IMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n11 \nXYZ \nIS \nXYZ1234 \n6 \n19283746 4 \nATAB \nAutoantibody SJOGRENS SS-B \nANTIGEN \n \nQUANTIFY 169 \nU/mL \n169 \n169 \nU/mL \nSERUM MULTIPLEXED BEAD \nBASED IMMUNOASSAY \n1 \nSCREENING 2018-\n06-20 \n \nExample 11 \nThis example shows how to represent data from various allergy tests, specifically data from a mixed animal allergens test. \nRow 1: \nShows the detection of immunoglobulin E (IgE) antibody against multiple animal allergens. ISBDAGNT is used to house the generic but controlled value \"ANIMAL MIX ANTIGENS, MULTIPLE\". \nRows 2-3: \nShow the amount of IgE antibody against dog dander and its RAST classification score. \nRows 4-5: \nShow the amount of IgE antibody against cat dander and its RAST classification score. \nRows 6-7: \nShow the amount of IgE antibody against horse dander and its RAST classification score. \nRows 8-9: \nShow the amount of IgE antibody against cow dander and its RAST classification score.", "mimetype": "text/plain", "start_char_idx": 3342, "end_char_idx": 4584, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5e9991bf-653b-4f69-9044-9b4fa42fe50b": {"__data__": {"id_": "5e9991bf-653b-4f69-9044-9b4fa42fe50b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 241, "section": "0.19 0.19"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "28f3484e-dcd8-4148-95ba-6fe7b0b89284", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 241, "section": "0.19 0.19"}, "hash": "6ac2abce05f66e0ab14964e8f5b4eb4de7b824c0adbbf653d28ba2df471ca6bf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "U/mL \nSERUM RIA \n1 \nSCREENING 2018-06-\n20 \n5 \nXYZ \nIS \nXYZ1234 3 \n12456666 ARIGEAB \nAllergen-induced IgE \nAntibody \nCAT DANDER ANTIGEN \nRAST \nSCORE \n0 \n \n0 \n0 \n \nSERUM RIA \n1 \nSCREENING 2018-06-\n20 \n6 \nXYZ \nIS \nXYZ1234 4 \n12456666 ARIGEAB \nAllergen-induced IgE \nAntibody \nHORSE DANDER ANTIGEN \n \n44 \nU/mL \n44 \n44 \nU/mL \nSERUM RIA \n1 \nSCREENING 2018-06-\n20 \n7 \nXYZ \nIS \nXYZ1234 4 \n12456666 ARIGEAB \nAllergen-induced IgE \nAntibody \nHORSE DANDER ANTIGEN \nRAST \nSCORE \n4 \n \n4 \n4 \n \nSERUM RIA \n1 \nSCREENING 2018-06-\n20 \n8 \nXYZ \nIS \nXYZ1234 5 \n12456666 ARIGEAB \nAllergen-induced IgE \nAntibody \nCOW DANDER ANTIGEN \n \n120 \nU/mL \n120 \n120 \nU/mL \nSERUM RIA \n1 \nSCREENING 2018-06-\n20 \n9 \nXYZ \nIS \nXYZ1234 5 \n12456666 ARIGEAB \nAllergen-induced IgE \nAntibody \nCOW DANDER ANTIGEN \nRAST \nSCORE \n6 \n \n6 \n6 \n \nSERUM RIA \n1 \nSCREENING 2018-06-\n20 \nThe SUPPIS dataset shows the specific and individual animal allergens within the animal mixed antigens panel test. \nsuppis.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \nQEVAL \n1 \nXYZ \nIS \nXYZ1234 \nISBDAGNT \n1 \nISMIXCOP \nMixture Component \nDOG \nCRF \n \n2 \nXYZ \nIS \nXYZ1234 \nISBDAGNT \n1 \nISMIXCOP \nMixture Component \nCAT \nCRF \n \n3 \nXYZ \nIS \nXYZ1234 \nISBDAGNT \n1 \nISMIXCOP \nMixture Component \nHORSE \nCRF \n \n4 \nXYZ \nIS \nXYZ1234 \nISBDAGNT \n1 \nISMIXCOP \nMixture Component \nCOW \nCRF \n \nAlternatively, instead of reporting the specific components of a mixed allergen panel, regional allergen mixes may also be reported by the specific regions/areas where they are predominant, as shown in the SUPPIS \ndataset below. \nsuppis.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \nQEVAL \n1 \nXYZ \nIS \nXYZ1234 \nISBDAGNT \n1 \nISALGREG \nAllergen Mixture Region \nCENTRAL CA, AREA 14 \nCRF", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1758, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "412031a4-2043-4843-95a2-6cd6d8c5dfc8": {"__data__": {"id_": "412031a4-2043-4843-95a2-6cd6d8c5dfc8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 242, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f91cd471-cce3-4f26-9e0f-7d656e596eba", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 242, "section": "UNSPECIFIED"}, "hash": "980169a07a3d839caca4731baf50251d8ab4a38b2382811fe2e35c3d9b489204", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1fa7ce8c-2a1c-48ef-9515-07f0d3f5a39b", "node_type": "1", "metadata": {}, "hash": "bfc434f2388bd301a315113ceaac069c555480eb5a03ea3160d728b0d66787c7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 242 \n2021-11-29 \nLB \u2013 Specification \nlb.xpt, Laboratory Test Results \u2014 Findings. One record per lab test per time point per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar LB \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nLBSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid number. Req \nLBGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nLBREFID \nSpecimen ID \nChar  \nIdentifier \nInternal or external specimen identifier. Example: specimen ID. \nPerm \nLBSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined in \nthe sponsor's operational database. Example: Line number on the Lab page. \nPerm \nLBTESTCD \nLab Test or \nExamination Short \nName \nChar (LBTESTCD) \nTopic \nShort name of the measurement, test, or examination described in LBTEST. It can be used as a column \nname when converting a dataset from a vertical to a horizontal format. The value in LBTESTCD cannot be \nlonger than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). LBTESTCD cannot \ncontain characters other than letters, numbers, or underscores. Examples: \"ALT\", \"LDH\". \nReq \nLBTEST \nLab Test or \nExamination Name \nChar (LBTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. Note: Any test \nnormally performed by a clinical laboratory is considered a lab test. The value in LBTEST cannot be longer \nthan 40 characters. Examples: \"Alanine Aminotransferase\", \"Lactate Dehydrogenase\". \nReq \nLBTSTCND \nTest Condition \nChar (TESTCOND) \nVariable \nQualifier \nIdentifies any planned condition imposed by the assay system on the specimen at the time the test is \nperformed. \nPerm \nLBBDAGNT \nBinding Agent \nChar  \nVariable \nQualifier \nThe textual description of the agent that is binding to the entity in the LBTEST variable. The LBBDAGNT \nvariable is used to indicate that there is a binding relationship between the entities in the LBTEST and \nLBBDAGNT variables, regardless of direction. \nLBBDAGNT is not a method qualifier. It should only be used when the actual interest of the measurement is \nthe binding interaction between the 2 entities in LBTEST and LBBDAGNT. In other words, the combination \nof LBTEST and LBBDAGNT should describe the thing, the entity, or the analyte being measured, without the \nneed for additional variables.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3132, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1fa7ce8c-2a1c-48ef-9515-07f0d3f5a39b": {"__data__": {"id_": "1fa7ce8c-2a1c-48ef-9515-07f0d3f5a39b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 242, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f91cd471-cce3-4f26-9e0f-7d656e596eba", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 242, "section": "UNSPECIFIED"}, "hash": "980169a07a3d839caca4731baf50251d8ab4a38b2382811fe2e35c3d9b489204", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "412031a4-2043-4843-95a2-6cd6d8c5dfc8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 242, "section": "UNSPECIFIED"}, "hash": "a7c262456b4b71be9b6b48f58247f242dc7ea97354e7d280b654ff04f40549b6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Req \nLBTSTCND \nTest Condition \nChar (TESTCOND) \nVariable \nQualifier \nIdentifies any planned condition imposed by the assay system on the specimen at the time the test is \nperformed. \nPerm \nLBBDAGNT \nBinding Agent \nChar  \nVariable \nQualifier \nThe textual description of the agent that is binding to the entity in the LBTEST variable. The LBBDAGNT \nvariable is used to indicate that there is a binding relationship between the entities in the LBTEST and \nLBBDAGNT variables, regardless of direction. \nLBBDAGNT is not a method qualifier. It should only be used when the actual interest of the measurement is \nthe binding interaction between the 2 entities in LBTEST and LBBDAGNT. In other words, the combination \nof LBTEST and LBBDAGNT should describe the thing, the entity, or the analyte being measured, without the \nneed for additional variables. \nThe binding agent may be (but is not limited to) a test article, a portion of the test article, a related \ncompound, or an endogenous molecule. \nPerm \nLBTSTOPO \nTest Operational \nObjective \nChar (TSTOPOBJ) \nVariable \nQualifier \nText description of the high-level purpose of the test at the operational level. \nPerm \nLBCAT \nCategory for Lab \nTest \nChar * \nGrouping \nQualifier \nUsed to define a category of related records across subjects. Examples: \"HEMATOLOGY\", \"URINALYSIS\", \n\"CHEMISTRY\". \nExp \nLBSCAT \nSubcategory for \nLab Test \nChar * \nGrouping \nQualifier \nA further categorization of a test category. Examples: \"DIFFERENTIAL\", \"COAGULATION\", \"LIVER \nFUNCTION\", \"ELECTROLYTES\". \nPerm \nLBORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nLBORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for LBORRES. Example: \"g/L\". \nExp \nLBRESSCL \nResult Scale \nChar (RSLSCLRS) \nRecord \nQualifier \nClassifies the scale of the original result value; for example, whether the result is ordinal, nominal, \nquantitative, or narrative. \nPerm \nLBRESTYP \nResult Type \nChar (RESTYPRS) \nRecord \nQualifier \nClassifies the kind of result (i.e., property type) originally reported for the test. Examples include substance \nconcentration, proportion, mass rate, and arbitrary concentration. \nPerm \nLBCOLSRT \nCollected Summary \nResult Type \nChar (COLSTYP) \nRecord \nQualifier \nUsed to indicate the type of collected summary result. This includes source summary results collected on a \nCRF or provided by an external vendor (e.g., central lab). If the summary result is derived by the sponsor \nPerm", "mimetype": "text/plain", "start_char_idx": 2286, "end_char_idx": 4872, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "56a6c8ac-ec85-4f83-b1b5-83e568d1a357": {"__data__": {"id_": "56a6c8ac-ec85-4f83-b1b5-83e568d1a357", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 243, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12d91bc8-e76d-4b96-8f38-9ce5fc8d8bae", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 243, "section": "UNSPECIFIED"}, "hash": "821ccfd8be51e1338bcfe6533aa4715920539e588565ab9337dff3cb39ae0390", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9e8c5977-e749-490d-92fc-0eabbcb9bc55", "node_type": "1", "metadata": {}, "hash": "b2b3b158f2ed0935553b84c7fe30f3b761452b41ee4ff2a75bf5bc25fd103856", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 243 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nusing individual source data records from SDTM, the derived summary result is represented in ADaM. If the \nsummary result is produced and reported by the lab, the collected summary result is represented in SDTM. \nLBORNRLO \nReference Range \nLower Limit in Orig \nUnit \nChar  \nVariable \nQualifier \nLower end of reference range for continuous measurement in original units. Should be populated only for \ncontinuous results. \nExp \nLBORNRHI \nReference Range \nUpper Limit in Orig \nUnit \nChar  \nVariable \nQualifier \nUpper end of reference range for continuous measurement in original units. Should be populated only for \ncontinuous results. \nExp \nLBLLOD \nLower Limit of \nDetection \nChar  \nVariable \nQualifier \nThe lowest threshold (as originally received or collected) for reliably detecting the presence or absence of \nsubstance measured by a specific test. The value for the field will be as described in documentation from the \ninstrument or lab vendor. \nPerm \nLBSTRESC \nCharacter \nResult/Finding in \nStd Format \nChar (LBSTRESC) \nResult \nQualifier \nContains the result value for all findings, copied or derived from LBORRES in a standard format or standard \nunits. LBSTRESC should store all results or findings in character format; if results are numeric, they should \nalso be stored in numeric format in LBSTRESN. For example, if a test has results \"NONE\", \"NEG\", and \n\"NEGATIVE\" in LBORRES and these results effectively have the same meaning, they could be represented \nin standard format in LBSTRESC as \"NEGATIVE\". For other examples, see Original and Standardized \nResults. \nExp \nLBSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nLBSTRESC. LBSTRESN should store all numeric test results or findings. \nExp \nLBSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for LBSTRESC or LBSTRESN. \nExp \nLBSTNRLO \nReference Range \nLower Limit-Std \nUnits \nNum  \nVariable \nQualifier \nLower end of reference range for continuous measurements for LBSTRESC/LBSTRESN in standardized \nunits. Should be populated only for continuous results. \nExp \nLBSTNRHI \nReference Range \nUpper Limit-Std \nUnits \nNum  \nVariable \nQualifier \nUpper end of reference range for continuous measurements in standardized units. Should be populated only \nfor continuous results. \nExp \nLBSTNRC \nReference Range \nfor Char Rslt-Std \nUnits \nChar  \nVariable \nQualifier \nFor normal range values that are character in ordinal scale or if categorical ranges were supplied. Examples: \n\"-1 to +1\", \"NEGATIVE TO TRACE\". \nPerm \nLBNRIND \nReference Range \nIndicator \nChar (NRIND) \nVariable \nQualifier \nIndicates where the value falls with respect to reference range defined by LBORNRLO and LBORNRHI, \nLBSTNRLO and LBSTNRHI, or by LBSTNRC. Examples: \"NORMAL\", \"ABNORMAL\", \"HIGH\", \"LOW\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3186, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9e8c5977-e749-490d-92fc-0eabbcb9bc55": {"__data__": {"id_": "9e8c5977-e749-490d-92fc-0eabbcb9bc55", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 243, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "12d91bc8-e76d-4b96-8f38-9ce5fc8d8bae", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 243, "section": "UNSPECIFIED"}, "hash": "821ccfd8be51e1338bcfe6533aa4715920539e588565ab9337dff3cb39ae0390", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "56a6c8ac-ec85-4f83-b1b5-83e568d1a357", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 243, "section": "UNSPECIFIED"}, "hash": "8102f35b7d319efde669d2525d73a0533ad6bc168bab95fcb850ac072db6851b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Should be populated only for continuous results. \nExp \nLBSTNRHI \nReference Range \nUpper Limit-Std \nUnits \nNum  \nVariable \nQualifier \nUpper end of reference range for continuous measurements in standardized units. Should be populated only \nfor continuous results. \nExp \nLBSTNRC \nReference Range \nfor Char Rslt-Std \nUnits \nChar  \nVariable \nQualifier \nFor normal range values that are character in ordinal scale or if categorical ranges were supplied. Examples: \n\"-1 to +1\", \"NEGATIVE TO TRACE\". \nPerm \nLBNRIND \nReference Range \nIndicator \nChar (NRIND) \nVariable \nQualifier \nIndicates where the value falls with respect to reference range defined by LBORNRLO and LBORNRHI, \nLBSTNRLO and LBSTNRHI, or by LBSTNRC. Examples: \"NORMAL\", \"ABNORMAL\", \"HIGH\", \"LOW\". \nSponsors should specify in the study metadata (Comments column in the Define-XML document) whether \nLBNRIND refers to the original or standard reference ranges and results. LBNRIND is not used to indicate \nclinical significance. \nExp \nLBSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate exam not done. Should be null if a result exists in LBORRES. \nPerm \nLBREASND \nReason Test Not \nDone \nChar  \nRecord \nQualifier \nDescribes why a measurement or test was not performed. Examples: \"BROKEN EQUIPMENT\", \"SUBJECT \nREFUSED\", or \"SPECIMEN LOST\". Used in conjunction with LBSTAT when value is \"NOT DONE\". \nPerm \nLBNAM \nVendor Name \nChar  \nRecord \nQualifier \nThe name or identifier of the laboratory that performed the test. \nPerm \nLBLOINC \nLOINC Code \nChar LOINC \nSynonym \nQualifier \nCode for the lab test from the LOINC code system. The sponsor is expected to provide the dictionary name \nand version used to map the terms utilizing the Define-XML external codelist attributes. \nPerm \nLBSPEC \nSpecimen Type \nChar (SPECTYPE) \nRecord \nQualifier \nDefines the type of specimen used for a measurement. Examples: \"SERUM\", \"PLASMA\", \"URINE\". \nPerm \nLBSPCCND \nSpecimen \nCondition \nChar (SPECCOND) \nRecord \nQualifier \nThe physical state or quality of a sample for an assessment. Examples: \"HEMOLYZED\", \"ICTERIC\", \n\"LIPEMIC\". \nPerm \nLBSPCUFL \nSpecimen Usability \nfor the Test \nChar (NY) \nRecord \nQualifier \nDescribes the usability of the specimen for the test. The value will be \"N\" if the specimen is not usable, and \nnull if the specimen is usable. \nPerm", "mimetype": "text/plain", "start_char_idx": 2431, "end_char_idx": 4749, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "be956667-0536-46da-a359-62a1e2601052": {"__data__": {"id_": "be956667-0536-46da-a359-62a1e2601052", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 244, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "adfdc12e-a7af-45c4-a37b-8271000964fd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 244, "section": "UNSPECIFIED"}, "hash": "c952a6f7faa440a3e6b9847fae35e7472010acc4118d43bc2f6d531d11bdd2df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1bf1751f-8a11-48d5-a550-e91d14ce784c", "node_type": "1", "metadata": {}, "hash": "b00a819d0335d652ecc68934f93b5685f4d60e61006ef5c90f65a329806306f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 244 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nLBMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"EIA\" (enzyme immunoassay), \"ELECTROPHORESIS\", \n\"DIPSTICK\". \nPerm \nLBANMETH \nAnalysis Method \nChar (LBANMET) \nRecord \nQualifier \nAnalysis method applied to obtain a summarized result. Analysis method describes the method of secondary \nprocessing applied to a complex observation result (e.g., a calculation used to measure eGFR). \nPerm \nLBTMTHSN \nTest Method \nSensitivity \nChar (TSTMTHSN) \nRecord \nQualifier \nThe sensitivity of the test methodology with respect to observation, detection, or quantification. \nPerm \nLBLOBXFL \nLast Observation \nBefore Exposure \nFlag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The value \nshould be \"Y\" or null. \nExp \nLBBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that LBBLFL is retained for backward \ncompatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nLBFAST \nFasting Status \nChar (NY) \nRecord \nQualifier \nIndicator used to identify fasting status. Examples: \"Y\", \"N\". \nPerm \nLBDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Records that represent the average of \nother records, or do not come from the CRF, or are not as originally received or collected are examples of \nrecords that might be derived for the submission datasets. If LBDRVFL=\"Y\", then LBORRES may be null, \nwith LBSTRESC and (if numeric) LBSTRESN having the derived value. \nPerm \nLBTOX \nToxicity \nChar * \nVariable \nQualifier \nDescription of toxicity quantified by LBTOXGR. The sponsor is expected to provide the name of the scale \nand version used to map the terms, utilizing the external codelist element in the Define-XML document. \nPerm \nLBTOXGR \nStandard Toxicity \nGrade \nChar * \nRecord \nQualifier \nRecords toxicity grade value using a standard toxicity scale (e.g., the NCI CTCAE). If value is from a numeric \nscale, represent only the number (e.g., \"2\" not \"Grade 2\"). The sponsor is expected to provide the name of \nthe scale and version used to map the terms, utilizing the external codelist element in the Define-XML \ndocument. \nPerm \nLBCLSIG \nClinically \nSignificant, \nCollected \nChar (NY) \nRecord \nQualifier \nUsed to indicate whether a collected observation is clinically significant based on judgment. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or VISITDY.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3071, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1bf1751f-8a11-48d5-a550-e91d14ce784c": {"__data__": {"id_": "1bf1751f-8a11-48d5-a550-e91d14ce784c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 244, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "adfdc12e-a7af-45c4-a37b-8271000964fd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 244, "section": "UNSPECIFIED"}, "hash": "c952a6f7faa440a3e6b9847fae35e7472010acc4118d43bc2f6d531d11bdd2df", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "be956667-0536-46da-a359-62a1e2601052", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 244, "section": "UNSPECIFIED"}, "hash": "1ddfcf87685f92bc5a9fefcb8a458e75db732835011756a9fc8d50cb2afc27e3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If value is from a numeric \nscale, represent only the number (e.g., \"2\" not \"Grade 2\"). The sponsor is expected to provide the name of \nthe scale and version used to map the terms, utilizing the external codelist element in the Define-XML \ndocument. \nPerm \nLBCLSIG \nClinically \nSignificant, \nCollected \nChar (NY) \nRecord \nQualifier \nUsed to indicate whether a collected observation is clinically significant based on judgment. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day \nof Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the observation, or the date/time of collection if start date/time is \nnot collected. \nPerm \nLBDTC \nDate/Time of \nSpecimen \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of specimen collection represented in ISO 8601 character format. \nExp \nLBENDTC \nEnd Date/Time of \nSpecimen \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nEnd date/time of specimen collection represented in ISO 8601 character format. \nPerm \nLBDY \nStudy Day of \nSpecimen \nCollection \nNum  \nTiming \nStudy day of specimen collection, measured as integer days. Algorithm for calculations must be relative to \nthe sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent across the \nsubmission. \nPerm \nLBENDY \nStudy Day of End \nof Observation \nNum  \nTiming \nActual study day of end of observation expressed in integer days relative to the sponsor-defined RFSTDTC \nin Demographics. \nPerm \nLBTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when specimen should be taken. This may be represented as an elapsed time \nrelative to a fixed reference point, such as time of last dose. See LBTPTNUM and LBTPTREF. Examples: \n\"Start\", \"5 min post\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2385, "end_char_idx": 4610, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "43a77424-4b39-415b-b880-e7fae77ac002": {"__data__": {"id_": "43a77424-4b39-415b-b880-e7fae77ac002", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 245, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "39fe5a42-e5de-4532-8b89-3f6abcbdeee7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 245, "section": "UNSPECIFIED"}, "hash": "5c024054f156192a6d6c838f779184197ec2c78ca396903d657fc0a9ab63e7d4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c80bf8b8-90b6-4aae-8ff7-31afcb553107", "node_type": "1", "metadata": {}, "hash": "4dfa5261cb04c75264bf4fd6a54058b735e5fdb68fdc2b2a4e946676bb4f1fed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 245 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nLBTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of LBTPT to aid in sorting. \nPerm \nLBELTM \nPlanned Elapsed \nTime from Time \nPoint Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a planned fixed reference (LBTPTREF). This variable is \nuseful where there are repetitive measures. Not a clock time or a date/time variable. Represented as ISO \n8601 duration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point \nindicated by LBTPTREF, \"PT8H\" to represent the period of 8 hours after the reference point indicated by \nLBTPTREF. \nPerm \nLBTPTREF \nTime Point \nReference \nChar  \nTiming \nName of the fixed reference point referred to by LBELTM, LBTPTNUM, and LBTPT. Examples: \"PREVIOUS \nDOSE\", \"PREVIOUS MEAL\". \nPerm \nLBRFTDTC \nDate/Time of \nReference Time \nPoint \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of the reference time point, LBTPTREF. \nPerm \nLBPTFL \nPoint in Time Flag \nChar (NY) \nTiming \nAn indication that the specimen was collected at a single point in time. The value is \"Y\" or null. The intent of \nthis variable in the LB domain is to aid mapping to LOINC codes in the dataset, when LOINC part \"Time \nAspect\" = \"Pt\". \nPerm \nLBPDUR \nPlanned Duration \nChar ISO 8601 duration \nTiming \nPlanned duration of specimen collection. If LBPTFL is \"Y\" then LBPDUR is null. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nLB \u2013 Assumptions \n1. This domain captures laboratory data collected on the CRF or received from a central provider or vendor. \n2. For lab tests that do not have continuous numeric results (e.g., urine protein as measured by dipstick, descriptive tests such as urine color), LBSTNRC \ncould be populated either with normal range values that are a range of character values for an ordinal scale  (e.g., \u201cNEGATIVE to TRACE\") or a \ndelimited set of values that are considered to be normal (e.g., \u201cYELLOW\u201d, \u201cAMBER\u201d). LBORNRLO, LBORNRHI, LBSTNRLO, and LBSTNRHI \nshould be null for these types of tests. \n3. LBNRIND can be added to indicate where a result falls with respect to reference range defined by LBORNRLO and LBORNRHI. Examples: \"HIGH\", \n\"LOW\". If toxicity grading is available, values would be represented in the variables LBTOX and LBTOXGR. Clinical significance would be \nrepresented as described in Section 4.5.5, Clinical Significance for Findings Observation Class Data, in LBCLSIG (see also LB Example 1). \n4.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2857, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c80bf8b8-90b6-4aae-8ff7-31afcb553107": {"__data__": {"id_": "c80bf8b8-90b6-4aae-8ff7-31afcb553107", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 245, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "39fe5a42-e5de-4532-8b89-3f6abcbdeee7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 245, "section": "UNSPECIFIED"}, "hash": "5c024054f156192a6d6c838f779184197ec2c78ca396903d657fc0a9ab63e7d4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "43a77424-4b39-415b-b880-e7fae77ac002", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 245, "section": "UNSPECIFIED"}, "hash": "b13f644fa3c35e8a9d66c34ec0530100e1b14b1e25af1fa55da19b4c2c36b879", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "LBORNRLO, LBORNRHI, LBSTNRLO, and LBSTNRHI \nshould be null for these types of tests. \n3. LBNRIND can be added to indicate where a result falls with respect to reference range defined by LBORNRLO and LBORNRHI. Examples: \"HIGH\", \n\"LOW\". If toxicity grading is available, values would be represented in the variables LBTOX and LBTOXGR. Clinical significance would be \nrepresented as described in Section 4.5.5, Clinical Significance for Findings Observation Class Data, in LBCLSIG (see also LB Example 1). \n4. For lab tests where the specimen is collected over time (e.g., 24-hour urine collection), the start date/time of the collection goes into LBDTC and the end \ndate/time of collection goes into LBENDTC. See Section 4.4.8, Date and Time Reported in a Domain Based on Findings. \n5. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the LB domain, but the following qualifiers would \nnot generally be used: --BODSYS, --SEV. \n6. A value derived by a central lab according to its procedures is considered collected rather than derived. See Section 4.1.8.1, Origin Metadata for \nVariables. \n7. The variable LBORRESU uses the UNIT codelist. This means that sponsors should be submitting a term from the CDISC Submission Value column in \nthe published Controlled Terminology List that is maintained for CDISC by NCI EVS. When sponsors have units that are not in this column, they \nshould first check to see if their unit is mathematically synonymous with an existing/published unit from the UNIT codelist and submit their lab values \nusing the published CDISC submission value. Example: \"g/L\" and \"mg/mL\" are mathematically synonymous, but only \"g/L\" is the submission value in", "mimetype": "text/plain", "start_char_idx": 2351, "end_char_idx": 4074, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2e5c7582-ad80-440c-bde2-0e594d8abca1": {"__data__": {"id_": "2e5c7582-ad80-440c-bde2-0e594d8abca1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 246, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e27c9ab3-6745-4bce-9b2c-9d247a6f7946", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 246, "section": "UNSPECIFIED"}, "hash": "00b5d8cab8288a3943249360ed6ea1849db42502746187e072ba5f4fc65e8220", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3ce2dc4d-9dcb-4830-9e8c-096904af2e18", "node_type": "1", "metadata": {}, "hash": "88f901e8e13f0babe80a89cbed4c86c6bf4d1c14c7805ed655cb21849ecbd182", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 246 \n2021-11-29 \nthe CDISC Unit codelist. If this is not the case, the unit must be added as a codelist extensible value in the Define.xml, and a new-term request must be \nsubmitted. \na. \nCDISC Controlled Terminology Rules for Lab and Unit are available at https://www.cdisc.org/standards/terminology/controlled-terminology. \n8. The LBLOINC variable contains a code from the Logical Observation Identifiers Names and Codes (LOINC) database that identifies a specific \nlaboratory test. The LOINC to LB Mapping Codetable, available at https://www.cdisc.org/standards/terminology/controlled-terminology, may be used \nto identify appropriate CDISC CT values for a test with a particular LOINC code. In addition to LBTEST, LBSPEC, LBMETHOD, and LBORRESU, \nthe aspects of a test that are associated with a LOINC code may be represented in the variables LBTPT, LBANMETH, LBPOS, LBLOC, LBFAST, \nLBTSTCND, LBBDAGNT, LBTSTOPO, LBRESSCL, LBRESTYP, LBCOLSRT, LBLLOD, LBPTFL, and LBPDUR. These additional variables are \nonly required to be populated when necessary to provide a semantically meaningful distinction between records with different LBLOINC values. \nLB \u2013 Examples \nExample 1 \nThis example illustrates the use of previously published LB domain variables and introduces several new variables that were added to SDTMv2.0, \nincluding LBTSTCND, LBRESSCL, LBRESTYP, LBCOLSRT, LBLLOD, LBTMTHSN, LBPTFL, and LBPDUR. These variables, in part, aid in \nharmonization to LOINC. \nRow 1: \nShows a value collected in 1 unit, but converted to selected standard unit. See Section 4.5.1, Original and Standardized Results of Findings and \nTests Not Done, for additional examples for the population of result qualifiers. The result was evaluated by the investigator and determined to be \nnot clinically significant. \nRows 2-3: \nShow 2 records for alkaline phosphatase done at the same visit, a day apart. LBPTFL is set to \"Y\" for both rows because each result is based on a \nsample from a single point in time. \nRows 4-5: \nShow 2 derived records (mean of records 2 and 3 and maximum value of records 2 and 3) grouped by a common LBGRPID value. The derived \nresult in row 4 is described as a mean (LBCOLSRT=\"MEAN, ARITHMETIC\"), but LBDRVFL is missing because the mean result was provided \nby the vendor. The derived result in row 5 was derived by the sponsor, and so is flagged as derived (LBDRVFL=\"Y\"); LBCOLSRT is not \npopulated because the result is not a collected summary result. For both derived results, the sponsor chose to populate LBRESSCL, LBRESTYP, \nLBSPEC, and LBFAST consistent with the 2 individual alkaline phosphatase records but did not populate LBLOINC or LBPTFL because neither \nderived record represented a single point in time.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2907, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3ce2dc4d-9dcb-4830-9e8c-096904af2e18": {"__data__": {"id_": "3ce2dc4d-9dcb-4830-9e8c-096904af2e18", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 246, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e27c9ab3-6745-4bce-9b2c-9d247a6f7946", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 246, "section": "UNSPECIFIED"}, "hash": "00b5d8cab8288a3943249360ed6ea1849db42502746187e072ba5f4fc65e8220", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2e5c7582-ad80-440c-bde2-0e594d8abca1", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 246, "section": "UNSPECIFIED"}, "hash": "1da2ccb6f51613b9487d8cfced1d72cf884fed307cb5c18eee4d36ad103f04c1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rows 4-5: \nShow 2 derived records (mean of records 2 and 3 and maximum value of records 2 and 3) grouped by a common LBGRPID value. The derived \nresult in row 4 is described as a mean (LBCOLSRT=\"MEAN, ARITHMETIC\"), but LBDRVFL is missing because the mean result was provided \nby the vendor. The derived result in row 5 was derived by the sponsor, and so is flagged as derived (LBDRVFL=\"Y\"); LBCOLSRT is not \npopulated because the result is not a collected summary result. For both derived results, the sponsor chose to populate LBRESSCL, LBRESTYP, \nLBSPEC, and LBFAST consistent with the 2 individual alkaline phosphatase records but did not populate LBLOINC or LBPTFL because neither \nderived record represented a single point in time. The sponsor chose to populate LBDTC with the first of the 2 specimen collection dates. \nRow 6: \nShows use of LBTMTHSN to represent \"HIGH SENSITIVITY\" for the high-sensitivity C-reactive protein (hs-CRP) test. \nRows 7, 10: \nShow use of LBTSTCND. For the cryoglobulin test, 1-day cold incubation is noted; for the platelet aggregation test, collagen induced is noted. \nRow 8: \nShows use of LBLLOD for a prostate-specific antigen test. \nRow 9: \nShows use of LBPDUR to represent the planned duration of \"PT24H\" for collection of urine samples for the protein test. LBPTFL is set to \nmissing because this test was not conducted at a single point in time. \nRows 12-13: Show a suggested use of the LBSCAT variable. LBSCAT could be used to further classify types of tests within a laboratory panel (e.g., \n\"DIFFERENTIAL\"). The LYMLE result was evaluated by the investigator and determined to be not clinically significant. \nRow 15: \nShows the proper use of the LBSTAT variable to indicate \"NOT DONE\", where a reason was collected when a test was not done. LBRESSCL, \nLBRESTYP, LBLOINC, LBSPEC, LBMETHOD, and LBPTFL are populated to describe the properties of the test that was not done.", "mimetype": "text/plain", "start_char_idx": 2171, "end_char_idx": 4086, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "11d4d2dd-67e1-4464-9053-928b032b8d48": {"__data__": {"id_": "11d4d2dd-67e1-4464-9053-928b032b8d48", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "3.5 5"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "11d35be0-dbf0-44cb-acdb-2fac43d7f241", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "3.5 5"}, "hash": "5d323d1b605fc59cd8531a29c2bc1f55502f99c20ddf20667cbed7f001f73a4b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "LOW \n \n \n2862-1 \nSERUM \nELECTROPHORESIS \n \nY \nY \n \nN \n1 \nWeek \n1 \n1999-06-\n19 \nY \n \n2 \nABC \nLB \nABC-001-\n001 \n2 \nA \nALP \nAlkaline Phosphatase \n \nCHEMISTRY \n \n398 \nIU/L \nQUANTITATIVE \nCATALYTIC \nCONCENTRATION \n \n40 \n160 \n \n398 \n398 \nIU/L \n40 \n160 \n \n \n \n \n6768-6 \nSERUM \n \n \n \nY \n \n \n1 \nWeek \n1 \n1999-06-\n19 \nY \n \n3 \nABC \nLB \nABC-001-\n001 \n3 \nA \nALP \nAlkaline Phosphatase \n \nCHEMISTRY \n \n350 \nIU/L \nQUANTITATIVE \nCATALYTIC \nCONCENTRATION \n \n40 \n160 \n \n350 \n350 \nIU/L \n40 \n160 \n \n \n \n \n6768-6 \nSERUM \n \n \nY \nY \n \n \n1 \nWeek \n1 \n1999-06-\n20 \nY \n \n4 \nABC \nLB \nABC-001-\n001 \n4 \nA \nALP \nAlkaline Phosphatase \n \nCHEMISTRY \n \n \n \nQUANTITATIVE \nCATALYTIC \nCONCENTRATION \nMEAN, \nARITHMETIC \n \n \n \n374 \n374 \nIU/L \n40 \n160 \n \n \n \n \n \nSERUM \n \n \n \nY \n \n \n1 \nWeek \n1 \n1999-06-\n19 \n \n \n5 \nABC \nLB \nABC-001-\n001 \n5 \nA \nALP \nAlkaline Phosphatase \n \nCHEMISTRY \n \n \n \nQUANTITATIVE \nCATALYTIC \nCONCENTRATION \n \n \n \n \n398 \n398 \nIU/L \n40 \n160 \n \n \n \n \n \nSERUM \n \n \n \nY \nY \n \n1 \nWeek \n1 \n1999-06-\n19 \n \n \n6 \nABC \nLB \nABC-001-\n001 \n6 \n \nCRP \nC Reactive Protein \n \nCHEMISTRY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1048, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "953bf429-a1a4-462f-82f7-6a4d3ec3c340": {"__data__": {"id_": "953bf429-a1a4-462f-82f7-6a4d3ec3c340", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "0.5 10"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0fc9370b-c299-4d51-b02b-a3a2b70cdc57", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "0.5 10"}, "hash": "424afcc1723d6117f7d521f6e72ee57e94794be2807db6f25e37ab43ff09f017", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "30522-7 \nSERUM \n \nHIGH \nSENSITIVITY \nY \nY \n \n \n1 \nWeek \n1 \n1999-06-\n19 \nY \n \n7 \nABC \nLB \nABC-001-\n001 \n7 \n \nCRYOGLBN \nCryoglobulin \n1D COLD \nINCUBATION \nCHEMISTRY \n \nABSENT \n \nORDINAL \nPRESENCE OR THRESHOLD \n \n \n \n \nABSENT \n \n \n \n \n \n \n \n \n12201-0 \nSERUM \nOBSERVATION \n \nY \nY \n \n \n1 \nWeek \n1 \n1999-06-\n19 \nY \n \n8 \nABC \nLB \nABC-001-\n001 \n8 \n \nPSA \nProstate Specific Antigen \n \nCHEMISTRY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 385, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c38b4c8d-2fdf-48b0-b36a-7b62ea33323b": {"__data__": {"id_": "c38b4c8d-2fdf-48b0-b36a-7b62ea33323b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "2.5 35741-8"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dcbb194b-4b50-49f2-ae3b-35593ab90181", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "2.5 35741-8"}, "hash": "db3c3d7e4d561de6e1f6246aa0422a048eeb4a1df55a2be92b0fc711c6f3009d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SERUM \n \n \nY \nY \n \n \n1 \nWeek \n1 \n1999-06-\n19 \nY \n \n9 \nABC \nLB \nABC-001-\n001 \n9 \n \nPROT \nProtein \n \nCHEMISTRY \n \n200 \ng/L \nQUANTITATIVE \nMASS CONCENTRATION \n \n \n \n \n200 \n200 \ng/L \n \n \n \n \n \n \n21482-5 \nURINE \n \n \nY \n \n \n \n1 \nWeek \n1 \n1999-06-\n19 \n \nPT24H \n10 \nABC \nLB \nABC-001-\n001 \n10 \n \nPLATAGGR \nPlatelet Aggregation \nCOLLAGEN \nINDUCED \nCOAGULATION \n \nNORMAL \n \nORDINAL \nPRESENCE OR THRESHOLD \n \n \n \n \nNORMAL \n \n \n \n \n \n \n \n \n24379-0 \nPLATELET RICH \nPLASMA \n \n \nY \n \n \n \n1 \nWeek \n1 \n1999-06-\n19 \nY \n \n11 \nABC \nLB \nABC-001-\n001 \n11 \n \nWBC \nLeukocytes \n \nHEMATOLOGY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 564, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ce5e8db4-d114-4390-bdc1-0c9b44b53052": {"__data__": {"id_": "ce5e8db4-d114-4390-bdc1-0c9b44b53052", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "9.00 5803-2"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ccc85c77-be47-4234-bdb5-df0f9354a378", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "9.00 5803-2"}, "hash": "d1bddd7ebaabf506947bcf4ef115db05ca77bd5c60bfa64cfbe0fbcb0a712295", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "URINE \nTEST STRIP \n \nY \nY \n \n \n1 \nWeek \n1 \n1999-06-\n19 \nY \n \n15 \nABC \nLB \nABC-001-\n001 \n15 \n \nALB \nAlbumin \n \nCHEMISTRY \n \n \n \nQUANTITATIVE \nMASS CONCENTRATION \n \n \n \n \n \n \n \n \n \n \n \nNOT \nDONE \nINSUFFICIENT \nSAMPLE \n2862-1 \nSERUM \nELECTROPHORESIS \n \n \n \n \n \n2 \nWeek \n2 \n1999-07-\n21 \nY \n \n16 \nABC \nLB \nABC-001-\n001 \n16 \n \nCHOL \nCholesterol \n \nCHEMISTRY \n \n229 \nmg/dL \nQUANTITATIVE \nMASS CONCENTRATION \n \n0 \n<200 \n \n229 \n229 \nmg/dL \n0 \n199 \n \n \n \n \n2093-3 \nSERUM \n \n \n \n \n \n \n2 \nWeek \n2 \n1999-07-\n21 \nY \n \n17 \nABC \nLB \nABC-001-\n001 \n17 \n \nWBC \nLeukocytes \n \nHEMATOLOGY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 566, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f885a386-184a-4266-b6d3-2993a9eebeae": {"__data__": {"id_": "f885a386-184a-4266-b6d3-2993a9eebeae", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "5.9 5.9"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ac0c2c7c-01f2-4eca-8bac-e54409c8cd37", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "5.9 5.9"}, "hash": "9e09aa929339a5542dc969b46d320b732e76aa61d45e8bd3598a337769a225f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "10^9/L \n4 \n11 \n \n \n \n \n6690-2 \nBLOOD \nAUTOMATED \nCOUNT \n \n \nY \n \n \n2 \nWeek \n2 \n1999-07-\n21 \nY \n \n18 \nABC \nLB \nABC-001-\n001 \n18 \n \nPROT \nProtein \n \nURINALYSIS \n \nMODERATE \n \nORDINAL \nPRESENCE OR THRESHOLD \n \n \n \n \nMODERATE \n \n \n \n \nNEGATIVE to \nTRACE \nABNORMAL \n \n \n20454-5 \nURINE \nTEST STRIP \n \n \n \n \nN \n2 \nWeek \n2 \n1999-07-\n21 \nY \n \nExample 2 \nThis example illustrates the use of timing variables for pre- and post-dose timed urine collections. \nRow 1: \nShows an example of a pre-dose urine collection interval (from 4 hours prior to dosing until 15 minutes prior to dosing) with a negative value for LBELTM that reflects the end of the interval in \nreference to the fixed reference LBTPTREF, the date of which is recorded in LBRFTDTC. \nRows 2-3: \nShow an example of post-dose urine collection intervals with values for LBELTM that reflect the end of the intervals in reference to the fixed reference LBTPTREF, the date of which is recorded in \nLBRFTDTC. \nlb.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nLBSEQ \nLBTESTCD \nLBTEST \nLBCAT \nLBORRES \nLBORRESU \nLBRESSCL \nLBRESTYP \nLBORNRLO \nLBORNRHI \nLBSTRESC \nLBSTRESN \nLBSTRESU \nLBSTNRLO \nLBSTNRHI \nLBNRIND \nLBLOINC \nLBSPEC \nLBMETHOD \nLBLOBXFL \nVISITNUM \nVISIT \nLBDTC \nLBENDTC \nLBTPT \nLBTPTNUM \nLBELTM \nLBTPTREF \nLBRFTDTC \nLBPTFL \n1 \nABC \nLB \nABC-001-\n001 \n1 \nGLUC \nGlucose \nURINALYSIS \n7 \nmg/dL \nQUANTITATIVE \nMASS \nCONCENTRATION \n1 \n15", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1375, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7a9f0c15-a946-4d9e-8836-b3a524a216d6": {"__data__": {"id_": "7a9f0c15-a946-4d9e-8836-b3a524a216d6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "0.1 0.8"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "50825653-8065-4fb1-8fba-8c86bb9b61ac", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 247, "section": "0.1 0.8"}, "hash": "648681c0d48e54b4b85827bfdabec155b06da5f8fd88b6f3f39280e9213cd99f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "NORMAL \n5792-7 \nURINE \nTEST \nSTRIP \n \n2 \nINITIAL \nDOSING \n1999-06-\n19T16:00 \n1999-06-\n20T00:00 \n8-16 hours after \ndosing \n3 \nPT16H \nDosing \n1999-06-\n19T08:00 \nY \nExample 3 \nThis example illustrates the use of LBSTAT and LBREASND when there is no data value reported in LBORRES. \nRow 1: \nShows a pregnancy test with an original result of \u201c-\u201d (negative sign) standardized to the text value \u201cNEGATIVE\u201d in LBSTRESC. \nRow 2: \nShows a pregnancy test that was not performed because the subject was male. The sponsor felt it was necessary to include a record documenting the reason why the test was not performed, rather than \nsimply not including a record. \nlb.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nLBSEQ \nLBTESTCD \nLBTEST \nLBCAT \nLBORRES \nLBORRESU \nLBRESSCL \nLBRESTYP \nLBORNRLO \nLBORNRHI \nLBSTRESC \nLBSTRESN \nLBSTRESU \nLBSTNRLO \nLBSTRNHI \nLBNRIND \nLBSTAT \nLBREASND \nLBLOINC \nLBSPEC \nLBLOBXFL \nVISITNUM \nVISIT \nLBDTC \nLBPTFL \n1 \nABC \nLB \nABC-001-\n001 \n1 \nHCG \nChoriogonadotropin \nBeta \nCHEMISTRY \n- \n \nOrd \nPrThr \n \n \nNEGATIVE \n \n \n \n \n \n \n \n2106-3 \nURINE \nY \n1 \nBASELINE \n1999-06-\n19T04:00 \nY \n2 \nABC \nLB \nABC-001-\n002 \n1 \nHCG \nChoriogonadotropin \nBeta \nCHEMISTRY \n \n \nOrd \nPrThr \n \n \n \n \n \n \n \n \nNOT \nDONE \nNOT APPLICABLE \n(SUBJECT MALE) \n2106-3 \nURINE \n \n1 \nBASELINE \n1999-06-\n24T08:00 \nY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1282, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "46aee766-74a1-43e3-b569-2761f005ece4": {"__data__": {"id_": "46aee766-74a1-43e3-b569-2761f005ece4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 248, "section": "6.3.5.7 Microbiology Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e8313524-2bcb-4dfd-a7f3-6b64929ab14f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 248, "section": "6.3.5.7 Microbiology Domains"}, "hash": "71ba87dfe9a07ff15dadf1fdde4e85591f4cbfc2297a9f4a2f1faf5310cbce41", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The microbiology domains include Microbiology Specimen (MB) and Microbiology Susceptibility (MS). The MB domain is used for the detection, identification, quantification, and other characterizations of \nmicroorganisms in subject samples, except for drug susceptibility testing. MS is used for representing data from drug-susceptibility testing on the organisms identified in MB. All non-host infectious organisms\u2014\nincluding bacteria, viruses, fungi, and parasites\u2014are appropriate for the microbiology domains.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 509, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f4f3d963-746f-4879-96d6-9b7ea597a1b3": {"__data__": {"id_": "f4f3d963-746f-4879-96d6-9b7ea597a1b3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 249, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "636371f3-6b59-4f02-bc2c-d38f7c790d57", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 249, "section": "UNSPECIFIED"}, "hash": "1d500128b883546244a8ea0e2172ce5bafd820d73a877829fbb070308e4cd509", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "875add49-3f01-4b30-bafc-9517c1656aac", "node_type": "1", "metadata": {}, "hash": "3d977b0b1d8d65a19fb6ed3cac82cd5916a3a35da5a5c78be39f77c9484c8fd3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 249 \n2021-11-29 \nMB \u2013 Specification \nmb.xpt, Microbiology Specimen \u2014 Findings. One record per microbiology specimen finding per time point per visit per subject, \nTabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar MB \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier Char  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nFOCID \nFocus of Study-Specific \nInterest \nChar  \nIdentifier \nIdentification of a focus of study-specific interest on or within a subject or specimen as called out in the \nprotocol for which a measurement, test, or examination was performed. The value in this variable \nshould have inherent semantic meaning. \nPerm \nMBSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid \nnumber. \nReq \nMBGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nPerm \nMBREFID \nReference ID \nChar  \nIdentifier \nInternal or external specimen identifier (e.g., sample ID for a subject sample from which a microbial \nculture was generated). \nPerm \nMBSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. \nPerm \nMBLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. For example, it may be used to link genetic findings (in the PF domain) about a microbe to \nthe original culture of that microbe (in MB), or to susceptibility records (in MS) if needed. \nPerm \nMBLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nMBTESTCD \nMicrobiology Test or \nFinding Short Name \nChar (MBTESTCD) \nTopic \nShort name of the measurement, test, or finding described in MBTEST. It can be used as a column \nname when converting a dataset from a vertical to a horizontal format. The value in MBTESTCD \ncannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). \nMBTESTCD cannot contain characters other than letters, numbers, or underscores. Examples: \n\"MCORGIDN\" for Microbial Organism Identification \"GMNCOC\" for Gram Negative Cocci. \nReq \nMBTEST \nMicrobiology Test or \nFinding Name \nChar (MBTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in \nMBTEST cannot be longer than 40 characters. Examples: \"Microbial Organism Identification\", \"Gram \nNegative Cocci\", \"HIV-1 RNA\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3178, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "875add49-3f01-4b30-bafc-9517c1656aac": {"__data__": {"id_": "875add49-3f01-4b30-bafc-9517c1656aac", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 249, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "636371f3-6b59-4f02-bc2c-d38f7c790d57", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 249, "section": "UNSPECIFIED"}, "hash": "1d500128b883546244a8ea0e2172ce5bafd820d73a877829fbb070308e4cd509", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f4f3d963-746f-4879-96d6-9b7ea597a1b3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 249, "section": "UNSPECIFIED"}, "hash": "5996319decdec5e817c1adabc08b2dbbd313d1e3ddefd6671068c9b834aceb44", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It can be used as a column \nname when converting a dataset from a vertical to a horizontal format. The value in MBTESTCD \ncannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). \nMBTESTCD cannot contain characters other than letters, numbers, or underscores. Examples: \n\"MCORGIDN\" for Microbial Organism Identification \"GMNCOC\" for Gram Negative Cocci. \nReq \nMBTEST \nMicrobiology Test or \nFinding Name \nChar (MBTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in \nMBTEST cannot be longer than 40 characters. Examples: \"Microbial Organism Identification\", \"Gram \nNegative Cocci\", \"HIV-1 RNA\". \nReq \nMBTSTDTL \nMeasurement, Test or \nExamination Detail \nChar (MBFTSDTL) \nVariable \nQualifier \nFurther description of MBTESTCD and MBTEST. Example: \"VIRAL LOAD\" when MBTESTCD \nrepresents viral genetic material, such as \"HCRNA\", \"QUANTIFICATION\" when MBTESTCD \nrepresents any organism being quantified. \nPerm \nMBCAT \nCategory \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. \nPerm \nMBSCAT \nSubcategory \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of MBCAT values. \nPerm \nMBORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the microbiology measurement or finding as originally received or collected. Examples for \n\"GRAM STAIN\" findings: \"+3 MODERATE\", \"+2 FEW\", \"<10\". Examples for \"CULTURE PLATE\" \nfindings: \"KLEBSIELLA PNEUMONIAE\", \"STREPTOCOCCUS PNEUMONIAE\". \nExp \nMBORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal unit for MBORRES. Example: \"mcg/mL\". \nPerm \nMBSTRESC \nResult or Finding in \nStandard Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from MBORRES, in a standard format or \nstandard units. MBSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in MBSTRESN. For example, if a test has \nresults \"+3 MODERATE\", \"MOD\", and \"MODERATE\" in MBORRES and these results effectively have \nthe same meaning, they could be represented in standard format in MBSTRESC as \"MODERATE\". \nExp", "mimetype": "text/plain", "start_char_idx": 2474, "end_char_idx": 4697, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9e1c5743-a9cd-453b-83df-20b28f8b2603": {"__data__": {"id_": "9e1c5743-a9cd-453b-83df-20b28f8b2603", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 250, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a261c19-7abd-4440-bb8f-b73c547b338d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 250, "section": "UNSPECIFIED"}, "hash": "ff5a1f80add35d01e010c53d704e33a31eac2707568fe6a546200b8d50948ceb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3c9d8868-e327-4616-bb97-78742fa949bd", "node_type": "1", "metadata": {}, "hash": "c688fa7f79cb42ba41b788c97ea4f11b247adfbf63f66aa230ea23086989207c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 250 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nMBSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nMBSTRESC. MBSTRESN should store all numeric test results or findings. \nPerm \nMBSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for MBSTRESC and MBSTRESN. \nPerm \nMBRESCAT \nResult Category \nChar  \nVariable \nQualifier \nUsed to categorize the result of a finding in a standard format. \nPerm \nMBSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or that a test was attempted but \ndid not generate a result. Should be null or have a value of \"NOT DONE\". \nPerm \nMBREASND \nReason Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with MBSTAT when value is NOT DONE. Examples: \"BROKEN \nEQUIPMENT\", \"SUBJECT REFUSED\". \nPerm \nMBNAM \nLaboratory/Vendor \nName \nChar  \nRecord \nQualifier \nName or identifier of the vendor (e.g., laboratory) that provided the test results. \nPerm \nMBLOINC \nLOINC Code \nChar  \nSynonym \nQualifier \nLogical Observation Identifiers Names and Codes (LOINC) code for the topic variable (e.g., lab test). \nPerm \nMBSPEC \nSpecimen Material Type \nChar (SPECTYPE) \nRecord \nQualifier \nDefines the type of specimen used for a measurement. Examples: \"SPUTUM\", \"BLOOD\", \"PUS\". \nPerm \nMBSPCCND Specimen Condition \nChar (SPECCOND) \nRecord \nQualifier \nFree or standardized text describing the condition of the specimen. Example: \"CONTAMINATED\". \nPerm \nMBLOC \nSpecimen Collection \nLocation \nChar (LOC) \nRecord \nQualifier \nAnatomical location relevant to the collection of the measurement. \nPerm \nMBLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for specimen collection location further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\". \nPerm \nMBDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for specimen collection location further detailing directionality. Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nMBMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"GRAM STAIN\", \"MICROBIAL CULTURE, LIQUID\", \n\"QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION\". \nExp \nMBLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nPerm \nMBBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2931, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3c9d8868-e327-4616-bb97-78742fa949bd": {"__data__": {"id_": "3c9d8868-e327-4616-bb97-78742fa949bd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 250, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a261c19-7abd-4440-bb8f-b73c547b338d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 250, "section": "UNSPECIFIED"}, "hash": "ff5a1f80add35d01e010c53d704e33a31eac2707568fe6a546200b8d50948ceb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9e1c5743-a9cd-453b-83df-20b28f8b2603", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 250, "section": "UNSPECIFIED"}, "hash": "4d8b84cce7468a85e786384bccd3474d7355f33fd3f1d82476687106407933cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nMBMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"GRAM STAIN\", \"MICROBIAL CULTURE, LIQUID\", \n\"QUANTITATIVE REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION\". \nExp \nMBLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nPerm \nMBBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that MBBLFL is retained for \nbackward compatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nMBFAST \nFasting Status \nChar (NY) \nRecord \nQualifier \nIndicator used to identify fasting status. Valid values include \"Y\", \"N\", \"U\", or null if not relevant. \nPerm \nMBDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element which the specimen \ncollection occurred. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the specimen was collected. \nPerm \nMBDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of specimen collection. \nExp \nMBDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nStudy day of the specimen collection, measured as integer days. Algorithm for calculations must be \nrelative to the sponsor-defined RFSTDTC variable in Demographics. This formula should be consistent \nacross the submission. \nPerm \nMBTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when specimen should be taken. This may be represented as an elapsed time \nrelative to a fixed reference point, such as time of last dose. See MBTPTNUM and MBTPTREF. \nExamples: \"Start\", \"5 min post\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2310, "end_char_idx": 4755, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2a725a3e-a6e5-41b6-b7d1-1c2521603bdb": {"__data__": {"id_": "2a725a3e-a6e5-41b6-b7d1-1c2521603bdb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 251, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fdf1f935-4173-4cea-bb38-dd8972d6f371", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 251, "section": "UNSPECIFIED"}, "hash": "8f1402487caf1bf2d9dfc9f216be0f0a24b836c3fb9b7b14f37f4a5ef43e8dd9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "44fd2725-7b55-4de5-b096-1835ec9c161a", "node_type": "1", "metadata": {}, "hash": "102e6b877357347b603b9aaed1f776ccdd5497191468cc80e3c7472ce1c57558", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 251 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nMBTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of MBTPT used in sorting. \nPerm \nMBELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a planned fixed reference (MBTPTREF). This variable is \nuseful where there are repetitive measures. Not a clock time or a date time variable. Represented as \nan ISO 8601 duration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference \npoint indicated by MBTPTREF, or \"PT8H\" to represent the period of 8 hours after the reference point \nindicated by MBTPTREF. \nPerm \nMBTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by MBELTM, MBTPTNUM, and MBTPT. Example: \n\"PREVIOUS DOSE\". \nPerm \nMBRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point, MBTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nMB \u2013 Assumptions \n1. Representation of findings in the Microbiology Specimen domain should be handled as follows: \na. \nIn cases of tests that target an organism, group of organisms, or antigen for identification, MBTEST equals the name of the organism/antigen \ntargeted by the identification assay, and  \ni.  MBTSTDTL should be \u201cDETECTION\u201d. \nii. The result should generally be \"PRESENT\"/\"ABSENT\", \"POSITIVE\"/\"NEGATIVE\", or \"INDETERMINATE\". However, there may be cases \nwhere a test differentiates between 2 or more similar organisms, in which case it would be appropriate for the result to be the name of the \norganism detected. For example, a test may look for influenza A or influenza B antigen. In this case, MBTEST would be \"Influenza A/B \nAntigen\"; the result could be \"INFLUENZA A ANTIGEN\", \"INFLUENZA B ANTIGEN\", or \"INFLUENZA A/B ANTIGEN\". \nb. For non-targeted identification of organisms (i.e., tests that have the ability to identify a range of organisms without specifically targeting any), the \nvalue for MBTESTCD/MBTEST should be \"MCORGIDN\"/\"Microbial Organism Identification\", and the result should be the name of the organism \nor group of organisms found to be present (e.g., \"INFLUENZA A VIRUS SUBTYPE H1N1\"; \"CLONORCHIS SINENSIS\"). In this scenario \nMBORRES is populated with values from the Microorganism Codelist (C85491).   \nc. \nCulture characteristics covers concepts such as growth/no growth, colony quantification measures, colony color, colony morphology, and so on.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2885, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "44fd2725-7b55-4de5-b096-1835ec9c161a": {"__data__": {"id_": "44fd2725-7b55-4de5-b096-1835ec9c161a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 251, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fdf1f935-4173-4cea-bb38-dd8972d6f371", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 251, "section": "UNSPECIFIED"}, "hash": "8f1402487caf1bf2d9dfc9f216be0f0a24b836c3fb9b7b14f37f4a5ef43e8dd9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2a725a3e-a6e5-41b6-b7d1-1c2521603bdb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 251, "section": "UNSPECIFIED"}, "hash": "595aa9c0b70b4ac14303861101a354666807ff7b351eb7968d576796bcf57bd0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b. For non-targeted identification of organisms (i.e., tests that have the ability to identify a range of organisms without specifically targeting any), the \nvalue for MBTESTCD/MBTEST should be \"MCORGIDN\"/\"Microbial Organism Identification\", and the result should be the name of the organism \nor group of organisms found to be present (e.g., \"INFLUENZA A VIRUS SUBTYPE H1N1\"; \"CLONORCHIS SINENSIS\"). In this scenario \nMBORRES is populated with values from the Microorganism Codelist (C85491).   \nc. \nCulture characteristics covers concepts such as growth/no growth, colony quantification measures, colony color, colony morphology, and so on. \nNote that this does not include drug susceptibility testing, which is represented in the Microbiology Susceptibility (MS) domain. \ni. MBTESTCD/MBTEST should be the name of the organism or group of organisms being characterized. \nii. MBTSTDTL should be the name of the characteristic being described (e.g., \u201cCOLONY COUNT\", \"VIRAL LOAD\").   \niii. MBGRPID should be used to group characteristic records with the identification record of the organism to which the characteristics apply. \niv. CDISC Controlled Terminology Rules for Microbiology (MB/MS) domains are available at \nhttps://www.cdisc.org/standards/terminology/controlled-terminology. \n2. MBDTC represents the date the specimen was collected.", "mimetype": "text/plain", "start_char_idx": 2244, "end_char_idx": 3586, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d59522b9-9d21-49a5-9b10-1127e4d023ba": {"__data__": {"id_": "d59522b9-9d21-49a5-9b10-1127e4d023ba", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 252, "section": "6.3.5.7.2 Microbiology Susceptibility (MS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6cc15f68-cf3c-4a52-abf2-c1223ad10617", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 252, "section": "6.3.5.7.2 Microbiology Susceptibility (MS)"}, "hash": "5a2d5a7ca41c6e53c525f2848a226bb713d24904dc8643d31a59241443f68e61", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MS \u2013 Description/Overview \nA findings domain that represents drug susceptibility testing results only. This includes phenotypic testing (where drug is added directly to a culture of \norganisms) and genotypic tests that provide results in terms of susceptible or resistant. Drug susceptibility testing may occur on a wide variety of non-host \norganisms, including bacteria, viruses, fungi, protozoa and parasites. \nMS \u2013 Specification \nms.xpt, Microbiology Susceptibility \u2014 Findings. One record per microbiology susceptibility test (or other organism-related finding) per \norganism found in MB, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar MS \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier Char  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nNHOID \nNon-host Organism ID \nChar  \nIdentifier \nSponsor-defined identifier for a non-host organism which should only be used when the organism is \nthe subject of the TEST. This variable should be populated with an intuitive name based on the identity \nof the non-host organism as reported by a lab (e.g., \"A/California/7/2009 (H1N1)\"). It is not to be used \nas a qualifier of the result in the record on which it appears. \nPerm \nMSSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject (or within a \nparameter, in the case of the Trial Summary domain). May be any valid number (including decimals) \nand does not have to start at 1. \nReq \nMSGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nIn SDTMIG v3.2 this was an Expected variable. In this version, the core designation has been changed \nto Permissible. \nPerm \nMSREFID \nReference ID \nChar  \nIdentifier \nOptional internal or external identifier (e.g., an identifier for the culture/isolate being tested for \nsusceptibility). \nPerm \nMSSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or \ndefined in the sponsor's operational database. \nPerm \nMSLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. For example, it may be used to link genetic findings (in the PF domain) about a microbe to \nthe original culture of that microbe (in MB), or to susceptibility records (in MS) if needed. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2768, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30707f22-7d50-4e27-82d9-76f693be17a5": {"__data__": {"id_": "30707f22-7d50-4e27-82d9-76f693be17a5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 253, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0049559a-77f4-4cb5-ade2-75fd5413b5dd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 253, "section": "UNSPECIFIED"}, "hash": "69e423698987217fa2aa9cb17e4101d2c580fd81b092e79eac1b89cb3fb6c7c9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "49eb4586-ba1c-4edb-b977-a48a88fb2e6f", "node_type": "1", "metadata": {}, "hash": "afb6387998e6980cf189742ce0db4c43ce4c15c3f6feb93838bcdd11cbe46722", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 253 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nMSTESTCD \nShort Name of \nAssessment \nChar (MSTESTCD) \nTopic \nShort character value for MSTEST used as a column name when converting a dataset from a vertical \nformat to a horizontal format. It can be used as a column name when converting a dataset from a \nvertical to a horizontal format. The value in MSTESTCD cannot be longer than 8 characters, nor can it \nstart with a number (e.g., \"1TEST\" is not valid). MSTESTCD cannot contain characters other than \nletters, numbers, or underscores. Examples: \"MIC\" for Minimum Inhibitory Concentration; \n\"MICROSUS\" for Microbial Susceptibility. \nReq \nMSTEST \nName of Assessment \nChar (MSTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in \nMSTEST cannot be longer than 40 characters. Examples: \"Minimum Inhibitory Concentration\", \n\"Microbial Susceptibility\". \nReq \nMSAGENT \nAgent Name \nChar  \nVariable \nQualifier \nThe name of the agent for which resistance is tested. The agent specified may be based on genetic \nmarkers or direct phenotypic drug sensitivity testing. Examples: \"Penicillin\", name of study drug. \nExp \nMSCONC \nAgent Concentration \nNum  \nVariable \nQualifier \nNumeric concentration of agent listed in MSAGENT. \nPerm \nMSCONCU \nAgent Concentration \nUnits \nChar (UNIT) \nVariable \nQualifier \nUnits for value of the agent concentration listed in MSCONC. Example: \"mg/L\". \nPerm \nMSTSTDTL \nMeasurement, Test or \nExamination Detail \nChar  \nVariable \nQualifier \nFurther description of MSTESTCD and MSTEST. \nPerm \nMSCAT \nCategory \nChar * \nGrouping \nQualifier \nUsed to define a category of MSTEST values. \nPerm \nMSSCAT \nSubcategory \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of MSCAT values. \nPerm \nMSORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nMSORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nUnit for MSORRES. Examples: \"ug/mL\". \nPerm \nMSSTRESC \nResult or Finding in \nStandard Format \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from MSORRES in a standard format or in \nstandard units. MSSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in MSSTRESN. For example, if various tests \nhave results \"NONE\", \"NEG\", and \"NEGATIVE\" in MSORRES and these results effectively have the \nsame meaning, they could be represented in standard format in MSSTRESC as \"NEGATIVE\". \nExp \nMSSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nMSSTRESC. MSSTRESN should store all numeric test results or findings.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3107, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "49eb4586-ba1c-4edb-b977-a48a88fb2e6f": {"__data__": {"id_": "49eb4586-ba1c-4edb-b977-a48a88fb2e6f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 253, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0049559a-77f4-4cb5-ade2-75fd5413b5dd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 253, "section": "UNSPECIFIED"}, "hash": "69e423698987217fa2aa9cb17e4101d2c580fd81b092e79eac1b89cb3fb6c7c9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30707f22-7d50-4e27-82d9-76f693be17a5", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 253, "section": "UNSPECIFIED"}, "hash": "b069bf6b3c3ecca477a48be2765b4b92d619fe9028ac2fa2b6e72ce36c4b2263", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nMSSTRESC \nResult or Finding in \nStandard Format \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from MSORRES in a standard format or in \nstandard units. MSSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in MSSTRESN. For example, if various tests \nhave results \"NONE\", \"NEG\", and \"NEGATIVE\" in MSORRES and these results effectively have the \nsame meaning, they could be represented in standard format in MSSTRESC as \"NEGATIVE\". \nExp \nMSSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nMSSTRESC. MSSTRESN should store all numeric test results or findings. \nPerm \nMSSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for MSSTRESC and MSSTRESN. Example: \"mol/L\". \nPerm \nMSNRIND \nNormal/Reference \nRange Indicator \nChar (NRIND) \nVariable \nQualifier \nUsed to indicate the value is outside the normal range or reference range. May be defined by \nMSORNRLO and MSORNRHI or other objective criteria. Examples: \"Y\", \"N\", \"HIGH\", \"LOW\", \n\"NORMAL\". \"ABNORMAL\". \nPerm \nMSRESCAT \nResult Category \nChar (MSRESCAT) \nVariable \nQualifier \nUsed to categorize the result of a finding. In SDTMIG v3.2, MSRESCAT was used to categorize a \nnumeric susceptibility result represented in MSORRES as either \"SUSCEPTIBLE\", \"INTERMEDIATE\", \nor \"RESISTANT\". However, results from some susceptibility tests may report only a categorical result \nand not a numeric result. Thus, in order for susceptibility results to be represented consistently, \nMSRESCAT should no longer be used for this purpose. In this version, the core designation has been \nchanged from Expected to Permissible. \nPerm \nMSSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or a test was attempted but did \nnot generate a result. Should be null or have a value of \"NOT DONE\". \nPerm \nMSREASND \nReason Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with MSSTAT when value is \"NOT DONE\". \nPerm \nMSXFN \nExternal File Path \nChar  \nRecord \nQualifier \nFilename for an external file. \nPerm", "mimetype": "text/plain", "start_char_idx": 2291, "end_char_idx": 4604, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5def7a88-70f4-46eb-98bb-bdeb3e1a5464": {"__data__": {"id_": "5def7a88-70f4-46eb-98bb-bdeb3e1a5464", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 254, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ad2f737-7d46-4997-81ca-bf3e9bad9ca5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 254, "section": "UNSPECIFIED"}, "hash": "3e474dcf97638f26e33193ad12cef16583823aba680255c5d25ba33c6d93f2aa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc65e377-520e-407c-99fa-1113cbebc0c7", "node_type": "1", "metadata": {}, "hash": "ef1fca5d68fc81f33503f0269187b35a66cd16692b422638968cc864a4486216", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 254 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nMSNAM \nLaboratory/Vendor \nName \nChar  \nRecord \nQualifier \nName or identifier of the vendor (e.g., laboratory) that provided the test results. \nPerm \nMSLOINC \nLOINC Code \nChar  \nSynonym \nQualifier \nLogical Observation Identifiers Names and Codes (LOINC) code for the topic variable such as a lab \ntest. \nPerm \nMSSPEC \nSpecimen Material Type \nChar (SPECTYPE) \nRecord \nQualifier \nDefines the type of specimen used for a measurement. Example: \"SPUTUM\". \nPerm \nMSSPCCND \nSpecimen Condition \nChar (SPECCOND) \nRecord \nQualifier \nDefines the condition of the specimen. Example: \"CLOUDY\". \nPerm \nMSLOC \nLocation Used for the \nMeasurement \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. \nPerm \nMSLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\". \nPerm \nMSDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nMSMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"EPSILOMETER\", \"MACRO BROTH DILUTION\". \nPerm \nMSANMETH \nAnalysis Method \nChar  \nRecord \nQualifier \nAnalysis method applied to obtain a summarized result. Analysis method describes the method of \nsecondary processing applied to a complex observation result (e.g., an image or a genetic sequence). \nPerm \nMSLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nPerm \nMSBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that MSBLFL is retained for \nbackward compatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nMSFAST \nFasting Status \nChar (NY) \nRecord \nQualifier \nIndicator used to identify fasting status. Valid values include \"Y\", \"N\", \"U\", or null if not relevant. \nPerm \nMSDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nMSEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\", \"MICROSCOPIST\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2945, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc65e377-520e-407c-99fa-1113cbebc0c7": {"__data__": {"id_": "dc65e377-520e-407c-99fa-1113cbebc0c7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 254, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ad2f737-7d46-4997-81ca-bf3e9bad9ca5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 254, "section": "UNSPECIFIED"}, "hash": "3e474dcf97638f26e33193ad12cef16583823aba680255c5d25ba33c6d93f2aa", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5def7a88-70f4-46eb-98bb-bdeb3e1a5464", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 254, "section": "UNSPECIFIED"}, "hash": "cee56156b78f4bb471917b0d70fd26aed619c439f93ebf85ea0cf06fcf991147", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nMSFAST \nFasting Status \nChar (NY) \nRecord \nQualifier \nIndicator used to identify fasting status. Valid values include \"Y\", \"N\", \"U\", or null if not relevant. \nPerm \nMSDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nMSEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\", \"MICROSCOPIST\". \nPerm \nMSEVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in MSEVAL. Examples: \n\"RADIOLOGIST1\" or \"RADIOLOGIST2\". \nPerm \nMSACPTFL \nAccepted Record Flag \nChar (NY) \nRecord \nQualifier \nIn cases where more than 1 assessor provides an evaluation of a result or response, this flag identifies \nthe record that is considered, by an independent assessor, to be the accepted evaluation. Expected to \nbe \"Y\" or null. \nPerm \nMSLLOQ \nLower Limit of \nQuantitation \nNum  \nVariable \nQualifier \nIndicates the lower limit of quantitation for an assay. Units will be those used for MSSTRESU. \nPerm \nMSULOQ \nUpper Limit of \nQuantitation \nNum  \nVariable \nQualifier \nIndicates the upper limit of quantitation for an assay. Units will be those used for MSSTRESU. \nPerm \nMSREPNUM Repetition Number \nNum  \nRecord \nQualifier \nThe incidence number of a test that is repeated within a given timeframe for the same test. The level of \ngranularity can vary (e.g., within a time point, within a visit). Examples: multiple measurements of blood \npressure, multiple analyses of a sample. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nspecimen was collected. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the specimen was collected. \nPerm", "mimetype": "text/plain", "start_char_idx": 2230, "end_char_idx": 4717, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "371f0627-7ff8-4fe8-9a59-bb4f974a2ef9": {"__data__": {"id_": "371f0627-7ff8-4fe8-9a59-bb4f974a2ef9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 255, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aca046ca-5a30-4c57-8305-7be3a2365069", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 255, "section": "UNSPECIFIED"}, "hash": "22cf10accd3c69505b123bd7baaaefb9b78e5a8455363ce11e67d1c6afa31cd5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d5268f87-4dcd-4409-a097-aed5ccaa8e63", "node_type": "1", "metadata": {}, "hash": "1a0e2f80802efede7ad58e6b8e0b60ac7f22961b8eaf909288f84defa08e2fbd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 255 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nMSDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of an observation. \nPerm \nMSDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nMSDUR \nDuration \nChar ISO 8601 duration \nTiming \nCollected duration of an event, intervention, or finding. Used only if collected on the CRF and not \nderived. \nPerm \nMSTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point (e.g., time of \nlast dose). See MSTPTNUM and MSTPTREF. \nPerm \nMSTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nMSELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time relative to a planned fixed reference (MSTPTREF; e.g., previous dose, previous \nmeal). This variable is useful where there are repetitive measures. Not a clock time or a date/time \nvariable, but an interval, represented as ISO duration. \nPerm \nMSTPTREF \nTime Point Reference \nChar  \nTiming \nDescription of the fixed reference point referred to by MSELTM, MSTPTNUM, and MSTPT. Example: \n\"PREVIOUS DOSE\". \nPerm \nMSRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point defined by MSTPTREF. \nPerm \nMSEVLINT \nEvaluation Interval \nChar ISO 8601 duration \nor interval \nTiming \nDuration of interval associated with an observation such as a finding MSTESTCD. Example: \"-P2M\" to \nrepresent a period of the past 2 months before the assessment. \nPerm \nMSEVINTX \nEvaluation Interval Text \nChar  \nTiming \nEvaluation interval associated with an observation, where the interval is not able to be represented in \nISO 8601 format. Examples: \"LIFETIME\", \"LAST NIGHT\", \"RECENTLY\", \"OVER THE LAST FEW \nWEEKS\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nMS \u2013 Assumptions \n1. Microbiology Susceptibility testing includes testing of the following types: \na. \nPhenotypic drug susceptibility testing (qualitative), which may involve determining susceptibility/resistance (qualitative) at a predefined \nconcentration of drug, or determining a specific dose (quantitative) at which a drug inhibits organism growth or some other process associated with \nvirulence.  \ni. For studies using qualitative testing methods, MSAGENT, MSCONC, and MSCONCU are used to represent the predefined drug, \nconcentration, and units, respectively.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3098, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d5268f87-4dcd-4409-a097-aed5ccaa8e63": {"__data__": {"id_": "d5268f87-4dcd-4409-a097-aed5ccaa8e63", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 255, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aca046ca-5a30-4c57-8305-7be3a2365069", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 255, "section": "UNSPECIFIED"}, "hash": "22cf10accd3c69505b123bd7baaaefb9b78e5a8455363ce11e67d1c6afa31cd5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "371f0627-7ff8-4fe8-9a59-bb4f974a2ef9", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 255, "section": "UNSPECIFIED"}, "hash": "0131b0fc2903828a82c6ab696c3f15d826ce28b6057266a7a4619eb775c0c728", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"LIFETIME\", \"LAST NIGHT\", \"RECENTLY\", \"OVER THE LAST FEW \nWEEKS\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nMS \u2013 Assumptions \n1. Microbiology Susceptibility testing includes testing of the following types: \na. \nPhenotypic drug susceptibility testing (qualitative), which may involve determining susceptibility/resistance (qualitative) at a predefined \nconcentration of drug, or determining a specific dose (quantitative) at which a drug inhibits organism growth or some other process associated with \nvirulence.  \ni. For studies using qualitative testing methods, MSAGENT, MSCONC, and MSCONCU are used to represent the predefined drug, \nconcentration, and units, respectively. Results are represented with values such as \u201cSUSCEPTIBLE\u201d or \u201cRESISTANT\u201d. \nii. For studies using quantitative testing methods, MSAGENT is used to represent the drug being tested; MSCONC and MSCONCU are not used. \nThe concentration at which growth is inhibited is the result in these cases (MSORRES, MSSTRESC/MSSTRESN), with units being \nrepresented in MSORRESU/MSSTRESU. \nb. Genetic tests that provide results in terms of susceptible/resistant only (e.g., nucleic acid amplification tests (NAAT)). Genotypic tests that \nprovide results in terms of specific changes to nucleotides, codons, or amino acids of genes/gene products associated with resistance should be \nrepresented in the Genomic Findings (GF) domain, as that domain structure contains the variables necessary to accommodate data of this type. \nIf a test provides both mutation data and susceptibility data, the mutation results should be represented in GF and the susceptibility information \nshould be represented in MS. In these cases, the GF records should be linked via RELREC to susceptibility records in MS.", "mimetype": "text/plain", "start_char_idx": 2285, "end_char_idx": 4174, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f60f66c1-691f-467d-bb33-eca818c58492": {"__data__": {"id_": "f60f66c1-691f-467d-bb33-eca818c58492", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 256, "section": "6.3.5.7.3 Microbiology Specimen/Microbiology Susceptibility Examples"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "897b6679-3267-4bc9-8b80-a2cfe236d67d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 256, "section": "6.3.5.7.3 Microbiology Specimen/Microbiology Susceptibility Examples"}, "hash": "768e5596b2d8f9e86fe2d2d7943150a1cce8f8577b653c0729b4c847d957b121", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example 1 \nIn this example, both a central and a local lab (MBNAM) independently identified Enterococcus faecalis (MBORRES) in a fluid specimen (MBSPEC) taken \nfrom the skin (MBLOC) of a subject at visit 1. The method used by both labs was a solid microbial culture (MBMETHOD). Because the culture was not targeted \nto encourage the growth of a specific organism, MBTESTCD/MBTEST = \"MCORGIDN\"/\"Microbial Organism Identification\" and MBORRES represents the \nname of the organism identified. \nmb.xpt \nRow STUDYID DOMAIN USUBJID \nMBSEQ MBREFID MBLNKID MBTESTCD MBTEST \nMBORRES \nMBSTRESC \nMBNAM \nMBSPEC MBLOC MBMETHOD \nVISITNUM VISIT \nMBDTC \n1 \nABC \nMB \nABC-001-\n002 \n1 \nSPEC01 \n1 \nMCORGIDN Microbial \nOrganism \nIdentification \nENTEROCOCCUS \nFAECALIS \nENTEROCOCCUS \nFAECALIS \nCENTRAL \nLAB ABC \nFLUID \nSKIN \nMICROBIAL \nCULTURE, \nSOLID \n1 \nVISIT \n1 \n2005-07-\n21T08:00 \n2 \nABC \nMB \nABC-001-\n002 \n2 \nSPEC01 \n2 \nMCORGIDN Microbial \nOrganism \nIdentification \nENTEROCOCCUS \nFAECALIS \nENTEROCOCCUS \nFAECALIS \nLOCAL \nLAB XYZ \nFLUID \nSKIN \nMICROBIAL \nCULTURE, \nSOLID \n1 \nVISIT \n1 \n2005-07-\n21T08:00 \nAfter E. faecalis was identified in the subject sample, drug susceptibility testing was performed at each of the labs using both the sponsor's investigational drug \nand amoxicillin. Because an identified organism is the subject of the test, the NHOID variable is populated with \"ENTEROCOCCUS FAECALIS\". Between the \n2 labs (MSNAM), a total of 3 susceptibility testing methods were used: epsilometer, disk diffusion, and macro broth dilution (MSMETHOD). Epsilometer and \ndisk diffusion both use agar diffusion methods, in which an agar plate is inoculated with the microorganism of interest and either a strip (epsilometer) or discs \n(disk diffusion) containing various concentrations of the drug are placed on the agar plate. The epsilometer test method provides both a  minimum inhibitory \nconcentration (MSTESTCD = \"MIC\"), the  lowest concentration of a drug  that inhibits the growth of a microorganism, and a qualitative interpretation \n(MSTESTCD = \"MICROSUS\") such as susceptible, intermediate, or resistant. The disk diffusion test method provides the diameter of the zone of inhibition", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2178, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbc89dc6-3a79-418b-8104-1ec494f75c7c": {"__data__": {"id_": "dbc89dc6-3a79-418b-8104-1ec494f75c7c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 257, "section": "0.25 0.25"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dd5d13cd-55a3-4381-938a-a6446337c7f9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 257, "section": "0.25 0.25"}, "hash": "8b58d53b8a322f951b0490213bae101b9d2f6f9a53538a7e9549e3099e36ceda", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ug/dL \nCENTRAL \nLAB ABC \nEPSILOMETER \n2005-06-\n19T08:00 \n2 \nABC \nMS \nABC-001-\n002 \nENTEROCOCCUS \nFAECALIS \n1 \n2 \nSPEC01 \n1 \nMICROSUS \nMicrobial \nSusceptibility \nSponsor \nDrug \n \n \nSUSCEPTIBLE  \nSUSCEPTIBLE  \n \nCENTRAL \nLAB ABC \nEPSILOMETER \n2005-06-\n19T08:00 \n3 \nABC \nMS \nABC-001-\n002 \nENTEROCOCCUS \nFAECALIS \n2 \n3 \nSPEC01 \n1 \nMIC \nMinimum Inhibitory \nConcentration \nAmoxicillin \n \n \n1 \nug/dL \n1 \n1 \nug/dL \nCENTRAL \nLAB ABC \nEPSILOMETER \n2005-06-\n19T08:00 \n4 \nABC \nMS \nABC-001-\n002 \nENTEROCOCCUS \nFAECALIS \n2 \n4 \nSPEC01 \n1 \nMICROSUS \nMicrobial \nSusceptibility \nAmoxicillin \n \n \nRESISTANT \n \nRESISTANT \n \n \nCENTRAL \nLAB ABC \nEPSILOMETER \n2005-06-\n19T08:00 \n5 \nABC \nMS \nABC-001-\n002 \nENTEROCOCCUS \nFAECALIS \n \n5 \nSPEC01 \n2 \nMICROSUS \nMicrobial \nSusceptibility \nSponsor \nDrug", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 772, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6fbbacb2-6db6-43f1-8617-c222e274ccce": {"__data__": {"id_": "6fbbacb2-6db6-43f1-8617-c222e274ccce", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 257, "section": "0.5 ug/dL"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a18f6a85-0883-4e33-976f-179135859ada", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 257, "section": "0.5 ug/dL"}, "hash": "4978c50a31d6e9b24ac610111ac2eb85c407dfb94307b9d4c98556b486bcd160", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RESISTANT \n \nRESISTANT \n \n \nLOCAL LAB \nXYZ \nMACRO BROTH \nDILUTION \n2005-06-\n19T08:00 \n7 \nABC \nMS \nABC-001-\n002 \nENTEROCOCCUS \nFAECALIS \n3 \n7 \nSPEC01 \n2 \nDIAZOINH \nDiameter of the \nZone of Inhibition \nSponsor \nDrug \n \n \n23 \nmm \n23 \n23 \nmm \nLOCAL LAB \nXYZ \nDISK DIFFUSION \n2005-06-\n26T08:00 \n8 \nABC \nMS \nABC-001-\n002 \nENTEROCOCCUS \nFAECALIS \n3 \n8 \nSPEC01 \n2 \nMICROSUS \nMicrobial \nSusceptibility \nSponsor \nDrug \n \n \nSUSCEPTIBLE  \nSUSCEPTIBLE  \n \nLOCAL LAB \nXYZ \nDISK DIFFUSION \n2005-06-\n26T08:00 \n9 \nABC \nMS \nABC-001-\n002 \nENTEROCOCCUS \nFAECALIS \n4 \n9 \nSPEC01 \n2 \nDIAZOINH \nDiameter of the \nZone of Inhibition \nAmoxicillin \n \n \n25 \nmm \n \n25 \nmm \nLOCAL LAB \nXYZ \nDISK DIFFUSION \n2005-06-\n26T08:00 \n10 \nABC \nMS \nABC-001-\n002 \nENTEROCOCCUS \nFAECALIS \n4 \n10 \nSPEC01 \n2 \nMICROSUS \nMicrobial \nSusceptibility \nAmoxicillin \n \n \nRESISTANT \n \nRESISTANT \n \n \nLOCAL LAB \nXYZ \nDISK DIFFUSION \n2005-06-\n26T08:00 \nAlthough not expected, the sponsor decided to connect the identification records in MB to the records in MS using the variables MBLNKID and MSLNKGRP. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC \nMB \n \nMBLNKID \n \nONE \nA \n2 \nABC \nMS \n \nMSLNKGRP  \nMANY \nA \nExample 2 \nIn this example, a sputum sample, collected from the subject at 3 visits over the course of 15 days, was tested for the presence of infectious organisms. The 2 organisms identified were also tested for susceptibility to \nboth penicillin and the sponsor's study drug (MSAGENT). The example shows that the 2 infecting organisms were cleared over the course of the 3 visits. \nSpecimen collection was represented in the Biospecimen Events (BE) domain.  \nbe.xpt \nRow STUDYID DOMAIN USUBJID \nBESEQ BEREFID BETERM \nBEDTC \n1 \nABC \nBE \nABC-001-001 1 \nSP01 \nCollecting 2005-06-19T08:00 \n2 \nABC \nBE \nABC-001-001 2 \nSP02 \nCollecting 2005-06-26T08:00 \n3 \nABC \nBE \nABC-001-001 3 \nSP03 \nCollecting 2005-07-06T08:00", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1895, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e78ec48c-a453-47b1-a6e9-758840dfe22b": {"__data__": {"id_": "e78ec48c-a453-47b1-a6e9-758840dfe22b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 258, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0573f79f-96c2-429e-81b2-18333869bb9f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 258, "section": "UNSPECIFIED"}, "hash": "b52abc8f364a6affd530e887a35346e963396b901533f9c8a5cfec92422af0ac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5ddf69a5-21f9-454d-9928-a179ce5517fc", "node_type": "1", "metadata": {}, "hash": "a032d4861480d1082d4972fb5b95bbd1ea01b4789d5a1f0c4de9463ecc088c62", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 258 \n2021-11-29 \nThe SUPPBE dataset is used to represent 2 non-standard variables of BE. \nRows 1-3: \nShow that all 3 samples (IDVARVAL where IDVAR=\"BEREFID\") were sputum, as indicated by QVAL where QNAM=\"BESPEC\" and QLABEL=\"Specimen Type\". \nRows 4-6: \nShow that all 3 sputum samples were collected via expectoration, as indicated by QVAL where QNAM=\"Specimen Collection Method\". QVAL is populated using the CDISC Controlled Terminology \ncodelist, \"Specimen Collection Method\". \nsuppbe.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \n1 \nABC \nBE \nABC-01-101 \nBEREFID \nSP01 \nBESPEC \nSpecimen Type \nSPUTUM \nCRF \n2 \nABC \nBE \nABC-01-101 \nBEREFID \nSP02 \nBESPEC \nSpecimen Type \nSPUTUM \nCRF \n3 \nABC \nBE \nABC-01-101 \nBEREFID \nSP03 \nBESPEC \nSpecimen Type \nSPUTUM \nCRF \n4 \nABC \nBE \nABC-01-101 \nBEREFID \nSP01 \nBECLMETH \nSpecimen Collection Method \nEXPECTORATION \nCRF \n5 \nABC \nBE \nABC-01-101 \nBEREFID \nSP02 \nBECLMETH \nSpecimen Collection Method \nEXPECTORATION \nCRF \n6 \nABC \nBE \nABC-01-101 \nBEREFID \nSP03 \nBECLMETH \nSpecimen Collection Method \nEXPECTORATION \nCRF \nRows 1-2: \nShow that a gram stain was used on a subject sputum sample to identify the presence of gram negative cocci (row 1) and to quantify the bacteria (row 2). MBORRES in row 2 represents an ordinal result \n(MBRSLSCL = \"Ord\"), such as from a published quantification scale. This value decodes to \"FEW\" as shown in MBSTRESC. The quantification scale used is represented as Supplemental Qualifiers of \nMB. \nRows 3-4: \nShow that the same gram-stained sample was used to identify and quantify the presence of gram negative rods. \nRows 5-6: \nShow that microbial culture of the same sample was used at the same visit to identify the presence of two organisms, \"STREPTOCOCCUS PNEUMONIAE\" and \"KLEBSIELLA PNEUMONIAE\" \n(MBORRES). \nRow 7: \nShows that microbial culture of a subsequent sample at a later visit indicated only the presence of \"KLEBSIELLA PNEUMONIAE\" (MBORRES). \nRow 8: \nShows that microbial culture of a third subject sample at the third visit indicated \"NO GROWTH\" (MBORRES) of any organisms.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2262, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5ddf69a5-21f9-454d-9928-a179ce5517fc": {"__data__": {"id_": "5ddf69a5-21f9-454d-9928-a179ce5517fc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 258, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0573f79f-96c2-429e-81b2-18333869bb9f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 258, "section": "UNSPECIFIED"}, "hash": "b52abc8f364a6affd530e887a35346e963396b901533f9c8a5cfec92422af0ac", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e78ec48c-a453-47b1-a6e9-758840dfe22b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 258, "section": "UNSPECIFIED"}, "hash": "e444a3a347cc7d4f77854b1f320acd6977f81bde0bae71e72f5d434b2a767860", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Row 8: \nShows that microbial culture of a third subject sample at the third visit indicated \"NO GROWTH\" (MBORRES) of any organisms. \nmb.xpt \nRow STUDYID DOMAIN USUBJID \nMBSEQ MBREFID MBTESTCD MBTEST \nMBTSTDTL \nMBORRES \nMBRSLSCL MBSTRESC \nMBLOC MBMETHOD \nVISITNUM VISIT \nMBDTC \n1 \nABC \nMB \nABC-001-\n001 \n1 \nSP01 \nGMNCOC \nGram Negative Cocci \nDETECTION \nPRESENT \nOrd \nPRESENT \nLUNG \nGRAM STAIN \n1 \nVISIT \n1 \n2005-06-\n19T08:00 \n2 \nABC \nMB \nABC-001-\n001 \n2 \nSP01 \nGMNCOC \nGram Negative Cocci \nCELL \nCOUNT \n2+ \nOrd \nFEW \nLUNG \nGRAM STAIN \n1 \nVISIT \n1 \n2005-06-\n19T08:00 \n3 \nABC \nMB \nABC-001-\n001 \n3 \nSP01 \nGMNROD \nGram Negative Rods \nDETECTION \nPRESENT \nOrd \nPRESENT \nLUNG \nGRAM STAIN \n1 \nVISIT \n1 \n2005-06-\n19T08:00 \n4 \nABC \nMB \nABC-001-\n001 \n4 \nSP01 \nGMNROD \nGram Negative Rods \nCELL \nCOUNT \n2+ \nOrd \nFEW \nLUNG \nGRAM STAIN \n1 \nVISIT \n1 \n2005-06-\n19T08:00 \n5 \nABC \nMB \nABC-001-\n001 \n5 \nSP01 \nMCORGIDN Microbial Organism \nIdentification \n \nSTREPTOCOCCUS \nPNEUMONIAE \nNom \nSTREPTOCOCCUS \nPNEUMONIAE \nLUNG \nMICROBIAL CULTURE, \nSOLID \n1 \nVISIT \n1 \n2005-06-\n19T08:00 \n6 \nABC \nMB \nABC-001-\n001 \n6 \nSP01 \nMCORGIDN Microbial Organism \nIdentification \n \nKLEBSIELLA PNEUMONIAE \nNom \nKLEBSIELLA PNEUMONIAE \nLUNG \nMICROBIAL CULTURE, \nSOLID \n1 \nVISIT \n1 \n2005-06-\n19T08:00 \n7 \nABC \nMB \nABC-001-\n001 \n7 \nSP02 \nMCORGIDN Microbial Organism \nIdentification \n \nKLEBSIELLA PNEUMONIAE \nNom \nKLEBSIELLA PNEUMONIAE \nLUNG \nMICROBIAL CULTURE, \nSOLID \n2 \nVISIT \n2 \n2005-06-\n26T08:00 \n8 \nABC \nMB \nABC-001-\n001 \n8 \nSP03 \nMCORGIDN Microbial Organism \nIdentification \n \nNO GROWTH \nNom \nNO GROWTH \nLUNG \nMICROBIAL CULTURE, \nSOLID \n3 \nVISIT \n3 \n2005-07-\n06T08:00 \n \nsuppmb.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \n1 \nABC \nMB \nABC-01-101 \nMBTSTDTL \nCELL COUNT \nMBQSCAL \nQuantification Scale \nCDC semi-quantitative score for gram staining \nCRF", "mimetype": "text/plain", "start_char_idx": 2131, "end_char_idx": 3977, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "76515d7e-e3ee-4544-8302-a662a1207651": {"__data__": {"id_": "76515d7e-e3ee-4544-8302-a662a1207651", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.004 0.004"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c679ec3a-77fa-43c5-809c-7139dbad247a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.004 0.004"}, "hash": "78d038ef8a4ddcef4cc0873c83733768f9d9c075bfe43723e91d57119adfc8f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mg/L \nEPSILOMETER 2005-06-\n19T08:00 \n2 \nABC \nMS \nABC-001-\n001 \nSTREPTOCOCCUS \nPNEUMONIAE \n2 \nSP01 \n1 \nMICROSUS Microbial Susceptibility \nSponsor \nDrug \nSUSCEPTIBLE \n \nSUSCEPTIBLE \n \n \nEPSILOMETER 2005-06-\n19T08:00 \n3 \nABC \nMS \nABC-001-\n001 \nSTREPTOCOCCUS \nPNEUMONIAE \n3 \nSP01 \n2 \nMIC \nMinimum Inhibitory \nConcentration \nPenicillin", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 330, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "78ee7abd-2a39-4586-9332-5ecf12c55283": {"__data__": {"id_": "78ee7abd-2a39-4586-9332-5ecf12c55283", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.023 0.023"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bd9ea46f-f4df-469e-930e-22dc8921e85e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.023 0.023"}, "hash": "e951071769dbacf982860550b0a3593c6d59af0cd20f226d0336db5c644bcffd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mg/L \nEPSILOMETER 2005-06-\n19T08:00 \n4 \nABC \nMS \nABC-001-\n001 \nSTREPTOCOCCUS \nPNEUMONIAE \n4 \nSP01 \n2 \nMICROSUS Microbial Susceptibility \nPenicillin \nRESISTANT \n \nRESISTANT \n \n \nEPSILOMETER 2005-06-\n19T08:00 \n5 \nABC \nMS \nABC-001-\n001 \nKLEBSIELLA PNEUMONIAE \n5 \nSP02 \n3 \nMIC \nMinimum Inhibitory \nConcentration \nSponsor \nDrug", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 322, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d6354800-d9f7-4c0e-ba99-df33b6554ac4": {"__data__": {"id_": "d6354800-d9f7-4c0e-ba99-df33b6554ac4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.125 0.125"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d9621b70-0205-4af1-ab94-9552f5581fd1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.125 0.125"}, "hash": "da8c03f2ac2744f6d6b78b29c4f5ac02758b58936db12445d0d8d93ec2936d9e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mg/L \nEPSILOMETER 2005-06-\n26T08:00 \n6 \nABC \nMS \nABC-001-\n001 \nKLEBSIELLA PNEUMONIAE \n6 \nSP02 \n3 \nMICROSUS Microbial Susceptibility \nSponsor \nDrug \nSUSCEPTIBLE \n \nSUSCEPTIBLE \n \n \nEPSILOMETER 2005-06-\n26T08:00 \n7 \nABC \nMS \nABC-001-\n001 \nKLEBSIELLA PNEUMONIAE \n7 \nSP02 \n4 \nMIC \nMinimum Inhibitory \nConcentration \nPenicillin", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 322, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "276e0850-e483-4b5f-b009-3e1ef9da40a2": {"__data__": {"id_": "276e0850-e483-4b5f-b009-3e1ef9da40a2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.023 0.023"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "87d2a4c7-ed99-47de-ba57-407d010dc2a6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.023 0.023"}, "hash": "ebf811e2e0ef214365ee54a28ef187af4aeaf21c9c74a84bc1152c55fe0ce95e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mg/L \nEPSILOMETER 2005-06-\n26T08:00 \n8 \nABC \nMS \nABC-001-\n001 \nKLEBSIELLA PNEUMONIAE \n8 \nSP02 \n4 \nMICROSUS Microbial Susceptibility \nPenicillin \nINTERMEDIATE  \nINTERMEDIATE  \n \nEPSILOMETER 2005-06-\n26T08:00 \n9 \nABC \nMS \nABC-001-\n001 \nKLEBSIELLA PNEUMONIAE \n9 \nSP03 \n5 \nMIC \nMinimum Inhibitory \nConcentration \nPenicillin", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 319, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b5bfb05a-d7b9-4cf8-a255-422299284d98": {"__data__": {"id_": "b5bfb05a-d7b9-4cf8-a255-422299284d98", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.026 0.026"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dee0496d-78fe-41f8-b5c8-53cdeb488bcd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 259, "section": "0.026 0.026"}, "hash": "940d9ac8106f9d72eb7bd619ec315c40fd41e256c93bbf5b1ff776b6558ba207", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "mg/L \nEPSILOMETER 2005-07-\n06T08:00 \n10 \nABC \nMS \nABC-001-\n001 \nKLEBSIELLA PNEUMONIAE \n10 \nSP03 \n5 \nMICROSUS Microbial Susceptibility \nPenicillin \nINTERMEDIATE  \nINTERMEDIATE  \n \nEPSILOMETER 2005-07-\n06T08:00 \nExample 3 \nThis example shows the microorganisms detected from a gastric aspirate specimen from a child with suspected tuberculosis (TB). In this example, gastric lavage is only performed once. Three records in the MB \ndomain store detection records for 2 levels of detection: acid-fast bacilli, and Mycobacterium tuberculosis (Mtb). Characteristics from a culture on solid media that support the presumptive detection of Mtb are also \nrepresented in MB. The susceptibility results from both the nucleic acid amplification test (NAAT) and the solid culture are represented in the MS domain. \nSpecimen processing events included sample collection, preparation, and culturing; these events are represented in the BE domain. For TB studies, each sample needs a separate identifier to link it to further actions \nor characteristics of the sample. Therefore, each aliquot is assigned a unique BEREFID value that can be traced to the BEREFID value assigned to the collected \"parent\" sample. BEREFID is also used to connect the \nBE and Biospecimen Findings (BS) domains (via BSREFID), as well as any results obtained from the sample that are in the MB or MS domains (via MBREFID and MSREFID). If the same sample is used in many \ntests, the use of --REFID may result in a potentially undesirable many-to-many merge; users may need to make use of additional linking variables such as --LNKID and --LNKGRP. Information about the BE and BS \ndomains including the specification tables, assumptions, and examples can be found in the Sections 6.2.2 and 6.3.5.2 of this document. \nIn the BE, BS, MB, and MS domains, --DTC represents the date of sample collection. --LNKID and --LNKGRP are used to link culture start and stop dates (BE) with culture results (MB and MS). \nRow 1: \nShows the event of specimen collection. This is the genesis of the sample identified by BEREFID=\"100\"; therefore, BEDTC and BESTDTC are the same. The specimen collection setting, collection \nmethod, and specimen type are represented using supplemental qualifiers. Even though the variable Specimen Type is available for use in Findings domains, it is not available for use in Events domains \nand thus it is represented as supplemental qualifier.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2419, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "51765ee9-6dc6-4ecf-a6e6-808e1e0ffaff": {"__data__": {"id_": "51765ee9-6dc6-4ecf-a6e6-808e1e0ffaff", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 260, "section": "100.1 Concentrating"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "46101aaa-5584-4139-8b93-58e3b270c390", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 260, "section": "100.1 Concentrating"}, "hash": "af401298b60bd7386a203aea7c8d3d0ac9fda84cb9e82954a75372f9742013eb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PREPARATION \n2011-01-17T06:00 \n2011-01-17T09:15 \n \n \nsuppbe.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \n1 \nABC \nBE \nABC-01-101 \nBEREFID \n100 \nBECLSET \nSpecimen Collection Setting \nHOSPITAL \nCRF \n2 \nABC \nBE \nABC-01-101 \nBEREFID \n100 \nBECLMETH \nSpecimen Collection Method \nGASTRIC LAVAGE \nCRF \n3 \nABC \nBE \nABC-01-101 \nBEREFID \n100 \nBESPEC \nSpecimen Type \nLAVAGE FLUID \nCRF \n4 \nABC \nBE \nABC-01-101 \nBEREFID", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 440, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2c5a3ba-e4b3-4ef2-acca-9af108e54224": {"__data__": {"id_": "c2c5a3ba-e4b3-4ef2-acca-9af108e54224", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 260, "section": "100.5 BESPEC"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e91d9423-0028-4f02-9b8f-1f666879d1e6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 260, "section": "100.5 BESPEC"}, "hash": "0fbdd05d3b38bc70697af2bb24ed48ec64ad0bd7ac1572b1d9632b1bbf026da8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Specimen Type \nLAVAGE FLUID \nCRF \nFindings data captured about the specimen during collection, preparation, and handling are represented in the BS domain. \nRow 1: \nShows the total volume of lavage fluid collected during the gastric lavage by using the same values for BSREFID and BEREFID. This is the parent \n(collected) sample from which further aliquots were generated. \nRows 2-6: \nShow the volume of each aliquot created. \nbs.xpt \nRow STUDYID DOMAIN USUBJID \nBSSEQ BSREFID BSTESTCD BSTEST BSORRES BSORRESU BSSTRESC BSSTRESN BSSTRESU BSSPEC \nBSLOC \nBSDTC \n1 \nABC \nBS \nABC-01-101 1 \n100 \nVOLUME \nVolume \n20 \nmL \n20 \n20 \nmL \nLAVAGE FLUID STOMACH 2011-01-17T06:00 \n2 \nABC \nBS \nABC-01-101 2", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 688, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9717d46b-ddd4-475a-ae3f-725dc541023b": {"__data__": {"id_": "9717d46b-ddd4-475a-ae3f-725dc541023b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 261, "section": "100.5 LAVAGE FLUID"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "02e02b10-65f8-41d5-a179-6ff25bdbd003", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 261, "section": "100.5 LAVAGE FLUID"}, "hash": "0e1ec5b3aaf2893ed7b7e9c10f554ee2e1851f267bffadd6bc35b9c010febe53", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "100 \n2 \nResults from detection tests performed on samples are represented in the MB domain. The sputum sample was aliquoted 5 times. Three of these aliquots \nunderwent detection testing using 3 separate tests: 1 for acid-fast bacillus (AFB), 1 for M. tuberculosis complex, and 1 for M. tuberculosis. \nMBTESTCD/MBTEST represents the organism being investigated, MBMETHOD represents the testing method, and MBREFID represents which aliquot was \ntested. The variable MBTSTDTL is used to provide further description of the test performed in producing the MB result. In addition to detection, MBTSTDTL \ncan be used to represent specific attributes (e.g., quantifiable and semi-quantifiable results of the culture) as well as qualitative details about the culture (e.g., \ncolony color, morphology). \nRow 1: \nShows a test targeting the presence or absence of AFB using a stain. The MBSPCCND shows that the sample used in the test was concentrated. \nMBGRPID can be used to connect the detection record with the corresponding AFB quantification results shown in row 2. \nRow 2: \nShows a categorical result for an AFB test using a stain. MBORRES contains a result based on a CDC AFB quantification scale. The name of the \nscale used is represented as a supplemental qualifier. MBREFID indicates which aliquot the procedure was performed upon and MBGRPID is used \nto connect the AFB quantification record to the detection record in row 1. \nRow 3: \nShows a test targeting the presence or absence of M. tuberculosis complex using a genotyping method. Details about the assay can be found in the \nDevice Identifiers (DI) domain. The value in SPDEVID links the genotype result to the assay information in the DI domain. The microbial \ndetection certainty is represented as a supplemental qualifier. Because genotyping was used, the detection is considered to be definitive. \nRow 4: \nShows a test targeting the presence or absence of M. tuberculosis performed on a solid culture. The medium type and microbial detection certainty \nare represented as supplemental qualifier. Because genotyping was not used, the detection is considered to be presumptive. The culture start and \nstop dates are represented in BE and are connected to the culture results via BELNKID and MBLNKGRP. MBGRPID is used to connect the \ndetection record in MB with the corresponding culture characteristics shown in rows 5-7. \nRow 5: \nShows a colony-forming unit (CFU) count from a solid culture. The MBORRES value represents the actual colony count from this plate. However, \nthe sample that was spread on this plate represented a 100-fold dilution from the original subject sample. This information is represented in the \nDilution Factor supplemental qualifier (MBDILFCT), whose value = 10^-2 (1/100th). In order to enable more straightforward pooling of CFU data, \na simple integer result (14700) is used in MBSTRESC/N, and MBSTRESU=\"CFU/mL\". The medium type for the solid culture is also represented \nas a supplemental qualifier.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2988, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4a99ab5a-2450-4414-ba97-6cfb9b6dc36f": {"__data__": {"id_": "4a99ab5a-2450-4414-ba97-6cfb9b6dc36f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 262, "section": "100.3 MTB"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "170ff836-ac26-4ab8-bef4-54faf54bb6b9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 262, "section": "100.3 MTB"}, "hash": "532b958575626dddfe327ae916a0c988acbbfd4336e7c9d38283ab2cdb94dbe1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Mycobacterium \ntuberculosis \nCOLONY \nCOUNT \n2+ \n \nOrd \n2+ \n \n \nSTOMACH  \nMICROBIAL CULTURE, \nSOLID \n1 \nWEEK \n1 \n2011-01-\n17T06:00 \n \nsuppmb.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \n1 \nABC \nMB \nABC-01-101 \nMBSEQ \n2 \nMBQSCAL \nQuantification Scale \nSmear Quantification: Centers for Disease Control Method for Carbol Fuchsin Staining (1000X) \nCollected \n2 \nABC \nMB \nABC-01-101 \nMBSEQ \n3 \nMBMICERT \nMicrobial Identification Certainty \nDEFINITIVE \nCollected \n3 \nABC \nMB \nABC-01-101 \nMBSEQ \n4 \nMBMICERT \nMicrobial Identification Certainty \nPRESUMPTIVE \nCollected \n4 \nABC \nMB \nABC-01-101 \nMBREFID", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 629, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8193f68f-a56d-4b62-8f0b-6c9ce055fd43": {"__data__": {"id_": "8193f68f-a56d-4b62-8f0b-6c9ce055fd43", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 262, "section": "100.3 MBMEDTYP"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a5c68f11-2106-4e30-9aed-c0f175a9d6cc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 262, "section": "100.3 MBMEDTYP"}, "hash": "c7adc45fb0a70442dcc9151bda2d6027f76e59ff3c66340a172594d381315654", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Medium Type \nMIDDLEBROOK 7H10 AGAR \nCollected \n7 \nABC \nMB \nABC-01-101 \nMBSEQ \n6 \nMBQSCAL \nQuantification Scale \nSolid Media Result: Centers for Disease Control (CDC) Quantification Scale \nCollected \n8 \nABC \nMB \nABC-01-101 \nMBSEQ \n5 \nMBDILFCT \nDilution Factor \n10^-2 \nCollected \nResults from drug susceptibility tests performed on samples are represented in the MS domain. This includes all phenotypic tests (where the drug is added directly to the culture medium) and genotypic tests (when \nthe result is given as susceptible or resistant). Genotypic tests that give results of specific genetic polymorphisms should be represented in the Pharmacogenomics/Genetics Findings (PF) domain, even though such \nresults may be categorized as susceptible or resistant. In this example, the variable NHOID (Non-host Organism Identifier) is populated with the name of the organism that is the subject of the test. \nRows 1-2: \nShow phenotypic testing results on 2 separate culture plates: 1 with medium containing rifampicin (row 1) and 1 with medium containing isoniazid (row 2). MSAGENT is populated with the name of \nthe drug being used in the susceptibility test. The variables MSCONC and MSCONCU represent the concentration and units of the drug being used. The culture start and stop dates are represented in BE \nand can be linked to MS by BELNKID and MSLNKID. \nRows 3-4: \nShow genotypic susceptibility testing results on the same aliquot from a NAAT that looks for mutations that confer resistance to 2 drugs. MSAGENT should be populated with the name of the drug \nwhose action is affected by the mutation being tested for. However, because the drug is not used in the test, MSCONC and MSCONU should be null. These results are represented in MS because the \nonly result given is in terms of resistant/susceptible; no genetic results are reported. \nms.xpt \nRow STUDYID DOMAIN USUBJID \nSPDEVID NHOID \nMSSEQ MSREFID MSLNKID MSTESTCD MSTEST \nMSAGENT MSCONC MSCONCU MSORRES \nMSSTRESC \nMSSPEC \nMSLOC \nMSMETHOD \nMSDTC \n1 \nABC \nMS \nABC-01-\n101 \n \nMYCOBACTERIUM \nTUBERCULOSIS \n1", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2064, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4c20b2e5-1c8d-451c-8dad-3b721e2b3bcf": {"__data__": {"id_": "4c20b2e5-1c8d-451c-8dad-3b721e2b3bcf", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 264, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9789d345-c228-47fd-89f0-436c7d1d7b84", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 264, "section": "UNSPECIFIED"}, "hash": "54325ea85e0db10eba42afd90ed672b9cff45732210a63564602d6b21101fe9b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "384a48aa-760a-4457-ad4c-cdc4e3b964fa", "node_type": "1", "metadata": {}, "hash": "cce12ed89e8b31cc0f426fc4ca2054cb2342a768759a3d8e550380b6a3f4d490", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 264 \n2021-11-29 \nMI \u2013 Specification \nmi.xpt, Microscopic Findings \u2014 Findings. One record per finding per specimen per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar MI \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nMISEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nMIGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. This is not the treatment \ngroup number. \nPerm \nMIREFID \nReference ID \nChar  \nIdentifier \nInternal or external specimen identifier. Example: specimen barcode number. \nPerm \nMISPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be printed on the CRF as an explicit line identifier or defined in \nthe sponsor's operational database. Example: line number from the MI Findings page. \nPerm \nMITESTCD \nMicroscopic \nExamination Short \nName \nChar (MITSCD) \nTopic \nShort name of the measurement, test, or examination described in MITEST. It can be used as a column \nname when converting a dataset from a vertical to a horizontal format. The value in MITESTCD cannot \nbe longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). MITESTCD \ncannot contain characters other than letters, numbers, or underscores. Examples: \"HER2\", \"BRCA1\", \n\"TTF1\". \nReq \nMITEST \nMicroscopic \nExamination Name \nChar (MITS) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in \nMITEST cannot be longer than 40 characters. Examples: \"Human Epidermal Growth Factor Receptor \n2\", \"Breast Cancer Susceptibility Gene 1\", \"Thyroid Transcription Factor 1\". \nReq \nMITSTDTL \nMicroscopic \nExamination Detail \nChar (MIFTSDTL) \nRecord \nQualifier \nFurther description of the test performed in producing the MI result. This would be used to represent \nspecific attributes, such as intensity score or percentage of cells displaying presence of the biomarker or \ncompound. \nPerm \nMICAT \nCategory for \nMicroscopic Finding \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. \nPerm \nMISCAT \nSubcategory for \nMicroscopic Finding \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of MICAT. \nPerm \nMIORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the histopathology measurement or finding as originally received or collected. \nExp \nMIORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal unit for MIORRES.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3142, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "384a48aa-760a-4457-ad4c-cdc4e3b964fa": {"__data__": {"id_": "384a48aa-760a-4457-ad4c-cdc4e3b964fa", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 264, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9789d345-c228-47fd-89f0-436c7d1d7b84", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 264, "section": "UNSPECIFIED"}, "hash": "54325ea85e0db10eba42afd90ed672b9cff45732210a63564602d6b21101fe9b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "4c20b2e5-1c8d-451c-8dad-3b721e2b3bcf", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 264, "section": "UNSPECIFIED"}, "hash": "6f6d1ebefd3f970826d3e4595e62f1f4fdaf7e1981a678c61d6e33fc579da41a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Req \nMITSTDTL \nMicroscopic \nExamination Detail \nChar (MIFTSDTL) \nRecord \nQualifier \nFurther description of the test performed in producing the MI result. This would be used to represent \nspecific attributes, such as intensity score or percentage of cells displaying presence of the biomarker or \ncompound. \nPerm \nMICAT \nCategory for \nMicroscopic Finding \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. \nPerm \nMISCAT \nSubcategory for \nMicroscopic Finding \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of MICAT. \nPerm \nMIORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the histopathology measurement or finding as originally received or collected. \nExp \nMIORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal unit for MIORRES. \nPerm \nMISTRESC \nCharacter \nResult/Finding in Std \nFormat \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from MIORRES in a standard format or \nstandard units. MISTRESC should store all results or findings in character format; if results are numeric, \nthey should also be stored in numeric format in MISTRESN. \nExp \nMISTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nMISTRESC. MISTRESN should store all numeric test results or findings. \nPerm \nMISTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for MISTRESC and MISTRESN. \nPerm \nMIRESCAT \nResult Category \nChar * \nVariable \nQualifier \nUsed to categorize the result of a finding. Examples: \"MALIGNANT\" or \"BENIGN\" for tumor findings. \nPerm \nMISTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate examination not done or result is missing. Should be null if a result exists in MIORRES \nor have a value of \"NOT DONE\" when MIORRES = \"NULL\". \nPerm \nMIREASND \nReason Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with MISTAT when value is NOT DONE. Examples: \"SAMPLE \nAUTOLYZED\", \"SPECIMEN LOST\". \nPerm \nMINAM \nLaboratory/Vendor \nName \nChar  \nRecord \nQualifier \nName or identifier of the vendor (e.g., laboratory) that provided the test results. \nPerm", "mimetype": "text/plain", "start_char_idx": 2319, "end_char_idx": 4586, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e1a6c14c-efae-4f8f-bedc-dd6fe5dc56e7": {"__data__": {"id_": "e1a6c14c-efae-4f8f-bedc-dd6fe5dc56e7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 265, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ce7278ea-66eb-429f-bd20-12b04f6d67a2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 265, "section": "UNSPECIFIED"}, "hash": "e275127591471f3eb501fed32e0d64d16e11bb25460a9b816a11ecea4b00f21f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dfb48ec1-0270-4e03-8e6e-c67158e3b436", "node_type": "1", "metadata": {}, "hash": "9159e3085a3f28ca774abd8cffb3f8ccf860b76d8283b62cff292fea1c8fc726", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 265 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nMISPEC \nSpecimen Material \nType \nChar (SPECTYPE) \nRecord \nQualifier \nSubject of the observation. Defines the type of specimen used for a measurement. Examples: \n\"TISSUE\", \"BLOOD\", \"BONE MARROW\". \nReq \nMISPCCND \nSpecimen Condition \nChar (SPECCOND) \nRecord \nQualifier \nFree or standardized text describing the condition of the specimen. Example: \"AUTOLYZED\". \nExp \nMILOC \nSpecimen Collection \nLocation \nChar (LOC) \nRecord \nQualifier \nLocation relevant to the collection of the specimen. Examples: \"LUNG\", \"KNEE JOINT\", \"ARM\", \n\"THIGH\". \nPerm \nMILAT \nSpecimen Laterality \nwithin Subject \nChar (LAT) \nVariable \nQualifier \nQualifier for laterality of the location of the specimen in MILOC. Examples: \"LEFT\", \"RIGHT\", \n\"BILATERAL\". \nPerm \nMIDIR \nSpecimen Directionality \nwithin Subject \nChar (DIR) \nVariable \nQualifier \nQualifier for directionality of the location of the specimen in MILOC. Examples: \"DORSAL\", \n\"PROXIMAL\". \nPerm \nMIMETHOD \nMethod of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. This could include the technique or type of staining used for the \nslides. Examples: \"IHC\", \"Crystal violet\", \"Safranin\", \"Trypan blue\", or \"Propidium iodide\". \nPerm \nMILOBXFL \nLast Observation \nBefore Exposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nExp \nMIBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. The value should be \"Y\" or null. Note that MIBLFL is retained \nfor backward compatibility. The authoritative baseline flag for statistical analysis is in an ADaM dataset. \nPerm \nMIEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Example: \"PATHOLOGIST\", \"PEER REVIEW\", \n\"SPONSOR PATHOLOGIST\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the specimen was collected.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2842, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dfb48ec1-0270-4e03-8e6e-c67158e3b436": {"__data__": {"id_": "dfb48ec1-0270-4e03-8e6e-c67158e3b436", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 265, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ce7278ea-66eb-429f-bd20-12b04f6d67a2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 265, "section": "UNSPECIFIED"}, "hash": "e275127591471f3eb501fed32e0d64d16e11bb25460a9b816a11ecea4b00f21f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e1a6c14c-efae-4f8f-bedc-dd6fe5dc56e7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 265, "section": "UNSPECIFIED"}, "hash": "9a8c245009c21cff6fe711f4022b450ebdd15ee7af785a038a93466eec7ae2c7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example: \"PATHOLOGIST\", \"PEER REVIEW\", \n\"SPONSOR PATHOLOGIST\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the specimen was collected. \nPerm \nMIDTC \nDate/Time of Specimen \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of specimen collection, in ISO 8601 format. \nExp \nMIDY \nStudy Day of Specimen \nCollection \nNum  \nTiming \nStudy day of specimen collection, in integer days. The algorithm for calculations must be relative to the \nsponsor-defined RFSTDTC variable in the Demographics (DM) domain. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nMI \u2013 Assumptions \n1. This domain holds findings resulting from the microscopic examination of tissue samples. These examinations are performed on a specimen, usually \none that has been prepared with some type of stain. Some examinations of cells in fluid specimens (e.g., blood, urine) are classified as lab tests and \nshould be stored in the Laboratory Test Results (LB) domain. Biomarkers assessed by histologic or histopathological examination (by employing \ncytochemical/immunocytochemical stains) are stored in the MI domain. \n2. When biomarker results are represented in MI, MITESTCD reflects the biomarker of interest (e.g., \"BRCA1\", \"HER2\", \"TTF1\"), and MITSTDTL \nfurther qualifies the record. MITSTDTL is used to represent details descriptive of staining results (e.g., \"H SCORE TOTAL SCORE\", \"STAINING \nINTENSITY\", \"PERCENT POSITIVE CELL\"). \n3. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the MI domain, but the following qualifiers would \ngenerally not be used: --POS, --MODIFY, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STNRC, --NRIND, --LEAD, --CSTATE, --BLFL, --\nFAST, --DRVFL, --LLOQ, --ULOQ.", "mimetype": "text/plain", "start_char_idx": 2092, "end_char_idx": 4554, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "503c243f-c32d-42a5-9053-2ca44d5f0757": {"__data__": {"id_": "503c243f-c32d-42a5-9053-2ca44d5f0757", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 266, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca53e90c-8285-49b8-af6a-69794cc8bd68", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 266, "section": "UNSPECIFIED"}, "hash": "86cb7660df56bd28c64d664930dd2d13d2bd215364dbd41d1e8063ce8e64a015", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "268804e8-5ddc-4ce7-930b-cfef8b9b6c19", "node_type": "1", "metadata": {}, "hash": "c4f607b906df36201c43ae0d8085428e7dbc8e1200030f32045272eb7b87759e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 266 \n2021-11-29 \nMI \u2013 Examples \nExample 1 \nImmunohistochemistry (IHC) is a method that involves treating tissue with a stain that adheres to very specific substances. IHC is the method most commonly \nused to assess the amount of HER2 receptor protein on the surface of the cancer cells. A cell with too many receptors receives too many growth signals. In this \nstudy, IHC assessment of HER2 in samples of breast cancer tissue yielded staining intensity on a scale of 0 to 3+. Staining intensity values of 0 to 1+ were \ncategorized as negative; values of 2+ and 3+ were categorized as positive. \nRow 1: \nShows a subject with a receptor protein stain intensity value of \"0\", categorized in MIRESCAT as \"NEGATIVE\". \nRow 2: \nShows a subject with a receptor protein stain intensity value of \"2+\", categorized in MIRESCAT as \"POSITIVE\". \nmi.xpt \nRow STUDYID DOMAIN USUBJID MISEQ MITESTCD MITEST \nMITSTDTL \nMIORRES MISTRESC MIRESCAT MISPEC MILOC \nMIMETHOD VISIT \nMIDTC \n1 \nABC \nMI \nABC-\n1001 \n1 \nHER2 \nHuman Epidermal Growth \nFactor Receptor 2 \nSTAINING \nINTENSITY \n0 \n0 \nNEGATIVE TISSUE \nBREAST IHC \nSCREENING 2001-06-\n15 \n2 \nABC \nMI \nABC-\n2002 \n1 \nHER2 \nHuman Epidermal Growth \nFactor Receptor 2 \nSTAINING \nINTENSITY \n2+ \n2+ \nPOSITIVE \nTISSUE \nBREAST IHC \nSCREENING 2001-06-\n15 \nExample 2 \nIn this study, IHC for estrogen receptor protein expression in a tissue was reported using the Allred scoring system. The proportion positive score was assessed as \nthe percentage of tumor cells that stained positive on a scale from 0 to 5. Staining intensity was assessed as none, weak, intermediate, or strong, and scored from \n0 to 3, respectively. The total score is the sum of the proportion positive and stain intensity scores. \nRow 1: \nShows the Allred proportion positive score. \nRow 2: \nShows the staining intensity, which was assessed as \"Strong\". The score associated with an intensity of \"STRONG\" is in MISTRESC and \nMISTRESN. \nRow 3: \nThe total score is a represented in a derived record, so MIORRES is null.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2185, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "268804e8-5ddc-4ce7-930b-cfef8b9b6c19": {"__data__": {"id_": "268804e8-5ddc-4ce7-930b-cfef8b9b6c19", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 266, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ca53e90c-8285-49b8-af6a-69794cc8bd68", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 266, "section": "UNSPECIFIED"}, "hash": "86cb7660df56bd28c64d664930dd2d13d2bd215364dbd41d1e8063ce8e64a015", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "503c243f-c32d-42a5-9053-2ca44d5f0757", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 266, "section": "UNSPECIFIED"}, "hash": "fb55b848120a35d3981947a3e2258cc54b64b9187f0e5d24d271e665de1a225d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The proportion positive score was assessed as \nthe percentage of tumor cells that stained positive on a scale from 0 to 5. Staining intensity was assessed as none, weak, intermediate, or strong, and scored from \n0 to 3, respectively. The total score is the sum of the proportion positive and stain intensity scores. \nRow 1: \nShows the Allred proportion positive score. \nRow 2: \nShows the staining intensity, which was assessed as \"Strong\". The score associated with an intensity of \"STRONG\" is in MISTRESC and \nMISTRESN. \nRow 3: \nThe total score is a represented in a derived record, so MIORRES is null. \nmi.xpt \nRow STUDYID DOMAIN USUBJID MISEQ MIGRPID MITESTCD MITEST \nMITSTDTL \nMIORRES MISTRESC MISTRESN MISPEC MILOC \nMIMETHOD MIDRVFL VISIT \nMIDTC \n1 \nABC \nMI \nABC-\n1001 \n1 \n1 \nESTRCPT \nEstrogen \nReceptor \nALLRED \nPROPORTION \nPOSITIVE SCORE \n3 \n3 \n3 \nTISSUE \nBREAST IHC \n \nSCREENING 2001-\n06-15 \n2 \nABC \nMI \nABC-\n1001 \n2 \n1 \nESTRCPT \nEstrogen \nReceptor \nALLRED STAINING \nINTENSITY \nSCORE \nSTRONG \n3 \n3 \nTISSUE \nBREAST IHC \n \nSCREENING 2001-\n06-15 \n3 \nABC \nMI \nABC-\n1001 \n3 \n1 \nESTRCPT \nEstrogen \nReceptor \nALLRED TOTAL \nSCORE \n \n6 \n6 \nTISSUE \nBREAST IHC \nY \nSCREENING 2001-\n06-15 \nThese IHC staining results were all for the cell nucleus, represented using a supplemental qualifier for subcellular location.  \nsuppmi.xpt \nRow STUDYID RDOMAIN USUBJID \nIDVAR \nIDVARVAL QNAM \nQLABEL \nQVAL \nQORIG QEVAL \n1 \nABC \nMI \nABC-1001 MIGRPID 1 \nMISCELOC Subcellular Location NUCLEUS CRF", "mimetype": "text/plain", "start_char_idx": 1582, "end_char_idx": 3059, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ce6b4a27-a50d-4eea-b16a-de22875cf63a": {"__data__": {"id_": "ce6b4a27-a50d-4eea-b16a-de22875cf63a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 267, "section": "6.3.5.9.1 Pharmacokinetics Concentrations (PC)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "28e1917d-e8cf-4e89-b8ba-89dabead36d4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 267, "section": "6.3.5.9.1 Pharmacokinetics Concentrations (PC)"}, "hash": "09a8f877ef7352bf56e0a8c9d5fa74a89ce815018bc84c0903ce04ad7926b68c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PC \u2013 Description/Overview \nA findings domain that contains concentrations of drugs or metabolites in fluids or tissues as a function of time. \nPC \u2013 Specification \npc.xpt, Pharmacokinetics Concentrations \u2014 Findings. One record per sample characteristic or time-point concentration per reference time point or per \nanalyte per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar PC \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nPCSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nPCGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain to support relationships within the \ndomain and between domains. \nPerm \nPCREFID \nReference ID \nChar  \nIdentifier \nInternal or external specimen identifier. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1239, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9818001e-53a7-4cb2-b62c-d517db3ead0f": {"__data__": {"id_": "9818001e-53a7-4cb2-b62c-d517db3ead0f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 268, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3be146d2-bbc0-4967-b795-d7e16b067861", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 268, "section": "UNSPECIFIED"}, "hash": "1c009b30e8ac9a89fe7ebcced245ede485cdfe5ad3c403ec7535327bf52dce56", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5419bc1e-89bb-4ccb-aa45-9992cabb40db", "node_type": "1", "metadata": {}, "hash": "1ea5b1c077dcb0537f30b460a4ba930b5d9537d1e1aa58abfc8737da8936e5d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 268 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nPCSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. \nPerm \nPCTESTCD \nPharmacokinetic Test \nShort Name \nChar  \nTopic \nShort name of the analyte or specimen characteristic. It can be used as a column name when converting \na dataset from a vertical to a horizontal format. The value in PCTESTCD cannot be longer than 8 \ncharacters, nor can it start with a number (e.g., \"1TEST\" is not valid). PCTESTCD cannot contain \ncharacters other than letters, numbers, or underscores. Examples: \"ASA\", \"VOL\", \"SPG\". \nReq \nPCTEST \nPharmacokinetic Test \nName \nChar  \nSynonym \nQualifier \nName of the analyte or specimen characteristic. Note any test normally performed by a clinical laboratory \nis considered a lab test. The value in PCTEST cannot be longer than 40 characters. Examples: \n\"Acetylsalicylic Acid\", \"Volume\", \"Specific Gravity\". \nReq \nPCCAT \nTest Category \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. Examples: \"ANALYTE\", \"SPECIMEN PROPERTY\". \nPerm \nPCSCAT \nTest Subcategory \nChar * \nGrouping \nQualifier \nA further categorization of a test category. \nPerm \nPCORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nPCORRESU Original Units \nChar (PKUNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for PCORRES. Example: \"mg/L\". \nExp \nPCSTRESC \nCharacter \nResult/Finding in Std \nFormat \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from PCORRES in a standard format or \nstandard units. PCSTRESC should store all results or findings in character format; if results are numeric, \nthey should also be stored in numeric format in PCSTRESN. For example, if a test has results \"NONE\", \n\"NEG\", and \"NEGATIVE\" in PCORRES, and these results effectively have the same meaning, they could \nbe represented in standard format in PCSTRESC as \"NEGATIVE\". For other examples, see general \nassumptions. \nExp \nPCSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nPCSTRESC. PCSTRESN should store all numeric test results or findings. \nExp \nPCSTRESU \nStandard Units \nChar (PKUNIT) \nVariable \nQualifier \nStandardized unit used for PCSTRESC and PCSTRESN. \nExp \nPCSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate a result was not obtained. Should be null if a result exists in PCORRES. \nPerm \nPCREASND \nReason Test Not \nDone \nChar  \nRecord \nQualifier \nDescribes why a result was not obtained, such as \"SPECIMEN LOST\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2983, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5419bc1e-89bb-4ccb-aa45-9992cabb40db": {"__data__": {"id_": "5419bc1e-89bb-4ccb-aa45-9992cabb40db", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 268, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3be146d2-bbc0-4967-b795-d7e16b067861", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 268, "section": "UNSPECIFIED"}, "hash": "1c009b30e8ac9a89fe7ebcced245ede485cdfe5ad3c403ec7535327bf52dce56", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9818001e-53a7-4cb2-b62c-d517db3ead0f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 268, "section": "UNSPECIFIED"}, "hash": "397cb238307c77f069e8521feb5253cd646f7b914ff26afb86572c7d8ca14794", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "For other examples, see general \nassumptions. \nExp \nPCSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nPCSTRESC. PCSTRESN should store all numeric test results or findings. \nExp \nPCSTRESU \nStandard Units \nChar (PKUNIT) \nVariable \nQualifier \nStandardized unit used for PCSTRESC and PCSTRESN. \nExp \nPCSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate a result was not obtained. Should be null if a result exists in PCORRES. \nPerm \nPCREASND \nReason Test Not \nDone \nChar  \nRecord \nQualifier \nDescribes why a result was not obtained, such as \"SPECIMEN LOST\". Used in conjunction with PCSTAT \nwhen value is \"NOT DONE\". \nPerm \nPCNAM \nVendor Name \nChar  \nRecord \nQualifier \nName or identifier of the laboratory or vendor who provides the test results. \nExp \nPCSPEC \nSpecimen Material \nType \nChar (SPECTYPE) \nRecord \nQualifier \nDefines the type of specimen used for a measurement. Examples: \"SERUM\", \"PLASMA\", \"URINE\". \nExp \nPCSPCCND \nSpecimen Condition \nChar (SPECCOND) \nRecord \nQualifier \nFree or standardized text describing the condition of the specimen. Examples: \"HEMOLYZED\", \n\"ICTERIC\", \"LIPEMIC\". \nPerm \nPCMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"HPLC/MS\", \"ELISA\". This should contain sufficient \ninformation and granularity to allow differentiation of various methods that might have been used within a \nstudy. \nPerm \nPCFAST \nFasting Status \nChar (NY) \nRecord \nQualifier \nIndicator used to identify fasting status. \nPerm \nPCDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Records that represent the average of \nother records, which do not come from the CRF, are examples of records that would be derived for the \nsubmission datasets. If PCDRVFL = \"Y\", then PCORRES may be null with PCSTRESC, and PCSTRESN \n(if the result is numeric) having the derived value. \nPerm \nPCLLOQ \nLower Limit of \nQuantitation \nNum  \nVariable \nQualifier \nIndicates the lower limit of quantitation for an assay. Units should be those used in PCSTRESU. \nExp", "mimetype": "text/plain", "start_char_idx": 2278, "end_char_idx": 4511, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9d810208-af30-4af2-8afe-5560e676e50e": {"__data__": {"id_": "9d810208-af30-4af2-8afe-5560e676e50e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 269, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95595593-3501-4404-890f-4bc88a6e1e20", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 269, "section": "UNSPECIFIED"}, "hash": "e67b77cff231098b0e86aeb1f026257aa050275da2a077a07360d0ed38a4b62a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "70c13757-8248-420f-886f-11e58efd908f", "node_type": "1", "metadata": {}, "hash": "2205108b48dd8403761a1dc9991c525bbdd68cfc6ca3aa66f6c0140ec07cfc15", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 269 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nPCULOQ \nUpper Limit of \nQuantitation \nNum  \nVariable \nQualifier \nIndicates the upper limit of quantitation for an assay. Units should be those used in PCSTRESU. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the observation, or the date/time of collection if start date/time \nis not collected. \nPerm \nPCDTC \nDate/Time of \nSpecimen Collection \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of specimen collection represented in ISO 8601 character format. If there is no end time, then \nthis will be the collection time. \nExp \nPCENDTC \nEnd Date/Time of \nSpecimen Collection \nChar ISO 8601 datetime \nor interval \nTiming \nEnd date/time of specimen collection represented in ISO 8601 character format. If there is no end time, \nthe collection time should be stored in PCDTC, and PCENDTC should be null. \nPerm \nPCDY \nActual Study Day of \nSpecimen Collection \nNum  \nTiming \nStudy day of specimen collection, measured as integer days. Algorithm for calculations must be relative to \nthe sponsor-defined RFSTDTC variable in Demographics. \nPerm \nPCENDY \nStudy Day of End of \nObservation \nNum  \nTiming \nActual study day of end of observation expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nPCTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when specimen should be taken. This may be represented as an elapsed time \nrelative to a fixed reference point, such as time of last dose. See PCTPTNUM and PCTPTREF. \nExamples: \"Start\", \"5 min post\". \nPerm \nPCTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of PCTPT to aid in sorting. \nPerm \nPCELTM \nPlanned Elapsed \nTime from Time Point \nRef \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a planned fixed reference (PCTPTREF; e.g., \"PREVIOUS \nDOSE\", \"PREVIOUS MEAL\"). This variable is useful where there are repetitive measures. Not a clock \ntime or a date time variable. \nPerm \nPCTPTREF \nTime Point Reference Char  \nTiming \nName of the fixed reference point used as a basis for PCTPT, PCTPTNUM, and PCELTM. Example: \n\"MOST RECENT DOSE\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2956, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "70c13757-8248-420f-886f-11e58efd908f": {"__data__": {"id_": "70c13757-8248-420f-886f-11e58efd908f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 269, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "95595593-3501-4404-890f-4bc88a6e1e20", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 269, "section": "UNSPECIFIED"}, "hash": "e67b77cff231098b0e86aeb1f026257aa050275da2a077a07360d0ed38a4b62a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9d810208-af30-4af2-8afe-5560e676e50e", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 269, "section": "UNSPECIFIED"}, "hash": "1d4627f93405cc91133cd49cb0a401ad957dea92519b97e605013311c39561c5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "See PCTPTNUM and PCTPTREF. \nExamples: \"Start\", \"5 min post\". \nPerm \nPCTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of PCTPT to aid in sorting. \nPerm \nPCELTM \nPlanned Elapsed \nTime from Time Point \nRef \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a planned fixed reference (PCTPTREF; e.g., \"PREVIOUS \nDOSE\", \"PREVIOUS MEAL\"). This variable is useful where there are repetitive measures. Not a clock \ntime or a date time variable. \nPerm \nPCTPTREF \nTime Point Reference Char  \nTiming \nName of the fixed reference point used as a basis for PCTPT, PCTPTNUM, and PCELTM. Example: \n\"MOST RECENT DOSE\". \nPerm \nPCRFTDTC \nDate/Time of \nReference Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of the reference time point described by PCTPTREF. \nPerm \nPCEVLINT \nEvaluation Interval \nChar ISO 8601 duration \nor interval \nTiming \nEvaluation Interval associated with a PCTEST record represented in ISO 8601 character format. \nExample: \"-PT2H\" to represent an evaluation interval of 2 hours prior to a PCTPT. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nPC \u2013 Assumptions \n1. This domain can be used to represent specimen properties (e.g., volume, pH) in addition to drug and metabolite concentration measurements. \n2. CDISC Controlled Terminology Rules for Pharmacokinetics are available at https://www.cdisc.org/standards/terminology/controlled-terminology. \n3. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the PC domain, but the following Qualifiers would \nnot generally be used: --BODSYS, --SEV. \nPC \u2013 Examples \nDue to space limitations, not all expected or permissible findings variables are included in the example for this domain.", "mimetype": "text/plain", "start_char_idx": 2304, "end_char_idx": 4177, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4a8d67fa-3b75-4a2c-98de-ee579e5fb529": {"__data__": {"id_": "4a8d67fa-3b75-4a2c-98de-ee579e5fb529", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "2.00 500"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1a79c130-3f9c-41a6-8220-c19b4bb4523f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "2.00 500"}, "hash": "8d22e496afc83dac7a3903832607db8eba0574e6c995657164349240ac8ee9c6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1 \nDAY 1 \n1 \n2001-02-\n01T07:45 \n2001-02-\n01T07:45 \n1 \nPREDOSE \n0 \nDay 1 Dose \n2001-02-\n01T08:00 \n-PT15M \n \n5 \nABC-123 \nPC \n123-0001 \n5 \nDay 1 \nA554134-\n11 \nVOLUME \nVolume \nSPECIMEN \nPROPERTY \nURINE \n3500 \nmL \n100 \n100 \nmL \n \n \n \n1 \nDAY 1 \n1 \n2001-02-\n01T07:45 \n2001-02-\n01T07:45 \n1 \nPREDOSE \n0 \nDay 1 Dose \n2001-02-\n01T08:00 \n-PT15M \n \n6 \nABC-123 \nPC \n123-0001 \n6 \nDay 1 \nA554134-\n11 \nPH \nPH \nSPECIMEN \nPROPERTY \nURINE", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 418, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c989a9b8-ee07-4ebb-af25-42ecc401e2b8": {"__data__": {"id_": "c989a9b8-ee07-4ebb-af25-42ecc401e2b8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "0.10 20"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "083a40d5-71b6-4cd8-bc44-ce0842bf5834", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "0.10 20"}, "hash": "b1250327540e199c014eefb3c0a16c5db467d8601294f32391aec7d488f013ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1 \nDAY 1 \n1 \n2001-02-\n01T14:00 \n \n1 \n6H \n6 \nDay 1 Dose \n2001-02-\n01T08:00 \nPT6H \n \n11 \nABC-123 \nPC \n123-0001 \n11 \nDay 1 \nA554134-\n14 \nDRGA_MET \nDrug A \nMetabolite \nANALYTE \nPLASMA \n \n \n \n \n \nNOT \nDONE \n \n20 \n2 \nDAY 2 \n2 \n2001-02-\n02T08:00 \n \n2 \n24H \n24 \nDay 1 Dose \n2001-02-\n01T08:00 \nPT24H \n \n12 \nABC-123 \nPC \n123-0001 \n12 \nDay 1 \nA554134-\n14 \nDRGA_PAR \nDrug A \nParent \nANALYTE \nPLASMA \n<0.1 \nng/mL \n<0.1 \n \nng/mL", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 414, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0ded33eb-c6ac-4914-9862-4271e8248f7b": {"__data__": {"id_": "0ded33eb-c6ac-4914-9862-4271e8248f7b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "2.00 500"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "234c0449-cb1f-4345-a903-23d62d94ac12", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 270, "section": "2.00 500"}, "hash": "179b9fe1026a9070a9ff5b95d1c076bdde73a57530c2d9643f200956a2f90cd5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3 \nDAY \n11 \n11 \n2001-02-\n11T08:00 \n2001-02-\n11T14:03 \n11 \n6H \n6 \nDay 11 \nDose \n2001-02-\n11T08:00 \nPT6H \n-PT6H \n19 \nABC-123 \nPC \n123-0001 \n19 \nDay 11 \nA554134-\n17 \nVOLUME \nVolume \nSPECIMEN \nPROPERTY \nURINE \n574 \nmL \n574 \n574 \nmL \n \n \n \n3 \nDAY \n11 \n11 \n2001-02-\n11T08:00 \n2001-02-\n11T14:03 \n11 \n6H \n6 \nDay 11 \nDose \n2001-02-\n11T08:00 \nPT6H \n-PT6H \n20 \nABC-123 \nPC \n123-0001 \n20 \nDay 11 \nA554134-\n17 \nPH \nPH \nSPECIMEN \nPROPERTY \nURINE", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 431, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "973e8382-100c-4eeb-ae25-175179d0d53e": {"__data__": {"id_": "973e8382-100c-4eeb-ae25-175179d0d53e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "2.00 3"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d586f953-027c-4f70-b7db-04fa13a546e6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "2.00 3"}, "hash": "70c70f9c437c9cecd6482867783ed03a2969e92f58ec4f5a094f2d83c15896b5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DAY \n11 \n11 \n2001-02-\n11T14:03 \n2001-02-\n11T20:10 \n11 \n12H \n12 \nDay 11 \nDose \n2001-02-\n11T08:00 \nPT12H \n-PT6H \n25 \nABC-123 \nPC \n123-0001 \n25 \nDay 11 \nA554134-\n19 \nVOLUME \nVolume \nSPECIMEN \nPROPERTY \nURINE \n363 \nmL \n363 \n363 \nmL \n \n \n \n3 \nDAY \n11 \n11 \n2001-02-\n11T14:03 \n2001-02-\n11T20:10 \n11 \n12H \n12 \nDay 11 \nDose \n2001-02-\n11T08:00 \nPT12H \n-PT6H \n26 \nABC-123 \nPC \n123-0001 \n26 \nDay 11 \nA554134-\n19 \nPH \nPH \nSPECIMEN \nPROPERTY \nURINE", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 434, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "953d3004-36a3-48ae-ae62-909320142837": {"__data__": {"id_": "953d3004-36a3-48ae-ae62-909320142837", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "2.00 4"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2f6a0a0f-780a-4d3a-9730-17f9a41200dc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "2.00 4"}, "hash": "9a5eb37082fe01a769cc89973d86372e13abf4897d5e07a755efba74a2dbed65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DAY \n12 \n12 \n2001-02-\n11T20:03 \n2001-02-\n12T08:10 \n12 \n24H \n24 \nDay 11 \nDose \n2001-02-\n11T08:00 \nPT24H \n-PT12H \n29 \nABC-123 \nPC \n123-0001 \n29 \nDay 11 \nA554134-\n20 \nVOLUME \nVolume \nSPECIMEN \nPROPERTY \nURINE \n606 \nmL \n606 \n606 \nmL \n \n \n \n4 \nDAY \n12 \n12 \n2001-02-\n11T20:03 \n2001-02-\n12T08:10 \n12 \n24H \n24 \nDay 11 \nDose \n2001-02-\n11T08:00 \nPT24H \n-PT12H \n30 \nABC-123 \nPC \n123-0001 \n30 \nDay 11 \nA554134-\n20 \nPH \nPH \nSPECIMEN \nPROPERTY \nURINE", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 436, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0aac08e7-2a90-4143-a110-e688ca5507c4": {"__data__": {"id_": "0aac08e7-2a90-4143-a110-e688ca5507c4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "6.3.5.9.2 Pharmacokinetics Parameters (PP)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4b4c7c41-d269-4c5f-9185-c669441d1062", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 271, "section": "6.3.5.9.2 Pharmacokinetics Parameters (PP)"}, "hash": "31f8413373cfb676d6817f5f615d4f2186244a0134eebdb01f3de3bfc28d163c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PP \u2013 Description/Overview \nA findings domain that contains pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data. \nPP \u2013 Specification \npp.xpt, Pharmacokinetics Parameters \u2014 Findings. One record per PK parameter per time-concentration profile per modeling method per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar PP \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier Char  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the product. \n \nReq \nPPSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid number. \nReq \nPPGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain to support relationships within the domain and between domains. \nPerm \nPPTESTCD \nParameter Short Name \nChar (PKPARMCD) \nTopic \nShort name of the pharmacokinetic parameter. It can be used as a column name when converting a dataset from a vertical to a horizontal format. The value in \nPPTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). PPTESTCD cannot contain characters other than \nletters, numbers, or underscores. Examples: \"AUCALL\", \"TMAX\", \"CMAX\". \nReq \nPPTEST \nParameter Name \nChar (PKPARM) \nSynonym \nQualifier \nName of the pharmacokinetic parameter. The value in PPTEST cannot be longer than 40 characters. Examples: \"AUC All\", \"Time of CMAX\", \"Max Conc\". \nReq \nPPCAT \nParameter Category \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. For PP, this should be the name of the analyte in PCTEST whose profile the parameter is associated with. \nExp \nPPSCAT \nParameter Subcategory \nChar * \nGrouping \nQualifier \nCategorization of the model type used to calculate the PK parameters. Examples: \"COMPARTMENTAL\", \"NON-COMPARTMENTAL\". \nPerm \nPPORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nPPORRESU \nOriginal Units \nChar (PKUNIT) \n(PKUWG) \n(PKUWKG) \n(PKUDMG) \n(PKUDUG) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for PPORRES. Example: \"ng/L\". See PP Assumption 3. \nExp", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2535, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a2acad43-6e57-4fa6-9edb-3420c2c8bd6b": {"__data__": {"id_": "a2acad43-6e57-4fa6-9edb-3420c2c8bd6b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 272, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d8a59c8d-d77a-43d6-8976-a856459fe07f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 272, "section": "UNSPECIFIED"}, "hash": "fc3693923c6b314895633eecec6f876185f8f19dc4a8f4d5ad222e1702dd3214", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "337b1d01-ff37-44fa-af98-0837610be230", "node_type": "1", "metadata": {}, "hash": "e46fa6aa3069d65206f32fd900e1819a1e577a9a1d4286c4ffa34227edcd2c65", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 272 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nPPSTRESC \nCharacter \nResult/Finding in Std \nFormat \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from PPORRES in a standard format or standard units. PPSTRESC should store all results or findings \nin character format; if results are numeric, they should also be stored in numeric format in PPSTRESN. \nExp \nPPSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from PPSTRESC. PPSTRESN should store all numeric test \nresults or findings. \nExp \nPPSTRESU \nStandard Units \nChar (PKUNIT) \n(PKUWG) \n(PKUWKG) \n(PKUDMG) \n(PKUDUG) \nVariable \nQualifier \nStandardized unit used for PPSTRESC and PPSTRESN. See PP Assumption 3. \nExp \nPPSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a parameter was not calculated. Should be null if a result exists in PPORRES. \nPerm \nPPREASND \nReason Parameter Not \nCalculated \nChar  \nRecord \nQualifier \nDescribes why a parameter was not calculated, such as \"INSUFFICIENT DATA\". Used in conjunction with PPSTAT when value is \"NOT DONE\". \nPerm \nPPSPEC \nSpecimen Material Type Char (SPECTYPE) \nRecord \nQualifier \nDefines the type of specimen used for a measurement. If multiple specimen types are used for a calculation (e.g., serum and urine for renal clearance), then this \nfield should be left blank. Examples: \"SERUM\", \"PLASMA\", \"URINE\". \nExp \nPPANMETH \nAnalysis Method \nChar (PKANMET) \nRecord \nQualifier \nAnalysis method applied to obtain a summarized result. Analysis method describes the method of secondary processing applied to a complex observation result. \nExample: A named formula used to calculate AUC, such as \"LIN-LOG TRAPEZOIDAL METHOD\". \nSponsor-defined formulas can also be represented by this variable. Example: Calculating ratio AUCs where the PPANMETH may be \"DRUG METABOLITE 1 TO \nDRUG PARENT\" or \"DRUG METABOLITE 2 TO METABOLITE 1\". \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the observation, or the date/time of collection if start date/time is not collected. \nPerm \nPPDTC \nDate/Time of Parameter \nCalculations \nChar ISO 8601 datetime or \ninterval \nTiming \nNominal date/time of parameter calculations. \nPerm \nPPDY \nStudy Day of Parameter \nCalculations \nNum  \nTiming \nStudy day of the collection, in integer days. The algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in the Demographics (DM) \ndomain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2947, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "337b1d01-ff37-44fa-af98-0837610be230": {"__data__": {"id_": "337b1d01-ff37-44fa-af98-0837610be230", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 272, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d8a59c8d-d77a-43d6-8976-a856459fe07f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 272, "section": "UNSPECIFIED"}, "hash": "fc3693923c6b314895633eecec6f876185f8f19dc4a8f4d5ad222e1702dd3214", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a2acad43-6e57-4fa6-9edb-3420c2c8bd6b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 272, "section": "UNSPECIFIED"}, "hash": "016e5b37c0b4d6738a19be15e569bed90d78fad93b3a723936406a50d6aadc67", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the observation, or the date/time of collection if start date/time is not collected. \nPerm \nPPDTC \nDate/Time of Parameter \nCalculations \nChar ISO 8601 datetime or \ninterval \nTiming \nNominal date/time of parameter calculations. \nPerm \nPPDY \nStudy Day of Parameter \nCalculations \nNum  \nTiming \nStudy day of the collection, in integer days. The algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in the Demographics (DM) \ndomain. \nPerm \nPPTPTREF \nTime Point Reference \nChar  \nTiming \nThe description of a time point that acts as a fixed reference for a series of planned time points. \nPerm \nPPRFTDTC \nDate/Time of Reference \nPoint \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time of the reference time point from the PC records used to calculate a parameter record. The values in PPRFTDTC should be the same as that in \nPCRFTDTC for related records. \nExp \nPPSTINT \nPlanned Start of \nAssessment Interval \nChar ISO 8601 duration \nTiming \nThe start of a planned evaluation or assessment interval relative to the time point reference. \nPerm \nPPENINT \nPlanned End of \nAssessment Interval \nChar ISO 8601 duration \nTiming \nThe end of a planned evaluation or assessment interval relative to the time point reference. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.  \nPP \u2013 Assumptions \n1. Pharmacokinetics Parameters is a derived dataset, and may be produced from an analysis dataset with a different structure. As a result, some sponsors may need to normalize their analysis dataset in order for \nit to fit into the SDTM-based PP domain. \n2. Information pertaining to all parameters (e.g., number of exponents, model weighting) should be submitted in the SUPPPP dataset. \n3. There are separate codelists used for PPORRESU/PPSTRESU where the choice depends on whether the value of the pharmacokinetic parameter is normalized. \na. \nCodelist \u201cPKUNIT\u201d is used for non-normalized parameters. \nb. Codelists \u201cPKUDMG\u201d and \u201cPKUDUG\u201d are used when parameters are normalized by dose amount in milligrams or micrograms, respectively. \nc. \nCodelists \u201cPKUWG\u201d and \u201cPKUWKG\u201d are used when parameters are normalized by weight in grams or kilograms, respectively.", "mimetype": "text/plain", "start_char_idx": 2266, "end_char_idx": 4777, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e81e507e-85fa-42e8-968d-6c4bfd4515d4": {"__data__": {"id_": "e81e507e-85fa-42e8-968d-6c4bfd4515d4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 273, "section": "0.88 0.88"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "921c0272-ed93-4218-be54-f138a10a87a7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 273, "section": "0.88 0.88"}, "hash": "122b790b93065a93085be726f21a3fbf1c8f2cd495e5be28d9680e5fe620e395", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "L/h \n \n2 \nDAY 11 2001-03-01 \n2001-02-11T08:00 \nExample 2 \nThis example shows various AUCs calculated using sponsor-defined formulas or the linear-log trapezoidal method. \nRows 1-3: \nShow the \"AUC from T1 to T2\" measurements for Drug Parent (row 1), Drug Metabolite 1 (row 2) and Drug Metabolite 2 (row 3). These parameters are calculated using the LIN-LOG TRAPEZOIDAL \nMETHOD which is in PPANMETH. \nRow 4: \nShows the \"Ratio AUC\" measurement of Drug Metabolite 1 to Drug Parent. Instead of pre-corrdinating \"Ratio AUC of Drug Metabolite 1 to Drug Parent\" all into the PPTEST, PPANMETH is used to \ndescribe the numerator (Drug Metabolite 1) and the denominator (Drug Parent) values that contribute to the Ratio AUC calculation in PPTEST. This post-coordination approach liberates the PPTEST \nvariable from having to house hyper-specific, pre-coordinated PK parameter values.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 872, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e032ab53-d058-4e0e-9864-d63b3f7a0ef5": {"__data__": {"id_": "e032ab53-d058-4e0e-9864-d63b3f7a0ef5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 274, "section": "0.52 PLASMA"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0f428bfc-1b65-4406-b095-1c5e398960f8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 274, "section": "0.52 PLASMA"}, "hash": "2ddcd517927cbc1f88dca740c43eb82d7414c476a80e08ada0b9bc977270cd72", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DRUG METABOLITE 2 TO \nMETABOLITE 1 \nY \n1 \n2001-02-\n01T12:00 \n6 \nABC-123 \nPP \n123-1001 \n1 \nB2222 \nAUCIFO \nAUC Infinity \nObs \nDRUG PARENT \nNCA \n520 \nh*ng/L \n520 \n520 \nh*ng/L \nPLASMA \nLIN-LOG TRAPEZOIDAL \nMETHOD \nY \n1 \n2001-02-\n01T12:00 \n7 \nABC-123 \nPP \n123-1001 \n2 \nB2222 \nAUCIFP \nAUC Infinity \nPred \nDRUG PARENT \nNCA \n510 \nh*ng/L \n510 \n510 \nh*ng/L \nPLASMA \nLIN-LOG TRAPEZOIDAL \nMETHOD \nY \n1 \n2001-02-\n01T12:00 \nThe SUPPPP dataset example shows the specific condition under which the PK analysis was performed. \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \nQEVAL \n1 \nABC-123 \nPP \n123-1001 \nPPSEQ \n1 \nPKCOND \nCondition of PK Analysis \nMULTIPLE DOSE, STEADY STATE \nCollected \n \n2 \nABC-123 \nPP \n123-1001 \nPPSEQ \n2 \nPKCOND \nCondition of PK Analysis \nMULTIPLE DOSE, STEADY STATE \nCollected \n \n3 \nABC-123 \nPP \n123-1001 \nPPSEQ \n3 \nPKCOND \nCondition of PK Analysis \nMULTIPLE DOSE, STEADY STATE \nCollected \n \n4 \nABC-123 \nPP \n123-1001 \nPPSEQ \n4 \nPKCOND \nCondition of PK Analysis \nMULTIPLE DOSE, STEADY STATE \nCollected \n \n5 \nABC-123 \nPP \n123-1001 \nPPSEQ \n5 \nPKCOND \nCondition of PK Analysis \nMULTIPLE DOSE, STEADY STATE \nCollected \n \n6 \nABC-123 \nPP \n123-1001 \nPPSEQ \n6 \nPKCOND \nCondition of PK Analysis \nMULTIPLE DOSE, STEADY STATE \nCollected \n \n7 \nABC-123 \nPP \n123-1001 \nPPSEQ \n7 \nPKCOND \nCondition of PK Analysis \nSINGLE DOSE \n \n \nExample 3 \nThis example shows the use of PPSTINT and PPENINT to describe the AUC segments for the test code \"AUCINT\", the area under the curve from time T1 to time T2. Time T1 is represented in PPSTINT as the \nelapsed time since PPRFTDTC and time T2 is represented in PPENINT as the elapsed time since PPRFTDTC. \nRows 1-7: \nShow parameters for day 1. \nRows 8-14: Show parameters for day 14. \npp.xpt \nRow STUDYID DOMAIN USUBJID \nPPSEQ PPGRPID \nPPTESTCD PPTEST \nPPCAT \nPPORRES PPORRESU PPSTRESC PPSTRESN PPSTRESU PPSPEC VISITNUM VISIT \nPPDTC \nPPRFTDTC \nPPSTINT PPENINT \n1 \nABC-123 \nPP \nABC-123-\n001 \n1 \nDRUGA_DAY1 \nTMAX \nTime of CMAX \nDRUG A \nPARENT", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1998, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f664593d-6d52-427f-bd53-dd5239b51b9b": {"__data__": {"id_": "f664593d-6d52-427f-bd53-dd5239b51b9b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 275, "section": "7.6 7.6"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2c77557f-3e0d-4767-96c3-a468a290760a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 275, "section": "7.6 7.6"}, "hash": "7e219fc74fdfdf569e091b1854abc317ec457558cafe47f90ef08b58e35ff18a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "h \nPLASMA 2 \nDAY \n14 \n2001-02-\n25 \n2001-02-\n15T08:00 \n \n \n15 \nABC-123 \nPP \nABC-123-\n001 \n22 \nDRUGA_DAY14 VZFO \nVz Obs by F \nDRUG A \nPARENT \n283 \nL \n283 \n283 \nL \nPLASMA 2 \nDAY \n14 \n2001-02-\n25 \n2001-02-\n15T08:00 \n \n \n16 \nABC-123 \nPP \nABC-123-\n001 \n23 \nDRUGA_DAY14 CLFO \nTotal CL Obs \nby F \nDRUG A \nPARENT", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 303, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9a4f4c38-d7d5-4357-b345-3bd86b028ede": {"__data__": {"id_": "9a4f4c38-d7d5-4357-b345-3bd86b028ede", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 275, "section": "6.3.5.9.3 Relating PP Records to PC Records"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dc734550-480b-4437-9e9e-e54439352817", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 275, "section": "6.3.5.9.3 Relating PP Records to PC Records"}, "hash": "a1f1a6e6fbcfdfc0e94ff03c97e9414d66e0549a265fc8a795a9ed18dd757c45", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Sponsors must document the concentrations used to calculate each parameter. This may be done in analysis dataset metadata or by documenting relationships between records in the Pharmacokinetics Parameters (PP) \nand Pharmacokinetics Concentrations (PC) datasets in a RELREC dataset (see Section 8.2, Relating Peer Records, and Section 8.3, Relating Datasets). \nPC-PP \u2013 Relating Datasets \nIf all time-point concentrations in PC are used to calculate all parameters for all subjects, then the relationship between the 2 datasets can be documented as shown in this table: \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC-123 \nPC \n \nPCGRPID  \nMANY \nA \n2 \nABC-123 \nPP \n \nPPGRPID  \nMANY \nA \nNote that the reference time point and the analyte are part of the natural key (see Section 3.2.1.1, Primary Keys) for both datasets. In this relationship, --GRPID is a surrogate key, and must be populated so that \neach combination of  analyte and reference time point has a separate value of --GRPID. \nPC-PP \u2013 Relating Records \nThis section illustrates 4 methods for representing relationships between PC and PP records under 4 different circumstances. All these examples are based on the same PC and PP data for 1 drug (i.e., drug X). \nThe different methods for representing relationships are based on which linking variables are used in RELREC. \n\u2022 \nMethod A (many to many, using PCGRPID and PPGRPID) \n\u2022 \nMethod B (one to many, using PCSEQ and PPGRPID) \n\u2022 \nMethod C (many to one, using PCGRPID and PPSEQ)", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1520, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "24320d04-1ca4-4836-a3d7-4b7a7fddfea0": {"__data__": {"id_": "24320d04-1ca4-4836-a3d7-4b7a7fddfea0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 277, "section": "1.75 1.75"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "425fcd81-d7b1-4a13-8c46-55adbcff2ef4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 277, "section": "1.75 1.75"}, "hash": "ccfe83a772733bcee76192ba916d3e502a26a8953cfb3864e731dc7c177a4c74", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "L/h \nPLASMA 8 \n2001-02-08T08:35 \nExample 1 \nAll PC records used to calculate all pharmacokinetic parameters. \nThis example uses --GRPID values in the PCGRPID (Example 1) and PPGRPID (Example 1) columns. \nMethod A (Many to Many, Using PCGRPID and PPGRPID) \nRows 1-2: \nThe relationship with RELID \"1\" includes all PC records with PCGRPID = \"DY1_DRGX\" and all PP records with PPGRPID = \"DY1DRGX\". \nRows 3-4: \nThe relationship with RELID \"2\" includes all PC records with GRPID = \"DY8_DRGX\" and all PP records with GRPID = \"DY8DRGX\". \nrelrec.xpt \nRow STUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX \n \n1 \n2 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nDY1DRGX \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPPGRPID \nDY8_DRGX \n \n2 \n4 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nDY8DRGX \n \n2 \nMethod B (One to Many, Using PCSEQ and PPGRPID) \nRows 1-13: \nThe relationship with RELID \"1\" includes the individual PC records with PCSEQ values \"1\" to \"12\" and all PP records with PPGRPID = \"DY1DRGX\". \nRows 14-26: The relationship with RELID \"2\" includes the individual PC records with PCSEQ values \"13\" to \"24\" and all PP records with PPGRPID = \"DY8DRGX\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1178, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16ef36b5-dc18-4454-b2bc-4905b9734137": {"__data__": {"id_": "16ef36b5-dc18-4454-b2bc-4905b9734137", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 278, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "06f20a7e-c8a6-45f6-8a96-203d3351d2dd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 278, "section": "UNSPECIFIED"}, "hash": "9e89f4f664f0283418584045d166112e930b1911957b2f324a1c7ab496958d61", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f8f76594-5328-4748-abb9-2ebe4b1cf54e", "node_type": "1", "metadata": {}, "hash": "6ef52e3396e78e3c60a380552c64639a56dbd3f5814ead3ac909e905b2828f00", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 278 \n2021-11-29 \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n1 \n5 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n1 \n6 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n1 \n7 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n1 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n8 \n \n1 \n9 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n9 \n \n1 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n1 \n11 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n1 \n12 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n1 \n13 \nABC-123 \nPC \nABC-123-0001 \nPPGRPID \nDY1DRGX \n \n1 \n14 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n13 \n \n1 \n15 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n14 \n \n1 \n16 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n15 \n \n1 \n17 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n16 \n \n1 \n18 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n17 \n \n1 \n19 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n18 \n \n1 \n20 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n19 \n \n1 \n21 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n20 \n \n1 \n22 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n21 \n \n1 \n23 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n22 \n \n1 \n24 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n23 \n \n1 \n25 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n24 \n \n1 \n26 \nABC-123 \nPC \nABC-123-0001 \nPPGRPID \nDY1DRGX \n \n1 \nMethod C (Many to One, Using PCGRPID and PPSEQ) \nRows 1-8: \nThe relationship with RELID = \"1\" includes all PC records with a PCGRPID = \"DY1_DRGX\" and PP \nrecords with PPSEQ values \"1\" through \"7\". \nRows 9-16: The relationship with RELID = \"2\" includes all PC records with a PCGRPID = \"DY8_DRGX\" and PP \nrecords with PPSEQ values of \"8\" through \"14\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1840, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f8f76594-5328-4748-abb9-2ebe4b1cf54e": {"__data__": {"id_": "f8f76594-5328-4748-abb9-2ebe4b1cf54e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 278, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "06f20a7e-c8a6-45f6-8a96-203d3351d2dd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 278, "section": "UNSPECIFIED"}, "hash": "9e89f4f664f0283418584045d166112e930b1911957b2f324a1c7ab496958d61", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16ef36b5-dc18-4454-b2bc-4905b9734137", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 278, "section": "UNSPECIFIED"}, "hash": "fe5113e3d9fa2f09d9d844bda73a6c563eff0eb15b290e7b36ff2d7f9f510627", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rows 9-16: The relationship with RELID = \"2\" includes all PC records with a PCGRPID = \"DY8_DRGX\" and PP \nrecords with PPSEQ values of \"8\" through \"14\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX \n \n1 \n2 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n1 \n \n1 \n3 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n2 \n \n1 \n4 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n3 \n \n1 \n5 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n4 \n \n1 \n6 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n5 \n \n1 \n7 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n6 \n \n1 \n8 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n7 \n \n1 \n9 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY8_DRGX \n \n2 \n10 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n8 \n \n2 \n11 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n9 \n \n2 \n12 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n10 \n \n2 \n13 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n11 \n \n2 \n14 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n12 \n \n2 \n15 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n13 \n \n2 \n16 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n14 \n \n2 \nMethod D (One to One, Using PCSEQ and PPSEQ) \nRows 1-19: \nThe relationship with RELID \"1\" includes individual PC records with PCSEQ values \"1\" through \n\"12\" and PP records with PPSEQ values \"1\" through \"7\". \nRows 20-38: The relationship with RELID \"2\" includes individual PC records with PCSEQ values \"13\" through \n\"24\" and PP records with PPSEQ values \"8\" through \"14\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n1 \n5 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n1 \n6 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n1", "mimetype": "text/plain", "start_char_idx": 1689, "end_char_idx": 3386, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5dd01787-b77b-4618-bfbc-62c09b58f0fc": {"__data__": {"id_": "5dd01787-b77b-4618-bfbc-62c09b58f0fc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ee554bda-b280-4f5b-9605-5a77ffd9974d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}, "hash": "4986dcd9aba3de0c18e4fdc50f40faf12b49039cded4ab96a379f1c6595da8b7", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8508ffe-1c27-405e-b8fa-f5fe011a22e0", "node_type": "1", "metadata": {}, "hash": "a0c04295a8080a6290696006caefb045c6bb4c89d879a732fd7c149270492fa3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 150, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e8508ffe-1c27-405e-b8fa-f5fe011a22e0": {"__data__": {"id_": "e8508ffe-1c27-405e-b8fa-f5fe011a22e0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ee554bda-b280-4f5b-9605-5a77ffd9974d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}, "hash": "4986dcd9aba3de0c18e4fdc50f40faf12b49039cded4ab96a379f1c6595da8b7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5dd01787-b77b-4618-bfbc-62c09b58f0fc", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}, "hash": "916018c9a5ad1b43bdfba0fc2b981fe9b80b50b029a783827a31792bb73a9c0f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8aa08596-f931-4aaa-af2c-4b601b059cc6", "node_type": "1", "metadata": {}, "hash": "4eb2468cc8e5e9d0570c211594cf56d389f0f809d86cf914b86e1f6b2aecdb5f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All rights reserved  \n Page 279 \n2021-11-29 \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n7 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n1 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n8 \n \n1 \n9 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n9 \n \n1 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n1 \n11 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n1 \n12 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n1 \n13 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n1 \n \n1 \n14 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n2 \n \n1 \n15 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n3 \n \n1 \n16 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n4 \n \n1 \n17 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n5 \n \n1 \n18 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n6 \n \n1 \n19 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n7 \n \n1 \n20 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n13 \n \n2 \n21 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n14 \n \n2 \n22 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n15 \n \n2 \n23 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n16 \n \n2 \n24 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n17 \n \n2 \n25 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n18 \n \n2 \n26 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n19 \n \n2 \n27 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n20 \n \n2 \n28 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n21 \n \n2 \n29 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n22 \n \n2 \n30 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n23 \n \n2 \n31 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n24 \n \n2 \n32 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n8 \n \n2 \n33 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n9 \n \n2 \n34 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n10 \n \n2 \n35 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n11 \n \n2 \n36 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n12 \n \n2 \n37 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n13 \n \n2 \n38 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n14 \n \n2 \nExample 2 \nOnly some records in PC were used to calculate all pharmacokinetic parameters;", "mimetype": "text/plain", "start_char_idx": 151, "end_char_idx": 1839, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8aa08596-f931-4aaa-af2c-4b601b059cc6": {"__data__": {"id_": "8aa08596-f931-4aaa-af2c-4b601b059cc6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ee554bda-b280-4f5b-9605-5a77ffd9974d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}, "hash": "4986dcd9aba3de0c18e4fdc50f40faf12b49039cded4ab96a379f1c6595da8b7", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e8508ffe-1c27-405e-b8fa-f5fe011a22e0", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 279, "section": "UNSPECIFIED"}, "hash": "69330534400d59eab40afe9d0c9474a2121d4ad5052ffec4628af8f315d5c21b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "time points 8 and 9 on day 1 were \nnot used for any pharmacokinetic parameters. \nThis example uses --GRPID values in the PCGRPID (Example 2) and PPGRPID (Example 2) columns. Note that \nfor the 2 excluded PC records, PCGRPID = \"EXCLUDE\"; for other PC records, PCGRPID = \"DY1_DRGX\". \nAll pharmacokinetic concentrations for day 8 were used to calculate all pharmacokinetic parameters. Because day 8 \nrelationships are the same as in Example 1, they are not included here. \nMethod A (Many to Many, Using PCGRPID and PPGRPID) \nThe relationship with RELID \"1\" includes PC records with PCGRPID = \"DY1_DRGX\" and all PP records with \nPPGRPID = \"DY1DRGX\". PC records with PCGRPID = \"EXCLUDE\" are not included in this relationship. \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX \n \n1 \n2 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nDY1DRGX \n \n1 \nMethod B (One to Many, Using PCSEQ and PPGRPID) \nThe relationship with RELID \"1\" includes individual PC records with PCSEQ values \"1\" through \"7\" and \"10\" \nthrough 12\", and all the PP records with PPGRPID = \"DY1DRGX\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n1 \n5 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n1 \n6 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n1 \n7 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n1 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n1 \n9 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n1 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n1 \n11 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nDY1DRGX \n \n1", "mimetype": "text/plain", "start_char_idx": 1840, "end_char_idx": 3548, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f1f5b8cd-1688-4469-a1f1-78cf34769262": {"__data__": {"id_": "f1f5b8cd-1688-4469-a1f1-78cf34769262", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cf4951a1-0e6b-4185-a9b3-fc404b11c0b9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}, "hash": "1bc7a46d933c756b47f39f03f2794a1ee9cfebd3a9dfcb2666610177ed819a97", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "532229ed-8f7a-4924-89c0-88d550ac2fd3", "node_type": "1", "metadata": {}, "hash": "807a93f87ba11a7faca9f6b02fabf72065f4893ea23c71429b60ccbb9e6eb0e6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 280 \n2021-11-29 \nMethod C (Many to One, Using PCGRPID and PPSEQ) \nThe relationship with RELID \"1\" includes all PC records with PCGRPID = \"DY1_DRGX\" and individual PP \nrecords with PPSEQ values \"1\" through \"7\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX \n \n1 \n2 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n1 \n \n1 \n3 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n2 \n \n1 \n4 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n3 \n \n1 \n5 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n4 \n \n1 \n6 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n5 \n \n1 \n7 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n6 \n \n1 \n8 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n7 \n \n1 \nMethod D (One to One, Using PCSEQ and PPSEQ) \nThe relationship with RELID \"1\" includes individual PC records with PCSEQ values \"1\" through \"7\" and \"10\" \nthrough \"12\" and individual PP records with PPSEQ values \"1 through \"7\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1061, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "532229ed-8f7a-4924-89c0-88d550ac2fd3": {"__data__": {"id_": "532229ed-8f7a-4924-89c0-88d550ac2fd3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cf4951a1-0e6b-4185-a9b3-fc404b11c0b9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}, "hash": "1bc7a46d933c756b47f39f03f2794a1ee9cfebd3a9dfcb2666610177ed819a97", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f1f5b8cd-1688-4469-a1f1-78cf34769262", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}, "hash": "08a6caf64a70d3d8bc005dbdfd6cb41f4eb0014b5506c0f87f528b988eb83eaa", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "db8b5414-98f3-4012-9570-7f57ad341147", "node_type": "1", "metadata": {}, "hash": "51232c8f5d171a23c8e026a5f20cec64bc35daed36410c64630c06de3f5efe84", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "relrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n1 \n5 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n1 \n6 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n1 \n7 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n1 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n1 \n9 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n1 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n1 \n11 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n1 \n \n1 \n12 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n2 \n \n1 \n13 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n3 \n \n1 \n14 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n4 \n \n1 \n15 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n5 \n \n1 \n16 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n6 \n \n1 \n17 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n7 \n \n1 \nExample 3 \nOnly some records in PC were used to calculate some parameters; time points 8 and 9 on day 1 were not used for \nhalf-life calculations, but were used for other parameters. \nThis example uses --GRPID values in the PCGRPID (Example 3) and PPGRPID (Example 3) columns. Note that \nthe 2 excluded PC records have PCGRPID = \"DY1_DRGX_B\"; the other PC records have PCGRPID = \n\"DY1_DRGX_A\". Note also that the PP records for half-life calculations have PPGRPID = \"DYDRGX_HALF\", \nwhereas the other PP records have PPGRPID = \"DY1DRGX_A\". \nAll pharmacokinetic concentrations for day 8 were used to calculate all pharmacokinetic parameters. Because day 8 \nrelationships are the same as in Example 1, they are not included here. \nMethod A (Many to Many, Using PCGRPID and PPGRPID) \nRows 1-3: \nThe relationship with RELID \"1\" includes all PC records with PCGRPID = \"DY1_DRGX_A\", all PC \nrecords with PCGRPID = \"DY1_DRGX_B\" (which in this case is all the PP records for Day 1) and all \nPP records with PPGRPID = \"DYIDRGX_A\". \nRows 4-6: \nThe relationship with RELID \"2\" includes only PC records with PCGRPID = \"DY1_DRGX_A\" and \nall PP records with PPGRPID = \"DYIDRGX_HALF\".", "mimetype": "text/plain", "start_char_idx": 1063, "end_char_idx": 3084, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "db8b5414-98f3-4012-9570-7f57ad341147": {"__data__": {"id_": "db8b5414-98f3-4012-9570-7f57ad341147", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cf4951a1-0e6b-4185-a9b3-fc404b11c0b9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}, "hash": "1bc7a46d933c756b47f39f03f2794a1ee9cfebd3a9dfcb2666610177ed819a97", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "532229ed-8f7a-4924-89c0-88d550ac2fd3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 280, "section": "UNSPECIFIED"}, "hash": "5dc67c39cfb2cbd5872c3db733b09f15c287dbb8bc24e41cc75a4d8aba1a32b7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All pharmacokinetic concentrations for day 8 were used to calculate all pharmacokinetic parameters. Because day 8 \nrelationships are the same as in Example 1, they are not included here. \nMethod A (Many to Many, Using PCGRPID and PPGRPID) \nRows 1-3: \nThe relationship with RELID \"1\" includes all PC records with PCGRPID = \"DY1_DRGX_A\", all PC \nrecords with PCGRPID = \"DY1_DRGX_B\" (which in this case is all the PP records for Day 1) and all \nPP records with PPGRPID = \"DYIDRGX_A\". \nRows 4-6: \nThe relationship with RELID \"2\" includes only PC records with PCGRPID = \"DY1_DRGX_A\" and \nall PP records with PPGRPID = \"DYIDRGX_HALF\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX_A \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX_B \n \n1 \n3 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nDY1DRGX_A \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX_A \n \n2 \n5 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nDY1DRGX_HALF \n \n2", "mimetype": "text/plain", "start_char_idx": 2456, "end_char_idx": 3442, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3f1f9f55-208b-4739-b28a-1c4c4a2519e8": {"__data__": {"id_": "3f1f9f55-208b-4739-b28a-1c4c4a2519e8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85d3aaa6-8ba8-4b91-a142-c0a109aab745", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}, "hash": "36f9f34a1ca53a3f49f001d8d7ec745ebf9d5a90e21db3f49e5ae334383275d4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ebdd22d4-a168-45c2-bae5-dc391c1162cd", "node_type": "1", "metadata": {}, "hash": "73d793687b7745ca00805d8a1ed593e436fccc0d2f6a21fc01b24590a3036632", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 281 \n2021-11-29 \nMethod B (One to Many, Using PCSEQ and PPGRPID) \nRows 1-13: \nThe relationship with RELID \"1\" includes PP records with PCSEQ values \"1\" through \"12\" and PP \nrecords with PPGRPID = \"DY1DRGX_A\". \nRows 14-24: The relationship with RELID \"2\" includes PP records with PCSEQ values \"1\" through \"7\" and \"10\" \nthrough \"12\" and PP records with PPGRPID = \"DY1DRGX_HALF\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 555, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ebdd22d4-a168-45c2-bae5-dc391c1162cd": {"__data__": {"id_": "ebdd22d4-a168-45c2-bae5-dc391c1162cd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85d3aaa6-8ba8-4b91-a142-c0a109aab745", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}, "hash": "36f9f34a1ca53a3f49f001d8d7ec745ebf9d5a90e21db3f49e5ae334383275d4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3f1f9f55-208b-4739-b28a-1c4c4a2519e8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}, "hash": "91e639a633f07c9176e0ad6e99a309dc3949b79f6873374d446535603791eac2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "45e3ad74-1721-4dcb-bae8-375346dc94ca", "node_type": "1", "metadata": {}, "hash": "7e666a232c283d0244d2d40907634c0a6d5f8037ff88ebf246c9935a9a89c279", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All rights reserved  \n Page 281 \n2021-11-29 \nMethod B (One to Many, Using PCSEQ and PPGRPID) \nRows 1-13: \nThe relationship with RELID \"1\" includes PP records with PCSEQ values \"1\" through \"12\" and PP \nrecords with PPGRPID = \"DY1DRGX_A\". \nRows 14-24: The relationship with RELID \"2\" includes PP records with PCSEQ values \"1\" through \"7\" and \"10\" \nthrough \"12\" and PP records with PPGRPID = \"DY1DRGX_HALF\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n1 \n5 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n1 \n6 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n1 \n7 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n1 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n8 \n \n1 \n9 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n9 \n \n1 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n1 \n11 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n1 \n12 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n1 \n13 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nDY1DRGX_A \n \n1 \n14 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n2 \n15 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n2 \n16 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n2 \n17 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n2 \n18 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n2 \n19 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n2 \n20 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n2 \n21 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n2 \n22 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n2 \n23 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n2 \n24 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nDY1DRGX_HALF \n \n2 \nMethod C (Many to One, Using PCGRPID and PPSEQ) \nRows 1-7: \nThe relationship with RELID \"1\" includes all PP records with PGRPID values \"DY1_DRGX_A\" and \n\"DY1_DRGX_B\" and PP records with PPSEQ values \"1\" through \"3\", \"6\", and \"7\".", "mimetype": "text/plain", "start_char_idx": 151, "end_char_idx": 1987, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "45e3ad74-1721-4dcb-bae8-375346dc94ca": {"__data__": {"id_": "45e3ad74-1721-4dcb-bae8-375346dc94ca", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85d3aaa6-8ba8-4b91-a142-c0a109aab745", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}, "hash": "36f9f34a1ca53a3f49f001d8d7ec745ebf9d5a90e21db3f49e5ae334383275d4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ebdd22d4-a168-45c2-bae5-dc391c1162cd", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 281, "section": "UNSPECIFIED"}, "hash": "8783237c6a86afa3bed01c5d3a4910181a760c897c476af6fd064852873cfebc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rows 8-10: The relationship with RELID \"2\" includes all PP records with PGRPID value \"DY1_DRGX_A\" and \nPP records with PPSEQ values \"4\" and \"5\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX_A \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX_B \n \n1 \n3 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n1 \n \n1 \n4 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n2 \n \n1 \n5 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n3 \n \n1 \n6 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n6 \n \n1 \n7 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n7 \n \n1 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1_DRGX_A \n \n2 \n9 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n4 \n \n2 \n10 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n5 \n \n2 \nMethod D (One to One, Using PCSEQ and PPSEQ) \nRows 1-17: \nThe relationship with RELID \"1\" includes PC records with PCSEQ values of \"1\" through \"12\" and \nPP records with PPSEQ values \"1\" through \"3\" and \"6\" and \"7\". \nRows 18-29: The relationship with RELID \"2\" includes PC records with PCSEQ values of \"1\" through \"7\" and \n\"10\" through \"12\" and PP records with PPSEQ values \"4\" and \"5\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n1 \n5 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n1", "mimetype": "text/plain", "start_char_idx": 1989, "end_char_idx": 3383, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0c377f69-3f04-43ad-b957-64039950e275": {"__data__": {"id_": "0c377f69-3f04-43ad-b957-64039950e275", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c0ca706-f1dc-42be-9d9c-2a187148fc6b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}, "hash": "6e500f5785756848c23052f4759b4c10d54ca01b798ee45db3cb90f33421f9cc", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2d1974d7-2d48-43a8-b237-4e9b8a3d8b02", "node_type": "1", "metadata": {}, "hash": "5c090a4f199bf5c511a95a8a0a156a8a8de0d47b3159768e835ef7547bd5e247", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 282 \n2021-11-29 \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n6 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n1 \n7 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n1 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n8 \n \n1 \n9 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n9 \n \n1 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n1 \n11 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n1 \n12 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n1 \n13 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n1 \n \n1 \n14 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n2 \n \n1 \n15 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n3 \n \n1 \n16 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n6 \n \n1 \n17 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n7 \n \n1 \n18 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n2 \n19 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n2 \n20 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n2 \n21 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n2 \n22 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n2 \n23 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n2 \n24 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n2 \n25 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n2 \n26 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n2 \n27 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n2 \n28 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n4 \n \n2 \n29 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n5 \n \n2 \nExample 4 \nOnly some records in PC were used to calculate parameters; time point 5 was excluded from Tmax, time point 6 \nfrom Cmax, and time points 11 and 12 from AUC. \nThis example uses --GRPID values in the PCGRPID (Example 4) and PPGRPID (Example 4) columns. Note that 4 \nvalues of PCGRPID and 4 values of PPGRPID were used. \nBecause of the complexity of this example, only methods A and D are illustrated.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1776, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2d1974d7-2d48-43a8-b237-4e9b8a3d8b02": {"__data__": {"id_": "2d1974d7-2d48-43a8-b237-4e9b8a3d8b02", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c0ca706-f1dc-42be-9d9c-2a187148fc6b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}, "hash": "6e500f5785756848c23052f4759b4c10d54ca01b798ee45db3cb90f33421f9cc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0c377f69-3f04-43ad-b957-64039950e275", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}, "hash": "edca389018a01f6c322aebaaf122b3e811358cc6153fbaa0b3902c2b55b596f3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "89fa5270-86c0-446c-9662-e4e72cebfb23", "node_type": "1", "metadata": {}, "hash": "f9b6b7ce15730ebfac9774fdd2f761e21c9b2540f7ef1a3ee6b68578327e228b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This example uses --GRPID values in the PCGRPID (Example 4) and PPGRPID (Example 4) columns. Note that 4 \nvalues of PCGRPID and 4 values of PPGRPID were used. \nBecause of the complexity of this example, only methods A and D are illustrated. \nMethod A (Many to Many, Using PCGRPID and PPGRPID) \nRows 1-4: \nThe relationship with RELID \"1\" includes PC records with PCGRPID values \"DY1DRGX_A\", \n\"DY1DRGX_C\", and \"DY1DRGX_D\" and the one PP record with PPGRPID = \"TMAX\". \nRows 5-8: \nThe relationship with RELID \"2\" includes PC records with PCGRPID values \"DY1DRGX_A\", \n\"DY1DRGX_B\", and \"DY1DRGX_D\" and the one PP record with PPGRPID = \"CMAX\". \nRows 9-12: \nThe relationship with RELID \"3\" includes PC records with PCGRPID values \"DY1DRGX_A\", \n\"DY1DRGX_B\", and \"DY1DRGX_C\" and the one PP record with PPGRPID = \"AUC\". \nRows 13-17: The relationship with RELID \"4\" includes PC records with PCGRPID values \"DY1DRGX_A\", \n\"DY1DRGX_B\", \"DY1DRGX_C\", and \"DY1DRGX_D\" (in this case, all PC records) and all PP \nrecords with PPGRPID = \"OTHER\".", "mimetype": "text/plain", "start_char_idx": 1536, "end_char_idx": 2560, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "89fa5270-86c0-446c-9662-e4e72cebfb23": {"__data__": {"id_": "89fa5270-86c0-446c-9662-e4e72cebfb23", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5c0ca706-f1dc-42be-9d9c-2a187148fc6b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}, "hash": "6e500f5785756848c23052f4759b4c10d54ca01b798ee45db3cb90f33421f9cc", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2d1974d7-2d48-43a8-b237-4e9b8a3d8b02", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 282, "section": "UNSPECIFIED"}, "hash": "585dc655b0773d8f86bb3f4fec206dcbbe5d981f013699dc133b0857a6b5310b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rows 5-8: \nThe relationship with RELID \"2\" includes PC records with PCGRPID values \"DY1DRGX_A\", \n\"DY1DRGX_B\", and \"DY1DRGX_D\" and the one PP record with PPGRPID = \"CMAX\". \nRows 9-12: \nThe relationship with RELID \"3\" includes PC records with PCGRPID values \"DY1DRGX_A\", \n\"DY1DRGX_B\", and \"DY1DRGX_C\" and the one PP record with PPGRPID = \"AUC\". \nRows 13-17: The relationship with RELID \"4\" includes PC records with PCGRPID values \"DY1DRGX_A\", \n\"DY1DRGX_B\", \"DY1DRGX_C\", and \"DY1DRGX_D\" (in this case, all PC records) and all PP \nrecords with PPGRPID = \"OTHER\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nTMAX \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_A \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_C \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_D \n \n1 \n5 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nCMAX \n \n2 \n6 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_A \n \n2 \n7 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_B \n \n2 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_D \n \n2 \n9 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nAUC \n \n3 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_A \n \n3 \n11 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_B \n \n3 \n12 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_C \n \n3 \n13 \nABC-123 \nPP \nABC-123-0001 \nPPGRPID \nOTHER \n \n4 \n14 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_A \n \n4 \n15 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_B \n \n4 \n16 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_C \n \n4 \n17 \nABC-123 \nPC \nABC-123-0001 \nPCGRPID \nDY1DRGX_D \n \n4", "mimetype": "text/plain", "start_char_idx": 2002, "end_char_idx": 3560, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e794825a-14c1-4370-a8ce-d343562e291b": {"__data__": {"id_": "e794825a-14c1-4370-a8ce-d343562e291b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be661258-2bd1-4019-924d-e6aa631ca982", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}, "hash": "733bbe22667fe55377b818dcbecb868dc6e7ef4e31f3a8dc68050bd11d10b9c5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ba032d5e-ea91-4003-b58d-82a9ea458f3a", "node_type": "1", "metadata": {}, "hash": "165ee17d6e11e1137a80b22f781a9f5f030082277bf5d1a76ed58a8f9895b16a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 283 \n2021-11-29 \nNote that in the RELREC table for method A, the single records in rows 1, 3, 5, 7, and 9, represented by their \nPPGRPID values, could have been referenced by their PPSEQ values; both identify the records sufficiently. \nAt least 2 other hybrid approaches would also be acceptable: \n\u2022 \nUsing PPSEQ values; use PCGRPID values wherever possible \n\u2022 \nUsing PPGRPID values wherever possible; use PCSEQ values \nMethod D uses only PCSEQ and PPSEQ values. \nMethod D (One to One, Using PCSEQ and PPSEQ) \nRows 1-12: \nThe relationship with RELID \"1\" includes PC records with PCSEQ values \"1\" through \"4\" and \"6\" \nthrough \"12\" and PP records with PPSEQ = \"1\". \nRows 13-24: The relationship with RELID \"2\" includes PC records with PCSEQ values \"1\" through \"5\" and \"7\" \nthrough \"12\" and PP records with PPSEQ = \"2\". \nRows 24-35: The relationship with RELID \"3\" includes PC records with PCSEQ values \"1\" through \"10\" and PP \nrecords with PPSEQ = \"3\". \nRows 36-51: The relationship with RELID \"4\" includes PC records with PCSEQ values \"1\" through \"12\" and PP \nrecords with PPSEQ values \"4\" through \"7\". \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n1 \n2 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n1 \n3 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n1 \n4 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n1 \n5 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n1 \n6 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n1 \n7 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n8 \n \n1 \n8 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n9 \n \n1 \n9 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n1 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n1 \n11 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n1 \n12 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n1 \n \n1 \n13 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n2 \n14 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n2 \n15 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n2 \n16 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n2 \n17 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2128, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ba032d5e-ea91-4003-b58d-82a9ea458f3a": {"__data__": {"id_": "ba032d5e-ea91-4003-b58d-82a9ea458f3a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be661258-2bd1-4019-924d-e6aa631ca982", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}, "hash": "733bbe22667fe55377b818dcbecb868dc6e7ef4e31f3a8dc68050bd11d10b9c5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e794825a-14c1-4370-a8ce-d343562e291b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}, "hash": "325b7334d1f0f21f7a6f3f5de72db884b4fafaeb239e3614140c3ff8d3001780", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1e2d60e0-f9f5-49ce-a2aa-f2c835b8d856", "node_type": "1", "metadata": {}, "hash": "09561e060aae89c28c232f77b1badbdacb946475695a613a741869a94e7a99e5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PC \nABC-123-0001 \nPCSEQ \n10 \n \n1 \n10 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n1 \n11 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n1 \n12 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n1 \n \n1 \n13 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n2 \n14 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n2 \n15 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n2 \n16 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n2 \n17 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n2 \n18 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n2 \n19 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n8 \n \n2 \n20 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n9 \n \n2 \n21 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n2 \n22 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n2 \n23 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n2 \n24 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n2 \n \n2 \n25 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n3 \n26 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n3 \n27 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n3 \n28 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n3 \n29 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n3 \n30 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n3 \n31 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n3 \n32 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n8 \n \n3 \n33 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n9 \n \n3 \n34 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n3 \n35 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n3 \n \n3 \n36 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n4 \n37 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n4 \n38 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n4 \n39 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n4 \n40 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n4 \n41 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n4 \n42 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n4 \n43", "mimetype": "text/plain", "start_char_idx": 1731, "end_char_idx": 3291, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1e2d60e0-f9f5-49ce-a2aa-f2c835b8d856": {"__data__": {"id_": "1e2d60e0-f9f5-49ce-a2aa-f2c835b8d856", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be661258-2bd1-4019-924d-e6aa631ca982", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}, "hash": "733bbe22667fe55377b818dcbecb868dc6e7ef4e31f3a8dc68050bd11d10b9c5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ba032d5e-ea91-4003-b58d-82a9ea458f3a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 283, "section": "UNSPECIFIED"}, "hash": "b5628bc292f5e368158c95ad01b9d58583938330b4b69a89903cd311b246353b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PCSEQ \n10 \n \n3 \n35 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n3 \n \n3 \n36 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n1 \n \n4 \n37 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n2 \n \n4 \n38 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n3 \n \n4 \n39 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n4 \n \n4 \n40 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n5 \n \n4 \n41 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n6 \n \n4 \n42 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n7 \n \n4 \n43 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n8 \n \n4 \n44 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n9 \n \n4 \n45 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n10 \n \n4 \n46 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n11 \n \n4", "mimetype": "text/plain", "start_char_idx": 2905, "end_char_idx": 3473, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bec9114c-e55a-471d-895f-0570c41c0530": {"__data__": {"id_": "bec9114c-e55a-471d-895f-0570c41c0530", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 284, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a94a0c06-768e-4cc0-b542-049c964b11de", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 284, "section": "UNSPECIFIED"}, "hash": "e724d31126d98e30841cfa2a72038278b23e3fb8a3990289198f2c0ab92602af", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "57c59627-8c09-4516-b8f7-ed8aa7774754", "node_type": "1", "metadata": {}, "hash": "65a936ee00d9bdb5b62afa12a1b961088e1b3f245279ebd93c75a014526e1a59", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 284 \n2021-11-29 \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n47 \nABC-123 \nPC \nABC-123-0001 \nPCSEQ \n12 \n \n4 \n48 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n4 \n \n4 \n49 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n5 \n \n4 \n50 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n6 \n \n4 \n51 \nABC-123 \nPP \nABC-123-0001 \nPPSEQ \n7 \n \n4 \nPC-PP Conclusions \nRelating the datasets (as described in Section 8, Representing Relationships and Data) is the simplest method; \nhowever, all time-point concentrations in PC must be used to calculate all parameters for all subjects. If datasets \ncannot be related, then individual subject records must be related. In either case, the values of PCGRPID and \nPPGRPID must take into account multiple analytes and multiple reference time points, if they exist. \nMethod A is clearly the most efficient in terms of having the least number of RELREC records, but it does require \nthe assignment of --GRPID values (which are optional) in both the PC and PP datasets. Method D, in contrast, does \nnot require the assignment of --GRPID values, relying instead on the required --SEQ values in both datasets to relate \nthe records. Although Method D results in the largest number of RELREC records compared to the other methods, it \nmay be the easiest to implement consistently across the range of complexities shown in the examples. Two \nadditional methods, methods B and C, are also shown for Examples 1-3. They represent hybrid approaches, using --\nGRPID values in only 1 dataset (PP and PC, respectively) and --SEQ values for the other. These methods are best \nsuited for sponsors who want to minimize the number of RELREC records while not having to assign --GRPID \nvalues in both domains. Methods B and C would not be ideal, however, if one expected complex scenarios as shown \nin Example 4. \nNote that an attempt has been made to approximate real pharmacokinetic data; however, the example values are not \nintended to reflect data used for actual analysis. When certain time-point concentrations have been omitted from PP \ncalculations in Examples 2-4, the actual parameter values in the PP dataset have not been recalculated from those in \nExample 1 to reflect those omissions. \nPC-PP \u2013 Suggestions for Implementing RELREC in the Submission of PK Data \nDetermine which of the scenarios best reflects how PP data are related to PC data. Questions that should be \nconsidered include: \n1. Do all parameters for each PK profile use all concentrations for all subjects? If so, create a PPGRPID value \nfor all PP records and a PCGRPID value for all PC records for each profile for each subject, analyte, and \nreference time point. Decide whether to relate datasets or records. If choosing the latter, create records in \nRELREC for each PCGRPID value and each PPGRPID value (method A). Use RELID to show which \nPCGRPID and PPGRPID records are related. Consider RELREC methods B, C, and D as applicable. \n2.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3089, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "57c59627-8c09-4516-b8f7-ed8aa7774754": {"__data__": {"id_": "57c59627-8c09-4516-b8f7-ed8aa7774754", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 284, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a94a0c06-768e-4cc0-b542-049c964b11de", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 284, "section": "UNSPECIFIED"}, "hash": "e724d31126d98e30841cfa2a72038278b23e3fb8a3990289198f2c0ab92602af", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "bec9114c-e55a-471d-895f-0570c41c0530", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 284, "section": "UNSPECIFIED"}, "hash": "342b9635e2acece761e4e700f7bfe9ca17b091c870193aecbccc5f4b240e8ced", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PC-PP \u2013 Suggestions for Implementing RELREC in the Submission of PK Data \nDetermine which of the scenarios best reflects how PP data are related to PC data. Questions that should be \nconsidered include: \n1. Do all parameters for each PK profile use all concentrations for all subjects? If so, create a PPGRPID value \nfor all PP records and a PCGRPID value for all PC records for each profile for each subject, analyte, and \nreference time point. Decide whether to relate datasets or records. If choosing the latter, create records in \nRELREC for each PCGRPID value and each PPGRPID value (method A). Use RELID to show which \nPCGRPID and PPGRPID records are related. Consider RELREC methods B, C, and D as applicable. \n2. Do all parameters use the same concentrations, although maybe not all of them (Example 2)? If so, create a \nsingle PPGRPID value for all PP records, and 2 PCGRPID values for the PC records: a PCGRPID value for \nones that were used and a PCGRPID value for those that were not used. Create records in RELREC for \neach PCGRPID value and each PPGRPID value (method A). Use RELID to show which PCGRPID and \nPPGRPID records are related. Consider RELREC methods B, C, and D as applicable. \n3. Do any parameters use the same concentrations, but not as consistently as shown in Examples 1 and 2? If \nso, refer to Example 3. Assign a GRPID value to the PP records that use the same concentrations. More \nthan 1 PPGRPID value may be necessary. Assign as many PCGRPID values in the PC domain as needed to \ngroup these records. Create records in RELREC for each PCGRPID value and each PPGRPID value \n(method A). Use RELID to show which PCGRPID and PPGRPID records are related. Consider RELREC \nmethods B, C, and D as applicable. \n4. If none of the above applies, or the data become difficult to group, then start with Example 4, and decide \nwhich RELREC method would be easiest to implement and represent.", "mimetype": "text/plain", "start_char_idx": 2369, "end_char_idx": 4282, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "93629bd7-c736-4584-8555-bda2753252c4": {"__data__": {"id_": "93629bd7-c736-4584-8555-bda2753252c4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.6 Morphology (MO)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c646f8de-d8d0-4033-86a6-d6d74a7f23fc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.6 Morphology (MO)"}, "hash": "2896a81f0926949a2e16abd72373337aba5900e9d94b7c8e9e773c4739af5627", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Domain Decommissioning Update \nThe MO domain has been decommissioned as of SDTMIG v3.4. \nWhen the Morphology domain was introduced in SDTMIG v3.2, the SDS Team planned to represent \nmorphology and physiology findings in separate domains: morphology findings in the MO domain and \nphysiology findings in separate domains by body systems. Since then, the team found that separating \nmorphology and physiology findings was more difficult than anticipated and provided little added value. This \nled to the decision to expand the body system-based domains to cover both morphology and physiology \nfindings and to deprecate MO in a future version of the SDTMIG. Submissions using that later SDTMIG \nversion would represent morphology results in the appropriate body system-based physiology/morphology \ndomain. \nFor data prepared using a version of the SDTMIG that includes both the MO domain and body system-based \nphysiology/morphology domains, morphology findings may be represented in either the MO domain or in a \nbody-system based physiology/morphology domain. Custom body system-based domains may be used if the \nappropriate body system-based domain is not included in the SDTMIG version being used.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1199, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bd1d9d39-7e41-4340-9a93-ce26a9de28a9": {"__data__": {"id_": "bd1d9d39-7e41-4340-9a93-ce26a9de28a9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.7 Morphology/Physiology Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "775b54ea-5567-41ab-974f-aa3335796041", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.7 Morphology/Physiology Domains"}, "hash": "73f68d7f12dd10c614ca4e23b26c6d30b105e5988c0ac8e5962dc8d0a0904c49", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Individual domains for morphology and physiology findings about specific body systems are grouped together in \nthis section. This grouping is not meant to imply that there is a single morphology/physiology domain. Additional \ndomains for other body systems are expected to be added in future versions of the SDTMIG. The CDISC Controlled \nTerminology of SDTM domain abbreviations and the therapeutic area user guides may have examples of other body \nsystem domains that are not yet in the SDTMIG.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 495, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cca2a079-785f-45ff-bb74-b74c333efbb1": {"__data__": {"id_": "cca2a079-785f-45ff-bb74-b74c333efbb1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.7.1 Generic Morphology/Physiology Specification"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b1a09b81-e97c-46b4-8219-f169d8249b38", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 285, "section": "6.3.7.1 Generic Morphology/Physiology Specification"}, "hash": "e48e60c0bd745e728ba06d299eec6ab80b955c4279090d948289dcc0e41a04e7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This section describes properties common to all the body system-based morphology/physiology domains. \n\u2022 \nThe SDTMIG includes several domains for physiology and morphology findings for different body \nsystems. These differ only in body system, in domain code, and in informative content such as examples. \n\u2022 \nIn the partial generic domain specification table, \"--\" is used as a placeholder. In each individual body \nsystem-based morphology/physiology domain specification, this placeholder is replaced by the appropriate \ndomain code. \n\u2022 \nThe variables included in the generic morphology/physiology domain specification table are those required \nor expected in the individual body system-based morphology/physiology domains. Individual \nmorphology/physiology domains may included additional expected variables. All other variables allowed \nin findings domains are allowed in the body system-based morphology/physiology domains \n\u2022 \nAll body system-based physiology/morphology domains share the same structure, provided here. Although \ntime point is not in the structure, it can be included in the structure of a particular domain if time point \nvariables were included in the data represented. \n\u2022 \nCDISC Controlled Terminology includes codelists for TEST and TESTCD values for each body-system \nbased domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1306, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fd7ab557-298a-48dc-aebb-c597bf26a0b4": {"__data__": {"id_": "fd7ab557-298a-48dc-aebb-c597bf26a0b4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 286, "section": "6.3.7.2 Cardiovascular System Findings (CV)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f7d882b9-6173-4ff9-918f-ec406ccea0d8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 286, "section": "6.3.7.2 Cardiovascular System Findings (CV)"}, "hash": "0573e1cc8bb4ef1d06b95e2088fed9bf27b38fbccabe3299111b97f983cd16f5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CV \u2013 Description/Overview \nA findings domain that contains physiological and morphological findings related to the cardiovascular system, including the heart, blood vessels and lymphatic \nvessels. \nCV \u2013 Specification \ncv.xpt, Cardiovascular System Findings \u2014 Findings. One record per finding or result per time point per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 537, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ce5e05b2-26e0-4c79-8f8e-2b7e7e6bd9e8": {"__data__": {"id_": "ce5e05b2-26e0-4c79-8f8e-2b7e7e6bd9e8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 287, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f77565f6-0359-48ef-8bbe-d9f6f96fe6db", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 287, "section": "UNSPECIFIED"}, "hash": "b7a213cafd278adb73ea8e0626e0c1e9c75198dea5dbfc56d567a17cf0a2ec95", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f585792c-aa98-46af-b366-35039065f8b6", "node_type": "1", "metadata": {}, "hash": "8a739b5f8a1ce471f320303e8344744453429f051686f9d5ca3186292fe6d0eb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 287 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nDOMAIN \nDomain Abbreviation \nChar CV \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier Char  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nCVSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid \nnumber (including decimals) and does not have to start at 1. \nReq \nCVGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nPerm \nCVREFID \nReference ID \nChar  \nIdentifier \nOptional internal or external identifier. \nPerm \nCVSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. Example: a preprinted line identifier on a CRF. \nPerm \nCVLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nCVLNKGRP \nLink Group \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nCVTESTCD \nShort Name of \nCardiovascular Test \nChar (CVTESTCD) \nTopic \nShort name of the measurement, test, or examination described in CVTEST. It can be used as a \ncolumn name when converting a dataset from a vertical to a horizontal format. The value in CVTESTCD \ncannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" would not be valid). \nCVTESTCD cannot contain characters other than letters, numbers, or underscores. \nReq \nCVTEST \nName of Cardiovascular \nTest \nChar (CVTEST) \nSynonym \nQualifier \nLong name For CVTESTCD. The value in CVTEST cannot be longer than 40 characters. \nReq \nCVCAT \nCategory for \nCardiovascular Test \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. \nPerm \nCVSCAT \nSubcategory for \nCardiovascular Test \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of CVCAT values. \nPerm \nCVPOS \nPosition of Subject \nDuring Observation \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during a measurement or examination. Examples: \"SUPINE\", \"STANDING\", \n\"SITTING\". \nPerm \nCVORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nCVORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. Unit for CVORRES. \nPerm \nCVSTRESC \nCharacter Result/Finding \nin Std Format \nChar * \nResult \nQualifier \nContains the result value for all findings, copied or derived, from CVORRES in a standard format or in \nstandard units. CVSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in CVSTRESN.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3195, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f585792c-aa98-46af-b366-35039065f8b6": {"__data__": {"id_": "f585792c-aa98-46af-b366-35039065f8b6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 287, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f77565f6-0359-48ef-8bbe-d9f6f96fe6db", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 287, "section": "UNSPECIFIED"}, "hash": "b7a213cafd278adb73ea8e0626e0c1e9c75198dea5dbfc56d567a17cf0a2ec95", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ce5e05b2-26e0-4c79-8f8e-2b7e7e6bd9e8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 287, "section": "UNSPECIFIED"}, "hash": "7230cd2b5c1d3c36eefd1a3d63464df148991bd9a7ede2c2841652b981f32f56", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"SUPINE\", \"STANDING\", \n\"SITTING\". \nPerm \nCVORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nCVORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. Unit for CVORRES. \nPerm \nCVSTRESC \nCharacter Result/Finding \nin Std Format \nChar * \nResult \nQualifier \nContains the result value for all findings, copied or derived, from CVORRES in a standard format or in \nstandard units. CVSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in CVSTRESN. For example, if various tests \nhave results \"NONE\", \"NEG\", and \"NEGATIVE\" in CVORRES and these results effectively have the \nsame meaning, they could be represented in standard format in CVSTRESC as \"NEGATIVE\". \nExp \nCVSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nCVSTRESC. CVSTRESN should store all numeric test results or findings. \nPerm \nCVSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for CVSTRESC and CVSTRESN. \nPerm \nCVSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or a test was attempted but did \nnot generate a result. Should be null or have a value of \"NOT DONE\". \nPerm \nCVREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a measurement or test was not performed (e.g., \"BROKEN EQUIPMENT\", \"SUBJECT \nREFUSED\"). Used in conjunction with CVSTAT when value is \"NOT DONE\". \nPerm \nCVLOC \nLocation Used for the \nMeasurement \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. Examples: \"HEART\", \n\"LEFT VENTRICLE\". \nPerm \nCVLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\", \"UNILATERAL\". \nPerm \nCVDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nCVMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod used to create the result. \nPerm", "mimetype": "text/plain", "start_char_idx": 2511, "end_char_idx": 4937, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aae9153a-0f0e-4c38-a0a6-ec44b45a5791": {"__data__": {"id_": "aae9153a-0f0e-4c38-a0a6-ec44b45a5791", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 288, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bc72bd0b-9340-4c36-87bb-261b67d94989", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 288, "section": "UNSPECIFIED"}, "hash": "f9c6c4634c8689a157b5d5fdc9f5aaa6c6e21c7fafee45d09cfd352fc456377a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1a164456-4c34-476d-a7d8-a7f15912b8a8", "node_type": "1", "metadata": {}, "hash": "6701814c29b643ddff7e788bace91d3d6746c5e3201016ccf24233b2e99a285b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 288 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nCVLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally-derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nExp \nCVBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that CVBLFL is retained for \nbackward compatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nCVDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (i.e., a record that represents the average of other records, such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nCVEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned \nby a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \" INDEPENDENT ASSESSOR\", \n\"RADIOLOGIST\". \nPerm \nCVEVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in CVEVAL. Examples: \n\"RADIOLOGIST1\" or \"RADIOLOGIST2\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nCVDTC \nDate/Time of Test \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nCollection date and time of an observation. \nExp \nCVDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nCVTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken, as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point, such as time \nof last dose. See CVTPTNUM and CVTPTREF. \nPerm \nCVTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nCVELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration Timing \nPlanned elapsed time relative to a planned fixed reference (CVTPTREF).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2993, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1a164456-4c34-476d-a7d8-a7f15912b8a8": {"__data__": {"id_": "1a164456-4c34-476d-a7d8-a7f15912b8a8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 288, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bc72bd0b-9340-4c36-87bb-261b67d94989", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 288, "section": "UNSPECIFIED"}, "hash": "f9c6c4634c8689a157b5d5fdc9f5aaa6c6e21c7fafee45d09cfd352fc456377a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aae9153a-0f0e-4c38-a0a6-ec44b45a5791", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 288, "section": "UNSPECIFIED"}, "hash": "b74ea077299011b5764cc43767883ec722a17a5c35272dbf7f633402fdff6413", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Exp \nCVDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nCVTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken, as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point, such as time \nof last dose. See CVTPTNUM and CVTPTREF. \nPerm \nCVTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nCVELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration Timing \nPlanned elapsed time relative to a planned fixed reference (CVTPTREF). Examples: \"PREVIOUS \nDOSE\", \"PREVIOUS MEAL\". This variable is useful where there are repetitive measures. Not a clock \ntime or a date/time variable, but an interval, represented as ISO duration. \nPerm \nCVTPTREF \nTime Point Reference \nChar  \nTiming \nDescription of the fixed reference point referred to by CVELTM, CVTPTNUM, and CVTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nCVRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by CVTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nCV \u2013 Assumptions \n1. The Cardiovascular System Findings domain is used to represent results and findings of cardiovascular diagnostic procedures. Information about the \nconduct of the procedure(s), if collected, is submitted in the Procedures (PR) domain. \n2. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the CV domain, but the following qualifiers would \ngenerally not be used: --MODIFY, --BODSYS, --FAST, --ORNRLO, --ORNRHI, --TNRLO, --STNRHI, and --LOINC.", "mimetype": "text/plain", "start_char_idx": 2237, "end_char_idx": 4218, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb30cb3c-0f99-4135-aa6c-76502b100aaf": {"__data__": {"id_": "eb30cb3c-0f99-4135-aa6c-76502b100aaf", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 290, "section": "6.3.7.3 Musculoskeletal System Findings (MK)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f59e0007-e6ff-4c11-bb25-772c0b47af9d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 290, "section": "6.3.7.3 Musculoskeletal System Findings (MK)"}, "hash": "fa50bdf3bc53d156a5ba4f419008728f75fe14fadc6a5c6a5e3dcc60512863f1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e3934546-344c-446b-b9da-8537f1aa5a20", "node_type": "1", "metadata": {}, "hash": "6a797848aea0da692ee50af508b87adec394648065275e9cdecda48bb50bb104", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "MK \u2013 Description/Overview \nA findings domain that contains physiological and morphological findings related to the system of muscles, tendons, ligaments, bones, joints, and associated \ntissues. \nMK \u2013 Specification \nmk.xpt, Musculoskeletal System Findings \u2014 Findings. One record per assessment per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar MK \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier Char  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nMKSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject (or within a \nparameter, in the case of the Trial Summary domain). May be any valid number (including decimals) \nand does not have to start at 1. \nReq \nMKGRPID \nGroup ID \nChar  \nIdentifier \nUsed to link together a block of related records within a subject in a domain. \nPerm \nMKREFID \nReference ID \nChar  \nIdentifier \nOptional internal or external identifier such as lab specimen ID or a medical image. \nPerm \nMKSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. Example: Preprinted line identifier on a Concomitant Medications page. \nPerm \nMKLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nMKLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nMKTESTCD \nShort Name of \nMusculoskeletal Test \nChar (MUSCTSCD) \nTopic \nShort character value for MKTEST used as a column name when converting a dataset from a vertical \nformat to a horizontal format. The value in MKTESTCD cannot be longer than 8 characters, nor can it \nstart with a number (e.g., \"1TEST\" is not valid). MKTESTCD cannot contain characters other than \nletters, numbers, or underscores. Examples: \"TNDRIND\", \"SWLLIND\", \"SGJSNSCR\". \nReq \nMKTEST \nName of \nMusculoskeletal Test \nChar (MUSCTS) \nSynonym \nQualifier \nLong name For MKTESTCD. Examples: \"Tenderness Indicator\", \"Swollen Indicator\", \"Sharp/Genant \nJSN Score\". \nReq \nMKCAT \nCategory for \nMusculoskeletal Test \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Examples: \"SWOLLEN/TENDER JOINT \nASSESSMENT\". \nPerm \nMKSCAT \nSubcategory for \nMusculoskeletal Test \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of MKCAT values. \nPerm \nMKPOS \nPosition of Subject \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during a measurement or examination. Examples: \"SUPINE\", \"STANDING\", \n\"SITTING\". \nPerm \nMKORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3082, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e3934546-344c-446b-b9da-8537f1aa5a20": {"__data__": {"id_": "e3934546-344c-446b-b9da-8537f1aa5a20", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 290, "section": "6.3.7.3 Musculoskeletal System Findings (MK)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f59e0007-e6ff-4c11-bb25-772c0b47af9d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 290, "section": "6.3.7.3 Musculoskeletal System Findings (MK)"}, "hash": "fa50bdf3bc53d156a5ba4f419008728f75fe14fadc6a5c6a5e3dcc60512863f1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "eb30cb3c-0f99-4135-aa6c-76502b100aaf", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 290, "section": "6.3.7.3 Musculoskeletal System Findings (MK)"}, "hash": "85b2f4e96df77ca688cebbccd37b76d994d86c232c231cf36dab73340a73f4d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"Tenderness Indicator\", \"Swollen Indicator\", \"Sharp/Genant \nJSN Score\". \nReq \nMKCAT \nCategory for \nMusculoskeletal Test \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Examples: \"SWOLLEN/TENDER JOINT \nASSESSMENT\". \nPerm \nMKSCAT \nSubcategory for \nMusculoskeletal Test \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of MKCAT values. \nPerm \nMKPOS \nPosition of Subject \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during a measurement or examination. Examples: \"SUPINE\", \"STANDING\", \n\"SITTING\". \nPerm \nMKORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nMKORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nUnit for MKORRES. \nPerm \nMKSTRESC \nCharacter Result/Finding \nin Std Format \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from MKORRES in a standard format or in \nstandard units. MKSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in MKSTRESN. For example, if various tests \nhave results \"NONE\", \"NEG\", and \"NEGATIVE\" in MKORRES and these results effectively have the \nsame meaning, they could be represented in standard format in MKSTRESC as \"NEGATIVE\". \nExp \nMKSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nMKSTRESC. MKSTRESN should store all numeric test results or findings. \nPerm", "mimetype": "text/plain", "start_char_idx": 2355, "end_char_idx": 3991, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8ba0e1d2-11de-493c-9ede-5c3aacf03bad": {"__data__": {"id_": "8ba0e1d2-11de-493c-9ede-5c3aacf03bad", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 291, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1922f186-6e73-444b-ae8b-b28f5184331d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 291, "section": "UNSPECIFIED"}, "hash": "1e5fbc6783643ff66f04683b64d514f5f484a2852498dceafef3f44c5b7f2e1b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "69526e9a-3e4e-4cc4-baed-bef3a4256456", "node_type": "1", "metadata": {}, "hash": "561b3a83eb125d2c90dcfcb12f814481d22044301a438570f4428e0f5b89c738", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 291 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nMKSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for MKSTRESC and MKSTRESN. \nPerm \nMKSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or that a test was attempted but \ndid not generate a result. Should be null if a result exists in MKORRES. \nPerm \nMKREASND \nReason Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with MKSTAT when value is \"NOT DONE\". \nPerm \nMKLOC \nLocation Used for the \nMeasurement \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. Examples: \n\"INTERPHALANGEAL JOINT 1\", \"SHOULDER JOINT\". \nExp \nMKLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\". \nPerm \nMKDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location further detailing directionality. Examples: \"ANTERIOR\", \"LOWER\", \n\"PROXIMAL\". \nPerm \nMKMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"X-RAY\", \"MRI\", \"CT SCAN\". \nPerm \nMKLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nExp \nMKBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that MKBLFL is retained for \nbackward compatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nMKDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nMKEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\", \"RADIOLOGIST\". \nPerm \nMKEVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in MKEVAL. Examples: \n\"RADIOLOGIST1\" or \"RADIOLOGIST2\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2870, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "69526e9a-3e4e-4cc4-baed-bef3a4256456": {"__data__": {"id_": "69526e9a-3e4e-4cc4-baed-bef3a4256456", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 291, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1922f186-6e73-444b-ae8b-b28f5184331d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 291, "section": "UNSPECIFIED"}, "hash": "1e5fbc6783643ff66f04683b64d514f5f484a2852498dceafef3f44c5b7f2e1b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8ba0e1d2-11de-493c-9ede-5c3aacf03bad", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 291, "section": "UNSPECIFIED"}, "hash": "4ea0ff15fe72456c8686e219f3de8fab4481ac5da21cda461e7ca7404c21fffd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Should be \"Y\" or null. \nPerm \nMKEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\", \"RADIOLOGIST\". \nPerm \nMKEVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in MKEVAL. Examples: \n\"RADIOLOGIST1\" or \"RADIOLOGIST2\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nMKDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of an observation. \nExp \nMKDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nMKTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point, such as time \nof last dose. See MKTPTNUM and MKTPTREF. \nPerm \nMKTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nMKELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned Elapsed time relative to a planned fixed reference (MKTPTREF; e.g., \"PREVIOUS DOSE\", \n\"PREVIOUS MEAL\"). This variable is useful where there are repetitive measures. Not a clock time or a \ndate/time variable, but an interval, represented as ISO duration. \nPerm \nMKTPTREF \nTime Point Reference \nChar  \nTiming \nDescription of the fixed reference point referred to by MKELTM, MKTPTNUM, and MKTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nMKRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point defined by MKTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.", "mimetype": "text/plain", "start_char_idx": 2172, "end_char_idx": 4865, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7438f099-b8fd-459b-8369-960745b0bda3": {"__data__": {"id_": "7438f099-b8fd-459b-8369-960745b0bda3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 292, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3b275cf1-f139-4263-b401-b501bc83c8c9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 292, "section": "UNSPECIFIED"}, "hash": "a50bfe2e3cacd869f7080285747314f8e7b6ae1af770f4d2b93e873a020d0bea", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 292 \n2021-11-29 \nMK \u2013 Assumptions \n1. The Musculoskeletal System Findings domain should not be used for oncology data related to the musculoskeletal system (e.g., bone lesions). Such data \nshould be placed in the appropriate oncology domains: Tumor/Lesion Identification (TU), Tumor/Lesion Results (TR), and/or Disease Response and \nClinical Classification (RS). \n2. Musculoskeletal assessment examples that may have results represented in the MK domain include the following: morphology/physiology observations \n(e.g., swollen/tender joint count, limb movement, strength/grip measurements). \n3. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the MK domain, but the following qualifiers would \ngenerally not be used: --MODIFY, --BODSYS, --LOINC, --TOX, --TOXGR, --FAST, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --ORREF, --\nSTREFC, --STREFN. \nMK \u2013 Examples \nExample 1 \nThis example illustrates data collected for the swollen/tender joint count assessment, specifically the 68-joint count.  \nAfter determining whether each joint is swollen or tender, the assessor will add up the number of \"Yes\" responses for swollen joints and tender joints to obtain a \ntotal count for each. Total counts were not collected on the CRF since they were to be derived in ADaM datasets. Data collection included a field for marking a \njoint not evaluable when that joint met a condition (e.g., infection of the overlying tissue or skin, grossly edematous, fused), which precluded joint assessment, as \nspecified by the protocol and the protocol-related joint assessor training. A field for the reason that a joint was not evaluable was not needed. Note that there was \na field for marking a joint assessment as not done; this was to be used if the joint assessor overlooked or missed a joint while performing the joint assessment. \nThe data collected are represented in the MK domain. Each joint location is specified in MKLOC with laterality (\"RIGHT\" or \"LEFT\") in MKLAT. Because the \nevaluation includes a large number of joints that would result in many records, only a subset of the data collected is shown below. \nRows 1-8, 11-12, 15-16: Show the occurrence of tenderness or swelling (MKORRES/MKSTRESC=\"Y\", \"N\") at specific joint locations, represented in \nMKLOC, on the right and left sides (MKLAT) of the body. \nRows 9-10: \nShow that the assessments for tenderness and swelling of the acromioclavicular joint (see MKLOC) on the right side of the body was \nnot performed (MKSTAT=\"NOT DONE\"), but a specific reason was not collected on the CRF. \nRows 13-14: \nShow that the assessments for tenderness and swelling of the shoulder joint (see MKLOC) on the right side of the body was not \nperformed (MKSTAT=\"NOT DONE\") because it was not evaluable (MKREASND=\"JOINT NOT EVALUABLE\").", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2994, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4d138c82-1ee1-49fd-a5fc-9630e2e913d6": {"__data__": {"id_": "4d138c82-1ee1-49fd-a5fc-9630e2e913d6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 293, "section": "2.5 2.5"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d643ac5d-35fa-4dc3-8379-8057711c0d76", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 293, "section": "2.5 2.5"}, "hash": "7f1ff58fd0827c58e5c225afd7e7ccffa0c614780f05a818f4672ca314871b81", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "INTERPHALANGEAL JOINT 1 \nLEFT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n3 \nXYZ \nMK \nXYZ-002 \n3 \nSGJSNSCR \nSharp/Genant \nJSN Score \n \n \n \nNOT \nDONE \nAMPUTATION/MISSING \nANATOMY/JOINT REPLACEMENT/ \nSURGICAL ALTERATION \nPROXIMAL \nINTERPHALANGEAL JOINT 2 \nOF THE HAND \nRIGHT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n4 \nXYZ \nMK \nXYZ-002 \n4 \nSGJSNSCR \nSharp/Genant \nJSN Score \nSEVERE; PARTIAL OR \nEQUIVOCAL ANKYLOSIS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 461, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "303e9f88-cc85-4163-b631-061c39aec275": {"__data__": {"id_": "303e9f88-cc85-4163-b631-061c39aec275", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 293, "section": "3.5 3.5"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7df68562-d35c-4110-bf60-f512b3b0788f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 293, "section": "3.5 3.5"}, "hash": "0f6ad614a7ee8e16f595f256ee7440f80757c35ad65e9ff66e72525ff8d8ebe1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PROXIMAL \nINTERPHALANGEAL JOINT 2 \nOF THE HAND \nLEFT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n5 \nXYZ \nMK \nXYZ-002 \n5 \nSGJSNSCR \nSharp/Genant \nJSN Score \nMODERATE; 51\u201375% \nLOSS OF JOINT SPACE \n2 \n2 \n \n \nPROXIMAL \nINTERPHALANGEAL JOINT 3 \nOF THE HAND \nRIGHT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n6 \nXYZ \nMK \nXYZ-002 \n6 \nSGJSNSCR \nSharp/Genant \nJSN Score \n \n \n \nNOT \nDONE \nINADEQUATE IMAGE QUALITY \nPROXIMAL \nINTERPHALANGEAL JOINT 3 \nOF THE HAND \nLEFT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 569, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f16982fc-9f21-49d8-b2c9-eb81827bb2a5": {"__data__": {"id_": "f16982fc-9f21-49d8-b2c9-eb81827bb2a5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "3.5 3.5"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9244289-13e7-4001-9d8e-49f53f49aa67", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "3.5 3.5"}, "hash": "fafb5f463f0ca4e51837a3b65a5a30af067ee2a794e9438e531ba2bdc63560b7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "METACARPOPHALANGEAL \nJOINT 1 \nLEFT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n9 \nXYZ \nMK \nXYZ-002 \n9 \nSGJSNSCR \nSharp/Genant \nJSN Score \n \n \n \nNOT \nDONE \nINADEQUATE IMAGE QUALITY \nMETACARPOPHALANGEAL \nJOINT 2 \nRIGHT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n10 \nXYZ \nMK \nXYZ-002 \n10 \nSGJSNSCR \nSharp/Genant \nJSN Score \nMILD-MODERATE; 26\u2013\n50% LOSS OF JOINT \nSPACE", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 411, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e1839a7d-73a0-4ef8-8017-a53fdc07440f": {"__data__": {"id_": "e1839a7d-73a0-4ef8-8017-a53fdc07440f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "1.5 1.5"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5cb54a7a-39c1-4b53-aa40-a74732532525", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "1.5 1.5"}, "hash": "0476c6f003cabdcb74b546e16d9bcdae553f737bda95927e4df89b46d95d9ea9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "METACARPOPHALANGEAL \nJOINT 2 \nLEFT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n11 \nXYZ \nMK \nXYZ-002 \n11 \nSGJSNSCR \nSharp/Genant \nJSN Score \nNORMAL \n0 \n0 \n \n \nMETACARPOPHALANGEAL \nJOINT 3 \nRIGHT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n12 \nXYZ \nMK \nXYZ-002 \n12 \nSGJSNSCR \nSharp/Genant \nJSN Score \n \n \n \nNOT \nDONE \nAMPUTATION/MISSING \nANATOMY/JOINT \nREPLACEMENT/SURGICAL \nALTERATION \nMETACARPOPHALANGEAL \nJOINT 3 \nLEFT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n13 \nXYZ \nMK \nXYZ-002 \n13 \nSGJSNSCR \nSharp/Genant \nJSN Score \nSEVERE; COMPLETE \nLOSS OF JOINT SPACE, \nDISLOCATION WITH \nEROSION \n3 \n3 \n \n \nMETACARPOPHALANGEAL \nJOINT 4 \nRIGHT \nX-RAY \nINDEPENDENT \nASSESSOR \nREADER 1 \n4 \nWEEK \n12 \n2013-\n08-12 \n14 \nXYZ \nMK \nXYZ-002 \n14 \nSGJSNSCR \nSharp/Genant \nJSN Score \nSEVERE; PARTIAL OR \nEQUIVOCAL ANKYLOSIS", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 874, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0394dbe8-35f8-4f1d-af79-06efd16cf817": {"__data__": {"id_": "0394dbe8-35f8-4f1d-af79-06efd16cf817", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "6.3.7.4 Nervous System Findings (NV)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ed8e5b08-2cc9-4e9c-a2f4-f017c3fe58a0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 294, "section": "6.3.7.4 Nervous System Findings (NV)"}, "hash": "0e13285e651eb9d869cf6f7582013c6aae602ef8ecd66c49617491037617d8d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "NV \u2013 Description/Overview \nA findings domain that contains physiological and morphological findings related to the nervous system, including the brain, spinal cord, the cranial and spinal nerves, autonomic ganglia and plexuses. \nNV \u2013 Specification \nnv.xpt, Nervous System Findings \u2014 Findings. One record per finding per location per time point per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar NV \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the product. \nReq \nFOCID \nFocus of Study-Specific \nInterest \nChar  \nIdentifier \nIdentification of a focus of study-specific interest on or within a subject or specimen as called out in the protocol for which a measurement, test, or examination \nwas performed, such as a drug application site (e.g., \"Injection site 1\", \"Biopsy site 1\", \"Treated site 1\") or a more specific focus (e.g., \"OD\" (right eye), \"Upper \nleft quadrant of the back\"). The value in this variable should have inherent semantic meaning. \nPerm \nNVSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid number. \nReq \nNVGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nNVREFID \nReference ID \nChar  \nIdentifier \nInternal or external procedure identifier. \nPerm \nNVSPID \nSponsor-Defined Identifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined in the sponsor's operational database. Example: Line \nnumber from the Procedure or Test page. \nPerm \nNVLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link a procedure to the assessment results over the course of the study. \nPerm \nNVLNKGRP \nLink Group \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nNVTESTCD \nShort Name of Nervous \nSystem Test \nChar (NVTESTCD) \nTopic \nShort name of the measurement, test, or examination described in NVTEST. It can be used as a column name when converting a dataset from a vertical to a \nhorizontal format. The value in NVTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). NVTESTCD cannot \ncontain characters other than letters, numbers, or underscores. Examples: \"SUVR\", \"N75LAT\", \"P100LAT\",\"N145LAT\". \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2761, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5870bf2a-6b64-4dd1-ab71-bb9308cfa90b": {"__data__": {"id_": "5870bf2a-6b64-4dd1-ab71-bb9308cfa90b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "421693c2-4526-4469-9ce0-1bd0d1176943", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}, "hash": "90d6467e743e9d965c328d51141cfc667662464deea2d48155ebcb185cd73aee", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "75558ccd-1573-41d2-98bf-ae637fa314f2", "node_type": "1", "metadata": {}, "hash": "a904f0069385760ad41847903614246163a2dc99dca4e76993d0d41eef0a4059", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 295 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nNVTEST \nName of Nervous System \nTest \nChar (NVTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in NVTEST cannot be longer than 40 characters. Examples: \n\"Standard Uptake Value Ratio\", \"N75 Latency\", \"P100 Latency\", \"N145 Latency\". \nReq \nNVCAT \nCategory for Nervous \nSystem Test \nChar  \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Example: \"VISUAL EVOKED POTENTIAL\". \nPerm \nNVSCAT \nSubcategory for Nervous \nSystem Test \nChar  \nGrouping \nQualifier \nUsed to define a further categorization of NVCAT values. \nPerm \nNVORRES \nResult or Finding in Original \nUnits \nChar  \nResult \nQualifier \nResult of the procedure measurement or finding as originally received or collected. \nExp \nNVORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for NVORRES. \nPerm \nNVSTRESC \nCharacter Result/Finding in \nStd Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from NVORRES, in a standard format or standard units. NVSTRESC should store all results or \nfindings in character format; if results are numeric, they should also be stored in numeric format in NVSTRESN. \nExp \nNVSTRESN \nNumeric Result/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from NVSTRESC. NVSTRESN should store all numeric test \nresults or findings. \nPerm \nNVSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for NVSTRESC or NVSTRESN. \nPerm \nNVSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate a test was not done, or a measurement was not taken. Should be null if a result exists in NVORRES. \nPerm \nNVREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a measurement or test was not performed. Examples: \"BROKEN EQUIPMENT\", \"SUBJECT REFUSED\". Used in conjunction with NVSTAT \nwhen value is \"NOT DONE\". \nPerm \nNVLOC \nLocation Used for the \nMeasurement \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. Examples: \"BRAIN\", \"EYE\", \"PRECUNEUS\", \"CINGULATE CORTEX\". \nPerm \nNVLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \"BILATERAL\". \nPerm \nNVDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \"LOWER\", \"PROXIMAL\". \nPerm \nNVMETHOD \nMethod of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3028, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "75558ccd-1573-41d2-98bf-ae637fa314f2": {"__data__": {"id_": "75558ccd-1573-41d2-98bf-ae637fa314f2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "421693c2-4526-4469-9ce0-1bd0d1176943", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}, "hash": "90d6467e743e9d965c328d51141cfc667662464deea2d48155ebcb185cd73aee", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5870bf2a-6b64-4dd1-ab71-bb9308cfa90b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}, "hash": "7b2bf88fc111dfd28b278a9462f155b8ee1bcea79db22140f481f3cb52a00cd2", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "84ddd6ae-4053-4ccf-b3d9-2d0e12c15f04", "node_type": "1", "metadata": {}, "hash": "81fd6778383c61a96e4fad9a8592f82d1d50624c94475e77e8daa1712958e57c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Used in conjunction with NVSTAT \nwhen value is \"NOT DONE\". \nPerm \nNVLOC \nLocation Used for the \nMeasurement \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. Examples: \"BRAIN\", \"EYE\", \"PRECUNEUS\", \"CINGULATE CORTEX\". \nPerm \nNVLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \"BILATERAL\". \nPerm \nNVDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \"LOWER\", \"PROXIMAL\". \nPerm \nNVMETHOD \nMethod of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"EEG\", \"PET/CT SCAN \", \"FDGPET\". \nPerm \nNVLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The value should be \"Y\" or null. \nPerm \nNVBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that NVBLFL is retained for backward compatibility. The authoritative baseline flag for \nstatistical analysis is in an ADaM dataset. \nPerm \nNVDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a computed baseline). Should be \"Y\" or null. \nPerm \nNVEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned by a person or a group). Examples: \"ADJUDICATION \nCOMMITTEE\", \"INDEPENDENT ASSESSOR\", \"RADIOLOGIST\". \nPerm \nNVEVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in NVEVAL. Examples: \"RADIOLOGIST 1\", \"RADIOLOGIST 2\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day of Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of Element \nwithin Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the assessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nNVDTC \nDate/Time of Collection \nChar ISO 8601 datetime or \ninterval \nTiming \nDate of procedure or test. \nExp \nNVDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nStudy day of the procedure or test, measured as integer days. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in \nDemographics.", "mimetype": "text/plain", "start_char_idx": 2269, "end_char_idx": 5244, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "84ddd6ae-4053-4ccf-b3d9-2d0e12c15f04": {"__data__": {"id_": "84ddd6ae-4053-4ccf-b3d9-2d0e12c15f04", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "421693c2-4526-4469-9ce0-1bd0d1176943", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}, "hash": "90d6467e743e9d965c328d51141cfc667662464deea2d48155ebcb185cd73aee", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75558ccd-1573-41d2-98bf-ae637fa314f2", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 295, "section": "UNSPECIFIED"}, "hash": "42552cd97571a7100a3fa0a30a159855d883ff91f808c658a3894deda5d18ae0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nVISITDY \nPlanned Study Day of Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of Element \nwithin Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the assessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nNVDTC \nDate/Time of Collection \nChar ISO 8601 datetime or \ninterval \nTiming \nDate of procedure or test. \nExp \nNVDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nStudy day of the procedure or test, measured as integer days. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in \nDemographics. \nPerm \nNVTPT \nPlanned Time Point Name \nChar  \nTiming \nText description of time when measurement should be taken. This may be represented as an elapsed time relative to a fixed reference point (e.g., \"TIME OF \nLAST DOSE\"). See NVTPTNUM and NVTPTREF. Examples: \"START\", \"5 MIN POST\". \nPerm", "mimetype": "text/plain", "start_char_idx": 4486, "end_char_idx": 5532, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b6862bf2-ef1a-4a0e-8d06-ac4a856b99c0": {"__data__": {"id_": "b6862bf2-ef1a-4a0e-8d06-ac4a856b99c0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 297, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3405c67c-ee88-4fa7-849b-45f62ca0315a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 297, "section": "UNSPECIFIED"}, "hash": "9338fa1c0b8fb0b1ec66c9af59421c09b89938ac64541160453730cbd90b32d5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "35847642-fa18-4abe-af7f-7478c1f24251", "node_type": "1", "metadata": {}, "hash": "5045e955ee21286466c19afb0bb5b1bfa7205b30a955175e367714f5d2bb2b8c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 297 \n2021-11-29 \nsuppnv.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \n1 \nABC123 \nNV \nAD01-101 \nNVSEQ \n1 \nREFREG \nReference Region \nCEREBELLUM \n2 \nABC123 \nNV \nAD01-101 \nNVSEQ \n2 \nREFREG \nReference Region \nCEREBELLUM \n3 \nABC123 \nNV \nAD01-102 \nNVSEQ \n1 \nREFREG \nReference Region \nCEREBELLUM \n4 \nABC123 \nNV \nAD01-102 \nNVSEQ \n2 \nREFREG \nReference Region \nCEREBELLUM \n5 \nABC123 \nNV \nAD01-103 \nNVSEQ \n1 \nREFREG \nReference Region \nPONS \n6 \nABC123 \nNV \nAD01-103 \nNVSEQ \n2 \nREFREG \nReference Region \nPONS \nThe RELREC table displays the dataset relationship that links procedure to multiple NV domain records\u2014specifically how an individual AG administration record related to a scan is linked to multiple NV domain \nrecords. The RELREC table uses --LNKID to relate the PR and AG domains to each other and to NV, and --REFID to relate NV and Device in Use (DU). \nIn this example, the sponsor has maintained 2 sets of reference identifiers (REFID values) for the specific purpose of being able to relate records across multiple domains. Because the SDTMIG-MD advocates the use \nof --REFID to link a group of settings to the results obtained from the reading or interpretation of the test (see SDTMIG-MD, Device-in-Use (DU) domain assumptions), --LNKID has been used to establish the \nrelationships between the procedure, the substance administered during the procedure, and the results obtained from the procedure. --LNKID is unique for each procedure for each subject, so datasets may be related \nto each other as a whole. \nRows 1-2: \nShow the relationship between the scan, represented in PR, and the radiolabel tracer used, represented in AG. There is only 1 tracer administration for each scan, and only 1 scan for each tracer \nadministration, so the relationship is one-to-one. \nRows 3-4: \nShow the relationship between the scan, represented in PR, and the SUVR results obtained from the scan, represented in NV. Each scan yields 2 results, so the relationship is one-to-many. \nRows 5-6: \nShow the relationship between the radiolabel tracer used and the SUVR results for each scan. This relationship may seem indirect, but it is not: The choice of radiolabel has the potential to affect the \nresults obtained. Because the relationship between PR and AG is one-to-one and the relationship between PR and NV is one-to-many, the relationship between AG and NV must be one-to-many. \nRows 7-8: \nShow the relationship between the SUVR results and the specific settings for the device used for each scan. There is more than 1 result from each scan, and more than 1 setting for each scan, so the \nrelationship is many-to-many. This relationship is unusual and challenging to manage in a join/merge, and only represents the concept of this relationship.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2943, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "35847642-fa18-4abe-af7f-7478c1f24251": {"__data__": {"id_": "35847642-fa18-4abe-af7f-7478c1f24251", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 297, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3405c67c-ee88-4fa7-849b-45f62ca0315a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 297, "section": "UNSPECIFIED"}, "hash": "9338fa1c0b8fb0b1ec66c9af59421c09b89938ac64541160453730cbd90b32d5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b6862bf2-ef1a-4a0e-8d06-ac4a856b99c0", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 297, "section": "UNSPECIFIED"}, "hash": "456b62222dddff81cec8063e49a8dfc7828748dd7e4fae6a81116f24f2c9e2ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Each scan yields 2 results, so the relationship is one-to-many. \nRows 5-6: \nShow the relationship between the radiolabel tracer used and the SUVR results for each scan. This relationship may seem indirect, but it is not: The choice of radiolabel has the potential to affect the \nresults obtained. Because the relationship between PR and AG is one-to-one and the relationship between PR and NV is one-to-many, the relationship between AG and NV must be one-to-many. \nRows 7-8: \nShow the relationship between the SUVR results and the specific settings for the device used for each scan. There is more than 1 result from each scan, and more than 1 setting for each scan, so the \nrelationship is many-to-many. This relationship is unusual and challenging to manage in a join/merge, and only represents the concept of this relationship. \nrelrec.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nRELTYPE \nRELID \n1 \nABC123 \nPR \n \nPRLNKID \n \nONE \n6 \n2 \nABC123 \nAG \n \nAGLNKID \n \nONE \n6 \n3 \nABC123 \nPR \n \nPRLNKID \n \nONE \n7 \n4 \nABC123 \nNV \n \nNVLNKID \n \nMANY \n7 \n5 \nABC123 \nAG \n \nAGLNKID \n \nONE \n8 \n6 \nABC123 \nNV \n \nNVLNKID \n \nMANY \n8 \n7 \nABC123 \nNV \n \nNVLNKID \n \nMANY \n9 \n8 \nABC123 \nDU \n \nDULNKID \n \nMANY \n9 \nExample 2 \nThis example shows how to represent components of a pattern-reversal visual evoked-potential (VEP) test elicited by checkerboard stimuli for a subject with optic neuritis. VEPs are detected via an EEG using leads \nthat are placed on the back of the subject\u2019s head. It is important to note that the nature of VEP testing is such that NVMETHOD should be equal to \"EEG\", and that NVCAT should be equal to \"VISUAL EVOKED \nPOTENTIAL\". Several latencies from each eye\u2014including N75, P100, and N145, as well as the P100 peak-to-peak amplitude (75-100)\u2014are collected and should be represented in NVTESTCD/NVTEST. Details \nabout the VEP equipment including the checkerboard size should be represented in the appropriate device domains. To interpret, each VEP component is compared against normative values established by the \nlaboratory using healthy controls. \nIn this example, a VEP component is considered abnormal if it falls outside of 3 standard deviations from the normative lab mean. These low and high values are stored in NVORNRLO and NVORNRHI, \nrespectively, and the interpretation of each VEP component is represented in NVNRIND. In addition to interpreting each VEP component as normal or abnormal, the overall test for each eye may have an", "mimetype": "text/plain", "start_char_idx": 2112, "end_char_idx": 4569, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "25c58ab6-cc63-4595-ae07-50555e419a35": {"__data__": {"id_": "25c58ab6-cc63-4595-ae07-50555e419a35", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 298, "section": "4.78 12.7"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8401c088-705b-4463-a213-997ac3b63c28", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 298, "section": "4.78 12.7"}, "hash": "77af2bf009dd95052e1301c427642928cf7361cc2cabe508b1ae88f1d2a3c2b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ABNORMAL EYE \nLEFT \nEEG \n1 \n2013-02-\n08 \n10 \nMS123 \nNV \nMS01-01 \n123 \nOS \n10 \n2 \nINTP \nInterpretation \nVISUAL EVOKED \nPOTENTIAL \nABNORMAL  \nABNORMAL  \n \n \n \n \nEYE \nLEFT \nEEG \n1 \n2013-02-\n08 \nInformation about the VEP device is not shown. Identifying information would be represented using the DI domain, and any properties of the device that may change between assessments would be represented in the \nDO and DU domains. See the SDTMIG-MD for examples of these domains.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 469, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c37f575b-2241-4815-9fc3-c1ec0c5acfb4": {"__data__": {"id_": "c37f575b-2241-4815-9fc3-c1ec0c5acfb4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 299, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ee3931b9-632a-4556-bd68-a29e3ae2e9e2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 299, "section": "UNSPECIFIED"}, "hash": "139a885c32ae7ec70522cee43535090c7e35f068c2d4d916592b5bbc09d5d825", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "90bde5d9-3dd5-43f3-83c7-e71069131683", "node_type": "1", "metadata": {}, "hash": "42cba24a966afb0df8512af6c828962c383415b2f8bbcd3cd5f176379230c77d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 299 \n2021-11-29 \nOE \u2013 Specification \noe.xpt, Ophthalmic Examinations \u2014 Findings. One record per ophthalmic finding per method per location, per time point per visit per \nsubject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar OE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nFOCID \nFocus of Study-Specific \nInterest \nChar (OEFOCUS) \nIdentifier \nIdentification of a focus of study-specific interest on or within a subject or specimen as called out in the \nprotocol for which a measurement, test, or examination was performed. \nPerm \nOESEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nOEGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nPerm \nOELNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nOELNKGRP \nLink Group \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nOETESTCD \nShort Name of \nOphthalmic Test or \nExam \nChar (OETESTCD) \nTopic \nShort character value for OETEST used as a column name when converting a dataset from a vertical \nformat to a horizontal format. It can be used as a column name when converting a dataset from a \nvertical to a horizontal format. The value in OETESTCD cannot be longer than 8 characters, nor can it \nstart with a number (e.g., \"1TEST\" is not valid). OETESTCD cannot contain characters other than \nletters, numbers, or underscores. Example: \"NUMLCOR\". \nReq \nOETEST \nName of Ophthalmic \nTest or Exam \nChar (OETEST) \nSynonym \nQualifier \nLong name for the test or examination used to obtain the measurement or finding. The value in \nOETEST cannot be longer than 40 characters. Example: \"Number of Letters Correct\" for OETESTCD \n= \"NUMLCOR\". \nReq \nOETSTDTL \nOphthalmic Test or \nExam Detail \nChar * \nVariable \nQualifier \nFurther description of OETESTCD and OETEST. \nPerm \nOECAT \nCategory for Ophthalmic \nTest or Exam \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Examples: \"VISUAL ACUITY\", \"CONTRAST \nSENSITIVITY\", \"OCULAR COMFORT\". \nPerm \nOESCAT \nSubcategory for \nOphthalmic Test or \nExam \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of OECAT values.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2993, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "90bde5d9-3dd5-43f3-83c7-e71069131683": {"__data__": {"id_": "90bde5d9-3dd5-43f3-83c7-e71069131683", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 299, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ee3931b9-632a-4556-bd68-a29e3ae2e9e2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 299, "section": "UNSPECIFIED"}, "hash": "139a885c32ae7ec70522cee43535090c7e35f068c2d4d916592b5bbc09d5d825", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c37f575b-2241-4815-9fc3-c1ec0c5acfb4", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 299, "section": "UNSPECIFIED"}, "hash": "b5b8a5673f2cc1209ca2622c8dfb1ebed45fe931e9988a4880e1116a4b4f8756", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The value in \nOETEST cannot be longer than 40 characters. Example: \"Number of Letters Correct\" for OETESTCD \n= \"NUMLCOR\". \nReq \nOETSTDTL \nOphthalmic Test or \nExam Detail \nChar * \nVariable \nQualifier \nFurther description of OETESTCD and OETEST. \nPerm \nOECAT \nCategory for Ophthalmic \nTest or Exam \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Examples: \"VISUAL ACUITY\", \"CONTRAST \nSENSITIVITY\", \"OCULAR COMFORT\". \nPerm \nOESCAT \nSubcategory for \nOphthalmic Test or \nExam \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of OECAT values. Example: \"HIGH CONTRAST\" or \"LOW \nCONTRAST\" when OECAT is \"VISUAL ACUITY\". \nPerm \nOEORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. Examples: \"120\", \"<1, \nNORMAL\", \"RED SPOT VISIBLE\". \nExp \nOEORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal unit for OEORRES. Examples: \"mm\", \"um\". \nExp \nOEORNRLO Normal Range Lower \nLimit-Original Units \nChar  \nVariable \nQualifier \nLower end of normal range or reference range for results stored in OEORRES. \nPerm \nOEORNRHI \nNormal Range Upper \nLimit-Original Units \nChar  \nVariable \nQualifier \nUpper end of normal range or reference range for results stored in OEORRES. \nPerm \nOESTRESC \nCharacter Result/Finding \nin Std Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from OEORRES, in a standard format or in \nstandard units. OESTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in OESTRESN. \nExp \nOESTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nOESTRESC. OESTRESN should store all numeric test results or findings. \nExp \nOESTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for OESTRESC and OESTRESN. Examples: \"mm\", \"um\". \nExp \nOESTNRLO \nNormal Range Lower \nLimit-Standard Units \nNum  \nVariable \nQualifier \nLower end of normal range or reference range for standardized results (e.g., OESTRESC, \nOESTRESN) represented in standardized units (OESTRESU). \nPerm", "mimetype": "text/plain", "start_char_idx": 2402, "end_char_idx": 4695, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0c5f4a06-cef0-4111-9885-72a470fb2d79": {"__data__": {"id_": "0c5f4a06-cef0-4111-9885-72a470fb2d79", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 300, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "216d3c89-5566-411e-8eb9-a8273ea2d283", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 300, "section": "UNSPECIFIED"}, "hash": "ac13f6eaaea19e58301021252a291242abf6d8a6d6bcde73c1507865c0a0b790", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ac191482-0594-4173-9109-c66c8a9bf415", "node_type": "1", "metadata": {}, "hash": "c51d255b180dec96542f903c700bfa7a7d80b509ce647b8de92bdbdb19b97ec6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 300 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nOESTNRHI \nNormal Range Upper \nLimit-Standard Units \nNum  \nVariable \nQualifier \nUpper end of normal range or reference range for standardized results (e.g., OESTRESC, \nOESTRESN) represented in standardized units (OESTRESU). \nPerm \nOESTNRC \nNormal Range for \nCharacter Results \nChar  \nVariable \nQualifier \nNormal range or reference range for results stored in OESTRESC that are character in ordinal or \ncategorical scale. Example: \"Negative to Trace\". \nPerm \nOENRIND \nNormal/Reference \nRange Indicator \nChar (NRIND) \nVariable \nQualifier \nUsed to indicate the value is outside the normal range or reference range. May be defined by \nOEORNRLO and OEORNRHI or other objective criteria. Examples: \"Y\", \"N\"; \"HIGH\", \"LOW\"; \n\"NORMAL\", \"ABNORMAL\". \nPerm \nOERESCAT \nResult Category \nChar  \nVariable \nQualifier \nUsed to categorize the result of a finding or medical status per interpretation of test results. Examples: \n\"POSITIVE\", \"NEGATIVE\". The variable OERESCAT is not meant to replace the use of OENRIND for \ncases where normal ranges are provided. \nPerm \nOESTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or a test was attempted but did \nnot generate a result. Should be null or have a value of \"NOT DONE\". \nPerm \nOEREASND \nReason Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with OESTAT when value is \"NOT DONE\". \nPerm \nOEXFN \nExternal File Path \nChar  \nRecord \nQualifier \nFilename for an external file, such as one for a retinal OCT image. \nPerm \nOELOC \nLocation Used for the \nMeasurement \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. Examples: \"EYE\" for \na finding record relative to the complete eye, \"RETINA\" for a measurement or assessment of only the \nretina. \nExp \nOELAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\". \nExp \nOEDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nOEPORTOT \nPortion or Totality \nChar (PORTOT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing the distribution (i.e., arrangement of, \napportioning of). Examples: \"ENTIRE\", \"SINGLE\", \"SEGMENT\", \"MANY\". \nPerm \nOEMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Example: \"ETDRS EYE CHART\" for OETESTCD = \"NUMLCOR\". \nThe different methods may offer different functionality or granularity, affecting the set of results and \nassociated meaning.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3038, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ac191482-0594-4173-9109-c66c8a9bf415": {"__data__": {"id_": "ac191482-0594-4173-9109-c66c8a9bf415", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 300, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "216d3c89-5566-411e-8eb9-a8273ea2d283", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 300, "section": "UNSPECIFIED"}, "hash": "ac13f6eaaea19e58301021252a291242abf6d8a6d6bcde73c1507865c0a0b790", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "0c5f4a06-cef0-4111-9885-72a470fb2d79", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 300, "section": "UNSPECIFIED"}, "hash": "7bcdc7985fcc4e3a052ee871434633047f1e5f6b78e383d7c349a8f078eb78d3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Exp \nOEDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nOEPORTOT \nPortion or Totality \nChar (PORTOT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing the distribution (i.e., arrangement of, \napportioning of). Examples: \"ENTIRE\", \"SINGLE\", \"SEGMENT\", \"MANY\". \nPerm \nOEMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Example: \"ETDRS EYE CHART\" for OETESTCD = \"NUMLCOR\". \nThe different methods may offer different functionality or granularity, affecting the set of results and \nassociated meaning. \nExp \nOELOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nExp \nOEBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that OEBLFL is retained for \nbackward compatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nOEDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nOEEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"INDEPENDENT ASSESSOR\", \"INVESTIGATOR\". \nPerm \nOEEVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in OEEVAL. Examples: \n\"RADIOLOGIST1\", \"RADIOLOGIST2\". \nPerm \nOEACPTFL \nAccepted Record Flag \nChar (NY) \nRecord \nQualifier \nIn cases where more than one assessor provides an evaluation of a result or response, this flag \nidentifies the record that is considered, by an independent assessor, to be the accepted evaluation. \nExpected to be \"Y\" or null. \nPerm \nOEREPNUM Repetition Number \nNum  \nRecord \nQualifier \nThe incidence number of a test that is repeated within a given timeframe for the same test. The level of \ngranularity can vary (e.g., within a time point, within a visit). Examples: multiple measurements of blood \npressure, multiple analyses of a sample. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm", "mimetype": "text/plain", "start_char_idx": 2311, "end_char_idx": 5113, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a858f1e9-fea2-40d3-a952-00d9b641652f": {"__data__": {"id_": "a858f1e9-fea2-40d3-a952-00d9b641652f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 301, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "602a71b8-6c70-474f-8805-eb620c229423", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 301, "section": "UNSPECIFIED"}, "hash": "d3524733aeea9ab4a2fd62f9830b5e1b97b6701bf614e6f5c39e43d9678f19e5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "64504566-f6a0-4519-a9d3-b96adaec0cb9", "node_type": "1", "metadata": {}, "hash": "5f86c011ea0a996ad1248a6f88beff08aba96dfb266f0d3bcc15eab9fe2f53ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 301 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nOEDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date/time of the observation. \nExp \nOEDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of observation/exam expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nExp \nOETPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point. \nPerm \nOETPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nOEELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration Timing \nPlanned elapsed time relative to a planned fixed reference (OETPTREF; e.g., \"PREVIOUS DOSE\", \n\"PREVIOUS MEAL\"). This variable is useful where there are repetitive measures. Not a clock time or a \ndate/time variable, but an interval, represented as ISO duration. \nPerm \nOETPTREF \nTime Point Reference \nChar  \nTiming \nDescription of the fixed reference point referred to by OETPT, OETPTNUM, and OEELTM. \nPerm \nOERFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of the reference time point, OETPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nOE \u2013 Assumptions \n1. In ophthalmic studies, the eyes are usually sites of treatment. It is appropriate to identify sites using the variable FOCID. When FOCID is used to \nidentify the eyes, it is recommended that the values \"OD\" (oculus dexter, right eye), \"OS\" (oculus sinister, left eye), and \"OU\" (oculus uterque, both \neyes) be used in FOCID. These terms are the exclusively preferred terms used by the ophthalmology community as abbreviations for the expanded Latin \nterms, and are included in the nonextensible CDISC Ophthalmic Focus of Study Specific Interest (OEFOCUS) codelist. \n2. In any study that uses FOCID, FOCID would be included in records in any subject-level domain representing findings, interventions, or events (e.g., \nAdverse Events) related to the eyes. Whether or not FOCID is used in a study, --LOC and --LAT should be populated in records related to the eyes. The \nvalue in OELOC may be \"EYE\" but may also be a part of the eye (e.g., \"RETINA\", \"CORNEA\"). \n3.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3040, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "64504566-f6a0-4519-a9d3-b96adaec0cb9": {"__data__": {"id_": "64504566-f6a0-4519-a9d3-b96adaec0cb9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 301, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "602a71b8-6c70-474f-8805-eb620c229423", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 301, "section": "UNSPECIFIED"}, "hash": "d3524733aeea9ab4a2fd62f9830b5e1b97b6701bf614e6f5c39e43d9678f19e5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a858f1e9-fea2-40d3-a952-00d9b641652f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 301, "section": "UNSPECIFIED"}, "hash": "e2045ae79d3080e69579c7462c1933eda1041ad953a2d458a7516ad10a8639c4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These terms are the exclusively preferred terms used by the ophthalmology community as abbreviations for the expanded Latin \nterms, and are included in the nonextensible CDISC Ophthalmic Focus of Study Specific Interest (OEFOCUS) codelist. \n2. In any study that uses FOCID, FOCID would be included in records in any subject-level domain representing findings, interventions, or events (e.g., \nAdverse Events) related to the eyes. Whether or not FOCID is used in a study, --LOC and --LAT should be populated in records related to the eyes. The \nvalue in OELOC may be \"EYE\" but may also be a part of the eye (e.g., \"RETINA\", \"CORNEA\"). \n3. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the OE domain, but the following qualifiers would \nnot generally be used: --MODIFY, --NSPCES, --POS, --BODSYS, --ORREF, --STREFC, --STREFN, --CHRON, --DISTR, --ANTREG, --LEAD, --\nFAST, --TOX, --TOXGR, --LLOQ, --ULOQ. \nOE \u2013 Examples \nExample 1 \nThis example shows a general anterior segment examination performed on each eye at 1 visit, with the purpose of evaluating general abnormalities. \nRows 1-2: \nRepresent an overall interpretation (i.e., normal/abnormal) finding from the anterior segment examination, using OETESTCD=\"INTP\". OELOC \nindicates that the assessor examined the lens and OELAT indicates which lens was examined. \nRow 3: \nRepresents an abnormality observed during the anterior segment examination of the right eye. OEDIR=\"MULTIPLE\" and indicates multiple \ndirectionality values are applicable. OELOC, OELAT, and the multiple OEDIR values specify the location of the abnormality represented in \nOEORRES and OESTRESC. This observed abnormality (i.e., red spot visible) was determined to be clinically significant (OECLSIG=\"Y\").", "mimetype": "text/plain", "start_char_idx": 2403, "end_char_idx": 4183, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e0361bc8-4e92-4f33-b0c3-c3bd1043c979": {"__data__": {"id_": "e0361bc8-4e92-4f33-b0c3-c3bd1043c979", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aeeb624e-c3f3-46be-b9a3-10f9fafdaf83", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}, "hash": "6b68462f95588f30046362ab7717143fb15bbb54a5d9bd3d311dd09ff38261e3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f7fe8066-d1f9-49cc-a9ce-0cbc69033f50", "node_type": "1", "metadata": {}, "hash": "e80e585be81f90051a8d40e95d45566fe6115b6a981bd4f72067d54965749d5f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 303 \n2021-11-29 \nsuppoe.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \n1 \nXXX \nOE \nXXX- 450-120 \nOESEQ \n7 \nOEEDILST \nEye Dilation Status \nDILATED \n2 \nXXX \nOE \nXXX- 450-120 \nOESEQ \n8 \nOEEDILST \nEye Dilation Status \nDILATED \nExample 3 \nThis example shows: \n\u2022 \nPartial results of the macula examination performed by the site investigator, as well as results provided by an independent assessor, for 1 visit \n\u2022 \nThe use of the NSV EVLDTC \n\u2022 \nThe use of the Procedures (PR) domain to represent the optical coherence tomography (OCT) procedure details, with specific device characteristics in the DI domain \n\u2022 \nThe relationship between the OE and PR domains in the RELREC dataset \nRows 1-2: \nRepresent the assessments performed by the investigator. OECLSIG represents the investigator's assessment of clinical significance. OEDTC represents the ophthalmoscopy exam date. \nRows 3-6: \nRepresent the assessments performed by an independent assessor. OEDTC represents the OCT image date.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1183, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f7fe8066-d1f9-49cc-a9ce-0cbc69033f50": {"__data__": {"id_": "f7fe8066-d1f9-49cc-a9ce-0cbc69033f50", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aeeb624e-c3f3-46be-b9a3-10f9fafdaf83", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}, "hash": "6b68462f95588f30046362ab7717143fb15bbb54a5d9bd3d311dd09ff38261e3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e0361bc8-4e92-4f33-b0c3-c3bd1043c979", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}, "hash": "866303ca5fa6953b32800431d83a16d3ac1d83f987017713dc91dacd84d349e5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c101b0d9-6ce8-4760-a84a-ebef44df93bd", "node_type": "1", "metadata": {}, "hash": "cd4aace3a450ae555b34ef6105c15cf2dadc4e848a53c06d81a8aa8ca3682c73", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "OECLSIG represents the investigator's assessment of clinical significance. OEDTC represents the ophthalmoscopy exam date. \nRows 3-6: \nRepresent the assessments performed by an independent assessor. OEDTC represents the OCT image date. \noe.xpt \nRow STUDYID DOMAIN USUBJID \nFOCID OESEQ OELNKID OETESTCD OETEST \nOEORRES OEORRESU OESTRESC OESTRESN OESTRESU OELOC \nOELAT OEMETHOD \nOEEVAL \nOECLSIG VISITNUM VISIT \nOEDTC \n1 \nXYZ \nOE \nXYZ-100-\n001 \nOS \n1 \n \nEDEMA \nEdema \nPRESENT \n \nPRESENT \n \n \nMACULA LEFT \nOPHTHALMOSCOPY \nINVESTIGATOR \nY \n1 \nSCREENING 2012-04-\n25 \n2 \nXYZ \nOE \nXYZ- 100-\n001 \nOD \n2 \n \nEDEMA \nEdema \nABSENT \n \nABSENT \n \n \nMACULA RIGHT \nOPHTHALMOSCOPY \nINVESTIGATOR \nN \n1 \nSCREENING 2012-04-\n25 \n3 \nXYZ \nOE \nXYZ- 100-\n001 \nOS \n3 \n1 \nEDEMA \nEdema \nPRESENT \n \nPRESENT \n \n \nMACULA LEFT \nOPTICAL COHERENCE \nTOMOGRAPHY \nINDEPENDENT \nASSESSOR \n \n1 \nSCREENING 2012-04-\n25 \n4 \nXYZ \nOE \nXYZ- 100-\n001 \nOD \n4 \n2 \nEDEMA \nEdema \nABSENT \n \nABSENT \n \n \nMACULA RIGHT \nOPTICAL COHERENCE \nTOMOGRAPHY \nINDEPENDENT \nASSESSOR \n \n1 \nSCREENING 2012-04-\n25 \n5 \nXYZ \nOE \nXYZ- 100-\n001 \nOS \n5 \n1 \nTHICK \nThickness 1030 \num \n1030 \n1030 \num \nMACULA LEFT \nOPTICAL COHERENCE \nTOMOGRAPHY \nINDEPENDENT \nASSESSOR \n \n1 \nSCREENING 2012-04-\n25 \n6 \nXYZ \nOE \nXYZ- 100-\n001 \nOD \n6 \n2 \nTHICK \nThickness 1005 \num \n1005 \n1005 \num \nMACULA RIGHT \nOPTICAL COHERENCE \nTOMOGRAPHY \nINDEPENDENT \nASSESSOR \n \n1 \nSCREENING 2012-04-\n25 \nThe suppoe.xpt dataset represents the date the independent assessor performed the evaluation of the OCT image. \nsuppoe.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \n1 \nXYZ \nOE \nXYZ- 100-001 \nOELNKID \n1 \nOEEVLDTC \nEvaluation Date \n2012-04-30 \n2 \nXYZ \nOE \nXYZ- 100-001 \nOELNKID \n2 \nOEEVLDTC \nEvaluation Date \n2012-04-30 \n \nRows 1-4: \nRepresent OCT procedures performed at screening and visit 1 on the right and left eyes. SPDEVID identifies the device used in performing these tests. \nRow 5: \nIndicates that an OCT procedure was not performed at visit 2. The reason the procedure was not performed was collected and is represented in PRREASOC.", "mimetype": "text/plain", "start_char_idx": 949, "end_char_idx": 3013, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c101b0d9-6ce8-4760-a84a-ebef44df93bd": {"__data__": {"id_": "c101b0d9-6ce8-4760-a84a-ebef44df93bd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aeeb624e-c3f3-46be-b9a3-10f9fafdaf83", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}, "hash": "6b68462f95588f30046362ab7717143fb15bbb54a5d9bd3d311dd09ff38261e3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f7fe8066-d1f9-49cc-a9ce-0cbc69033f50", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 303, "section": "UNSPECIFIED"}, "hash": "64edc6d3cdf92c660acaed74b5b193e09c5d734fc6ccabc232ab37f91316badf", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "suppoe.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \n1 \nXYZ \nOE \nXYZ- 100-001 \nOELNKID \n1 \nOEEVLDTC \nEvaluation Date \n2012-04-30 \n2 \nXYZ \nOE \nXYZ- 100-001 \nOELNKID \n2 \nOEEVLDTC \nEvaluation Date \n2012-04-30 \n \nRows 1-4: \nRepresent OCT procedures performed at screening and visit 1 on the right and left eyes. SPDEVID identifies the device used in performing these tests. \nRow 5: \nIndicates that an OCT procedure was not performed at visit 2. The reason the procedure was not performed was collected and is represented in PRREASOC. \npr.xpt \nRow STUDYID \nDOMAIN \nUSUBJID \nFOCID SPDEVID \nPRSEQ \nPRLNKID \nPRTRT PRPRESP \nPROCCUR \nPRREASOC \nPRLOC PRLAT PRSTDTC \nVISITNUM \nVISIT \n1 \nXYZ \nPR \nXYZ- 100-001 \nOS \n100 \n1 \n1 \nOCT \nY \nY \n \nEYE \nLEFT \n2012-04-25T09:30:00 \n1 \nSCREENING \n2 \nXYZ \nPR \nXYZ- 100-001 \nOD \n100 \n2 \n2 \nOCT \nY \nY \n \nEYE \nRIGHT \n2012-04-25T10:10:00 \n1 \nSCREENING \n3 \nXYZ \nPR \nXYZ- 100-001 \nOS \n100 \n3 \n3 \nOCT \nY \nY \n \nEYE \nLEFT \n2012-05-25T08:00:00 \n2 \nVISIT 1 \n4 \nXYZ \nPR \nXYZ- 100-001 \nOD \n100 \n4 \n4 \nOCT \nY \nY \n \nEYE \nRIGHT \n2012-05-25T08:30:00 \n2 \nVISIT 1", "mimetype": "text/plain", "start_char_idx": 2456, "end_char_idx": 3552, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "51a7accb-6c81-4040-be97-fea4f665f7d9": {"__data__": {"id_": "51a7accb-6c81-4040-be97-fea4f665f7d9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 304, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "91cf89d6-d60a-438f-a2b9-023262f98c9e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 304, "section": "UNSPECIFIED"}, "hash": "21b4bef8e9b64122c4c81ba8725cc58c5c02d8a9a32b43e7ace634da54735628", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "357cf8a8-0cc0-49e7-a17e-409c3ce68566", "node_type": "1", "metadata": {}, "hash": "44a28005f5e9622c6da7903977f351477c98a576bd6d12af68b8f9cd7cea9e9f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 304 \n2021-11-29 \nRow STUDYID \nDOMAIN \nUSUBJID \nFOCID SPDEVID \nPRSEQ \nPRLNKID \nPRTRT PRPRESP \nPROCCUR \nPRREASOC \nPRLOC PRLAT PRSTDTC \nVISITNUM \nVISIT \n5 \nXYZ \nPR \nXYZ- 100-001 \nOU \n \n5 \n \nOCT \nY \nN \nPATIENT WAS SICK FOR SEVERAL WEEKS \n \n \n \n3 \nVISIT 2 \nIdentifying information for the device with SPDEVID = \"100\" included in the PR domain is represented in the Device Identifiers (DI) domain. \ndi.xpt \nRow \nSTUDYID \nDOMAIN \nSPDEVID \nDISEQ \nDIPARMCD \nDIPARM \nDIVAL \n1 \nXYZ \nDI \n100 \n1 \nTYPE \nDevice Type \nOCT \n2 \nXYZ \nDI \n100 \n2 \nMANUF \nManufacturer \nZEISS \n3 \nXYZ \nDI \n100 \n3 \nMODEL \nModel \nCIRRUS \n4 \nXYZ \nDI \n100 \n4 \nSERIAL \nSerial Number \nyyyyyy \nThe many-to-one relationship between records in the PR and OE domains is described in RELREC. \nrelrec.xpt \nRow STUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARAL \nRELTYPE \nRELID \n1 \nXYZ \nPR \n \nPRLNKID \n \nONE \n13 \n2 \nXYZ \nOE \n \nOELNKID \n \nMANY \n13 \nExample 4 \nThis example shows: \n\u2022 \nA CRF that collects subject's comfort of a lubricant eye drop for keratoconjunctivitis sicca (dry eye) on a numeric scale (i.e., 1 to 10, with 1 meaning most comfortable and 10 meaning most uncomfortable) \n\u2022 \nThe use of the NSV OERESCRT, to describe the numeric scale \n\u2022 \nA subject who experienced an adverse event on the eye. The FOCID variable is included in the AE domain to allow the grouping of all ophthalmic observations. \nRow 1: \nRepresents the subject's assessment of ocular comfort in the right eye, upon instillation of a lubricant eye drop for dry eye. \nRow 2: \nRepresents the subject's assessment of ocular comfort in the right eye, 1 minute post-instillation of a lubricant eye drop for dry eye. \nRow 3: \nRepresents the subject's assessment of ocular comfort in the left eye, upon instillation of a lubricant eye drop for dry eye. \nRow 4: \nRepresents the subject's assessment of ocular comfort in the left eye, 1 minute post-instillation of a lubricant eye drop for dry eye.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2090, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "357cf8a8-0cc0-49e7-a17e-409c3ce68566": {"__data__": {"id_": "357cf8a8-0cc0-49e7-a17e-409c3ce68566", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 304, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "91cf89d6-d60a-438f-a2b9-023262f98c9e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 304, "section": "UNSPECIFIED"}, "hash": "21b4bef8e9b64122c4c81ba8725cc58c5c02d8a9a32b43e7ace634da54735628", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "51a7accb-6c81-4040-be97-fea4f665f7d9", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 304, "section": "UNSPECIFIED"}, "hash": "b9790272220c5d0bd377ccfd0a30b71b0e85ea6e4d7770d65475956a97bfb1ab", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The FOCID variable is included in the AE domain to allow the grouping of all ophthalmic observations. \nRow 1: \nRepresents the subject's assessment of ocular comfort in the right eye, upon instillation of a lubricant eye drop for dry eye. \nRow 2: \nRepresents the subject's assessment of ocular comfort in the right eye, 1 minute post-instillation of a lubricant eye drop for dry eye. \nRow 3: \nRepresents the subject's assessment of ocular comfort in the left eye, upon instillation of a lubricant eye drop for dry eye. \nRow 4: \nRepresents the subject's assessment of ocular comfort in the left eye, 1 minute post-instillation of a lubricant eye drop for dry eye. \noe.xpt \nRow STUDYID DOMAIN USUBJID \nFOCID OESEQ OETESTCD \nOETEST \nOECAT \nOEORRES OESTRESC OESTRESN OELOC OELAT OEMETHOD \nOEEVAL \nVISITNUM VISIT \nOEDTC \nOETPT \nOETPTNUM \n1 \nXYZ \nOE \nXYZ-100-\n0001 \nOD \n1 \nEYDCOMGR Eye Drop \nComfort \nGrade \nOCCULAR \nCOMFORT \n1 \n1 \n1 \nEYE \nRIGHT \nVISUAL \nANALOG \nSCALE \nSTUDY \nSUBJECT \n1 \nVISIT \n1 \n2011-02-\n11T09:00 \nUPON \nINSTILLATION \n1 \n2 \nXYZ \nOE \nXYZ-100-\n0001 \nOD \n2 \nEYDCOMGR Eye Drop \nComfort \nGrade \nOCCULAR \nCOMFORT \n10 \n10 \n10 \nEYE \nRIGHT \nVISUAL \nANALOG \nSCALE \nSTUDY \nSUBJECT \n1 \nVISIT \n1 \n2011-02-\n11T09:01 \n1 MINUTE POST-\nINSTILLATION \n2 \n3 \nXYZ \nOE \nXYZ-100-\n0001 \nOS \n1 \nEYDCOMGR Eye Drop \nComfort \nGrade \nOCCULAR \nCOMFORT \n1 \n1 \n1 \nEYE \nLEFT \nVISUAL \nANALOG \nSCALE \nSTUDY \nSUBJECT \n1 \nVISIT \n1 \n2011-05-\n01T09:00 \nUPON \nINSTILLATION \n1 \n4 \nXYZ \nOE \nXYZ-100-\n0001 \nOS \n2 \nEYDCOMGR Eye Drop \nComfort \nGrade \nOCCULAR \nCOMFORT \n10 \n10 \n10 \nEYE \nLEFT \nVISUAL \nANALOG \nSCALE \nSTUDY \nSUBJECT \n1 \nVISIT \n1 \n2011-05-\n01T09:01 \n1 MINUTE POST-\nINSTILLATION \n2", "mimetype": "text/plain", "start_char_idx": 1429, "end_char_idx": 3089, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9de29564-4579-435d-9a09-732af1bb9893": {"__data__": {"id_": "9de29564-4579-435d-9a09-732af1bb9893", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 305, "section": "6.3.7.6 Reproductive System Findings (RP)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "45aac0c9-d716-4bf6-af63-3fe2b4cf06a6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 305, "section": "6.3.7.6 Reproductive System Findings (RP)"}, "hash": "8e76d53521fb2f35a21b048e5d2159e9c38cf9f4f962116bd624adf04504593c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RP \u2013 Description/Overview \nA findings domain that contains physiological and morphological findings related to the male and female reproductive systems. \nRP \u2013 Specification \nrp.xpt, Reproductive System Findings \u2014 Findings. One record per finding or result per time point per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar RP \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the product. \nReq \nRPSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject (or within a parameter, in the case of the Trial Summary domain). May be any \nvalid number (including decimals) and does not have to start at 1. \nReq \nRPGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. Also used to link together a block of related records in the \nTrial Summary dataset. \nPerm \nRPREFID \nReference ID \nChar  \nIdentifier \nOptional internal or external identifier (e.g., lab specimen ID, UUID for an ECG waveform or a medical image). \nPerm \nRPSPID \nSponsor-Defined Identifier \nChar  \nIdentifier \nSponsor-defined identifier. Example: Preprinted line identifier on a CRF. \nPerm \nRPLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many relationship. \nPerm \nRPLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nRPTESTCD \nShort Name of \nReproductive Test \nChar (RPTESTCD) \nTopic \nShort character value for RPTEST used as a column name when converting a dataset from a vertical format to a horizontal format. The short value can be up to \n8 characters. Examples: \"CHILDPOT\", \"BCMETHOD\", \"MENARAGE\". \nReq \nRPTEST \nName of Reproductive Test Char (RPTEST) \nSynonym \nQualifier \nLong name For RPTESTCD. Examples: \"Childbearing Potential\", \"Birth Control Method\", \"Menarche Age\". \nReq \nRPCAT \nCategory for Reproductive \nTest \nChar  \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Example: \"No use case to date, but values would be relative to reproduction tests grouping\". \nPerm \nRPSCAT \nSubcategory for \nReproductive Test \nChar  \nGrouping \nQualifier \nUsed to define a further categorization of RPCAT values. Example: \"No use case to date, but values would be relative to reproduction tests grouping\". \nPerm \nRPORRES \nResult or Finding in Original \nUnits \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. Examples: \"120\", \"<1\", \"POS\". \nExp \nRPORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nUnit for RPORRES. Examples: \"in\", \"LB\", \"kg/L\". \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3105, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a0ec3121-e7b1-4c2d-b9d5-983f1df408b0": {"__data__": {"id_": "a0ec3121-e7b1-4c2d-b9d5-983f1df408b0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "22eeda53-78cf-40e6-9842-f83dbb45844a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}, "hash": "1b8248bfd51845819c40063ca9cef18befdce7bbd6969549c9880630a0776c00", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8356ec45-c682-4996-891d-e1b9a31b540d", "node_type": "1", "metadata": {}, "hash": "76725ee777e04b229679d8956e99af8fa229eac984de03bb95c002bbd434ae3e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 306 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nRPSTRESC \nCharacter Result/Finding in \nStd Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from RPORRES, in a standard format or in standard units. RPSTRESC should store all results or \nfindings in character format; if results are numeric, they should also be stored in numeric format in RPSTRESN. For example, if various tests have results \n\"NONE\", \"NEG\", and \"NEGATIVE\" in RPORRES, and these results effectively have the same meaning, they could be represented in standard format in \nRPSTRESC as \"NEGATIVE\". \nExp \nRPSTRESN \nNumeric Result/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from RPSTRESC. RPSTRESN should store all numeric test \nresults or findings. \nPerm \nRPSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for RPSTRESC and RPSTRESN. Example: \"mol/L\". \nPerm \nRPSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or a test was attempted but did not generate a result. Should be null or have a value of \n\"NOT DONE\". \nPerm \nRPREASND \nReason Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with RPSTAT when value is \"NOT DONE\". \nPerm \nRPLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The value should be \"Y\" or null. \nPerm \nRPBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that RPBLFL is retained for backward compatibility. The authoritative baseline for statistical \nanalysis is in an ADaM dataset. \nPerm \nRPDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Records which represent the average of other records or which do not come from the CRF are \nexamples of records that would be derived for the submission datasets. If RPDRVFL = \"Y\", then RPORRES may be null, with RPSTRESC and (if numeric) \nRPSTRESN having the derived value. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of Visit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of Element \nwithin Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the assessment was made.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2998, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8356ec45-c682-4996-891d-e1b9a31b540d": {"__data__": {"id_": "8356ec45-c682-4996-891d-e1b9a31b540d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "22eeda53-78cf-40e6-9842-f83dbb45844a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}, "hash": "1b8248bfd51845819c40063ca9cef18befdce7bbd6969549c9880630a0776c00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a0ec3121-e7b1-4c2d-b9d5-983f1df408b0", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}, "hash": "9ab3dcb4d6eb2972e85c7ee29a5d7f3f3c002e9574be9d242f9776353e8dbf50", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "06ef60cf-20c3-4ca7-a75d-06ac78da4745", "node_type": "1", "metadata": {}, "hash": "dc1d99dae34f48f295a1b0742dd302e0a1474f035833163150b2ce313d174edb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Records which represent the average of other records or which do not come from the CRF are \nexamples of records that would be derived for the submission datasets. If RPDRVFL = \"Y\", then RPORRES may be null, with RPSTRESC and (if numeric) \nRPSTRESN having the derived value. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of Visit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of Element \nwithin Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the assessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nRPDTC \nDate/Time of Collection \nChar ISO 8601 datetime or \ninterval \nTiming \nCollection date and time of an observation. \nExp \nRPDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to the sponsor-defined RFSTDTC in Demographics. \nPerm \nRPDUR \nDuration \nChar ISO 8601 duration \nTiming \nCollected duration of an event, intervention, or finding represented in ISO 8601 character format. Used only if collected on the CRF and not derived. \nPerm \nRPTPT \nPlanned Time Point Name \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the protocol. This may be represented as an elapsed time relative to \na fixed reference point, such as time of last dose. \nPerm \nRPTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nRPELTM \nPlanned Elapsed Time from \nTime Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time in ISO 8601 character format relative to a planned fixed reference (RPTPTREF; e.g., \"PREVIOUS DOSE\", \"PREVIOUS MEAL\"). This \nvariable is useful where there are repetitive measures. Not a clock time or a date/time variable, but an interval, represented as ISO duration. \nPerm \nRPTPTREF \nTime Point Reference \nChar  \nTiming \nDescription of the fixed reference point referred to by RPELTM, RPTPTNUM, and RPTPT. Examples: \"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nRPRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by RPTPTREF in ISO 8601 character format. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nRP \u2013 Assumptions \n1. Reproductive System Findings domain contains information regarding a subject\u2019s reproductive ability and reproductive history (e.g., number of previous pregnancies, number of births, pregnant during the \nstudy). \n2. Information on medications related to reproduction (e.g., contraceptives, fertility treatments) should be included in the Concomitant/Prior Medications (CM) domain; see Section 6.1.2. \n3.", "mimetype": "text/plain", "start_char_idx": 2223, "end_char_idx": 5359, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "06ef60cf-20c3-4ca7-a75d-06ac78da4745": {"__data__": {"id_": "06ef60cf-20c3-4ca7-a75d-06ac78da4745", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "22eeda53-78cf-40e6-9842-f83dbb45844a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}, "hash": "1b8248bfd51845819c40063ca9cef18befdce7bbd6969549c9880630a0776c00", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8356ec45-c682-4996-891d-e1b9a31b540d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 306, "section": "UNSPECIFIED"}, "hash": "5c114370b750cae9c359994c62ef7bea7e05ba621cdbe0ceaa241729352b29f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nRPRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by RPTPTREF in ISO 8601 character format. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nRP \u2013 Assumptions \n1. Reproductive System Findings domain contains information regarding a subject\u2019s reproductive ability and reproductive history (e.g., number of previous pregnancies, number of births, pregnant during the \nstudy). \n2. Information on medications related to reproduction (e.g., contraceptives, fertility treatments) should be included in the Concomitant/Prior Medications (CM) domain; see Section 6.1.2. \n3. There are separate codelists for RP tests, responses, and units.", "mimetype": "text/plain", "start_char_idx": 4532, "end_char_idx": 5424, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7220941e-0382-4e8c-8938-485ad7978eb3": {"__data__": {"id_": "7220941e-0382-4e8c-8938-485ad7978eb3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "63a1f3d8-06dd-47e0-8495-d78b5fdac9f6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}, "hash": "1588ee852b3a87d3b9e8abd41d0c6a2b8a717e2c977432d58fedc09536c18e72", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9f0e78b0-799b-4bc2-8790-c632a2b4ae9f", "node_type": "1", "metadata": {}, "hash": "4a39e9acea1c246265f7d52f944cf0e4f2f5f68b4cafe66d9b77f8c25f98d0e4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 307 \n2021-11-29 \na. \nAssociations between RP tests and response codelists are described in the RP Codetable, available at https://www.cdisc.org/standards/terminology/controlled-terminology. \n4. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the RP domain, but the following qualifiers would not generally be used: --MODIFY, --BODSYS, --\nLOINC, --SPCCND, --FAST, --TOX, --TOXGR, --SEV. \nRP \u2013 Examples \nExample 1 \nThis example represents reproductive system findings at the screening visit, visit 1, and visit 2 for 2 subjects. \nrp.xpt \nRow STUDYID DOMAIN USUBJID \nRPSEQ RPTESTCD \nRPTEST \nRPORRES \nRPORRESU RPSTRESC \nRPSTRESN RPSTRESU RPDUR RPBLFL VISITNUM VISIT \nVISITDY RPDTC \nRPDY \n1 \nSTUDYX \nRP \n2324-\nP0001 \n1 \nSPABORTN Number of Spontaneous \nAbortions \n1 \n \n1 \n1 \n \n \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n2 \nSTUDYX \nRP \n2324-\nP0001 \n2 \nBRTHLVN \nNumber of Live Births \n2 \n \n2 \n2 \n \n \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n3 \nSTUDYX \nRP \n2324-\nP0001 \n3 \nPREGNN \nNumber of Pregnancies \n3 \n \n3 \n3 \n \n \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n4 \nSTUDYX \nRP \n2324-\nP0001 \n4 \nMENOSTAT Menopause Status \nPre-Menopause \n \nPre-Menopause \n \n \n \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n5 \nSTUDYX \nRP \n2324-\nP0001 \n5 \nMENARAGE Menarche Age \n10 \nYEARS \n10 \n10 \nYEARS \n \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n6 \nSTUDYX \nRP \n2324-\nP0001 \n6 \nBCMETHOD Birth Control Method \nFOAM OR OTHER \nSPERMICIDES \n \nFOAM OR OTHER \nSPERMICIDES \n \n \nP3Y \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n7 \nSTUDYX \nRP \n2324-\nP0001 \n7 \nCHILDPOT \nChildbearing Potential \nY \n \nY \n \n \n \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n8 \nSTUDYX \nRP \n2324-\nP0001 \n8 \nCHILDPOT \nChildbearing Potential \nY \n \nY \n \n \n \n \n2 \nDay 1 \n1 \n2008-03-\n19 \n1 \n9 \nSTUDYX \nRP \n2324-\nP0001 \n9 \nPREGST \nPregnant During the Study N \n \nN \n \n \n \n \n2 \nDay 1 \n1 \n2008-03-\n19 \n1 \n10", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2026, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9f0e78b0-799b-4bc2-8790-c632a2b4ae9f": {"__data__": {"id_": "9f0e78b0-799b-4bc2-8790-c632a2b4ae9f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "63a1f3d8-06dd-47e0-8495-d78b5fdac9f6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}, "hash": "1588ee852b3a87d3b9e8abd41d0c6a2b8a717e2c977432d58fedc09536c18e72", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7220941e-0382-4e8c-8938-485ad7978eb3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}, "hash": "de5b36ee77bdd282142a3530f97599c38bb249bcf330d3eacd0ad74631b131a8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f1dba7a8-fa8a-4b5d-8395-9282ae261196", "node_type": "1", "metadata": {}, "hash": "f6a9d1d5c6d22e11a3298cda85c3cfc9ac608a0f0a3a11ebb09251d6ba2ac48a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "FOAM OR OTHER \nSPERMICIDES \n \n \nP3Y \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n7 \nSTUDYX \nRP \n2324-\nP0001 \n7 \nCHILDPOT \nChildbearing Potential \nY \n \nY \n \n \n \nY \n1 \nSCREENING 1 \n2008-03-\n09 \n-10 \n8 \nSTUDYX \nRP \n2324-\nP0001 \n8 \nCHILDPOT \nChildbearing Potential \nY \n \nY \n \n \n \n \n2 \nDay 1 \n1 \n2008-03-\n19 \n1 \n9 \nSTUDYX \nRP \n2324-\nP0001 \n9 \nPREGST \nPregnant During the Study N \n \nN \n \n \n \n \n2 \nDay 1 \n1 \n2008-03-\n19 \n1 \n10 \nSTUDYX \nRP \n2324-\nP0001 \n10 \nCHILDPOT \nChildbearing Potential \nY \n \nY \n \n \n \n \n3 \nDay 29 \n29 \n2008-04-\n16 \n29 \n11 \nSTUDYX \nRP \n2324-\nP0001 \n11 \nPREGST \nPregnant During the Study N \n \nN \n \n \n \n \n3 \nDay 29 \n29 \n2008-04-\n16 \n29 \n12 \nSTUDYX \nRP \n2324-\nP0002 \n1 \nINABORTN \nNumber of Induced \nAbortions \n0 \n \n0 \n0 \n \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n13 \nSTUDYX \nRP \n2324-\nP0002 \n2 \nBRTHLVN \nNumber of Live Births \n1 \n \n1 \n1 \n \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n14 \nSTUDYX \nRP \n2324-\nP0002 \n3 \nPREGNN \nNumber of Pregnancies \n1 \n \n1 \n1 \n \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n15 \nSTUDYX \nRP \n2324-\nP0002 \n4 \nMENOSTAT Menopause Status \nMENOPAUSE \n \nMENOPAUSE \n \n \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n16 \nSTUDYX \nRP \n2324-\nP0002 \n5 \nMENOAGE \nMenopause Age \n55 \nYEARS \n55 \n55 \nYEARS \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n17 \nSTUDYX \nRP \n2324-\nP0002 \n6 \nMENARAGE Menarche Age \n11 \nYEARS \n11 \n11 \nYEARS \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n18 \nSTUDYX \nRP \n2324-\nP0002 \n7 \nBCMETHOD Birth Control Method \nDIAPHRAGM \n \nDIAPHRAGM \n \n \nP3Y \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n19 \nSTUDYX \nRP \n2324-\nP0002 \n8 \nCHILDPOT \nChildbearing Potential \nN \n \nN \n \n \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n20 \nSTUDYX \nRP", "mimetype": "text/plain", "start_char_idx": 1614, "end_char_idx": 3240, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f1dba7a8-fa8a-4b5d-8395-9282ae261196": {"__data__": {"id_": "f1dba7a8-fa8a-4b5d-8395-9282ae261196", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "63a1f3d8-06dd-47e0-8495-d78b5fdac9f6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}, "hash": "1588ee852b3a87d3b9e8abd41d0c6a2b8a717e2c977432d58fedc09536c18e72", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9f0e78b0-799b-4bc2-8790-c632a2b4ae9f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 307, "section": "UNSPECIFIED"}, "hash": "6e3fc7897926f8a72c01cb3275facd5f9ba43a594a66f11546b45363a3dfe6da", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SCREENING 1 \n2009-03-\n09 \n-10 \n17 \nSTUDYX \nRP \n2324-\nP0002 \n6 \nMENARAGE Menarche Age \n11 \nYEARS \n11 \n11 \nYEARS \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n18 \nSTUDYX \nRP \n2324-\nP0002 \n7 \nBCMETHOD Birth Control Method \nDIAPHRAGM \n \nDIAPHRAGM \n \n \nP3Y \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n19 \nSTUDYX \nRP \n2324-\nP0002 \n8 \nCHILDPOT \nChildbearing Potential \nN \n \nN \n \n \n \nY \n1 \nSCREENING 1 \n2009-03-\n09 \n-10 \n20 \nSTUDYX \nRP \n2324-\nP0002 \n9 \nCHILDPOT \nChildbearing Potential \nN \n \nN \n \n \n \n \n2 \nDay 1 \n1 \n2009-03-\n19 \n1 \n21 \nSTUDYX \nRP \n2324-\nP0002 \n10 \nCHILDPOT \nChildbearing Potential \nN \n \nN \n \n \n \n \n3 \nDay 29 \n29 \n2009-04-\n16 \n29", "mimetype": "text/plain", "start_char_idx": 2825, "end_char_idx": 3450, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "58b7167d-0417-4c51-8c66-1b36861d1433": {"__data__": {"id_": "58b7167d-0417-4c51-8c66-1b36861d1433", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 308, "section": "6.3.7.7 Respiratory System Findings (RE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2cd1ebdf-75e7-4223-a4c1-b7491664d6d3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 308, "section": "6.3.7.7 Respiratory System Findings (RE)"}, "hash": "4b492a3bb05ced7a956ca277cab1899e7d2d7cb1cdf3ea95bb81a0305f7bc117", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5ad6fdb7-963b-4986-b0c6-278ca588c119", "node_type": "1", "metadata": {}, "hash": "842a3dbc30134079110aff47f18533c5e2db03db26895361106f3b8afe83fb3c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RE \u2013 Description/Overview \nA findings domain that contains physiological and morphological findings related to the respiratory system, including the organs that are involved in breathing \nsuch as the nose, throat, larynx, trachea, bronchi and lungs. \nRE \u2013 Specification \nre.xpt, Respiratory System Findings \u2014 Findings. One record per finding or result per time point per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar RE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nSPDEVID \nSponsor Device Identifier \nChar  \nIdentifier \nSponsor-defined identifier for a device. \nPerm \nRESEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid \nnumber (including decimals) and does not have to start at 1. \nReq \nREGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nPerm \nREREFID \nReference ID \nChar  \nIdentifier \nOptional internal or external procedure identifier. \nPerm \nRESPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. May be preprinted on the CRF as an explicit line identifier or defined in the \nsponsor's operational database. \nPerm \nRELNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nRELNKGRP \nLink Group \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. Perm \nRETESTCD \nShort Name of \nRespiratory Test \nChar (RETESTCD) \nTopic \nShort name of the measurement, test, or examination. It can be used as a column name when \nconverting a dataset from a vertical format to a horizontal format. The value in RETESTCD cannot be \nlonger than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). RETESTCD \ncannot contain characters other than letters, numbers, or underscores. Examples: \"FEV1\", \"FVC\". \nReq \nRETEST \nName of Respiratory Test Char (RETEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in \nRETEST cannot be longer than 40 characters. Examples: \"Forced Expiratory Volume in 1 Second\", \n\"Forced Vital Capacity\". \nReq \nRECAT \nCategory for Respiratory \nTest \nChar  \nGrouping \nQualifier \nUsed to categorize observations across subjects. \nPerm \nRESCAT \nSubcategory for \nRespiratory Test \nChar  \nGrouping \nQualifier \nA further categorization. \nPerm \nREPOS \nPosition of Subject During \nObservation \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during a measurement or examination. Examples: \"SUPINE\", \"STANDING\", \n\"SITTING\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3113, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5ad6fdb7-963b-4986-b0c6-278ca588c119": {"__data__": {"id_": "5ad6fdb7-963b-4986-b0c6-278ca588c119", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 308, "section": "6.3.7.7 Respiratory System Findings (RE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2cd1ebdf-75e7-4223-a4c1-b7491664d6d3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 308, "section": "6.3.7.7 Respiratory System Findings (RE)"}, "hash": "4b492a3bb05ced7a956ca277cab1899e7d2d7cb1cdf3ea95bb81a0305f7bc117", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "58b7167d-0417-4c51-8c66-1b36861d1433", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 308, "section": "6.3.7.7 Respiratory System Findings (RE)"}, "hash": "1da90c79da2fe28e709f9783b02e6705c5a1712a21299f8622db218b1ce3b4d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"FEV1\", \"FVC\". \nReq \nRETEST \nName of Respiratory Test Char (RETEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in \nRETEST cannot be longer than 40 characters. Examples: \"Forced Expiratory Volume in 1 Second\", \n\"Forced Vital Capacity\". \nReq \nRECAT \nCategory for Respiratory \nTest \nChar  \nGrouping \nQualifier \nUsed to categorize observations across subjects. \nPerm \nRESCAT \nSubcategory for \nRespiratory Test \nChar  \nGrouping \nQualifier \nA further categorization. \nPerm \nREPOS \nPosition of Subject During \nObservation \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during a measurement or examination. Examples: \"SUPINE\", \"STANDING\", \n\"SITTING\". \nPerm \nREORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the procedure measurement or finding as originally received or collected. \nExp \nREORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for REORRES and REORREF. \nPerm \nREORREF \nReference Result in \nOriginal Units \nChar  \nVariable \nQualifier \nReference result for continuous measurements in original units. Should be collected only for \ncontinuous results. \nPerm \nRESTRESC \nCharacter Result/Finding \nin Std Format \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from REORRES in a standard format or in \nstandard units. RESTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in RESTRESN. \nExp \nRESTRESN \nNumeric Result/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nRESTRESC. RESTRESN should store all numeric test results or findings. \nPerm", "mimetype": "text/plain", "start_char_idx": 2375, "end_char_idx": 4236, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cbf253ae-4450-4861-b04a-f956ade37b42": {"__data__": {"id_": "cbf253ae-4450-4861-b04a-f956ade37b42", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 309, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d11daa53-8c99-49eb-abe5-4483b02ac317", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 309, "section": "UNSPECIFIED"}, "hash": "50eb03197291e4b6e896fd5bd9f5c4c2b11080a5be8cc1e789685978270676c1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "201215ff-7581-4f28-8155-0274381b9ed8", "node_type": "1", "metadata": {}, "hash": "4fc78bc028fcec904ae897ccf5ce9d7dcd5e35a568cd0ce5a0713a31033b39ce", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 309 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nRESTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for RESTRESC, RESTRESN and RESTREFN. \nPerm \nRESTREFC \nCharacter Reference \nResult \nChar  \nVariable \nQualifier \nReference value for the result or finding copied or derived from --ORREF in a standard format. \nPerm \nRESTREFN \nNumeric Reference \nResult in Std Units \nNum  \nVariable \nQualifier \nReference result for continuous measurements in standard units. Should be populated only for \ncontinuous results. \nPerm \nRESTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a test was not done or a measurement was not taken. Should be null if a result \nexists in REORRES. \nPerm \nREREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a measurement or test was not performed. Examples: \"BROKEN EQUIPMENT\", \n\"SUBJECT REFUSED\". Used in conjunction with RESTAT when value is \"NOT DONE\". \nPerm \nRELOC \nLocation Used for the \nMeasurement \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. Examples: \"LUNG\", \n\"BRONCHUS\". \nPerm \nRELAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nSide of the body used to collect measurement. Examples: \"RIGHT\", \"LEFT\". \nPerm \nREDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nREMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod used to create the result. \nPerm \nRELOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally-derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nExp \nREBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be Y or null. Note that REBLFL is retained for \nbackward compatibility. The authoritative baseline flag for statistical analysis is in an ADaM dataset. \nPerm \nREDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. Should be \"Y\" or null. Records that represent the average of other \nrecords, or that do not come from the CRF, or are not as originally collected or received are \nexamples of records that would be derived for the submission datasets. If REDRVFL = \"Y\", then \nREORRES could be null, with RESTRESC and (if numeric) RESTRESN having the derived value. \nPerm \nREEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\", \"RADIOLOGIST\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3009, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "201215ff-7581-4f28-8155-0274381b9ed8": {"__data__": {"id_": "201215ff-7581-4f28-8155-0274381b9ed8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 309, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d11daa53-8c99-49eb-abe5-4483b02ac317", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 309, "section": "UNSPECIFIED"}, "hash": "50eb03197291e4b6e896fd5bd9f5c4c2b11080a5be8cc1e789685978270676c1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "cbf253ae-4450-4861-b04a-f956ade37b42", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 309, "section": "UNSPECIFIED"}, "hash": "4e7b30bd130108c48941d418445385af9d3d0901620dea0045409766f63fde00", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nREDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. Should be \"Y\" or null. Records that represent the average of other \nrecords, or that do not come from the CRF, or are not as originally collected or received are \nexamples of records that would be derived for the submission datasets. If REDRVFL = \"Y\", then \nREORRES could be null, with RESTRESC and (if numeric) RESTRESN having the derived value. \nPerm \nREEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\", \"RADIOLOGIST\". \nPerm \nREEVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in REEVAL. Examples: \n\"RADIOLOGIST1\", \"RADIOLOGIST2\". \nPerm \nREREPNUM Repetition Number \nNum  \nRecord \nQualifier \nThe instance number of a test that is repeated within a given time frame for the same test. The level \nof granularity can vary (e.g., within a time point, within a visit). Example: multiple measurements of \npulmonary function. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nREDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of procedure or test. \nExp \nREDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nRETPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point (e.g., \"TIME \nOF LAST DOSE\"). See RETPTNUM and RETPTREF. Examples: \"START\", \"5 MINUTES POST\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2303, "end_char_idx": 4824, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6685157d-afd1-42da-8aeb-32e2b41c74c2": {"__data__": {"id_": "6685157d-afd1-42da-8aeb-32e2b41c74c2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 310, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "57965d55-c1ad-4d7f-90a1-a3791a2a78c0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 310, "section": "UNSPECIFIED"}, "hash": "fe7d5315f38179f277ed91cf40968196f65d8ab2947d1c35d1d41a00ba5e5c39", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "bcdf0afa-b938-44ad-8cb3-ba4b1b5fbfed", "node_type": "1", "metadata": {}, "hash": "fb43c201569ac337c9765d45ee3bd9d21a404c3d40ca0a31d5c55e5f9fb0f723", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 310 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nRETPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of RETPT to aid in sorting. \nPerm \nREELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time relative to a planned fixed reference (RETPTREF). Not a clock time or a \ndate/time variable, but an interval, represented as ISO duration. Examples: \"-PT15M\" to represent 15 \nminutes prior to the reference time point indicated by RETPTREF, \"PT8H\" to represent 8 hours after \nthe reference time point represented by RETPTREF. \nPerm \nRETPTREF \nTime Point Reference \nChar  \nTiming \nDescription of the fixed reference point referred to by REELTM, RETPTNUM, and RETPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nRERFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point defined by RETPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nRE \u2013 Assumptions \n1. The Respiratory System Findings domain is used to represent the results/findings of respiratory diagnostic procedures (e.g., spirometry). Information \nabout the conduct of the procedure(s), if collected, should be submitted in the Procedures (PR) domain. \n2. Many respiratory assessments require the use of a device. When data about the device used for an assessment or additional information about its use in \nthe assessment are collected, SPDEVID should be included in the record. See the SDTMIG for Medical Devices (SDTMIG-MD, available at \nhttps://www.cdisc.org/standards/foundational/medical-devices-sdtmig/) for further information about SPDEVID and the Device domains. \n3. Any Identifier variables, Timing variables, or Findings general observation class qualifiers may be added to the RE domain, but the following qualifiers \nwould generally not be used: --MODIFY, --BODSYS, and --FAST. \nRE \u2013 Examples \nExample 1 \nThis example shows results from several spirometry tests using either a spirometer or a peak flow meter. When spirometry tests are performed, the subject \nusually makes several efforts, each of which produces results, but only the best result for each test is used in analyses. In this study, the sponsor collected only the \nbest results. The Device Identifiers (DI) domain was submitted for device identification, and the Device in Use (DU) domain was submitted to provide \ninformation about the use of the device. \nBecause the original and standardized units of measure are identical in this example, RESTRESC, RESTRESN, RESTRESU, and RESTREFN are not shown. \nInstead, an ellipsis marks their place in the dataset. Spirometry test values are compared to a predicted value, rather than a normal range. Predicted values are \nrepresented in REORREF.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3134, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bcdf0afa-b938-44ad-8cb3-ba4b1b5fbfed": {"__data__": {"id_": "bcdf0afa-b938-44ad-8cb3-ba4b1b5fbfed", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 310, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "57965d55-c1ad-4d7f-90a1-a3791a2a78c0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 310, "section": "UNSPECIFIED"}, "hash": "fe7d5315f38179f277ed91cf40968196f65d8ab2947d1c35d1d41a00ba5e5c39", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6685157d-afd1-42da-8aeb-32e2b41c74c2", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 310, "section": "UNSPECIFIED"}, "hash": "a43956103aa2a6bc0093a2bb2f56a44561561292f9afd90da7febfaa797bccde", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RE \u2013 Examples \nExample 1 \nThis example shows results from several spirometry tests using either a spirometer or a peak flow meter. When spirometry tests are performed, the subject \nusually makes several efforts, each of which produces results, but only the best result for each test is used in analyses. In this study, the sponsor collected only the \nbest results. The Device Identifiers (DI) domain was submitted for device identification, and the Device in Use (DU) domain was submitted to provide \ninformation about the use of the device. \nBecause the original and standardized units of measure are identical in this example, RESTRESC, RESTRESN, RESTRESU, and RESTREFN are not shown. \nInstead, an ellipsis marks their place in the dataset. Spirometry test values are compared to a predicted value, rather than a normal range. Predicted values are \nrepresented in REORREF. \nRows 1-2: \nShow the results for the spirometry tests FEV1 and FVC, with the predicted values in REORREF. The spirometer used in the tests is identified by \nthe SPDEVID. \nRows 3-4: \nShow the results for FEV1 and FVC as percentages of the predicted values. This result is output by the spirometer device, not derived by the \nsponsor. REORREF is null as there are no reference results for percent predicted tests. \nRow 5: \nShows the results of the PEF test with the predicted values in REORREF. These results were obtained with a different device, a peak flow meter, \nidentified by the SPDEVID.", "mimetype": "text/plain", "start_char_idx": 2260, "end_char_idx": 3727, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5c6097f1-60c2-41b0-8707-603bb4af8a8a": {"__data__": {"id_": "5c6097f1-60c2-41b0-8707-603bb4af8a8a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 311, "section": "7.33 4"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "31df4760-baa6-4df8-b6a3-ad6e87d4178d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 311, "section": "7.33 4"}, "hash": "632b8e87ea071a86964e83d71af85100f18a428838eb8f49534c77c3c771b643", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "VISIT 4 2013-07-17 \nThe DI domain provides the information needed to distinguish among devices used in the study. In this example, the only parameter needed to establish \nidentifiers was the device type. \ndi.xpt \nRow \nSTUDYID \nDOMAIN \nSPDEVID \nDISEQ \nDIPARMCD \nDIPARM \nDIVAL \n1 \nXYZ \nDI \nABC001 \n1 \nDEVTYPE \nDevice Type \nSPIROMETER \n2 \nXYZ \nDI \nDEF999 \n1 \nDEVTYPE \nDevice Type \nPEAK FLOW METER \nThe DU domain shows settings used on the devices with identifier \"ABC001\".  The device was set to use the NHANES III reference equation. Because this \nsetting was the same for all uses of the device for all subjects, USUBJID is null. \ndu.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSPDEVID \nDUSEQ \nDUTESTCD \nDUTEST \nDUORRES \n1 \nXYZ \nDU \n \nABC001 \n1 \nSPIREFEQ \nSpirometric Reference Equation \nNATIONAL HEALTH NUTRITION EXAMINATION SURVEY (NHANES) III \nExample 2 \nIn this example, a subject made 4 attempts at the FEV1 pulmonary function test, and data about all attempts were collected. It is standard practice for multiple \nattempts to be made, and for the best result to be used in analyses. In this example, the spirometry report included an indicator of which was the best result. The \nspirometry report also included an indicator that 1 of the attempts was considered to have produced an inadequate result, with the reasons the result was \nconsidered inadequate. \nRows 1-3: \nShow individual test results for FEV1 as measured by spirometry. \nRow 4: \nShows an individual test result for FEV1 as measured by spirometry. Note that this result is much less than the others. \nre.xpt \nRow STUDYID DOMAIN USUBJID \nSPDEVID RESEQ RETESTCD RETEST \nREORRES REORRESU RESTRESN RESTRESU REREPNUM VISITNUM VISIT \nREDTC \n1 \nXYZ \nRE \nXYZ-001-\n001 \nABC001 \n1 \nFEV1 \nForced Expiratory \nVolume in 1 Second", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1775, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6b8f641e-f7cc-4ccb-89da-b58b94963d60": {"__data__": {"id_": "6b8f641e-f7cc-4ccb-89da-b58b94963d60", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 311, "section": "1.57 L"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6b582910-a64c-418a-a7c9-bc493f745ad5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 311, "section": "1.57 L"}, "hash": "7965622e158f28b7c541f47fce3958c98c0ab375f2506a061bd1fbc4da98054c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4 \n2 \nVISIT \n2 \n2013-04-\n23 \nSupplemental qualifiers were used to indicate which was the best result and to provide information on the attempt that was considered to produce inadequate \nresults. \nRow 1: \nShows the record with RESEQ=\"1\" was the best test result, indicated by BRESFL=\"Y\". \nRows 2-4: \nThe presence of a flag, IRESFL, indicates that the data were inadequate. The 2 reasons why this was the case are represented by \nQNAM=\"IRREA1\" and \"IREEA2\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 455, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a50d4f16-6e5d-4dd6-b32f-22ee22cd58cc": {"__data__": {"id_": "a50d4f16-6e5d-4dd6-b32f-22ee22cd58cc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 312, "section": "6.3.7.8 Urinary System Findings (UR)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d93a2112-147a-4f5d-8fdf-5af9cd17b893", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 312, "section": "6.3.7.8 Urinary System Findings (UR)"}, "hash": "38132f7299a919760094a7b2377aa696e7fae5fffca3c8bd8ae84c98625ed6f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "UR \u2013 Description/Overview \nA findings domain that contains physiological and morphological findings related to the urinary tract, including the organs involved in the creation and excretion \nof urine such as the kidneys, ureters, bladder and urethra. \nUR \u2013 Specification \nur.xpt, Urinary System Findings \u2014 Findings. One record per finding per location per per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar UR \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier Char  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nURSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid \nnumber (including decimals) and does not have to start at 1. \nReq \nURGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nPerm \nURREFID \nReference ID \nChar  \nIdentifier \nOptional internal or external identifier (e.g., lab specimen ID, universally unique identifier (UUID) for a \nmedical image). \nPerm \nURSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. Example: Preprinted line identifier. \nPerm \nURLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This may be a one-to-one or a one-to-many \nrelationship. \nPerm \nURLNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nURTESTCD \nShort Name of Urinary \nTest \nChar (URNSTSCD) \nTopic \nShort character value for URTEST used as a column name when converting a dataset from a vertical \nformat to a horizontal format. It can be used as a column name when converting a dataset from a \nvertical to a horizontal format. The value in URTESTCD cannot be longer than 8 characters, nor can it \nstart with a number (e.g., \"1TEST\" is not valid). URTESTCD cannot contain characters other than \nletters, numbers, or underscores. Examples: \"COUNT\", \"LENGTH\", \"RBLDFLW\". \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2372, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1a9202a2-1801-4cce-9b33-ff97502bee53": {"__data__": {"id_": "1a9202a2-1801-4cce-9b33-ff97502bee53", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 313, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f5ea06cc-02bd-4020-a102-5e446b0b6966", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 313, "section": "UNSPECIFIED"}, "hash": "5d198f746f3cec64f96cf042148b5d318f9b28cfadf60b7131cde7ccf0e23954", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ffe8459-978b-41bc-ae67-0e612bbbc966", "node_type": "1", "metadata": {}, "hash": "bb6e775afc9c9fcdd543e3076f87edb33bcc562ab06bda78643a893b82949881", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 313 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nURTEST \nName of Urinary Test \nChar (URNSTS) \nSynonym \nQualifier \nLong name For URTESTCD. Examples: \"Count\", \"Length\", \"Renal Blood Flow\". \nReq \nURTSTDTL \nUrinary Test Detail \nChar * \nVariable \nQualifier \nFurther description of URTESTCD and URTEST. \nPerm \nURCAT \nCategory for Urinary \nTest \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. \nPerm \nURSCAT \nSubcategory for Urinary \nTest \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of URCAT values. \nPerm \nURORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nURORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nUnit for URORRES. \nPerm \nURSTRESC \nCharacter Result/Finding \nin Std Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from URORRES, in a standard format or in \nstandard units. URSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in URSTRESN. \nExp \nURSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nURSTRESC. URSTRESN should store all numeric test results or findings. \nPerm \nURSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for URSTRESC and URSTRESN. \nPerm \nURRESCAT \nResult Category \nChar  \nVariable \nQualifier \nUsed to categorize the result of a finding. \nPerm \nURSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a question was not asked or a test was not done, or a test was attempted but did \nnot generate a result. Should be null or have a value of \"NOT DONE\". \nPerm \nURREASND \nReason Not Done \nChar  \nRecord \nQualifier \nReason not done. Used in conjunction with URSTAT when value is \"NOT DONE\". \nPerm \nURLOC \nLocation Used for the \nMeasurement \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. \nPerm \nURLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\". \nPerm \nURDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nURMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. \nPerm \nURLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3068, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7ffe8459-978b-41bc-ae67-0e612bbbc966": {"__data__": {"id_": "7ffe8459-978b-41bc-ae67-0e612bbbc966", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 313, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f5ea06cc-02bd-4020-a102-5e446b0b6966", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 313, "section": "UNSPECIFIED"}, "hash": "5d198f746f3cec64f96cf042148b5d318f9b28cfadf60b7131cde7ccf0e23954", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1a9202a2-1801-4cce-9b33-ff97502bee53", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 313, "section": "UNSPECIFIED"}, "hash": "a553f65458860157b0045c355694c52a2326b5150c7681e5c1295c06cea844f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nURLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\". \nPerm \nURDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality. Examples: \"ANTERIOR\", \n\"LOWER\", \"PROXIMAL\". \nPerm \nURMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. \nPerm \nURLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nExp \nURBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nA baseline defined by the sponsor The value should be \"Y\" or null. Note that URBLFL is retained for \nbackward compatibility. The authoritative baseline flag for statistical analysis is in an ADaM dataset. \nPerm \nURDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nUREVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\", \"RADIOLOGIST\". \nPerm \nUREVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in UREVAL. Examples: \n\"RADIOLOGIST1\", \"RADIOLOGIST2\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm", "mimetype": "text/plain", "start_char_idx": 2408, "end_char_idx": 4364, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "46f15ac8-a103-4000-a730-aa518e327da8": {"__data__": {"id_": "46f15ac8-a103-4000-a730-aa518e327da8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 314, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a1fe64d-f4a9-4062-863f-37cf1a17576a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 314, "section": "UNSPECIFIED"}, "hash": "114435b3a075af96d9e97f4586293fae970688817de046ee999cf66f48043b3a", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8298082-52c3-437b-9dea-b4002529c28d", "node_type": "1", "metadata": {}, "hash": "c8b4403f4f501afacc568a2ee57bf4472cd7af6d7ff2d5ae6f9a7cee4a1e7640", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 314 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nobservation was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the observation was made. \nPerm \nURDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of an observation. \nExp \nURDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to the sponsor-defined \nRFSTDTC in Demographics. \nPerm \nURTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point (e.g., time of \nlast dose). See URTPTNUM and URTPTREF. \nPerm \nURTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nURELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration Timing \nPlanned elapsed time relative to a planned fixed reference (URTPTREF; e.g., \"PREVIOUS DOSE\", \n\"PREVIOUS MEAL\"). This variable is useful where there are repetitive measures. Not a clock time or a \ndate/time variable, but an interval, represented as ISO duration. \nPerm \nURTPTREF \nTime Point Reference \nChar  \nTiming \nDescription of the fixed reference point referred to by URELTM, URTPTNUM, and URTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nURRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point defined by URTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n \nUR \u2013 Assumptions \n1.  Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the UR domain, but the following qualifiers would \nnot generally be used: --MODIFY, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --NRIND, --LOINC, --SPCCND, --FAST, --TOX, --\nTOXGR, --SEV, --LLOQ. \nUR \u2013 Examples \nExample 1 \nThis example shows measurements of the kidney, number of renal arteries and veins, and presence/absence results for prespecified abnormalities of the kidneys. \nThese findings were made using computed tomography (CT) imaging. \nRow 1: \nShows that the subject's left kidney was measured to be 126 mm long. \nRow 2: \nShows that the subject's left kidney had 2 renal arteries. \nRow 3: \nShows that the subject's left kidney had 1 renal vein.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2966, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e8298082-52c3-437b-9dea-b4002529c28d": {"__data__": {"id_": "e8298082-52c3-437b-9dea-b4002529c28d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 314, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a1fe64d-f4a9-4062-863f-37cf1a17576a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 314, "section": "UNSPECIFIED"}, "hash": "114435b3a075af96d9e97f4586293fae970688817de046ee999cf66f48043b3a", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "46f15ac8-a103-4000-a730-aa518e327da8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 314, "section": "UNSPECIFIED"}, "hash": "ab47164acbfcc0d9a90bf174928e8d2a2cedda68a11a2074cc62a2a1e4afa454", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "UR \u2013 Examples \nExample 1 \nThis example shows measurements of the kidney, number of renal arteries and veins, and presence/absence results for prespecified abnormalities of the kidneys. \nThese findings were made using computed tomography (CT) imaging. \nRow 1: \nShows that the subject's left kidney was measured to be 126 mm long. \nRow 2: \nShows that the subject's left kidney had 2 renal arteries. \nRow 3: \nShows that the subject's left kidney had 1 renal vein. \nRow 4: \nShows that no hematomas were found in the kidney. If a hematoma had been present, the variable URLOC (with URDIR as necessary) would have \nspecified where within the kidney. \nRow 5: \nShows that surgical damage was noted in the superior portion of the kidney cortex. Note that in SDTM, there is no way to clearly distinguish \nbetween the use of --LOC as a qualifier of --TEST vs. as a qualifier of results, as it is used here.", "mimetype": "text/plain", "start_char_idx": 2506, "end_char_idx": 3401, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f15204e8-67de-4de4-a3a1-c7c410b7d484": {"__data__": {"id_": "f15204e8-67de-4de4-a3a1-c7c410b7d484", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 315, "section": "12.6 cm"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d38ee834-7582-4bf7-84ec-a68555bd2bc2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 315, "section": "12.6 cm"}, "hash": "6fca9a4eacf98c3ecdb4be5e0afd5928bf995c7bed0d3a1a01db470807c899b5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "126 \n126 \nmm \nKIDNEY \nLEFT \n \nCT SCAN \n2016-03-\n30 \n2 \nABC \nUR \nABC-001-\n011 \n2 \nRNLANUM \nNumber of Renal \nArteries \n2 \n \n2 \n2 \n \nKIDNEY \nLEFT \n \nCT SCAN \n2016-03-\n30 \n3 \nABC \nUR \nABC-001-\n011 \n3 \nRNLVNUM \nNumber of Renal \nVeins \n1 \n \n1 \n1 \n \nKIDNEY \nLEFT \n \nCT SCAN \n2016-03-\n30 \n4 \nABC \nUR \nABC-001-\n011 \n4 \nHEMAIND \nHematoma \nIndicator \nN \n \nN \n \n \nKIDNEY \n \n \nCT SCAN \n2016-03-\n30 \n5 \nABC \nUR \nABC-001-\n011 \n5 \nSGDMGIND Surgical Damage \nIndicator \nY \n \nY \n \n \nKIDNEY, \nCORTEX \nLEFT \nSUPERIOR CT SCAN \n2016-03-\n30 \nExample 2 \nThis example shows a subject's renal blood flow measurement for each visit based on the subject's para-amino hippuric acid (PAH) clearance, indicated by \nURMETHOD = \"PARA-AMINO HIPPURIC ACID CLEARANCE\". \nur.xpt \nRow STUDYID DOMAIN USUBJID URSEQ URTESTCD URTEST \nURORRES URORRESU URSTRESC URSTRESN URSTRESU URLOC URLAT \nURMETHOD \nVISITNUM VISIT URDTC \n1 \nDEF \nUR \nDEF-\n0123 \n1 \nBLDFLRT \nBlood \nFlow \nRate \n20 \nmL/min \n20 \n20 \nmL/min \nKIDNEY BILATERAL PARA-AMINO \nHIPPURIC ACID \nCLEARANCE \n1 \nVISIT \n1 \n2016-\n03-15 \n2 \nDEF \nUR \nDEF-\n0123 \n2 \nBLDFLRT \nBlood \nFlow \nRate \n10 \nmL/min \n10 \n10 \nmL/min \nKIDNEY LEFT \nPARA-AMINO \nHIPPURIC ACID \nCLEARANCE \n2 \nVISIT \n2 \n2016-\n03-20 \n3 \nDEF \nUR \nDEF-\n0123 \n3 \nBLDFLRT \nBlood \nFlow \nRate \n10 \nmL/min \n10 \n10 \nmL/min \nKIDNEY RIGHT \nPARA-AMINO \nHIPPURIC ACID \nCLEARANCE \n3 \nVISIT \n3 \n2016-\n04-07", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1360, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c704a46c-c5d4-4a95-bb64-ce171ed9f1a6": {"__data__": {"id_": "c704a46c-c5d4-4a95-bb64-ce171ed9f1a6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 315, "section": "6.3.8 Physical Examination (PE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ceb135aa-8c1b-4cff-ba92-5561e4591ed8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 315, "section": "6.3.8 Physical Examination (PE)"}, "hash": "55e0b4a9c8712b375977547710ccfac5a5b70a12ca5e69688203e132184a4229", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PE - Proposed Removal of --MODIFY and --BODSYS \nIn the version of the SDTM associated with the next version of the SDTMIG, --MODIFY is being considered for deprecation as a qualifier variable for findings \nclass domains and --BODSYS will be considered for restriction to use in nonclinical studies. \nPE - Alignment with CDASH Best Practice \nIn the CDASH \"Best Practice\" approach as described in the CDASHIG, which is becoming common in human clinical trials, the PE domain is not used to record \nthe \u201cfindings\u201d from a physical exam. The abnormalities found are recorded in the appropriate events-class domain. An abnormality is recorded in Medical \nHistory (MH) when found to previously exist at a baseline or screening examination. Abnormalities identified after baseline or screening, or worsening \nabnormalities, are recorded on the Adverse Events (AE) form (or possibly on a Clinical Events form). When following this approach, the PE domain is not used \nin SDTM. The Procedure (PR) domain is used to document the examination details (e.g., occurrence, date) using a Procedure record for each physical exam. \nPE \u2013 Description/Overview \nA findings domain that contains findings observed during a physical examination where the body is evaluated by inspection, palpation, percussion, and \nauscultation.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1304, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1af2ca28-450c-489c-b8de-93e20b9b6985": {"__data__": {"id_": "1af2ca28-450c-489c-b8de-93e20b9b6985", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 316, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "733581aa-97e5-431c-9e31-485d6245edbd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 316, "section": "UNSPECIFIED"}, "hash": "21fc9e44571ce55dfa183346a40acd075bcfd858e358ddaf2a002c8769bf9852", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d21ace7d-02bd-47c4-9773-9ccb39443137", "node_type": "1", "metadata": {}, "hash": "4e2072bc1a643bad28b35e2d4711b4a7b1edd6bd4349e6ee9ce0cc4b530c552e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 316 \n2021-11-29 \nPE \u2013 Specification \npe.xpt, Physical Examination \u2014 Findings. One record per body system or abnormality per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar PE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the \nproduct. \nReq \nPESEQ \nSequence Number Num  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid number. \nReq \nPEGRPID \nGroup ID \nChar  \nIdentifier \nUsed to link together a block of related records in a single domain for a subject. \nPerm \nPESPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. Perhaps preprinted on the CRF as an explicit line identifier or defined in \nthe sponsor's operational database. Example: Line number on a CRF. \nPerm \nPETESTCD \nBody System \nExamined Short \nName \nChar * \nTopic \nShort name of a part of the body examined in a physical examination. It can be used as a column name when \nconverting a dataset from a vertical to a horizontal format. The value in PETESTCD cannot be longer than 8 \ncharacters, nor can it start with a number (e.g., \"1TEST\" is not valid). PETESTCD cannot contain characters \nother than letters, numbers, or underscores. Examples: \"HEAD\", \"ENT\". If the results of the entire physical \nexamination are represented in one record, value should be \"PHYSEXAM\". \nReq \nPETEST \nBody System \nExamined \nChar * \nSynonym \nQualifier \nLong name of a part of the body examined in a physical examination. The value in PETEST cannot be longer \nthan 40 characters. Examples: \"Head\", \"Ear/Nose/Throat\". If the results of the entire physical examination are \nrepresented in one record, value should be \"Physical Examination\". \nReq \nPEMODIFY \nModified Reported \nTerm \nChar  \nSynonym \nQualifier \nIf the value of PEORRES is modified for coding purposes, then the modified text is placed here. \nPerm \nPECAT \nCategory for \nExamination \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Example: \"GENERAL\". \nPerm \nPESCAT \nSubcategory for \nExamination \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of --CAT values. \nPerm \nPEBODSYS \nBody System or \nOrgan Class \nChar  \nRecord \nQualifier \nBody system or organ class (e.g., MedDRA SOC) that is involved for a finding from the standard hierarchy for \ndictionary-coded results. \nPerm \nPEORRES \nVerbatim \nExamination \nFinding \nChar  \nResult \nQualifier \nText description of any abnormal findings. If the examination was completed and there were no abnormal \nfindings, the value should be \"NORMAL\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3105, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d21ace7d-02bd-47c4-9773-9ccb39443137": {"__data__": {"id_": "d21ace7d-02bd-47c4-9773-9ccb39443137", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 316, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "733581aa-97e5-431c-9e31-485d6245edbd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 316, "section": "UNSPECIFIED"}, "hash": "21fc9e44571ce55dfa183346a40acd075bcfd858e358ddaf2a002c8769bf9852", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1af2ca28-450c-489c-b8de-93e20b9b6985", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 316, "section": "UNSPECIFIED"}, "hash": "e73071589d847afa70b3982e0e6ddd2c2cdafd9cb4ac7112d03795ad0ef67f00", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nPECAT \nCategory for \nExamination \nChar * \nGrouping \nQualifier \nUsed to define a category of topic-variable values. Example: \"GENERAL\". \nPerm \nPESCAT \nSubcategory for \nExamination \nChar * \nGrouping \nQualifier \nUsed to define a further categorization of --CAT values. \nPerm \nPEBODSYS \nBody System or \nOrgan Class \nChar  \nRecord \nQualifier \nBody system or organ class (e.g., MedDRA SOC) that is involved for a finding from the standard hierarchy for \ndictionary-coded results. \nPerm \nPEORRES \nVerbatim \nExamination \nFinding \nChar  \nResult \nQualifier \nText description of any abnormal findings. If the examination was completed and there were no abnormal \nfindings, the value should be \"NORMAL\". If the examination was not performed on a particular body system, or \nat the subject level, then the value should be null, and \"NOT DONE\" should appear in PESTAT. \nExp \nPEORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for PEORRES. \nPerm \nPESTRESC \nCharacter \nResult/Finding in \nStd Format \nChar  \nResult \nQualifier \nIf there are findings for a body system, then either the dictionary preferred term (if findings are coded using a \ndictionary) or PEORRES (if findings are not encoded) should appear here. If PEORRES is null, PESTRESC \nmust be null. \nExp \nPESTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate exam not done. Must be null if a result exists in PEORRES/PESTRESC. \nPerm \nPEREASND \nReason Not \nExamined \nChar  \nRecord \nQualifier \nDescribes why an examination was not performed or why a body system was not examined. Example: \n\"SUBJECT REFUSED\". Used in conjunction with PESTAT when value is \"NOT DONE\". \nPerm \nPELOC \nLocation of \nPhysical Exam \nFinding \nChar (LOC) \nRecord \nQualifier \nAnatomical location of the subject relevant to the collection of the measurement. Example: \"ARM\" for skin rash. Perm \nPELAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterallity. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\". \nPerm \nPEMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of the test or examination. Examples: \"PALPATION\", \"PERCUSSION\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2408, "end_char_idx": 4637, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "32e34bdf-ca80-40df-a185-fcd682ff3449": {"__data__": {"id_": "32e34bdf-ca80-40df-a185-fcd682ff3449", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 317, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0b1318a3-f7b1-4622-9b3d-2e42f66e5d8d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 317, "section": "UNSPECIFIED"}, "hash": "3eef091ae385e4da0c106df5bbbd3ad405619aa17e561e8ac2d35f25fa0a054c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e8699fb6-d147-4c39-a9e1-cbb6691beb64", "node_type": "1", "metadata": {}, "hash": "532badbde14a98100c1d8577415cc535193d3ad025c3863f1c9d78017a69c8b8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 317 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nPELOBXFL \nLast Observation \nBefore Exposure \nFlag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. Should be \"Y\" or \nnull. \nPerm \nPEBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nA baseline defined by the sponsor (could be derived in the same manner as PELOBXFL or ABLFL, but is not \nrequired to be). The value should be \"Y\" or null. Note that PEBLFL is retained for backward compatibility. The \nauthoritative baseline flag for statistical analysis is in an ADaM dataset. \nPerm \nPEEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned by a \nperson or a group). Example: \"INVESTIGATOR\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. May be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study \nDay of Visit \nNum  \nTiming \nPlanned study day of VISIT. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within \nArm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the assessment \nwas made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the observation date/time of the physical exam finding. \nPerm \nPEDTC \nDate/Time of \nExamination \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nDate and time of the physical examination represented in ISO 8601 character format. \nExp \nPEDY \nStudy Day of \nExamination \nNum  \nTiming \nStudy day of physical exam, measured as integer days. Algorithm for calculations must be relative to the \nsponsor-defined RFSTDTC variable in Demographics. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nPE \u2013 Assumptions \n1. PE findings reflect the presence or absence of physical signs of disease or abnormality observed during a general physical examination. Multiple body \nsystems are assessed during a physical examination, often starting at the head and ending at the toes, where the body is evaluated by inspection, \npalpation (feeling with the hands), percussion (tapping with fingers), and auscultation (listening). The examination often includes macro assessments \n(e.g., normal/abnormal) of appearance, general health, behavior, and body system review from head to toe.  \na. \nEvaluation of targeted body systems (e.g., cardiovascular, ophthalmic, reproductive) as part of therapeutic specific assessments should be \nrepresented in the appropriate body system domain (e.g., CV, OE, RP, respectively).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3096, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e8699fb6-d147-4c39-a9e1-cbb6691beb64": {"__data__": {"id_": "e8699fb6-d147-4c39-a9e1-cbb6691beb64", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 317, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0b1318a3-f7b1-4622-9b3d-2e42f66e5d8d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 317, "section": "UNSPECIFIED"}, "hash": "3eef091ae385e4da0c106df5bbbd3ad405619aa17e561e8ac2d35f25fa0a054c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "32e34bdf-ca80-40df-a185-fcd682ff3449", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 317, "section": "UNSPECIFIED"}, "hash": "07a20c6908226a8b0e032823b3f83e5837f13f28a391566f98a92b6f7ed305b7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC/NCI codelist values are enclosed in parentheses. \nPE \u2013 Assumptions \n1. PE findings reflect the presence or absence of physical signs of disease or abnormality observed during a general physical examination. Multiple body \nsystems are assessed during a physical examination, often starting at the head and ending at the toes, where the body is evaluated by inspection, \npalpation (feeling with the hands), percussion (tapping with fingers), and auscultation (listening). The examination often includes macro assessments \n(e.g., normal/abnormal) of appearance, general health, behavior, and body system review from head to toe.  \na. \nEvaluation of targeted body systems (e.g., cardiovascular, ophthalmic, reproductive) as part of therapeutic specific assessments should be \nrepresented in the appropriate body system domain (e.g., CV, OE, RP, respectively). \nb. See CDASHIG Section 8.3.11, PE - Physical Examination (available at https://www.cdisc.org/standards/foundational/cdash/), for additional \ncollection guidance.  \n2. Abnormalities observed during a physical examination may be encoded. When collected/reported as a PE finding, the verbatim value is represented in \nPEORRES and the encoded value in PESTRESC. When collected/reported as medical history or an adverse event, the verbatim value is represented in \nMHTERM or AETERM and the encoded value is represented in MHDECOD or AEDECOD, respectively.   \n3. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the PE domain, but the following qualifiers would \ngenerally not be used: --XFN, --NAM, --LOINC, --FAST, --TOX, --TOXGR.", "mimetype": "text/plain", "start_char_idx": 2235, "end_char_idx": 3875, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16c7fd2e-7386-4a4a-86f9-8f22504dadbe": {"__data__": {"id_": "16c7fd2e-7386-4a4a-86f9-8f22504dadbe", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 318, "section": "6.3.9 Questionnaires, Ratings, and Scales (QRS) Domains (FT, QS, RS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4c2b9b37-0d6a-4241-99fd-d6c85afaa8c4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 318, "section": "6.3.9 Questionnaires, Ratings, and Scales (QRS) Domains (FT, QS, RS)"}, "hash": "9548d24253c512ee41bdc23ee4e80478ee9b1919563981f25ded322bfd66af54", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This section includes domains used to represent data from questionnaires, ratings, and scales (QRS). The Functional Tests (FT) and Questionnaires (QS) sections \neach provide an overview, specifications, assumptions, and examples for these domains. The Disease Response and Clin Classification (RS) section contains an \noverview and specification for that domain; assumptions and examples are provided in subsections for the 2 use cases within the RS domain (i.e., disease \nresponse use case, clinical classifications use case). \nThe SDTMIG includes the FT, QS, and RS domains for QRS findings for different QRS concepts. These differ only in concept, in domain code, and in \ninformative content such as examples. A set of shared assumptions is included in each of the domain sections. \nCDISC develops controlled terminology and publishes supplements for individual QRS instruments when the instrument is in the public domain or when \npermission has been granted by the copyright holder.  \n\u2022 \nControlled Terminology release downloads and information about the CT development process are available \nat: https://www.cdisc.org/standards/terminology/controlled-terminology. \n\u2022 \nQRS supplements, implementation documents, and information about the QRS development process are available \nat: https://www.cdisc.org/standards/foundational/qrs. \nEach QRS supplement includes instrument-specific implementation assumptions, a dataset example, SDTM mapping strategies, and a list of any applicable \nsupplemental qualifiers. SDTM annotated CRFs are also provided where available.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1566, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5a855c2b-dc5f-46d1-9a69-8f11427ac120": {"__data__": {"id_": "5a855c2b-dc5f-46d1-9a69-8f11427ac120", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 319, "section": "6.3.9.1 Functional Tests (FT)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ae0db44a-ba09-4b74-b4e2-566d71094900", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 319, "section": "6.3.9.1 Functional Tests (FT)"}, "hash": "cf2fa6465b1023f7b4f67a76f898db06af966bf0641c32eba597a38bb8861736", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "394abb19-2ff6-4a77-86c2-197c707570ed", "node_type": "1", "metadata": {}, "hash": "82782574adf11b33145948b007190188d0226fe993f41a8b8ce4c2a45fd51f1d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "FT \u2013 Description/Overview \nA findings domain that contains data for named, stand-alone, task-based evaluations designed to provide an assessment of mobility, dexterity, or cognitive \nability. \nFT \u2013 Specification \nft.xpt, Functional Tests \u2014 Findings. One record per Functional Test finding per time point per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar FT \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nFTSEQ \nSequence Number \nNum  \nIdentifier \nSequence number to ensure uniqueness of records within a dataset for a subject. May be any valid number. Req \nFTGRPID \nGroup ID \nChar  \nIdentifier \nOptional group identifier, used to link together a block of related records within a subject in a domain. \nPerm \nFTREFID \nReference ID \nChar  \nIdentifier \nOptional internal or external identifier. \nPerm \nFTSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. May be preprinted on the CRF as an explicit line identifier or defined in the \nsponsor's operational database. Example: Line number on the Test page. \nPerm \nFTTESTCD \nShort Name of Test Char * \nTopic \nShort character value for FTTEST, which can be used as a column name when converting a dataset from a \nvertical format to a horizontal format. The value cannot be longer than 8 characters, nor can it start with a \nnumber (e.g., \"1TEST\" is not valid). FTTESTCD cannot contain characters other than letters, numbers, or \nunderscores. \nControlled terminology for FTTESTCD is published in separate codelists for each instrument. See \nhttps://www.cdisc.org/standards/terminology/controlled-terminology for values for FTTESTCD. Examples: \n\"W250101\", \"W25F0102\". \nReq \nFTTEST \nName of Test \nChar * \nSynonym \nQualifier \nVerbatim name of the question used to obtain the finding. The value in FTTEST cannot be longer than 40 \ncharacters. \nControlled terminology for FTTEST is published in separate codelists for each instrument. See \nhttps://www.cdisc.org/standards/terminology/controlled-terminology for values for FTTEST. Examples: \n\"W2501-25 Foot Walk Time\", \"W25F-More Than Two Attempts\". \nReq \nFTCAT \nCategory \nChar (FTCAT) \nGrouping \nQualifier \nUsed to specify the functional test in which the functional test question identified by FTTEST and \nFTTESTCD was included. \nReq \nFTSCAT \nSubcategory \nChar  \nGrouping \nQualifier \nUsed to define a further categorization of FTCAT values. \nPerm \nFTPOS \nPosition of Subject \nDuring Observation \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during the test. Examples: \"SUPINE\", \"STANDING\", \"SITTING\". \nPerm \nFTORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nFTORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3212, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "394abb19-2ff6-4a77-86c2-197c707570ed": {"__data__": {"id_": "394abb19-2ff6-4a77-86c2-197c707570ed", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 319, "section": "6.3.9.1 Functional Tests (FT)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ae0db44a-ba09-4b74-b4e2-566d71094900", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 319, "section": "6.3.9.1 Functional Tests (FT)"}, "hash": "cf2fa6465b1023f7b4f67a76f898db06af966bf0641c32eba597a38bb8861736", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5a855c2b-dc5f-46d1-9a69-8f11427ac120", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 319, "section": "6.3.9.1 Functional Tests (FT)"}, "hash": "a787c63b6f9265ed815192895a7a535cd83260000e46da9b1a617b2d1e108012", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Req \nFTCAT \nCategory \nChar (FTCAT) \nGrouping \nQualifier \nUsed to specify the functional test in which the functional test question identified by FTTEST and \nFTTESTCD was included. \nReq \nFTSCAT \nSubcategory \nChar  \nGrouping \nQualifier \nUsed to define a further categorization of FTCAT values. \nPerm \nFTPOS \nPosition of Subject \nDuring Observation \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during the test. Examples: \"SUPINE\", \"STANDING\", \"SITTING\". \nPerm \nFTORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the measurement or finding as originally received or collected. \nExp \nFTORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. Unit for FTORRES. \nPerm \nFTSTRESC \nResult or Finding in \nStandard Format \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from FTORRES in a standard format or in \nstandard units. FTSTRESC should store all results or findings in character format; if results are numeric, \nthey should also be stored in numeric format in FTSTRESN. \nExp \nFTSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nFTSTRESC. FTSTRESN should store all numeric test results or findings. \nPerm", "mimetype": "text/plain", "start_char_idx": 2477, "end_char_idx": 3844, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "63bd4f1e-4881-4252-a923-33877ce14f91": {"__data__": {"id_": "63bd4f1e-4881-4252-a923-33877ce14f91", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 320, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "16372890-a5f1-4c5e-8b81-8134278494a1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 320, "section": "UNSPECIFIED"}, "hash": "2c0c0f4be472224ca919c121571419e9b8cb24fb8c1128a4223c9ff1121a8510", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "127225ef-a33d-4812-a0d7-3ccf9d0fe1f2", "node_type": "1", "metadata": {}, "hash": "a3434f5a96c2cd751a949ebc5ba0b989f0657a51e27b6f139eddef72d0832d4d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 320 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nFTSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for FTSTRESC and FTSTRESN. \nPerm \nFTSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a test was not done, or a test was attempted but did not generate a result. Should be \nnull or have a value of \"NOT DONE\". \nPerm \nFTREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a test was not done, or a test was attempted but did not generate a result. Used in \nconjunction with FTSTAT when value is \"NOT DONE\". \nPerm \nFTXFN \nExternal File Path \nChar  \nRecord \nQualifier \nFile path to an external file. \nPerm \nFTNAM \nVendor Name \nChar  \nRecord \nQualifier \nName or identifier of the vendor or laboratory that provided the test results. \nPerm \nFTMETHOD Method of Test or \nExamination \nChar (QRSMTHOD) \nRecord \nQualifier \nMethod of the test or examination. \nPerm \nFTLOBXFL \nLast Observation \nBefore Exposure \nFlag \nChar (NY) \nRecord \nQualifier \nOperationally-derived indicator used to identify the last non-missing value prior to RFXSTDTC. The value \nshould be \"Y\" or null. \nExp \nFTBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nA baseline defined by the sponsor (could be derived in the same manner as FTLOBXFL or ABLFL, but is \nnot required to be). The value should be \"Y\" or null. Note that FTBLFL is retained for backward compatibility. \nThe authoritative baseline flag for statistical analysis is in an ADaM dataset. \nPerm \nFTDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as a \ncomputed baseline). Should be \"Y\" or null. \nPerm \nFTREPNUM Repetition Number \nNum  \nRecord \nQualifier \nThe incidence number of a test that is repeated within a given timeframe for the same test. The level of \ngranularity can vary (e.g., within a time point, within a visit). Examples: multiple measurements of blood \npressure, multiple analyses of a sample. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day \nof Visit \nNum  \nTiming \nPlanned study day of VISIT based upon RFSTDTC in Demographics. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the assessment \nwas made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the observation date/time of the functional tests finding. \nPerm \nFTDTC \nDate/Time of Test \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of functional test.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3048, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "127225ef-a33d-4812-a0d7-3ccf9d0fe1f2": {"__data__": {"id_": "127225ef-a33d-4812-a0d7-3ccf9d0fe1f2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 320, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "16372890-a5f1-4c5e-8b81-8134278494a1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 320, "section": "UNSPECIFIED"}, "hash": "2c0c0f4be472224ca919c121571419e9b8cb24fb8c1128a4223c9ff1121a8510", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "63bd4f1e-4881-4252-a923-33877ce14f91", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 320, "section": "UNSPECIFIED"}, "hash": "9839a58cd0cc148999bd5dfd668e62726b92da7b32efe101f6ad6f277a2bbabe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day \nof Visit \nNum  \nTiming \nPlanned study day of VISIT based upon RFSTDTC in Demographics. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the assessment \nwas made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the observation date/time of the functional tests finding. \nPerm \nFTDTC \nDate/Time of Test \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of functional test. \nExp \nFTDY \nStudy Day of Test \nNum  \nTiming \nActual study day of test expressed in integer days relative to the sponsor-defined RFSTDTC in \nDemographics. \nPerm \nFTTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when a measurement or observation should be taken, as defined in the protocol. \nThis may be represented as an elapsed time relative to a fixed reference point, such as time of last dose. \nSee FTTPTNUM and FTTPTREF. \nPerm \nFTTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nFTELTM \nPlanned Elapsed \nTime from Time \nPoint Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time relative to a planned fixed reference (FTTPTREF). Not a clock time or a date/time \nvariable, but an interval, represented as ISO duration. \nPerm \nFTTPTREF \nTime Point \nReference \nChar  \nTiming \nDescription of the fixed reference point referred to by FTELTM, FTTPTNUM, and FTTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nFTRFTDTC \nDate/Time of \nReference Time \nPoint \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time for a fixed reference time point defined by FTTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses.", "mimetype": "text/plain", "start_char_idx": 2264, "end_char_idx": 4375, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "593161fd-cc36-4d60-8076-43a77e720a5b": {"__data__": {"id_": "593161fd-cc36-4d60-8076-43a77e720a5b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 321, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0ae89faf-3ec0-40cd-a36e-2ff6a194988a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 321, "section": "UNSPECIFIED"}, "hash": "68025cd3b3d86e9344a354414fe8035ef311e3088616876d474cf6dc79049269", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 321 \n2021-11-29 \nFT \u2013 Assumptions \nThe following assumptions are unique to the FT domain: \n1. A functional test is not a subjective assessment of how the subject generally performs a task, but rather an objective measurement of the performance of \nthe task by the subject in a specific instance.  \n2. Functional tests have documented methods for administration and analysis and require a subject to perform specific activities that are evaluated and \nrecorded. Most often, functional tests are direct quantitative measurements. Examples of functional tests include the Timed 25-Foot Walk, 9-Hole Peg \nTest, and the Hauser Ambulation Index. \nQRS Shared Assumptions \nThe following assumptions are common to the FT and QS domains as well as the Clinical Classifications use case of the RS domain (not the Disease Response \nuse case of RS): \n1. The name of a QRS instrument is described under the variable --CAT in the relevant QRS domain (i.e., FT, QS, RS), and may be either abbreviations or \nlonger names. For example, \"ADAS-COG\", \"BPI SHORT FORM\", and \"APACHE II\" are all --CATs which are shortened names for the instruments \nthey represent, whereas \"4 STAIR ASCEND\" is the FTCAT for the instrument of the same name. Sponsors should always reference CDISC Controlled \nTerminology. \na. \nThe QRS Naming Rules for --CAT, --TEST, and --TESTCD and the list of QRS instruments that have published CDISC Controlled Terminology \nwith NCI/EVS are available at: https://www.cdisc.org/standards/terminology/controlled-terminology. \nb. Refer to the following CDISC Controlled Terminology codelists for QRS instrument --CAT terminology: \ni. Category of Clinical Classification \nii. Category of Functional Test \niii. Category of Questionnaire \nc. \nQRS --TESTCD/--TEST terminology codelists are listed separately by instrument name.        \n2. Names of subcategories for groups of items/questions are described under the --SCAT variable. \na. \n--SCAT values are not included in the CDISC Controlled Terminology system but rather controlled as described in the QRS supplements in which \nthey are used. \n3. There are cases where QRS CRFs do not include numeric \u201cstandardized responses\u201d assigned to text responses (e.g., mild, moderate, severe being 1, 2, \n3). It is clearly in everyone's best interest to include the numeric \u201cstandardized responses\u201d in the SDTMIG QRS dataset. This is only done when the \nnumeric \u201cstandardized responses\u201d are documented in the QRS CRF instructions, a user manual, a website specific to the QRS instrument, or another \nreference document that provides a clear explanation and rationale for providing them in the SDTMIG QRS dataset. \n4. Sponsors should always consult published QRS supplements for guidance on submitting derived information in a SDTMIG QRS domain. Derived \nvariable results in QRS are usually considered captured data. If sponsors operationally derive variable results, then the derived records that are submitted \nin a QRS domain should be flagged by --DRVFL. \na. \nThe following rules apply for \u201ctotal\u201d-type scores in QRS datasets.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3241, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7fa7c3c0-428a-45b1-aae5-7845e63fa64f": {"__data__": {"id_": "7fa7c3c0-428a-45b1-aae5-7845e63fa64f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 322, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26a2de5a-37ca-4993-be72-f3451e471d09", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 322, "section": "UNSPECIFIED"}, "hash": "38796f4475d5a4f4c097f3c5d8f6b8395c3dce7d4e465df1071d0cb7d3d9c7da", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "371f9c81-42a1-467b-873e-5f1c973a4e23", "node_type": "1", "metadata": {}, "hash": "29fdf6afd1c4167082504eadcc44bc97f88edb80f7d0dc2c826d9b742b8c99b0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 322 \n2021-11-29 \ni. QRS subtotal, total, etc. scores listed on the CRF are considered captured data and are included in the instrument\u2019s controlled terminology. \nii. QRS subtotal, total, etc. scores not listed on the CRF but documented in an associated instrument manual or reference paper are considered \ncaptured data and are included in the instrument\u2019s controlled terminology. \niii. QRS subtotal, total, etc. scores not listed on the CRF, but known to be included in eData by sponsors are considered as captured data, are \nincluded in the instrument\u2019s controlled terminology. The QRS instrument\u2019s CT is considered extensible for this case and the subtotal or total \nscore should be requested to be added. \n1. Any imputations/calculations done to numeric \u201cstandardized responses\u201d to produce the total score via transforming numeric \u201cstandardized \nresponses\u201d in any way would be done as ADaM derivations. \nb. The QRS instrument subtotal or total score, which is the sum of the numeric responses for an instrument, is populated in --ORRES, --STRESC, and \n--STRESN. It is considered a captured subtotal or total score without any knowledge of the sponsor-data management processes related to the score. \ni. If operationally derived by the sponsor, it is the sponsor's responsibility to set the --DRVFL flag based on their eCRF process to derive subtotal \nand total scores. An investigator-derived score written on a CRF will be considered a captured score and not flagged. When subtotal and total \nscores are derived by the sponsor, the derived flag (--DRVFL) is set to \"Y\". However, when the subtotal and total scores are received from a \ncentral provider or vendor, the value would go into --ORRES and --DRVFL would be null (see Section 4.1.8.1, Origin Metadata for \nVariables). \n5. The variable --REPNUM variable is populated when there are multiple repeats of the same question. When records are related to the first trial of the \nquestion, the variable --REPNUM should be set to \"1\". When records are related to the second trial of the same question, --REPNUM should be set to \n\"2\", and so forth. \n6. The actual version number of an instrument is represented in the --CAT value as designated by the QRS Terminology Team. If it is determined that this \nis not the case for an instrument: \na. \nNotify the QRS Terminology Team that the instrument has a specific or multiple version numbers. This team will assist in providing an resolution \non how the situation will be handled. \nb. Consider the use of the --GRPID variable to indicate the instrument's version number prior to a decision by the QRS Terminology Team. \nc. \nThe sponsor is expected to provide information about the version used for each QRS instrument in the metadata (using the Comments column in the \nDefine-XML document). This could be provided as value-level metadata for --CAT. \nd. The sponsor is expected to provide information about the scoring rules in the metadata. \n7. If the variable --TEST is represented with verbatim text >40 characters, represent the abbreviated meaningful text in --TEST within 40 characters and \ndescribe the full text of the item in the study metadata.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3332, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "371f9c81-42a1-467b-873e-5f1c973a4e23": {"__data__": {"id_": "371f9c81-42a1-467b-873e-5f1c973a4e23", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 322, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26a2de5a-37ca-4993-be72-f3451e471d09", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 322, "section": "UNSPECIFIED"}, "hash": "38796f4475d5a4f4c097f3c5d8f6b8395c3dce7d4e465df1071d0cb7d3d9c7da", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7fa7c3c0-428a-45b1-aae5-7845e63fa64f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 322, "section": "UNSPECIFIED"}, "hash": "c9ae13d03c7de596fe6cb7fb539962bc66eeff55be0aa7ed1cf7bb61ca6138d4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If it is determined that this \nis not the case for an instrument: \na. \nNotify the QRS Terminology Team that the instrument has a specific or multiple version numbers. This team will assist in providing an resolution \non how the situation will be handled. \nb. Consider the use of the --GRPID variable to indicate the instrument's version number prior to a decision by the QRS Terminology Team. \nc. \nThe sponsor is expected to provide information about the version used for each QRS instrument in the metadata (using the Comments column in the \nDefine-XML document). This could be provided as value-level metadata for --CAT. \nd. The sponsor is expected to provide information about the scoring rules in the metadata. \n7. If the variable --TEST is represented with verbatim text >40 characters, represent the abbreviated meaningful text in --TEST within 40 characters and \ndescribe the full text of the item in the study metadata. If the verbatim item response (e.g., --QSORRES) is >200 characters, represent the abbreviated \nmeaningful text in QSORRES within the 200 characters and describe the full text in the study metadata; see Section 4 of the QRS supplement. See \nSection 4.5.3, Text Strings that Exceed the Maximum Length for General Observation-class Domain Variables, for further information. \na. \nThe instrument\u2019s annotated CRF can also be used as a reference for the full text in both of these situations. \n8. --EVAL and --EVALID must not be used to model QRS data in SDTM. These variables have had various interpretations on QRS CRFs and were used \nto represent a multitude of evaluator information about QRS instruments. This has made it more difficult for users of SDTM QRS data to interpret this", "mimetype": "text/plain", "start_char_idx": 2405, "end_char_idx": 4113, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2b85f8c-8a07-483b-b508-3281943203d2": {"__data__": {"id_": "c2b85f8c-8a07-483b-b508-3281943203d2", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 323, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1bbbc91e-59c6-4d9a-86ee-93fb7ffac84b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 323, "section": "UNSPECIFIED"}, "hash": "2204c8cdfa4e6287b5c1326b0a628a0311f50917e3efe927b246f578f598064c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c45cf6a7-82f5-41ea-9da2-fb8bc4eed9d5", "node_type": "1", "metadata": {}, "hash": "9bebd88aa9a75a671cfd66b4c5a1ebb69bb125fc6ec4ff152af59f5831506631", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 323 \n2021-11-29 \ndata and more difficult to pool data for analyses. If needed, supplemental qualifiers may be used to represent this data. Updated information on a \nproposed solution to this issue will be posted on the CDISC QRS webpage (https://www.cdisc.org/standards/foundational/qrs).  \n9. All standard QRS supplement development is coordinated with the CDISC SDS QRS Subteam as the governing body. The process involves drafting the \ncontrolled terminology and defining instrument-specific standardized values for qualifier, timing, and result variables to populate the SDTMIG FT, QS, \nand RS domains. These supplements are developed based on user demand and therapeutic area standards development needs. Sponsors should always \nconsult the CDISC website to review the terminology and supplements prior to modeling any QRS instrument. \na. \nSponsors may participate and/or request the development of additional QRS supplements and terminology through the CDISC SDS QRS subteam \nand the Controlled Terminology QRS subteam. \ni. Once generated, the QRS supplement is posted on the CDISC website (https://www.cdisc.org/standards/foundational/qrs). \nii. Sponsors should always consult the published QRS supplements for guidance on submitting derived information in SDTMIG-based domains. \n10. Any identifiers, timing variables, or findings general observation class qualifiers may be added to a QRS domain, but the following qualifiers would \ngenerally not be used: --POS, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STRNC, --NRIND, --XFN, --LOINC, --SPEC, --\nSPCCND, --LOC, --FAST, --TOX, --TOXGR, --SEV. \nFT \u2013 Examples \nCDISC publishes supplements for individual functional tests (at https://www.cdisc.org/standards/foundational/qrs Additional FT examples can be found in \nsupplements on that webpage. \nExample 1 \n6-Minute Walk Test (SIX MINUTE WALK) \nThe example represents the distance (in meters) that were walked at each minute of the 6-Minute Walk Test. The assistive device the subject used during the test \nis represented in the SUPPFT dataset.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2237, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c45cf6a7-82f5-41ea-9da2-fb8bc4eed9d5": {"__data__": {"id_": "c45cf6a7-82f5-41ea-9da2-fb8bc4eed9d5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 323, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1bbbc91e-59c6-4d9a-86ee-93fb7ffac84b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 323, "section": "UNSPECIFIED"}, "hash": "2204c8cdfa4e6287b5c1326b0a628a0311f50917e3efe927b246f578f598064c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c2b85f8c-8a07-483b-b508-3281943203d2", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 323, "section": "UNSPECIFIED"}, "hash": "e8f5b4b8e94e9974b2ecf1d974480ce6217250bc5f6d7e60f87e7de2e91affe5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "FT \u2013 Examples \nCDISC publishes supplements for individual functional tests (at https://www.cdisc.org/standards/foundational/qrs Additional FT examples can be found in \nsupplements on that webpage. \nExample 1 \n6-Minute Walk Test (SIX MINUTE WALK) \nThe example represents the distance (in meters) that were walked at each minute of the 6-Minute Walk Test. The assistive device the subject used during the test \nis represented in the SUPPFT dataset. \nft.xpt \nRow STUDYID DOMAIN USUBJID FTSEQ FTGRPID FTTESTCD FTTEST \nFTCAT \nFTORRES FTORRESU FTSTRESC FTSTRESN FTSTRESU FTBLFL VISITNUM FTDTC \n1 \nSTUDYX \nFT \nMS01-01 \n1 \n1 \nSIXMW101 SIXMW1-\nDistance at 1 \nMinute \nSIX \nMINUTE \nWALK \n101 \nm \n101 \n101 \nm \nY \n1 \n2014-\n03-10 \n2 \nSTUDYX \nFT \nMS01-01 \n2 \n1 \nSIXMW102 SIXMW1-\nDistance at 2 \nMinutes \nSIX \nMINUTE \nWALK \n201 \nm \n201 \n201 \nm \nY \n1 \n2014-\n03-10 \n3 \nSTUDYX \nFT \nMS01-01 \n3 \n1 \nSIXMW103 SIXMW1-\nDistance at 3 \nMinutes \nSIX \nMINUTE \nWALK \n299 \nm \n299 \n299 \nm \nY \n1 \n2014-\n03-10 \n4 \nSTUDYX \nFT \nMS01-01 \n4 \n1 \nSIXMW104 SIXMW1-\nDistance at 4 \nMinutes \nSIX \nMINUTE \nWALK \n396 \nm \n396 \n396 \nm \nY \n1 \n2014-\n03-10 \n5 \nSTUDYX \nFT \nMS01-01 \n5 \n1 \nSIXMW105 SIXMW1-\nDistance at 5 \nMinutes \nSIX \nMINUTE \nWALK \n493 \nm \n493 \n493 \nm \nY \n1 \n2014-\n03-10 \n6 \nSTUDYX \nFT \nMS01-01 \n6 \n1 \nSIXMW106 SIXMW1-\nDistance at 6 \nMinutes \nSIX \nMINUTE \nWALK \n597 \nm \n597 \n597 \nm \nY \n1 \n2014-\n03-10", "mimetype": "text/plain", "start_char_idx": 1791, "end_char_idx": 3156, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7fb996dd-3fe5-4e1a-b691-31100987adfd": {"__data__": {"id_": "7fb996dd-3fe5-4e1a-b691-31100987adfd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 324, "section": "6.3.9.2 Questionnaires (QS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2bac64ee-5976-45ec-b2e0-7819b43e2d68", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 324, "section": "6.3.9.2 Questionnaires (QS)"}, "hash": "a18050d8d04fb1d207ab4142a3a5f2cb3cdabb126b543738949222534954575f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "a93ea63e-1a7c-4f2d-a32e-1bde74c958da", "node_type": "1", "metadata": {}, "hash": "9d5ef50be84e1137a2bcedb5f223bf06662dcc339ffb7aba566eeef77d0b3837", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "QS \u2013 Description/Overview \nA findings domain that contains data for named, stand-alone instruments designed to provide an assessment of a concept. Questionnaires have a defined standard \nstructure, format, and content; consist of conceptually related items that are typically scored; and have documented methods for administration and analysis. \nQS \u2013 Specification \nqs.xpt, Questionnaires \u2014 Findings. One record per questionnaire per question per time point per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar QS \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the \nproduct. \nReq \nQSSEQ \nSequence \nNumber \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid number. \nReq \nQSGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nQSSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined in the \nsponsor's operational database. Example: Question number on a questionnaire. \nPerm \nQSTESTCD \nQuestion Short \nName \nChar * \nTopic \nTopic variable for QS. Short name for the value in QSTEST, which can be used as a column name when \nconverting the dataset from a vertical format to a horizontal format. The value in QSTESTCD cannot be longer \nthan 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). QSTESTCD cannot contain \ncharacters other than letters, numbers, or underscores. \nControlled terminology for QSTESTCD is published in separate codelists for each questionnaire. See \nhttps://www.cdisc.org/standards/semantics/terminology for values for QSTESTCD. Examples: \"ADCCMD01\", \n\"BPR0103\". \nReq \nQSTEST \nQuestion Name \nChar * \nSynonym \nQualifier \nVerbatim name of the question or group of questions used to obtain the measurement or finding. The value in \nQSTEST cannot be longer than 40 characters. \nControlled terminology for QSTEST is published in separate codelists for each questionnaire. See \nhttps://www.cdisc.org/standards/semantics/terminology for values for QSTEST. Example: \"BPR01 - Emotional \nWithdrawal\". \nReq \nQSCAT \nCategory of \nQuestion \nChar (QSCAT) \nGrouping \nQualifier \nUsed to specify the questionnaire in which the question identified by QSTEST and QSTESTCD was included. \nExamples: \"ADAS-COG\", \"MDS-UPDRS\". \nReq \nQSSCAT \nSubcategory for \nQuestion \nChar * \nGrouping \nQualifier \nA further categorization of the questions within the category. Examples: \"MENTAL HEALTH\" , \n\"DEPRESSION\", \"WORD RECALL\". \nPerm \nQSORRES \nFinding in Original \nUnits \nChar  \nResult \nQualifier \nFinding as originally received or collected (e.g., \"RARELY\", \"SOMETIMES\").", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3107, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a93ea63e-1a7c-4f2d-a32e-1bde74c958da": {"__data__": {"id_": "a93ea63e-1a7c-4f2d-a32e-1bde74c958da", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 324, "section": "6.3.9.2 Questionnaires (QS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2bac64ee-5976-45ec-b2e0-7819b43e2d68", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 324, "section": "6.3.9.2 Questionnaires (QS)"}, "hash": "a18050d8d04fb1d207ab4142a3a5f2cb3cdabb126b543738949222534954575f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7fb996dd-3fe5-4e1a-b691-31100987adfd", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 324, "section": "6.3.9.2 Questionnaires (QS)"}, "hash": "b2b72b353f87b7fed7874a46875d9a0948fe0b52c89d55d7fd144003d49fa26f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "See \nhttps://www.cdisc.org/standards/semantics/terminology for values for QSTEST. Example: \"BPR01 - Emotional \nWithdrawal\". \nReq \nQSCAT \nCategory of \nQuestion \nChar (QSCAT) \nGrouping \nQualifier \nUsed to specify the questionnaire in which the question identified by QSTEST and QSTESTCD was included. \nExamples: \"ADAS-COG\", \"MDS-UPDRS\". \nReq \nQSSCAT \nSubcategory for \nQuestion \nChar * \nGrouping \nQualifier \nA further categorization of the questions within the category. Examples: \"MENTAL HEALTH\" , \n\"DEPRESSION\", \"WORD RECALL\". \nPerm \nQSORRES \nFinding in Original \nUnits \nChar  \nResult \nQualifier \nFinding as originally received or collected (e.g., \"RARELY\", \"SOMETIMES\"). When sponsors apply codelist to \nindicate that code values are statistically meaningful standardized scores (which are defined by sponsors or by \nvalid methodologies, e.g., SF36 questionnaires), QSORRES will contain the decode format; QSSTRESC and \nQSSTRESN may contain the standardized code values or scores. \nExp", "mimetype": "text/plain", "start_char_idx": 2437, "end_char_idx": 3422, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "994440a2-f7c5-4ee0-a524-be2174b43d25": {"__data__": {"id_": "994440a2-f7c5-4ee0-a524-be2174b43d25", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 325, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "45f14817-c099-4e06-935e-244fb3622c55", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 325, "section": "UNSPECIFIED"}, "hash": "0b6c1ec951fa2ac60a233bc92dd0c3d188765fbde54f73543eb0b47b08fbcded", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ffd41f7c-1b9f-403c-83df-97b902e4db8b", "node_type": "1", "metadata": {}, "hash": "98712d8983ee9ddcd180245d2fdedbe8aa1fe7c0e91857d32b1c9fedc0ee433c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 325 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nQSORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for QSORRES, such as minutes or seconds or the \nunits associated with a visual analog scale. \nPerm \nQSSTRESC \nCharacter \nResult/Finding in \nStd Format \nChar  \nResult \nQualifier \nContains the finding for all questions or subscores copied or derived from QSORRES, in a standard format or \nstandard units. QSSTRESC should store all findings in character format; if findings are numeric, they should \nalso be stored in numeric format in QSSTRESN. If question scores are derived from the original finding, then \nthe standard format is the score. Examples: \"0\", \"1\". \nWhen sponsors apply codelist to indicate the code values are statistically meaningful standardized scores \n(which are defined by sponsors or by valid methodologies, e.g., SF36 questionnaires), QSORRES will contain \nthe decode format; QSSTRESC and QSSTRESN may contain the standardized code values or scores. \nExp \nQSSTRESN \nNumeric Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric findings in standard format; copied in numeric format from QSSTRESC. \nQSSTRESN should store all numeric results or findings. \nPerm \nQSSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for QSSTRESC or QSSTRESN. \nPerm \nQSSTAT \nCompletion Status Char (ND) \nRecord \nQualifier \nUsed to indicate that a question was not done or was not answered. Should be null if a result exists in \nQSORRES. \nPerm \nQSREASND \nReason Not \nPerformed \nChar  \nRecord \nQualifier \nDescribes why a question was not answered. Used in conjunction with QSSTAT when value is \"NOT DONE\". \nExample: \"SUBJECT REFUSED\". \nPerm \nQSMETHOD Method of Test or \nExamination \nChar (QRSMTHOD) \nRecord \nQualifier \nMethod of the test or examination. \nPerm \nQSLOBXFL \nLast Observation \nBefore Exposure \nFlag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. Should be \"Y\" \nor null. \nExp \nQSBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that QSBLFL is retained for backward \ncompatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nQSDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Records that represent the average of other \nrecords or questionnaire subscores that do not come from the CRF are examples of records that would be \nderived for the submission datasets. If QSDRVFL = \"Y\", then QSORRES may be null with QSSTRESC and (if \nnumeric) QSSTRESN having the derived value. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3133, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ffd41f7c-1b9f-403c-83df-97b902e4db8b": {"__data__": {"id_": "ffd41f7c-1b9f-403c-83df-97b902e4db8b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 325, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "45f14817-c099-4e06-935e-244fb3622c55", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 325, "section": "UNSPECIFIED"}, "hash": "0b6c1ec951fa2ac60a233bc92dd0c3d188765fbde54f73543eb0b47b08fbcded", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "994440a2-f7c5-4ee0-a524-be2174b43d25", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 325, "section": "UNSPECIFIED"}, "hash": "aeacce8e2a21a3a0eb9591cbccc73ddc2a1fd8d9f9fb44e4c2824a665d8059db", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Should be \"Y\" or null. Note that QSBLFL is retained for backward \ncompatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nQSDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Records that represent the average of other \nrecords or questionnaire subscores that do not come from the CRF are examples of records that would be \nderived for the submission datasets. If QSDRVFL = \"Y\", then QSORRES may be null with QSSTRESC and (if \nnumeric) QSSTRESN having the derived value. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study \nDay of Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within \nArm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the assessment \nwas made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the observation date/time of the physical exam finding. \nPerm \nQSDTC \nDate/Time of \nFinding \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nDate of questionnaire. \nExp \nQSDY \nStudy Day of \nFinding \nNum  \nTiming \nStudy day of finding collection, measured as integer days. Algorithm for calculations must be relative to the \nsponsor-defined RFSTDTC variable in Demographics. \nPerm \nQSTPT \nPlanned Time \nPoint Name \nChar  \nTiming \nText description of time when questionnaire should be administered. This may be represented as an elapsed \ntime relative to a fixed reference point (e.g., \"TIME OF LAST DOSE\"). See QSTPTNUM and QSTPTREF. \nPerm \nQSTPTNUM \nPlanned Time \nPoint Number \nNum  \nTiming \nNumerical version of QSTPT to aid in sorting. \nPerm \nQSELTM \nPlanned Elapsed \nTime from Time \nPoint Ref \nChar ISO 8601 duration Timing \nPlanned elapsed time (in ISO 8601) relative to a planned fixed reference (QSTPTREF). This variable is useful \nwhere there are repetitive measures. Not a clock time or a date time variable. Represented as an ISO 8601 \nduration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point indicated by \nQSTPTREF, \"PT8H\" to represent the period of 8 hours after the reference point indicated by QSTPTREF. \nPerm", "mimetype": "text/plain", "start_char_idx": 2438, "end_char_idx": 4914, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c95931ed-76e8-4477-8e3d-9f2eda4d33d7": {"__data__": {"id_": "c95931ed-76e8-4477-8e3d-9f2eda4d33d7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 326, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "81ef302a-8dc0-4838-910b-2908b0b0489c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 326, "section": "UNSPECIFIED"}, "hash": "e5f2e08f198bef86afe199ce278872297c18fa5bb232e1570f921e7d06a2279f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d9963c07-b0c2-47b5-93a6-10c1ad6b65bf", "node_type": "1", "metadata": {}, "hash": "dea1cb5d02dd8a5bb78230f614cfbf8610decae49ca1a858eb81c29981495a2b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 326 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nQSTPTREF \nTime Point \nReference \nChar  \nTiming \nName of the fixed reference point referred to by QSELTM, QSTPTNUM, and QSTPT. Examples: \"PREVIOUS \nDOSE\", \"PREVIOUS MEAL\". \nPerm \nQSRFTDTC \nDate/Time of \nReference Time \nPoint \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nDate/time of the reference time point, QSTPTREF. \nPerm \nQSEVLINT \nEvaluation Interval Char ISO 8601 duration \nor interval \nTiming \nEvaluation interval associated with a QSTEST question represented in ISO 8601 character format. Example: \"-\nP2Y\" to represent an interval of 2 years in the question \"Have you experienced any episodes in the past 2 \nyears?\". \nPerm \nQSEVINTX \nEvaluation Interval \nText \nChar  \nTiming \nEvaluation interval associated with an observation, where the interval is not able to be represented in ISO \n8601 format. Examples: \"LIFETIME\", \"LAST NIGHT\", \"RECENTLY\", \"OVER THE LAST FEW WEEKS\". \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nQS \u2013 Assumptions \nThere are no additional QS-specific assumptions; all are included in the QRS Shared Assumptions. \nQRS Shared Assumptions \nThe following assumptions are common to the FT and QS domains as well as the Clinical Classifications use case of the RS domain (not the Disease Response \nuse case of RS): \n1. The name of a QRS instrument is described under the variable --CAT in the relevant QRS domain (i.e., FT, QS, RS), and may be either abbreviations or \nlonger names. For example, \"ADAS-COG\", \"BPI SHORT FORM\", and \"APACHE II\" are all --CATs which are shortened names for the instruments \nthey represent, whereas \"4 STAIR ASCEND\" is the FTCAT for the instrument of the same name. Sponsors should always reference CDISC Controlled \nTerminology. \na. \nThe QRS Naming Rules for --CAT, --TEST, and --TESTCD and the list of QRS instruments that have published CDISC Controlled Terminology \nwith NCI/EVS are available at: https://www.cdisc.org/standards/terminology/controlled-terminology. \nb. Refer to the following CDISC Controlled Terminology codelists for QRS instrument --CAT terminology: \ni. Category of Clinical Classification \nii. Category of Functional Test \niii. Category of Questionnaire \nc. \nQRS --TESTCD/--TEST terminology codelists are listed separately by instrument name.        \n2. Names of subcategories for groups of items/questions are described under the --SCAT variable. \na. \n--SCAT values are not included in the CDISC Controlled Terminology system but rather controlled as described in the QRS supplements in which \nthey are used. \n3. There are cases where QRS CRFs do not include numeric \u201cstandardized responses\u201d assigned to text responses (e.g., mild, moderate, severe being 1, 2, \n3).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3063, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d9963c07-b0c2-47b5-93a6-10c1ad6b65bf": {"__data__": {"id_": "d9963c07-b0c2-47b5-93a6-10c1ad6b65bf", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 326, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "81ef302a-8dc0-4838-910b-2908b0b0489c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 326, "section": "UNSPECIFIED"}, "hash": "e5f2e08f198bef86afe199ce278872297c18fa5bb232e1570f921e7d06a2279f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c95931ed-76e8-4477-8e3d-9f2eda4d33d7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 326, "section": "UNSPECIFIED"}, "hash": "b56d3a41241baafa0f1c18cbf900b21386ea76514564a1d4e32dc6d86a1221b2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "b. Refer to the following CDISC Controlled Terminology codelists for QRS instrument --CAT terminology: \ni. Category of Clinical Classification \nii. Category of Functional Test \niii. Category of Questionnaire \nc. \nQRS --TESTCD/--TEST terminology codelists are listed separately by instrument name.        \n2. Names of subcategories for groups of items/questions are described under the --SCAT variable. \na. \n--SCAT values are not included in the CDISC Controlled Terminology system but rather controlled as described in the QRS supplements in which \nthey are used. \n3. There are cases where QRS CRFs do not include numeric \u201cstandardized responses\u201d assigned to text responses (e.g., mild, moderate, severe being 1, 2, \n3). It is clearly in everyone's best interest to include the numeric \u201cstandardized responses\u201d in the SDTMIG QRS dataset. This is only done when the \nnumeric \u201cstandardized responses\u201d are documented in the QRS CRF instructions, a user manual, a website specific to the QRS instrument, or another \nreference document that provides a clear explanation and rationale for providing them in the SDTMIG QRS dataset.", "mimetype": "text/plain", "start_char_idx": 2343, "end_char_idx": 3467, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b7a06797-c66f-4ad0-b2ca-ee350668a3fb": {"__data__": {"id_": "b7a06797-c66f-4ad0-b2ca-ee350668a3fb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 327, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8277e6f2-c090-4bdf-ba6f-d4c3730d6597", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 327, "section": "UNSPECIFIED"}, "hash": "0748e7bd2601ca574c3b26bec5556e40eb54061802a38bcde1e6c51785f25e46", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6d7d3942-5f62-4e06-8cc7-1b0ffc0df501", "node_type": "1", "metadata": {}, "hash": "4f34c1045b0df87bc354677677ba66b1216f00379c9d111ae7b3e937122df76d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 327 \n2021-11-29 \n4. Sponsors should always consult published QRS supplements for guidance on submitting derived information in a SDTMIG QRS domain. Derived \nvariable results in QRS are usually considered captured data. If sponsors operationally derive variable results, then the derived records that are submitted \nin a QRS domain should be flagged by --DRVFL. \na. \nThe following rules apply for \u201ctotal\u201d-type scores in QRS datasets. \ni. QRS subtotal, total, etc. scores listed on the CRF are considered captured data and are included in the instrument\u2019s controlled terminology. \nii. QRS subtotal, total, etc. scores not listed on the CRF but documented in an associated instrument manual or reference paper are considered \ncaptured data and are included in the instrument\u2019s controlled terminology. \niii. QRS subtotal, total, etc. scores not listed on the CRF, but known to be included in eData by sponsors are considered as captured data, are \nincluded in the instrument\u2019s controlled terminology. The QRS instrument\u2019s CT is considered extensible for this case and the subtotal or total \nscore should be requested to be added. \n1. Any imputations/calculations done to numeric \u201cstandardized responses\u201d to produce the total score via transforming numeric \u201cstandardized \nresponses\u201d in any way would be done as ADaM derivations. \nb. The QRS instrument subtotal or total score, which is the sum of the numeric responses for an instrument, is populated in --ORRES, --STRESC, and \n--STRESN. It is considered a captured subtotal or total score without any knowledge of the sponsor-data management processes related to the score. \ni. If operationally derived by the sponsor, it is the sponsor's responsibility to set the --DRVFL flag based on their eCRF process to derive subtotal \nand total scores. An investigator-derived score written on a CRF will be considered a captured score and not flagged. When subtotal and total \nscores are derived by the sponsor, the derived flag (--DRVFL) is set to \"Y\". However, when the subtotal and total scores are received from a \ncentral provider or vendor, the value would go into --ORRES and --DRVFL would be null (see Section 4.1.8.1, Origin Metadata for \nVariables). \n5. The variable --REPNUM variable is populated when there are multiple repeats of the same question. When records are related to the first trial of the \nquestion, the variable --REPNUM should be set to \"1\". When records are related to the second trial of the same question, --REPNUM should be set to \n\"2\", and so forth. \n6. The actual version number of an instrument is represented in the --CAT value as designated by the QRS Terminology Team. If it is determined that this \nis not the case for an instrument: \na. \nNotify the QRS Terminology Team that the instrument has a specific or multiple version numbers. This team will assist in providing an resolution \non how the situation will be handled. \nb. Consider the use of the --GRPID variable to indicate the instrument's version number prior to a decision by the QRS Terminology Team. \nc. \nThe sponsor is expected to provide information about the version used for each QRS instrument in the metadata (using the Comments column in the \nDefine-XML document).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3386, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6d7d3942-5f62-4e06-8cc7-1b0ffc0df501": {"__data__": {"id_": "6d7d3942-5f62-4e06-8cc7-1b0ffc0df501", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 327, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8277e6f2-c090-4bdf-ba6f-d4c3730d6597", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 327, "section": "UNSPECIFIED"}, "hash": "0748e7bd2601ca574c3b26bec5556e40eb54061802a38bcde1e6c51785f25e46", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b7a06797-c66f-4ad0-b2ca-ee350668a3fb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 327, "section": "UNSPECIFIED"}, "hash": "2be57ba16c68fa6381392611e9d47e87c04e61bc0a37701a1e6bc4e6424814ef", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "When records are related to the second trial of the same question, --REPNUM should be set to \n\"2\", and so forth. \n6. The actual version number of an instrument is represented in the --CAT value as designated by the QRS Terminology Team. If it is determined that this \nis not the case for an instrument: \na. \nNotify the QRS Terminology Team that the instrument has a specific or multiple version numbers. This team will assist in providing an resolution \non how the situation will be handled. \nb. Consider the use of the --GRPID variable to indicate the instrument's version number prior to a decision by the QRS Terminology Team. \nc. \nThe sponsor is expected to provide information about the version used for each QRS instrument in the metadata (using the Comments column in the \nDefine-XML document). This could be provided as value-level metadata for --CAT. \nd. The sponsor is expected to provide information about the scoring rules in the metadata. \n7. If the variable --TEST is represented with verbatim text >40 characters, represent the abbreviated meaningful text in --TEST within 40 characters and \ndescribe the full text of the item in the study metadata. If the verbatim item response (e.g., --QSORRES) is >200 characters, represent the abbreviated \nmeaningful text in QSORRES within the 200 characters and describe the full text in the study metadata; see Section 4 of the QRS supplement. See \nSection 4.5.3, Text Strings that Exceed the Maximum Length for General Observation-class Domain Variables, for further information.", "mimetype": "text/plain", "start_char_idx": 2585, "end_char_idx": 4121, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a57342b8-1361-4d8a-80b7-91a4f8a15a7f": {"__data__": {"id_": "a57342b8-1361-4d8a-80b7-91a4f8a15a7f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 328, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "76d20f18-e95d-4500-92c1-bea0f5a9eae7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 328, "section": "UNSPECIFIED"}, "hash": "461b67ebfe1af9121abeb3a5557a3da9d56d746c0bdaefc321aa804434c3f0df", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fb33f237-6e7a-4081-acbd-47dd0949fd4d", "node_type": "1", "metadata": {}, "hash": "fc528448225dfd1421f33571aac62b613212a4cd5223f430bbde93e6a8aae9ed", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 328 \n2021-11-29 \na. \nThe instrument\u2019s annotated CRF can also be used as a reference for the full text in both of these situations. \n8. --EVAL and --EVALID must not be used to model QRS data in SDTM. These variables have had various interpretations on QRS CRFs and were used \nto represent a multitude of evaluator information about QRS instruments. This has made it more difficult for users of SDTM QRS data to interpret this \ndata and more difficult to pool data for analyses. If needed, supplemental qualifiers may be used to represent this data. Updated information on a \nproposed solution to this issue will be posted on the CDISC QRS webpage (https://www.cdisc.org/standards/foundational/qrs).  \n9. All standard QRS supplement development is coordinated with the CDISC SDS QRS Subteam as the governing body. The process involves drafting the \ncontrolled terminology and defining instrument-specific standardized values for qualifier, timing, and result variables to populate the SDTMIG FT, QS, \nand RS domains. These supplements are developed based on user demand and therapeutic area standards development needs. Sponsors should always \nconsult the CDISC website to review the terminology and supplements prior to modeling any QRS instrument. \na. \nSponsors may participate and/or request the development of additional QRS supplements and terminology through the CDISC SDS QRS subteam \nand the Controlled Terminology QRS subteam. \ni. Once generated, the QRS supplement is posted on the CDISC website (https://www.cdisc.org/standards/foundational/qrs). \nii. Sponsors should always consult the published QRS supplements for guidance on submitting derived information in SDTMIG-based domains. \n10. Any identifiers, timing variables, or findings general observation class qualifiers may be added to a QRS domain, but the following qualifiers would \ngenerally not be used: --POS, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STRNC, --NRIND, --XFN, --LOINC, --SPEC, --\nSPCCND, --LOC, --FAST, --TOX, --TOXGR, --SEV. \nQS \u2013 Examples \nCDISC publishes supplements for individual questionnaires (at https://www.cdisc.org/standards/foundational/qrs). Additional QS examples can be found in \nsupplements on that webpage. \nExample 1 \nSatisfaction With Life Scale (SWLS) \nThe example represents the items from the SWLS instrument.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2504, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fb33f237-6e7a-4081-acbd-47dd0949fd4d": {"__data__": {"id_": "fb33f237-6e7a-4081-acbd-47dd0949fd4d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 328, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "76d20f18-e95d-4500-92c1-bea0f5a9eae7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 328, "section": "UNSPECIFIED"}, "hash": "461b67ebfe1af9121abeb3a5557a3da9d56d746c0bdaefc321aa804434c3f0df", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a57342b8-1361-4d8a-80b7-91a4f8a15a7f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 328, "section": "UNSPECIFIED"}, "hash": "732f4bb980cbf933f8806cc45f2b4332345d1c56700c3950e71c3b5f2548c903", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "10. Any identifiers, timing variables, or findings general observation class qualifiers may be added to a QRS domain, but the following qualifiers would \ngenerally not be used: --POS, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STRNC, --NRIND, --XFN, --LOINC, --SPEC, --\nSPCCND, --LOC, --FAST, --TOX, --TOXGR, --SEV. \nQS \u2013 Examples \nCDISC publishes supplements for individual questionnaires (at https://www.cdisc.org/standards/foundational/qrs). Additional QS examples can be found in \nsupplements on that webpage. \nExample 1 \nSatisfaction With Life Scale (SWLS) \nThe example represents the items from the SWLS instrument. \nqs.xpt \nRow STUDYID DOMAIN USUBJID \nQSSEQ QSTESTCD QSTEST \nQSCAT QSORRES \nQSSTRESC QSSTRESN QSLOBXFL VISITNUM QSDTC \nQSDY \n1 \nCDISC01 QS \nCDISC01.100008 1 \nSWLS0101 \nSWLS01-My Life is Close to Ideal \nSWLS \nSlightly agree \n5 \n5 \nY \n1 \n2003-04-\n15 \n1 \n2 \nCDISC01 QS \nCDISC01.100008 2 \nSWLS0102 \nSWLS01-My Life Conditions are \nExcellent \nSWLS \nNeither agree nor \ndisagree \n4 \n4 \nY \n1 \n2003-04-\n15 \n1 \n3 \nCDISC01 QS \nCDISC01.100008 3 \nSWLS0103 \nSWLS01-I Am Satisfied with My \nLife \nSWLS \nAgree \n6 \n6 \nY \n1 \n2003-04-\n15 \n1 \n4 \nCDISC01 QS \nCDISC01.100008 4 \nSWLS0104 \nSWLS01-Have Gotten Important \nThings \nSWLS \nDisagree \n2 \n2 \nY \n1 \n2003-04-\n15 \n1 \n5 \nCDISC01 QS \nCDISC01.100008 5 \nSWLS0105 \nSWLS01-Live Life Over Change \nNothing \nSWLS \nStrongly disagree \n1 \n1 \nY \n1 \n2003-04-\n15 \n1 \n6 \nCDISC01 QS \nCDISC01.100014 6 \nSWLS0101 \nSWLS01-My Life is Close to Ideal \nSWLS \nSlightly agree \n5 \n5 \nY \n1 \n2003-04-\n15 \n1 \n7 \nCDISC01 QS \nCDISC01.100014 7 \nSWLS0102 \nSWLS01-My Life Conditions are \nExcellent \nSWLS \nNeither agree nor \ndisagree \n4 \n4 \nY \n1 \n2003-04-\n15 \n1 \n8 \nCDISC01 QS \nCDISC01.100014 8 \nSWLS0103 \nSWLS01-I Am Satisfied with My \nLife \nSWLS \nAgree \n6 \n6 \nY \n1 \n2003-04-\n15 \n1", "mimetype": "text/plain", "start_char_idx": 1874, "end_char_idx": 3679, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6acce295-5e15-4a0b-8e60-2731719660eb": {"__data__": {"id_": "6acce295-5e15-4a0b-8e60-2731719660eb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 329, "section": "6.3.9.3 Disease Response and Clin Classification (RS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a54d56db-33a2-4a37-8cb7-d478e2ef5510", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 329, "section": "6.3.9.3 Disease Response and Clin Classification (RS)"}, "hash": "72274212c35939c971f99be135f5df83db31a351a5743ab93aded460facda345", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RS \u2013 Description/Overview \nA findings domain for the assessment of disease response to therapy, or clinical classification based on published criteria. \nData in this domain may or may not be collected by means of a standard CRF. \n\u2022 \nClinical classification instruments usually have a standard CRF for data capture, but also may instead be based on an evaluator providing response \nevaluations based on published criteria. \n\u2022 \nOncology response criteria are evaluated based on published criteria. \n\u2022 \nAdditional disease classifications or scoring systems (e.g., staging criteria) are based on published criteria. \n\u2022 \nThere are separate supplements prepared for clinical classification instruments and therapeutic-area disease response criteria use cases. \nRS \u2013 Specification \nrs.xpt, Disease Response and Clin Classification \u2014 Findings. One record per response assessment or clinical classification \nassessment per time point per visit per subject per assessor per medical evaluator, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar RS \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nRSSEQ \nSequence Number Num  \nIdentifier \nSequence number given to ensure uniqueness within a dataset for a subject. May be any valid \nnumber. \nReq \nRSGRPID \nGroup ID \nChar  \nIdentifier \nUsed to link together a block of related records within a subject in a domain. \nPerm \nRSREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier. \nPerm \nRSSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. \nPerm \nRSLNKID \nLink ID \nChar  \nIdentifier \nAn identifier used to link the response assessment to the related measurement record in another \ndomain which was used to determine the response result. LNKID values group records within \nUSUBJID. \nPerm \nRSLNKGRP \nLink Group ID \nChar  \nIdentifier \nA grouping identifier used to link the response assessment to a group of measurement/assessment \nrecords which were used in the assessment of the response. LNKGRP values group records within \nUSUBJID. \nPerm \nRSTESTCD \nAssessment Short \nName \nChar (ONCRTSCD) \nTopic \nShort name of the TEST in RSTEST. The value in RSTESTCD cannot be longer than 8 characters, \nnor can it start with a number (e.g., \"1TEST\" is not valid). RSTESTCD cannot contain characters other \nthan letters, numbers, or underscores. Examples: \"TRGRESP\", \"NTRGRESP\", \"OVRLRESP\", \n\"SYMPTDTR\", \"CPS0102\". \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2773, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "92358d77-c67d-48ea-8a63-85a2d12ae106": {"__data__": {"id_": "92358d77-c67d-48ea-8a63-85a2d12ae106", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 330, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f8609595-4f2f-4262-affc-75255774868f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 330, "section": "UNSPECIFIED"}, "hash": "ab7a3500a359ff38f0c0d075f68b4e6969a124db4863c9c03eb4f6c5af9a82e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ef86c120-5d25-49f4-a096-58bf968df9a3", "node_type": "1", "metadata": {}, "hash": "b09160c12b390f7b45447151a04512b0e186e98c2f89865d54f043876b6ac402", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 330 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nThere are separate codelists used for RSTESTCD where the choice depends on the value of RSCAT. \nCodelist \"ONCRTSCD\" is used for oncology response criteria (when RSCAT is a term in codelist \n\"ONCRSCAT\"). Examples: TRGRESP, \"NTRGRESP, \"OVRLRESP\". For Clinical Classifications \n(when RSCAT is a term in codelist \"CCCAT\"), QRS Naming Rules apply. These instruments have \nindividual dedicated terminology codelists. \nRSTEST \nAssessment Name Char (ONCRTS) \nSynonym \nQualifier \nVerbatim name of the response assessment. The value in RSTEST cannot be longer than 40 \ncharacters. \nThere are separate codelists used for RSTEST where the choice depends on the value of RSCAT. \nCodelist \"ONCRTS\" is used for oncology response criteria (when RSCAT is a term in codelist \n\"ONCRSCAT\"). Examples: \"Target Response\", \"Non-target Response\", \"Overall Response\", \n\"Symptomatic Deterioration\". For Clinical Classifications (when RSCAT is a term in codelist \n\"CCCAT\"), QRS Naming Rules apply. These instruments have individual dedicated terminology \ncodelists. \nReq \nRSCAT \nCategory for \nAssessment \nChar (ONCRSCAT)(CCCAT) \nGrouping \nQualifier \nUsed to define a category of related records across subjects. Examples: \"RECIST 1.1\", \"CHILD-\nPUGH CLASSIFICATION\". There are separate codelists used for RSCAT where the choice depends \non whether the related records are about an oncology response criterion or another clinical \nclassification. \nRSCAT is required for clinical classifications other than oncology response criteria. \nExp \nRSSCAT \nSubcategory \nChar  \nGrouping \nQualifier \nUsed to define a further categorization of RSCAT values. \nPerm \nRSORRES \nResult or Finding \nin Original Units \nChar  \nResult \nQualifier \nResult of the response assessment as originally received, collected, or calculated. \nExp \nRSORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nUnit for RSORRES. \nPerm \nRSSTRESC \nCharacter \nResult/Finding in \nStd Format \nChar (ONCRSR) \nResult \nQualifier \nContains the result value for the response assessment, copied, or derived from RSORRES in a \nstandard format or standard units. RSSTRESC should store all results or findings in character format. \nFor Clinical Classifications, this may be a score. \nExp \nRSSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from --\nSTRESC. --STRESN should store all numeric test results or findings. For Clinical Classifications, this \nmay be a score. \nPerm \nRSSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for RSSTRESC and RSSTRESN. \nPerm \nRSSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate the response assessment was not performed.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3052, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ef86c120-5d25-49f4-a096-58bf968df9a3": {"__data__": {"id_": "ef86c120-5d25-49f4-a096-58bf968df9a3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 330, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f8609595-4f2f-4262-affc-75255774868f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 330, "section": "UNSPECIFIED"}, "hash": "ab7a3500a359ff38f0c0d075f68b4e6969a124db4863c9c03eb4f6c5af9a82e4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "92358d77-c67d-48ea-8a63-85a2d12ae106", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 330, "section": "UNSPECIFIED"}, "hash": "25f13a1bd6a0d5e30363359b4f235b417538454e1854de195134c6d9bc2ab427", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RSSTRESC should store all results or findings in character format. \nFor Clinical Classifications, this may be a score. \nExp \nRSSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from --\nSTRESC. --STRESN should store all numeric test results or findings. For Clinical Classifications, this \nmay be a score. \nPerm \nRSSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for RSSTRESC and RSSTRESN. \nPerm \nRSSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate the response assessment was not performed. Should be null if a result exists in \nRSORRES. \nPerm \nRSREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a response assessment was not performed. Examples: \"All target tumors not \nevaluated\", \"Subject does not have non-target tumors\". Used in conjunction with RSSTAT when value \nis \"NOT DONE\". \nPerm \nRSNAM \nVendor Name \nChar  \nRecord \nQualifier \nThe name or identifier of the vendor that performed the response assessment. This column can be left \nnull when the investigator provides the complete set of data in the domain. \nPerm \nRSMETHOD Method of Test or \nExamination \nChar (QRSMTHOD) \nRecord \nQualifier \nMethod of the test or examination. \nPerm \nRSLOBXFL \nLast Observation \nBefore Exposure \nFlag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nWhen a clinical classification is assessed at multiple times, including baseline, RSLOBXFL should be \nincluded in the dataset. \nPerm \nRSBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that --BLFL is retained for \nbackward compatibility. The authoritative baseline for statistical analysis is in an ADaM dataset. \nPerm \nRSDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record (e.g., a record that represents the average of other records such as \na computed baseline). Should be \"Y\" or null. \nPerm", "mimetype": "text/plain", "start_char_idx": 2383, "end_char_idx": 4533, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "876d6d4e-9aec-4b95-90a2-cc3219fa18aa": {"__data__": {"id_": "876d6d4e-9aec-4b95-90a2-cc3219fa18aa", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 331, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9e2a9d2c-9026-4764-a237-af4877be3604", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 331, "section": "UNSPECIFIED"}, "hash": "019b5cbf8d000f802dac7405dcba55c23137ffa8e9842167204cd91982b91af1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "776f5a90-a5f7-49d7-96c6-5d6c4031af00", "node_type": "1", "metadata": {}, "hash": "ccbb84bee5a63dc91ce7dedfd8d9d56abe585b51c6054e3aeebcd2a0be0c3f15", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 331 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nRSEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\", \"RADIOLOGIST\". \nRSEVAL is expected for oncology response criteria. It can be left null when the investigator provides \nthe complete set of data in the domain. However, the column should contain no null values when data \nfrom one or more independent assessors is included, meaning that the rows attributed to the \ninvestigator should contain a value of \"INVESTIGATOR\". \nPerm \nRSEVALID \nEvaluator Identifier Char (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in RSEVAL. Examples: \n\"RADIOLOGIST1\", \"RADIOLOGIST2\". See assumptions in Section 6.3.9.3.1, Disease Response Use \nCase. \nPerm \nRSACPTFL \nAccepted Record \nFlag \nChar (NY) \nRecord \nQualifier \nIn cases where more than 1 independent assessor (e.g., \"RADIOLOGIST 1\", \"RADIOLOGIST 2\", \n\"ADJUDICATOR\") provides an evaluation of response, this flag identifies the record that is considered \nto be the accepted evaluation. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study \nDay of Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within \nArm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nRSDTC \nDate/Time of \nAssessment \nChar ISO 8601 datetime or \ninterval \nTiming \nCollection date and time of the assessment represented in ISO 8601 character format. \nExp \nRSDY \nStudy Day of \nAssessment \nNum  \nTiming \nStudy day of the assessment, measured as integer days. Algorithm for calculations must be relative to \nthe sponsor-defined RFSTDTC variable in Demographics. \nPerm \nRSTPT \nPlanned Time \nPoint Name \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point, such as time \nof last dose. See RSTPTNUM and RSTPTREF. \nPerm \nRSTPTNUM \nPlanned Time \nPoint Number \nNum  \nTiming \nNumeric version of planned time point used in sorting.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2888, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "776f5a90-a5f7-49d7-96c6-5d6c4031af00": {"__data__": {"id_": "776f5a90-a5f7-49d7-96c6-5d6c4031af00", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 331, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9e2a9d2c-9026-4764-a237-af4877be3604", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 331, "section": "UNSPECIFIED"}, "hash": "019b5cbf8d000f802dac7405dcba55c23137ffa8e9842167204cd91982b91af1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "876d6d4e-9aec-4b95-90a2-cc3219fa18aa", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 331, "section": "UNSPECIFIED"}, "hash": "e4397d68320e14db7ca0471bca71a4503c0312d1b7e72624c8c23cb3a5400d48", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nRSDTC \nDate/Time of \nAssessment \nChar ISO 8601 datetime or \ninterval \nTiming \nCollection date and time of the assessment represented in ISO 8601 character format. \nExp \nRSDY \nStudy Day of \nAssessment \nNum  \nTiming \nStudy day of the assessment, measured as integer days. Algorithm for calculations must be relative to \nthe sponsor-defined RFSTDTC variable in Demographics. \nPerm \nRSTPT \nPlanned Time \nPoint Name \nChar  \nTiming \nText description of time when a measurement or observation should be taken as defined in the \nprotocol. This may be represented as an elapsed time relative to a fixed reference point, such as time \nof last dose. See RSTPTNUM and RSTPTREF. \nPerm \nRSTPTNUM \nPlanned Time \nPoint Number \nNum  \nTiming \nNumeric version of planned time point used in sorting. \nPerm \nRSELTM \nPlanned Elapsed \nTime from Time \nPoint Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time in ISO 8601 character format relative to a planned fixed reference (RSTPTREF; \ne.g., \"PREVIOUS DOSE\", \"PREVIOUS MEAL\"). This variable is useful where there are repetitive \nmeasures. Not a clock time or a date/time variable, but an interval, represented as ISO duration. \nPerm \nRSTPTREF \nTime Point \nReference \nChar  \nTiming \nDescription of the fixed reference point referred to by RSELTM, RSTPTNUM, and RSTPT. Examples: \n\"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nRSRFTDTC \nDate/Time of \nReference Time \nPoint \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time for a fixed reference time point defined by RSTPTREF in ISO 8601 character format. \nPerm \nRSEVLINT \nEvaluation Interval \nChar ISO 8601 duration or \ninterval \nTiming \nDuration of interval associated with an observation such as a finding RSTESTCD, represented in ISO \n8601 character format. Example: \"-P2M\" to represent a period of the past 2 months as the evaluation \ninterval. \nPerm \nRSEVINTX \nEvaluation Interval \nText \nChar  \nTiming \nEvaluation interval associated with an observation, where the interval is not able to be represented in \nISO 8601 format. Examples: \"LIFETIME\", \"LAST NIGHT\", \"RECENTLY\", \"OVER THE LAST FEW \nWEEKS\". \nPerm \nRSSTRTPT \nStart Relative to \nReference Time \nPoint \nChar (STENRF) \nTiming \nIdentifies the start of the observation as being before or after the sponsor-defined reference time point \ndefined by variable RSSTTPT. \nNot all values of the codelist are allowable for this variable. See Section 4.4.7, Use of Relative Timing \nVariables. \nPerm \nRSSTTPT \nStart Reference \nTime Point \nChar  \nTiming \nDescription or date/time in ISO 8601 character format of the sponsor-defined reference point referred \nto by RSSTRTPT. Examples: \"2003-12-15\", \"VISIT 1\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2103, "end_char_idx": 4755, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e2a0d222-980d-4170-b46b-283029ec6078": {"__data__": {"id_": "e2a0d222-980d-4170-b46b-283029ec6078", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 332, "section": "6.3.9.3.1 Disease Response Use Case"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4fb76642-c6a1-4af3-bea3-5ce3ec162acf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 332, "section": "6.3.9.3.1 Disease Response Use Case"}, "hash": "efad436d5318353ad16ef9e166adbaedcbe06156cd7d09649ba60eb4e7964386", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RS \u2013 Disease Response Use Case Assumptions \nAssumptions here discuss the oncology use case, which is the only disease-response use case that currently exists. \n1. RSCAT is used to group a set of assessments based on a disease response criterion (published or protocol-defined). One of the codelists for RSCAT is \nONCRSCAT. The ONCRSCAT codelist contains controlled terminology for oncology disease response assessments. \n2. Oncology response criteria assess the change in tumor burden, an important feature of the clinical evaluation of cancer therapeutics: Both tumor \nshrinkage (objective response) and disease progression are useful endpoints in cancer clinical trials. The RS domain is applicable for representing \nresponses to assessment criteria such as RECIST[1] or Lugano classification.[2] The SDTM domain examples provided reference RECIST. Disease \nResponse supplements will be developed as 1 supplement per response criterion and will contained criterion-specific guidance and examples.  \na. \nCDISC submission values and definitions in the ONCRSR codelist have been developed to facilitate reuse by keeping the definitions focused on the \nmeaning of the result rather than on relating them to a specific published criterion or a particular tumor type. CDISC submission values and \ndefinitions are intended to apply across multiple tumor types, imaging modalities, therapeutic agents, and published criterion. This means that there \nmay be cases where the appropriate ONCRSR CDISC submission value may not exactly match the term used in the published criterion. It is \nexpected that clinicians should use the precise criterion definitions outlined in the individual papers to assign the appropriate response according to \nthe CDISC submission values. \nb. The terms \"response\" and \"remission\" are commonly used to describe functionally synonymous terms. \"Response\" is used in CDISC submission \nvalues based on the following agreement: FDA, CDISC, NCI-EVS, and select academic experts came to consensus that because the words \n\"response\" (used in solid tumors as an indicator of a favorable change in tumor burden) and \"remission\" (used in non-solid tumors) were \nfunctionally synonymous, 2 distinct terms were not required to be added to the ONCRSR codelist. Instead, \"remission\" has been added as a \nsynonym in all instances where \"response\" is used in a CDISC submission value, for response values used in both solid and non-solid tumors. The \nFDA expects a single CDISC submission value to be submitted for both solid and non-solid tumors. \nc. \nRefer to the Controlled Terminology Rules for Oncology for more information (available \nat https://www.cdisc.org/standards/terminology/controlled-terminology). \nd. RSTESTCD/RSTEST values for this domain are published as Controlled Terminology. For some RSTESTCD/RSTEST values, CDISC CT \nincludes codelists for use with RSORRES. The associations between the test values and results are in the Oncology codetable, available at \nhttps://www.cdisc.org/standards/terminology/controlled-terminology.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3051, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "59309db5-e341-4d7f-93d0-ebc057a0f7a6": {"__data__": {"id_": "59309db5-e341-4d7f-93d0-ebc057a0f7a6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 333, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b5bb01f8-34ed-4001-a1de-5d393d12d3bc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 333, "section": "UNSPECIFIED"}, "hash": "0b64ab46d8cdfe2d5a209c552db26e36466044734f1e4647a2b344a0ffb351bb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "64aa1fef-73d2-4c8d-912d-2ce58773c2aa", "node_type": "1", "metadata": {}, "hash": "94d7f0a7449f718c0599eb6cd9419e3593f71e486ad0c6187d0e44045474946a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 333 \n2021-11-29 \n3. The RS domain disease response criteria use case may include records derived by the investigator or with a data collection tool, but not sponsor-derived \nrecords. Sponsor-derived records and results should be provided in an analysis dataset (ADaM).  \na. \nFor disease response criteria, the BEST Response assessment records are included in the RS domain only when provided by the investigator or an \nindependent assessor (i.e., Best responses that are derived by the sponsor for the analysis are not included in the RS domain). \n4. The RSLNKGRP variable is used to provide a link between the records in a findings domain (e.g., Tumor/Lesion Results, TR; Laboratory Test Results, \nLB) that contribute to a record in the RS domain. Records should exist in the RELREC dataset to support this relationship. A RELREC relationship \ncould also be defined using RSLNKID when a response evaluation or clinical classification measure relates back to another source dataset (e.g., tumor \nassessment in TR). The domain in which data that contribute to an assessment of response reside should not affect whether a link to the RS record \nthrough a RELREC relationship is created. For example, a set of oncology response criteria might require lab results in the LB domain, not only tumor \nresults in the TR domain. \n5. When using the RS domain to represent response evaluation or clinical classification instruments that incorporate data from other domains: \na. \nWhenever possible, all source data must be represented in the topic-based domain(s) to which they pertain. For example, if a lab test value is \ncollected and then scored for a response evaluation, the lab test value must be recorded in the LB domain using the rules that apply to the domain \nand the tests being represented. \nb. In the oncology setting, the response to therapy would often be determined, at least in part, from data in the TR domain. Data from other sources (in \nother SDTM domains) might also be used in an assessment of response (e.g., lab test results, assessments of symptoms). \nc. \nOncology response assessments sometimes include symptomatic deterioration. \n \nSymptomatic deterioration may be considered as non-radiologic evidence of progressive disease. Symptomatic deterioration is recorded in RS with \nRSTEST = \"Symptomatic Deterioration\" and the standardized response (e.g., \"PD\") in RSSTRESC. \nRSTESTCD \nRSTEST \nRSCAT \nRSORRES \nRSSTRESC \nSYMPTDTR \nSymptomatic \nDeterioration \nPROTOCOL DEFINED \nRESPONSE CRITERIA \nIncreased weakness and \nweight loss \nPD \n \nd. In all cases, RSSTRESC should be populated as indicated in controlled terminology. \n6. Best response, duration of response, or the progression to prior therapies and follow-up therapies may be represented in the RS domain. \na. \nThe record in RS may be related and linked to record(s) in Concomitant/Prior Medications (CM) using CMLNKGRP and RSLNKGRP. Likewise, \nthe link to Procedures (PR; e.g., radiotherapy, surgery) would be made using PRLNKGRP. \nb. If the criteria used to determine the response is unknown or not collected, this is represented as RSCAT = \"UNSPECIFIED\". \n7.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3311, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "64aa1fef-73d2-4c8d-912d-2ce58773c2aa": {"__data__": {"id_": "64aa1fef-73d2-4c8d-912d-2ce58773c2aa", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 333, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b5bb01f8-34ed-4001-a1de-5d393d12d3bc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 333, "section": "UNSPECIFIED"}, "hash": "0b64ab46d8cdfe2d5a209c552db26e36466044734f1e4647a2b344a0ffb351bb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "59309db5-e341-4d7f-93d0-ebc057a0f7a6", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 333, "section": "UNSPECIFIED"}, "hash": "d3be88cb6a42dd79c19d797ef0351d4c1d2c34d7a8a592d116e479bfcc069842", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "6. Best response, duration of response, or the progression to prior therapies and follow-up therapies may be represented in the RS domain. \na. \nThe record in RS may be related and linked to record(s) in Concomitant/Prior Medications (CM) using CMLNKGRP and RSLNKGRP. Likewise, \nthe link to Procedures (PR; e.g., radiotherapy, surgery) would be made using PRLNKGRP. \nb. If the criteria used to determine the response is unknown or not collected, this is represented as RSCAT = \"UNSPECIFIED\". \n7. The evaluator identifier variable (RSEVALID) can be used in conjunction with RSEVAL to provide additional detail of who is providing the \nassessment. For example, RSEVAL = \"INDEPENDENT ASSESSOR\" and RSEVALID = \"RADIOLOGIST 1\" may further qualify the RSEVALID \nvariable. RSEVALID may be subject to controlled terminology but may also represent free text values depending on the use case. When used with \ndisease response data, RSEVALID is subject to MEDEVAL controlled terminology. \n8. In cases where an independent assessor identifies one of multiple assessments/measurements to be the accepted one, the accepted record flag variable \n(RSACPTFL) identifies records that have been determined to be the accepted assessments/measurements by an independent assessor. This flag would", "mimetype": "text/plain", "start_char_idx": 2817, "end_char_idx": 4090, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30ca29fe-09be-4def-aa71-1bc526746362": {"__data__": {"id_": "30ca29fe-09be-4def-aa71-1bc526746362", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 334, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dc40b0e1-c5f9-428a-86a2-10dd95b17f94", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 334, "section": "UNSPECIFIED"}, "hash": "fbedee60d370b7aa39e0c31a712189227a3cdde01ee7f4e7e07649715c138d62", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2584ffab-4c58-457b-a821-b2ea10e5d595", "node_type": "1", "metadata": {}, "hash": "959ba481c4361ee1efa47d42d326226fdcc00aacae460a38cf66131db8bcdebb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 334 \n2021-11-29 \nbe provided by an independent assessor when multiple assessors (e.g., \"RADIOLOGIST 1\", \"RADIOLOGIST 2\", \"ADJUDICATOR\") provide \nassessments or evaluations at the same time point or for an overall evaluation. \na. \nRSACPTFL should not be derived by the sponsor. If a derivation is needed to make the record selection, then this derivation should be done in the \nanalysis dataset (ADaM). \n9. Disease recurrence can be represented in the RS domain using RSTEST = \"Disease Recurrence Indicator\" to indicate that there was an assessment of \nwhether there was disease recurrence. The RSCAT = \"PROTOCOL DEFINED RESPONSE CRITERIA\" can be used to indicate that the \nresponse assessment of disease recurrence was based on protocol-specified criteria rather than published response criteria.  \n10. When a disease response result is based on multiple procedures/scans/images/physical exams performed on different dates, RSDTC may be derived . \n11. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the RS domain, but the following qualifiers would \nnot generally be used: --POS, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STNRC, --NRIND, --XFN, --LOINC, --SPEC, --\nSPCCND, --FAST, --TOX, --TOXGR, --SEV. \nRS \u2013 Examples - Disease Response \nThe following are examples for oncology response criteria. \nExample 1 \nThis example shows response assessments determined from the TR domain based on RECIST 1.1 criteria and also shows a case where progressive disease due to \nsymptomatic deterioration was determined based on a clinical assessment by the investigator. \nRows 1-3: \nShow the target response, non-target response, and the overall response by the investigator using RECIST 1.1 at the week 6 visit. \nRows 4-7: \nShow the target response and non-target response by the investigator using RECIST 1.1, as well as the determination of symptomatic determination \n(pleural effusion) and overall response using protocol-defined response criteria, at the week 12 visit.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2203, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2584ffab-4c58-457b-a821-b2ea10e5d595": {"__data__": {"id_": "2584ffab-4c58-457b-a821-b2ea10e5d595", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 334, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dc40b0e1-c5f9-428a-86a2-10dd95b17f94", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 334, "section": "UNSPECIFIED"}, "hash": "fbedee60d370b7aa39e0c31a712189227a3cdde01ee7f4e7e07649715c138d62", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30ca29fe-09be-4def-aa71-1bc526746362", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 334, "section": "UNSPECIFIED"}, "hash": "838350f4892df98101329e083b0539e7784bdaef84db8d1d63ab5ebe1b47d521", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RS \u2013 Examples - Disease Response \nThe following are examples for oncology response criteria. \nExample 1 \nThis example shows response assessments determined from the TR domain based on RECIST 1.1 criteria and also shows a case where progressive disease due to \nsymptomatic deterioration was determined based on a clinical assessment by the investigator. \nRows 1-3: \nShow the target response, non-target response, and the overall response by the investigator using RECIST 1.1 at the week 6 visit. \nRows 4-7: \nShow the target response and non-target response by the investigator using RECIST 1.1, as well as the determination of symptomatic determination \n(pleural effusion) and overall response using protocol-defined response criteria, at the week 12 visit. \nrs.xpt \nRow STUDYID DOMAIN USUBJID RSSEQ RSLNKGRP RSTESTCD RSTEST \nRSCAT \nRSORRES \nRSSTRESC RSEVAL \nVISITNUM VISIT \nRSDTC \nRSDY \n1 \nABC \nRS \n44444 \n1 \n \nTRGRESP \nTarget Response \nRECIST 1.1 \nPR \nPR \nINVESTIGATOR 40 \nWEEK \n6 \n2010-02-\n18 \n46 \n2 \nABC \nRS \n44444 \n2 \n \nNTRGRESP Non-target \nResponse \nRECIST 1.1 \nSD \nSD \nINVESTIGATOR 40 \nWEEK \n6 \n2010-02-\n18 \n46 \n3 \nABC \nRS \n44444 \n3 \nA2 \nOVRLRESP Overall Response \nRECIST 1.1 \nPR \nPR \nINVESTIGATOR 40 \nWEEK \n6 \n2010-02-\n18 \n46 \n4 \nABC \nRS \n44444 \n4 \n \nTRGRESP \nTarget Response \nRECIST 1.1 \nNE \nNE \nINVESTIGATOR 60 \nWEEK \n12 \n2010-04-\n02 \n88 \n5 \nABC \nRS \n44444 \n5 \n \nNTRGRESP Non-target \nResponse \nRECIST 1.1 \nNE \nNE \nINVESTIGATOR 60 \nWEEK \n12 \n2010-04-\n02 \n88 \n6 \nABC \nRS \n44444 \n6 \n \nSYMPTDTR Symptomatic \nDeterioration \nPROTOCOL DEFINED \nRESPONSE CRITERIA \nPleural \nEffusion \nPD \nINVESTIGATOR 60 \nWEEK \n12 \n2010-04-\n02 \n88 \n7 \nABC \nRS \n44444 \n7 \nA3 \nOVRLRESP Overall Response \nPROTOCOL DEFINED \nRESPONSE CRITERIA \nPD \nPD \nINVESTIGATOR 60 \nWEEK \n12 \n2010-04-\n02 \n88 \nExample 2 \nThis example shows response assessments determined from the TR domain based on RECIST 1.1 criteria and also shows a confirmation of an equivocal new \nlesion progression.", "mimetype": "text/plain", "start_char_idx": 1447, "end_char_idx": 3401, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "79650cfb-edc2-4554-9124-ab2cb1e2f297": {"__data__": {"id_": "79650cfb-edc2-4554-9124-ab2cb1e2f297", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 335, "section": "1.1 PD"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b0f95f32-a136-4524-a344-14ef4e6fd677", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 335, "section": "1.1 PD"}, "hash": "21c7eb688f268e1a190856a7d6e3dd5405009e91bea18a2b1d8ecbac20988153", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "PD \nACE \nIMAGING \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \nY \n60 \nWEEK \n12 \n2010-04-\n02 \n88 \nExample 3 \nThis example shows best response and the overall response of progression to prior therapies and follow-up therapies. \nRow 1: \nShows disease progression on or after a prior chemotherapy regimen. The date of progression is represented in RSDTC. RSENTPT and RSENRTPT represent that the disease progression was prior to \nscreening. RSCAT = \"UNSPECIFIED\" indicates that the criteria used to determine the disease progression was unknown or not collected. RSPLNKGRP = \"CM1\" is used to link this record in RS to the \nprior chemotherapy in CM where the CMLNKGRP = \"CM1\". \nRow 2: \nShows best response to prior chemotherapy regimen. The date of best response is represented in RSDTC. RSENTPT and RSENRTPT represent that the best response was prior to screening. RSCAT = \n\"UNSPECIFIED\" indicates that the criteria used to determine the best response was unknown or not collected. RSPLNKGRP = \"CM2\" is used to link this record in RS to the prior chemotherapy in CM \nwhere the CMLNKGRP = \"CM2\". \nRow 3: \nShows best response to prior radiotherapy. The date of best response is represented in RSDTC. RSENTPT and RSENRTPT represent that the best response was prior to screening. RSCAT = \n\"UNSPECIFIED\" indicates that the criteria used to determine the best response was unknown or not collected. RSPLNKGRP = \"PR2\" is used to link this record in RS to the prior radiotherapy in PR \nwhere the PRLNKGRP = \"PR2\". \nRows 4-5: \nShow best response and progression to a follow-up anti-cancer therapy. The date of best response and date of progression are represented in RSDTC. RSSTTPT and RSSTRTPT represent that the best \nresponse and progression were after study treatment discontinuation. RSCAT = \"UNSPECIFIED\" indicates that the criteria used to determine the best response and progression was unknown or not \ncollected. RSPLNKGRP = \"CM3\" is used to link this record in RS to the prior chemotherapy in CM where the CMLNKGRP = \"CM3\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2013, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3ab7061e-3ca9-4e2f-84b4-3183ffcac7c1": {"__data__": {"id_": "3ab7061e-3ca9-4e2f-84b4-3183ffcac7c1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 336, "section": "6.3.9.3.2 Clinical Classifications Use Case"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "da24a0bd-ea7d-4e60-951c-f458c0d2a6e1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 336, "section": "6.3.9.3.2 Clinical Classifications Use Case"}, "hash": "2504eec80b9534b1559b1da1094dc05a8036d3d4d72f9a1641df340294a421d0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RS \u2013 Clinical Classifications Use Case Assumptions \nThe following assumptions are unique to the RS domain clinical classifications use case: \n1. Clinical classifications are named instruments whose output is an ordinal or categorical score that serves as a surrogate for or ranking of disease status or other physiological or biological status.  \na. \nClinical classifications may be based solely on objective data from clinical records, or they may involve a clinical judgment or interpretation of directly observable signs, behaviors, or other physical \nmanifestations related to a condition or subject status. These physical manifestations may be findings (e.g., lab results, vital signs, clinical events) that are typically represented in other SDTM domains . \n2. RSCAT is used to group a set of assessments based on a clinical classification. One of the codelists for RSCAT is CCCAT. The CCCAT codelist contains CDISC Controlled Terminology for clinical \nclassifications instruments. \n3. When using the RS domain to represent a clinical classification instrument that incorporates data from other domains: \na. \nWhenever possible, all source data must be represented in the topic-based domain(s) to which they pertain. For example, if a lab test value is collected and then scored for a response evaluation or \nclinical classification instrument, the lab test value must be recorded in the LB domain using the rules that apply to that domain and the tests being represented. \nb. If the source value is directly collected on the clinical classification instrument, then the values from the source record may be transcribed to the corresponding RS record, with RSORRES and \nRSORRESU populated to agree with the units shown on the clinical classification instrument, which may be different from the sponsor\u2019s usual practice for original and standard units. \nc. \nIf a clinical classification uses a a source value by comparing it to a range (e.g., \"2-5\", \">3\"), then the source value will exist only in the source domain; the range is represented in the corresponding RS \nrecord in RSORRES and RSORRESU. \nd. In all cases, RSSTRESC/RSSTRESN should be populated with the assigned ordinal score as indicated on the instrument.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2222, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "225cf31b-aa81-499a-95ab-eba9d3d2f3df": {"__data__": {"id_": "225cf31b-aa81-499a-95ab-eba9d3d2f3df", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 337, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1982e495-a119-4fc3-80f2-9642414896f8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 337, "section": "UNSPECIFIED"}, "hash": "b8c27deb4722c5e011fb3ee8768ccd86f941091900f06a0d895343ac92b3c8a3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "af693991-a2fb-4594-9d83-10a0e9484e72", "node_type": "1", "metadata": {}, "hash": "f8eff3c5b31672acc3dc0e0b321dee70bddd70d6f5a1bab8a0413b1abc9b8487", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 337 \n2021-11-29 \nThe following assumptions are common to the FT and QS domains as well as the Clinical Classifications use case of the RS domain (not the Disease Response \nuse case of RS): \n1. The name of a QRS instrument is described under the variable --CAT in the relevant QRS domain (i.e., FT, QS, RS), and may be either abbreviations or \nlonger names. For example, \"ADAS-COG\", \"BPI SHORT FORM\", and \"APACHE II\" are all --CATs which are shortened names for the instruments \nthey represent, whereas \"4 STAIR ASCEND\" is the FTCAT for the instrument of the same name. Sponsors should always reference CDISC Controlled \nTerminology. \na. \nThe QRS Naming Rules for --CAT, --TEST, and --TESTCD and the list of QRS instruments that have published CDISC Controlled Terminology \nwith NCI/EVS are available at: https://www.cdisc.org/standards/terminology/controlled-terminology. \nb. Refer to the following CDISC Controlled Terminology codelists for QRS instrument --CAT terminology: \ni. Category of Clinical Classification \nii. Category of Functional Test \niii. Category of Questionnaire \nc. \nQRS --TESTCD/--TEST terminology codelists are listed separately by instrument name.        \n2. Names of subcategories for groups of items/questions are described under the --SCAT variable. \na. \n--SCAT values are not included in the CDISC Controlled Terminology system but rather controlled as described in the QRS supplements in which \nthey are used. \n3. There are cases where QRS CRFs do not include numeric \u201cstandardized responses\u201d assigned to text responses (e.g., mild, moderate, severe being 1, 2, \n3). It is clearly in everyone's best interest to include the numeric \u201cstandardized responses\u201d in the SDTMIG QRS dataset. This is only done when the \nnumeric \u201cstandardized responses\u201d are documented in the QRS CRF instructions, a user manual, a website specific to the QRS instrument, or another \nreference document that provides a clear explanation and rationale for providing them in the SDTMIG QRS dataset. \n4. Sponsors should always consult published QRS supplements for guidance on submitting derived information in a SDTMIG QRS domain. Derived \nvariable results in QRS are usually considered captured data. If sponsors operationally derive variable results, then the derived records that are submitted \nin a QRS domain should be flagged by --DRVFL. \na. \nThe following rules apply for \u201ctotal\u201d-type scores in QRS datasets. \ni. QRS subtotal, total, etc. scores listed on the CRF are considered captured data and are included in the instrument\u2019s controlled terminology. \nii. QRS subtotal, total, etc. scores not listed on the CRF but documented in an associated instrument manual or reference paper are considered \ncaptured data and are included in the instrument\u2019s controlled terminology. \niii. QRS subtotal, total, etc. scores not listed on the CRF, but known to be included in eData by sponsors are considered as captured data, are \nincluded in the instrument\u2019s controlled terminology. The QRS instrument\u2019s CT is considered extensible for this case and the subtotal or total \nscore should be requested to be added. \n1.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3290, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "af693991-a2fb-4594-9d83-10a0e9484e72": {"__data__": {"id_": "af693991-a2fb-4594-9d83-10a0e9484e72", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 337, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1982e495-a119-4fc3-80f2-9642414896f8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 337, "section": "UNSPECIFIED"}, "hash": "b8c27deb4722c5e011fb3ee8768ccd86f941091900f06a0d895343ac92b3c8a3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "225cf31b-aa81-499a-95ab-eba9d3d2f3df", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 337, "section": "UNSPECIFIED"}, "hash": "b461760cca8860d4261bad60962925dfac7dcbe6cb8dd6c5038323135ab0d8ae", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "a. \nThe following rules apply for \u201ctotal\u201d-type scores in QRS datasets. \ni. QRS subtotal, total, etc. scores listed on the CRF are considered captured data and are included in the instrument\u2019s controlled terminology. \nii. QRS subtotal, total, etc. scores not listed on the CRF but documented in an associated instrument manual or reference paper are considered \ncaptured data and are included in the instrument\u2019s controlled terminology. \niii. QRS subtotal, total, etc. scores not listed on the CRF, but known to be included in eData by sponsors are considered as captured data, are \nincluded in the instrument\u2019s controlled terminology. The QRS instrument\u2019s CT is considered extensible for this case and the subtotal or total \nscore should be requested to be added. \n1. Any imputations/calculations done to numeric \u201cstandardized responses\u201d to produce the total score via transforming numeric \u201cstandardized \nresponses\u201d in any way would be done as ADaM derivations.", "mimetype": "text/plain", "start_char_idx": 2523, "end_char_idx": 3484, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "70c28908-3544-4945-9cb5-9927bc3f42aa": {"__data__": {"id_": "70c28908-3544-4945-9cb5-9927bc3f42aa", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 338, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d7e45c-607a-4d62-9587-bf023879a73c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 338, "section": "UNSPECIFIED"}, "hash": "098986042ade8cfacaf27ad8c76a0dd1980889d0b650e638db780c9b6c4cefe1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6abd2204-9b78-4ddb-b46b-53ff0aeec16a", "node_type": "1", "metadata": {}, "hash": "0bc0fbb6f2473d23dda364e99f174b59e765341889352d5c3999e2c1663550f8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 338 \n2021-11-29 \nb. The QRS instrument subtotal or total score, which is the sum of the numeric responses for an instrument, is populated in --ORRES, --STRESC, and \n--STRESN. It is considered a captured subtotal or total score without any knowledge of the sponsor-data management processes related to the score. \ni. If operationally derived by the sponsor, it is the sponsor's responsibility to set the --DRVFL flag based on their eCRF process to derive subtotal \nand total scores. An investigator-derived score written on a CRF will be considered a captured score and not flagged. When subtotal and total \nscores are derived by the sponsor, the derived flag (--DRVFL) is set to \"Y\". However, when the subtotal and total scores are received from a \ncentral provider or vendor, the value would go into --ORRES and --DRVFL would be null (see Section 4.1.8.1, Origin Metadata for \nVariables). \n5. The variable --REPNUM variable is populated when there are multiple repeats of the same question. When records are related to the first trial of the \nquestion, the variable --REPNUM should be set to \"1\". When records are related to the second trial of the same question, --REPNUM should be set to \n\"2\", and so forth. \n6. The actual version number of an instrument is represented in the --CAT value as designated by the QRS Terminology Team. If it is determined that this \nis not the case for an instrument: \na. \nNotify the QRS Terminology Team that the instrument has a specific or multiple version numbers. This team will assist in providing an resolution \non how the situation will be handled. \nb. Consider the use of the --GRPID variable to indicate the instrument's version number prior to a decision by the QRS Terminology Team. \nc. \nThe sponsor is expected to provide information about the version used for each QRS instrument in the metadata (using the Comments column in the \nDefine-XML document). This could be provided as value-level metadata for --CAT. \nd. The sponsor is expected to provide information about the scoring rules in the metadata. \n7. If the variable --TEST is represented with verbatim text >40 characters, represent the abbreviated meaningful text in --TEST within 40 characters and \ndescribe the full text of the item in the study metadata. If the verbatim item response (e.g., --QSORRES) is >200 characters, represent the abbreviated \nmeaningful text in QSORRES within the 200 characters and describe the full text in the study metadata; see Section 4 of the QRS supplement. See \nSection 4.5.3, Text Strings that Exceed the Maximum Length for General Observation-class Domain Variables, for further information. \na. \nThe instrument\u2019s annotated CRF can also be used as a reference for the full text in both of these situations. \n8. --EVAL and --EVALID must not be used to model QRS data in SDTM. These variables have had various interpretations on QRS CRFs and were used \nto represent a multitude of evaluator information about QRS instruments. This has made it more difficult for users of SDTM QRS data to interpret this \ndata and more difficult to pool data for analyses. If needed, supplemental qualifiers may be used to represent this data.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3345, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6abd2204-9b78-4ddb-b46b-53ff0aeec16a": {"__data__": {"id_": "6abd2204-9b78-4ddb-b46b-53ff0aeec16a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 338, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "24d7e45c-607a-4d62-9587-bf023879a73c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 338, "section": "UNSPECIFIED"}, "hash": "098986042ade8cfacaf27ad8c76a0dd1980889d0b650e638db780c9b6c4cefe1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "70c28908-3544-4945-9cb5-9927bc3f42aa", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 338, "section": "UNSPECIFIED"}, "hash": "8e9824bac7145af610730f303223c776680c719abef2202bbcdf4ebe11df0803", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "See \nSection 4.5.3, Text Strings that Exceed the Maximum Length for General Observation-class Domain Variables, for further information. \na. \nThe instrument\u2019s annotated CRF can also be used as a reference for the full text in both of these situations. \n8. --EVAL and --EVALID must not be used to model QRS data in SDTM. These variables have had various interpretations on QRS CRFs and were used \nto represent a multitude of evaluator information about QRS instruments. This has made it more difficult for users of SDTM QRS data to interpret this \ndata and more difficult to pool data for analyses. If needed, supplemental qualifiers may be used to represent this data. Updated information on a \nproposed solution to this issue will be posted on the CDISC QRS webpage (https://www.cdisc.org/standards/foundational/qrs).  \n9. All standard QRS supplement development is coordinated with the CDISC SDS QRS Subteam as the governing body. The process involves drafting the \ncontrolled terminology and defining instrument-specific standardized values for qualifier, timing, and result variables to populate the SDTMIG FT, QS, \nand RS domains. These supplements are developed based on user demand and therapeutic area standards development needs. Sponsors should always \nconsult the CDISC website to review the terminology and supplements prior to modeling any QRS instrument. \na. \nSponsors may participate and/or request the development of additional QRS supplements and terminology through the CDISC SDS QRS subteam \nand the Controlled Terminology QRS subteam. \ni. Once generated, the QRS supplement is posted on the CDISC website (https://www.cdisc.org/standards/foundational/qrs).", "mimetype": "text/plain", "start_char_idx": 2677, "end_char_idx": 4353, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "96425a16-fce6-484c-a152-b64c7a26169f": {"__data__": {"id_": "96425a16-fce6-484c-a152-b64c7a26169f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 340, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e395f3db-f03c-498e-8192-9970c56d21f1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 340, "section": "UNSPECIFIED"}, "hash": "34627fb14d186b5c5c3f7f3983a2102fd7faa8bf5cf0f956680f86ade2cc2075", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "39341ce7-f9ee-4f64-a053-538d99b8ff7d", "node_type": "1", "metadata": {}, "hash": "edb563f202e886779d8064f3fe9bab1367dee11d955248bf669a9ac03365280c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 340 \n2021-11-29 \nSC \u2013 Specification \nsc.xpt, Subject Characteristics \u2014 Findings. One record per characteristic per visit per subject., Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar SC \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nSCSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nSCGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nSCSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined in \nthe sponsor's operational database. \nPerm \nSCTESTCD \nSubject \nCharacteristic Short \nName \nChar (SCTESTCD) \nTopic \nShort name of the measurement, test, or examination described in SCTEST. It can be used as a column \nname when converting a dataset from a vertical to a horizontal format. The value in SCTESTCD cannot be \nlonger than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). SCTESTCD cannot \ncontain characters other than letters, numbers, or underscores. Examples: \"MARISTAT\", \"NATORIG\". \nReq \nSCTEST \nSubject \nCharacteristic \nChar (SCTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in SCTEST \ncannot be longer than 40 characters. Examples: \"Marital Status\", \"National Origin\". \nReq \nSCCAT \nCategory for \nSubject \nCharacteristic \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. \nPerm \nSCSCAT \nSubcategory for \nSubject \nCharacteristic \nChar * \nGrouping \nQualifier \nA further categorization of the subject characteristic. \nPerm \nSCORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the subject characteristic as originally received or collected. \nExp \nSCORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal unit in which the data were collected. The unit for SCORRES. \nPerm \nSCSTRESC \nCharacter \nResult/Finding in \nStd Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from SCORRES, in a standard format or standard \nunits. SCSTRESC should store all results or findings in character format; if results are numeric, they should \nalso be stored in numeric format in SCSTRESN. For example, if a test has results \"NONE\", \"NEG\", and \n\"NEGATIVE\" in SCORRES, and these results effectively have the same meaning, they could be \nrepresented in standard format in SCSTRESC as \"NEGATIVE\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3141, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "39341ce7-f9ee-4f64-a053-538d99b8ff7d": {"__data__": {"id_": "39341ce7-f9ee-4f64-a053-538d99b8ff7d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 340, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e395f3db-f03c-498e-8192-9970c56d21f1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 340, "section": "UNSPECIFIED"}, "hash": "34627fb14d186b5c5c3f7f3983a2102fd7faa8bf5cf0f956680f86ade2cc2075", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "96425a16-fce6-484c-a152-b64c7a26169f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 340, "section": "UNSPECIFIED"}, "hash": "dec83a2f7577c86278d7f567023973b39d45f265035fa30283b65dd39825d7b6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Exp \nSCORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal unit in which the data were collected. The unit for SCORRES. \nPerm \nSCSTRESC \nCharacter \nResult/Finding in \nStd Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from SCORRES, in a standard format or standard \nunits. SCSTRESC should store all results or findings in character format; if results are numeric, they should \nalso be stored in numeric format in SCSTRESN. For example, if a test has results \"NONE\", \"NEG\", and \n\"NEGATIVE\" in SCORRES, and these results effectively have the same meaning, they could be \nrepresented in standard format in SCSTRESC as \"NEGATIVE\". \nExp \nSCSTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nSCSTRESC. SCSTRESN should store all numeric test results or findings. \nPerm \nSCSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for SCSTRESC or SCSTRESN. \nPerm \nSCSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that the measurement was not done. Should be null if a result exists in SCORRES. \nPerm \nSCREASND \nReason Not \nPerformed \nChar  \nRecord \nQualifier \nDescribes why the observation has no result. Example: \"Subject refused\". Used in conjunction with SCSTAT \nwhen value is \"NOT DONE\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nPerm \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. May be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day \nof Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm", "mimetype": "text/plain", "start_char_idx": 2453, "end_char_idx": 4269, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "20132331-989a-44cc-85c8-e63a8a9ed346": {"__data__": {"id_": "20132331-989a-44cc-85c8-e63a8a9ed346", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 341, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "46927469-ee86-4e08-9017-b52723046954", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 341, "section": "UNSPECIFIED"}, "hash": "928314c975391592d94dab565f9c1431eea102fbdd11bd935cb4a93ea5d54559", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d21e99c2-f858-446b-b0d9-9ba3ba035648", "node_type": "1", "metadata": {}, "hash": "fe5f4b4249c361d218aa26fbc25340e9af4a84bd7049aeabd1b8d770b68b5c71", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 341 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time at which the assessment was made. \nPerm \nSCDTC \nDate/Time of \nCollection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of the subject characteristic represented in ISO 8601 character format. \nPerm \nSCDY \nStudy Day of \nExamination \nNum  \nTiming \nStudy day of collection, measured as integer days. Algorithm for calculations must be relative to the \nsponsor-defined RFSTDTC variable in Demographics. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \nSC \u2013 Assumptions \n1. The structure of subject characteristics is based on the Findings general observation class and is an extension of the demographics data, including \nsocioeconomic or other broad characteristics. The structure for demographic data is fixed and includes date of birth, age, sex, race, ethnicity, and \ncountry. Subject characteristics may be collected periodically over time. Some examples of subject characteristics include education level, marital status, \nand national origin. \n2. Associations between some subject characteristic tests and response codelists are described in the SC Codetable, available \nat https://www.cdisc.org/standards/terminology/controlled-terminology. \n3. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the SC domain, but the following qualifiers would \ngenerally not be used in SC: --MODIFY, --POS, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STNRC, --NRIND, --RESCAT, --\nXFN, --NAM, --LOINC, --SPEC, --SPCCND, --BLFL, --LOBXFL, --FAST, --DRVFL, --TOX, --TOXGR, --SEV. \nSC \u2013 Examples \nExample 1 \nThis example shows data collected once per subject that does not fit into the Demographics (DM) domain. For this example, national origin and marital status \nwere collected.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2377, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d21e99c2-f858-446b-b0d9-9ba3ba035648": {"__data__": {"id_": "d21e99c2-f858-446b-b0d9-9ba3ba035648", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 341, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "46927469-ee86-4e08-9017-b52723046954", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 341, "section": "UNSPECIFIED"}, "hash": "928314c975391592d94dab565f9c1431eea102fbdd11bd935cb4a93ea5d54559", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "20132331-989a-44cc-85c8-e63a8a9ed346", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 341, "section": "UNSPECIFIED"}, "hash": "38c837db7bd2d113eb878909dcc4532e1c5ba431b56d06d584162221cfe77db4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the SC domain, but the following qualifiers would \ngenerally not be used in SC: --MODIFY, --POS, --BODSYS, --ORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STNRC, --NRIND, --RESCAT, --\nXFN, --NAM, --LOINC, --SPEC, --SPCCND, --BLFL, --LOBXFL, --FAST, --DRVFL, --TOX, --TOXGR, --SEV. \nSC \u2013 Examples \nExample 1 \nThis example shows data collected once per subject that does not fit into the Demographics (DM) domain. For this example, national origin and marital status \nwere collected. \nsc.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nSCSEQ \nSCTESTCD \nSCTEST \nSCORRES \nSCSTRESC \nSCDTC \n1 \nABC \nSC \nABC-001-001 \n1 \nNATORIG \nNational Origin \nUNITED STATES \nUSA \n1999-06-19 \n2 \nABC \nSC \nABC-001-001 \n2 \nMARISTAT \nMarital Status \nDIVORCED \nDIVORCED \n1999-06-19 \n3 \nABC \nSC \nABC-001-002 \n1 \nNATORIG \nNational Origin \nCANADA \nCAN \n1999-03-19 \n4 \nABC \nSC \nABC-001-002 \n2 \nMARISTAT \nMarital Status \nMARRIED \nMARRIED \n1999-03-19 \n5 \nABC \nSC \nABC-001-003 \n1 \nNATORIG \nNational Origin \nUSA \nUSA \n1999-05-03 \n6 \nABC \nSC \nABC-001-003 \n2 \nMARISTAT \nMarital Status \nNEVER MARRIED \nNEVER MARRIED \n1999-05-03 \n7 \nABC \nSC \nABC-001-201 \n1 \nNATORIG \nNational Origin \nJAPAN \nJPN \n1999-06-14 \n8 \nABC \nSC \nABC-002-001 \n2 \nMARISTAT \nMarital Status \nWIDOWED \nWIDOWED \n1999-06-14 \nExample 2 \nIn this example, only infants were study subjects. However, with the possible exception of USUBJID values, the example would be unchanged for a study in \nwhich mothers were study subjects. If these data were collected for an infant who was an associated person, they would be represented in the APSC domain and \nthe dataset would include APID, RSUBJID, and SREL, rather than USUBJID.", "mimetype": "text/plain", "start_char_idx": 1799, "end_char_idx": 3532, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf5551ac-1edb-44a6-9cc3-b436e7d92108": {"__data__": {"id_": "bf5551ac-1edb-44a6-9cc3-b436e7d92108", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 342, "section": "13.1 20-17-"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9ed85387-4afd-4709-b45a-9141a7c0e4e6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 342, "section": "13.1 20-17-"}, "hash": "600af722174cfc495cc845ad352798b65f6dc820aac0241e07dc971a7e33fe1b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "06-10 \n297 \nExample 3 \nThis example shows data from a multi-year study in which marital status and whether the subject was a student were collected annually. \nsc.xpt \nRow STUDYID DOMAIN USUBJID SCSEQ SCTESTCD \nSCTEST \nSCORRES \nSCSTRESC \nSCDTC \nSCDY \n1 \nABC123 \nSC \n305 \n1 \nMARISTAT \nMarital Status \nNEVER MARRIED \nNEVER MARRIED \n2012-01-14 \n-2 \n2 \nABC123 \nSC \n305 \n2 \nSTDNTIND \nStudent Indicator \nY \nY \n2012-01-14 \n-2 \n3 \nABC123 \nSC \n305 \n3 \nMARISTAT \nMarital Status \nDOMESTIC PARTNER \nDOMESTIC PARTNER \n2013-01-22 \n374 \n4 \nABC123 \nSC \n305 \n4 \nSTDNTIND \nStudent Indicator \nY \nY \n2013-01-22 \n374 \n5 \nABC123 \nSC \n305 \n5 \nMARISTAT \nMarital Status \nMARRIED \nMARRIED \n2014-01-16 \n734 \n6 \nABC123 \nSC \n305 \n6 \nSTDNTIND \nStudent Indicator \nN \nN \n2014-01-16 \n734", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 753, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6e041b12-1da7-43ef-82e7-e6432a0d54f1": {"__data__": {"id_": "6e041b12-1da7-43ef-82e7-e6432a0d54f1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 342, "section": "6.3.11 Subject Status (SS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0ea08a38-eccf-4460-8ad9-5fbe5bb43b41", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 342, "section": "6.3.11 Subject Status (SS)"}, "hash": "b004bb90c676d193863e0bd3fc2fc82bcc7345951ad8024b72584ee43d7c9dd6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SS \u2013 Description/Overview \nA findings domain that contains the subject's status that is evaluated periodically to determine if it has changed. \nSS \u2013 Specification \nss.xpt, Subject Status \u2014 Findings. One record per status per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar SS \nIdentifier \nTwo-character abbreviation for the domain. \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 541, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "164fba56-d7c8-46db-bc43-c0a3abf915b3": {"__data__": {"id_": "164fba56-d7c8-46db-bc43-c0a3abf915b3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 343, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d8c0ec17-137a-42d1-bd12-adf8fb061db1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 343, "section": "UNSPECIFIED"}, "hash": "bc43465b0544b72826c95332714e8a3619b73cd377430a6469f2a52bb6341a15", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "32ac11a2-eb6d-4ec1-9290-2cb649a8182b", "node_type": "1", "metadata": {}, "hash": "a7253d99cce55211aaea5da5f4ac40cdf02dc4f5976b5b1073cbf6750d93faad", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 343 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving \nthe product. \nReq \nSSSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nSSGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nSSSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined \nin the sponsor's operational database. Example: Line number from the Procedure or Test page. \nPerm \nSSTESTCD \nStatus Short Name \nChar (SSTESTCD) \nTopic \nShort name of the status assessment described in SSTEST. It can be used as a column name when \nconverting a dataset from a vertical to a horizontal format. The value in SSTESTCD cannot be longer than \n8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). SSTESTCD cannot contain \ncharacters other than letters, numbers, or underscores. Example: \"SURVSTAT\". \nReq \nSSTEST \nStatus Name \nChar (SSTEST) \nSynonym \nQualifier \nVerbatim name of the status assessment used to obtain the finding. The value in SSTEST cannot be \nlonger than 40 characters. Example: \"Survival Status\". \nReq \nSSCAT \nCategory for \nAssessment \nChar * \nGrouping \nQualifier \nUsed to categorize observations across subjects. \nPerm \nSSSCAT \nSubcategory for \nAssessment \nChar * \nGrouping \nQualifier \nA further categorization. \nPerm \nSSORRES \nResult or Finding \nOriginal Result \nChar  \nResult \nQualifier \nResult of the status assessment finding as originally received or collected. \nExp \nSSSTRESC \nCharacter \nResult/Finding in \nStd Format \nChar (SSTATRS) \nResult \nQualifier \nContains the result value for all findings copied or derived from SSORRES, in a standard format. \nExp \nSSSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate a status assessment was not done. Should be null if a result exists in SSORRES. \nPerm \nSSREASND \nReason \nAssessment Not \nPerformed \nChar  \nRecord \nQualifier \nDescribes why an assessment was not performed. Example: \"Subject refused\". Used in conjunction with \nSSSTAT when value is \"NOT DONE\". \nPerm \nSSEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned by \na person or a group). Should be null for records that contain collected or derived data. Examples: \n\"CAREGIVER\", \"ADJUDICATION COMMITTEE\", \"FRIEND\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3132, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "32ac11a2-eb6d-4ec1-9290-2cb649a8182b": {"__data__": {"id_": "32ac11a2-eb6d-4ec1-9290-2cb649a8182b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 343, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d8c0ec17-137a-42d1-bd12-adf8fb061db1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 343, "section": "UNSPECIFIED"}, "hash": "bc43465b0544b72826c95332714e8a3619b73cd377430a6469f2a52bb6341a15", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "164fba56-d7c8-46db-bc43-c0a3abf915b3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 343, "section": "UNSPECIFIED"}, "hash": "5db730e72e61f45c03f94e1d879321f5dee30f3d842a3b6e4cec2edec9879e5c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Should be null if a result exists in SSORRES. \nPerm \nSSREASND \nReason \nAssessment Not \nPerformed \nChar  \nRecord \nQualifier \nDescribes why an assessment was not performed. Example: \"Subject refused\". Used in conjunction with \nSSSTAT when value is \"NOT DONE\". \nPerm \nSSEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned by \na person or a group). Should be null for records that contain collected or derived data. Examples: \n\"CAREGIVER\", \"ADJUDICATION COMMITTEE\", \"FRIEND\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day \nof Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time of the subject status assessment. \nPerm \nSSDTC \nDate/Time of \nAssessment \nChar ISO 8601 datetime \nor interval \nTiming \nDate and time of the subject status assessment represented in ISO 8601 character format. \nExp \nSSDY \nStudy Day of \nAssessment \nNum  \nTiming \nStudy day of the subject status assessment, measured as integer days. Algorithm for calculations must be \nrelative to the sponsor-defined RFSTDTC variable in Demographics. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n \nSS \u2013 Assumptions \n1. Details about the circumstances of a subject's status are stored in the appropriate separate domain(s), even when collection is triggered by the response \nto the status assessment. For example, if a subject's survival status is \"DEAD\", the date of death must be stored in DM and within a final disposition \nrecord in DS. Only the status collection date, the status question, and the status response are stored in SS.", "mimetype": "text/plain", "start_char_idx": 2350, "end_char_idx": 4568, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "03cb6b5f-7015-4480-bd69-450e853c09a7": {"__data__": {"id_": "03cb6b5f-7015-4480-bd69-450e853c09a7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 344, "section": "6.3.12 Tumor/Lesion Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "26cdb1e4-9a7c-4f4d-86a2-b3ad0da865cf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 344, "section": "6.3.12 Tumor/Lesion Domains"}, "hash": "acba3e1c02968c90e6bdb759392ca5166a1fef68f0c98b49bb6927dfa763a121", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Tumor/Lesion domains (TU, TR) represent data collected in clinical trials where sites of disease (e.g., tumors/lesions/locations of interest, lymph nodes, \norgans of interest in the assessment of the disease) are identified and then repeatedly measured/assessed at subsequent time points and often used in an evaluation \nof disease response(s). As such, these domains would be applicable for representing data to support disease response criteria. These 2 domains each have a \ndistinct purpose and are related to each other, and may also be related to assessments in the RS domain (see Section 6.3.9.3, Disease Response and Clin \nClassification).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 650, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fc6d92fc-a933-43cd-84f4-203af63a99c9": {"__data__": {"id_": "fc6d92fc-a933-43cd-84f4-203af63a99c9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 344, "section": "6.3.12.1 Tumor/Lesion Identification (TU)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6f282b2e-ba44-46e9-adfd-35761c9b68d2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 344, "section": "6.3.12.1 Tumor/Lesion Identification (TU)"}, "hash": "120249164b7995252542572825c05d5d76113a45419db538780aab692946501e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TU \u2013 Description/Overview \nA findings domain that represents data that uniquely identifies tumors, lesions, or locations of interest under study. \nThe TU domain represents data that uniquely identifies tumors, lesions, or locations of interest (e.g., tumors, cardiovascular culprit lesions, organs, bone marrow, \nother sites of disease such as lymph nodes). Commonly, tumors/lesions/locations of interest are identified by an investigator and/or independent assessor and \nclassified according to the disease assessment criteria. For example, an oncology study using RECIST criteria would identify target, non-target, and new tumors. \nA record in the TU domain contains the following information: \n\u2022 \na unique tumor ID value", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 723, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "61a9ea69-13bd-477c-9ca6-804d7e2f1d83": {"__data__": {"id_": "61a9ea69-13bd-477c-9ca6-804d7e2f1d83", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 345, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6eb113ae-4d87-4781-801b-6550e06b2f92", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 345, "section": "UNSPECIFIED"}, "hash": "cb72a0424cc2187b951edff1f307bae8555d448ead4de8000f38afb74af6fc87", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "09f30451-29ea-4911-9add-396bf3e487b9", "node_type": "1", "metadata": {}, "hash": "9ca7279133f6440c9bf34025b3841f26846ded5d80d300208d1b24a4e96204cb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 345 \n2021-11-29 \n\u2022 \nanatomical location of the tumor \n\u2022 \nmethod used to identify the tumor \n\u2022 \nrole of the individual identifying the tumor \n\u2022 \ntiming information. \nTU \u2013 Specification \ntu.xpt, Tumor/Lesion Identification \u2014 Findings. One record per identified tumor per subject per assessor, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar TU \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nTUSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness within a dataset for a subject. May be any valid \nnumber. \nReq \nTUGRPID \nGroup ID \nChar  \nIdentifier \nUsed to link together a block of related records within a subject in a domain. Can be used to group \nsplit or merged tumors/lesions which have been identified. \nPerm \nTUREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier (e.g., medical image ID number). \nPerm \nTUSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. \nPerm \nTULNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link identified tumor/lesion/location of interest to the assessment results (in TR \ndomain) over the course of the study. \nExp \nTULNKGRP \nLink Group ID \nChar  \nIdentifier \nIdentifier used to link related records across domains. This will usually be a many-to-one relationship. \nPerm \nTUTESTCD \nTumor/Lesion ID Short \nName \nChar (TUTESTCD) \nTopic \nShort name of the TEST in TUTEST. TUTESTCD cannot be longer than 8 characters nor can start \nwith a number. TUTESTCD cannot contain characters other than letters, numbers, or underscores. \nExample: \"TUMIDENT\". See assumption 3. \nReq \nTUTEST \nTumor/Lesion ID Test \nName \nChar (TUTEST) \nSynonym \nQualifier \nVerbatim name of the test for the tumor/lesion identification. The value in TUTEST cannot be longer \nthan 40 characters. Example: \"Tumor identification\". See assumption 3. \nReq \nTUORRES \nTumor/Lesion ID Result Char  \nResult \nQualifier \nResult of the tumor/lesion identification. The result of tumor/lesion identification is a classification of \nthe identified tumor/lesion. Example: When TUTESTCD = \"TUMIDENT\", values of TUORRES might \nbe \"TARGET\", \"NON-TARGET\", \"NEW\", or \"BENIGN ABNORMALITY\". \nExp \nTUSTRESC \nTumor/Lesion ID Result \nStd. Format \nChar (TUIDRS) \nResult \nQualifier \nContains the result value for all findings copied or derived from TUORRES in a standard format. \nExp \nTUNAM \nLaboratory/Vendor \nName \nChar  \nRecord \nQualifier \nThe name or identifier of the vendor that performed the tumor/lesion Identification.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3049, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "09f30451-29ea-4911-9add-396bf3e487b9": {"__data__": {"id_": "09f30451-29ea-4911-9add-396bf3e487b9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 345, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6eb113ae-4d87-4781-801b-6550e06b2f92", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 345, "section": "UNSPECIFIED"}, "hash": "cb72a0424cc2187b951edff1f307bae8555d448ead4de8000f38afb74af6fc87", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "61a9ea69-13bd-477c-9ca6-804d7e2f1d83", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 345, "section": "UNSPECIFIED"}, "hash": "3f5165dda2109b2af0b042eefbc4102d0a6be5452c1f80c7c446b8a9420fd4bd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example: \"Tumor identification\". See assumption 3. \nReq \nTUORRES \nTumor/Lesion ID Result Char  \nResult \nQualifier \nResult of the tumor/lesion identification. The result of tumor/lesion identification is a classification of \nthe identified tumor/lesion. Example: When TUTESTCD = \"TUMIDENT\", values of TUORRES might \nbe \"TARGET\", \"NON-TARGET\", \"NEW\", or \"BENIGN ABNORMALITY\". \nExp \nTUSTRESC \nTumor/Lesion ID Result \nStd. Format \nChar (TUIDRS) \nResult \nQualifier \nContains the result value for all findings copied or derived from TUORRES in a standard format. \nExp \nTUNAM \nLaboratory/Vendor \nName \nChar  \nRecord \nQualifier \nThe name or identifier of the vendor that performed the tumor/lesion Identification. This column can be \nleft null when the investigator provides the complete set of data in the domain. \nPerm \nTULOC \nLocation of the \nTumor/Lesion \nChar (LOC) \nRecord \nQualifier \nUsed to specify the anatomical location of the identified tumor/lesion (e.g., \"LIVER\"). \nNote: When anatomical location is broken down and collected as distinct pieces of data that when \ncombined provide the overall location information (e.g., laterality/directionality/distribution), then \nadditional anatomical location qualifiers should be used. See assumption 3. \nExp \nTULAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality (e.g., \"LEFT\", \"RIGHT\", \n\"BILATERAL\"). \nPerm \nTUDIR \nDirectionality \nChar (DIR) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing directionality (e.g., \"UPPER\", \n\"INTERIOR\"). \nPerm \nTUPORTOT \nPortion or Totality \nChar (PORTOT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing the distribution, which means \narrangement of, or apportioning of. Examples: \"ENTIRE\", \"SINGLE\", \"SEGMENT\", \"MULTIPLE\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2344, "end_char_idx": 4201, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8f94f0a4-c77a-4c50-a075-1edcbe1a10d3": {"__data__": {"id_": "8f94f0a4-c77a-4c50-a075-1edcbe1a10d3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 346, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b615bd25-1ae2-4a7a-9d48-836752fae871", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 346, "section": "UNSPECIFIED"}, "hash": "c402c3d6ca17e9afd2d3a2c85e47d98ccb26791117b88824153782278baaac18", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "1d2c524c-19e9-4aa6-bd74-ed099e3550f0", "node_type": "1", "metadata": {}, "hash": "174a74ebba5341ba64e1e940ae6068b7f9772e923bcc36d5bc0df01bc83abb76", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 346 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nTUMETHOD Method of Identification \nChar (METHOD) \nRecord \nQualifier \nMethod used to identify the tumor/lesion. Examples: \"MRI\", \"CT SCAN\". \nExp \nTULOBXFL \nLast Observation \nBefore Exposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. Should \nbe \"Y\" or null. \nExp \nTUBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that TUBLFL is retained for \nbackward compatibility. The authoritative baseline flag for statistical analysis is in an ADaM dataset. \nPerm \nTUEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Examples: \"ADJUDICATION COMMITTEE\", \n\"INDEPENDENT ASSESSOR\". \nThis column can be left null when the investigator provides the complete set of data in the domain. \nHowever, the column should contain no null values when data from 1 or more independent assessors \nis included. For example, the rows attributed to the investigator should contain a value of \n\"INVESTIGATOR\". \nExp \nTUEVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in --EVAL. Examples: \n\"RADIOLOGIST1\", \"RADIOLOGIST2\". See assumption 9. \nPerm \nTUACPTFL \nAccepted Record Flag \nChar (NY) \nRecord \nQualifier \nIn cases where more than 1 independent assessor (e.g., \"RADIOLOGIST 1\", \"RADIOLOGIST 2\", \n\"ADJUDICATION COMMITTEE\") provide independent assessments at the same time point, this flag \nidentifies the record that is considered to be the accepted assessment. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nTUDTC \nDate/Time of \nTumor/Lesion \nIdentification \nChar ISO 8601 datetime \nor interval \nTiming \nTUDTC variable represents the date of the scan/image/physical exam. TUDTC does not represent the \ndate that the image was read to identify tumors. TUDTC also does not represent the VISIT date. \nExp \nTUDY \nStudy Day of \nTumor/Lesion \nIdentification \nNum  \nTiming \nStudy day of the scan/image/physical exam, measured as integer days.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3013, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d2c524c-19e9-4aa6-bd74-ed099e3550f0": {"__data__": {"id_": "1d2c524c-19e9-4aa6-bd74-ed099e3550f0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 346, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b615bd25-1ae2-4a7a-9d48-836752fae871", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 346, "section": "UNSPECIFIED"}, "hash": "c402c3d6ca17e9afd2d3a2c85e47d98ccb26791117b88824153782278baaac18", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8f94f0a4-c77a-4c50-a075-1edcbe1a10d3", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 346, "section": "UNSPECIFIED"}, "hash": "386e357273bddab020d5275c787333b03b43a60c89fff0ca9828d18696425b86", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Should be an integer. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm for the element in which the \nassessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nTUDTC \nDate/Time of \nTumor/Lesion \nIdentification \nChar ISO 8601 datetime \nor interval \nTiming \nTUDTC variable represents the date of the scan/image/physical exam. TUDTC does not represent the \ndate that the image was read to identify tumors. TUDTC also does not represent the VISIT date. \nExp \nTUDY \nStudy Day of \nTumor/Lesion \nIdentification \nNum  \nTiming \nStudy day of the scan/image/physical exam, measured as integer days. Algorithm for calculations \nmust be relative to the sponsor-defined RFSTDTC variable in Demographics. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nTU \u2013 Assumptions \n1. The TU domain should contain only 1 record for each unique tumor/lesion/location of interest identified by an assessor (e.g., investigator, independent \nassessor) per medical evaluator. The initial identification of a tumor/lesion/location of interest is done once, usually at baseline (e.g., identification of \ntarget and non-target tumors/lesions) or first appearance of new tumor/lesion. The identification information, including the location description, must \nnot be repeated for every visit. A record is required in TU to identify and create the TULNKID when there are associated records in TR with matching \nTRLNKID. The following are examples of when post-baseline records might be included in the TU domain: \na. \nA new tumor/lesion may emerge at any time during a study; therefore, a new post-baseline record would represent the identification of the new \ntumor/lesion. \nb. If a tumor/lesion identified at baseline subsequently splits into separate distinct tumors/lesions, then additional post-baseline records can be \nincluded to distinctly identify the split tumors/lesions.", "mimetype": "text/plain", "start_char_idx": 2259, "end_char_idx": 4392, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aa59dd89-5997-46e3-98aa-14ae0fb2741a": {"__data__": {"id_": "aa59dd89-5997-46e3-98aa-14ae0fb2741a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 347, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3ac0ffdf-af59-4b99-94fe-8af07b0a4149", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 347, "section": "UNSPECIFIED"}, "hash": "e05b24ee94368e06508385eaa1def7bde3c1e40c46e667007791d703245fb467", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7d8ac91f-8d9e-4a15-b0c1-ec89cba2bf1b", "node_type": "1", "metadata": {}, "hash": "0cf585382d73a389006d99c3ad79d9a7cb1533f487678314a2922907bd7562f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 347 \n2021-11-29 \nc. \nIn situations where a re-baseline of targets and non-targets is required (e.g., a cross-over study), then a \nseparate set of target and non-target tumors/lesions might be identified and those identification records \nwould be represented. \n2. TRLNKID is used to relate an identification record in the TU domain to assessment records in the \nTumor/Lesion Results (TR) domain. The organization of data across the TU and TR domains requires a \nlinking mechanism. The TULNKID variable is used to provide a unique code for each identified \ntumor/lesion. The values of TULNKID are compound values that may carry the following information: an \nindication of the role (or assessor) providing the data record, when it is someone other than the principal \ninvestigator; an indication of whether the data record is for a target or non-target tumor/lesion; a tracking \nidentifier or number; and an indication of whether the tumor/lesion has split (see assumption 3 for details \non splitting). A RELREC relationship record can be created to describe the link, probably as a dataset-to-\ndataset link. \nTUTESTCD/TUTEST values for this domain are published as Controlled Terminology. For some \nTUTESTCD/TUTEST values, CDISC CT includes codelists for use with TUORRES. The associations \nbetween the test values and results are in the Oncology codetable, which, along with the CT Rules for \nOncology, is available at https://www.cdisc.org/standards/terminology/controlled-terminology. During the \ncourse of a trial, a tumor/lesion might split into one or more distinct tumors/lesions, or 2 or more \ntumors/lesions might merge to form a single tumor/lesion. The following example shows the preferred \napproach for representing split lesions in TU. However, the approach depends on how the data for split and \nmerged tumors/lesions are captured. The preferred approach requires the measurements of each distinct \ntumor/lesion to be captured individually. \nExample target tumor T04, identified at the screening visit, splits into 2 at week 16. Two new records are \ncreated with TUTEST = \"Tumor Split\u201d; TULNKID reflects the split by adding 0.1 and 0.2 to the original \nTULNKID value.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2360, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d8ac91f-8d9e-4a15-b0c1-ec89cba2bf1b": {"__data__": {"id_": "7d8ac91f-8d9e-4a15-b0c1-ec89cba2bf1b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 347, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3ac0ffdf-af59-4b99-94fe-8af07b0a4149", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 347, "section": "UNSPECIFIED"}, "hash": "e05b24ee94368e06508385eaa1def7bde3c1e40c46e667007791d703245fb467", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "aa59dd89-5997-46e3-98aa-14ae0fb2741a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 347, "section": "UNSPECIFIED"}, "hash": "fbce28379ebc64d03b35803b92702cfffe590637574337d7d1e6c4da6738dd1a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "During the \ncourse of a trial, a tumor/lesion might split into one or more distinct tumors/lesions, or 2 or more \ntumors/lesions might merge to form a single tumor/lesion. The following example shows the preferred \napproach for representing split lesions in TU. However, the approach depends on how the data for split and \nmerged tumors/lesions are captured. The preferred approach requires the measurements of each distinct \ntumor/lesion to be captured individually. \nExample target tumor T04, identified at the screening visit, splits into 2 at week 16. Two new records are \ncreated with TUTEST = \"Tumor Split\u201d; TULNKID reflects the split by adding 0.1 and 0.2 to the original \nTULNKID value.  \nTULNKID \nTUTESTCD \nTUTEST \nTUORRES \nVISIT \nT01 \nTUMIDENT \nTumor Identification \nTARGET \nSCREEN \nT02 \nTUMIDENT \nTumor Identification \nTARGET \nSCREEN \nT03 \nTUMIDENT \nTumor Identification \nTARGET \nSCREEN \nT04 \nTUMIDENT \nTumor Identification \nTARGET \nSCREEN \nNT01 \nTUMIDENT \nTumor Identification \nNON-TARGET \nSCREEN \nNT02 \nTUMIDENT \nTumor Identification \nNON-TARGET \nSCREEN \nT04.1 \nTUSPLIT \nTumor Split \nTARGET \nWEEK 16 \nT04.2 \nTUSPLIT \nTumor Split \nTARGET \nWEEK 16 \nNEW01 \nTUMIDENT \nTumor Identification \nNEW \nWEEK 32 \n \nIf the data collection does not support this approach (i.e., measurements of split tumors/lesions are reported \nas a summary under the \"parent\" tumor/lesion), then it may not be possible to include a record in the TU \ndomain. In this situation, the assessments of split and merge tumors/lesions would be represented only in \nthe TR domain. \n3. For some response criteria (e.g., Lugano, Kumar IMWG 2016), tumors are assessed by location of interest. \nA record is required in TU in order to link the assessments of the particular location of interest in TR. \nThis example represents tumors assessed by location of interest. In TULNKID = \"L01\", the spleen is \nidentified as a location of interest using computerized tomography (CT) scan. In TULNKID = \"L04\", the \nwhole body is identified as a location of interest using positron emission tomography (PET) scan. \nTULNKID \nTUTESTCD \nTUTEST \nTUORRES \nTULOC \nTUMETHOD \nL01 \nTUMIDENT \nTumor Identification \nLOCATION OF \nINTEREST \nSPLEEN \nCT SCAN \nL02 \nTUMIDENT \nTumor Identification \nLOCATION OF \nINTEREST \nLIVER \nCT SCAN \nL03 \nTUMIDENT \nTumor Identification \nLOCATION OF \nINTEREST \nBONE MARROW \nPET SCAN \nL04 \nTUMIDENT \nTumor Identification \nLOCATION OF \nINTEREST \nBODY \nPET SCAN \n4. During the course of a trial, when a new tumor/lesion is identified, information about that new tumor/lesion \nmay be collected to different levels of detail. For example, if anatomical location of a new tumor/lesion is \nnot collected, TULOC will be blank. All new tumors/lesions are to be represented in TU and TR domains.", "mimetype": "text/plain", "start_char_idx": 1666, "end_char_idx": 4430, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "291071e9-fd52-4bf3-b86a-ebd05b935d1c": {"__data__": {"id_": "291071e9-fd52-4bf3-b86a-ebd05b935d1c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 348, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e70268a6-e9cf-41f4-884f-3f9ad1300828", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 348, "section": "UNSPECIFIED"}, "hash": "aa75047327ea4297dc8f562c73d6bbd015f0f1e1ba625755bbb0da9a3ef06d5d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f0afa10c-2d24-413b-92b4-9f0d213e46ab", "node_type": "1", "metadata": {}, "hash": "174b63872e1d418ed8beee3a471429b3e70d96cad85ae8ef15d4b6ed08bac1f6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 348 \n2021-11-29 \n5. The additional anatomical location variables --LAT, --DIR, --PORTOT were added from the SDTM. These \nextra variables allow for more detailed information to be collected that further clarifies the value of the \nTULOC variable. \n6. In the oncology setting, when a new tumor is identified, a record must be included in both the TU and TR \ndomains. At a minimum, the TR record would contain TRLNKID = \"NEW0\" and TRTESTCD = \n\"TUMSTATE\" and TRORRES = \"PRESENT\" for unequivocal new tumors. The TU record may contain \ndifferent levels of detail depending upon the data collection methods employed. Although it is possible that \na sponsor may have a different chosen method, the following are the most common scenarios: \na. \nThe occurrence of a new tumor/lesion is the sole piece of information that a sponsor collects, because \nthis is a sign of disease progression; no further details are required. In such cases, a record would be \ncreated where TUTEST = \"Tumor Identification\" and TUORRES = \"NEW\", and the identifier, \nTULNKID, would be populated in order to link to the associated information in the TR domain. \nb. The occurrence of a new tumor/lesion and the anatomical location of that newly identified tumor/lesion \nare the only collected pieces of information. In this case, it is expected that a record would be created \nwhere TUTEST = \u201cTumor Identification\u201d and TUORRES = \"NEW\"; the TULOC variable would be \npopulated with the anatomical location information (the additional location variables may be populated \ndepending on the level of detail collected), and the identifier, TULNKID, would be populated in order \nto link to the associated information in the TR domain. \nc. \nThe sponsor records the occurrence of a new tumor/lesion to the same level of detail as target \ntumors/lesions. For example, with the occurrence of a new tumor/lesion, its anatomical location and its \nmeasurement might be recorded. In this case, it is expected that a record would be created where \nTUTEST = \"Tumor Identification\" and TUORRES = \"NEW\". The TULOC variable would be \npopulated with the anatomical location information (the additional location variables may be populated \ndepending on the level of detail collected) and the identifier, TULNKID, would be populated in order \nto link to the associated information in the TR domain. In this scenario, measurements/assessments \nwould also be recorded in the TR domain. \n7. The acceptance flag variable (TUACPTFL) identifies records that have been determined to be the accepted \nassessments/measurements by an independent assessor. This flag would be provided by an independent \nassessor and when multiple evaluators (e.g., \"RADIOLOGIST 1\", \"RADIOLOGIST 2\", \n\"ADJUDICATOR\") provide assessments or evaluations at the same time point or an overall evaluation. \nThis flag should not be used by a sponsor for any other purpose. It is not expected that the TUACPTFL flag \nwould be populated by the sponsor; instead, that type of record selection should be handled in the analysis \ndataset (ADaM). \n8.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3230, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f0afa10c-2d24-413b-92b4-9f0d213e46ab": {"__data__": {"id_": "f0afa10c-2d24-413b-92b4-9f0d213e46ab", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 348, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e70268a6-e9cf-41f4-884f-3f9ad1300828", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 348, "section": "UNSPECIFIED"}, "hash": "aa75047327ea4297dc8f562c73d6bbd015f0f1e1ba625755bbb0da9a3ef06d5d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "291071e9-fd52-4bf3-b86a-ebd05b935d1c", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 348, "section": "UNSPECIFIED"}, "hash": "bb9315509129d1cebc48c127a39e2747623c32ca82c8306c01fe43a1e9146361", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In this scenario, measurements/assessments \nwould also be recorded in the TR domain. \n7. The acceptance flag variable (TUACPTFL) identifies records that have been determined to be the accepted \nassessments/measurements by an independent assessor. This flag would be provided by an independent \nassessor and when multiple evaluators (e.g., \"RADIOLOGIST 1\", \"RADIOLOGIST 2\", \n\"ADJUDICATOR\") provide assessments or evaluations at the same time point or an overall evaluation. \nThis flag should not be used by a sponsor for any other purpose. It is not expected that the TUACPTFL flag \nwould be populated by the sponsor; instead, that type of record selection should be handled in the analysis \ndataset (ADaM). \n8. The evaluator-specified variable TUEVALID is used in conjunction with TUEVAL to provide additional \ndetail regarding who is providing tumor identification information (e.g., TUEVAL = \"INDEPENDENT \nASSESSOR\", TUEVALID = \"RADIOLOGIST 1\"). The TUEVALID variable is subject to controlled \nterminology. Note: TUEVAL must also be populated when TUEVALID is populated. \n9. If indicator questions for specific types of tumor or lesions are collected (e.g., Does the subject have target \ntumors? Does the subject have any non-targets? Did the subject have metastatic disease at screening?), then \nthese TUTESTs will be included in TU. If indicator questions are not collected, do not introduce them into \nTU. \nThis example shows indicator TUTESTs for a subject with non-target lesions only. \nTULNKID \nTUTESTCD \nTUTEST \nTUORRES \nTULOC \nTUMETHOD \n \nNTIND \nNon-Target Indicator \nY \n \nCT SCAN \n \nTIND \nTarget Indicator \nN \n \nCT SCAN \nNT01 \nTUMIDENT \nTumor Identification \nNON-TARGET \nLUNG \nCT SCAN \nThis example shows indicator TUTESTs for the identification of the sites of metastatic disease sites at \nbaseline.", "mimetype": "text/plain", "start_char_idx": 2520, "end_char_idx": 4331, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b66f6201-8f85-4fc0-adb9-6661f2ed23da": {"__data__": {"id_": "b66f6201-8f85-4fc0-adb9-6661f2ed23da", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 349, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e0d0b33e-84c7-4e76-811f-98b1bfd619f4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 349, "section": "UNSPECIFIED"}, "hash": "8174b1d71d09586c54b39daea049c33f9386f8dd293d65f046326900453cf809", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "92a90b77-df1c-4ad7-ac7d-b051a9911306", "node_type": "1", "metadata": {}, "hash": "725452f49c76b095f261bc270a23f2f2eb8dbcce4a0ad249f2da29fd4f4c201c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 349 \n2021-11-29 \nTULNKID \nTUTESTCD \nTUTEST \nTUORRES \nTUSTAT \nTULOC \nTUMETHOD \nVISIT \n \nMETIND \nMetastatic \nTumor Site \nIndicator \nY \n  \nLIVER \nCT SCAN \nBASELINE \n \nMETIND \nMetastatic \nTumor Site \nIndicator \nN \n  \nBRAIN \nMRI \nBASELINE \n \nMETIND \nMetastatic \nTumor Site \nIndicator \n \nNOT DONE \nPLEURAL \nCAVITY \n  \nBASELINE \n10. Disease recurrence can be represented in the TU domain as an identification for the appearance of new \ntumors. The TUTEST Disease Recurrence Relative Location is used identify the region or relative location \nfor the disease recurrence. The image identifier is in TUREFID and may match a PRREFID in the \nProcedures (PR) domain. The PR domain would contain the scans performed per protocol at each \nassessment; only when new tumors appear would records be included in TU. \nThis example shows disease recurrence data in an adjuvant breast cancer study where the subject was \ninitially diagnosed with cancer in the left breast only. This example shows a case where disease recurrence \nwas identified in various locations. TUTEST=Disease Recurrence Relative Location is used to identify the \nreference location of the recurrence (e.g., LOCAL, REGIONAL, DISTANT, LOCOREGIONAL). A local \ndisease recurrence was identified in the left breast, regional disease recurrence was identified in the \nipsilateral internal mammary and the ipsilateral infraclavicular nodes, distant disease recurrence was \nidentified in the liver and colon, and contralateral disease recurrence was identified in the right breast.   \nTUREFID \nTULNKID \nTUTESTCD \nTUTEST \nTUORRES \nTULOC \nTULAT \nTUMETHOD \nIMG-00007 \nLOC01 \nDRCRLTLC \nDisease \nRecurrence \nRelative \nLocation \nLOCAL \nBREAST \nLEFT \nCT SCAN \nIMG-00007 \nREG01 \nDRCRLTLC \nDisease \nRecurrence \nRelative \nLocation \nREGIONAL \nINTERNAL \nMAMMARY \nLYMPH NODE \n \nCT SCAN \nIMG-00007 \nREG02 \nDRCRLTLC \nDisease \nRecurrence \nRelative \nLocation \nREGIONAL \nINFRACLAVIC\nULAR LYMPH \nNODE \n \nCT SCAN \nIMG-00007 \nDIS01 \nDRCRLTLC \nDisease \nRecurrence \nRelative \nLocation \nDISTANT \nLIVER \n \nCT SCAN \nIMG-00007 \nDIS02 \nDRCRLTLC \nDisease \nRecurrence \nRelative \nLocation \nDISTANT \nCOLON \n \nCT SCAN \nIMG-00007 \nCON01 \nDRCRLTLC \nDisease \nRecurrence \nRelative \nLocation \nCONTRALATE\nRAL \nBREAST \nRIGHT \nCT SCAN \n \n11. The following proposed supplemental qualifiers would be used for oncology studies to represent \ninformation regarding previous irradiation of a tumor when that information is captured in association with \na specific tumor. \nQNAM \nQLABEL \nDefinition \nTUPREVIR \nPreviously Irradiated \nIndication of previous irradiation to a tumor \nTUPREISP \n \nIrradiated then Subsequent Progression \nIndication of documented progression subsequent to \nirradiation \n \n12.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2875, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "92a90b77-df1c-4ad7-ac7d-b051a9911306": {"__data__": {"id_": "92a90b77-df1c-4ad7-ac7d-b051a9911306", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 349, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e0d0b33e-84c7-4e76-811f-98b1bfd619f4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 349, "section": "UNSPECIFIED"}, "hash": "8174b1d71d09586c54b39daea049c33f9386f8dd293d65f046326900453cf809", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b66f6201-8f85-4fc0-adb9-6661f2ed23da", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 349, "section": "UNSPECIFIED"}, "hash": "015c2670af162fbbb6ba21097fb65db27b81ada1543d26e04ba06666c4d27dc9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The following proposed supplemental qualifiers would be used for oncology studies to represent \ninformation regarding previous irradiation of a tumor when that information is captured in association with \na specific tumor. \nQNAM \nQLABEL \nDefinition \nTUPREVIR \nPreviously Irradiated \nIndication of previous irradiation to a tumor \nTUPREISP \n \nIrradiated then Subsequent Progression \nIndication of documented progression subsequent to \nirradiation \n \n12. When additional data are collected about a procedure used for tumor/lesion identification, the data about \nthe procedure are stored in the PR domain; the link between the tumor/lesion identification and the \nprocedure should be recorded using RELREC. \n13. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the TU \ndomain, but the following qualifiers would not generally be used: --MODIFY, --POS, --BODSYS, --\nORNRLO, --ORNRHI, --STNRLO, --STNRHI, --STNRC, --NRIND, --XFN, --LOINC, --SPEC, --\nSPCCND, --FAST, --TOX, --TOXGR, --SEV.", "mimetype": "text/plain", "start_char_idx": 2423, "end_char_idx": 3457, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "68a887b8-6b2e-45cc-b34b-ec4cd9a6c4a5": {"__data__": {"id_": "68a887b8-6b2e-45cc-b34b-ec4cd9a6c4a5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 350, "section": "6.3.12.2 Tumor/Lesion Results (TR)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea5abddb-c16a-4a92-a021-d6c7e380e39b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 350, "section": "6.3.12.2 Tumor/Lesion Results (TR)"}, "hash": "19f8ebdf32c23ba646d5da55fb0c9227dd49e766644dd4c56dcab832d60e9af3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TR \u2013 Description/Overview \nA findings domain that represents quantitative measurements and/or qualitative assessments of the tumors, lesions, or locations of interest identified in the \nTumor/Lesion Identification (TU) domain. \nThe TR domain represents quantitative measurements and/or qualitative assessments of the tumors, lesions, or locations of interest (e.g., tumors, cardiovascular \nculprit lesions, organs, bone marrow, other sites of disease such as lymph nodes) identified in the Tumor/Lesion Identification (TU) domain. These \nmeasurements or qualitative assessments may be recorded at baseline and then at each subsequent assessment to support response evaluations. A typical record in \nthe TR domain contains the following information: \n\u2022 \na unique tumor/lesion/location of interest ID value \n\u2022 \ntest and result \n\u2022 \nmethod used \n\u2022 \nrole of the individual making the assessment \n\u2022 \ntiming information \nClinically accepted evaluation criteria expect that a tumor/lesion/location of interest identified by the ID is the same tumor/lesion/location of interest at each \nsubsequent assessment. The TR domain does not include anatomical location information on each measurement/assessment record, because this would duplicate \ninformation represented in TU. The multi-domain approach to representing oncology assessment data was developed largely to reduce duplication of stored \ninformation. \nTR \u2013 Specification \ntr.xpt, Tumor/Lesion Results \u2014 Findings. One record per tumor measurement/assessment per visit per subject per assessor, \nTabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar TR \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nTRSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness within a dataset for a subject. May be any valid \nnumber. \nReq \nTRGRPID \nGroup ID \nChar  \nIdentifier \nUsed to link together a block of related records within a subject in a domain. \nPerm \nTRREFID \nReference ID \nChar  \nIdentifier \nInternal or external identifier. \nPerm \nTRSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. \nPerm \nTRLNKID \nLink ID \nChar  \nIdentifier \nIdentifier used to link the assessment result records to the individual tumor/lesion identification \nrecord in TU domain. \nExp \nTRLNKGRP \nLink Group \nChar  \nIdentifier \nUsed to group and link all of the measurement/assessment records used in the assessment of the \nresponse record in the RS domain. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2813, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f89336ed-d7e0-490d-8581-706965ab4141": {"__data__": {"id_": "f89336ed-d7e0-490d-8581-706965ab4141", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 351, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c1343274-5a38-4f0b-820a-2b11e2ea0c53", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 351, "section": "UNSPECIFIED"}, "hash": "b9fa4a12067c8ef9e3abfd7658fafe56b22d7cddd5d62c1b4e287e2951a3789c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "55228acf-59c3-406c-8468-9b57982c816f", "node_type": "1", "metadata": {}, "hash": "d588801d2a296bc78af65c58728b4c8a12e3cf77895d8128789c714e8f8b3383", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 351 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nTRTESTCD \nTumor/Lesion \nAssessment Short Name \nChar (TRTESTCD) \nTopic \nShort name of the TEST in TRTEST. TRTESTCD cannot contain characters other than letters, \nnumbers, or underscores. Examples: \"TUMSTATE\", \"DIAMETER\", \"LESSCIND\", \"LESRVIND\". \nSee assumption 3. \nReq \nTRTEST \nTumor/Lesion \nAssessment Test Name \nChar (TRTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in \nTRTEST cannot be longer than 40 characters. Examples: \"Tumor State\", \"Diameter\", \"Volume\", \n\"Lesion Success Indicator\", \"Lesion Revascularization Indicator\". See assumption 3. \nReq \nTRORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the tumor/lesion measurement/assessment as originally received or collected. \nExp \nTRORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for TRORRES. Example: \"mm\". \nExp \nTRSTRESC \nCharacter Result/Finding \nin Std Format \nChar (TRPROPRS) \nResult \nQualifier \nContains the result value for all findings copied or derived from TRORRES, in a standard format or \nstandard units. TRSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in TRSTRESN. \nExp \nTRSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format \nfrom TRSTRESC. TRSTRESN should store all numeric test results or findings. \nExp \nTRSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for TRSTRESN. \nExp \nTRSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate a scan/image/physical exam was not performed or a tumor/lesion measurement \nwas not taken. Should be null if a result exists in TRORRES. \nPerm \nTRREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a scan/image/physical exam was not performed or a tumor/lesion measurement \nwas not taken. Examples: \"SCAN NOT PERFORMED\", \"NOT ASSESSABLE: IMAGE OBSCURED \nTUMOR\". Used in conjunction with TRSTAT when value is \"NOT DONE\". \nPerm \nTRNAM \nLaboratory/Vendor Name Char  \nRecord \nQualifier \nThe name or identifier of the vendor that performed the tumor/lesion measurement or assessment. \nThis column can be left null when the investigator provides the complete set of data in the domain. \nPerm \nTRMETHOD \nMethod Used to Identify \nthe Tumor/Lesion \nChar (METHOD) \nRecord \nQualifier \nMethod used to measure the tumor/lesion/location of interest. Examples: \"MRI\", \"CT SCAN\", \"PET \nSCAN\", \"Coronary angiography\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2949, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "55228acf-59c3-406c-8468-9b57982c816f": {"__data__": {"id_": "55228acf-59c3-406c-8468-9b57982c816f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 351, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c1343274-5a38-4f0b-820a-2b11e2ea0c53", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 351, "section": "UNSPECIFIED"}, "hash": "b9fa4a12067c8ef9e3abfd7658fafe56b22d7cddd5d62c1b4e287e2951a3789c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "f89336ed-d7e0-490d-8581-706965ab4141", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 351, "section": "UNSPECIFIED"}, "hash": "1f6af824b685201bc0571ce9a0f8d35660c747f7d2290261331135f3508f4748", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nTRREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a scan/image/physical exam was not performed or a tumor/lesion measurement \nwas not taken. Examples: \"SCAN NOT PERFORMED\", \"NOT ASSESSABLE: IMAGE OBSCURED \nTUMOR\". Used in conjunction with TRSTAT when value is \"NOT DONE\". \nPerm \nTRNAM \nLaboratory/Vendor Name Char  \nRecord \nQualifier \nThe name or identifier of the vendor that performed the tumor/lesion measurement or assessment. \nThis column can be left null when the investigator provides the complete set of data in the domain. \nPerm \nTRMETHOD \nMethod Used to Identify \nthe Tumor/Lesion \nChar (METHOD) \nRecord \nQualifier \nMethod used to measure the tumor/lesion/location of interest. Examples: \"MRI\", \"CT SCAN\", \"PET \nSCAN\", \"Coronary angiography\". \nExp \nTRLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally-derived indicator used to identify the last non-missing value prior to RFXSTDTC. \nShould be \"Y\" or null. \nExp \nTRBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that TRBLFL is retained for \nbackward compatibility. The authoritative baseline flag for statistical analysis is in an ADaM \ndataset. \nPerm \nTREVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., \nassigned by a person or a group). Examples: \"ADJUDICATION COMMITTEE\", \"INDEPENDENT \nASSESSOR\". \nExp \nTREVALID \nEvaluator Identifier \nChar (MEDEVAL) \nVariable \nQualifier \nUsed to distinguish multiple evaluators with the same role recorded in TREVAL. Examples: \n\"RADIOLOGIST1\", \"RADIOLOGIST2\". See assumption 6. \nPerm \nTRACPTFL \nAccepted Record Flag \nChar (NY) \nRecord \nQualifier \nIn cases where more than 1 independent assessor (e.g., \"RADIOLOGIST 1\", \"RADIOLOGIST 2\", \n\"ADJUDICATION COMMITTEE\") provide independent assessments at the same time point, this \nflag identifies the record that is considered to be the accepted assessment. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of a clinical encounter. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nEpoch associated with the date/time at which the assessment was made. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the element in the planned sequence of elements for the arm to which the \nsubject was assigned. \nPerm \nTRDTC \nDate/Time of \nTumor/Lesion \nMeasurement \nChar ISO 8601 datetime or \ninterval \nTiming \nThe date of the scan/image/physical exam. TRDTC does not represent the date that the image was \nread to identify tumors/lesions. TRDTC also does not represent the VISIT date. \nExp", "mimetype": "text/plain", "start_char_idx": 2174, "end_char_idx": 5125, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9ce2028b-2002-4131-a2a5-b5ab0ac25a4f": {"__data__": {"id_": "9ce2028b-2002-4131-a2a5-b5ab0ac25a4f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 352, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7bc34106-b4ef-451e-999e-779866b856b2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 352, "section": "UNSPECIFIED"}, "hash": "2406477c1a8a9bcbd78e62f5f4f01847557aef5f93118d52d9bcaa71ca6c47ec", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "60b5bc34-5919-4b89-be63-59ec4594bd64", "node_type": "1", "metadata": {}, "hash": "2c65bb368932b5e53663d59881706bca53e09768d68a014d7757e546dcdb521c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 352 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nTRDY \nStudy Day of \nTumor/Lesion \nMeasurement \nNum  \nTiming \nStudy day of the scan/image/physical exam, measured as integer days. Algorithm for calculations \nmust be relative to the sponsor-defined RFSTDTC variable in Demographics. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nTR \u2013 Assumptions \n1. TRLNKID is used to relate records in the TR domain to an identification record in TU domain. The organization of data across the TU and TR domains \nrequires a RELREC relationship to link the related data rows. A dataset-to-dataset link would be the most appropriate linking mechanism. Utilizing 1 of \nthe existing ID variables is not possible, because --GRPID, --REFID, and --SPID may be used for other purposes, per the SDTM. The --LNKID variable \nis used for values that support a RELREC dataset-to-dataset relationship and to provide a unique code for each identified tumor/lesion/location of \ninterest. \n2. TRLNKGRP is used to relate records in the TR domain to a response assessment record in the RS domain. The organization of data across the TR and \nRS domains requires a RELREC relationship to link the related data rows. A dataset-to-dataset link would be the most appropriate linking mechanism. \nUtilizing 1 of the existing ID variables is not possible because --GRPID, --REFID, and --SPID may be used for other purposes, per the SDTM. The --\nLNKGRP variable is used for values that support a RELREC dataset-to-dataset relationship and to provide a unique code for each response and \nassociated tumor/lesion measurements/assessments. \n3. TRTESTCD/TRTEST values for this domain are published as Controlled Terminology. For some TRTESTCD/TRTEST values, CDISC CT includes \ncodelists for use with TRORRES. The associations between the test values and results are in the Oncology codetable, which, along with the Controlled \nTerminology Rules for Oncology, is available at https://www.cdisc.org/standards/terminology/controlled-terminology. \nThe sponsor should not derive results for any test (e.g., percent change from nadir in sum of diameter) if the result was not collected. Tests would be \nincluded in the domain only if those data points have been collected on a CRF, presented by the CRF collection system, or supplied by an external \nassessor as part of an electronic data transfer. It is not intended that the sponsor would create derived records to supply those values in the TR domain. \nDerived records/results (outside the CRF) should be provided in the analysis dataset (ADaM). \n4. In order to support data value standardization it is sometimes appropriate to standardize an original result value in TRORRES to a standardized result \nvalue in TRSTRESC and TRSTRESN. For example, in the published RECIST criteria, a standardized value of 5 mm is used in the calculation to \ndetermine response when a tumor is \u201ctoo small to measure.\"", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3269, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "60b5bc34-5919-4b89-be63-59ec4594bd64": {"__data__": {"id_": "60b5bc34-5919-4b89-be63-59ec4594bd64", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 352, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7bc34106-b4ef-451e-999e-779866b856b2", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 352, "section": "UNSPECIFIED"}, "hash": "2406477c1a8a9bcbd78e62f5f4f01847557aef5f93118d52d9bcaa71ca6c47ec", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "9ce2028b-2002-4131-a2a5-b5ab0ac25a4f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 352, "section": "UNSPECIFIED"}, "hash": "36c002c20bf08275e643bccee57b95c5009d9cd735b5de5cf2fec4ffdb894fa9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Tests would be \nincluded in the domain only if those data points have been collected on a CRF, presented by the CRF collection system, or supplied by an external \nassessor as part of an electronic data transfer. It is not intended that the sponsor would create derived records to supply those values in the TR domain. \nDerived records/results (outside the CRF) should be provided in the analysis dataset (ADaM). \n4. In order to support data value standardization it is sometimes appropriate to standardize an original result value in TRORRES to a standardized result \nvalue in TRSTRESC and TRSTRESN. For example, in the published RECIST criteria, a standardized value of 5 mm is used in the calculation to \ndetermine response when a tumor is \u201ctoo small to measure.\" The original or collected value \"TOO SMALL TO MEASURE\" should be represented in \nthe TRORRES variable and the standardized value should be represented in the TRSTRESC and TRSTRESN variables. The information should be \nrepresented on a single row of data showing the standardization between the original result, TRORRES, and the standard results, \nTRSTRESC/TRSTRESN, as follows: \nTRLNKID \nTRTESTCD \nTRTEST \nTRORRES \nTRORRESU \nTRSTRESC \nTRSTRESN \nTRSTRESU \nT01 \nDIAMETER \nDiameter \nTOO SMALL \nTO MEASURE \nmm \n5 \n5 \nmm \n \nNote: This is an exception to SDTMIG general variable rule 4.1.5.1, Original and Standardized Results \nof Findings and Tests Not Done.", "mimetype": "text/plain", "start_char_idx": 2504, "end_char_idx": 3923, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "58001648-9d8d-448e-883f-f8c1874d28bc": {"__data__": {"id_": "58001648-9d8d-448e-883f-f8c1874d28bc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 353, "section": "6.3.12.3 Tumor Identification/Tumor Results Examples"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6e0bd672-07d5-46d1-b421-b037e5ab783b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 353, "section": "6.3.12.3 Tumor Identification/Tumor Results Examples"}, "hash": "6f9fc9f729523da6217a6e196f46d2b1f97fde6fd8df177bc5f5eb803a9fcddc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example 1 \nThis is an example of using the TU domain to represent non-cancerous lesions identified in the heart. \nSubject 40913 had a peripheral vascular intervention (PVI) procedure on February 1, 2007. A target lesion (L01) was identified in the infrarenal aorta within the \naorto-iliac vessel (L01-1). During the same PVI procedure, the subject also had a target graft lesion (L01-G) identified in the left femoro-popliteal graft (L01-\nG1). The lesion location was noted within the graft anastomosis proximal, the type was a synthetic graft composed of Gore-Tex, and the anastomosis was in the \nleft popliteal artery. \nRows 1-2: \nShow the target lesion located in the infrarenal aorta and within the aorta-iliac vessel. \nRow 3: \nShows the PVI target limb in which the graft lesion is located identified by the investigator. \nRows 4-5: \nShow the target graft lesion located in the left femoro-popliteal graft and within the femoro-popliteal vessel. \ntu.xpt \nRow STUDYID DOMAIN USUBJID TUSEQ TULNKID TUTESTCD TUTEST \nTUORRES TUSTRESC TULOC \nTULAT TUMETHOD \nTUEVAL \nVISITNUM VISIT \nTUDTC \n1 \nSTUDY01 TU \n40913 \n1 \nL01 \nLESIDENT \nLesion \nIdentification \nTARGET \nTARGET \nINFRARENAL \nAORTA \nLEFT \nANGIOGRAPHY INVESTIGATOR 1 \nSCREEN 2007-\n02-01 \n2 \nSTUDY01 TU \n40913 \n2 \nL01-1 \nVSLIDENT \nVessel Lesion \nIdentification \nTARGET \nTARGET \nAORTO-ILIAC \nPERIPHERAL \nARTERY \nLEFT \nANGIOGRAPHY INVESTIGATOR 1 \nSCREEN 2007-\n02-01 \n3 \nSTUDY01 TU \n40913 \n3 \nL01-2 \nLMLIDENT \nLimb Lesion \nIdentification \nTARGET \nTARGET \nLEG \nLEFT \nANGIOGRAPHY INVESTIGATOR 1 \nSCREEN 2007-\n02-01 \n4 \nSTUDY01 TU \n40913 \n4 \nL01-G \nGRLIDENT \nGraft Lesion \nIdentification \nTARGET \nTARGET \nFEMORO-\nPOPLITEAL \nPERIPHERAL \nARTERY \nLEFT \nANGIOGRAPHY INVESTIGATOR 1 \nSCREEN 2007-\n02-01 \n5 \nSTUDY01 TU \n40913 \n5 \nL01-G1 \nVSLIDENT \nVessel Lesion \nIdentification \nTARGET \nTARGET \nFEMORO-\nPOPLITEAL \nPERIPHERAL \nARTERY \nLEFT \nANGIOGRAPHY INVESTIGATOR 1 \nSCREEN 2007-\n02-01", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c1d7d178-e9f0-4717-ae1a-9f4e66f8f36c": {"__data__": {"id_": "c1d7d178-e9f0-4717-ae1a-9f4e66f8f36c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aadb65dc-3cb9-4f52-a6a8-3a3eaf220142", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}, "hash": "069f41371aaaa8afcfe0f00f1124c5efefe1c10916f8ef02b6c03a49a4685141", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c38889ea-fdf6-4907-940c-26e5f1320012", "node_type": "1", "metadata": {}, "hash": "ec06817feacc41518a571f14858e6d800db5b5dfc0aab788d1351abed9d41c77", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 354 \n2021-11-29 \nAdditional information about the lesion (e.g., lesion location within the graft, graft anastomosis) as well as details regarding the graft type and material are given using supplemental qualifiers. \nsupptu.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \nQORIG \nQEVAL \n1 \nSTUDY01 \nTU \n40913 \nTUSEQ \n4 \nTUPAGLL \nPeripheral Graft Lesion Location \nGRAFT ANASTOMOSIS PROXIMAL \nCRF \n \n2 \nSTUDY01 \nTU \n40913 \nTUSEQ \n4 \nTUPAGA \nPeripheral Artery Graft Anastomosis \nLEFT POPLITEAL ARTERY \nCRF \n \n3 \nSTUDY01 \nTU \n40913 \nTUSEQ \n4 \nTUOTHLDS \nOther Lesion Description \nLESION IS 5MM FROM THE ORIGIN OF THE GRAFT \nCRF \n \n4 \nSTUDY01 \nTU \n40913 \nTUSEQ \n4 \nTUPAGT \nPeripheral Artery Graft Type \nSYNTHETIC GRAFT \nCRF \n \n5 \nSTUDY01 \nTU \n40913 \nTUSEQ \n4 \nTUPAGSM \nPeripheral Artery Graft Synthetic Material \nGORE-TEX \nCRF \n \nExample 2 \nThis is an example of tumors identified and tracked using RECIST 1.1 criteria. \nTU shows the target and non-target tumors identified by an investigator at a screening visit and also shows that the investigator determined at the week 6 visit that 1 of the previously identified tumors had split. \nRows 1-6: \nShow for subject 44444 the target and non-target tumors identified by the investigator at the screening visit. \nRows 7-8: \nShow the investigator determined that a tumor (TULNKID = \"T04\" at screening) had split into 2 separate tumors at the week 6 visit. The 2 distinct pieces of the original tumor were then tracked \nindependently from that point in the study forward.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1713, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c38889ea-fdf6-4907-940c-26e5f1320012": {"__data__": {"id_": "c38889ea-fdf6-4907-940c-26e5f1320012", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aadb65dc-3cb9-4f52-a6a8-3a3eaf220142", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}, "hash": "069f41371aaaa8afcfe0f00f1124c5efefe1c10916f8ef02b6c03a49a4685141", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c1d7d178-e9f0-4717-ae1a-9f4e66f8f36c", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}, "hash": "5e492d72a7e389ff14eaa8cb499c2c6c822daa4dbeb410dd5f9005c2eee621ae", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2eee5f44-52fd-4dd5-80e6-938ef12658ad", "node_type": "1", "metadata": {}, "hash": "1f5652ac9fb64098074ad5aaa31636d101ce9965f89e7db04d9cad33bdb10451", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TU shows the target and non-target tumors identified by an investigator at a screening visit and also shows that the investigator determined at the week 6 visit that 1 of the previously identified tumors had split. \nRows 1-6: \nShow for subject 44444 the target and non-target tumors identified by the investigator at the screening visit. \nRows 7-8: \nShow the investigator determined that a tumor (TULNKID = \"T04\" at screening) had split into 2 separate tumors at the week 6 visit. The 2 distinct pieces of the original tumor were then tracked \nindependently from that point in the study forward. \ntu.xpt \nRow STUDYID \nDOMAIN USUBJID \nTUSEQ TUGRPID \nTULNKID \nTUTESTCD \nTUTEST \nTUORRES \nTUSTRESC \nTULOC \nTULAT TUMETHOD \nTUEVAL \nVISITNUM \nVISIT \nTUDTC \nTUDY \n1 \nABC \nTU \n44444 \n1 \n \nT01 \nTUMIDENT \nTumor Identification \nTARGET \nTARGET \nLIVER \n \nCT SCAN \nINVESTIGATOR \n10 \nSCREEN \n2010-01-01 \n-3 \n2 \nABC \nTU \n44444 \n2 \n \nT02 \nTUMIDENT \nTumor Identification \nTARGET \nTARGET \nKIDNEY \nRIGHT \nCT SCAN \nINVESTIGATOR \n10 \nSCREEN \n2010-01-01 \n-3 \n3 \nABC \nTU \n44444 \n3 \n \nT03 \nTUMIDENT \nTumor Identification \nTARGET \nTARGET \nCERVICAL LYMPH NODE \nLEFT \nMRI \nINVESTIGATOR \n10 \nSCREEN \n2010-01-02 \n-2 \n4 \nABC \nTU \n44444 \n4 \n \nT04 \nTUMIDENT \nTumor Identification \nTARGET \nTARGET \nSKIN OF THE TRUNK \n \nPHOTOGRAPHY \nINVESTIGATOR \n10 \nSCREEN \n2010-01-03 \n-1 \n5 \nABC \nTU \n44444 \n5 \n \nNT01 \nTUMIDENT \nTumor Identification \nNON-TARGET \nNON-TARGET \nTHYROID GLAND \nRIGHT \nCT SCAN \nINVESTIGATOR \n10 \nSCREEN \n2010-01-01 \n-3 \n6 \nABC \nTU \n44444 \n6 \n \nNT02 \nTUMIDENT \nTumor Identification \nNON-TARGET \nNON-TARGET \nCEREBELLUM \nRIGHT \nMRI \nINVESTIGATOR \n10 \nSCREEN \n2010-01-02 \n-2 \n7 \nABC \nTU \n44444 \n7 \nT04 \nT04.1 \nTUSPLIT \nTumor Split \nTARGET \nTARGET \nSKIN OF THE TRUNK \n \nPHOTOGRAPHY \nINVESTIGATOR \n40 \nWEEK 6 \n2010-02-20 \n48 \n8 \nABC \nTU \n44444 \n8 \nT04 \nT04.2 \nTUSPLIT \nTumor Split \nTARGET \nTARGET \nSKIN OF THE TRUNK \n \nPHOTOGRAPHY \nINVESTIGATOR \n40 \nWEEK 6 \n2010-02-20 \n48 \nThe supplemental qualifier dataset below shows that \"T01\", \"T02\", and \"T04\" were not previously irradiated and \"T03\" was previously irradiated with subsequent progression after irradiation.", "mimetype": "text/plain", "start_char_idx": 1118, "end_char_idx": 3254, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2eee5f44-52fd-4dd5-80e6-938ef12658ad": {"__data__": {"id_": "2eee5f44-52fd-4dd5-80e6-938ef12658ad", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aadb65dc-3cb9-4f52-a6a8-3a3eaf220142", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}, "hash": "069f41371aaaa8afcfe0f00f1124c5efefe1c10916f8ef02b6c03a49a4685141", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c38889ea-fdf6-4907-940c-26e5f1320012", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 354, "section": "UNSPECIFIED"}, "hash": "4ef011ddb3768ded3018da266e72028b592a722f427bcc0a439facbb2edad40a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "supptu.xpt \nRow \nSTUDYID \nRDOMAIN \nUSUBJID \nIDVAR \nIDVARVAL \nQNAM \nQLABEL \nQVAL \n1 \nABC \nTU \n44444 \nTULNKID \nT01 \nTUPREVIR \nPreviously Irradiated \nN \n2 \nABC \nTU \n44444 \nTULNKID \nT02 \nTUPREVIR \nPreviously Irradiated \nN \n3 \nABC \nTU \n44444 \nTULNKID \nT03 \nTUPREVIR \nPreviously Irradiated \nY \n4 \nABC \nTU \n44444 \nTULNKID \nT03 \nTUPREISP \nIrradiated then Subsequent Progression \nY \n5 \nABC \nTU \n44444 \nTULNKID \nT04 \nTUPREVIR \nPreviously Irradiated \nN \nTR shows measurements (i.e., short axis) of lymph nodes as well as measurements of other non-lymph node target tumors (i.e., longest diameter). In this example, when TRTEST = \"Tumor State\" and TRORRES = \n\"ABSENT\", it indicates that the target lymph node lesion was no longer pathological (i.e., diameter reduced below 10mm). The overall assessment of lymph nodes is represented with TRTEST = \"Lymph Nodes \nState\". A lymph node state of \"NON-PATHOLOGICAL\" means that all target lymph node lesions have a short axis less than 10mm. A lymph node state of \"PATHOLOGICAL\" means that at least 1 target lymph \nnode lesion has a short axis greater than or equal to 10mm. \nRows 1-8: \nShow the measurements of the target tumors and other assessments of the target and non-target tumors at the screening visit. \nRows 9-21: \nShow the measurements of the target tumors and other assessments of the target and non-target tumors at the week 6 visit. \nRows 22-27: Show the measurements of the target tumors and other assessments of the target and non-target tumors at the week 12 visit.", "mimetype": "text/plain", "start_char_idx": 3256, "end_char_idx": 4769, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "75edba8f-6a73-4dbf-b53e-7aea5a81659e": {"__data__": {"id_": "75edba8f-6a73-4dbf-b53e-7aea5a81659e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "hash": "9b492fbad0b3b7af27e1ce4e300d1a64e3bc8291c056684ae2c8b08d6e18ab1f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "05a12eaa-49c8-4379-a329-267057e3df58", "node_type": "1", "metadata": {}, "hash": "989f5fb3815c0f0f752099f6f032df61bf6d43781d8b32cd862d3afc41151c21", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 355 \n2021-11-29 \ntr.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 199, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "05a12eaa-49c8-4379-a329-267057e3df58": {"__data__": {"id_": "05a12eaa-49c8-4379-a329-267057e3df58", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "hash": "9b492fbad0b3b7af27e1ce4e300d1a64e3bc8291c056684ae2c8b08d6e18ab1f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "75edba8f-6a73-4dbf-b53e-7aea5a81659e", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "hash": "412b0614e0e13117814a13fa47e6c3ac0cef05707761398f57793437b5d51fb0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "dc3e0fd5-5514-494b-82a2-90754486553c", "node_type": "1", "metadata": {}, "hash": "c77e8d31aa77a334726794cbd1916755c4ab6bded7b42ca7dccf29de017388c5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "All rights reserved  \n Page 355 \n2021-11-29 \ntr.xpt \nRow STUDYID DOMAIN USUBJID TRSEQ TRGRPID \nTRLNKGRP TRLNKID TRTESTCD \nTRTEST \nTRORRES \nTRORRESU TRSTRESC \nTRSTRESN TRSTRESU TRSTAT \nTRREASND \nTRMETHOD \nTREVAL \nVISITNUM VISIT \nTRDTC \nTRDY \n1 \nABC \nTR \n44444 \n1 \nTARGET \nA1 \nT01 \nDIAMETER \nDiameter \n17 \nmm \n17 \n17 \nmm \n \n \nCT SCAN \nINVESTIGATOR 10 \nSCREEN 2010-\n01-01 \n-3 \n2 \nABC \nTR \n44444 \n2 \nTARGET \nA1 \nT02 \nDIAMETER \nDiameter \n16 \nmm \n16 \n16 \nmm \n \n \nCT SCAN \nINVESTIGATOR 10 \nSCREEN 2010-\n01-01 \n-3 \n3 \nABC \nTR \n44444 \n3 \nTARGET \nA1 \nT03 \nDIAMETER \nDiameter \n15 \nmm \n15 \n15 \nmm \n \n \nMRI \nINVESTIGATOR 10 \nSCREEN 2010-\n01-02 \n-2 \n4 \nABC \nTR \n44444 \n4 \nTARGET \nA1 \nT04 \nDIAMETER \nDiameter \n14 \nmm \n14 \n14 \nmm \n \n \nPHOTOGRAPHY INVESTIGATOR 10 \nSCREEN 2010-\n01-03 \n-1 \n5 \nABC \nTR \n44444 \n5 \nTARGET \nA1 \n \nSUMDIAM \nSum of \nDiameter \n62 \nmm \n62 \n62 \nmm \n \n \n \nINVESTIGATOR 10 \nSCREEN  \n \n6 \nABC \nTR \n44444 \n6 \nTARGET \nA1 \n \nSUMNLNLD Sum \nDiameters of \nNon Lymph \nNode Tumors \n47 \nmm \n47 \n47 \nmm \n \n \n \nINVESTIGATOR 10 \nSCREEN  \n \n7 \nABC \nTR \n44444 \n7 \nNON-\nTARGET \nA1 \nNT01 \nTUMSTATE \nTumor State \nPRESENT \n \nPRESENT \n \n \n \n \nCT SCAN \nINVESTIGATOR 10 \nSCREEN 2010-\n01-01 \n-3 \n8 \nABC \nTR \n44444 \n8 \nNON-\nTARGET \nA1 \nNT02 \nTUMSTATE \nTumor State \nPRESENT \n \nPRESENT \n \n \n \n \nMRI \nINVESTIGATOR 10 \nSCREEN 2010-\n01-02 \n-2 \n9 \nABC \nTR \n44444 \n9 \nTARGET \nA2 \nT01 \nDIAMETER \nDiameter \n0 \nmm \n0 \n0 \nmm \n \n \nCT SCAN \nINVESTIGATOR 40 \nWEEK 6 \n2010-\n02-18 \n46 \n10 \nABC \nTR \n44444 \n10 \nTARGET \nA2 \nT02 \nDIAMETER \nDiameter \nTOO SMALL TO \nMEASURE \nmm \n5 \n5 \nmm \n \n \nCT SCAN \nINVESTIGATOR 40 \nWEEK 6 \n2010-\n02-18 \n46 \n11 \nABC \nTR \n44444 \n11 \nTARGET \nA2 \nT03 \nDIAMETER \nDiameter \n12 \nmm \n12 \n12 \nmm \n \n \nMRI \nINVESTIGATOR 40 \nWEEK 6 \n2010-\n02-19 \n47 \n13 \nABC \nTR \n44444 \n13 \nTARGET \nA2 \nT04.", "mimetype": "text/plain", "start_char_idx": 151, "end_char_idx": 1926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc3e0fd5-5514-494b-82a2-90754486553c": {"__data__": {"id_": "dc3e0fd5-5514-494b-82a2-90754486553c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "hash": "9b492fbad0b3b7af27e1ce4e300d1a64e3bc8291c056684ae2c8b08d6e18ab1f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "05a12eaa-49c8-4379-a329-267057e3df58", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "hash": "81eeebd832cbb277f1bcd6172329ea70f41bbf1a3c4f88d334a1ad7ff0e5875f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "30a0d08e-c923-4553-89cb-744b440ba3ed", "node_type": "1", "metadata": {}, "hash": "117f944df2cca2d63abf2ec780e776fa7052eedb148323fbd446fbd16b74e763", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1 \nDIAMETER \nDiameter \n6 \nmm \n6 \n6 \nmm \n \n \nPHOTOGRAPHY INVESTIGATOR 40 \nWEEK 6 \n2010-\n02-20 \n48 \n14 \nABC \nTR \n44444 \n14 \nTARGET \nA2 \nT04.", "mimetype": "text/plain", "start_char_idx": 1926, "end_char_idx": 2064, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30a0d08e-c923-4553-89cb-744b440ba3ed": {"__data__": {"id_": "30a0d08e-c923-4553-89cb-744b440ba3ed", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fa0d88ac-db67-4c20-ac70-f3e17f0ca06f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "hash": "9b492fbad0b3b7af27e1ce4e300d1a64e3bc8291c056684ae2c8b08d6e18ab1f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "dc3e0fd5-5514-494b-82a2-90754486553c", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 355, "section": "UNSPECIFIED"}, "hash": "3cb1fa89060ab687fecc6b7ac95d51e6bb081e895c833ab41b157cf97497a47d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2 \nDIAMETER \nDiameter \n7 \nmm \n7 \n7 \nmm \n \n \nPHOTOGRAPHY INVESTIGATOR 40 \nWEEK 6 \n2010-\n02-20 \n48 \n15 \nABC \nTR \n44444 \n15 \nTARGET \nA2 \n \nSUMDIAM \nSum of \nDiameter \n30 \nmm \n30 \n30 \nmm \n \n \n \nINVESTIGATOR 40 \nWEEK 6 \n \n \n16 \nABC \nTR \n44444 \n16 \nTARGET \nA2 \n \nSUMNLNLD Sum \nDiameters of \nNon Lymph \nNode Tumors \n18 \nmm \n18 \n18 \nmm \n \n \n \nINVESTIGATOR 40 \nWEEK 6 \n \n \n17 \nABC \nTR \n44444 \n17 \nTARGET \nA2 \n \nLNSTATE \nLymph Node \nState \nPATHOLOGICAL \n \nPATHOLOGICAL  \n \n \n \n \nINVESTIGATOR 40 \nWEEK 6 \n \n \n18 \nABC \nTR \n44444 \n18 \nTARGET \nA2 \n \nACNSD \nAbsolute \nChange Nadir \nin Sum of \nDiam \n-32 \nmm \n-32 \n-32 \nmm \n \n \n \nINVESTIGATOR 40 \nWEEK 6 \n \n \n19 \nABC \nTR \n44444 \n19 \nTARGET \nA2 \n \nPCBSD \nPercent \nChange From \nBaseline in \nSum of \nDiameter \n-52 \n% \n-52 \n-52 \n% \n \n \n \nINVESTIGATOR 40 \nWEEK 6 \n \n \n20 \nABC \nTR \n44444 \n20 \nTARGET \nA2 \n \nPCNSD \nPercent \nChange Nadir \nin Sum of \nDiam \n-52 \n% \n-52 \n-52 \n% \n \n \n \nINVESTIGATOR 40 \nWEEK 6 \n \n \n21 \nABC \nTR \n44444 \n21 \nNON-\nTARGET \nA2 \nNT01 \nTUMSTATE \nTumor State \nPRESENT \n \nPRESENT \n \n \n \n \nCT SCAN \nINVESTIGATOR 40 \nWEEK 6 \n2010-\n02-18 \n46 \n22 \nABC \nTR \n44444 \n22 \nNON-\nTARGET \nA2 \nNT02 \nTUMSTATE \nTumor State \nPRESENT \n \nPRESENT \n \n \n \n \nMRI \nINVESTIGATOR 40 \nWEEK 6 \n2010-\n02-19 \n47 \n23 \nABC \nTR \n44444 \n23 \nTARGET \nA3 \nT01 \nDIAMETER \nDiameter \n0 \nmm \n0 \n0 \nmm \n \n \nCT SCAN \nINVESTIGATOR 60 \nWEEK \n12 \n2010-\n04-02 \n88 \n24 \nABC \nTR \n44444 \n24 \nTARGET \nA3 \nT02 \nDIAMETER \nDiameter \n6 \nmm \n6 \n6 \nmm \n \n \nCT SCAN \nINVESTIGATOR 60 \nWEEK \n12 \n2010-\n04-02 \n88 \n25 \nABC \nTR \n44444 \n25 \nTARGET \nA3 \nT03 \nDIAMETER \nDiameter \n \n \n \n \n \nNOT \nDONE \nSCAN NOT \nPERFORMED \nMRI \nINVESTIGATOR 60 \nWEEK \n12 \n \n \n26 \nABC \nTR \n44444 \n26 \nTARGET \nA3 \nT04 \nDIAMETER \nDiameter \n \n \n \n \n \nNOT \nDONE \nNOT \nASSESSABLE: \nPHOTOGRAPHY INVESTIGATOR 60 \nWEEK \n12", "mimetype": "text/plain", "start_char_idx": 2064, "end_char_idx": 3840, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6f48087c-0815-426b-a511-f5c96eaa4862": {"__data__": {"id_": "6f48087c-0815-426b-a511-f5c96eaa4862", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6f62a57b-a8b0-4ff4-b5c3-ccf8c967ff65", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}, "hash": "79aa8e39227f44c37d6f529adf4f6f39b48d1f915c30f6958213f3f66ca18a52", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7f49d108-4b8e-4077-a3f9-9f82c68674ae", "node_type": "1", "metadata": {}, "hash": "1627b885e5024fe560af5f512402d0a93061b2a4dd4198a7a005e64905e02a63", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 356 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID TRSEQ TRGRPID \nTRLNKGRP TRLNKID TRTESTCD \nTRTEST \nTRORRES \nTRORRESU TRSTRESC \nTRSTRESN TRSTRESU TRSTAT \nTRREASND \nTRMETHOD \nTREVAL \nVISITNUM VISIT \nTRDTC \nTRDY \nPOOR \nIMAGEQUALITY \n27 \nABC \nTR \n44444 \n27 \nNON-\nTARGET \nA3 \nNT01 \nTUMSTATE \nTumor State \n \n \n \n \n \n \n \nCT SCAN \nINVESTIGATOR 60 \nWEEK \n12 \n2010-\n04-02 \n88 \n28 \nABC \nTR \n44444 \n28 \nNON-\nTARGET \nA3 \nNT02 \nTUMSTATE \nTumor State \n \n \n \n \n \nNOT \nDONE \nSCAN NOT \nPERFORMED \nMRI \nINVESTIGATOR 60 \nWEEK \n12 \n \n \nThe relationship between the TU and TR datasets is represented in RELREC. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC \nTU \n \nTULNKID  \nONE \n1 \n2 \nABC \nTR \n \nTRLNKID  \nMANY \n1 \nExample 3 \nThis is an example of tumors identified and tracked following RECIST 1.1 criteria, with an additional opinion provided by an independent assessor. \nTU shows the target and non-target tumors identified by a radiologist at a screening visit. It also shows that the radiologist identified 2 new tumors: 1 at the week 6 visit and 1 at the week 12 visit. \nRows 1-5: \nShow the target and non-target tumors identified at screening by the independent assessor, Radiologist 1. \nRow 6: \nShows that a new tumor was identified at week 6 by the independent assessor, Radiologist 1.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1479, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7f49d108-4b8e-4077-a3f9-9f82c68674ae": {"__data__": {"id_": "7f49d108-4b8e-4077-a3f9-9f82c68674ae", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6f62a57b-a8b0-4ff4-b5c3-ccf8c967ff65", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}, "hash": "79aa8e39227f44c37d6f529adf4f6f39b48d1f915c30f6958213f3f66ca18a52", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6f48087c-0815-426b-a511-f5c96eaa4862", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}, "hash": "3a79500a3c87e2a4df01dd7d3c939a5aae19187be536763b92c9ef4a72cc31e9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3710586d-0764-421e-b90a-3b79b31619d6", "node_type": "1", "metadata": {}, "hash": "f32d751b0464337cb15462514eacdadce437aa5aa888cb6f85d726949257886c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TU shows the target and non-target tumors identified by a radiologist at a screening visit. It also shows that the radiologist identified 2 new tumors: 1 at the week 6 visit and 1 at the week 12 visit. \nRows 1-5: \nShow the target and non-target tumors identified at screening by the independent assessor, Radiologist 1. \nRow 6: \nShows that a new tumor was identified at week 6 by the independent assessor, Radiologist 1. \nRow 7: \nShows that another new tumor was identified at week 12 by the independent assessor, Radiologist 1. \ntu.xpt \nRow STUDYID DOMAIN USUBJID TUSEQ TULNKID \nTUTESTCD TUTEST \nTUORRES \nTUSTRESC \nTULOC \nTULAT TUMETHOD TUNAM \nTUEVAL \nTUEVALID \nVISITNUM VISIT \nTUDTC \nTUDY \n1 \nABC \nTU \n55555 \n1 \nR1-T01 \nTUMIDENT Tumor \nIdentification \nTARGET \nTARGET \nCERVICAL LYMPH \nNODE \nLEFT \nMRI \nACE \nIMAGING \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-01-\n02 \n-2 \n2 \nABC \nTU \n55555 \n2 \nR1-T02 \nTUMIDENT Tumor \nIdentification \nTARGET \nTARGET \nLIVER \n \nCT SCAN \nACE \nIMAGING \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-01-\n01 \n-3 \n3 \nABC \nTU \n55555 \n3 \nR1-T03 \nTUMIDENT Tumor \nIdentification \nTARGET \nTARGET \nTHYROID GLAND \nRIGHT CT SCAN \nACE \nIMAGING \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-01-\n01 \n-3 \n4 \nABC \nTU \n55555 \n4 \nR1-NT01 \nTUMIDENT Tumor \nIdentification \nNON-\nTARGET \nNON-\nTARGET \nKIDNEY \nRIGHT CT SCAN \nACE \nIMAGING \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-01-\n01 \n-3 \n5 \nABC \nTU \n55555 \n5 \nR1-NT02 \nTUMIDENT Tumor \nIdentification \nNON-\nTARGET \nNON-\nTARGET \nCEREBELLUM \nRIGHT MRI \nACE \nIMAGING \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-01-\n02 \n-2 \n6 \nABC \nTU \n55555 \n6 \nR1-\nNEW01 \nTUMIDENT Tumor \nIdentification \nNEW \nNEW \nLUNG \n \nCT SCAN \nACE \nIMAGING \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-02-\n20 \n48 \n7 \nABC \nTU \n55555 \n7 \nR1-\nNEW02 \nTUMIDENT Tumor \nIdentification \nNEW \nNEW \nCEREBELLUM \nLEFT \nMRI \nACE \nIMAGING \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n2010-04-\n02 \n88 \nTR shows assessments provided by an independent assessor as opposed to the principal investigator.", "mimetype": "text/plain", "start_char_idx": 1059, "end_char_idx": 3149, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3710586d-0764-421e-b90a-3b79b31619d6": {"__data__": {"id_": "3710586d-0764-421e-b90a-3b79b31619d6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6f62a57b-a8b0-4ff4-b5c3-ccf8c967ff65", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}, "hash": "79aa8e39227f44c37d6f529adf4f6f39b48d1f915c30f6958213f3f66ca18a52", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7f49d108-4b8e-4077-a3f9-9f82c68674ae", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 356, "section": "UNSPECIFIED"}, "hash": "d3daf5157fb64f1bc19006bd8a41d14b5773d644474869dbbca8278eb7ea13bd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Rows 1-7: \nShow the measurements of the target tumors and other assessments of the target and non-target tumors at the screening visit by the independent assessor, Radiologist 1. \nRows 8-19: \nShow the measurements of the target tumors and other assessments of the target and non-target tumors at the week 6 visit by the independent assessor, Radiologist 1. \nRows 20-32: Show the measurements of the target tumors and other assessments of the target and non-target tumors at the week 12 visit by the independent assessor, Radiologist 1. \ntr.xpt \nRow STUDYID DOMAIN USUBJID TRSEQ TRGRPID \nTRLNKGRP TRLNKID TRTESTCD \nTRTEST \nTRORRES \nTRORRESU TRSTRESC \nTRSTRESN TRSTRESU TRNAM \nTRMETHOD TREVAL \nTREVALID \nVISITNUM VISIT \nTRDTC \nTRDY \n1 \nABC \nTR \n55555 \n1 \nTARGET \nA1 \nR1-T01 \nDIAMETER \nDiameter \n20 \nmm \n20 \n20 \nmm \nACE \nIMAGING \nMRI \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-\n01-02 \n-2", "mimetype": "text/plain", "start_char_idx": 3151, "end_char_idx": 4048, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "1d63eb5d-21d0-4a4e-8fcf-733ff6280d8d": {"__data__": {"id_": "1d63eb5d-21d0-4a4e-8fcf-733ff6280d8d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b9cffea-5a56-4a6e-bbf2-47f6875d941c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "hash": "6377f20642643d205ac8dd39437cce5b1b8b365601c6230b977fa89dd3a87d7b", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "b2881837-3687-4c2f-a859-dd7534e5cf62", "node_type": "1", "metadata": {}, "hash": "4ce77d24cf07320e135664037dd39706ee1b176051c7f7bb01c3f239e292a0f1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 357 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID TRSEQ TRGRPID \nTRLNKGRP TRLNKID TRTESTCD \nTRTEST \nTRORRES \nTRORRESU TRSTRESC \nTRSTRESN TRSTRESU TRNAM \nTRMETHOD TREVAL \nTREVALID \nVISITNUM VISIT \nTRDTC \nTRDY \n2 \nABC \nTR \n55555 \n2 \nTARGET \nA1 \nR1-T02 \nDIAMETER \nDiameter \n15 \nmm \n15 \n15 \nmm \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-\n01-01 \n-3 \n3 \nABC \nTR \n55555 \n3 \nTARGET \nA1 \nR1-T03 \nDIAMETER \nDiameter \n15 \nmm \n15 \n15 \nmm \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-\n01-01 \n-3 \n4 \nABC \nTR \n55555 \n4 \nTARGET \nA1 \n \nSUMDIAM \nSum of \nDiameter \n50 \nmm \n50 \n50 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN  \n \n5 \nABC \nTR \n55555 \n5 \nTARGET \nA1 \n \nSUMNLNLD Sum \nDiameters of \nNon Lymph \nNode Tumors \n30 \nmm \n30 \n30 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN  \n \n6 \nABC \nTR \n55555 \n6 \nNON-\nTARGET \nA1 \nR1-NT01 \nTUMSTATE \nTumor State \nPRESENT \n \nPRESENT \n \n \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-\n01-02 \n-2 \n7 \nABC \nTR \n55555 \n7 \nNON-\nTARGET \nA1 \nR1-NT02 \nTUMSTATE \nTumor State \nPRESENT \n \nPRESENT \n \n \nACE \nIMAGING \nMRI \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n10 \nSCREEN 2010-\n01-04 \n1 \n8 \nABC \nTR \n55555 \n8 \nTARGET \nA2 \nR1-T01 \nDIAMETER \nDiameter \n12 \nmm \n12 \n12 \nmm \nACE \nIMAGING \nMRI \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-18 \n46 \n9 \nABC \nTR \n55555 \n9 \nTARGET \nA2 \nR1-T02 \nDIAMETER \nDiameter \n0 \nmm \n0 \n0 \nmm \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-19 \n47 \n10 \nABC \nTR \n55555 \n10 \nTARGET \nA2 \nR1-T03 \nDIAMETER \nDiameter \n13 \nmm \n13 \n13 \nmm \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1889, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b2881837-3687-4c2f-a859-dd7534e5cf62": {"__data__": {"id_": "b2881837-3687-4c2f-a859-dd7534e5cf62", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b9cffea-5a56-4a6e-bbf2-47f6875d941c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "hash": "6377f20642643d205ac8dd39437cce5b1b8b365601c6230b977fa89dd3a87d7b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1d63eb5d-21d0-4a4e-8fcf-733ff6280d8d", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "hash": "79534342bbb530e4f7c45946a3b6eec7a2d02db86eaabad7b1e1c0b1627e51b9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3e8b3962-c1d6-4bd0-aef2-9fd61b6824cb", "node_type": "1", "metadata": {}, "hash": "0e9a5eb2658fbaf42f997392d35557fca137b4193ef066882ec8082a92e3a68b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TARGET \nA2 \nR1-T01 \nDIAMETER \nDiameter \n12 \nmm \n12 \n12 \nmm \nACE \nIMAGING \nMRI \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-18 \n46 \n9 \nABC \nTR \n55555 \n9 \nTARGET \nA2 \nR1-T02 \nDIAMETER \nDiameter \n0 \nmm \n0 \n0 \nmm \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-19 \n47 \n10 \nABC \nTR \n55555 \n10 \nTARGET \nA2 \nR1-T03 \nDIAMETER \nDiameter \n13 \nmm \n13 \n13 \nmm \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-19 \n47 \n11 \nABC \nTR \n55555 \n11 \nTARGET \nA2 \n \nSUMDIAM \nSum of \nDiameter \n25 \nmm \n25 \n25 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n \n \n12 \nABC \nTR \n55555 \n12 \nTARGET \nA2 \n \nSUMNLNLD Sum \nDiameters of \nNon Lymph \nNode Tumors \n13 \nmm \n13 \n13 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n \n \n13 \nABC \nTR \n55555 \n13 \nTARGET \nA2 \n \nLNSTATE \nLymph Nodes \nState \nPATHOLOGICAL \n \nPATHOLOGICAL \n \n \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n \n \n14 \nABC \nTR \n55555 \n14 \nTARGET \nA2 \n \nACNSD \nAbsolute \nChange From \nNadir in Sum \nof Diameters \n-25 \nmm \n-25 \n-25 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n \n \n15 \nABC \nTR \n55555 \n15 \nTARGET \nA2 \n \nPCBSD \nPercent \nChange From \nBaseline in \nSum of \nDiameters \n-50 \n% \n-60 \n-50 \n% \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n \n \n16 \nABC \nTR \n55555 \n16 \nTARGET \nA2 \n \nPCNSD \nPercent \nChange From \nNadir in Sum \nof Diameters \n-50 \n% \n-50 \n-50 \n% \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n \n \n17 \nABC \nTR \n55555 \n17 \nNON-\nTARGET \nA2 \nR1-NT01 \nTUMSTATE \nTumor State \nABSENT \n \nABSENT \n \n \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-19 \n47 \n18 \nABC \nTR \n55555 \n18 \nNON-\nTARGET \nA2", "mimetype": "text/plain", "start_char_idx": 1444, "end_char_idx": 3238, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3e8b3962-c1d6-4bd0-aef2-9fd61b6824cb": {"__data__": {"id_": "3e8b3962-c1d6-4bd0-aef2-9fd61b6824cb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b9cffea-5a56-4a6e-bbf2-47f6875d941c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "hash": "6377f20642643d205ac8dd39437cce5b1b8b365601c6230b977fa89dd3a87d7b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b2881837-3687-4c2f-a859-dd7534e5cf62", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "hash": "987d3171e2a13955d5b7a78bcf1431b02966062c0131198d801aa4897d519541", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "2b8a97a7-99a6-4424-bcb5-d7bc28b34505", "node_type": "1", "metadata": {}, "hash": "50b54b42298635188aaf1ceaa955acca7902d538fbffe4a1e66fa7b22cab6ee3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n \n \n16 \nABC \nTR \n55555 \n16 \nTARGET \nA2 \n \nPCNSD \nPercent \nChange From \nNadir in Sum \nof Diameters \n-50 \n% \n-50 \n-50 \n% \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n \n \n17 \nABC \nTR \n55555 \n17 \nNON-\nTARGET \nA2 \nR1-NT01 \nTUMSTATE \nTumor State \nABSENT \n \nABSENT \n \n \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-19 \n47 \n18 \nABC \nTR \n55555 \n18 \nNON-\nTARGET \nA2 \nR1-NT02 \nTUMSTATE \nTumor State \nABSENT \n \nABSENT \n \n \nACE \nIMAGING \nMRI \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-18 \n46 \n19 \nABC \nTR \n55555 \n19 \nNEW \nA2 \nR1-\nNEW01 \nTUMSTATE \nTumor State \nEQUIVOCAL \n \nEQUIVOCAL \n \n \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n40 \nWEEK 6 \n2010-\n02-18 \n46 \n20 \nABC \nTR \n55555 \n20 \nTARGET \nA3 \nR1-T01 \nDIAMETER \nDiameter \n7 \nmm \n7 \n7 \nmm \nACE \nIMAGING \nMRI \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n2010-\n04-02 \n88 \n21 \nABC \nTR \n55555 \n21 \nTARGET \nA3 \nR1-T02 \nDIAMETER \nDiameter \n20 \nmm \n20 \n20 \nmm \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n2010-\n04-02 \n88 \n22 \nABC \nTR \n55555 \n22 \nTARGET \nA3 \nR1-T03 \nDIAMETER \nDiameter \n10 \nmm \n10 \n10 \nmm \nACE \nIMAGING \nCT SCAN \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n2010-\n04-02 \n88 \n23 \nABC \nTR \n55555 \n23 \nTARGET \nA3 \n \nSUMDIAM \nSum of \nDiameter \n37 \nmm \n37 \n37 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n \n \n24 \nABC \nTR \n55555 \n24 \nTARGET \nA3 \n \nSUMNLNLD Sum \nDiameters of \nNon Lymph \nNode Tumors \n30 \nmm \n30 \n30 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n \n \n25 \nABC \nTR \n55555 \n25 \nTARGET \nA3 \n \nLNSTATE \nLymph Nodes \nState \nNONPATHOLOGICAL  \nNONPATHOLOGICAL  \n \nACE \nIMAGING \n \nINDEPENDENT", "mimetype": "text/plain", "start_char_idx": 2784, "end_char_idx": 4564, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2b8a97a7-99a6-4424-bcb5-d7bc28b34505": {"__data__": {"id_": "2b8a97a7-99a6-4424-bcb5-d7bc28b34505", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9b9cffea-5a56-4a6e-bbf2-47f6875d941c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "hash": "6377f20642643d205ac8dd39437cce5b1b8b365601c6230b977fa89dd3a87d7b", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3e8b3962-c1d6-4bd0-aef2-9fd61b6824cb", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 357, "section": "UNSPECIFIED"}, "hash": "5353fe6de6ceef5afa894246b1553baeb8a25fabfa7b0c4b10c87a79fff67359", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "88 \n23 \nABC \nTR \n55555 \n23 \nTARGET \nA3 \n \nSUMDIAM \nSum of \nDiameter \n37 \nmm \n37 \n37 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n \n \n24 \nABC \nTR \n55555 \n24 \nTARGET \nA3 \n \nSUMNLNLD Sum \nDiameters of \nNon Lymph \nNode Tumors \n30 \nmm \n30 \n30 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n \n \n25 \nABC \nTR \n55555 \n25 \nTARGET \nA3 \n \nLNSTATE \nLymph Nodes \nState \nNONPATHOLOGICAL  \nNONPATHOLOGICAL  \n \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12 \n \n \n26 \nABC \nTR \n55555 \n26 \nTARGET \nA3 \n \nACNSD \nAbsolute \nChange Nadir \n17 \nmm \n17 \n17 \nmm \nACE \nIMAGING \n \nINDEPENDENT \nASSESSOR \nRADIOLOGIST \n1 \n60 \nWEEK \n12", "mimetype": "text/plain", "start_char_idx": 4087, "end_char_idx": 4766, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c6ac6818-6634-46c3-93af-3314b548283a": {"__data__": {"id_": "c6ac6818-6634-46c3-93af-3314b548283a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 358, "section": "6.3.13 Vital Signs (VS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3262b4aa-55a3-4633-b9e4-090add93b670", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 358, "section": "6.3.13 Vital Signs (VS)"}, "hash": "6df22b60bd271a1423ba221bcdf3c47802ddfabc0999fcec3da3ee706962c2fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "VS \u2013 Description/Overview \nA findings domain that contains measurements including but not limited to blood pressure, temperature, respiration, body surface area, body mass index, height and weight. \nVS \u2013 Specification \nvs.xpt, Vital Signs \u2014 Findings. One record per vital sign measurement per time point per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar VS \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the product. \nReq \nVSSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid number. \nReq \nVSGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nVSSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined in the sponsor's operational database. \nPerm \nVSTESTCD \nVital Signs Test Short \nName \nChar (VSTESTCD) \nTopic \nShort name of the measurement, test, or examination described in VSTEST. It can be used as a column name when converting a dataset from a vertical to a \nhorizontal format. The value in VSTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). VSTESTCD cannot \ncontain characters other than letters, numbers, or underscores. Examples: \"SYSBP\", \"DIABP\", \"BMI\". \nReq \nVSTEST \nVital Signs Test Name \nChar (VSTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in VSTEST cannot be longer than 40 characters. Examples: \n\"Systolic Blood Pressure\", \"Diastolic Blood Pressure\", \"Body Mass Index\". \nReq \nVSCAT \nCategory for Vital Signs Char * \nGrouping \nQualifier \nUsed to define a category of related records. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2184, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "91ac189b-8735-45bf-b645-cc6d12d42449": {"__data__": {"id_": "91ac189b-8735-45bf-b645-cc6d12d42449", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3fcae6e8-660a-41c5-abd3-6141943b9ee7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}, "hash": "ca66263b41be5e90ce9a54e726b49035fe5ac612416b11b040dc3c2a8c8a58bb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e2ff06b3-8ccd-454b-9e5d-2534203d4293", "node_type": "1", "metadata": {}, "hash": "53d76b3cd23df6034a77bf484504b6cd2ffbaec422a90c0c2abf868d8ace48d5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 359 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nVSSCAT \nSubcategory for Vital \nSigns \nChar * \nGrouping \nQualifier \nA further categorization of a measurement or examination. \nPerm \nVSPOS \nVital Signs Position of \nSubject \nChar (POSITION) \nRecord \nQualifier \nPosition of the subject during a measurement or examination. Examples: \"SUPINE\", \"STANDING\", \"SITTING\". \nPerm \nVSORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the vital signs measurement as originally received or collected. \nExp \nVSORRESU \nOriginal Units \nChar (VSRESU) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for VSORRES. Examples: \"in\", \"LB\", \"beats/min\". \nExp \nVSSTRESC \nCharacter \nResult/Finding in Std \nFormat \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from VSORRES in a standard format or standard units. VSSTRESC should store all results or findings in \ncharacter format; if results are numeric, they should also be stored in numeric format in VSSTRESN. For example, if a test has results \"NONE\", \"NEG\", and \n\"NEGATIVE\" in VSORRES, and these results effectively have the same meaning, they could be represented in standard format in VSSTRESC as \"NEGATIVE\". \nExp \nVSSTRESN \nNumeric Result/Finding \nin Standard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from VSSTRESC. VSSTRESN should store all numeric test results \nor findings. \nExp \nVSSTRESU \nStandard Units \nChar (VSRESU) \nVariable \nQualifier \nStandardized unit used for VSSTRESC and VSSTRESN. \nExp \nVSSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that a vital sign measurement was not done. Should be null if a result exists in VSORRES. \nPerm \nVSREASND \nReason Not Performed \nChar  \nRecord \nQualifier \nDescribes why a measurement or test was not performed. Examples: \"BROKEN EQUIPMENT\", \"SUBJECT REFUSED\". Used in conjunction with VSSTAT when \nvalue is \"NOT DONE\". \nPerm \nVSLOC \nLocation of Vital Signs \nMeasurement \nChar (LOC) \nRecord \nQualifier \nLocation relevant to the collection of vital signs measurement. Example: \"ARM\" for blood pressure. \nPerm \nVSLAT \nLaterality \nChar (LAT) \nResult \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \"BILATERAL\". \nPerm \nVSLOBXFL \nLast Observation \nBefore Exposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. Should be \"Y\" or null. \nExp \nVSBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that VSBLFL is retained for backward compatibility.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3007, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e2ff06b3-8ccd-454b-9e5d-2534203d4293": {"__data__": {"id_": "e2ff06b3-8ccd-454b-9e5d-2534203d4293", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3fcae6e8-660a-41c5-abd3-6141943b9ee7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}, "hash": "ca66263b41be5e90ce9a54e726b49035fe5ac612416b11b040dc3c2a8c8a58bb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "91ac189b-8735-45bf-b645-cc6d12d42449", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}, "hash": "93924976f7897fe941ffdbf98c796f46e41f8a62fea08dc91efe54aaaad6d2e9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "edd689e2-65e6-40ad-9698-f94a88b834b6", "node_type": "1", "metadata": {}, "hash": "2a53d2eea6bcdbea315860816b42500687a4966a7f8feac4b8824f465d2015e2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nVSLOC \nLocation of Vital Signs \nMeasurement \nChar (LOC) \nRecord \nQualifier \nLocation relevant to the collection of vital signs measurement. Example: \"ARM\" for blood pressure. \nPerm \nVSLAT \nLaterality \nChar (LAT) \nResult \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \"BILATERAL\". \nPerm \nVSLOBXFL \nLast Observation \nBefore Exposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. Should be \"Y\" or null. \nExp \nVSBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. Should be \"Y\" or null. Note that VSBLFL is retained for backward compatibility. The authoritative baseline for statistical \nanalysis is in an ADaM dataset. \nPerm \nVSDRVFL \nDerived Flag \nChar (NY) \nRecord \nQualifier \nUsed to indicate a derived record. The value should be \"Y\" or null. Records that represent the average of other records or that do not come from the CRF are \nexamples of records that would be derived for the submission datasets. If VSDRVFL = \"Y,\" then VSORRES may be null, with VSSTRESC and (if numeric) \nVSSTRESN having the derived value. \nPerm \nVSTOX \nToxicity \nChar * \nVariable \nQualifier \nDescription of toxicity quantified by VSTOXGR. The sponsor is expected to provide the name of the scale and version used to map the terms, utilizing the external \ncodelist element in the Define-XML document. \nPerm \nVSTOXGR \nStandard Toxicity \nGrade \nChar * \nRecord \nQualifier \nRecords toxicity grade value using a standard toxicity scale (e.g., NCI CTCAE). If value is from a numeric scale, represent only the number (e.g., \"2\", not \"Grade 2\"). \nThe sponsor is expected to provide the name of the scale and version used to map the terms, utilizing the external codelist element in the Define-XML document. \nPerm \nVSCLSIG \nClinically Significant, \nCollected \nChar (NY) \nRecord \nQualifier \nUsed to indicate whether a collected observation is clinically significant based on judgment. \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time at which the assessment was made. \nPerm \nVSDTC \nDate/Time of \nMeasurements \nChar ISO 8601 datetime or \ninterval \nTiming \nDate and time of the vital signs assessment represented in ISO 8601 character format. \nExp \nVSDY \nStudy Day of Vital \nSigns \nNum  \nTiming \nStudy day of vital signs measurements, measured as integer days. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in \nDemographics.", "mimetype": "text/plain", "start_char_idx": 2265, "end_char_idx": 5351, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "edd689e2-65e6-40ad-9698-f94a88b834b6": {"__data__": {"id_": "edd689e2-65e6-40ad-9698-f94a88b834b6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3fcae6e8-660a-41c5-abd3-6141943b9ee7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}, "hash": "ca66263b41be5e90ce9a54e726b49035fe5ac612416b11b040dc3c2a8c8a58bb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e2ff06b3-8ccd-454b-9e5d-2534203d4293", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 359, "section": "UNSPECIFIED"}, "hash": "635eaced849f135fb1a0aa41ff7fab69a34eb5d6bb1c29e8dfa8f97c9be5557b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the start date/time at which the assessment was made. \nPerm \nVSDTC \nDate/Time of \nMeasurements \nChar ISO 8601 datetime or \ninterval \nTiming \nDate and time of the vital signs assessment represented in ISO 8601 character format. \nExp \nVSDY \nStudy Day of Vital \nSigns \nNum  \nTiming \nStudy day of vital signs measurements, measured as integer days. Algorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in \nDemographics. \nPerm \nVSTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when measurement should be taken. This may be represented as an elapsed time relative to a fixed reference point (e.g., time of last dose). \nSee VSTPTNUM and VSTPTREF. Examples: \"START\", \"5 MIN POST\". \nPerm", "mimetype": "text/plain", "start_char_idx": 4580, "end_char_idx": 5638, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "81e00488-7f7a-4432-8694-884d4e42fecc": {"__data__": {"id_": "81e00488-7f7a-4432-8694-884d4e42fecc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 360, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "72c1dd8d-45a7-4d98-9f36-a4df747f287f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 360, "section": "UNSPECIFIED"}, "hash": "d5d15bd848026303ff590af83154700d735f2e4ed367055a7124e536b5bd641c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "43305226-919f-4482-bded-bb24c05b01de", "node_type": "1", "metadata": {}, "hash": "b9d42ceda314d25ad9f91c9fda834be3e04bf7f551c76f26fb928f7307704f9d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 360 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or Format1 \nRole \nCDISC Notes \nCore \nVSTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of VSTPT to aid in sorting. \nPerm \nVSELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a planned fixed reference (VSTPTREF). This variable is useful where there are repetitive measures. Not a clock time \nor a date time variable. Represented as an ISO 8601 Duration. Examples: \"-PT15M\" to represent the period of 15 minutes prior to the reference point indicated by \nVSTPTREF, \"PT8H\" to represent the period of 8 hours after the reference point indicated by VSTPTREF. \nPerm \nVSTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by VSELTM, VSTPTNUM, and VSTPT. Examples: \"PREVIOUS DOSE\", \"PREVIOUS MEAL\". \nPerm \nVSRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime or \ninterval \nTiming \nDate/time of the reference time point, VSTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nVS \u2013 Assumptions \n1. In cases where the LOINC dictionary is used for vital sign tests, the permissible variable VSLOINC may be used. Sponsors are expected to provide the dictionary name and version used to map terms using \nthe external codelist element in the Define-XML document. \n2. If a reference range is available for a vital signs test, the variables VSORNRLO, VSORNRHI, VSNRIND from the Findings observation class may be added to the domain. VSORNRLO and VSORNRHI \nwould represent the reference range, and VSNRIND would be used to indicate where a result falls with respect to the reference range (e.g., \"HIGH\", \"LOW\").  If toxicity grading is available, values would \nbe represented in the variables VSTOX and VSTOXGR. Clinical significance would be represented in VSCLSIG, as described in Section 4.5.5, Clinical Significance for Findings Observation Class Data. \n3. Associations between some vital sign tests and qualifier codelists are described in the VS codetable, available at https://www.cdisc.org/standards/terminology/controlled-terminology. \n4. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the VS domain, but the following qualifiers would not generally be used: --BODSYS, --XFN, --SPEC, --\nSPCCND, --FAST. \nVS \u2013 Examples \nExample 1 \nThis example shows results for 1 subject from 2 visits (i.e., baseline, visit 2). \nRows 1-4, 6-7: \nVSTPT and VSTPTNUM are populated because more than 1 measurement was taken at this visit.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2900, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "43305226-919f-4482-bded-bb24c05b01de": {"__data__": {"id_": "43305226-919f-4482-bded-bb24c05b01de", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 360, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "72c1dd8d-45a7-4d98-9f36-a4df747f287f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 360, "section": "UNSPECIFIED"}, "hash": "d5d15bd848026303ff590af83154700d735f2e4ed367055a7124e536b5bd641c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "81e00488-7f7a-4432-8694-884d4e42fecc", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 360, "section": "UNSPECIFIED"}, "hash": "963143466093fd80651d002268004f5ff1e6a0bb302b2ac729244a897f6267bb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Clinical significance would be represented in VSCLSIG, as described in Section 4.5.5, Clinical Significance for Findings Observation Class Data. \n3. Associations between some vital sign tests and qualifier codelists are described in the VS codetable, available at https://www.cdisc.org/standards/terminology/controlled-terminology. \n4. Any Identifiers, Timing variables, or Findings general observation class qualifiers may be added to the VS domain, but the following qualifiers would not generally be used: --BODSYS, --XFN, --SPEC, --\nSPCCND, --FAST. \nVS \u2013 Examples \nExample 1 \nThis example shows results for 1 subject from 2 visits (i.e., baseline, visit 2). \nRows 1-4, 6-7: \nVSTPT and VSTPTNUM are populated because more than 1 measurement was taken at this visit. \nRows 2, 4-5, 7-9: \nVSLOBXFL=\"Y\" indicates that the observation was used as the last observation before exposure measurement. \nRows 10-11: \nShow blood pressure observations obtained at visit 2. \nRow 12: \nShows a value collected in one unit, but converted to selected standard unit. \nRow 13: \nShows the proper use of the --STAT variable to indicate \"NOT DONE\" where a reason was collected when a test was not done. \nvs.xpt \nRow STUDYID DOMAIN USUBJID \nVSSEQ VSTESTCD VSTEST \nVSPOS \nVSORRES VSORRESU VSSTRESC VSSTRESN VSSTRESU VSSTAT \nVSREASND \nVSLOC \nVSLAT VSLOBXFL VISITNUM VISIT \nVISITDY VSDTC \nVSDY VSTPT \nVSTPTNUM \n1 \nABC \nVS \nABC-001-\n001 \n1 \nSYSBP \nSystolic Blood \nPressure \nSITTING \n154 \nmmHg \n154 \n154 \nmmHg \n \n \nARM \nLEFT \n \n1 \nBaseline 1 \n1999-06-\n19T08:45 \n1 \nBASELINE \n1 \n1 \n2 \nABC \nVS \nABC-001-\n001 \n2 \nSYSBP \nSystolic Blood \nPressure \nSITTING \n152 \nmmHg \n152 \n152 \nmmHg \n \n \nARM \nLEFT \nY \n1 \nBaseline 1 \n1999-06-\n19T09:00 \n1 \nBASELINE \n2 \n2 \n3 \nABC \nVS \nABC-001-\n001 \n3 \nDIABP \nDiastolic Blood \nPressure \nSITTING \n44 \nmmHg \n44 \n44 \nmmHg \n \n \nARM \nLEFT \n \n1 \nBaseline 1 \n1999-06-\n19T08:45 \n1 \nBASELINE \n1 \n1 \n4 \nABC \nVS \nABC-001-\n001 \n4 \nDIABP \nDiastolic Blood \nPressure \nSITTING \n48 \nmmHg \n48 \n48 \nmmHg \n \n \nARM \nLEFT \nY \n1 \nBaseline 1 \n1999-06-\n19T09:00 \n1 \nBASELINE \n2 \n2", "mimetype": "text/plain", "start_char_idx": 2132, "end_char_idx": 4187, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ee721241-c50a-4db6-bdbe-7b65e9f51bf5": {"__data__": {"id_": "ee721241-c50a-4db6-bdbe-7b65e9f51bf5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 361, "section": "90.5 90.5"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "596286fc-7286-42d6-a2be-460997c2e1bd", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 361, "section": "90.5 90.5"}, "hash": "fd4ad92cecde199e84c925ace4b18c1cae93ed1710455c92868ebd74b0fff4db", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "kg \n \n \n \n \nY \n1 \nBaseline 1 \n1999-06-\n19 \n1 \n \n \n9 \nABC \nVS \nABC-001-\n001 \n9 \nHEIGHT \nHeight \nSTANDING 157 \ncm \n157 \n157 \ncm \n \n \n \n \nY \n1 \nBaseline 1 \n1999-06-\n19 \n1 \n \n \n10 \nABC \nVS \nABC-001-\n001 \n10 \nSYSBP \nSystolic Blood \nPressure \nSITTING \n95 \nmmHg \n95 \n95 \nmmHg \n \n \nARM \nLEFT \n \n2 \nVisit 2 \n35 \n1999-07-\n21 \n33 \n \n \n11 \nABC \nVS \nABC-001-\n001 \n11 \nDIABP \nDiastolic Blood \nPressure \nSITTING \n44 \nmmHg \n44 \n44 \nmmHg \n \n \nARM \nLEFT \n \n2 \nVisit 2 \n35 \n1999-07-\n21 \n33 \n \n \n12 \nABC \nVS \nABC-001-\n001 \n12 \nTEMP \nTemperature", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 524, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b987f275-5caa-4210-a84e-63efefe1989a": {"__data__": {"id_": "b987f275-5caa-4210-a84e-63efefe1989a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 361, "section": "6.4.1 When to Use Findings About Events or Interventions"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cd5669f0-8768-45a2-8700-6e00aa39eb54", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 361, "section": "6.4.1 When to Use Findings About Events or Interventions"}, "hash": "b4c8581df48b2ee260e0f1f572b67063af841e89155ee9dc8b1677b1b7854bbd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Findings About Events or Interventions structure (or \"FA structure\") is intended, as its name implies, to be used when collected data represent \u201dfindings about\u201d an event or intervention that cannot be represented \nwithin an event or intervention record or as a supplemental qualifier to such a record. Not all findings associated with an event or intervention should be represented in the FA structure. The following are criteria for \nusing the FA structure. \nCriterion 1: Data or observations that have different timing from an associated event or intervention as a whole \nPer Section 6.2.1, Adverse Events, assumption 7.e, \"It is the sponsor's responsibility to define an event.\" One common practice is to define an event as the period of time during which an adverse event has a constant \nseverity (or, sometimes, other properties). In this approach, a single medical condition may be represented by multiple AE records (see AE Example 4), each with a start and end date, and FA records with a test of \nseverity would not be applicable. Another common practice is to define an adverse event as the whole of a medical condition, even if severity (and other properties) change over time. With this approach, FA records \nmay be used to represent data about severity (or other properties) of the adverse event that have timing different from the medical condition as a whole. \nA finding that is about part of an event, rather than the event as a whole, meets this criterion for the use of FA. An assessment of an event that is not about the whole of an event may be a \"snapshot,\" an assessment at \na point in time, or a \"slice,\" an assessment over a period of time (i.e., evaluation interval) during the event. In Section 6.4.4., Findings About Events or Interventions, Example 1 shows snapshot assessments at 3 \npoints in time. The timing variables used to represent a snapshot assessment generally include FADTC, along with visit and time point variables as applicable, but not FAEVLINT or FAEVINTX. FA Example 5 \nshows assessments over 24-hour slices of the event. Slice assessments use an evaluation interval, so the timing variables used would generally include FADTC and either FAEVLINT or FAEVINTX. \nRepeated assessments of disease or treatment-related symptoms, particularly symptoms that are likely to be intermittent, generally produce results that apply to only part of an event; these are represented as findings \nabout clinical events. For example, if severity of an AE is collected at scheduled time points (e.g., per visit) throughout the duration of the AE, as in Section 6.4.4., Findings About Events or Interventions, Example 6, \nthe severities have timing that are different from that of the AE as a whole. Instead, the collected severities represent snapshots or slices of the AE over time. \nOccasionally, data collection will include questions about the occurrence of prespecified events which are of naturally short duration, so that even though the assessments are repeated during the study, each \nassessment will provide information about an event as a whole. These type of assessments can be represented in the Events domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3153, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "16b5490c-2e08-4422-b297-1080381e4f44": {"__data__": {"id_": "16b5490c-2e08-4422-b297-1080381e4f44", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 362, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "696df7ff-0499-40e1-856a-611c9a8c0f21", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 362, "section": "UNSPECIFIED"}, "hash": "430d76df997c128b5b0f30d14cb27374853a89aa06ebc3aa36408515b707e162", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fa5b3d69-c24c-4b78-b9d0-665b394f770a", "node_type": "1", "metadata": {}, "hash": "50a1514142947cd1adcf1f8faddf1f96ecdde6072a93c32052e7d4c670d84002", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 362 \n2021-11-29 \nA finding which is a summary of multiple occurrences of a particular kind of event meets this criterion. For \nexample, the number of episodes of vomiting during a particular time period is a finding about vomiting. \nFor events that have not ended at the time of an assessment, \"event as a whole\" means the event up to the time of the \nassessment. An event need not have ended for information about the event to be considered information about the \nevent as a whole. Data about medical conditions collected before start of study treatment are usually about the event \nas a whole and are usually represented in Medical History (MH). See Section 6.4.4., Findings About Events or \nInterventions, Example 3. \nAssessments of parts of events (snapshots or slices) are represented in FA and may or may not have parent records \n(e.g., FA Example 5). If the FA dataset is split by parent domain, the sponsor must decide which Events domain \nwould have held a parent record for a parent-less FA record. A sponsor may consider that symptoms of the disease \nunder study would be considered clinical events represented in the CE domain, so that FA records for symptoms of \nthe disease under study would be in the FACE split of the FA domain. \nThis criterion is less likely to apply to interventions records than to events records. Interventions records often \nrepresent a series of individual substance administrations. When there is a change in dosing or other characteristics \nduring the series, the most appropriate solution may be to represent the series of individual administrations in 2 \nrecords, one for the administrations before the change and a second for administrations after the change, rather than \nto create findings about records. \nCriterion 2: An observation about an event or intervention which requires more than 1 variable for its \nrepresentation, particularly when the observation may be represented with Findings class variables (e.g., units, \nmethod) \nThe need to represent data which require more than 1 variable in a findings about structure, rather than by adding 2 \nor more supplemental qualifiers to an Events or Interventions domain, is driven by the fact that each supplemental \nqualifier is in a separate record that links only to the parent record. For example, if the size of a rash is measured, \nthen the result and measurement unit (e.g., centimeters, inches) can be represented in an FA domain in a single \nrecord; other information regarding the rash (e.g., start and end times) would, if collected, appear in an Event record. \nSee, for example, the longest diameter measurements in Section 6.4.4., Findings About Events or \nInterventions, Example 2. \nCriterion 3: Data or information that indicate the occurrence of pre-specified AEs \nEvery record in the AE domain must represent an event that actually occurred. Therefore, AE probing questions that \nare answered in the negative (e.g., did not occur, unknown, not done) cannot be stored in the AE domain. All \nanswers to probing questions about the occurrence of pre-specified adverse events can be stored in the FA domain. \n(See Section 6.4.4., Findings About Events or Interventions, Example 4.) For each \"Y\" response to a probing \nquestion there should be a record in the AE domain. The FA record and the AE record may be linked via RELREC.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3515, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fa5b3d69-c24c-4b78-b9d0-665b394f770a": {"__data__": {"id_": "fa5b3d69-c24c-4b78-b9d0-665b394f770a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 362, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "696df7ff-0499-40e1-856a-611c9a8c0f21", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 362, "section": "UNSPECIFIED"}, "hash": "430d76df997c128b5b0f30d14cb27374853a89aa06ebc3aa36408515b707e162", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "16b5490c-2e08-4422-b297-1080381e4f44", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 362, "section": "UNSPECIFIED"}, "hash": "46409fdb9c1d9bc1184012a24635a5ca7f6aa27a5410425c18c2c454a68ec57c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "See, for example, the longest diameter measurements in Section 6.4.4., Findings About Events or \nInterventions, Example 2. \nCriterion 3: Data or information that indicate the occurrence of pre-specified AEs \nEvery record in the AE domain must represent an event that actually occurred. Therefore, AE probing questions that \nare answered in the negative (e.g., did not occur, unknown, not done) cannot be stored in the AE domain. All \nanswers to probing questions about the occurrence of pre-specified adverse events can be stored in the FA domain. \n(See Section 6.4.4., Findings About Events or Interventions, Example 4.) For each \"Y\" response to a probing \nquestion there should be a record in the AE domain. The FA record and the AE record may be linked via RELREC. \nThe responses to all AE occurrence questions\u2014whether \"Y\", \"N\", or \"NOT DONE\"\u2014are represented in FAAE. \nThis approach supports summarization of incidence directly from the FA dataset. \nPrevious versions of the SDTMIG included the criterion, \"Data or observations about an Event or Intervention for \nwhich no Event or Intervention record has been collected or created.\" This criterion has been removed, because the \namount of data collected about an event or intervention should not determine whether data are represented in an FA \ndataset. Data that can be represented in an event or intervention record, particularly data for which standard \nvariables exist, should be represented in the appropriate Event or Intervention domain, even if the record is \nsparse. The absence of a \"parent\" event or intervention record does not prevent representing data about an event or \nintervention in an FA dataset. One situation that previously used this criterion was the collection of a diagnosis date \nor symptom onset date for the disease under study when the occurrence of the disease was collected in an inclusion \ncriterion, rather than as medical history. That situation can now be represented in an MH record that includes \nMHEVDTYP. Events identified during a physical examination would, in accordance with CDASH best practices, be \nrecorded in medical history or adverse events CRFs. \nPrevious versions of the SDTMIG included the criterion, \"Data or information about an Event or Intervention that \nindicate the occurrence of related symptoms or therapies.\" This criterion has been removed because information \nabout related symptoms or therapies is more appropriately represented as information about those symptoms or \ntherapies rather than as information about the event or intervention to which they are thought be related. Data about \nrelated symptoms or interventions should be evaluated against the above Criterion 1 - 3 to determine whether they \nshould be represented in an FA dataset. If data do not meet one of the criteria above, they should be represented in", "mimetype": "text/plain", "start_char_idx": 2748, "end_char_idx": 5585, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c2768d1b-1714-4b42-8d0d-33bfb337707e": {"__data__": {"id_": "c2768d1b-1714-4b42-8d0d-33bfb337707e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 363, "section": "6.4.2 Naming Findings About Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cad38abf-5546-45a3-be24-40dce9faf12e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 363, "section": "6.4.2 Naming Findings About Domains"}, "hash": "41fe9d08bf2be806280ad6aa6d5dacc9c0137c55e9e9291c9320fe7cf451ea71", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Findings About domains are defined to store findings about events or interventions. Sponsors may choose to \nrepresent FA data collected in the study in a single FA dataset (potentially splitting the FA domain into physically \nseparate datasets following the guidance described in Section 4.1.6, Additional Guidance on Dataset Naming), or \nseparate datasets, assigning unique custom 2-character domain codes (see examples in Section 6.4.5, Skin \nResponse). \nFor example, if findings about clinical events and findings about medical history are collected in a study, these could \nbe represented as: \n1. A single FA domain, perhaps separated with different FACAT and/or FASCAT values \n2. A split FA domain following the guidance in Section 4.1.7, Splitting Domains: \no \nThe DOMAIN value would be \u201cFA\u201d. \no \nVariables that require a prefix would use \u201cFA\u201d. \no \nThe dataset names would be the domain name plus up to 2 additional characters indicating the parent \ndomain (e.g., FACE for Findings About Clinical Events, FAMH for Findings About Medical History). \nThis naming convention may be used for an FA domain that has a parent domain even when the study \nhas only 1 FA dataset that is not being split. \no \nFASEQ must be unique within USUBJID for all records across the split datasets. \no \nSupplemental qualifier datasets would need to be managed at the split-file level (e.g., \nsuppface.xpt, suppfamh.xpt). Within each supplemental qualifier dataset, RDOMAIN would be \"FA\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1470, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dbaf2a3d-2126-4603-a7fb-f52338a4c4fa": {"__data__": {"id_": "dbaf2a3d-2126-4603-a7fb-f52338a4c4fa", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 364, "section": "6.4.3 Variables Unique to Findings About"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d383be07-84e4-479a-b226-4de6a2076450", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 364, "section": "6.4.3 Variables Unique to Findings About"}, "hash": "5aa15b083f66c810aecad596bcc01087a1cc1e557f2e59e08b9c6531c5b0d44b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The variable --OBJ is unique to Findings About. In conjunction with FATESTCD, it describes what the topic of the \nobservation is; therefore, both are required to be populated for every record. FATESTCD describes the \nmeasurement/evaluation and FAOBJ describes the event or intervention that the measurement/evaluation is about. \nWhen collected data fit a qualifier variable (see SDTM Sections 3.1.1, 3.1.2, and 3.1.3) and are represented in the \nFA domain, the name of the variable should be used as the value of FATESTCD. For example, \nFATESTCD FATEST \nOCCUR \nOccurrence Indicator \nSEV \nSeverity/Intensity \nTOXGR \nToxicity Grade \nThe use of the same names (e.g., SEV, OCCUR) for both qualifier variables in the observation classes and \nFATESTCD is deliberate, but should not lead users to conclude that the collection of such data (e.g., \nseverity/intensity, occurrence) must be stored in the FA domain. In fact, data should only be stored in the FA \ndomain if they do not fit in the general observation-class domain. If the data describe the underlying event or \nintervention as a whole and share its timing, then the data should be stored as a qualifier of the general observation-\nclass record. \nA record in FA may or may not have a parent record in an events or interventions domain. If an FA record does have \na parent record, the value in FAOBJ should match the value in --TERM or --TRT, unless the parent domain is \ndictionary coded or subject to controlled terminology, in which case FAOBJ should match the value in --DECOD. \nExamples for the FA and Skin Response (SR) domains include the use of RELREC to represent the relationship \nbetween an FA domain and a parent domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1684, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "54f63d7b-3c68-46b2-9c38-70963a04a713": {"__data__": {"id_": "54f63d7b-3c68-46b2-9c38-70963a04a713", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 365, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4eafe6cb-6cd5-4d54-b898-55ad86b3c703", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 365, "section": "UNSPECIFIED"}, "hash": "40a9f296f5ad710f03841c10b7bb97f31f09d9248da50a07f19295a2ad72e84f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "47097f74-f345-4bc9-b920-c3dd1f4c2e94", "node_type": "1", "metadata": {}, "hash": "49a4f2515d6b946c80d64a22f1d3ace6a944baefa97c96129d36ae84a158be05", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 365 \n2021-11-29 \nFA \u2013 Specification \nfa.xpt, Findings About Events or Interventions \u2014 Findings About. One record per finding, per object, per time point, per visit per \nsubject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar FA \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions involving the \nproduct. \nReq \nFASEQ \nSequence Number Num  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid number. \nReq \nFAGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nFASPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined reference number. May be preprinted on the CRF as an explicit line identifier or defined in \nthe sponsor's operational database. Example: Line number on a CRF. \nPerm \nFATESTCD \nFindings About \nTest Short Name \nChar (FATESTCD) \nTopic \nShort name of the measurement, test, or examination described in FATEST. It can be used as a column \nname when converting a dataset from a vertical to a horizontal format. The value in FATESTCD cannot be \nlonger than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not valid). FATESTCD cannot \ncontain characters other than letters, numbers, or underscores. Examples: \"SEV\", \"OCCUR\". Note that \ncontrolled terminology is in a FATESTCD general codelist and in several therapeutic area-specific codelists. \nReq \nFATEST \nFindings About \nTest Name \nChar (FATEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in FATEST \ncannot be longer than 40 characters. Examples: \"Severity/Intensity\", \"Occurrence\". Note that controlled \nterminology is in a FATEST general codelist and in several therapeutic area-specific codelists. \nReq \nFAOBJ \nObject of the \nObservation \nChar  \nRecord \nQualifier \nUsed to describe the object or focal point of the findings observation that is represented by --TEST. \nExamples: the term (e.g., \"Acne\") describing a clinical sign or symptom that is being measured by a severity \ntest; an event (e.g., \"VOMIT, where the volume of vomit is being measured by a VOLUME test). \nReq \nFACAT \nCategory for \nFindings About \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. Examples: \"GERD\", \"PRE-SPECIFIED AE\". \nPerm \nFASCAT \nSubcategory for \nFindings About \nChar * \nGrouping \nQualifier \nA further categorization of FACAT. \nPerm \nFAORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the test as originally received or collected.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3105, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "47097f74-f345-4bc9-b920-c3dd1f4c2e94": {"__data__": {"id_": "47097f74-f345-4bc9-b920-c3dd1f4c2e94", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 365, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4eafe6cb-6cd5-4d54-b898-55ad86b3c703", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 365, "section": "UNSPECIFIED"}, "hash": "40a9f296f5ad710f03841c10b7bb97f31f09d9248da50a07f19295a2ad72e84f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "54f63d7b-3c68-46b2-9c38-70963a04a713", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 365, "section": "UNSPECIFIED"}, "hash": "92ab0e050466097c5f78e978a127eb9fd8bcee5b6d456b3749fc1eb02decfd10", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Req \nFAOBJ \nObject of the \nObservation \nChar  \nRecord \nQualifier \nUsed to describe the object or focal point of the findings observation that is represented by --TEST. \nExamples: the term (e.g., \"Acne\") describing a clinical sign or symptom that is being measured by a severity \ntest; an event (e.g., \"VOMIT, where the volume of vomit is being measured by a VOLUME test). \nReq \nFACAT \nCategory for \nFindings About \nChar * \nGrouping \nQualifier \nUsed to define a category of related records. Examples: \"GERD\", \"PRE-SPECIFIED AE\". \nPerm \nFASCAT \nSubcategory for \nFindings About \nChar * \nGrouping \nQualifier \nA further categorization of FACAT. \nPerm \nFAORRES \nResult or Finding in \nOriginal Units \nChar  \nResult \nQualifier \nResult of the test as originally received or collected. \nExp \nFAORRESU Original Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for FAORRES. \nPerm \nFASTRESC \nCharacter \nResult/Finding in \nStd Format \nChar  \nResult \nQualifier \nContains the result value for all findings, copied or derived from FAORRES in a standard format or standard \nunits. FASTRESC should store all results or findings in character format; if results are numeric, they should \nalso be stored in numeric format in FASTRESN. For example, if a test has results \"NONE\", \"NEG\", and \n\"NEGATIVE\" in FAORRES, and these results effectively have the same meaning; they could be represented \nin standard format in FASTRESC as \"NEGATIVE\". \nExp \nFASTRESN \nNumeric \nResult/Finding in \nStandard Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nFASTRESC. FASTRESN should store all numeric test results or findings. \nPerm \nFASTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized unit used for FASTRESC and FASTRESN. \nPerm \nFASTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate that the measurement was not done. Should be null if a result exists in FAORRES. \nPerm \nFAREASND \nReason Not \nPerformed \nChar  \nRecord \nQualifier \nDescribes why a question was not answered. Example: \"Subject refused\". Used in conjunction with FASTAT \nwhen value is \"NOT DONE\". \nPerm", "mimetype": "text/plain", "start_char_idx": 2330, "end_char_idx": 4534, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "32fe5c3a-f7fa-4472-a983-c1c15cba0e5e": {"__data__": {"id_": "32fe5c3a-f7fa-4472-a983-c1c15cba0e5e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 366, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70d0aa84-bacc-45ff-bac4-996c43a41502", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 366, "section": "UNSPECIFIED"}, "hash": "30e90f08e8a3986771ea0ebef6ab8150b49ed0c71a94ebbbf749de867967135d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8a292ec8-d7da-47eb-8f5e-6e6a0548a649", "node_type": "1", "metadata": {}, "hash": "057d4de9b29a7c23b5c2141ca1d304c679ec2dfa994c6e8c738fab5cda50f99c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 366 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nFALOC \nLocation of the \nFinding About \nChar (LOC) \nRecord \nQualifier \nUsed to specify the location of the clinical evaluation. Example: \"ARM\". \nPerm \nFALAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location or specimen further detailing laterality. Examples: \"RIGHT\", \"LEFT\", \n\"BILATERAL\". \nPerm \nFALOBXFL \nLast Observation \nBefore Exposure \nFlag \nChar (NY) \nRecord \nQualifier \nOperationally-derived indicator used to identify the last non-missing value prior to RFXSTDTC. The value \nshould be \"Y\" or null. \nPerm \nFABLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. The value should be \"Y\" or null. Note that FABLFL is retained for \nbackward compatibility. The authoritative baseline flag for statistical analysis is in an ADaM dataset. \nPerm \nFAEVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of the person who provided the evaluation. Used only for results that are subjective (e.g., assigned by a \nperson or a group). Should be null for records that contain collected or derived data. Examples: \n\"INVESTIGATOR\", \"ADJUDICATION COMMITTEE\", \"VENDOR\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \n1. \nClinical encounter number. \n2. \nNumeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \n1. \nProtocol-defined description of clinical encounter. \n2. \nMay be used in addition to VISITNUM and/or VISITDY. \nPerm \nVISITDY \nPlanned Study Day \nof Visit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time of the observation. Examples: \"SCREENING\", \"TREATMENT\", \n\"FOLLOW-UP\". \nPerm \nFADTC \nDate/Time of \nCollection \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nCollection date and time of findings assessment represented in ISO 8601 character format. \nExp \nFADY \nStudy Day of \nCollection \nNum  \nTiming \n1. \nStudy day of collection, measured as integer days. \n2. \nAlgorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in \nDemographics. This formula should be consistent across the submission. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nFA \u2013 Assumptions \n1. The Findings About domain shares all qualities and conventions of findings observations. \n2.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2848, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8a292ec8-d7da-47eb-8f5e-6e6a0548a649": {"__data__": {"id_": "8a292ec8-d7da-47eb-8f5e-6e6a0548a649", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 366, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "70d0aa84-bacc-45ff-bac4-996c43a41502", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 366, "section": "UNSPECIFIED"}, "hash": "30e90f08e8a3986771ea0ebef6ab8150b49ed0c71a94ebbbf749de867967135d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "32fe5c3a-f7fa-4472-a983-c1c15cba0e5e", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 366, "section": "UNSPECIFIED"}, "hash": "d0716788a82e1f710e501305c7751357162ee91206c6d28faaf8b6c2175d26cd", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"SCREENING\", \"TREATMENT\", \n\"FOLLOW-UP\". \nPerm \nFADTC \nDate/Time of \nCollection \nChar ISO 8601 \ndatetime or \ninterval \nTiming \nCollection date and time of findings assessment represented in ISO 8601 character format. \nExp \nFADY \nStudy Day of \nCollection \nNum  \nTiming \n1. \nStudy day of collection, measured as integer days. \n2. \nAlgorithm for calculations must be relative to the sponsor-defined RFSTDTC variable in \nDemographics. This formula should be consistent across the submission. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nFA \u2013 Assumptions \n1. The Findings About domain shares all qualities and conventions of findings observations. \n2. See Section 6.4.1, When to Use Findings About Events or Interventions; and Section 8.6.3, Guidelines for Differentiating Between Interventions, \nEvents, Findings, and Findings About Events or Interventions; for guidance on deciding between the use of the FA domain and other SDTM structures. \n3. See Section 6.4.2, Naming Findings About Domains, for advice on splitting the FA domain. \n4. Some variables in the events and interventions domains (e.g., OCCUR, SEV, TOXGR) represent findings about the whole of the event or intervention. \nWhen FA is used to represent findings about a part of the event or intervention (i.e., the assessment has different timing from the event as a whole), the \nFATEST and FATESTCD values should be the same as the variable name and variable label in the corresponding event or intervention domain. See \nSection 6.4.3, Variables Unique to Findings About. \na. \nAssociations between some findings about cardiovascular interventions or events and their response codelists are described in the CV codetable, \navailable at https://www.cdisc.org/standards/terminology/controlled-terminology.", "mimetype": "text/plain", "start_char_idx": 2069, "end_char_idx": 3964, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "895ae7c1-75c2-4ea6-a4ba-daf13e6558f0": {"__data__": {"id_": "895ae7c1-75c2-4ea6-a4ba-daf13e6558f0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 367, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b458fdf1-2816-4b83-9ec7-042a7edf93b7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 367, "section": "UNSPECIFIED"}, "hash": "422f933460d3276a1c7aa7d545327cdb554a3bf372ae3d264b130481ae639672", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 367 \n2021-11-29 \n5. When data collection establishes a relationship between FA records and an events or interventions record, the relationship should be represented in \nRELREC. \na. \nThe FAOBJ variable alone is not sufficient to establish a relationship, because an events or interventions dataset may have multiple records for the \nsame topic (e.g., --TERM or --DECOD, --TRT or --DECOD). \n6. Any Identifier variables, Timing variables, or Findings general observation-class qualifiers may be added to the FA domain, but the following qualifiers \nshould generally not be used: --BODSYS, --MODIFY, --SEV, --TOXGR.  \nFA \u2013 Examples \nExample 1 \nThe following example CRF collects severity and symptoms data at multiple time points about a migraine event, relative to dosing. \nMigraine Symptoms Diary \nMigraine Reference Number \nxx \nWhen did the migraine start? \nDD-MMM-YYYY \nHH:MM \nWhen was study treatment taken? DD-MMM-YYYY \nHH:MM \nAnswer the following 5 minutes BEFORE dosing \nSeverity of migraine \n\u25cb Mild   \u25cb Moderate   \u25cb Severe \nAssociated symptoms: \nSensitivity to light \nSensitivity to sound \nNausea \nAura \n \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes \nAnswer the following 30 minutes AFTER dosing \nSeverity of migraine \n\u25cb Mild   \u25cb Moderate   \u25cb Severe \nAssociated symptoms: \nSensitivity to light \nSensitivity to sound \nNausea \nAura \n \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes \nAnswer the following 90 minutes AFTER dosing \nSeverity of migraine \n\u25cb Mild   \u25cb Moderate   \u25cb Severe \nAssociated symptoms: \nSensitivity to light \nSensitivity to sound \nNausea \nAura \n \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes \n\u25cb No   \u25cb Yes", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1820, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "63168e92-d50c-493b-a895-92e3e403d304": {"__data__": {"id_": "63168e92-d50c-493b-a895-92e3e403d304", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 368, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e665bed8-e9dd-46e9-840d-beb5a980d49b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 368, "section": "UNSPECIFIED"}, "hash": "5715dd3b8bd9b2956d6d37dd42263e8ac4b4e3c2ee2643008428cfbde7873482", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d2b138d0-4e4f-45f5-bdc3-96f57eaa4550", "node_type": "1", "metadata": {}, "hash": "9f44e8a9a62a923cb599b55567f2986c4109709354d4b1eb0231af4670d78349", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 368 \n2021-11-29 \nIn this example trial, migraines and symptoms associated with migraines were considered clinical events rather than reportable adverse events. The migraine, its \nsponsor identifier (i.e., the \"Migraine Reference Number\" on the CRF), and its start date were represented in a CE record. \nce.xpt \nRow STUDYID DOMAIN USUBJID CESEQ CESPID CETERM CEDECOD CESTDTC \n1 \nABC \nCE \nABC-123 \n1 \n90567 \nMigraine \nMigraine \n2007-05-16T10:30 \nThe time migraine medication was taken was recorded in the Exposure (EX) domain. This date also serves as the reference time point for the symptom \nassessments. \nex.xpt \nRow \nSTUDYID \nDOMAIN \nUSUBJID \nEXSEQ \nEXSPID \nEXTRT \nEXDOSE \nEXDOSU \nEXDOSFRM \nEXDOSFRQ \nEXROUTE \nEPOCH \nEXSTDTC \nEXENDTC \n1 \nABC \nEX \nABC-123 \n1 \n4 \nCURALL \n50 \nmg \nTABLET \nONCE \nORAL \nTREATMENT \n2007-05-16T11:05 \n2007-05-16T11:05 \nThe remaining data on the CRF were \"snapshots\" taken at 3 time points; in accordance with Section 6.4.1, When to Use Findings About Events or Interventions, \ncriterion 1, these were represented as findings about events. The FACAT value \"MIGRAINE SYMPTOMS\" was used to represent the fact that these data were \ncollected in a CRF module called \"Migraine Symptoms Diary.\" \nRows 1, 6, 11: \nSeverity of the migraine was represented with FATESTCD=\"SEV\". This FATESTCD value is derived from the events class variable \nname --SEV, and represents the same assessment as CESEV, except that this assessment is at a point in time rather than for the event \nas a whole. \nRows 2-5, 7-10, 12-15: \nThe presence of symptoms associated with migraine was represented with the name of the symptom in FAOBJ, as the data collected is \nabout the occurrence of a particular symptom. The test code value \"OCCUR\" is derived from the events class variable name --\nOCCUR, but is an assessment at a point in time, rather than about the event as a whole. The relationship of these symptoms to \nmigraine is represented in FACAT, which indicates that these data were collected in the Migraine Symptoms Diary.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2202, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d2b138d0-4e4f-45f5-bdc3-96f57eaa4550": {"__data__": {"id_": "d2b138d0-4e4f-45f5-bdc3-96f57eaa4550", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 368, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e665bed8-e9dd-46e9-840d-beb5a980d49b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 368, "section": "UNSPECIFIED"}, "hash": "5715dd3b8bd9b2956d6d37dd42263e8ac4b4e3c2ee2643008428cfbde7873482", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "63168e92-d50c-493b-a895-92e3e403d304", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 368, "section": "UNSPECIFIED"}, "hash": "d6d2016294f77fa51c923b009ba584f21e8af48f47abb5b75b71dcd4e4d6fc95", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The test code value \"OCCUR\" is derived from the events class variable name --\nOCCUR, but is an assessment at a point in time, rather than about the event as a whole. The relationship of these symptoms to \nmigraine is represented in FACAT, which indicates that these data were collected in the Migraine Symptoms Diary. \nface.xpt \nRow STUDYID DOMAIN USUBJID FASEQ FASPID FATESTCD FATEST \nFAOBJ \nFACAT \nFAORRES \nFASTRESC \nFADTC \nFATPT \nFATPTNUM FAELTM FATPTREF \n1 \nABC \nFA \nABC-123 \n1 \n90567 \nSEV \nSeverity/Intensity \nMigraine \nMIGRAINE \nSYMPTOMS \nSEVERE \nSEVERE \n2007-05-\n16 \n5M PRE-\nDOSE \n1 \n-PT5M \nDOSING \n2 \nABC \nFA \nABC-123 \n2 \n90567 \nOCCUR \nOccurrence \nIndicator \nSensitivity To \nLight \nMIGRAINE \nSYMPTOMS \nY \nY \n2007-05-\n16 \n5M PRE-\nDOSE \n1 \n-PT5M \nDOSING \n3 \nABC \nFA \nABC-123 \n3 \n90567 \nOCCUR \nOccurrence \nIndicator \nSensitivity To \nSound \nMIGRAINE \nSYMPTOMS \nN \nN \n2007-05-\n16 \n5M PRE-\nDOSE \n1 \n-PT5M \nDOSING \n4 \nABC \nFA \nABC-123 \n4 \n90567 \nOCCUR \nOccurrence \nIndicator \nNausea \nMIGRAINE \nSYMPTOMS \nY \nY \n2007-05-\n16 \n5M PRE-\nDOSE \n1 \n-PT5M \nDOSING \n5 \nABC \nFA \nABC-123 \n5 \n90567 \nOCCUR \nOccurrence \nIndicator \nAura \nMIGRAINE \nSYMPTOMS \nY \nY \n2007-05-\n16 \n5M PRE-\nDOSE \n1 \n-PT5M \nDOSING \n6 \nABC \nFA \nABC-123 \n6 \n90567 \nSEV \nSeverity/Intensity \nMigraine \nMIGRAINE \nSYMPTOMS \nMODERATE MODERATE 2007-05-\n16 \n30M \nPOST-\nDOSE \n2 \nPT30M \nDOSING \n7 \nABC \nFA \nABC-123 \n7 \n90567 \nOCCUR \nOccurrence \nIndicator \nSensitivity To \nLight \nMIGRAINE \nSYMPTOMS \nY \nY \n2007-05-\n16 \n30M \nPOST-\nDOSE \n2 \nPT30M \nDOSING \n8 \nABC \nFA \nABC-123 \n8 \n90567 \nOCCUR \nOccurrence \nIndicator \nSensitivity To \nSound \nMIGRAINE \nSYMPTOMS \nN \nN \n2007-05-\n16 \n30M \nPOST-\nDOSE \n2 \nPT30M \nDOSING \n9 \nABC \nFA \nABC-123 \n9 \n90567 \nOCCUR \nOccurrence \nIndicator \nNausea \nMIGRAINE \nSYMPTOMS \nN \nN \n2007-05-\n16 \n30M \nPOST-\nDOSE \n2 \nPT30M \nDOSING", "mimetype": "text/plain", "start_char_idx": 1885, "end_char_idx": 3688, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fbaa295a-3898-4b8a-9640-53e81f07ec39": {"__data__": {"id_": "fbaa295a-3898-4b8a-9640-53e81f07ec39", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 369, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5ac04188-968b-4cc7-b7a4-541ee3c04d6b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 369, "section": "UNSPECIFIED"}, "hash": "009e2873763f54d87c6a15ee0824dfe312346ca17e597f10b59cdf9f23ab64a9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6c0c7cf6-cc27-41c0-b95e-702c266c4239", "node_type": "1", "metadata": {}, "hash": "6dea2d2cbd7a9e88a3ce1cb957349494aae3ae85c53f37596f8ac38024ef849f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 369 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID FASEQ FASPID FATESTCD FATEST \nFAOBJ \nFACAT \nFAORRES \nFASTRESC \nFADTC \nFATPT \nFATPTNUM FAELTM FATPTREF \n10 \nABC \nFA \nABC-123 \n10 \n90567 \nOCCUR \nOccurrence \nIndicator \nAura \nMIGRAINE \nSYMPTOMS \nY \nY \n2007-05-\n16 \n30M \nPOST-\nDOSE \n2 \nPT30M \nDOSING \n11 \nABC \nFA \nABC-123 \n11 \n90567 \nSEV \nSeverity/Intensity \nMigraine \nMIGRAINE \nSYMPTOMS \nMILD \nMILD \n2007-05-\n16 \n90M \nPOST-\nDOSE \n3 \nPT90M \nDOSING \n12 \nABC \nFA \nABC-123 \n12 \n90567 \nOCCUR \nOccurrence \nIndicator \nSensitivity To \nLight \nMIGRAINE \nSYMPTOMS \nN \nN \n2007-05-\n16 \n90M \nPOST-\nDOSE \n3 \nPT90M \nDOSING \n13 \nABC \nFA \nABC-123 \n13 \n90567 \nOCCUR \nOccurrence \nIndicator \nSensitivity To \nSound \nMIGRAINE \nSYMPTOMS \nN \nN \n2007-05-\n16 \n90M \nPOST-\nDOSE \n3 \nPT90M \nDOSING \n14 \nABC \nFA \nABC-123 \n14 \n90567 \nOCCUR \nOccurrence \nIndicator \nNausea \nMIGRAINE \nSYMPTOMS \nN \nN \n2007-05-\n16 \n90M \nPOST-\nDOSE \n3 \nPT90M \nDOSING \n15 \nABC \nFA \nABC-123 \n15 \n90567 \nOCCUR \nOccurrence \nIndicator \nAura \nMIGRAINE \nSYMPTOMS \nN \nN \n2007-05-\n16 \n90M \nPOST-\nDOSE \n3 \nPT90M \nDOSING \nA dataset-level relationship in RELREC is based on the sponsor ID (--SPID) value, which was populated with a system-generated identifier unique to each \niteration of this form. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC \nCE \n \nCESPID  \nONE \n1 \n2 \nABC \nFA \n \nFASPID  \nMANY \n1 \nExample 2 \nThis CRF collects details about injection site rash events at each visit, until resolved.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1637, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c0c7cf6-cc27-41c0-b95e-702c266c4239": {"__data__": {"id_": "6c0c7cf6-cc27-41c0-b95e-702c266c4239", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 369, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5ac04188-968b-4cc7-b7a4-541ee3c04d6b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 369, "section": "UNSPECIFIED"}, "hash": "009e2873763f54d87c6a15ee0824dfe312346ca17e597f10b59cdf9f23ab64a9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fbaa295a-3898-4b8a-9640-53e81f07ec39", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 369, "section": "UNSPECIFIED"}, "hash": "4a350ca471fa160bff56c7d6e9c4f6afa20325b4087821cb1fae21dcabb1b210", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "relrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC \nCE \n \nCESPID  \nONE \n1 \n2 \nABC \nFA \n \nFASPID  \nMANY \n1 \nExample 2 \nThis CRF collects details about injection site rash events at each visit, until resolved. \nRash Assessment \nDate of assessment \nDD-MMM-YYYY \nAssociated AE reference number xx \nRash longest diameter \n________     \u25cb cm     \u25cb in \nLesion type and count \n \nMacules \n\u25cb 0     \u25cb 1 to 25     \u25cb 26 to 100     \u25cb 101 to 200     \u25cb 201 to 300     \u25cb >300 \nPapules \n\u25cb 0     \u25cb 1 to 25     \u25cb 26 to 100     \u25cb 101 to 200     \u25cb 201 to 300     \u25cb >300 \nVesicles \n\u25cb 0     \u25cb 1 to 25     \u25cb 26 to 100     \u25cb 101 to 200     \u25cb 201 to 300     \u25cb >300 \nPustules \n\u25cb 0     \u25cb 1 to 25     \u25cb 26 to 100     \u25cb 101 to 200     \u25cb 201 to 300     \u25cb >300 \nScabs \n\u25cb 0     \u25cb 1 to 25     \u25cb 26 to 100     \u25cb 101 to 200     \u25cb 201 to 300     \u25cb >300 \nScars \n\u25cb 0     \u25cb 1 to 25     \u25cb 26 to 100     \u25cb 101 to 200     \u25cb 201 to 300     \u25cb >300 \nIn this scenario, the injection site rash event was considered a reportable adverse event; therefore, the rash itself was represented in the AE domain. The rash \nassessment form collects a reference number for the AE, represented in AESPID. Certain required or expected variables have been omitted from the example \ndataset in consideration of space and clarity.", "mimetype": "text/plain", "start_char_idx": 1403, "end_char_idx": 2694, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "04bd2ccf-75c5-4d58-b62c-2998811f3594": {"__data__": {"id_": "04bd2ccf-75c5-4d58-b62c-2998811f3594", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 370, "section": "2.5 IN"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dd5d93fd-28dd-46cc-90c9-01dd1e1d3e04", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 370, "section": "2.5 IN"}, "hash": "19042be5872bc4ee5061a975c7616979310218dd317439e20323feb78def3670", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "3 \n2007-05-12 \n2 \nXYZ \nFA \nXYZ-789 \n123452 5 \nMACRNG \nNumber of Macules Range Injection Site Rash 26 to 100 \n \n26 to 100 \n \n3 \n2007-05-12 \n3 \nXYZ \nFA \nXYZ-789 \n123453 5 \nPAPRNG \nNumber of Papules Range Injection Site Rash 1 to 25 \n \n1 to 25 \n \n3 \n2007-05-12 \n4 \nXYZ \nFA \nXYZ-789 \n123454 5 \nVESRNG \nNumber of Vesicles Range Injection Site Rash 0 \n \n0 \n \n3 \n2007-05-12 \n5 \nXYZ \nFA \nXYZ-789 \n123455 5 \nPUSRNG \nNumber of Pustules Range Injection Site Rash 0 \n \n0 \n \n3 \n2007-05-12 \n6 \nXYZ \nFA \nXYZ-789 \n123456 5 \nSCBRNG \nNumber of Scabs Range \nInjection Site Rash 0 \n \n0 \n \n3 \n2007-05-12 \n7 \nXYZ \nFA \nXYZ-789 \n123457 5 \nSCRRNG \nNumber of Scars Range \nInjection Site Rash 0 \n \n0 \n \n3 \n2007-05-12 \n8 \nXYZ \nFA \nXYZ-789 \n123459 5 \nLDIAM \nLongest Diameter \nInjection Site Rash 1 \nIN \n1 \nIN \n4 \n2007-05-19 \n9 \nXYZ \nFA \nXYZ-789 \n123460 5 \nMACRNG \nNumber of Macules Range Injection Site Rash 1 to 25 \n \n1 to 25 \n \n4 \n2007-05-19 \n10 \nXYZ \nFA \nXYZ-789 \n123461 5 \nPAPRNG \nNumber of Papules Range Injection Site Rash 1 to 25 \n \n1 to 25 \n \n4 \n2007-05-19 \n11 \nXYZ \nFA \nXYZ-789 \n123462 5 \nVESRNG \nNumber of Vesicles Range Injection Site Rash 0 \n \n0 \n \n4 \n2007-05-19 \n12 \nXYZ \nFA \nXYZ-789 \n123463 5 \nPUSRNG \nNumber of Pustules Range Injection Site Rash 0 \n \n0 \n \n4 \n2007-05-19 \n13 \nXYZ \nFA \nXYZ-789 \n123464 5 \nSCBRNG \nNumber of Scabs Range \nInjection Site Rash 0 \n \n0 \n \n4 \n2007-05-19 \n14 \nXYZ \nFA \nXYZ-789 \n123465 5 \nSCRRNG \nNumber of Scars Range \nInjection Site Rash 0 \n \n0 \n \n4 \n2007-05-19 \nThe FA records were linked to the parent CE record via the AE reference number, which was used to populate both AESPID and FASPID. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nXYZ \nAE \n \nAESPID  \nONE \n23 \n2 \nXYZ \nFA \n \nFASPID  \nMANY \n23", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1739, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5591579c-ed00-40c4-b04d-9e6fcc2b9f62": {"__data__": {"id_": "5591579c-ed00-40c4-b04d-9e6fcc2b9f62", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 371, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fadd21e-73f2-4359-933e-93e650849acf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 371, "section": "UNSPECIFIED"}, "hash": "0d4acef5f5a16908daaecfb7dc3ccdb6703a98b0cf6d4edd3c159825145be692", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c7e440f3-7f84-4a56-bb6a-063a43eb9b5e", "node_type": "1", "metadata": {}, "hash": "0acdf76f0bdd1cd7afbe4b56849e49ae36195bd8b2b6237f0b192daf4c29bb2c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 371 \n2021-11-29 \nExample 3 \nThis CRF collects information about rheumatoid arthritis. In this scenario, rheumatoid arthritis is a prerequisite for participation in an osteoporosis trial and was \nnot collected as a Medical History (MH) event. \nRheumatoid Arthritis History \nDate of assessment \n \nDD-MMM-YYYY \nDate of diagnosis \n \nDD-MMM-YYYY \nDuring the past 6 months, how would you rate the following: \nSymptom \n Was the symptom present? If yes, what was the severity? \nJoint stiffness \n\u25cb Yes    \u25cb No \n\u25cb Mild     \u25cb Moderate     \u25cb Severe \nJoint swelling \n\u25cb Yes    \u25cb No \n\u25cb Mild     \u25cb Moderate     \u25cb Severe \nJoint pain (arthralgia) \n\u25cb Yes    \u25cb No \n\u25cb Mild     \u25cb Moderate     \u25cb Severe \nMalaise \n\u25cb Yes    \u25cb No \n\u25cb Mild     \u25cb Moderate     \u25cb Severe \nEarly morning stiffness \u25cb Yes    \u25cb No \nIf yes, what was its average daily duration? \n_____Hours _____Minutes \nIn this study, data were collected only at baseline. Because the occurrence and severity apply to the symptoms as a whole, they are represented in the MH \ndomain. Note that the average duration of early morning stiffness cannot be represented in MHDUR because MHDUR would be the duration of the entire event, \nrather than the average of daily durations. \nRow 1: \nBecause the CRF specifically collected date of diagnosis for rheumatoid arthritis, MHEVDTYP is populated with DIAGNOSIS to indicate that the \ndate in MHSTDTC is the date of diagnosis. \nRows 2-6: \nNo start or end dates were collected for the symptoms, so the variable MHEVDTYP is not relevant for those records. MHEVDTYP is used only to \nspecify the aspect of the event used to determine start and/or end dates.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1803, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c7e440f3-7f84-4a56-bb6a-063a43eb9b5e": {"__data__": {"id_": "c7e440f3-7f84-4a56-bb6a-063a43eb9b5e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 371, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8fadd21e-73f2-4359-933e-93e650849acf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 371, "section": "UNSPECIFIED"}, "hash": "0d4acef5f5a16908daaecfb7dc3ccdb6703a98b0cf6d4edd3c159825145be692", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "5591579c-ed00-40c4-b04d-9e6fcc2b9f62", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 371, "section": "UNSPECIFIED"}, "hash": "10550ad18af51c96ca6e2efd11f3cd5194e65641caedd526ad7e3da1f326721d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "_____Hours _____Minutes \nIn this study, data were collected only at baseline. Because the occurrence and severity apply to the symptoms as a whole, they are represented in the MH \ndomain. Note that the average duration of early morning stiffness cannot be represented in MHDUR because MHDUR would be the duration of the entire event, \nrather than the average of daily durations. \nRow 1: \nBecause the CRF specifically collected date of diagnosis for rheumatoid arthritis, MHEVDTYP is populated with DIAGNOSIS to indicate that the \ndate in MHSTDTC is the date of diagnosis. \nRows 2-6: \nNo start or end dates were collected for the symptoms, so the variable MHEVDTYP is not relevant for those records. MHEVDTYP is used only to \nspecify the aspect of the event used to determine start and/or end dates. \nmh.xpt \nRow STUDYID DOMAIN USUBJID MHSEQ MHTERM \nMHDECOD MHEVDTYP MHCAT \nMHSCAT \nMHPRESP MHOCCUR MHSEV \nMHDTC MHSTDTC MHEVLINT \n1 \nABC \nMH \n001-001 \n1 \nRHEUMATOID \nARTHRITIS \nRheumatoid \narthritis \nDIAGNOSIS RHEUMATOID \nARTHRITIS \nHISTORY \n \nY \nY \n \n \n2003 \n \n2 \nABC \nMH \n001-001 \n2 \nJOINT \nSTIFFNESS \nJoint \nstiffness \n \nRHEUMATOID \nARTHRITIS \nHISTORY \nRHEUMATOID \nARTHRITIS \nSYMPTOMS \nY \nY \nSEVERE \n2006-\n08-13 \n \n-P6M \n3 \nABC \nMH \n001-001 \n3 \nJOINT \nSWELLING \nJoint \nswelling \n \nRHEUMATOID \nARTHRITIS \nHISTORY \nRHEUMATOID \nARTHRITIS \nSYMPTOMS \nY \nY \nMODERATE 2006-\n08-13 \n \n-P6M \n4 \nABC \nMH \n001-001 \n4 \nJOINT PAIN \nArthralgia \n \nRHEUMATOID \nARTHRITIS \nHISTORY \nRHEUMATOID \nARTHRITIS \nSYMPTOMS \nY \nY \nMODERATE 2006-\n08-13 \n \n-P6M \n5 \nABC \nMH \n001-001 \n5 \nMALAISE \nMalaise \n \nRHEUMATOID \nARTHRITIS \nHISTORY \nRHEUMATOID \nARTHRITIS \nSYMPTOMS \nY \nY \nMILD \n2006-\n08-13 \n \n-P6M \n6 \nABC \nMH \n001-001 \n6 \nEARLY \nMORNING \nSTIFFNESS \nStiffness \n \nRHEUMATOID \nARTHRITIS \nHISTORY \nRHEUMATOID \nARTHRITIS \nSYMPTOMS \nY \nY \n \n2006-\n08-13 \n \n-P6M", "mimetype": "text/plain", "start_char_idx": 1005, "end_char_idx": 2837, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "00520418-f8a5-4a8c-94c4-767cb0be8f6b": {"__data__": {"id_": "00520418-f8a5-4a8c-94c4-767cb0be8f6b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 372, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a8815e0d-98d5-454e-9e85-c15431126bb0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 372, "section": "UNSPECIFIED"}, "hash": "7c9c9d53bf52da6702e939af7d50d447c44b9800a994403b948e36bc97e0bdf0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "17130685-c381-4613-b806-8da43a5217d3", "node_type": "1", "metadata": {}, "hash": "b37b0ffeb4114147f30763bc9469c1b33238ed64773a41a44da5bd35858a23b5", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 372 \n2021-11-29 \nThe average duration of early morning stiffness would be represented in ISO 8601 duration format as a supplemental qualifier. \nsuppmh.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL QNAM \nQLABEL \nQVAL \nQORIG QEVAL \n1 \nABC \nMH \n001-001 \nMHSEQ 6 \nMHAVDDUR Average Daily Duration PT1H30M CRF \n \nExample 4 \nIn this example, the occurrence of prespecified adverse events was solicited at every visit and the visit date was used as the date of collection. The data collected \nmeet criterion 3 in Section 6.4.1, When to Use Findings About Events or Interventions; that is, data that indicate the occurrence of prespecified AEs. \nPrespecified Adverse Events of Clinical Interest \nDate of assessment \nDD-MMM-YYYY \nDid the following occur? If Yes, enter a complete record in the AE CRF \nHeadache \nRespiratory infection \nNausea \n\u25cb No    \u25cb Yes    \u25cb Not Done \n\u25cb No    \u25cb Yes    \u25cb Not Done \n\u25cb No    \u25cb Yes    \u25cb Not Done \nThis example shows data for 1 subject at 2 visits. Each response (e.g., No, Yes) to the prespecified terms is represented in the FA domain. The visit date was used \nto populated FADTC. \nRows 1, 4: \"Headache\" was reported at both visits. \nRows 2, 5: \"Respiratory infection\" was not present at either visit. \nRow 3: \nThe investigator did not ask the subject about the occurrence of nausea. This was represented by FASTAT=\"NOT DONE\".", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1532, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "17130685-c381-4613-b806-8da43a5217d3": {"__data__": {"id_": "17130685-c381-4613-b806-8da43a5217d3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 372, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a8815e0d-98d5-454e-9e85-c15431126bb0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 372, "section": "UNSPECIFIED"}, "hash": "7c9c9d53bf52da6702e939af7d50d447c44b9800a994403b948e36bc97e0bdf0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "00520418-f8a5-4a8c-94c4-767cb0be8f6b", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 372, "section": "UNSPECIFIED"}, "hash": "625a22513b1a2eb3bb00fbd03d36d1f28959114436256ed00de5549cd8521d99", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "If Yes, enter a complete record in the AE CRF \nHeadache \nRespiratory infection \nNausea \n\u25cb No    \u25cb Yes    \u25cb Not Done \n\u25cb No    \u25cb Yes    \u25cb Not Done \n\u25cb No    \u25cb Yes    \u25cb Not Done \nThis example shows data for 1 subject at 2 visits. Each response (e.g., No, Yes) to the prespecified terms is represented in the FA domain. The visit date was used \nto populated FADTC. \nRows 1, 4: \"Headache\" was reported at both visits. \nRows 2, 5: \"Respiratory infection\" was not present at either visit. \nRow 3: \nThe investigator did not ask the subject about the occurrence of nausea. This was represented by FASTAT=\"NOT DONE\". \nRow 6: \n\"Nausea\" was reported at visit 3. \nfaae.xpt \nRow STUDYID DOMAIN USUBJID FASEQ FATESTCD FATEST \nFAOBJ \nFAORRES FASTRESC FASTAT \nVISITNUM VISIT \nFADTC \nFAEVINTX \n1 \nABC101 \nFA \n1234 \n1 \nOCCUR \nOccurrence Indicator Headache \nY \nY \n \n2 \nVISIT 2 2005-10-01 SINCE LAST VISIT \n2 \nABC101 \nFA \n1234 \n2 \nOCCUR \nOccurrence Indicator Respiratory Infection N \nN \n \n2 \nVISIT 2 2005-10-01 SINCE LAST VISIT \n3 \nABC101 \nFA \n1234 \n3 \nOCCUR \nOccurrence Indicator Nausea \n \n \nNOT DONE 2 \nVISIT 2 2005-10-01 SINCE LAST VISIT \n4 \nABC101 \nFA \n1234 \n4 \nOCCUR \nOccurrence Indicator Headache \nY \nY \n \n3 \nVISIT 3 2005-10-10 SINCE LAST VISIT \n5 \nABC101 \nFA \n1234 \n5 \nOCCUR \nOccurrence Indicator Respiratory Infection N \nN \n \n3 \nVISIT 3 2005-10-10 SINCE LAST VISIT \n6 \nABC101 \nFA \n1234 \n6 \nOCCUR \nOccurrence Indicator Nausea \nY \nY \n \n3 \nVISIT 3 2005-10-10 SINCE LAST VISIT \nFor each prespecified adverse event for which FAORRES = \"Y\", the adverse event has a record in the AE domain with AEPRESP = \"Y\". No relationship was \ncollected to link the FAAE record for the occurrence indicator test with the AE entries, so no RELREC was created. \nNote that not all AE expected variables are included in the following example. \nRow 1: \nComparison of this AE record with the FA dataset records for \"Headache\" shows that there are 2 records with FAOBJ=\"Headache\". \nFAORRES=\"Y\" indicates that this AE record is associated with both FA records, because this headache started before visit 2 and ended between \nvisits 2 and 3. \nRow 2: \nComparison of this AE record with the FA dataset shows that this AE started and ended in the time between visits 2 and 3, and is consistent with \nthe FA response for FAOBJ=\"Nausea\" for visit 3.", "mimetype": "text/plain", "start_char_idx": 927, "end_char_idx": 3228, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b2b7e769-373b-4927-9dea-d30fdcdfd771": {"__data__": {"id_": "b2b7e769-373b-4927-9dea-d30fdcdfd771", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 373, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7b6ca58d-df3d-4106-ad32-b03493eb6fec", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 373, "section": "UNSPECIFIED"}, "hash": "ac53eb532c2cdc3c489dde50b5ef7855cb4fbc872bd6db941935ed08cd032518", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "44f3426f-45fa-431a-b8ce-68ef23ff2c26", "node_type": "1", "metadata": {}, "hash": "548f993ed594acfc38944a0a073667910194d0b4fd2db8714d9e011888667a2a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 373 \n2021-11-29 \nae.xpt \nRow STUDYID DOMAIN USUBJID AESEQ AETERM \nAEDECOD AEPRESP AEBODSYS \nAESEV \nAEACN AESTDTC \nAEENDTC \n1 \nABC101 \nAE \n1234 \n1 \nHeadache Headache \nY \nNervous system disorders \nMILD \nNONE \n2005-09-30 2005-10-03 \n2 \nABC101 \nAE \n1234 \n2 \nNausea \nNausea \nY \nGastrointestinal disorders \nMODERATE NONE \n2005-10-08 2005-10-09 \nExample 5 \nIn this example, data about prespecified symptoms of the disease under study were collected on a daily basis. Although the date of the assessment was captured \nin the CRF header (not shown), start and end timing of the prespecified symptoms was not. \nSymptoms   \nInvestigator GERD Symptom Measurement (if symptom occurred) \n \nOccurred in last 24 hours? Volume (mL) Number of episodes \nMaximum severity \nVomiting \n\u25cb Yes    \u25cb No \n  \n  \n \u25cb Mild   \u25cb Moderate   \u25cb Severe \nDiarrhea \n\u25cb Yes    \u25cb No \n  \n  \n \u25cb Mild   \u25cb Moderate   \u25cb Severe \nNausea \n\u25cb Yes    \u25cb No \n  \n  \n \u25cb Mild   \u25cb Moderate   \u25cb Severe \nThe collected data were represented in FA because they meet criterion 1 in Section 6.4.1, When to Use Findings About Events or Interventions, that is, data that \ndo not describe an event or intervention as a whole. In this study, GERD symptoms were considered clinical events. In addition, the volume of vomit data met \ncriterion 2 data (\u201cabout\u201d an event or intervention), having qualifiers that can be represented in Findings variables (e.g., units, method). \nThis SDTM example represents data from 2 visits for 1 subject. FAEVINTX indicates that assessments were for the previous 24 hours. \nRows 1-4: \nShow the results for the vomiting tests at visit 1. Because the number of episodes was recorded as \">10\", this is represented in FASTRESC but \nnot in FASTRESN. \nRows 5-7: \nShow the results for the diarrhea tests at visit 1. \nRows 8-10: \nShow the results for the nausea tests at visit 1. \nRow 11: \nShows that vomiting did not occur in the 24 hours before visit 2; thus, volume, number of episodes, and severity were not applicable. \nRows 12-14: Show the results for the diarrhea tests at visit 2.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2221, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "44f3426f-45fa-431a-b8ce-68ef23ff2c26": {"__data__": {"id_": "44f3426f-45fa-431a-b8ce-68ef23ff2c26", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 373, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7b6ca58d-df3d-4106-ad32-b03493eb6fec", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 373, "section": "UNSPECIFIED"}, "hash": "ac53eb532c2cdc3c489dde50b5ef7855cb4fbc872bd6db941935ed08cd032518", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b2b7e769-373b-4927-9dea-d30fdcdfd771", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 373, "section": "UNSPECIFIED"}, "hash": "ccda3714eec8527c0aa2519cdae1713d73f6e32cecd70577c4b5368802a16ffe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This SDTM example represents data from 2 visits for 1 subject. FAEVINTX indicates that assessments were for the previous 24 hours. \nRows 1-4: \nShow the results for the vomiting tests at visit 1. Because the number of episodes was recorded as \">10\", this is represented in FASTRESC but \nnot in FASTRESN. \nRows 5-7: \nShow the results for the diarrhea tests at visit 1. \nRows 8-10: \nShow the results for the nausea tests at visit 1. \nRow 11: \nShows that vomiting did not occur in the 24 hours before visit 2; thus, volume, number of episodes, and severity were not applicable. \nRows 12-14: Show the results for the diarrhea tests at visit 2. \nRow 15: \nIndicates that the occurrence of nausea was not assessed at visit 2. \nface.xpt \nRow STUDYID DOMAIN USUBJID \nFASEQ FATESTCD FATEST \nFAOBJ \nFACAT \nFAORRES \nFAORRESU FASTRESC \nFASTRESN FASTRESU FASTAT \nVISITNUM VISIT \nFADTC \nFAEVLINT \n1 \nXYZ \nFA \nXYZ-701-\n002 \n1 \nOCCUR \nOccurrence \nIndicator \nVomiting GERD \nSYMPTOMS \nY \n \nY \n \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n2 \nXYZ \nFA \nXYZ-701-\n002 \n2 \nVOL \nVolume \nVomiting GERD \nSYMPTOMS \n250 \nmL \n250 \n250 \nmL \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n3 \nXYZ \nFA \nXYZ-701-\n002 \n3 \nNUMEPISD Number of \nEpisodes \nVomiting GERD \nSYMPTOMS \n>10 \n \n>10 \n \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n4 \nXYZ \nFA \nXYZ-701-\n002 \n4 \nSEV \nSeverity/Intensity \nVomiting GERD \nSYMPTOMS \nSEVERE \n \nSEVERE \n \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n5 \nXYZ \nFA \nXYZ-701-\n002 \n5 \nOCCUR \nOccurrence \nIndicator \nDiarrhea GERD \nSYMPTOMS \nY \n \nY \n \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n6 \nXYZ \nFA \nXYZ-701-\n002 \n6 \nNUMEPISD Number of \nEpisodes \nDiarrhea GERD \nSYMPTOMS \n2 \n \n2 \n2 \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n7 \nXYZ \nFA \nXYZ-701-\n002 \n7 \nSEV \nSeverity/Intensity \nDiarrhea GERD \nSYMPTOMS \nSEVERE \n \nSEVERE \n \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n8 \nXYZ \nFA \nXYZ-701-\n002 \n8 \nOCCUR \nOccurrence \nIndicator \nNausea \nGERD \nSYMPTOMS \nY \n \nY \n \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H", "mimetype": "text/plain", "start_char_idx": 1583, "end_char_idx": 3526, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "686e050e-30ed-4a2a-88fd-35dfa54422e4": {"__data__": {"id_": "686e050e-30ed-4a2a-88fd-35dfa54422e4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 374, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3c121948-25a6-4b3a-b850-4202c2c55b4d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 374, "section": "UNSPECIFIED"}, "hash": "51abfd256725899eb5144fad8ff3e32f8b672a95e8ce84e07a90efb81f46c8eb", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "73cce467-b727-4bf3-b1d3-5cfadae82f3b", "node_type": "1", "metadata": {}, "hash": "ad305c75b177e8fedc43fc38b43a30fa1b65b0f5ee6d4bcb4b44fe280c9d69f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 374 \n2021-11-29 \nRow STUDYID DOMAIN USUBJID \nFASEQ FATESTCD FATEST \nFAOBJ \nFACAT \nFAORRES \nFAORRESU FASTRESC \nFASTRESN FASTRESU FASTAT \nVISITNUM VISIT \nFADTC \nFAEVLINT \n9 \nXYZ \nFA \nXYZ-701-\n002 \n9 \nNUMEPISD Number of \nEpisodes \nNausea \nGERD \nSYMPTOMS \n1 \n \n1 \n1 \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n10 \nXYZ \nFA \nXYZ-701-\n002 \n10 \nSEV \nSeverity/Intensity \nNausea \nGERD \nSYMPTOMS \nMODERATE  \nMODERATE  \n \n \n1 \nVISIT \n1 \n2006-\n02-02 \n-PT24H \n11 \nXYZ \nFA \nXYZ-701-\n002 \n11 \nOCCUR \nOccurrence \nIndicator \nVomiting GERD \nSYMPTOMS \nN \n \nN \n \n \n \n2 \nVISIT \n2 \n2006-\n02-03 \n-PT24H \n12 \nXYZ \nFA \nXYZ-701-\n002 \n12 \nOCCUR \nOccurrence \nIndicator \nDiarrhea GERD \nSYMPTOMS \nY \n \nY \n \n \n \n2 \nVISIT \n2 \n2006-\n02-03 \n-PT24H \n13 \nXYZ \nFA \nXYZ-701-\n002 \n13 \nNUMEPISD Number of \nEpisodes \nDiarrhea GERD \nSYMPTOMS \n1 \n \n1 \n1 \n \n \n2 \nVISIT \n2 \n2006-\n02-03 \n-PT24H \n14 \nXYZ \nFA \nXYZ-701-\n002 \n14 \nSEV \nSeverity/Intensity \nDiarrhea GERD \nSYMPTOMS \nSEVERE \n \nSEVERE \n \n \n \n2 \nVISIT \n2 \n2006-\n02-03 \n-PT24H \n15 \nXYZ \nFA \nXYZ-701-\n002 \n15 \nOCCUR \nOccurrence \nIndicator \nNausea \nGERD \nSYMPTOMS \n \n \n \n \n \nNOT \nDONE \n2 \nVISIT \n2 \n2006-\n02-03 \n-PT24H \nExample 6 \nIn this example, the sponsor's definition of \"event\" meant that 1 record would be created for each adverse event, covering it from start to finish (see Section 6.2.1, \nAdverse Events, assumption 6.4). The AE module also collected information about severity at each visit. \nA paper CRF to be updated at each visit might look like this: \n   \nAt each visit, record the maximum severity of the adverse event since the last visit.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1738, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "73cce467-b727-4bf3-b1d3-5cfadae82f3b": {"__data__": {"id_": "73cce467-b727-4bf3-b1d3-5cfadae82f3b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 374, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3c121948-25a6-4b3a-b850-4202c2c55b4d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 374, "section": "UNSPECIFIED"}, "hash": "51abfd256725899eb5144fad8ff3e32f8b672a95e8ce84e07a90efb81f46c8eb", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "686e050e-30ed-4a2a-88fd-35dfa54422e4", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 374, "section": "UNSPECIFIED"}, "hash": "7e9c983d7f9c6226edcc0095626855bf99c01a656338a8766382cbb4ac7a9f5b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The AE module also collected information about severity at each visit. \nA paper CRF to be updated at each visit might look like this: \n   \nAt each visit, record the maximum severity of the adverse event since the last visit. \nAE ID Adverse Event Start Date End Date Visit 2 \nVisit 3 \nVisit 4 \nVisit 5 \nVisit 6 \n \n \n \n \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n \n \n \n \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n \n \n \n \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe \nAn electronic data collection instrument would probably be constructed as 2 related modules: \n\u2022 \nA module for the adverse event, where a record would be entered for each event \nAE ID Adverse Event Start Date End Date \n \n \n \n \n\u2022 \nA module for the severity assessment, where a record would be entered for each assessment \nVisit AE ID Maximum severity since last visit \n \n \n\u25cb Mild \n\u25cb Moderate \n\u25cb Severe", "mimetype": "text/plain", "start_char_idx": 1514, "end_char_idx": 2698, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a9fa2a83-47dd-47bb-b4b5-4f356e0c29c4": {"__data__": {"id_": "a9fa2a83-47dd-47bb-b4b5-4f356e0c29c4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 376, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a22cebfd-4862-4be0-a6cf-22e0c45997af", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 376, "section": "UNSPECIFIED"}, "hash": "30b5c87fc1fc05d9cb1829088a91e3028c96828fc1cdd2a274cb6dd6cc67616c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6beb1b5a-249e-4324-9dba-b2fe75268449", "node_type": "1", "metadata": {}, "hash": "a528ceba6eaf223572c7fdee17964cb43eea4bc9ca910e2c75ea4ea0e9fea55c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 376 \n2021-11-29 \nSR \u2013 Specification \nsr.xpt, Skin Response \u2014 Findings About. One record per finding, per object, per time point, per visit per subject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain Abbreviation \nChar SR \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nUSUBJID \nUnique Subject Identifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all applications or submissions \ninvolving the product. \nReq \nSRSEQ \nSequence Number \nNum  \nIdentifier \nSequence number given to ensure uniqueness of subject records within a domain. May be any valid \nnumber. \nReq \nSRGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a block of related records in a single domain for a subject. \nPerm \nSRREFID \nReference ID \nChar  \nIdentifier \nInternal or external specimen identifier. Example: \"Specimen ID\". \nPerm \nSRSPID \nSponsor-Defined \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier. \nPerm \nSRTESTCD \nSkin Response Test or \nExam Short Name \nChar (SRTESTCD) \nTopic \nShort name of the measurement, test, or examination described in SRTEST. It can be used as a \ncolumn name when converting a dataset from a vertical to a horizontal format. The value in \nSRTESTCD cannot be longer than 8 characters, nor can it start with a number (e.g., \"1TEST\" is not \nvalid). SRTESTCD cannot contain characters other than letters, numbers, or underscores. \nReq \nSRTEST \nSkin Response Test or \nExamination Name \nChar (SRTEST) \nSynonym \nQualifier \nVerbatim name of the test or examination used to obtain the measurement or finding. The value in \nSRTEST cannot be longer than 40 characters. Example: \"Wheal Diameter\". \nReq \nSROBJ \nObject of the Observation Char  \nRecord \nQualifier \nUsed to describe the object or focal point of the findings observation that is represented by --TEST. \nExamples: the dose of the immunogenic material or the allergen associated with the response (e.g., \n\"Johnson Grass IgE 0.15 BAU mL\"). \nReq \nSRCAT \nCategory for Test \nChar  \nGrouping \nQualifier \nUsed to define a category of topic-variable values across subjects. \nPerm \nSRSCAT \nSubcategory for Test \nChar  \nGrouping \nQualifier \nA further categorization of SRCAT values. \nPerm \nSRORRES \nResults or Findings in \nOriginal Units \nChar  \nResult \nQualifier \nResults of measurement or finding as originally received or collected. \nExp \nSRORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for SRORRES. Example: \"mm\". \nExp \nSRSTRESC \nCharacter Result/Finding \nin Std Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from SRORRES, in a standard format or in \nstandard units. SRSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in SRSTRESN.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3201, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6beb1b5a-249e-4324-9dba-b2fe75268449": {"__data__": {"id_": "6beb1b5a-249e-4324-9dba-b2fe75268449", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 376, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a22cebfd-4862-4be0-a6cf-22e0c45997af", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 376, "section": "UNSPECIFIED"}, "hash": "30b5c87fc1fc05d9cb1829088a91e3028c96828fc1cdd2a274cb6dd6cc67616c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a9fa2a83-47dd-47bb-b4b5-4f356e0c29c4", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 376, "section": "UNSPECIFIED"}, "hash": "6e6f783d5ad0aa1057a913c6b3e794f78bab1803c562a118a7654ab640850869", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nSRSCAT \nSubcategory for Test \nChar  \nGrouping \nQualifier \nA further categorization of SRCAT values. \nPerm \nSRORRES \nResults or Findings in \nOriginal Units \nChar  \nResult \nQualifier \nResults of measurement or finding as originally received or collected. \nExp \nSRORRESU \nOriginal Units \nChar (UNIT) \nVariable \nQualifier \nOriginal units in which the data were collected. The unit for SRORRES. Example: \"mm\". \nExp \nSRSTRESC \nCharacter Result/Finding \nin Std Format \nChar  \nResult \nQualifier \nContains the result value for all findings copied or derived from SRORRES, in a standard format or in \nstandard units. SRSTRESC should store all results or findings in character format; if results are \nnumeric, they should also be stored in numeric format in SRSTRESN. \nExp \nSRSTRESN \nNumeric Results/Findings \nin Std. Units \nNum  \nResult \nQualifier \nUsed for continuous or numeric results or findings in standard format; copied in numeric format from \nSRSTRESC. SRSTRESN should store all numeric test results or findings. \nExp \nSRSTRESU \nStandard Units \nChar (UNIT) \nVariable \nQualifier \nStandardized units used for SRSTRESC and SRSTRESN. Example: \"mm\". \nExp \nSRSTAT \nCompletion Status \nChar (ND) \nRecord \nQualifier \nUsed to indicate exam not done. Should be null if a result exists in SRORRES. \nPerm \nSRREASND \nReason Not Done \nChar  \nRecord \nQualifier \nDescribes why a measurement or test was not performed. Used in conjunction with SRSTAT when \nvalue is \"NOT DONE\". \nPerm \nSRNAM \nVendor Name \nChar  \nRecord \nQualifier \nName or identifier of the laboratory or vendor who provided the test results. \nPerm \nSRSPEC \nSpecimen Type \nChar (SPECTYPE) \nRecord \nQualifier \nDefines the types of specimen used for a measurement. Example: \"SKIN\". \nPerm \nSRLOC \nLocation Used for \nMeasurement \nChar (LOC) \nRecord \nQualifier \nLocation relevant to the collection of the measurement. \nPerm", "mimetype": "text/plain", "start_char_idx": 2439, "end_char_idx": 4309, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8096ff3c-fb27-44d8-a6d0-75bb5d2f01e5": {"__data__": {"id_": "8096ff3c-fb27-44d8-a6d0-75bb5d2f01e5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 377, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "097b9294-3483-44bc-b101-44cfd738ab31", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 377, "section": "UNSPECIFIED"}, "hash": "5968ed4d40d514bb3937dea1f89ab3c882c8e3c599a480a680e65a45b5c06a65", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ab5f8423-b2ec-4cab-8cc3-80ef50ccba50", "node_type": "1", "metadata": {}, "hash": "d5f144cbae70a0b0687453fc7191952f7330844605e2ce9001d48fbae7344d90", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 377 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSRLAT \nLaterality \nChar (LAT) \nVariable \nQualifier \nQualifier for anatomical location further detailing laterality of intervention administration. Examples: \n\"RIGHT\", \"LEFT\", \"BILATERAL\". \nPerm \nSRMETHOD Method of Test or \nExamination \nChar (METHOD) \nRecord \nQualifier \nMethod of test or examination. Examples: \"ELISA\", \"EIA\", \"MICRONEUTRALIZATION ASSAY\", \n\"PLAQUE REDUCTION NEUTRALIZATION ASSAY\". \nPerm \nSRLOBXFL \nLast Observation Before \nExposure Flag \nChar (NY) \nRecord \nQualifier \nOperationally derived indicator used to identify the last non-missing value prior to RFXSTDTC. The \nvalue should be \"Y\" or null. \nPerm \nSRBLFL \nBaseline Flag \nChar (NY) \nRecord \nQualifier \nIndicator used to identify a baseline value. The value should be \"Y\" or null. Note that SRBLFL is \nretained for backward compatibility. The authoritative baseline flag for statistical analysis is in an \nADaM dataset. \nPerm \nSREVAL \nEvaluator \nChar (EVAL) \nRecord \nQualifier \nRole of person who provided evaluation. Used only for results that are subjective (e.g., assigned by a \nperson or a group). Should be null for records that contain collected or derived data. Examples: \n\"INVESTIGATOR\", \"ADJUDICATION COMMITTEE\", \"VENDOR\". \nPerm \nVISITNUM \nVisit Number \nNum  \nTiming \nClinical encounter number. Numeric version of VISIT, used for sorting. \nExp \nVISIT \nVisit Name \nChar  \nTiming \nProtocol-defined description of clinical encounter. May be used in addition to VISITNUM and/or \nVISITDY. \nPerm \nVISITDY \nPlanned Study Day of \nVisit \nNum  \nTiming \nPlanned study day of the visit based upon RFSTDTC in Demographics. \nPerm \nTAETORD \nPlanned Order of \nElement within Arm \nNum  \nTiming \nNumber that gives the planned order of the element within the arm. \nPerm \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nEpoch associated with the date/time of the observation. Examples: \"SCREENING\", \"TREATMENT\", \nand \"FOLLOW-UP\". \nPerm \nSRDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of an observation represented in ISO 8601. \nExp \nSRDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to sponsor- defined \nRFSTDTC in Demographics. \nPerm \nSRTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when measurement should be taken. This may be represented as an elapsed \ntime relative to a fixed reference point, such as time of last dose. See SRTPTNUM and SRTPTREF. \nExamples: \"START\", \"5 MIN POST\". \nPerm \nSRTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of SRTPT to aid in sorting.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2902, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ab5f8423-b2ec-4cab-8cc3-80ef50ccba50": {"__data__": {"id_": "ab5f8423-b2ec-4cab-8cc3-80ef50ccba50", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 377, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "097b9294-3483-44bc-b101-44cfd738ab31", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 377, "section": "UNSPECIFIED"}, "hash": "5968ed4d40d514bb3937dea1f89ab3c882c8e3c599a480a680e65a45b5c06a65", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "8096ff3c-fb27-44d8-a6d0-75bb5d2f01e5", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 377, "section": "UNSPECIFIED"}, "hash": "e9fb180a66970a17bf3e6ffe27cf9b985d978a06c27a43f1d8cc91a561c8a90b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Perm \nSRDTC \nDate/Time of Collection \nChar ISO 8601 datetime \nor interval \nTiming \nCollection date and time of an observation represented in ISO 8601. \nExp \nSRDY \nStudy Day of \nVisit/Collection/Exam \nNum  \nTiming \nActual study day of visit/collection/exam expressed in integer days relative to sponsor- defined \nRFSTDTC in Demographics. \nPerm \nSRTPT \nPlanned Time Point \nName \nChar  \nTiming \nText description of time when measurement should be taken. This may be represented as an elapsed \ntime relative to a fixed reference point, such as time of last dose. See SRTPTNUM and SRTPTREF. \nExamples: \"START\", \"5 MIN POST\". \nPerm \nSRTPTNUM \nPlanned Time Point \nNumber \nNum  \nTiming \nNumerical version of SRTPT to aid in sorting. \nPerm \nSRELTM \nPlanned Elapsed Time \nfrom Time Point Ref \nChar ISO 8601 duration \nTiming \nPlanned elapsed time (in ISO 8601) relative to a fixed time point reference (SRTPTREF). Not a clock \ntime or a date time variable. Represented as an ISO 8601 duration. Examples: \"-PT15M\" to represent \nthe period of 15 minutes prior to the reference point indicated by EGTPTREF, \"PT8H\" to represent the \nperiod of 8 hours after the reference point indicated by SRTPTREF. \nPerm \nSRTPTREF \nTime Point Reference \nChar  \nTiming \nName of the fixed reference point referred to by SRELTM, SRTPTNUM, and SRTPT. Example: \n\"INTRADERMAL INJECTION\". \nPerm \nSRRFTDTC \nDate/Time of Reference \nTime Point \nChar ISO 8601 datetime \nor interval \nTiming \nDate/time of the reference time point, SRTPTREF. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in parentheses. \n  \nSR \u2013 Assumptions \n1. The Skin Response (SR) domain is used to represent findings about an intervention, but it has its own domain code, SR, rather than the domain code \nFA. \n2. This domain is intended specifically for tests of the immune response to substances that are intended to provoke such a response (e.g., allergens used in \nallergy testing). SR is not intended for other injection-site reactions, including reactogencity events that may follow a vaccine administration.", "mimetype": "text/plain", "start_char_idx": 2178, "end_char_idx": 4323, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5f2496d1-e65d-47dd-a0ae-ebf612c7e735": {"__data__": {"id_": "5f2496d1-e65d-47dd-a0ae-ebf612c7e735", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 378, "section": "0.20 BAU/mL"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6f1c5cd5-4958-4f61-92ea-e165808eda85", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 378, "section": "0.20 BAU/mL"}, "hash": "4bb9f16228dcb22de61be8bff7ef2a654461115aa81824296bd02f297787908a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "30 \nmm \n30 \n30 \nmm \nBACK \n1 \nVISIT \n1 \nExample 2 \nIn this example, the study product dose, Dog Epi IgG, was administered at increasing concentrations. The size of the wheal is being measured (reaction to Dog \nEpi IgG ) to evaluate the efficacy of the Dog Epi IgG extract versus a negative control (NC) and a positive control (PC) in the testing of allergenic extracts. \nWhile SROBJ is populated with information about the substance administered, full details regarding the study product would be submitted in the Exposure (EX) \ndataset. The relationship between SR records and EX records would be represented using RELREC. \nRows 1-6: \nShow the response (description and reaction grade) to the study product at a series of different dose levels, the latter reflected in SROBJ. The \ndescriptions of SRORRES values are correlated to a grade, and the grade values are stored in SRSTRESC.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 883, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d8fab46a-c8cc-4626-a1fb-7f871eaf74f0": {"__data__": {"id_": "d8fab46a-c8cc-4626-a1fb-7f871eaf74f0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "0.5 mg"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "66f2466b-3464-4c59-9f94-5592c3cec3b9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "0.5 mg"}, "hash": "c0ff19539118bedbf470f999091c14b5f20c59609e7d85a7fdbb37be61de8934", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ERYTHEMA, \nINFILTRATION, \nPOSSIBLY \nDISCRETE \nPAPULES \n \n1+ \n \n \nFOREARM 1 \nWEEK \n1 \n4 \nCC-001 \nSR \nCC-001-\n101 \n4 \n4 \nREACTGR \nReaction \nGrade \nDog Epi \n1 mg \nERYTHEMA, \nINFILTRATION, \nPAPULES, \nVESICLES \n \n2+ \n \n \nFOREARM 1 \nWEEK \n1 \n5 \nCC-001 \nSR \nCC-001-\n101 \n5 \n5 \nREACTGR \nReaction \nGrade \nDog Epi", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 303, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "23a3456d-aeec-4b43-ac66-cdb2ad50d88c": {"__data__": {"id_": "23a3456d-aeec-4b43-ac66-cdb2ad50d88c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "1.5 mg"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6c76a2ef-6994-4224-8b60-08f89a7b58ce", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "1.5 mg"}, "hash": "126a29ac0f09da6711e538069e34522d3ea6ad52e982a4657f4a985db6deb3fc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ERYTHEMA, \nINFILTRATION, \nPAPULES, \nVESICLES \n \n2+ \n \n \nFOREARM 1 \nWEEK \n1 \n6 \nCC-001 \nSR \nCC-001-\n101 \n6 \n6 \nREACTGR \nReaction \nGrade \nDog Epi \n2 mg \nERYTHEMA, \nINFILTRATION, \nPAPULES, \nCOALESCING \nVESICLES \n \n3+ \n \n \nFOREARM 1 \nWEEK \n1 \n7 \nCC-001 \nSR \nCC-001-\n101 \n7 \n7 \nFLRMDIAM Flare \nMean \nDiameter \nDog Epi \n0 mg \n5 \nmm \n5 \n5 \nmm \nFOREARM 1 \nWEEK \n1 \n8 \nCC-001 \nSR \nCC-001-\n101 \n8 \n8 \nFLRMDIAM Flare \nMean \nDiameter \nDog Epi", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 430, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "24765497-6050-4698-9f57-e0ab3cb76644": {"__data__": {"id_": "24765497-6050-4698-9f57-e0ab3cb76644", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "1.5 mg"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a1366068-f121-4afc-b703-7b6c9c5bbd82", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 379, "section": "1.5 mg"}, "hash": "987a5ef2ae055fcf6722ac235ed9cbb87cd94f838dcab34e2c73ecf565e6c3f3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1 \nmm \n1 \n1 \nmm \nFOREARM 1 \nWEEK \n1 \n12 \nCC-001 \nSR \nCC-001-\n101 \n12 \n12 \nFLRMDIAM Flare \nMean \nDiameter \nDog Epi \n2 mg \n8 \nmm \n8 \n8 \nmm \nFOREARM 1 \nWEEK \n1 \n \nex.xpt \nRow STUDYID DOMAIN USUBJID EXSPID EXTRT \nEXDOSE EXDOSEU EXROUTE \nEXLOC \n1 \nCC-001 \nEX \n101 \n1 \nDog Epi IgG 0 \nmg \nCUTANEOUS FOREARM \n2 \nCC-001 \nEX \n101 \n2 \nDog Epi IgG 0.1 \nmg \nCUTANEOUS FOREARM \n3 \nCC-001 \nEX \n101 \n3 \nDog Epi IgG 0.5 \nmg \nCUTANEOUS FOREARM \n4 \nCC-001 \nEX \n101 \n4 \nDog Epi IgG 1 \nmg \nCUTANEOUS FOREARM \n5 \nCC-001 \nEX \n101 \n5 \nDog Epi IgG 1.5 \nmg \nCUTANEOUS FOREARM \n6 \nCC-001 \nEX \n101 \n6 \nDog Epi IgG 2 \nmg \nCUTANEOUS FOREARM", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 610, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7f853707-02b5-482b-9151-eeada1258310": {"__data__": {"id_": "7f853707-02b5-482b-9151-eeada1258310", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 380, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fff33bcc-3118-4ccb-a956-b733a4aea3fa", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 380, "section": "UNSPECIFIED"}, "hash": "fdbd8ffa4dc9c00ca6be889b5a13fdd3cc81080a7f304f15e1aa6eae37e3b42d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "54eccbdb-cf9c-4749-86d6-6fdbd3176c29", "node_type": "1", "metadata": {}, "hash": "682a89725a49bb710bdd066d9ab346f7741e9cc35e5d4c9dbffd33a567156766", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 380 \n2021-11-29 \nThe relationships between SR and EX records are represented at the record level in RELREC. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID \nIDVAR \nIDVARVAL RELTYPE RELID \n1 \nCC-001 \nSR \nCC-001-101 SRSPID 1 \n \nR1 \n2 \nCC-001 \nSR \nCC-001-101 SRSPID 7 \n \nR1 \n3 \nCC-001 \nEX \nCC-001-101 EXSPID 1 \n \nR1 \n4 \nCC-001 \nSR \nCC-001-101 SRSPID 2 \n \nR2 \n5 \nCC-001 \nSR \nCC-001-101 SRSPID 8 \n \nR2 \n6 \nCC-001 \nEX \nCC-001-101 EXSPID 2 \n \nR2 \n7 \nCC-001 \nSR \nCC-001-101 SRSPID 3 \n \nR3 \n8 \nCC-001 \nSR \nCC-001-101 SRSPID 9 \n \nR3 \n9 \nCC-001 \nEX \nCC-001-101 EXSPID 3 \n \nR3 \n10 \nCC-001 \nSR \nCC-001-101 SRSPID 4 \n \nR4 \n11 \nCC-001 \nSR \nCC-001-101 SRSPID 10 \n \nR4 \n12 \nCC-001 \nEX \nCC-001-101 EXSPID 4 \n \nR4 \n13 \nCC-001 \nSR \nCC-001-101 SRSPID 5 \n \nR5 \n14 \nCC-001 \nSR \nCC-001-101 SRSPID 11 \n \nR5 \n15 \nCC-001 \nEX \nCC-001-101 EXSPID 5 \n \nR5 \n16 \nCC-001 \nSR \nCC-001-101 SRSPID 6 \n \nR6 \n17 \nCC-001 \nSR \nCC-001-101 SRSPID 12 \n \nR6 \n18 \nCC-001 \nEX \nCC-001-101 EXSPID 6 \n \nR6 \nExample 3 \nThis example shows the results from a tuberculin purified protein derivative (PPD) skin test administered using the Mantoux technique. The subject was given an intradermal injection of standard tuberculin PPD \n(i.e., PPD-S) in the left forearm at visit 1; see the Procedure Agents (AG) record below. At visit 2, the induration diameter and presence of blistering were recorded. Because the tuberculin PPD skin test cannot be \ninterpreted using the induration diameter and blistering alone (e.g., risk for being infected with TB must also be considered), the interpretation of the skin test resides in its own row. The time point variables show \nthat the planned time for reading the test was 48 hours after Mantoux administration. However, a comparison of datetime values in SRDTC and SRRFTDTC shows that in this case the test was read at 53 hours and \n56 minutes after Mantoux administration. \nRow 1: \nShows the longest diameter in millimeters of the induration after receiving an intradermal injection of 0.1 mL containing 5TU of PPD-S in the left forearm. \nRow 2: \nShows the presence of blistering at the tuberculin PPD skin test site.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2277, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "54eccbdb-cf9c-4749-86d6-6fdbd3176c29": {"__data__": {"id_": "54eccbdb-cf9c-4749-86d6-6fdbd3176c29", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 380, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fff33bcc-3118-4ccb-a956-b733a4aea3fa", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 380, "section": "UNSPECIFIED"}, "hash": "fdbd8ffa4dc9c00ca6be889b5a13fdd3cc81080a7f304f15e1aa6eae37e3b42d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "7f853707-02b5-482b-9151-eeada1258310", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 380, "section": "UNSPECIFIED"}, "hash": "983146c98198ca6db7d1b6c3791e391aab32f65fa16be3b6eeaa551267bb18e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "At visit 2, the induration diameter and presence of blistering were recorded. Because the tuberculin PPD skin test cannot be \ninterpreted using the induration diameter and blistering alone (e.g., risk for being infected with TB must also be considered), the interpretation of the skin test resides in its own row. The time point variables show \nthat the planned time for reading the test was 48 hours after Mantoux administration. However, a comparison of datetime values in SRDTC and SRRFTDTC shows that in this case the test was read at 53 hours and \n56 minutes after Mantoux administration. \nRow 1: \nShows the longest diameter in millimeters of the induration after receiving an intradermal injection of 0.1 mL containing 5TU of PPD-S in the left forearm. \nRow 2: \nShows the presence of blistering at the tuberculin PPD skin test site. \nRow 3: \nShows the interpretation of the tuberculin PPD skin test. SRGRPID is used to tie together the results to the interpretation. \nsr.xpt \nRow STUDYID DOMAIN USUBJID SRSEQ \nSRGRPID SRTESTCD SRTEST \nSROBJ \nSRORRES SRORRESU SRSTRESC SRSTRESN SRSTRESU SRLOC \nSRLAT SRMETHOD VISITNUM VISIT \nEPOCH \nSRDTC \nSRTPT SRELTM SRTPTREF \nSRRFTDTC \n1 \nABC \nSR \nABC-001 \n1 \n1 \nIDRLDIAM \nInduration \nLongest Diameter \nTuberculin \nPPD-S \n16 \nmm \n16 \n16 \nmm \nFOREARM LEFT \nRULER \n2 \nVISIT \n2 \nOPEN LABEL \nTREATMENT \n2011-01-\n19T14:08:24 \n48 H \nPT48H \nMANTOUX \nADMINISTRATION \n2011-01-\n17T08:30:00 \n2 \nABC \nSR \nABC-001 \n2 \n1 \nBLISTIND \nBlistering \nIndicator \nTuberculin \nPPD-S \nY \n \nY \n \n \nFOREARM LEFT \n \n2 \nVISIT \n2 \nOPEN LABEL \nTREATMENT \n2011-01-\n19T14:08:24 \n48 H \nPT48H \nMANTOUX \nADMINISTRATION \n2011-01-\n17T08:30:00 \n3 \nABC \nSR \nABC-001 \n3 \n1 \nINTP \nInterpretation \nTuberculin \nPPD-S \nPOSITIVE \n \nPOSITIVE \n \n \n \n \n \n2 \nVISIT \n2 \nOPEN LABEL \nTREATMENT \n2011-01-\n19T14:08:24 \n48 H \nPT48H \nMANTOUX \nADMINISTRATION \n2011-01-\n17T08:30:00 \nThe tuberculin PPD skin test administration was represented in the AG domain. \nag.xpt \nRow STUDYID DOMAIN USUBJID AGSEQ AGTRT \nAGDOSE AGDOSU \nAGVAMT AGVAMTU VISITNUM VISIT \nEPOCH \nAGSTDTC \n1 \nABC \nAG \nABC-001 \n1 \nTuberculin PPD-S 5 \ntuberculin unit 0.1 \nmL \n1 \nVISIT 1 OPEN LABEL TREATMENT 2011-01-17T08:30:00", "mimetype": "text/plain", "start_char_idx": 1439, "end_char_idx": 3613, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "523bd2bf-ab78-401a-bc23-90d6f91b72be": {"__data__": {"id_": "523bd2bf-ab78-401a-bc23-90d6f91b72be", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 381, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4294a3da-1df4-4124-8f1d-2ca8a9524bcf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 381, "section": "UNSPECIFIED"}, "hash": "ecd0b7d6ada92b2c79da81122921518f2891b6464dd594bd5e365133c9b407db", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 381 \n2021-11-29 \nRelationships between SR and AG records were shown in RELREC. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nABC \nSR \nABC-001 \nSRGRPID 1 \n \nR1 \n2 \nABC \nAG \nABC-001 \nAGSEQ \n1 \n \nR1", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 403, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "56671b4e-1d36-43d9-9fdd-227e98f8ddb7": {"__data__": {"id_": "56671b4e-1d36-43d9-9fdd-227e98f8ddb7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 382, "section": "7.1.1 Purpose of the Trial Design Model"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "338921a6-dc4c-46aa-a742-86ed7e8ac4d4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 382, "section": "7.1.1 Purpose of the Trial Design Model"}, "hash": "4bb1d97ec25fff8a7303faec6e00deead2d4e69418977567c763df87418b427f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ICH E3, Guidance for Industry, Structure and Content of Clinical Study Reports (available at \nhttp://www.ich.org/products/guidelines/), Section 9.1, calls for a brief, clear description of the overall plan and \ndesign of the study, and supplies examples of charts and diagrams for this purpose in Annex IIIa and Annex IIIb. \nEach Annex corresponds to an example trial, and each shows a diagram describing the study design and a table \nshowing the schedule of assessments. The Trial Design Model provides a standardized way to describe those aspects \nof the planned conduct of a clinical trial shown in the study design diagrams of these examples. The standard Trial \nDesign Datasets will allow reviewers to: \n\u2022 \nClearly and quickly grasp the design of a clinical trial \n\u2022 \nCompare the designs of different trials \n\u2022 \nSearch a data warehouse for clinical trials with certain features \n\u2022 \nCompare planned and actual treatments and visits for subjects in a clinical trial \nModeling a clinical trial in this standardized way requires the explicit statement of certain decision rules that may \nnot be addressed or may be vague or ambiguous in the usual prose protocol document. Prospective modeling of the \ndesign of a clinical trial should lead to a clearer, better protocol. Retrospective modeling of the design of a clinical \ntrial should ensure a clear description of how the trial protocol was interpreted by the sponsor.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1421, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "47b8a49d-ffce-410c-bf2b-f27d004ed9fa": {"__data__": {"id_": "47b8a49d-ffce-410c-bf2b-f27d004ed9fa", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 382, "section": "7.1.2 Definitions of Trial Design Concepts"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "614859aa-9e47-4098-b7cb-c7c492c867a0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 382, "section": "7.1.2 Definitions of Trial Design Concepts"}, "hash": "2939a9871f07c636c7ccec73f822e94fe60f7af334f678d84d989a662a967776", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "A clinical trial is a scientific experiment involving human subjects, intended to address certain scientific questions \n(i.e., the objectives of the trial). See the CDISC Glossary (https://www.cdisc.org/standards/glossary) for more \ncomplete definitions of clinical trial and objective. \n \nConcept \nDefinition \nTrial design \nThe design of a clinical trial is a plan for what will be done to subjects and what data will be collected \nabout them, in the course of the trial, to address the trial's objectives. \nEpoch \nAs part of the design of a trial, the planned period of subjects' participation in the trial is divided into \nepochs. Each epoch is a period of time that serves a purpose in the trial as a whole. That purpose will \nbe at the level of the primary objectives of the trial. Typically, the purpose of an epoch will be to \nexpose subjects to a treatment or to prepare for such a treatment period (e.g., determine subject \neligibility, washout previous treatments), or to gather data on subjects after a treatment has ended. \nNote that at this high level, a \u201ctreatment\u201d is a treatment strategy, which may be simple (e.g., exposure \nto a single drug at a single dose) or complex. Complex treatment strategies could involve tapering \nthrough several doses, titrating dose according to clinical criteria, complex regimens involving multiple \ndrugs, or strategies for adding or dropping drugs according to clinical criteria. \nArm \nAn arm is a planned path through the trial. This path covers the entire time of the trial. The group of \nsubjects assigned to a planned path is also often colloquially called an \"arm.\" The group of subjects \nassigned to an arm is also often called a \"treatment group\"; in this sense, an arm is equivalent to a \ntreatment group. \nStudy cell \nEach planned path through the trial (i.e., each arm) is divided into pieces, 1 for each epoch. Each of \nthese pieces is called a study cell. Thus, there is a study cell for each combination of arm and epoch. \nEach study cell represents an implementation of the purpose of its associated epoch. For an epoch \nwhose purpose is to expose subjects to treatment, each study cell associated with the epoch has an \nassociated treatment strategy. For example, a 3-arm parallel trial might have a treatment epoch whose \npurpose is to expose subjects to one of 3 study treatments: placebo, investigational product, or active \ncontrol. There would be 3 study cell associated with the treatment epoch, 1 for each arm. Each of \nthese study cells exposes the subject to 1 of the 3 study treatments. Another example involving more \ncomplex treatment strategies would be a trial comparing the effects of cycles of chemotherapy drug A \ngiven alone or in combination with drug B, where drug B is given as a pretreatment to each cycle of \ndrug A.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2805, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec4b4a11-3780-417d-bc0f-486a1fccc241": {"__data__": {"id_": "ec4b4a11-3780-417d-bc0f-486a1fccc241", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 383, "section": "7.1.3 Current and Future Contents of the Trial Design Model"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "997361f6-035d-494b-b53c-589467c8286c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 383, "section": "7.1.3 Current and Future Contents of the Trial Design Model"}, "hash": "8289a4227dfac569c48f9469c6f05f5468e4217d72005fe7e576748b1afa8f1c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Datasets currently in the Trial Design Model include: \n\u2022 \nTrial Arms: Describes the sequences of elements in each epoch for each arm, and thus describes the \ncomplete sequence of elements in each arm \n\u2022 \nTrial Elements: Describes the elements used in the trial \n\u2022 \nTrial Visits: Describes the planned schedule of visits \n\u2022 \nTrial Disease Assessment: Provides information on the protocol-specified disease assessment schedule, and \nis used for comparison with the actual occurrence of the efficacy assessments in order to determine whether \nthere was good compliance with the schedule \n\u2022 \nTrial Disease Milestones: Describes observations or activities identified for the trial which are anticipated \nto occur in the course of the disease under study and which trigger the collection of data", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 789, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fd57999b-5b74-41a9-b803-8de4edcfb5f8": {"__data__": {"id_": "fd57999b-5b74-41a9-b803-8de4edcfb5f8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 384, "section": "7.2 Experimental Design (TA and TE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ccf944c1-e7f6-4113-8e94-e1ef5d8804a9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 384, "section": "7.2 Experimental Design (TA and TE)"}, "hash": "898ac42bbf0bb56da32a14e867405837296e4d352fccb07f22e114d2db553ffa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This subsection contains the Trial Design datasets that describe the planned design of the study, and provide the \nrepresentation of study treatment in its most granular components (Section 7.2.2, Trial Elements (TE)), as well as \nthe representation of all sequences of these components (Section 7.2.1, Trial Arms (TA)) as specified by the study \nprotocol. \nThe TA and TE datasets are interrelated, and they provide the building blocks for the development of subject-level \ntreatment information (see Sections 5.2, Demographics (DM), and 5.3, Subject Elements (SE), for the subject\u2019s \nactual study treatment information).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 621, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d7efdacb-77fc-49f9-8e9e-2fb1f07d478d": {"__data__": {"id_": "d7efdacb-77fc-49f9-8e9e-2fb1f07d478d", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 384, "section": "7.2.1 Trial Arms (TA)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6368d491-2054-4793-91ba-0335accbb817", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 384, "section": "7.2.1 Trial Arms (TA)"}, "hash": "089059325204c0be505d24588b19db8870694684f056aed3ca1b682ff89d7a2e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TA \u2013 Description/Overview \nA trial design domain that contains each planned arm in the trial. This section contains: \n\u2022\nThe Trial Arms dataset and assumptions\n\u2022\nA series of example trials, which illustrate the development of the TA dataset\n\u2022\nAdvice on various issues in the development of the TA dataset\n\u2022\nA recap of the TA dataset and the function of its variables\nTA \u2013 Specification \nta.xpt, Trial Arms \u2014 Trial Design. One record per planned Element per Arm, Tabulation. \nVariable \nName \nVariable Label Type Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier Char \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar TA \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nARMCD \nPlanned Arm \nCode \nChar * \nTopic \nARMCD is limited to 20 characters and does not have special \ncharacter restrictions. The maximum length of ARMCD is longer \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 926, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "498a709a-6e6b-4bda-82eb-00346e1f9cf8": {"__data__": {"id_": "498a709a-6e6b-4bda-82eb-00346e1f9cf8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 385, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fbfe30ea-c738-4a9c-b738-7202a960de77", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 385, "section": "UNSPECIFIED"}, "hash": "36caf2a5838500cf876d3a8f5c3e3687b8e7929417f69fb4f1e94e305b966f88", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "9a7e298c-062a-41a8-a352-c11ad5084fd9", "node_type": "1", "metadata": {}, "hash": "fe4dbf05030697fc2adb63169d07cde218183acf9cc45a93f9f8264cbd8907a6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 385 \n2021-11-29 \nVariable \nName \nVariable Label Type Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nthan that for other \"short\" variables to accommodate the kind of \nvalues that are likely to be needed for crossover trials. For \nexample, if ARMCD values for a 7-period crossover were \nconstructed using 2-character abbreviations for each treatment \nand separating hyphens, the length of ARMCD values would be \n20. \nARM \nDescription of \nPlanned Arm \nChar * \nSynonym \nQualifier \nName given to an arm or treatment group. \nReq \nTAETORD \nPlanned Order \nof Element \nwithin Arm \nNum \nTiming \nNumber that gives the order of the element within the arm. \nReq \nETCD \nElement Code \nChar * \nRecord \nQualifier \nETCD (the companion to ELEMENT) is limited to 8 characters \nand does not have special character restrictions. These values \nshould be short for ease of use in programming, but it is not \nexpected that ETCD will need to serve as a variable name. \nReq \nELEMENT \nDescription of \nElement \nChar * \nSynonym \nQualifier \nThe name of the element. The same element may occur more \nthan once within an arm. \nPerm \nTABRANCH Branch \nChar \nRule \nCondition subject met, at a \"branch\" in the trial design at the end \nof this element, to be included in this arm (e.g., \"Randomization \nto DRUG X\"). \nExp \nTATRANS \nTransition Rule Char \nRule \nIf the trial design allows a subject to transition to an element \nother than the next element in sequence, then the conditions for \ntransitioning to those other elements, and the alternative \nelement sequences, are specified in this rule (e.g., \"Responders \ngo to washout\"). \nExp \nEPOCH \nEpoch \nChar (EPOCH) \nTiming \nName of the trial epoch with which this element of the arm is \nassociated. \nReq \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \nTA \u2013 Assumptions \n1.\nTAETORD is an integer. In general, the value of TAETORD is 1 for the first element in each arm, 2 for the\nsecond element in each arm, and so on. Occasionally, it may be convenient to skip some values\n(see Example Trial 6). Although the values of TAETORD need not always be sequential, their order must\nalways be the correct order for the elements in the arm path.\n2.\nElements in different arms with the same value of TAETORD may or may not be at the same time,\ndepending on the design of the trial. The example trials illustrate a variety of possible situations. The same\nelement may occur more than once within an arm.\n3.\nTABRANCH describes the outcome of a branch decision point in the trial design for subjects in the arm. A\nbranch decision point takes place between epochs, and is associated with the element that ends at the\ndecision point. For instance, if subjects are assigned to an arm where they receive treatment A through a\nrandomization at the end of element X, the value of TABRANCH for element X would be \"Randomized to\nA.\"\n4.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3139, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9a7e298c-062a-41a8-a352-c11ad5084fd9": {"__data__": {"id_": "9a7e298c-062a-41a8-a352-c11ad5084fd9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 385, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fbfe30ea-c738-4a9c-b738-7202a960de77", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 385, "section": "UNSPECIFIED"}, "hash": "36caf2a5838500cf876d3a8f5c3e3687b8e7929417f69fb4f1e94e305b966f88", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "498a709a-6e6b-4bda-82eb-00346e1f9cf8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 385, "section": "UNSPECIFIED"}, "hash": "1e826302d98db1ac78165259204224d2d6adc0e59b2c73470e7842e18a98bd26", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Although the values of TAETORD need not always be sequential, their order must\nalways be the correct order for the elements in the arm path.\n2.\nElements in different arms with the same value of TAETORD may or may not be at the same time,\ndepending on the design of the trial. The example trials illustrate a variety of possible situations. The same\nelement may occur more than once within an arm.\n3.\nTABRANCH describes the outcome of a branch decision point in the trial design for subjects in the arm. A\nbranch decision point takes place between epochs, and is associated with the element that ends at the\ndecision point. For instance, if subjects are assigned to an arm where they receive treatment A through a\nrandomization at the end of element X, the value of TABRANCH for element X would be \"Randomized to\nA.\"\n4.\nBranch decision points may be based on decision processes other than randomizations (e.g., clinical\nevaluations of disease response, subject choice).\n5.\nThere is usually some gap in time between the performance of a randomization and the start of randomized\ntreatment. However, in many trials this gap in time is small and it is highly unlikely that subjects will leave\nthe trial between randomization and treatment. In these circumstances, the trial does not need to be\nmodeled with this time period between randomization and start of treatment as a separate element.\n6.\nSome trials include multiple paths that are closely enough related so that they are all considered to belong\nto 1 arm. In general, this set of paths will include a \"complete\" path along with shorter paths that skip some\nelements. The sequence of elements represented in the trial arms should be the complete, longest path.\nTATRANS describes the decision points that may lead to a shortened path within the arm.\n7.\nIf an element does not end with a decision that could lead to a shortened path within the arm, then\nTATRANS will be blank. If there is such a decision, TATRANS will be in a form like, \"If condition X is\ntrue, then go to epoch Y\" or \"If condition X is true, then go to element with TAETORD = 'Z'\".", "mimetype": "text/plain", "start_char_idx": 2321, "end_char_idx": 4422, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "39ad5baf-20e7-4df2-b5cd-8d23b36f883a": {"__data__": {"id_": "39ad5baf-20e7-4df2-b5cd-8d23b36f883a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 386, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "13d96e67-c91f-47b4-a53f-4d39e6db72fa", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 386, "section": "UNSPECIFIED"}, "hash": "5a016ff71f93ab222062977551dd0cecdc557de6716dc3bc450cf8beee510ca3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "7ddecaf4-becf-4386-8277-42393c3631ea", "node_type": "1", "metadata": {}, "hash": "b9bb291e3687cfe153e8903b4c7c78a2a32bbd78e1500e7adb38f63b5adfcc5a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 386 \n2021-11-29 \n8. EPOCH is not strictly necessary for describing the sequence of elements in an arm path, but it is the \nconceptual basis for comparisons between arms and also provides a useful way to talk about what is \nhappening in a blinded trial while it is blinded. During periods of blinded treatment, blinded participants \nwill not know which arm and element a subject is in, but EPOCH should provide a description of the time \nperiod that does not depend on knowing arm. \n9. EPOCH should be assigned in such a way that elements from different arms with the same value of \nEPOCH are \"comparable\" in some sense. The degree of similarity across arms varies considerably in \ndifferent trials, as illustrated in the examples. \n10. EPOCH values for multiple similar epochs: \na. \n When a study design includes multiple epochs with the same purpose (e.g., multiple similar treatment \nepochs), it is recommended that the EPOCH values be terms from controlled terminology, but with \nnumbers appended. For example, multiple treatment epochs could be represented using \n\"TREATMENT 1\", \"TREATMENT 2\", and so on.  Because the codelist is extensible, this convention \nallows multiple similar epochs to be represented without adding numbered terms to the CDISC \nControlled Terminology for epoch. The inclusion of multiple numbered terms in the EPOCH codelist \nis not considered to add value. \nb. Note that the controlled terminology does include some more granular terms for distinguishing \nbetween epochs that differ in ways other than mere order, and these terms should be used where \napplicable, as they are more informative. For example, when \"BLINDED TREATMENT\" and \"OPEN \nLABEL TREATMENT\" are applicable, those terms would be preferred over \"TREATMENT 1\" and \n\"TREATMENT 2\". \n11. Note that study cells are not explicitly defined in the TA dataset. A set of records with a common value of \nboth ARMCD and EPOCH constitute the description of a study cell. Transition rules within this set of \nrecords are also part of the description of the study cell. \n12. EPOCH may be used as a timing variable in other datasets, such as Exposure (EX) and Disposition (DS), \nand values of EPOCH must be different for different epochs. For instance, in a crossover trial with 3 \ntreatment epochs, each must be given a distinct name; all 3 cannot be called \u201cTREATMENT\u201d. \nTA \u2013 Examples  \nThe core of the Trial Design Model is the TA dataset. For each arm of the trial, the TA dataset contains 1 record for \neach occurrence of an element in the path of the arm. \nAlthough the TA dataset has 1 record for each trial element traversed by subjects assigned to the arm, it is generally \nmore useful to work out the overall design of the trial at the study cell level first, then to work out the elements \nwithin each study cell, and finally to develop the definitions of the elements that are contained in the Trial Elements \n(TE) table. \nWhen working out the design of a trial, it is generally useful to draw diagrams such as those mentioned in ICH E3. \nThe protocol may include a diagram that can serve as a starting point. Such a diagram can then be converted into a \ntrial design matrix that displays the study cells and which in turn can be converted into the TA dataset.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3431, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7ddecaf4-becf-4386-8277-42393c3631ea": {"__data__": {"id_": "7ddecaf4-becf-4386-8277-42393c3631ea", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 386, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "13d96e67-c91f-47b4-a53f-4d39e6db72fa", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 386, "section": "UNSPECIFIED"}, "hash": "5a016ff71f93ab222062977551dd0cecdc557de6716dc3bc450cf8beee510ca3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "39ad5baf-20e7-4df2-b5cd-8d23b36f883a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 386, "section": "UNSPECIFIED"}, "hash": "34f36f9af9f85d73901c1bd2fd93a38e77bac38c29d8cbc31025ef41308f9b4c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TA \u2013 Examples  \nThe core of the Trial Design Model is the TA dataset. For each arm of the trial, the TA dataset contains 1 record for \neach occurrence of an element in the path of the arm. \nAlthough the TA dataset has 1 record for each trial element traversed by subjects assigned to the arm, it is generally \nmore useful to work out the overall design of the trial at the study cell level first, then to work out the elements \nwithin each study cell, and finally to develop the definitions of the elements that are contained in the Trial Elements \n(TE) table. \nWhen working out the design of a trial, it is generally useful to draw diagrams such as those mentioned in ICH E3. \nThe protocol may include a diagram that can serve as a starting point. Such a diagram can then be converted into a \ntrial design matrix that displays the study cells and which in turn can be converted into the TA dataset. \nThis section uses example trials of increasing complexity to illustrate the concepts of trial design. For each example \ntrial, the process of working out the TA table is illustrated by means of a series of diagrams and tables, including: \n\u2022 \nA diagram showing the branching structure of the trial in a \u201cstudy schema\u201d format such as might appear in \na protocol \n\u2022 \nA diagram that shows the \u201cprospective\u201d view of the trial (i.e., the view of those participating in the trial). \nThis is similar to the study schema view in that it usually shows a single pool of subjects at the beginning \nof the trial, with the pool of subjects being split into separate treatment groups at randomizations and other \nbranches. Such diagrams include the epochs of the trial, and, for each group of subjects and each epoch, the \nsequence of elements within each epoch for that treatment group. The arms are also indicated on these \ndiagrams. \n\u2022 \nA diagram that shows the \u201cretrospective\u201d view of the trial (i.e., the view of the analyst reporting on the \ntrial). This style of diagram looks more like a matrix; it is also more like the structure of the TA dataset. \nThe retrospective view is arm-centered and shows, for each study cell (epoch/arm combination) the", "mimetype": "text/plain", "start_char_idx": 2532, "end_char_idx": 4674, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "963c3759-e86c-46e8-894b-0eb831d6e7e6": {"__data__": {"id_": "963c3759-e86c-46e8-894b-0eb831d6e7e6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 387, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "cb1bbc6a-73b6-4c93-aa25-fb451e1dc895", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 387, "section": "UNSPECIFIED"}, "hash": "b75016ec4a8e2be52050df23fb48cb55b3f89159e4631840d60b98d5373a5099", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 387 \n2021-11-29 \nsequence of elements within that study cell. It can be thought of as showing, for each arm, the elements \ntraversed by a subject who completed that arm as intended. \n\u2022\nIf the trial is blinded, a diagram that shows the trial as it appears to a blinded participant\n\u2022\nA trial design matrix, an alternative format for representing most of the information in the diagram that\nshows arms and epochs, and which emphasizes the study cells\n\u2022\nThe TA dataset\nExample 1 should be reviewed before reading other examples, as it explains the conventions used for all diagrams \nand tables in the examples. \nExample 1\nDiagrams that represent study schemas generally conceive of time as moving from left to right, using horizontal \nlines to represent periods of time and slanting lines to represent branches into separate treatments, convergence into \na common follow-up, or crossover to a different treatment. \nIn this type of document, diagrams are drawn using \"blocks\" corresponding to trial elements rather than horizontal \nlines. Trial elements are the various treatment and non-treatment time periods of the trial and we want to emphasize \nthe separate trial elements might otherwise be \"hidden\" in a single horizontal line. See Section 7.2.2, Trial \nElements (TE), for more information about defining trial elements. In general, the elements of a trial will be fairly \nclear. However, in the process of working out a trial design, alternative definitions of trial elements may be \nconsidered, in which case diagrams for each alternative may be constructed. \nIn the study schema diagrams in this example, the only slanting lines used are those that represent branches (i.e., \ndecision points where subjects are divided into separate treatment groups). One advantage of this style of diagram, \nwhich does not show convergence of separate paths into a single block, is that the number of arms in the trial can be \ndetermined by counting the number of parallel paths at the right end of the diagram. \nAs illustrated in the study schema diagram for Example Trial 1, this simple parallel trial has 3 arms, corresponding \nto the 3 possible left-to-right \"paths\" through the trial. Each path corresponds to 1 of the 3 treatment elements at the \nright end of the diagram. Randomization is represented by the 3 red arrows leading from the Run-in block. \nExample Trial 1, Parallel Design Study Schema \nThe next diagram for this trial shows the 3 epochs of the trial, indicates the 3 arms, and shows the sequence of \nelements for each group of subjects in each epoch. The arrows are at the right side of the diagram because it is at the \nend of the trial that all the separate paths through the trial can be seen. Note that, in this diagram, randomization\u2014\nwhich was shown using 3 red arrows connecting the Run-in block with the 3 treatment blocks in the first diagram\u2014\nis indicated by a note with an arrow pointing to the line between 2 epochs.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3117, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "101169e9-73cc-4605-9375-6c9ae1ed78f8": {"__data__": {"id_": "101169e9-73cc-4605-9375-6c9ae1ed78f8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 388, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a5b57957-05c1-4162-8bc2-2a45988523d1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 388, "section": "UNSPECIFIED"}, "hash": "d7fe6f467c5888538a3b3f60e9a7bda9930030d2630db60ab69cc383425d07b1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 388 \n2021-11-29 \nExample Trial 1, Parallel Design Prospective View \nThe next diagram can be thought of as the retrospective view of a trial, the view back from a point in time when a \nsubject\u2019s assignment to an arm is known. In this view, the trial appears as a grid, with an arm represented by a series \nof study cells, one for each epoch, and a sequence of elements within each study cell. In this example (as in many \ntrials), there is exactly 1 element in each study cell. Later examples will illustrate that this is not always the case. \nExample Trial 1, Parallel Design Retrospective View \nThe next diagram shows the trial from the viewpoint of blinded participants. To blinded participants in this trial, all \narms look alike. They know when a subject is in the screen element or the run-in element, but when a subject is in \nthe treatment epoch, participants know only that the subject is receiving a study drug, not which study drug, and \ntherefore not which element. \nExample Trial 1, Parallel Design Blinded View", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1201, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "30206999-ea0e-4449-aafa-015f5e5d09d8": {"__data__": {"id_": "30206999-ea0e-4449-aafa-015f5e5d09d8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 389, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6b5a9268-49a8-4e11-8eb4-afd0ef9a7e57", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 389, "section": "UNSPECIFIED"}, "hash": "d891d3122f0d68a10ffc5a9e5d3cd782b92842df8ae56b19b37f5b75b9ee7a5e", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5daa80c2-7885-4185-ac33-4fc5d0f3382c", "node_type": "1", "metadata": {}, "hash": "130106c2b7f42bd06efcb13cebde4230bfe6c26101bdda2ca93718787d8b5440", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 389 \n2021-11-29 \nA trial design matrix is a table with a row for each arm in the trial and a column for each epoch in the trial. It is \nclosely related to the retrospective view of the trial, and many users may find it easier to construct a table than to \ndraw a diagram. The cells in the matrix represent the study cells, which are populated with trial elements. In this \ntrial, each study cell contains exactly 1 element. \nAs illustrated in the following table, the columns of a trial design matrix are the epochs of the trial, the rows are the \narms of the trial, and the cells of the matrix (the study cells) contain elements. Note that randomization is not \nrepresented in the trial design matrix. All of the preceding diagrams and the trial design matrix are alternative \nrepresentations of the trial design. None of them contains all the information that will be in the finished TA dataset; \nusers may find it useful to draw some or all of these diagrams when working out the dataset. \nTrial Design Matrix \nScreen Run-in Treatment \nPlacebo Screen Run-in PLACEBO \nA \nScreen Run-in DRUG A \nB \nScreen Run-in DRUG B \nFor Example Trial 1, the conversion of the trial design matrix into the TA dataset is straightforward. For each cell of \nthe matrix, there is a record in the TA dataset. ARM, EPOCH, and ELEMENT can be populated directly from the \nmatrix. TAETORD acts as a sequence number for the elements within an arm, so it can be populated by counting \nacross the cells in the matrix. The randomization information, which is not represented in the trial design matrix, is \nheld in TABRANCH in the TA dataset. TABRANCH is populated only if there is a branch at the end of an element \nfor the arm. When TABRANCH is populated, it describes how the decision at the branch point would result in a \nsubject being in this arm. \nta.xpt\nRow \nSTUDYID \nDOMAIN \nARMCD \nARM \nTAETORD \nETCD \nELEMENT \nTABRANCH \nTATRANS \nEPOCH \n1 \nEX1 \nTA \nP \nPlacebo \n1 \nSCRN \nScreen \nSCREENING \n2 \nEX1 \nTA \nP \nPlacebo \n2 \nRI \nRun-In \nRandomized to Placebo \nRUN-IN \n3 \nEX1 \nTA \nP \nPlacebo \n3 \nP \nPlacebo \nTREATMENT \n4 \nEX1 \nTA \nA \nA \n1 \nSCRN \nScreen \nSCREENING \n5 \nEX1 \nTA \nA \nA \n2 \nRI \nRun-In \nRandomized to Drug A \nRUN-IN \n6 \nEX1 \nTA \nA \nA \n3 \nA \nDrug A \nTREATMENT \n7 \nEX1 \nTA \nB \nB \n1 \nSCRN \nScreen \nSCREENING \n8 \nEX1 \nTA \nB \nB \n2 \nRI \nRun-In \nRandomized to Drug B \nRUN-IN \n9 \nEX1 \nTA \nB \nB \n3 \nB \nDrug B \nTREATMENT \nExample 2\nThe following diagram for a crossover trial does not use the crossing slanted lines sometimes used to represent \ncrossover trials, because the order of the blocks is sufficient to represent the design of the trial.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2797, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5daa80c2-7885-4185-ac33-4fc5d0f3382c": {"__data__": {"id_": "5daa80c2-7885-4185-ac33-4fc5d0f3382c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 389, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6b5a9268-49a8-4e11-8eb4-afd0ef9a7e57", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 389, "section": "UNSPECIFIED"}, "hash": "d891d3122f0d68a10ffc5a9e5d3cd782b92842df8ae56b19b37f5b75b9ee7a5e", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "30206999-ea0e-4449-aafa-015f5e5d09d8", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 389, "section": "UNSPECIFIED"}, "hash": "9308e298757bb520826e8267bb0e08fef190924b83f0fbb8975714baeaece64f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Slanted lines are \nused only to represent the branch point at randomization, when a subject is assigned to a sequence of treatments. As \nin most crossover trials, the arms are distinguished by the order of treatments, with the same treatments present in \neach arm. Note that even though all 3 arms of this trial end with the same block (i.e., the block for the follow-up \nelement), the diagram does not show the arms converging into one block. Also note that the same block (the \u201crest\u201d \nelement) occurs twice within each arm. Elements are conceived of as \u201creusable\u201d and can appear in more than 1 arm, \nin more than 1 epoch, and more than once in an arm. \nExample Trial 2, Crossover Trial Study Schema", "mimetype": "text/plain", "start_char_idx": 2798, "end_char_idx": 3498, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ca8f9d13-f352-486a-820c-c63fd5f390dc": {"__data__": {"id_": "ca8f9d13-f352-486a-820c-c63fd5f390dc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 390, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8f1e48d9-1b7c-4e7b-baf2-112029fe5bec", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 390, "section": "UNSPECIFIED"}, "hash": "f852f43239d275f42062bb80d4fa232153cb22c3d2059ae7f9af8924461a9fdc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 390 \n2021-11-29 \nThe next diagram for this crossover trial shows the prospective view of the trial; it identifies the epoch and arms of \nthe trial, and gives each a name. As for most crossover studies, the objectives of the trial will be addressed by \ncomparisons between the arms and by within-subject comparisons between treatments. Because the design depends \non differentiating the periods during which the subject receives the 3 different treatments, there are 3 different \ntreatment epochs. The fact that the rest periods are identified as separate epochs suggests that these also play an \nimportant part in the design of the trial; they are probably designed to allow subjects to return to \u201cbaseline,\u201d with \ndata collected to show that this occurred. Note that epochs are not considered reusable; each epoch has a different \nname, even though all the treatment epochs are similar and both the rest epochs are similar. As with the first \nexample trial, there is a one-to-one relationship between the epochs of the trial and the elements in each arm. \nExample Trial 2, Crossover Trial Prospective View \nThe next diagram shows the retrospective view of the trial. \nExample Trial 2, Crossover Trial Retrospective View \nThe last diagram for this trial shows the trial from the viewpoint of blinded participants. As in the simple parallel \ntrial in Example Trial 1, blinded participants see only 1 sequence of elements; during the treatment epochs they do \nnot know which of the treatment elements a subject is in.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1693, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a2d3cc83-b087-4db1-a8e9-736ac757efe4": {"__data__": {"id_": "a2d3cc83-b087-4db1-a8e9-736ac757efe4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 391, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c7a08a80-3f9f-4fcb-9bd9-76f5d31703f3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 391, "section": "UNSPECIFIED"}, "hash": "9cb0ba5edb04c1407805f1c21d5e740c0f6e73f5612e27ff908daed386ab7718", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6fb9b602-0d48-4d41-9b2c-0563e62faf9f", "node_type": "1", "metadata": {}, "hash": "122a3d403887bc59809c7fd7f8f3cfce3b74a4e7760ca0b70a38d9fa1b4f96de", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 391 \n2021-11-29 \nExample Trial 2, Crossover Trial Blinded View \nThe following table illustrates the trial design matrix for this crossover example trial. It corresponds closely to the \npreceding retrospective diagram. \nTrial Design Matrix \nScreen First Treatment First Rest Second Treatment Second Rest Third Treatment Follow-up \nP-5-10 Screen Placebo \nRest \n5 mg \nRest \n10 mg \nFollow-up \n5-P-10 Screen 5 mg \nRest \nPlacebo \nRest \n10 mg \nFollow-up \n5-10-P Screen 5 mg \nRest \n10 mg \nRest \nPlacebo \nFollow-up \nIt is straightforward to produce the TA dataset for this crossover trial from the diagram showing arms and epochs, or \nfrom the trial design matrix.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 833, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6fb9b602-0d48-4d41-9b2c-0563e62faf9f": {"__data__": {"id_": "6fb9b602-0d48-4d41-9b2c-0563e62faf9f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 391, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c7a08a80-3f9f-4fcb-9bd9-76f5d31703f3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 391, "section": "UNSPECIFIED"}, "hash": "9cb0ba5edb04c1407805f1c21d5e740c0f6e73f5612e27ff908daed386ab7718", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a2d3cc83-b087-4db1-a8e9-736ac757efe4", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 391, "section": "UNSPECIFIED"}, "hash": "f26b09c5463609cd930f5488f50b4613a9cb8e914624c3d103ff36cf4c7e9f89", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ta.xpt\nRow STUDYID DOMAIN ARMCD ARM \nTAETORD ETCD ELEMENT TABRANCH \nTATRANS EPOCH \n1 \nEX2 \nTA \nP-5-10\nPlacebo-5mg-\n10mg \n1 \nSCRN Screen \nRandomized to Placebo - 5 \nmg - 10 mg \nSCREENING \n2 \nEX2 \nTA \nP-5-10\nPlacebo-5mg-\n10mg \n2 \nP \nPlacebo \nTREATMENT \n1 \n3 \nEX2 \nTA \nP-5-10\nPlacebo-5mg-\n10mg \n3 \nREST Rest \nWASHOUT 1 \n4 \nEX2 \nTA \nP-5-10\nPlacebo-5mg-\n10mg \n4 \n5 \n5 mg \nTREATMENT \n2 \n5 \nEX2 \nTA \nP-5-10\nPlacebo-5mg-\n10mg \n5 \nREST Rest \nWASHOUT 2 \n6 \nEX2 \nTA \nP-5-10\nPlacebo-5mg-\n10mg \n6 \n10 \n10 mg \nTREATMENT \n3 \n7 \nEX2 \nTA \nP-5-10\nPlacebo-5mg-\n10mg \n7 \nFU \nFollow-up \nFOLLOW-UP \n8 \nEX2 \nTA \n5-P-10\n5mg-Placebo-\n10mg \n1 \nSCRN Screen \nRandomized to 5 mg - \nPlacebo - 10 mg \nSCREENING \n9 \nEX2 \nTA \n5-P-10\n5mg-Placebo-\n10mg \n2 \n5 \n5 mg \nTREATMENT \n1 \n10 \nEX2 \nTA \n5-P-10\n5mg-Placebo-\n10mg \n3 \nREST Rest \nWASHOUT 1 \n11 \nEX2 \nTA \n5-P-10\n5mg-Placebo-\n10mg \n4 \nP \nPlacebo \nTREATMENT \n2 \n12 \nEX2 \nTA \n5-P-10\n5mg-Placebo-\n10mg \n5 \nREST Rest \nWASHOUT 2 \n13 \nEX2 \nTA \n5-P-10\n5mg-Placebo-\n10mg \n6 \n10 \n10 mg \nTREATMENT \n3 \n14 \nEX2 \nTA \n5-P-10\n5mg-Placebo-\n10mg \n7 \nFU \nFollow-up \nFOLLOW-UP \n15 \nEX2 \nTA \n5-10-P\n5mg-10mg-\nPlacebo \n1 \nSCRN Screen \nRandomized to 5 mg - 10 \nmg \u2013 Placebo \nSCREENING \n16 \nEX2 \nTA \n5-10-P\n5mg-10mg-\nPlacebo \n2 \n5 \n5 mg \nTREATMENT \n1 \n17 \nEX2 \nTA \n5-10-P\n5mg-10mg-\nPlacebo \n3 \nREST Rest \nWASHOUT 1 \n18 \nEX2 \nTA \n5-10-P\n5mg-10mg-\nPlacebo \n4 \n10 \n10 mg \nTREATMENT \n2 \n19 \nEX2 \nTA \n5-10-P\n5mg-10mg-\nPlacebo \n5 \nREST Rest \nWASHOUT 2", "mimetype": "text/plain", "start_char_idx": 835, "end_char_idx": 2274, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b8d68078-4dfd-400a-af31-76253ead4126": {"__data__": {"id_": "b8d68078-4dfd-400a-af31-76253ead4126", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 392, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a1a3e470-290c-42c6-a9ec-c0739f49daa7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 392, "section": "UNSPECIFIED"}, "hash": "4981b6d0d559f1e2fc0b9e3950e412cb4fe64cea2ae03e012ca4384090c91e52", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 392 \n2021-11-29 \nRow STUDYID DOMAIN ARMCD ARM \nTAETORD ETCD ELEMENT TABRANCH \nTATRANS EPOCH \n20 \nEX2 \nTA \n5-10-P \n5mg-10mg-\nPlacebo \n6 \nP \nPlacebo \n \n \nTREATMENT \n3 \n21 \nEX2 \nTA \n5-10-P \n5mg-10mg-\nPlacebo \n7 \nFU \nFollow-up \n \n \nFOLLOW-UP \nExample 3 \nEach of the paths for the trial illustrated in the following diagram goes through one branch point at randomization, \nand then through another branch point when response is evaluated. This results in 4 arms, corresponding to the \nnumber of possible paths through the trial, and also to the number of blocks at the right end of the diagram. The fact \nthat there are only 2 kinds of block at the right end (Open DRUG X and Rescue) does not affect the fact that there \nare 4 paths and thus 4 arms. \nExample Trial 3, Multiple Branches Study Schema \n \nThe next diagram for this trial is the prospective view. It shows the epochs of the trial and how the initial group of \nsubjects is split into 2 treatment groups for the double-blind treatment epoch, and how each of those initial treatment \ngroups is split in 2 at the response evaluation, resulting in the 4 arms of this trial The names of the arms have been \nchosen to represent the outcomes of the successive branches that, together, assign subjects to arms. These compound \nnames were chosen to facilitate description of subjects who may drop out of the trial after the first branch and before \nthe second branch. Example 7 in Section 5.2, Demographics, illustrates DM and Subject Elements (SE) data for such \nsubjects. \nExample Trial 3, Multiple Branches Prospective View", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1752, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6f40bab6-f003-41ff-a5c2-b993497cb8c0": {"__data__": {"id_": "6f40bab6-f003-41ff-a5c2-b993497cb8c0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 393, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "aee496cd-8833-4126-9076-61ff13f1f550", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 393, "section": "UNSPECIFIED"}, "hash": "c7d6a14927cc9c4bac9f60856fd3c28fa820028a8a07b93b636e72a9bd2683f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 393 \n2021-11-29 \nThe next diagram shows the retrospective view. As with the first 2 example trials, there is 1 element in each study \ncell. \nExample Trial 3, Multiple Branches Retrospective View \n \nThe last diagram for this trial shows the trial from the viewpoint of blinded participants. Since the prospective view \nis the view most relevant to study participants, the blinded view shown here is a prospective view. Because blinded \nparticipants can tell which treatment a subject receives in the Open Label epoch, they see 2 possible element \nsequences. \nExample Trial 3, Multiple Branches Blinded View \n \nThe trial design matrix for this trial can be constructed easily from the diagram showing arms and epochs. \nTrial Design Matrix \n \nScreen Double Blind Open Label \nA-Open A Screen Treatment A \nOpen Drug A \nA-Rescue Screen Treatment A \nRescue \nB-Open A Screen Treatment B \nOpen Drug A \nB-Rescue Screen Treatment B \nRescue", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1107, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "241b2168-f0aa-4a50-a34c-9cba732e1e47": {"__data__": {"id_": "241b2168-f0aa-4a50-a34c-9cba732e1e47", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 394, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3c9d15e8-677a-4f33-9955-9d5005325156", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 394, "section": "UNSPECIFIED"}, "hash": "208b198d0ad4461f7c85f3eae0dcc57bca6885a3e09dec96a87cc164ac484184", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "8b4afa60-269f-45d3-919f-c306f0a54508", "node_type": "1", "metadata": {}, "hash": "e76cf4ba24a8e8497ced032c215142b5880916015a060d67675c845f9da46fd0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 394 \n2021-11-29 \nCreating the TA dataset for this example trial is similarly straightforward. Note that because there are 2 branch \npoints in this trial, TABRANCH is populated for 2 records in each arm. Note also that the values of ARMCD, like \nthe values of ARM, reflect the 2 separate processes that result in a subject's assignment to an arm. \nta.xpt\nRow STUDYID DOMAIN ARMCD ARM \nTAETORD ETCD ELEMENT \nTABRANCH \nTATRANS EPOCH \n1 \nEX3 \nTA \nAA \nA-Open \nA\n1 \nSCRN Screen \nRandomized to Treatment A \nSCREENING \n2 \nEX3 \nTA \nAA \nA-Open \nA\n2 \nDBA \nTreatment \nA \nAssigned to Open Drug A on \nbasis of response evaluation \nBLINDED \nTREATMENT \n3 \nEX3 \nTA \nAA \nA-Open \nA\n3 \nOA \nOpen Drug \nA \nOPEN LABEL \nTREATMENT \n4 \nEX3 \nTA \nAR \nA-\nRescue \n1 \nSCRN Screen \nRandomized to Treatment A \nSCREENING \n5 \nEX3 \nTA \nAR \nA-\nRescue \n2 \nDBA \nTreatment \nA \nAssigned to Rescue on basis \nof response evaluation \nBLINDED \nTREATMENT \n6 \nEX3 \nTA \nAR \nA-\nRescue \n3 \nRSC \nRescue \nOPEN LABEL \nTREATMENT \n7 \nEX3 \nTA \nBA \nB-Open \nA\n1 \nSCRN Screen \nRandomized to Treatment B \nSCREENING \n8 \nEX3 \nTA \nBA \nB-Open \nA\n2 \nDBB \nTreatment \nB \nAssigned to Open Drug A on \nbasis of response evaluation \nBLINDED \nTREATMENT \n9 \nEX3 \nTA \nBA \nB-Open \nA\n3 \nOA \nOpen Drug \nA \nOPEN LABEL \nTREATMENT \n10 \nEX3 \nTA \nBR \nB-\nRescue \n1 \nSCRN Screen \nRandomized to Treatment B \nSCREENING \n11 \nEX3 \nTA \nBR \nB-\nRescue \n2 \nDBB \nTreatment \nB \nAssigned to Rescue on basis \nof response evaluation \nBLINDED \nTREATMENT \n12 \nEX3 \nTA \nBR \nB-\nRescue \n3 \nRSC \nRescue \nOPEN LABEL \nTREATMENT \nSee Section 7.2.1.1 Trial Arms Issues, Distinguishing Between Branches and Transitions, for additional \ndiscussion regarding when a decision point in a trial design should be considered to give rise to a new arm. \nExample 4\nThe following diagram uses a new symbol, a large curved arrow representing the fact that the chemotherapy \ntreatment (A or B) and the rest period that follows it are to be repeated. In this trial, the chemotherapy cycles are to \nbe repeated until disease progression. Although some chemotherapy trials specify a maximum number of cycles, \nprotocols that allow an indefinite number of repeats are not uncommon. \nExample Trial 4, Cyclical Chemotherapy Study Schema \nThe next diagram shows the prospective view of this trial. Note that, in spite of the repeating element structure, this \nis, at its core, a 2-arm parallel study, and thus has 2 arms.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2572, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8b4afa60-269f-45d3-919f-c306f0a54508": {"__data__": {"id_": "8b4afa60-269f-45d3-919f-c306f0a54508", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 394, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3c9d15e8-677a-4f33-9955-9d5005325156", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 394, "section": "UNSPECIFIED"}, "hash": "208b198d0ad4461f7c85f3eae0dcc57bca6885a3e09dec96a87cc164ac484184", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "241b2168-f0aa-4a50-a34c-9cba732e1e47", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 394, "section": "UNSPECIFIED"}, "hash": "0e12d81daa9e06d7df3681c9af26b41b9cd031f98c43874c952d05195f025b79", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example 4\nThe following diagram uses a new symbol, a large curved arrow representing the fact that the chemotherapy \ntreatment (A or B) and the rest period that follows it are to be repeated. In this trial, the chemotherapy cycles are to \nbe repeated until disease progression. Although some chemotherapy trials specify a maximum number of cycles, \nprotocols that allow an indefinite number of repeats are not uncommon. \nExample Trial 4, Cyclical Chemotherapy Study Schema \nThe next diagram shows the prospective view of this trial. Note that, in spite of the repeating element structure, this \nis, at its core, a 2-arm parallel study, and thus has 2 arms. In SDTMIG 3.1.1, there was an implicit assumption that \neach element must be in a separate epoch, and trials with cyclical chemotherapy were difficult to handle. The \nintroduction of the concept of study cells and the dropping of the assumption that elements and epochs have a one-\nto-one relationship resolved these difficulties. This trial is best treated as having just 3 epochs, since the main \nobjectives of the trial involve comparisons between the 2 treatments and do not require data to be considered cycle \nby cycle.", "mimetype": "text/plain", "start_char_idx": 1916, "end_char_idx": 3098, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "cf82c8a0-3593-4796-8067-2502fdfe0694": {"__data__": {"id_": "cf82c8a0-3593-4796-8067-2502fdfe0694", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 395, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "642faa24-463a-4fc7-aeb4-538c958acf80", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 395, "section": "UNSPECIFIED"}, "hash": "4371bdb1b9f5afce0754adf24e160ded5d89b1a251491a0fbd10152a561028d8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 395 \n2021-11-29 \nExample Trial 4, Cyclical Chemotherapy Prospective View \nThe next diagram shows the retrospective view of this trial. \nExample Trial 4, Cyclical Chemotherapy Retrospective View \nFor the purpose of developing a TA dataset for this oncology trial, the diagram must be redrawn to explicitly \nrepresent multiple treatment and rest elements. If a maximum number of cycles is not given by the protocol, then\u2014\nfor the purposes of constructing an SDTM TA dataset for submission, which can only take place after the trial is \ncomplete\u2014the number of repeats included in the TA dataset should be the maximum number of repeats that \noccurred in the trial. The next diagram assumes that the maximum number of cycles that occurred in this trial was 4. \nSome subjects will not have received all 4 cycles, because their disease progressed. The rule that directed that they \nreceive no further cycles of chemotherapy is represented by a set of green arrows, 1 at the end of each rest epoch, \nthat shows that a subject \u201cskips forward\u201d if their disease progresses. In the TA dataset, each skip-forward instruction \nis a transition rule, recorded in the TATRANS variable; when TATRANS is not populated, the rule is to transition to \nthe next element in sequence. \nExample Trial 4, Cyclical Chemotherapy Retrospective View with Explicit Repeats", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1518, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec397fb9-9f63-4e4c-9673-d1f58975379a": {"__data__": {"id_": "ec397fb9-9f63-4e4c-9673-d1f58975379a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 396, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea94f67f-0fcb-448c-a732-57b2d9f9d071", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 396, "section": "UNSPECIFIED"}, "hash": "861fc7ec3e5c4af41c1b74a8eca7d07c3c60ac7d5d84da82dac0573020cb073f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "14ddef11-ddec-45be-a6eb-b33eaf1d07e3", "node_type": "1", "metadata": {}, "hash": "66a3d7a7cf34f9cbf631c88a1314bdb4d0b91925e20e35f1186e341c385edd7f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 396 \n2021-11-29 \nThe logistics of dosing mean that few oncology trials are blinded; the next diagram, however, shows the trial from \nthe viewpoint of blinded participants if this trial is blinded. \nExample Trial 4, Cyclical Chemotherapy Blinded View \nThe trial design matrix for this example trial corresponds to the diagram showing the retrospective view, with \nexplicit repeats of the treatment and rest elements. As previously noted, the trial design matrix does not include \ninformation regarding when randomization occurs; similarly, information corresponding to the skip-forward rules is \nnot represented in the trial design matrix. \nTrial Design Matrix \n  \nScreen Treatment \nFollow-up \nA Screen Trt A Rest Trt A Rest Trt A Rest Trt A Rest Follow-up \nB Screen Trt B Rest Trt B Rest Trt B Rest Trt B Rest Follow-up \nThe TA dataset for this example trial requires the use of the TATRANS variable to represent the \"repeat until \ndisease progression\" feature (the green \"skip forward\" arrow represented this rule in the diagrams). In the TA \ndataset, TATRANS is populated for each element with a green arrow in the diagram. In other words, if there is a \npossibility that a subject will, at the end of this element, skip forward to a later part of the arm, then TATRANS is \npopulated with the rule describing the conditions under which a subject will go to a later element. If the subject \nalways goes to the next element in the arm (see Example Trials 1-3), then TATRANS is null. The TA dataset \npresented below corresponds to the trial design matrix.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1733, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "14ddef11-ddec-45be-a6eb-b33eaf1d07e3": {"__data__": {"id_": "14ddef11-ddec-45be-a6eb-b33eaf1d07e3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 396, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ea94f67f-0fcb-448c-a732-57b2d9f9d071", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 396, "section": "UNSPECIFIED"}, "hash": "861fc7ec3e5c4af41c1b74a8eca7d07c3c60ac7d5d84da82dac0573020cb073f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "ec397fb9-9f63-4e4c-9673-d1f58975379a", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 396, "section": "UNSPECIFIED"}, "hash": "bee139f0afcf0e3a3131e275a7db5af2fd5797621cf96cfff0f532bc3bcab485", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In the TA \ndataset, TATRANS is populated for each element with a green arrow in the diagram. In other words, if there is a \npossibility that a subject will, at the end of this element, skip forward to a later part of the arm, then TATRANS is \npopulated with the rule describing the conditions under which a subject will go to a later element. If the subject \nalways goes to the next element in the arm (see Example Trials 1-3), then TATRANS is null. The TA dataset \npresented below corresponds to the trial design matrix. \nta.xpt \nRow STUDYID DOMAIN ARMCD ARM TAETORD ETCD ELEMENT TABRANCH \nTATRANS \nEPOCH \n1 \nEX4 \nTA \nA \nA \n1 \nSCRN Screen \nRandomized to \nA \n \nSCREENING \n2 \nEX4 \nTA \nA \nA \n2 \nA \nTrt A \n \n \nTREATMENT \n3 \nEX4 \nTA \nA \nA \n3 \nREST Rest \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n4 \nEX4 \nTA \nA \nA \n4 \nA \nTrt A \n \n \nTREATMENT \n5 \nEX4 \nTA \nA \nA \n5 \nREST Rest \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n6 \nEX4 \nTA \nA \nA \n6 \nA \nTrt A \n \n \nTREATMENT \n7 \nEX4 \nTA \nA \nA \n7 \nREST Rest \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n8 \nEX4 \nTA \nA \nA \n8 \nA \nTrt A \n \n \nTREATMENT \n9 \nEX4 \nTA \nA \nA \n9 \nREST Rest \n \n \nTREATMENT \n10 \nEX4 \nTA \nA \nA \n10 \nFU \nFollow-up \n \n \nFOLLOW-UP \n11 \nEX4 \nTA \nB \nB \n1 \nSCRN Screen \nRandomized to \nB \n \nSCREENING \n12 \nEX4 \nTA \nB \nB \n2 \nB \nTrt B \n \n \nTREATMENT \n13 \nEX4 \nTA \nB \nB \n3 \nREST Rest \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n14 \nEX4 \nTA \nB \nB \n4 \nB \nTrt B \n \n \nTREATMENT \n15 \nEX4 \nTA \nB \nB \n5 \nREST Rest \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n16 \nEX4 \nTA \nB \nB \n6 \nB \nTrt B \n \n \nTREATMENT \n17 \nEX4 \nTA \nB \nB \n7 \nREST Rest \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n18 \nEX4 \nTA \nB \nB \n8 \nB \nTrt B \n \n \nTREATMENT \n19 \nEX4 \nTA \nB \nB \n9 \nREST Rest \n \n \nTREATMENT \n20 \nEX4 \nTA \nB \nB \n10 \nFU \nFollow-up \n \n \nFOLLOW-UP", "mimetype": "text/plain", "start_char_idx": 1212, "end_char_idx": 3082, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8914e95b-3de1-4797-9f2e-4b10a44267f0": {"__data__": {"id_": "8914e95b-3de1-4797-9f2e-4b10a44267f0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 397, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f988e311-6937-47d3-bdbe-1fbd26cf9e6b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 397, "section": "UNSPECIFIED"}, "hash": "52709f480439d24e18370dc6934ca9c1ebff04f6986bea9391b8d212f03c16da", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 397 \n2021-11-29 \nExample 5\nExample Trial 5 is much like Example Trial 4, in that the 2 treatments being compared are given in cycles, and the \ntotal length of the cycle is the same for both treatments. In this trial, however, treatment A is given over longer \nduration than treatment B. Because of this difference in treatment patterns, this trial cannot be blinded. \nExample Trial 5, Different Chemo Durations Study Schema \nThe assumption of a one-to-one relationship between elements and epochs makes such situations difficult to handle. \nHowever, without that assumption, this trial is essentially the same as Trial 4. The next diagram shows the \nretrospective view of this trial. \nExample Trial 5, Cyclical Chemotherapy Retrospective View \nThe trial design matrix for this trial is almost the same as for Example Trial 4; the only difference is that the \nmaximum number of cycles for this trial was assumed to be 3. \nTrial Design Matrix \nScreen Treatment \nFollow-up \nA Screen Trt A Rest A Trt A Rest A Trt A Rest A Follow-up \nB Screen Trt B Rest B Trt B Rest B Trt B Rest B Follow-up \nThe TA dataset for this trial shown below corresponds to the trial design matrix. \nta.xpt\nRow STUDYID DOMAIN ARMCD ARM TAETORD ETCD \nELEMENT TABRANCH \nTATRANS \nEPOCH \n1 \nEX5 \nTA \nA \nA \n1 \nSCRN \nScreen \nRandomized to \nA \nSCREENING \n2 \nEX5 \nTA \nA \nA \n2 \nA \nTrt A \nTREATMENT \n3 \nEX5 \nTA \nA \nA \n3 \nRESTA Rest A \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n4 \nEX5 \nTA \nA \nA \n4 \nA \nTrt A \nTREATMENT \n5 \nEX5 \nTA \nA \nA \n5 \nRESTA Rest A \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n6 \nEX5 \nTA \nA \nA \n6 \nA \nTrt A \nTREATMENT \n7 \nEX5 \nTA \nA \nA \n7 \nRESTA Rest A \nTREATMENT \n8 \nEX5 \nTA \nA \nA \n8 \nFU \nFollow-up \nFOLLOW-UP \n9 \nEX5 \nTA \nB \nB \n1 \nSCRN \nScreen \nRandomized to \nB \nSCREENING", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1967, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf0ca4d3-db94-42d4-bd50-e2efc6b053e1": {"__data__": {"id_": "bf0ca4d3-db94-42d4-bd50-e2efc6b053e1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 398, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fdd49707-f4e0-4201-b243-aaad2e013138", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 398, "section": "UNSPECIFIED"}, "hash": "680285682667b7351c0dafb93e4bd7a2679b77d3c273f8eb7b6b054978b24e61", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 398 \n2021-11-29 \nRow STUDYID DOMAIN ARMCD ARM TAETORD ETCD \nELEMENT TABRANCH \nTATRANS \nEPOCH \n10 \nEX5 \nTA \nB \nB \n2 \nB \nTrt B \nTREATMENT \n11 \nEX5 \nTA \nB \nB \n3 \nRESTB Rest B \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n12 \nEX5 \nTA \nB \nB \n4 \nB \nTrt B \nTREATMENT \n13 \nEX5 \nTA \nB \nB \n5 \nRESTB Rest B \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n14 \nEX5 \nTA \nB \nB \n6 \nB \nTrt B \nTREATMENT \n15 \nEX5 \nTA \nB \nB \n7 \nRESTB Rest B \nTREATMENT \n16 \nEX5 \nTA \nB \nB \n8 \nFU \nFollow-up \nFOLLOW-UP \nExample 6\nExample Trial 6 is an oncology trial comparing 2 types of chemotherapy that are given using cycles of different \nlengths with different internal patterns. Treatment A is given in 3-week cycles with a longer duration of treatment \nand a short rest; treatment B is given in 4-week cycles with a short duration of treatment and a long rest. \nExample Trial 6, Different Cycle Durations Study Schema \nThe design of this trial is very similar to that for Example Trials 4 and 5. The main difference is that there are 2 \ndifferent rest elements: the short one used with drug A and the long one used with drug B. The next diagram shows \nthe retrospective view of this trial. \nExample Trial 6, Cyclical Chemotherapy Retrospective View \nThe trial design matrix for this trial assumes that there was a maximum of 4 cycles of drug A and a maximum of \nthree cycles of drug B. \nTrial Design Matrix \nScreen Treatment \nFollow-up \nA Screen Trt A Rest A Trt A Rest A Trt A Rest A Trt A Rest A Follow-up \nB Screen Trt B Rest B \nTrt B \nRest B \nTrt B \nRest B \nFollow-up \nIn the following TA dataset, because the treatment epoch for arm A has more elements than the treatment epoch for \narm B, TAETORD is 10 for the follow-up element in arm A, but 8 for the follow-up element in arm B. (It would \nalso be possible to assign a TAETORD value of 10 to the follow-up element in arm B.) The primary purpose of \nTAETORD is to order elements within an arm; leaving gaps in the series of TAETORD values does not interfere \nwith this purpose.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2207, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6c52ed2d-9d3b-482b-a26b-fa2dc26550bd": {"__data__": {"id_": "6c52ed2d-9d3b-482b-a26b-fa2dc26550bd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 399, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a044a364-08a8-49b3-8489-990c6a3b1800", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 399, "section": "UNSPECIFIED"}, "hash": "83436c375aa89e608c26abfc2a406cac44f3e2b670c8479b30e1de3fa7a1005c", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "eb9f5ef9-8c4a-4074-82a8-5ba958174a70", "node_type": "1", "metadata": {}, "hash": "6a94fa3ca7cac6c9e6c8b70bd76cc99f6f2dd74bc93bb09b4a7ddc1a318a42aa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 399 \n2021-11-29 \nta.xpt \nRow STUDYID DOMAIN ARMCD ARM TAETORD ETCD \nELEMENT TABRANCH \nTATRANS \nEPOCH \n1 \nEX6 \nTA \nA \nA \n1 \nSCRN \nScreen \nRandomized to \nA \n \nSCREENING \n2 \nEX6 \nTA \nA \nA \n2 \nA \nTrt A \n \n \nTREATMENT \n3 \nEX6 \nTA \nA \nA \n3 \nRESTA Rest A \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n4 \nEX6 \nTA \nA \nA \n4 \nA \nTrt A \n \n \nTREATMENT \n5 \nEX6 \nTA \nA \nA \n5 \nRESTA Rest A \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n6 \nEX6 \nTA \nA \nA \n6 \nA \nTrt A \n \n \nTREATMENT \n7 \nEX6 \nTA \nA \nA \n7 \nRESTA Rest A \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n8 \nEX6 \nTA \nA \nA \n8 \nA \nTrt A \n \n \nTREATMENT \n9 \nEX6 \nTA \nA \nA \n9 \nRESTA Rest A \n \n \nTREATMENT \n10 \nEX6 \nTA \nA \nA \n10 \nFU \nFollow-up \n \n \nFOLLOW-UP \n11 \nEX6 \nTA \nB \nB \n1 \nSCRN \nScreen \nRandomized to \nB \n \nSCREENING \n12 \nEX6 \nTA \nB \nB \n2 \nB \nTrt B \n \n \nTREATMENT \n13 \nEX6 \nTA \nB \nB \n3 \nRESTB Rest B \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n14 \nEX6 \nTA \nB \nB \n4 \nB \nTrt B \n \n \nTREATMENT \n15 \nEX6 \nTA \nB \nB \n5 \nRESTB Rest B \n \nIf disease progression, go to \nFollow-up Epoch \nTREATMENT \n16 \nEX6 \nTA \nB \nB \n6 \nB \nTrt B \n \n \nTREATMENT \n17 \nEX6 \nTA \nB \nB \n7 \nRESTB Rest B \n \n \nTREATMENT \n18 \nEX6 \nTA \nB \nB \n8 \nFU \nFollow-up \n \n \nFOLLOW-UP \nExample 7 \nIn open trials, there is no requirement to maintain a blind, and the arms of a trial may be quite different from each \nother. In such a case, changes in treatment in one arm may differ in number and timing from changes in treatment in \nanother, so that there is nothing like a one-to-one match between the elements in the different arms. In such a case, \nepochs are likely to be defined as broad intervals of time, spanning several elements, and chosen to correspond to \nperiods of time that will be compared in analyses of the trial. \nExample Trial 7, RTOG 93-09, involves treatment of lung cancer with chemotherapy and radiotherapy, with or \nwithout surgery. The protocol (RTOG-93-09), which was provided by the Radiation Oncology Therapy Group \n(RTOG), does not include a study schema diagram, but does include a text-based representation of diverging \n\u201coptions\u201d to which a subject may be assigned.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2339, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "eb9f5ef9-8c4a-4074-82a8-5ba958174a70": {"__data__": {"id_": "eb9f5ef9-8c4a-4074-82a8-5ba958174a70", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 399, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a044a364-08a8-49b3-8489-990c6a3b1800", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 399, "section": "UNSPECIFIED"}, "hash": "83436c375aa89e608c26abfc2a406cac44f3e2b670c8479b30e1de3fa7a1005c", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "6c52ed2d-9d3b-482b-a26b-fa2dc26550bd", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 399, "section": "UNSPECIFIED"}, "hash": "59347124e6689a1084ad815cb66962b3be1cd315a9bfb838683527b846561b9b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In such a case, changes in treatment in one arm may differ in number and timing from changes in treatment in \nanother, so that there is nothing like a one-to-one match between the elements in the different arms. In such a case, \nepochs are likely to be defined as broad intervals of time, spanning several elements, and chosen to correspond to \nperiods of time that will be compared in analyses of the trial. \nExample Trial 7, RTOG 93-09, involves treatment of lung cancer with chemotherapy and radiotherapy, with or \nwithout surgery. The protocol (RTOG-93-09), which was provided by the Radiation Oncology Therapy Group \n(RTOG), does not include a study schema diagram, but does include a text-based representation of diverging \n\u201coptions\u201d to which a subject may be assigned. All subjects go through the branch point at randomization, when they \nare assigned to either chemotherapy plus radiotherapy (CR) or chemotherapy and radiotherapy plus surgery (CRS). \nAll subjects receive induction chemotherapy and radiation, with a slight difference between those randomized to the \n2 arms during the second cycle of chemotherapy. Those randomized to the non-surgery arm are evaluated for \ndisease somewhat earlier, to avoid delays in administering the radiation boost to those whose disease has not \nprogressed. After induction chemotherapy and radiation, subjects are evaluated for disease progression, and those \nwhose disease has progressed stop treatment, but enter follow-up. Not all subjects randomized to receive surgery \nwho do not have disease progression will necessarily receive surgery. If they are poor candidates for surgery or do \nnot wish to receive surgery, they will not receive surgery, but will receive further chemotherapy. The following \ndiagram is based on the text \u201cschema\u201d in the protocol, with the 5 options it names. The diagram in this form might \nsuggest that the trial has 5 arms.", "mimetype": "text/plain", "start_char_idx": 1564, "end_char_idx": 3468, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5539d1ca-34c5-4f60-a5f2-a33925328ba6": {"__data__": {"id_": "5539d1ca-34c5-4f60-a5f2-a33925328ba6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 400, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e1e88af1-f877-4e13-bd8f-7f4a59693384", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 400, "section": "UNSPECIFIED"}, "hash": "34751aeaf17a1778bbb71a60e5a5d305387632d38eb5430483f60adbc97080d2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 400 \n2021-11-29 \nExample Trial 7, RTOG 93-09 Study Schema with 5 \"options\" \n \n*Disease evaluation earlier **Disease evaluation later \nHowever, the objectives of the trial make it clear that this trial is designed to compare 2 treatment strategies, \nchemotherapy and radiation with and without surgery, so this study is better modeled as a 2-arm trial, but with major \n\"skip forward\" arrows for some subjects, as illustrated in the following diagram. This diagram also shows more \ndetail within the Induction Chemo + RT and Additional Chemo blocks than the preceding diagram. Both the \ninduction and additional chemotherapy are given in 2 cycles. The second induction cycle is different for the 2 arms, \nsince radiation therapy for those assigned to the non-surgery arm includes a \u201cboost\u201d which those assigned to the \nsurgery arm do not receive. \nThe next diagram shows the prospective view of this trial. The protocol conceives of treatment as being divided into \n2 parts, induction and continuation, so these have been treated as 2 different epochs. This is also an important point \nin the trial operationally, the point when subjects are \u201cregistered\u201d a second time, and when subjects who will skip \nforward are identified (i.e., because of disease progression or ineligibility for surgery). \nExample Trial 7, RTOG-93-09 Prospective View \n \n*Disease evaluation earlier **Disease evaluation later \nThe next diagram shows the retrospective view of this trial. The fact that the elements in the study cell for the CR \narm in the continuation treatment epoch do not fill the space in the diagram is an artifact of the diagram conventions. \nThose subjects who do receive surgery will in fact spend a longer time completing treatment and moving into \nfollow-up. Although it is tempting to think of the horizontal axis of these diagrams as a timeline, this can sometimes", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2043, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d3643e2c-c5e8-4786-a8be-ec3f6f1116ee": {"__data__": {"id_": "d3643e2c-c5e8-4786-a8be-ec3f6f1116ee", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 401, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2eb720d0-f96f-4905-ad66-a7e3af10f15e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 401, "section": "UNSPECIFIED"}, "hash": "2c1ee499af4ed70b56641120b20b9c0513082c98106f9885e4ed216c5df59c76", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 401 \n2021-11-29 \nbe misleading. The diagrams are not necessarily to scale in the sense that the length of the block representing an \nelement represents its duration, and elements that line up on the same vertical line in the diagram may not occur at \nthe same relative time within the study. \nExample Trial 7, RTOG 93-09 Retrospective View \n \n*Disease evaluation earlier **Disease evaluation later \n \nThe following table shows the trial design matrix for this 2-arm example trial. \nTrial Design Matrix \n \nScreen Induction \nContinuation \nFollow-up \nCR \nScreen Initial Chemo + \nRT \nChemo + RT (non-\nSurgery) \nChemo \nChemo \nOff Treatment Follow-\nup \nCRS Screen Initial Chemo + \nRT \nChemo + RT (Surgery) 3-5 w \nRest \nSurgery 4-6 w \nRest \nChemo Chemo Off Treatment \nFollow-up \n \nThe TA dataset reflects that this is a 2-arm trial. \nta.xpt \nRow STUDYID DOMAIN ARMCD ARM TAETORD ETCD ELEMENT \nTABRANCH \nTATRANS \nEPOCH \n1 \nEX7 \nTA \n1 \nCR \n1 \nSCRN Screen \nRandomized \nto CR \n \nSCREENING \n2 \nEX7 \nTA \n1 \nCR \n2 \nICR \nInitial Chemo \n+ RT \n \n \nINDUCTION \nTREATMENT \n3 \nEX7 \nTA \n1 \nCR \n3 \nCRNS Chemo+RT \n(non-\nSurgery) \n \nIf progression, skip to \nFollow-up. \nINDUCTION \nTREATMENT \n4 \nEX7 \nTA \n1 \nCR \n4 \nC \nChemo \n \n \nCONTINUATION \nTREATMENT \n5 \nEX7 \nTA \n1 \nCR \n5 \nC \nChemo \n \n \nCONTINUATION \nTREATMENT \n6 \nEX7 \nTA \n1 \nCR \n6 \nFU \nOff \nTreatment \nFollow-up \n \n \nFOLLOW-UP \n7 \nEX7 \nTA \n2 \nCRS 1 \nSCRN Screen \nRandomized \nto CRS \n \nSCREENING \n8 \nEX7 \nTA \n2 \nCRS 2 \nICR \nInitial Chemo \n+ RT \n \n \nINDUCTION \nTREATMENT \n9 \nEX7 \nTA \n2 \nCRS 3 \nCRS \nChemo+RT \n(Surgery) \n \nIf progression, skip to \nFollow-up. If no \nprogression, but subject is \nineligible for or does not \nconsent to surgery, skip to \nChemo. \nINDUCTION \nTREATMENT \n10 \nEX7 \nTA \n2 \nCRS 4 \nR3 \n3-5 week rest  \n \nCONTINUATION \nTREATMENT \n11 \nEX7 \nTA \n2 \nCRS 5 \nSURG Surgery \n \n \nCONTINUATION \nTREATMENT", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2021, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8d8630f4-a5ce-48bf-b98e-797373d318a6": {"__data__": {"id_": "8d8630f4-a5ce-48bf-b98e-797373d318a6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 402, "section": "7.2.1.1 Trial Arms Issues"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "264ed794-faa5-40e2-96b8-4f2188d47be5", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 402, "section": "7.2.1.1 Trial Arms Issues"}, "hash": "64e85eb2272aa50e409453b66791364e69f9e5f33a2ad8a1a16372a1694227c0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Distinguishing Between Branches and Transitions \nBoth the Branch and Transition columns contain rules, but the 2 columns represent 2 different types of rules. \nBranch rules represent forks in the trial flowchart, giving rise to separate arms. The rule underlying a branch in the \ntrial design appears in multiple records, once for each \"fork\" of the branch. Within any one record, there is no choice \n(no \"if\" clause) in the value of the branch condition. For example, the value of TABRANCH for a record in arm A is \n\"Randomized to Arm A\" because a subject in arm A must have been randomized to arm A. Transition rules are \nused for choices within an arm. The value for TATRANS does contain a choice (an \"if\" clause). In Example Trial 4, \nsubjects who receive 1, 2, 3, or 4 cycles of treatment A are all considered to belong to arm A. \nIn modeling a trial, decisions may have to be made about whether a decision point in the flow chart represents the \nseparation of paths that represent different arms, or paths that represent variations within the same arm, as illustrated \nin the discussion of Example Trial 7. This decision will depend on the comparisons of interest in the trial. \nSome trials refer to groups of subjects who follow a particular path through the trial as \"cohorts,\" particularly if the \ngroups are formed successively over time. The term \"cohort\" is used with different meanings in different protocols \nand does not always correspond to an arm. \nSubjects Not Assigned to an Arm \nSome trial subjects may drop out of the study before they reach all of the branch points in the trial design. In the \nDemographics (DM) domain, the values of ARM and ARMCD must be supplied for such subjects, but the special \nvalues used for these subjects should not be included in the Trial Arms (TA) dataset; only complete arm paths \nshould be described in the TA dataset. In Section 5.2, Demographics, assumption 4 describes special ARM and \nARMCD values used for subjects who do not reach the first branch point in a trial. When a trial design includes 2 or \nmore branches, special values of ARM and ARMCD may be needed for subjects who pass through the first branch \npoint, but drop out before the final branch point. See DM Example 3 for how to represent ARM and ARMCD values \nfor such trials. \nDefining Epochs \nThe series of examples for the TA dataset provides a variety of scenarios and guidance about how to assign epoch in \nthose scenarios. In general, assigning epochs for blinded trials is easier than for unblinded trials. The blinded view of \nthe trial will generally make the possible choices clear. For unblinded trials, the comparisons that will be made \nbetween arms can guide the definition of epochs. For trials that include many variant paths within an arm, \ncomparisons of arms will mean that subjects on a variety of paths will be included in the comparison, and this is \nlikely to lead to definition of broader epochs. \nRule Variables \nThe Branch and Transition columns shown in the example tables are variables with a Role of \u201cRule.\u201d The values of \na Rule variable describe conditions under which something is planned to happen. At the moment, values of Rule \nvariables are text. At some point in the future, it is expected that a mechanism to provide machine-readable rules \nwill become available. Other Rule variables are present in the Trial Elements (TE) and Trial Visits (TV) datasets.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3415, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b66ae480-77b0-4cb2-9351-ce2809433e74": {"__data__": {"id_": "b66ae480-77b0-4cb2-9351-ce2809433e74", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 403, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73d7d395-d05c-485f-a718-5c80d619654b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 403, "section": "UNSPECIFIED"}, "hash": "c1acd24972135463111bc87f012b51514cfe5f1a06a3a2c0f3b1b9a16f396fac", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3e7cd9bb-78fb-4a10-96e7-0d3beb23eefe", "node_type": "1", "metadata": {}, "hash": "6e1570f6fbd33e035a22c5dae2ae4a13c6e842812e7378596635aebef763f92b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 403 \n2021-11-29 \nThe Trial Elements (TE) dataset contains the definitions of the elements that appear in the Trial Arms (TA) dataset. \nAn element may appear multiple times in the TA table because it appears either (1) in multiple arms, (2) multiple \ntimes within an arm, or (3) both. However, an element will appear only once in the TE table. \nEach row in the TE dataset may be thought of as representing a \"unique element\" in the same sense of \"unique\" as a \nCRF template page for a collecting certain type of data referred to as \"unique page.\" For instance, a CRF might be \ndescribed as containing 87 pages, but only 23 unique pages. By analogy, the trial design matrix in Example Trial \n1 (see Section 7.2.1, Trial Arms) has 9 study cells, each of which contains 1 element, but the same trial design \nmatrix contains only 5 unique elements, so the TE dataset for that trial has only 5 records. \nAn element is a building block for creating study cells, and an arm is composed of study cells. Or, from another \npoint of view, an arm is composed of elements; that is, the trial design assigns subjects to arms, which comprise a \nsequence of steps called elements. \nTrial elements represent an interval of time that serves a purpose in the trial and are associated with certain activities \naffecting the subject. \u201cWeek 2 to week 4\u201d is not a valid element. A valid element has a name that describes the \npurpose of the element and includes a description of the activity or event that marks the subject's transition into the \nelement as well as the conditions for leaving the element. \nTE \u2013 Specification \nte.xpt, Trial Elements \u2014 Trial Design. One record per planned Element, Tabulation. \nVariable \nName \nVariable Label Type Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar TE \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nETCD \nElement Code \nChar * \nTopic \nETCD (the companion to ELEMENT) is limited to 8 \ncharacters and does not have special character restrictions. \nThese values should be short for ease of use in \nprogramming, but it is not expected that ETCD will need to \nserve as a variable name. \nReq \nELEMENT \nDescription of \nElement \nChar * \nSynonym \nQualifier \nThe name of the element. \nReq \nTESTRL \nRule for Start of \nElement \nChar  \nRule \nDescribes condition for beginning element. \nReq \nTEENRL \nRule for End of \nElement \nChar  \nRule \nDescribes condition for ending element. Either TEENRL or \nTEDUR must be present for each element. \nPerm \nTEDUR \nPlanned \nDuration of \nElement \nChar ISO 8601 \nduration \nTiming \nPlanned duration of element in ISO 8601 format. Used when \nthe rule for ending the element is applied after a fixed \nduration. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTE \u2013 Assumptions \n1. There are no gaps between elements.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3205, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3e7cd9bb-78fb-4a10-96e7-0d3beb23eefe": {"__data__": {"id_": "3e7cd9bb-78fb-4a10-96e7-0d3beb23eefe", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 403, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "73d7d395-d05c-485f-a718-5c80d619654b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 403, "section": "UNSPECIFIED"}, "hash": "c1acd24972135463111bc87f012b51514cfe5f1a06a3a2c0f3b1b9a16f396fac", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b66ae480-77b0-4cb2-9351-ce2809433e74", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 403, "section": "UNSPECIFIED"}, "hash": "04d1a6b28e103ccf84ce492ac0097882b691f8dc33bcd08b11fc4ee1ae6b03ba", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Req \nELEMENT \nDescription of \nElement \nChar * \nSynonym \nQualifier \nThe name of the element. \nReq \nTESTRL \nRule for Start of \nElement \nChar  \nRule \nDescribes condition for beginning element. \nReq \nTEENRL \nRule for End of \nElement \nChar  \nRule \nDescribes condition for ending element. Either TEENRL or \nTEDUR must be present for each element. \nPerm \nTEDUR \nPlanned \nDuration of \nElement \nChar ISO 8601 \nduration \nTiming \nPlanned duration of element in ISO 8601 format. Used when \nthe rule for ending the element is applied after a fixed \nduration. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTE \u2013 Assumptions \n1. There are no gaps between elements. The instant one element ends, the next element begins. A subject \nspends no time \u201cbetween\u201d elements. \n2. The ELEMENT (Description of the Element) variable usually indicates the treatment being administered \nduring an element, or, if no treatment is being administered, the other activities that are the purpose of this \nperiod of time (e.g., \"Screening\", \"Follow-up\", \"Washout\"). In some cases, this time period may be quite \npassive (e.g., \"Rest\"; \"Wait, for disease episode\"). \n3. The TESTRL (Rule for Start of Element) variable identifies the event that marks the transition into this \nelement. For elements that involve treatment, this is the start of treatment. \n4. For elements that do not involve treatment, TESTRL can be more difficult to define. For washout and \nfollow-up elements, which always follow treatment elements, the start of the element may be defined \nrelative to the end of a preceding treatment. For example, a washout period might be defined as starting 24 \nor 48 hours after the last dose of drug for the preceding treatment element or epoch. This definition is not \ntotally independent of the TA dataset, because it relies on knowing where in the trial design the element is \nused, and that it always follows a treatment element. Defining a clear starting point for the start of a non-\ntreatment element that always follows another non-treatment element can be particularly difficult. The", "mimetype": "text/plain", "start_char_idx": 2433, "end_char_idx": 4620, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "50b631fe-efd5-4f4f-bb6e-e3feec05ce9e": {"__data__": {"id_": "50b631fe-efd5-4f4f-bb6e-e3feec05ce9e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 404, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3b31322e-6d70-4a44-bb20-63b367c09a8c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 404, "section": "UNSPECIFIED"}, "hash": "1e550b2aed2eeba82c7e03454c5b347da6abbe26215256299a743240c8ecd5b8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "fcbf8dfb-6b0e-4a4e-9011-e536f31d2328", "node_type": "1", "metadata": {}, "hash": "3787f052e859f82092e2b177ed9a8e3fc372a801f61bc330a8b96f5640a1834f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 404 \n2021-11-29 \ntransition may be defined by a decision-making activity such as enrollment or randomization. For example, \nevery arm of a trial that involves treating disease episodes might start with a screening element followed by \nan element that consists of waiting until a disease episode occurs. The activity that marks the beginning of \nthe wait element might be randomization. \n5. TESTRL for a treatment element may be thought of as \u201cactive\u201d whereas the start rule for a non-treatment \nelement\u2014particularly a follow-up or washout element\u2014may be \u201cpassive.\u201d The start of a treatment \nelement will not occur until a dose is given, no matter how long that dose is delayed. Once the last dose is \ngiven, the start of a subsequent non-treatment element is inevitable, as long as another dose is not given. \n6. Note that the date/time of the event described in TESTRL will be used to populate the date/times in the \nSubject Elements (SE) dataset, so the date/time of the event should be captured in the CRF. \n7. Specifying TESTRL for an element that serves the first element of an arm in the TA dataset involves \ndefining the start of the trial. In the examples in this document, obtaining informed consent has been used \nas \"Trial Entry.\" \n8. TESTRL should be expressed without referring to arm. If the element appears in more than 1 arm in the TA \ndataset, then the element description (ELEMENT) must not refer to any arms. \n9. TESTRL should be expressed without referring to epoch. If the element appears in more than 1 epoch in \nthe TA dataset, then the Element description (ELEMENT) must not refer to any epochs. \n10. For a blinded trial, it is useful to describe TESTRL in terms that separate the properties of the event that are \nvisible to blinded participants from the properties that are visible only to those who are unblinded. For \ntreatment elements in blinded trials, wording such as the following is suitable: \"First dose of study drug for \na treatment epoch, where study drug is X.\" \n11. Element end rules are rather different from element start rules. The actual end of one element is the \nbeginning of the next element. Thus, the element end rule does not give the conditions under which an \nelement does end, but the conditions under which it should end or is planned to end. \n12. At least 1 of TEENRL and TEDUR must be populated. Both may be populated. \n13. TEENRL describes the circumstances under which a subject should leave this element. Element end rules \nmay depend on a variety of conditions. For instance, a typical criterion for ending a rest element between \noncology chemotherapy-treatment element would be, \u201c15 days after start of element and after WBC values \nhave recovered.\" The TA dataset, not the TE dataset, describes where the subject moves next, so TEENRL \nmust be expressed without referring to arm. \n14. TEDUR serves the same purpose as TEENRL for the special (but very common) case of an element with a \nfixed duration. TEDUR is expressed in ISO 8601. For example, a TEDUR value of P6W is equivalent to a \nTEENRL of \"6 weeks after the start of the element.\" \n15.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3286, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fcbf8dfb-6b0e-4a4e-9011-e536f31d2328": {"__data__": {"id_": "fcbf8dfb-6b0e-4a4e-9011-e536f31d2328", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 404, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3b31322e-6d70-4a44-bb20-63b367c09a8c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 404, "section": "UNSPECIFIED"}, "hash": "1e550b2aed2eeba82c7e03454c5b347da6abbe26215256299a743240c8ecd5b8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "50b631fe-efd5-4f4f-bb6e-e3feec05ce9e", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 404, "section": "UNSPECIFIED"}, "hash": "cf0def1133ea6c8175f470851952a16ca85d6cc758a25559444cb0fbf8d2bbe4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Both may be populated. \n13. TEENRL describes the circumstances under which a subject should leave this element. Element end rules \nmay depend on a variety of conditions. For instance, a typical criterion for ending a rest element between \noncology chemotherapy-treatment element would be, \u201c15 days after start of element and after WBC values \nhave recovered.\" The TA dataset, not the TE dataset, describes where the subject moves next, so TEENRL \nmust be expressed without referring to arm. \n14. TEDUR serves the same purpose as TEENRL for the special (but very common) case of an element with a \nfixed duration. TEDUR is expressed in ISO 8601. For example, a TEDUR value of P6W is equivalent to a \nTEENRL of \"6 weeks after the start of the element.\" \n15. Note that elements that have different start and end rules are different elements and must have different \nvalues of ELEMENT and ETCD. For instance, elements that involve the same treatment but have different \ndurations are different elements. The same applies to non-treatment elements. For instance, a washout with \na fixed duration of 14 days is different from a washout that is to end after 7 days if drug cannot be detected \nin a blood sample, or after 14 days otherwise. \nTE \u2013 Examples \nBoth of the trials in TA Examples 1 and 2 (see Section 7.2.1, Trial Arms) are assumed to have fixed-duration \nelements. The wording in TESTRL is intended to separate the description of the event that starts the element into the \npart that would be visible to a blinded participant in the trial (e.g., \"First dose of a treatment epoch\") from the part \nthat is revealed when the study is unblinded (e.g., \"where dose is 5 mg\"). Care must be taken in choosing these \ndescriptions to be sure that they are arm- and epoch-neutral. For instance, in a crossover trial such as TA Example \nTrial 3, where an element may appear in 1 of multiple epochs, the wording must be appropriate for all possible \nepochs (e.g., \"OPEN LABEL TREATMENT\"). The SDS Team is considering adding a separate variable to the TE \ndataset that would hold information on the treatment that is associated with an element. This would make it clearer \nwhich elements are \"treatment elements\u201d and, therefore, which epochs contain treatment elements and thus are \n\"treatment Epochs.\"", "mimetype": "text/plain", "start_char_idx": 2531, "end_char_idx": 4824, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "81b5ccb4-8c44-4a89-9464-4be324161a64": {"__data__": {"id_": "81b5ccb4-8c44-4a89-9464-4be324161a64", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 405, "section": "7.2.2.1 Trial Elements Issues"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b310ff1e-bd1b-4c31-83f7-98b40eebc7ec", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 405, "section": "7.2.2.1 Trial Elements Issues"}, "hash": "41f3be64bb2b3c2e504317725ca0565d568a93865dc7aa6c8fed3e4ec9e8975f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Granularity of Trial Elements \nDeciding how finely to divide trial time when identifying trial elements is a matter of judgment, as illustrated by the \nfollowing examples: \n1. TA Example Trial 2 was represented using 3 treatment epochs separated by 2 washout epochs and followed \nby a follow-up epoch. This might have been modeled using 3 treatment epochs that included both the 2-\nweek treatment period and the 1-week rest period. Because the first week after the third treatment period \nwould be included in the third treatment epoch, the follow-up epoch would then have a duration of 2 \nweeks. \n2. In TA Example Trials 4, 5, and 6, separate treatment and rest elements were identified. However, the \ncombination of treatment and rest could be represented as a single element. \n3. A trial might include a dose titration, with subjects receiving increasing doses on a weekly basis until \ncertain conditions are met. The trial design could be modeled in any of the following ways: \na. \nUsing several 1-week elements at specific doses, followed by an element of variable length at the \nchosen dose", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1096, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "801b7f4c-8770-48f3-b224-23b429d498fd": {"__data__": {"id_": "801b7f4c-8770-48f3-b224-23b429d498fd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 406, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a89a33d6-519d-43c2-a121-aa43525fa1e6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 406, "section": "UNSPECIFIED"}, "hash": "86f6c29ac87835849383b4943c348ddeaccae16194d22ffcefefe7a7ba8142b6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0a7e6ae5-d0a3-4481-b279-9e1ca5667c1f", "node_type": "1", "metadata": {}, "hash": "ba0f58a03b9923a1ab1b23ace43ceb5ccef6d30712781c23bf6fb7fc51a8228a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 406 \n2021-11-29 \nb. As a titration element of variable length followed by a constant dosing element of variable length \nc. \nOne element with dosing determined by titration. \nThe choice of elements used to represent this dose titration will depend on the objectives of the trial \nand how the data will be analyzed and reported. If it is important to examine side effects or lab values \nat each individual dose, the first model is appropriate. If it is important only to identify the time to \ncompletion of titration, the second model might be appropriate. If the titration process is routine and is \nof little interest, the third model might be adequate for the purposes of the trial. \nDistinguishing Elements, Study Cells, and Epochs \nIt is easy to confuse elements, which are reusable trial building blocks, with study cells (which contain the \nelements for a particular epoch and Arm) and with epochs (which are time periods for the trial as a whole). In part, \nthis is because many trials have epochs for which the same element appears in all arms. In other words, in the trial \ndesign matrix for many trials, there are columns (Epochs) in which all the study cells have the same contents. It also \nis natural to use the same name (e.g., screen, follow-up) for both such an epoch and the single element that appears \nwithin it. \nConfusion can also arise from the fact that in the blinded treatment portions of blinded trials, blinded participants do \nnot know which element a subject is in, but do know what epoch the subject is in. \nIn describing a trial, one way to avoid confusion between elements and epochs is to include \"Element\" or \"Epoch\" in \nthe values of ELEMENT or EPOCH when these values (e.g., screening, follow-up) would otherwise be the same. It \nbecomes tedious to do this in every case, but can be useful to resolve confusion when it arises or is likely to arise. \nThe difference between epoch and element is perhaps clearest in crossover trials. In TA Example Trial 2, as for most \ncrossover trials, the analysis of pharmacokinetic (PK) results would include both treatment and period effects in the \nmodel. \u201cTreatment effect\u201d derives from element (placebo, 5 mg, 10 mg), whereas \u201cperiod effect\u201d derives from the \nepoch (first, second, or third treatment epoch). \nTransitions Between Elements \nThe transition between one element and the next can be thought of as a 3-step process: \nStep Step question \nHow step question is answered by information in the TA datasets \n1 \nShould the subject leave the current \nelement? \nThe criteria for ending the current element are in TEENRL in the TE dataset. \n2 \nWhich element should the subject enter \nnext? \nIf there is a branch point at this point in the trial, evaluate criteria described in \nTABRANCH (e.g., randomization results) in the TA dataset. Otherwise, if \nTATRANS in the TA dataset is populated in this arm at this point, follow those \ninstructions. Otherwise, move to the next element in this arm as specified by \nTAETORD in the TA dataset. \n3 \nWhat does the subject do to enter the \nnext element? \nThe action or event that marks the start of the next element is specified in \nTESTRL in the TE dataset. \nNote that the subject is not \"in limbo\" during this process.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3415, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0a7e6ae5-d0a3-4481-b279-9e1ca5667c1f": {"__data__": {"id_": "0a7e6ae5-d0a3-4481-b279-9e1ca5667c1f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 406, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a89a33d6-519d-43c2-a121-aa43525fa1e6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 406, "section": "UNSPECIFIED"}, "hash": "86f6c29ac87835849383b4943c348ddeaccae16194d22ffcefefe7a7ba8142b6", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "801b7f4c-8770-48f3-b224-23b429d498fd", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 406, "section": "UNSPECIFIED"}, "hash": "e6fdff32d72782edf35ec9d95b4dd990fc71eaaf72706479c6cb00b5a2b69555", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The criteria for ending the current element are in TEENRL in the TE dataset. \n2 \nWhich element should the subject enter \nnext? \nIf there is a branch point at this point in the trial, evaluate criteria described in \nTABRANCH (e.g., randomization results) in the TA dataset. Otherwise, if \nTATRANS in the TA dataset is populated in this arm at this point, follow those \ninstructions. Otherwise, move to the next element in this arm as specified by \nTAETORD in the TA dataset. \n3 \nWhat does the subject do to enter the \nnext element? \nThe action or event that marks the start of the next element is specified in \nTESTRL in the TE dataset. \nNote that the subject is not \"in limbo\" during this process. The subject remains in the current element until step 3, at \nwhich point the subject transitions to the new element. There are no gaps between elements. \nAs illustrated in the table, executing a transition depends on information that is split between the TE and the TA \ndatasets. \nIt can be useful, in the process of working out the Trial Design (TD) datasets, to create a dataset that supplements \nthe TA dataset with the TESTRL, TEENRL, and TEDUR variables, so that full information on the transitions is \neasily accessible. However, such a working dataset is not an SDTM dataset, and should not be submitted. \nThe following table shows a fragment of such a table for TA Example Trial 4. \nNote that \n\u2022 \nfor all records that contain a particular element, all the TE variable values are exactly the same; and \n\u2022 \nwhen both TABRANCH and TATRANS are blank, the implicit decision in step 2 is that the subject moves \nto the next element in sequence for the arm.", "mimetype": "text/plain", "start_char_idx": 2718, "end_char_idx": 4374, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "fd051930-5238-44eb-aa78-d495ac0ec520": {"__data__": {"id_": "fd051930-5238-44eb-aa78-d495ac0ec520", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 407, "section": "7.3 Schedule for Assessments (TV, TD, and TM)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e3992249-d474-42a9-bb87-0b1d0562a364", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 407, "section": "7.3 Schedule for Assessments (TV, TD, and TM)"}, "hash": "9b68e30982b61dcb1485c67057700263398a9b996e2c75ed1eb3c189c2d49bf0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This section contains the Trial Design (TD) datasets that describe: \n\u2022 \nThe protocol-defined planned schedule of subject encounters at the healthcare facility where the study is \nbeing conducted (Section 7.3.1, Trial Visits (TV)) \n\u2022 \nThe planned schedule of efficacy assessments related to the disease under study (Section 7.3.2, Trial \nDisease Assessments (TD)) \n\u2022 \nThe things (events, interventions, or findings) which, if and when they happen, are the occasion for \nassessments planned in the protocol (Section 7.3.3, Trial Disease Milestones (TM)) \nThe Trial Visits (TV) and TD datasets provide the planned scheduling of assessments to which a subject\u2019s actual \nvisits and disease assessments can be compared.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 713, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "66741ebf-4b45-4106-9ad4-1d677fd55924": {"__data__": {"id_": "66741ebf-4b45-4106-9ad4-1d677fd55924", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 407, "section": "7.3.1 Trial Visits (TV)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8ff9594a-be99-4026-8121-9b6d5df6eee7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 407, "section": "7.3.1 Trial Visits (TV)"}, "hash": "71502848dd0e56000da947e3e3106c4ebff247bf0947e2aa3e1b68cfb0c381e2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TV \u2013 Description/Overview \nA trial design domain that contains the planned order and number of visits in the study within each arm. \nVisits are defined as \"clinical encounters\" and are described using the timing variables VISIT, VISITNUM, and \nVISITDY. \nProtocols define visits in order to describe assessments and procedures that are to be performed at the visits. \nTV \u2013 Specification \ntv.xpt, Trial Visits \u2014 Trial Design. One record per planned Visit per Arm, Tabulation. \nVariable \nName \nVariable \nLabel \nType Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy \nIdentifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar TV \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nVISITNUM Visit Number \nNum  \nTopic \nClinical encounter number. Numeric version of VISIT, used for \nsorting. \nReq \nVISIT \nVisit Name \nChar  \nSynonym \nQualifier \nDescription of clinical encounter. This is often defined in the \nprotocol. Used in addition to VISITNUM and/or VISITDY as a text \ndescription of the clinical encounter. \nReq \nVISITDY \nPlanned \nStudy Day of \nVisit \nNum  \nTiming \nPlanned study day of VISIT. Due to its sequential nature, used for \nsorting. \nPerm", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1234, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "73019f38-55c1-4bce-8cd8-820febeefb78": {"__data__": {"id_": "73019f38-55c1-4bce-8cd8-820febeefb78", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 408, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba81448f-0442-4c2f-b16c-bce67bc8038b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 408, "section": "UNSPECIFIED"}, "hash": "b3eb3a669e764bb3da0fe278b6fe9fff7467798d6d8b7eae9f0a9d16667eb2ce", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "68b8ca25-04ad-4468-9102-e00ae27cc392", "node_type": "1", "metadata": {}, "hash": "2ff140985d77f039c1434c82cc56470c74342af21650dc984dac959fa0ce81e9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 408 \n2021-11-29 \nVariable \nName \nVariable \nLabel \nType Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nARMCD \nPlanned Arm \nCode \nChar * \nRecord \nQualifier \n1. ARMCD is limited to 20 characters and does not have special \ncharacter restrictions. The maximum length of ARMCD is \nlonger than for other \"short\" variables to accommodate the kind \nof values that are likely to be needed for crossover trials. For \nexample, if ARMCD values for a 7-period crossover were \nconstructed using 2-character abbreviations for each treatment \nand separating hyphens, the length of ARMCD values would be \n20. \n2. If the timing of visits for a trial does not depend on which arm a \nsubject is in, then ARMCD should be null. \nExp \nARM \nDescription of \nPlanned Arm \nChar * \nSynonym \nQualifier \n1. Name given to an arm or treatment group. \n2. If the timing of visits for a trial does not depend on which arm a \nsubject is in, then Arm should be left blank. \nPerm \nTVSTRL \nVisit Start \nRule \nChar  \nRule \nRule describing when the visit starts, in relation to the sequence of \nelements. \nReq \nTVENRL \nVisit End Rule Char  \nRule \nRule describing when the visit ends, in relation to the sequence of \nelements. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTV \u2013 Assumptions \n1. Although the general structure of the Trial Visits (TV) dataset is \"One Record per Planned Visit per Arm,\" \nfor many clinical trials\u2014particularly blinded clinical trials\u2014the schedule of visits is the same for all arms, \nand the structure of the TV dataset will be \"One Record per Planned Visit.\" If the schedule of visits is the \nsame for all arms, ARMCD should be left blank for all records in the TV dataset. For trials with trial \nvisits that are different for different arms (e.g., Example Trial 7 in Section 7.2.1, Trial Arms), ARMCD and \nARM should be populated for all records. If some visits are the same for all arms, and some visits differ by \narm, then ARMCD and ARM should be populated for all records, to ensure clarity, even though this will \nmean creating near-duplicate records for visits that are the same for all arms. \n2. A visit may start in one element and end in another. This means that a visit may start in one epoch and end \nin another. For example, if one of the activities planned for a visit is the administration of the first dose of \nstudy drug, the visit might start in the screen epoch and end in a treatment epoch. \n3. TVSTRL describes the scheduling of the visit and should reflect the wording in the protocol. In many trials, \nall visits are scheduled relative to the study's day 1 (RFSTDTC). In such trials, it is useful to include \nVISITDY, which is, in effect, a special case representation of TVSTRL. \n4. Note that there is a subtle difference between the following 2 examples.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3090, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "68b8ca25-04ad-4468-9102-e00ae27cc392": {"__data__": {"id_": "68b8ca25-04ad-4468-9102-e00ae27cc392", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 408, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba81448f-0442-4c2f-b16c-bce67bc8038b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 408, "section": "UNSPECIFIED"}, "hash": "b3eb3a669e764bb3da0fe278b6fe9fff7467798d6d8b7eae9f0a9d16667eb2ce", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "73019f38-55c1-4bce-8cd8-820febeefb78", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 408, "section": "UNSPECIFIED"}, "hash": "ccc3634d493d503a3b3972eafe24dc2930d8f531af9cbfd1ad6ab5bab786d084", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2. A visit may start in one element and end in another. This means that a visit may start in one epoch and end \nin another. For example, if one of the activities planned for a visit is the administration of the first dose of \nstudy drug, the visit might start in the screen epoch and end in a treatment epoch. \n3. TVSTRL describes the scheduling of the visit and should reflect the wording in the protocol. In many trials, \nall visits are scheduled relative to the study's day 1 (RFSTDTC). In such trials, it is useful to include \nVISITDY, which is, in effect, a special case representation of TVSTRL. \n4. Note that there is a subtle difference between the following 2 examples. In the first case, if visit 3 were \ndelayed for some reason, visit 4 would be unaffected. In the second case, a delay to visit 3 would result in \nvisit 4 being delayed as well. \na. \nCase 1: Visit 3 starts 2 weeks after RFSTDTC. Visit 4 starts 4 weeks after RFSTDTC. \nb. Case 2: Visit 3 starts 2 weeks after RFSTDTC. Visit 4 starts 2 weeks after visit 3. \n5. Many protocols do not give any information about visit ends because visits are assumed to end on the same \nday they start. In such a case, TVENRL may be left blank to indicate that the visit ends on the same day it \nstarts. Care should be taken to assure that this is appropriate; common practice may be to record data \ncollected over more than 1 day as occurring within a single visit. Screening visits may be particularly prone \nto collection of data over multiple days. The examples for this domain show how TVENRL could be \npopulated. \n6. The values of VISITNUM in the TV dataset are the valid values of VISITNUM for planned visits. Any \nvalues of VISITNUM that appear in subject-level datasets that are not in the TV dataset are assumed to \ncorrespond to unplanned visits. This applies, in particular, to the subject-level dataset; see Section 5.5, \nSubject Visits, for additional information about handling unplanned visits. If a subject-level dataset \nincludes both VISITNUM and VISIT, then records that include values of VISITNUM that appear in the TV \ndataset should also include the corresponding values of VISIT from the TV dataset.", "mimetype": "text/plain", "start_char_idx": 2412, "end_char_idx": 4592, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "aab7b970-e50a-48a7-8ba3-0305e7aa66e8": {"__data__": {"id_": "aab7b970-e50a-48a7-8ba3-0305e7aa66e8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 409, "section": "7.3.1.1 Trial Visits Issues"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "8aa0ac21-e820-487b-9349-d7228e05c00c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 409, "section": "7.3.1.1 Trial Visits Issues"}, "hash": "e568c6e2821dfa419bc34b89b3a976cf342bc9ddeb362b12c93b459c10f4a722", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Identifying Trial Visits \nIn general, a trial's visits are defined in its protocol. The term \u201cvisit\u201d reflects the fact that data in outpatient studies is \nusually collected during a physical visit by the subject to a clinic. Sometimes a trial visit defined by the protocol \nmay not correspond to a physical visit. It may span multiple physical visits, as when screening data is collected over \nseveral clinic visits but recorded under one TV name (VISIT) and number (VISITNUM). A trial visit also", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 496, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "00d2203b-ebf3-408b-9cc0-851346acaed3": {"__data__": {"id_": "00d2203b-ebf3-408b-9cc0-851346acaed3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 410, "section": "7.3.2 Trial Disease Assessments (TD)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "5cf35a21-4456-4129-9c6d-8c3e26a936f8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 410, "section": "7.3.2 Trial Disease Assessments (TD)"}, "hash": "2483c61458ddca607f1a87f6b1e24bc52548fb253701127c8bf0c4769ab1780b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TD \u2013 Description/Overview \nA trial design domain that provides information on the protocol-specified disease assessment schedule, to be used \nfor comparison with the actual occurrence of the efficacy assessments in order to determine whether there was good \ncompliance with the schedule. \nTD \u2013 Specification \ntd.xpt, Trial Disease Assessments \u2014 Trial Design. One record per planned constant assessment \nperiod, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 609, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a28ae5ab-fb8e-47cc-8eac-2a6bfecc0482": {"__data__": {"id_": "a28ae5ab-fb8e-47cc-8eac-2a6bfecc0482", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 411, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a4831223-b50a-4dcf-862c-49bffc3222ed", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 411, "section": "UNSPECIFIED"}, "hash": "0c9c3c6fed81e0dac181ae3d9365e58a048c0f611701b27add3dcaa9f0965a0d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "c5b705a4-aac7-4165-b7b9-dd0caa25675f", "node_type": "1", "metadata": {}, "hash": "5b718de66f00302658bdbe9ba011a12efdd6bdf4d377574680224e75e9855513", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 411 \n2021-11-29 \nDOMAIN \nDomain \nAbbreviation \nChar TD \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nTDORDER \nSequence of \nPlanned \nAssessment \nSchedule \nNum  \nTiming \nA number given to ensure ordinal sequencing of the planned \nassessment schedules within a trial. \nReq \nTDANCVAR Anchor Variable \nName \nChar  \nTiming \nA reference to the date variable name that provides the start \npoint from which the planned disease assessment schedule is \nmeasured. This must be a referenced from the ADaM ADSL \ndataset (e.g., \"ANCH1DT\"). Note: TDANCVAR will contain the \nname of a reference date variable. \nReq \nTDSTOFF \nOffset from the \nAnchor \nChar ISO 8601 \nduration \nTiming \nA fixed offset from the date provided by the variable referenced \nin TDANCVAR. This is used when the timing of planned cycles \ndoes not start on the exact day referenced in the variable \nindicated in TDANCVAR. The value of this variable will be \neither zero or a positive value and will be represented in ISO \n8601 character format. \nReq \nTDTGTPAI \nPlanned \nAssessment \nInterval \nChar ISO 8601 \nduration \nTiming \nThe planned interval between disease assessments \nrepresented in ISO 8601 character format. \nReq \nTDMINPAI \nPlanned \nAssessment \nInterval \nMinimum \nChar ISO 8601 \nduration \nTiming \nThe lower limit of the allowed range for the planned interval \nbetween disease assessments represented in ISO 8601 \ncharacter format. \nReq \nTDMAXPAI \nPlanned \nAssessment \nInterval \nMaximum \nChar ISO 8601 \nduration \nTiming \nThe upper limit of the allowed range for the planned interval \nbetween disease assessments represented in ISO 8601 \ncharacter format. \nReq \nTDNUMRPT Maximum \nNumber of \nActual \nAssessments \nNum  \nRecord \nQualifier \nThis variable must represent the maximum number of actual \nassessments for the analysis that this disease assessment \nschedule describes. In a trial where the maximum number of \nassessments is not defined explicitly in the protocol (e.g., \nassessments occur until death), TDNUMRPT should represent \nthe maximum number of disease assessments that support the \nefficacy analysis encountered by any subject across the trial at \nthat point in time. \nReq \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTD \u2013 Assumptions \n1. The purpose of the Trial Disease Assessments (TD) domain is to provide information on planned \nscheduling of disease assessments when the scheduling of disease assessments is not necessarily tied to the \nscheduling of visits. In oncology studies, good compliance with the disease-assessment schedule is \nessential to reduce the risk of \"assessment time bias.\" The TD domain makes possible an evaluation of \nassessment time bias from the SDTM, in particular for studies with progression-free survival (PFS) \nendpoints. TD has limited utility within oncology and was developed specifically with RECIST in mind \nand where an assessment-time bias analysis is appropriate. It is understood that extending this approach to \nCheson and other criteria may not be appropriate or may pose difficulties.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3320, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c5b705a4-aac7-4165-b7b9-dd0caa25675f": {"__data__": {"id_": "c5b705a4-aac7-4165-b7b9-dd0caa25675f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 411, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a4831223-b50a-4dcf-862c-49bffc3222ed", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 411, "section": "UNSPECIFIED"}, "hash": "0c9c3c6fed81e0dac181ae3d9365e58a048c0f611701b27add3dcaa9f0965a0d", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a28ae5ab-fb8e-47cc-8eac-2a6bfecc0482", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 411, "section": "UNSPECIFIED"}, "hash": "301f224f748e13fbe5c4f3e02a33c1a7effa9c32b30960608fe3975fdee57250", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTD \u2013 Assumptions \n1. The purpose of the Trial Disease Assessments (TD) domain is to provide information on planned \nscheduling of disease assessments when the scheduling of disease assessments is not necessarily tied to the \nscheduling of visits. In oncology studies, good compliance with the disease-assessment schedule is \nessential to reduce the risk of \"assessment time bias.\" The TD domain makes possible an evaluation of \nassessment time bias from the SDTM, in particular for studies with progression-free survival (PFS) \nendpoints. TD has limited utility within oncology and was developed specifically with RECIST in mind \nand where an assessment-time bias analysis is appropriate. It is understood that extending this approach to \nCheson and other criteria may not be appropriate or may pose difficulties. It is also understood that this \napproach may not be necessary in non-oncology studies, although it is available for use if appropriate. \n2. A planned schedule of assessments will have a defined start point; the TDANCVAR variable is used to \nidentify the variable in the ADaM subject-level dataset (ADSL) that holds the \u201canchor\u201d date. By default, \nthe anchor variable for the first pattern is ANCH1DT. An anchor date must be provided for each pattern of \nassessments, and each anchor variable must exist in ADSL. TDANCVAR is therefore a Required variable. \nAnchor date variable names should adhere to ADaM variable naming conventions (e.g. ANCH1DT, \nANCH2DT). One anchor date may be used to anchor more than 1 pattern of disease assessments. When \nthat is the case, the appropriate offset for the start of a subsequent pattern, represented as an ISO 8601 \nduration value, should be provided in the TDSTOFF variable. \n3. The TDSTOFF variable is used in conjunction with the anchor date value (from the anchor date variable \nidentified in TDANCVAR). If the pattern of disease assessments does not start exactly on a date collected \non the CRF, this variable will represent the offset between the anchor date value and the start date of the \npattern of disease assessments. This may be a positive or zero interval value represented in an ISO 8601 \nformat.", "mimetype": "text/plain", "start_char_idx": 2447, "end_char_idx": 4673, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "2a32b7e8-4aaf-40e7-9771-672d129e34a5": {"__data__": {"id_": "2a32b7e8-4aaf-40e7-9771-672d129e34a5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 412, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "9f18c7dd-0b93-45c7-84b2-f815311531d8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 412, "section": "UNSPECIFIED"}, "hash": "a8669b2c4ab0d994a424902d613202359f66b65b55b3835e508aace029942d22", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 412 \n2021-11-29 \n4. A pattern of assessments consists of a series of intervals of equal duration, each followed by an assessment. \nThus, the first assessment in a pattern is planned to occur at the anchor date (given by the variable named in \nTDANCVAR) plus the offset (TDSTOFF) plus the target assessment interval (TDTGTPAI). A baseline \nevaluation is usually not preceded by an interval, and would therefore not be considered part of an \nassessment pattern. \n5. This domain should not be created when the disease assessment schedule may vary for individual subjects \n(e.g., when completion of the first phase of a study is event-driven). \nTD \u2013 Examples \nExample 1 \n  \n \nThis example shows a study where the disease assessment schedule changes over the course of the study. In this \nexample, there are 3 distinct disease-assessment schedule patterns. A single anchor date variable (TDANCVAR) \nprovides the anchor date for each pattern. The offset variable (TDSTOFF), used in conjunction with the anchor date \nvariable, provides the start point of each pattern of assessments.. \n\u2022 \nThe first disease-assessment schedule pattern starts at the reference start date (identified in the ADSL \nANCH1DT variable) and repeats every 8 weeks for a total of 6 repeated assessments (i.e., week 8, week 16, \nweek 24, week 32, week 40, week 48). Note that there is an upper and lower limit around the planned \ndisease assessment target where the first assessment (8 weeks) could occur as early as day 53 and as late as \nweek 9. This upper and lower limit (-3 days, +1 week) would be applied to all assessments during that \npattern. \n\u2022 \nThe second disease assessment schedule starts from week 48 and repeats every 12 weeks for a total of 4 \nrepeats (i.e., week 60, week 72, week 84, week 96), with respective upper and lower limits of -1 week and \n+ 1 week. \n\u2022 \nThe third disease assessment schedule starts from week 96 and repeats every 24 weeks (week 120, \nweek 144, and so on), with respective upper and lower limits of -1 week and + 1 week, for an indefinite \nlength of time. The preceding schematic shows that, for the third pattern, assessments will occur until \ndisease progression; this therefore leaves the pattern open-ended. However, when data is included in an \nanalysis, the total number of repeats can be identified and the highest number of repeat assessments for any \nsubject in that pattern must be recorded in the TDNUMRPT variable on the final pattern record. \ntd.xpt \nRow STUDYID DOMAIN TDORDER TDANCVAR TDSTOFF TDTGTPAI TDMINPAI TDMAXPAI TDNUMRPT \n1 \nABC123 \nTD \n1 \nANCH1DT \nP0D \nP8W \nP53D \nP9W \n6 \n2 \nABC123 \nTD \n2 \nANCH1DT \nP48W \nP12W \nP11W \nP13W \n4 \n3 \nABC123 \nTD \n3 \nANCH1DT \nP96W \nP24W \nP23W \nP25W \n12", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2891, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc4bf212-f3b8-483b-9c87-57b402559beb": {"__data__": {"id_": "dc4bf212-f3b8-483b-9c87-57b402559beb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 413, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a35cbd3c-cf26-4161-80d7-3901f6c2c469", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 413, "section": "UNSPECIFIED"}, "hash": "f7648dc8e698872bb5cd95138300270abe8375560fbefa6ff6f8c3389ff79285", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 413 \n2021-11-29 \nExample 2 \n \nThis example shows a crossover study, where subjects are given the period 1 treatment according to the first disease-\nassessment schedule until disease progression, then there is a rest period of 28 days prior to the start of period 2 \ntreatment (i.e., re-baseline for period 2). The subjects are then given the period 2 treatment according to the second \ndisease assessment schedule until disease progression.  This example also shows how two different reference/anchor \ndates can be used. \n\u2022 \nThe Rest element is not represented as a row in the TD dataset, since no disease assessments occur during \nthe Rest. Note that although the Rest epoch in this example is not important for TD, it is important that it is \nrepresented in other trial design datasets. \nRow 1: \nShows the disease assessment schedule for the first treatment period. The diagram above shows that \nthis schedule repeats until disease progression. After the trial ended, the maximum number of repeats \nin this schedule was determined to be 6, so that is the value in TDNUMRPT for this schedule. \nRow 2: \nShows the disease assessment schedule for the second period. The pattern starts on the date identified \nin the ADSL variable ANCH2DT and repeats every 8 weeks with respective upper and lower limits of \n-1 week and + 1 week. The maximum number of repeats that occurred on this schedule was 4. \ntd.xpt \nRow STUDYID DOMAIN TDORDER TDANCVAR TDSTOFF TDTGTPAI TDMINPAI TDMAXPAI TDNUMRPT \n1 \nABC123 \nTD \n1 \nANCH1DT \nP0D \nP8W \nP53D \nP9W \n6 \n2 \nABC123 \nTD \n2 \nANCH2DT \nP0D \nP8W \nP53D \nP9W \n4", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1764, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6dfce659-fe14-453e-963c-f790ba2c34df": {"__data__": {"id_": "6dfce659-fe14-453e-963c-f790ba2c34df", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 414, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a92d3ed-1101-4ca6-8ea5-92e9555cafb3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 414, "section": "UNSPECIFIED"}, "hash": "64478a414ec84afedbe4511eae1dd54e0c6ca48f20f840c673e905e2b1942dd3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 414 \n2021-11-29 \nExample 3 \n \nThis example shows a study where subjects are randomized to standard treatment or an experimental treatment. The \nsubjects who are randomized to standard treatment are given the option to receive experimental treatment after they \nend the standard treatment (e.g., due to disease progression on standard treatment). In the randomized treatment \nepoch, the disease assessment schedule changes over the course of the study. At the start of the extension treatment \nepoch, subjects are re-baselined, i.e., an extension baseline disease assessment is performed and the disease \nassessment schedule is restarted). \nIn this example, there are 3 distinct disease-assessment schedule patterns: \n\u2022 \nThe first disease-assessment schedule pattern starts at the reference start date (identified in the ADSL \nANCH1DT variable) and repeats every 8 weeks for a total of 6 repeats ( i.e., week 8, week 16, week 24, \nweek 32, week 40, week 48), with respective upper and lower limits of - 3 days and + 1 week. \n\u2022 \nThe second disease assessment schedule starts from week 48 and repeats every 12 weeks (week 60, \nweek 72, etc.), with respective upper and lower limits of -1 week and + 1 week, for an indefinite length of \ntime. The preceding schematic shows that, for the second pattern, assessments will occur until disease \nprogression; this therefore leaves the pattern open-ended. \n\u2022 \nThe third disease assessment schedule starts at the extension reference start date (identified in the ADSL \nANCH2DT variable) from week 96 and repeats every 24 weeks (week 120, week 144, etc.), with respective \nupper and lower limits of -1 week and + 1 week, for an indefinite length of time. The schematic shows that, \nfor the third pattern, assessments will occur until disease progression; this therefore leaves the pattern open-\nended. \nFor open-ended patterns, the total number of repeats can be identified when the data analysis is performed; the \nhighest number of repeat assessments for any subject in that pattern must be recorded in the TDNUMRPT variable \non the final pattern record. \ntd.xpt \nRow STUDYID \nDOMAIN TDORDER \nTDANCVAR \nTDSTOFF \nTDTGPAI TDMINPAI \nTDMAXPAI \nTDNUMRPT \n1 \nABC123 \nTD \n1 \nANCH1DT \nP0D \nP8W \nP53D \nP9W \n6 \n2 \nABC123 \nTD \n2 \nANCH1DT \nP48W \nP12W \nP11W \nP13W \n17 \n3 \nABC123 \nTD \n3 \nANCH2DT \nP0D \nP12W \nP11W \nP13W \n17", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2527, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "837959cd-503d-4937-8c2e-19c3945f3b74": {"__data__": {"id_": "837959cd-503d-4937-8c2e-19c3945f3b74", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 415, "section": "7.3.3 Trial Disease Milestones (TM)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0cc2738d-c326-411e-aa7b-6dbdae135a46", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 415, "section": "7.3.3 Trial Disease Milestones (TM)"}, "hash": "8b584555889f9293ceb98bc1df9f86f03896345c70531d0740a543d290028b80", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TM \u2013 Description/Overview \nA trial design domain that is used to describe disease milestones, which are observations or activities anticipated to \noccur in the course of the disease under study, and which trigger the collection of data. \nTM \u2013 Specification \ntm.xpt, Trial Disease Milestones \u2014 Trial Design. One record per Disease Milestone type, \nTabulation. \nVariable \nName \nVariable Label \nType Controlled Terms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar TM \nIdentifier \nTwo-character abbreviation for the domain, which \nmust be TM. \nReq \nMIDSTYPE \nDisease Milestone \nType \nChar  \nTopic \nThe type of disease milestone. Example: \n\"HYPOGLYCEMIC EVENT\". \nReq \nTMDEF \nDisease Milestone \nDefinition \nChar  \nVariable \nQualifier \nDefinition of the disease milestone. \nReq \nTMRPT \nDisease Milestone \nRepetition Indicator \nChar (NY) \nRecord \nQualifier \nIndicates whether this is a disease milestone that can \noccur only once (\"N\") or a type of disease milestone \nthat can occur multiple times (\"Y\"). \nReq \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTM \u2013 Assumptions \n1. Disease milestones may be things that would be expected to happen before the study, or things that are \nanticipated to happen during the study. The occurrence of disease milestones for particular subjects are \nrepresented in the Subject Disease Milestones (SM) dataset. \n2. The Trial Disease Milestones (TM) dataset contains a record for each type of disease milestone. The \ndisease milestone is defined in TMDEF. \nTM \u2013 Examples \nExample 1 \nIn this diabetes study, initial diagnosis of diabetes and the hypoglycemic events that occur during the trial have been \nidentified as disease milestones of interest. \nRow 1: \nShows that the initial diagnosis is given the MIDSTYPE of \"DIAGNOSIS\" and is defined in TMDEF. \nIt is not repeating (occurs only once). \nRow 2: \nShows that hypoglycemic events are given the MIDSTYPE of \"HYPOGLYCEMIC EVENT\", and a \ndefinition in TMDEF. (For an actual study, the definition would be expected to include a particular \nthreshold level, rather than the text \"threshold level\" used in this example.) A subject may experience \nmultiple hypoglycemic events, as indicated by TMRPT = \"Y\". \ntm.xpt \nRow STUDYID DOMAIN MIDSTYPE \nTMDEF \nTMRPT \n1 \nXYZ \nTM \nDIAGNOSIS \nInitial diagnosis of diabetes, the first time a physician told the subject they had \ndiabetes \nN \n2 \nXYZ \nTM \nHYPOGLYCEMIC \nEVENT \nHypoglycemic Event, the occurrence of a glucose level below (threshold level) \nY", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2706, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "dc1c10c5-0257-4ec9-b3d0-7126799e6bd7": {"__data__": {"id_": "dc1c10c5-0257-4ec9-b3d0-7126799e6bd7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 415, "section": "7.4 Trial Eligibility and Summary (TI and TS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "59bce370-ead3-48a0-a98a-c4141d6550e1", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 415, "section": "7.4 Trial Eligibility and Summary (TI and TS)"}, "hash": "9eedabfc721f78d2dbc71d2011cf46ece5df925777a6753ac3b09dff0420c40b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "This section contains the Trial Design (TD) datasets that describe: \n\u2022 \nSubject eligibility criteria for trial participation (Section 7.4.1, Trial Inclusion/Exclusion Criteria (TI)) \n\u2022 \nThe characteristics of the trial (Section 7.4.2, Trial Summary (TS)) \nThe TI and TS datasets are tabular synopses of parts of the study protocol.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 331, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a4114a8f-3167-4f8c-b1dc-bc53cccd5777": {"__data__": {"id_": "a4114a8f-3167-4f8c-b1dc-bc53cccd5777", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 416, "section": "7.4.1 Trial Inclusion/Exclusion Criteria (TI)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b9d06f77-becf-422f-a203-8ecd0c070ec7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 416, "section": "7.4.1 Trial Inclusion/Exclusion Criteria (TI)"}, "hash": "7bbab8212a4afa86a934204ccbed70f211d6eff532e2873088c494f01b14162f", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "d183174d-db5e-46de-bbd6-52c410347a90", "node_type": "1", "metadata": {}, "hash": "408fac2c4137a8758a65e076a0fa3256ef51420d253450aba8ab9bc68b756b40", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TI \u2013 Proposed Removal of Variable TIRL \nThe variable TIRL was included in the Trial Inclusion/Exclusion Criteria (TI) domain in anticipation of developing \na way to represent eligibility criteria in a computer-executable manner. However, such a method has not been \ndeveloped, and it is not clear that an SDTM dataset would be the best place to represent such a computer-executable \nrepresentation. \nTI \u2013 Description/Overview \nA trial design domain that contains one record for each of the inclusion and exclusion criteria for the trial. This \ndomain is not subject oriented. \nTI contains all the inclusion and exclusion criteria for the trial, and thus provides information that may not be \npresent in the subject-level data on inclusion and exclusion criteria. The IE domain (described in Section \n6.3.4, Inclusion/Exclusion Criteria Not Met) contains records only for inclusion and exclusion criteria that subjects \ndid not meet. \nTI \u2013 Specification \nti.xpt, Trial Inclusion/Exclusion Criteria \u2014 Trial Design. One record per I/E criterion, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar TI \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nIETESTCD Incl/Excl Criterion \nShort Name \nChar * \nTopic \nShort name IETEST. It can be used as a column name \nwhen converting a dataset from a vertical to a horizontal \nformat. The value in IETESTCD cannot be longer than 8 \ncharacters, nor can it start with a number (e.g., \"1TEST\" is \nnot valid). IETESTCD cannot contain characters other than \nletters, numbers, or underscores. The prefix \"IE\" is used to \nensure consistency with the IE domain. \nReq \nIETEST \nInclusion/Exclusion \nCriterion \nChar * \nSynonym \nQualifier \nFull text of the inclusion or exclusion criterion. The prefix \n\"IE\" is used to ensure consistency with the IE domain. \nReq \nIECAT \nInclusion/Exclusion \nCategory \nChar (IECAT) \nGrouping \nQualifier \nUsed for categorization of the inclusion or exclusion criteria. Req \nIESCAT \nInclusion/Exclusion \nSubcategory \nChar * \nGrouping \nQualifier \nA further categorization of the exception criterion. Can be \nused to distinguish criteria for a sub-study or to categorize \nas major or minor exceptions. Examples: \"MAJOR\", \n\"MINOR\". \nPerm \nTIRL \nInclusion/Exclusion \nCriterion Rule \nChar  \nRule \nRule that expresses the criterion in computer-executable \nform. See Assumption 4. \nPerm \nTIVERS \nProtocol Criteria \nVersions \nChar  \nRecord \nQualifier \nThe number of this version of the Inclusion/Exclusion \ncriteria. May be omitted if there is only 1 version. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTI \u2013 Assumptions \n1. If inclusion/exclusion criteria were amended during the trial, then each complete set of criteria must be \nincluded in the TI domain. TIVERS is used to distinguish between the versions. \n2.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3085, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d183174d-db5e-46de-bbd6-52c410347a90": {"__data__": {"id_": "d183174d-db5e-46de-bbd6-52c410347a90", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 416, "section": "7.4.1 Trial Inclusion/Exclusion Criteria (TI)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b9d06f77-becf-422f-a203-8ecd0c070ec7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 416, "section": "7.4.1 Trial Inclusion/Exclusion Criteria (TI)"}, "hash": "7bbab8212a4afa86a934204ccbed70f211d6eff532e2873088c494f01b14162f", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "a4114a8f-3167-4f8c-b1dc-bc53cccd5777", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 416, "section": "7.4.1 Trial Inclusion/Exclusion Criteria (TI)"}, "hash": "af7b0fedbae10a6ee67501cb6dae5b7f1a87038591e191bcf4f0ca56dc1e526f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Examples: \"MAJOR\", \n\"MINOR\". \nPerm \nTIRL \nInclusion/Exclusion \nCriterion Rule \nChar  \nRule \nRule that expresses the criterion in computer-executable \nform. See Assumption 4. \nPerm \nTIVERS \nProtocol Criteria \nVersions \nChar  \nRecord \nQualifier \nThe number of this version of the Inclusion/Exclusion \ncriteria. May be omitted if there is only 1 version. \nPerm \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTI \u2013 Assumptions \n1. If inclusion/exclusion criteria were amended during the trial, then each complete set of criteria must be \nincluded in the TI domain. TIVERS is used to distinguish between the versions. \n2. Protocol version numbers should be used to identify criteria versions, although there may be more versions \nof the protocol than versions of the inclusion/exclusion criteria. For example, a protocol might have \nversions 1, 2, 3, and 4, but if the inclusion/exclusion criteria in version 1 were unchanged through versions \n2 and 3, and changed only in version 4, then there would be 2 sets of inclusion/exclusion criteria in TI: one \nfor version 1 and one for version 4. \n3. Individual criteria do not have versions. If a criterion changes, it should be treated as a new criterion, with a \nnew value for IETESTCD. If criteria have been numbered and values of IETESTCD are generally of the \nform INCL00n or EXCL00n, and new versions of a criterion have not been given new numbers, separate \nvalues of IETESTCD might be created by appending letters (e.g., INCL003A, INCL003B).", "mimetype": "text/plain", "start_char_idx": 2353, "end_char_idx": 3959, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e3f08d88-bf64-491f-8fa1-a919e50e8ef0": {"__data__": {"id_": "e3f08d88-bf64-491f-8fa1-a919e50e8ef0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 417, "section": "2.2 7.4.2 Trial Summary (TS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4da47ca7-499e-46d6-8e45-7f8b50eef566", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 417, "section": "2.2 7.4.2 Trial Summary (TS)"}, "hash": "edb7cbd8153060b50bd7e30349c16f4d8f8f5c227932e0db2a33b8cb2b6495c3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TS \u2013 Description/Overview \nA trial design domain that contains one record for each trial summary characteristic. This domain is not subject \noriented. \nThe Trial Summary (TS) dataset allows the sponsor to submit a summary of the trial in a structured format. Each \nrecord in the TS dataset contains the value of a parameter, a characteristic of the trial. For example, TS is used to \nrecord basic information about the study such as trial phase, protocol title, and trial objectives. The TS dataset \ncontains information about the planned and actual trial characteristics. \nTS \u2013 Specification \nts.xpt, Trial Summary \u2014 Trial Design. One record per trial summary parameter value, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar TS \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nTSSEQ \nSequence \nNumber \nNum  \nIdentifier \nSequence number given to ensure uniqueness within a \nparameter. Allows inclusion of multiple records for the \nsame TSPARMCD. \nReq \nTSGRPID \nGroup ID \nChar  \nIdentifier \nUsed to tie together a group of related records. \nPerm \nTSPARMCD Trial Summary \nParameter Short \nName \nChar (TSPARMCD) \nTopic \nTSPARMCD (the companion to TSPARM) is limited to 8 \ncharacters and does not have special character \nrestrictions. These values should be short for ease of use \nin programming, but it is not expected that TSPARMCD \nwill need to serve as variable names. Examples: \n\"AGEMIN\", \"AGEMAX\". \nReq \nTSPARM \nTrial Summary \nParameter \nChar (TSPARM) \nSynonym \nQualifier \nTerm for the trial summary parameter. The value in \nTSPARM cannot be longer than 40 characters. Examples: \n\"Planned Minimum Age of Subjects\", \"Planned Maximum \nAge of Subjects\". \nReq \nTSVAL \nParameter \nValue \nChar * \nResult \nQualifier \nValue of TSPARM. Example: \"ASTHMA\" when TSPARM \nvalue is \"Trial Indication\". TSVAL can only be null when \nTSVALNF is populated. Text over 200 characters can be \nadded to additional columns TSVAL1-TSVALn. See \nAssumption 8. \nExp", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2137, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e348beee-8b20-4022-82e2-1a96f4e9cacd": {"__data__": {"id_": "e348beee-8b20-4022-82e2-1a96f4e9cacd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 418, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d781a0f7-a106-4e74-9761-12264b5d0ca0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 418, "section": "UNSPECIFIED"}, "hash": "458a76c035928036c46e34d4b8ff09bf843f65eb1c8572512c8c161cc1bbafb0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "54b4c65c-9cf2-4c68-9c31-d01dcb805f8a", "node_type": "1", "metadata": {}, "hash": "4d28f30c9268325ae9ce247b20959cd607a9fbdbae8fc6d4874e1f19366af23c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 418 \n2021-11-29 \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nTSVALNF \nParameter \nValue Null \nFlavor \nChar ISO 21090 \nNullFlavor \nResult \nQualifier \nNull flavor for the value of TSPARM, to be populated only \nif TSVAL is null. \nPerm \nTSVALCD \nParameter \nValue Code \nChar * \nResult \nQualifier \nThis is the code of the term in TSVAL. For example, \n\"6CW7F3G59X\" is the code for gabapentin; \"C49488\" is \nthe code for Y. The length of this variable can be longer \nthan 8 to accommodate the length of the external \nterminology. \nExp \nTSVCDREF \nName of the \nReference \nTerminology \nChar (DICTNAM) \nResult \nQualifier \nThe name of the reference terminology from which \nTSVALCD is taken. For example; CDISC CT, SNOMED, \nISO 8601. \nExp \nTSVCDVER \nVersion of the \nReference \nTerminology \nChar  \nResult \nQualifier \nThe version number of the reference terminology, if \napplicable. \nExp \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \n  \nTS \u2013 Assumptions \n1. The intent of this dataset is to provide a summary of trial information. This is not subject-level data. \n2. Recipients may specify their requirements for which trial summary parameters should be included under \nwhich circumstances. For example, the US FDA includes such information in their Study Data Technical \nConformance Guide. \n3. The order of parameters in the examples of TS datasets should not be taken as a requirement. There are no \nrequirements or expectations about the order of parameters within the TS dataset. \n4. The method for treating text >200 characters in TS is similar to that used for the Comments (CO) special-\npurpose domain (Section 5.1, Comments). If TSVAL is >200 characters, then it should be split into \nmultiple variables, TSVAL-TSVALn. See Section 4.5.3.2, Text Strings Greater than 200 Characters in \nOther Variables. \n5. A list of values for TSPARM and TSPARMCD can be found in CDISC Controlled Terminology, available \nat https://www.cancer.gov/research/resources/terminology/cdisc. \n6. Controlled terminology for TSPARM is extensible. The meaning of any added parameters should be \nexplained in the metadata for the TS dataset. \n7. For a particular trial summary parameter, responses (values in TSVAL) may be numeric, datetimes or \namounts of time represented in ISO8601 format, or text. For some parameters, textual responses may be \ntaken from controlled terminology; for others, responses may be free text. \n8. For some trial summary parameters, CDISC Controlled Terminology includes codelists for use with \nTSVAL. The associations between trial summary parameters and response codelists are in the TS \ncodetable, available at https://www.cdisc.org/standards/terminology/controlled-terminology. Recipients \nmay also specify controlled terminology for TSVAL.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3089, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "54b4c65c-9cf2-4c68-9c31-d01dcb805f8a": {"__data__": {"id_": "54b4c65c-9cf2-4c68-9c31-d01dcb805f8a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 418, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d781a0f7-a106-4e74-9761-12264b5d0ca0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 418, "section": "UNSPECIFIED"}, "hash": "458a76c035928036c46e34d4b8ff09bf843f65eb1c8572512c8c161cc1bbafb0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e348beee-8b20-4022-82e2-1a96f4e9cacd", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 418, "section": "UNSPECIFIED"}, "hash": "a7e02bc5f3b624bc467563f6445b880ecef1f70dc695a7696b8c056c2a7384fa", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "6. Controlled terminology for TSPARM is extensible. The meaning of any added parameters should be \nexplained in the metadata for the TS dataset. \n7. For a particular trial summary parameter, responses (values in TSVAL) may be numeric, datetimes or \namounts of time represented in ISO8601 format, or text. For some parameters, textual responses may be \ntaken from controlled terminology; for others, responses may be free text. \n8. For some trial summary parameters, CDISC Controlled Terminology includes codelists for use with \nTSVAL. The associations between trial summary parameters and response codelists are in the TS \ncodetable, available at https://www.cdisc.org/standards/terminology/controlled-terminology. Recipients \nmay also specify controlled terminology for TSVAL. These specifications may be for trial summary \nparameters for which there is no CDISC Controlled Terminology or they may replace CDISC Controlled \nTerminology for a trial summary parameter.  For example, the US FDA Data Standards Catalog includes \nterminologies to be used for certain trial summary parameters. \n9. There is a code value for TSVALCD only when there is controlled terminology for TSVAL. For example, \nwhen TSPARMCD = \"PLANSUB\" (Planned Number of Subjects) or TSPARMCD = \"TITLE\" (Trial \nTitle), then TSVALCD will be null. \n10. TSVALNF contains a \u201cnull flavor,\u201d a value that provides additional coded information when TSVAL is \nnull. For example, for TSPARM = \"AGEMAX\" (Planned Maximum Age of Subjects), there is no value if a \nstudy does not specify a maximum age. In this case, the appropriate null flavor is \"PINF\", which stands for \n\"positive infinity.\" In a clinical pharmacology study conducted in healthy volunteers for a drug where \nindications are not yet established, the appropriate null flavor for TSPARM = \"INDIC\" (Trial \nDisease/Condition Indication) would be \"NA\" (i.e., not applicable). TSVALNF can also be used in a case \nwhere the value of a particular parameter is unknown.", "mimetype": "text/plain", "start_char_idx": 2312, "end_char_idx": 4295, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c5f916c0-867c-44bf-a52a-0023b1f66555": {"__data__": {"id_": "c5f916c0-867c-44bf-a52a-0023b1f66555", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 419, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2fc404a3-0b9c-46c3-bd1c-80e5760176e8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 419, "section": "UNSPECIFIED"}, "hash": "05a00bb9bcaa1f1c04d588743c985bda6c8d0ce1f92e58bd0869ae0dbbb0aecf", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "0338220d-15e0-486e-a3ba-5f686756c094", "node_type": "1", "metadata": {}, "hash": "2518527628d53719df91b4b69b6162a1d5925e41c8853a3f1b01ea9be19fa0f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 419 \n2021-11-29 \n11. Some codelists used for TSVAL include terms which are also null flavors. For example, the Pharmaceutical \nDosage Form codelist includes the values \"UNKNOWN\" and \"NOT APPLICABLE\". In such cases, \nTSVAL should have the term from the codelist and TSVALNF should be null. \n12. For some trials, there will be multiple records in the TS dataset for a single parameter. For example, a trial \nthat addresses both safety and efficacy could have 2 records with TSPARMCD = \"TTYPE\" (Trial Type), \none with the TSVAL = \"SAFETY\" and the other with TSVAL = \"EFFICACY\". TSSEQ has a different \nvalue for each record for the same parameter. \nNote that this is different from datasets that contain subject data, where the --SEQ variable has a different \nvalue for each record for the same subject. \n13. TS does not contain subject-level data, so there is no restriction analogous to the requirement in subject-\nlevel datasets that the blocks bound by TSGRPID are within a subject. TSGRPID can be used to tie \ntogether any block of records in the dataset. TSGRPID is most likely to be used when the TS dataset \nincludes multiple records for the same parameter. \n \nFor example, if a trial compared administration of a total daily dose given once a day to that dose split over \n2 administrations, the TS dataset might include the following records.  There are 2 records each for \nTSPARMCD = \"Dose\" and TSPARMCD = \"DOSFREQ\".  Records with the same TSGRPID are associated \nwith each other. In this example, dose units are the same for both administration schedules, so only 1 record \nfor DOSU is needed. \nTSSEQ \nTSGRPID \nTSPARMCD \nTSPARM \nTSVAL \n1 \nA \nDOSE \nDose per Administration \n50 \n1 \nA \nDOSFREQ \nDosing Frequency \nBID \n2 \nB \nDOSE \nDose per Administration \n100 \n2 \nB \nDOSFREQ \nDosing Frequency \nQ24H \n1 \n \nDOSU \nDose Units \nmg \n14. Protocols vary in how they describe objectives. If the protocol does not provide information about which \nobjectives meet the definition of TSPARM = \"OBJPRIM\" (Trial Primary Objective; i.e., the principal \npurpose of the trial), then the objectives should be provided as values of TSPARM = \"OBJPRIM\". Consult \nthe controlled terminology for trial summary parameters for appropriate parameter values for representing \nother objective designations (e.g., secondary, exploratory). \n15. As per the definitions, the primary outcome measure is associated with the primary objective, the secondary \noutcome measure is associated with the secondary objective, and the exploratory outcome measure is \nassociated with the exploratory objective. It is possible for the same outcome measure to be associated with \nmore than 1 objective. For example, 2 objectives could use the same outcome measure at different time \npoints, or using different analysis methods. \n16. If a primary objective is assessed by means of multiple outcome measures, then all of these outcome \nmeasures should be provided as values of TSPARM = \"OUTMSPR\" (Primary Outcome Measure).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3155, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0338220d-15e0-486e-a3ba-5f686756c094": {"__data__": {"id_": "0338220d-15e0-486e-a3ba-5f686756c094", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 419, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "2fc404a3-0b9c-46c3-bd1c-80e5760176e8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 419, "section": "UNSPECIFIED"}, "hash": "05a00bb9bcaa1f1c04d588743c985bda6c8d0ce1f92e58bd0869ae0dbbb0aecf", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c5f916c0-867c-44bf-a52a-0023b1f66555", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 419, "section": "UNSPECIFIED"}, "hash": "9492b6d0af1986a269013eb7fde2664e92d2bb82632c4c20c59da55ddc4f32fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Consult \nthe controlled terminology for trial summary parameters for appropriate parameter values for representing \nother objective designations (e.g., secondary, exploratory). \n15. As per the definitions, the primary outcome measure is associated with the primary objective, the secondary \noutcome measure is associated with the secondary objective, and the exploratory outcome measure is \nassociated with the exploratory objective. It is possible for the same outcome measure to be associated with \nmore than 1 objective. For example, 2 objectives could use the same outcome measure at different time \npoints, or using different analysis methods. \n16. If a primary objective is assessed by means of multiple outcome measures, then all of these outcome \nmeasures should be provided as values of TSPARM = \"OUTMSPR\" (Primary Outcome Measure). \nSimilarly, all outcome measures used to assess secondary objectives should be provided as values of \nTSPARM = \"OUTMSSEC\" (Secondary Outcome Measure), and all outcome measures used to assess \nexploratory objectives should be provided as values of TSPARM = \"OUTMSEXP\" (Exploratory Outcome \nMeasure). Additional key measures of a study that are not designated as primary, secondary, or exploratory \nshould be provided as values of TSPARM = \"OUTMSADD\" (Additional Outcome Measure). \n17. Trial indication: Values for TSVAL when TSPARMCD = \"INDIC\" would indicate the condition, disease, \nor disorder the trial is intended to investigate or address. A vaccine study of healthy subjects, with the \nintended purpose of preventing influenza infection, would have TSVAL = \"Influenza\". A clinical \npharmacology study of healthy volunteers, with the purpose of collecting pharmacokinetic data, would \nhave no trial indication; TSVAL would be null and TSVALNF = \"NA\" if TS contains a row where \nTSPARMCD = \"INDIC\". \n18. Values for TSVAL when TSPARMCD = \"REGID\" (Registry Identifier) will be identifiers assigned by the \nregistry (e.g., ClinicalTrials.gov, EudraCT).", "mimetype": "text/plain", "start_char_idx": 2314, "end_char_idx": 4308, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "c6a5d138-c5c0-4b14-a1cf-2d6422d137d7": {"__data__": {"id_": "c6a5d138-c5c0-4b14-a1cf-2d6422d137d7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 420, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "28ae9adb-4011-451d-a9cd-b9dca6dcbadb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 420, "section": "UNSPECIFIED"}, "hash": "e27397144841b1e4e1bc1400687f020db380eeb95e72a17cfb165cfc3865e3ef", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6ac07c39-00bb-40b5-b09c-8c46b18486f1", "node_type": "1", "metadata": {}, "hash": "e30a62e35f11530ea9eba559aa471c5a7f6c9263805cc4acc5eaf282e34974f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 420 \n2021-11-29 \nTS \u2013 Examples \nExample 1 \nThis example shows a subset of published controlled terminology parameters and the relationship of values across response variables TSVAL, TSVALNF, \nTSVALCD, TSVCDREF, and TSVCDVER. \nts.xpt \nRow STUDYID DOMAIN TSSEQ TSGRPID TSPARMCD TSPARM \nTSVAL \nTSVALNF TSVALCD \nTSVCDREF \nTSVCDVER \n1 \nXYZ \nTS \n1 \n \nADDON \nAdded on to Existing \nTreatments \nY \n \nC49488 \nCDISC CT \n2011-06-10 \n2 \nXYZ \nTS \n1 \n \nAGEMAX \nPlanned Maximum Age \nof Subjects \nP70Y \n \n \nISO 8601 \n \n3 \nXYZ \nTS \n1 \n \nAGEMIN \nPlanned Minimum Age \nof Subjects \nP18M \n \n \nISO 8601 \n \n4 \nXYZ \nTS \n1 \n \nLENGTH \nTrial Length \nP3M \n \n \nISO 8601 \n \n5 \nXYZ \nTS \n1 \n \nPLANSUB \nPlanned Number of \nSubjects \n300 \n \n \n \n \n6 \nXYZ \nTS \n1 \n \nRANDOM \nTrial is Randomized \nY \n \nC49488 \nCDISC CT \n2011-06-10 \n7 \nXYZ \nTS \n1 \n \nSEXPOP \nSex of Participants \nBOTH \n \nC49636 \nCDISC CT \n2011-06-10 \n8 \nXYZ \nTS \n1 \n \nSTOPRULE \nStudy Stop Rules \nINTERIM ANALYSIS FOR FUTILITY \n \n \n \n \n9 \nXYZ \nTS \n1 \n \nTBLIND \nTrial Blinding Schema \nDOUBLE BLIND \n \nC15228 \nCDISC CT \n2011-06-10 \n10 \nXYZ \nTS \n1 \n \nTCNTRL \nControl Type \nPLACEBO \n \nC49648 \nCDISC CT \n2011-06-10 \n11 \nXYZ \nTS \n1 \n \nTDIGRP \nDiagnosis Group \nNeurofibromatosis Syndrome (Disorder) \n \n19133005 \nSNOMED \n2011-03 \n12 \nXYZ \nTS \n1 \n \nINDIC \nTrial Disease/Condition \nIndication \nTonic-Clonic Epilepsy (Disorder) \n \n352818000 \nSNOMED \n2011-03 \n13 \nXYZ \nTS \n1 \n \nTINDTP \nTrial Intent Type \nTREATMENT \n \nC49656 \nCDISC CT \n2011-06-10 \n14 \nXYZ \nTS \n1 \n \nTITLE \nTrial Title \nA 24 Week Study of Oral Gabapentin vs.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1715, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6ac07c39-00bb-40b5-b09c-8c46b18486f1": {"__data__": {"id_": "6ac07c39-00bb-40b5-b09c-8c46b18486f1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 420, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "28ae9adb-4011-451d-a9cd-b9dca6dcbadb", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 420, "section": "UNSPECIFIED"}, "hash": "e27397144841b1e4e1bc1400687f020db380eeb95e72a17cfb165cfc3865e3ef", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "c6a5d138-c5c0-4b14-a1cf-2d6422d137d7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 420, "section": "UNSPECIFIED"}, "hash": "52e92d1d7def9838512f12e73f72586b8d4464557d238731f1bd7e167c7737fe", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Placebo \nas add-on Treatment to Phenytoin in Subjects with \nEpilepsy due to Neurofibromatosis \n \n \n \n \n15 \nXYZ \nTS \n1 \n \nTPHASE \nTrial Phase \nClassification \nPhase II Trial \n \nC15601 \nCDISC CT \n2011-06-10 \n16 \nXYZ \nTS \n1 \n \nTTYPE \nTrial Type \nEFFICACY \n \nC49666 \nCDISC CT \n2011-06-10 \n17 \nXYZ \nTS \n2 \n \nTTYPE \nTrial Type \nSAFETY \n \nC49667 \nCDISC CT \n2011-06-10 \n18 \nXYZ \nTS \n1 \n \nCURTRT \nCurrent Therapy or \nTreatment \nPhenytoin \n \n6158TKW0C5 \nUNII \n \n19 \nXYZ \nTS \n1 \n \nOBJPRIM \nTrial Primary Objective \nReduction in the 3-month seizure frequency from \nbaseline \n \n \n \n \n20 \nXYZ \nTS \n1 \n \nOBJSEC \nTrial Secondary \nObjective \nPercent reduction in the 3-month seizure \nfrequency from baseline \n \n \n \n \n21 \nXYZ \nTS \n2 \n \nOBJSEC \nTrial Secondary \nObjective \nReduction in the 3-month tonic-clonic seizure \nfrequency from baseline \n \n \n \n \n22 \nXYZ \nTS \n1 \n \nSPONSOR \nClinical Study Sponsor \nPharmaco \n \n123456789 \nD-U-N-S \nNUMBER \n \n23 \nXYZ \nTS \n1 \n \nTRT \nInvestigational Therapy \nor Treatment \nGabapentin \n \n6CW7F3G59X \nUNII \n \n24 \nXYZ \nTS \n1 \n \nRANDQT \nRandomization Quotient 0.67 \n \n \n \n \n25 \nXYZ \nTS \n1 \n \nSTRATFCT \nStratification Factor \nSEX \n \n \n \n \n26 \nXYZ \nTS \n1 \n \nREGID \nRegistry Identifier \nNCT123456789 \n \nNCT123456789 ClinicalTrials.gov \n \n27 \nXYZ \nTS \n2 \n \nREGID \nRegistry Identifier \nXXYYZZ456 \n \nXXYYZZ456 \nEudraCT \n \n28 \nXYZ \nTS \n1 \n \nOUTMSPRI \nPrimary Outcome \nMeasure \nSEIZURE FREQUENCY \n \n \n \n \n29 \nXYZ \nTS \n1 \n \nOUTMSSEC Secondary Outcome \nMeasure \nSEIZURE FREQUENCY", "mimetype": "text/plain", "start_char_idx": 1716, "end_char_idx": 3197, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "93693f54-fe50-4e74-bee5-c0babcf61ad5": {"__data__": {"id_": "93693f54-fe50-4e74-bee5-c0babcf61ad5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 421, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a88af453-b979-4a38-9136-3d4d40ffea01", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 421, "section": "UNSPECIFIED"}, "hash": "33179e19cc948315190fe73181048ac225bb211dd26d61175b19b1b2c2b9bd56", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "de499c9d-a799-4906-ad5d-45c8505ce538", "node_type": "1", "metadata": {}, "hash": "feb40682cf1ea63a04cf945ca1795135dddbd33dccd537c69c37d5e97943038e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 421 \n2021-11-29 \nRow STUDYID DOMAIN TSSEQ TSGRPID TSPARMCD TSPARM \nTSVAL \nTSVALNF TSVALCD \nTSVCDREF \nTSVCDVER \n30 \nXYZ \nTS \n2 \n \nOUTMSSEC Secondary Outcome \nMeasure \nSEIZURE DURATION \n \n \n \n \n31 \nXYZ \nTS \n1 \n \nOUTMSEXP Exploratory Outcome \nMeasure \nSEIZURE INTENSITY \n \n \n \n \n32 \nXYZ \nTS \n1 \n \nPCLAS \nPharmacological Class \nAnti-epileptic Agent \n \nN0000175753 \nMED-RT \n \n33 \nXYZ \nTS \n1 \n \nFCNTRY \nPlanned Country of \nInvestigational Sites \nUSA \n \n \nISO 3166-1 \nAlpha-3 \n \n34 \nXYZ \nTS \n2 \n \nFCNTRY \nPlanned Country of \nInvestigational Sites \nCAN \n \n \nISO 3166-1 \nAlpha-3 \n \n35 \nXYZ \nTS \n3 \n \nFCNTRY \nPlanned Country of \nInvestigational Sites \nMEX \n \n \nISO 3166-1 \nAlpha-3 \n \n36 \nXYZ \nTS \n1 \n \nADAPT \nAdaptive Design \nN \n \nC49487 \nCDISC CT \n2011-06-10 \n37 \nXYZ \nTS \n1 \nPA \nDCUTDTC \nData Cutoff Date \n2010-04-10 \n \n \nISO 8601 \n \n38 \nXYZ \nTS \n1 \nPA \nDCUTDESC Data Cutoff Description \nPRIMARY ANALYSIS \n \n \n \n \n39 \nXYZ \nTS \n1 \n \nINTMODEL \nIntervention Model \nPARALLEL \n \nC82639 \nCDISC CT \n2011-06-10 \n40 \nXYZ \nTS \n1 \n \nNARMS \nPlanned Number of \nArms \n3 \n \n \n \n \n41 \nXYZ \nTS \n1 \n \nSTYPE \nStudy Type \nINTERVENTIONAL \n \nC98388 \nCDISC CT \n2011-06-10 \n42 \nXYZ \nTS \n1 \n \nINTTYPE \nIntervention Type \nDRUG \n \nC1909 \nCDISC CT \n2011-06-10 \n43 \nXYZ \nTS \n1 \n \nSSTDTC \nStudy Start Date \n2009-03-11 \n \n \nISO 8601 \n \n44 \nXYZ \nTS \n1 \n \nSENDTC \nStudy End Date \n2011-04-01 \n \n \nISO 8601 \n \n45 \nXYZ \nTS \n1 \n \nACTSUB \nActual Number of \nSubjects \n304 \n \n \n \n \n46 \nXYZ \nTS \n1 \n \nHLTSUBJI \nHealthy Subject \nIndicator \nN \n \nC49487 \nCDISC CT \n2011-06-10 \n47 \nXYZ \nTS \n1 \n \nSDMDUR \nStable Disease \nMinimum Duration \nP3W \n \n \nISO 8601 \n \n48 \nXYZ \nTS \n1 \n \nCRMDUR \nConfirmed Response \nMinimum Duration \nP28D \n \n \nISO 8601 \n \nExample 2 \nThis example shows the relationship between parameters involving diagnosis and indication. Only selected trial summary parameters are included. \nRow 1: \nShows the trial title. \nRow 2: \nShows that subjects in this trial have a diagnosis of diabetes. \nRows 3-4: \nShow the conditions with the intervention in the trial are intended to address. The 2 rows for the same parameter are differentiated by their TSSEQ \nvalues.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2299, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "de499c9d-a799-4906-ad5d-45c8505ce538": {"__data__": {"id_": "de499c9d-a799-4906-ad5d-45c8505ce538", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 421, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a88af453-b979-4a38-9136-3d4d40ffea01", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 421, "section": "UNSPECIFIED"}, "hash": "33179e19cc948315190fe73181048ac225bb211dd26d61175b19b1b2c2b9bd56", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "93693f54-fe50-4e74-bee5-c0babcf61ad5", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 421, "section": "UNSPECIFIED"}, "hash": "b8cfaaafc77c8941d0629cecbf357f6bc68b589710db2b339f0cfd5efee0763d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Only selected trial summary parameters are included. \nRow 1: \nShows the trial title. \nRow 2: \nShows that subjects in this trial have a diagnosis of diabetes. \nRows 3-4: \nShow the conditions with the intervention in the trial are intended to address. The 2 rows for the same parameter are differentiated by their TSSEQ \nvalues. \nRow 5: \nShows that the intent of this trial is prevention of the conditions represented using the parameter \"Trial Indication\". \nts.xpt \nRow STUDYID DOMAIN TSSEQ TSGRPID TSPARMCD TSPARM \nTSVAL \nTSVALNF TSVALCD \nTSVCDREF TSVCDVER \n1 \nXYZ \nTS \n1 \n \nTITLE \nTrial Type \nA Study Comparing Cardiovascular Effects of Ticagrelor Versus \nPlacebo in Patients With Type 2 Diabetes Mellitus (THEMIS) \n \n \n \n \n2 \nXYZ \nTS \n1 \n \nTDIGRP \nDiagnosis \nGroup \nDiabetes mellitus type 2 \n \n44054006 \nSNOMED \n2017-03 \n3 \nXYZ \nTS \n1 \n \nINDIC \nTrial \nIndication \nCardiac infarction \n \n22298006 \nSNOMED \n2017-03 \n4 \nXYZ \nTS \n2 \n \nINDIC \nTrial \nIndication \nCerebrovascular accident \n \n230690007 SNOMED \n2017-01", "mimetype": "text/plain", "start_char_idx": 1973, "end_char_idx": 2984, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "40ff5d0c-4924-4f9a-b1aa-944557e5a9a7": {"__data__": {"id_": "40ff5d0c-4924-4f9a-b1aa-944557e5a9a7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 422, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a3252ef-d6bb-4ab5-a290-65a2405fe179", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 422, "section": "UNSPECIFIED"}, "hash": "dd27768c738e9e717c49c4fc22e0dd349405218a276c56bc7f072dc62e16a7b0", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5aed8f39-bf4b-45f9-9623-ee680f6955a1", "node_type": "1", "metadata": {}, "hash": "8358d9bcb73fafec27e6abcfe49151725cc71c79d932f594bc603c350f9e5dec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 422 \n2021-11-29 \nRow STUDYID DOMAIN TSSEQ TSGRPID TSPARMCD TSPARM \nTSVAL \nTSVALNF TSVALCD \nTSVCDREF TSVCDVER \n5 \nXYZ \nTS \n1 \n \nTINDTP \nTrial Intent \nType \nPREVENTION \n \nC49657 \nCDISC CT \n2017-03-01 \nExample 3 \nThis example shows how to implement the null flavor in TSVALNF when the value in TSVAL is missing. Note that when TSVAL is null, TSVALCD is also \nnull, and no code system is specified in TSVCDREF and TSVCDVER. \nRow 1: \nShows that there was no upper limit on planned age of subjects, as indicated by TSVALNF=\"PINF\" (the null value that means \"positive infinity\"). \nRow 2: \nShows that trial phase classification is not applicable, as indicated by TSVALNF=\"NA\". \nts.xpt \nRow STUDYID DOMAIN TSSEQ TSGRPID TSPARMCD TSPARM \nTSVAL TSVALNF TSVALCD TSVCDREF TSVCDVER \n1 \nXYZ \nTS \n1 \n \nAGEMAX \nPlanned Maximum Age of Subjects  \nPINF \n \n \n \n2 \nXYZ \nTS \n1 \n \nTPHASE \nTrial Phase Classification \n \nNA \n \n \n \nExample 4 \nThis example shows use of TSGRPID to group parameter values describing specific study parts (e.g., PHASE 1B, PHASE 3) and specific study treatments (e.g., \nDRUG X, DRUG Z). \nRows 1-6: \nShow parameters and values that apply to the whole trial (i.e., both Phase 1B and Phase 3 parts of the trial). TSGRPID is null for this set of \nparameters. \nRows 7-17: \nShow parameters and values that describe the Phase 1B part of the trial. TSGRPID is populated with a value of \"PHASE 1B\" for this set of \nparameters. \nRows 18-29: Show parameters and values that describe the Phase 3 part of the trial. TSGRPID is populated with a value of \"PHASE 3\" for this set of \nparameters. \nRows 30-33: Show parameters and values that describe details about 1 of the treatments planned in the trial. TSGRPID=\"DRUG X\" for this set of parameters. \nRows 34-37: Show parameters and values that describe details about 1 of the treatments planned in the trial. TSGRPID=\"DRUG Z\" for this set of parameters.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2069, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "5aed8f39-bf4b-45f9-9623-ee680f6955a1": {"__data__": {"id_": "5aed8f39-bf4b-45f9-9623-ee680f6955a1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 422, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6a3252ef-d6bb-4ab5-a290-65a2405fe179", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 422, "section": "UNSPECIFIED"}, "hash": "dd27768c738e9e717c49c4fc22e0dd349405218a276c56bc7f072dc62e16a7b0", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "40ff5d0c-4924-4f9a-b1aa-944557e5a9a7", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 422, "section": "UNSPECIFIED"}, "hash": "9edba40d5e0b2c62c07639510771533d1a36e11c682da83a963039231883ed46", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "TSGRPID is null for this set of \nparameters. \nRows 7-17: \nShow parameters and values that describe the Phase 1B part of the trial. TSGRPID is populated with a value of \"PHASE 1B\" for this set of \nparameters. \nRows 18-29: Show parameters and values that describe the Phase 3 part of the trial. TSGRPID is populated with a value of \"PHASE 3\" for this set of \nparameters. \nRows 30-33: Show parameters and values that describe details about 1 of the treatments planned in the trial. TSGRPID=\"DRUG X\" for this set of parameters. \nRows 34-37: Show parameters and values that describe details about 1 of the treatments planned in the trial. TSGRPID=\"DRUG Z\" for this set of parameters. \nts.xpt \nRow STUDYID DOMAIN TSSEQ TSGRPID TSPARMCD TSPARM \nTSVAL \nTSVALNF TSVALCD \nTSVCDREF TSVCDVER \n1 \nABC123 \nTS \n1 \n \nTITLE \nTrial Title \nA Phase 1b/3, Multicenter Trial of Drug Z in Combination with \nDrug X for Treatment of Melanoma \n \n \n \n \n2 \nABC123 \nTS \n1 \n \nINDIC \nTrial Indication \nMalignant melanoma \n \n372244006 SNOMED \n2018-09-01 \n3 \nABC123 \nTS \n1 \n \nSEXPOP \nSex of Participants \nBOTH \n \nC49636 \nCDISC CT \n2018-12-21 \n4 \nABC123 \nTS \n1 \n \nAGEMIN \nPlanned Minimum \nAge of Subjects \nP18Y \n \n \nISO 8601 \n \n5 \nABC123 \nTS \n1 \n \nAGEMAX \nPlanned Maximum \nAge of Subjects \n \nPINF \n \n \n \n6 \nABC123 \nTS \n1 \n \nHLTSUBJI \nHealthy Subject \nIndicator \nN \n \nC49487 \nCDISC CT \n2018-12-21 \n7 \nABC123 \nTS \n1 \nPHASE \n1B \nTPHASE \nTrial Phase \nClassification \nPHASE IB TRIAL \n \n \n \n \n8 \nABC123 \nTS \n1 \nPHASE \n1B \nTBLIND \nTrial Blinding \nSchema \nOPEN LABEL \n \nC49659 \nCDISC CT \n2018-12-21", "mimetype": "text/plain", "start_char_idx": 1391, "end_char_idx": 2947, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "660cff5d-bb06-4377-b87c-e8d18c65c74f": {"__data__": {"id_": "660cff5d-bb06-4377-b87c-e8d18c65c74f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 423, "section": "0.5 27"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6d46bc92-2755-4d0b-90f3-7f006a9355f0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 423, "section": "0.5 27"}, "hash": "b2cdc7c7f061e6ea917a8ddcb90eaec73bd6166f6fdd13117856a73d68b1de87", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ABC123 \nTS \n1 \nPHASE 3 \nOBJPRIM \nTrial Primary \nObjective \nTo evaluate the efficacy of combination therapy (Drug X + Drug \nZ) versus monotherapy (Drug X + Placebo), as assessed by \nprogression-free survival using RECIST 1.1 \n \n \n \n \n28 \nABC123 \nTS \n1 \nPHASE 3 \nOUTMEAS \nPrimary Outcome \nMeasure \nProgression Free Survival (response evaluation by blinded \ncentral review using RECIST 1.1) \n \n \n \n \n29 \nABC123 \nTS \n1 \nPHASE 3 \nCOMPTRT \nComparative \nTreatment \nDRUG X \n \n \n \n \n30 \nABC123 \nTS \n1 \nDRUG X \nDOSE \nDose per \nAdministration \n200 \n \n \n \n \n31 \nABC123 \nTS \n1 \nDRUG X \nDOSU \nDose Units \nmg \n \nC28253 \nCDISC CT \n2018-12-21 \n32 \nABC123 \nTS \n1 \nDRUG X \nDOSFRQ \nDosing Frequency \nEVERY WEEK \n \nC67069 \nCDISC CT \n2018-12-21 \n33 \nABC123 \nTS \n1 \nDRUG X \nROUTE \nRoute of \nAdministration \nORAL \n \nC38288 \nCDISC CT \n2018-12-21 \n34 \nABC123 \nTS \n1 \nDRUG Z \nDOSE \nDose per \nAdministration \n10000 \n \n \n \n \n35 \nABC123 \nTS \n1 \nDRUG Z \nDOSU \nDose Units \nPFU \n \nC67264 \nCDISC CT \n2018-12-21 \n36 \nABC123 \nTS \n1 \nDRUG Z \nDOSFRQ \nDosing Frequency \nEVERY 2 WEEKS \n \nC71127 \nCDISC CT \n2018-12-21 \n37 \nABC123 \nTS \n1 \nDRUG Z \nROUTE \nRoute of \nAdministration \nINTRATUMOR \n \nC38269 \nCDISC CT \n2018-12-21", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1180, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "92625e3f-078a-4863-8457-2ff1fda52318": {"__data__": {"id_": "92625e3f-078a-4863-8457-2ff1fda52318", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 424, "section": "7.4.2.1 Use of Null Flavor"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "334840fe-c0d9-44ac-ad83-e7814c616fbe", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 424, "section": "7.4.2.1 Use of Null Flavor"}, "hash": "5cf2f4333d4e99b996d27c24f3f2252ce03527027df4fcd6d8d9e9cec58465d3", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "82646e5a-a7c4-485d-91f8-73f67dde9d26", "node_type": "1", "metadata": {}, "hash": "8ba25c56d1923bd356e3ae0076afc674ba5f5ddd438bbd0ec9c7827f2495b303", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The variable TSVALNF is based on the idea of a \u201cnull flavor\u201d as embodied in the ISO 21090 standard (Health \nInformatics \u2013 Harmonized data types for information exchange; https://www.iso.org/standard/35646.html). A null \nflavor is an ancillary piece of data that provides additional information when its primary piece of data is null (has a \nmissing value). There is controlled terminology for the null flavor data item which includes such familiar values as \n\"Unknown\", \"Other\", and \"Not Applicable\" among its 14 terms. \nThe proposal to include a null flavor variable to supplement the TSVAL variable in the Trial Summary Information \n(TS) dataset arose when it was realized that the TS model did not have a good way to represent the fact that a \nprotocol placed no upper limit on the age of study subjects. When the trial summary parameter is AGEMAX, then \nTSVAL should have a value expressed as an ISO 8601 time duration (e.g., P43Y for 43 years old, P6M for 6 months \nold). Although it would be possible to allow a value such as \"NONE\" or \"UNBOUNDED\" to be entered in TSVAL, \nvalidation programs would then have to recognize this special term as an exception to the expected data format. \nTherefore, the SDS team decided that a separate null flavor variable that uses the ISO 21090 null-flavor terminology \nwould be a better solution. \nThe SDS Team also decided to specify the use of a null-flavor variable in the TS domain with SDTMIG v3.4 as a \nway of testing the use of such a variable in a limited setting. As the title of ISO 21090 suggests, that standard was \ndeveloped for use with healthcare data; it is expected that it will eventually see wide use in the clinical data from \nwhich clinical trial data are derived. CDISC already uses this data-type standard (see BRIDG; \nhttps://www.cdisc.org/standards/). The null flavor, in particular, is a solution to the widespread problem of needing \nor wanting to convey information that will help in the interpretation of a missing value. Although null flavors could \ncertainly be eventually used for this purpose in other cases (e.g., with subject data), doing so at this time would be \nextremely disruptive and premature. The use of null flavors for the variable TSVAL provides an opportunity for \nsponsors and reviewers to learn about the null flavors and to evaluate their usefulness in a concrete setting. \nThe controlled terminology for null flavor, which supersedes Appendix C1, Supplemental Qualifiers Name Codes, is \nincluded below. \nNullFlavor Enumeration. OID: 2.16.840.1.113883.5.1008 \n1 NI \nNo information The value is exceptional (i.e., missing, omitted, incomplete, improper). No information as to the reason \nfor being an exceptional value is provided. This is the most general exceptional value. It is also the \ndefault exceptional value. \n2 INV \nInvalid \nThe value as represented in the instance is not a member of the set of permitted data values in the \nconstrained value domain of a variable. \n3 OTH \nOther \nThe actual value is not a member of the set of permitted data values in the constrained value domain \nof a variable (e.g., concept not provided by required code system).", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3151, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "82646e5a-a7c4-485d-91f8-73f67dde9d26": {"__data__": {"id_": "82646e5a-a7c4-485d-91f8-73f67dde9d26", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 424, "section": "7.4.2.1 Use of Null Flavor"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "334840fe-c0d9-44ac-ad83-e7814c616fbe", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 424, "section": "7.4.2.1 Use of Null Flavor"}, "hash": "5cf2f4333d4e99b996d27c24f3f2252ce03527027df4fcd6d8d9e9cec58465d3", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "92625e3f-078a-4863-8457-2ff1fda52318", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 424, "section": "7.4.2.1 Use of Null Flavor"}, "hash": "b17980cc63449a8377d318f2de02e47c461dbfac333eb33ad9bd75adb5026a26", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The controlled terminology for null flavor, which supersedes Appendix C1, Supplemental Qualifiers Name Codes, is \nincluded below. \nNullFlavor Enumeration. OID: 2.16.840.1.113883.5.1008 \n1 NI \nNo information The value is exceptional (i.e., missing, omitted, incomplete, improper). No information as to the reason \nfor being an exceptional value is provided. This is the most general exceptional value. It is also the \ndefault exceptional value. \n2 INV \nInvalid \nThe value as represented in the instance is not a member of the set of permitted data values in the \nconstrained value domain of a variable. \n3 OTH \nOther \nThe actual value is not a member of the set of permitted data values in the constrained value domain \nof a variable (e.g., concept not provided by required code system). \n4 PINF \nPositive infinity Positive infinity of numbers \n4 NINF \nNegative \ninfinity \nNegative infinity of numbers \n3 UNC \nUnencoded \nNo attempt has been made to encode the information correctly, but the raw source information is \nrepresented (usually in original Text). \n3 DER \nDerived \nAn actual value may exist, but it must be derived from the information provided (usually an expression \nis provided directly). \n2 UNK \nUnknown \nA proper value is applicable, but not known. \n3 ASKU Asked but \nunknown \nInformation was sought but not found (e.g., patient was asked but didn't know). \n4 NAV \nTemporarily \nunavailable \nInformation is not available at this time, but is expected to be available later. \n3 NASK Not asked \nThis information has not been sought (e.g., patient was not asked). \n3 QS \nSufficient \nquantity \nThe specific quantity is not known, but is known to be non-zero and is not specified because it makes \nup the bulk of the material. For example, if directions said, \"Add 10 mg of ingredient X, 50 mg of \ningredient Y, and sufficient quantity of water to 100 ml\", the null flavor \"QS\" would be used to express \nthe quantity of water. \n3 TRC \nTrace \nThe content is greater than zero, but too small to be quantified. \n2 MSK \nMasked \nThere is information on this item available, but it has not been provided by the sender due to security, \nprivacy or other reasons. There may be an alternate mechanism for gaining access to this information.", "mimetype": "text/plain", "start_char_idx": 2365, "end_char_idx": 4604, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3bdc97fe-1a41-4f7f-b80b-c395945e6d12": {"__data__": {"id_": "3bdc97fe-1a41-4f7f-b80b-c395945e6d12", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 425, "section": "7.5 How to Model the Design of a Clinical Trial"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "41107b66-0840-4c4e-9e5b-c86eee3aa48c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 425, "section": "7.5 How to Model the Design of a Clinical Trial"}, "hash": "b06e773abdfe5ae228be4461c1ad26499365e1aec8703d43941be3b76eef7b2f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The following steps allow the modeler to move from more-familiar concepts, such as arms, to less-familiar concepts, \nsuch as elements and epochs. The actual process of modeling a trial may depart from these numbered steps. Some \nsteps will overlap; there may be several iterations; and not all steps are relevant for all studies. \n1. Start from the flow chart or schema diagram usually included in the trial protocol. This diagram will show \nhow many arms the trial has, and the branch points or decision points where the arms diverge. \n2. Write down the decision rule for each branching point in the diagram. Does the assignment of a subject to \nan arm depend on a randomization? On whether the subject responded to treatment? On some other \ncriterion? \n3. If the trial has multiple branching points, check whether all the branches that have been identified really \nlead to different arms. The arms will relate to the major comparisons the trial is designed to address. For", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 974, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9a7d948f-0a0d-4e9a-814a-4511f18fdd00": {"__data__": {"id_": "9a7d948f-0a0d-4e9a-814a-4511f18fdd00", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 426, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c5d758aa-9d5f-4e07-bca2-9e66dc661ed7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 426, "section": "UNSPECIFIED"}, "hash": "90da7c36eda28eade3b0e35a68004381b011b6eaafbe622c3ed84d5e3127c986", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 426 \n2021-11-29 \nsome trials, there may be a group of somewhat different paths through the trial that are all considered to \nbelong to a single arm. \n4. For each arm, identify the major time periods of treatment and non-treatment a subject assigned to that \narm will go through. These are the elements, or building blocks, of which the arm is composed. \n5. Define the starting point of each element. Define the rule for how long the element should last. Determine \nwhether the element is of fixed duration. \n6. Re-examine the sequences of elements that make up the various arms and consider alternative \nelement definitions. Would it be better to \u201csplit\u201d some elements into smaller pieces or \u201clump\u201d some \nelements into larger pieces? Such decisions will depend on the aims of the trial and plans for analysis. \n7. Compare the various arms. In most clinical trials, especially blinded trials, the pattern of elements will be \nsimilar for all arms, and it will make sense to define trial epochs. Assign names to these epochs. During the \nconduct of a blinded trial, it will not be known which arm a subject has been assigned to, or which \ntreatment elements they are experiencing, but the epochs they are passing through will be known. \n8. Identify the visits planned for the trial. Define the planned start timings for each visit, expressed relative to \nthe ordered sequences of elements that make up the arms. Define the rules for when each visit should end. \n9. For oncology trials or other trials with disease assessments that are not necessarily tied to visits, find the \nplanned timing of disease assessments in the protocol and record it in the Trial Disease Assessments (TD) \ndataset. \n10. If the protocol includes data collection that is triggered by the occurrence of certain events, interventions, \nor findings, record those triggers in the Trial Disease Milestones (TM) dataset. Note that disease milestones \nmay be pre- (e.g., disease diagnosis) or on-study. \n11. Identify the inclusion and exclusion criteria to be able to populate the Trial Inclusion/Exclusion Criteria \n(TI) dataset. If inclusion and exclusion criteria were amended so that subjects entered under different \nversions, populate TIVERS to represent the different versions. \n12. Populate the TS dataset with summary information.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2485, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3ffb4b22-d482-4815-b419-8c6e2245ae5c": {"__data__": {"id_": "3ffb4b22-d482-4815-b419-8c6e2245ae5c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 427, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bdd3480-78e3-4e1b-8a2f-56082cd10f98", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 427, "section": "UNSPECIFIED"}, "hash": "64abd632c1498e830e62fe0dbc4ef83c3f1392355a77c4fd3270c4b24deb7172", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "f453061d-c379-4dc4-8e36-d78e58496ac1", "node_type": "1", "metadata": {}, "hash": "7cfcb9c0321086af6ec88d3a7b9b974dc75c2b2c1ba84dd1551dbffd1252f995", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 427 \n2021-11-29 \n8 Representing Relationships and Data \nThe defined variables of the SDTM general observation classes could restrict the ability of sponsors to represent all \nthe data they wish to submit. Collected data that may not entirely fit includes relationships between records within a \ndomain, records in separate domains, and sponsor-defined \"variables.\" As a result, the SDTM has methods to \nrepresent distinct types of relationships, all of which are described in more detail in subsequent sections: \n\u2022\nSection 8.1, Relating Groups of Records Within a Domain Using the --GRPID Variable, describes\nrepresenting a relationship between a group of records for a given subject within the same domain.\n\u2022\nSection 8.2, Relating Peer Records, describes representing relationships between independent records\n(usually in separate domains) for a subject, such as a concomitant medication taken to treat an adverse\nevent.\n\u2022\nSection 8.3, Relating Datasets, describes representing a relationship between 2 (or more) datasets where\nrecords of 1 (or more) dataset(s) are related to record(s) in another dataset (or datasets).\n\u2022\nSection 8.4, Relating Non-standard Variable Values to a Parent Domain, describes the method for\nrepresenting the dependent relationship where data that cannot be represented by a standard variable within\nthe demographics domain (DM) or a general observation-class domain record (or records) can be related\nback to that record (or records).\n\u2022\nSection 8.5, Relating Comments to a Parent Domain, describes representing a dependent relationship\nbetween a comment in the Comments (CO) domain (see also Section 5.1, Comments) and a parent record\n(or records) in other domains, such as a comment recorded in association with an adverse event.\n\u2022\nSection 8.6, How to Determine Where Data Belong in SDTM-Compliant Data Tabulations, discusses the\nconcept of related datasets and whether to place additional data in a separate domain or a supplemental\nqualifier special-purpose dataset, and the concept of modeling findings data that refer to data in another\ngeneral observation class domain.\n\u2022\nSection 8.7, Relating Subjects, describes representing collected relationships between persons, both of\nwhom are study subjects. For example: \"MOTHER, BIOLOGICAL\"; \"CHILD, BIOLOGICAL\"; \"TWIN,\nDIZOGOTIC\".\n\u2022\nSection 8.8, Related Specimens, is a dataset used to represent relationships between specimens.\nAll relationships make use of the standard domain identifiers STUDYID, DOMAIN, and USUBJID. In addition, the \nvariables IDVAR and IDVARVAL are used for identifying the record-level merge/join keys. These keys are used to \ntie information together by linking records. The specific set of identifiers necessary to properly identify each type of \nrelationship is described in detail in the following sections. The following are examples of variables that could be \nused in IDVAR: \n\u2022\nThe sequence number (--SEQ) variable uniquely identifies a record for a given USUBJID within a domain.\nThe variable --SEQ is required in all domains except DM. For example, if a subject has 25 adverse events\nin the Adverse Event (AE) domain, then 25 unique AESEQ values should be established for this subject.\nConventions for establishing and maintaining --SEQ values are sponsor-defined. Values may or may not be\nsequential depending on data processes and sources.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3532, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "f453061d-c379-4dc4-8e36-d78e58496ac1": {"__data__": {"id_": "f453061d-c379-4dc4-8e36-d78e58496ac1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 427, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6bdd3480-78e3-4e1b-8a2f-56082cd10f98", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 427, "section": "UNSPECIFIED"}, "hash": "64abd632c1498e830e62fe0dbc4ef83c3f1392355a77c4fd3270c4b24deb7172", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3ffb4b22-d482-4815-b419-8c6e2245ae5c", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 427, "section": "UNSPECIFIED"}, "hash": "f42422f87d9005f99bae45a4f483c6e51d481c200451a737e0ab10c88d23e372", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "In addition, the \nvariables IDVAR and IDVARVAL are used for identifying the record-level merge/join keys. These keys are used to \ntie information together by linking records. The specific set of identifiers necessary to properly identify each type of \nrelationship is described in detail in the following sections. The following are examples of variables that could be \nused in IDVAR: \n\u2022\nThe sequence number (--SEQ) variable uniquely identifies a record for a given USUBJID within a domain.\nThe variable --SEQ is required in all domains except DM. For example, if a subject has 25 adverse events\nin the Adverse Event (AE) domain, then 25 unique AESEQ values should be established for this subject.\nConventions for establishing and maintaining --SEQ values are sponsor-defined. Values may or may not be\nsequential depending on data processes and sources.\n\u2022\nThe reference identifier (--REFID) variable can be used to capture a sponsor-defined or external identifier,\nsuch as an identifier provided in an electronic data transfer. Some examples are lab-specimen identifiers\nand ECG identifiers. --REFID is permissible in all general observation-class domains, but is never required.\nValues for --REFID are sponsor-defined and can be any alphanumeric strings the sponsor chooses,\nconsistent with their internal practices.\n\u2022\nThe grouping identifier (--GRPID) variable, used to link related records for a subject within a domain, is\nexplained in Section 8.1, Relating Groups of Records Within a Domain Using the --GRPID Variable.", "mimetype": "text/plain", "start_char_idx": 2679, "end_char_idx": 4202, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b4712b0f-fae9-47e8-a9f3-03b6d0cb39cd": {"__data__": {"id_": "b4712b0f-fae9-47e8-a9f3-03b6d0cb39cd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "8.1 Relating Groups of Records Within a Domain Using the --"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7bb5fbf9-72e1-4185-a112-a35bc5d08029", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "8.1 Relating Groups of Records Within a Domain Using the --"}, "hash": "8f128a6da838d0707dc66a539af2b8b2e096ec3ca53c71a5228fca9e93f0d6e6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "GRPID Variable \nThe optional grouping identifier variable --GRPID is Permissible in all domains that are based on the general \nobservation classes. It is used to identify relationships between records within a USUBJID within a single domain \n(e.g., intervention records for a combination therapy where treatments in the combination varies from subject to \nsubject). In such cases, the relationship is defined by assigning the same unique character value to the --GRPID \nvariable. The values used for --GRPID can be any values the sponsor chooses; however, if the sponsor uses values \nwith some embedded meaning (rather than arbitrary numbers), those values should be consistent across the \nsubmission to avoid confusion. It is important to note that --GRPID has no inherent meaning across subjects or \nacross domains. \nUsing --GRPID in the general-observation class domains can reduce the number of records in the RELREC, SUPP--\n, and CO datasets, when those datasets are submitted to describe relationships/associations for records or values to a \n\"group\" of general observation class records.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1094, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a17f9368-24e4-48f7-b4cf-1f562953191a": {"__data__": {"id_": "a17f9368-24e4-48f7-b4cf-1f562953191a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "8.1.1 --GRPID Example"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "fd6ecb25-da29-4603-8c7c-847d48028560", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "8.1.1 --GRPID Example"}, "hash": "2a61853d454544e73779d3bf38e182d34565fa9242c20e2406e2f8d970ebf399", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The following table illustrates --GRPID used in the Concomitant Medications (CM) domain to identify a \ncombination therapy. In this example, both subjects 1234 and 5678 have reported 2 combination therapies, each \nconsisting of 3 separate medications. The components of a combination all have the same value for CMGRPID. \nThis example illustrates how CMGRPID groups information only within a subject within a domain. \nRows 1-3: \nShow 3 medications taken by subject 1234. GMGRPID=\"COMBO THPY 1\" has been used to group \nthese medications. \nRows 4-6: \nShow 3 different medications taken by subject 1234, with CMGRPID=\"COMBO THPY 2\". \nRows 7-9: \nShow 3 medications taken by subject 5678. CMGRPID=\"COMBO THPY 1\" has been used to group \nthese medications. Note that the medications with GMGRPID \"COMBO THPY 1\" are completely \ndifferent for subjects 1234 and 5678. \nRows 10-12: Show 3 different medications taken by subject 5678, with CMGRPID=\u201cCOMBO THPY 2\u201d. Again, \nthe medications with \u201cCOMBO THPY 2\u201d are completely different for subjects 1234 and 5678. \ncm.xpt \nRow STUDYID DOMAIN USUBJID CMSEQ CMGRPID \nCMTRT \nCMDECOD \nCMDOSE CMDOSU CMSTDTC CMENDTC \n1 \n1234 \nCM \n1234 \n1 \nCOMBO \nTHPY 1 \nVerbatim Med \nA \nGeneric Med \nA \n100 \nmg \n2004-01-\n17 \n2004-01-\n19 \n2 \n1234 \nCM \n1234 \n2 \nCOMBO \nTHPY 1 \nVerbatim Med \nB \nGeneric Med \nB \n50 \nmg \n2004-01-\n17 \n2004-01-\n19 \n3 \n1234 \nCM \n1234 \n3 \nCOMBO \nTHPY 1 \nVerbatim Med \nC \nGeneric Med \nC \n200 \nmg \n2004-01-\n17 \n2004-01-\n19 \n4 \n1234 \nCM \n1234 \n4 \nCOMBO \nTHPY 2 \nVerbatim Med \nD \nGeneric Med \nD \n150 \nmg \n2004-01-\n21 \n2004-01-\n22 \n5 \n1234 \nCM \n1234 \n5 \nCOMBO \nTHPY 2 \nVerbatim Med \nE \nGeneric Med \nE \n100 \nmg \n2004-01-\n21 \n2004-01-\n22 \n6 \n1234 \nCM \n1234 \n6 \nCOMBO \nTHPY 2 \nVerbatim Med \nF \nGeneric Med \nF \n75 \nmg \n2004-01-\n21 \n2004-01-\n22 \n7 \n1234 \nCM \n5678 \n1 \nCOMBO \nTHPY 1 \nVerbatim Med \nG \nGeneric Med \nG", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1843, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0e974173-447e-4f5e-8258-4ef90159864c": {"__data__": {"id_": "0e974173-447e-4f5e-8258-4ef90159864c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "37.5 mg"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c4df8cc3-4a95-4ac8-9876-61aa3c88fe72", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 428, "section": "37.5 mg"}, "hash": "5376fc14c01768f2c3b624030c5b7cdb127476a0408ef4fd9d34d5c5bec32d48", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2004-03-\n17 \n2004-03-\n25 \n8 \n1234 \nCM \n5678 \n2 \nCOMBO \nTHPY 1 \nVerbatim Med \nH \nGeneric Med \nH \n60 \nmg \n2004-03-\n17 \n2004-03-\n25 \n9 \n1234 \nCM \n5678 \n3 \nCOMBO \nTHPY 1 \nVerbatim Med \nI \nGeneric Med I 20 \nmg \n2004-03-\n17 \n2004-03-\n25 \n10 \n1234 \nCM \n5678 \n4 \nCOMBO \nTHPY 2 \nVerbatim Med \nJ \nGeneric Med \nJ \n100 \nmg \n2004-03-\n21 \n2004-03-\n22 \n11 \n1234 \nCM \n5678 \n5 \nCOMBO \nTHPY 2 \nVerbatim Med \nK \nGeneric Med \nK \n50 \nmg \n2004-03-\n21 \n2004-03-\n22 \n12 \n1234 \nCM \n5678 \n6 \nCOMBO \nTHPY 2 \nVerbatim Med \nL \nGeneric Med \nL \n10 \nmg \n2004-03-\n21 \n2004-03-\n22", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 546, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "0e3da09d-c538-46f8-80ac-eeed4a321867": {"__data__": {"id_": "0e3da09d-c538-46f8-80ac-eeed4a321867", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 429, "section": "8.2 Relating Peer Records"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c6c3138d-c4ea-41c5-82a0-9d6cbba3976b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 429, "section": "8.2 Relating Peer Records"}, "hash": "0a8adfcd97cf4772bb64676ff3c80142514481c5f1bc98842ccce079e750b056", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Related Records (RELREC) special-purpose dataset is used to describe relationships between records for a \nsubject (as described in this section), and relationships between datasets (as described in Section 8.3, Relating \nDatasets). In both cases, relationships represented in RELREC are collected relationships, either by explicit \nreferences or checkboxes on the CRF, or by design of the CRF (e.g., vital signs captured during an exercise stress \ntest). \nA relationship is defined by adding a record to RELREC for each record to be related and by assigning a unique \ncharacter identifier value for the relationship. Each record in the RELREC special-purpose dataset contains keys that \nidentify a record (or group of records) and the relationship identifier, which is stored in the RELID variable. The \nvalue of RELID is chosen by the sponsor, but must be identical for all related records within USUBJID. It is \nrecommended that the sponsor use a standard system or naming convention for RELID (e.g., all letters, all numbers, \ncapitalized). \nRecords expressing a relationship are specified using the key variables STUDYID, RDOMAIN (the domain code of \nthe record in the relationship), and USUBJID, along with IDVAR and IDVARVAL. Single records can be related by \nusing a unique-record-identifier variable such as --SEQ in IDVAR. Groups of records can be related by using \ngrouping variables such as --GRPID in IDVAR. IDVARVAL would contain the value of the variable described in \nIDVAR. Using --GRPID can be a more efficient method of representing relationships in RELREC, such as when \nrelating an adverse event (or events) to a group of concomitant medications taken to treat the adverse event(s). \nThe RELREC dataset should be used to represent either: \n\u2022 \nexplicit relationships, such as concomitant medications taken as a result of an adverse event; or \n\u2022 \ninformation of a nature that necessitates using multiple datasets, as described in Section 8.3, Relating \nDatasets.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1984, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a8c1ed72-e745-4273-acb6-91deaf16c3af": {"__data__": {"id_": "a8c1ed72-e745-4273-acb6-91deaf16c3af", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 429, "section": "8.2.1 Related Records (RELREC)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0a0b2be5-12d8-4c32-80b0-fbc723405f61", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 429, "section": "8.2.1 Related Records (RELREC)"}, "hash": "69f7286d782cf143682f7d2961b209ea1fdd33fab6aed21a5e6d54088d21f55b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RELREC - Description/Overview \nA dataset used to describe relationships between records for a subject within or across domains, and relationships of \nrecords across datasets. \nRELREC \u2013 Specification \nrelrec.xpt, Related Records \u2014 Relationship. One record per related record, group of records or \ndataset, Tabulation. \nVariable \nName \nVariable \nLabel \nType Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier Char  \nIdentifier \nUnique identifier for a study. \nReq \nRDOMAIN \nRelated \nDomain \nAbbreviation \nChar (DOMAIN) \nIdentifier \nAbbreviation for the domain of the parent record(s). \nReq \nUSUBJID \nUnique \nSubject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for \nall applications or submissions involving the product. \nExp \nIDVAR \nIdentifying \nVariable \nChar * \nIdentifier \nName of the identifying variable in the general-observation-class \ndataset that identifies the related record(s). Examples: --SEQ, --\nGRPID. \nReq \nIDVARVAL \nIdentifying \nVariable Value \nChar  \nIdentifier \nValue of identifying variable described in IDVAR. If --SEQ is the \nvariable being used to describe this record, then the value of --\nSEQ would be entered here. \nExp \nRELTYPE \nRelationship \nType \nChar (RELTYPE) \nRecord \nQualifier \nIdentifies the hierarchical level of the records in the relationship. \nValues should be either \"ONE\" or \"MANY\". Used only when \nidentifying a relationship between datasets (as described in \nSection 8.3, Relating Datasets). \nExp \nRELID \nRelationship \nIdentifier \nChar  \nRecord \nQualifier \nUnique value within USUBJID that identifies the relationship. All \nrecords for the same USUBJID that have the same RELID are \nconsidered related/associated. RELID can be any value the \nsponsor chooses, and is only meaningful within the RELREC \ndataset to identify the related/associated domain records. \nReq \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2060, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bf6400e9-68e4-432d-8258-2a9e01fa2e0f": {"__data__": {"id_": "bf6400e9-68e4-432d-8258-2a9e01fa2e0f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 430, "section": "8.2.2 RELREC Dataset Examples"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "32696bea-6ff2-4b60-a5da-5c5b7d62f06c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 430, "section": "8.2.2 RELREC Dataset Examples"}, "hash": "15fc0900c990988acac07158fa1e687336ee19708c4816675126fb5a857d90d6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example 1 \nThis example illustrates the use of the RELREC dataset to relate records stored in separate domains for USUBJID = \n\"123456\". This example represents a situation in which a single adverse event is part of 2 collected relationships, \none with 2 concomitant medications and the other with 2 laboratory findings, but there is no collected relationship \nbetween the 2 laboratory findings and the 2 concomitant medications. \nRows 1-3: \nShow the representation of a relationship between an AE record and 2 concomitant medication records. \nRows 4-6: \nShow the representation of a relationship between the same AE record and 2 laboratory findings \nrecords. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nEFC1234 AE \n123456 \nAESEQ 5 \n \n1 \n2 \nEFC1234 CM \n123456 \nCMSEQ 11 \n \n1 \n3 \nEFC1234 CM \n123456 \nCMSEQ 12 \n \n1 \n4 \nEFC1234 AE \n123456 \nAESEQ 5 \n \n2 \n5 \nEFC1234 LB \n123456 \nLBSEQ \n47 \n \n2 \n6 \nEFC1234 LB \n123456 \nLBSEQ \n48 \n \n2 \nExample 2 \nExample 2 is the same scenario as Example 1. In this case, however, the way the data were collected indicated that \nthe concomitant medications and laboratory findings were all in a single relationship to each other and the adverse \nevent. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nEFC1234 AE \n123456 \nAESEQ 5 \n \n1 \n2 \nEFC1234 CM \n123456 \nCMSEQ 11 \n \n1 \n3 \nEFC1234 CM \n123456 \nCMSEQ 12 \n \n1 \n4 \nEFC1234 LB \n123456 \nLBSEQ \n47 \n \n1 \n5 \nEFC1234 LB \n123456 \nLBSEQ \n48 \n \n1 \nExample 3 \nExample 3 is the same scenario as Example 2. However, the sponsor grouped the 2 concomitant medications in the \nCM domain using CMGRPID = \u201cCOMBO 1\u201d, allowing the relationship among these 5 records to be represented \nwith 4, rather than 5, records in the RELREC dataset. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nEFC1234 AE \n123456 \nAESEQ \n5 \n \n1 \n2 \nEFC1234 CM \n123456 \nCMGRPID COMBO1 \n \n1 \n3 \nEFC1234 LB \n123456 \nLBSEQ \n47 \n \n1 \n4 \nEFC1234 LB \n123456 \nLBSEQ \n48 \n \n1 \nAdditional examples may be found in the domain examples such as Section 6.2.4, Disposition, Example 4, and all of \nthe Pharmacokinetics examples in Section 6.3.5.9.3, Relating PP Records to PC Records.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2187, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8a474dd1-d275-44f7-a397-ab3b350ca041": {"__data__": {"id_": "8a474dd1-d275-44f7-a397-ab3b350ca041", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 430, "section": "8.3 Relating Datasets"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3e773a27-c45f-4d6b-a1ec-12225542f4db", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 430, "section": "8.3 Relating Datasets"}, "hash": "f6f48c4524bfa79f3274eebd56bdae492c594335446bd3315fb2fbb17265b961", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Related Records (RELREC) special-purpose dataset can also be used to identify relationships between datasets \n(e.g., a one-to-many or parent-child relationship). The relationship is defined by including a single record for each \nrelated dataset that identifies the key(s) of the dataset that can be used to relate the respective records. \nRelationships between datasets should only be recorded in the RELREC dataset when the sponsor has found it \nnecessary to split information between datasets that are related, and that may need to be examined together for \nanalysis or proper interpretation. Note that it is not necessary to use the RELREC dataset to identify associations \nfrom data in the SUPP-- datasets or the Comments (CO) dataset to their parent general-observation class dataset \nrecords or special-purpose domain records, as both these datasets include the key variable identifiers of the parent \nrecord(s) that are necessary to make the association.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 965, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "d280de3c-49f4-4441-b1d2-ff9ec2bc9db0": {"__data__": {"id_": "d280de3c-49f4-4441-b1d2-ff9ec2bc9db0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 431, "section": "8.3.1 RELREC Dataset Relationship Example"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e8e02b64-8d30-4aff-ab71-9b7bb0a3376c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 431, "section": "8.3.1 RELREC Dataset Relationship Example"}, "hash": "033a00e82d6bf0ef952d6ce45c55f44978e915dc15ead8d3bf3dee862641cc99", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Example 1 \nThis example illustrates RELREC records used to represent the relationship between records in 2 datasets that have \na one-to-many relationship. Note that because this is a dataset-to-dataset relationship, USUBJID and IDVARVAL \nare null. \nrelrec.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL RELTYPE RELID \n1 \nEFC1234 TU \n \nTULNKID  \nONE \n1 \n2 \nEFC1234 TR \n \nTRLNKID  \nMANY \n1 \nIn the sponsor's operational database, these datasets may have existed as either separate datasets that were merged \nfor analysis, or a single dataset that may have included observations from more than 1 general observation class \n(e.g., Events and Findings). The value in IDVAR must be the name of the key used to merge/join the 2 datasets. In \nthis example, the --LNKID variable is used as the key to identify the related observations. The values for the \n\u2011\u2011LNKID variable in the 2 datasets are sponsor-defined. Although other variables may also serve as a single merge \nkey when the corresponding values for IDVAR are equal, --GRPID, --SPID, --REFID, --LNKID, or --LNKGRP are \ntypically used for this purpose. \nThe variable RELTYPE identifies the type of relationship between the datasets. The allowable values are ONE and \nMANY (controlled terminology is expected). This information defines how a merge/join would be written, and what \nwould be the result of the merge/join. The possible combinations are: \n1. ONE and ONE. This combination indicates that there is NO hierarchical relationship between the datasets \nand the records in the datasets. Only 1 record from each dataset will potentially have the same value of the \nIDVAR within USUBJID. \n2. ONE and MANY. This combination indicates that there IS a hierarchical (parent-child) relationship \nbetween the datasets. One record within USUBJID in the dataset identified by RELTYPE = \"ONE\" will \npotentially have the same value of the IDVAR with many (1 or more) records in the dataset identified by \nRELTYPE = \"MANY\". \n3. MANY and MANY. This combination is unusual and challenging to manage in a merge/join, and may \nrepresent a relationship that was never intended to convey a usable merge/join, such as described in Section \n6.3.5.9.3, Relating PP Records to PC Records. \nBecause IDVAR identifies the keys that can be used to merge/join records between the datasets, --SEQ cannot be \nused. --SEQ only has meaning within a subject within a dataset, not across datasets.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2419, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "715d5b7e-9743-484b-b0fc-d9d569461a00": {"__data__": {"id_": "715d5b7e-9743-484b-b0fc-d9d569461a00", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 431, "section": "8.4 Relating Non-standard Variable Values to a Parent"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "09e342e1-1ebc-4272-8ad5-8c06e7d9778a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 431, "section": "8.4 Relating Non-standard Variable Values to a Parent"}, "hash": "14adecaa065027150d019dede9fc193df91f05f5985edea2163a77f40ad4dbd8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Domain \nThe SDTM does not allow the addition of new variables. Therefore, the Supplemental Qualifiers special-purpose \ndataset model is used to capture non-standard variables (NSVs) and their association to parent records in general-\nobservation class datasets (Events, Findings, Interventions), Demographics (DM), and Subject Visits (SV). \nSupplemental qualifiers are represented as separate SUPP-- datasets for each dataset containing sponsor-defined \nvariables (see Section 8.4.2, Submitting Supplemental Qualifiers in Separate Datasets). \nSUPP-- represents the metadata and data for each NSV/value combination. As the name suggests, this dataset is \nintended to capture additional qualifiers for an observation. Data that represent separate observations should be \ntreated as separate observations. The Supplemental Qualifiers dataset is structured similarly to the RELREC dataset, \nin that it uses the same set of keys to identify parent records. Each SUPP-- record also includes the name of the \nqualifier variable being added (QNAM), the label for the variable (QLABEL), the actual value for each instance or \nrecord (QVAL), the origin (QORIG) of the value (see Section 4.1.8, Origin Metadata), and the evaluator (QEVAL) \nto specify the role of the individual who assigned the value (e.g., \"ADJUDICATION COMMITTEE\", \n\"SPONSOR\"). Controlled terminology for certain expected values for QNAM and QLABEL is included in \nAppendix C1, Supplemental Qualifiers Name Codes.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1471, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9da83d00-c20c-4e4b-bf4e-e71ddd618dcc": {"__data__": {"id_": "9da83d00-c20c-4e4b-bf4e-e71ddd618dcc", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 432, "section": "8.4.1 Supplemental Qualifiers (SUPP--)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "97f2c2de-83a2-49f0-8d33-62717964451d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 432, "section": "8.4.1 Supplemental Qualifiers (SUPP--)"}, "hash": "2b8f4ac2788da9c52f52c07b67523a169cb4971c6999685d5632186c2318cfc3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "supp--.xpt, Supplemental Qualifiers for [domain name] \u2014 Relationship. One record per \nsupplemental qualifier per related parent domain record(s), Tabulation. \nVariable \nName \nVariable \nLabel \nType Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy \nIdentifier \nChar \n \nIdentifier \nStudy identifier of the parent record(s). \nReq \nRDOMAIN \nRelated \nDomain \nAbbreviation \nChar \n(DOMAIN) \nIdentifier \nTwo-character abbreviation for the domain of the parent record(s). \nReq \nUSUBJID \nUnique \nSubject \nIdentifier \nChar \n \nIdentifier \nIdentifier used to uniquely identify a subject across all studies for all \napplications or submissions involving the product. This is the value of \nUSUBJID in the parent record(s). \nReq \nIDVAR \nIdentifying \nVariable \nChar \n* \nIdentifier \nIdentifying variable in the dataset that identifies the related record(s). \nExamples: --SEQ, --GRPID. \nExp \nIDVARVAL \nIdentifying \nVariable Value \nChar \n \nIdentifier \nValue of identifying variable of the parent record(s). \nExp \nQNAM \nQualifier \nVariable Name \nChar \n* \nTopic \nThe short name of the qualifier variable, which is used as a column \nname in a domain view with data from the parent domain. The value in \nQNAM cannot be longer than 8 characters, nor can it start with a \nnumber (e.g., \"1TEST\" is not valid). QNAM cannot contain characters \nother than letters, numbers, or underscores. This will often be the \ncolumn name in the sponsor's operational dataset. \nReq \nQLABEL \nQualifier \nVariable Label \nChar \n \nSynonym \nQualifier \nThis is the long name or label associated with QNAM. The value in \nQLABEL cannot be longer than 40 characters. This will often be the \ncolumn label in the sponsor's original dataset. \nReq \nQVAL \nData Value \nChar \n \nResult \nQualifier \nResult of, response to, or value associated with QNAM. A value for this \ncolumn is required; no records can be in SUPP-- with a null value for \nQVAL. \nReq \nQORIG \nOrigin \nChar \n \nRecord \nQualifier \nBecause QVAL can represent a mixture of collected (on a CRF), \nderived, or assigned items, QORIG is used to indicate the origin of this \ndata. Examples: \"CRF\", \"Assigned\", \"Derived\". See Section 4.1.8, Origin \nMetadata. \nReq \nQEVAL \nEvaluator \nChar \n(EVAL) \nRecord \nQualifier \nUsed only for results that are subjective (e.g., assigned by a person or a \ngroup). Should be null for records that contain objectively collected or \nderived data. Examples: \"ADJUDICATION COMMITTEE\", \n\"STATISTICIAN\", \"DATABASE ADMINISTRATOR\", \"CLINICAL \nCOORDINATOR\". \nExp \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed in \nparentheses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2676, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "725356ed-7b47-4c1b-83fd-af18b53537a4": {"__data__": {"id_": "725356ed-7b47-4c1b-83fd-af18b53537a4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 433, "section": "8.4.2 Submitting Supplemental Qualifiers in Separate Datasets"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be350762-028d-4c47-a398-24816b706c87", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 433, "section": "8.4.2 Submitting Supplemental Qualifiers in Separate Datasets"}, "hash": "3f80c0b3a3bf1cc5a63f573d701633f46c0835db0c3157ca631c5f084136d7bc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "There is a one-to-one correspondence between a domain dataset and its Supplemental Qualifier dataset. The single \nSUPPQUAL dataset option that was introduced in SDTMIG v3.1 was deprecated. The set of supplemental qualifiers \nfor each domain is included in a separate dataset with the name SUPP-- (where \"--\" denotes the source \ndomain which the supplemental qualifiers relate back to). For example, Demographics (DM) qualifiers would be \nsubmitted in suppdm.xpt. When data have been split into multiple datasets (see Section 4.1.7, Splitting Domains), \nlonger names such as SUPPFAMH may be needed. In cases where data about associated persons have been \ncollected, supplemental qualifiers for Findings About events or interventions for an associated person may need to \nbe represented (see the SDTMIG for Associated Persons, https://www.cdisc.org/standards/foundational/sdtmig/). A \ndataset name with the SUPP fragment (e.g., SUPPAPFAMH) would be too long. In this case only, the \u201cSUPP\u201d \nportion should be shortened to \u201cSQ\u201d (e.g., resulting in the dataset name SQAPFAMH.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1070, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "07aff125-6b7c-4414-b261-82582d482709": {"__data__": {"id_": "07aff125-6b7c-4414-b261-82582d482709", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 433, "section": "8.4.3 SUPP-- Examples"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f6d2e636-1c20-4db5-b1ce-26059ec0e8f3", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 433, "section": "8.4.3 SUPP-- Examples"}, "hash": "621f1487f6f19940efe6bb7129ad879e3c44de74c392aefd3679384b7d385236", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "These examples llustrate how a set of SUPP-- datasets could be used to relate non-standard information to a parent \ndomain. \nExample 1 \nThe 2 rows of suppae.xpt add qualifying information to adverse event data (RDOMAIN = \"AE\"). IDVAR defines \nthe key variable used to link this information to the AE data (AESEQ). IDVARVAL specifies the value of the key \nvariable within the parent AE record to which the SUPPAE record applies. The remaining columns specify the \nsupplemental variables\u2019 names (AESOSP and AETRTEM), labels, values, origin, and who made the evaluation. \nsuppae.xpt \nRow STUDYID RDOMAIN USUBJID IDVAR \nIDVARVAL QNAM \nQLABEL \nQVAL \nQORIG QEVAL \n1 \n1996001 \nAE \n99-401 \nAESEQ 1 \nAESOSP \nOther Medically \nImportant SAE \nSpontaneous \nAbortion \nCRF \n \n2 \n1996001 \nAE \n99-401 \nAESEQ 1 \nAETRTEM Treatment Emergent \nFlag \nN \nDerived SPONSOR \nExample \nThis example illustrates how the language used for a questionnaire might be represented. The parent domain \n(RDOMAIN) is QS, and IDVAR is QSCAT. QNAM holds the name of the supplemental qualifier variable being \ndefined (QSLANG). The language recorded in QVAL applies to all of the subject\u2019s records, where IDVAR \n(QSCAT) equals the value specified in IDVARVAL. In this case, IDVARVAL has values for 2 questionnaires\u2014\nBrief Pain Inventory (BPI) and Alzheimer's Disease Assessment Scale\u2013Cognitive Subscale (ADAS-Cog)\u2014for 2 \nseparate subjects. QVAL identifies the questionnaire language version (French or German) for each subject.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1485, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "272250f2-8c85-47c6-9d67-898267e3c5b1": {"__data__": {"id_": "272250f2-8c85-47c6-9d67-898267e3c5b1", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 434, "section": "8.4.4 When Not to Use Supplemental Qualifiers"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b839f269-0355-4f87-9f73-81ead996a694", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 434, "section": "8.4.4 When Not to Use Supplemental Qualifiers"}, "hash": "082ad9a96598390cd18deb2e7f5e0ea836fc393faa8ee4aa57ed1150cacc71bb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The following are examples of data that should not be submitted as supplemental qualifiers: \n\u2022 \nSubject-level objective data that fit in Subject Characteristics (SC; e.g., national origin, twin type) \n\u2022 \nFindings interpretations that should be added as an additional test code and result. An example of this \nwould be a record for electrocardiogram interpretation where EGTESTCD = \u201cINTP\u201d, and the same \nEGGRPID or EGREFID value would be assigned for all records associated with that ECG (see Section \n4.5.5, Clinical Significance for Findings Observation Class Data). \n\u2022 \nComments related to a record or records contained within a parent dataset. Although they may have been \ncollected in the same record by the sponsor, comments should instead be captured in the CO special-\npurpose domain. \n\u2022 \nData not directly related to records in a parent domain. Such records should instead be captured in either a \nseparate general observation class domain or special-purpose domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 974, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b81e596e-f3a2-4184-9f21-2c9f0dc7355b": {"__data__": {"id_": "b81e596e-f3a2-4184-9f21-2c9f0dc7355b", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 434, "section": "8.5 Relating Comments to a Parent Domain"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "dbf97873-d5a8-4f59-85e8-a491f7808f0e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 434, "section": "8.5 Relating Comments to a Parent Domain"}, "hash": "73bdb115b9dcf5094a2102cc4348e1027300477bfc24e13a908597a345ebc609", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Comments (CO) special-purpose domain (see Section 5.1, Comments) is used to capture unstructured free-text \ncomments. It allows for the submission of comments related to a particular domain (e.g., Adverse Events) or those \ncollected on separate general-comment log-style pages not associated with a domain. Comments may be related to a \nsubject, a domain for a subject, or to specific parent records in any domain. The CO special-purpose domain is \nstructured similarly to the Supplemental Qualifiers (SUPP--) dataset, in that it uses the same set of keys (STUDYID, \nRDOMAIN, USUBJID, IDVAR, and IDVARVAL) to identify related records. \nAll comments except those collected on log-style pages not associated with a domain are considered child records of \nsubject data captured in domains. STUDYID, USUBJID, and DOMAIN (with the value CO) must always be \npopulated. RDOMAIN, IDVAR, and IDVARVAL should be populated as follows: \n1. Comments related only to a subject in general (likely collected on a log-style CRF page/screen) would have \nRDOMAIN, IDVAR, IDVARVAL null, as the only key needed to identify the relationship/association to \nthat subject is USUBJID. \n2. Comments related only to a specific domain (and not to any specific records) for a subject would populate \nRDOMAIN with the domain code for the domain with which they are associated. IDVAR and IDVARVAL \nwould be null. \n3. Comments related to specific domain record(s) for a subject would populate the RDOMAIN, IDVAR, and \nIDVARVAL variables with values that identify the specific parent record(s). \nFor additional information collected further describing the comment relationship to a parent record(s) that cannot be \nrepresented using the relationship variables RDOMAIN, IDVAR and IDVARVAL: \n1. Values (e.g., CRF page number or name) may be placed in COREF. \n2. Timing variables (e.g., VISITNUM, VISIT) may be added to the CO special-purpose domain. See Section \n5.1, Comments, assumption 5 for a complete list of identifier and timing variables that can be added to the \nCO special-purpose domain. \nAs with Supplemental Qualifiers (SUPP--) and Related Records (RELREC), --GRPID and other grouping variables \ncan be used as the value in IDVAR to identify comments with relationships to multiple domain records, for example \na comment that applies to a group of concomitant medications, perhaps taken as a combination therapy. The", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2398, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b770b72a-34fc-40b4-ad4e-8c66bf22c76c": {"__data__": {"id_": "b770b72a-34fc-40b4-ad4e-8c66bf22c76c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 435, "section": "8.6.1 Guidelines for Determining the General Observation Class"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "f81cb997-ad85-4462-a817-eb6293923ace", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 435, "section": "8.6.1 Guidelines for Determining the General Observation Class"}, "hash": "69055fe25456edad9fbc5f9c4ea0ff32ce8c262b9a739cec589655ef0b5c4a42", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Section 2.6, Creating a New Domain, discusses when to place data in an existing domain and how to create a new \ndomain. A key part of the process of creating a new domain is determining whether an observation represents an \nevent, an intervention, or a finding. Begin by considering the content of the information in the light of the definitions \nof the 3 general observation classes (see Section 2.3, The General Observation Classes), rather than by trying to \ndeduce the class from the information's physical structure; physical structure can sometimes be misleading. For \nexample, from a structural standpoint, one might expect events observations to include a start and stop date. \nHowever, medical history data (data about previous conditions or events) is events data regardless of whether dates \nwere collected. \nAn intervention is something that is done to a subject (possibly by the subject) that is expected to have a \nphysiological effect. This concept of intended effect makes interventions relatively easy to recognize, although there \nare gray areas around some testing procedures. For example, exercise stress tests are designed to produce and then \nmeasure certain physiological effects. The measurements from such a testing procedure are findings, although some \naspects of the procedure might be modeled as interventions. \nAn event is something that happens to a subject spontaneously. Most, although not all, events data captured in \nclinical trials is about medical events. Because many medical events must, by regulation, be treated as adverse \nevents, a new Events domain will be created only for events that are clearly not adverse events; the existing Medical \nHistory (MH) and Clinical Events (CE) domains are the appropriate places to store most medical events that are not \nadverse events. Many aspects of medical events\u2014including tests performed to evaluate them, interventions that may \nhave caused them, and interventions given to treat them\u2014may be collected in clinical trials. Where to place data on \nassessments of events can be particularly challenging, and is discussed further in Section 8.6.3, Guidelines for \nDifferentiating Between Interventions, Events, Findings, and Findings About Events or Interventions. \nFindings general observation class data include measurements, tests, assessments, or examinations performed on a \nsubject in the clinical trial. These may be performed on the subject as a whole (e.g., height, heart rate), or on a \nspecimen taken from a subject (e.g., blood sample, ECG tracing, tissue sample). Sometimes the relationship between \na subject and a finding is less direct; a finding may be about an event that happened to the subject or an intervention \nreceived. Findings about events and interventions are discussed further in Section 8.6.3, Guidelines for \nDifferentiating Between Interventions, Events, Findings, and Findings About Events or Interventions.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2923, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "60ee5fe7-08b3-43f6-9ef8-2d0dc127e5f4": {"__data__": {"id_": "60ee5fe7-08b3-43f6-9ef8-2d0dc127e5f4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 435, "section": "8.6.2 Guidelines for Forming New Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c0fed31f-5e8c-4f33-a2e3-ad634048ba78", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 435, "section": "8.6.2 Guidelines for Forming New Domains"}, "hash": "52751cf0483ca072e1fad90886c5c575438558e66f2e1d65aecf5d903f9eafe4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "It may not always be clear whether a set of data represents a single topic or more, and thus whether it should be \ncombined into 1 domain or split into 2 or more domains. This implementation guide shows examples of both. \nIn some cases, a single data structure works well for a variety of types of data. For example, all questionnaire data \nare placed in the QS domain, with particular questionnaires identified by QSCAT (see Section 6.3.9, Questionnaires, \nRatings, and Scales (QRS) Domains (FT, QS, RS)). Although some operational databases may store urinalysis data \nin a separate dataset, the SDTM places all lab data in the LB domain (see Section 6.3.5.6, Laboratory Test Results \n(LB)) with urinalysis tests identified using LBSPEC. \nIn other cases, a particular topic may be very broad and/or require more than 1 data structure (and therefore require \nmore than 1 dataset). This implementation guide includes examples in microbiology and pharmacokinetics (see \nSection 6.3.5.7, Microbiology Domains, and Section 6.3.5.9, Pharmacokinetics Domains). These examples use 2 \ndomain datasets because within these scientific areas there is more than 1 topic, and each topic results in a different \ndata structure. In the Pharmacokinetics domain example, the topic for PC is plasma (or other specimen) drug", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1305, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "731f1637-f8ee-4f89-9f47-0d2fe69fd9ad": {"__data__": {"id_": "731f1637-f8ee-4f89-9f47-0d2fe69fd9ad", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 436, "section": "8.6.3 Guidelines for Differentiating Between Interventions, Events,"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6e18cf07-cbd2-4513-8156-635a63f903e9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 436, "section": "8.6.3 Guidelines for Differentiating Between Interventions, Events,"}, "hash": "727685c365e86e1ec26a265298bf04d71e49b56c56f1fb9557a40658cfdc15b9", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "37b12b78-518a-4f05-b55d-49772679d9d4", "node_type": "1", "metadata": {}, "hash": "6030ac836c7a0f11ee688ebbec61e5428b9336d84f0dbad9601b053160cdd6f1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Findings, and Findings About Events or Interventions \nThis section discusses events, findings, and findings about events. The relationship between interventions, findings, \nand findings about interventions would be handled similarly. \nThe Findings About (FA) domain was initially created to represent findings about events, but can also be used for \nfindings about interventions. This section discusses events and findings generally, but it is particularly useful for \nunderstanding the distinction between the Clinical Events (CE) and FA domains. \nThere may be several sources of confusion about whether a particular piece of data belongs in an Event record or a \nFindings record. Although an \"event\" is generally perceived as something that happens spontaneously, and has a \nbeginning and end, one should consider the following: \n\u2022 \nEvents of interest in a particular trial may be prespecified, rather than collected as free text. \n\u2022 \nSome events may be so long-lasting that they are perceived as \"conditions\" rather than events, and their \nbeginning and end dates are not of interest. \n\u2022 \nSome variables or data items one generally expects to see in an Events record may not be present. For \nexample, a post-marketing study might collect the occurrence of certain adverse events, but no dates. \n\u2022 \nProperties of an event may be measured or assessed, and these are then treated as findings about events, \nrather than as events. \n\u2022 \nSome assessments of events (e.g., severity, relationship to study treatment) have been built into the SDTM \nEvents model as qualifiers, rather than being treated as findings about events. \n\u2022 \nSponsors may choose how they define an event. See Section 6.2.1, Adverse Events, assumption 7e. \nThe structure of the data being considered, although not definitive, will often help determine whether the data \nrepresent as an event or a finding. The following table presents questions that may assist sponsors in deciding where \ndata should be placed in SDTM. \nQuestion \nInterpretation of Answers \nIs this a measurement, with \nunits, etc.? \n\u2022 A \u201cYes\u201d answer indicates a finding. If the measurement is of some aspect of an event, it may be \nrepresented as a finding about the event. \n\u2022 A \u201cNo\u201d answer is inconclusive. \nAre the data collected in a \nCRF for each visit, or an \noverall CRF log form? \n\u2022 Log forms (forms that are completed over the course of the study rather than at a single visit) \nsuggest Events or Interventions general observation class data. Dates collected are usually \nstart and end dates of an event or intervention. Dates when the information was collected are \ngenerally not of interest and are usually not recorded by the investigator. \n\u2022 Observations made at individual visits are usually planned findings. \no Data collected at an initial visit may include information about past events and interventions, \nas well as findings. \nWhat date/times are \ncollected? \n\u2022 If the dates collected are start and/or end dates, then data are probably about an event or \nintervention. \n\u2022 If the dates collected are dates of assessments, then data probably represent a finding. \n\u2022 If dates of collection are different from other dates collected, it suggests that data are historical \nor are about an event or intervention that happened independently of the study schedule for \ndata collection. \nIs verbatim text collected and \nthen coded? \n\u2022 A \u201cYes\u201d answer suggests that this is Events or Interventions general observation class data.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3469, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "37b12b78-518a-4f05-b55d-49772679d9d4": {"__data__": {"id_": "37b12b78-518a-4f05-b55d-49772679d9d4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 436, "section": "8.6.3 Guidelines for Differentiating Between Interventions, Events,"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6e18cf07-cbd2-4513-8156-635a63f903e9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 436, "section": "8.6.3 Guidelines for Differentiating Between Interventions, Events,"}, "hash": "727685c365e86e1ec26a265298bf04d71e49b56c56f1fb9557a40658cfdc15b9", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "731f1637-f8ee-4f89-9f47-0d2fe69fd9ad", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 436, "section": "8.6.3 Guidelines for Differentiating Between Interventions, Events,"}, "hash": "8168a3a595771d89e3892e0329177a62fffadc2b82f0993252ef7eb6af6e4fec", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Dates collected are usually \nstart and end dates of an event or intervention. Dates when the information was collected are \ngenerally not of interest and are usually not recorded by the investigator. \n\u2022 Observations made at individual visits are usually planned findings. \no Data collected at an initial visit may include information about past events and interventions, \nas well as findings. \nWhat date/times are \ncollected? \n\u2022 If the dates collected are start and/or end dates, then data are probably about an event or \nintervention. \n\u2022 If the dates collected are dates of assessments, then data probably represent a finding. \n\u2022 If dates of collection are different from other dates collected, it suggests that data are historical \nor are about an event or intervention that happened independently of the study schedule for \ndata collection. \nIs verbatim text collected and \nthen coded? \n\u2022 A \u201cYes\u201d answer suggests that this is Events or Interventions general observation class data. \nHowever, Findings general observation class data from an examination (e.g., physical \nexamination) that identifies abnormalities may also be coded). Note that for Events and \nInterventions general observation class data, the topic variable is coded, whereas for Findings \ngeneral observation class data, the result is coded.", "mimetype": "text/plain", "start_char_idx": 2485, "end_char_idx": 3795, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "77e0fc29-1fd4-48ab-a376-b4c4a41bee91": {"__data__": {"id_": "77e0fc29-1fd4-48ab-a376-b4c4a41bee91", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 437, "section": "8.7 Related Subjects (RELSUB)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "bae113e6-52f4-42e2-a3ff-19ad468b9545", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 437, "section": "8.7 Related Subjects (RELSUB)"}, "hash": "12c71c77daf52c85463f51e710ed2df0d19c42196c4033ba6881e920de1a9216", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "RELSUB \u2013 Description/Overview \nA dataset used to represent relationships between study subjects. \nSome studies include subjects who are related to each other, and in some cases it is important to record those \nrelationships. A study in which pregnant women are treated and both the mother and her child(ren) are study \nsubjects is the most common case in which relationships between subjects are collected. There are also studies of \ngenetically based diseases where subjects who are related to each other are enrolled, and the relationships between \nsubjects are recorded.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 573, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "99b9bb89-c201-4910-8c73-c56fc5292e66": {"__data__": {"id_": "99b9bb89-c201-4910-8c73-c56fc5292e66", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 438, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1242d105-7922-49c2-b69e-0b57fa3319ee", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 438, "section": "UNSPECIFIED"}, "hash": "7402d7b4bd1612329311eabd1686cc4cda872d6ee1462a276e58c06338d22516", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "02f90e2f-2c94-4f3f-8158-4c6861c607ca", "node_type": "1", "metadata": {}, "hash": "caec864a15451c4a8347ff81159e5365539450714bb73377f281de66e7d36f38", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 438 \n2021-11-29 \nRELSUB \u2013 Specification \nrelsub.xpt, Related Subjects \u2014 Relationship. One record per relationship per related subject per \nsubject, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nUSUBJID \nUnique Subject \nIdentifier \nChar  \nIdentifier \nIdentifier used to uniquely identify a subject across all \nstudies for all applications or submissions involving the \nproduct. Either USUBJID or POOLID must be populated. \nExp \nPOOLID \nPool Identifier \nChar  \nIdentifier \nIdentifier used to identify a pool of subjects. If POOLID is \nentered, POOLDEF records must exist for each subject in \nthe pool and USUBJID must be null. Either USUBJID or \nPOOLID must be populated. \nPerm \nRSUBJID \nRelated Subject \nor Pool Identifier \nChar  \nIdentifier \nIdentifier used to identify a related subject or pool of \nsubjects. RSUBJID will be populated with either the \nUSUBJID of the related subject or the POOLID of the \nrelated pool. \nReq \nSREL \nSubject \nRelationship \nChar (RELSUB) \nRecord \nQualifier \nDescribes the relationship of the subject identified in \nUSUBJID or the pool identified in POOLID to the subject or \npool identified in RSUBJID. \nReq \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses. \nRELSUB \u2013 Assumptions \n1. RELSUB is used to represent relationships between persons, both of whom are study subjects. A \nrelationship between a study subject and a person who is not a study subject may not be represented in \nRELSUB; this may only be reported in APRELSUB. The existence of the RELSUB dataset should not \naffect whether relationships are collected; that should remain a decision based on the needs of the particular \nstudy. \n2. The variable POOLID was developed for nonclinical studies, where assessments may be made for groups \nof animals, and identifiers are needed for those groups (pools). It is included here because POOLID can be \nused for human clinical trials, if necessary. If POOLID is submitted, the POOLDEF dataset must be \nsubmitted. \n3. If POOLID is submitted, then in any record, 1 and only 1 of USUBJID and POOLID must be populated. \n4. If a study does not include the use of POOLID, then USUBJID must be populated in every record. \n5. RSUBJID must be a USUBJID value present in the Demographics (DM) domain. RSUBJID must be \npopulated in every record. \n6. Values of SREL should be taken from the CDISC Controlled Terminology codelist RELSUB wherever \npossible. However, if an appropriate term does not exist in the codelist, another term may be used. The \nSREL term should not be less specific than the verbatim term collected. For instance, it would be \ninappropriate to record a relationship using the term \"RELATIVE, FIRST DEGREE\" when the collected \nrelationship was \"brother\". \n7.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3148, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "02f90e2f-2c94-4f3f-8158-4c6861c607ca": {"__data__": {"id_": "02f90e2f-2c94-4f3f-8158-4c6861c607ca", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 438, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1242d105-7922-49c2-b69e-0b57fa3319ee", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 438, "section": "UNSPECIFIED"}, "hash": "7402d7b4bd1612329311eabd1686cc4cda872d6ee1462a276e58c06338d22516", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "99b9bb89-c201-4910-8c73-c56fc5292e66", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 438, "section": "UNSPECIFIED"}, "hash": "5d0fea8b44e200b645b93e3e3d5bbaf5b4da3806b5ddef43b40620624bd5f36c", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "4. If a study does not include the use of POOLID, then USUBJID must be populated in every record. \n5. RSUBJID must be a USUBJID value present in the Demographics (DM) domain. RSUBJID must be \npopulated in every record. \n6. Values of SREL should be taken from the CDISC Controlled Terminology codelist RELSUB wherever \npossible. However, if an appropriate term does not exist in the codelist, another term may be used. The \nSREL term should not be less specific than the verbatim term collected. For instance, it would be \ninappropriate to record a relationship using the term \"RELATIVE, FIRST DEGREE\" when the collected \nrelationship was \"brother\". \n7. Every relationship between 2 study subjects is represented in RELSUB as 2 directional relationships: (1) \nwith the first subject's identifier in USUBJID and the second subject's identifier in RSUBJID, and (2) with \nthe second subject's identifier in USUBJID and the first subject's identifier in RSUBJID. The SREL values \nin the 2 records will describe the same relationship, but from the viewpoint of each subject (e.g., \n\"MOTHER, BIOLOGICAL\"; \"CHILD, BIOLOGICAL\") \n8. All collected relationships between subjects should be recorded in RELSUB. In some cases, 2 subjects may \nhave more than 1 relationship. For instance, a woman might be both maternal aunt and wet nurse to an \ninfant. When there are multiple relationships between 2 subjects, each relationship will be represented by 2 \nrecords in RELSUB.", "mimetype": "text/plain", "start_char_idx": 2496, "end_char_idx": 3955, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "90c99896-2a8f-4a76-a5ad-6c1756874a2c": {"__data__": {"id_": "90c99896-2a8f-4a76-a5ad-6c1756874a2c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 439, "section": "8.8 Related Specimens (RELSPEC)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "92c2d505-353a-40a3-8599-07f8b0c5b82a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 439, "section": "8.8 Related Specimens (RELSPEC)"}, "hash": "e667cbc877478021b761a76ca76ccfc4b791eaae83cc9e058dcddad03fb2bf62", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "BE, BS, and RELSPEC domain specifications, assumptions, and examples were copied and minimally updated \nfrom the provisional SDTMIG-PGx, published 2015-05-26. This was done in preparation for the retirement of the \nSDTMIG-PGx upon publication of SDTMIG v3.4. These domains are currently under extensive revision for \ninclusion in a future SDTMIG. \nRELSPEC \u2013 Description/Overview \nA dataset used to represent relationships between specimens. \nRELSPEC \u2013 Specification \nrelspec.xpt, Related Specimens \u2014 Relationship. One record per specimen identifier per subject, \nTabulation. \nVariable \nName \nVariable \nLabel \nType Controlled Terms, Codelist \nor Format1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy \nIdentifier \nChar \nIdentifier \nUnique identifier for a study. \nReq \nUSUBJID \nUnique \nSubject \nIdentifier \nChar \nIdentifier \nIdentifier used to uniquely identify a subject \nacross all studies for all applications or \nsubmissions involving the product. \nReq \nREFID \nSpecimen ID \nChar \nIdentifier \nSpecimen identifier, unique within USUBJID. \nReq \nSPEC \nSpecimen \nType \nChar (SPECTYPE)(GENSMP) \nVariable \nQualifier \nDefines the type of specimen used for a \nmeasurement. Examples: \"SERUM\", \"PLASMA\", \n\"URINE\", \"SOFT TISSUE\". \nPerm \nPARENT \nSpecimen \nParent \nChar \nIdentifier \nIdentifies the REFID of the parent of a specimen \nto support tracking its genealogy. \nExp \nLEVEL \nSpecimen \nLevel \nNum \nVariable \nQualifier \nIdentifies the generation number of the sample \nwhere the collected sample is considered the \nfirst generation. \nReq \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1683, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ac7ded5a-4b28-49fb-b742-167b07a3ffba": {"__data__": {"id_": "ac7ded5a-4b28-49fb-b742-167b07a3ffba", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 440, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "35b4a361-67a7-4fc9-8357-01978184fd31", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 440, "section": "UNSPECIFIED"}, "hash": "0214242b18b4fa3945c65c69733b3b2a8ad825fd172e8cfeb8bc291859e0a642", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved \n Page 440 \n2021-11-29 \nRELSPEC \u2013 Assumptions \n1.\nThe RELSPEC dataset is not used to manage relationships between any other datasets or domains.\n2.\nThe RELSPEC dataset is only used to maintain relationships between specimens, therefore is does not\nrequire any additional variables such as those used in RELREC.\n3.\nThere are three CDISC controlled terminology codelists that may be applicable to SPEC: SPEC (C77529),\nSPECTYPE (C78734), and GENSMP (C111114). Sponsors are responsible for determining the most\nappropriate codelist(s) for their submission.\nRELSPEC \u2013 Examples \nExample 1\nThis example uses the sample specimen lineage illustrated below. \nFigure. Sample Specimen Relationship \nA specimen with a LEVEL value of \"1\" and a blank value for PARENT indicates a collected sample. All other \nvalues represent a derived sample. SPEC reflects the specimen type for the sample regardless of whether it is \ncollected or derived. \nrelspec.xpt\nRow \nSTUDYID \nUSUBJID \nREFID \nSPEC \nPARENT \nLEVEL \n1 \nABC-123 \n001-01\nSPC-001 \nTISSUE \n1 \n2 \nABC-123 \n001-01\nSPC-001-A \nTISSUE \nSPC-001 \n2 \n3 \nABC-123 \n001-01\nSPC-001-B \nTISSUE \nSPC-001 \n2 \n4 \nABC-123 \n001-01\nSPC-001-B-1 \nDNA \nSPC-001-B \n3 \n5 \nABC-123 \n001-01\nSPC-003 \nTISSUE \n1 \n6 \nABC-123 \n001-01\nSPC-003-A \nRNA \nSPC-003 \n2", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1436, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "467056a7-088b-46ef-b02d-ac1b37a2e8e4": {"__data__": {"id_": "467056a7-088b-46ef-b02d-ac1b37a2e8e4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 441, "section": "9.1 Device Identifiers"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "279062c8-1cdd-40d6-945f-eb9542299ca4", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 441, "section": "9.1 Device Identifiers"}, "hash": "52cfe359f96c834b83f908475d257e3aff1ebefff6ac0e5c4b91a1014aec7dfb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The Device Identifiers (DI) dataset establishes identifiers for devices, which are used to populate the variable \nSPDEVID. The DI dataset was introduced as part of the SDTMIG for Medical Devices (SDTMIG-MD). It was \noriginally classified as a special-purpose domain, but since SDTM v1.7 it has been classified as a study reference \ndataset. The SDTMIG-MD (available at https://www.cdisc.org/standards/foundational/medical-devices-sdtmig/) \nincludes the DI domain specification and assumptions and provides examples of its use.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 526, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "27de4ff4-fe81-4524-a852-b4c088d73bdd": {"__data__": {"id_": "27de4ff4-fe81-4524-a852-b4c088d73bdd", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 441, "section": "9.2 Non-host Organism Identifiers (OI)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c41c8e6b-2663-49c0-a442-06d0d1b5c040", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 441, "section": "9.2 Non-host Organism Identifiers (OI)"}, "hash": "55352aa660eeb7ae6343ee0693c37f620af89c183b26597f519a6525b785011b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "OI \u2013 Description/Overview \nA special-purpose domain containing information that identifies levels of taxonomic nomenclature of microbes or \nparasites that have been either experimentally determined in the course of a study or are previously known, as in the \ncase of lab strains used as reference in the study. \nThe biological classification of a non-host organism typically stops at the taxonomic rank of \"species.\" Scientific \ntaxonomic nomenclature below the rank of species is not clearly defined, lacks a globally accepted standard \nterminology, and is frequently organism-dependent. Therefore, the OI domain addresses organism taxonomy with a \nseries of parameters that name the taxa appropriate to the organism and the granularity with which the organism has \nbeen identified in the particular study. \nOI \u2013 Specification \noi.xpt, Non-host Organism Identifiers \u2014 Study Reference. One record per taxon per non-host \norganism, Tabulation. \nVariable \nName \nVariable Label \nType Controlled \nTerms, \nCodelist or \nFormat1 \nRole \nCDISC Notes \nCore \nSTUDYID \nStudy Identifier \nChar  \nIdentifier \nUnique identifier for a study. \nReq \nDOMAIN \nDomain \nAbbreviation \nChar OI \nIdentifier \nTwo-character abbreviation for the domain. \nReq \nNHOID \nNon-host \nOrganism \nIdentifier \nChar  \nIdentifier \nSponsor-defined identifier for a non-host organism. NHOID \nshould be populated with an intuitive name based on the \nidentity of the organism as reported by the lab. It must be \nunique for each unique organism as defined by the specific \nvalues of the organism's entire known taxonomy described by \npairs of OIPARMCD and OIVAL . \nReq \nOISEQ \nSequence \nNumber \nNum  \nIdentifier \nSequence number to given to ensure uniqueness within a \nparameter within an organism (NHOID) within dataset. \nReq \nOIPARMCD Non-host \nOrganism ID \nElement Short \nName \nChar (OIPRMCD) \nTopic \nShort name of the taxon being described. Examples: \n\"GROUP\", \"GENTYP\", \"SUBTYP\". \nReq \nOIPARM \nNon-host \nOrganism ID \nElement Name \nChar (OIPRM) \nSynonym \nQualifier \nName of the taxon being described. Examples: \"Group\", \n\"Genotype\", \"Subtype\". \nReq \nOIVAL \nNon-host \nOrganism ID \nElement Value \nChar * \nResult \nQualifier \nValue for the taxon in OIPARMCD/OIPARM for the organism \nidentified by NHOID. \nReq \n1In this column, an asterisk (*) indicates that the variable may be subject to controlled terminology. CDISC/NCI codelist values are enclosed \nin parentheses.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2421, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "3af8991d-21d4-4422-b792-dcfa186bd97f": {"__data__": {"id_": "3af8991d-21d4-4422-b792-dcfa186bd97f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 442, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9b12e86-8640-49fb-851b-93d641a9c67f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 442, "section": "UNSPECIFIED"}, "hash": "822fc23f72be301f9b43014c875efaade243a65dba238d45742e9ae21887b034", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "ec4d78d7-0318-414e-8098-1efc7b9c820e", "node_type": "1", "metadata": {}, "hash": "664895843c857c897144a3f946d2910e624091ac29e5967af23205958633b47b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 442 \n2021-11-29 \nOI \u2013 Assumptions \n1. Non-host organisms include viruses and organisms such as pathogens or parasites, but also non-pathogenic \norganisms such as normal intestinal flora. Non-host organism identifiers are not to be used for host species \nidentification (e.g., for animals used in preclinical studies), nor should they be used to represent other, non-\ntaxonomy characteristics of non-host species (e.g., drug susceptibility, growth rates). \n2. NHOID is sponsor-defined, with the following constraints: \na. \nA unique NHOID must represent a unique identity as represented in its combination of \nOIPARMCD/OIVAL pairs. If 2 organisms share the same first 2 levels of taxonomy with regard to \nOIPARMCD/OIVAL, but 1 is identified to a third level and the other is not, they should be assigned 2 \nunique NHOIDs. \nb. Study sponsors should populate NHOID with intuitive name values based on either \ni. the name of the organism as reported by a lab or specified by the investigator, or \nii. published references/databases where applicable and appropriate (e.g., when reference strain H77 \nis used in a HCV study, NHOID for this strain should be populated with \u201cH77\u201d or \u201cHCV1a-\nH77\u201d). \n3. NHOID can be used in any domain where observations about these organisms are being represented, \nallowing end users to determine what is known about the organism\u2019s identity by merging on NHOID, or by \notherwise referring to the OI domain. \n4. OIPARMCD and OIPARM must represent parameters for the identification of non-host organisms with \nregard to nomenclature only. \na. \nMostly, this will represent taxonomic ranks (i.e., species) as well as commonly used grouping terms \n(taxa that are not officially ranked, e.g., subtype, group, strain). \nb. They may also include other nomenclature terms that are less widely known but are used frequently for \norganism identification in a specific field of study (e.g., spoligotype in tuberculosis). \nc. \nThey should be listed in the OI dataset in hierarchical order of least to most specific with increasing \nOISEQ values. \n5. Variables not listed in the OI domain specification table should not be used in OI data sets. \nOI \u2013 Examples \nExample 1 \nThis example shows taxonomic identifiers for human immunodeficiency virus (HIV) and hepatitis C virus \n(HCV). NHOID is a unique non-host organism ID used to link findings on that organism in other datasets with \ndetails about its identification in OI. OIPARM shows the name of the individual taxa identified and OIVAL shows \nthe experimentally determined values of those taxa. \nRows 1-4: \nShow the taxonomy for the HIV organism given the NHOID of HIV1MC. This virus has been \nidentified as HIV-1, Group M, Subtype C. \nRows 5-8: \nShow the taxonomy for the HIV organism given the NHOID of HIV1MB, which was used as a \nreference. This virus has been identified as HIV-1, Group M, Subtype B. \nRows 9-11: \nShow the taxonomy for the HCV organism given the NHOID of HCV2C.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3127, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ec4d78d7-0318-414e-8098-1efc7b9c820e": {"__data__": {"id_": "ec4d78d7-0318-414e-8098-1efc7b9c820e", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 442, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a9b12e86-8640-49fb-851b-93d641a9c67f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 442, "section": "UNSPECIFIED"}, "hash": "822fc23f72be301f9b43014c875efaade243a65dba238d45742e9ae21887b034", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "3af8991d-21d4-4422-b792-dcfa186bd97f", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 442, "section": "UNSPECIFIED"}, "hash": "2a84f5f3b08cf2626724b3dc9ca1fce54ec04d937e62ef8ba08f74da245e8e31", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "NHOID is a unique non-host organism ID used to link findings on that organism in other datasets with \ndetails about its identification in OI. OIPARM shows the name of the individual taxa identified and OIVAL shows \nthe experimentally determined values of those taxa. \nRows 1-4: \nShow the taxonomy for the HIV organism given the NHOID of HIV1MC. This virus has been \nidentified as HIV-1, Group M, Subtype C. \nRows 5-8: \nShow the taxonomy for the HIV organism given the NHOID of HIV1MB, which was used as a \nreference. This virus has been identified as HIV-1, Group M, Subtype B. \nRows 9-11: \nShow the taxonomy for the HCV organism given the NHOID of HCV2C. This virus has been \nidentified as HCV 2c. \nRows 12-14: Show the taxonomy for the HCV organism given the NHOID of H77. This virus is a known \nreference strain of HCV 1a. \noi.xpt \nRow \nSTUDYID \nDOMAIN \nNHOID \nOISEQ \nOIPARMCD \nOIPARM \nOIVAL \n1 \nSTUDY123 \nOI \nHIV1MC \n1 \nSPCIES \nSpecies \nHIV \n2 \nSTUDY123 \nOI \nHIV1MC \n2 \nTYPE \nType \n1 \n3 \nSTUDY123 \nOI \nHIV1MC \n3 \nGROUP \nGroup \nM \n4 \nSTUDY123 \nOI \nHIV1MC \n4 \nSUBTYP \nSubtype \nC \n5 \nSTUDY123 \nOI \nHIV1MB \n1 \nSPCIES \nSpecies \nHIV", "mimetype": "text/plain", "start_char_idx": 2472, "end_char_idx": 3602, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7d4ca857-8b7e-4f5e-a867-4acd71a4cb36": {"__data__": {"id_": "7d4ca857-8b7e-4f5e-a867-4acd71a4cb36", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 443, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1867539c-3c6c-44ac-9580-729cb3b3960f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 443, "section": "UNSPECIFIED"}, "hash": "6940d5559355a844a4060fb8dd194cacf9804d05ee060f1c203d4632e2145de3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 443 \n2021-11-29 \nRow \nSTUDYID \nDOMAIN \nNHOID \nOISEQ \nOIPARMCD \nOIPARM \nOIVAL \n6 \nSTUDY123 \nOI \nHIV1MB \n2 \nTYPE \nType \n1 \n7 \nSTUDY123 \nOI \nHIV1MB \n3 \nGROUP \nGroup \nM \n8 \nSTUDY123 \nOI \nHIV1MB \n4 \nSUBTYP \nSubtype \nB \n9 \nSTUDY123 \nOI \nHCV2C \n1 \nSPCIES \nSpecies \nHCV \n10 \nSTUDY123 \nOI \nHCV2C \n2 \nGENTYP \nGenotype \n2 \n11 \nSTUDY123 \nOI \nHCV2C \n3 \nSUBTYP \nSubtype \nC \n12 \nSTUDY123 \nOI \nH77 \n1 \nSPCIES \nSpecies \nHCV \n13 \nSTUDY123 \nOI \nH77 \n2 \nGENTYP \nGenotype \n1 \n14 \nSTUDY123 \nOI \nH77 \n3 \nSUBTYP \nSubtype \nA", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 678, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "06ca7e49-a752-4218-8e77-2e5200b1af89": {"__data__": {"id_": "06ca7e49-a752-4218-8e77-2e5200b1af89", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 444, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4eadccd5-73ee-4d1f-8dcc-11083f33e74a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 444, "section": "UNSPECIFIED"}, "hash": "776d35b8e94c721698e5f54477b33844862ff02ff9329c5fa9e81eda100c35c9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 444 \n2021-11-29 \n10 Appendices \nAppendix A: CDISC SDS Team \nThe CDISC SDS Team would like to thank the many volunteers who contributed to the development, review, and \npublication of SDTMIG v3.4. Additionally, this publication would not have been possible without the support of the \nFoundational Team Leads, Global Governance Group, Regulatory Liaisons, and CDISC. \nName \nCompany \nDana Booth (Project Manager) \nCDISC \nEllina Babouchkina \nQuality Data Services \nGlenn Barnes \nGlobal Specimen Solutions \nGlenn Beeman \nMerck KGaA \nAnthony Chow \nCDISC \nJulie Chason \nCDISC \nChristine Connolly (Current \nLeadership Team) \nCDISC; previously as a CDISC volunteer thru EMD Serono (current affiliation Bill & \nMelinda Gates Medical Research Institute) \nAbhishek Dabral \nAllergan \nVilma Decman \nGSK \nCarolyne Dumont \nCharles River Laboratories (formerly MPI Research) \nGisbert Gelfort \nBayer \nPatricia Gleason \nMerck & Co. \nTom Guinter \nNurocor \nBrenda Gumbs-Petty \nNCI-EVS \nPawan Gupta \nPfizer \nMike Hamidi (Current Leadership \nTeam) \ncurrently as a CDISC volunteer thru Pfizer; previously as a CDISC employee \nSterling Hardy \nMerck & Co. \nDenise Hargreaves \nCharles River Laboratories (formerly MPI Research) \nElaine Hazzard \nJanssen Pharmaceutical Companies of Johnson & Johnson \nKathleen Hectors \nJanssen Pharmaceutical Companies of Johnson & Johnson \nLester Hui \nBristol Myers Squibb \nMarcelina Hungria \nDIcore Group \nKristin Kelly \nPinnacle 21 \n\u00c9anna Kiely \nClinBuild \nSteve Kopko \nCDISC \nBess LeRoy \nCDISC \nGerman Leparc \nBoehringer Ingelheim \nJordan Li \nNCI EVS \nStetson Line \nClinventive \nChristine Martersteck \nEli Lilly and Company \nErin Muhlbradt \nNCI EVS \nCatherine Mulvaney \nMint Medical Inc. \nFizal Nabbie \nBristol Myers Squibb \nDavid Neubauer \nClinical Solutions Group, LLC an IQVIA business \nJon Neville \nCDISC", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1997, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "49586917-3323-4a56-8bfd-ad68360d5476": {"__data__": {"id_": "49586917-3323-4a56-8bfd-ad68360d5476", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 445, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "be246367-1e4b-4bc6-954b-9769289b3cd9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 445, "section": "UNSPECIFIED"}, "hash": "b855b14ea2776d31bdd4773f7f145421b03b648fe9f3aa2f1b7145a9f10643f9", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 445 \n2021-11-29 \nName \nCompany \nGbenga Ogunsulire \nRegeneron \nDebra O'Neill \nMerck & Co. \nAlla Ostrovsky \nBiogen \nAmy Palmer \nCDISC \nLisa T. Panting \nBristol Myers Squibb \nMelanie Paules \nGlaxoSmithKline \nNik Pemble \nJanssen Pharmaceutical Companies of Johnson & Johnson \nRichard Phillips \nCovance \nStefan Pinkert \nMerck KGaA \nPhil Pochon \nCovance \nAnna Pron-Zwick \nAstraZeneca \nWard Puttemans \nUCB \nBen Qgunsulire \nRegeneron \nCarlo Radovsky \nImmanant \nSoumya Rajesh \nClinical Solutions Group, LLC an IQVIA business \nManjula Reddy \nJanssen Pharmaceutical Companies of Johnson & Johnson \nMichael Schmitz \nBayer AG \nDave Scocca \nRho, Inc. \nMaria Sekac \nPRA Health Sciences \nKalai Selvanathan \nBoehringer Ingelheim \nMihaela Simion \nBiogen \nDaniel Sinnett \nEmmes \nSanket Sinojia \nIQVIA \nCary Smoak \nS-cubed \nAileen St. Marie \nBristol Myers Squibb \nErin Tibbs-Slone \nCharles River Laboratories (formerly MPI Research) \nSusan Tierney \nIQVIA \nAnita Umesh \n \nMadhavi Vemuri \nJanssen Research \nKevin Viel \nHistonis, Incorporated \nGary Walker \nIndependent Contractor \nLacey Wallace \nAudentes Therapeutics \nRuohan Wang \nHorizon Therapeutics \nJoleen T. White \nEMD Serono (current affiliation Bill & Melinda Gates Medical Research Institute) \nDarcy Wold \nCDISC \nDiane Wold \nCDISC \nIne Wolfs \nJanssen Pharmaceutical Companies of Johnson & Johnson \nFred Wood \nData Standards Consulting \nCraig Zwickl \nTransendix LLC", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1579, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "903402fd-5433-4111-beb3-e88b70913c91": {"__data__": {"id_": "903402fd-5433-4111-beb3-e88b70913c91", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 446, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "94698283-d8a7-4477-b7b2-80eef423f4c6", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 446, "section": "UNSPECIFIED"}, "hash": "059e37059534281509a2f9e961ce77fab753468f7142ce50fd0c75a11b5610af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 446 \n2021-11-29 \nAppendix B: Glossary and Abbreviations \nThe following table lists some of the abbreviations and terms are used in this document. Additional definitions can \nbe found in the individual sections of this document (see esp. Section 7.1.2, Definitions of Trial Design Concepts) \nand in the CDISC Glossary (available at https://www.cdisc.org/standards/glossary). \nADaM \nCDISC Analysis Dataset Model \nADSL \n(ADaM) Subject-level Analysis Dataset \nATC \nAnatomic Therapeutic Chemical (code; WHO) \nCDASH \nClinical Data Acquisition Standards Harmonization \nCDISC \nClinical Data Interchange Standards Consortium \nCRF \nCase report form (sometimes case record form) \nCRO \nContract research organization \nCTCAE \nCommon Terminology Criteria for Adverse Events \nDataset \nA collection of structured data in a single file \nDefine-XML \nCDISC standard for transmitting metadata that describes any tabular dataset structure. \nDomain \nA collection of observations with a topic-specific commonality \neDT \nElectronic data transfer \nFDA \n(US) Food and Drug Administration \nHL7 \nHealth Level 7 \nICH \nInternational Conference on Harmonisation of Technical Requirements for Registration of \nPharmaceuticals for Human Use \nICH E2A \nICH guidelines on Clinical Safety Data Management: Definitions and Standards for Expedited \nReporting \nICH E2B \nICH guidelines on Clinical Safety Data Management: Data Elements for Transmission of Individual \nCases Safety Reports \nICH E3 \nICH guidelines on Structure and Content of Clinical Study Reports \nICH E9 \nICH guidelines on Statistical Principles for Clinical Trials \nISO \nInternational Organization for Standardization \nISO 8601 \nISO character representation of dates, date/times, intervals, and durations of time. The SDTM uses \nthe extended format. \nISO 3166 \nISO codelist for representing countries; the Alpha-3 codelist uses 3-character codes. \nLOINC \nLogical Observation, Identifiers, Names, and Codes \nMedDRA \nMedical Dictionary for Regulatory Activities \nNCI \nNational Cancer Institute (NIH) \nNSV \nNon-standard variable \nPRO \nPatient-reported outcome \nSAP \nStatistical analysis plan \nSDS \nSubmission Data Standards. Also the name of the team that created the SDTM and SDTMIG. \nSDTM \nStudy Data Tabulation Model \nSDTMIG \nStudy Data Tabulation Model Implementation Guide: Human Clinical Trials [this document] \nSDTMIG-AP \nStudy Data Tabulation Model Implementation Guide: Associated Persons", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2601, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "09ed455a-0e41-43dc-ac61-7ac03f666e92": {"__data__": {"id_": "09ed455a-0e41-43dc-ac61-7ac03f666e92", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 447, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a018680b-ab0e-40b9-a1dc-e47944555193", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 447, "section": "UNSPECIFIED"}, "hash": "ccb51a38057bfc1211b356562b39a7b73b44b48a92a5e102c9cdae64bd6c3c1d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 447 \n2021-11-29 \nSDTMIG-MD \nStudy Data Tabulation Model Implementation Guide for Medical Devices \nSDTMIG-PGx \nStudy Data Tabulation Model Implementation Guide: Pharmacogenomics/Genetics \nSEND \nStandard for Exchange of Non-Clinical Data \nSNOMED \nSystematized Nomenclature of Medicine (a dictionary) \nSOC \nSystem organ class \nTDM \nTrial Design Model \nWHODRUG \nWorld Health Organization Drug Dictionary \nXML \neXtensible Markup Language", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 611, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "8549aaec-1dec-48ea-9838-09a2cfdd1081": {"__data__": {"id_": "8549aaec-1dec-48ea-9838-09a2cfdd1081", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 448, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "548505ec-72a0-4728-9ea6-34b61841854b", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 448, "section": "UNSPECIFIED"}, "hash": "cf710f3ebac51039997984a2bbeb7c2545f09cdcd2c92d7f78285db6d121b9f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 448 \n2021-11-29 \nAppendix C: Controlled Terminology \nCDISC Terminology is centrally managed by the CDISC Controlled Terminology Team, supporting the terminology \nneeds of all CDISC foundational standards (SDTM, CDASH, ADaM, SEND) and all disease/therapeutic area \nstandards. \nNew/modified terms have a 3-month development period during which the Controlled Terminology Team evaluates \nthe requests received, incorporating as much as possible for each quarterly release, and a quarterly public-review \ncomment period followed by publication release. \nVisit the CDISC Controlled Terminology page (https://www.cdisc.org/standards/terminology/controlled-\nterminology) to find the most recently published terminology packages (final or under review), or the NCI \nEnterprise Vocabulary Services CDISC Terminology website \n(https://www.cancer.gov/research/resources/terminology/cdisc) for access to the full list of CDISC terminology. \nNote that the SDTM terminology was previously provided separately for questionnaires and other domains. \nHowever, as of the 2015-12-18 release of CDISC Controlled Terminology, these were merged into a single \npublication. \nEarlier versions of the SDTMIG included several appendices regarding controlled terminology. Starting with \nSDTMIG 3.2, Appendix C was simplified. Appendix C1 will be considered for expansion in the next version, to \ncontain a complete list of supplemental qualifiers used in the SDTMIG. \nAppendix C1: Supplemental Qualifiers Name Codes \nThe following table contains an initial set of standard name codes for use in the supplemental qualifiers  \n(SUPP--) special-purpose datasets. \nQNAM \nQLABEL \nApplicable Domains \nAESOSP \nOther Medically Important SAE AE \nAETRTEM \nTreatment Emergent Flag \nAE \n--REAS \nReason \nIntervention domains where the reason for an intervention is other than a medical \nindication. It may be used in select Event domains (e.g., Healthcare Encounters) \nwhere the topic is not a medical condition.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 2151, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a8d9715d-07fb-4362-876b-28363f910c00": {"__data__": {"id_": "a8d9715d-07fb-4362-876b-28363f910c00", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 449, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "0c5503f8-88e0-48ab-bafe-cf95ce3bf302", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 449, "section": "UNSPECIFIED"}, "hash": "8cf745cddfb1b5038c273291d2860a74af07f5a52e7df4ee28cf288ac56f2804", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 449 \n2021-11-29 \nAppendix D: CDISC Variable-naming Fragments \nThe CDISC SDS group has defined a standard list of fragments to use as a guide when naming variables in SUPP-- \ndatasets (as QNAM) or assigning --TESTCD values that could conceivably be treated as variables in a horizontal \nlisting derived from a Findings dataset. In some cases, more than 1 fragment is used for a given keyword. This is \nnecessary when a shorter fragment must be used for a --TESTCD or QNAM that incorporates several keywords that \nmust be combined while still meeting the 8-character variable naming limit of SAS transport files. When using \nfragments, the general rule is to use the fragment(s) that best conveys the meaning of the variable within the 8-\ncharacter limit; thus, the longer fragment should be used when space allows. If the combination of fragments still \nexceeds 8 characters, a character should be dropped where most appropriate (while avoiding naming conflicts if \npossible) to fit within the 8-character limit. \nIn other cases the same fragment may be used for more than one meaning, but these would not normally overlap for \nthe same variable. \nKeyword(s) \nFragment \nACTION \nACN \nADJUSTMENT \nADJ \nANALYSIS DATASET \nAD \nASSAY \nAS \nBASELINE \nBL \nBIRTH \nBRTH \nBODY \nBOD \nCANCER \nCAN \nCATEGORY \nCAT \nCHARACTER \nC \nCLASS \nCLAS \nCLINICAL \nCL \nCODE \nCD \nCOMMENT \nCOM \nCONCOMITANT \nCON \nCONDITION \nCND \nCONGENITAL \nCONG \nDATE TIME - CHARACTER \nDTC \nDAY \nDY \nDEATH \nDTH \nDECODE \nDECOD \nDERIVED \nDRV \nDESCRIPTION \nDESC \nDISABILITY \nDISAB \nDOSE, DOSAGE \nDOS, DOSE \nDURATION \nDUR \nELAPSED \nEL \nELEMENT \nET \nEMERGENT \nEM \nEND \nEND, EN \nETHNICITY \nETHNIC \nEVALUATION \nEVL \nEVALUATOR \nEVAL", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1855, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e96ec9b-4a6b-4757-b32f-d329c15a6a61": {"__data__": {"id_": "7e96ec9b-4a6b-4757-b32f-d329c15a6a61", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 450, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "94dc4d92-1732-4f79-8445-a5e9ea858543", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 450, "section": "UNSPECIFIED"}, "hash": "e80d34ba229dbf573f847a6f2b9de4a6b8cc5a3c588d4e071623623c6cfe98e4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 450 \n2021-11-29 \nEXTERNAL \nX \nFASTING \nFAST \nFILENAME \nFN \nFLAG \nFL \nFORMULATION, FORM \nFRM \nFREQUENCY \nFRQ \nGRADE \nGR \nGROUP \nGRP \nHOSPITALIZATION \nHOSP \nIDENTIFIER \nID \nINDICATION \nINDC \nINDICATOR \nIND \nINTERPRETATION \nINTP \nINTERVAL \nINT \nINVESTIGATOR \nINV \nLIFE-THREATENING \nLIFE \nLOCATION \nLOC \nLOINC CODE \nLOINC \nLOWER LIMIT \nLO \nMEDICALLY-IMPORTANT EVENT \nMIE \nNAME \nNAM \nNON-STUDY THERAPY \nNST \nNORMAL RANGE \nNR \nNOT DONE \nND \nNUMBER \nNUM \nNUMERIC \nN \nOBJECT \nOBJ \nONGOING \nONGO \nORDER \nORD \nORIGIN \nORIG \nORIGINAL \nOR \nOTHER \nOTH, O \nOUTCOME \nOUT \nOVERDOSE \nOD \nPARAMETER \nPARM \nPATTERN \nPATT \nPOPULATION \nPOP \nPOSITION \nPOS \nQUALIFIER \nQUAL \nREASON \nREAS \nREFERENCE \nREF, RF \nREGIMEN \nRGM \nRELATED \nREL, R \nRELATIONSHIP \nREL \nRESULT \nRES \nRULE \nRL \nSEQUENCE \nSEQ", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 951, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "4682e043-fb9c-442f-ba3e-529b15264515": {"__data__": {"id_": "4682e043-fb9c-442f-ba3e-529b15264515", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 451, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d4880f8c-df20-47a7-a667-60e16aafd687", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 451, "section": "UNSPECIFIED"}, "hash": "67852c5121b172f02a52dfeb44e3a1e2af9a450e47d66e5bdc4d923308b6b8e6", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 451 \n2021-11-29 \nSERIOUS \nS, SER \nSEVERITY \nSEV \nSIGNIFICANT \nSIG \nSPECIMEN \nSPEC, SPC \nSPONSOR \nSP \nSTANDARD \nST, STD \nSTART \nST \nSTATUS \nSTAT \nSUBCATEGORY \nSCAT \nSUBJECT \nSUBJ \nSUPPLEMENTAL \nSUPP \nSYSTEM \nSYS \nTEXT \nTXT \nTIME \nTM \nTIME POINT \nTPT \nTOTAL \nTOT \nTOXICITY \nTOX \nTRANSITION \nTRANS \nTREATMENT \nTRT \nUNIQUE \nU \nUNIT \nU \nUNPLANNED \nUP \nUPPER LIMIT \nHI \nVALUE \nVAL \nVARIABLE \nVAR \nVEHICLE \nV", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 580, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "73f0dac6-26d9-4c4f-8ad6-c15376a5e74c": {"__data__": {"id_": "73f0dac6-26d9-4c4f-8ad6-c15376a5e74c", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 452, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "e6a0d757-1805-4e21-8884-f50e8a2ad757", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 452, "section": "UNSPECIFIED"}, "hash": "0a6b0b1fde58a280570232ad3298b31d49704dc025ab4231770317d4daf96d59", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 452 \n2021-11-29 \nAppendix E: Revision History \nThis appendix provides an overview only of revisions since the last production version, SDTMIG v3.3; not all \nrevisions are included. \n\u2022 \nA Diff file with details of changes to domain specification tables is available as a member benefit on the \nCDISC Library Archives page in the Members Only Area of the CDISC \nwebsite (https://www.cdisc.org/members-only/cdisc-library-archives), and those changes are not repeated \nhere. \n\u2022 \nPublic review comments and their dispositions will be available upon publication of the SDTMIG. \nThe following changes have been made throughout: \n\u2022 \nText and examples have been clarified as needed. \n\u2022 \nText was updated to reflect new table names in SDTM v2.0. \n\u2022 \nValues were updated to current CDISC Controlled Terminology. \n\u2022 \nISO formats were made more granular. \n\u2022 \nNew variables from SDTM v2.0 have been added. \n\u2022 \nTables with domain codes and descriptions at the start of a section have been replaced with a sectional table \nof contents since each domain section already contains all of the information previously in the tables. \n\u2022 \nWith few exceptions (e.g., the DM domain), the names of supplemental qualifier variables have been \nupdated to include 2-character domain abbreviations at the start of the variable name. \n\u2022 \nAssumptions which provided domain definitions were removed as these are provided under the \nDescription/Overview for each domain. \n\u2022 \nWhere numbered lists occurred in CDISC Notes, these have been converted to text for consistency with the \nrest of the document. \n\u2022 \nLinks were updated as needed. \n\u2022 \nTypographical errors were corrected. \nA note on the decommissioning of MO \nThe following domain was removed: \n\u2022 \nMorphology (MO) \nWhen the Morphology domain was introduced in SDTMIG v3.2, the SDS Team planned to represent \nmorphology and physiology findings in separate domains: morphology findings in the MO domain and \nphysiology findings in separate domains by body systems. Since then, the team found that separating \nmorphology and physiology findings was more difficult than anticipated and provided little added value. This \nled to the decision to expand the body system-based domains to cover both morphology and physiology \nfindings and to deprecate MO in SDTMIG v3.4. Submissions using that later SDTMIG version would \nrepresent morphology results in the appropriate body system-based physiology/morphology domain. \nFor data prepared using a version of the SDTMIG that includes both the MO domain and body system-based \nphysiology/morphology domains, morphology findings may be represented in either the MO domain or in a \nbody-system based physiology/morphology domain. Custom body system-based domains may be used if the \nappropriate body system-based domain is not included in the SDTMIG version being used.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3005, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "9f308a24-f1a9-40ee-b16a-c439b3e3ad03": {"__data__": {"id_": "9f308a24-f1a9-40ee-b16a-c439b3e3ad03", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "2.5 The SDTM Standard Domain Models"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7468d813-627c-47d7-9a67-7b323b1585a7", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "2.5 The SDTM Standard Domain Models"}, "hash": "c96b71275585e230d4a417ed0f8c829a09f080542f2bf88a9ccb660f971db8e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Domain-specific versioning, introduced in SDTMIG v3.3, was \nremoved. The text in this section describing domain versions was \nremoved. Domain version numbers were also removed for each \ndomain. \n\u2022 Removed sentence that referred to the FDA repository. \n\u2022 Added reference to the Define-XML standard for details on no data \navailability.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 336, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6946da5e-0491-4088-855d-16d374afed9a": {"__data__": {"id_": "6946da5e-0491-4088-855d-16d374afed9a", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "2.7 SDTM Variables Not Allowed in the"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d3b377d4-ea13-4932-99ed-46011b7560b9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "2.7 SDTM Variables Not Allowed in the"}, "hash": "2a7b91456d88f236eb5a3aa788b8f32d167716e8b3d7e7855c0504b1c24694cc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SDTMIG \n\u2022 Updated based on the Usage Restrictions column of Study Data \nTabulation Model 2.0. Review Section 2.7 for the complete list of \nvariables not to be used in SDTM-based data for human clinical trials. \nMoved --METHOD (Interventions) from the not-evaluated list to the list \nof variables not to be used. Updated order of list to match order within \nthe model. \nSection 3. Submitting Data in a Standard Format", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 416, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7029ed75-ff46-44e7-a287-d9f8a15f0291": {"__data__": {"id_": "7029ed75-ff46-44e7-a287-d9f8a15f0291", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "3.2 Using the CDISC Domain Models in"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "85e91e75-16a5-4840-9510-30fd5f8c08fc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "3.2 Using the CDISC Domain Models in"}, "hash": "1b533e6f7d6657d9ccf245bcd183b4a6623ebe2c67e7df1f91e87d5e8ecf40b0", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Regulatory Submissions \u2013 Dataset \nMetadata \n\u2022 Removed the following paragraph as there are now guidelines in the \nMSG v2.0 and the Define-XML v2.1 standard:  \n\"In the event that no records are present in a dataset (e.g., a small PK \nstudy where no subjects took concomitant medications), the empty \ndataset should not be submitted and should not be described in the \nDefine-XML document. The annotated CRF will show the data that \nwould have been submitted had data been received; it need not be re-\nannotated to indicate that no records exist.\"", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 545, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7e3988ae-0ba0-40c4-840b-0d65f98a25e5": {"__data__": {"id_": "7e3988ae-0ba0-40c4-840b-0d65f98a25e5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "4.2 General Variable Assumptions"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "7f42ea25-2d20-479d-a851-e11a7ebcef30", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 453, "section": "4.2 General Variable Assumptions"}, "hash": "a3c0cab5a5d0cfeaaf7f24247c017f25c8c9514bb9a8fcf41e594f367eb04e21", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Added, \"CDISC does not recommend any specific format for the \nvalues of USUBJID, only that the values need to be unique for all \nsubjects in the submission, and across multiple submissions for the \nsame compound. Many sponsors concatenate values for the Study, \nSite and Subject into USUBJID, but this is not a requirement. It is", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 331, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "49ea0a44-1b86-4582-b98e-c9dbf90216a4": {"__data__": {"id_": "49ea0a44-1b86-4582-b98e-c9dbf90216a4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.4 Actual and Relative Time Assumptions"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1ae502f1-b57f-45ad-8c63-d88edec4926f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.4 Actual and Relative Time Assumptions"}, "hash": "c6423aacf1753b2e111f27e08f114dde474aaab3cd6921e7537ae34756cdf62d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Updated values for unknown from U to UNKNOWN to reflect changes \nin controlled terminology. \n\u2022 Clarified that if the reference time point corresponds to or is prior to \nthe date of collection or assessment that it can be unknown by adding \n\"can be\". \n\u2022 Text was clarified to note that --STDTC is not used in Findings class \ndomains \n\u2022 the use of --DRVFL was clarified", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 369, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e4f09c23-f037-4354-9c61-2fc3e1c711cb": {"__data__": {"id_": "e4f09c23-f037-4354-9c61-2fc3e1c711cb", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.5 Original and Standardized Results"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "581d55a6-14c8-4fd2-b318-fd118d719471", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.5 Original and Standardized Results"}, "hash": "2019da42bd4af114bc70b76f57e962d4836f3849d486aa8ae88a08320b6c25d8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Clarified description of when to use the derived flag (\u2013DRVFL). \n\u2022 Two QRS exceptions were added to Section 4.5.1.2 noting that \nregulatory agencies may require a record for all items on the CRF and \nthat --REASND will be populated for QRS logically skipped items. \n\u2022 Example 3 in Section 4.5.3.2, the value of IDVARVAL was corrected \nin supppr.xpt. \n\u2022 Promoted the concept --CLSIG to an SDTM variable. \n\u2022 Clarified the use of --REASPF in Findings domains, --REAS in \nInterventions/Events, and --REASOC for pre-specified \nEvents/Interventions. \n\u2022 Changed the description of --REASOC to reflect its promotion to a \nstandard variable. \n\u2022 Added text describing representation of pre-specified groups of \ninterventions or events in --TRT or --TERM, respectively.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 760, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "70b1f75b-86a6-488f-b81a-aea1224ed1a5": {"__data__": {"id_": "70b1f75b-86a6-488f-b81a-aea1224ed1a5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.1 General Domain Assumptions"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "76ef005e-8281-4cdd-b0c6-d0f7232a253c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "4.1 General Domain Assumptions"}, "hash": "7934a34f19cf01f164147cdb2861f8039e54fc1aae37bac07556aa46499c82f4", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 QRS Examples for splitting questionnaires were updated. \n\u2022 Origin Metadata traceability was clarified. \nSection 5. Models for Special-purpose Domains \n5 \nModels for Special-purpose Domains \n\u2022 All SDTMIG v3.4 metadata specifications (under Controlled Terms, \nCodelist or Format column) have been updated to reflect ISO 8601 \ngranularity (e.g., \"ISO 8601 datetime or interval\" or \"ISO 8601 \nduration\"), where applicable. This also aligns to the updates made in \nSDTM v2.0.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 472, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "09877178-09dd-443a-9a44-3c2e8f7cde77": {"__data__": {"id_": "09877178-09dd-443a-9a44-3c2e8f7cde77", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "5.1 Comments (CO)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1a8548d5-5e01-4e8d-8c2b-f86719163755", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "5.1 Comments (CO)"}, "hash": "38e993fbf28ea55fab4a242ebd09219811b9126e33aa40fb044edcdd98fb9374", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Assumption 2 was added to explain the difference between the \nstructure of the Comments domain in the SDTM and the SDTMIG. \n\u2022 VISIT, VISITNUM, and VISITDY have been removed from the list of \ngenerally not used variables in CO Assumptions #5. \n\u2022 Clarity was added to Assumption 1 regarding adverse events and \nclinical events", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 326, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b6f869a1-fa5c-470e-9c4e-9e490e27db41": {"__data__": {"id_": "b6f869a1-fa5c-470e-9c4e-9e490e27db41", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "5.2 Demographics (DM)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "74c4fa35-756a-4fce-9a6d-a95a3206c06f", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 454, "section": "5.2 Demographics (DM)"}, "hash": "dbe173bb1a093a8bc41a3f086c9ffcf1515de90c61428d30f53b542d7a1990d1", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Revised DM.COUNTRY CDISC Notes to include \"Generally \nrepresented using ISO 3166-1 Alpha-3. However, please be advised \nthat regulatory agency specific requirements may differ (e.g., U.S. \nFDA), in which, those need to be followed.\"  We removed the ISO \n3166-1 Alpha-3 format from the Controlled Terms column as we \nbecame aware of the varied national requirements for this \nterminology. \n\u2022 Assumption 6 was updated to include cases where race self-\nidentification can also correspond to \"Unknown\" (e.g., a refugee, was \nadopted, or cases where this information was not available). \n\u2022 Updated assumption 6a to reference the Racec-Ethnicc Codetable \navailable at https://www.cdisc.org/standards/terminology/controlled-\nterminology. \n\u2022 Extensive updates occurred with DM examples. Previous DM \nExamples 2, 3, 4, 5, 8 and 10 were removed; Current Examples 4 thru", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 861, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "363cf67f-a4ad-4c15-92f0-ee91e1b65fd5": {"__data__": {"id_": "363cf67f-a4ad-4c15-92f0-ee91e1b65fd5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "5.5 Subject Visits (SV)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ce584bb2-c431-4af9-9e30-17f4589b697c", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "5.5 Subject Visits (SV)"}, "hash": "0632add1fc21987ac4f507517749cf9d1ba143dd5458ec3f8374479d6bba591f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 This domain had been considered for moving to Events, but the \ndecision after public review was to keep it as a Subject Visits domain \nat this time. \n\u2022 Now contains visits that did not occur as well as those that did occur \n\u2022 Information was added about contacts with subjects which may not \nhave been designated as \"visits\" in the protocol \n\u2022 New variables were added:  SVPRESP, SVOCCUR, SVREASOC, \nSVCNTMOD, SVEPCHGI \nSection 6. Domain Models Based on the General Observation Classes", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 487, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bc4e36c9-3a7a-40b5-8802-f1e2797829f4": {"__data__": {"id_": "bc4e36c9-3a7a-40b5-8802-f1e2797829f4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.1.3 Exposure Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "38df8e15-792e-411c-8293-8fb13275554a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.1.3 Exposure Domains"}, "hash": "65a7be1fa62eb679670918bed28e804a6659f5bc3397442c37372db90c7c4b98", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 EX assumptions were updated to note that since EX includes only \ntreatments received, --MOOD would generally not be used in EX. \n\u2022 ECREASOC was added, as this was promoted from a supplemental \nqualifier to a standard variable. An assumption was added to EC to \ndescribe the use of ECREASOC and some examples were updated to \nreflect this.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 340, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "bb3b1534-bfc7-43f9-b28b-5cc48119c40f": {"__data__": {"id_": "bb3b1534-bfc7-43f9-b28b-5cc48119c40f", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.1.5 Procedures (PR)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d49960a7-3881-47dd-894b-1fdaa340b827", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.1.5 Procedures (PR)"}, "hash": "36eb5f444100079c63e7dd018ccd85c4b4c887bd7781c9fea965d807b916600b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 PRSEQ's CDISC Notes were updated to reflect that Sequence \nNumber is given to ensure uniqueness of subject records within a \ndomain and that it may be any valid number. \n\u2022 Added CT reference to the procedure codelist (PROCEDUR) for the \nPRDECOD variable. \n\u2022 More explanations were provided in examples to explain why values \nin PRTRT are in mixed case.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 354, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "7be75279-72a5-48f0-8e43-53115ed64ed9": {"__data__": {"id_": "7be75279-72a5-48f0-8e43-53115ed64ed9", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.2.1 Adverse Events (AE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4b1b81ae-94d2-4aaa-8811-1cc911043e3a", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 455, "section": "6.2.1 Adverse Events (AE)"}, "hash": "9036632dcdf05e231135ff89ba3e301a03977e4d4c4adf2f221eab33a6366e25", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 New AE variables for Medical Devices were added:  SPDEVID, \nAEACNDEV, AEUNANT, AERLPRC, AERLPRT, AERLDEV, \nAESINTV. \n\u2022 New Examples 5 and 6 were added to show examples of the new AE \nvariables. \n\u2022 We have deleted AE Assumption 2e as this was superseded by the \naddition of MedDRA coding variables in Amendment 1 to SDTMIG \nv3.1.2 and SDTM v1.2. \n\u2022 Assumption 6, Actions taken, was added.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 389, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "84caa7f0-c9a5-49f0-99f2-736f0d2399e7": {"__data__": {"id_": "84caa7f0-c9a5-49f0-99f2-736f0d2399e7", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3 Models for Findings Domains"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "6ea5f5c6-1dfb-4b57-b9f1-4eb7aa99eae9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3 Models for Findings Domains"}, "hash": "58521c238599f67d40375f605950fee59e544557626774a12265e8c924061d2e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 The BS Domain specification and examples were copied from the \nSDTMIG-PGx, originally published 2015-05-26, to be deprecated with \nthe publication of SDTMIG v3.4. \n\u2022 Assumptions and examples have been updated where used in the \nFindings Domains to reflect that --CLSIG has been promoted to a \nstandard variable. Notes were added to emphasize that the variable is \nabout collected observations.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 395, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "71d61065-7623-4dc7-baf9-0563b4b10bd6": {"__data__": {"id_": "71d61065-7623-4dc7-baf9-0563b4b10bd6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.1 Product Accountability (DA)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "c60fd9ed-145a-4951-b9d2-bd917600cda8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.1 Product Accountability (DA)"}, "hash": "9e49dddbdb1b5880d677fdd92d4640ea8b34a75a66281d09f6d3a882f4352a50", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Revised domain name (and definition) to \"Product Accountability\" \nfrom \"Drug Accountability\". \n\u2022 Added the permissible variables DALNKID and DALNKGRP. \n\u2022 Revised assumptions to describe broadened product accountability \nscope (e.g., drugs, nutrition). \n\u2022 Excluded devices from representation in this domain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 309, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "e9e0f646-07d8-4406-a8c6-833bd666ce30": {"__data__": {"id_": "e9e0f646-07d8-4406-a8c6-833bd666ce30", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.5.2 Biospecimen Findings (BS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "4216e4eb-e5eb-4db5-baf7-aa111da14c00", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.5.2 Biospecimen Findings (BS)"}, "hash": "bd17c69c9d30e8a25cb7198ad35748b0f79aa115c9aee6880c9f066ffce01898", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 This is newly copied from SDTMIG-PGx, with only minor corrections \n(e.g., typos). SDTMIG-PGx, originally published 2015-05-26, is to be \ndeprecated with the publication of SDTMIG v3.4. \n\u2022 Row 5 has been removed as well as the reference to the Maycox \npaper because these are out of date and may be incorrect.  It would \ncause confusion to leave it in.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 353, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "ebd520d3-b4eb-47fb-af15-3adc59174c75": {"__data__": {"id_": "ebd520d3-b4eb-47fb-af15-3adc59174c75", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.5.5 Immunogenicity Specimen Assessments"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "b11c04ae-d94b-43a3-bdd1-d10080e96ebf", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 456, "section": "6.3.5.5 Immunogenicity Specimen Assessments"}, "hash": "e15cfb097511b70a38bf5440b6f799b1ec0d055f19cdf0d1f07ffcdef167c32d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(IS) \n\u2022 The domain definition has been updated. Note, however, that the \ndefinition will be finalized through the Controlled Terminology process, \nand the final definition may change from that shown here. \n\u2022 Added 6 new variables: ISBDAGNT, ISMSCBCE, ISTSTOPO, \nISTSTCND, ISCNDAGT, and NHOID. \n\u2022 Added permissible variables that were previously not included in the \nIS domain specification. \n\u2022 Replaced assumptions from SDTMIG v3.3. \n\u2022 Examples 1 and 2 replaced with new content; Examples 3-11 added.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 500, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "897248a9-dc50-4b49-aba8-152fadeedead": {"__data__": {"id_": "897248a9-dc50-4b49-aba8-152fadeedead", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.3.5.6 Laboratory Test Results (LB)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ce867913-2ac3-4052-a73e-aa31979f7199", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.3.5.6 Laboratory Test Results (LB)"}, "hash": "4a1129af875a7b87c2f34195388a52dfd8982f9d26c8e1af0725963711c57dcb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Revised LBTESTCD variable label to Lab Test or Examination Short \nName.  \n\u2022 Revised Core value for LBSTREFC to Perm (from Exp). \n\u2022 Added new variables: LBTSTCND, LBBDAGNT, \nLBTSTOPO, LBRSLSCL, LBRESTYP, LBCOLSRT, \nLBLLOD, LBTMTHSN, LBCLSIG, LBPTFL, and LBPDUR. \n\u2022 Added permissible variables that were previously not included in the \nLB domain specification: LBSPCUFL, LBANMETH, LBORREF, \nLBSTREFN. \n\u2022 Added hyperlink to Controlled Terminology codelists . \n\u2022 LBORREF, LBSTREFC, and LBSTREFN were removed because \nthere is no clear use case. \n\u2022 Updated several assumptions; added Assumption 8. \n\u2022 Revised Examples 1-3 per changes to variables; added Examples 4 \nand 5 to demonstrate the use of some of the new variables.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 721, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "6051e6c7-2e78-4c8f-bc04-8a5c5fe7b8e6": {"__data__": {"id_": "6051e6c7-2e78-4c8f-bc04-8a5c5fe7b8e6", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.4.1 When to Use Findings About Events or"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ba9dc1b5-5a61-4730-af41-ffd126776388", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.4.1 When to Use Findings About Events or"}, "hash": "7f90d9c5ae3b1992d4c581376404faf4175c54cf00e148f13cbfef8e8a4f63af", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Interventions \n\u2022 Additional explanation and examples were added for each criterion. \n\u2022 The new criterion added in version the underwent the first public \nreview was removed.  The new \"Points to Consider\" section was \nadded. \n\u2022 The third and fourth bullets were dropped as a criterion for \nrepresenting data in FA.  The reasons for dropping these criteria, and \nguidance on how these situations should be approached were added.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 426, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "df43d9a9-16aa-4102-87b3-cbd9d13aa6d8": {"__data__": {"id_": "df43d9a9-16aa-4102-87b3-cbd9d13aa6d8", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.4.4 Findings About Events or Interventions"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3498c175-c3e5-4b1b-ad43-f1307428850e", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 457, "section": "6.4.4 Findings About Events or Interventions"}, "hash": "c12eb2e9961bc71d703f5c0fa1bd229b1c2c0beac6b06b1341c85d8f5d55c145", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "(FA) \n\u2022 The core value for FADTC was changed from \"Perm\" to \"Exp\" for \nconsistency with other Findings domains. \n\u2022 Updated the FATEST and FATESTCD CDISC Notes to refer to the \nFATEST and FATESTCD general codelists, which are expected to be \navailable at time of publication in Nov, 2021. \n\u2022 Added assumption 4.a, referencing the CV Code table. \n\u2022 The example about fracture events (previous Example 4) was \nremoved.  A revised version of the example was added to Section \n6.2.3, Clinical Events. \n\u2022 All Examples and associated CRFs were updated for clarity. \n\u2022 In Example 2, the modeling of numbers of lesions associated with the \nrash was changed to a TEST/TESTCD for a categorical measure of \nthe number of lesions (e.g. \"MACRNG\"/\"Macule Range\" with OBJ = \n\"Injection Site Rash\").  The rationale behind this change was that the \nlesion counts are properties of the rash in the same way that its \nlongest diameter is a property of the rash, so that OBJ should be the \nrash, rather than the name of one of its kinds of component lesions. \n\u2022 In Example 3, symptom occurrence and severity data that was \nrepresented in FA in previous versions of the example was \nrepresented in MH in this version of the example. \no Whether or not there is a record for RA in the MH domain does not \naffect the modeling of the symptoms of RA. \no Average daily duration of early morning stiffness that was \nrepresented in FA in previous versions of the example was \nrepresented in SUPPMH in this version of the example. \n\u2022 One of two similar examples about GERD symptoms was removed. \nThe difference between the previous Example 6 and Example 7 was \nthat Example 6 did not include collection of occurrence of symptoms. \nWithout collection of occurrence, there would be no records for \nsymptoms that did not occur, and no indication that these terms were \npre-specified. The form that collects occurrence is preferable as it is \nmore explicit. Added mock eCRF modules. Other variables were", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1968, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "23655168-60e7-4e0e-9284-d05f20aca781": {"__data__": {"id_": "23655168-60e7-4e0e-9284-d05f20aca781", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "6.4.5 Skin Response (SR)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "3bbdeba5-f3a4-4835-8b71-7746d59293c8", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "6.4.5 Skin Response (SR)"}, "hash": "b03bcc2466ffd275a02f29f6ad4fba36ac9fbcff2bcc69098855b0e984cf87e8", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Updated CDISC Notes for USUBJID to be consistent with other \ndomains. \n\u2022 In Example 1, revised representation of quadrants 1, 2, 3, 4 of the \nback from a supplemental qualifier to FOCID. QUADRANT1-\nQUADRANT4 values were changed to SITE1-SITE8 so each site has \na unique FOCID. \n\u2022 Example 3 was updated per CDISC CT. \nSection 7. Trial Design Model Datasets", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 357, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "47a1f889-3023-44f8-b86c-23b2073a5ef4": {"__data__": {"id_": "47a1f889-3023-44f8-b86c-23b2073a5ef4", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "7.2 Experimental Design (TA and TE)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "d54ea398-3832-4835-8095-c0d8dbf16de0", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "7.2 Experimental Design (TA and TE)"}, "hash": "daec8872ad9f1334db37651fc376725b8b43b85d4c2c5df1d1e6bdfbbdfb0cf7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Text about executable code in Section 7.2.1.1 was replaced to note \nthat it is expected that a mechanism to provide machine-readable rules \nwill become available in the future. \n\u2022 Aligned wording for Rule variables on CDISC Notes between TA \nand TE. \n\u2022 The name of the dataset in the Section 7.2.2.1 example was \nchanged from \"ta.xpt\" to \"special.xpt\" since, as explained in the text, this \nis a dataset that would not be submitted and is not based on the TA \ndomain.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 469, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "a84e826a-5cea-4797-a050-0f75d449aec3": {"__data__": {"id_": "a84e826a-5cea-4797-a050-0f75d449aec3", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "7.4.2 Trial Summary (TS)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "99e79fd2-7517-44b4-ac93-fa99dc4d26d9", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 458, "section": "7.4.2 Trial Summary (TS)"}, "hash": "fe327240be7b918d45c4afa246ac47c3b6403e69689219efe60b883e4522568a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 Changed the CDISC Notes for TSSEQ to reflect that the sequence \nnumber is to ensure uniqueness within a parameter. \n\u2022 Revisions to most TS assumptions to remove references to \nAppendix C1, Trial Summary Codes, as this appendix was removed. \nAssumptions were replaced with ones that note recipients may specify \nrequirements and terminology. A reference was added for the TS \nCodetable on the CDISC website. \n\u2022 Revised TS Assumption 17 to clarify the value expectations for \nTSPARMCD = \"INDIC\" for the two example use cases that are \ndescribed. \n\u2022 Additional assumptions revised for clarity; information added about \nexploratory outcome measures. \n\u2022 Examples 1-3 were revised per changes in assumptions. \n\u2022 New content was added to Example 4 to show the use of TSGRPID \nfor study parts and treatments. \nSection 8. Representing Relationships and Data \n8 \nRepresenting Relationships and Data \n\u2022 Section 8.8, Related Specimens, was added due to BE, BS, and \nRELSPEC being copied in from the SDTMIG-PGx, originally \npublished 2015-05-26, to be deprecated with the publication of \nSDTMIG v3.4.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1089, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "237c9d01-f4a4-4062-aa99-8759a3258ba0": {"__data__": {"id_": "237c9d01-f4a4-4062-aa99-8759a3258ba0", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 459, "section": "8.6.3 Guidelines for Differentiating Between"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "a412e7eb-0d6a-4655-a2e1-fdac112f27bc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 459, "section": "8.6.3 Guidelines for Differentiating Between"}, "hash": "add9955ae472f95b5795472d8c22fb9ea28f750ddc4980049cd7be65c22c3ee7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Interventions, Events, Findings, and \nFindings About Events or Interventions \n\u2022 \"Interventions\" added to section title. \n\u2022 Some changes to text to correct typos and clarify wording. \n\u2022 The second column of the second row of the table was revised to \nexplain what a log form is and to clarify how the data collection format \nmay help to understand the general observation class of data \ncollected. \n\u2022 Added a row to the table to help in deciding between QS and FA for \ndata about symptoms. \n\u2022 Reordered sentences in paragraph after the table and reiterated \nreference to AE structure assumption.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 594, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "34ef93f8-cfdf-4d83-a827-bb7d36dcdaed": {"__data__": {"id_": "34ef93f8-cfdf-4d83-a827-bb7d36dcdaed", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 459, "section": "8.8 Related Specimens (RELSPEC)"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "ac318338-13ed-41d2-a783-42df447ea166", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 459, "section": "8.8 Related Specimens (RELSPEC)"}, "hash": "a6199a088d50571749c599ffb4273ab7c7c76283b2f3a9beb0f9789fb04c9325", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "\u2022 This section was added to SDTMIG v3.4 in preparation for the \neventual retirement of the SDTMIG-PGx, originally published 2015-\n05-26, to be deprecated with the publication of SDTMIG v3.4. \nSection 9. Study References \n \n \n\u2022  \n \n \n\u2022  \n \n \n\u2022  \n \n \n\u2022  \n \n \n\u2022  \n \n \n\u2022  \n \n \n\u2022  \n \n \n\u2022  \n \n \n\u2022  \n \n \n\u2022  \n \n \nSection \nNumber \nSection \nName \nChange \n9 \nStudy \nReferences \n\u2022 \nRemoved \"Identifiers for pharmacogenomic/genetic biomarkers\" from the list, \nand deleted Section 9.3 PB was part of SDTMIG-PGx. SDTMIG-PGx, \noriginally published 2015-05-26, is to be deprecated with the publication of \nSDTMIG v3.4. \nAppendices \n \nSection \nNumber \nSection Name \nChange \nAppendix \nA \nCDISC SDS Team The team list has been updated. \nAppendix \nC \nControlled \nTerminology \n\u2022 \nAppendix C1 Trial Summary Codes has been removed from SDTMIG \nv3.4. TS Assumptions were updated to reference CDISC controlled \nterminology, CDISC TS codetable, and recipient (regulatory agency) \nimplementation expectations. \n\u2022 \nRemoved --CLSIG due to promotion as a Findings variable \n\u2022 \nAdded --REASOC \n\u2022 \nAll references to Appendix C2 in the SDTMIG were changed to \nAppendix C1", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1137, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "b96527d5-9fd5-4b94-8663-1327a4b815c5": {"__data__": {"id_": "b96527d5-9fd5-4b94-8663-1327a4b815c5", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 460, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "32df3d74-c677-4e4e-9b11-e1a719b7a1bc", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 460, "section": "UNSPECIFIED"}, "hash": "cb0f57b71ab2a65d15f6013d4ccba4e9f07130894e212f3d4547907b7a3bcf9e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 460 \n2021-11-29 \nAppendix \nD \nCDISC Variable-\nnaming Fragments \n\u2022 \n\"V3.x dataset\" was replaced with \"Findings dataset\" because the V3.x \nterminology was somewhat confusing and is being phased out. \nAppendix \nE \nThis appendix \n\u2022 \nThis appendix was updated to reflect an overview of changes from \nSDTMIG v3.3 to SDTMIG v3.4.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 501, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "37f00e35-f698-4aaf-848d-df38e71e6913": {"__data__": {"id_": "37f00e35-f698-4aaf-848d-df38e71e6913", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 461, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1d479855-bc36-4d95-b5dc-04d096634c6d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 461, "section": "UNSPECIFIED"}, "hash": "9571aee60938b99f5a47b5f4e4ed475311bd5a50b773ea3b74598fc35cc9abc5", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "18b6362b-1019-48a3-8134-097aaa900b65", "node_type": "1", "metadata": {}, "hash": "cab49ac33b1360f0d865e3899eb282579225ff5f2839901f43b8d52fda5f317f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "CDISC Study Data Tabulation Model Implementation Guide: Human Clinical Trials (3.4 Final) \n\u00a9 2021 Clinical Data Interchange Standards Consortium, Inc. All rights reserved  \n Page 461 \n2021-11-29 \nAppendix F: Representations and Warranties, Limitations of \nLiability, and Disclaimers \nCDISC Patent Disclaimers \nIt is possible that implementation of and compliance with this standard may require use of subject matter covered by \npatent rights. By publication of this standard, no position is taken with respect to the existence or validity of any \nclaim or of any patent rights in connection therewith. CDISC, including the CDISC Board of Directors, shall not be \nresponsible for identifying patent claims for which a license may be required in order to implement this standard or \nfor conducting inquiries into the legal validity or scope of those patents or patent claims that are brought to its \nattention. \n \nRepresentations and Warranties \n\u201cCDISC grants open public use of this User Guide (or Final Standards) under CDISC\u2019s copyright.\u201d  \n \nEach Participant in the development of this standard shall be deemed to represent, warrant, and covenant, at the time \nof a Contribution by such Participant (or by its Representative), that to the best of its knowledge and ability: (a) it \nholds or has the right to grant all relevant licenses to any of its Contributions in all jurisdictions or territories in \nwhich it holds relevant intellectual property rights; (b) there are no limits to the Participant\u2019s ability to make the \ngrants, acknowledgments, and agreements herein; and (c) the Contribution does not subject any Contribution, Draft \nStandard, Final Standard, or implementations thereof, in whole or in part, to licensing obligations with additional \nrestrictions or requirements inconsistent with those set forth in this Policy, or that would require any such \nContribution, Final Standard, or implementation, in whole or in part, to be either: (i) disclosed or distributed in \nsource code form; (ii) licensed for the purpose of making derivative works (other than as set forth in Section 4.2 of \nthe CDISC Intellectual Property Policy (\u201cthe Policy\u201d)); or (iii) distributed at no charge, except as set forth in \nSections 3, 5.1, and 4.2 of the Policy. If a Participant has knowledge that a Contribution made by any Participant or \nany other party may subject any Contribution, Draft Standard, Final Standard, or implementation, in whole or in \npart, to one or more of the licensing obligations listed in Section 9.3, such Participant shall give prompt notice of the \nsame to the CDISC President who shall promptly notify all Participants. \n \nNo Other Warranties/Disclaimers. ALL PARTICIPANTS ACKNOWLEDGE THAT, EXCEPT AS PROVIDED \nUNDER SECTION 9.3 OF THE CDISC INTELLECTUAL PROPERTY POLICY, ALL DRAFT STANDARDS \nAND FINAL STANDARDS, AND ALL CONTRIBUTIONS TO FINAL STANDARDS AND DRAFT \nSTANDARDS, ARE PROVIDED \u201cAS IS\u201d WITH NO WARRANTIES WHATSOEVER, WHETHER EXPRESS, \nIMPLIED, STATUTORY, OR OTHERWISE, AND THE PARTICIPANTS, REPRESENTATIVES, THE CDISC \nPRESIDENT, THE CDISC BOARD OF DIRECTORS, AND CDISC EXPRESSLY DISCLAIM ANY \nWARRANTY OF MERCHANTABILITY, NONINFRINGEMENT, FITNESS FOR ANY PARTICULAR OR \nINTENDED PURPOSE, OR ANY OTHER WARRANTY OTHERWISE ARISING OUT OF ANY PROPOSAL, \nFINAL STANDARDS OR DRAFT STANDARDS, OR CONTRIBUTION.", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 3342, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}, "18b6362b-1019-48a3-8134-097aaa900b65": {"__data__": {"id_": "18b6362b-1019-48a3-8134-097aaa900b65", "embedding": null, "metadata": {"source": "SDTMIG v3.4", "page": 461, "section": "UNSPECIFIED"}, "excluded_embed_metadata_keys": [], "excluded_llm_metadata_keys": [], "relationships": {"1": {"node_id": "1d479855-bc36-4d95-b5dc-04d096634c6d", "node_type": "4", "metadata": {"source": "SDTMIG v3.4", "page": 461, "section": "UNSPECIFIED"}, "hash": "9571aee60938b99f5a47b5f4e4ed475311bd5a50b773ea3b74598fc35cc9abc5", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "37f00e35-f698-4aaf-848d-df38e71e6913", "node_type": "1", "metadata": {"source": "SDTMIG v3.4", "page": 461, "section": "UNSPECIFIED"}, "hash": "7cf706756f4ef5ed296ad47b47880767d3db9a26eaefdac844cffc16824d8a61", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "No Other Warranties/Disclaimers. ALL PARTICIPANTS ACKNOWLEDGE THAT, EXCEPT AS PROVIDED \nUNDER SECTION 9.3 OF THE CDISC INTELLECTUAL PROPERTY POLICY, ALL DRAFT STANDARDS \nAND FINAL STANDARDS, AND ALL CONTRIBUTIONS TO FINAL STANDARDS AND DRAFT \nSTANDARDS, ARE PROVIDED \u201cAS IS\u201d WITH NO WARRANTIES WHATSOEVER, WHETHER EXPRESS, \nIMPLIED, STATUTORY, OR OTHERWISE, AND THE PARTICIPANTS, REPRESENTATIVES, THE CDISC \nPRESIDENT, THE CDISC BOARD OF DIRECTORS, AND CDISC EXPRESSLY DISCLAIM ANY \nWARRANTY OF MERCHANTABILITY, NONINFRINGEMENT, FITNESS FOR ANY PARTICULAR OR \nINTENDED PURPOSE, OR ANY OTHER WARRANTY OTHERWISE ARISING OUT OF ANY PROPOSAL, \nFINAL STANDARDS OR DRAFT STANDARDS, OR CONTRIBUTION. \n \nLimitation of Liability \nIN NO EVENT WILL CDISC OR ANY OF ITS CONSTITUENT PARTS (INCLUDING, BUT NOT LIMITED \nTO, THE CDISC BOARD OF DIRECTORS, THE CDISC PRESIDENT, CDISC STAFF, AND CDISC \nMEMBERS) BE LIABLE TO ANY OTHER PERSON OR ENTITY FOR ANY LOSS OF PROFITS, LOSS OF \nUSE, DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR SPECIAL DAMAGES, WHETHER \nUNDER CONTRACT, TORT, WARRANTY, OR OTHERWISE, ARISING IN ANY WAY OUT OF THIS \nPOLICY OR ANY RELATED AGREEMENT, WHETHER OR NOT SUCH PARTY HAD ADVANCE NOTICE \nOF THE POSSIBILITY OF SUCH DAMAGES. \n \nNote: The CDISC Intellectual Property Policy can be found at  \nhttp://www.cdisc.org/system/files/all/article/application/pdf/cdisc_20ip_20policy_final.pdf", "mimetype": "text/plain", "start_char_idx": 2650, "end_char_idx": 4046, "metadata_seperator": "\n", "text_template": "{metadata_str}\n\n{content}", "class_name": "TextNode"}, "__type__": "1"}}}